PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Medlyn, BE				Medlyn, Belinda E.			Comment on "Drought-Induced Reduction in Global Terrestrial Net Primary Production from 2000 Through 2009"	SCIENCE			English	Editorial Material							SEVERITY INDEX; RESPIRATION; ACCLIMATION; VEGETATION	Zhao and Running (Reports, 20 August 2010, p. 940) reported that global net primary production has declined over the past decade and that this reduction was caused by drought. However, their findings are not direct measurements, but rather are based on outcomes from models in which a strong temperature dependence is assumed. I examine the assumptions underlying their results and show that their findings can be explained as logical consequences of these assumptions.	Macquarie Univ, Dept Biol Sci, N Ryde, NSW 2109, Australia	Macquarie University	Medlyn, BE (corresponding author), Macquarie Univ, Dept Biol Sci, N Ryde, NSW 2109, Australia.	belinda.medlyn@mq.edu.au	Myneni, Ranga B./AAU-6088-2021; Vieira, Simone/H-1225-2011; Myneni, Ranga B/F-5129-2012; Xu, Liang/D-1247-2013; Vieira, Sabrina Nunes/X-1702-2018; Medlyn, Belinda/O-5038-2019	Vieira, Simone/0000-0002-0129-4181; Myneni, Ranga B/0000-0002-0234-6393; Medlyn, Belinda/0000-0001-5728-9827				ALLEY WM, 1984, J CLIM APPL METEOROL, V23, P1100, DOI 10.1175/1520-0450(1984)023<1100:TPDSIL>2.0.CO;2; Atkin OK, 2005, FUNCT PLANT BIOL, V32, P87, DOI 10.1071/FP03176; Atkin OK, 2008, GLOBAL CHANGE BIOL, V14, P2709, DOI 10.1111/j.1365-2486.2008.01664.x; Atkin OK, 2009, ANN BOT-LONDON, V103, P581, DOI 10.1093/aob/mcn094; Crous KY, 2011, GLOBAL CHANGE BIOL, V17, P1560, DOI 10.1111/j.1365-2486.2010.02325.x; Hu Q, 2000, INT J CLIMATOL, V20, P1899, DOI 10.1002/1097-0088(200012)20:15&lt;1899::AID-JOC588&gt;3.0.CO;2-M; Tjoelker MG, 2001, GLOBAL CHANGE BIOL, V7, P223, DOI 10.1046/j.1365-2486.2001.00397.x; Zhao MS, 2010, SCIENCE, V329, P940, DOI [10.1126/science.1192666, 10.1126/science.1189590]	8	93	96	2	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 26	2011	333	6046								10.1126/science.1199544	http://dx.doi.org/10.1126/science.1199544			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811VM	21868654				2022-12-28	WOS:000294244300024
J	Samanta, A; Costa, MH; Nunes, EL; Vieira, SA; Xu, L; Myneni, RB				Samanta, Arindam; Costa, Marcos H.; Nunes, Edson L.; Vieira, Simone A.; Xu, Liang; Myneni, Ranga B.			Comment on "Drought-Induced Reduction in Global Terrestrial Net Primary Production from 2000 Through 2009"	SCIENCE			English	Editorial Material							FOREST	Zhao and Running (Reports, 20 August 2010, p. 940) reported a reduction in global terrestrial net primary production (NPP) from 2000 through 2009. We argue that the small trends, regional patterns, and interannual variations that they describe are artifacts of their NPP model. Satellite observations of vegetation activity show no statistically significant changes in more than 85% of the vegetated lands south of 70 degrees N during the same 2000 to 2009 period.	[Samanta, Arindam; Xu, Liang; Myneni, Ranga B.] Boston Univ, Dept Geog & Environm, Boston, MA 02215 USA; [Samanta, Arindam] Atmospher & Environm Res Inc, Lexington, MA 02421 USA; [Costa, Marcos H.; Nunes, Edson L.] Univ Fed Vicosa, BR-36570000 Vicosa, MG, Brazil; [Vieira, Simone A.] Univ Estadual Campinas, UNICAMP, BR-13083867 Campinas, SP, Brazil	Boston University; Atmospheric & Environmental Research; Universidade Federal de Vicosa; Universidade Estadual de Campinas	Samanta, A (corresponding author), Boston Univ, Dept Geog & Environm, Boston, MA 02215 USA.	arindam.sam@gmail.com	Myneni, Ranga B./AAU-6088-2021; Vieira, Simone/H-1225-2011; Myneni, Ranga B/F-5129-2012; Xu, Liang/D-1247-2013; Vieira, Sabrina Nunes/X-1702-2018; Medlyn, Belinda/O-5038-2019	Vieira, Simone/0000-0002-0129-4181; Myneni, Ranga B/0000-0002-0234-6393; Medlyn, Belinda/0000-0001-5728-9827				ARAGAO L. E. O. C., 2009, BIOGEOSCIENCES, V6, P2441, DOI [DOI 10.5194/BGD-6-2441-2009, DOI 10.5194/BG-6-2759-2009]; Ciais P, 2005, NATURE, V437, P529, DOI 10.1038/nature03972; Llovel W, 2010, CR GEOSCI, V342, P179, DOI 10.1016/j.crte.2009.12.004; Myneni RB, 1997, NATURE, V386, P698, DOI 10.1038/386698a0; MYNENI RB, 1995, IEEE T GEOSCI REMOTE, V33, P481, DOI 10.1109/36.377948; Nemani RR, 2003, SCIENCE, V300, P1560, DOI 10.1126/science.1082750; Phillips OL, 2009, SCIENCE, V323, P1344, DOI 10.1126/science.1164033; Samanta A, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL042154; TUCKER CJ, 1986, NATURE, V319, P195, DOI 10.1038/319195a0; Turner DP, 2006, REMOTE SENS ENVIRON, V102, P282, DOI 10.1016/j.rse.2006.02.017; Vieira S, 2004, OECOLOGIA, V140, P468, DOI 10.1007/s00442-004-1598-z; Zhao MS, 2010, SCIENCE, V329, P940, DOI [10.1126/science.1192666, 10.1126/science.1189590]; Zhao MS, 2005, REMOTE SENS ENVIRON, V95, P164, DOI 10.1016/j.rse.2004.12.011; [No title captured]; [No title captured]	15	93	96	2	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 26	2011	333	6046								10.1126/science.1199048	http://dx.doi.org/10.1126/science.1199048			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811VM	21868654				2022-12-28	WOS:000294244300023
J	Mori, R; Takemi, K; Fineberg, HV				Mori, Rintaro; Takemi, Keizo; Fineberg, Harvey V.			Science and consensus for health policy making in Japan	LANCET			English	Editorial Material									[Mori, Rintaro] Univ Tokyo, Grad Sch Med, Dept Global Hlth Policy, Bunkyo Ku, Tokyo 1130033, Japan; [Takemi, Keizo] Tokai Univ, Sch Polit Sci & Econ, Hiratsuka, Kanagawa 25912, Japan; [Fineberg, Harvey V.] Natl Acad Sci, Inst Med, Washington, DC 20418 USA	University of Tokyo; Tokai University; National Academies of Sciences, Engineering & Medicine	Mori, R (corresponding author), Univ Tokyo, Grad Sch Med, Dept Global Hlth Policy, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	rintaromori@gmail.com		Mori, Rintaro/0000-0001-7656-6156				Chalkidou K, 2009, MILBANK Q, V87, P339, DOI 10.1111/j.1468-0009.2009.00560.x; Dobrow MJ, 2004, SOC SCI MED, V58, P207, DOI 10.1016/S0277-9536(03)00166-7; EXTER A, 2004, HLTH CARE SYSTEMS TR; Ikegami N, 2011, LANCET, V378, P1106, DOI 10.1016/S0140-6736(11)60828-3; Niessen LW, 2000, SOC SCI MED, V51, P859, DOI 10.1016/S0277-9536(00)00066-6	5	5	5	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 7	2012	379	9810					12	13		10.1016/S0140-6736(11)60820-9	http://dx.doi.org/10.1016/S0140-6736(11)60820-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	873WC	21885108				2022-12-28	WOS:000298913000012
J	Bailes, M; Bates, SD; Bhalerao, V; Bhat, NDR; Burgay, M; Burke-Spolaor, S; D'Amico, N; Johnston, S; Keith, MJ; Kramer, M; Kulkarni, SR; Levin, L; Lyne, AG; Milia, S; Possenti, A; Spitler, L; Stappers, B; van Straten, W				Bailes, M.; Bates, S. D.; Bhalerao, V.; Bhat, N. D. R.; Burgay, M.; Burke-Spolaor, S.; D'Amico, N.; Johnston, S.; Keith, M. J.; Kramer, M.; Kulkarni, S. R.; Levin, L.; Lyne, A. G.; Milia, S.; Possenti, A.; Spitler, L.; Stappers, B.; van Straten, W.			Transformation of a Star into a Planet in a Millisecond Pulsar Binary	SCIENCE			English	Article							NEUTRON-STAR; PSR J2051-0827; RADIO PULSAR; WHITE-DWARF; DISCOVERY; MASS; COMPANION; EVOLUTION; SYSTEM; DONORS	Millisecond pulsars are thought to be neutron stars that have been spun-up by accretion of matter from a binary companion. Although most are in binary systems, some 30% are solitary, and their origin is therefore mysterious. PSR J1719-1438, a 5.7-millisecond pulsar, was detected in a recent survey with the Parkes 64-meter radio telescope. We show that this pulsar is in a binary system with an orbital period of 2.2 hours. The mass of its companion is near that of Jupiter, but its minimum density of 23 grams per cubic centimeter suggests that it may be an ultralow-mass carbon white dwarf. This system may thus have once been an ultracompact low-mass x-ray binary, where the companion narrowly avoided complete destruction.	[Bailes, M.; Bhat, N. D. R.; Levin, L.; Spitler, L.; van Straten, W.] Swinburne Univ Technol, Ctr Astrophys & Supercomp, Hawthorn, Vic 3122, Australia; [Bailes, M.; Bhat, N. D. R.; Levin, L.; Spitler, L.; van Straten, W.] Swinburne Univ Technol, ARC Ctr All Sky Astrophys CAASTRO, Hawthorn, Vic 3122, Australia; [Bailes, M.] Univ Calif Berkeley, Dept Astron, Berkeley, CA 94720 USA; [Bates, S. D.; Kramer, M.; Lyne, A. G.; Stappers, B.] Univ Manchester, Jodrell Bank Ctr Astrophys, Sch Phys & Astron, Manchester M13 9PL, Lancs, England; [Bhalerao, V.; Kulkarni, S. R.] CALTECH, Caltech Opt Observ, Pasadena, CA 91125 USA; [Burgay, M.; D'Amico, N.; Milia, S.; Possenti, A.] Osservatorio Astron Cagliari, Ist Nazl Astrofis, I-09012 Capoterra, Italy; [Burke-Spolaor, S.; Johnston, S.; Keith, M. J.; Levin, L.] Commonwealth Sci & Ind Res Org CSIRO Astron & Spa, Australia Telescope Natl Facil, Epping, NSW 1710, Australia; [Kramer, M.] Max Planck Inst Radioastron, D-53121 Bonn, Germany; [D'Amico, N.; Milia, S.] Univ Cagliari, Dipartimento Fis, I-09042 Monserrato, CA, Italy	Swinburne University of Technology; Swinburne University of Technology; University of California System; University of California Berkeley; University of Manchester; Jodrell Bank Centre for Astrophysics; California Institute of Technology; Istituto Nazionale Astrofisica (INAF); Commonwealth Scientific & Industrial Research Organisation (CSIRO); Max Planck Society; University of Cagliari	Bailes, M (corresponding author), Swinburne Univ Technol, Ctr Astrophys & Supercomp, POB 218, Hawthorn, Vic 3122, Australia.	mbailes@swin.edu.au	Keith, Michael/AAH-2606-2019; Bhalerao, Varun/AAC-1467-2022; D'Amico, Nichi/A-5715-2009; Johnston, Simon/AAW-8490-2020; Bhat, Ramesh/B-7396-2013	Keith, Michael/0000-0001-5567-5492; Bhalerao, Varun/0000-0002-6112-7609; Johnston, Simon/0000-0002-7122-4963; Bailes, Matthew/0000-0003-3294-3081; van Straten, Willem/0000-0003-2519-7375; Bhat, Ramesh/0000-0002-8383-5059; Milia, Sabrina/0000-0002-1110-5882; Spolaor, Sarah/0000-0003-4052-7838; Levin Preston, Lina/0000-0002-2034-2986; Burgay, Marta/0000-0002-8265-4344; Spitler, Lee/0000-0001-5185-9876; Kramer, Michael/0000-0002-4175-2271	Commonwealth of Australia; ARC [DP0985270, DP1094370, CE110001020]; Science and Technologies Facilities Council; STFC [ST/G002487/1, ST/F002874/1] Funding Source: UKRI; Direct For Mathematical & Physical Scien [1009987] Funding Source: National Science Foundation; Science and Technology Facilities Council [ST/G002487/1, ST/F002874/1] Funding Source: researchfish	Commonwealth of Australia(Australian Government); ARC(Australian Research Council); Science and Technologies Facilities Council; STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	The Parkes Observatory is part of the Australia Telescope, which is funded by the Commonwealth of Australia for operation as a National Facility managed by CSIRO. This project is supported by the ARC Programmes under grants DP0985270, DP1094370, and CE110001020. Access to the Lovell telescope is funded through a Science and Technologies Facilities Council rolling grant. Keck telescope time is made available through a special collaborative program between Swinburne Univ. of Technology and California Institute of Technology. We are grateful to J. Roy and Y. Gupta for early attempts to obtain a pulsar position with the Giant Metrewave Radio Telescope.	BHATTACHARYA D, 1991, PHYS REP, V203, P1, DOI 10.1016/0370-1573(91)90064-S; BONSEMA PFJ, 1985, ASTRON ASTROPHYS, V146, pL3; CAMILO F, 1994, ASTROPHYS J, V421, pL15, DOI 10.1086/187176; Deloye CJ, 2003, ASTROPHYS J, V598, P1217, DOI 10.1086/379063; Demorest PB, 2010, NATURE, V467, P1081, DOI 10.1038/nature09466; Edwards RT, 2001, MON NOT R ASTRON SOC, V326, P358, DOI 10.1046/j.1365-8711.2001.04637.x; FRANK J, 1985, ACCRETION POWER ASTR; FRUCHTER AS, 1988, NATURE, V333, P237, DOI 10.1038/333237a0; Galloway DK, 2002, ASTROPHYS J, V576, pL137, DOI 10.1086/343841; GRINDLAY JE, 1988, NATURE, V336, P48, DOI 10.1038/336048a0; Hansen BMS, 2009, ASTROPHYS J, V691, P382, DOI 10.1088/0004-637X/691/1/382; Hessels JWT, 2006, SCIENCE, V311, P1901, DOI 10.1126/science.1123430; Jacoby BA, 2005, ASTROPHYS J, V629, pL113, DOI 10.1086/449311; Juett AM, 2001, ASTROPHYS J, V560, pL59, DOI 10.1086/324225; Kaspi VM, 2000, ASTROPHYS J, V543, P321, DOI 10.1086/317103; Keith MJ, 2011, MON NOT R ASTRON SOC, V414, P1292, DOI 10.1111/j.1365-2966.2011.18464.x; Keith MJ, 2010, MON NOT R ASTRON SOC, V409, P619, DOI 10.1111/j.1365-2966.2010.17325.x; LAI D, 1991, ASTROPHYS J, V377, P612, DOI 10.1086/170389; PACZYNSKI B, 1971, ANNU REV ASTRON ASTR, V9, P183, DOI 10.1146/annurev.aa.09.090171.001151; PODSIADLOWSKI P, 1993, ASTR SOC P, V36, P149; RASIO FA, 1992, ASTRON ASTROPHYS, V256, pL35; Stappers BW, 1999, ASTROPHYS J, V510, pL45, DOI 10.1086/311795; Stappers BW, 1998, ASTROPHYS J, V499, pL183, DOI 10.1086/311382; Toscano M, 1999, MON NOT R ASTRON SOC, V307, P925, DOI 10.1046/j.1365-8711.1999.02685.x; VANDENHEUVEL EPJ, 1984, ASTRON ASTROPHYS, V139, pL16; VANDENHEUVEL EPJ, 1992, NATURE, V356, P668, DOI 10.1038/356668b0; Verbiest JPW, 2008, ASTROPHYS J, V679, P675, DOI 10.1086/529576; WOLSZCZAN A, 1992, NATURE, V355, P145, DOI 10.1038/355145a0	28	101	103	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 23	2011	333	6050					1717	1720		10.1126/science.1208890	http://dx.doi.org/10.1126/science.1208890			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	823KQ	21868629	Green Submitted			2022-12-28	WOS:000295121500033
J	Oberlander, J				Oberlander, Jonathan			Health Care Policy in an Age of Austerity	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ N Carolina, Chapel Hill, NC 27514 USA	University of North Carolina; University of North Carolina Chapel Hill	Oberlander, J (corresponding author), Univ N Carolina, Chapel Hill, NC 27514 USA.							Aaron HJ, 2011, NEW ENGL J MED, V364, P1588, DOI 10.1056/NEJMp1103764; Frakt AB, 2011, MILBANK Q, V89, P90, DOI 10.1111/j.1468-0009.2011.00621.x; MERLIS M, 2010, ADDING NUMBERS UNDER; MULVEY J, 2011, COMMUNITY LIVING ASS; Oberlander Jonathan, 2003, POLITICAL LIFE MED	5	9	9	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 22	2011	365	12					1075	1077		10.1056/NEJMp1109352	http://dx.doi.org/10.1056/NEJMp1109352			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	822WR	21879889				2022-12-28	WOS:000295081600006
J	Gulledge, J				Gulledge, Jay			Crunch time for US science	NATURE			English	Editorial Material									[Gulledge, Jay] Pew Ctr Global Climate Change, Arlington, VA 22201 USA; [Gulledge, Jay] Ctr New Amer Secur, Washington, DC USA		Gulledge, J (corresponding author), Pew Ctr Global Climate Change, Arlington, VA 22201 USA.	gulledgej@pewclimate.org	Gulledge, Jay/G-3252-2010	Gulledge, Jay/0000-0002-9779-8690				Reardon S, 2011, SCIENCE, V333, P688, DOI 10.1126/science.333.6043.688	1	4	4	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 8	2011	477	7363					155	156		10.1038/477155a	http://dx.doi.org/10.1038/477155a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	816MC	21900992				2022-12-28	WOS:000294603900013
J	Tocheva, EI; Matson, EG; Morris, DM; Moussavi, F; Leadbetter, JR; Jensen, GJ				Tocheva, Elitza I.; Matson, Eric G.; Morris, Dylan M.; Moussavi, Farshid; Leadbetter, Jared R.; Jensen, Grant J.			Peptidoglycan Remodeling and Conversion of an Inner Membrane into an Outer Membrane during Sporulation	CELL			English	Article							BACILLUS-SUBTILIS; SPORE COAT; ELECTRON CRYOTOMOGRAPHY; CRYOELECTRON TOMOGRAPHY; PROTEIN LOCALIZATION; GENE-EXPRESSION; CELL-DIVISION; SP-NOV; MORPHOGENESIS; ULTRASTRUCTURE	Two hallmarks of the Firmicute phylum, which includes the Bacilli and Clostridia classes, are their ability to form endospores and their "Gram-positive'' single-membraned, thick-cell-wall envelope structure. Acetonema longum is part of a lesser-known family (the Veillonellaceae) of Clostridia that form endospores but that are surprisingly "Gram negative,'' possessing both an inner and outer membrane and a thin cell wall. Here, we present macromolecular resolution, 3D electron cryotomographic images of vegetative, sporulating, and germinating A. longum cells showing that during the sporulation process, the inner membrane of the mother cell is inverted and transformed to become the outer membrane of the germinating cell. Peptidoglycan persists throughout, leading to a revised, "continuous'' model of its role in the process. Coupled with genomic analyses, these results point to sporulation as a mechanism by which the bacterial outer membrane may have arisen and A. longum as a potential "missing link'' between single- and double-membraned bacteria.	[Tocheva, Elitza I.; Morris, Dylan M.; Jensen, Grant J.] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Matson, Eric G.; Leadbetter, Jared R.] CALTECH, Ronald & Maxine Linde Ctr Global Environm Sci, Pasadena, CA 91125 USA; [Jensen, Grant J.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; [Moussavi, Farshid] Stanford Univ, Dept Elect Engn, Stanford, CA 94305 USA	California Institute of Technology; California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute; Stanford University	Jensen, GJ (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	jensen@caltech.edu		Leadbetter, Jared/0000-0002-7033-0844	DOE [DE-FG02-09ER20097, DE-FG02-07ER64484]; Natural Sciences and Engineering Research Council of Canada; Howard Hughes Medical Foundation; Gordon and Betty Moore Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094800] Funding Source: NIH RePORTER	DOE(United States Department of Energy (DOE)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Howard Hughes Medical Foundation(Howard Hughes Medical Institute); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Alasdair McDowall and Mark Ladinsky for their help with the preparation of mature spores by traditional EM methods and Dr. Martin Pilhofer for helping with the immunofluorescence and western blotting experiments. The GC-MS analysis of LPS was performed at the Complex Carbohydrate Research Center and was supported by DOE grant DE-FG02-09ER20097. We thank Everett Kane for the generation of Movie S2 and Jane H. Ding for helping with the generation of Movie S1 and Movie S2. We thank Ivan Tochev for generating Figure 4B. We thank Dr. Stephen Quake and Richard White at Stanford University for performing the shotgun genome sequencing of A. longum. The authors gratefully acknowledge the IGS annotation engine. This work was supported by a Natural Sciences and Engineering Research Council of Canada Postdoctorate Fellowship (to E.I.T.), the Howard Hughes Medical Foundation, and gifts to Caltech from the Gordon and Betty Moore Foundation, including support for the Caltech Center for Integrative Study of Cell Regulation. E.G.M was supported by the Department of Energy (award DE-FG02-07ER64484 to J.R.L).	Atrih A, 1996, J BACTERIOL, V178, P6173, DOI 10.1128/jb.178.21.6173-6183.1996; BECHTEL DB, 1976, J BACTERIOL, V127, P1472, DOI 10.1128/JB.127.3.1472-1481.1976; Ben-Harush K, 2010, J CELL SCI, V123, P7, DOI 10.1242/jcs.060111; BLADEN HA, 1964, J BACTERIOL, V88, P1482, DOI 10.1128/JB.88.5.1482-1492.1964; Blaylock B, 2004, GENE DEV, V18, P2916, DOI 10.1101/gad.1252704; Bos MP, 2007, ANNU REV MICROBIOL, V61, P191, DOI 10.1146/annurev.micro.61.080706.093245; Briegel A, 2006, MOL MICROBIOL, V62, P5, DOI 10.1111/j.1365-2958.2006.05355.x; Briegel A, 2009, P NATL ACAD SCI USA, V106, P17181, DOI 10.1073/pnas.0905181106; Buchanan C.E., 1994, BACTERIAL CELL WALL, V1; CAVALIERSMITH T, 2004, ORGANELLES GENOMES E; CHART H, 1992, EPIDEMIOL INFECT, V108, P77, DOI 10.1017/S0950268800049529; Chen SY, 2011, EMBO J, V30, P2972, DOI 10.1038/emboj.2011.186; Dmitriev BA, 2003, J BACTERIOL, V185, P3458, DOI 10.1128/JB.185.11.3458-3468.2003; Dowd MM, 2008, J BACTERIOL, V190, P4541, DOI 10.1128/JB.00249-08; Driks A, 2002, TRENDS MICROBIOL, V10, P251, DOI 10.1016/S0966-842X(02)02373-9; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Erickson HP, 2009, BIOL PROCED ONLINE, V11, P32, DOI 10.1007/s12575-009-9008-x; Errington J, 2003, NAT REV MICROBIOL, V1, P117, DOI 10.1038/nrmicro750; ERRINGTON J, 1993, MICROBIOL REV, V57, P1; Gan L, 2008, P NATL ACAD SCI USA, V105, P18953, DOI 10.1073/pnas.0808035105; Gueiros-Filho F., 2007, BACILLUS CELULAR MOL, V1; Gutierrez J, 2010, J BACTERIOL, V192, P3174, DOI 10.1128/JB.00127-10; Harwood C.R., 1989, BIOTECHNOLOGY HDB, P169; Hayhurst EJ, 2008, P NATL ACAD SCI USA, V105, P14603, DOI 10.1073/pnas.0804138105; Henriques AO, 2007, ANNU REV MICROBIOL, V61, P555, DOI 10.1146/annurev.micro.61.080706.093224; Hilbert DW, 2004, MICROBIOL MOL BIOL R, V68, P234, DOI 10.1128/MMBR.68.2.234-262.2004; HOFSTAD T, 1970, Acta Pathologica et Microbiologica Scandinavica Section B Microbiology and Immunology, V78, P760; HOFSTAD T, 1978, ACTA PATH MICRO IM B, V86, P47; Iancu CV, 2006, NAT PROTOC, V1, P2813, DOI 10.1038/nprot.2006.432; ILLING N, 1991, J BACTERIOL, V173, P3159, DOI 10.1128/JB.173.10.3159-3169.1991; Joseleau-Petit D, 2007, J BACTERIOL, V189, P6512, DOI 10.1128/JB.00273-07; KANE MD, 1991, ARCH MICROBIOL, V156, P91, DOI 10.1007/BF00290979; Komeili A, 2006, SCIENCE, V311, P242, DOI 10.1126/science.1123231; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Kuo CH, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001050; Lake JA, 2009, NATURE, V460, P967, DOI 10.1038/nature08183; Leadbetter JR, 1996, APPL ENVIRON MICROB, V62, P3620, DOI 10.1128/AEM.62.10.3620-3631.1996; Li Z, 2009, CURR OPIN MICROBIOL, V12, P333, DOI 10.1016/j.mib.2009.03.007; Liu J, 2009, J BACTERIOL, V191, P5026, DOI 10.1128/JB.00340-09; Margolin W, 2002, CURR BIOL, V12, pR391, DOI 10.1016/S0960-9822(02)00882-5; MERGENHAGEN SE, 1965, J BACTERIOL, V90, P1730, DOI 10.1128/JB.90.6.1730-1734.1965; Meyer P, 2010, MOL MICROBIOL, V76, P956, DOI 10.1111/j.1365-2958.2010.07155.x; NICHOLSON WL, 1990, J BACTERIOL, V172, P7, DOI 10.1128/JB.172.1.7-14.1990; Onyenwoke RU, 2004, ARCH MICROBIOL, V182, P182, DOI 10.1007/s00203-004-0696-y; Perez AR, 2000, J BACTERIOL, V182, P1096, DOI 10.1128/JB.182.4.1096-1108.2000; Piggot PJ, 2004, CURR OPIN MICROBIOL, V7, P579, DOI 10.1016/j.mib.2004.10.001; Pilhofer M., 2010, ELECT MICROSCOPY MOD; POINDEXTER JS, 1981, CAN J MICROBIOL, V27, P704, DOI 10.1139/m81-109; Popham DL, 1996, J BACTERIOL, V178, P6451, DOI 10.1128/jb.178.22.6451-6458.1996; Prajapati RS, 2000, BBA-GEN SUBJECTS, V1475, P353, DOI 10.1016/S0304-4165(00)00089-1; Rainey F. A., 2009, BERGEYS MANUAL SYSTE, V3; Ramamurthi KS, 2008, MOL CELL, V31, P406, DOI 10.1016/j.molcel.2008.05.030; Ramamurthi KS, 2006, MOL MICROBIOL, V62, P1547, DOI 10.1111/j.1365-2958.2006.05468.x; Ramamurthi KS, 2009, P NATL ACAD SCI USA, V106, P13541, DOI 10.1073/pnas.0906851106; Ramamurthi KS, 2009, SCIENCE, V323, P1354, DOI 10.1126/science.1169218; ROELS S, 1992, J BACTERIOL, V174, P575, DOI 10.1128/jb.174.2.575-585.1992; SABATINI DD, 1963, J CELL BIOL, V17, P19, DOI 10.1083/jcb.17.1.19; Setlow P, 2008, CELL, V135, P410, DOI 10.1016/j.cell.2008.10.006; Setlow P, 2007, TRENDS MICROBIOL, V15, P172, DOI 10.1016/j.tim.2007.02.004; Smith TJ, 2000, MICROBIOL-UK, V146, P249, DOI 10.1099/00221287-146-2-249; Steichen CT, 2007, MOL MICROBIOL, V64, P359, DOI 10.1111/j.1365-2958.2007.05658.x; STEVENS CM, 1992, J BACTERIOL, V174, P586, DOI 10.1128/jb.174.2.586-594.1992; TIPPER DJ, 1976, J BACTERIOL, V126, P213, DOI 10.1128/JB.126.1.213-221.1976; YANOURI A, 1993, J BACTERIOL, V175, P7604, DOI 10.1128/JB.175.23.7604-7616.1993	64	68	68	0	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 2	2011	146	5					799	812		10.1016/j.cell.2011.07.029	http://dx.doi.org/10.1016/j.cell.2011.07.029			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	814SM	21884938	Green Accepted, Bronze			2022-12-28	WOS:000294477500019
J	Jiang, JX; Jorda, JL; Yu, JH; Baumes, LA; Mugnaioli, E; Diaz-Cabanas, MJ; Kolb, U; Corma, A				Jiang, Jiuxing; Jorda, Jose L.; Yu, Jihong; Baumes, Laurent A.; Mugnaioli, Enrico; Diaz-Cabanas, Maria J.; Kolb, Ute; Corma, Avelino			Synthesis and Structure Determination of the Hierarchical Meso-Microporous Zeolite ITQ-43	SCIENCE			English	Article							AUTOMATED DIFFRACTION TOMOGRAPHY; MOLECULAR-SIEVE; POLYMORPH-C; PORE; ATOMS	The formation of mesopores in microporous zeolites is generally performed by postsynthesis acid, basic, and steam treatments. The hierarchical pore systems thus formed allow better adsorption, diffusion, and reactivity of these materials. By combining organic and inorganic structure-directing agents and high-throughput methodologies, we were able to synthesize a zeolite with a hierarchical system of micropores and mesopores, with channel openings delimited by 28 tetrahedral atoms. Its complex crystalline structure was solved with the use of automated diffraction tomography.	[Jiang, Jiuxing; Jorda, Jose L.; Baumes, Laurent A.; Diaz-Cabanas, Maria J.; Corma, Avelino] Univ Politecn Valencia, Consejo Super Invest Cient, Inst Tecnol Quim, Valencia 46022, Spain; [Mugnaioli, Enrico; Kolb, Ute] Johannes Gutenberg Univ Mainz, Inst Phys Chem, D-55099 Mainz, Germany; [Jiang, Jiuxing; Yu, Jihong] Jilin Univ, Coll Chem, State Key Lab Inorgan Synth & Preparat Chem, Changchun 130012, Peoples R China	Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Tecnologia Quimica (ITQ); Johannes Gutenberg University of Mainz; Jilin University	Corma, A (corresponding author), Univ Politecn Valencia, Consejo Super Invest Cient, Inst Tecnol Quim, Ave Naranjos S-N, Valencia 46022, Spain.	acorma@itq.upv.es	yu, jihong/C-1381-2011; CANOS, AVELINO CORMA/A-3040-2013; Jiang, Jiuxing/X-6616-2019; Jorda, Jose L./D-1334-2009; min, guo/F-3813-2014; Mugnaioli, Enrico/E-6237-2011; baumes, laurent a/E-2175-2013; Kolb, Ute/A-2642-2011; Mugnaioli, Enrico/E-6237-2011	yu, jihong/0000-0003-1991-2942; CANOS, AVELINO CORMA/0000-0002-2232-3527; Jiang, Jiuxing/0000-0001-9664-3235; Jorda, Jose L./0000-0002-0304-5680; Mugnaioli, Enrico/0000-0001-9543-9064; baumes, laurent a/0000-0001-9363-9089; Kolb, Ute/0000-0003-0559-2482; Mugnaioli, Enrico/0000-0001-5831-0819	Spanish government [MAT2009-14528-C02-01, PLE2009-0054]; Generalitat Valenciana; Deutsche Forschungsgemeinschaft [SFB 625]; China Scholarship Council; Instituto de Tecnologia Quimica (UPV-CSIC); National Basic Research Program of China [2011CB808703, 2007CB936402]; Major International Collaboration Project of China; Fachinformationszentrum Karlsruhe [CDS-423044]	Spanish government(Spanish GovernmentEuropean Commission); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); China Scholarship Council(China Scholarship Council); Instituto de Tecnologia Quimica (UPV-CSIC); National Basic Research Program of China(National Basic Research Program of China); Major International Collaboration Project of China; Fachinformationszentrum Karlsruhe	We thank the Spanish government (projects MAT2009-14528-C02-01, PLE2009-0054, and CONSOLIDER INGENIO 2010) and Generalitat Valenciana (Project Prometeo) for financial support, and the Deutsche Forschungsgemeinschaft SFB 625 Projekt B8 for supporting the development of automated diffraction tomography. J.J. thanks the China Scholarship Council for support and Instituto de Tecnologia Quimica (UPV-CSIC) for a Ph.D. scholarship. J.Y. thanks the National Basic Research Program of China (grants 2011CB808703 and 2007CB936402) and the Major International Collaboration Project of China. Further details on the crystal structure may be obtained from the Fachinformationszentrum Karlsruhe (www.fiz-karlsruhe.de), depository no. CDS-423044.	Baerlocher C, 2007, SCIENCE, V315, P1113, DOI 10.1126/science.1137920; Baumes LA, 2011, PHYS CHEM CHEM PHYS, V13, P4674, DOI 10.1039/c0cp02833a; Burla MC, 2007, J APPL CRYSTALLOGR, V40, P609, DOI 10.1107/S0021889807010941; Burton A, 2003, CHEM-EUR J, V9, P5737, DOI 10.1002/chem.200305238; Cantin A, 2006, ANGEW CHEM INT EDIT, V45, P8013, DOI 10.1002/anie.200603027; Cejka J, 2007, CATAL REV, V49, P457, DOI 10.1080/01614940701583240; Choi M, 2009, NATURE, V461, P246, DOI 10.1038/nature08288; Corma A, 2003, NAT MATER, V2, P493, DOI 10.1038/nmat921; Corma A, 2003, J CATAL, V216, P298, DOI 10.1016/S0021-9517(02)00132-X; Corma A, 1998, NATURE, V396, P353, DOI 10.1038/24592; Corma A, 2006, NATURE, V443, P842, DOI 10.1038/nature05238; Corma A, 2008, J AM CHEM SOC, V130, P16482, DOI 10.1021/ja806903c; Davis ME, 2002, NATURE, V417, P813, DOI 10.1038/nature00785; Dodin M, 2010, J AM CHEM SOC, V132, P10221, DOI 10.1021/ja103648k; ESTERMANN M, 1991, NATURE, V352, P320, DOI 10.1038/352320a0; Freyhardt CC, 1996, NATURE, V381, P295, DOI 10.1038/381295a0; Gao FF, 2009, J AM CHEM SOC, V131, P16580, DOI 10.1021/ja904458y; Jiang JX, 2010, ANGEW CHEM INT EDIT, V49, P4986, DOI 10.1002/anie.201001506; Jorda JL, 2007, Z KRISTALLOGR, P393; Kisielowski C, 2008, MICROSC MICROANAL, V14, P469, DOI 10.1017/S1431927608080902; Kolb U, 2008, ULTRAMICROSCOPY, V108, P763, DOI 10.1016/j.ultramic.2007.12.002; Kolb U, 2007, ULTRAMICROSCOPY, V107, P507, DOI 10.1016/j.ultramic.2006.10.007; Liu Y, 2002, J MATER CHEM, V12, P3179, DOI 10.1039/b204094h; Rodriguez-Carvajal J., 2001, NEWSL, V26, P12; Sastre G, 2002, ANGEW CHEM INT EDIT, V41, P4722, DOI 10.1002/anie.200290028; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Strohmaier KG, 2003, J AM CHEM SOC, V125, P16035, DOI 10.1021/ja0371653; Sun JL, 2009, NATURE, V458, P1154, DOI 10.1038/nature07957	28	295	304	12	605	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 26	2011	333	6046					1131	1134		10.1126/science.1208652	http://dx.doi.org/10.1126/science.1208652			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811VM	21868673				2022-12-28	WOS:000294244300044
J	Hsiang, SM; Meng, KC; Cane, MA				Hsiang, Solomon M.; Meng, Kyle C.; Cane, Mark A.			Civil conflicts are associated with the global climate	NATURE			English	Article							EL-NINO; TEMPERATURE; SHOCKS; WAR	It has been proposed that changes in global climate have been responsible for episodes of widespread violence and even the collapse of civilizations(1,2). Yet previous studies have not shown that violence can be attributed to the global climate, only that random weather events might be correlated with conflict in some cases(3-7). Here we directly associate planetary-scale climate changes with global patterns of civil conflict by examining the dominant interannual mode of the modern climate(8-10), the El Nino/Southern Oscillation (ENSO). Historians have argued that ENSO may have driven global patterns of civil conflict in the distant past(11-13), a hypothesis that we extend to the modern era and test quantitatively. Using data from 1950 to 2004, we show that the probability of new civil conflicts arising throughout the tropics doubles during El Nino years relative to La Nina years. This result, which indicates that ENSO may have had a role in 21% of all civil conflicts since 1950, is the first demonstration that the stability of modern societies relates strongly to the global climate.	[Cane, Mark A.] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA; [Hsiang, Solomon M.; Meng, Kyle C.] Columbia Univ, Sch Int & Publ Affairs, New York, NY 10027 USA	Columbia University; Columbia University	Hsiang, SM (corresponding author), Princeton Univ, Woodrow Wilson Sch Publ & Int Affairs, Princeton, NJ 08544 USA.	shsiang@princeton.edu	Cane, Mark/I-8086-2012	Cane, Mark/0000-0001-5408-2388	Environmental Protection Agency [FP-916932]; Paul and Daisy Soros Fellowship for New Americans; National Bureau of Economic Research	Environmental Protection Agency(United States Environmental Protection Agency); Paul and Daisy Soros Fellowship for New Americans; National Bureau of Economic Research	S.M.H. was supported by Environmental Protection Agency Science to Achieve Results grant FP-916932 and a postdoctoral fellowship in Applied Econometrics at the National Bureau of Economic Research; K. C. M. was supported by the Paul and Daisy Soros Fellowship for New Americans. We thank W. B. MacLeod, B. Salanie, A. Sobel, J. Sachs, W. Schlenker, E. Miguel, D. Almond, S. Barrett, G. Heal, M. Neidell, J. Mutter, N. Keohane, A. Cassella, J. Currie, W. Kopczuk, C. Pop-Eleches, R. Fisman, S. Naidu, M. Humphreys, D. Lobell, M. Roberts, M. Greenstone, M. Biasutti, G. Wagner, G. McCord, J. Anttila-Hughes, R. Fishman, A. Tompsett, A. Neal, B. R. Chen and seminar participants at Columbia, Massachusetts Institute of Technology, Stanford, University of California Santa Barbara, Environmental Defense Fund, the National Bureau of Economic Research Summer Institute and the American Geophysical Union Fall Meeting for suggestions. We also thank H. Buhaugand M. Burke for sharing replication materials.	Blattman C, 2010, J ECON LIT, V48, P3, DOI 10.1257/jel.48.1.3; Brunner AD, 2002, REV ECON STAT, V84, P176, DOI 10.1162/003465302317332008; Buhaug H, 2010, P NATL ACAD SCI USA, V107, P16477, DOI 10.1073/pnas.1005739107; Burke MB, 2009, P NATL ACAD SCI USA, V106, P20670, DOI 10.1073/pnas.0907998106; Camargo SJ, 2005, J CLIMATE, V18, P2996, DOI 10.1175/JCLI3457.1; Chen D, 2004, NATURE, V428, P733, DOI 10.1038/nature02439; Chiang JCH, 2002, J CLIMATE, V15, P2616, DOI 10.1175/1520-0442(2002)015<2616:TTTVCB>2.0.CO;2; Davis Mike, 2002, LATE VICTORIAN HOLOC; de Bruin KC, 2009, CLIMATIC CHANGE, V95, P63, DOI 10.1007/s10584-008-9535-5; Diamond J., 2011, COLLAPSE SOC CHOOSE, V4th ed; Fagan B.M., 2009, FLOODS FAMINES EMPER, V2nd ed.; Grove RH, 2007, MEDIEV HIST J, V10, P75, DOI 10.1177/097194580701000203; HOLLAND PW, 1986, J AM STAT ASSOC, V81, P945, DOI 10.2307/2289064; HOMERDIXON TF, 1991, INT SECURITY, V16, P76, DOI 10.2307/2539061; Hsiang SM, 2010, P NATL ACAD SCI USA, V107, P15367, DOI 10.1073/pnas.1009510107; Jensen PS, 2009, DEFENCE PEACE ECON, V20, P359, DOI 10.1080/10242690902868277; Jones BF, 2010, AM ECON REV, V100, P454, DOI 10.1257/aer.100.2.454; Kovats RA, 2003, LANCET, V12, P917; Larrick RP, 2011, PSYCHOL SCI, V22, P423, DOI 10.1177/0956797611399292; Levy MA, 2005, INT WORKSH HUM SEC C; Miguel E, 2004, J POLIT ECON, V112, P725, DOI 10.1086/421174; ROPELEWSKI CF, 1987, MON WEATHER REV, V115, P1606, DOI 10.1175/1520-0493(1987)115<1606:GARSPP>2.0.CO;2; Rosenzweig C., 2008, CLIMATE CHANGE GLOBA; Salehyan I, 2008, J PEACE RES, V45, P315, DOI 10.1177/0022343308088812; Sarachik E.S., 2010, NINO SO OSCILLATION; Schlenker W, 2009, P NATL ACAD SCI USA, V106, P15594, DOI 10.1073/pnas.0906865106; Strand Havard, 2006, ONSET ARMED CONFLICT; Zhang DD, 2007, P NATL ACAD SCI USA, V104, P19214, DOI 10.1073/pnas.0703073104	28	425	429	7	200	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 25	2011	476	7361					438	441		10.1038/nature10311	http://dx.doi.org/10.1038/nature10311			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	811KT	21866157				2022-12-28	WOS:000294209400033
J	Viljoen, A; Wierzbicki, AS				Viljoen, Adie; Wierzbicki, Anthony S.			RATIONAL TESTING Investigating mixed hyperlipidaemia	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							RISK; DISEASE; LIPIDS; SERUM		[Wierzbicki, Anthony S.] Guys & St Thomas NHS Trust, St Thomas Hosp, Dept Chem Pathol, London SE1 7EH, England; [Viljoen, Adie] Lister Hosp, Stevenage SG1 4AB, Herts, England	Guy's & St Thomas' NHS Foundation Trust; Lister Hospital	Wierzbicki, AS (corresponding author), Guys & St Thomas NHS Trust, St Thomas Hosp, Dept Chem Pathol, London SE1 7EH, England.	Anthony.Wierzbicki@kcl.ac.uk	Wierzbicki, Anthony/AAP-1735-2020	Wierzbicki, Anthony/0000-0003-2756-372X				ALVAREZ C, 1986, CLIN CHEM, V32, P142; ANDERSON KM, 1991, AM HEART J, V121, P293, DOI 10.1016/0002-8703(91)90861-B; ASSMANN G, 1992, AM J CARDIOL, V70, P733, DOI 10.1016/0002-9149(92)90550-I; Castera L, 2005, GASTROENTEROLOGY, V128, P343, DOI 10.1053/j.gastro.2004.11.018; Department of Health, 2009, PUTT PREV 1 NHS HLTH; Eckel RH, 2010, LANCET, V375, P181, DOI 10.1016/S0140-6736(09)61794-3; Hippisley-Cox J, 2008, BMJ-BRIT MED J, V336, P1475, DOI 10.1136/bmj.39609.449676.25; Lorenzo C, 2003, DIABETES CARE, V26, P3153, DOI 10.2337/diacare.26.11.3153; Mann DM, 2010, AM J EPIDEMIOL, V171, P980, DOI 10.1093/aje/kwq030; National Institute for Health and Clinical Excellence, 2008, CLIN GUID NAT I HLTH, V67; POWNALL HJ, 1994, J LIPID RES, V35, P2105; WOCHOS DN, 1976, MAYO CLIN PROC, V51, P660; Wood D, 2005, HEART, V91, P1, DOI 10.1136/hrt.2005.079988	13	1	1	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 25	2011	343								d5146	10.1136/bmj.d5146	http://dx.doi.org/10.1136/bmj.d5146			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	813ZQ	21868456				2022-12-28	WOS:000294410400005
J	Barreira, TV; Harrington, DM; Staiano, AE; Heymsfield, SB; Katzmarzyk, PT				Barreira, Tiago V.; Harrington, Deirdre M.; Staiano, Amanda E.; Heymsfield, Steven B.; Katzmarzyk, Peter T.			Body Adiposity Index, Body Mass Index, and Body Fat in White and Black Adults	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							RACE; BMI; SEX		[Barreira, Tiago V.; Harrington, Deirdre M.; Staiano, Amanda E.; Heymsfield, Steven B.; Katzmarzyk, Peter T.] Louisiana State Univ Syst, Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center	Barreira, TV (corresponding author), Louisiana State Univ Syst, Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA.	peter.katzmarzyk@pbrc.edu	Staiano, Amanda E/H-3956-2017; Heymsfield, Steven B/N-1968-2017; Barreira, Tiago/AAD-9429-2021; Katzmarzyk, Peter T/N-1974-2017	Staiano, Amanda E/0000-0001-7846-046X; Heymsfield, Steven B/0000-0003-1127-9425; Katzmarzyk, Peter T/0000-0002-9280-6022; Barreira, Tiago/0000-0001-7108-3374; Harrington, Deirdre/0000-0003-0278-6812	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072476] Funding Source: NIH RePORTER; NIDDK NIH HHS [P30 DK072476, 2P30-DK072476-06] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bergman RN, 2011, OBESITY, V19, P1083, DOI 10.1038/oby.2011.38; Bouchard C, 2007, INT J OBESITY, V31, P1552, DOI 10.1038/sj.ijo.0803653; Camhi SM, 2011, OBESITY, V19, P402, DOI 10.1038/oby.2010.248; Jackson AS, 2002, INT J OBESITY, V26, P789, DOI 10.1038/sj.ijo.0802006; Katzmarzyk PT, 2010, AM J CLIN NUTR, V91, P7, DOI 10.3945/ajcn.2009.28136	5	61	66	0	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 24	2011	306	8					828	830		10.1001/jama.2011.1189	http://dx.doi.org/10.1001/jama.2011.1189			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	810VY	21862743	Bronze, Green Accepted			2022-12-28	WOS:000294157300019
J	Zimmerberg, J; Hess, ST				Zimmerberg, Joshua; Hess, Samuel T.			Elongated Membrane Zones Boost Interactions of Diffusing Proteins	CELL			English	Editorial Material									[Zimmerberg, Joshua] Eunice Kennedy Schriver Natl Inst Child Hlth & Hu, Program Phys Biol, NIH, Bethesda, MD 20892 USA; [Hess, Samuel T.] Univ Maine, Dept Phys & Astron, Orono, ME 04469 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Maine System; University of Maine Orono	Zimmerberg, J (corresponding author), Eunice Kennedy Schriver Natl Inst Child Hlth & Hu, Program Phys Biol, NIH, Bethesda, MD 20892 USA.	joshz@mail.nih.gov; sam.hess@umit.maine.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001415, ZIAHD001409] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM094713] Funding Source: NIH RePORTER; NIGMS NIH HHS [R15 GM094713] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BEREZHKOVSKII AM, 1989, CHEM PHYS, V137, P41, DOI 10.1016/0301-0104(89)87091-0; Goswami D, 2008, CELL, V135, P1085, DOI 10.1016/j.cell.2008.11.032; Hess ST, 2007, P NATL ACAD SCI USA, V104, P17370, DOI 10.1073/pnas.0708066104; Jaqaman K, 2011, CELL, V146, P593, DOI 10.1016/j.cell.2011.06.049; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Morone N, 2006, J CELL BIOL, V174, P851, DOI 10.1083/jcb.200606007; Semrau S, 2007, BIOPHYS J, V92, P613, DOI 10.1529/biophysj.106.092577; Yu CH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011878	8	3	3	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 19	2011	146	4					501	503		10.1016/j.cell.2011.08.003	http://dx.doi.org/10.1016/j.cell.2011.08.003			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	809HY	21854976	Bronze			2022-12-28	WOS:000294043600004
J	Ritchie, CS; Roth, DL; Allman, RM				Ritchie, Christine S.; Roth, David L.; Allman, Richard M.			Living With an Aging Parent "It Was a Beautiful Invitation"	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CAREGIVERS; CARE; DEMENTIA; HEALTH; DISABILITY; INDIVIDUALS; PREDICTORS; SYMPTOMS; OUTCOMES; STRAIN	In the United States and globally, increasing numbers of older parents are living with their adult children. Making the decision to live together requires careful thought and planning; particularly when the decision means the children will be responsible for their elder parents' care, the physicians of all parties should be consulted. More than one-third of caregivers state that they seek advice from their physician or other clinician when information is needed about this transition. Using the case of a couple receiving care from their daughter in her own home, we review the prevalence and epidemiology of adult children caring for a parent in the adult child's home, important issues to consider, and a framework for clinicians to help guide their patients through this transition. We describe the physician's ongoing role in caring for and advising both the older parent and the adult children during common stages of multigenerational living: before the move and during coresidency and subsequent care transitions.	[Ritchie, Christine S.; Roth, David L.; Allman, Richard M.] Dept Vet Affairs Med Ctr, Birmingham Atlanta Geriatr Res Educ & Clin Ctr, Birmingham, AL USA; [Ritchie, Christine S.; Allman, Richard M.] Univ Alabama Birmingham, Sch Med, Dept Med, Div Gerontol Geriatr & Palliat Care, Birmingham, AL USA; [Roth, David L.] Univ Alabama Birmingham, Sch Publ Hlth, Dept Biostat, Birmingham, AL 35294 USA	Geriatric Research Education & Clinical Center; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Ritchie, CS (corresponding author), CH19,Ste 219,933 19th St S, Birmingham, AL 35205 USA.	critchie@uab.edu	Allman, Richard M./O-1693-2019	Allman, Richard M./0000-0002-1850-6515	National Institute on Aging [1K07AG31779]; National Institutes of Health (NIH) [R01 AG015062, UB4HP19045, R18-HS017786-02]; Agency for Healthcare Research and Quality; Health Resources and Services Administration; Donald W. Reynolds Foundation; Centers for Disease Control and Prevention; John A. Hartford Foundation; NIH; National Center for Research Resources; NHLBI; Veterans Administration; NIA; SCAN Foundation;  [P30AG031054];  [5UL1RR025777];  [P30AG031054 0-2S1]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R18HS017786] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025777] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG015062, P30AG031054, K07AG031779] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Health Resources and Services Administration(United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA)); Donald W. Reynolds Foundation; Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); John A. Hartford Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Administration(US Department of Veterans Affairs); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); SCAN Foundation; ; ; ; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Dr Ritchie reports receipt of support from a Geriatric Academic Leadership Award through the National Institute on Aging (1K07AG31779), R01 AG015062, UB4HP19045, and R18-HS017786-02; grants from the National Institutes of Health (NIH), Agency for Healthcare Research and Quality, Health Resources and Services Administration, and the Donald W. Reynolds Foundation. Dr Roth reports receipt of support from NIH grants and the Centers for Disease Control and Prevention. Dr Allman reports receipt of support from awards R01 AG015062, P30AG031054, 5UL1RR025777, and P30AG031054 0-2S1 diversity supplement from NIH and NIA; the John A. Hartford Foundation; the NIH and National Center for Research Resources; the NHLBI; a Veterans Administration Career Development Award; and the NIA. The Care of the Aging Patient series is made possible by funding from The SCAN Foundation.	[Anonymous], 2003, AB NEGL EXPL AG AM; Aravanis S C, 1993, Arch Fam Med, V2, P371, DOI 10.1001/archfami.2.4.371; Arkowitz H, 2009, J CLIN PSYCHOL, V65, P1149, DOI 10.1002/jclp.20640; Barrett L., 2009, CAREGIVING US FOCUSE; Bedell SE, 2001, NEW ENGL J MED, V344, P1162, DOI 10.1056/NEJM200104123441510; Bucks Brian K., 2009, FEDERAL RESERVE B, V95, pA1; Callahan CM, 2006, JAMA-J AM MED ASSOC, V295, P2148, DOI 10.1001/jama.295.18.2148; Chan N, 2011, GERONTOLOGY, V57, P180, DOI 10.1159/000314158; Coleman EA, 2004, J AM GERIATR SOC, V52, P1817, DOI 10.1111/j.1532-5415.2004.52504.x; Covinsky KE, 2001, J GERONTOL A-BIOL, V56, pM707, DOI 10.1093/gerona/56.11.M707; D'Souza JC, 2009, GERONTOLOGIST, V49, P154, DOI 10.1093/geront/gnp020; Elliott AF, 2010, J AM GERIATR SOC, V58, P30, DOI 10.1111/j.1532-5415.2009.02631.x; England M, 2001, EDUC GERONTOL, V27, P139, DOI 10.1080/03601270151075543; Gaugler JE, 2009, MED CARE, V47, P191, DOI 10.1097/MLR.0b013e31818457ce; Gill TM, 2010, NEW ENGL J MED, V362, P1173, DOI 10.1056/NEJMoa0909087; Gillespie Lesley D, 2012, Cochrane Database Syst Rev, pCD007146, DOI 10.1002/14651858.CD007146.pub3; Gitlin LN, 2010, JAMA-J AM MED ASSOC, V304, P983, DOI 10.1001/jama.2010.1253; Gitlin LN, 2010, J AM GERIATR SOC, V58, P1465, DOI 10.1111/j.1532-5415.2010.02971.x; Hepburn K, 2007, J GERONTOL NURS, V33, P30, DOI 10.3928/00989134-20070301-06; Kane RL, 2011, JAMA-J AM MED ASSOC, V305, P284, DOI 10.1001/jama.2010.2015; Kang SY, 2006, J GERONTOL SOC WORK, V47, P107, DOI 10.1300/J083v47n01_08; Kendig H, 2010, AGE AGEING, V39, P342, DOI 10.1093/ageing/afq016; Koerner SS, 2009, ARCH GERONTOL GERIAT, V48, P238, DOI 10.1016/j.archger.2008.01.015; Lyketsos CG, 1999, AM J PSYCHIAT, V156, P66, DOI 10.1176/ajp.156.1.66; Lynn J, 2001, JAMA-J AM MED ASSOC, V285, P925, DOI 10.1001/jama.285.7.925; Main J, 2000, BRIT J GEN PRACT, V50, P863; Mason A, 2007, J AM GERIATR SOC, V55, P290, DOI 10.1111/j.1532-5415.2006.01037.x; Miller EA, 2000, MED CARE RES REV, V57, P259, DOI 10.1177/107755870005700301; Mosqueda L, 2011, JAMA-J AM MED ASSOC, V306; National Association of Adult Protective Services Administrators, 2001, ETH POL ISS RES INV, P6; [National Institute on Aging Alzheimer's Disease Education and Referral Center], HOM SAF PEOPL ALZH D; Parker M. W., 2003, J GERONTOLOGICAL SOC, V40, P101, DOI [DOI 10.1300/J083V40N01_07, 10.1300/J083v40n01_07]; Pew Research Center Social & Demographic Trends, 2010, RET MULT FAM HOUS 3; Pinquart M, 2003, PSYCHOL AGING, V18, P250, DOI 10.1037/0882-7974.18.2.250; Robison J, 2009, J GERONTOL B-PSYCHOL, V64, P788, DOI 10.1093/geronb/gbp015; Rollnick S, 1992, J MENT HEALTH, V1, P25, DOI DOI 10.3109/09638239209034509; Rosalynn Carter Institute for Caregiving, CAR INT DAT; Sauvaget C, 2002, GERONTOLOGY, V48, P226, DOI 10.1159/000058355; Tatara T, 1997, TRENDS ELDER ABUSE D; Tergesen A, 2010, WALL STREET J   1211; UN, 2005, LIVING ARRANGEMENTS; US Department of Health & Human Services, HLTH INF PRIV SOM HA; US Dept of Housing and Urban Development, 1998, FAIR HOUS ACT DES MA; Wahl HW, 2009, GERONTOLOGIST, V49, P355, DOI 10.1093/geront/gnp056; Whittier Stephanie, 2005, J Aging Soc Policy, V17, P45; Wiglesworth A, 2010, J AM GERIATR SOC, V58, P493, DOI 10.1111/j.1532-5415.2010.02737.x	46	8	8	3	18	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 17	2011	306	7					746	753		10.1001/jama.2011.1163	http://dx.doi.org/10.1001/jama.2011.1163			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	807LP	21846856	Green Accepted			2022-12-28	WOS:000293900000024
J	Walker, LM; Huber, M; Doores, KJ; Falkowska, E; Pejchal, R; Julien, JP; Wang, SK; Ramos, A; Chan-Hui, PY; Moyle, M; Mitcham, JL; Hammond, PW; Olsen, OA; Phung, P; Fling, S; Wong, CH; Phogat, S; Wrin, T; Simek, MD; Koff, WC; Wilson, IA; Burton, DR; Poignard, P				Walker, Laura M.; Huber, Michael; Doores, Katie J.; Falkowska, Emilia; Pejchal, Robert; Julien, Jean-Philippe; Wang, Sheng-Kai; Ramos, Alejandra; Chan-Hui, Po-Ying; Moyle, Matthew; Mitcham, Jennifer L.; Hammond, Phillip W.; Olsen, Ole A.; Pham Phung; Fling, Steven; Wong, Chi-Huey; Phogat, Sanjay; Wrin, Terri; Simek, Melissa D.; Koff, Wayne C.; Wilson, Ian A.; Burton, Dennis R.; Poignard, Pascal		Protocol G Principal Investigators	Broad neutralization coverage of HIV by multiple highly potent antibodies	NATURE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; HUMAN MONOCLONAL-ANTIBODY; CROSS-CLADE NEUTRALIZATION; VACCINE; PROTECTION; CHALLENGE; MACAQUES; TRIAL; TITER; ASSAY	Broadly neutralizing antibodies against highly variable viral pathogens are much sought after to treat or protect against global circulating viruses. Here we probed the neutralizing antibody repertoires of four human immunodeficiency virus (HIV)-infected donors with remarkably broad and potent neutralizing responses and rescued 17 new monoclonal antibodies that neutralize broadly across clades. Many of the new monoclonal antibodies are almost tenfold more potent than the recently described PG9, PG16 and VRC01 broadly neutralizing monoclonal antibodies and 100-fold more potent than the original prototype HIV broadly neutralizing monoclonal antibodies(1-3). The monoclonal antibodies largely recapitulate the neutralization breadth found in the corresponding donor serum and many recognize novel epitopes on envelope (Env) glycoprotein gp120, illuminating new targets for vaccine design. Analysis of neutralization by the full complement of anti-HIV broadly neutralizing monoclonal antibodies now available reveals that certain combinations of antibodies should offer markedly more favourable coverage of the enormous diversity of global circulating viruses than others and these combinations might be sought in active or passive immunization regimes. Overall, the isolation of multiple HIV broadly neutralizing monoclonal antibodies from several donors that, in aggregate, provide broad coverage at low concentrations is a highly positive indicator for the eventual design of an effective antibody-based HIV vaccine.	[Walker, Laura M.; Huber, Michael; Doores, Katie J.; Falkowska, Emilia; Ramos, Alejandra; Burton, Dennis R.; Poignard, Pascal] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Walker, Laura M.; Huber, Michael; Doores, Katie J.; Falkowska, Emilia; Pejchal, Robert; Julien, Jean-Philippe; Ramos, Alejandra; Wilson, Ian A.; Burton, Dennis R.; Poignard, Pascal] Scripps Res Inst, IAVI Neutralizing Antibody Ctr, La Jolla, CA 92037 USA; [Huber, Michael; Doores, Katie J.; Falkowska, Emilia; Burton, Dennis R.] Ragon Inst MGH MIT & Harvard, Boston, MA 02129 USA; [Pejchal, Robert; Julien, Jean-Philippe; Wilson, Ian A.] Scripps Res Inst, Skaggs Inst Chem Biol, Dept Mol Biol, La Jolla, CA 92037 USA; [Wang, Sheng-Kai; Wong, Chi-Huey] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Chan-Hui, Po-Ying; Moyle, Matthew; Mitcham, Jennifer L.; Hammond, Phillip W.; Olsen, Ole A.] Theraclone Sci Inc, Seattle, WA 98104 USA; [Pham Phung; Wrin, Terri] Monogram Biosci Inc, San Francisco, CA 94080 USA; [Fling, Steven; Phogat, Sanjay; Simek, Melissa D.; Koff, Wayne C.; Poignard, Pascal] Int AIDS Vaccine Initiat, New York, NY 10038 USA	Scripps Research Institute; International AIDS Vaccine Initiative; Scripps Research Institute; Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute; Scripps Research Institute; Scripps Research Institute; International AIDS Vaccine Initiative	Burton, DR (corresponding author), Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA.	burton@scripps.edu; poignard@scripps.edu	Huber, Michael/B-8509-2015; poignard, pascal/N-6678-2013; poignard, pascal/AAB-4613-2020	Huber, Michael/0000-0002-0384-0000; Doores, Katie/0000-0002-5507-1725; Poignard, Pascal/0000-0002-0021-7192; Wang, Sheng-Kai/0000-0002-3827-7983; Julien, Jean-Philippe/0000-0001-7602-3995	IAVI; NIAID; Ragon Institute; United States for International Development (USAID); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI084817, R01AI033292] Funding Source: NIH RePORTER	IAVI; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Ragon Institute; United States for International Development (USAID)(United States Agency for International Development (USAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank N. Schultz, K. Le and V. Thaney for technical assistance at The Scripps Research Institute. We also thank C. Corbaci, S. M. Eagol and C. Williams for assistance with Fig. 3. We would also like to thank the research staff members of the Theraclone I-STAR Discovery and Antibody Purification Team, and K. Limoli, S. Jauregui, K. Tran, P. Sitou, J. Perea, B. Huang and P. Guinto at Monogram BioSciences. We thank R. McBride for assistance with the glycan array and are grateful to W. Olson for providing purified KNH1144 SOSIP trimer, R. Wyatt for providing the YU2 Foldon trimer and J. Mascola for providing monoclonal antibody VRC01. In addition, we would like to thank all of the International AIDS Vaccine Initiative (IAVI) Protocol G project, clinical and site team members, the IAVI Human Immunology Laboratory (HIL) and all of the Protocol G clinical investigators, specifically, G. Miiro, A. Pozniak, D. McPhee, O. Manigart, E. Karita, A. Inwoley, W. Jaoko, J. DeHovitz, L.-G. Bekker, P. Pitisuttithum, R. Paris, J. Serwanga and S. Allen. This work was supported by IAVI, NIAID, the Ragon Institute and the United States for International Development (USAID). The contents are the responsibility of the authors and do not necessarily reflect the views of USAID or the United States Government.	Amanna IJ, 2008, HUM VACCINES, V4, P316, DOI 10.4161/hv.4.4.5751; Barouch DH, 2008, NATURE, V455, P613, DOI 10.1038/nature07352; Binley JA, 2004, J VIROL, V78, P13232, DOI 10.1128/JVI.78.23.13232-13252.2004; Blixt O, 2004, P NATL ACAD SCI USA, V101, P17033, DOI 10.1073/pnas.0407902101; Bridges CB, 2000, JAMA-J AM MED ASSOC, V284, P1655, DOI 10.1001/jama.284.13.1655; Brochet X, 2008, NUCLEIC ACIDS RES, V36, pW503, DOI 10.1093/nar/gkn316; BURTON DR, 1994, SCIENCE, V266, P1024, DOI 10.1126/science.7973652; Haynes BF, 2005, SCIENCE, V308, P1906, DOI 10.1126/science.1111781; Hedestam GBK, 2008, NAT REV MICROBIOL, V6, P143, DOI 10.1038/nrmicro1819; Herrera GA, 2007, VACCINE, V25, P154, DOI 10.1016/j.vaccine.2006.05.129; Hessell AJ, 2009, NAT MED, V15, P951, DOI 10.1038/nm.1974; Hessell AJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000433; Kwong PD, 2009, NAT IMMUNOL, V10, P573, DOI 10.1038/ni.1746; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Martell BA, 2009, ARCH GEN PSYCHIAT, V66, P1116, DOI 10.1001/archgenpsychiatry.2009.128; Mouquet H, 2010, NATURE, V467, P591, DOI 10.1038/nature09385; Munshaw S, 2010, BIOINFORMATICS, V26, P867, DOI 10.1093/bioinformatics/btq056; Nishimura Y, 2002, J VIROL, V76, P2123, DOI 10.1128/jvi.76.5.2123-2130.2002; Pantophlet R, 2003, J VIROL, V77, P642, DOI 10.1128/JVI.77.1.642-658.2003; Parren PWHI, 2001, J VIROL, V75, P8340, DOI 10.1128/JVI.75.17.8340-8347.2001; Plotkin SA, 2001, PEDIATR INFECT DIS J, V20, P63, DOI 10.1097/00006454-200101000-00013; Plotkin SA, 2013, VACCINES; Richman DD, 2003, P NATL ACAD SCI USA, V100, P4144, DOI 10.1073/pnas.0630530100; Schief WR, 2009, CURR OPIN HIV AIDS, V4, P431, DOI 10.1097/COH.0b013e32832e6184; Simek MD, 2009, J VIROL, V83, P7337, DOI 10.1128/JVI.00110-09; Stamatatos L, 2009, NAT MED, V15, P866, DOI 10.1038/nm.1949; Stiegler G, 2001, AIDS RES HUM RETROV, V17, P1757, DOI 10.1089/08892220152741450; TRKOLA A, 1995, J VIROL, V69, P6609, DOI 10.1128/JVI.69.11.6609-6617.1995; Walker LM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001028; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wang SK, 2008, P NATL ACAD SCI USA, V105, P3690, DOI 10.1073/pnas.0712326105; Willey R, 2010, AIDS RES HUM RETROV, V26, P89, DOI 10.1089/aid.2009.0144; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659	33	1120	1210	3	179	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 22	2011	477	7365					466	U117		10.1038/nature10373	http://dx.doi.org/10.1038/nature10373			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822WH	21849977	Green Accepted			2022-12-28	WOS:000295080500041
J	Rignot, E; Mouginot, J; Scheuchl, B				Rignot, E.; Mouginot, J.; Scheuchl, B.			Ice Flow of the Antarctic Ice Sheet	SCIENCE			English	Article							PINE ISLAND GLACIER; RADAR INTERFEROMETRY; EAST ANTARCTICA; MOTION; BASAL	We present a reference, comprehensive, high-resolution, digital mosaic of ice motion in Antarctica assembled from multiple satellite interferometric synthetic-aperture radar data acquired during the International Polar Year 2007 to 2009. The data reveal widespread, patterned, enhanced flow with tributary glaciers reaching hundreds to thousands of kilometers inland over the entire continent. This view of ice sheet motion emphasizes the importance of basal-slip-dominated tributary flow over deformation-dominated ice sheet flow, redefines our understanding of ice sheet dynamics, and has far-reaching implications for the reconstruction and prediction of ice sheet evolution.	[Rignot, E.; Mouginot, J.; Scheuchl, B.] Univ Calif Irvine, Dept Earth Syst Sci, Irvine, CA 92697 USA; [Rignot, E.] CALTECH, Jet Prop Lab, Pasadena, CA 91106 USA	University of California System; University of California Irvine; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL)	Rignot, E (corresponding author), Univ Calif Irvine, Dept Earth Syst Sci, Irvine, CA 92697 USA.	erignot@uci.edu	Mouginot, Jeremie/G-7045-2015; Rignot, Eric/A-4560-2014	Mouginot, Jeremie/0000-0001-9155-5455; Rignot, Eric/0000-0002-3366-0481; Scheuchl, Bernd/0000-0001-5947-7709				Allison I., 1982, POLAR REC, V21, P241, DOI [10.1017/S0032247400018994, DOI 10.1017/S0032247400018994]; Bamber J, 2005, EARTH PLANET SC LETT, V237, P516, DOI 10.1016/j.epsl.2005.06.008; Bamber J, 2002, J GLACIOL, V48, P237, DOI 10.3189/172756502781831395; Bamber JL, 2000, SCIENCE, V287, P1248, DOI 10.1126/science.287.5456.1248; Bamber JL, 2006, GEOLOGY, V34, P33, DOI 10.1130/G22160.1; Bell RE, 2007, NATURE, V445, P904, DOI 10.1038/nature05554; Cuffey K., 2010, PHYS GLACIERS; GOLDSTEIN RM, 1993, SCIENCE, V262, P1525, DOI 10.1126/science.262.5139.1525; Haran T., 2006, MODIS MODERATE RESOL; Jenkins A, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004449; Jezek KC, 2003, RADIO SCI, V38, DOI 10.1029/2002RS002643; Joughin I, 1999, SCIENCE, V286, P283, DOI 10.1126/science.286.5438.283; Kwok R, 2000, J GLACIOL, V46, P689, DOI 10.3189/172756500781832710; Le Brocq AM, 2006, COMPUT GEOSCI-UK, V32, P1780, DOI 10.1016/j.cageo.2006.05.003; Lemke P, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P337; Lythe MB, 2001, J GEOPHYS RES-SOL EA, V106, P11335, DOI 10.1029/2000JB900449; MCINTYRE NF, 1985, J GLACIOL, V31, P99, DOI 10.3189/S0022143000006328; Pattyn F, 2005, ANN GLACIOL-SER, V40, P225, DOI 10.3189/172756405781813672; Rignot E, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020697; Rignot E, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL046583; Rignot E, 2008, NAT GEOSCI, V1, P106, DOI 10.1038/ngeo102; Rippin DM, 2003, J GEOPHYS RES-EARTH, V108, DOI 10.1029/2003JF000039; Stenoien MD, 2000, J GEOPHYS RES-SOL EA, V105, P21761, DOI 10.1029/2000JB900151; Swithinbank C., 1988, 1386B US GEOL SURV	24	745	775	5	185	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 9	2011	333	6048					1427	1430		10.1126/science.1208336	http://dx.doi.org/10.1126/science.1208336			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817KU	21852457	Green Submitted			2022-12-28	WOS:000294672200037
J	Boggs, DA; Rosenberg, L; Cozier, YC; Wise, LA; Coogan, PF; Ruiz-Narvaez, EA; Palmer, JR				Boggs, Deborah A.; Rosenberg, Lynn; Cozier, Yvette C.; Wise, Lauren A.; Coogan, Patricia F.; Ruiz-Narvaez, Edward A.; Palmer, Julie R.			General and Abdominal Obesity and Risk of Death among Black Women	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BODY-MASS INDEX; AFRICAN-AMERICAN WOMEN; WAIST CIRCUMFERENCE; US ADULTS; PROSPECTIVE COHORT; FOLLOW-UP; ALL-CAUSE; MORTALITY; WHITE; HEALTH	Background Recent pooled analyses show an increased risk of death with increasing levels of the body-mass index (BMI, the weight in kilograms divided by the square of the height in meters) of 25.0 or higher in populations of European ancestry, a weaker association among East Asians, and no association of an increased BMI with an increased risk of death among South Asians. The limited data available on blacks indicate that the risk of death is increased only at very high levels of BMI (>= 35.0). Methods We prospectively assessed the relation of both BMI and waist circumference to the risk of death among 51,695 black women with no history of cancer or cardiovascular disease who were 21 to 69 years of age at study enrollment. Our analysis was based on follow-up data from 1995 through 2008 in the Black Women's Health Study. Multivariable proportional-hazards models were used to estimate hazard ratios and 95% confidence intervals. Results Of 1773 deaths identified during follow-up, 770 occurred among 33,916 women who had never smoked. Among nonsmokers, the risk of death was lowest for a BMI of 20.0 to 24.9. For a BMI above this range, the risk of death increased as the BMI increased. With a BMI of 22.5 to 24.9 as the reference category, multivariable-adjusted hazard ratios were 1.12 (95% confidence interval [CI], 0.87 to 1.44) for a BMI of 25.0 to 27.4, 1.31 (95% CI, 1.01 to 1.72) for a BMI of 27.5 to 29.9, 1.27 (95% CI, 0.99 to 1.64) for a BMI of 30.0 to 34.9, 1.51 (95% CI, 1.13 to 2.02) for a BMI of 35.0 to 39.9, and 2.19 (95% CI, 1.62 to 2.95) for a BMI of 40.0 to 49.9 (P < 0.001 for trend). A large waist circumference was associated with an increased risk of death from any cause among women with a BMI of less than 30.0. Conclusions The risk of death from any cause among black women increased with an increasing BMI of 25.0 or higher, which is similar to the pattern observed among whites. Waist circumference appeared to be associated with an increased risk of death only among nonobese women. (Funded by the National Cancer Institute.)	[Boggs, Deborah A.; Rosenberg, Lynn; Cozier, Yvette C.; Wise, Lauren A.; Coogan, Patricia F.; Ruiz-Narvaez, Edward A.; Palmer, Julie R.] Boston Univ, Slone Epidemiol Ctr, Boston, MA 02215 USA	Boston University	Boggs, DA (corresponding author), Boston Univ, Slone Epidemiol Ctr, 1010 Commonwealth Ave, Boston, MA 02215 USA.	dboggs@bu.edu		Wise, Lauren/0000-0003-2138-3752; Palmer, Julie/0000-0002-6534-335X; Rosenberg, Lynn/0000-0003-2760-2987; Ruiz-Narvaez, Edward/0000-0002-0339-5824; Coogan, Patricia/0000-0003-3671-7663; Cozier, Yvette/0000-0003-0625-7256	National Cancer Institute [CA058420]; NATIONAL CANCER INSTITUTE [R01CA058420] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by a grant (CA058420) from the National Cancer Institute.	Adams KF, 2006, NEW ENGL J MED, V355, P763, DOI 10.1056/NEJMoa055643; Beydoun MA, 2009, OBESITY, V17, P169, DOI 10.1038/oby.2008.492; Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501; Carter-Nolan PL, 2006, ETHNIC DIS, V16, P943; CORNONIHUNTLEY JC, 1991, J CLIN EPIDEMIOL, V44, P743, DOI 10.1016/0895-4356(91)90126-T; de Gonzalez AB, 2010, NEW ENGL J MED, V363, P2211, DOI 10.1056/NEJMoa1000367; *DEP COMM BUR CENS, 1996, ED ATT US; Deurenberg P, 1998, INT J OBESITY, V22, P1164, DOI 10.1038/sj/ijo/0800741; Durazo-Arvizu RA, 1998, AM J EPIDEMIOL, V147, P739, DOI 10.1093/oxfordjournals.aje.a009518; DurazoArvizu R, 1997, ANN EPIDEMIOL, V7, P383, DOI 10.1016/S1047-2797(97)00044-6; Flegal KM, 2005, JAMA-J AM MED ASSOC, V293, P1861, DOI 10.1001/jama.293.15.1861; Jacobs EJ, 2010, ARCH INTERN MED, V170, P1293, DOI 10.1001/archinternmed.2010.201; Jemal A, 2008, AM J PREV MED, V34, P1, DOI 10.1016/j.amepre.2007.09.017; Koster A, 2008, AM J EPIDEMIOL, V167, P1465, DOI 10.1093/aje/kwn079; Lantz PM, 1998, JAMA-J AM MED ASSOC, V279, P1703, DOI 10.1001/jama.279.21.1703; *NAT CTR HLTH STAT, 2000, NAT DEATH IND US MAN; Orpana HM, 2010, OBESITY, V18, P214, DOI 10.1038/oby.2009.191; Pischon T, 2010, NEW ENGL J MED, V362, P2433; Reis JP, 2009, ANN EPIDEMIOL, V19, P134, DOI 10.1016/j.annepidem.2008.10.008; Rosenberg L, 1999, AM J EPIDEMIOL, V150, P904; Stevens J, 1998, OBES RES, V6, P268, DOI 10.1002/j.1550-8528.1998.tb00349.x; STEVENS J, 1992, ARCH INTERN MED, V152, P1257, DOI 10.1001/archinte.152.6.1257; Stringhini S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000419; WIENPAHL J, 1990, J CLIN EPIDEMIOL, V43, P949, DOI 10.1016/0895-4356(90)90078-4; Wise LA, 2005, EPIDEMIOLOGY, V16, P346, DOI 10.1097/01.ede.0000158742.11877.99; Zhang C, 2008, CIRCULATION, V117, P1658, DOI 10.1161/CIRCULATIONAHA.107.739714; Zheng W, 2011, NEW ENGL J MED, V364, P719, DOI 10.1056/NEJMoa1010679	27	94	98	2	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 8	2011	365	10					901	908		10.1056/NEJMoa1104119	http://dx.doi.org/10.1056/NEJMoa1104119			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	816JX	21899451	Green Accepted			2022-12-28	WOS:000294595600006
J	Deng, HX; Chen, WJ; Hong, ST; Boycott, KM; Gorrie, GH; Siddique, N; Yang, Y; Fecto, F; Shi, Y; Zhai, H; Jiang, HJ; Hirano, M; Rampersaud, E; Jansen, GH; Donkervoort, S; Bigio, EH; Brooks, BR; Ajroud, K; Sufit, RL; Haines, JL; Mugnaini, E; Pericak-Vance, MA; Siddique, T				Deng, Han-Xiang; Chen, Wenjie; Hong, Seong-Tshool; Boycott, Kym M.; Gorrie, George H.; Siddique, Nailah; Yang, Yi; Fecto, Faisal; Shi, Yong; Zhai, Hong; Jiang, Hujun; Hirano, Makito; Rampersaud, Evadnie; Jansen, Gerard H.; Donkervoort, Sandra; Bigio, Eileen H.; Brooks, Benjamin R.; Ajroud, Kaouther; Sufit, Robert L.; Haines, Jonathan L.; Mugnaini, Enrico; Pericak-Vance, Margaret A.; Siddique, Teepu			Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS/dementia	NATURE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; PROTEIN AGGREGATION; SUPEROXIDE-DISMUTASE; GENE-MUTATIONS; TDP-43; CRITERIA; DOMAINS; FUS; PROTEASOME	Amyotrophic lateral sclerosis (ALS) is a paralytic and usually fatal disorder caused by motor-neuron degeneration in the brain and spinal cord. Most cases of ALS are sporadic but about 5-10% are familial. Mutations in superoxide dismutase 1 (SOD1)(1,2), TAR DNA-binding protein (TARDBP, also known as TDP43)(3,4) and fused in sarcoma (FUS, also known as translocated in liposarcoma (TLS))(5,6) account for approximately 30% of classic familial ALS. Mutations in several other genes have also been reported as rare causes of ALS or ALS-like syndromes(7-15). The causes of the remaining cases of familial ALS and of the vast majority of sporadic ALS are unknown. Despite extensive studies of previously identified ALS-causing genes, the pathogenic mechanism underlying motor-neuron degeneration in ALS remains largely obscure. Dementia, usually of the frontotemporal lobar type, may occur in some ALS cases. It is unclear whether ALS and dementia share common aetiology and pathogenesis in ALS/dementia. Here we show that mutations in UBQLN2, which encodes the ubiquitin-like protein ubiquilin 2, cause dominantly inherited, chromosome-X-linked ALS and ALS/dementia. We describe novel ubiquilin 2 pathology in the spinal cords of ALS cases and in the brains of ALS/dementia cases with or without UBQLN2 mutations. Ubiquilin 2 is a member of the ubiquilin family, which regulates the degradation of ubiquitinated proteins. Functional analysis showed that mutations in UBQLN2 lead to an impairment of protein degradation. Therefore, our findings link abnormalities in ubiquilin 2 to defects in the protein degradation pathway, abnormal protein aggregation and neurodegeneration, indicating a common pathogenic mechanism that can be exploited for therapeutic intervention.	[Deng, Han-Xiang; Chen, Wenjie; Hong, Seong-Tshool; Gorrie, George H.; Siddique, Nailah; Yang, Yi; Fecto, Faisal; Shi, Yong; Zhai, Hong; Jiang, Hujun; Hirano, Makito; Donkervoort, Sandra; Ajroud, Kaouther; Sufit, Robert L.; Siddique, Teepu] Northwestern Univ, Feinberg Sch Med, Davee Dept Neurol & Clin Neurosci, Div Neuromuscular Med, Chicago, IL 60611 USA; [Boycott, Kym M.] Childrens Hosp Eastern Ontario, Res Inst, Ottawa, ON K1H 8L1, Canada; [Boycott, Kym M.] Univ Ottawa, Dept Pediat, Ottawa, ON K1H 8L1, Canada; [Fecto, Faisal; Mugnaini, Enrico; Siddique, Teepu] Northwestern Univ, Feinberg Sch Med, Interdept Neurosci Program, Chicago, IL 60611 USA; [Rampersaud, Evadnie; Pericak-Vance, Margaret A.] Univ Miami, Miller Sch Med, John P Hussman Inst Human Genom, Miami, FL 33136 USA; [Jansen, Gerard H.] Ottawa Hosp, Div Anat Pathol, Ottawa, ON K1Y 4E9, Canada; [Bigio, Eileen H.] Northwestern Univ, Feinberg Sch Med, Dept Pathol, Div Neuropathol, Chicago, IL 60611 USA; [Brooks, Benjamin R.] Carolinas Med Ctr, Dept Neurol, Neurosci & Spine Inst, Charlotte, NC 28207 USA; [Haines, Jonathan L.] Vanderbilt Univ, Ctr Human Genet Res, Nashville, TN 37232 USA; [Mugnaini, Enrico; Siddique, Teepu] Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; University of Ottawa; Children's Hospital of Eastern Ontario; University of Ottawa; Northwestern University; Feinberg School of Medicine; University of Miami; University of Ottawa; Ottawa Hospital Research Institute; Northwestern University; Feinberg School of Medicine; Carolinas Medical Center; Vanderbilt University; Northwestern University; Feinberg School of Medicine	Siddique, T (corresponding author), Northwestern Univ, Feinberg Sch Med, Davee Dept Neurol & Clin Neurosci, Div Neuromuscular Med, Chicago, IL 60611 USA.	t-siddique@northwestern.edu	Haines, Jonathan/C-3374-2012; Siddique, Teepu/AAT-8166-2021; 陈, 文杰·/HHN-5495-2022	Haines, Jonathan/0000-0002-4351-4728; 陈, 文杰·/0000-0003-0556-7391; Fecto, Faisal/0000-0002-7587-8024; Hong, Seong-Tshool/0000-0001-8254-6581; Siddique, Teepu/0000-0001-7293-9146; Deng, Han-Xiang/0000-0002-0030-8465	National Institute of Neurological Disorders and Stroke [NS050641]; Les Turner ALS Foundation; Vena E. Schaff ALS Research Fund; Herbert and Florence C. Wenske Foundation; David C. Asselin MD Memorial Fund; Help America Foundation; Les Turner ALS Foundation/Herbert C. Wenske Foundation; NIH [T32AG20506]; MND Scotland; NCI [CCSG P30 CA060553]; NATIONAL CANCER INSTITUTE [P30CA060553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050641, R01NS037912] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG020506] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Les Turner ALS Foundation; Vena E. Schaff ALS Research Fund; Herbert and Florence C. Wenske Foundation; David C. Asselin MD Memorial Fund; Help America Foundation; Les Turner ALS Foundation/Herbert C. Wenske Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MND Scotland; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by the National Institute of Neurological Disorders and Stroke (NS050641), the Les Turner ALS Foundation, the Vena E. Schaff ALS Research Fund, the Harold Post Research Professorship, the Herbert and Florence C. Wenske Foundation, the David C. Asselin MD Memorial Fund, the Help America Foundation and the Les Turner ALS Foundation/Herbert C. Wenske Foundation Professorship. F. F. has support from NIH (T32AG20506). K. A. is a postdoctoral fellow of the Blazeman Foundation for ALS. G. H. G. received travel funds from MND Scotland. We thank N. Dantuma for the UPS reporter plasmid (through Addgene) and the staff of the Northwestern University Robert H. Lurie Comprehensive Cancer Center flow cytometry core facility for technical assistance. Imaging work was performed at the Northwestern University Cell Imaging Facility, supported by NCI CCSG P30 CA060553 awarded to the Robert H Lurie Comprehensive Cancer Center.	Aguzzi A, 2010, NAT REV DRUG DISCOV, V9, P237, DOI 10.1038/nrd3050; Aitio O, 2010, P NATL ACAD SCI USA, V107, P21743, DOI 10.1073/pnas.1010243107; Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, P293, DOI 10.1080/146608200300079536; Cairns NJ, 2007, ACTA NEUROPATHOL, V114, P5, DOI 10.1007/s00401-007-0237-2; Chen YZ, 2004, AM J HUM GENET, V74, P1128, DOI 10.1086/421054; Chow CY, 2009, AM J HUM GENET, V84, P85, DOI 10.1016/j.ajhg.2008.12.010; Dantuma NP, 2000, NAT BIOTECHNOL, V18, P538, DOI 10.1038/75406; Deng HX, 2010, ANN NEUROL, V67, P739, DOI 10.1002/ana.22051; DENG HX, 1993, SCIENCE, V261, P1047, DOI 10.1126/science.8351519; Deng HX, 2006, P NATL ACAD SCI USA, V103, P7142, DOI 10.1073/pnas.0602046103; Fecto F, 2011, J BIOL CHEM, V286, P17281, DOI 10.1074/jbc.M111.237685; Greenway MJ, 2006, NAT GENET, V38, P411, DOI 10.1038/ng1742; Haapasalo A, 2010, BIOCHEM SOC T, V38, P150, DOI 10.1042/BST0380150; Johnson JO, 2010, NEURON, V68, P857, DOI 10.1016/j.neuron.2010.11.036; Kabashi E, 2008, NAT GENET, V40, P572, DOI 10.1038/ng.132; Kay BK, 2000, FASEB J, V14, P231, DOI 10.1096/fasebj.14.2.231; Kim SH, 2009, J BIOL CHEM, V284, P8083, DOI 10.1074/jbc.M808064200; Ko HS, 2004, FEBS LETT, V566, P110, DOI 10.1016/j.febslet.2004.04.031; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; Lansbury PT, 2006, NATURE, V443, P774, DOI 10.1038/nature05290; Mackenzie IRA, 2007, ANN NEUROL, V61, P427, DOI 10.1002/ana.21147; Mackenzie IRA, 2006, ACTA NEUROPATHOL, V112, P539, DOI 10.1007/s00401-006-0138-9; Maruyama H, 2010, NATURE, V465, P223, DOI 10.1038/nature08971; Mitchell J, 2010, P NATL ACAD SCI USA, V107, P7556, DOI 10.1073/pnas.0914128107; Neary D, 1998, NEUROLOGY, V51, P1546, DOI 10.1212/WNL.51.6.1546; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Neumann M, 2009, BRAIN, V132, P2922, DOI 10.1093/brain/awp214; Nishimura AL, 2004, AM J HUM GENET, V75, P822, DOI 10.1086/425287; Nonaka T, 2009, HUM MOL GENET, V18, P3353, DOI 10.1093/hmg/ddp275; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Shibata N, 1996, J NEUROPATH EXP NEUR, V55, P481, DOI 10.1097/00005072-199604000-00011; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Ticozzi N, 2010, ANN NEUROL, V68, P102, DOI 10.1002/ana.21993; Urwin H, 2010, ACTA NEUROPATHOL, V120, P33, DOI 10.1007/s00401-010-0698-6; Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942; Yang Y, 2001, NAT GENET, V29, P160, DOI 10.1038/ng1001-160	36	813	841	4	117	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 8	2011	477	7363					211	U113		10.1038/nature10353	http://dx.doi.org/10.1038/nature10353			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	816MC	21857683	Green Accepted			2022-12-28	WOS:000294603900036
J	van den Aardweg, MTA; Boonacker, CWB; Rovers, MM; Hoes, AW; Schilder, AGM				van den Aardweg, M. T. A.; Boonacker, C. W. B.; Rovers, M. M.; Hoes, A. W.; Schilder, A. G. M.			Effectiveness of adenoidectomy in children with recurrent upper respiratory tract infections: open randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							QUALITY-OF-LIFE; OTITIS-MEDIA SURGERY; HEALTH QUESTIONNAIRE; MANAGEMENT; COSTS; FEVER	Objective To assess the effectiveness of adenoidectomy in children with recurrent upper respiratory tract infections. Design Open randomised controlled trial. Setting 11 general hospitals and two academic centres. Participants 111 children aged 1-6 with recurrent upper respiratory tract infections selected for adenoidectomy. Intervention A strategy of immediate adenoidectomy with or without myringotomy or a strategy of initial watchful waiting. Main outcome measure Primary outcome measure: number of upper respiratory tract infections per person year calculated from data obtained during the total follow-up (maximum 24 months). Secondary outcome measures: days with upper respiratory tract infection per person year, middle ear complaints with fever in episodes and days, days with fever, prevalence of upper respiratory tract infections, and health related quality of life. Results During the median follow-up of 24 months, there were 7.91 episodes of upper respiratory tract infections per person year in the adenoidectomy group and 7.84 in the watchful waiting group (difference in incidence rate 0.07, 95% confidence interval -0.70 to 0.85). No relevant differences were found for days of upper respiratory tract infections and middle ear complaints with fever in episodes and days, nor for health related quality of life. The prevalence of upper respiratory tract infections decreased over time in both groups. Children in the adenoidectomy group had significantly more days with fever than the children in the watchful waiting group. Two children had complications related to surgery. Conclusion In children selected for adenoidectomy for recurrent upper respiratory tract infections, a strategy of immediate surgery confers no clinical benefits over a strategy of initial watchful waiting.	[Schilder, A. G. M.] Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Dept Otorhinolaryngol, NL-3590 AB Utrecht, Netherlands; [Boonacker, C. W. B.; Rovers, M. M.; Hoes, A. W.; Schilder, A. G. M.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, NL-3590 AB Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; Utrecht University; Utrecht University Medical Center	Schilder, AGM (corresponding author), Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Dept Otorhinolaryngol, HP KE 04-140-5,POB 85090, NL-3590 AB Utrecht, Netherlands.	A.Schilder@umcutrecht.nl	Rovers, Maroeska/F-2969-2014	Rovers, Maroeska/0000-0002-3095-170X; Schilder, Anne/0000-0002-5496-4580	ZonMw-the Netherlands Organisation for Health Research and Development [80-007022-98-07901]	ZonMw-the Netherlands Organisation for Health Research and Development(Netherlands Organization for Health Research and Development)	This study was funded by ZonMw-the Netherlands Organisation for Health Research and Development, healthcare efficiency research programme, subprogramme effects and costs 2007 No 80-007022-98-07901. The funder had no role in the study design and the collection, analysis, and interpretation of data and the writing of the article and the decision to submit it for publication. All authors were independent from the funder and had access to all the data.	Altman DG, 2005, BRIT MED J, V330, P843, DOI 10.1136/bmj.330.7495.843; [Anonymous], 2011, LAND LMR INF VERR; Bhattacharyya N, 2010, OTOLARYNG HEAD NECK, V143, P680, DOI 10.1016/j.otohns.2010.06.918; Carabin H, 1999, PEDIATRICS, V103, P556, DOI 10.1542/peds.103.3.556; DIXON RE, 1985, AM J MED, V78, P45, DOI 10.1016/0002-9343(85)90363-8; Dutch Society for Otorhinolaryngology and Head and Neck Surgery, 2007, GUID AD TONS DIS; ESKERUD JR, 1992, FAM PRACT, V9, P263, DOI 10.1093/fampra/9.3.263; Georgalas C, 2004, LARYNGOSCOPE, V114, P1849, DOI 10.1097/00005537-200410000-00032; Haapkya J, 2008, INT J PEDIATR OTORHI, V72, P1207, DOI 10.1016/j.ijporl.2008.04.012; HARSTEN G, 1990, ACTA PAEDIATR SCAND, V79, P402, DOI 10.1111/j.1651-2227.1990.tb11484.x; Karevold G, 2007, INT J PEDIATR OTORHI, V71, P1035, DOI 10.1016/j.ijporl.2007.03.010; Kay DJ, 2003, OTOLARYNG HEAD NECK, V128, P17, DOI 10.1067/mhn.2003.41; Koivunen P, 2004, BMJ-BRIT MED J, V328, P487, DOI 10.1136/bmj.37972.678345.0D; Kvaerner KJ, 2002, ANN OTO RHINOL LARYN, V111, P1034, DOI 10.1177/000348940211101115; Lock C, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14130; Paradise JL, 2002, PEDIATRICS, V110; Post M W, 1998, Ned Tijdschr Geneeskd, V142, P2680; Post M W, 1998, Ned Tijdschr Geneeskd, V142, P2675; Rosenfeld RM, 1997, ARCH OTOLARYNGOL, V123, P1049; RYNNELDAGOO B, 1978, ANN OTO RHINOL LARYN, V87, P272, DOI 10.1177/000348947808700223; Schilder AGM, 2004, INT J PEDIATR OTORHI, V68, P29, DOI 10.1016/j.ijporl.2003.09.002; Sohn H, 2003, OTOLARYNG HEAD NECK, V128, P344, DOI 10.1067/mhn.2003.4; SOMAN M, 1985, J FAM PRACTICE, V21, P117; van den Aardweg MTA, 2010, B-ENT, V6, P15; van den Aardweg MTA, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007810.pub2; van den Aardweg MT, 2010, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD008282.); van Staaij BK, 2004, BMJ-BRIT MED J, V329, P651, DOI 10.1136/bmj.38210.827917.7C; van Staaij BK, 2003, INT J PEDIATR OTORHI, V67, P1091, DOI 10.1016/S0165-5876(03)00198-8; Wulffraat N, 2001, CLIN EXP RHEUMATOL, V19, pS111	29	25	25	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 6	2011	343								d5154	10.1136/bmj.d5154	http://dx.doi.org/10.1136/bmj.d5154			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	819RF	21896611	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000294846500002
J	Swan, BK; Martinez-Garcia, M; Preston, CM; Sczyrba, A; Woyke, T; Lamy, D; Reinthaler, T; Poulton, NJ; Masland, EDP; Gomez, ML; Sieracki, ME; DeLong, EF; Herndl, GJ; Stepanauskas, R				Swan, Brandon K.; Martinez-Garcia, Manuel; Preston, Christina M.; Sczyrba, Alexander; Woyke, Tanja; Lamy, Dominique; Reinthaler, Thomas; Poulton, Nicole J.; Masland, E. Dashiell P.; Gomez, Monica Lluesma; Sieracki, Michael E.; DeLong, Edward F.; Herndl, Gerhard J.; Stepanauskas, Ramunas			Potential for Chemolithoautotrophy Among Ubiquitous Bacteria Lineages in the Dark Ocean	SCIENCE			English	Article							MARINE-BACTERIA; NORTH-ATLANTIC; MONTEREY BAY; ONE-CELL; INTERIOR; ARCHAEA; TIME; ASSEMBLAGES; METABOLISM; AUTOTROPHY	Recent studies suggest that unidentified prokaryotes fix inorganic carbon at globally significant rates in the immense dark ocean. Using single-cell sorting and whole-genome amplification of prokaryotes from two subtropical gyres, we obtained genomic DNA from 738 cells representing most cosmopolitan lineages. Multiple cells of Deltaproteobacteria cluster SAR324, Gammaproteobacteria clusters ARCTIC96BD-19 and Agg47, and some Oceanospirillales from the lower mesopelagic contained ribulose-1,5-bisphosphate carboxylase-oxygenase and sulfur oxidation genes. These results corroborated community DNA and RNA profiling from diverse geographic regions. The SAR324 genomes also suggested C(1) metabolism and a particle-associated life-style. Microautoradiography and fluorescence in situ hybridization confirmed bicarbonate uptake and particle association of SAR324 cells. Our study suggests potential chemolithoautotrophy in several uncultured Proteobacteria lineages that are ubiquitous in the dark oxygenated ocean and provides new perspective on carbon cycling in the ocean's largest habitat.	[Swan, Brandon K.; Martinez-Garcia, Manuel; Poulton, Nicole J.; Masland, E. Dashiell P.; Gomez, Monica Lluesma; Sieracki, Michael E.; Stepanauskas, Ramunas] Bigelow Lab Ocean Sci, W Boothbay Harbor, ME 04575 USA; [Preston, Christina M.] Monterey Bay Aquarium Res Inst, Moss Landing, CA 95064 USA; [Sczyrba, Alexander; Woyke, Tanja] US DOE, Joint Genome Inst, Walnut Creek, CA 94598 USA; [Lamy, Dominique; Reinthaler, Thomas; Herndl, Gerhard J.] Univ Vienna, Dept Marine Biol, Fac Ctr Ecol, A-1090 Vienna, Austria; [DeLong, Edward F.] MIT, Dept Biol Engn, Cambridge, MA 02138 USA; [DeLong, Edward F.] MIT, Dept Civil & Environm Engn, Cambridge, MA 02138 USA	Bigelow Laboratory for Ocean Sciences; Monterey Bay Aquarium Research Institute; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; University of Vienna; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Stepanauskas, R (corresponding author), Bigelow Lab Ocean Sci, 180 McKown Point Rd,POB 475, W Boothbay Harbor, ME 04575 USA.	rstepanauskas@bigelow.org	Herndl, Gerhard J./B-1513-2013; Herndl, Gerhard J./S-3011-2019; Martínez-García, Manuel/AAT-1935-2021; Reinthaler, Thomas/E-6563-2013; Swan, Brandon K/O-9824-2018	Herndl, Gerhard J./0000-0002-2223-2852; Herndl, Gerhard J./0000-0002-2223-2852; Martínez-García, Manuel/0000-0001-5056-1525; Reinthaler, Thomas/0000-0003-3881-3122; Swan, Brandon K/0000-0003-0465-1444; Stepanauskas, Ramunas/0000-0003-4458-3108; Sczyrba, Alexander/0000-0002-4405-3847; Poulton, Nicole/0000-0003-3020-4509; Sieracki, Michael/0000-0001-7959-1832	NSF [EF-826924, OCE-0821374]; Maine Technology Institute (Bigelow Laboratory); U.S. Department of Energy (DOE) [CSP77]; David and Lucille Packard Foundation; Gordon and Betty Moore Foundation; Dutch Science Fund-Earth and Life Sciences; Austrian Science Fund-FWF; European Science Foundation; Marie Curie project ARCADIA; Office of Science of the DOE [DE-AC02-05CH11231]; Austrian Science Fund (FWF) [I 486, Z 194] Funding Source: researchfish	NSF(National Science Foundation (NSF)); Maine Technology Institute (Bigelow Laboratory); U.S. Department of Energy (DOE)(United States Department of Energy (DOE)); David and Lucille Packard Foundation(The David & Lucile Packard Foundation); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Dutch Science Fund-Earth and Life Sciences; Austrian Science Fund-FWF(Austrian Science Fund (FWF)); European Science Foundation(European Science Foundation (ESF)European Commission); Marie Curie project ARCADIA; Office of Science of the DOE(United States Department of Energy (DOE)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by NSF grants EF-826924 and OCE-0821374 (R. S. and M. E. S.), a grant from the Maine Technology Institute (Bigelow Laboratory), U.S. Department of Energy (DOE) JGI 2010 Microbes Program grant CSP77 (R. S. and M. E. S.), the David and Lucille Packard Foundation (C. M. P.), the Gordon and Betty Moore Foundation (E. F. D.), the Dutch Science Fund-Earth and Life Sciences (G.J.H.), the Austrian Science Fund-FWF and European Science Foundation EuroEEFG project MOCA (G.J.H.), and Marie Curie project ARCADIA (G.J.H.). Work conducted by the DOE Joint Genome Institute is supported by the Office of Science of the DOE under contract no. DE-AC02-05CH11231. We thank chief scientist S. Curless, the officers and crew of the RV Ka'imikai-O-Kanaloa, and the HOT team for sample collection at station ALOHA; S. Sievert of the Woods Hole Oceanographic Institute for providing PCR primer information; J. Heywood of Bigelow for collecting South Atlantic field samples; the crew of the RV Point Lobos; V. Rich for initial screening of Monterey Bay libraries; and F. Chavez, R. Michasaki, and T. Pennington for providing Monterey Bay oceanographic data. SSU rRNA and metabolic gene sequences have been deposited in GenBank with the following accession numbers: SSU rRNA, HQ675122 to HQ675859; cbbL, HQ675043 to HQ675069; cbbM, HQ675070-HQ675086; aprA, HQ675087-HQ675118; and rdsrA, HQ675119 to HQ675121. Whole-genome sequence data have accession numbers AFHZ00000000 (AAA001-B15), AFIB00000000 (AAA001-C10), AFHY00000000 (AAA007-O20), and AFIA00000000 (AAA240-J09). Raw sequences were deposited in the GenBank Short Read Archive under accession numbers SRA029592 and SRA035467 (AAA001-B15), SRA029604 and SRA035394 (AAA001-C10), SRA029593 and SRA035468 (AAA007-O20), and SRA029596 and SRA035470 (AAA240-J09).	Agogue H, 2008, NATURE, V456, P788, DOI 10.1038/nature07535; Aristegui J, 2009, LIMNOL OCEANOGR, V54, P1501, DOI 10.4319/lo.2009.54.5.1501; Berg IA, 2007, SCIENCE, V318, P1782, DOI 10.1126/science.1149976; Canfield DE, 2010, SCIENCE, V330, P1375, DOI 10.1126/science.1196889; del Giorgio PA, 2002, NATURE, V420, P379, DOI 10.1038/nature01165; DeLong EF, 2006, SCIENCE, V311, P496, DOI 10.1126/science.1120250; DELONG EF, 1993, LIMNOL OCEANOGR, V38, P924, DOI 10.4319/lo.1993.38.5.0924; Giovannoni SJ, 2005, SCIENCE, V309, P1242, DOI 10.1126/science.1114057; Hanson TE, 2001, P NATL ACAD SCI USA, V98, P4397, DOI 10.1073/pnas.081610398; Hayashi NR, 1997, BIOCHEM BIOPH RES CO, V241, P565, DOI 10.1006/bbrc.1997.7853; Herndl GJ, 2005, APPL ENVIRON MICROB, V71, P2303, DOI 10.1128/AEM.71.5.2303-2309.2005; KARL DM, 1984, NATURE, V309, P54, DOI 10.1038/309054a0; Marcy Y, 2007, P NATL ACAD SCI USA, V104, P11889, DOI 10.1073/pnas.0704662104; Meyer B, 2007, APPL ENVIRON MICROB, V73, P7664, DOI 10.1128/AEM.01272-07; Pham VD, 2008, ENVIRON MICROBIOL, V10, P2313, DOI 10.1111/j.1462-2920.2008.01657.x; Radford-Knoery J, 2001, LIMNOL OCEANOGR, V46, P461, DOI 10.4319/lo.2001.46.2.0461; Raghunathan A, 2005, APPL ENVIRON MICROB, V71, P3342, DOI 10.1128/AEM.71.6.3342-3347.2005; Reinthaler T, 2010, DEEP-SEA RES PT II, V57, P1572, DOI 10.1016/j.dsr2.2010.02.023; Rich VI, 2011, ENVIRON MICROBIOL, V13, P116, DOI 10.1111/j.1462-2920.2010.02314.x; SHANKS AL, 1993, MAR ECOL PROG SER, V96, P43, DOI 10.3354/meps096043; Shi YM, 2009, NATURE, V459, P266, DOI 10.1038/nature08055; Stepanauskas R, 2007, P NATL ACAD SCI USA, V104, P9052, DOI 10.1073/pnas.0700496104; Stocker R, 2008, P NATL ACAD SCI USA, V105, P4209, DOI 10.1073/pnas.0709765105; Suzuki MT, 2004, MICROB ECOL, V48, P473, DOI 10.1007/s00248-004-0213-5; Taylor GT, 2001, LIMNOL OCEANOGR, V46, P148, DOI 10.4319/lo.2001.46.1.0148; Tripp HJ, 2010, NATURE, V464, P90, DOI 10.1038/nature08786; TURLEY CM, 1995, DEEP-SEA RES PT I, V42, P1453, DOI 10.1016/0967-0637(95)00056-C; Varela MM, 2011, ENVIRON MICROBIOL, V13, P1524, DOI 10.1111/j.1462-2920.2011.02457.x; Walsh DA, 2009, SCIENCE, V326, P578, DOI 10.1126/science.1175309; Woyke T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005299; Wuchter C, 2006, P NATL ACAD SCI USA, V103, P12317, DOI 10.1073/pnas.0600756103; Zhang K, 2006, NAT BIOTECHNOL, V24, P680, DOI 10.1038/nbt1214	32	371	376	10	206	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 2	2011	333	6047					1296	1300		10.1126/science.1203690	http://dx.doi.org/10.1126/science.1203690			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	813YM	21885783				2022-12-28	WOS:000294406400056
J	Overbaugh, J				Overbaugh, Julie			A healthy work-life balance can enhance research	NATURE			English	Editorial Material									Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center	Overbaugh, J (corresponding author), Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98109 USA.	joverbau@fhcrc.org							0	9	9	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 1	2011	477	7362					27	28		10.1038/477027a	http://dx.doi.org/10.1038/477027a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	813XT	21886140	Bronze			2022-12-28	WOS:000294404300012
J	Buitrago-Lopez, A; Sanderson, J; Johnson, L; Warnakula, S; Wood, A; Di Angelantonio, E; Franco, OH				Buitrago-Lopez, Adriana; Sanderson, Jean; Johnson, Laura; Warnakula, Samantha; Wood, Angela; Di Angelantonio, Emanuele; Franco, Oscar H.			Chocolate consumption and cardiometabolic disorders: systematic review and meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BLOOD-PRESSURE; DARK CHOCOLATE; CARDIOVASCULAR-DISEASE; ENDOTHELIAL FUNCTION; INSULIN SENSITIVITY; VASCULAR FUNCTION; RISK-FACTORS; DOUBLE-BLIND; COCOA; FLAVANOLS	Objective To evaluate the association of chocolate consumption with the risk of developing cardiometabolic disorders. Design Systematic review and meta-analysis of randomised controlled trials and observational studies. Data sources Medline, Embase, Cochrane Library, PubMed, CINAHL, IPA, Web of Science, Scopus, Pascal, reference lists of relevant studies to October 2010, and email contact with authors. Study selection Randomised trials and cohort, case-control, and cross sectional studies carried out in human adults, in which the association between chocolate consumption and the risk of outcomes related to cardiometabolic disorders were reported. Data extraction Data were extracted by two independent investigators, and a consensus was reached with the involvement of a third. The primary outcome was cardiometabolic disorders, including cardiovascular disease (coronary heart disease and stroke), diabetes, and metabolic syndrome. A meta-analysis assessed the risk of developing cardiometabolic disorders by comparing the highest and lowest level of chocolate consumption. Results From 4576 references seven studies met the inclusion criteria (including 114 009 participants). None of the studies was a randomised trial, six were cohort studies, and one a cross sectional study. Large variation was observed between these seven studies for measurement of chocolate consumption, methods, and outcomes evaluated. Five of the seven studies reported a beneficial association between higher levels of chocolate consumption and the risk of cardiometabolic disorders. The highest levels of chocolate consumption were associated with a 37% reduction in cardiovascular disease (relative risk 0.63 (95% confidence interval 0.44 to 0.90)) and a 29% reduction in stroke compared with the lowest levels. Conclusions Based on observational evidence, levels of chocolate consumption seem to be associated with a substantial reduction in the risk of cardiometabolic disorders. Further experimental studies are required to confirm a potentially beneficial effect of chocolate consumption.	[Sanderson, Jean; Johnson, Laura; Warnakula, Samantha; Wood, Angela; Di Angelantonio, Emanuele; Franco, Oscar H.] Univ Cambridge, Dept Publ Hlth & Primary Care, Cardiovasc Epidemiol Unit, Strangeways Res Lab, Cambridge CB1 8RN, England	University of Cambridge	Franco, OH (corresponding author), Univ Cambridge, Dept Publ Hlth & Primary Care, Cardiovasc Epidemiol Unit, Strangeways Res Lab, Cambridge CB1 8RN, England.	ohf22@medschl.cam.ac.uk	Franco, Óscar H/ABE-2305-2020; DiAngelantonio, Emanuele/ABE-6852-2020; Johnson, Laura/C-2700-2008; Buitrago-Lopez, Adriana/AAD-6697-2019; Hug, Balthasar L./G-1568-2010; Wood, Angela/GZA-5762-2022	Franco, Óscar H/0000-0002-4606-4929; Buitrago-Lopez, Adriana/0000-0002-2840-0781; Wood, Angela/0000-0002-7937-304X; Di Angelantonio, Emanuele/0000-0001-8776-6719; Johnson, Laura/0000-0001-8985-3154; Hamilton, Jean/0000-0003-3326-9842	British Heart Foundation [RG/08/014/24067] Funding Source: Medline	British Heart Foundation(British Heart Foundation)		Allen R, 2007, FASEB J, V21, pA338; Allen RR, 2008, J NUTR, V138, P725, DOI 10.1093/jn/138.4.725; Balzer J, 2008, J AM COLL CARDIOL, V51, P2141, DOI 10.1016/j.jacc.2008.01.059; Balzer J, 2006, J CARDIOVASC PHARM, V47, pS122, DOI 10.1097/00005344-200606001-00006; Buijsse B, 2006, CIRCULATION, V113, pE372; Buijsse B, 2006, ARCH INTERN MED, V166, P411, DOI 10.1001/.411; Buijsse B, 2010, EUR HEART J, V31, P1616, DOI 10.1093/eurheartj/ehq068; Carter P, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4229; Corti R, 2009, CIRCULATION, V119, P1433, DOI 10.1161/CIRCULATIONAHA.108.827022; Crews WD, 2008, AM J CLIN NUTR, V87, P872, DOI 10.1093/ajcn/87.4.872; Davison K, 2008, INT J OBESITY, V32, P1289, DOI 10.1038/ijo.2008.66; Desch S, 2010, AM J HYPERTENS, V23, P97, DOI 10.1038/ajh.2009.213; Ding EL, 2006, NUTR METAB, V3, DOI 10.1186/1743-7075-3-2; Djousse L, 2011, CLIN NUTR, V30, P182, DOI 10.1016/j.clnu.2010.08.005; Faridi Z, 2008, AM J CLIN NUTR, V88, P58, DOI 10.1093/ajcn/88.1.58; Farouque HMO, 2006, CLIN SCI, V111, P71, DOI 10.1042/CS20060048; Grassi D, 2005, HYPERTENSION, V46, P398, DOI 10.1161/01.HYP.0000174990.46027.70; Grassi D, 2005, AM J CLIN NUTR, V81, P611; Grassi D, 2008, J NUTR, V138, P1671, DOI 10.1093/jn/138.9.1671; Heiss C, 2010, J AM COLL CARDIOL, V56, P218, DOI 10.1016/j.jacc.2010.03.039; Hermann F, 2006, HEART, V92, P119, DOI 10.1136/hrt.2005.063362; Hooper L, 2008, AM J CLIN NUTR, V88, P38, DOI 10.1093/ajcn/88.1.38; Irwig L, 1998, BRIT MED J, V316, P470; Janszky I, 2009, J INTERN MED, V266, P248, DOI 10.1111/j.1365-2796.2009.02088.x; Jia L, 2010, AM J CLIN NUTR, V92, P218, DOI 10.3945/ajcn.2009.28202; Kurlandsky SB, 2006, NUTR RES, V26, P509, DOI 10.1016/j.nutres.2006.08.007; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; MANTEL N, 1959, J NATL CANCER I, V22, P719; Mink PJ, 2007, AM J CLIN NUTR, V85, P895, DOI 10.1093/ajcn/85.3.895; Monagas M, 2009, AM J CLIN NUTR, V90, P1144, DOI 10.3945/ajcn.2009.27716; Mostofsky E, 2010, CIRC-HEART FAIL, V3, P612, DOI 10.1161/CIRCHEARTFAILURE.110.944025; Oba S, 2010, BRIT J NUTR, V103, P453, DOI 10.1017/S0007114509991966; Ogbera AO, 2010, DIABETOL METAB SYNDR, V2, DOI 10.1186/1758-5996-2-1; Ried K, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-39; Taubert D, 2007, ARCH INTERN MED, V167, P626, DOI 10.1001/archinte.167.7.626; World Health Organization, 2011, CARD DIS; World Health Organization, 2000, 2008 2013 ACT PLAN G	37	164	167	0	48	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 29	2011	343								d4488	10.1136/bmj.d4488	http://dx.doi.org/10.1136/bmj.d4488			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	816KZ	21875885	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000294599700001
J	Choi, WS; Peifer, M				Choi, Wangsun; Peifer, Mark			Arranging a Cellular Checkerboard	SCIENCE			English	Editorial Material							DROSOPHILA EYE; ADHESION; JUNCTIONS; MORPHOGENESIS; NECTIN; CELLS		[Choi, Wangsun; Peifer, Mark] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; [Peifer, Mark] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Choi, WS (corresponding author), Univ N Carolina, Dept Biol, CB 3280, Chapel Hill, NC 27599 USA.	peifer@unc.edu		Peifer, Mark/0000-0003-1412-3987	Grants-in-Aid for Scientific Research [10J00984] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Bao SJ, 2005, DEV CELL, V8, P925, DOI 10.1016/j.devcel.2005.03.011; Bao SJ, 2010, DEV BIOL, V344, P948, DOI 10.1016/j.ydbio.2010.06.013; Fischbach KF, 2009, J NEUROGENET, V23, P48, DOI 10.1080/01677060802471668; Inagaki M, 2005, DEVELOPMENT, V132, P1525, DOI 10.1242/dev.01697; Ozaki-Kuroda K, 2002, CURR BIOL, V12, P1145, DOI 10.1016/S0960-9822(02)00922-3; Schwander M, 2010, J CELL BIOL, V190, P9, DOI 10.1083/jcb.201001138; STEINBERG MS, 1963, SCIENCE, V141, P401, DOI 10.1126/science.141.3579.401; Takai Y, 2008, ANNU REV CELL DEV BI, V24, P309, DOI 10.1146/annurev.cellbio.24.110707.175339; TAKEICHI M, 1991, SCIENCE, V251, P1451, DOI 10.1126/science.2006419; Tepass U, 2002, CURR OPIN GENET DEV, V12, P572, DOI 10.1016/S0959-437X(02)00342-8; Tepass U, 2007, TRENDS CELL BIOL, V17, P26, DOI 10.1016/j.tcb.2006.11.006; Togashi H, 2011, SCIENCE, V333, P1144, DOI 10.1126/science.1208467; TOWNES PL, 1955, J EXP ZOOL, V128, P53, DOI 10.1002/jez.1401280105	14	0	0	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 26	2011	333	6046					1099	1100		10.1126/science.1211158	http://dx.doi.org/10.1126/science.1211158			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811VM	21868660				2022-12-28	WOS:000294244300030
J	Murff, HJ; FitzHenry, F; Matheny, ME; Gentry, N; Kotter, KL; Crimin, K; Dittus, RS; Rosen, AK; Elkin, PL; Brown, SH; Speroff, T				Murff, Harvey J.; FitzHenry, Fern; Matheny, Michael E.; Gentry, Nancy; Kotter, Kristen L.; Crimin, Kimberly; Dittus, Robert S.; Rosen, Amy K.; Elkin, Peter L.; Brown, Steven H.; Speroff, Theodore			Automated Identification of Postoperative Complications Within an Electronic Medical Record Using Natural Language Processing	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PATIENT-SAFETY-INDICATORS; QUALITY IMPROVEMENT PROGRAM; ADMINISTRATIVE DATA; ADVERSE EVENTS; TIME; CARE	Context Currently most automated methods to identify patient safety occurrences rely on administrative data codes; however, free-text searches of electronic medical records could represent an additional surveillance approach. Objective To evaluate a natural language processing search-approach to identify postoperative surgical complications within a comprehensive electronic medical record. Design, Setting, and Patients Cross-sectional study involving 2974 patients undergoing inpatient surgical procedures at 6 Veterans Health Administration (VHA) medical centers from 1999 to 2006. Main Outcome Measures Postoperative occurrences of acute renal failure requiring dialysis, deep vein thrombosis, pulmonary embolism, sepsis, pneumonia, or myocardial infarction identified through medical record review as part of the VA Surgical Quality Improvement Program. We determined the sensitivity and specificity of the natural language processing approach to identify these complications and compared its performance with patient safety indicators that use discharge coding information. Results The proportion of postoperative events for each sample was 2% (39 of 1924) for acute renal failure requiring dialysis, 0.7% (18 of 2327) for pulmonary embolism, 1% (29 of 2327) for deep vein thrombosis, 7% (61 of 866) for sepsis, 16% (222 of 1405) for pneumonia, and 2% (35 of 1822) for myocardial infarction. Natural language processing correctly identified 82% (95% confidence interval [CI], 67%-91%) of acute renal failure cases compared with 38% (95% CI, 25%-54%) for patient safety indicators. Similar results were obtained for venous thromboembolism (59%, 95% CI, 44%-72% vs 46%, 95% CI, 32%-60%), pneumonia (64%, 95% CI, 58%-70% vs 5%, 95% CI, 3%-9%), sepsis (89%, 95% CI, 78%-94% vs 34%, 95% CI, 24%-47%), and postoperative myocardial infarction (91%, 95% CI, 78%-97%) vs 89%, 95% CI, 74%-96%). Both natural language processing and patient safety indicators were highly specific for these diagnoses. Conclusion Among patients undergoing inpatient surgical procedures at VA medical centers, natural language processing analysis of electronic medical records to identify postoperative complications had higher sensitivity and lower specificity compared with patient safety indicators based on discharge coding. JAMA. 2011;306(8):848-855 www.jama.com	[Murff, Harvey J.; FitzHenry, Fern; Matheny, Michael E.; Gentry, Nancy; Dittus, Robert S.; Brown, Steven H.; Speroff, Theodore] Vet Affairs Med Ctr, Tennessee Valley Healthcare Syst, Nashville, TN 37212 USA; [Murff, Harvey J.; Matheny, Michael E.; Dittus, Robert S.; Speroff, Theodore] Vanderbilt Univ, Div Gen Internal Med & Publ Hlth, Nashville, TN USA; [FitzHenry, Fern; Matheny, Michael E.; Brown, Steven H.] Vanderbilt Univ, Dept Biomed Informat, Nashville, TN USA; [Kotter, Kristen L.; Crimin, Kimberly; Speroff, Theodore] Vanderbilt Univ, Dept Biostat, Nashville, TN USA; [Rosen, Amy K.] Boston Univ, Sch Publ Hlth, Ctr Org Leadership & Management Res, VA Boston Healthcare Syst, Boston, MA USA; [Rosen, Amy K.] Boston Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA USA; [Elkin, Peter L.] Mt Sinai Sch Med, New York, NY USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; Vanderbilt University; Vanderbilt University; Vanderbilt University; Boston University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Boston University; Icahn School of Medicine at Mount Sinai	Murff, HJ (corresponding author), Vanderbilt Epidemiol Ctr, Inst Med & Publ Hlth, 2525 W End Ave,Ste 600,6th Floor, Nashville, TN 37203 USA.	harvey.j.murff@vanderbilt.edu	Hug, Balthasar L./G-1568-2010; Matheny, Michael E/B-3541-2008	Matheny, Michael E/0000-0003-3217-4147	Veterans Health Administration [CDA-08-020]; Veterans Health Consortium for Health Informatics Research (CHIR) [HIR 09-001, HIR 09-003]; National Institutes of Health; Department of Veterans Affairs [SAF-03-223]	Veterans Health Administration(US Department of Veterans Affairs); Veterans Health Consortium for Health Informatics Research (CHIR)(Canadian Institutes of Health Research (CIHR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs)	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interests. Dr Matheny reported that he is supported by the Veterans Health Administration HSR&D Career Development Award CDA-08-020. Drs Matheny and Speroff reported that they are supported by the Veterans Health Consortium for Health Informatics Research (CHIR) awards HIR 09-001 and HIR 09-003. Dr Elkins reported that a pending grant gfrom the National Institutes of Health. No other disclosures were made.; This study was supported by grant SAF-03-223 from the Department of Veterans Affairs.	[Anonymous], 2003, AHRQ QUID PAT SAF IN; Bahl V, 2008, MED CARE, V46, P516, DOI 10.1097/MLR.0b013e31815f537f; Blumenthal D, 2010, NEW ENGL J MED, V362, P382, DOI 10.1056/NEJMp0912825; Brown SH, 2006, MAYO CLIN PROC, V81, P1472, DOI 10.4065/81.11.1472; Brown Steven H, 2008, AMIA Annu Symp Proc, P71; Centers for Medicare and Medicaid Services, MED QUAL MON SYST; Davis CL, 2007, J AM COLL SURGEONS, V204, P550, DOI 10.1016/j.jamcollsurg.2007.01.012; Elkin PL, 2006, MAYO CLIN PROC, V81, P741, DOI 10.4065/81.6.741; HealthGrades, 2010, HEALTHGRADES 7 ANN P; Houchens RL, 2008, JT COMM J QUAL PATIE, V34, P154, DOI 10.1016/S1553-7250(08)34018-5; Hripcsak G, 2003, J BIOMED INFORM, V36, P120, DOI 10.1016/j.jbi.2003.08.001; IEZZONI LI, 1994, MED CARE, V32, P700, DOI 10.1097/00005650-199407000-00004; International Health Terminology Standards Development Organisation, SNOMED CT; Itani KMF, 2009, AM J SURG, V198, pS9, DOI 10.1016/j.amjsurg.2009.08.003; Jha AK, 2009, NEW ENGL J MED, V360, P1628, DOI 10.1056/NEJMsa0900592; Kaafarani HMA, 2009, AM J SURG, V198, pS63, DOI 10.1016/j.amjsurg.2009.08.008; Khuri SF, 1998, ANN SURG, V228, P491, DOI 10.1097/00000658-199810000-00006; Melton CB, 2005, J AM MED INFORM ASSN, V12, P448, DOI 10.1197/jamia.M1794; Meystre S M, 2008, Yearb Med Inform, P128; Penz JFE, 2007, J BIOMED INFORM, V40, P174, DOI 10.1016/j.jbi.2006.06.003; Premier I, 2010, CMS PREM HOSP QUAL I; Rivard P, 2005, ADV PATIENT SAFETY R, V2, P7; Romano PS, 2009, HEALTH SERV RES, V44, P182, DOI 10.1111/j.1475-6773.2008.00905.x; Rosen AK, 2005, MED CARE, V43, P873, DOI 10.1097/01.mlr.0000173561.79742.fb; Rosen AK, 2006, MED CARE, V44, P850, DOI 10.1097/01.mlr.0000220686.82472.9c; White RH, 2009, MED CARE, V47, P1237, DOI 10.1097/MLR.0b013e3181b58940; Zhan C, 2003, QUAL SAF HEALTH CARE, V12, pII58, DOI 10.1136/qhc.12.suppl_2.ii58	27	277	279	1	36	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 24	2011	306	8					848	855		10.1001/jama.2011.1204	http://dx.doi.org/10.1001/jama.2011.1204			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	810VY	21862746	Bronze			2022-12-28	WOS:000294157300022
J	Blaha, MJ; Budoff, MJ; DeFilippis, AP; Blankstein, R; Rivera, JJ; Agatston, A; O'Leary, DH; Lima, J; Blumenthal, RS; Nasir, K				Blaha, Michael J.; Budoff, Matthew J.; DeFilippis, Andrew P.; Blankstein, Ron; Rivera, Juan J.; Agatston, Arthur; O'Leary, Daniel H.; Lima, Joao; Blumenthal, Roger S.; Nasir, Khurram			Associations between C-reactive protein, coronary artery calcium, and cardiovascular events: implications for the JUPITER population from MESA, a population-based cohort study	LANCET			English	Article							TRIAL EVALUATING ROSUVASTATIN; ALL-CAUSE MORTALITY; DENSITY-LIPOPROTEIN CHOLESTEROL; HEART-DISEASE; COMPUTED-TOMOGRAPHY; SUBCLINICAL ATHEROSCLEROSIS; PRIMARY PREVENTION; RISK; INTERVENTION; MEN	Background The JUPITER trial showed that some patients with LDL-cholesterol concentrations less than 3.37 mmol/L (<130 mg/dL) and high-sensitivity C-reactive protein (hsCRP) concentrations of 2 mg/L or more benefit from treatment with rosuvastatin, although absolute rates of cardiovascular events were low. In a population eligible for JUPITER, we established whether coronary artery calcium (CAC) might further stratify risk; additionally we compared hsCRP with CAC for risk prediction across the range of low and high hsCRP values. Methods 950 participants from the Multi-Ethnic Study of Atheroslcerosis (MESA) met all criteria for JUPITER entry. We compared coronary heart disease and cardiovascular disease event rates and multivariable-adjusted hazard ratios after stratifying by burden of CAC (scores of 0, 1-100, or >100). We calculated 5-year number needed to treat (NNT) by applying the benefit recorded in JUPITER to the event rates within each CAC strata. Findings Median follow-up was 5.8 years (IQR 5.7-5.9). 444 (47%) patients in the MESA JUPITER population had CAC scores of 0 and, in this group, rates of coronary heart disease events were 0.8 per 1000 person-years. 74% of all coronary events were in the 239 (25%) of participants with CAC scores of more than 100 (20.2 per 1000 person-years). For coronary heart disease, the predicted 5-year NNT was 549 for CAC score 0,94 for scores 1-100, and 24 for scores greater than 100. For cardiovascular disease, the NNT was 124,54, and 19. In the total study population, presence of CAC was associated with a hazard ratio of 4.29 (95% CI 1-99-9.25) for coronary heart disease, and of 2.57 (1.48-4.48) for cardiovascular disease. hsCRP was not associated with either disease after multivariable adjustment. Interpretation CAC seems to further stratify risk in patients eligible for JUPITER, and could be used to target subgroups of patients who are expected to derive the most, and the least, absolute benefit from statin treatment. Focusing of treatment on the subset of individuals with measurable atherosclerosis could allow for more appropriate allocation of resources.	[Blaha, Michael J.; DeFilippis, Andrew P.; Rivera, Juan J.; Blumenthal, Roger S.] Johns Hopkins Ciccarone Prevent Cardiol Ctr, Baltimore, MD USA; [Budoff, Matthew J.] Harbor UCLA, Div Cardiol, Los Angeles Biomed Res Inst, Torrance, CA USA; [Blankstein, Ron] Brigham & Womens Hosp, Noninvas Cardiovasc Imaging Program, Boston, MA 02115 USA; [Rivera, Juan J.; Agatston, Arthur] Univ Miami, S Beach Prevent Cardiol Ctr, Miami, FL USA; [O'Leary, Daniel H.] St Elizabeths Med Ctr, Boston, MA USA; [Lima, Joao] Johns Hopkins Univ, Div Cardiol, Baltimore, MD USA; [Nasir, Khurram] Yale Univ, Sch Med, Sect Cardiovasc Med, New Haven, CT USA	Johns Hopkins University; Johns Hopkins Medicine; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; Harvard University; Brigham & Women's Hospital; University of Miami; St. Elizabeth's Medical Center; Johns Hopkins University; Yale University	Blaha, MJ (corresponding author), Johns Hopkins Univ Hosp, Div Cardiol, Carnegie 568A, Baltimore, MD 21287 USA.	mblaha1@jhmi.edu	Budoff, Matthew/ABD-5175-2021; Blumenthal, Roger S/H-3223-2018	Budoff, Matthew/0000-0002-9616-1946; Blumenthal, Roger S/0000-0003-1910-3168	National Heart, Lung, and Blood Institute [N01-HC-95159, N01-HC-95167, N01-HC-95169]; National Institutes of Health-National Heart, Lung, and Blood Institute; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC095162, N01HC095160, N01HC095167, N01HC095161, N01HC095165, N01HC095166, N01HC095169, N01HC095164, N01HC095163, N01HC095159] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R44HL095169, T32HL007227, R43HL095169, R43HL095167] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health-National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank the other investigators, staff, and participants of the MESA study for their valuable contributions. The MESA study which supplied the data for this analysis was supported by contracts N01-HC-95159 through N01-HC-95167 and N01-HC-95169 from the National Heart, Lung, and Blood Institute.; Funding National Institutes of Health-National Heart, Lung, and Blood Institute.	Altman DG, 1999, BRIT MED J, V319, P1492, DOI 10.1136/bmj.319.7223.1492; Arad Y, 2005, J AM COLL CARDIOL, V46, P166, DOI 10.1016/j.jacc.2005.02.089; Bild DE, 2002, AM J EPIDEMIOL, V156, P871, DOI 10.1093/aje/kwf113; Blaha M, 2009, JACC-CARDIOVASC IMAG, V2, P692, DOI 10.1016/j.jcmg.2009.03.009; Blaha MJ, 2011, ARTERIOSCL THROM VAS, V31, P1430, DOI 10.1161/ATVBAHA.111.223768; Blaha Michael J, 2011, Circ Cardiovasc Qual Outcomes, V4, P253, DOI 10.1161/CIRCOUTCOMES.110.958496; Blumenthal RS, 2011, J AM COLL CARDIOL, V57, P1601, DOI 10.1016/j.jacc.2010.11.037; Bucloff MJ, 2008, ACAD RADIOL, V15, P58, DOI 10.1016/j.acra.2007.08.011; Budoff MJ, 2006, CIRCULATION, V114, P1761, DOI 10.1161/CIRCULATIONAHA.106.178458; Budoff MJ, 2010, JACC-CARDIOVASC IMAG, V3, P1229, DOI 10.1016/j.jcmg.2010.08.018; Carr JJ, 2005, RADIOLOGY, V234, P35, DOI 10.1148/radiol.2341040439; Detrano R, 2008, NEW ENGL J MED, V358, P1336, DOI 10.1056/NEJMoa072100; Downs JR, 1998, JAMA-J AM MED ASSOC, V279, P1615, DOI 10.1001/jama.279.20.1615; Emberson J, 2011, LANCET, V377, P469; Greenland P, 2010, CIRCULATION, V122, P2748, DOI 10.1161/CIR.0b013e3182051bab; Kaptoge S, 2010, LANCET, V375, P132, DOI 10.1016/S0140-6736(09)61717-7; Kim HC, 2010, J AM COLL CARDIOL, V55, P2080, DOI 10.1016/j.jacc.2009.12.047; Lakoski SG, 2006, AM HEART J, V152, P593, DOI 10.1016/j.ahj.2006.02.015; Lauer MS, 2010, J AM COLL CARDIOL, V56, P106, DOI 10.1016/j.jacc.2010.01.059; Lee KK, 2010, CIRCULATION, V122, P1478, DOI 10.1161/CIRCULATIONAHA.110.947960; Libby P, 2009, J AM COLL CARDIOL, V54, P2129, DOI 10.1016/j.jacc.2009.09.009; McEvoy JW, 2010, J AM COLL CARDIOL, V56, P1613, DOI 10.1016/j.jacc.2010.06.038; Michos ED, 2009, J AM COLL CARDIOL, V53, P931, DOI 10.1016/j.jacc.2008.12.010; Mohlenkamp S, 2011, J AM COLL CARDIOL, V57, P1455, DOI 10.1016/j.jacc.2010.10.043; Park R, 2002, CIRCULATION, V106, P2073, DOI 10.1161/01.CIR.0000033819.29662.09; Polonsky TS, 2010, JAMA-J AM MED ASSOC, V303, P1610, DOI 10.1001/jama.2010.461; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Ridker PM, 2010, AM J CARDIOL, V106, P204, DOI 10.1016/j.amjcard.2010.03.018; Ridker PM, 2009, CIRC-CARDIOVASC QUAL, V2, P616, DOI 10.1161/CIRCOUTCOMES.109.848473; Ridker PM, 2009, LANCET, V373, P1175, DOI 10.1016/S0140-6736(09)60447-5; Rubin J, 2011, CIRC-CARDIOVASC IMAG, V4, P201, DOI 10.1161/CIRCIMAGING.109.929901; Sarwar A, 2009, JACC-CARDIOVASC IMAG, V2, P675, DOI 10.1016/j.jcmg.2008.12.031; Sattar N, 2010, LANCET, V375, P735, DOI 10.1016/S0140-6736(09)61965-6; Sever PS, 2003, LANCET, V361, P1149, DOI 10.1016/S0140-6736(03)12948-0; Shah T, 2010, CIRC-CARDIOVASC GENE, V3, P436, DOI 10.1161/CIRCGENETICS.110.957431; Shaw LJ, 2009, J AM COLL CARDIOL, V54, P1258, DOI 10.1016/j.jacc.2009.07.018; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; Yang EY, 2009, J AM COLL CARDIOL, V54, P2388, DOI 10.1016/j.jacc.2009.10.006	38	249	255	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 20	2011	378	9792					684	692		10.1016/S0140-6736(11)60784-8	http://dx.doi.org/10.1016/S0140-6736(11)60784-8			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	815EW	21856482	Green Accepted			2022-12-28	WOS:000294509900028
J	Feldon, DF; Peugh, J; Timmerman, BE; Maher, MA; Hurst, M; Strickland, D; Gilmore, JA; Stiegelmeyer, C				Feldon, David F.; Peugh, James; Timmerman, Briana E.; Maher, Michelle A.; Hurst, Melissa; Strickland, Denise; Gilmore, Joanna A.; Stiegelmeyer, Cindy			Graduate Students' Teaching Experiences Improve Their Methodological Research Skills	SCIENCE			English	Article							EDUCATION	Science, technology, engineering, and mathematics (STEM) graduate students are often encouraged to maximize their engagement with supervised research and minimize teaching obligations. However, the process of teaching students engaged in inquiry provides practice in the application of important research skills. Using a performance rubric, we compared the quality of methodological skills demonstrated in written research proposals for two groups of early career graduate students (those with both teaching and research responsibilities and those with only research responsibilities) at the beginning and end of an academic year. After statistically controlling for preexisting differences between groups, students who both taught and conducted research demonstrate significantly greater improvement in their abilities to generate testable hypotheses and design valid experiments. These results indicate that teaching experience can contribute substantially to the improvement of essential research skills.	[Feldon, David F.] Univ Virginia, Dept Curriculum Instruct & Special Educ, Charlottesville, VA 22904 USA; [Feldon, David F.; Maher, Michelle A.; Hurst, Melissa; Strickland, Denise] Univ Virginia, Ctr Adv Study Teaching & Learning Higher Educ, Charlottesville, VA 22904 USA; [Peugh, James] Cincinnati Childrens Hosp & Med Ctr, Cincinnati, OH 45229 USA; [Timmerman, Briana E.] Univ S Carolina, Off Res & Grad Educ, Columbia, SC 29208 USA; [Maher, Michelle A.] Univ S Carolina, Dept Educ Leadership & Policies, Columbia, SC 29208 USA; [Gilmore, Joanna A.] Univ Texas Austin, Ctr Teaching & Learning, Austin, TX 78713 USA; [Stiegelmeyer, Cindy] Zayed Univ, Dept Math, Abu Dhabi, U Arab Emirates	University of Virginia; University of Virginia; Cincinnati Children's Hospital Medical Center; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of Texas System; University of Texas Austin; Zayed University	Feldon, DF (corresponding author), Univ Virginia, Dept Curriculum Instruct & Special Educ, Charlottesville, VA 22904 USA.	dff2j@virginia.edu		Feldon, David/0000-0003-3268-5764	National Science Foundation [NSF-0723686]	National Science Foundation(National Science Foundation (NSF))	This work is supported by a grant from the National Science Foundation to D. F., M. M., B. E. T., J. Lyons, and S. Thompson (NSF-0723686). The views expressed do not necessarily represent the views of the supporting funding agency. Data used to conduct the reported analyses can be found in (22).	Adamson SL, 2003, J RES SCI TEACH, V40, P939, DOI 10.1002/tea.10117; Anderson WA, 2011, SCIENCE, V331, P152, DOI 10.1126/science.1198280; Austin AE, 2009, NEW DIR TEACH LEARN, V117, P83, DOI DOI 10.1002/TL.346; BERARDICOLETTA B, 1995, J EXP PSYCHOL LEARN, V21, P205, DOI 10.1037/0278-7393.21.1.205; Bianchini JA, 2002, SCI EDUC, V86, P42, DOI 10.1002/sce.1043; Brawner C. E., 2002, 1999 2000 SUCCEED FA; CHI MTH, 1994, COGNITIVE SCI, V18, P439, DOI 10.1207/s15516709cog1803_3; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Delamont S, 2001, SOC STUD SCI, V31, P87, DOI 10.1177/030631201031001005; Enders C.K., 2010, APPL MISSING DATA AN; ETHINGTON CA, 1993, RES HIGH EDUC, V34, P343, DOI 10.1007/BF00991848; Feldon DF, 2010, SCIENCE, V329, P282, DOI 10.1126/science.1191269; French D, 2002, BIOSCIENCE, V52, P1036, DOI 10.1641/0006-3568(2002)052[1036:DGTABF]2.0.CO;2; Golde C., 2001, CROSS PURPOSES WHAT; Johnson RL, 2000, APPL MEAS EDUC, V13, P121, DOI 10.1207/S15324818AME1302_1; Jones R. M., 1992, J LEARN SCI, V2, P1, DOI DOI 10.1207/S15327809JLS0201_1; LITTLE RJA, 1988, J AM STAT ASSOC, V83, P1198, DOI 10.2307/2290157; Muthen L.K., 2012, MPLUS STAT ANAL LATE, V7th, DOI DOI 10.1111/J.1532-5415.2004.52225.X; NISBETT RE, 1977, PSYCHOL REV, V84, P231, DOI 10.1037/0033-295X.84.3.231; Pruitt-Logan A. S., 2004, PATHS PROFESSORIATE, P177; Robertson J., 2001, HIGHER ED RES DEV, V20, P5, DOI [10.1080/07924360120043612, DOI 10.1080/07924360120043612]; Timmerman BEC, 2011, ASSESS EVAL HIGH EDU, V36, P509, DOI 10.1080/02602930903540991; Townsend CL, 2011, MEM COGNITION, V39, P204, DOI 10.3758/s13421-010-0019-2; Trautmann NM, 2006, BIOSCIENCE, V56, P159, DOI 10.1641/0006-3568(2006)056[0159:ITARAN]2.0.CO;2; Williams V. L., 2002, MERGING U STUDENTS K; Wulff D. H., 2004, PATHS PROFESSORIATE, P46	26	103	107	2	87	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 19	2011	333	6045					1037	1039		10.1126/science.1204109	http://dx.doi.org/10.1126/science.1204109			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	808TD	21852504				2022-12-28	WOS:000294000400061
J	Jaqaman, K; Kuwata, H; Touret, N; Collins, R; Trimble, WS; Danuser, G; Grinstein, S				Jaqaman, Khuloud; Kuwata, Hirotaka; Touret, Nicolas; Collins, Richard; Trimble, William S.; Danuser, Gaudenz; Grinstein, Sergio			Cytoskeletal Control of CD36 Diffusion Promotes Its Receptor and Signaling Function	CELL			English	Article							GPI-ANCHORED PROTEINS; SINGLE-PARTICLE TRACKING; PLASMA-MEMBRANE MICRODOMAINS; LOW-DENSITY-LIPOPROTEIN; LIVING CELL-MEMBRANES; MOLECULE TRACKING; LIPID RAFTS; ACTIN CYTOSKELETON; ENDOTHELIAL-CELLS; T-CELLS	The mechanisms that govern receptor coalescence into functional clusters-often a critical step in their stimulation by ligand-are poorly understood. We used single-molecule tracking to investigate the dynamics of CD36, a clustering-responsive receptor that mediates oxidized LDL uptake by macrophages. We found that CD36 motion in the membrane was spatially structured by the cortical cytoskeleton. A subpopulation of receptors diffused within linear confinement regions whose unique geometry simultaneously facilitated freedom of movement along one axis while increasing the effective receptor density. Co-confinement within troughs enhanced the probability of collisions between unligated receptors and promoted their clustering. Cytoskeleton perturbations that inhibited diffusion in linear confinement regions reduced receptor clustering in the absence of ligand and, following ligand addition, suppressed CD36-mediated signaling and internalization. These observations demonstrate a role for the cytoskeleton in controlling signal transduction by structuring receptor diffusion within membrane regions that increase their collision frequency.	[Jaqaman, Khuloud; Danuser, Gaudenz] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; [Jaqaman, Khuloud] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Kuwata, Hirotaka; Collins, Richard; Trimble, William S.; Grinstein, Sergio] Hosp Sick Children, Cell Biol Program, Toronto, ON M5G 1X8, Canada; [Touret, Nicolas] Univ Alberta, Dept Biochem, Edmonton, AB T6G 2E1, Canada; [Danuser, Gaudenz] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Scripps Research Institute; Harvard University; Harvard Medical School; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Alberta; Harvard University; Harvard Medical School	Danuser, G (corresponding author), Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA.	gaudenz_danuser@hms.harvard.edu; sergio.grinstein@sickkids.ca	Kuwata, Hiro/N-2023-2019	Kuwata, Hiro/0000-0002-5023-1777; Jaqaman, Khuloud/0000-0003-3471-1911; Danuser, Gaudenz/0000-0001-8583-2014	Heart and Stroke Foundation of Ontario; Canadian Institutes of Health Research [MOP-102474]; NIH [U01 GM67230]; Uehara Memorial Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Kanae Foundation for the Promotion of Medical Science; Alberta Heritage Foundation for Medical Research Scholarship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM067230, P50GM068762] Funding Source: NIH RePORTER	Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Uehara Memorial Foundation(Uehara Memorial Foundation); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Kanae Foundation for the Promotion of Medical Science; Alberta Heritage Foundation for Medical Research Scholarship(Alberta Heritage Foundation for Medical Research); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Work in the Grinstein lab was supported by the Heart and Stroke Foundation of Ontario and by Canadian Institutes of Health Research Grant MOP-102474. Work in the Danuser lab was supported by NIH grant U01 GM67230. K.J. is an investigator in the Center for Cell Decision Processes (NIH P50 GM068762). HK was supported in part by the Uehara Memorial Foundation, the Mochida Memorial Foundation for Medical and Pharmaceutical Research and the Kanae Foundation for the Promotion of Medical Science. N.T. is supported by an Alberta Heritage Foundation for Medical Research Scholarship. S. G. is the current holder of the Pitblado Chair in Cell Biology.	Andrews NL, 2008, NAT CELL BIOL, V10, P955, DOI 10.1038/ncb1755; Berg, 2018, RANDOM WALKS BIOL; Bouzigues C, 2007, P NATL ACAD SCI USA, V104, P11251, DOI 10.1073/pnas.0702536104; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; Cambi A, 2006, MOL BIOL CELL, V17, P4270, DOI 10.1091/mbc.E05-12-1098; Cebecauer M, 2010, J CELL SCI, V123, P309, DOI 10.1242/jcs.061739; Chung I, 2010, NATURE, V464, P783, DOI 10.1038/nature08827; Collins RF, 2009, J BIOL CHEM, V284, P30288, DOI 10.1074/jbc.M109.045104; Daviet L, 1997, THROMB HAEMOSTASIS, V78, P897; de Keijzer S, 2011, BBA-BIOMEMBRANES, V1808, P1701, DOI 10.1016/j.bbamem.2011.02.009; Dorahy DJ, 1996, BIOCHEM J, V319, P67, DOI 10.1042/bj3190067; Douglass AD, 2005, CELL, V121, P937, DOI 10.1016/j.cell.2005.04.009; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; ENDEMANN G, 1993, J BIOL CHEM, V268, P11811; Espenel C, 2008, J CELL BIOL, V182, P765, DOI 10.1083/jcb.200803010; Ewers H, 2005, P NATL ACAD SCI USA, V102, P15110, DOI 10.1073/pnas.0504407102; Febbraio M, 2001, J CLIN INVEST, V108, P785, DOI 10.1172/JCI200114006; Ferrari R, 2001, PHYSICA D, V154, P111, DOI 10.1016/S0167-2789(01)00234-2; Foster LJ, 2003, P NATL ACAD SCI USA, V100, P5813, DOI 10.1073/pnas.0631608100; Friedrichson T, 1998, NATURE, V394, P802, DOI 10.1038/29570; Gambin Y, 2006, P NATL ACAD SCI USA, V103, P2098, DOI 10.1073/pnas.0511026103; Goswami D, 2008, CELL, V135, P1085, DOI 10.1016/j.cell.2008.11.032; Groves JT, 2010, NAT STRUCT MOL BIOL, V17, P659, DOI 10.1038/nsmb.1844; Harder T, 1997, MOL BIOL CELL, V8, P533, DOI 10.1091/mbc.8.3.533; HELDIN CH, 1995, CELL, V80, P213, DOI 10.1016/0092-8674(95)90404-2; Hess ST, 2007, P NATL ACAD SCI USA, V104, P17370, DOI 10.1073/pnas.0708066104; Huet S, 2006, BIOPHYS J, V91, P3542, DOI 10.1529/biophysj.105.080622; Iino R, 2001, BIOPHYS J, V80, P2667, DOI 10.1016/S0006-3495(01)76236-4; Kaizuka Y, 2009, J CELL BIOL, V185, P521, DOI 10.1083/jcb.200809136; Kasai RS, 2011, J CELL BIOL, V192, P463, DOI 10.1083/jcb.201009128; Kennedy DJ, 2011, CARDIOVASC RES, V89, P604, DOI 10.1093/cvr/cvq360; KILSDONK EPC, 1995, J BIOL CHEM, V270, P17250, DOI 10.1074/jbc.270.29.17250; Kusumi A, 2005, SEMIN IMMUNOL, V17, P3, DOI 10.1016/j.smim.2004.09.004; Kusumi A, 2005, ANNU REV BIOPH BIOM, V34, P351, DOI 10.1146/annurev.biophys.34.040204.144637; Livnah O, 1999, SCIENCE, V283, P987, DOI 10.1126/science.283.5404.987; Long BR, 2010, BIOPHYS J, V98, P1712, DOI 10.1016/j.bpj.2009.12.4299; Manneville JB, 2003, J CELL SCI, V116, P3927, DOI 10.1242/jcs.00672; McGilvray ID, 2000, BLOOD, V96, P3231, DOI 10.1182/blood.V96.9.3231; McGrath JL, 1998, BIOPHYS J, V75, P2070, DOI 10.1016/S0006-3495(98)77649-0; OHTANI Y, 1989, EUR J BIOCHEM, V186, P17, DOI 10.1111/j.1432-1033.1989.tb15171.x; Pike LJ, 2003, J LIPID RES, V44, P655, DOI 10.1194/jlr.R200021-JLR200; Plowman SJ, 2005, P NATL ACAD SCI USA, V102, P15500, DOI 10.1073/pnas.0504114102; Ponti A, 2005, BIOPHYS J, V89, P3456, DOI 10.1529/biophysj.104.058701; Rahaman SO, 2006, CELL METAB, V4, P211, DOI 10.1016/j.cmet.2006.06.007; Rodriguez OC, 2003, NAT CELL BIOL, V5, P599, DOI 10.1038/ncb0703-599; Sako Y, 2000, NAT CELL BIOL, V2, P168, DOI 10.1038/35004044; Savill J, 1997, BRIT MED BULL, V53, P491; Saxton MJ, 1997, ANNU REV BIOPH BIOM, V26, P373, DOI 10.1146/annurev.biophys.26.1.373; Schamel WWA, 2005, J EXP MED, V202, P493, DOI 10.1084/jem.20042155; Scott JD, 2009, SCIENCE, V326, P1220, DOI 10.1126/science.1175668; Serge A, 2003, J CELL SCI, V116, P5015, DOI 10.1242/jcs.00822; Sethna JP, 2006, STAT MECH ENTROPY OR; Sharma P, 2004, CELL, V116, P577, DOI 10.1016/S0092-8674(04)00167-9; Subbaramaiah K, 2000, J BIOL CHEM, V275, P14838, DOI 10.1074/jbc.275.20.14838; Suzuki KGN, 2007, J CELL BIOL, V177, P717, DOI 10.1083/jcb.200609174; Thorne RF, 2000, J BIOL CHEM, V275, P35264, DOI 10.1074/jbc.M003969200; Varma R, 1998, NATURE, V394, P798, DOI 10.1038/29563; Viola A, 2007, NAT REV IMMUNOL, V7, P889, DOI 10.1038/nri2193; Yang G, 2007, NAT CELL BIOL, V9, P1233, DOI 10.1038/ncb1643; Yujiri T, 1999, J BIOL CHEM, V274, P12605, DOI 10.1074/jbc.274.18.12605; Zeng YC, 2003, J BIOL CHEM, V278, P45931, DOI 10.1074/jbc.M307722200	62	173	173	0	60	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 19	2011	146	4					593	606		10.1016/j.cell.2011.06.049	http://dx.doi.org/10.1016/j.cell.2011.06.049			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	809HY	21854984	Green Accepted, Bronze			2022-12-28	WOS:000294043600014
J	Smyth, MJ; Kershaw, MH				Smyth, Mark J.; Kershaw, Michael H.			The Adjuvant Effects of Antibodies	SCIENCE			English	Editorial Material							FC-GAMMA RECEPTORS; CELLS; IMMUNITY; MATURATION; ENGAGEMENT; CD40		[Smyth, Mark J.] Peter MacCallum Canc Ctr, Canc Immunol Program, Melbourne, Vic 3002, Australia; Univ Melbourne, Melbourne, Vic 3010, Australia	Peter Maccallum Cancer Center; University of Melbourne	Smyth, MJ (corresponding author), Peter MacCallum Canc Ctr, Canc Immunol Program, Melbourne, Vic 3002, Australia.	mark.smyth@petermac.org	Smyth, Mark J/H-8709-2014	Smyth, Mark J/0000-0001-7098-7240; Kershaw, Michael/0000-0002-2697-487X				Antignano F, 2010, J LEUKOCYTE BIOL, V88, P925, DOI 10.1189/jlb.1209825; Antignano F, 2010, J IMMUNOL, V184, P2805, DOI 10.4049/jimmunol.0903170; Beatty GL, 2011, SCIENCE, V331, P1612, DOI 10.1126/science.1198443; Bergtold A, 2005, IMMUNITY, V23, P503, DOI 10.1016/j.immuni.2005.09.013; Boruchov AM, 2005, J CLIN INVEST, V115, P2914, DOI 10.1172/JCI24772; Dhodapkar KM, 2005, P NATL ACAD SCI USA, V102, P2910, DOI 10.1073/pnas.0500014102; El Shikh ME, 2006, EUR J IMMUNOL, V36, P2715, DOI 10.1002/eji.200636122; Grewal IS, 1998, ANNU REV IMMUNOL, V16, P111, DOI 10.1146/annurev.immunol.16.1.111; Kalergis AM, 2002, J EXP MED, V195, P1653, DOI 10.1084/jem.20020338; Li FB, 2011, SCIENCE, V333, P1030, DOI 10.1126/science.1206954; Nimmerjahn F, 2005, SCIENCE, V310, P1510, DOI 10.1126/science.1118948; Nimmerjahn F, 2008, NAT REV IMMUNOL, V8, P34, DOI 10.1038/nri2206; Wilson NS, 2011, CANCER CELL, V19, P101, DOI 10.1016/j.ccr.2010.11.012	13	4	5	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 19	2011	333	6045					944	945		10.1126/science.1210801	http://dx.doi.org/10.1126/science.1210801			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808TD	21852479				2022-12-28	WOS:000294000400033
J	Grenader, T; Shavit, L				Grenader, Tal; Shavit, Linda			Scrotal Calcinosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Grenader, Tal; Shavit, Linda] Shaare Zedek Med Ctr, Jerusalem, Israel	Hebrew University of Jerusalem; Shaare Zedek Medical Center	Grenader, T (corresponding author), Shaare Zedek Med Ctr, Jerusalem, Israel.	talgrenader65@hotmail.com							0	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 18	2011	365	7					647	647		10.1056/NEJMicm1013803	http://dx.doi.org/10.1056/NEJMicm1013803			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	808ER	21848465				2022-12-28	WOS:000293960500012
J	Swartz, K				Swartz, Katherine			Sharing the Financial Responsibility of Caring for Parents	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							LONG-TERM-CARE		Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Swartz, K (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, 677 Huntington Ave, Boston, MA 02115 USA.	kswartz@hsph.harvard.edu						Campbell JC, 2010, HEALTH AFFAIR, V29, P87, DOI 10.1377/hlthaff.2009.0548; Commission on funding of care and support, FAIR CAR FUND REP CO; Feinberg L, AARP PUBLIC POLICY I; Kaiser Commission on Medicaid and the Uninsured, MED LONG TERM CAR SE; Karlsson M, 2010, 20102 U OSL HLTH EC; Kemper P, 2005, INQUIRY-J HEALTH CAR, V42, P335, DOI 10.5034/inquiryjrnl_42.4.335; Ritchie CS, 2011, JAMA-J AM MED ASSOC, V306, P746, DOI 10.1001/jama.2011.1163; United States Census Bureau, INT DAT BAS; Vincent GK, 2010, P251138 US DEP COMM	9	2	2	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 17	2011	306	7					760	761		10.1001/jama.2011.1173	http://dx.doi.org/10.1001/jama.2011.1173			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	807LP	21846859				2022-12-28	WOS:000293900000028
J	King, D				King, David			The future challenge of obesity	LANCET			English	Editorial Material									Univ Oxford, Smith Sch Enterprise & Environm, Oxford OX1 2BQ, England	University of Oxford	King, D (corresponding author), Univ Oxford, Smith Sch Enterprise & Environm, Oxford OX1 2BQ, England.	anne.saunders@smithschool.ox.ac.uk						Gortmaker SL, 2011, LANCET, V378, P838, DOI 10.1016/S0140-6736(11)60815-5; Hall KD, 2011, LANCET, V378, P826, DOI 10.1016/S0140-6736(11)60812-X; Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P1, DOI 10.1596/978-0-8213-6262-4; Rodgers JL, 2010, AM PSYCHOL, V65, P1, DOI 10.1037/a0018326; Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1; UK Government Office for Science, 2007, FOR TACKL OB FUT CHO; Wang YC, 2011, LANCET, V378, P815, DOI 10.1016/S0140-6736(11)60814-3	7	31	31	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG-SEP	2011	378	9793					743	744		10.1016/S0140-6736(11)61261-0	http://dx.doi.org/10.1016/S0140-6736(11)61261-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	816FY	21872734				2022-12-28	WOS:000294585300004
J	Shibuya, K; Hashimoto, H; Ikegami, N; Nishi, A; Tanimoto, T; Miyata, H; Takemi, K; Reich, MR				Shibuya, Kenji; Hashimoto, Hideki; Ikegami, Naoki; Nishi, Akihiro; Tanimoto, Tetsuya; Miyata, Hiroaki; Takemi, Keizo; Reich, Michael R.			Japan: Universal Health Care at 50 Years 6 Future of Japan's system of good health at low cost with equity: beyond universal coverage	LANCET			English	Article							INSURANCE; SERVICES; POLICY; GHANA	Japan's premier health accomplishment in the past 50 years has been the achievement of good population health at low cost and increased equity between different population groups. The development of Japan's policies for universal coverage are similar to the policy debates that many countries are having in their own contexts. The financial sustainability of Japan's universal coverage is under threat from demographic, economic, and political factors. Furthermore, a series of crises-both natural and nuclear-after the magnitude 9.0 Great East Japan Earthquake on March 11, 2011, has shaken up the entire Japanese social system that was developed and built after World War 2, and shown existing structural problems in the Japanese health system. Here, we propose four major reforms to assure the sustainability and equity of Japan's health accomplishments in the past 50 years-implement a human-security value-based reform; redefine the role of the central and local governments; improve the quality of health care; and commit to global health. Now is the time for rebirth of Japan and its health system.	[Shibuya, Kenji] Univ Tokyo, Grad Sch Med, Dept Global Hlth Policy, Bunkyo Ku, Tokyo 1130033, Japan; [Hashimoto, Hideki] Univ Tokyo, Dept Hlth Econ & Epidemiol Res, Tokyo 1130033, Japan; [Ikegami, Naoki] Keio Univ, Sch Med, Dept Hlth Policy & Management, Tokyo, Japan; [Nishi, Akihiro] Harvard Univ, Sch Publ Hlth, Dept Soc Human Dev & Hlth, Boston, MA 02115 USA; [Nishi, Akihiro] Univ Tokyo, Grad Sch Med, Dept Publ Hlth, Tokyo 1130033, Japan; [Tanimoto, Tetsuya] Japanese Fdn Canc Res, Inst Canc, Tokyo 170, Japan; [Miyata, Hiroaki] Univ Tokyo, Dept Healthcare Qual Assessment, Tokyo 1130033, Japan; [Takemi, Keizo] Tokai Univ, Sch Polit Sci & Econ, Kanagawa 2591100, Japan; [Reich, Michael R.] Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA	University of Tokyo; University of Tokyo; Keio University; Harvard University; Harvard T.H. Chan School of Public Health; University of Tokyo; Japanese Foundation for Cancer Research; University of Tokyo; Tokai University; Harvard University; Harvard T.H. Chan School of Public Health	Shibuya, K (corresponding author), Univ Tokyo, Grad Sch Med, Dept Global Hlth Policy, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	shibuyak@m.u-tokyo.ac.jp		Shibuya, Kenji/0000-0003-2528-7530; Reich, Michael R./0000-0003-3338-0612; Nishi, Akihiro/0000-0003-1629-5985	Bill & Melinda Gates Foundation; China Medical Board; Ministry of Health, Labour and Welfare [H23-seisaku-shitei-033]	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); China Medical Board; Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan)	This work is partly funded by the generous support from the Bill & Melinda Gates Foundation and the China Medical Board and a research grant from the Ministry of Health, Labour and Welfare (H23-seisaku-shitei-033). We thank Tomoko Suzuki and Tadashi Yamamoto for their administrative support. The views expressed in this report are solely those of the authors.	Ablin RJ, 2002, LANCET, V359, P446, DOI 10.1016/S0140-6736(02)07581-5; Agyepong IA, 2008, HEALTH POLICY PLANN, V23, P150, DOI 10.1093/heapol/czn002; [Anonymous], 2011, LANCET, V377, P968, DOI 10.1016/S0140-6736(11)60368-1; [Anonymous], 2011, ECONOMIST       0317; Association of the British Pharmaceutical Industry: Pharmaceutical Industry Competitiveness Task Force, 2006, COMP PERF IND 2005; Carrin G, 2008, B WORLD HEALTH ORGAN, V86, P857, DOI 10.2471/BLT.07.049387; Chen FM, 2005, MED EDUC, V39, P350, DOI 10.1111/j.1365-2929.2005.02117.x; Chen FM, 2002, FAM MED, V34, P663; Cyranoski D, 2011, NATURE, V474, P136, DOI 10.1038/474136a; Danzon PM, 2005, HEALTH ECON, V14, P269, DOI 10.1002/hec.931; Ding HS, 2005, TOHOKU J EXP MED, V206, P195, DOI 10.1620/tjem.206.195; Fukukawa K, 2011, LANCET, V377, P1652; Garrett L, 2009, LANCET, V374, P1294, DOI 10.1016/S0140-6736(09)61503-8; Government of Japan, 2010, LIF INN SOC HLTH LON; Halstead S, 1985, GOOD HLTH LOW COST; Hashimoto H, 2011, LANCET, V378, P1174, DOI 10.1016/S0140-6736(11)60987-2; Hashimoto S, 2010, J EPIDEMIOL, V20, P308, DOI 10.2188/jea.JE20090190; Health and Global Policy Institute, 2010, SUMM 2010 PUBL SURV; Henke N, IMPROVING JAPANS HLT; Hirai Y, 2010, CLIN PHARMACOL THER, V87, P212, DOI 10.1038/clpt.2009.215; Honda H, 2003, HOKKAIDO LAW REV, V54, P205; Ide H, 2009, J OBSTET GYNAECOL RE, V35, P761, DOI 10.1111/j.1447-0756.2009.01039.x; Ide H, 2009, PEDIATR INT, V51, P645, DOI 10.1111/j.1442-200X.2009.02839.x; Ide S, 2011, SCIENCE, V332, P1426, DOI 10.1126/science.1207020; Ikeda N, 2011, LANCET, V378, P1094, DOI 10.1016/S0140-6736(11)61055-6; Ikegami N, 2004, HEALTH AFFAIR, V23, P26, DOI 10.1377/hlthaff.23.3.26; Ikegami N, 2011, LANCET, V378, P1106, DOI 10.1016/S0140-6736(11)60828-3; Kyo Shunei, 2009, Kyobu Geka, V62, P704; Latko B, 2011, LANCET, V377, P2161, DOI 10.1016/S0140-6736(10)62006-5; Llano R, 2011, LANCET; London School of Hygiene & Tropical Medicine, 2011, GOOD HLTH LOW COST 2; McCurry J, 2011, LANCET, V377, P1061, DOI 10.1016/S0140-6736(11)60413-3; McIntyre D, 2008, B WORLD HEALTH ORGAN, V86, P871, DOI 10.2471/BLT.08.053413; Ministry of Finance, 2009, HEIS 21 NEND IPP KAI; Ministry of Health Labour and Welfare, 2011, POL VACC WORK TEAM R; Ministry of Health Labour and Welfare, 2003, SHUG KEIT NO TAYOUK; Ministry of Health Labour and Welfare, 2011, ADV PAN REP VACC IMP; Ministry of Health Labour and Welfare, 2009, HEIS 20 NEN JUR KOD; Miyazawa K, 1992, IRYO TO FUKUSHI NO S; Miyazawa K, 2003, IRYO TO FUKUSHI NO S; Murashige N, 2011, LANCET, V377, P299, DOI 10.1016/S0140-6736(11)60091-3; National Hospital Organization, 2009, CLIN IND; National Police Agency, 2011, CAUS DEATH GREAT E J; Nihon senmonisei hyoka nintei kikou, NIH SENM HYOK NINT K; OECD, 2011, EC OUTL 2010; Ogaka S, 2003, COMMISSION HUMAN SEC; Onishi N, NUCL CRISIS CRIPPLIN; Reich MR, 2011, LANCET, V378, P1051, DOI 10.1016/S0140-6736(11)60274-2; Roberts MJ., 2004, GETTING HLTH REFORM; Sato N, 2011, GENERATION NEXT IS R; Tamiya N, 2011, LANCET, V378, P1183, DOI 10.1016/S0140-6736(11)61176-8; Tokyo Electric Power Company, 2011, AN IMP ASS FUK DAIIC; Twahirwa A, 2008, B WORLD HEALTH ORGAN, V86, P823, DOI 10.2471/BLT.08.021108; World Health Organization, 2000, WHO EUR SER, V91; Yasunaga H, 2007, LANCET, V370, P2063, DOI 10.1016/S0140-6736(07)61867-4; Yomiuri Shimbun, 2011, 2 PAT HEM DEAD EV CT	56	85	86	2	27	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 1	2011	378	9798					1265	1273		10.1016/S0140-6736(11)61098-2	http://dx.doi.org/10.1016/S0140-6736(11)61098-2			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	831IO	21885100				2022-12-28	WOS:000295723600029
J	Slade, D; Dunstan, MS; Barkauskaite, E; Weston, R; Lafite, P; Dixon, N; Ahel, M; Leys, D; Ahel, I				Slade, Dea; Dunstan, Mark S.; Barkauskaite, Eva; Weston, Ria; Lafite, Pierre; Dixon, Neil; Ahel, Marijan; Leys, David; Ahel, Ivan			The structure and catalytic mechanism of a poly(ADP-ribose) glycohydrolase	NATURE			English	Article							IDENTIFICATION; CHROMATIN; BINDING; MODEL; METABOLITES; FIELD	Post-translational modification of proteins by poly(ADP-ribosyl) ation regulates many cellular pathways that are critical for genome stability, including DNA repair, chromatin structure, mitosis and apoptosis(1). Poly(ADP-ribose) (PAR) is composed of repeating ADPribose units linked via a unique glycosidic ribose-ribose bond, and is synthesized from NAD by PAR polymerases(1,2). PAR glycohydrolase (PARG) is the only protein capable of specific hydrolysis of the ribose-ribose bonds present in PAR chains; its deficiency leads to cell death(3,4). Here we show that filamentous fungi and a number of bacteria possess a divergent form of PARG that has all the main characteristics of the human PARG enzyme. We present the first PARG crystal structure (derived from the bacterium Thermomonospora curvata), which reveals that the PARG catalytic domain is a distant member of the ubiquitous ADP-ribose-binding macrodomain family(5,6). High-resolution structures of T. curvata PARG in complexes with ADP-ribose and the PARG inhibitor ADP-HPD, complemented by biochemical studies, allow us to propose a model for PAR binding and catalysis by PARG. The insights into the PARG structure and catalytic mechanism should greatly improve our understanding of how PARG activity controls reversible protein poly(ADP-ribosyl) ation and potentially of how the defects in this regulation are linked to human disease.	[Slade, Dea; Barkauskaite, Eva; Weston, Ria; Ahel, Ivan] Univ Manchester, Paterson Inst Canc Res, Canc Res UK, Manchester M20 4BX, Lancs, England; [Slade, Dea] Univ Paris 05, Fac Med, INSERM, U1001, F-75015 Paris, France; [Dunstan, Mark S.; Dixon, Neil; Leys, David] Manchester Interdisciplinary Bioctr, Manchester M1 7DN, Lancs, England; [Lafite, Pierre] Univ Orleans, ICOA, CNRS, UMR 6005, F-45067 Orleans, France; [Ahel, Marijan] Rudjer Boskovic Inst, HR-10000 Zagreb, Croatia	Cancer Research UK; Paterson Institute for Cancer Research; University of Manchester; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Manchester; CEA; Centre National de la Recherche Scientifique (CNRS); Universite de Orleans; Rudjer Boskovic Institute	Ahel, I (corresponding author), Univ Manchester, Paterson Inst Canc Res, Canc Res UK, Wilmslow Rd, Manchester M20 4BX, Lancs, England.	iahel@picr.man.ac.uk	Lafite, Pierre/F-6806-2011; dixon, neil/E-5230-2012; Dunstan, Mark/B-8934-2013	Lafite, Pierre/0000-0003-1637-4966; dixon, neil/0000-0001-9065-6764; Weston, Ria/0000-0001-8316-0728; Ahel, Marijan/0000-0001-6923-8461; Dunstan, Mark/0000-0002-9416-5505; Slade, Dea/0000-0002-0052-5910; Ahel, Ivan/0000-0002-9446-3756	Cancer Research UK; AXA Research Fund	Cancer Research UK(Cancer Research UK); AXA Research Fund(AXA Research Fund)	We thank G. Clark for genomic DNA from E. dispar, G. Smith for the PARP inhibitor, M. Rossi for purified proteins and R. Thorough for editing English. We thank D. Ahel, A. Jordan, D. Ogilvie, S. Terzic, D. Neuhaus and S. Eustermann for helpful discussions. We are grateful to B. Luscher for the gift of the PARP10 expression plasmid, and K. Labib and the members of his laboratory for advice with yeast work. This work was funded by Cancer Research UK. D. S. holds an AXA Research Fund post-doctoral fellowship. D. L. is a Royal Society University Research Fellow. Access to Diamond beamlines is gratefully acknowledged.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ahel D, 2009, SCIENCE, V325, P1240, DOI 10.1126/science.1177321; Ahel I, 2008, NATURE, V451, P81, DOI 10.1038/nature06420; Alberti S, 2007, YEAST, V24, P913, DOI 10.1002/yea.1502; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; Coulier L, 2006, ANAL CHEM, V78, P6573, DOI 10.1021/ac0607616; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gottschalk AJ, 2009, P NATL ACAD SCI USA, V106, P13770, DOI 10.1073/pnas.0906920106; Hakme A, 2008, EMBO REP, V9, P1094, DOI 10.1038/embor.2008.191; Hanai S, 2004, P NATL ACAD SCI USA, V101, P82, DOI 10.1073/pnas.2237114100; Hassa PO, 2008, FRONT BIOSCI-LANDMRK, V13, P3046, DOI 10.2741/2909; Jakalian A, 2002, J COMPUT CHEM, V23, P1623, DOI 10.1002/jcc.10128; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P916, DOI 10.1107/S0021889888007903; Karras GI, 2005, EMBO J, V24, P1911, DOI 10.1038/sj.emboj.7600664; Koh DW, 2004, P NATL ACAD SCI USA, V101, P17699, DOI 10.1073/pnas.0406182101; Koh DW, 2003, BIOCHEMISTRY-US, V42, P4855, DOI 10.1021/bi0272048; Kothe GO, 2010, FUNGAL GENET BIOL, V47, P297, DOI 10.1016/j.fgb.2009.12.012; Kustatscher G, 2005, NAT STRUCT MOL BIOL, V12, P624, DOI 10.1038/nsmb956; Lin WS, 1997, J BIOL CHEM, V272, P11895, DOI 10.1074/jbc.272.18.11895; Mueller-Dieckmann C, 2006, P NATL ACAD SCI USA, V103, P15026, DOI 10.1073/pnas.0606762103; Oka S, 2006, J BIOL CHEM, V281, P705, DOI 10.1074/jbc.M510290200; Panda S, 2002, DEV CELL, V3, P51, DOI 10.1016/S1534-5807(02)00200-9; Patel CN, 2005, BIOCHEM J, V388, P493, DOI 10.1042/BJ20040942; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Semighini CP, 2006, GENETICS, V173, P87, DOI 10.1534/genetics.105.053199; Tao ZH, 2009, BIOCHEMISTRY-US, V48, P11745, DOI 10.1021/bi901387k; Till S, 2009, FRONT BIOSCI-LANDMRK, V14, P3246, DOI 10.2741/3448; Timinszky G, 2009, NAT STRUCT MOL BIOL, V16, P923, DOI 10.1038/nsmb.1664	30	254	262	2	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 29	2011	477	7366					616	U150		10.1038/nature10404	http://dx.doi.org/10.1038/nature10404			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825ZM	21892188	Green Accepted			2022-12-28	WOS:000295320900045
J	Ikegami, N; Yoo, BK; Hashimoto, H; Matsumoto, M; Ogata, H; Babazono, A; Watanabe, R; Shibuya, K; Yang, BM; Reich, MR; Kobayashi, Y				Ikegami, Naoki; Yoo, Byung-Kwang; Hashimoto, Hideki; Matsumoto, Masatoshi; Ogata, Hiroya; Babazono, Akira; Watanabe, Ryo; Shibuya, Kenji; Yang, Bong-Min; Reich, Michael R.; Kobayashi, Yasuki			Japan: Universal Health Care at 50 Years 2 Japanese universal health coverage: evolution, achievements, and challenges	LANCET			English	Article							INEQUALITIES; EQUITY; ASIA	Japan shows the advantages and limitations of pursuing universal health coverage by establishment of employee-based and community-based social health insurance. On the positive side, almost everyone came to be insured in 1961; the enforcement of the same fee schedule for all plans and almost all providers has maintained equity and contained costs; and the co-payment rate has become the same for all, except for elderly people and children. This equity has been achieved by provision of subsidies from general revenues to plans that enrol people with low incomes, and enforcement of cross-subsidisation among the plans to finance the costs of health care for elderly people. On the negative side, the fragmentation of enrolment into 3500 plans has led to a more than a three-times difference in the proportion of income paid as premiums, and the emerging issue of the uninsured population. We advocate consolidation of all plans within prefectures to maintain universal and equitable coverage in view of the ageing society and changes in employment patterns. Countries planning to achieve universal coverage by social health insurance based on employment and residential status should be aware of the limitations of such plans.	[Ikegami, Naoki] Keio Univ, Sch Med, Dept Hlth Policy & Management, Tokyo 1608582, Japan; [Yoo, Byung-Kwang] Univ Rochester, Sch Med & Dent, Dept Community & Prevent Med, Rochester, NY USA; [Yoo, Byung-Kwang] Univ Calif Davis, Sch Med, Dept Publ Hlth Serv, Davis, CA 95616 USA; [Hashimoto, Hideki; Watanabe, Ryo] Univ Tokyo, Sch Publ Hlth, Dept Hlth Econ & Epidemiol Res, Tokyo, Japan; [Shibuya, Kenji] Univ Tokyo, Grad Sch Med, Dept Global Hlth Policy, Tokyo, Japan; [Kobayashi, Yasuki] Univ Tokyo, Grad Sch Med, Dept Publ Hlth, Tokyo, Japan; [Matsumoto, Masatoshi] Hiroshima Univ, Fac Med, Dept Community Based Med Syst, Hiroshima, Japan; [Ogata, Hiroya; Babazono, Akira] Kyushu Univ, Grad Sch Med Sci, Dept Hlth Care Adm & Management, Fukuoka 812, Japan; [Yang, Bong-Min] Seoul Natl Univ, Sch Publ Hlth, Seoul, South Korea; [Reich, Michael R.] Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA	Keio University; University of Rochester; University of California System; University of California Davis; University of Tokyo; University of Tokyo; University of Tokyo; Hiroshima University; Kyushu University; Seoul National University (SNU); Harvard University; Harvard T.H. Chan School of Public Health	Ikegami, N (corresponding author), Keio Univ, Sch Med, Dept Hlth Policy & Management, Tokyo 1608582, Japan.	nikegami@a5.keio.jp	YOO, BYUNG KWANG/AAU-2366-2021	Reich, Michael R./0000-0003-3338-0612; Matsumoto, Masatoshi/0000-0002-8341-9303; Watanabe, Ryo/0000-0002-7444-2624; Shibuya, Kenji/0000-0003-2528-7530	Bill & Melinda Gates Foundation; China Medical Board; Ministry of Health, Labour and Welfare [H22-seisaku-shitei-033]	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); China Medical Board; Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan)	We thank John Creighton Campbell and Keizo Takemi for their valuable comments, Megumi Kasajima for technical assistance in the statistical analysis, Andrew Stickley for his technical edits, and Tomoko Suzuki and Tadashi Yamamoto for their administrative support. This work is in part funded by the Bill & Melinda Gates Foundation and the China Medical Board, and in part by a research grant from the Ministry of Health, Labour and Welfare (H22-seisaku-shitei-033). The views and opinions expressed by the independent authors in this publication are provided in their personal capacity and are their sole responsibility.	*ALL JAP FED NAT H, 2010, SEEK STAB NAT HLTH I; [Anonymous], 1984, ILLNESS CULTURE CONT; Babazono A, 2003, INT J TECHNOL ASSESS, V19, P465; Bump JB, 2010, LONG ROAD UNIVERSAL; Campbell J, 1998, ART BALANCE HLTH POL; *FED HLTH INS SOC, 2008, FISC YEAR 2007 DAT H; *FED HLTH INS SOC, 2010, HLTH SEC SEEN FIG TA, P8; Flood CM, 2010, HEALTH ECON POLICY L, V5, P319, DOI 10.1017/S1744133110000046; FUSE S, 1979, HIST DOCTORS JAPANES; Hashimoto H, 2011, LANCET, V378, P1174, DOI 10.1016/S0140-6736(11)60987-2; HIGUCHI T, 1974, INT LABOUR REV, V109, P251; HONDA R, 2010, REPORTAGE PUBLIC ASS; Hsiao WC, 2007, WBI DEV STUD, P21; IKEGAMI N, 2010, SHAKAI HOKEN JUNPO, V2410, P16; Ikegami N, 2006, J HEALTH POLIT POLIC, V31, P1129, DOI 10.1215/03616878-2006-022; Kakwani N, 1997, J ECONOMETRICS, V77, P87, DOI 10.1016/S0304-4076(96)01807-6; Katsumata Y, 1996, CONTAINING HLTH CARE, P19; Kwon S, 2003, INT SOCIAL SECURITY, V56, P75, DOI [10.1111/1468-246x.00150, DOI 10.1111/1468-246X.00150]; Lu JFR, 2007, SOC SCI MED, V64, P199, DOI 10.1016/j.socscimed.2006.08.033; *MIN FIN, 2011, INT COMP DEBT PERC G; *MIN HLTH LAB WELF, 2010, REF COST BURD COUNC; *MIN HLTH LAB WELF, RES SURV ISS CERT ST; *MIN HLTH LAB WELF, 2010, J HLTH WELFARE STAT, V57, P46; *MIN HLTH LAB WELF, 2010, PAT SURV REP 1950 20; *MIN HLTH LAB WELF, 2007, BAS DAT HLTH INS; *MIN PUBL MAN HOM, 2011, HIST DAT 10 EMPL AG; *MIN PUBL MAN HOM, 2011, RES IND CLASS LAB FO; Ministry of Health Labor and Welfare, 2005, DAT 3 PROJ NAT MED E; MOYNIHAN R, 2010, FOCUS HLTH POLICY TI; O'Donnell O, 2008, J HEALTH ECON, V27, P460, DOI 10.1016/j.jhealeco.2007.08.005; OECD, 2011, OECD HLTH DAT 2011; Pierson P, 2000, AM POLIT SCI REV, V94, P251, DOI 10.2307/2586011; *REG DISP STUD GRO, 2001, DISP HEALTHC EXP; Saltman R. B., 2004, SOCIAL HLTH INSURANC; *SHAK HOK KENK, 1991, PROGR SOC INS; SHIMAZAKI K, 2011, HLTH CARE JAPAN I PO; TAKAGI Y, 1994, KIKAN SHAKAI HOSHO K, V30, P239; Tamiya N, 2011, LANCET, V378, P1183, DOI 10.1016/S0140-6736(11)61176-8; TAMURA M, 2003, SHAKAI HOKEN JYUNPOU, V2192, P6; van Doorslaer E, 2004, HEALTH ECON, V13, P629, DOI 10.1002/hec.919; Van Doorslaer E, 2007, HEALTH ECON, V16, P1159, DOI 10.1002/hec.1209; Vogel Steven, 2006, JAPAN REMODELED GOVT; Wagstaff A, 1999, J HEALTH ECON, V18, P263, DOI 10.1016/S0167-6296(98)00044-7; WHO, 2010, WOR HEALT REP, P1; Wong J., 2006, HLTH DEMOCRACIES WEL; 2011, EVEN VAT 10 STILL NO	46	364	368	1	65	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 17	2011	378	9796					1106	1115		10.1016/S0140-6736(11)60828-3	http://dx.doi.org/10.1016/S0140-6736(11)60828-3			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	829BE	21885107				2022-12-28	WOS:000295548900027
J	Kirby, T				Kirby, Tony			Profile Kenji Shibuya: promoting global health in Japan	LANCET			English	Biographical-Item																			0	0	0	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 17	2011	378	9796					1064	1064		10.1016/S0140-6736(11)61388-3	http://dx.doi.org/10.1016/S0140-6736(11)61388-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	829BE	21885106	Bronze			2022-12-28	WOS:000295548900012
J	Hara, MR; Kovacs, JJ; Whalen, EJ; Rajagopal, S; Strachan, RT; Grant, W; Towers, AJ; Williams, B; Lam, CM; Xiao, KH; Shenoy, SK; Gregory, SG; Ahn, S; Duckett, DR; Lefkowitz, RJ				Hara, Makoto R.; Kovacs, Jeffrey J.; Whalen, Erin J.; Rajagopal, Sudarshan; Strachan, Ryan T.; Grant, Wayne; Towers, Aaron J.; Williams, Barbara; Lam, Christopher M.; Xiao, Kunhong; Shenoy, Sudha K.; Gregory, Simon G.; Ahn, Seungkirl; Duckett, Derek R.; Lefkowitz, Robert J.			A stress response pathway regulates DNA damage through beta(2)-adrenoreceptors and beta-arrestin-1	NATURE			English	Article							SHORT-INTERFERING RNAS; NUCLEAR EXPORT SIGNAL; BETA-ARRESTINS; ADENYLYL-CYCLASE; N-DOMAIN; RECEPTOR; ACTIVATION; EXPRESSION; GROWTH; P53	The human mind and body respond to stress(1), a state of perceived threat to homeostasis, by activating the sympathetic nervous system and secreting the catecholamines adrenaline and noradrenaline in the 'fight-or-flight' response. The stress response is generally transient because its accompanying effects (for example, immunosuppression, growth inhibition and enhanced catabolism) can be harmful in the long term(2). When chronic, the stress response can be associated with disease symptoms such as peptic ulcers or cardiovascular disorders(3), and epidemiological studies strongly indicate that chronic stress leads to DNA damage(4,5). This stress-induced DNA damage may promote ageing(6), tumorigenesis(4,7), neuropsychiatric conditions(8,9) and miscarriages(10). However, the mechanisms by which these DNA-damage events occur in response to stress are unknown. The stress hormone adrenaline stimulates beta(2)-adrenoreceptors that are expressed throughout the body, including in germline cells and zygotic embryos(11). Activated beta(2)-adrenoreceptors promote Gs-protein-dependent activation of protein kinase A (PKA), followed by the recruitment of beta-arrestins, which desensitize G-protein signalling and function as signal transducers in their own right(12). Here we elucidate a molecular mechanism by which beta-adrenergic catecholamines, acting through both Gs-PKA and beta-arrestin-mediated signalling pathways, trigger DNA damage and suppress p53 levels respectively, thus synergistically leading to the accumulation of DNA damage. In mice and in human cell lines, beta-arrestin-1 (ARRB1), activated via beta(2)-adrenoreceptors, facilitates AKT-mediated activation of MDM2 and also promotes MDM2 binding to, and degradation of, p53, by acting as a molecular scaffold. Catecholamine-induced DNA damage is abrogated in Arrb1-knockout (Arrb1(-/-)) mice, which show preserved p53 levels in both the thymus, an organ that responds prominently to acute or chronic stress(1), and in the testes, in which paternal stress may affect the offspring's genome. Our results highlight the emerging role of ARRB1 as an E3-ligase adaptor in the nucleus, and reveal how DNA damage may accumulate in response to chronic stress.	[Hara, Makoto R.; Kovacs, Jeffrey J.; Whalen, Erin J.; Rajagopal, Sudarshan; Strachan, Ryan T.; Towers, Aaron J.; Williams, Barbara; Lam, Christopher M.; Xiao, Kunhong; Shenoy, Sudha K.; Gregory, Simon G.; Ahn, Seungkirl; Lefkowitz, Robert J.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Grant, Wayne; Duckett, Derek R.] Scripps Res Inst, Translat Res Inst, Jupiter, FL 33458 USA; [Towers, Aaron J.; Gregory, Simon G.] Duke Univ, Med Ctr, Ctr Human Genet, Durham, NC 27710 USA; [Lefkowitz, Robert J.] Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA	Duke University; Scripps Research Institute; Duke University; Duke University; Howard Hughes Medical Institute	Lefkowitz, RJ (corresponding author), Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA.	lefko001@receptor-biol.duke.edu	Shenoy, Sudha/AAN-4075-2021; Lefkowitz, Robert/AAW-2649-2021; Rajagopal, Sudarshan/G-8975-2013; Xiao, Kunhong/AAG-4275-2020	Shenoy, Sudha/0000-0002-2565-4663; Rajagopal, Sudarshan/0000-0002-3443-5040; Xiao, Kunhong/0000-0002-1069-1226; Gregory, Simon/0000-0002-7805-1743	 [HL16037];  [HL70631]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL016037, R01HL016037, R01HL070631] Funding Source: NIH RePORTER	; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	R.J.L. is a Howard Hughes Medical Institute investigator. This work was supported by HL16037 and HL70631 (R.J.L.). We thank D. Addison and Q. Lennon for secretarial assistance; S. H. Snyder and M. A. Koldobskiy for providing p53 deletion constructs; B. K. Kobilka and H. A. Rockman for providing Adrb2<SUP>-/-</SUP> mice; M. C. Hung for providing the MDM2-S166D plasmid; A. K. Shukla, A. Kahsai, J. Kim, J. Sun, S. M. DeWire and N. Odajima for discussion and comments.	Antoni MH, 2006, NAT REV CANCER, V6, P240, DOI 10.1038/nrc1820; ATTRAMADAL H, 1992, J BIOL CHEM, V267, P17882; Baker JG, 2005, BRIT J PHARMACOL, V144, P317, DOI 10.1038/sj.bjp.0706048; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Boularan C, 2007, P NATL ACAD SCI USA, V104, P18061, DOI 10.1073/pnas.0705550104; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Buchanan FG, 2006, P NATL ACAD SCI USA, V103, P1492, DOI 10.1073/pnas.0510562103; Charmandari E, 2005, ANNU REV PHYSIOL, V67, P259, DOI 10.1146/annurev.physiol.67.040403.120816; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Chruscinski AJ, 1999, J BIOL CHEM, V274, P16694, DOI 10.1074/jbc.274.24.16694; Cikos S, 2005, MOL REPROD DEV, V71, P145, DOI 10.1002/mrd.20256; Conner DA, 1997, CIRC RES, V81, P1021; De Gregorio G, 2007, ONCOGENE, V26, P2039, DOI 10.1038/sj.onc.1210011; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Flint MS, 2007, PSYCHONEUROENDOCRINO, V32, P470, DOI 10.1016/j.psyneuen.2007.02.013; Fratiglioni L, 2004, LANCET NEUROL, V3, P343, DOI 10.1016/S1474-4422(04)00767-7; Freedman DA, 1998, MOL CELL BIOL, V18, P7288, DOI 10.1128/MCB.18.12.7288; Goel R, 2002, J BIOL CHEM, V277, P18640, DOI 10.1074/jbc.M108995200; Goldstein David S, 2003, Endocr Regul, V37, P69; Hara MR, 2005, NAT CELL BIOL, V7, P665, DOI 10.1038/ncb1268; HAUSDORFF WP, 1990, J BIOL CHEM, V265, P1388; Khachaturian AS, 2006, ARCH NEUROL-CHICAGO, V63, P686, DOI 10.1001/archneur.63.5.noc60013; Kinney DK, 2008, NEUROSCI BIOBEHAV R, V32, P1519, DOI 10.1016/j.neubiorev.2008.06.004; Kohout TA, 2001, P NATL ACAD SCI USA, V98, P1601, DOI 10.1073/pnas.041608198; Koldobskiy MA, 2010, P NATL ACAD SCI USA, V107, P20947, DOI 10.1073/pnas.1015671107; Kovacs JJ, 2008, SCIENCE, V320, P1777, DOI 10.1126/science.1157983; Kovacs JJ, 2009, DEV CELL, V17, P443, DOI 10.1016/j.devcel.2009.09.011; Lista F, 1997, CANCER RES, V57, P4408; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; Nepomnaschy PA, 2006, P NATL ACAD SCI USA, V103, P3938, DOI 10.1073/pnas.0511183103; Ni YX, 2006, NAT MED, V12, P1390, DOI 10.1038/nm1485; Nobles KN, 2007, J BIOL CHEM, V282, P21370, DOI 10.1074/jbc.M611483200; Nowak DE, 2005, BIOTECHNIQUES, V39, P715, DOI 10.2144/000112014; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; RAINBOW TC, 1984, P NATL ACAD SCI-BIOL, V81, P1585, DOI 10.1073/pnas.81.5.1585; Schuller HM, 2002, NAT REV CANCER, V2, P455, DOI 10.1038/nrc824; Scott MGH, 2002, J BIOL CHEM, V277, P37693, DOI 10.1074/jbc.M207552200; Selye H, 1936, NATURE, V138, P32, DOI 10.1038/138032a0; Sengupta S, 2005, NAT REV MOL CELL BIO, V6, P44, DOI 10.1038/nrm1546; SESHADRI T, 1990, SCIENCE, V247, P205, DOI 10.1126/science.2104680; Thaker PH, 2006, NAT MED, V12, P939, DOI 10.1038/nm1447; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Wang P, 2003, J BIOL CHEM, V278, P11648, DOI 10.1074/jbc.M208109200; Wang P, 2003, J BIOL CHEM, V278, P6363, DOI 10.1074/jbc.M210350200; Xiao KH, 2004, J BIOL CHEM, V279, P55744, DOI 10.1074/jbc.M409785200; Yan L, 2007, CELL, V130, P247, DOI 10.1016/j.cell.2007.05.038; Yu JY, 2002, P NATL ACAD SCI USA, V99, P6047, DOI 10.1073/pnas.092143499; Zhou BHP, 2001, NAT CELL BIOL, V3, P973, DOI 10.1038/ncb1101-973	49	278	289	1	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 15	2011	477	7364					349	U129		10.1038/nature10368	http://dx.doi.org/10.1038/nature10368			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819TD	21857681	Green Accepted			2022-12-28	WOS:000294852400035
J	Kibii, JM; Churchill, SE; Schmid, P; Carlson, KJ; Reed, ND; de Ruiter, DJ; Berger, LR				Kibii, Job M.; Churchill, Steven E.; Schmid, Peter; Carlson, Kristian J.; Reed, Nichelle D.; de Ruiter, Darryl J.; Berger, Lee R.			A Partial Pelvis of Australopithecus sediba	SCIENCE			English	Article							HOMO-ERECTUS; EARLY HOMININS; EVOLUTION; SIZE; LOCOMOTOR; BIPEDALITY; HADAR; BIRTH; GAIT; GONA	The fossil record of the hominin pelvis reflects important evolutionary changes in locomotion and parturition. The partial pelves of two individuals of Australopithecus sediba were reconstructed from previously reported finds and new material. These remains share some features with australopiths, such as large biacetabular diameter, small sacral and coxal joints, and long pubic rami. The specimens also share derived features with Homo, including more vertically oriented and sigmoid-shaped iliac blades, greater robusticity of the iliac body, sinusoidal anterior iliac borders, shortened ischia, and more superiorly oriented pubic rami. These derived features appear in a species with a small adult brain size, suggesting that the birthing of larger-brained babies was not driving the evolution of the pelvis at this time.	[Kibii, Job M.; Churchill, Steven E.; Schmid, Peter; Carlson, Kristian J.; de Ruiter, Darryl J.; Berger, Lee R.] Univ Witwatersrand, Inst Human Evolut, ZA-2050 Johannesburg, South Africa; [Churchill, Steven E.; Reed, Nichelle D.] Duke Univ, Dept Evolutionary Anthropol, Durham, NC 27708 USA; [Schmid, Peter] Univ Zurich, Anthropol Inst & Museum, CH-8057 Zurich, Switzerland; [Carlson, Kristian J.] Indiana Univ, Dept Anthropol, Bloomington, IN 47405 USA; [de Ruiter, Darryl J.] Texas A&M Univ, Dept Anthropol, College Stn, TX 77843 USA; [Berger, Lee R.] Univ Witwatersrand, Sch Geosci, ZA-2050 Johannesburg, South Africa	University of Witwatersrand; Duke University; University of Zurich; Indiana University System; Indiana University Bloomington; Texas A&M University System; Texas A&M University College Station; University of Witwatersrand	Churchill, SE (corresponding author), Univ Witwatersrand, Inst Human Evolut, Private Bag 3, ZA-2050 Johannesburg, South Africa.	churchy@duke.edu	Churchill, Steven/AAA-9386-2022; Berger, Lee Rogers/AAC-3484-2020	Berger, Lee Rogers/0000-0002-0367-7629; de Ruiter, Darryl/0000-0003-1183-0352	South African Department of Science and Technology; South African National Research Foundation; Institute for Human Evolution, University of the Witwatersrand; University of the Witwatersrand; National Geographic Society; Palaeontological Scientific Trust; Andrew W. Mellon Foundation; Ford Foundation; U.S. Diplomatic Mission to South Africa; French Embassy of South Africa; A. H. Schultz Foundation; Texas AM University; Oppenheimer and Ackerman families; R. Branson; University of the Witwatersrand's Schools of Geosciences and Anatomical Sciences; Bernard Price Institute for Palaeontology	South African Department of Science and Technology; South African National Research Foundation(National Research Foundation - South Africa); Institute for Human Evolution, University of the Witwatersrand; University of the Witwatersrand; National Geographic Society(National Geographic Society); Palaeontological Scientific Trust; Andrew W. Mellon Foundation; Ford Foundation; U.S. Diplomatic Mission to South Africa; French Embassy of South Africa; A. H. Schultz Foundation; Texas AM University; Oppenheimer and Ackerman families; R. Branson; University of the Witwatersrand's Schools of Geosciences and Anatomical Sciences; Bernard Price Institute for Palaeontology	We thank the South African Heritage Resource Agency for the permits to work at the Malapa site; the Nash family for granting access to the Malapa site and continued support of research on their reserve; the South African Department of Science and Technology, the South African National Research Foundation, the Institute for Human Evolution, University of the Witwatersrand, the University of the Witwatersrand's Vice Chancellor's Discretionary Fund, the National Geographic Society, the Palaeontological Scientific Trust, the Andrew W. Mellon Foundation, the Ford Foundation, the U.S. Diplomatic Mission to South Africa, the French Embassy of South Africa, the A. H. Schultz Foundation, a Ray A. Rothrock '77 fellowship and an International Research Travel Assistance grant of Texas A&M University, the Oppenheimer and Ackerman families, and R. Branson for funding; the University of the Witwatersrand's Schools of Geosciences and Anatomical Sciences and the Bernard Price Institute for Palaeontology for support and facilities; the Gauteng Government, Gauteng Department of Agriculture, Conservation and Environment and the Cradle of Humankind Management Authority; and our respective universities for ongoing support. For access to comparative specimens, we thank E. Mbua, P. Kiura, V. Iminjili, and the National Museums of Kenya; B. Billings, B. Zipfel, and the School of Anatomical Sciences at the University of the Witwatersrand; and S. Potze, L.C. Kgasi, and the Ditsong Museum. For comparative data, we thank T. Holliday. For technical and material support, we thank Duke University and the University of Zurich 2009 and 2010 Field Schools. Numerous individuals have been involved in the ongoing preparation and excavation of these fossils, including C. Dube, C. Kemp, M. Kgasi, M. Languza, J. Malaza, G. Mokoma, P. Mukanela, T. Nemvhundi, M. Ngcamphalala, S. Jirah, S. Tshabalala, and C. Yates. Other individuals who have given significant support to this project include B. de Klerk, W. Lawrence, C. Steininger, B. Kuhn, L. Pollarolo, B. Zipfel, J. Kretzen, D. Conforti, J. McCaffery, C. Dlamini, H. Visser, R. McCrae-Samuel, B. Nkosi, B. Louw, L. Backwell, F. Thackeray, and M. Peltier. J. Smilg facilitated computed tomography scanning of the specimens. J. DeSilva, T. Kivell, and three anonymous reviewers gave useful comments on drafts of the manuscript. The Au. sediba specimens are archived at the Institute of Human Evolution at the University of the Witwatersrand.	ABITBOL MM, 1987, AM J PHYS ANTHROPOL, V72, P361; Aiello L, 1990, INTRO HUMAN EVOLUTIO; BERGE C, 1986, FOLIA PRIMATOL, V46, P185, DOI 10.1159/000156253; BERGE C, 1984, J HUM EVOL, V13, P573, DOI 10.1016/S0047-2484(84)80029-9; Berge C, 2010, J HUM EVOL, V58, P262, DOI 10.1016/j.jhevol.2009.11.006; Berger LR, 2010, SCIENCE, V328, P195, DOI 10.1126/science.1184944; Bondioli L, 2006, J HUM EVOL, V50, P479, DOI 10.1016/j.jhevol.2006.01.001; Carlson KJ, 2011, SCIENCE, V333, P1402, DOI 10.1126/science.1203922; DALSTRA M, 1995, J BIOMECH, V28, P715, DOI 10.1016/0021-9290(94)00125-N; DAY MH, 1971, NATURE, V232, P383, DOI 10.1038/232383a0; DEARSUAGA JL, 1981, J HUM EVOL, V10, P293, DOI 10.1016/S0047-2484(81)80051-6; DeSilva JM, 2008, J HUM EVOL, V55, P1064, DOI 10.1016/j.jhevol.2008.07.008; Haeusler M, 2002, EVOL ANTHROPOL, V11, P53, DOI 10.1002/evan.10056; Haile-Selassie Y, 2010, P NATL ACAD SCI USA, V107, P12121, DOI 10.1073/pnas.1004527107; Herries AIR, 2010, AM J PHYS ANTHROPOL, V143, P640, DOI 10.1002/ajpa.21389; Kivell TL, 2011, SCIENCE, V333, P1411, DOI 10.1126/science.1202625; LAVELLE M, 1995, AM J PHYS ANTHROPOL, V98, P59, DOI 10.1002/ajpa.1330980106; LOVEJOY CO, 1973, AM J PHYS ANTHROPOL, V38, P757, DOI 10.1002/ajpa.1330380315; Lovejoy CO, 2005, GAIT POSTURE, V21, P95, DOI 10.1016/j.gaitpost.2004.01.001; MCHENRY HM, 1975, AM J PHYS ANTHROPOL, V43, P263, DOI 10.1002/ajpa.1330430212; PROST JH, 1980, AM J PHYS ANTHROPOL, V52, P175, DOI 10.1002/ajpa.1330520204; ROSE MD, 1984, AM J PHYS ANTHROPOL, V63, P371, DOI 10.1002/ajpa.1330630404; RUFF CB, 1995, AM J PHYS ANTHROPOL, V98, P527, DOI 10.1002/ajpa.1330980412; Ruff C, 2010, J HUM EVOL, V58, P166, DOI 10.1016/j.jhevol.2009.10.003; SCHMID P, 1983, FOLIA PRIMATOL, V40, P283, DOI 10.1159/000156111; Schmitt D, 2003, J EXP BIOL, V206, P1437, DOI 10.1242/jeb.00279; Simpson SW, 2008, SCIENCE, V322, P1089, DOI 10.1126/science.1163592; Sponheimer Matt, 2009, P185, DOI 10.1007/978-1-4020-9980-9_16; Stern JT, 2000, EVOL ANTHROPOL, V9, P113, DOI 10.1002/1520-6505(2000)9:3<113::AID-EVAN2>3.0.CO;2-W; STERN JT, 1983, AM J PHYS ANTHROPOL, V60, P279, DOI 10.1002/ajpa.1330600302; Steudel-Numbers KL, 2006, J HUM EVOL, V51, P445, DOI 10.1016/j.jhevol.2006.05.001; Steudel-Numbers KL, 2004, J HUM EVOL, V47, P95, DOI 10.1016/j.jhevol.2004.06.002; SUSMAN RL, 1984, FOLIA PRIMATOL, V43, P113, DOI 10.1159/000156176; TAGUE RG, 1989, AM J PHYS ANTHROPOL, V80, P59, DOI 10.1002/ajpa.1330800108; TAGUE RG, 1991, J HUM EVOL, V21, P153, DOI 10.1016/0047-2484(91)90059-5; TAGUE RG, 1986, J HUM EVOL, V15, P237; Walker Alan, 1993, P95; Ward CV, 2011, AM J PHYS ANTHROPOL, V144, P305; Ward CV, 2002, YEARB PHYS ANTHROPOL, V45, P185, DOI 10.1002/ajpa.10185; Wood B, 2011, NATURE, V470, P347, DOI 10.1038/nature09709; Zipfel B, 2011, SCIENCE, V333, P1417, DOI 10.1126/science.1202703	41	106	111	0	63	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 9	2011	333	6048					1407	1411		10.1126/science.1202521	http://dx.doi.org/10.1126/science.1202521			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	817KU	21903805				2022-12-28	WOS:000294672200032
J	Blaya, M; Saba, N				Blaya, Marcelo; Saba, Nakhle			Chemotherapy-Induced Hyperpigmentation of the Tongue	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Blaya, Marcelo; Saba, Nakhle] Tulane Univ, New Orleans, LA 70118 USA	Tulane University	Blaya, M (corresponding author), Tulane Univ, New Orleans, LA 70118 USA.	mblaya@tulane.edu							0	8	8	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 8	2011	365	10					E20	E20		10.1056/NEJMicm1014268	http://dx.doi.org/10.1056/NEJMicm1014268			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	816JX	21899446				2022-12-28	WOS:000294595600011
J	Frezza, C; Zheng, L; Folger, O; Rajagopalan, KN; MacKenzie, ED; Jerby, L; Micaroni, M; Chaneton, B; Adam, J; Hedley, A; Kalna, G; Tomlinson, IPM; Pollard, PJ; Watson, DG; Deberardinis, RJ; Shlomi, T; Ruppin, E; Gottlieb, E				Frezza, Christian; Zheng, Liang; Folger, Ori; Rajagopalan, Kartik N.; MacKenzie, Elaine D.; Jerby, Livnat; Micaroni, Massimo; Chaneton, Barbara; Adam, Julie; Hedley, Ann; Kalna, Gabriela; Tomlinson, Ian P. M.; Pollard, Patrick J.; Watson, Dave G.; Deberardinis, Ralph J.; Shlomi, Tomer; Ruppin, Eytan; Gottlieb, Eyal			Haem oxygenase is synthetically lethal with the tumour suppressor fumarate hydratase	NATURE			English	Article							RENAL-CANCER; MODELS; CELLS; RECONSTRUCTION; PROTEIN; ASSAY	Fumarate hydratase (FH) is an enzyme of the tricarboxylic acid cycle (TCA cycle) that catalyses the hydration of fumarate into malate. Germline mutations of FH are responsible for hereditary leiomyomatosis and renal-cell cancer (HLRCC)(1). It has previously been demonstrated that the absence of FH leads to the accumulation of fumarate, which activates hypoxia-inducible factors (HIFs) at normal oxygen tensions(2-4). However, so far no mechanism that explains the ability of cells to survive without a functional TCA cycle has been provided. Here we use newly characterized genetically modified kidney mouse cells in which Fh1 has been deleted, and apply a newly developed computer model of the metabolism of these cells to predict and experimentally validate a linear metabolic pathway beginning with glutamine uptake and ending with bilirubin excretion from Fh1-deficient cells. This pathway, which involves the biosynthesis and degradation of haem, enables Fh1-deficient cells to use the accumulated TCA cycle metabolites and permits partial mitochondrial NADH production. We predicted and confirmed that targeting this pathway would render Fh1-deficient cells nonviable, while sparing wild-type Fh1-containing cells. This work goes beyond identifying a metabolic pathway that is induced in Fh1-deficient cells to demonstrate that inhibition of haem oxygenation is synthetically lethal when combined with Fh1 deficiency, providing a new potential target for treating HLRCC patients.	[Frezza, Christian; Zheng, Liang; MacKenzie, Elaine D.; Chaneton, Barbara; Hedley, Ann; Kalna, Gabriela; Gottlieb, Eyal] Beatson Inst Canc Res, Canc Res UK, Glasgow G61 1BD, Lanark, Scotland; [Folger, Ori; Jerby, Livnat; Ruppin, Eytan] Tel Aviv Univ, Blavatnik Sch Comp Sci, IL-69978 Tel Aviv, Israel; [Rajagopalan, Kartik N.; Deberardinis, Ralph J.] Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA; [Rajagopalan, Kartik N.; Deberardinis, Ralph J.] Univ Texas SW Med Ctr Dallas, McDermott Ctr Human Growth & Dev, Dallas, TX 75390 USA; [Micaroni, Massimo] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Tomlinson, Ian P. M.] Univ Oxford, Wellcome Trust Ctr Human Genet, Mol & Populat Genet Lab, Oxford OX3 7BN, England; [Watson, Dave G.] Univ Strathclyde, Strathclyde Inst Pharmaceut & Biomed Sci, Glasgow G4 0NR, Lanark, Scotland; [Shlomi, Tomer] Technion Israel Inst Technol, Dept Comp Sci, IL-32000 Haifa, Israel; [Ruppin, Eytan] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel	Beatson Institute; Cancer Research UK; Tel Aviv University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Queensland; University of Oxford; Wellcome Centre for Human Genetics; University of Strathclyde; Technion Israel Institute of Technology; Tel Aviv University; Sackler Faculty of Medicine	Gottlieb, E (corresponding author), Beatson Inst Canc Res, Canc Res UK, Switchback Rd, Glasgow G61 1BD, Lanark, Scotland.	e.gottlieb@beatson.gla.ac.uk	Gottlieb, Eyal/G-6450-2010; Ruppin, Eytan/R-9698-2017; Pollard, Patrick/F-7516-2012; Frezza, Christian/G-2174-2010	Gottlieb, Eyal/0000-0002-9770-0956; Ruppin, Eytan/0000-0002-7862-3940; Pollard, Patrick/0000-0002-4459-4993; Frezza, Christian/0000-0002-3293-7397; Adam, Julie/0000-0002-7980-7151; Zheng, Liang/0000-0002-5346-4111; Micaroni, Massimo/0000-0001-6405-0451	Cancer Research UK; EMBO [ALTF330]; Wellcome Trust [WT091112MA]; NIH [DK072565-05]; Cancer Prevention and Research Institute of Texas [HIRP100437-01]; Israel Science Foundation (ISF); Israel Cancer Research Foundation; Edmond J. Safra Bioinformatics program at TAU; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK072565] Funding Source: NIH RePORTER	Cancer Research UK(Cancer Research UK); EMBO(European Molecular Biology Organization (EMBO)); Wellcome Trust(Wellcome TrustEuropean Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention and Research Institute of Texas; Israel Science Foundation (ISF)(Israel Science Foundation); Israel Cancer Research Foundation; Edmond J. Safra Bioinformatics program at TAU; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Cancer Research UK. We would like to acknowledge the Patterson Institute for Cancer Research for the Exon Array analysis. C. F. is supported by an EMBO long term fellowship (ALTF330). P.J.P. is in receipt of a Beit Memorial Fellowship funded by the Wellcome Trust (WT091112MA). D. G. W. and L.Z. would like to acknowledge SULSA (Scottish Universities Life Science Alliance). R.J.D. and K.N.R. are supported by the NIH (DK072565-05) and the Cancer Prevention and Research Institute of Texas (HIRP100437-01). O.F., T. S. and E. R. are supported by the Israel Science Foundation (ISF) and the Israel Cancer Research Foundation. L.J. is supported by the Edmond J. Safra Bioinformatics program at TAU. We thank UOB Tumor Cell Line Repository and W. Marston Linehan for providing us with the UOK262 cell lines, and A. King for editorial work.	Anderson KE, 2006, AM J MED, V119, DOI 10.1016/j.amjmed.2006.05.026; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; Deutscher D, 2006, NAT GENET, V38, P993, DOI 10.1038/ng1856; Duarte NC, 2007, P NATL ACAD SCI USA, V104, P1777, DOI 10.1073/pnas.0610772104; Fernandez CA, 1996, J MASS SPECTROM, V31, P255, DOI 10.1002/(SICI)1096-9888(199603)31:3<255::AID-JMS290>3.0.CO;2-3; Folger O, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.35; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Frezza C, 2011, J MOL MED, V89, P213, DOI 10.1007/s00109-011-0728-4; Isaacs JS, 2005, CANCER CELL, V8, P143, DOI 10.1016/j.ccr.2005.06.017; Jerby L, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.56; Labbe RF, 1999, CLIN CHEM, V45, P2060; Lee JK, 2007, P NATL ACAD SCI USA, V104, P13086, DOI 10.1073/pnas.0610292104; Malena A, 2009, HUM MOL GENET, V18, P3407, DOI 10.1093/hmg/ddp281; Mathew R, 2008, METHOD ENZYMOL, V446, P77, DOI 10.1016/S0076-6879(08)01605-4; Orth JD, 2010, NAT BIOTECHNOL, V28, P245, DOI 10.1038/nbt.1614; Pollard PJ, 2007, CANCER CELL, V11, P311, DOI 10.1016/j.ccr.2007.02.005; Price ND, 2003, TRENDS BIOTECHNOL, V21, P162, DOI 10.1016/S0167-7799(03)00030-1; SCHOENFELD N, 1984, BIOCHEM PHARMACOL, V33, P2783, DOI 10.1016/0006-2952(84)90696-8; Sudarshan S, 2009, MOL CELL BIOL, V29, P4080, DOI 10.1128/MCB.00483-09; Tomlinson IPM, 2002, NAT GENET, V30, P406, DOI 10.1038/ng849; Uc A, 2004, AM J PHYSIOL-GASTR L, V287, pG1150, DOI 10.1152/ajpgi.00157.2004; Vanharanta S, 2006, HUM MOL GENET, V15, P97, DOI 10.1093/hmg/ddi431; Vichai V, 2006, NAT PROTOC, V1, P1112, DOI 10.1038/nprot.2006.179; Yang Y, 2010, CANCER GENET CYTOGEN, V196, P45, DOI 10.1016/j.cancergencyto.2009.08.018	24	349	352	3	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 8	2011	477	7363					225	U132		10.1038/nature10363	http://dx.doi.org/10.1038/nature10363			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	816MC	21849978				2022-12-28	WOS:000294603900039
J	Cook, DA; Hatala, R; Brydges, R; Zendejas, B; Szostek, JH; Wang, AT; Erwin, PJ; Hamstra, SJ				Cook, David A.; Hatala, Rose; Brydges, Ryan; Zendejas, Benjamin; Szostek, Jason H.; Wang, Amy T.; Erwin, Patricia J.; Hamstra, Stanley J.			Technology-Enhanced Simulation for Health Professions Education A Systematic Review and Meta-analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							MEDICAL-EDUCATION; SURGICAL SIMULATION; FRAMEWORK; QUALITY; TRIALS; BIAS	Context Although technology-enhanced simulation has widespread appeal, its effectiveness remains uncertain. A comprehensive synthesis of evidence may inform the use of simulation in health professions education. Objective To summarize the outcomes of technology-enhanced simulation training for health professions learners in comparison with no intervention. Data Source Systematic search of MEDLINE, EMBASE, CINAHL, ERIC, PsychINFO, Scopus, key journals, and previous review bibliographies through May 2011. Study Selection Original research in any language evaluating simulation compared with no intervention for training practicing and student physicians, nurses, dentists, and other health care professionals. Data Extraction Reviewers working in duplicate evaluated quality and abstracted information on learners, instructional design (curricular integration, distributing training over multiple days, feedback, mastery learning, and repetitive practice), and outcomes. We coded skills (performance in a test setting) separately for time, process, and product measures, and similarly classified patient care behaviors. Data Synthesis From a pool of 10 903 articles, we identified 609 eligible studies enrolling 35 226 trainees. Of these, 137 were randomized studies, 67 were nonrandomized studies with 2 or more groups, and 405 used a single-group pretest-posttest design. We pooled effect sizes using random effects. Heterogeneity was large (I-2>50%) in all main analyses. In comparison with no intervention, pooled effect sizes were 1.20 (95% CI, 1.04-1.35) for knowledge outcomes (n=118 studies), 1.14 (95% CI, 1.03-1.25) for time skills (n=210), 1.09 (95% CI, 1.03-1.16) for process skills (n=426), 1.18 (95% CI, 0.98-1.37) for product skills (n=54), 0.79 (95% CI, 0.47-1.10) for time behaviors (n=20), 0.81 (95% CI, 0.66-0.96) for other behaviors (n=50), and 0.50 (95% CI, 0.34-0.66) for direct effects on patients (n=32). Subgroup analyses revealed no consistent statistically significant interactions between simulation training and instructional design features or study quality. Conclusion In comparison with no intervention, technology-enhanced simulation training in health professions education is consistently associated with large effects for outcomes of knowledge, skills, and behaviors and moderate effects for patient-related outcomes. JAMA. 2011;306(9):978-988	[Cook, David A.; Szostek, Jason H.; Wang, Amy T.] Mayo Clin, Coll Med, Div Gen Internal Med, Rochester, MN 55905 USA; [Cook, David A.] Mayo Clin, Coll Med, Mayo Med Sch, Off Educ Res, Rochester, MN 55905 USA; [Zendejas, Benjamin] Mayo Clin, Coll Med, Dept Surg, Rochester, MN 55905 USA; [Erwin, Patricia J.] Mayo Clin, Coll Med, Mayo Lib, Rochester, MN 55905 USA; [Hatala, Rose] Univ British Columbia, Dept Med, Vancouver, BC, Canada; [Brydges, Ryan] Univ Toronto, Dept Med, Toronto, ON, Canada; [Hamstra, Stanley J.] Univ Ottawa, Fac Med, Acad Innovat Med Educ, Ottawa, ON, Canada	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; University of British Columbia; University of Toronto; University of Ottawa	Cook, DA (corresponding author), Mayo Clin, Coll Med, Div Gen Internal Med, Baldwin 4-A,200 1st St SW, Rochester, MN 55905 USA.	cook.david33@mayo.edu	Hamstra, Stanley/A-3808-2016; Hamstra, Stanley/N-1310-2019; amy.tu.wang, amy.tu.wang/F-8331-2014	Hamstra, Stanley/0000-0002-0680-366X; Hamstra, Stanley/0000-0002-0680-366X; amy.tu.wang, amy.tu.wang/0000-0002-0929-1399; Brydges, Ryan/0000-0001-5203-7049; Zendejas, Benjamin/0000-0002-1231-5283	Division of General Internal Medicine, Mayo Clinic	Division of General Internal Medicine, Mayo Clinic	This work was supported by intramural funds, including an award from the Division of General Internal Medicine, Mayo Clinic.	ABRAHAMSON S, 1969, J MED EDUC, V44, P515; Borenstein M., 2009, HDB RES SYNTHESIS ME, VVolume 2, P221, DOI DOI 10.7758/9781610441384; Borenstein M, 2009, INTRO METAANALYSIS; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Cook DA, 2008, JAMA-J AM MED ASSOC, V300, P1181, DOI 10.1001/jama.300.10.1181; Cook DA, 2008, MED EDUC, V42, P128, DOI 10.1111/j.1365-2923.2007.02974.x; Cook DA, 2011, MED EDUC, V45, P227, DOI 10.1111/j.1365-2923.2010.03890.x; Cook DA, 2010, ACAD MED, V85, P1589, DOI 10.1097/ACM.0b013e3181edfe13; Cook DA, 2010, SIMUL HEALTHC, V5, P1, DOI 10.1097/SIH.0b013e3181c82aaa; Curtin F, 2002, STAT MED, V21, P2131, DOI 10.1002/sim.1205; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Gaba DM, 2007, QUAL SAF HLTH CAR S1, V2, P126, DOI DOI 10.1136/QSHC.2004.009878; Gurusamy K, 2008, BRIT J SURG, V95, P1088, DOI 10.1002/bjs.6344; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hunter J. E., 2004, METHODS METAANALYSIS; Issenberg SB, 2005, MED TEACH, V27, P10, DOI 10.1080/01421590500046924; Kirkpatrick D, 1996, TRAINING DEV, V50, P54; Lau J, 2006, BMJ-BRIT MED J, V333, P597, DOI 10.1136/bmj.333.7568.597; Macdonald G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub3; McGaghie WC, 2006, MED EDUC, V40, P792, DOI 10.1111/j.1365-2929.2006.02528.x; McGaghie WC, 2011, ACAD MED, V86, P706, DOI 10.1097/ACM.0b013e318217e119; McGaghie WC, 2010, MED EDUC, V44, P50, DOI 10.1111/j.1365-2923.2009.03547.x; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1016/j.ijsu.2010.02.007, 10.1136/bmj.b2535]; Morris SB, 2002, PSYCHOL METHODS, V7, P105, DOI 10.1037//1082-989X.7.1.105; Oxman A, 2002, USERS GUIDES INTERAC; Reed DA, 2007, JAMA-J AM MED ASSOC, V298, P1002, DOI 10.1001/jama.298.9.1002; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Sturm LP, 2008, ANN SURG, V248, P166, DOI 10.1097/SLA.0b013e318176bf24; Sutherland LM, 2006, ANN SURG, V243, P291, DOI 10.1097/01.sla.0000200839.93965.26; Terrin N, 2003, STAT MED, V22, P2113, DOI 10.1002/sim.1461; Weinger MB, 2010, SIMUL HEALTHC, V5, P8, DOI 10.1097/SIH.0b013e3181c91d4a; Wells G., NEWCASTLE OTTAWA SCA	32	1091	1102	13	239	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 7	2011	306	9					978	988		10.1001/jama.2011.1234	http://dx.doi.org/10.1001/jama.2011.1234			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	815QT	21900138				2022-12-28	WOS:000294542600016
J	Golub, RM				Golub, Robert M.			Orchestrating Excellence	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												robert.golub@jama-archives.org						Austad KE, 2011, JAMA-J AM MED ASSOC, V306, P991, DOI 10.1001/jama.2011.1233; Cavalcanti RB, 2011, JAMA-J AM MED ASSOC, V306, P993, DOI 10.1001/jama.2011.1232; Cook DA, 2011, JAMA-J AM MED ASSOC, V306, P978, DOI 10.1001/jama.2011.1234; Curry RH, 2011, JAMA-J AM MED ASSOC, V306, P997, DOI 10.1001/jama.2011.1266; Feero WG, 2011, JAMA-J AM MED ASSOC, V306, P989, DOI 10.1001/jama.2011.1245; Golub Robert M, 2011, JAMA, V306, P914, DOI 10.1001/jama.2011.1237; Green AR, 2007, J GEN INTERN MED, V22, P1231, DOI 10.1007/s11606-007-0258-5; Haider AH, 2011, JAMA-J AM MED ASSOC, V306, P942, DOI 10.1001/jama.2011.1248; Jeffe DB, 2011, JAMA-J AM MED ASSOC, V306, P961, DOI 10.1001/jama.2011.1099; Obedin-Maliver J, 2011, JAMA-J AM MED ASSOC, V306, P971, DOI 10.1001/jama.2011.1255; Prasad M, 2011, JAMA-J AM MED ASSOC, V306, P935, DOI 10.1001/jama.2011.1226; van Ryn M, 2011, JAMA-J AM MED ASSOC, V306, P995, DOI 10.1001/jama.2011.1275; West CP, 2011, JAMA-J AM MED ASSOC, V306, P952, DOI 10.1001/jama.2011.1247	13	2	2	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 7	2011	306	9					999	1000		10.1001/jama.2011.1274	http://dx.doi.org/10.1001/jama.2011.1274			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	815QT	21900144				2022-12-28	WOS:000294542600022
J	Perlman, SE; Friedman, S; Galea, S; Nair, HP; Eros-Sarnyai, M; Stellman, SD; Hon, J; Greene, CM				Perlman, Sharon E.; Friedman, Stephen; Galea, Sandro; Nair, Hemanth P.; Eros-Sarnyai, Monika; Stellman, Steven D.; Hon, Jeffrey; Greene, Carolyn M.			Short-term and medium-term health effects of 9/11	LANCET			English	Review							WORLD-TRADE-CENTER; POSTTRAUMATIC-STRESS-DISORDER; NEW-YORK-CITY; GASTROESOPHAGEAL-REFLUX DISEASE; 11 SEPTEMBER 2001; TERRORIST ATTACKS; CENTER DISASTER; CENTER RESCUE; RESPIRATORY SYMPTOMS; PSYCHOLOGICAL TRAUMA	The New York City terrorist attacks on Sept 11, 2001 (9/11), killed nearly 2800 people and thousands more had subsequent health problems. In this Review of health effects in the short and medium terms, strong evidence is provided for associations between experiencing or witnessing events related to 9/11 and post-traumatic stress disorder and respiratory illness, with a correlation between prolonged, intense exposure and increased overall illness and disability. Rescue and recovery workers, especially those who arrived early at the World Trade Center site or worked for longer periods, were more likely to develop respiratory illness than were other exposed groups. Risk factors for post-traumatic stress disorder included proximity to the site on 9/11, living or working in lower Manhattan, rescue or recovery work at the World Trade Center site, event-related loss of spouse, and low social support. Investigators note associations between 9/11 exposures and additional disorders, such as depression and substance use; however, for some health problems association with exposures related to 9/11 is unclear.	[Perlman, Sharon E.; Friedman, Stephen; Nair, Hemanth P.; Stellman, Steven D.; Hon, Jeffrey; Greene, Carolyn M.] New York City Dept Hlth & Mental Hyg, Div Epidemiol, Queens, NY 11101 USA; [Eros-Sarnyai, Monika] New York City Dept Hlth & Mental Hyg, Div Mental Hyg, Queens, NY 11101 USA; [Galea, Sandro; Stellman, Steven D.] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA	New York City Department of Health & Mental Hygiene; New York City Department of Health & Mental Hygiene; Columbia University	Perlman, SE (corresponding author), New York City Dept Hlth & Mental Hyg, Div Epidemiol, 42-09 28th St,CN 6, Queens, NY 11101 USA.	sperlma1@health.nyc.gov	Galea, Sandro/GLR-6066-2022	Galea, Sandro/0000-0002-7534-0945	National Institute for Occupational Safety and Health [1U50/OH009739]; New York City Department of Health and Mental Hygiene; Columbia University; NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH [U50OH009739] Funding Source: NIH RePORTER	National Institute for Occupational Safety and Health(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH)); New York City Department of Health and Mental Hygiene; Columbia University; NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH))	We thank Thomas Farley, James Hadler, Adam Karpati, and Katherine Wheeler for their thoughtful comments on this Review, and Margaret Millstone and Rhoda Schlamm for assistance with preparation of the report. This work was supported by the National Institute for Occupational Safety and Health (Cooperative Agreement 1U50/OH009739), the New York City Department of Health and Mental Hygiene, and Columbia University. The New York City Department of Health and Mental Hygiene participated in the design, development, and review of the Review.	Aldrich TK, 2010, NEW ENGL J MED, V362, P1263, DOI 10.1056/NEJMoa0910087; Altman KW, 2011, INT ARCH OCC ENV HEA, V84, P131, DOI 10.1007/s00420-010-0556-9; Banauch GI, 2006, AM J RESP CRIT CARE, V174, P312, DOI 10.1164/rccm.200511-1736OC; Berkowitz GS, 2003, JAMA-J AM MED ASSOC, V290, P595, DOI 10.1001/jama.290.5.595-b; Berninger A, 2010, AM J IND MED, V53, P1177, DOI 10.1002/ajim.20894; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Boscarino JA, 2006, ADDICT BEHAV, V31, P606, DOI 10.1016/j.addbeh.2005.05.035; Brackbill Robert M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Brackbill RM, 2009, JAMA-J AM MED ASSOC, V302, P502, DOI 10.1001/jama.2009.1121; Breslau N, 2010, J NERV MENT DIS, V198, P539, DOI 10.1097/NMD.0b013e3181ea1e2f; Brewin CR, 2005, J TRAUMA STRESS, V18, P53, DOI 10.1002/jts.20007; Cardena Etzel, 2005, J Trauma Dissociation, V6, P69, DOI 10.1300/J229v06n02_07; *CDCP, 2002, MMWR-MORBID MORTAL W, V51, P453; *CDCP, 2003, LIF ASTHM PREV PERC; Centers for Disease Control and Prevention, 2011, WORLD TRAD CTR HLTH; Chemtob CM, 2008, ARCH PEDIAT ADOL MED, V162, P126, DOI 10.1001/archpediatrics.2007.36; Chemtob CM, 2009, DISASTERS, V33, P337, DOI 10.1111/j.1467-7717.2008.01077.x; Claassen CA, 2010, BRIT J PSYCHIAT, V196, P359, DOI 10.1192/bjp.bp.109.071928; Cohen P, 2006, SOC PSYCH PSYCH EPID, V41, P251, DOI 10.1007/s00127-006-0033-7; Crowley LE, 2011, AM J IND MED, V54, P175, DOI 10.1002/ajim.20924; Dalton PH, 2010, ENVIRON HEALTH PERSP, V118, P1251, DOI 10.1289/ehp.1001924; de la Hoz RE, 2008, INT ARCH OCC ENV HEA, V81, P479, DOI 10.1007/s00420-007-0240-x; de la Hoz RE, 2010, J OCCUP ENVIRON MED, V52, P29, DOI 10.1097/JOM.0b013e3181c2bb18; de la Hoz RE, 2008, J OCCUP ENVIRON MED, V50, P1351, DOI 10.1097/JOM.0b013e3181845f9b; DiGrande L, 2011, AM J EPIDEMIOL, V173, P271, DOI 10.1093/aje/kwq372; Engel SM, 2005, PAEDIATR PERINAT EP, V19, P334, DOI 10.1111/j.1365-3016.2005.00676.x; Eskenazi B, 2007, HUM REPROD, V22, P3013, DOI 10.1093/humrep/dem301; Evans S, 2009, J CLIN PSYCHOL, V65, P684, DOI 10.1002/jclp.20575; Fairbrother G, 2003, AMBUL PEDIATR, V3, P304, DOI 10.1367/1539-4409(2003)003<0304:PSRINY>2.0.CO;2; Farfel M, 2008, J URBAN HEALTH, V85, P880, DOI 10.1007/s11524-008-9317-4; Galea S, 2005, CNS SPECTRUMS, V10, P107, DOI 10.1017/S1092852900019441; Galea S, 2002, NEW ENGL J MED, V346, P982, DOI 10.1056/NEJMsa013404; Galea S, 2003, AM J EPIDEMIOL, V158, P514, DOI 10.1093/aje/kwg187; Geyh AS, 2005, J OCCUP ENVIRON HYG, V2, P179, DOI 10.1080/15459620590923154; Havemann BD, 2007, GUT, V56, P1654, DOI 10.1136/gut.2007.122465; Henriksen CA, 2010, DEPRESS ANXIETY, V27, P993, DOI 10.1002/da.20742; Herbert R, 2006, ENVIRON HEALTH PERSP, V114, P1853, DOI 10.1289/ehp.9592; Herbstman JB, 2005, ENVIRON RES, V99, P85, DOI 10.1016/j.envres.2004.08.010; Herbstman JB, 2010, ENVIRON HEALTH PERSP, V118, P712, DOI 10.1289/ehp.0901340; Holman EA, 2008, ARCH GEN PSYCHIAT, V65, P73, DOI 10.1001/archgenpsychiatry.2007.6; Hoven CW, 2005, ARCH GEN PSYCHIAT, V62, P545, DOI 10.1001/archpsyc.62.5.545; Izbicki G, 2007, CHEST, V131, P1414, DOI 10.1378/chest.06-2114; KATZ C, 2009, PSYCHIAT B, V131, P49; Landrigan PJ, 2004, ENVIRON HEALTH PERSP, V112, P731, DOI 10.1289/ehp.6702; Lederman SA, 2004, ENVIRON HEALTH PERSP, V112, P1772, DOI 10.1289/ehp.7348; Lederman SA, 2008, ENVIRON HEALTH PERSP, V116, P1085, DOI 10.1289/ehp.10831; Lin S, 2007, J ASTHMA, V44, P325, DOI 10.1080/02770900701344181; Lin S, 2010, ARCH ENVIRON OCCUP H, V65, P12, DOI 10.1080/19338240903390230; Lipkind HS, 2010, OBSTET GYNECOL, V116, P917, DOI 10.1097/AOG.0b013e3181f2f6a2; Locke GR, 1997, GASTROENTEROLOGY, V112, P1448, DOI 10.1016/S0016-5085(97)70025-8; Lorber M, 2007, RISK ANAL, V27, P1203, DOI 10.1111/j.1539-6924.2007.00956.x; Lowers HA, 2009, J EXPO SCI ENV EPID, V19, P325, DOI 10.1038/jes.2008.25; Mallonee S, 1996, JAMA-J AM MED ASSOC, V276, P382, DOI 10.1001/jama.276.5.382; Mann JM, 2005, AM J IND MED, V48, P225, DOI 10.1002/ajim.20196; Mauer MP, 2010, OCCUP MED-OXFORD, V60, P145, DOI 10.1093/occmed/kqp176; Mauer MP, 2010, INT ARCH OCC ENV HEA, V83, P21, DOI 10.1007/s00420-009-0474-x; Mayer EA, 2000, GUT, V47, P861, DOI 10.1136/gut.47.6.861; McGee JK, 2003, ENVIRON HEALTH PERSP, V111, P972, DOI 10.1289/ehp.5930; Mendelson DS, 2007, J OCCUP ENVIRON MED, V49, P840, DOI 10.1097/JOM.0b013e3180d09e87; Mezuk B, 2009, J TRAUMA STRESS, V22, P481, DOI 10.1002/jts.20473; Mizyed I, 2009, ALIMENT PHARM THER, V29, P351, DOI 10.1111/j.1365-2036.2008.03883.x; MOLINE MS, 2009, J OCCUP ENVIRON MED, V51, P1; Murphy J, 2007, STAT MED, V26, P1688, DOI 10.1002/sim.2806; Nandi A, 2004, J OCCUP ENVIRON MED, V46, P1057, DOI 10.1097/01.jom.0000141663.22902.0a; North CS, 2005, BRIT J PSYCHIAT, V186, P487, DOI 10.1192/bjp.186.6.487; *NY CIT HLTH DEP, 2011, WTC HLTH REG; Oppenheimer BW, 2007, CHEST, V132, P1275, DOI 10.1378/chest.07-0913; Perera FP, 2007, ENVIRON HEALTH PERSP, V115, P1497, DOI 10.1289/ehp.10144; Perrin MA, 2007, AM J PSYCHIAT, V164, P1385, DOI 10.1176/appi.ajp.2007.06101645; Pfefferbaum B, 2006, J TRAUMA STRESS, V19, P217, DOI 10.1002/jts.20118; Prezant DJ, 2002, NEW ENGL J MED, V347, P806, DOI 10.1056/NEJMoa021300; Pridemore WA, 2009, SUICIDE LIFE-THREAT, V39, P659, DOI 10.1521/suli.2009.39.6.659; Rani S, 2022, SPAT INF RES, V30, P417, DOI 10.1007/s41324-022-00442-9; Reibman J, 2009, J OCCUP ENVIRON MED, V51, P534, DOI 10.1097/JOM.0b013e3181a0365b; Rom WN, 2002, AM J RESP CRIT CARE, V166, P797, DOI 10.1164/rccm.200206-576OC; Ruigomez A, 2005, CHEST, V128, P85, DOI 10.1378/chest.128.1.85; Safirstein BH, 2003, CHEST, V123, P301, DOI 10.1378/chest.123.1.301; Salib E, 2003, BRIT J PSYCHIAT, V183, P207, DOI 10.1192/bjp.183.3.207; Salzman SH, 2004, J OCCUP ENVIRON MED, V46, P113, DOI 10.1097/01.jom.0000111612.68916.d0; Savitz DA, 2008, MT SINAI J MED, V75, P77, DOI 10.1002/msj.20023; Schlenger WE, 2002, JAMA-J AM MED ASSOC, V288, P581, DOI 10.1001/jama.288.5.581; Schuster MA, 2001, NEW ENGL J MED, V345, P1507, DOI 10.1056/NEJM200111153452024; Silver RC, 2002, JAMA-J AM MED ASSOC, V288, P1235, DOI 10.1001/jama.288.10.1235; Skloot GS, 2009, CHEST, V135, P492, DOI 10.1378/chest.08-1391; Steinberg JS, 2004, J AM COLL CARDIOL, V44, P1261, DOI 10.1016/j.jacc.2004.06.032; Stellman JM, 2008, ENVIRON HEALTH PERSP, V116, P1248, DOI 10.1289/ehp.11164; Szema AM, 2004, J ALLERGY CLIN IMMUN, V113, P420, DOI 10.1016/j.jaci.2003.12.015; Thomas PA, 2008, ENVIRON HEALTH PERSP, V116, P1383, DOI 10.1289/ehp.11205; Vlahov D, 2004, AM J DRUG ALCOHOL AB, V30, P385, DOI 10.1081/ADA-120037384; Vlahov D, 2002, AM J EPIDEMIOL, V155, P988, DOI 10.1093/aje/155.11.988; Webber MP, 2011, SLEEP BREATH, V15, P283, DOI 10.1007/s11325-010-0379-7; Webber MP, 2009, ENVIRON HEALTH PERSP, V117, P975, DOI 10.1289/ehp.0800291; Weiden MD, 2010, CHEST, V137, P566, DOI 10.1378/chest.09-1580; Wheeler K, 2007, ENVIRON HEALTH PERSP, V115, P1584, DOI 10.1289/ehp.10248; World Trade Center Medical Working Group of New York City, 2009, 2009 ANN REP 9 11 HL; Wu P, 2006, AM J PUBLIC HEALTH, V96, P804, DOI 10.2105/AJPH.2004.058925; Yehuda R, 2005, J CLIN ENDOCR METAB, V90, P4115, DOI 10.1210/jc.2005-0550	97	110	110	0	16	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 3	2011	378	9794					925	934		10.1016/S0140-6736(11)60967-7	http://dx.doi.org/10.1016/S0140-6736(11)60967-7			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	818XZ	21890057	Green Submitted			2022-12-28	WOS:000294791300033
J	Chao, LH; Stratton, MM; Lee, IH; Rosenberg, OS; Levitz, J; Mandell, DJ; Kortemme, T; Groves, JT; Schulman, H; Kuriyan, J				Chao, Luke H.; Stratton, Margaret M.; Lee, Il-Hyung; Rosenberg, Oren S.; Levitz, Joshua; Mandell, Daniel J.; Kortemme, Tanja; Groves, Jay T.; Schulman, Howard; Kuriyan, John			A Mechanism for Tunable Autoinhibition in the Structure of a Human Ca2+/Calmodulin-Dependent Kinase II Holoenzyme	CELL			English	Article							DEPENDENT PROTEIN-KINASE; RAY SOLUTION SCATTERING; CAM KINASE; INHIBITORY AUTOPHOSPHORYLATION; CA2+ OSCILLATIONS; IN-VITRO; CALMODULIN; ACTIVATION; ALPHA; BRAIN	Calcium/calmodulin-dependent kinase II (CaMKII) forms a highly conserved dodecameric assembly that is sensitive to the frequency of calcium pulse trains. Neither the structure of the dodecameric assembly nor how it regulates CaMKII are known. We present the crystal structure of an autoinhibited full-length human CaMKII holoenzyme, revealing an unexpected compact arrangement of kinase domains docked against a central hub, with the calmodulin-binding sites completely inaccessible. We show that this compact docking is important for the autoinhibition of the kinase domains and for setting the calcium response of the holoenzyme. Comparison of CaMKII isoforms, which differ in the length of the linker between the kinase domain and the hub, demonstrates that these interactions can be strengthened or weakened by changes in linker length. This equilibrium between autoinhibited states provides a simple mechanism for tuning the calcium response without changes in either the hub or the kinase domains.	[Chao, Luke H.; Stratton, Margaret M.; Rosenberg, Oren S.; Kuriyan, John] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Chao, Luke H.; Stratton, Margaret M.; Lee, Il-Hyung; Rosenberg, Oren S.; Groves, Jay T.; Kuriyan, John] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Chao, Luke H.; Stratton, Margaret M.; Lee, Il-Hyung; Rosenberg, Oren S.; Groves, Jay T.; Kuriyan, John] Univ Calif Berkeley, Calif Inst Quantitat Biosci QB3, Berkeley, CA 94720 USA; [Chao, Luke H.; Stratton, Margaret M.; Lee, Il-Hyung; Rosenberg, Oren S.; Groves, Jay T.; Kuriyan, John] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Levitz, Joshua; Groves, Jay T.; Kuriyan, John] Univ Calif Berkeley, Biophys Grad Grp, Berkeley, CA 94720 USA; [Mandell, Daniel J.; Kortemme, Tanja] Univ Calif San Francisco, Calif Inst Quantitat Biosci QB3, San Francisco, CA 94143 USA; [Mandell, Daniel J.; Kortemme, Tanja] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [Schulman, Howard] Allosteros Therapeut, Sunnyvale, CA 94089 USA; [Groves, Jay T.] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Mat Sci, Berkeley, CA 94720 USA; [Groves, Jay T.; Kuriyan, John] Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California San Francisco; University of California System; University of California San Francisco; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Kuriyan, J (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	kuriyan@berkeley.edu	Chao, Luke/R-4627-2019; Kortemme, Tanja/AAN-3180-2021	Chao, Luke/0000-0002-4849-4148; Lee, Il-Hyung/0000-0001-6755-3257; Kortemme, Tanja/0000-0002-8494-680X	Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy [DE-AC02-05CH11231]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045547] Funding Source: NIH RePORTER	Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Angus Nairn, Andre Hoelz, Sebastian Deindl, Patricia Pellicena, Paul De Koninck, Jonathan Winger, and the members of the Kuriyan Lab for many discussions and insights. We thank Giulio Superi-Furga for bosutinib, David King for peptide synthesis and mass spectrometry, Alice Ting for the BirA vector, Tony lavarone for mass spectrometry support, and Greg Hura for SAXS data collection. We thank Tiago Barros and Joel Guenther for review of the manuscript. We acknowledge Corie Ralston and the staff at Advanced Light Source beamlines 8.2.2 and 8.2.1 for assistance with data collection. The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy under Contract No. DE-AC02-05CH11231.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BARKER SC, 1995, BIOCHEMISTRY-US, V34, P14843, DOI 10.1021/bi00045a027; Bayer KU, 2002, EMBO J, V21, P3590, DOI 10.1093/emboj/cdf360; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chao LH, 2010, NAT STRUCT MOL BIOL, V17, P264, DOI 10.1038/nsmb.1751; Chiba H, 2008, BIOPHYS J, V95, P2139, DOI 10.1529/biophysj.107.118505; COLBRAN RJ, 1993, J BIOL CHEM, V268, P7163; De Koninck P, 1998, SCIENCE, V279, P227, DOI 10.1126/science.279.5348.227; Elgersma Y, 2002, NEURON, V36, P493, DOI 10.1016/S0896-6273(02)01007-3; Ellis RJ, 2001, TRENDS BIOCHEM SCI, V26, P597, DOI 10.1016/S0968-0004(01)01938-7; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GILLESPIE DT, 1976, J COMPUT PHYS, V22, P403, DOI 10.1016/0021-9991(76)90041-3; HANSON PI, 1994, NEURON, V12, P943, DOI 10.1016/0896-6273(94)90306-9; HANSON PI, 1992, J BIOL CHEM, V267, P17216; HANSON PI, 1989, NEURON, V3, P59, DOI 10.1016/0896-6273(89)90115-3; Hoelz A, 2003, MOL CELL, V11, P1241, DOI 10.1016/S1097-2765(03)00171-0; Hoffman L, 2011, EMBO J, V30, P1251, DOI 10.1038/emboj.2011.40; Howarth M, 2008, NAT PROTOC, V3, P534, DOI 10.1038/nprot.2008.20; Hudmon A, 2002, BIOCHEM J, V364, P593, DOI 10.1042/BJ20020228; Hura GL, 2009, NAT METHODS, V6, P606, DOI 10.1038/nmeth.1353; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KENNEDY MB, 1983, J NEUROSCI, V3, P818; Kim C, 2007, CELL, V130, P1032, DOI 10.1016/j.cell.2007.07.018; Kolodziej SJ, 2000, J BIOL CHEM, V275, P14354, DOI 10.1074/jbc.275.19.14354; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kuriyan J, 2007, NATURE, V450, P983, DOI 10.1038/nature06524; LeBoeuf B, 2007, PLOS GENET, V3, P1622, DOI 10.1371/journal.pgen.0030156; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Mandell DJ, 2009, NAT METHODS, V6, P551, DOI 10.1038/nmeth0809-551; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MILLER SG, 1986, CELL, V44, P861, DOI 10.1016/0092-8674(86)90008-5; Morris EP, 2001, J MOL BIOL, V308, P1, DOI 10.1006/jmbi.2001.4584; NAIRN AC, 1985, ANNU REV BIOCHEM, V54, P931, DOI 10.1146/annurev.bi.54.070185.004435; Pepke S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000675; Putkey JA, 1996, J BIOL CHEM, V271, P29619, DOI 10.1074/jbc.271.47.29619; Puttini M, 2006, CANCER RES, V66, P11314, DOI 10.1158/0008-5472.CAN-06-1199; Rellos P, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000426; Rix U, 2010, LEUKEMIA, V24, P44, DOI 10.1038/leu.2009.228; Rosenberg OS, 2005, CELL, V123, P849, DOI 10.1016/j.cell.2005.10.029; Ryan TJ, 2009, NAT REV NEUROSCI, V10, P701, DOI 10.1038/nrn2717; SCHULMAN H, 1978, NATURE, V271, P478, DOI 10.1038/271478a0; Shen K, 1998, J NEUROCHEM, V70, P96; SILVA AJ, 1992, SCIENCE, V257, P206, DOI 10.1126/science.1321493; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Thaler C, 2009, P NATL ACAD SCI USA, V106, P6369, DOI 10.1073/pnas.0901913106; Tombes RM, 2003, GENE, V322, P17, DOI 10.1016/j.gene.2003.08.023; Wang P, 2000, FEBS LETT, V475, P107, DOI 10.1016/S0014-5793(00)01634-3; WOODGETT JR, 1984, FEBS LETT, V170, P49, DOI 10.1016/0014-5793(84)81366-6	50	164	167	2	43	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 2	2011	146	5					732	745		10.1016/j.cell.2011.07.038	http://dx.doi.org/10.1016/j.cell.2011.07.038			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	814SM	21884935	Green Accepted, Bronze			2022-12-28	WOS:000294477500014
J	Cheng, X; McCoy, JH; Israelachvili, JN; Cohen, I				Cheng, Xiang; McCoy, Jonathan H.; Israelachvili, Jacob N.; Cohen, Itai			Imaging the Microscopic Structure of Shear Thinning and Thickening Colloidal Suspensions	SCIENCE			English	Article							CONCENTRATED SUSPENSIONS; DENSE SUSPENSIONS; RHEOLOGY; FLOW; DISPERSIONS; SIMULATION; SPHERES	The viscosity of colloidal suspensions varies with shear rate, an important effect encountered in many natural and industrial processes. Although this non-Newtonian behavior is believed to arise from the arrangement of suspended particles and their mutual interactions, microscopic particle dynamics are difficult to measure. By combining fast confocal microscopy with simultaneous force measurements, we systematically investigate a suspension's structure as it transitions through regimes of different flow signatures. Our measurements of the microscopic single-particle dynamics show that shear thinning results from the decreased relative contribution of entropic forces and that shear thickening arises from particle clustering induced by hydrodynamic lubrication forces. This combination of techniques illustrates an approach that complements current methods for determining the microscopic origins of non-Newtonian flow behavior in complex fluids.	[Cheng, Xiang; Cohen, Itai] Cornell Univ, Dept Phys, Ithaca, NY 14853 USA; [McCoy, Jonathan H.] Colby Coll, Dept Phys & Astron, Waterville, ME 04901 USA; [Israelachvili, Jacob N.] Univ Calif Santa Barbara, Dept Chem Engn, Santa Barbara, CA 93106 USA; [Israelachvili, Jacob N.] Univ Calif Santa Barbara, Mat Res Lab, Santa Barbara, CA 93106 USA	Cornell University; Colby College; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Cheng, X (corresponding author), Cornell Univ, Dept Phys, Ithaca, NY 14853 USA.	xc92@cornell.edu	Cheng, Xiang/G-5704-2017; Cheng, Xiang/E-7494-2012; Cheng, Xiang/G-1802-2015	Cheng, Xiang/0000-0002-2759-764X; Cohen, Itai/0000-0001-9218-043X	NSF Civil, Mechanical, and Manufacturing Innovation, Division of Materials Research (DMR); DMR Materials Research Science and Engineering Centers; King Abdullah University of Science and Technology (KAUST) [KUS-C1-018-02]; U.S. Department of Energy, Division of Materials Sciences and Engineering [FG02-87ER-45331]	NSF Civil, Mechanical, and Manufacturing Innovation, Division of Materials Research (DMR); DMR Materials Research Science and Engineering Centers; King Abdullah University of Science and Technology (KAUST)(King Abdullah University of Science & Technology); U.S. Department of Energy, Division of Materials Sciences and Engineering(United States Department of Energy (DOE))	We thank T. Beatus, Y.-C. Lin, J. Brady, L. Ristroph, and N. Wagner for useful discussions. This research was supported by grants from NSF Civil, Mechanical, and Manufacturing Innovation, Division of Materials Research (DMR), and DMR Materials Research Science and Engineering Centers, and in part by award KUS-C1-018-02 from King Abdullah University of Science and Technology (KAUST). J. N. I. was supported by the U.S. Department of Energy, Division of Materials Sciences and Engineering under award DE-FG02-87ER-45331.	Beiersdorfer P, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.058301; BRADY JF, 1985, J FLUID MECH, V155, P105, DOI 10.1017/S0022112085001732; BROWN E, 2010, PREPRINT; Brown E, 2010, NAT MATER, V9, P220, DOI [10.1038/NMAT2627, 10.1038/nmat2627]; Dzenis Y, 2004, SCIENCE, V304, P1917, DOI 10.1126/science.1099074; Fall A, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.018301; Foss DR, 2000, J FLUID MECH, V407, P167, DOI 10.1017/S0022112099007557; Gao C, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.041403; HOFFMAN RL, 1974, J COLLOID INTERF SCI, V46, P491, DOI 10.1016/0021-9797(74)90059-9; Hoffman RL, 1998, J RHEOL, V42, P111, DOI 10.1122/1.550884; Holmes CB, 2005, J RHEOL, V49, P237, DOI 10.1122/1.1814114; Isa L, 2010, ADV POLYM SCI, V236, P163, DOI 10.1007/12_2009_38; Kalman DP, 2009, RHEOL ACTA, V48, P897, DOI 10.1007/s00397-009-0351-2; Larson R. G., 1999, STRUCTURE RHEOLOGY C, P443; LAUN HM, 1992, J RHEOL, V36, P743, DOI 10.1122/1.550314; Lootens D, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.268302; Maranzano BJ, 2002, J CHEM PHYS, V117, P10291, DOI 10.1063/1.1519253; Melrose JR, 2004, J RHEOL, V48, P961, DOI 10.1122/1.1784784; Nugent CR, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.025702; PARSI F, 1987, J RHEOL, V31, P725, DOI 10.1122/1.549944; Schmoller KM, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1134; Stickel JJ, 2005, ANNU REV FLUID MECH, V37, P129, DOI 10.1146/annurev.fluid.36.050802.122132; Urbakh M, 2004, NATURE, V430, P525, DOI 10.1038/nature02750; Vermant J, 2005, J PHYS-CONDENS MAT, V17, pR187, DOI 10.1088/0953-8984/17/4/R02; Wagner NJ, 2009, PHYS TODAY, V62, P27, DOI 10.1063/1.3248476; Wu YL, 2009, P NATL ACAD SCI USA, V106, P10564, DOI 10.1073/pnas.0812519106	27	351	363	23	415	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 2	2011	333	6047					1276	1279		10.1126/science.1207032	http://dx.doi.org/10.1126/science.1207032			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	813YM	21885778	Green Submitted			2022-12-28	WOS:000294406400050
J	Nandagopal, N; Elowitz, MB				Nandagopal, Nagarajan; Elowitz, Michael B.			Synthetic Biology: Integrated Gene Circuits	SCIENCE			English	Review							OSCILLATOR; NOTCH; PATHWAYS; NETWORK; CELLS; DIFFERENTIATION; SPECIFICITY; UNDERSTAND; EXPRESSION; SYSTEMS	A major goal of synthetic biology is to develop a deeper understanding of biological design principles from the bottom up, by building circuits and studying their behavior in cells. Investigators initially sought to design circuits "from scratch" that functioned as independently as possible from the underlying cellular system. More recently, researchers have begun to develop a new generation of synthetic circuits that integrate more closely with endogenous cellular processes. These approaches are providing fundamental insights into the regulatory architecture, dynamics, and evolution of genetic circuits and enabling new levels of control across diverse biological systems.	[Elowitz, Michael B.] CALTECH, Howard Hughes Med Inst, Div Biol, Pasadena, CA 91125 USA; [Nandagopal, Nagarajan; Elowitz, Michael B.] CALTECH, Dept Bioengn, Pasadena, CA 91125 USA	California Institute of Technology; Howard Hughes Medical Institute; California Institute of Technology	Elowitz, MB (corresponding author), CALTECH, Howard Hughes Med Inst, Div Biol, Pasadena, CA 91125 USA.	melowitz@caltech.edu			NIH [5R01GM086793, 5R01GM079771, P50GM068763]; NSF [0644463]; Packard Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086793, R01GM079771, P50GM068763] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Packard Fellowship(The David & Lucile Packard Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank D. Sprinzak, J. Locke, J. Levine, P. Neveu, J. Young, and other members of the Elowitz lab for helpful discussions and critical reading of the manuscript. This work was supported by NIH grants 5R01GM086793, 5R01GM079771, and P50GM068763; NSF Career Award 0644463; and a Packard Fellowship.	Bashor CJ, 2008, SCIENCE, V319, P1539, DOI 10.1126/science.1151153; Bayer TS, 2010, CURR BIOL, V20, pR772, DOI 10.1016/j.cub.2010.06.049; Burrill DR, 2011, GENE DEV, V25, P434, DOI 10.1101/gad.1994911; Cagatay T, 2009, CELL, V139, P512, DOI 10.1016/j.cell.2009.07.046; Chen CH, 2007, SCIENCE, V316, P597, DOI [10.1126/science. 1138595, 10.1126/science.1138595]; Cookson NA, 2009, FEBS LETT, V583, P3931, DOI 10.1016/j.febslet.2009.10.089; Coudreuse D, 2010, NATURE, V468, P1074, DOI 10.1038/nature09543; del Alamo D, 2011, CURR BIOL, V21, pR40, DOI 10.1016/j.cub.2010.10.034; Eldar A, 2010, NATURE, V467, P167, DOI 10.1038/nature09326; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Elowitz M, 2010, NATURE, V468, P889, DOI 10.1038/468889a; Endy D, 2005, NATURE, V438, P449, DOI 10.1038/nature04342; Fung E, 2005, NATURE, V435, P118, DOI 10.1038/nature03508; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Hasty J, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.148101; Huang CYF, 1996, P NATL ACAD SCI USA, V93, P10078, DOI 10.1073/pnas.93.19.10078; Kobayashi H, 2004, P NATL ACAD SCI USA, V101, P8414, DOI 10.1073/pnas.0402940101; Laub MT, 2007, ANNU REV GENET, V41, P121, DOI 10.1146/annurev.genet.41.042007.170548; Lee J, 2008, SCIENCE, V322, P438, DOI 10.1126/science.1159052; Lim WA, 2010, NAT REV MOL CELL BIO, V11, P393, DOI 10.1038/nrm2904; Lu TK, 2009, NAT BIOTECHNOL, V27, P1139, DOI 10.1038/nbt.1591; Mody A, 2009, NAT CELL BIOL, V11, P484, DOI 10.1038/ncb1856; Mukherji S, 2009, NAT REV GENET, V10, P859, DOI 10.1038/nrg2697; O'Shaughnessy EC, 2011, CELL, V144, P119, DOI 10.1016/j.cell.2010.12.014; Park SH, 2003, SCIENCE, V299, P1061, DOI 10.1126/science.1076979; Peisajovich SG, 2010, SCIENCE, V328, P368, DOI 10.1126/science.1182376; Purnick PEM, 2009, NAT REV MOL CELL BIO, V10, P410, DOI 10.1038/nrm2698; Ruder WC, 2011, SCIENCE, V333, P1248, DOI 10.1126/science.1206843; Skerker JM, 2008, CELL, V133, P1043, DOI 10.1016/j.cell.2008.04.040; Sprinzak D, 2005, NATURE, V438, P443, DOI 10.1038/nature04335; Sprinzak D, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002069; Sprinzak D, 2010, NATURE, V465, P86, DOI 10.1038/nature08959; Stricker J, 2008, NATURE, V456, P516, DOI 10.1038/nature07389; Struhl G, 1998, CELL, V93, P649, DOI 10.1016/S0092-8674(00)81193-9; Suel GM, 2006, NATURE, V440, P545, DOI 10.1038/nature04588; Swinburne IA, 2008, GENE DEV, V22, P2342, DOI 10.1101/gad.1696108; Tigges M, 2009, NATURE, V457, P309, DOI 10.1038/nature07616; Toettcher JE, 2010, P NATL ACAD SCI USA, V107, P17047, DOI 10.1073/pnas.1005615107; Weinmaster G, 2006, DEVELOPMENT, V133, P3277, DOI 10.1242/dev.02515; Windbichler N, 2011, NATURE, V473, P212, DOI 10.1038/nature09937; Xavier JB, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.16	41	202	218	18	235	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 2	2011	333	6047					1244	1248		10.1126/science.1207084	http://dx.doi.org/10.1126/science.1207084			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	813YM	21885772	Green Accepted			2022-12-28	WOS:000294406400040
J	Breitbach, CJ; Burke, J; Jonker, D; Stephenson, J; Haas, AR; Chow, LQM; Nieva, J; Hwang, TH; Moon, A; Patt, R; Pelusio, A; Le Boeuf, F; Burns, J; Evgin, L; De Silva, N; Cvancic, S; Robertson, T; Je, JE; Lee, YS; Parato, K; Diallo, JS; Fenster, A; Daneshmand, M; Bell, JC; Kirn, DH				Breitbach, Caroline J.; Burke, James; Jonker, Derek; Stephenson, Joe; Haas, Andrew R.; Chow, Laura Q. M.; Nieva, Jorge; Hwang, Tae-Ho; Moon, Anne; Patt, Richard; Pelusio, Adina; Le Boeuf, Fabrice; Burns, Joe; Evgin, Laura; De Silva, Naomi; Cvancic, Sara; Robertson, Terri; Je, Ji-Eun; Lee, Yeon-Sook; Parato, Kelley; Diallo, Jean-Simon; Fenster, Aaron; Daneshmand, Manijeh; Bell, John C.; Kirn, David H.			Intravenous delivery of a multi-mechanistic cancer-targeted oncolytic poxvirus in humans	NATURE			English	Article							VACCINIA VIRUS; GM-CSF; IMATINIB MESYLATE; THYMIDINE KINASE; MEASLES-VIRUS; GROWTH-FACTOR; THERAPY; TUMORS; CRITERIA; PROGRESS	The efficacy and safety of biological molecules in cancer therapy, such as peptides and small interfering RNAs (siRNAs), could be markedly increased if high concentrations could be achieved and amplified selectively in tumour tissues versus normal tissues after intravenous administration. This has not been achievable so far in humans. We hypothesized that a poxvirus, which evolved for blood-borne systemic spread in mammals, could be engineered for cancer-selective replication and used as a vehicle for the intravenous delivery and expression of transgenes in tumours. JX-594 is an oncolytic poxvirus engineered for replication, transgene expression and amplification in cancer cells harbouring activation of the epidermal growth factor receptor (EGFR)/Ras pathway, followed by cell lysis and anticancer immunity(1). Here we show in a clinical trial that JX-594 selectively infects, replicates and expresses transgene products in cancer tissue after intravenous infusion, in a dose-related fashion. Normal tissues were not affected clinically. This platform technology opens up the possibility of multifunctional products that selectively express high concentrations of several complementary therapeutic and imaging molecules in metastatic solid tumours in humans.	[Breitbach, Caroline J.; Moon, Anne; Pelusio, Adina; Robertson, Terri; Kirn, David H.] Jennerex Inc, San Francisco, CA 94111 USA; [Burke, James; Nieva, Jorge] Billings Clin, Dept Hematol Oncol, Billings, MT 59101 USA; [Jonker, Derek; Chow, Laura Q. M.; Le Boeuf, Fabrice; Burns, Joe; Evgin, Laura; De Silva, Naomi; Cvancic, Sara; Parato, Kelley; Diallo, Jean-Simon; Daneshmand, Manijeh; Bell, John C.] Ottawa Hosp Res Inst, Ottawa, ON K1H 8L6, Canada; [Jonker, Derek; Chow, Laura Q. M.; Burns, Joe; Evgin, Laura; De Silva, Naomi; Cvancic, Sara; Daneshmand, Manijeh; Bell, John C.] Univ Ottawa, Ottawa, ON K1N 6N5, Canada; [Stephenson, Joe] Canc Ctr Carolinas, Greenville, SC 29605 USA; [Haas, Andrew R.] Univ Penn, Med Ctr, Philadelphia, PA 19104 USA; [Hwang, Tae-Ho; Je, Ji-Eun; Lee, Yeon-Sook] Pusan Natl Univ, Pusan 609735, South Korea; [Patt, Richard] RadMD, Doylestown, PA 18901 USA; [Fenster, Aaron] Robarts Res Inst, London, ON N6A 5K8, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Pennsylvania; Pusan National University; Western University (University of Western Ontario)	Kirn, DH (corresponding author), Jennerex Inc, 450 Sansome St,16th Floor, San Francisco, CA 94111 USA.	dkirn@jennerex.com	FENSTER, Aaron/K-4337-2013; Nieva, Jorge/AAE-3634-2022; Diallo, Jean-Simon/G-4465-2017	Nieva, Jorge/0000-0003-1605-4719; Burns, Joseph/0000-0002-6926-232X; Diallo, Jean-Simon/0000-0002-4862-2795; Evgin, Laura/0000-0002-0913-5038	Terry Fox Foundation; Canadian Institute for Health Research (CIHR); Ministry for Health, Welfare and Family Affairs, Republic of Korea [A091047]; Vanier Scholarship; Natural Sciences and Engineering Research Council of Canada (NSERC); Ontario Graduate Scholarships in Science and Technology (OGSST); Canadian Institutes of Health Research/Small and Medium Enterprises (CIHR/SME); Ontario Institute for Cancer Research	Terry Fox Foundation; Canadian Institute for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Ministry for Health, Welfare and Family Affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); Vanier Scholarship; Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ontario Graduate Scholarships in Science and Technology (OGSST); Canadian Institutes of Health Research/Small and Medium Enterprises (CIHR/SME)(Canadian Institutes of Health Research (CIHR)); Ontario Institute for Cancer Research	Jennerex Inc. was involved in the study design, data monitoring, analysis and interpretation, and in writing and submission of the report for publication. Jennerex Inc. funded the clinical study. Translational work was supported by grants to J.B. from the Terry Fox Foundation and the Canadian Institute for Health Research (CIHR) and by grants to T.-H.H. from the Korea Healthcare technology R&D Project, Ministry for Health, Welfare and Family Affairs, Republic of Korea (A091047). N.D.S. is supported by a Vanier Scholarship. C.J.B. was supported by a Natural Sciences and Engineering Research Council of Canada (NSERC) studentship. L.E. is supported by Ontario Graduate Scholarships in Science and Technology (OGSST). F.L.B. is supported by a Canadian Institutes of Health Research/Small and Medium Enterprises (CIHR/SME) Collaborative Research Program Fellowship. A.F. and J.C.B. are supported by Ontario Institute for Cancer Research.	BULLER RML, 1985, NATURE, V317, P813, DOI 10.1038/317813a0; Byrne MJ, 2004, ANN ONCOL, V15, P257, DOI 10.1093/annonc/mdh059; Choi H, 2004, AM J ROENTGENOL, V183, P1619, DOI 10.2214/ajr.183.6.01831619; Choi H, 2007, J CLIN ONCOL, V25, P1753, DOI 10.1200/JCO.2006.07.3049; Davis ME, 2010, NATURE, V464, P1067, DOI 10.1038/nature08956; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; HOVGAARD D, 1992, EUR J CLIN INVEST, V22, P45, DOI 10.1111/j.1365-2362.1992.tb01934.x; Katsafanas GC, 2004, J BIOL CHEM, V279, P52210, DOI 10.1074/jbc.M411033200; Kim JH, 2006, MOL THER, V14, P361, DOI 10.1016/j.ymthe.2006.05.008; Kirn DH, 2009, NAT REV CANCER, V9, P64, DOI 10.1038/nrc2545; Kulesh DA, 2004, J CLIN MICROBIOL, V42, P601, DOI 10.1128/JCM.42.2.601-609.2004; Liu TC, 2007, NAT CLIN PRACT ONCOL, V4, P101, DOI 10.1038/ncponc0736; Mastrangelo MJ, 1999, CANCER GENE THER, V6, P409, DOI 10.1038/sj.cgt.7700066; McCart JA, 2001, CANCER RES, V61, P8751; McCart JA, 2004, MOL THER, V10, P553, DOI 10.1016/j.ymthe.2004.06.158; MOSS B, 1991, SCIENCE, V252, P1662, DOI 10.1126/science.2047875; Msaouel P, 2009, MOL THER, V17, P2041, DOI 10.1038/mt.2009.218; MYERS JLW, 2003, RES DESIGN STAT ANAL, P505; Parato KA, 2005, NAT REV CANCER, V5, P965, DOI 10.1038/nrc1750; Park BH, 2008, LANCET ONCOL, V9, P533, DOI 10.1016/S1470-2045(08)70107-4; Peng KW, 2002, CANCER RES, V62, P4656; Rozen S, 2000, Methods Mol Biol, V132, P365; Smith GL, 2003, ANNU REV MICROBIOL, V57, P323, DOI 10.1146/annurev.micro.57.030502.091037; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Thorne SH, 2010, MOL THER, V18, P1698, DOI 10.1038/mt.2010.140; Thorne SH, 2007, J CLIN INVEST, V117, P3350, DOI 10.1172/JCI32727; Vanderplasschen A, 1997, J GEN VIROL, V78, P2041, DOI 10.1099/0022-1317-78-8-2041; Vanderplasschen A, 1998, P NATL ACAD SCI USA, V95, P7544, DOI 10.1073/pnas.95.13.7544; Wein LM, 2003, CANCER RES, V63, P1317; Yang HL, 2005, J CLIN INVEST, V115, P379, DOI 10.1172/jc1200523200	30	381	409	2	130	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 1	2011	477	7362					99	U102		10.1038/nature10358	http://dx.doi.org/10.1038/nature10358			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	813XT	21886163				2022-12-28	WOS:000294404300039
J	Hoffmann, AA; Montgomery, BL; Popovici, J; Iturbe-Ormaetxe, I; Johnson, PH; Muzzi, F; Greenfield, M; Durkan, M; Leong, YS; Dong, Y; Cook, H; Axford, J; Callahan, AG; Kenny, N; Omodei, C; McGraw, EA; Ryan, PA; Ritchie, SA; Turelli, M; O'Neill, SL				Hoffmann, A. A.; Montgomery, B. L.; Popovici, J.; Iturbe-Ormaetxe, I.; Johnson, P. H.; Muzzi, F.; Greenfield, M.; Durkan, M.; Leong, Y. S.; Dong, Y.; Cook, H.; Axford, J.; Callahan, A. G.; Kenny, N.; Omodei, C.; McGraw, E. A.; Ryan, P. A.; Ritchie, S. A.; Turelli, M.; O'Neill, S. L.			Successful establishment of Wolbachia in Aedes populations to suppress dengue transmission	NATURE			English	Article							LIFE-SHORTENING WOLBACHIA; CYTOPLASMIC INCOMPATIBILITY; GENETIC-CONTROL; AEGYPTI; AUSTRALIA; MOSQUITOS; DROSOPHILA; DISPERSAL; INFECTION; REPLACEMENT	Genetic manipulations of insect populations for pest control have been advocated for some time, but there are few cases where manipulated individuals have been released in the field and no cases where they have successfully invaded target populations(1). Population transformation using the intracellular bacterium Wolbachia is particularly attractive because this maternally-inherited agent provides a powerful mechanism to invade natural populations through cytoplasmic incompatibility(2). When Wolbachia are introduced into mosquitoes, they interfere with pathogen transmission and influence key life history traits such as lifespan(3-6). Here we describe how the wMel Wolbachia infection, introduced into the dengue vector Aedes aegypti from Drosophila melanogaster(7), successfully invaded two natural A. aegypti populations in Australia, reaching near-fixation in a few months following releases of wMel-infected A. aegypti adults. Models with plausible parameter values indicate that Wolbachia-infected mosquitoes suffered relatively small fitness costs, leading to an unstable equilibrium frequency <30% that must be exceeded for invasion. These findings demonstrate that Wolbachia-based strategies can be deployed as a practical approach to dengue suppression with potential for area-wide implementation.	[Montgomery, B. L.; Popovici, J.; Iturbe-Ormaetxe, I.; Muzzi, F.; Greenfield, M.; Durkan, M.; Leong, Y. S.; Dong, Y.; Cook, H.; Kenny, N.; McGraw, E. A.; Ryan, P. A.; O'Neill, S. L.] Univ Queensland, Sch Biol Sci, Brisbane, Qld 4072, Australia; [Hoffmann, A. A.; Axford, J.; Callahan, A. G.] Univ Melbourne, Dept Genet, Inst Bio21, Melbourne, Vic 3010, Australia; [Popovici, J.; Iturbe-Ormaetxe, I.; Dong, Y.; Kenny, N.; McGraw, E. A.; Ryan, P. A.; O'Neill, S. L.] Monash Univ, Sch Biol Sci, Clayton, Vic 3800, Australia; [Johnson, P. H.; Omodei, C.; Ritchie, S. A.] James Cook Univ, Sch Publ Hlth & Trop Med & Rehabil Sci, Cairns, Qld 4870, Australia; [Ryan, P. A.] Royal Brisbane Hosp, Queensland Inst Med Res, Brisbane, Qld 4029, Australia; [Turelli, M.] Univ Calif Davis, Dept Evolut & Ecol, Davis, CA 95616 USA	University of Queensland; University of Melbourne; Monash University; James Cook University; QIMR Berghofer Medical Research Institute; Royal Brisbane & Women's Hospital; University of California System; University of California Davis	O'Neill, SL (corresponding author), Univ Queensland, Sch Biol Sci, Brisbane, Qld 4072, Australia.	scott.oneill@monash.edu	O'Neill, Scott L/B-3568-2009; O'Neill, Scott/R-9560-2019; Popovici, Jean/K-7192-2014; Hoffmann, Ary/R-2972-2019; McGraw, Elizabeth A/A-6658-2012; McGraw, Elizabeth/GRF-0434-2022; Hoffmann, Ary/C-2961-2011	O'Neill, Scott L/0000-0002-4131-3615; O'Neill, Scott/0000-0002-4131-3615; Popovici, Jean/0000-0002-3135-1175; Hoffmann, Ary/0000-0001-9497-7645; McGraw, Elizabeth A/0000-0001-7973-088X; Ryan, Peter/0000-0003-0674-4441; Greenfield, Melinda/0000-0001-6026-7602	Foundation for the National Institutes of Health through the Grand Challenges in Global Health Initiative of the Bill and Melinda Gates Foundation; National Health and Medical Research Council, Australia; Queensland Government; NIH; Climate Health Cluster of the CSIRO; National Science Foundation; Australian Research Council	Foundation for the National Institutes of Health through the Grand Challenges in Global Health Initiative of the Bill and Melinda Gates Foundation; National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia); Queensland Government; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Climate Health Cluster of the CSIRO; National Science Foundation(National Science Foundation (NSF)); Australian Research Council(Australian Research Council)	We are grateful to J. Sutton, C. Paton, G. Omodei, S. Long, A. Gofton, V. White, A. Weeks, A. James, J. Dick, R. Bagita, P. Gibson, J. Jeffery, E. Rances, D. Rossi and J. Gough for technical and mapping support. We thank B. Kay for ongoing advice. We acknowledge and thank both D. McNaughton and D. Eastop for the early community engagement work preceding the trial. We thank all of our volunteers who helped blood-feed the mosquito colonies and we are particularly grateful to the residents of Gordonvale and Yorkeys Knob for their strong support and participation. This research was supported by a grant from the Foundation for the National Institutes of Health through the Grand Challenges in Global Health Initiative of the Bill and Melinda Gates Foundation, The National Health and Medical Research Council, Australia, the National and International Research Alliances Program of the Queensland Government, the RAPIDD program of the NIH, the Climate Health Cluster of the CSIRO Flagship Collaboration Fund, the National Science Foundation and Fellowships from the Australian Research Council.	Ball TS, 2010, J MED ENTOMOL, V47, P649, DOI 10.1603/ME09218; Barton NH, 2011, AM NAT, V178, pE48, DOI 10.1086/661246; BEEBE NW, 1995, AM J TROP MED HYG, V53, P478, DOI 10.4269/ajtmh.1995.53.478; Bian GW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000833; CASPARI E, 1959, EVOLUTION, V13, P568, DOI 10.2307/2406138; CURTIS CF, 1985, BIOL J LINN SOC, V26, P359, DOI 10.1111/j.1095-8312.1985.tb02047.x; David MR, 2009, MEM I OSWALDO CRUZ, V104, P927, DOI 10.1590/S0074-02762009000600019; De Barro PJ, 2011, J VERBRAUCH LEBENSM, V6, P33, DOI 10.1007/s00003-011-0671-x; Endersby NM, 2009, J MED ENTOMOL, V46, P1074, DOI 10.1603/033.046.0514; Endersby N. M., J MED ENTOM IN PRESS; FOSTER GG, 1980, WOOL TECH SHEEP BREE, V28, P5; Gould F, 2004, ANNU REV ENTOMOL, V49, P193, DOI 10.1146/annurev.ento.49.061802.123344; Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460; Harrington LC, 2005, AM J TROP MED HYG, V72, P209, DOI 10.4269/ajtmh.2005.72.209; Hemme RR, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000634; Kambris Z, 2009, SCIENCE, V326, P134, DOI 10.1126/science.1177531; Kyle JL, 2008, ANNU REV MICROBIOL, V62, P71, DOI 10.1146/annurev.micro.62.081307.163005; LAVEN H, 1967, NATURE, V216, P383, DOI 10.1038/216383a0; McMeniman CJ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000748; McMeniman CJ, 2009, SCIENCE, V323, P141, DOI 10.1126/science.1165326; McNaughton D, 2010, ACTA TROP, V116, P74, DOI 10.1016/j.actatropica.2010.05.012; Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042; Osborne SE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000656; Popovici J, 2010, MEM I OSWALDO CRUZ, V105, P957, DOI 10.1590/S0074-02762010000800002; REITER P, 1995, AM J TROP MED HYG, V52, P177, DOI 10.4269/ajtmh.1995.52.177; Riegler M, 2005, CURR BIOL, V15, P1428, DOI 10.1016/j.cub.2005.06.069; Ritchie SA, 2001, J AM MOSQUITO CONTR, V17, P206; Ritchie Scott A, 2011, PLoS Negl Trop Dis, V5, pe988, DOI 10.1371/journal.pntd.0000988; TURELLI M, 1991, NATURE, V353, P440, DOI 10.1038/353440a0; TURELLI M, 1995, GENETICS, V140, P1319; Turelli M, 2010, EVOLUTION, V64, P232, DOI 10.1111/j.1558-5646.2009.00822.x; Williams CR, 2006, J AM MOSQUITO CONTR, V22, P296, DOI 10.2987/8756-971X(2006)22[296:FEOTBC]2.0.CO;2; Yeap HL, 2011, GENETICS, V187, P583, DOI 10.1534/genetics.110.122390	33	928	972	9	425	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 25	2011	476	7361					454	U107		10.1038/nature10356	http://dx.doi.org/10.1038/nature10356			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811KT	21866160				2022-12-28	WOS:000294209400037
J	Holmes, D				Holmes, David			John Teerlink: Renaissance man and leader in heart failure research	LANCET			English	Editorial Material																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 20	2011	378	9792					657	657		10.1016/S0140-6736(11)61321-4	http://dx.doi.org/10.1016/S0140-6736(11)61321-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	815EW	21856469	Bronze			2022-12-28	WOS:000294509900013
J	Kolber, A				Kolber, Adam			Give memory-altering drugs a chance	NATURE			English	Editorial Material							POSTTRAUMATIC-STRESS-DISORDER; PROPRANOLOL		Brooklyn Law Sch, Brooklyn, NY 11201 USA		Kolber, A (corresponding author), Brooklyn Law Sch, Brooklyn, NY 11201 USA.	adam.kolber@brooklaw.edu						Cukor J, 2009, CLIN PSYCHOL REV, V29, P715, DOI 10.1016/j.cpr.2009.09.001; HAIG S, 2007, TIME            1015; Kolber A, 2008, NEUROETHICS-NETH, V1, P145, DOI 10.1007/s12152-008-9011-y; Kolber AJ, 2006, VANDERBILT LAW REV, V59, P1561; Li YQ, 2011, J NEUROSCI, V31, P5436, DOI 10.1523/JNEUROSCI.5884-10.2011; Marin MF, 2011, J CLIN ENDOCR METAB, V96, pE1221, DOI 10.1210/jc.2011-0226; Pitman RK, 2002, BIOL PSYCHIAT, V51, P189, DOI 10.1016/S0006-3223(01)01279-3; *PRES COUNC BIOETH, 2003, THER BIOT PURS HUM H, P205; Schiller D, 2010, NATURE, V463, P49, DOI 10.1038/nature08637; Vaiva G, 2003, BIOL PSYCHIAT, V54, P947, DOI 10.1016/S0006-3223(03)00412-8	10	9	10	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 18	2011	476	7360					275	276		10.1038/476275a	http://dx.doi.org/10.1038/476275a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811JV	21850084	Bronze			2022-12-28	WOS:000294206500012
J	Rutter, H				Rutter, Harry			Where next for obesity?	LANCET			English	Editorial Material									Natl Obes Observ, Oxford OX4 2GX, England		Rutter, H (corresponding author), Natl Obes Observ, Oxford OX4 2GX, England.	harry.rutter@dph.ox.ac.uk	Rutter, Harry/HCI-8765-2022	Rutter, Harry/0000-0002-9322-0656				Berlin Isaiah, 1953, HEDGEHOG FOX ESSAY T; Bhopal R, 2011, LANCET, V378, P464, DOI 10.1016/S0140-6736(11)61147-1; Butland B, 2007, FORESIGHT TACKLING O; Chapman J., 2004, SYSTEM FAILURE; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Lang T, 2007, OBES REV, V8, P165, DOI 10.1111/j.1467-789X.2007.00338.x; RITTEL HWJ, 1973, POLICY SCI, V4, P155, DOI 10.1007/BF01405730; Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1	8	34	34	1	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG-SEP	2011	378	9793					746	747		10.1016/S0140-6736(11)61272-5	http://dx.doi.org/10.1016/S0140-6736(11)61272-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	816FY	21872736				2022-12-28	WOS:000294585300006
J	Wirth, A; Hassan, MT; Grguras, I; Gagnon, J; Moulet, A; Luu, TT; Pabst, S; Santra, R; Alahmed, ZA; Azzeer, AM; Yakovlev, VS; Pervak, V; Krausz, F; Goulielmakis, E				Wirth, A.; Hassan, M. Th.; Grguras, I.; Gagnon, J.; Moulet, A.; Luu, T. T.; Pabst, S.; Santra, R.; Alahmed, Z. A.; Azzeer, A. M.; Yakovlev, V. S.; Pervak, V.; Krausz, F.; Goulielmakis, E.			Synthesized Light Transients	SCIENCE			English	Article							MODE-LOCKED LASERS; FEW-CYCLE; PHASE-CONTROL; ELECTRON LOCALIZATION; ATTOSECOND CONTROL; NONLINEAR OPTICS; GENERATION; FREQUENCY; PULSES; FIELDS	Manipulation of electron dynamics calls for electromagnetic forces that can be confined to and controlled over sub-femtosecond time intervals. Tailored transients of light fields can provide these forces. We report on the generation of subcycle field transients spanning the infrared, visible, and ultraviolet frequency regimes with a 1.5-octave three-channel optical field synthesizer and their attosecond sampling. To demonstrate applicability, we field-ionized krypton atoms within a single wave crest and launched a valence-shell electron wavepacket with a well-defined initial phase. Half-cycle field excitation and attosecond probing revealed fine details of atomic-scale electron motion, such as the instantaneous rate of tunneling, the initial charge distribution of a valence-shell wavepacket, the attosecond dynamic shift (instantaneous ac Stark shift) of its energy levels, and its few-femtosecond coherent oscillations.	[Wirth, A.; Hassan, M. Th.; Grguras, I.; Gagnon, J.; Moulet, A.; Luu, T. T.; Yakovlev, V. S.; Krausz, F.; Goulielmakis, E.] Max Planck Inst Quantenopt MPQ, D-85748 Garching, Germany; [Hassan, M. Th.; Alahmed, Z. A.; Azzeer, A. M.] King Saud Univ, Dept Phys & Astron, Riyadh 11451, Saudi Arabia; [Pabst, S.; Santra, R.] DESY, Ctr Free Electron Laser Sci, D-22607 Hamburg, Germany; [Pabst, S.; Santra, R.] Univ Hamburg, Dept Phys, D-20355 Hamburg, Germany; [Yakovlev, V. S.; Pervak, V.; Krausz, F.] Univ Munich, Dept Phys, D-85748 Garching, Germany	Max Planck Society; King Saud University; Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); University of Hamburg; University of Munich	Goulielmakis, E (corresponding author), Max Planck Inst Quantenopt MPQ, Hans Kopfermann Str 1, D-85748 Garching, Germany.	elgo@mpq.mpg.de	Santra, Robin/E-8332-2014; Azzeer, Abdallah M/A-4542-2011; Pabst, Stefan/Y-3617-2019; Alahmed, Zeyad A/F-1683-2013; Goulielmakis, Eleftherios/AAZ-1052-2020; Pabst, Stefan/J-6541-2013; Luu, Tran Trung/HCH-4815-2022; Hassan, Mohammed TH/I-5793-2019; Yakovlev, Vladislav S/C-4091-2015; Goulielmakis, Eleftherios/F-1693-2011	Santra, Robin/0000-0002-1442-9815; Azzeer, Abdallah M/0000-0001-8334-9256; Pabst, Stefan/0000-0003-1134-4629; Alahmed, Zeyad A/0000-0001-7304-8118; Pabst, Stefan/0000-0003-1134-4629; Hassan, Mohammed TH/0000-0002-9669-534X; Yakovlev, Vladislav S/0000-0002-0648-9375; Luu, Tran Trung/0000-0003-3772-3379; Goulielmakis, Eleftherios/0000-0003-3386-0245	Max Planck Society; European Research Council [Attoelectronics-258501]; Deutsche Forschungsgemeinschaft: Munich Centre for Advanced Photonics; King Saud University-MPQ; European Research Training Network ATTOFEL	Max Planck Society(Max Planck SocietyFoundation CELLEX); European Research Council(European Research Council (ERC)European Commission); Deutsche Forschungsgemeinschaft: Munich Centre for Advanced Photonics; King Saud University-MPQ; European Research Training Network ATTOFEL	We acknowledge the development of dedicated attosecond soft x-ray optics by M. Hofstetter and U. Kleineberg (LMU, MPQ). This work was supported by the Max Planck Society, the European Research Council grant (Attoelectronics-258501), the Deutsche Forschungsgemeinschaft Cluster of Excellence: Munich Centre for Advanced Photonics (www.munich-photonics.de), the King Saud University-MPQ collaboration, and the European Research Training Network ATTOFEL.	Apolonski A, 2000, PHYS REV LETT, V85, P740, DOI 10.1103/PhysRevLett.85.740; AUTLER SH, 1955, PHYS REV, V100, P703, DOI 10.1103/PhysRev.100.703; Baltuska A, 2003, NATURE, V421, P611, DOI 10.1038/nature01414; Brabec T, 2000, REV MOD PHYS, V72, P545, DOI 10.1103/RevModPhys.72.545; Chan HS, 2011, SCIENCE, V331, P1165, DOI 10.1126/science.1198397; CRUZ CHB, 1988, IEEE J QUANTUM ELECT, V24, P261, DOI 10.1109/3.122; Cundiff ST, 2003, REV MOD PHYS, V75, P325, DOI 10.1103/RevModPhys.75.325; Delone NB, 1999, USP FIZ NAUK+, V169, P753, DOI 10.3367/UFNr.0169.199907c.0753; Diddams SA, 2000, PHYS REV LETT, V84, P5102, DOI 10.1103/PhysRevLett.84.5102; Durach M, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.086803; Eckle P, 2008, SCIENCE, V322, P1525, DOI 10.1126/science.1163439; Gertsvolf M, 2010, J PHYS B-AT MOL OPT, V43, DOI 10.1088/0953-4075/43/13/131002; Goulielmakis E, 2008, SCIENCE, V320, P1614, DOI 10.1126/science.1157846; Goulielmakis E, 2004, SCIENCE, V305, P1267, DOI 10.1126/science.1100866; Goulielmakis E, 2007, SCIENCE, V317, P769, DOI 10.1126/science.1142855; Goulielmakis E, 2010, NATURE, V466, P739, DOI 10.1038/nature09212; Greenman L, 2010, PHYS REV A, V82, DOI 10.1103/PhysRevA.82.023406; Harris SE, 1998, PHYS REV LETT, V81, P2894, DOI 10.1103/PhysRevLett.81.2894; Hentschel M, 2001, NATURE, V414, P509, DOI 10.1038/35107000; Hsieh ZM, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.213902; Jones DJ, 2000, SCIENCE, V288, P635, DOI 10.1126/science.288.5466.635; Kienberger R, 2004, NATURE, V427, P817, DOI 10.1038/nature02277; Kling MF, 2006, SCIENCE, V312, P246, DOI 10.1126/science.1126259; Krauss G, 2010, NAT PHOTONICS, V4, P33, DOI 10.1038/NPHOTON.2009.258; Liang JQ, 2000, PHYS REV LETT, V85, P2474, DOI 10.1103/PhysRevLett.85.2474; Mauritsson J, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.053001; Meckel M, 2008, SCIENCE, V320, P1478, DOI 10.1126/science.1157980; MOLLOW BR, 1972, PHYS REV A-GEN PHYS, V5, P1522, DOI 10.1103/PhysRevA.5.1522; Okamura K, 2011, OPT LETT, V36, P226, DOI 10.1364/OL.36.000226; Pabst S, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.053003; Rausch S, 2008, OPT EXPRESS, V16, P17410, DOI 10.1364/OE.16.017410; Reichert J, 1999, OPT COMMUN, V172, P59, DOI 10.1016/S0030-4018(99)00491-5; Remacle F, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.183902; Sansone G, 2006, SCIENCE, V314, P443, DOI 10.1126/science.1132838; Sansone G, 2010, NATURE, V465, P763, DOI 10.1038/nature09084; Schultze M, 2010, SCIENCE, V328, P1658, DOI 10.1126/science.1189401; Shelton RK, 2001, SCIENCE, V293, P1286, DOI 10.1126/science.1061754; Smirnova O, 2009, NATURE, V460, P972, DOI 10.1038/nature08253; Sokolov AV, 2000, PHYS REV LETT, V85, P562, DOI 10.1103/PhysRevLett.85.562; Sokolov AV, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.033402; Sussman BJ, 2011, AM J PHYS, V79, P477, DOI 10.1119/1.3553018; Suzuki T, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.243602; Udem T, 2002, NATURE, V416, P233, DOI 10.1038/416233a; Unold T, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.157401; Whitaker J. F., 1990, Microelectronic Engineering, V12, P369, DOI 10.1016/0167-9317(90)90050-4; Xu L, 1996, OPT LETT, V21, P2008, DOI 10.1364/OL.21.002008; Yamashita M, 2006, IEEE J SEL TOP QUANT, V12, P213, DOI 10.1109/JSTQE.2006.871961; Zherebtsov S, 2011, NAT PHYS, V7, P656, DOI [10.1038/nphys1983, 10.1038/NPHYS1983]	48	465	480	5	189	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 14	2011	334	6053					195	200		10.1126/science.1210268	http://dx.doi.org/10.1126/science.1210268			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832UI	21903778				2022-12-28	WOS:000295833600038
J	Hansen, SB; Tao, X; MacKinnon, R				Hansen, Scott B.; Tao, Xiao; MacKinnon, Roderick			Structural basis of PIP2 activation of the classical inward rectifier K+ channel Kir2.2	NATURE			English	Article							POTASSIUM CHANNELS; PROTEINS	The regulation of ion channel activity by specific lipid molecules is widely recognized as an integral component of electrical signalling in cells(1,2). In particular, phosphatidylinositol 4,5-bisphosphate (PIP2), a minor yet dynamic phospholipid component of cell membranes, is known to regulate many different ion channels(2-8). PIP2 is the primary agonist for classical inward rectifier (Kir2) channels, through which this lipid can regulate a cell's resting membrane potential(2,7-9). However, the molecular mechanism by which PIP2 exerts its action is unknown. Here we present the X-ray crystal structure of a Kir2.2 channel in complex with a short-chain (dioctanoyl) derivative of PIP2. We found that PIP2 binds at an interface between the transmembrane domain (TMD) and the cytoplasmic domain (CTD). The PIP2-binding site consists of a conserved non-specific phospholipid-binding region in the TMD and a specific phosphatidylinositol-binding region in the CTD. On PIP2 binding, a flexible expansion linker contracts to a compact helical structure, the CTD translates 6 angstrom and becomes tethered to the TMD and the inner helix gate begins to open. In contrast, the small anionic lipid dioctanoyl glycerol pyrophosphatidic acid (PPA) also binds to the non-specific TMD region, but not to the specific phosphatidylinositol region, and thus fails to engage the CTD or open the channel. Our results show how PIP2 can control the resting membrane potential through a specific ion-channel-receptor-ligand interaction that brings about a large conformational change, analogous to neurotransmitter activation of ion channels at synapses.	[Hansen, Scott B.; Tao, Xiao; MacKinnon, Roderick] Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Neurobiol & Biophys, New York, NY 10065 USA	Howard Hughes Medical Institute; Rockefeller University	MacKinnon, R (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Neurobiol & Biophys, 1230 York Ave, New York, NY 10065 USA.	mackinn@rockefeller.edu			Howard Hughes Medical Institute Funding Source: Medline; NIBIB NIH HHS [P30 EB009998] Funding Source: Medline; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))		Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; Cheng WWL, 2011, BIOPHYS J, V100, P620, DOI 10.1016/j.bpj.2010.12.3724; Cho WH, 2005, ANNU REV BIOPH BIOM, V34, P119, DOI 10.1146/annurev.biophys.33.110502.133337; Clarke OB, 2010, CELL, V141, P1018, DOI 10.1016/j.cell.2010.05.003; Cohen SX, 2004, ACTA CRYSTALLOGR D, V60, P2222, DOI 10.1107/S0907444904027556; Dart C, 2010, J PHYSIOL-LONDON, V588, P3169, DOI 10.1113/jphysiol.2010.191585; DeLano W, 2002, PYMOL 0 99; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Enkvetchakul D, 2005, J BIOL CHEM, V280, P35785, DOI 10.1074/jbc.C500355200; Fujiwara Y, 2006, J PHYSIOL-LONDON, V576, P135, DOI 10.1113/jphysiol.2006.115246; Gamper N, 2007, NAT REV NEUROSCI, V8, P921, DOI 10.1038/nrn2257; Heo WD, 2006, SCIENCE, V314, P1458, DOI 10.1126/science.1134389; Hilgemann D W, 2001, Sci STKE, V2001, pre19, DOI 10.1126/stke.2001.111.re19; Hilgemann DW, 1996, SCIENCE, V273, P956, DOI 10.1126/science.273.5277.956; Huang CL, 1998, NATURE, V391, P803, DOI 10.1038/35882; Logothetis DE, 2007, PFLUG ARCH EUR J PHY, V455, P83, DOI 10.1007/s00424-007-0276-5; Lopes CMB, 2002, NEURON, V34, P933, DOI 10.1016/S0896-6273(02)00725-0; Martin TFJ, 2001, CURR OPIN CELL BIOL, V13, P493, DOI 10.1016/S0955-0674(00)00241-6; Monserrate JP, 2010, CURR OPIN CELL BIOL, V22, P365, DOI 10.1016/j.ceb.2010.03.006; Pegan S, 2005, NAT NEUROSCI, V8, P279, DOI 10.1038/nn1411; Rohacs T, 2003, P NATL ACAD SCI USA, V100, P745, DOI 10.1073/pnas.0236364100; Stanfield PR, 2002, REV PHYSIOL BIOCH P, V145, P47, DOI 10.1007/BFb0116431; Suh BC, 2005, CURR OPIN NEUROBIOL, V15, P370, DOI 10.1016/j.conb.2005.05.005; Tao X, 2009, SCIENCE, V326, P1668, DOI 10.1126/science.1180310; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; Vaithianathan T, 2008, J GEN PHYSIOL, V132, P13, DOI 10.1085/jgp.200709913; Xie LH, 2007, PROG BIOPHYS MOL BIO, V94, P320, DOI 10.1016/j.pbiomolbio.2006.04.001; Zhang HL, 1999, NAT CELL BIOL, V1, P183, DOI 10.1038/11103	30	417	422	3	107	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 22	2011	477	7365					495	U152		10.1038/nature10370	http://dx.doi.org/10.1038/nature10370			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822WH	21874019	Green Accepted			2022-12-28	WOS:000295080500047
J	Kurian, L; Palanimurugan, R; Godderz, D; Dohmen, RJ				Kurian, Leo; Palanimurugan, R.; Goedderz, Daniela; Dohmen, R. Juergen			Polyamine sensing by nascent ornithine decarboxylase antizyme stimulates decoding of its mRNA	NATURE			English	Article							TRANSLATION; YEAST; RIBOSOME; DEGRADATION; PATHWAY; PROTEIN; STRESS; TUNNEL	Polyamines are essential organic polycations with multiple cellular functions relevant for cell division, cancer and ageing(1-3). Regulation of polyamine synthesis is mainly achieved by controlling the activity of ornithine decarboxylase (ODC) through an unusual mechanism involving ODC antizyme(1,4), the binding of which disrupts homodimeric ODC and targets it for ubiquitin-independent degradation by the 26S proteasome(5). Whereas mammals express several antizyme genes(6), we have identified a single orthologue, termed OAZ1, in Saccharomyces cerevisiae(7). Similar to its mammalian counterparts, OAZ1 synthesis is induced with rising intracellular polyamine concentrations, which also inhibit ubiquitin-dependent degradation of the OAZ1 protein(7). Together, these mechanisms contribute to a homeostatic feedback regulation of polyamines(1,7,8). Antizyme synthesis involves a conserved +1 ribosomal frameshifting (RFS) event at an internal STOP codon during decoding of its messenger RNA(6-10). Here we used S. cerevisiae OAZ1 to dissect the enigmatic mechanism underlying polyamine regulation of RFS. In contrast with previous assumptions, we report here that the nascent antizyme polypeptide is the relevant polyamine sensor that operates in cis to negatively regulate upstream RFS on the polysomes, where its own mRNA is being translated. At low polyamine levels, the emerging antizyme polypeptide inhibits completion of its synthesis causing a ribosome pile-up on antizyme mRNA, whereas polyamine binding to nascent antizyme promotes completion of its synthesis. Thus, our study reveals a novel autoregulatory mechanism, in which binding of a small metabolite to a nascent sensor protein stimulates the latter's synthesis co-translationally.	[Kurian, Leo; Palanimurugan, R.; Goedderz, Daniela; Dohmen, R. Juergen] Univ Cologne, Cologne Bioctr, Inst Genet, D-50674 Cologne, Germany	University of Cologne	Dohmen, RJ (corresponding author), Univ Cologne, Cologne Bioctr, Inst Genet, Zulpicher Str 47A, D-50674 Cologne, Germany.	j.dohmen@uni-koeln.de	Kurian, Leo/M-1598-2014; Dohmen, R. Jürgen/AAD-6649-2022	Kurian, Leo/0000-0001-7466-5169; Dohmen, R. Jürgen/0000-0002-5756-6780	NRW Graduate School in Genetics and Functional Genomics; Deutsche Forschungsgemeinschaft [Do 649/4]	NRW Graduate School in Genetics and Functional Genomics; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank M. Hochstrasser for comments, D. Richardson for critical reading of the manuscript, and D. H. Wolf for the pre1-1 strain. L. K. and D. G. were supported by the NRW Graduate School in Genetics and Functional Genomics. This work was supported by a grant from the Deutsche Forschungsgemeinschaft (Do 649/4) to R.J.D.	Arava Y, 2005, NUCLEIC ACIDS RES, V33, P2421, DOI 10.1093/nar/gki331; BAIM SB, 1988, MOL CELL BIOL, V8, P1591, DOI 10.1128/MCB.8.4.1591; Basuroy UK, 2006, J BIOCHEM, V139, P27, DOI 10.1093/jb/mvj022; Butcher NJ, 2007, J BIOL CHEM, V282, P28530, DOI 10.1074/jbc.M701265200; Coffino P, 2001, NAT REV MOL CELL BIO, V2, P188, DOI 10.1038/35056508; Dulloo I, 2010, P NATL ACAD SCI USA, V107, P4902, DOI 10.1073/pnas.0906782107; Eisenberg T, 2009, NAT CELL BIOL, V11, P1305, DOI 10.1038/ncb1975; Hayashi S, 1996, TRENDS BIOCHEM SCI, V21, P27, DOI 10.1016/0968-0004(96)80882-6; HEINEMEYER W, 1991, EMBO J, V10, P555, DOI 10.1002/j.1460-2075.1991.tb07982.x; Hoffman DW, 2005, BIOCHEMISTRY-US, V44, P11777, DOI 10.1021/bi051081k; Inada T, 2002, RNA, V8, P948, DOI 10.1017/S1355838202026018; Ivanov IP, 2007, NUCLEIC ACIDS RES, V35, P1842, DOI 10.1093/nar/gkm035; Lim SK, 2007, ONCOGENE, V26, P6593, DOI 10.1038/sj.onc.1210482; MATSUFUJI S, 1995, CELL, V80, P51, DOI 10.1016/0092-8674(95)90450-6; MURAKAMI Y, 1992, NATURE, V360, P597, DOI 10.1038/360597a0; Nakatogawa H, 2002, CELL, V108, P629, DOI 10.1016/S0092-8674(02)00649-9; Palanimurugan R, 2004, EMBO J, V23, P4857, DOI 10.1038/sj.emboj.7600473; Rato C, 2011, NUCLEIC ACIDS RES, V39, P4587, DOI 10.1093/nar/gkq1349; ROM E, 1994, P NATL ACAD SCI USA, V91, P9195; Tenson T, 2002, CELL, V108, P591, DOI 10.1016/S0092-8674(02)00669-4; Wallace HM, 2003, BIOCHEM J, V376, P1, DOI 10.1042/BJ20031327; Woolhead CA, 2006, MOL CELL, V22, P587, DOI 10.1016/j.molcel.2006.05.021	22	75	82	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 22	2011	477	7365					490	U147		10.1038/nature10393	http://dx.doi.org/10.1038/nature10393			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822WH	21900894				2022-12-28	WOS:000295080500046
J	[Anonymous]				[Anonymous]			Japan: universal health care at 50 years	LANCET			English	Editorial Material																			0	14	15	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 17	2011	378	9796					1049	1049		10.1016/S0140-6736(11)61223-3	http://dx.doi.org/10.1016/S0140-6736(11)61223-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	829BE	21885103				2022-12-28	WOS:000295548900001
J	Guse, A; Carroll, CW; Moree, B; Fuller, CJ; Straight, AF				Guse, Annika; Carroll, Christopher W.; Moree, Ben; Fuller, Colin J.; Straight, Aaron F.			In vitro centromere and kinetochore assembly on defined chromatin templates	NATURE			English	Article							XENOPUS EGG EXTRACTS; CENP-A NUCLEOSOMES; AURORA B; HISTONE; COMPLEX; PHOSPHORYLATION; CHECKPOINT; HJURP; DNA; ORGANIZATION	During cell division, chromosomes are segregated to nascent daughter cells by attaching to the microtubules of the mitotic spindle through the kinetochore. Kinetochores are assembled on a specialized chromatin domain called the centromere, which is characterized by the replacement of nucleosomal histone H3 with the histone H3 variant centromere protein A(CENP-A). CENP-A is essential for centromere and kinetochore formation in all eukaryotes but it is unknown how CENP-A chromatin directs centromere and kinetochore assembly(1). Here we generate synthetic CENP-A chromatin that recapitulates essential steps of centromere and kinetochore assembly in vitro. We show that reconstituted CENP-A chromatin when added to cell-free extracts is sufficient for the assembly of centromere and kinetochore proteins, microtubule binding and stabilization, and mitotic checkpoint function. Using chromatin assembled from histone H3/CENP-A chimaeras, we demonstrate that the conserved carboxy terminus of CENP-A is necessary and sufficient for centromere and kinetochore protein recruitment and function but that the CENP-A targeting domain-required for new CENP-A histone assembly(2)-is not. These data show that two of the primary requirements for accurate chromosome segregation, the assembly of the kinetochore and the propagation of CENP-A chromatin, are specified by different elements in the CENP-A histone. Our unique cell-free system enables complete control and manipulation of the chromatin substrate and thus presents a powerful tool to study centromere and kinetochore assembly.	[Guse, Annika; Carroll, Christopher W.; Moree, Ben; Fuller, Colin J.; Straight, Aaron F.] Stanford Med Sch, Dept Biochem, Stanford, CA 94305 USA	Stanford University	Straight, AF (corresponding author), Stanford Med Sch, Dept Biochem, Beckman 409A, Stanford, CA 94305 USA.	astraigh@stanford.edu	Guse, Annika/I-1183-2013	Guse, Annika/0000-0002-8737-9206; Straight, Aaron/0000-0001-5885-7881; Moree, Ben/0000-0002-8811-7400	German Research Foundation (DFG); Helen Hay Whitney Foundation; American Heart Association (AHA); Stanford Graduate Fellowship; National Institutes of Health (NIH) [R01GM074728];  [T32GM007276]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007276, R01GM074728] Funding Source: NIH RePORTER	German Research Foundation (DFG)(German Research Foundation (DFG)); Helen Hay Whitney Foundation; American Heart Association (AHA)(American Heart Association); Stanford Graduate Fellowship(Stanford University); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors would like to thank A. F. S. laboratory members for support and comments, J. E. Ferrell, A. Murray, R.-H. Chen, G. Kops and P. T. Stukenberg for providing antibodies. D. Rhodes, P. Robinson, K. Luger, J. Hansen, G. Narlikar and J. Yang for providing reagents and advice. A. G. was supported by a postdoctoral fellowship from the German Research Foundation (DFG). C. W. C. was supported by a postdoctoral fellowship from the Helen Hay Whitney Foundation and the American Heart Association (AHA). B. M. was supported by T32GM007276, C. J. F. was supported by a Stanford Graduate Fellowship and this work was supported by National Institutes of Health (NIH) R01GM074728 to A.F.S.	Black BE, 2004, NATURE, V430, P578, DOI 10.1038/nature02766; Black BE, 2008, CURR OPIN CELL BIOL, V20, P91, DOI 10.1016/j.ceb.2007.11.007; BLOW JJ, 1986, CELL, V47, P577, DOI 10.1016/0092-8674(86)90622-7; Blower MD, 2002, DEV CELL, V2, P319, DOI 10.1016/S1534-5807(02)00135-1; Budde PP, 2001, J CELL BIOL, V153, P149, DOI 10.1083/jcb.153.1.149; Carroll CW, 2010, J CELL BIOL, V189, P1143, DOI 10.1083/jcb.201001013; Carroll CW, 2009, NAT CELL BIOL, V11, P896, DOI 10.1038/ncb1899; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; Desai A, 1999, METHOD CELL BIOL, V61, P385; Dunleavy EM, 2009, CELL, V137, P485, DOI 10.1016/j.cell.2009.02.040; Field CM, 1998, METHOD ENZYMOL, V298, P525, DOI 10.1016/S0076-6879(98)98043-0; Foltz DR, 2009, CELL, V137, P472, DOI 10.1016/j.cell.2009.02.039; Foltz DR, 2006, NAT CELL BIOL, V8, P458, DOI 10.1038/ncb1397; Hannak E, 2006, NAT PROTOC, V1, P2305, DOI 10.1038/nprot.2006.396; Heald R, 1996, NATURE, V382, P420, DOI 10.1038/382420a0; Hori T, 2008, CELL, V135, P1039, DOI 10.1016/j.cell.2008.10.019; Hu H, 2011, GENE DEV, V25, P901, DOI 10.1101/gad.2045111; Huynh VAT, 2005, J MOL BIOL, V345, P957, DOI 10.1016/j.jmb.2004.10.075; Kawashima SA, 2010, SCIENCE, V327, P172, DOI 10.1126/science.1180189; Kelly AE, 2010, SCIENCE, V330, P235, DOI 10.1126/science.1189505; Kim SY, 2005, MOL CELL BIOL, V25, P10580, DOI 10.1128/MCB.25.23.10580-10590.2005; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Luger K, 1999, METHOD ENZYMOL, V304, P3; Luger K, 1997, J MOL BIOL, V272, P301, DOI 10.1006/jmbi.1997.1235; McClelland SE, 2007, EMBO J, V26, P5033, DOI 10.1038/sj.emboj.7601927; Milks KJ, 2009, MOL BIOL CELL, V20, P4246, DOI 10.1091/mbc.E09-05-0378; MINSHULL J, 1994, CELL, V79, P475, DOI 10.1016/0092-8674(94)90256-9; MURRAY AW, 1991, METHOD CELL BIOL, V36, P581; NICKLAS RB, 1995, J CELL BIOL, V130, P929, DOI 10.1083/jcb.130.4.929; Osborne J.W., 2008, BEST PRACT QUANT MET, DOI DOI 10.4135/9781412995627.D18; Ribeiro SA, 2010, P NATL ACAD SCI USA, V107, P10484, DOI 10.1073/pnas.1002325107; RIEDER CL, 1995, J CELL BIOL, V130, P941, DOI 10.1083/jcb.130.4.941; SAWIN KE, 1991, J CELL BIOL, V112, P925, DOI 10.1083/jcb.112.5.925; Sekulic N, 2010, NATURE, V467, P347, DOI 10.1038/nature09323; Tachiwana H, 2011, NATURE, V476, P232, DOI 10.1038/nature10258; Wang FW, 2010, SCIENCE, V330, P231, DOI 10.1126/science.1189435; ZINKOWSKI RP, 1991, J CELL BIOL, V113, P1091, DOI 10.1083/jcb.113.5.1091	37	170	170	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 15	2011	477	7364					354	U136		10.1038/nature10379	http://dx.doi.org/10.1038/nature10379			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819TD	21874020	Green Accepted			2022-12-28	WOS:000294852400036
J	Spiegelhalter, D; Pearson, M; Short, I				Spiegelhalter, David; Pearson, Mike; Short, Ian			Visualizing Uncertainty About the Future	SCIENCE			English	Review							RISK COMMUNICATION; HEALTH-RISK; PROBABILITY; INFORMATION; NUMERACY; FORMATS; COMPREHENSION; PERCEPTION; FORECAST	We are all faced with uncertainty about the future, but we can get the measure of some uncertainties in terms of probabilities. Probabilities are notoriously difficult to communicate effectively to lay audiences, and in this review we examine current practice for communicating uncertainties visually, using examples drawn from sport, weather, climate, health, economics, and politics. Despite the burgeoning interest in infographics, there is limited experimental evidence on how different types of visualizations are processed and understood, although the effectiveness of some graphics clearly depends on the relative numeracy of an audience. Fortunately, it is increasingly easy to present data in the form of interactive visualizations and in multiple types of representation that can be adjusted to user needs and capabilities. Nonetheless, communicating deeper uncertainties resulting from incomplete or disputed knowledge-or from essential indeterminacy about the future-remains a challenge.	[Spiegelhalter, David; Pearson, Mike] Univ Cambridge, Ctr Math Sci, Cambridge CB3 0WB, England; [Short, Ian] Open Univ, Dept Math & Stat, Milton Keynes MK7 6AA, Bucks, England	University of Cambridge; Open University - UK	Spiegelhalter, D (corresponding author), Univ Cambridge, Ctr Math Sci, Cambridge CB3 0WB, England.	d.spiegelhalter@statslab.cam.ac.uk		Short, Ian/0000-0002-7360-4089; Pearson, Mike/0000-0002-8161-2660	Winton Charitable Foundation; MRC [MC_U105260557] Funding Source: UKRI; Medical Research Council [MC_U105260557] Funding Source: researchfish	Winton Charitable Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Supported by an endowment from the Winton Charitable Foundation (D.S., M.P.).	American Council on Science and Health, RISK RISKRINGS; Ancker JS, 2006, J AM MED INFORM ASSN, V13, P608, DOI 10.1197/jamia.M2115; Ancker JS, 2011, MED DECIS MAKING, V31, P130, DOI 10.1177/0272989X10364847; Ancker JS, 2011, MED DECIS MAKING, V31, P143, DOI 10.1177/0272989X10369006; [Anonymous], DEFINITION NHC TRACK; [Anonymous], WHAT IS UKCP09 PROB; [Anonymous], GENETIC TESTING CARR; [Anonymous], KICK FOOTB STATS MAT; [Anonymous], BREAST SCREEN PERF M; Bank of England, 2007, BANK ENGL INFL REP 2; Bostrom A, 2003, RISK ANAL, V23, P241, DOI 10.1111/1539-6924.00304; Bostrom A, 2008, ANN NY ACAD SCI, V1128, P29, DOI 10.1196/annals.1399.005; Broad K., 2010, MISINTERPRETATIONS C; CLEVELAND WS, 1985, SCIENCE, V229, P828, DOI 10.1126/science.229.4716.828; DEFINETTI B, 1974, THEORY PROBABILITY; DENESRAJ V, 1994, J PERS SOC PSYCHOL, V66, P819, DOI 10.1037/0022-3514.66.5.819; Dolan JG, 2008, BMC MED INFORM DECIS, V8, DOI 10.1186/1472-6947-8-14; Fagerlin A, 2007, AM J HEALTH BEHAV, V31, pS47; Fry B., WRITING; Galesic M, 2010, ARCH INTERN MED, V170, P462, DOI 10.1001/archinternmed.2009.481; Galesic M, 2009, HEALTH PSYCHOL, V28, P210, DOI 10.1037/a0014474; Garcia-Retamero R, 2010, MED DECIS MAKING, V30, P672, DOI 10.1177/0272989X10369000; Gigerenzer G., 2007, PSYCHOL SCI PUBL INT, V8, P53, DOI [10.1111/j.1539-6053.2008.00033.x, DOI 10.1111/J.1539-6053.2008.00033.X]; Gigerenzer G. F., 2007, INTELLIGENCE UNCONSC; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Han PKJ, 2011, MED DECIS MAKING, V31, P354, DOI 10.1177/0272989X10371830; IBREKK H, 1987, RISK ANAL, V7, P519, DOI 10.1111/j.1539-6924.1987.tb00488.x; *INT PAN CLIM CHAN, 2007, IPCC 4 ASS REP PHYS; IPCC, 2010, CROSS WORK GROUP M C; Joslyn SL, 2009, METEOROL APPL, V16, P309, DOI 10.1002/met.121; Kahan D, 2010, NATURE, V463, P296, DOI 10.1038/463296a; Kahneman D., 2006, JUDGMENT UNCERTAINTY; Keller C, 2009, RISK ANAL, V29, P1255, DOI 10.1111/j.1539-6924.2009.01261.x; Kurz-Milcke E, 2008, ANN NY ACAD SCI, V1128, P18, DOI 10.1196/annals.1399.004; Leitner M., 2000, CARTOGR GEOGR INF SC, V27, P3, DOI DOI 10.1559/152304000783548037; Lipkus I M, 1999, J Natl Cancer Inst Monogr, P149; Lipkus IM, 2007, MED DECIS MAKING, V27, P696, DOI 10.1177/0272989x07307271; MacEachren A.M., 2005, CARTOGR GEOGR INF SC, V32, P139, DOI DOI 10.1559/1523040054738936; Many Eyes, MANY EYES; McCandless D., 2010, INFORM IS BEAUTIFUL; MCNEIL BJ, 1982, NEW ENGL J MED, V306, P1259, DOI 10.1056/NEJM198205273062103; Met Office, INV WEATH TEXT VIEW; MIT, MIT GLOBAL CHANGE PR; Morgan G. M., 2009, BEST PRACTICE APPROA, V5.2; Morgan M. G., 2001, RISK COMMUNICATION M; Morss RE, 2008, WEATHER FORECAST, V23, P974, DOI 10.1175/2008WAF2007088.1; NASA, NASA REV SHUTTL RISK; Neace WP, 2008, JUDGM DECIS MAK, V3, P140; Nelson D. E., 2009, MAKING DATA TALK COM; Neurath O., WORKS O NEUR M NEUR; Nightingale F, 1858, NOTES MATTERS AFFECT; Peters E, 2007, HEALTH AFFAIR, V26, P741, DOI 10.1377/hlthaff.26.3.741; Politi MC, 2007, MED DECIS MAKING, V27, P681, DOI 10.1177/0272989x07307270; Reyna VF, 2008, LEARN INDIVID DIFFER, V18, P89, DOI 10.1016/j.lindif.2007.03.011; Rogers L, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007583.pub2; Rosling Hans, GAPMINDER UNVEILING; Sanyal J, 2009, IEEE T VIS COMPUT GR, V15, P1209, DOI 10.1109/TVCG.2009.114; Skubisz C., 2009, COMMUNICATION YB, V33, P177; Slovic P, 2005, HEALTH PSYCHOL, V24, pS35, DOI 10.1037/0278-6133.24.4.S35; Smerecnik CMR, 2010, RISK ANAL, V30, P1387, DOI 10.1111/j.1539-6924.2010.01435.x; Sokolov AP, 2009, J CLIMATE, V22, P5175, DOI 10.1175/2009JCLI2863.1; Stirling A, 2010, NATURE, V468, P1029, DOI 10.1038/4681029a; Strecher Victor J., 1999, Journal of the National Cancer Institute Monographs, P134; Tufte ER, 2001, VISUAL DISPLAY QUANT; Visschers VHM, 2009, RISK ANAL, V29, P267, DOI 10.1111/j.1539-6924.2008.01137.x; WALLSTEN TS, 1986, J EXP PSYCHOL GEN, V115, P348, DOI 10.1037/0096-3445.115.4.348; Williams G., 1945, WOMEN WORK; Woloshin S, 2003, BRIT MED J, V327, P695, DOI 10.1136/bmj.327.7417.695; Zikmund-Fisher BJ, 2008, CANCER-AM CANCER SOC, V113, P3382, DOI 10.1002/cncr.23959	69	370	373	4	216	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 9	2011	333	6048					1393	1400		10.1126/science.1191181	http://dx.doi.org/10.1126/science.1191181			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	817KU	21903802				2022-12-28	WOS:000294672200029
J	De Matteis, MA; Luini, A				De Matteis, Maria Antonietta; Luini, Alberto			MECHANISMS OF DISEASE Mendelian Disorders of Membrane Trafficking	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							ENDOPLASMIC-RETICULUM; SECRETORY PATHWAY; PROTEIN SECRETION; CYSTIC-FIBROSIS; GOLGI; TRANSPORT; FUSION; ENDOSOMES; LYSOSOMES; MUTATIONS		[De Matteis, Maria Antonietta; Luini, Alberto] Telethon Inst Genet & Med, I-80131 Naples, Italy; [Luini, Alberto] CNR, Inst Prot Biochem, I-80125 Naples, Italy; [De Matteis, Maria Antonietta] Ist Ric Farmacol Mario Negri, Consorzio Mario Negri Sud, I-66030 Santa Maria Imbaro, Italy	Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); Consiglio Nazionale delle Ricerche (CNR); Istituto di Biochimica delle Proteine (IBP-CNR); Consorzio Mario Negri Sud; Istituto di Ricerche Farmacologiche Mario Negri IRCCS	De Matteis, MA (corresponding author), Telethon Inst Genet & Med, Via Pietro Castellino 111, I-80131 Naples, Italy.	dematteis@tigem.it	De Matteis, Maria Antonietta/AHE-5161-2022	De Matteis, Maria Antonietta/0000-0003-0053-3061	Telethon [TGM11CB5, TGM11CB1, TGM06F02] Funding Source: Medline	Telethon(Fondazione Telethon)		Allan VJ, 1999, CURR OPIN CELL BIOL, V11, P476, DOI 10.1016/S0955-0674(99)80068-4; Bethune J, 2006, J MEMBRANE BIOL, V211, P65, DOI 10.1007/s00232-006-0859-7; Blackstone C, 2011, NAT REV NEUROSCI, V12, P31, DOI 10.1038/nrn2946; Bonfanti L, 1998, CELL, V95, P993, DOI 10.1016/S0092-8674(00)81723-7; Boyadjiev SA, 2006, NAT GENET, V38, P1192, DOI 10.1038/ng1876; Braulke T, 2009, BBA-MOL CELL RES, V1793, P605, DOI 10.1016/j.bbamcr.2008.10.016; Brinkman RR, 2006, NAT REV GENET, V7, P249, DOI 10.1038/nrg1828; Christensen EI, 2009, PFLUG ARCH EUR J PHY, V458, P1039, DOI 10.1007/s00424-009-0685-8; De Matteis MA, 2008, NAT REV MOL CELL BIO, V9, P273, DOI 10.1038/nrm2378; Desjardins M, 2003, CURR OPIN CELL BIOL, V15, P498, DOI 10.1016/S0955-0674(03)00083-8; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Dowling JJ, 2008, TRAFFIC, V9, P1035, DOI 10.1111/j.1600-0854.2008.00716.x; Duclos S, 2000, J CELL SCI, V113, P3531; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Fishman MC, 2005, NATURE, V437, P491, DOI 10.1038/437491a; Gedeon AK, 1999, NAT GENET, V22, P400, DOI 10.1038/11976; Gilchrist A, 2006, CELL, V127, P1265, DOI 10.1016/j.cell.2006.10.036; Glick BS, 2009, ANNU REV CELL DEV BI, V25, P113, DOI 10.1146/annurev.cellbio.24.110707.175421; Hanson PI, 2009, CURR OPIN CELL BIOL, V21, P568, DOI 10.1016/j.ceb.2009.06.002; Hichri H, 2011, HUM MUTAT, V32, P379, DOI 10.1002/humu.21391; HICKMAN S, 1972, BIOCHEM BIOPH RES CO, V49, P992, DOI 10.1016/0006-291X(72)90310-5; Hirokawa N, 2009, NAT REV MOL CELL BIO, V10, P682, DOI 10.1038/nrm2774; Jones AM, 2009, DRUGS, V69, P1903, DOI 10.2165/11318500-000000000-00000; Jones B, 2003, NAT GENET, V34, P29, DOI 10.1038/ng1145; KORNFELD S, 1986, J CLIN INVEST, V77, P1, DOI 10.1172/JCI112262; Lenz M, 2009, FEBS LETT, V583, P3839, DOI 10.1016/j.febslet.2009.11.012; Lin WS, 2009, NAT NEUROSCI, V12, P379, DOI 10.1038/nn.2273; Loubery S, 2008, CELL MOL LIFE SCI, V65, P2790, DOI 10.1007/s00018-008-8350-5; Lupashin V, 2005, BBA-MOL CELL RES, V1744, P325, DOI 10.1016/j.bbamcr.2005.03.013; Luzio JP, 2007, NAT REV MOL CELL BIO, V8, P622, DOI 10.1038/nrm2217; Mellman I, 2000, CELL, V100, P99, DOI 10.1016/S0092-8674(00)81687-6; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Nichols WC, 1998, CELL, V93, P61, DOI 10.1016/S0092-8674(00)81146-0; Nickel W, 2009, NAT REV MOL CELL BIO, V10, P148, DOI 10.1038/nrm2617; Orso G, 2010, NATURE, V464, P942, DOI 10.1038/nature08886; Park SH, 2010, J CLIN INVEST, V120, P1097, DOI 10.1172/JCI40979; Picollo A, 2005, NATURE, V436, P420, DOI 10.1038/nature03720; Pryor PR, 2009, BBA-MOL CELL RES, V1793, P615, DOI 10.1016/j.bbamcr.2008.12.022; Pulvirenti T, 2008, NAT CELL BIOL, V10, P912, DOI 10.1038/ncb1751; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; Rizzoli SO, 2007, TRAFFIC, V8, P1137, DOI 10.1111/j.1600-0854.2007.00614.x; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rothman JE, 2002, NAT MED, V8, P1059, DOI 10.1038/nm770; Rowe SM, 2005, NEW ENGL J MED, V352, P1992, DOI 10.1056/NEJMra043184; Russell MRG, 2006, CURR OPIN CELL BIOL, V18, P422, DOI 10.1016/j.ceb.2006.06.002; Salinas S, 2008, LANCET NEUROL, V7, P1127, DOI 10.1016/S1474-4422(08)70258-8; Schekman R, 2002, NAT MED, V8, P1055, DOI 10.1038/nm769; Shibata Y, 2009, ANNU REV CELL DEV BI, V25, P329, DOI 10.1146/annurev.cellbio.042308.113324; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Trucco A, 2004, NAT CELL BIOL, V6, P1071, DOI 10.1038/ncb1180; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Vicinanza M, 2008, EMBO J, V27, P2457, DOI 10.1038/emboj.2008.169; Watson P, 2005, BBA-MOL CELL RES, V1744, P304, DOI 10.1016/j.bbamcr.2005.03.003; Winter EE, 2004, GENOME RES, V14, P54, DOI 10.1101/gr.1924004	54	72	73	0	19	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 8	2011	365	10					927	938		10.1056/NEJMra0910494	http://dx.doi.org/10.1056/NEJMra0910494			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	816JX	21899453				2022-12-28	WOS:000294595600009
J	Zhu, Q; Pao, GM; Huynh, AM; Suh, H; Tonnu, N; Nederlof, PM; Gage, FH; Verma, IM				Zhu, Quan; Pao, Gerald M.; Huynh, Alexis M.; Suh, Hoonkyo; Tonnu, Nina; Nederlof, Petra M.; Gage, Fred H.; Verma, Inder M.			BRCA1 tumour suppression occurs via heterochromatin-mediated silencing	NATURE			English	Article							NEURAL STEM-CELLS; LIGASE ACTIVITY; PROTEIN; BREAST; UBIQUITINATION; MAINTENANCE; MUTATIONS; CANCERS; REPAIR; BINDS	Mutations in the tumour suppressor gene BRCA1 lead to breast and/or ovarian cancer. Here we show that loss of Brca1 in mice results in transcriptional de-repression of the tandemly repeated satellite DNA. Brca1 deficiency is accompanied by a reduction of condensed DNA regions in the genome and loss of ubiquitylation of histone H2A at satellite repeats. BRCA1 binds to satellite DNA regions and ubiquitylates H2A in vivo. Ectopic expression of H2A fused to ubiquitin reverses the effects of BRCA1 loss, indicating that BRCA1 maintains heterochromatin structure via ubiquitylation of histone H2A. Satellite DNA de-repression was also observed in mouse and human BRCA1-deficient breast cancers. Ectopic expression of satellite DNA can phenocopy BRCA1 loss in centrosome amplification, cell-cycle checkpoint defects, DNA damage and genomic instability. We propose that the role of BRCA1 in maintaining global heterochromatin integrity accounts for many of its tumour suppressor functions.	[Zhu, Quan; Pao, Gerald M.; Huynh, Alexis M.; Suh, Hoonkyo; Tonnu, Nina; Gage, Fred H.; Verma, Inder M.] Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA; [Nederlof, Petra M.] Netherlands Canc Inst, Dept Pathol, NL-1066 CX Amsterdam, Netherlands	Salk Institute; Netherlands Cancer Institute	Pao, GM (corresponding author), Salk Inst Biol Studies, Genet Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	pao@salk.edu; verma@salk.edu	高, 雨莉/HGU-8187-2022	Zhu, Quan/0000-0001-5731-4658; Suh, Hoonkyo/0000-0002-4227-2982	California Breast Cancer Research Program; Ruth L. Kirschtein National Research Service Award; California Institute of Regenerative Medicine; ASPET-Merck fellowship; NIH [NS52842, NS50217]; Ipsen/Biomeasure; Sanofi Aventis; H.N. and Frances C. Berger Foundation; Lookout Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052842, R01NS050217] Funding Source: NIH RePORTER	California Breast Cancer Research Program; Ruth L. Kirschtein National Research Service Award; California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); ASPET-Merck fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ipsen/Biomeasure; Sanofi Aventis(Sanofi-Aventis); H.N. and Frances C. Berger Foundation; Lookout Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank B. Miller for assistance in culturing NPCs; E. Ke for discussion and analysis of Affymetrix data; A. Yanai for the BRCA1 targeting shRNA construct; C. Lilley for assistance with western blotting; and Z. You for assistance with the LI-COR Odyssey Infrared Imaging System. We thank A. Berns for his sustained interest in this work and providing mutant mice and materials, and M. Vidal for providing mouse embryo fibroblasts containing a conditional deletion allele of Ring1B. Q. Z. was supported by the California Breast Cancer Research Program and Ruth L. Kirschtein National Research Service Award. G. M. P. was supported by a fellowship of the California Institute of Regenerative Medicine. H. S. is a recipient of ASPET-Merck fellowship. I. M. V. is an American Cancer Society Professor of Molecular Biology, and holds the Irwin and Joan Jacobs Chair in Exemplary Life Science. This work was supported in part by grants from the NIH, Ipsen/Biomeasure, Sanofi Aventis, and the H.N. and Frances C. Berger Foundation. F. H. G. is supported by NIH NS52842, NS50217 and the Lookout Fund.	Doil C, 2009, CELL, V136, P435, DOI 10.1016/j.cell.2008.12.041; Hashizume R, 2001, J BIOL CHEM, V276, P14537, DOI 10.1074/jbc.C000881200; Huang JQ, 2004, NUCLEIC ACIDS RES, V32, P5019, DOI 10.1093/nar/gkh821; Huen MSY, 2010, NAT REV MOL CELL BIO, V11, P138, DOI 10.1038/nrm2831; Jensen DE, 1998, ONCOGENE, V16, P1097, DOI 10.1038/sj.onc.1201861; Kallin EM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000506; King MC, 2003, SCIENCE, V302, P643, DOI 10.1126/science.1088759; Korhonen L, 2003, J NEUROSCI RES, V71, P769, DOI 10.1002/jnr.10546; LANE TF, 1995, GENE DEV, V9, P2712, DOI 10.1101/gad.9.21.2712; Lie DC, 2005, NATURE, V437, P1370, DOI 10.1038/nature04108; Maison C, 2004, NAT REV MOL CELL BIO, V5, P296, DOI 10.1038/nrm1355; Martens JHA, 2005, EMBO J, V24, P800, DOI 10.1038/sj.emboj.7600545; MATSUI SI, 1979, P NATL ACAD SCI USA, V76, P6386, DOI 10.1073/pnas.76.12.6386; Meneghini MD, 2003, CELL, V112, P725, DOI 10.1016/S0092-8674(03)00123-5; Nakashima K, 1999, SCIENCE, V284, P479, DOI 10.1126/science.284.5413.479; Pageau GJ, 2007, NAT REV CANCER, V7, P628, DOI 10.1038/nrc2172; Palmer TD, 1999, J NEUROSCI, V19, P8487; Reid LJ, 2008, P NATL ACAD SCI USA, V105, P20876, DOI 10.1073/pnas.0811203106; Ruffner H, 2001, P NATL ACAD SCI USA, V98, P5134, DOI 10.1073/pnas.081068398; Sankaran S, 2005, MOL CELL BIOL, V25, P8656, DOI 10.1128/MCB.25.19.8656-8668.2005; Scheuermann JC, 2010, NATURE, V465, P243, DOI 10.1038/nature08966; Stewart GS, 2009, CELL, V136, P420, DOI 10.1016/j.cell.2008.12.042; Ting DT, 2011, SCIENCE, V331, P593, DOI 10.1126/science.1200801; Tutt A, 2002, TRENDS MOL MED, V8, P571, DOI 10.1016/S1471-4914(02)02434-6; van Es JH, 2005, NAT CELL BIOL, V7, P381, DOI 10.1038/ncb1240; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Xia Y, 2003, J BIOL CHEM, V278, P5255, DOI 10.1074/jbc.M204591200; Xu XL, 2001, NAT GENET, V28, P266, DOI 10.1038/90108; Zhou W, 2008, MOL CELL, V29, P69, DOI 10.1016/j.molcel.2007.11.002	29	324	333	0	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 8	2011	477	7363					179	U76		10.1038/nature10371	http://dx.doi.org/10.1038/nature10371			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	816MC	21901007	Green Accepted			2022-12-28	WOS:000294603900028
J	Hicks, MHR; Dardagan, H; Bagnall, PM; Spagat, M; Sloboda, JA				Hicks, Madelyn Hsiao-Rei; Dardagan, Hamit; Bagnall, Peter M.; Spagat, Michael; Sloboda, John A.			Casualties in civilians and coalition soldiers from suicide bombings in Iraq, 2003-10: a descriptive study	LANCET			English	Article							MORTALITY; CHILDREN; WEAPONS; DEATH	Background Suicide bombs in Iraq are a major public health problem. We aimed to describe documented casualties from suicide bombs in Iraq during 2003-10 in Iraqi civilians and coalition soldiers. Methods In this descriptive study, we analysed and compared suicide bomb casualties in Iraq that were documented in two datasets covering March 20, 2003, to Dec 31, 2010 one reporting coalition-soldier deaths from suicide bombs, the other reporting deaths and injuries of Iraqi civilians from armed violence. We analysed deaths and injuries over time, by bomb subtype and victim demographics. Findings In 2003-10, 1003 documented suicide bomb events caused 19% (42 928 of 225 789) of all Iraqi civilian casualties in our dataset, 26% (30 644 of 117 165) of injured civilians, and 11% (12 284 of 108 624) of civilian deaths. The injured-to-killed ratio for civilians was 2.5 people injured to one person killed from suicide bombs. Suicide bombers on foot caused 43% (5314 of 12 284) of documented suicide bomb deaths. Suicide bombers who used cars caused 40% (12 224 of 30 644) of civilian injuries. Of 3963 demographically identifiable suicide bomb fatalities, 2981 (75%) were men, 428 (11%) were women, and 554 (14%) were children. Children made up a higher proportion of demographically identifiable deaths from suicide bombings than from general armed violence (9%, 3669 of 40 276 deaths; p<0.0001). The injured-to-killed ratio for all suicide bombings was slightly higher for women than it was for men (p=0.02), but the ratio for children was lower than it was for both women (p<0.0001) and men (p=0.0002). 200 coalition soldiers were killed in 79 suicide bomb events during 2003-10. More Iraqi civilians per lethal event were killed than were coalition soldiers (12 vs 3; p=0.004). Interpretation Suicide bombers in Iraq kill significantly more Iraqi civilians than coalition soldiers. Among civilians, children are more likely to die than adults when injured by suicide bombs.	[Hicks, Madelyn Hsiao-Rei] Kings Coll London, Inst Psychiat, Hlth Serv & Populat Res Dept, London SE5 8AF, England; [Hicks, Madelyn Hsiao-Rei; Dardagan, Hamit; Bagnall, Peter M.; Sloboda, John A.] Iraq Body Count, London, England; [Spagat, Michael; Sloboda, John A.] Univ London, Dept Econ, London, England	University of London; King's College London; University of London	Hicks, MHR (corresponding author), Kings Coll London, Inst Psychiat, Hlth Serv & Populat Res Dept, Crespigny Pk,Denmark Hill, London SE5 8AF, England.	mjhhicks@aol.com	Zonies, David/B-6497-2011	Bagnall, Peter/0000-0002-0361-509X				Aharonson-Daniel L, 2006, ANN SURG, V244, P1018, DOI 10.1097/01.sla.0000225355.06362.0f; Al Sheibani BIM, 2006, BMJ-BRIT MED J, V333, P847, DOI 10.1136/bmj.38986.476782.68; Alkhuzai AH, 2008, NEW ENGL J MED, V358, P484, DOI 10.1056/NEJMsa0707782; BELLAMY RF, 1991, CONVENTIONAL WARFARE, P53; COHEN N, 2010, NY TIMES NEW YO 1121; Coppola CP, 2006, ARCH PEDIAT ADOL MED, V160, P972, DOI 10.1001/archpedi.160.9.972; Count Iraq Body, DOC CIV DEATHS VIOL; Coupland RM, 1999, BRIT MED J, V319, P407, DOI 10.1136/bmj.319.7207.407; DARDAGAN H, IRAQ BODY COUNT DOSS; DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083; GAMBETTA D, 2006, MAKING SENSE SUICIDE, P301; *GLOBALSECURITY, VEH BORN IEDS VBIEDS; Goldberg MS, 2010, MIL MED, V175, P220, DOI 10.7205/MILMED-D-09-00130; *GOV IR, 2005, IR LIV COND SURV 200, V2; *GOV IR, 2005, IR LIV COND SURV 200, V1; Guerrero Serdan G., 2009, 55 HICN, V55; Hafez MM, 2007, SUICIDE BOMBERS IN IRAQ: THE STRATEGY AND IDEOOLOGY OF MARTYRDOM, P1; Hashim AS., 2006, INSURGENCY COUNTER I; Hicks MHR, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000415; Hicks MHR, 2009, NEW ENGL J MED, V360, P1585, DOI 10.1056/NEJMp0807240; *IR COAL CAS COUNT, IR COAL MIL CAS YEAR; Matos RI, 2008, PEDIATRICS, V122, pE959, DOI 10.1542/peds.2008-1244; MURRAY CJL, 2002, BRIT MED J, V324, P246; Nessen S. C., 2008, WAR SURG AFGHANISTAN; Pape Robert., 2005, DYING WIN STRATEGIC; Shapira SC, 2006, WORLD J SURG, V30, P2071, DOI 10.1007/s00268-006-0048-y; Spinella PC, 2008, CRIT CARE MED, V36, pS293, DOI 10.1097/CCM.0b013e31817da99f; Taback Nathan, 2005, Med Confl Surviv, V21, P19, DOI 10.1080/1362369042000315032; *UN ASS MISS IR, 2010, UNAMI HUM RIGHTS REP; United Nations Office of the High Commissioner for Human Rights, 1989, CONV RIGHTS CHILD; Webster P, 2009, LANCET, V373, P617, DOI 10.1016/S0140-6736(09)60382-2; World Health Organization, 2002, WORLD REPORT VIOLENC; SUICIDE BOMBINGS IRA; HONOR FALLEN	34	42	43	2	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 3	2011	378	9794					906	914		10.1016/S0140-6736(11)61023-4	http://dx.doi.org/10.1016/S0140-6736(11)61023-4			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	818XZ	21890055				2022-12-28	WOS:000294791300031
J	Khan, AS				Khan, Ali S.			Public health preparedness and response in the USA since 9/11: a national health security imperative	LANCET			English	Editorial Material									Ctr Dis Control & Prevent, Off Publ Hlth Preparedness & Response, US Dept HHS, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Khan, AS (corresponding author), Ctr Dis Control & Prevent, Off Publ Hlth Preparedness & Response, US Dept HHS, 1600 Clifton Rd, Atlanta, GA 30333 USA.	askhan@cdc.gov						Alibek K, 1999, BIOHAZARD CHILLING T; CDC, 2011, PUBL HLTH PREP 2011; *CDC, 2009, PUBL HLTH PREP STREN; Center for Biosecurity of UPMC, 2009, HOSP RIS CHALL 1 5 Y; Centers for Disease Control and Prevention, 2011, PUBL HLTH PREP CAP N; Council of State and Territorial Epidemiologists, 2009, 2009 NAT ASS EP CAP; Fisher D, 2011, RESPIROLOGY, V16, P876, DOI 10.1111/j.1440-1843.2011.02003.x; IHR, 2005, INT HLTH REG 2005, V2; Khan AS, 2001, NEW ENGL J MED, V345, P287, DOI 10.1056/NEJM200107263450411; Kohn S, 2010, J PUBLIC HEALTH POL, V31, P256, DOI 10.1057/jphp.2010.17; Koppaka Ram, 2011, Morbidity and Mortality Weekly Report, V60, P619; Lederberg J., 1992, I MED US COMMITTEE; National Commission on Terrorist Attacks upon the United States, 2004, 9 11 COMM REP; Nelson C, 2010, DISASTER MED PUBLIC, V4, P285, DOI 10.1001/dmp.2010.39; Nicoll A, 2010, BUNDESGESUNDHEITSBLA, V53, P1267, DOI 10.1007/s00103-010-1163-3; Rani S, 2022, SPAT INF RES, V30, P417, DOI 10.1007/s41324-022-00442-9; *TRUST AM HLTH RW, 2010, READ NOT PROT PUBL H; *WHIT HOUS, 2009, 13527 WHIT HOUS; WHO Implementation of the International Health Regulations, 2011, IMPL INT HLTH REG 20; 2010, US FED REG      0702	20	36	38	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 3	2011	378	9794					953	956		10.1016/S0140-6736(11)61263-4	http://dx.doi.org/10.1016/S0140-6736(11)61263-4			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	818XZ	21890060	Green Published			2022-12-28	WOS:000294791300036
J	Godfray, HCJ				Godfray, H. Charles J.			Food and Biodiversity	SCIENCE			English	Editorial Material							LAND		[Godfray, H. Charles J.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Godfray, H. Charles J.] Univ Oxford, Oxford Martin Sch, Inst Biodivers, Oxford OX1 3PS, England	University of Oxford; University of Oxford	Godfray, HCJ (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.	charles.godfray@zoo.ox.ac.uk						Bateman IJ, 2011, ENVIRON RESOUR ECON, V48, P177, DOI 10.1007/s10640-010-9418-x; Ewers RM, 2009, GLOBAL CHANGE BIOL, V15, P1716, DOI 10.1111/j.1365-2486.2009.01849.x; Fischer J, 2008, FRONT ECOL ENVIRON, V6, P382, DOI 10.1890/070019; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Green RE, 2005, SCIENCE, V307, P550, DOI 10.1126/science.1106049; Hanski I., 1999, METAPOPULATION ECOLO; Lutz W, 2010, PHILOS T R SOC B, V365, P2779, DOI 10.1098/rstb.2010.0133; Medail F, 1999, CONSERV BIOL, V13, P1510, DOI 10.1046/j.1523-1739.1999.98467.x; Phalan B, 2011, SCIENCE, V333, P1289, DOI 10.1126/science.1208742; Stern N. H., 2006, STERN REV EC CLIMATE; Strzepek K, 2010, PHILOS T R SOC B, V365, P2927, DOI 10.1098/rstb.2010.0152	11	53	55	2	93	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 2	2011	333	6047					1231	1232		10.1126/science.1211815	http://dx.doi.org/10.1126/science.1211815			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	813YM	21885765				2022-12-28	WOS:000294406400033
J	Phalan, B; Onial, M; Balmford, A; Green, RE				Phalan, Ben; Onial, Malvika; Balmford, Andrew; Green, Rhys E.			Reconciling Food Production and Biodiversity Conservation: Land Sharing and Land Sparing Compared	SCIENCE			English	Article							AGRICULTURAL INTENSIFICATION; AGROFORESTRY; IMPACT; YIELD	The question of how to meet rising food demand at the least cost to biodiversity requires the evaluation of two contrasting alternatives: land sharing, which integrates both objectives on the same land; and land sparing, in which high-yield farming is combined with protecting natural habitats from conversion to agriculture. To test these alternatives, we compared crop yields and densities of bird and tree species across gradients of agricultural intensity in southwest Ghana and northern India. More species were negatively affected by agriculture than benefited from it, particularly among species with small global ranges. For both taxa in both countries, land sparing is a more promising strategy for minimizing negative impacts of food production, at both current and anticipated future levels of production.	[Phalan, Ben; Onial, Malvika; Balmford, Andrew; Green, Rhys E.] Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England; [Green, Rhys E.] Royal Soc Protect Birds, Sandy SG19 2DL, Beds, England	University of Cambridge; Royal Society for Protection of Birds	Phalan, B (corresponding author), Univ Cambridge, Dept Zool, Downing St, Cambridge CB2 3EJ, England.		Phalan, Ben/A-5783-2009	Phalan, Ben/0000-0001-7876-7226; Balmford, Andrew/0000-0002-0144-3589	Robert Gardiner Memorial Trust; St. John's College; Royal Society for the Protection of Birds; Isaac Newton Trust; United Nations Environment Programme-World Conservation Monitoring Centre; Domestic Research Studentship; British Ornithologists' Union; Smuts Memorial Fund; Cambridge Philosophical Society; Churchill College; Dorothy Hodgkin Scholarship; UK Natural Environment Research Council; Tim Whitmore Fund; S. T. Lee Fund	Robert Gardiner Memorial Trust; St. John's College; Royal Society for the Protection of Birds; Isaac Newton Trust; United Nations Environment Programme-World Conservation Monitoring Centre; Domestic Research Studentship; British Ornithologists' Union; Smuts Memorial Fund; Cambridge Philosophical Society; Churchill College; Dorothy Hodgkin Scholarship; UK Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Tim Whitmore Fund; S. T. Lee Fund	We thank the farmers, plantation managers, forest officials, local guides/assistants, and others who made fieldwork in Ghana (B. P.) and India (M.O.) possible. In Ghana, we particularly thank P. Ekpe, K. Dua, the Ghana Wildlife Society, the Forestry Commission, and the Ministry of Food and Agriculture. In India, we particularly thank the Uttarakhand Forest Department, G. B. Pant University, and the Wildlife Institute of India. For assistance with data, we are grateful to S. Jayson. B. P. received funding from the Robert Gardiner Memorial Trust, St. John's College, the Royal Society for the Protection of Birds, the Isaac Newton Trust, the United Nations Environment Programme-World Conservation Monitoring Centre, a Domestic Research Studentship, the British Ornithologists' Union, the Smuts Memorial Fund, and the Cambridge Philosophical Society, and was supported by a Sackler research fellowship at Churchill College. M.O. received funding from a Dorothy Hodgkin Scholarship, the UK Natural Environment Research Council, the Tim Whitmore Fund, and the S. T. Lee Fund. Data on species, model coefficients, and sample sizes are provided in the supporting online material.	Agrawal A, 2008, SCIENCE, V320, P1460, DOI 10.1126/science.1155369; Angelsen A, 2010, P NATL ACAD SCI USA, V107, P19639, DOI 10.1073/pnas.0912014107; Balmford A, 2005, GLOBAL CHANGE BIOL, V11, P1594, DOI 10.1111/j.1365-2486.2005.001035.x; Bhagwat SA, 2008, TRENDS ECOL EVOL, V23, P261, DOI 10.1016/j.tree.2008.01.005; Blay ET., 2004, MANAGING AGRODIVERSI, P203; Burney JA, 2010, P NATL ACAD SCI USA, V107, P12052, DOI 10.1073/pnas.0914216107; DeFries R, 2010, P NATL ACAD SCI USA, V107, P19627, DOI 10.1073/pnas.1011163107; Edwards DP, 2010, CONSERV LETT, V3, P236, DOI 10.1111/j.1755-263X.2010.00107.x; Eliasch J., 2008, CLIMATE CHANGE FINAN; Ewers RM, 2009, GLOBAL CHANGE BIOL, V15, P1716, DOI 10.1111/j.1365-2486.2009.01849.x; Fischer J, 2008, FRONT ECOL ENVIRON, V6, P382, DOI 10.1890/070019; Gabriel D, 2009, J APPL ECOL, V46, P323, DOI 10.1111/j.1365-2664.2009.01624.x; Gockowski J, 2011, ENVIRON MANAGE, V48, P307, DOI 10.1007/s00267-010-9602-3; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Green RE, 2005, SCIENCE, V307, P550, DOI 10.1126/science.1106049; Gullison RE, 2000, NATURE, V404, P923, DOI 10.1038/35010151; Harris G, 2008, CONSERV BIOL, V22, P163, DOI 10.1111/j.1523-1739.2007.00798.x; Hole DG, 2005, BIOL CONSERV, V122, P113, DOI 10.1016/j.biocon.2004.07.018; Kleijn D, 2006, ECOL LETT, V9, P243, DOI 10.1111/j.1461-0248.2005.00869.x; Lambin EF, 2011, P NATL ACAD SCI USA, V108, P3465, DOI 10.1073/pnas.1100480108; Mas AH, 2004, ECOL APPL, V14, P642, DOI 10.1890/02-5225; Matson PA, 2006, CONSERV BIOL, V20, P709, DOI 10.1111/j.1523-1739.2006.00442.x; McIntyre B.D., 2009, AGR CROSSROADS INT A; O'Brien KL, 2003, ANN ASSOC AM GEOGR, V93, P89, DOI 10.1111/1467-8306.93107; Olschewski R, 2010, ECOL COMPLEX, V7, P314, DOI 10.1016/j.ecocom.2010.01.002; Perfecto I, 2008, ANN NY ACAD SCI, V1134, P173, DOI 10.1196/annals.1439.011; Phalan B, 2011, FOOD POLICY, V36, pS62, DOI 10.1016/j.foodpol.2010.11.008; Rudel TK, 2009, P NATL ACAD SCI USA, V106, P20675, DOI 10.1073/pnas.0812540106; Sundar KSG, 2009, CONDOR, V111, P611, DOI 10.1525/cond.2009.080032; Tilman D, 2001, SCIENCE, V292, P281, DOI 10.1126/science.1057544; Trewavas AJ, 2001, PLANT PHYSIOL, V125, P174, DOI 10.1104/pp.125.1.174; Tscharntke T, 2011, J APPL ECOL, V48, P619, DOI 10.1111/j.1365-2664.2010.01939.x; Waltert M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016238	33	1017	1042	21	1203	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 2	2011	333	6047					1289	1291		10.1126/science.1208742	http://dx.doi.org/10.1126/science.1208742			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	813YM	21885781				2022-12-28	WOS:000294406400054
J	Moynihan, R				Moynihan, Ray			REALITY CHECK Is your mum on drugs?	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Newcastle, Callaghan, NSW 2308, Australia	University of Newcastle	Moynihan, R (corresponding author), Univ Newcastle, Callaghan, NSW 2308, Australia.	Ray.Moynihan@newcastle.edu.au	Moynihan, Ray/ABC-3010-2020					Garfinkel D, 2010, ARCH INTERN MED, V170, P1648, DOI 10.1001/archinternmed.2010.355; Mangin D, 2007, BMJ-BRIT MED J, V335, P285, DOI 10.1136/bmj.39241.630741.BE1; TRIMBLE J, IS YOUR MOM DRUGS FI; TRIMBLE J, IS YOUR MOM DRUGS OU	4	5	5	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 24	2011	343								d5184	10.1136/bmj.d5184	http://dx.doi.org/10.1136/bmj.d5184			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	813ZN	21865271				2022-12-28	WOS:000294409900001
J	Quinn, TJ; McArthur, K; Ellis, G; Stott, DJ				Quinn, T. J.; McArthur, K.; Ellis, G.; Stott, D. J.			Functional assessment in older people	BMJ-BRITISH MEDICAL JOURNAL			English	Review							ELDERLY-PATIENTS; ADULTS		[Quinn, T. J.; McArthur, K.; Stott, D. J.] Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland; [Ellis, G.] Monklands Hosp, Dept Med Elderly, Airdrie, Scotland	University of Glasgow; Monklands Hospital	Quinn, TJ (corresponding author), Glasgow Royal Infirm, Dept Acad Geriatr Med, Glasgow G4 0SF, Lanark, Scotland.	terry.quinn@glasgow.ac.uk	Quinn, Terence Joseph/H-7000-2019	Quinn, Terence Joseph/0000-0003-1401-0181				Bachmann S, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1718; Beswick AD, 2008, LANCET, V371, P725, DOI 10.1016/S0140-6736(08)60342-6; British Society of Rehabilitation Medicine, 2000, BASK MEAS; Collin C, 1988, Int Disabil Stud, V10, P61; Cooper R, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4467; Downing A, 2005, AGE AGEING, V34, P24, DOI 10.1093/ageing/afh214; Ellis G, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006211.pub2; Evans JR, 2002, BRIT J OPHTHALMOL, V86, P795, DOI 10.1136/bjo.86.7.795; Fletcher AE, 2004, LANCET, V364, P1667, DOI 10.1016/S0140-6736(04)17353-4; Ganz DA, 2007, JAMA-J AM MED ASSOC, V297, P77, DOI 10.1001/jama.297.1.77; Gravelle H, 2007, BMJ-BRIT MED J, V334, P31, DOI 10.1136/bmj.39020.413310.55; HOGAN DB, 2003, AGING CLIN EXP RE S3, V15, P3, DOI DOI 10.1016/B978-012369391-4/50051-5; LAWTON MP, 1968, GERONTOLOGIST, V8, P108, DOI 10.1093/geront/8.2.108; MAHONEY F I, 1965, Md State Med J, V14, P61; MATHIAS S, 1986, ARCH PHYS MED REHAB, V67, P387; MOSKOWITZ E, 1985, ARCH PHYS MED REHAB, V66, P647; Nouri F., 1987, CLIN REHABIL, V1, P301, DOI [DOI 10.1177/026921558700100409, 10.1177/026921558700100409]; Pearson V., 2000, ASSESSING OLDER PERS, P17; Pirozzo S, 2003, BRIT MED J, V327, P967, DOI 10.1136/bmj.327.7421.967; Quinn TJ, 2009, INT J STROKE, V4, P200, DOI 10.1111/j.1747-4949.2009.00271.x; Quinn TJ, 2011, STROKE, V42, P1146, DOI 10.1161/STROKEAHA.110.598540; Schumacher JG, 2005, AM J EMERG MED, V23, P556, DOI 10.1016/j.ajem.2004.12.011; Sinoff G, 1997, J AM GERIATR SOC, V45, P832, DOI 10.1111/j.1532-5415.1997.tb01510.x; Stott DJ, 2008, LANCET, V371, P699, DOI 10.1016/S0140-6736(08)60317-7; Wade DT., 1992, MEASUREMENT NEUROLOG; Williams EI, 1993, 59 ROYAL COLL GEN PR; World Health Organization, INT CLASS FUNCT DIS	27	43	44	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 22	2011	343								d4681	10.1136/bmj.d4681	http://dx.doi.org/10.1136/bmj.d4681			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	813ZH	21859792	Green Accepted			2022-12-28	WOS:000294408900001
J	Dickinson, DK				Dickinson, David K.			Teachers' Language Practices and Academic Outcomes of Preschool Children	SCIENCE			English	Review							VOCABULARY KNOWLEDGE; SCHOOL READINESS; CHILDHOOD; SPEED; CARE; INTERVENTION; CLASSROOMS; ABILITIES; INFANCY; GROWTH	Early childhood programs have long been known to be beneficial to children from low-income backgrounds, but recent studies have cast doubt on their ability to substantially increase the rate of children's academic achievement. This Review examines research on the role of language in later reading, describes home and classroom factors that foster early language growth, and reviews research on preschool interventions. It argues that one reason interventions are not having as great an impact as desired is because they fail to substantially change the capacity of teachers to support children's language and associated conceptual knowledge.	Vanderbilt Univ, Peabody Coll, Dept Teaching & Learning, Nashville, TN 37203 USA	Vanderbilt University; Vanderbilt University Peabody College	Dickinson, DK (corresponding author), Vanderbilt Univ, Peabody Coll, Dept Teaching & Learning, Nashville, TN 37203 USA.	david.dickinson@vanderbilt.edu						Appelbaum M, 2000, CHILD DEV, V71, P960; Belsky J, 2005, DEV PSYCHOL, V41, P428, DOI 10.1037/0012-1649.41.2.428; Burchinal M, 2010, EARLY CHILD RES Q, V25, P166, DOI 10.1016/j.ecresq.2009.10.004; Campbell FA, 2008, EARLY CHILD RES Q, V23, P452, DOI 10.1016/j.ecresq.2008.03.003; DARROW CL, 2011, CAMPB COLL JOINT S A; Dickinson D.K., 2002, AM ED RES ASS, V31, P26; Dickinson D. K., 2011, SOC RES ED EFF WASH; Dickinson DK, 2011, CHILD DEV, V82, P870, DOI 10.1111/j.1467-8624.2011.01576.x; Duncan GJ, 2007, DEV PSYCHOL, V43, P1428, DOI 10.1037/0012-1649.43.6.1428; Farkas G, 2004, SOC SCI RES, V33, P464, DOI 10.1016/j.ssresearch.2003.08.001; Fernald A, 2006, DEV PSYCHOL, V42, P98, DOI 10.1037/0012-1649.42.1.98; Fiester L., 2010, EARLY WARNING WHY RE; Forget-Dubois N, 2009, CHILD DEV, V80, P736, DOI 10.1111/j.1467-8624.2009.01294.x; Frede E., 2009, APPLES BLOSSOM ABBOT; Gormley WT, 2005, DEV PSYCHOL, V41, P872, DOI 10.1037/0012-1649.41.6.872; Harlaar N, 2008, J SPEECH LANG HEAR R, V51, P688, DOI 10.1044/1092-4388(2008/049); Hoff E, 2006, DEV REV, V26, P55, DOI 10.1016/j.dr.2005.11.002; Hulsey L, 2010, ACF OPRE REPORT DATA; Hurtado N, 2008, DEVELOPMENTAL SCI, V11, pF31, DOI 10.1111/j.1467-7687.2008.00768.x; Huttenlocher J, 2002, COGNITIVE PSYCHOL, V45, P337, DOI 10.1016/S0010-0285(02)00500-5; Justice LM, 2008, EARLY CHILD RES Q, V23, P51, DOI 10.1016/j.ecresq.2007.09.004; Lipsey M., 2011, INITIAL RESULTS EVAL; Marchman VA, 2008, DEVELOPMENTAL SCI, V11, pF9, DOI 10.1111/j.1467-7687.2008.00671.x; MAULIS LM, 2010, REV EDUC RES, V80, P300; Mendelsohn A, 2011, HDB EARLY LITERACY R, V3, P279; Metsala J. L., 2011, HDB EARLY LITERACY R, V3, P66; *NAT CTR ED SCI, 2009, DIG ED STAT; Ramey C.T., 2009, PROMISE PRE K, P79; Rampey B. D., 2009, NAEP 2008 TRENDS ACA; Reynolds AJ, 2004, CHILD DEV, V75, P1299, DOI 10.1111/j.1467-8624.2004.00742.x; Rowe ML, 2009, SCIENCE, V323, P951, DOI 10.1126/science.1167025; Silven M, 2007, J EDUC PSYCHOL, V99, P516, DOI 10.1037/0022-0663.99.3.516; Sylva K., 2011, HDB EARLY LITERACY R, V3, P97; *US DEP HHS, 2010, HEAD START IMP STUD; Vandell DL, 2010, CHILD DEV, V81, P737, DOI 10.1111/j.1467-8624.2010.01431.x; Vasilyeva M, 2008, DEVELOPMENTAL SCI, V11, P84, DOI 10.1111/j.1467-7687.2007.00656.x; Verhoeven L, 2011, SCI STUD READ, V15, P8, DOI 10.1080/10888438.2011.536125; Wasik BA, 2006, J EDUC PSYCHOL, V98, P63, DOI 10.1037/0022-0663.98.1.63; WILSON SJ, 2011, SOC RES ED EFF WASH; ZIL N, 2006, HEAD START PERFORMAN	40	129	129	3	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 19	2011	333	6045					964	967		10.1126/science.1204526	http://dx.doi.org/10.1126/science.1204526			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	808TD	21852487				2022-12-28	WOS:000294000400041
J	Silvestri, GA				Silvestri, Gerard A.			Screening for Lung Cancer: It Works, but Does It Really Work?	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							BREAST-CANCER; UNITED-STATES; MAMMOGRAPHY; MORTALITY; SMOKING; TRIAL; SURVIVAL	After the publication of the NLST (National Lung Screening Trial) results, physicians will be faced with whether to begin ordering low-dose computed tomography (LDCT) of the chest to screen for lung cancer in patients with a history of tobacco use. Despite the encouraging reduction in deaths observed by using LDCT in the NLST study population, recommending adoption of lung cancer screening in general practice is premature. Lessons learned from prostate and breast cancer screening should remind us that the reductions in deaths expected with screening are unfortunately not as readily achievable as initially believed. Furthermore, the potential harms of false-positive findings on chest computed tomography are very real. The morbidity and even mortality associated with invasive diagnostic testing and surgical resection due to false-and true-positive findings on computed tomography are likely to increase when the approach taken in the NLST is applied in non-specialty care settings and among the population at highest risk, namely, those with smoking-related comorbid conditions. Although the NLST results are perhaps encouraging, they do not tell us enough that we can be sure that patients who undergo LDCT in an attempt to find early-stage lung cancer will have more benefit than harm.	Med Univ S Carolina, Div Pulm & Crit Care Med, Charleston, SC 29425 USA	Medical University of South Carolina	Silvestri, GA (corresponding author), Med Univ S Carolina, Div Pulm & Crit Care Med, 171 Ashley Ave, Charleston, SC 29425 USA.	silvestr@musc.edu						Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Andriole GL, 2009, NEW ENGL J MED, V360, P1310, DOI 10.1056/NEJMoa0810696; Bach PB, 2001, NEW ENGL J MED, V345, P181, DOI 10.1056/NEJM200107193450306; Cromwell J, 1997, JAMA-J AM MED ASSOC, V278, P1759, DOI 10.1001/jama.278.21.1759; Dube S. R., 2010, Morbidity and Mortality Weekly Report, V59, P1135; Gotzsche PC, 2000, LANCET, V355, P129, DOI 10.1016/S0140-6736(99)06065-1; Kalager M, 2010, NEW ENGL J MED, V363, P1203, DOI 10.1056/NEJMoa1000727; Schwartz LM, 2004, JAMA-J AM MED ASSOC, V291, P71, DOI 10.1001/jama.291.1.71; Silvestri GA, 2007, THORAX, V62, P126, DOI 10.1136/thx.2005.056036; van der Aalst CM, 2010, THORAX, V65, P600, DOI 10.1136/thx.2009.133751; Welch HG, 2010, NEW ENGL J MED, V363, P1276, DOI 10.1056/NEJMe1008369; Welch HG, 2010, J NATL CANCER I, V102, P605, DOI 10.1093/jnci/djq099; Welch HG, 2000, JAMA-J AM MED ASSOC, V283, P2975, DOI 10.1001/jama.283.22.2975; Wiener RS, 2011, ANN INTERN MED, V155, P137, DOI 10.7326/0003-4819-155-3-201108020-00003	14	29	29	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 18	2011	155	8					537	539		10.7326/0003-4819-155-8-201110180-00364	http://dx.doi.org/10.7326/0003-4819-155-8-201110180-00364			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	835WB	21893614				2022-12-28	WOS:000296066300019
J	Refojo, D; Schweizer, M; Kuehne, C; Ehrenberg, S; Thoeringer, C; Vogl, AM; Dedic, N; Schumacher, M; von Wolff, G; Avrabos, C; Touma, C; Engblom, D; Schutz, G; Nave, KA; Eder, M; Wotjak, CT; Sillaber, I; Holsboer, F; Wurst, W; Deussing, JM				Refojo, Damian; Schweizer, Martin; Kuehne, Claudia; Ehrenberg, Stefanie; Thoeringer, Christoph; Vogl, Annette M.; Dedic, Nina; Schumacher, Marion; von Wolff, Gregor; Avrabos, Charilaos; Touma, Chadi; Engblom, David; Schuetz, Guenther; Nave, Klaus-Armin; Eder, Matthias; Wotjak, Carsten T.; Sillaber, Inge; Holsboer, Florian; Wurst, Wolfgang; Deussing, Jan M.			Glutamatergic and Dopaminergic Neurons Mediate Anxiogenic and Anxiolytic Effects of CRHR1	SCIENCE			English	Article							CORTICOTROPIN-RELEASING-FACTOR; FACTOR RECEPTOR 1-DEFICIENT; IMPAIRED STRESS-RESPONSE; MICE LACKING; I-H; HORMONE; ANXIETY; BRAIN; BEHAVIOR; CRF	The corticotropin-releasing hormone receptor 1 (CRHR1) critically controls behavioral adaptation to stress and is causally linked to emotional disorders. Using neurochemical and genetic tools, we determined that CRHR1 is expressed in forebrain glutamatergic and gamma-aminobutyric acid-containing (GABAergic) neurons as well as in midbrain dopaminergic neurons. Via specific CRHR1 deletions in glutamatergic, GABAergic, dopaminergic, and serotonergic cells, we found that the lack of CRHR1 in forebrain glutamatergic circuits reduces anxiety and impairs neurotransmission in the amygdala and hippocampus. Selective deletion of CRHR1 in midbrain dopaminergic neurons increases anxiety-like behavior and reduces dopamine release in the prefrontal cortex. These results define a bidirectional model for the role of CRHR1 in anxiety and suggest that an imbalance between CRHR1-controlled anxiogenic glutamatergic and anxiolytic dopaminergic systems might lead to emotional disorders.	[Refojo, Damian; Schweizer, Martin; Kuehne, Claudia; Ehrenberg, Stefanie; Thoeringer, Christoph; Vogl, Annette M.; Dedic, Nina; Schumacher, Marion; von Wolff, Gregor; Avrabos, Charilaos; Touma, Chadi; Eder, Matthias; Wotjak, Carsten T.; Sillaber, Inge; Holsboer, Florian; Wurst, Wolfgang; Deussing, Jan M.] Max Planck Inst Psychiat, Munich, Germany; [Schweizer, Martin; Sillaber, Inge] Affectis Pharmaceut, Munich, Germany; [Engblom, David; Schuetz, Guenther] German Canc Res Ctr, Div Mol Biol Cell 1, D-6900 Heidelberg, Germany; [Nave, Klaus-Armin] Max Planck Inst Expt Med, Dept Neurogenet, D-37075 Gottingen, Germany; [Wurst, Wolfgang] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Dev Genet, Neuherberg, Germany; [Wurst, Wolfgang] Tech Univ Weihenstephan, Inst Entwicklungsgenet, Neuherberg, Germany; [Wurst, Wolfgang] DZNE Demenzzentrum, Munich, Germany	Max Planck Society; Helmholtz Association; German Cancer Research Center (DKFZ); Max Planck Society; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Deussing, JM (corresponding author), Max Planck Inst Psychiat, Munich, Germany.	deussing@mpipsykl.mpg.de	Deussing, Jan M/ABB-5993-2021; Wotjak, Carsten T./S-3200-2019; Touma, Chadi/G-4677-2011	Eder, Matthias/0000-0002-2579-2628; Vogl, Annette/0000-0001-6283-2521; Wurst, Wolfgang/0000-0003-4422-7410; Refojo, Damian/0000-0002-9798-6413; Deussing, Jan/0000-0002-9329-5252	Max Planck Society; Bundesministerium fur Bildung und Forschung [01GS08151, 01GS08155]; Helmholtz Association [HA-215]; Deutsche Forschungsgemeinschaft center for Molecular Physiology of the brain; European Molecular Biology Organization; NARSAD Young Investigator Award	Max Planck Society(Max Planck Society); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Helmholtz Association(Helmholtz Association); Deutsche Forschungsgemeinschaft center for Molecular Physiology of the brain; European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); NARSAD Young Investigator Award(NARSAD)	We thank W. Zieglgansberger for his valuable suggestions and critical reading of the manuscript; S. Meyr, M. Schieven, U. Habersetzer, C. Flachskamm, S. Bourier, S. Weidemann, and A. Tasdemir for their excellent technical assistance; A. Chen for sharing unpublished data; S. Silberstein and E. Arzt for the CRHR1-HT22 stable-cell line; N. Singewald for his support with microdyalysis studies; J. Rubinstein and M. Ekker for providing Dlx5/6-cre mice; E. Deneris for providing the ePet-cre mouse line; and F. Stewart for providing hACTB::Flpe mice. This work was supported by the Max Planck Society; the Bundesministerium fur Bildung und Forschung within the framework of NGFN-Plus (grants 01GS08151 and 01GS08155; J. D. and W. W.); the Initiative and Networking Fund of the Helmholtz Association in the framework of the Helmholtz Alliance for Mental Health in an Aging Society (grant HA-215, J. D. and W. W.); the Deutsche Forschungsgemeinschaft center for Molecular Physiology of the brain (K. A. N.); the European Molecular Biology Organization (D. R.),; a NARSAD Young Investigator Award (D. R.); and the Max Planck Society (D. R., as a Max Planck Research Scientist).	Airan RD, 2007, SCIENCE, V317, P819, DOI 10.1126/science.1144400; ALDENHOFF JB, 1983, SCIENCE, V221, P875, DOI 10.1126/science.6603658; Arborelius L, 1999, J ENDOCRINOL, V160, P1, DOI 10.1677/joe.0.1600001; Berton O, 2006, NAT REV NEUROSCI, V7, P137, DOI 10.1038/nrn1846; Borgland SL, 2010, BRAIN RES, V1314, P139, DOI 10.1016/j.brainres.2009.10.068; de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683; Giesbrecht CJ, 2010, J NEUROSCI, V30, P16970, DOI 10.1523/JNEUROSCI.2306-10.2010; Hollrigel GS, 1998, NEUROSCIENCE, V84, P71, DOI 10.1016/S0306-4522(97)00499-5; Koob GF, 2008, NEURON, V59, P11, DOI 10.1016/j.neuron.2008.06.012; Lammel S, 2008, NEURON, V57, P760, DOI 10.1016/j.neuron.2008.01.022; Lu A, 2008, MOL PSYCHIATR, V13, P1028, DOI 10.1038/mp.2008.51; Luo L, 2008, NEURON, V57, P634, DOI 10.1016/j.neuron.2008.01.002; Magalhaes AC, 2010, NAT NEUROSCI, V13, P622, DOI 10.1038/nn.2529; Maier SF, 2005, NEUROSCI BIOBEHAV R, V29, P829, DOI 10.1016/j.neubiorev.2005.03.021; Matsumoto M, 2009, NATURE, V459, P837, DOI 10.1038/nature08028; Muller MB, 2003, NAT NEUROSCI, V6, P1100, DOI 10.1038/nn1123; Nestler EJ, 2006, BIOL PSYCHIAT, V59, P1151, DOI 10.1016/j.biopsych.2005.09.018; Refojo D, 2005, P NATL ACAD SCI USA, V102, P6183, DOI 10.1073/pnas.0502070102; Sanacora G, 2008, NAT REV DRUG DISCOV, V7, P426, DOI 10.1038/nrd2462; Shin LM, 2010, NEUROPSYCHOPHARMACOL, V35, P169, DOI 10.1038/npp.2009.83; Sillaber I, 2002, SCIENCE, V296, P931, DOI 10.1126/science.1069836; Smith GW, 1998, NEURON, V20, P1093, DOI 10.1016/S0896-6273(00)80491-2; SWANSON LW, 1983, NEUROENDOCRINOLOGY, V36, P165, DOI 10.1159/000123454; Timpl P, 1998, NAT GENET, V19, P162, DOI 10.1038/520; Tovote P, 2005, NEUROSCIENCE, V134, P1113, DOI 10.1016/j.neuroscience.2005.05.027; Van Pett K, 2000, J COMP NEUROL, V428, P191, DOI 10.1002/1096-9861(20001211)428:2<191::AID-CNE1>3.0.CO;2-U; von Wolff G, 2011, J PSYCHIATR RES, V45, P256, DOI 10.1016/j.jpsychires.2010.06.007; Wanat MJ, 2008, J PHYSIOL-LONDON, V586, P2157, DOI 10.1113/jphysiol.2007.150078; Wise RA, 2010, BRAIN RES, V1314, P38, DOI 10.1016/j.brainres.2009.09.101	29	212	220	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 30	2011	333	6051					1903	1907		10.1126/science.1202107	http://dx.doi.org/10.1126/science.1202107			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	826PJ	21885734				2022-12-28	WOS:000295365800060
J	Gu, TP; Guo, F; Yang, H; Wu, HP; Xu, GF; Liu, W; Xie, ZG; Shi, LY; He, XY; Jin, SG; Iqbal, K; Shi, YJG; Deng, ZX; Szabo, PE; Pfeifer, GP; Li, JS; Xu, GL				Gu, Tian-Peng; Guo, Fan; Yang, Hui; Wu, Hai-Ping; Xu, Gui-Fang; Liu, Wei; Xie, Zhi-Guo; Shi, Linyu; He, Xinyi; Jin, Seung-gi; Iqbal, Khursheed; Shi, Yujiang Geno; Deng, Zixin; Szabo, Piroska E.; Pfeifer, Gerd P.; Li, Jinsong; Xu, Guo-Liang			The role of Tet3 DNA dioxygenase in epigenetic reprogramming by oocytes	NATURE			English	Article							PRIMORDIAL GERM-CELLS; EMBRYONIC STEM-CELLS; PATERNAL GENOME; CRE RECOMBINASE; MOUSE ZYGOTES; 5-HYDROXYMETHYLCYTOSINE; DEMETHYLATION; GENES; 5-METHYLCYTOSINE; METHYLATION	Sperm and eggs carry distinctive epigenetic modifications that are adjusted by reprogramming after fertilization(1). The paternal genome in a zygote undergoes active DNA demethylation before the first mitosis(2,3). The biological significance and mechanisms of this paternal epigenome remodelling have remained unclear(4). Here we report that, within mouse zygotes, oxidation of 5-methylcytosine (5mC) occurs on the paternal genome, changing 5mC into 5-hydroxymethylcytosine (5hmC). Furthermore, we demonstrate that the dioxygenase Tet3 (ref. 5) is enriched specifically in the male pronucleus. In Tet3-deficient zygotes from conditional knockout mice, paternal-genome conversion of 5mC into 5hmC fails to occur and the level of 5mC remains constant. Deficiency of Tet3 also impedes the demethylation process of the paternal Oct4 and Nanog genes and delays the subsequent activation of a paternally derived Oct4 transgene in early embryos. Female mice depleted of Tet3 in the germ line show severely reduced fecundity and their heterozygous mutant offspring lacking maternal Tet3 suffer an increased incidence of developmental failure. Oocytes lacking Tet3 also seem to have a reduced ability to reprogram the injected nuclei from somatic cells. Therefore, Tet3-mediated DNA hydroxylation is involved in epigenetic reprogramming of the zygotic paternal DNA following natural fertilization and may also contribute to somatic cell nuclear reprogramming during animal cloning.	[Yang, Hui; Shi, Linyu; Li, Jinsong] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Cell Biol, Shanghai 200031, Peoples R China; [Gu, Tian-Peng; Guo, Fan; Wu, Hai-Ping; Xu, Gui-Fang; Liu, Wei; Xie, Zhi-Guo; Xu, Guo-Liang] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Grp DNA Metab,State Key Lab Mol Biol, Shanghai 200031, Peoples R China; [He, Xinyi; Deng, Zixin] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, State Key Lab Microbial Metab, Shanghai 200030, Peoples R China; [Jin, Seung-gi; Pfeifer, Gerd P.] Beckman Res Inst City Hope, Dept Canc Biol, Duarte, CA 91010 USA; [Iqbal, Khursheed; Szabo, Piroska E.] Beckman Res Inst City Hope, Dept Mol & Cellular Biol, Duarte, CA 91010 USA; [Shi, Yujiang Geno] Brigham & Womens Hosp, Div Endocrinol Diabet & Hypertens, Dept Med, Boston, MA 02115 USA; [Shi, Yujiang Geno] Brigham & Womens Hosp, BCMP, Boston, MA 02115 USA; [Shi, Yujiang Geno] Harvard Univ, Sch Med, Boston, MA 02115 USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Li, JS (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Cell Biol, Shanghai 200031, Peoples R China.	jsli@sibs.ac.cn; glxu@sibs.ac.cn	Xie, Zhiguo/AAD-8782-2020; Gu, Tianpeng/AGG-9579-2022; Guo, Fan/J-1857-2019; Guo, Fan/AAX-4952-2021	Guo, Fan/0000-0002-0165-073X; Jin, Seung-Gi/0000-0001-5041-0559; Iqbal, Khursheed/0000-0002-6742-4591; Xie, Zhiguo/0000-0001-5037-3807; Szabo, Piroska/0000-0001-9314-7009; li, jin song/0000-0003-3456-662X; yang, hui/0000-0003-3590-722X	Ministry of Science and Technology China [2007CB947503, 2007CB947101, 2009CB941101]; National Science Foundation of China [30730059, 30871430]; Chinese Academy of Sciences [XDA01010301, XDA01010403, KSCX2-YW-R-110]; NIH [GM078458]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078458] Funding Source: NIH RePORTER	Ministry of Science and Technology China(Ministry of Science and Technology, ChinaMinistry of Science, ICT & Future Planning, Republic of Korea); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. Walsh and M. Rots for critical reading of the manuscript, J. Walter for discussions, H. Qi for providing cDNA of mouse oocytes, R. Zhang & Q. Cui for Tet3 cDNA, L. Li for help with 5hmCMP synthesis, Shanghai Research Center for Model Organisms for blastocyst injection, and J. Gao for mouse work. This study was supported by grants from the Ministry of Science and Technology China (2007CB947503 to G.-L. X., 2007CB947101 to J. L., and 2009CB941101 to G.-L. X. and J. L.), National Science Foundation of China (30730059 to G.-L. X. and 30871430 to J. L.), the Chinese Academy of Sciences (XDA01010301 to G.-L. X.; XDA01010403 and KSCX2-YW-R-110 to J. L.) and the NIH (GM078458 to Y.G.S.).	Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Bui HT, 2008, DEVELOPMENT, V135, P3935, DOI 10.1242/dev.023747; de Vries WN, 2000, GENESIS, V26, P110, DOI 10.1002/(SICI)1526-968X(200002)26:2<110::AID-GENE2>3.0.CO;2-8; Egli D, 2007, NATURE, V447, P679, DOI 10.1038/nature05879; Egli D, 2009, CURR BIOL, V19, P1403, DOI 10.1016/j.cub.2009.06.065; ERLANGER BF, 1964, P NATL ACAD SCI USA, V52, P68, DOI 10.1073/pnas.52.1.68; Farthing CR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000116; Ge YZ, 2004, J BIOL CHEM, V279, P25447, DOI 10.1074/jbc.M312296200; Hajkova Petra, 2002, Methods Mol Biol, V200, P143; Hattori N, 2004, J BIOL CHEM, V279, P17063, DOI 10.1074/jbc.M309002200; Huang Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008888; Imamura M, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-34; Iqbal K, 2011, CLIN EXP DERMATOL, V36, P677, DOI 10.1111/j.1365-2230.2011.04048.x; Iqbal K, 2011, P NATL ACAD SCI USA, V108, P3642, DOI 10.1073/pnas.1014033108; Jin SG, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq223; KIMURA Y, 1995, BIOL REPROD, V52, P709, DOI 10.1095/biolreprod52.4.709; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Lewandoski M, 1997, CURR BIOL, V7, P148, DOI 10.1016/S0960-9822(06)00059-5; Li L, 2008, CHEMBIOCHEM, V9, P1286, DOI 10.1002/cbic.200800008; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Lomeli H, 2000, GENESIS, V26, P116, DOI 10.1002/(SICI)1526-968X(200002)26:2<116::AID-GENE4>3.0.CO;2-X; Mayer W, 2000, NATURE, V403, P501, DOI 10.1038/35000656; Ohbo K, 2003, DEV BIOL, V258, P209, DOI 10.1016/S0012-1606(03)00111-8; Ooi SKT, 2008, CELL, V133, P1145, DOI 10.1016/j.cell.2008.06.009; Oswald J, 2000, CURR BIOL, V10, P475, DOI 10.1016/S0960-9822(00)00448-6; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Seidman JG, 2002, J CLIN INVEST, V109, P451, DOI 10.1172/JC1200215043; Surani MA, 2007, CELL, V128, P747, DOI 10.1016/j.cell.2007.02.010; Szabo PE, 2002, MECH DEVELOP, V115, P157, DOI 10.1016/S0925-4773(02)00087-4; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Tsumura A, 2006, GENES CELLS, V11, P805, DOI 10.1111/j.1365-2443.2006.00984.x; Wakayama T, 1998, NATURE, V394, P369, DOI 10.1038/28615; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Wossidlo M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1240; Wossidlo M, 2010, EMBO J, V29, P1877, DOI 10.1038/emboj.2010.80; Wu SC, 2010, NAT REV MOL CELL BIO, V11, P607, DOI 10.1038/nrm2950; Yang H, 2010, CELL RES, V20, P1034, DOI 10.1038/cr.2010.97; Jamil AZ, 2011, JCPSP-J COLL PHYSICI, V21, P347, DOI 07.2011/JCPSP.347350	38	800	850	6	253	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 29	2011	477	7366					606	U136		10.1038/nature10443	http://dx.doi.org/10.1038/nature10443			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825ZM	21892189				2022-12-28	WOS:000295320900043
J	Chen, C; Scheffler, G; Chandra, A				Chen, Christopher; Scheffler, Gabriel; Chandra, Amitabh			Massachusetts' Health Care Reform and Emergency Department Utilization	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Chen, Christopher] Washington Univ, Sch Med, St Louis, MO 63130 USA; [Scheffler, Gabriel] Yale Univ, Yale Law Sch, New Haven, CT USA; [Chandra, Amitabh] Harvard Univ, Kennedy Sch Govt, Cambridge, MA 02138 USA	Washington University (WUSTL); Yale University; Harvard University	Chen, C (corresponding author), Washington Univ, Sch Med, St Louis, MO 63130 USA.							Chandra A, 2011, NEW ENGL J MED, V364, P293, DOI 10.1056/NEJMp1013067; KYL J, COMMUNICATION   1503; Long SK, 2010, HLTH REFORM MASSACHU; Newhouse JP, 1993, FREE ALL LESSONS RAN	4	51	51	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 22	2011	365	12								10.1056/NEJMp1109273	http://dx.doi.org/10.1056/NEJMp1109273			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	822WR	21899444				2022-12-28	WOS:000295081600002
J	Nardin, R; Zallman, L; Frank, C; Day, B; Boyd, JW				Nardin, Rachel; Zallman, Leah; Frank, Cassie; Day, Benjamin; Boyd, J. Wesley			US Medical Students' Health Insurance Coverage for Mental Health and Substance Abuse Treatment	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Nardin, Rachel; Zallman, Leah; Frank, Cassie] Cambridge Hlth Alliance, Dept Med, Cambridge, MA USA; [Boyd, J. Wesley] Cambridge Hlth Alliance, Dept Psychiat, Cambridge, MA USA; [Day, Benjamin] Phys Natl Hlth Program, Chicago, IL USA	Harvard University; Cambridge Health Alliance; Harvard University; Cambridge Health Alliance	Nardin, R (corresponding author), Cambridge Hlth Alliance, Dept Med, Cambridge, MA USA.	rnardin@challiance.org			PHS HHS [T32HP12706] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		BALDWIN DC, 1991, JAMA-J AM MED ASSOC, V265, P2074, DOI 10.1001/jama.265.16.2074; Dyrbye LN, 2010, JAMA-J AM MED ASSOC, V304, P1173, DOI 10.1001/jama.2010.1318; Dyrbye LN, 2006, ACAD MED, V81, P354, DOI 10.1097/00001888-200604000-00009; Givens JL, 2002, ACAD MED, V77, P918, DOI 10.1097/00001888-200209000-00024; Hodgkin D, 2009, ADM POLICY MENT HLTH, V36, P15, DOI 10.1007/s10488-008-0196-5; Trivedi AN, 2008, JAMA-J AM MED ASSOC, V300, P2879, DOI 10.1001/jama.2008.888	6	1	1	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 7	2011	306	9					931	933		10.1001/jama.2011.1262	http://dx.doi.org/10.1001/jama.2011.1262			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	815QT	21900132	Bronze			2022-12-28	WOS:000294542600007
J	Leaning, J; Lappi, M				Leaning, Jennifer; Lappi, Michael			Fighting a war, sparing civilians	LANCET			English	Editorial Material									[Leaning, Jennifer] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Lappi, Michael] Harvard Univ, Sch Med, Harvard Humanitarian Initiat, Cambridge, MA 02138 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University	Leaning, J (corresponding author), Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA.	jleaning@hsph.harvard.edu						Bonds Timothy M., 2010, ARMY DEPLOYMENTS OIF; CHAPMAN FS, 2003, JUNGLE IS NEUTRAL; Filkins D., 2009, NY TIMES        0217; PAVORD AC, 2008, SMALL WARS J    0513; Tavernise Sabrina, 2010, NY TIMES        1022; *US MAR CORPS WARF, 2007, US MAR CORPS WARF PU; Warner CH, 2011, LANCET, V378, P915, DOI 10.1016/S0140-6736(11)61039-8	7	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 3	2011	378	9794					857	859		10.1016/S0140-6736(11)61311-1	http://dx.doi.org/10.1016/S0140-6736(11)61311-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	818XZ	21890034				2022-12-28	WOS:000294791300008
J	Blair, JC; Peak, M; Gregory, JW				Blair, J. C.; Peak, M.; Gregory, J. W.			UNCERTAINTIES PAGE What is the best way to deliver subcutaneous insulin to infants, children, and young people with type 1 diabetes mellitus?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MULTIPLE DAILY INJECTIONS; PUMP THERAPY; INFUSION; TRIAL; ADOLESCENTS		[Blair, J. C.] Alder Hey Childrens NHS Fdn Trust, Dept Endocrinol, Liverpool L12 2AP, Merseyside, England; [Peak, M.] Cardiff Univ, Alder Hey Childrens NHS Fdn Trust, Dept Res & Dev, Cardiff, S Glam, Wales; [Gregory, J. W.] Cardiff Univ, Sch Med, Dept Child Hlth, Cardiff, S Glam, Wales	Alder Hey Children's NHS Foundation Trust; Alder Hey Children's NHS Foundation Trust; Cardiff University; Cardiff University	Blair, JC (corresponding author), Alder Hey Childrens NHS Fdn Trust, Dept Endocrinol, Eaton Rd, Liverpool L12 2AP, Merseyside, England.	jo.blair@alderhey.nhs.uk		Peak, Matthew/0000-0003-1909-3211	National Institute for Health Research [08/14/39] Funding Source: researchfish; Department of Health [08/14/39] Funding Source: Medline	National Institute for Health Research(National Institute for Health Research (NIHR)); Department of Health		Cohen D, 2003, J PEDIATR ENDOCR MET, V16, P1047; Cummins E, 2010, HLTH TECHNOLOGY ASSE, V14; DiMeglio LA, 2004, J PEDIATR-US, V145, P380, DOI 10.1016/j.jpeds.2004.06.022; Doyle EA, 2004, DIABETES CARE, V27, P1554, DOI 10.2337/diacare.27.7.1554; Fox LA, 2005, DIABETES CARE, V28, P1277, DOI 10.2337/diacare.28.6.1277; Gosden C, 2010, ARCH DIS CHILD, V95, P837, DOI 10.1136/adc.2009.176925; MESCHI F, 1982, ACTA DIABETOL LAT, V19, P371, DOI 10.1007/BF02629260; Misso ML, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005103.pub2; National Diabetes Information Service, 2009, INS PUMP AUD FIND EN; National Institute for Health and Care Excellence, 2008, TA151 CONT SUBC INS; Nuboer R, 2008, PEDIATR DIABETES, V9, P291, DOI 10.1111/j.1399-5448.2008.00396.x; Pankowska E, 2009, PEDIATR DIABETES, V10, P52, DOI 10.1111/j.1399-5448.2008.00440.x; Royal College of Paediatrics and Child Health, 2009, GROW DIAB CHILDR YOU; Schober E, 2002, J PEDIATR ENDOCR MET, V15, P369; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Skogsberg L, 2008, PEDIATR DIABETES, V9, P472, DOI 10.1111/j.1399-5448.2008.00390.x; Weintrob N, 2004, ARCH PEDIAT ADOL MED, V158, P677, DOI 10.1001/archpedi.158.7.677; Weintrob N, 2003, PEDIATRICS, V112, P559, DOI 10.1542/peds.112.3.559; Wilson DM, 2005, DIABETES CARE, V28, P15, DOI 10.2337/diacare.28.1.15	19	3	4	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 2	2011	343								d5221	10.1136/bmj.d5221	http://dx.doi.org/10.1136/bmj.d5221			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	816LI	21890564	Green Accepted			2022-12-28	WOS:000294600900001
J	Walker, HC; Fabrizi, F; Paolasini, L; de Bergevin, F; Herrero-Martin, J; Boothroyd, AT; Prabhakaran, D; McMorrow, DF				Walker, H. C.; Fabrizi, F.; Paolasini, L.; de Bergevin, F.; Herrero-Martin, J.; Boothroyd, A. T.; Prabhakaran, D.; McMorrow, D. F.			Femtoscale Magnetically Induced Lattice Distortions in Multiferroic TbMnO3	SCIENCE			English	Article								Magneto-electric multiferroics exemplified by TbMnO3 possess both magnetic and ferroelectric long-range order. The magnetic order is mostly understood, whereas the nature of the ferroelectricity has remained more elusive. Competing models proposed to explain the ferroelectricity are associated respectively with charge transfer and ionic displacements. Exploiting the magneto-electric coupling, we used an electric field to produce a single magnetic domain state, and a magnetic field to induce ionic displacements. Under these conditions, interference between charge and magnetic x-ray scattering arose, encoding the amplitude and phase of the displacements. When combined with a theoretical analysis, our data allow us to resolve the ionic displacements at the femtoscale, and show that such displacements make a substantial contribution to the zero-field ferroelectric moment.	[Walker, H. C.; Fabrizi, F.; Paolasini, L.; de Bergevin, F.; Herrero-Martin, J.] European Synchrotron Radiat Facil, F-38043 Grenoble, France; [Fabrizi, F.; McMorrow, D. F.] UCL, London Ctr Nanotechnol, London WC1E 6BT, England; [Fabrizi, F.; McMorrow, D. F.] UCL, Dept Phys & Astron, London WC1E 6BT, England; [Fabrizi, F.; Boothroyd, A. T.; Prabhakaran, D.] Univ Oxford, Dept Phys, Clarendon Lab, Oxford OX1 3PU, England	European Synchrotron Radiation Facility (ESRF); University of London; University College London; University of London; University College London; University of Oxford	Walker, HC (corresponding author), European Synchrotron Radiat Facil, Boite Postale 220, F-38043 Grenoble, France.	helen.walker@esrf.fr	McMorrow, Desmond Francis/M-9036-2019; Boothroyd, Andrew/AAA-7883-2021; Walker, Helen C/C-4201-2011; Herrero-Martín, Javier/H-8167-2015; McMorrow, Desmond/C-2655-2008	McMorrow, Desmond Francis/0000-0002-4947-7788; Boothroyd, Andrew/0000-0002-3575-7471; Walker, Helen C/0000-0002-7859-5388; Herrero-Martín, Javier/0000-0003-1986-8128; McMorrow, Desmond/0000-0002-4947-7788; Fabrizi, Federica/0000-0002-3809-065X	UK Engineering and Physical Sciences Research Council; Royal Society; EPSRC [EP/H033939/1, EP/D054176/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/D054176/1, EP/H033939/1] Funding Source: researchfish	UK Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Royal Society(Royal Society of London); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank C. Mazzoli and G. Pepellin for experimental assistance, and Y. Joly, A. Rogalev, and C. Vettier for fruitful discussions. Supported by the UK Engineering and Physical Sciences Research Council and the Royal Society. The data are stored at the European Synchrotron Radiation Facility.	Aliouane N, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.020102; Aliouane N, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.207205; Arima T, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.097202; Bridges F, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.092109; Cabrera I, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.087201; Cheong SW, 2007, NAT MATER, V6, P13, DOI 10.1038/nmat1804; Fabrizi F, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.024434; Fabrizi F, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.237205; Feyerherm R, 2010, J PHYS CONF SER, V200, DOI 10.1088/1742-6596/200/1/012032; Harris AB, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.054447; Katsura H, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.057205; Kenzelmann M, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.087206; Kimura T, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.224425; Kimura T, 2003, NATURE, V426, P55, DOI 10.1038/nature02018; Lawes G, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.087205; Lovesey S. W., 1996, X RAY SCATTERING ABS; Malashevich A, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.037210; Pettifer RF, 2005, NATURE, V435, P78, DOI 10.1038/nature03516; Prokhnenko O, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.057206; Sergienko IA, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.094434; Strempfer J, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.024429; Wilkins SB, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.207602; Xiang HJ, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.037209; Yamasaki Y, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.147204	24	78	82	3	106	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 2	2011	333	6047					1273	1276		10.1126/science.1208085	http://dx.doi.org/10.1126/science.1208085			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	813YM	21885777	Green Submitted			2022-12-28	WOS:000294406400049
J	Walker, T; Johnson, PH; Moreira, LA; Iturbe-Ormaetxe, I; Frentiu, FD; McMeniman, CJ; Leong, YS; Dong, Y; Axford, J; Kriesner, P; Lloyd, AL; Ritchie, SA; O'Neill, SL; Hoffmann, AA				Walker, T.; Johnson, P. H.; Moreira, L. A.; Iturbe-Ormaetxe, I.; Frentiu, F. D.; McMeniman, C. J.; Leong, Y. S.; Dong, Y.; Axford, J.; Kriesner, P.; Lloyd, A. L.; Ritchie, S. A.; O'Neill, S. L.; Hoffmann, A. A.			The wMel Wolbachia strain blocks dengue and invades caged Aedes aegypti populations	NATURE			English	Article							VIRUS; INFECTION; CULICIDAE; DIPTERA; MODELS; SPREAD	Dengue fever is the most important mosquito-borne viral disease of humans with more than 50 million cases estimated annually in more than 100 countries(1,2). Disturbingly, the geographic range of dengue is currently expanding and the severity of outbreaks is increasing(2-4). Control options for dengue are very limited and currently focus on reducing population abundance of the major mosquito vector, Aedes aegypti(5,6). These strategies are failing to reduce dengue incidence in tropical communities and there is an urgent need for effective alternatives. It has been proposed that endosymbiotic bacterial Wolbachia infections of insects might be used in novel strategies for dengue control(7-9). For example, the wMelPop-CLA Wolbachia strain reduces the lifespan of adult A. aegypti mosquitoes in stably transinfected lines(8). This life-shortening phenotype was predicted to reduce the potential for dengue transmission. The recent discovery that several Wolbachia infections, including wMelPop-CLA, can also directly influence the susceptibility of insects to infection with a range of insect and human pathogens(9-11) has markedly changed the potential for Wolbachia infections to control human diseases. Here we describe the successful transinfection of A. aegypti with the avirulent wMel strain of Wolbachia, which induces the reproductive phenotype cytoplasmic incompatibility with minimal apparent fitness costs and high maternal transmission, providing optimal phenotypic effects for invasion. Under semi-field conditions, the wMel strain increased from an initial starting frequency of 0.65 to near fixation within a few generations, invading A. aegypti populations at an accelerated rate relative to trials with the wMelPop-CLA strain. We also show that wMel and wMelPop-CLA strains block transmission of dengue serotype 2 (DENV-2) in A. aegypti, forming the basis of a practical approach to dengue suppression(12).	[Walker, T.; Moreira, L. A.; Iturbe-Ormaetxe, I.; Frentiu, F. D.; McMeniman, C. J.; Leong, Y. S.; Dong, Y.; O'Neill, S. L.] Univ Queensland, Sch Biol Sci, Brisbane, Qld 4072, Australia; [Axford, J.; Kriesner, P.; Hoffmann, A. A.] Univ Melbourne, Dept Genet, Inst Bio21, Melbourne, Vic 3010, Australia; [Johnson, P. H.; Ritchie, S. A.] James Cook Univ, Sch Publ Hlth & Trop Med & Rehabil Sci, Cairns, Qld 4870, Australia; [Lloyd, A. L.] N Carolina State Univ, Biomath Grad Program, Raleigh, NC 27695 USA; [Lloyd, A. L.] N Carolina State Univ, Dept Math, Raleigh, NC 27695 USA; [Lloyd, A. L.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA; [O'Neill, S. L.] Monash Univ, Sch Biol Sci, Clayton, Vic 3800, Australia	University of Queensland; University of Melbourne; James Cook University; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); Monash University	O'Neill, SL (corresponding author), Univ Queensland, Sch Biol Sci, Brisbane, Qld 4072, Australia.	scott.oneill@monash.edu	Hoffmann, Ary/C-2961-2011; Hoffmann, Ary/R-2972-2019; O'Neill, Scott L/B-3568-2009; Frentiu, Francesca D/K-4561-2012; O'Neill, Scott/R-9560-2019; Lloyd, Alun/AAN-6639-2020; Walker, Thomas/F-6572-2013; Walker, Thomas/B-9198-2014; Kriesner, Peter/L-7595-2013; Lloyd, Alun L/H-4944-2012	Hoffmann, Ary/0000-0001-9497-7645; O'Neill, Scott L/0000-0002-4131-3615; O'Neill, Scott/0000-0002-4131-3615; Lloyd, Alun/0000-0002-6389-6321; Walker, Thomas/0000-0003-4475-5395; Walker, Thomas/0000-0002-3545-012X; Kriesner, Peter/0000-0002-2382-7006; McMeniman, Conor/0000-0001-8502-8712; Frentiu, Francesca/0000-0001-8628-4216	Foundation for the National Institutes of Health through the Grand Challenges in Global Health Initiative of the Bill and Melinda Gates Foundation; National Health and Medical Research Council, Australia; NIH; Climate and Health Cluster of the CSIRO; Australian Research Council	Foundation for the National Institutes of Health through the Grand Challenges in Global Health Initiative of the Bill and Melinda Gates Foundation; National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Climate and Health Cluster of the CSIRO; Australian Research Council(Australian Research Council)	We are grateful to N. Kenny for technical support and to members of the O'Neill laboratory for critical reading of the manuscript. We thank R. Silcock, M. Janes, S. Long, C. Paton and C. Omodei for their assistance in the semi-field cages and laboratory at James Cook University. We are very grateful for all of our volunteers who helped to blood-feed the mosquitoes in the cages and to P. Young for providing the anti-dengue antibodies. This research was supported by a grant from the Foundation for the National Institutes of Health through the Grand Challenges in Global Health Initiative of the Bill and Melinda Gates Foundation, The National Health and Medical Research Council, Australia, the RAPIDD program of the NIH, the Climate and Health Cluster of the CSIRO Flagship collaboration Fund and fellowships from the Australian Research Council.	Bennett KE, 2002, AM J TROP MED HYG, V67, P85, DOI 10.4269/ajtmh.2002.67.85; Bian GW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000833; Calisher CH, 2005, EMERG INFECT DIS, V11, P738; Cook PE, 2008, ADV EXP MED BIOL, V627, P126, DOI 10.1007/978-0-387-78225-6_11; Dobson SL, 2002, APPL ENVIRON MICROB, V68, P656, DOI 10.1128/AEM.68.2.656-660.2002; Franco C, 2010, BIOSECUR BIOTERROR, V8, P273, DOI 10.1089/bsp.2010.0032; Frentiu FD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013398; Glaser RL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011977; GUBLER DJ, 1979, AM J TROP MED HYG, V28, P1045, DOI 10.4269/ajtmh.1979.28.1045; Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460; Hancock PA, 2011, AM NAT, V177, P323, DOI 10.1086/658121; Harrington LC, 2001, J MED ENTOMOL, V38, P537, DOI 10.1603/0022-2585-38.4.537; Hedges LM, 2008, SCIENCE, V322, P702, DOI 10.1126/science.1162418; Heintze C, 2007, T ROY SOC TROP MED H, V101, P317, DOI 10.1016/j.trstmh.2006.08.007; Hoffmann AA, 1997, INFLUENTIAL PASSENGERS, P42; Kyle JL, 2008, ANNU REV MICROBIOL, V62, P71, DOI 10.1146/annurev.micro.62.081307.163005; Macia A, 2006, J VECTOR ECOL, V31, P371, DOI 10.3376/1081-1710(2006)31[371:DIPOAA]2.0.CO;2; McMeniman CJ, 2008, APPL ENVIRON MICROB, V74, P6963, DOI 10.1128/AEM.01038-08; McMeniman CJ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000748; McMeniman CJ, 2009, SCIENCE, V323, P141, DOI 10.1126/science.1165326; Montgomery BL, 2002, AM J TROP MED HYG, V67, P244, DOI 10.4269/ajtmh.2002.67.244; Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042; Richardson J, 2006, AM J TROP MED HYG, V74, P132, DOI 10.4269/ajtmh.2006.74.132; Riegler M, 2005, CURR BIOL, V15, P1428, DOI 10.1016/j.cub.2005.06.069; Ritchie Scott A, 2011, PLoS Negl Trop Dis, V5, pe988, DOI 10.1371/journal.pntd.0000988; Salazar MI, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-9; Teixeira L, 2008, PLOS BIOL, V6, P2753, DOI 10.1371/journal.pbio.1000002; Telang A, 2004, J INSECT PHYSIOL, V50, P677, DOI 10.1016/j.jinsphys.2004.05.001; TURELLI M, 1991, NATURE, V353, P440, DOI 10.1038/353440a0; Turelli M, 2010, EVOLUTION, V64, P232, DOI 10.1111/j.1558-5646.2009.00822.x; WATTS DM, 1987, AM J TROP MED HYG, V36, P143, DOI 10.4269/ajtmh.1987.36.143; Whitehead SS, 2007, NAT REV MICROBIOL, V5, P518, DOI 10.1038/nrmicro1690; Williams CR, 2008, J MED ENTOMOL, V45, P1173, DOI 10.1603/0022-2585(2008)45[1173:REOAAP]2.0.CO;2; Wu M, 2004, PLOS BIOL, V2, P327, DOI 10.1371/journal.pbio.0020069; Yeap HL, 2011, GENETICS, V187, P583, DOI 10.1534/genetics.110.122390	36	809	838	8	287	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 25	2011	476	7361					450	U101		10.1038/nature10355	http://dx.doi.org/10.1038/nature10355			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811KT	21866159				2022-12-28	WOS:000294209400036
J	Chang, HJ				Chang, Huan J.			Skin Fragility and Blister Formation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							KINDLER-SYNDROME					tina.chang@jama-archives.org						Fine JD, 2008, J AM ACAD DERMATOL, V58, P931, DOI 10.1016/j.jaad.2008.02.004; Jobard F, 2003, HUM MOL GENET, V12, P925, DOI 10.1093/hmg/ddg097; Lai-Cheong JE, 2009, BRIT J DERMATOL, V160, P233, DOI 10.1111/j.1365-2133.2008.08976.x; Leal L, 2010, ARCH PEDIAT ADOL MED, V164, P875, DOI 10.1001/archpediatrics.2010.150-a; Mallo S, 2005, ACTAS DERMO-SIFILOGR, V96, P677, DOI 10.1016/S0001-7310(05)73157-4; Penagos H, 2004, ARCH DERMATOL, V140, P939, DOI 10.1001/archderm.140.8.939; Sadler E, 2006, ARCH DERMATOL, V142, P1619, DOI 10.1001/archderm.142.12.1619	7	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 17	2011	306	7					767	768		10.1001/jama.2011.1135	http://dx.doi.org/10.1001/jama.2011.1135			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	807LP	21846862				2022-12-28	WOS:000293900000031
J	Yu, NF; Genevet, P; Kats, MA; Aieta, F; Tetienne, JP; Capasso, F; Gaburro, Z				Yu, Nanfang; Genevet, Patrice; Kats, Mikhail A.; Aieta, Francesco; Tetienne, Jean-Philippe; Capasso, Federico; Gaburro, Zeno			Light Propagation with Phase Discontinuities: Generalized Laws of Reflection and Refraction	SCIENCE			English	Article							ORBITAL ANGULAR-MOMENTUM; NANOSTRUCTURES; REFLECTARRAYS; TRANSMITARRAY; DESIGN; BAND	Conventional optical components rely on gradual phase shifts accumulated during light propagation to shape light beams. New degrees of freedom are attained by introducing abrupt phase changes over the scale of the wavelength. A two-dimensional array of optical resonators with spatially varying phase response and subwavelength separation can imprint such phase discontinuities on propagating light as it traverses the interface between two media. Anomalous reflection and refraction phenomena are observed in this regime in optically thin arrays of metallic antennas on silicon with a linear phase variation along the interface, which are in excellent agreement with generalized laws derived from Fermat's principle. Phase discontinuities provide great flexibility in the design of light beams, as illustrated by the generation of optical vortices through use of planar designer metallic interfaces.	[Yu, Nanfang; Genevet, Patrice; Kats, Mikhail A.; Aieta, Francesco; Tetienne, Jean-Philippe; Capasso, Federico; Gaburro, Zeno] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Genevet, Patrice] Texas A&M Univ, Inst Quantum Studies, College Stn, TX 77843 USA; [Genevet, Patrice] Texas A&M Univ, Dept Phys, College Stn, TX 77843 USA; [Aieta, Francesco] Univ Politecn Marche, Dipartimento Fis & Ingn Mat & Terr, I-60131 Ancona, Italy; [Tetienne, Jean-Philippe] Ecole Normale Super, Lab Photon Quant & Mol, F-94235 Cachan, France; [Tetienne, Jean-Philippe] CNRS, F-94235 Cachan, France; [Gaburro, Zeno] Univ Trent, Dipartimento Fis, I-38100 Trento, Italy	Harvard University; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Marche Polytechnic University; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); University of Trento	Capasso, F (corresponding author), Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA.	capasso@seas.harvard.edu; gaburro@seas.harvard.edu	TETIENNE, Jean-Philippe/Q-4171-2019; Genevet, Patrice/HGB-7010-2022; Genevet, Patrice/AAE-6936-2019; Yu, Nanfang/AAA-2634-2020; Tetienne, Jean-Philippe/H-4896-2014; Kats, Mikhail A./G-6022-2011	TETIENNE, Jean-Philippe/0000-0001-5796-2508; Genevet, Patrice/0000-0003-0216-3885; Tetienne, Jean-Philippe/0000-0001-5796-2508; Kats, Mikhail A./0000-0003-4897-4720	National Science Foundation (NSF), Harvard Nanoscale Science and Engineering Center (NSEC) [NSF/PHY 06-46094]; Center for Nanoscale Systems (CNS) at Harvard University; Defense Advanced Research Projects Agency (DARPA) [N66001-10-1-4008]; European Communities [PIOF-GA-2009-235860]; NSF; Harvard Faculty of Arts and Sciences Sciences Division Research Computing Group	National Science Foundation (NSF), Harvard Nanoscale Science and Engineering Center (NSEC)(National Science Foundation (NSF)); Center for Nanoscale Systems (CNS) at Harvard University; Defense Advanced Research Projects Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); European Communities(European Commission); NSF(National Science Foundation (NSF)); Harvard Faculty of Arts and Sciences Sciences Division Research Computing Group	The authors acknowledge helpful discussion with J. Lin, R. Blanchard, and A. Belyanin. The authors acknowledge support from the National Science Foundation (NSF), Harvard Nanoscale Science and Engineering Center (NSEC) under contract NSF/PHY 06-46094, and the Center for Nanoscale Systems (CNS) at Harvard University. This work was supported in part by the Defense Advanced Research Projects Agency (DARPA) N/MEMS S&T Fundamentals program under grant N66001-10-1-4008 issued by the Space and Naval Warfare Systems Center Pacific (SPAWAR). Z.G. acknowledges funding from the European Communities Seventh Framework Programme (FP7/2007-2013) under grant agreement PIOF-GA-2009-235860. M.A.K. is supported by NSF through a Graduate Research Fellowship. Harvard CNS is a member of the National Nanotechnology Infrastructure Network. The Lumerical (Vancouver, BC, Canada) FDTD simulations in this Research Article were run on the Odyssey cluster supported by the Harvard Faculty of Arts and Sciences Sciences Division Research Computing Group.	ALLEN L, 1992, PHYS REV A, V45, P8185, DOI 10.1103/PhysRevA.45.8185; BEIJERSBERGEN MW, 1994, OPT COMMUN, V112, P321, DOI 10.1016/0030-4018(94)90638-6; Biagioni P, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.256801; BRORSON SD, 1988, J OPT SOC AM B, V5, P247, DOI 10.1364/JOSAB.5.000247; Cai W, 2010, OPTICAL METAMATERIALS: FUNDAMENTALS AND APPLICATIONS, P1, DOI 10.1007/978-1-4419-1151-3; Encinar JA, 2001, IEEE T ANTENN PROPAG, V49, P1403, DOI 10.1109/8.954929; Engheta N., 2006, METAMATERIALS PHYS E, DOI 10.1002/0471784192.; Fan JA, 2010, SCIENCE, V328, P1135, DOI 10.1126/science.1187949; Fattal D, 2010, NAT PHOTONICS, V4, P466, DOI [10.1038/nphoton.2010.116, 10.1038/NPHOTON.2010.116]; Feynman R.P., 1965, QUANTUM MECH PATH IN; Gibson G, 2004, OPT EXPRESS, V12, P5448, DOI 10.1364/OPEX.12.005448; Ginn J, 2010, OPT EXPRESS, V18, P4557, DOI 10.1364/OE.18.004557; Grober RD, 1997, APPL PHYS LETT, V70, P1354, DOI 10.1063/1.118577; HE H, 1995, PHYS REV LETT, V75, P826, DOI 10.1103/PhysRevLett.75.826; Hecht E., 1997, OPTICS, V3; HECKENBERG NR, 1992, OPT LETT, V17, P221, DOI 10.1364/OL.17.000221; Leonhardt U, 2006, SCIENCE, V312, P1777, DOI 10.1126/science.1126493; Liu S, 2009, OPT LETT, V34, P1255, DOI 10.1364/OL.34.001255; Luk'yanchuk B, 2010, NAT MATER, V9, P707, DOI [10.1038/NMAT2810, 10.1038/nmat2810]; Miyazaki HT, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2397037; Novotny L, 2011, NAT PHOTONICS, V5, P83, DOI [10.1038/nphoton.2010.237, 10.1038/NPHOTON.2010.237]; NYE JF, 1974, P ROY SOC LOND A MAT, V336, P165, DOI 10.1098/rspa.1974.0012; Padgett M, 2004, PHYS TODAY, V57, P35, DOI 10.1063/1.1768672; Padilla P, 2010, IEEE T ANTENN PROPAG, V58, P2571, DOI 10.1109/TAP.2010.2050426; Pendry JB, 2006, SCIENCE, V312, P1780, DOI 10.1126/science.1125907; Pozar DM, 1997, IEEE T ANTENN PROPAG, V45, P287, DOI 10.1109/8.560348; Ryan CGM, 2010, IEEE T ANTENN PROPAG, V58, P1486, DOI 10.1109/TAP.2010.2044356; Smolyaninov II, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.067402; Sukharev M, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.184302; Xu QB, 2007, NANO LETT, V7, P2800, DOI 10.1021/nl0713979	30	5630	5875	433	3296	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 21	2011	334	6054					333	337		10.1126/science.1210713	http://dx.doi.org/10.1126/science.1210713			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	835RC	21885733				2022-12-28	WOS:000296052500041
J	Scott, JAG; Berkley, JA; Mwangi, I; Ochola, L; Uyoga, S; Macharia, A; Ndila, C; Lowe, BS; Mwarumba, S; Bauni, E; Marsh, K; Williams, TN				Scott, J. Anthony G.; Berkley, James A.; Mwangi, Isaiah; Ochola, Lucy; Uyoga, Sophie; Macharia, Alexander; Ndila, Carolyne; Lowe, Brett S.; Mwarumba, Salim; Bauni, Evasius; Marsh, Kevin; Williams, Thomas N.			Relation between falciparum malaria and bacteraemia in Kenyan children: a population-based, case-control study and a longitudinal study	LANCET			English	Article							SICKLE-CELL TRAIT; INFLUENZAE TYPE-B; PLASMODIUM-FALCIPARUM; BACTERIAL-INFECTIONS; GAMBIAN CHILDREN; MORTALITY; MORBIDITY; RISK; IMMUNIZATION; ANTIGENS	Background Many investigators have suggested that malaria infection predisposes individuals to bacteraemia. We tested this hypothesis with mendelian randomisation studies of children with the malaria-protective phenotype of sickle-cell trait (HbAS). Methods This study was done in a defined area around Kilifi District Hospital, Kilifi, Kenya. We did a matched case-control study to identify risk factors for invasive bacterial disease, in which cases were children aged 3 months to 13 years who were admitted to hospital with bacteraemia between Sept 16, 1999, and July 31, 2002. We aimed to match two controls, by age, sex, location, and time of recruitment, for every case. We then did a longitudinal case-control study to assess the relation between HbAS and invasive bacterial disease as malaria incidence decreased. Cases were children aged 0-13 years who were admitted to hospital with bacteraemia between Jan 1, 1999, and Dec 31, 2007. Controls were born in the study area between Jan 1, 2006, and June 23, 2009. Finally, we modelled the annual incidence of bacteraemia against the community prevalence of malaria during 9 years with Poisson regression. Results In the matched case-control study, we recruited 292 cases-we recruited two controls for 236, and one for the remaining 56. Sickle-cell disease, HIV, leucocyte haemozoin pigment, and undernutrition were positively associated with bacteraemia and HbAS was strongly negatively associated with bacteraemia (odds ratio 0.36; 95% CI 0.20-0.65). In the longitudinal case-control study, we assessed data from 1454 cases and 10 749 controls. During the study period, the incidence of admission to hospital with malaria per 1000 child-years decreased from 28.5 to 3.45, with a reduction in protection afforded by HbAS against bacteraemia occurring in parallel (p=0.0008). The incidence of hospital admissions for bacteraemia per 1000 child-years also decreased from 2.59 to 1.45. The bacteraemia incidence rate ratio associated with malaria parasitaemia was 6.69 (95% CI 1.31-34.3) and, at a community parasite prevalence of 29% in 1999, 62% (8.2-91) of bacteraemia cases were attributable to malaria. Interpretation Malaria infection strongly predisposes individuals to bacteraemia and can account for more than half of all cases of bacteraemia in malaria-endemic areas. Interventions to control malaria will have a major additional benefit by reducing the burden of invasive bacterial disease.	[Scott, J. Anthony G.; Berkley, James A.; Mwangi, Isaiah; Ochola, Lucy; Uyoga, Sophie; Macharia, Alexander; Ndila, Carolyne; Lowe, Brett S.; Mwarumba, Salim; Bauni, Evasius; Marsh, Kevin; Williams, Thomas N.] Kenya Govt Med Res Ctr, Wellcome Trust Res Programme, Kilifi, Kenya; [Scott, J. Anthony G.; Berkley, James A.; Williams, Thomas N.] Univ Oxford, Dept Med, Oxford, England; [Scott, J. Anthony G.; Williams, Thomas N.] INDEPTH Network, Accra, Ghana; [Williams, Thomas N.] Univ Oxford, Dept Paediat, Oxford, England	Kenya Medical Research Institute; University of Oxford; INDEPTH Network; University of Oxford	Scott, JAG (corresponding author), Ctr Geog Med Res Coast, KEMRI Wellcome Trust Programme, POB 230, Kilifi, Kenya.	ascott@ikilifi.org		Berkley, James/0000-0002-1236-849X; Uyoga, Sophie/0000-0003-1746-7873; Ochola, Lucy/0000-0003-0264-5526	Kenya Medical Research Institute (KEMRI); Wellcome Trust of Great Britain; Wellcome Trust [081835, 083579, 076934]	Kenya Medical Research Institute (KEMRI); Wellcome Trust of Great Britain(Wellcome Trust); Wellcome Trust(Wellcome TrustEuropean Commission)	This study was supported by the Kenya Medical Research Institute (KEMRI) and the Wellcome Trust of Great Britain. JAGS (grant number 081835), JAB (083579), and TNW (076934) are supported by research fellowships from the Wellcome Trust. We thank the patients who took part in this study, and the many staff at Kilifi District Hospital and the KEMRI Centre for Geographic Medicine Research-Coast who contributed to this study including clinical and nursing staff and the staff of the microbiology and genetic laboratories. This paper was published with the permission of the Director of KEMRI.	Aidoo M, 2002, LANCET, V359, P1311, DOI 10.1016/S0140-6736(02)08273-9; ALLISON AC, 1964, COLD SPRING HARB SYM, V29, P137, DOI 10.1101/SQB.1964.029.01.018; ALONSO PL, 1991, LANCET, V337, P1499, DOI 10.1016/0140-6736(91)93194-E; BARRETTCONNOR E, 1971, MEDICINE, V50, P97, DOI 10.1097/00005792-197103000-00002; Berkley JA, 2005, NEW ENGL J MED, V352, P39, DOI 10.1056/NEJMoa040275; BRESLOW NE, 1980, STATISTICAL METHODS, V1, P1; Bronzan RN, 2007, J INFECT DIS, V195, P895, DOI 10.1086/511437; Cowgill KD, 2006, JAMA-J AM MED ASSOC, V296, P671, DOI 10.1001/jama.296.6.671; EECKELS R, 1967, NATURE, V216, P382, DOI 10.1038/216382a0; Giglioli G, 1929, Proc R Soc Med, V23, P165; GIGLIOLI G, 1972, B WORLD HEALTH ORGAN, V46, P181; HILL AVS, 1991, NATURE, V352, P595, DOI 10.1038/352595a0; KAYE D, 1963, J IMMUNOL, V91, P65; Kleinschmidt I, 2009, AM J TROP MED HYG, V80, P882, DOI 10.4269/ajtmh.2009.80.882; MABEY DCW, 1987, J INFECT DIS, V155, P1319, DOI 10.1093/infdis/155.6.1319; Mackenzie G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010568; Mayxay M, 2001, T ROY SOC TROP MED H, V95, P179, DOI 10.1016/S0035-9203(01)90156-7; Molineaux L, 1997, ANN TROP MED PARASIT, V91, P811, DOI 10.1080/00034989760572; MOLINEAUX L, 1985, HLTH POLICY SOCIAL P, P13; Ndiritu M, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-132; O'Meara WP, 2008, LANCET, V372, P1555, DOI 10.1016/S0140-6736(08)61655-4; Ochola LB, 2005, PARASITOLOGY, V131, P449, DOI 10.1017/S0031182005008085; Okiro EA, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-151; PHU NH, 1995, T ROY SOC TROP MED H, V89, P200, DOI 10.1016/0035-9203(95)90496-4; Poehling KA, 2010, EPIDEMIOLOGY, V21, P340, DOI 10.1097/EDE.0b013e3181d61af8; PONGPONRATN E, 1991, AM J TROP MED HYG, V44, P168, DOI 10.4269/ajtmh.1991.44.168; PRADA J, 1993, LANCET, V342, P1114, DOI 10.1016/0140-6736(93)92096-C; Ramakrishnan M, 2010, LANCET INFECT DIS, V10, P329, DOI 10.1016/S1473-3099(10)70055-4; Ross A, 2006, AM J TROP MED HYG, V75, P63, DOI 10.4269/ajtmh.2006.75.63; Schwarzer E., 2008, Parassitologia (Rome), V50, P143; Williams TN, 2009, LANCET, V374, P1364, DOI 10.1016/S0140-6736(09)61374-X; Williams TN, 2005, J INFECT DIS, V192, P178, DOI 10.1086/430744	32	201	202	1	13	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 8	2011	378	9799					1316	1323		10.1016/S0140-6736(11)60888-X	http://dx.doi.org/10.1016/S0140-6736(11)60888-X			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	831IU	21903251	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000295724300026
J	Mariantoni, M; Wang, H; Yamamoto, T; Neeley, M; Bialczak, RC; Chen, Y; Lenander, M; Lucero, E; O'Connell, AD; Sank, D; Weides, M; Wenner, J; Yin, Y; Zhao, J; Korotkov, AN; Cleland, AN; Martinis, JM				Mariantoni, Matteo; Wang, H.; Yamamoto, T.; Neeley, M.; Bialczak, Radoslaw C.; Chen, Y.; Lenander, M.; Lucero, Erik; O'Connell, A. D.; Sank, D.; Weides, M.; Wenner, J.; Yin, Y.; Zhao, J.; Korotkov, A. N.; Cleland, A. N.; Martinis, John M.			Implementing the Quantum von Neumann Architecture with Superconducting Circuits	SCIENCE			English	Article							FOURIER-TRANSFORM; ENTANGLED STATES; COMPUTATION; GATES; BITS	The von Neumann architecture for a classical computer comprises a central processing unit and a memory holding instructions and data. We demonstrate a quantum central processing unit that exchanges data with a quantum random-access memory integrated on a chip, with instructions stored on a classical computer. We test our quantum machine by executing codes that involve seven quantum elements: Two superconducting qubits coupled through a quantum bus, two quantum memories, and two zeroing registers. Two vital algorithms for quantum computing are demonstrated, the quantum Fourier transform, with 66% process fidelity, and the three-qubit Toffoli-class OR phase gate, with 98% phase fidelity. Our results, in combination especially with longer qubit coherence, illustrate a potentially viable approach to factoring numbers and implementing simple quantum error correction codes.	[Mariantoni, Matteo; Wang, H.; Yamamoto, T.; Neeley, M.; Bialczak, Radoslaw C.; Chen, Y.; Lenander, M.; Lucero, Erik; O'Connell, A. D.; Sank, D.; Weides, M.; Wenner, J.; Yin, Y.; Zhao, J.; Cleland, A. N.; Martinis, John M.] Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA; [Yamamoto, T.] NEC Corp Ltd, Green Innovat Res Labs, Tsukuba, Ibaraki 3058501, Japan; [Korotkov, A. N.] Univ Calif Riverside, Dept Elect Engn, Riverside, CA 92521 USA; [Mariantoni, Matteo; Cleland, A. N.; Martinis, John M.] Univ Calif Santa Barbara, Calif NanoSyst Inst, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; NEC Corporation; University of California System; University of California Riverside; University of California System; University of California Santa Barbara	Mariantoni, M (corresponding author), Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA.	matmar@physics.ucsb.edu; martinis@physics.ucsb.edu	chen, Yu/B-3363-2011; Wenner, James/G-3777-2014; Wang, Haohua/G-8875-2011; Cleland, Andrew/AAG-7581-2019; Weides, Martin/C-1470-2009	Wenner, James/0000-0001-7107-4734; Wang, Haohua/0000-0001-5380-4297; Weides, Martin/0000-0002-2718-6795	Intelligence Advanced Research Projects Activity (IARPA) under ARO [W911NF-08-1-0336, W911NF-09-1-0375]; Elings Postdoctoral Fellowship; NSF	Intelligence Advanced Research Projects Activity (IARPA) under ARO; Elings Postdoctoral Fellowship; NSF(National Science Foundation (NSF))	This work was supported by Intelligence Advanced Research Projects Activity (IARPA) under ARO award W911NF-08-1-0336 and under Army Research Office (ARO) award W911NF-09-1-0375. M. M. acknowledges support from an Elings Postdoctoral Fellowship. Devices were made at the University of California Santa Barbara Nanofabrication Facility, a part of the NSF-funded National Nanotechnology Infrastructure Network. The authors thank A. G. Fowler for useful comments on scalability, and M. H. Devoret and R. J. Schoelkopf for discussions on Toffoli gates. M. M. performed the experiments and analyzed the data. M. M. and H. W. fabricated the sample. T.Y., H. W., and Y.Y. helped with the Fourier transform, and M.N. with three-qubit gates. M. M., A.N.C., and J. M. M. conceived the experiment and cowrote the manuscript.	BARENCO A, 1995, PHYS REV A, V52, P3457, DOI 10.1103/PhysRevA.52.3457; Blatt R, 2008, NATURE, V453, P1008, DOI 10.1038/nature07125; Chiaverini J, 2005, SCIENCE, V308, P997, DOI 10.1126/science.1110335; Choi KS, 2008, NATURE, V452, P67, DOI 10.1038/nature06670; Clarke J, 2008, NATURE, V453, P1031, DOI 10.1038/nature07128; Cory DG, 1998, PHYS REV LETT, V81, P2152, DOI 10.1103/PhysRevLett.81.2152; David Mermin N., 2007, QUANTUM COMPUTER SCI; DiCarlo L, 2010, NATURE, V467, P574, DOI 10.1038/nature09416; DiCarlo L, 2009, NATURE, V460, P240, DOI 10.1038/nature08121; DiVincenzo DP, 2000, FORTSCHR PHYS, V48, P771, DOI 10.1002/1521-3978(200009)48:9/11<771::AID-PROP771>3.0.CO;2-E; Horodecki R, 2009, REV MOD PHYS, V81, P865, DOI 10.1103/RevModPhys.81.865; Lanyon BP, 2009, NAT PHYS, V5, P134, DOI 10.1038/NPHYS1150; Leek PJ, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.180511; Mariantoni M, 2011, NAT PHYS, V7, P287, DOI [10.1038/nphys1885, 10.1038/NPHYS1885]; Monz T, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.040501; Neeley M, 2010, NATURE, V467, P570, DOI 10.1038/nature09418; Nielsen Michael A., 2002, QUANTUM COMPUTATION; Plantenberg JH, 2007, NATURE, V447, P836, DOI 10.1038/nature05896; Ralph TC, 2007, PHYS REV A, V75, DOI 10.1103/PhysRevA.75.022313; Strauch FW, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.167005; Vandersypen LMK, 2001, NATURE, V414, P883, DOI 10.1038/414883a; Wang H, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.060401; Weinstein YS, 2001, PHYS REV LETT, V86, P1889, DOI 10.1103/PhysRevLett.86.1889; Wiseman H. M., 2010, QUANTUM MEASUREMENT; Yamamoto T, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.184515	27	215	220	1	102	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 7	2011	334	6052					61	65		10.1126/science.1208517	http://dx.doi.org/10.1126/science.1208517			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	829KW	21885732	Green Submitted			2022-12-28	WOS:000295580300038
J	Cuffey, KM				Cuffey, Kurt M.			Antarctic Ice Flow Revealed	SCIENCE			English	Editorial Material							RADAR INTERFEROMETRY		Univ Calif Berkeley, Dept Geog, Ctr Atmospher Sci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Cuffey, KM (corresponding author), Univ Calif Berkeley, Dept Geog, Ctr Atmospher Sci, 507 McCone Hall, Berkeley, CA 94720 USA.	kcuffey@berkeley.edu						Cuffey K., 2010, PHYS GLACIERS; GOLDSTEIN RM, 1993, SCIENCE, V262, P1525, DOI 10.1126/science.262.5139.1525; Joughin I, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2003JB002960; Rignot E, 2011, SCIENCE, V333, P1427, DOI 10.1126/science.1208336; Rignot E, 2008, NAT GEOSCI, V1, P106, DOI 10.1038/ngeo102; Shepherd A, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL021106; TWAIN M, 1880, TRAMP ABROAD; Velicogna I, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL040222	8	1	1	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 9	2011	333	6048					1386	1387		10.1126/science.1211157	http://dx.doi.org/10.1126/science.1211157			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817KU	21903797				2022-12-28	WOS:000294672200024
J	Hada, K; Doi, A; Kino, M; Nagai, H; Hagiwara, Y; Kawaguchi, N				Hada, Kazuhiro; Doi, Akihiro; Kino, Motoki; Nagai, Hiroshi; Hagiwara, Yoshiaki; Kawaguchi, Noriyuki			An origin of the radio jet in M87 at the location of the central black hole	NATURE			English	Article							ACTIVE GALACTIC NUCLEI; GAMMA-RAY EMISSION; INNER JET; RELATIVISTIC JETS; CENTRAL ENGINE; GALAXY M87; 3C 279; ACCRETION; MOTION; FLARE	Powerful radio jets from active galactic nuclei are thought to be powered by the accretion of material onto the supermassive black hole (the 'central engine')(1,2). M87 is one of the closest examples of this phenomenon, and the structure of its jet has been probed on a scale of about 100 Schwarzschild radii (R(s), the radius of the event horizon)(3). However, the location of the central black hole relative to the jet base (a bright compact radio 'core') remains elusive(4,5). Observations of other jets indicate that the central engines are located about 10(4)-10(6)R(s) upstream from the radio core(6-9). Here we report radio observations of M87 at six frequencies that allow us to achieve a positional accuracy of about 20 microarcseconds. As the jet base becomes more transparent at higher frequencies, the multifrequency position measurements of the radio core enable us to determine the upstream end of the jet. The data reveal that the central engine of M87 is located within 14-23R(s) of the radio core at 43 GHz. This implies that the site of material infall onto the black hole and the eventual origin of the jet reside in the bright compact region seen on the image at 43 GHz.	[Hada, Kazuhiro; Hagiwara, Yoshiaki; Kawaguchi, Noriyuki] Grad Univ Adv Studies SOKENDAI, Dept Astron Sci, Tokyo 1818588, Japan; [Hada, Kazuhiro; Kino, Motoki; Nagai, Hiroshi; Hagiwara, Yoshiaki; Kawaguchi, Noriyuki] Natl Astron Observ Japan, Tokyo 1818588, Japan; [Doi, Akihiro; Nagai, Hiroshi] Japan Aerosp Explorat Agcy, Inst Space & Astronaut Sci, Chuo Ku, Kanagawa 2525210, Japan; [Doi, Akihiro] Grad Univ Adv Studies SOKENDAI, Dept Space & Astronaut Sci, Chuo Ku, Kanagawa 2525210, Japan	Graduate University for Advanced Studies - Japan; National Institutes of Natural Sciences (NINS) - Japan; National Astronomical Observatory of Japan (NAOJ); Japan Aerospace Exploration Agency (JAXA); Institute of Space & Astronautical Science (ISAS); Graduate University for Advanced Studies - Japan	Hada, K (corresponding author), Grad Univ Adv Studies SOKENDAI, Dept Astron Sci, 2-21-1 Osawa, Tokyo 1818588, Japan.	kazuhiro.hada@nao.ac.jp			Graduate University for Advanced Studies (Sokendai)	Graduate University for Advanced Studies (Sokendai)(Graduate University for Advanced Studies - Japan)	We thank M. Honma, H. Sudou and T. Hirota for discussions about the astrometry analysis; and K. Asada, G. Giovannini, M. Giroletti, M. Inoue, S. Kameno, S. Koide, S. Sasaki, L. Stawarz, N. Sugiyama and N. Yoshida for comments. The Very Long Baseline Array is operated by the National Radio Astronomy Observatory, a facility of the National Science Foundation, operated under cooperative agreement by Associated Universities, Inc. This work was supported in part by the Graduate University for Advanced Studies (Sokendai).	Abdo AA, 2010, NATURE, V463, P919, DOI 10.1038/nature08841; Acciari VA, 2009, SCIENCE, V325, P444, DOI 10.1126/science.1175406; Agudo I, 2011, ASTROPHYS J LETT, V726, DOI 10.1088/2041-8205/726/1/L13; BARTEL N, 1986, NATURE, V319, P733, DOI 10.1038/319733a0; Biretta JA, 1999, ASTROPHYS J, V520, P621, DOI 10.1086/307499; Biretta JA, 2002, NEW ASTRON REV, V46, P239, DOI 10.1016/S1387-6473(01)00188-9; BLANDFORD RD, 1982, MON NOT R ASTRON SOC, V199, P883, DOI 10.1093/mnras/199.4.883; BLANDFORD RD, 1979, ASTROPHYS J, V232, P34, DOI 10.1086/157262; Broderick AE, 2009, ASTROPHYS J, V697, P1164, DOI 10.1088/0004-637X/697/2/1164; Chang CS, 2010, ASTRON ASTROPHYS, V515, DOI 10.1051/0004-6361/200913915; Cheung CC, 2007, ASTROPHYS J, V663, pL65, DOI 10.1086/520510; Di Matteo T, 2003, ASTROPHYS J, V582, P133, DOI 10.1086/344504; Doeleman SS, 2008, NATURE, V455, P78, DOI 10.1038/nature07245; Gebhardt K, 2009, ASTROPHYS J, V700, P1690, DOI 10.1088/0004-637X/700/2/1690; Ghisellini G, 2005, ASTRON ASTROPHYS, V432, P401, DOI 10.1051/0004-6361:20041404; HARRIS DE, 2008, ASP C SER, V386, P80; Jordan A, 2005, ASTROPHYS J, V634, P1002, DOI 10.1086/497092; Junor W, 1999, NATURE, V401, P891, DOI 10.1038/44780; KONIGL A, 1981, ASTROPHYS J, V243, P700, DOI 10.1086/158638; Kovalev YY, 2007, ASTROPHYS J, V668, pL27, DOI 10.1086/522603; Larionov VM, 2008, ASTRON ASTROPHYS, V492, P389, DOI 10.1051/0004-6361:200810937; Lobanov AP, 1998, ASTRON ASTROPHYS, V330, P79; Ly C, 2007, ASTROPHYS J, V660, P200, DOI 10.1086/512846; Marscher AP, 2008, NATURE, V452, P966, DOI 10.1038/nature06895; Marscher AP, 2010, ASTROPHYS J LETT, V710, pL126, DOI 10.1088/2041-8205/710/2/L126; McKinney JC, 2006, MON NOT R ASTRON SOC, V368, P1561, DOI 10.1111/j.1365-2966.2006.10256.x; O'Sullivan SP, 2009, MON NOT R ASTRON SOC, V400, P26, DOI 10.1111/j.1365-2966.2009.15428.x; Takahashi R, 2011, ASTROPHYS J, V729, DOI 10.1088/0004-637X/729/2/86; Yuan F, 2000, MON NOT R ASTRON SOC, V319, P1178, DOI 10.1046/j.1365-8711.2000.03939.x	29	196	197	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 8	2011	477	7363					185	187		10.1038/nature10387	http://dx.doi.org/10.1038/nature10387			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	816MC	21901008				2022-12-28	WOS:000294603900029
J	Cassidy, J				Cassidy, Jane			LOBBY WATCH Islamic Medical Association	BRITISH MEDICAL JOURNAL			English	Editorial Material												janecassi2@googlemail.com							0	1	1	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 7	2011	343								d5592	10.1136/bmj.d5592	http://dx.doi.org/10.1136/bmj.d5592			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	819RQ	21900349				2022-12-28	WOS:000294847800006
J	Young, J; Meagher, D; MacLullich, A				Young, John; Meagher, David; MacLullich, Alasdair			Cognitive assessment of older people	BRITISH MEDICAL JOURNAL			English	Review							DELIRIUM; DEPRESSION; IMPAIRMENT; DEMENTIA; VALIDITY		[Young, John] Univ Leeds, Leeds Inst Hlth Sci, Acad Unit Elderly Care & Rehabil, Leeds LS2 9LJ, W Yorkshire, England; [Meagher, David] Univ Limerick, Sch Med, Limerick, Ireland; [Meagher, David] Midwestern Reg Hosp, Limerick, Ireland; [MacLullich, Alasdair] Univ Edinburgh, Royal Infirm Edinburgh, Edinburgh Delirium Res Grp, Edinburgh EH16 4TJ, Midlothian, Scotland	University of Leeds; University of Limerick; University of Limerick; Royal Infirmary of Edinburgh; University of Edinburgh	Young, J (corresponding author), Bradford Teaching Hosp NHS Fdn Trust, Bradford Inst Hlth Res, Acad Unit Elderly Care & Rehabil, Bradford BD9 6RJ, W Yorkshire, England.	john.young@bradfordhospitals.nhs.uk		MacLullich, Alasdair/0000-0003-3159-9370; young, john/0000-0003-4085-9306	Medical Research Council [G0700704, G108/646] Funding Source: Medline; MRC [G108/646, G0700704] Funding Source: UKRI; Medical Research Council [G0700704B] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Alexapoulos GS, 2005, LANCET, V365, P1961, DOI 10.1016/S0140-6736(05)66665-2; [Anonymous], 2006, DEM SUPP PEOPL DEM T; Brodaty H, 2002, J AM GERIATR SOC, V50, P530, DOI 10.1046/j.1532-5415.2002.50122.x; Clegg A, 2011, AGE AGEING, V40, P23, DOI 10.1093/ageing/afq140; Collins N, 2010, AGE AGEING, V39, P131, DOI 10.1093/ageing/afp201; Davis D, 2009, AGE AGEING, V38, P559, DOI 10.1093/ageing/afp099; Fong TG, 2009, NEUROLOGY, V72, P1570, DOI 10.1212/WNL.0b013e3181a4129a; Galvin JE, 2006, NEUROLOGY, V67, P1942, DOI 10.1212/01.wnl.0000247042.15547.eb; Gonzalez M, 2009, PSYCHOSOMATICS, V50, P234, DOI 10.1176/appi.psy.50.3.234; Inouye S. K., 2003, CONFUSION ASSESSMENT; INOUYE SK, 1990, ANN INTERN MED, V113, P941, DOI 10.7326/0003-4819-113-12-941; JORM AF, 2004, INT PSYCHOGERIATR, V16, P1, DOI DOI 10.1017/S1041610204000018; Li CY, 2007, J AM GERIATR SOC, V55, P596, DOI 10.1111/j.1532-5415.2007.01103.x; MacLullich AMJ, 2009, INT REV PSYCHIATR, V21, P30, DOI 10.1080/09540260802675031; National Institute for Health and Clinical Excellence National Clinical Guideline Centre, 2010, DEL DIAGN PREV MAN; Royal College of Psychiatrists. National Audit of Dementia (Care in General Hospitals), 2010, NAT AUD DEM CAR GEN; SANS MB, 2010, PALLIATIVE MED, V24, P561; Schofield I, 2010, EUR J EMERG MED, V17, P340, DOI 10.1097/MEJ.0b013e32833777ab; Woodford HJ, 2007, QJM-INT J MED, V100, P469, DOI 10.1093/qjmed/hcm051	19	33	33	1	13	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 7	2011	343								d5042	10.1136/bmj.d5042	http://dx.doi.org/10.1136/bmj.d5042			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	819RQ	21900345	Green Submitted			2022-12-28	WOS:000294847800001
J	Farley, TA; Weisfuse, I				Farley, Thomas A.; Weisfuse, Isaac			Redefining of public health preparedness after 9/11	LANCET			English	Editorial Material							NEW-YORK-CITY; REGISTRY		[Farley, Thomas A.] New York City Dept Hlth & Mental Hyg, Gotham Ctr, Queens, NY 11101 USA	New York City Department of Health & Mental Hygiene	Farley, TA (corresponding author), New York City Dept Hlth & Mental Hyg, Gotham Ctr, Queens, NY 11101 USA.	tfarley@health.nyc.gov						Beatty ME, 2006, PUBLIC HEALTH REP, V121, P36, DOI 10.1177/003335490612100109; Blank S, 2003, EMERG INFECT DIS, V9, P615; Brackbill RM, 2009, JAMA-J AM MED ASSOC, V302, P502, DOI 10.1001/jama.2009.1121; Farfel M, 2008, J URBAN HEALTH, V85, P880, DOI 10.1007/s11524-008-9317-4; Heffernan Richard, 2004, MMWR Suppl, V53, P23; Lessler J, 2009, NEW ENGL J MED, V361, P2628, DOI 10.1056/NEJMoa0906089; Murphy J, 2007, STAT MED, V26, P1688, DOI 10.1002/sim.2806; New York City Department of Health and Mental Hygiene, WORLD TRAD CTR HLTH; *NY CIT DEP HLTH M, 2003, SUMM VIT STAT 2002 C; Rani S, 2022, SPAT INF RES, V30, P417, DOI 10.1007/s41324-022-00442-9; Rinchiuso-Hasselmann A, 2011, BIOSECUR BIOTERROR, V9, P13, DOI 10.1089/bsp.2010.0049; Trang QN, 2010, J PUBLIC HEALTH MAN, V16, P189, DOI 10.1097/PHH.0b013e3181ca64f2; United States General Accounting Office, 2001, BIOT REV PUBL HLTH P; Who, 2008, CIT PUBL HLTH CRIS R	14	5	5	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 3	2011	378	9794					957	959		10.1016/S0140-6736(11)60969-0	http://dx.doi.org/10.1016/S0140-6736(11)60969-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	818XZ	21890061				2022-12-28	WOS:000294791300037
J	Fleischhauer, M				Fleischhauer, Michael			Switching Light by Vacuum	SCIENCE			English	Editorial Material							ELECTROMAGNETICALLY INDUCED TRANSPARENCY; ONE-ATOM; CAVITY		[Fleischhauer, Michael] Univ Kaiserslautern, Fachbereich Phys, D-67663 Kaiserslautern, Germany; [Fleischhauer, Michael] Univ Kaiserslautern, Res Ctr OPTIMAS, D-67663 Kaiserslautern, Germany	University of Kaiserslautern; University of Kaiserslautern	Fleischhauer, M (corresponding author), Univ Kaiserslautern, Fachbereich Phys, D-67663 Kaiserslautern, Germany.	mfleisch@physik.uni-kl.de	Fleischhauer, Michael/G-6716-2011; Fleischhauer, Michael/ABC-1472-2021	Fleischhauer, Michael/0000-0003-4059-7289				Birnbaum KM, 2005, NATURE, V436, P87, DOI 10.1038/nature03804; Boozer AD, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.193601; FIELD JE, 1993, PHYS REV A, V47, P5064, DOI 10.1103/PhysRevA.47.5064; Fleischhauer M, 2005, REV MOD PHYS, V77, P633, DOI 10.1103/RevModPhys.77.633; Hijlkema M, 2007, NAT PHYS, V3, P253, DOI 10.1038/nphys569; Kampschulte T, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.153603; Kuhn A, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.067901; McKeever J, 2004, SCIENCE, V303, P1992, DOI 10.1126/science.1095232; Mucke M, 2010, NATURE, V465, P755, DOI 10.1038/nature09093; Specht HP, 2011, NATURE, V473, P190, DOI 10.1038/nature09997; Tanji-Suzuki H, 2011, SCIENCE, V333, P1266, DOI 10.1126/science.1208066	11	4	4	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 2	2011	333	6047					1228	1229		10.1126/science.1210104	http://dx.doi.org/10.1126/science.1210104			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	813YM	21885762				2022-12-28	WOS:000294406400030
J	Vinson, V; Pennisi, E				Vinson, Valda; Pennisi, Elizabeth			The Allure of Synthetic Biology INTRODUCTION	SCIENCE			English	Editorial Material													Vinson, Valda/GVR-8232-2022						0	5	5	2	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 2	2011	333	6047					1235	1235		10.1126/science.333.6047.1235	http://dx.doi.org/10.1126/science.333.6047.1235			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	813YM	21885767				2022-12-28	WOS:000294406400035
J	Chamarthi, B; Greene, MF; Dluhy, RG				Chamarthi, Bindu; Greene, Michael F.; Dluhy, Robert G.			A Problem in Gestation	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PRIMARY HYPERPARATHYROIDISM; PARATHYROID-HORMONE; HUMAN-PREGNANCY; CALCIUM; PANCREATITIS; METABOLISM; PEPTIDE		[Chamarthi, Bindu; Dluhy, Robert G.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Endocrinol Diabet & Hypertens, Boston, MA 02115 USA; [Greene, Michael F.] Massachusetts Gen Hosp, Dept Obstet & Gynecol, Boston, MA 02114 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Massachusetts General Hospital	Chamarthi, B (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Endocrinol Diabet & Hypertens, 221 Longwood Ave, Boston, MA 02115 USA.	bchamarthi@partners.org						Carnaille B, 1998, AUST NZ J SURG, V68, P117, DOI 10.1111/j.1445-2197.1998.tb04719.x; DAHLMAN T, 1994, ACTA OBSTET GYN SCAN, V73, P393, DOI 10.3109/00016349409006250; Eddy JJ, 2008, OBSTET GYNECOL, V112, P1075, DOI 10.1097/AOG.0b013e318185a032; FENTON AJ, 1991, ENDOCRINOLOGY, V129, P1762, DOI 10.1210/endo-129-4-1762; GERTNER JM, 1986, AM J MED, V81, P451, DOI 10.1016/0002-9343(86)90298-6; Jacob JJ, 2006, ANZ J SURG, V76, P740, DOI 10.1111/j.1445-2197.2006.03845.x; Khoo TK, 2009, J CLIN ENDOCR METAB, V94, P2115, DOI 10.1210/jc.2008-1965; Kovacs CS, 1996, P NATL ACAD SCI USA, V93, P15233, DOI 10.1073/pnas.93.26.15233; Kovacs CS, 2001, J CLIN ENDOCR METAB, V86, P2344, DOI 10.1210/jc.86.6.2344; Lockitch G, 1997, CRIT REV CL LAB SCI, V34, P67, DOI 10.3109/10408369709038216; PIECHOTA W, 1992, EUR J OBSTET GYN R B, V45, P27, DOI 10.1016/0028-2243(92)90190-A; PITKIN RM, 1977, AM J OBSTET GYNECOL, V127, P775, DOI 10.1016/0002-9378(77)90256-3; REDDY GS, 1983, J CLIN ENDOCR METAB, V56, P363, DOI 10.1210/jcem-56-2-363; Schnatz PF, 2002, OBSTET GYNECOL SURV, V57, P365, DOI 10.1097/00006254-200206000-00022; Seely EW, 1997, AM J OBSTET GYNECOL, V176, P214, DOI 10.1016/S0002-9378(97)80039-7	15	6	7	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 1	2011	365	9					843	848		10.1056/NEJMcps0902919	http://dx.doi.org/10.1056/NEJMcps0902919			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	813YC	21879903				2022-12-28	WOS:000294405200013
J	Taylor, MR				Taylor, Michael R.			Will the Food Safety Modernization Act Help Prevent Outbreaks of Foodborne Illness?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									US FDA, Off Deputy Commissioner Foods, Silver Spring, MD 20993 USA	US Food & Drug Administration (FDA)	Taylor, MR (corresponding author), US FDA, Off Deputy Commissioner Foods, Silver Spring, MD 20993 USA.							Cavallaro E, 2011, NEW ENGL J MED, V365, P601, DOI 10.1056/NEJMoa1011208; Frank C, 2011, NEW ENGL J MED, V365, P1771, DOI 10.1056/NEJMoa1106483	2	19	19	0	21	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 1	2011	365	9							e18	10.1056/NEJMp1109388	http://dx.doi.org/10.1056/NEJMp1109388			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	813YC	21848454				2022-12-28	WOS:000294405200004
J	Hashimoto, S; Boissel, S; Zarhrate, M; Rio, M; Munnich, A; Egly, JM; Colleaux, L				Hashimoto, Satoru; Boissel, Sarah; Zarhrate, Mohammed; Rio, Marlene; Munnich, Arnold; Egly, Jean-Marc; Colleaux, Laurence			MED23 Mutation Links Intellectual Disability to Dysregulation of Immediate Early Gene Expression	SCIENCE			English	Article							PREINITIATION COMPLEX; TRANSCRIPTIONAL REGULATION; CHROMATIN MODIFICATION; MEDIATOR COMPLEX; ACTIVATION; MECHANISM; TFIIH; RECRUITMENT; PATHWAY; JUN	MED23 is a subunit of the Mediator complex, a key regulator of protein-coding gene expression. Here, we report a missense mutation (p. R617Q) in MED23 that cosegregates with nonsyndromic autosomal recessive intellectual disability. This mutation specifically impaired the response of JUN and FOS immediate early genes (IEGs) to serum mitogens by altering the interaction between enhancer-bound transcription factors (TCF4 and ELK1, respectively) and Mediator. Transcriptional dysregulation of these genes was also observed in cells derived from patients presenting with other neurological disorders linked to mutations in other Mediator subunits or proteins interacting with MED. These findings highlight the crucial role of Mediator in brain development and functioning and suggest that altered IEG expression might be a common molecular hallmark of cognitive deficit.	[Hashimoto, Satoru; Egly, Jean-Marc] Univ Strasbourg, INSERM, CNRS, Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, Cu Strasbourg, France; [Boissel, Sarah; Zarhrate, Mohammed; Rio, Marlene; Munnich, Arnold; Colleaux, Laurence] Univ Paris 05, Hop Necker Enfants Malad, INSERM U781, F-75015 Paris, France; [Boissel, Sarah; Zarhrate, Mohammed; Rio, Marlene; Munnich, Arnold; Colleaux, Laurence] Univ Paris 05, Hop Necker Enfants Malad, Fdn IMAGINE, Dept Genet, F-75015 Paris, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Egly, JM (corresponding author), Univ Strasbourg, INSERM, CNRS, Inst Genet & Biol Mol & Cellulaire, BP 163, F-67404 Illkirch Graffenstaden, Cu Strasbourg, France.	egly@igbmc.fr; laurence.colleaux@inserm.fr	COLLEAUX, LAURENCE/AAA-8144-2022; COLLEAUX, Laurence/H-6455-2017	COLLEAUX, LAURENCE/0000-0002-0987-7648; Rio, Marlene/0000-0003-2049-5058	European Research Council [2009]; French National Research Agency [ANR-08-GENOPAT-042, ANR-08-MNP-010]; Association pour la Recherche sur le Cancer [SL220100601335]; Centre National de la Recherche Scientifique; INSERM; Region Ile-de France; Fondation pour la Recherche Medicale; Fondation Jerome Lejeune	European Research Council(European Research Council (ERC)European Commission); French National Research Agency(French National Research Agency (ANR)); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Region Ile-de France(Region Ile-de-France); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Fondation Jerome Lejeune	We are grateful to the patients and their families for their participation in the study. We thank J. P. Jais for LOD-score calculation. Work in the J.-M. Egly's laboratory was supported by a European Research Council Advanced Grant 2009, the French National Research Agency (no. ANR-08-GENOPAT-042), and the Association pour la Recherche sur le Cancer (SL220100601335). L. Colleaux's laboratory was supported in part by the Centre National de la Recherche Scientifique and the French National Research Agency (no. ANR-08-MNP-010). S.H. was supported by an INSERM young investigator grant. S.B. was supported by the Region Ile-de France, the Fondation pour la Recherche Medicale, and the Fondation Jerome Lejeune. The authors declare that they have no conflicts of interest.	Akoulitchev S, 2000, NATURE, V407, P102, DOI 10.1038/35024111; Balamotis MA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.1164302; Black JC, 2006, MOL CELL, V23, P809, DOI 10.1016/j.molcel.2006.07.018; Buchwalter G, 2004, GENE, V324, P1, DOI 10.1016/j.gene.2003.09.028; Cai G, 2009, STRUCTURE, V17, P559, DOI 10.1016/j.str.2009.01.016; Cantin GT, 2003, P NATL ACAD SCI USA, V100, P12003, DOI 10.1073/pnas.2035253100; Cleaver JE, 2009, NAT REV GENET, V10, P756, DOI 10.1038/nrg2663; Compe E, 2007, NAT NEUROSCI, V10, P1414, DOI 10.1038/nn1990; Conaway RC, 2005, TRENDS BIOCHEM SCI, V30, P250, DOI 10.1016/j.tibs.2005.03.002; Esnault C, 2008, MOL CELL, V31, P337, DOI 10.1016/j.molcel.2008.06.021; Hazzalin CA, 2002, NAT REV MOL CELL BIO, V3, P30, DOI 10.1038/nrm715; Herdegen T, 1998, BRAIN RES REV, V28, P370, DOI 10.1016/S0165-0173(98)00018-6; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kornberg RD, 2005, TRENDS BIOCHEM SCI, V30, P235, DOI 10.1016/j.tibs.2005.03.011; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Le May N, 2010, MOL CELL, V38, P54, DOI 10.1016/j.molcel.2010.03.004; Malik S, 2010, NAT REV GENET, V11, P761, DOI 10.1038/nrg2901; Nateri AS, 2005, NATURE, V437, P281, DOI 10.1038/nature03914; Phatnani HP, 2006, GENE DEV, V20, P2922, DOI 10.1101/gad.1477006; Risheg H, 2007, NAT GENET, V39, P451, DOI 10.1038/ng1992; Sanyal S, 2002, NATURE, V416, P870, DOI 10.1038/416870a; Schwartz CE, 2007, J MED GENET, V44, P472, DOI 10.1136/jmg.2006.048637; SINGH N, 1995, GENE DEV, V9, P2251, DOI 10.1101/gad.9.18.2251; Soutourina J, 2011, SCIENCE, V331, P1451, DOI 10.1126/science.1200188; Stevens JL, 2002, SCIENCE, V296, P755, DOI 10.1126/science.1068943; Taatjes DJ, 2010, TRENDS BIOCHEM SCI, V35, P315, DOI 10.1016/j.tibs.2010.02.004; Tischmeyer W, 1999, CELL MOL LIFE SCI, V55, P564, DOI 10.1007/s000180050315; Wang G, 2005, MOL CELL, V17, P683, DOI 10.1016/j.molcel.2005.02.010	28	83	91	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 26	2011	333	6046					1161	1163		10.1126/science.1206638	http://dx.doi.org/10.1126/science.1206638			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811VM	21868677				2022-12-28	WOS:000294244300053
J	Hayes, M; Scarlata, C; Siana, B				Hayes, Matthew; Scarlata, Claudia; Siana, Brian			Central powering of the largest Lyman-alpha nebula is revealed by polarized radiation	NATURE			English	Article							RESONANCE-LINE RADIATION; COLD ACCRETION; GALAXIES; BLOBS	High-redshift Lyman-alpha (Ly alpha) blobs(1,2) are extended, luminous but rare structures that seem to be associated with the highest peaks in the matter density of the Universe(3-6). Their energy output and morphology are similar to those of powerful radio galaxies(7), but the source of the luminosity is unclear. Some blobs are associated with ultraviolet or infrared bright galaxies, suggesting an extreme starburst event or accretion onto a central black hole(8-10). Another possibility is gas that is shock-excited by supernovae(11,12). But not all blobs are associated with galaxies(13,14), and these ones may instead be heated by gas falling into a dark-matter halo(15-19). The polarization of the Lya emission can in principle distinguish between these options(20-22), but a previous attempt to detect this signature returned a null detection(23). Here we report observations of polarized Ly alpha from the blob LAB1 (ref. 2). Although the central region shows no measurable polarization, the polarized fraction (P) increases to similar to 20 per cent at a radius of 45 kiloparsecs, forming an almost complete polarized ring. The detection of polarized radiation is inconsistent with the in situ production of Ly alpha photons, and we conclude that they must have been produced in the galaxies hosted within the nebula, and re-scattered by neutral hydrogen.	[Hayes, Matthew] Univ Toulouse, UPS OMP IRAP, Toulouse, France; [Hayes, Matthew] CNRS, IRAP, F-31400 Toulouse, France; [Hayes, Matthew] Univ Geneva, Observ Geneva, CH-1290 Versoix, Switzerland; [Scarlata, Claudia] Univ Minnesota, Sch Phys & Astron, Minnesota Inst Astrophys, Minneapolis, MN 55455 USA; [Scarlata, Claudia] CALTECH, Spitzer Sci Ctr, Pasadena, CA 91125 USA; [Siana, Brian] CALTECH, Dept Astron, Pasadena, CA 91125 USA	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); University of Geneva; University of Minnesota System; University of Minnesota Twin Cities; California Institute of Technology; California Institute of Technology	Hayes, M (corresponding author), Univ Toulouse, UPS OMP IRAP, Toulouse, France.	matthew.hayes@ast.obs-mip.fr	Hayes, Matthew J/D-6692-2014	Hayes, Matthew J/0000-0001-8587-218X	European Southern Observatory telescopes at the Paranal Observatory [084.A-0954]; Swiss National Science Foundation; Agence Nationale de la Recherche [ANR-09-BLAN-0234-01]	European Southern Observatory telescopes at the Paranal Observatory; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Agence Nationale de la Recherche(French National Research Agency (ANR))	We thank P. Ogle and J. Colbert for valuable suggestions about polarimetric observations; N. Panagia and T. Jones for comments on the manuscript; and D. Schaerer, N. Scoville, C. Lidman, A. Dey, M. Prescott and P. Lynam for discussions. This work was based on observations made with European Southern Observatory telescopes at the Paranal Observatory under programme ID 084.A-0954. M. H. was supported in part by the Swiss National Science Foundation, and also received support from Agence Nationale de la Recherche (reference ANR-09-BLAN-0234-01).	ADAMS TF, 1972, ASTROPHYS J, V174, P439, DOI 10.1086/151503; Colbert JW, 2011, ASTROPHYS J, V728, DOI 10.1088/0004-637X/728/1/59; Dekel A, 2008, MON NOT R ASTRON SOC, V383, P119, DOI 10.1111/j.1365-2966.2007.12569.x; Dijkstra M, 2008, MON NOT R ASTRON SOC, V386, P492, DOI 10.1111/j.1365-2966.2008.13066.x; Dijkstra M, 2009, MON NOT R ASTRON SOC, V400, P1109, DOI 10.1111/j.1365-2966.2009.15533.x; Fardal MA, 2001, ASTROPHYS J, V562, P605, DOI 10.1086/323519; Faucher-Giguere CA, 2010, ASTROPHYS J, V725, P633, DOI 10.1088/0004-637X/725/1/633; Francis PJ, 1996, ASTROPHYS J, V457, P490, DOI 10.1086/176747; Geach JE, 2009, ASTROPHYS J, V700, P1, DOI 10.1088/0004-637X/700/1/1; Goerdt T, 2010, MON NOT R ASTRON SOC, V407, P613, DOI 10.1111/j.1365-2966.2010.16941.x; Keres D, 2005, MON NOT R ASTRON SOC, V363, P2, DOI 10.1111/j.1365-2966.2005.09451.x; Lee HW, 1998, ASTROPHYS J, V504, pL61, DOI 10.1086/311572; Matsuda Y, 2004, ASTRON J, V128, P569, DOI 10.1086/422020; Mori M, 2004, ASTROPHYS J, V613, pL97, DOI 10.1086/425255; NEUFELD DA, 1990, ASTROPHYS J, V350, P216, DOI 10.1086/168375; Nilsson KK, 2006, ASTRON ASTROPHYS, V452, pL23, DOI 10.1051/0004-6361:200600025; Palunas P, 2004, ASTROPHYS J, V602, P545, DOI 10.1086/381145; Prescott MKM, 2008, ASTROPHYS J LETT, V678, pL77, DOI 10.1086/588606; Prescott MKM, 2011, ASTROPHYS J LETT, V730, DOI 10.1088/2041-8205/730/2/L25; Rybicki GB, 1999, ASTROPHYS J, V520, pL79, DOI 10.1086/312155; Saito T, 2006, ASTROPHYS J, V648, P54, DOI 10.1086/505678; Scarlata C, 2009, ASTROPHYS J, V706, P1241, DOI 10.1088/0004-637X/706/2/1241; Smith DJB, 2007, MON NOT R ASTRON SOC, V378, pL49, DOI 10.1111/j.1745-3933.2007.00318.x; Steidel CC, 2000, ASTROPHYS J, V532, P170, DOI 10.1086/308568; STENFLO JO, 1980, ASTRON ASTROPHYS, V84, P68; Taniguchi Y, 2000, ASTROPHYS J, V532, pL13, DOI 10.1086/312557; WARDLE JFC, 1974, ASTROPHYS J, V194, P249, DOI 10.1086/153240; Yang YJ, 2006, ASTROPHYS J, V640, P539, DOI 10.1086/497898; Yang YJ, 2009, ASTROPHYS J, V693, P1579, DOI 10.1088/0004-637X/693/2/1579	29	73	73	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 18	2011	476	7360					304	307		10.1038/nature10320	http://dx.doi.org/10.1038/nature10320			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811JV	21850104	Green Submitted			2022-12-28	WOS:000294206500032
J	Imazio, M; Brucato, A; Cemin, R; Ferrua, S; Belli, R; Maestroni, S; Trinchero, R; Spodick, DH; Adler, Y				Imazio, Massimo; Brucato, Antonio; Cemin, Roberto; Ferrua, Stefania; Belli, Riccardo; Maestroni, Silvia; Trinchero, Rita; Spodick, David H.; Adler, Yehuda		CORP COlchicine Recurrent Pericard	Colchicine for Recurrent Pericarditis (CORP) A Randomized Trial A Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							CONVENTIONAL THERAPY; CLINICAL BENEFITS; MANAGEMENT; DISEASES; PREVENTION; RATIONALE; DIAGNOSIS; OUTCOMES; ADJUNCT; DESIGN	Background: Recurrence is the most common complication of pericarditis, affecting 10% to 50% of patients. Objective: To evaluate the efficacy and safety of colchicine for the secondary prevention of recurrent pericarditis. Design: Prospective, randomized, double- blind, placebo-controlled multicenter trial. (ClinicalTrials.gov registration number: NCT00128414) Setting: 4 general hospitals in urban areas of Italy. Patients: 120 patients with a first recurrence of pericarditis. Intervention: In addition to conventional treatment, patients were randomly assigned to receive either placebo or colchicine, 1.0 to 2.0 mg on the first day followed by a maintenance dose of 0.5 to 1.0 mg/d, for 6 months. Measurements: The primary study end point was the recurrence rate at 18 months. Secondary end points were symptom persistence at 72 hours, remission rate at 1 week, number of recurrences, time to first recurrence, disease-related hospitalization, cardiac tamponade, and rate of constrictive pericarditis. Results: At 18 months, the recurrence rate was 24% in the colchicine group and 55% in the placebo group (absolute risk reduction, 0.31 [95% CI, 0.13 to 0.46]; relative risk reduction, 0.56 [CI, 0.27 to 0.73]; number needed to treat, 3 [CI, 2 to 7]). Colchicine reduced the persistence of symptoms at 72 hours (absolute risk reduction, 0.30 [CI, 0.13 to 0.45]; relative risk reduction, 0.56 [CI, 0.27 to 0.74]) and mean number of recurrences, increased the remission rate at 1 week, and prolonged the time to subsequent recurrence. The study groups had similar rates of side effects and drug withdrawal. Limitation: Multiple recurrences and neoplastic or bacterial causes were excluded. Conclusion: Colchicine is safe and effective for secondary prevention of recurrent pericarditis.	[Imazio, Massimo] Maria Vittoria Hosp, Dept Cardiol, I-10141 Turin, Italy; San Maurizio Reg Hosp, Bolzano, Italy; Osped Riuniti Bergamo, I-24100 Bergamo, Italy; Osped Infermi, Turin, Italy; SS Annunziata Hosp, Savigliano, Italy; Univ Massachusetts, St Vincent Hosp, Worcester, MA 01605 USA; Misgav Ladach Hosp, Jerusalem, Israel; Tel Aviv Univ, IL-69978 Tel Aviv, Israel	Maria Vittoria Hospital; Krankenhaus Bozen; Ospedali Riuniti di Bergamo; Hospital of Rimini; University of Massachusetts System; University of Massachusetts Worcester; Tel Aviv University	Imazio, M (corresponding author), Maria Vittoria Hosp, Dept Cardiol, Via Cibrario 72, I-10141 Turin, Italy.	massimo_imazio@yahoo.it	brucato, antonio/U-6879-2019	brucato, antonio/0000-0002-7566-5600; Imazio, Massimo/0000-0002-5722-0245	Maria Vittoria Hospital, Torino, Italy	Maria Vittoria Hospital, Torino, Italy	Maria Vittoria Hospital, Torino, Italy.	ADLER Y, 1994, AM J CARDIOL, V73, P916, DOI 10.1016/0002-9149(94)90828-1; Adler Y, 1998, CIRCULATION, V97, P2183, DOI 10.1161/01.CIR.97.21.2183; Adler Y, 2010, RECURRENT PERICARDIT; Brucato A, 2006, CLIN EXP RHEUMATOL, V24, P45; Brucato A, 2006, ARCH INTERN MED, V166, P696, DOI 10.1001/archinte.166.6.696; Brucato A, 2006, AM J CARDIOL, V98, P267, DOI 10.1016/j.amjcard.2006.01.086; GUINDO J, 1990, CIRCULATION, V82, P1117, DOI 10.1161/01.CIR.82.4.1117; Imazio M, 2005, CIRCULATION, V112, P2012, DOI 10.1161/CIRCULATIONAHA.105.542738; Imazio M, 2005, ARCH INTERN MED, V165, P1987, DOI 10.1001/archinte.165.17.1987; Imazio M, 2005, AM J CARDIOL, V96, P736, DOI 10.1016/j.amjcard.2005.04.055; Imazio M, 2008, CIRCULATION, V118, P667, DOI 10.1161/CIRCULATIONAHA.107.761064; Imazio M, 2007, J CARDIOVASC MED, V8, P830, DOI 10.2459/JCM.0b013e3280110616; Imazio M, 2007, J CARDIOVASC MED, V8, P613, DOI 10.2459/01.JCM.0000281702.46359.07; Imazio M, 2010, J CARDIOVASC MED, V11, P712, DOI 10.2459/JCM.0b013e3283340b97; Imazio M, 2010, CIRCULATION, V121, P916, DOI 10.1161/CIRCULATIONAHA.108.844753; Imazio Massimo, 2009, Expert Rev Cardiovasc Ther, V7, P965, DOI 10.1586/erc.09.82; Imazio M, 2009, NAT REV CARDIOL, V6, P743, DOI 10.1038/nrcardio.2009.185; Imazio M, 2009, EUR HEART J, V30, P532, DOI 10.1093/eurheartj/ehn608; Maisch B, 2004, EUR HEART J, V25, P587, DOI 10.1016/j.ehj.2004.02.002; MILLAIRE A, 1994, EUR HEART J, V15, P120, DOI 10.1093/oxfordjournals.eurheartj.a060363	20	234	243	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 4	2011	155	7					409	U27		10.7326/0003-4819-155-7-201110040-00359	http://dx.doi.org/10.7326/0003-4819-155-7-201110040-00359			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	833OC	21873705	Green Published			2022-12-28	WOS:000295893800001
J	Ransohoff, RM; Stevens, B				Ransohoff, Richard M.; Stevens, Beth			How Many Cell Types Does It Take to Wire a Brain?	SCIENCE			English	Editorial Material							FRACTALKINE RECEPTOR; MICROGLIAL ACTIVATION; SYNAPSE ELIMINATION; AMYLOID DEPOSITION; IN-VIVO; NEURONS; DISEASE; AUTISM; CX3CR1		[Ransohoff, Richard M.] Cleveland Clin, Neuroinflammat Res Ctr, Lerner Res Inst, Cleveland, OH 44195 USA; [Stevens, Beth] Harvard Univ, Sch Med, Dept Neurol, Childrens Hosp, Boston, MA 02115 USA	Cleveland Clinic Foundation; Harvard University; Boston Children's Hospital; Harvard Medical School	Ransohoff, RM (corresponding author), Cleveland Clin, Neuroinflammat Res Ctr, Lerner Res Inst, Cleveland, OH 44195 USA.	ransohr@ccf.org; beth.stevens@childrens.harvard.edu						Bastrikova N, 2008, P NATL ACAD SCI USA, V105, P3123, DOI 10.1073/pnas.0800027105; Bhaskar K, 2010, NEURON, V68, P19, DOI 10.1016/j.neuron.2010.08.023; Cardona AE, 2006, NAT NEUROSCI, V9, P917, DOI 10.1038/nn1715; Chu YX, 2010, P NATL ACAD SCI USA, V107, P7975, DOI 10.1073/pnas.0913449107; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Harrison JK, 1998, P NATL ACAD SCI USA, V95, P10896, DOI 10.1073/pnas.95.18.10896; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Lee S, 2010, AM J PATHOL, V177, P2549, DOI 10.2353/ajpath.2010.100265; Liu ZQ, 2010, J NEUROSCI, V30, P17091, DOI 10.1523/JNEUROSCI.4403-10.2010; Monji A, 2009, PSYCHIAT CLIN NEUROS, V63, P257, DOI 10.1111/j.1440-1819.2009.01945.x; Morgan JT, 2010, BIOL PSYCHIAT, V68, P368, DOI 10.1016/j.biopsych.2010.05.024; Paolicelli RC, 2011, SCIENCE, V333, P1456, DOI 10.1126/science.1202529; Perry VH, 2010, NAT REV NEUROL, V6, P193, DOI 10.1038/nrneurol.2010.17; Ransohoff RM, 2009, IMMUNITY, V31, P711, DOI 10.1016/j.immuni.2009.09.010; Ransohoff RM, 2009, ANNU REV IMMUNOL, V27, P119, DOI 10.1146/annurev.immunol.021908.132528; Roumier A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002595; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Tremblay ME, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000527; Vargas DL, 2005, ANN NEUROL, V57, P67, DOI 10.1002/ana.20315; Wake H, 2009, J NEUROSCI, V29, P3974, DOI 10.1523/JNEUROSCI.4363-08.2009	20	27	28	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 9	2011	333	6048					1391	1392		10.1126/science.1212112	http://dx.doi.org/10.1126/science.1212112			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817KU	21903801				2022-12-28	WOS:000294672200028
J	Warner, CH; Appenzeller, GN; Mobbs, A; Parker, JR; Warner, CM; Grieger, T; Hoge, CW				Warner, Christopher H.; Appenzeller, George N.; Mobbs, Angela; Parker, Jessica R.; Warner, Carolynn M.; Grieger, Thomas; Hoge, Charles W.			Effectiveness of battlefield-ethics training during combat deployment: a programme assessment	LANCET			English	Article							POSTTRAUMATIC-STRESS-DISORDER; PREVALENCE; CHECKLIST	Background Breakdowns in the ethical conduct of soldiers towards non-combatants on the battlefield are of grave concern in war. Evidence-based training approaches to prevent unethical conduct are scarce. We assessed the effectiveness of battlefield-ethics training and factors associated with unethical battlefield conduct. Methods The training package, based on movie vignettes and leader-led discussions, was administered 7 to 8 months into a 15-month high-intensity combat deployment in Iraq, between Dec 11,2007, and Jan 30,2008. Soldiers from an infantry brigade combat team (total population about 3500) were randomly selected, on the basis of company and the last four digits of each soldier's social security number, and invited to complete an anonymous survey 3 months after completion of the training. Reports of unethical behaviour and attitudes in this sample were compared with a randomly selected pre-training sample from the same brigade. The response patterns for ethical behaviour and reporting of ethical violations were analysed with chi-square analyses. We developed two logistic regression models using self-reported unethical behaviours as dependent variables. Factors associated with unethical conduct, including combat experiences and post-traumatic stress disorder (PTSD), were assessed with validated scales. Findings Of 500 randomly selected soldiers 421 agreed to participate in the anonymous post-training survey. A total of 397 soldiers of the same brigade completed the pre-training survey. Training was associated with significantly lower rates of unethical conduct of soldiers and greater willingness to report and address misconduct than in those before training. For example, reports of unnecessary damage or destruction of private property decreased from 13.6% (54 of 397; 95% CI 10.2-17.0) before training to 5.0% (21 of 421; 2.9-7.1) after training (percent difference -63.2%; p<0.0001), and willingness to report a unit member for mistreatment of a non-combatant increased from 36.0% (143 of 397; 31.3-40.7) to 58.9% (248 of 421; 54.2-63.6; percent difference 63.6; p<0.0001). Nearly all participants (410 [97%]) reported that training made it clear how to respond towards non-combatants. Combat frequency and intensity was the strongest predictor of unethical behaviour; PTSD was not a significant predictor of unethical behaviour after controlling for combat experiences. Interpretation Leader-led battlefield ethics training positively influenced soldiers' understanding of how to interact with and treat non-combatants, and reduced reports of ethical misconduct. Unethical battlefield conduct was associated with high-intensity combat but not with PTSD.	[Warner, Christopher H.; Appenzeller, George N.] USA Med Act Alaska, Ft Wainwright, AK 99703 USA; [Warner, Christopher H.] Command & Gen Staff Coll, Ft Leavenworth, KS USA; [Mobbs, Angela] 5th Special Forces Grp, Ft Bragg, NC USA; [Parker, Jessica R.] Winn Army Community Hosp, Warrior Restorat Ctr, Ft Stewart, GA USA; [Warner, Carolynn M.] Munson Army Hlth Clin, Ft Leavenworth, KS USA; [Grieger, Thomas] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA; [Hoge, Charles W.] Walter Reed Army Inst Res, Ctr Psychiat & Neurosci, Silver Spring, MD USA	United States Department of Defense; United States Army; Uniformed Services University of the Health Sciences - USA; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR)	Warner, CH (corresponding author), USA Med Act Alaska, Ft Wainwright, AK 99703 USA.	christopher.h.warner@us.army.mil						Baumann D, 2007, MIL MED, V172, P34, DOI 10.7205/MILMED.173.Supplement_2.34; Bliese PD, 2008, J CONSULT CLIN PSYCH, V76, P272, DOI 10.1037/0022-006X.76.2.272; Fleischmann ST, 2006, SCI ENG ETHICS, V12, P381, DOI 10.1007/s11948-006-0037-4; HOGE CW, 2010, ONCE WARRIOR ALWAYS, P154; Howe EG, 2003, KENNEDY INST ETHIC J, V13, P175, DOI 10.1353/ken.2003.0010; JUNOD T, 2008, ESQUIRE         0611; Kaplan S, 2006, SCI ENG ETHICS, V12, P391, DOI 10.1007/s11948-006-0038-3; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; MCGIRK T, 2006, TIME MAGAZINE   0319; Mental Health Advisory Team (MHAT-IV), 2006, OP IR FREED 05 07; MHAT-5, 2008, OP IR FREED 06 08; Miller J. Joseph, 2004, J MILITARY ETHICS, V3, P199; Robinson P, 2007, PARAMETERS, V27, P22; Robinson P., 2008, ETHICS ED MILITARY, P1; Terhakopian A, 2008, J TRAUMA STRESS, V21, P290, DOI 10.1002/jts.20341; Thomas JL, 2010, ARCH GEN PSYCHIAT, V67, P614, DOI 10.1001/archgenpsychiatry.2010.54; *USA, 1976, FIELD MAN 27 10 CHAN; *USA CHEM SCH, 2005, FM 3 11 9 POT MIL CH, P1; VANBAARDA TA, 2006, MILITARY ETHICS DUTC, P2; Verweij Desiree Kim, 2007, J MILITARY ETHICS, V6, P19; Vetter S, 2007, MIL MED, V172, P7, DOI 10.7205/MILMED.173.Supplement_2.7; WARNER CH, ARCH GEN PS IN PRESS; 2009, MORAL DILEMMAS MENTA; 2010, ARMY TIMES      1019	24	27	28	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 3	2011	378	9794					915	924		10.1016/S0140-6736(11)61039-8	http://dx.doi.org/10.1016/S0140-6736(11)61039-8			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	818XZ	21890056	Green Submitted			2022-12-28	WOS:000294791300032
J	Sayrin, C; Dotsenko, I; Zhou, XX; Peaudecerf, B; Rybarczyk, T; Gleyzes, S; Rouchon, P; Mirrahimi, M; Amini, H; Brune, M; Raimond, JM; Haroche, S				Sayrin, Clement; Dotsenko, Igor; Zhou, Xingxing; Peaudecerf, Bruno; Rybarczyk, Theo; Gleyzes, Sebastien; Rouchon, Pierre; Mirrahimi, Mazyar; Amini, Hadis; Brune, Michel; Raimond, Jean-Michel; Haroche, Serge			Real-time quantum feedback prepares and stabilizes photon number states	NATURE			English	Article							RADIATION-FIELD; ERROR; COHERENT; ENTANGLEMENT; CIRCUIT; CAVITY	Feedback loops are central to most classical control procedures. A controller compares the signal measured by a sensor (system output) with the target value or set-point. It then adjusts an actuator (system input) to stabilize the signal around the target value. Generalizing this scheme to stabilize a micro-system's quantum state relies on quantum feedback(1-3), which must overcome a fundamental difficulty: the sensor measurements cause a random back-action on the system. An optimal compromise uses weak measurements(4,5), providing partial information with minimal perturbation. The controller should include the effect of this perturbation in the computation of the actuator's operation, which brings the incrementally perturbed state closer to the target. Although some aspects of this scenario have been experimentally demonstrated for the control of quantum(6-9) or classical(10,11) micro-system variables, continuous feedback loop operations that permanently stabilize quantum systems around a target state have not yet been realized. Here we have implemented such a real-time stabilizing quantum feedback scheme(12) following a method inspired by ref. 13. It prepares on demand photon number states (Fock states) of a microwave field in a superconducting cavity, and subsequently reverses the effects of decoherence-induced field quantum jumps(14-16). The sensor is a beam of atoms crossing the cavity, which repeatedly performs weak quantum non-demolition measurements of the photon number(14). The controller is implemented in a real-time computer commanding the actuator, which injects adjusted small classical fields into the cavity between measurements. The microwave field is a quantum oscillator usable as a quantum memory(17) or as a quantum bus swapping information between atoms(18). Our experiment demonstrates that active control can generate non-classical states of this oscillator and combat their decoherence(15,16), and is a significant step towards the implementation of complex quantum information operations.	[Sayrin, Clement; Dotsenko, Igor; Zhou, Xingxing; Peaudecerf, Bruno; Rybarczyk, Theo; Gleyzes, Sebastien; Brune, Michel; Raimond, Jean-Michel; Haroche, Serge] UPMC Paris 6, ENS, CNRS, Lab Kastler Brossel, F-75005 Paris, France; [Rouchon, Pierre; Amini, Hadis] Mines ParisTech, Ctr Automat & Syst Math & Syst, F-75272 Paris 6, France; [Mirrahimi, Mazyar] INRIA Paris Rocquencourt, F-78153 Le Chesnay, France; [Haroche, Serge] Coll France, F-75231 Paris 05, France	UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; College de France; Ecole Normale Superieure (ENS); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; MINES ParisTech; UDICE-French Research Universities; PSL Research University Paris; College de France	Haroche, S (corresponding author), UPMC Paris 6, ENS, CNRS, Lab Kastler Brossel, 24 Rue Lhomond, F-75005 Paris, France.	haroche@lkb.ens.fr	gleyzes, sebastien/AAA-7078-2022	Mirrahimi, Mazyar/0000-0001-9471-6031; RAIMOND, Jean-Michel/0000-0002-4289-3455; Sayrin, Clement/0000-0002-9747-5912; Dotsenko, Igor/0000-0002-5074-6447; Peaudecerf, Bruno/0000-0002-2221-2034	Agence Nationale de la Recherche (ANR); EU; ERC	Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); EU(European Commission); ERC(European Research Council (ERC)European Commission)	This work was supported by the Agence Nationale de la Recherche (ANR) under the projects QUSCO-INCA, EPOQ2 and CQUID, and by the EU under the IP project AQUTE and ERC project DECLIC.	AHARONOV Y, 1990, PHYS REV A, V41, P11, DOI 10.1103/PhysRevA.41.11; Brune M, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.240402; Bushev P, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.043003; Cook RL, 2007, NATURE, V446, P774, DOI 10.1038/nature05655; DiCarlo L, 2010, NATURE, V467, P574, DOI 10.1038/nature09416; Doherty AC, 2000, PHYS REV A, V62, DOI 10.1103/PhysRevA.62.012105; Dotsenko I, 2009, PHYS REV A, V80, DOI 10.1103/PhysRevA.80.013805; Geremia JM, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.073601; GLAUBER RJ, 1963, PHYS REV, V131, P2766, DOI 10.1103/PhysRev.131.2766; Guerlin C, 2007, NATURE, V448, P889, DOI 10.1038/nature06057; Haroche S., 2006, EXPLORING QUANTUM; Hofheinz M, 2008, NATURE, V454, P310, DOI 10.1038/nature07136; Hofheinz M, 2009, NATURE, V459, P546, DOI 10.1038/nature08005; Khalil H., 2003, PATIENCE HALL, V3rd; Knill E, 2001, PHYS REV LETT, V86, P5811, DOI 10.1103/PhysRevLett.86.5811; Lu CY, 2008, P NATL ACAD SCI USA, V105, P11050, DOI 10.1073/pnas.0800740105; Maitre X, 1997, PHYS REV LETT, V79, P769, DOI 10.1103/PhysRevLett.79.769; Nelson RJ, 2000, PHYS REV LETT, V85, P3045, DOI 10.1103/PhysRevLett.85.3045; PERES A, 1991, PHYS REV LETT, V66, P1119, DOI 10.1103/PhysRevLett.66.1119; Raimond JM, 2001, REV MOD PHYS, V73, P565, DOI 10.1103/RevModPhys.73.565; Schindler P, 2011, SCIENCE, V332, P1059, DOI 10.1126/science.1203329; Smith WP, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.133601; Steane AM, 1996, PHYS REV LETT, V77, P793, DOI 10.1103/PhysRevLett.77.793; Varcoe BTH, 2000, NATURE, V403, P743, DOI 10.1038/35001526; Vitali D, 2004, J MOD OPTIC, V51, P799, DOI 10.1080/09500340410001664160; Wang H, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.240401; WISEMAN HM, 1994, PHYS REV A, V49, P2133, DOI 10.1103/PhysRevA.49.2133; Wiseman HM, 2009, QUANTUM MEASUREMENT	30	381	385	4	133	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 1	2011	477	7362					73	77		10.1038/nature10376	http://dx.doi.org/10.1038/nature10376			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	813XT	21886159	Green Submitted			2022-12-28	WOS:000294404300033
J	Matyjaszewski, K				Matyjaszewski, Krzysztof			Architecturally Complex Polymers with Controlled Heterogeneity	SCIENCE			English	Editorial Material							TRANSFER RADICAL POLYMERIZATION; CYCLIC POLYMERS; GRADIENT COPOLYMERS; BLOCK-COPOLYMERS; ROUTE		Carnegie Mellon Univ, Dept Chem, Pittsburgh, PA 15213 USA	Carnegie Mellon University	Matyjaszewski, K (corresponding author), Carnegie Mellon Univ, Dept Chem, 4400 5th Ave, Pittsburgh, PA 15213 USA.	km3b@andrew.cmu.edu	Matyjaszewski, Krzysztof/A-2508-2008	Matyjaszewski, Krzysztof/0000-0003-1960-3402				Bates FS, 1999, PHYS TODAY, V52, P32, DOI 10.1063/1.882522; Bielawski CW, 2002, SCIENCE, V297, P2041, DOI 10.1126/science.1075401; Glassner M, 2011, MACROMOL RAPID COMM, V32, P724, DOI 10.1002/marc.201100094; Hadjichristidis N, 2001, CHEM REV, V101, P3747, DOI 10.1021/cr9901337; Hadjichristidis N, 2006, PROG POLYM SCI, V31, P1068, DOI 10.1016/j.progpolymsci.2006.07.002; Li S, 2010, MACROMOLECULES, V43, P4761, DOI 10.1021/ma100609k; Listak J, 2008, MACROMOLECULES, V41, P5919, DOI 10.1021/ma800816j; Lynd NA, 2008, PROG POLYM SCI, V33, P875, DOI 10.1016/j.progpolymsci.2008.07.003; Matyjaszewski K, 2000, J PHYS ORG CHEM, V13, P775, DOI 10.1002/1099-1395(200012)13:12<775::AID-POC314>3.0.CO;2-D; Matyjaszewski K., 2007, MACROMOLECULAR ENG P; Matyjaszewski K, 2009, NAT CHEM, V1, P276, DOI [10.1038/NCHEM.257, 10.1038/nchem.257]; SEMLYEN JA, 1981, PURE APPL CHEM, V53, P1797, DOI 10.1351/pac198153091797; Shin EJ, 2011, ANGEW CHEM INT EDIT, V50, P6388, DOI 10.1002/anie.201101853; Tsarevsky NV, 2007, CHEM REV, V107, P2270, DOI 10.1021/cr050947p; Yagci Y, 2006, PROG POLYM SCI, V31, P1133, DOI 10.1016/j.progpolymsci.2006.07.003	15	229	234	6	233	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 26	2011	333	6046					1104	1105		10.1126/science.1209660	http://dx.doi.org/10.1126/science.1209660			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811VM	21868664				2022-12-28	WOS:000294244300034
J	Pate, BH				Pate, Brooks H.			Taking the Pulse of Molecular Rotational Spectroscopy	SCIENCE			English	Editorial Material							WATER; C-60		Univ Virginia, Dept Chem, Charlottesville, VA 22904 USA	University of Virginia	Pate, BH (corresponding author), Univ Virginia, Dept Chem, Charlottesville, VA 22904 USA.	brookspate@virginia.edu						Brugger G, 2011, J PHYS CHEM A, V115, P9567, DOI 10.1021/jp2001546; Cami J, 2010, SCIENCE, V329, P1180, DOI 10.1126/science.1192035; CHEUNG AC, 1968, PHYS REV LETT, V21, P1701, DOI 10.1103/PhysRevLett.21.1701; CHEUNG AC, 1969, NATURE, V221, P626, DOI 10.1038/221626a0; Decin L, 2010, NATURE, V467, P64, DOI 10.1038/nature09344; FELKER PM, 1987, J CHEM PHYS, V86, P2460, DOI 10.1063/1.452099; Hanson B, 2011, SCIENCE, V331, P649, DOI 10.1126/science.1203354; Karunatilaka C, 2010, J PHYS CHEM LETT, V1, P1547, DOI 10.1021/jz100426c; KROTO HW, 1985, NATURE, V318, P162, DOI 10.1038/318162a0; Medvedev IR, 2010, OPT LETT, V35, P1533, DOI 10.1364/OL.35.001533; Schroter C, 2011, SCIENCE, V333, P1011, DOI 10.1126/science.1204352; Shipman ST, 2011, J PHYS CHEM LETT, V2, P443, DOI 10.1021/jz200031w; WILSON EB, 1968, SCIENCE, V162, P59, DOI 10.1126/science.162.3849.59	13	16	20	2	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 19	2011	333	6045					947	948		10.1126/science.1207994	http://dx.doi.org/10.1126/science.1207994			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808TD	21852481				2022-12-28	WOS:000294000400035
J	Zabula, AV; Filatov, AS; Spisak, SN; Rogachev, AY; Petrukhina, MA				Zabula, Alexander V.; Filatov, Alexander S.; Spisak, Sarah N.; Rogachev, Andrey Yu.; Petrukhina, Marina A.			A Main Group Metal Sandwich: Five Lithium Cations Jammed Between Two Corannulene Tetraanion Decks	SCIENCE			English	Article							GEODESIC POLYARENES; BATTERIES; STABILITY; STACKING; LATTICES; IONS	Lithium-coordinated polyaromatic anions such as tetrareduced corannulene, C(20)H(10)(4-) (1(4-)), are useful substrates to model and ultimately improve the graphitic electrodes in lithium-ion (Li(+)) batteries. Previous studies suggested that 1(4-) forms dimers encasing four Li(+) ions in solution. Here, we report a single-crystal x-ray diffraction analysis confirming the formation of a sandwich-type supramolecular aggregate with a high degree of alkali metal intercalation. In contrast to the prior model, our data reveal that five Li(+) ions are sandwiched between the two tetrareduced corannulene decks, and (7)Li nuclear magnetic resonance spectroscopy delineates a conserved structure in tetrahydrofuran solution. Remarkably, the sandwich is robust in both solution and solid states even in the presence of crown ethers that compete for Li(+) coordination. These results should help elucidate Li(+) intercalation motifs between curved carbon surfaces more broadly.	[Zabula, Alexander V.; Filatov, Alexander S.; Spisak, Sarah N.; Petrukhina, Marina A.] SUNY Albany, Albany, NY 12222 USA; [Rogachev, Andrey Yu.] Univ Hamburg, Inst Anorgan & Angew Chem, D-20146 Hamburg, Germany	State University of New York (SUNY) System; State University of New York (SUNY) Albany; University of Hamburg	Petrukhina, MA (corresponding author), SUNY Albany, 1400 Washington Ave, Albany, NY 12222 USA.	marina@albany.edu	Zabula, Alexander V./J-3040-2017; Filatov, Alexander/G-5724-2010; Filatov, Alexander S./AAK-9474-2020	Zabula, Alexander V./0000-0003-4474-1962; Filatov, Alexander S./0000-0002-8378-1994	NSF [CHE-0546945]	NSF(National Science Foundation (NSF))	Supported by the CHE-0546945 CAREER grant from the NSF. We thank L. T. Scott (Boston College) for valuable comments on the manuscript and A. Shekhtman and D. Burz (University at Albany) for their assistance with collection of NMR data. The access to computational power provided by P. Burger (Universitat Hamburg, Germany) is also gratefully acknowledged. The x-ray crystallographic coordinates for structures I and II reported in this paper have been deposited at the Cambridge Crystallographic Data Centre (CCDC) under deposition nos. CCDC 813710 and 833488, respectively. These data can be obtained free of charge from the CCDC (www.ccdc.cam.ac.uk/data_request/cif).	Aoyagi S, 2010, NAT CHEM, V2, P678, DOI [10.1038/NCHEM.698, 10.1038/nchem.698]; Aprahamian I, 2005, J AM CHEM SOC, V127, P9581, DOI 10.1021/ja0515102; Armand M, 2008, NATURE, V451, P652, DOI 10.1038/451652a; AYALON A, 1994, SCIENCE, V265, P1065, DOI 10.1126/science.265.5175.1065; AYALON A, 1992, ANGEW CHEM INT EDIT, V31, P1636, DOI 10.1002/anie.199216361; BAUMGARTEN M, 1995, J AM CHEM SOC, V117, P6254, DOI 10.1021/ja00128a012; DAHN JR, 1995, SCIENCE, V270, P590, DOI 10.1126/science.270.5236.590; Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232; Eisenberg D, 2010, CHEM COMMUN, V46, P9010, DOI 10.1039/c0cc03965a; Filatov AS, 2010, COORDIN CHEM REV, V254, P2234, DOI 10.1016/j.ccr.2010.05.004; Geim AK, 2007, NAT MATER, V6, P183, DOI 10.1038/nmat1849; Gerald RE, 2000, J POWER SOURCES, V89, P237, DOI 10.1016/S0378-7753(00)00435-3; Hirsch A, 2010, NAT MATER, V9, P868, DOI 10.1038/nmat2885; Imai Y, 2007, J ALLOY COMPD, V439, P258, DOI 10.1016/j.jallcom.2006.08.061; Lahiri I, 2010, ACS NANO, V4, P3440, DOI 10.1021/nn100400r; Lee SW, 2010, NAT NANOTECHNOL, V5, P531, DOI [10.1038/NNANO.2010.116, 10.1038/nnano.2010.116]; Monaco G, 2008, J PHYS CHEM A, V112, P8136, DOI 10.1021/jp8038779; Petrukhina MA, 2005, J ORG CHEM, V70, P5713, DOI 10.1021/jo050233e; RABIDEAU PW, 1993, TETRAHEDRON LETT, V34, P6351, DOI 10.1016/0040-4039(93)85042-U; Saa JM, 2009, CHEM-EUR J, V15, P3123, DOI 10.1002/chem.200801057; Sakurai H, 2003, SCIENCE, V301, P1878, DOI 10.1126/science.1088290; Sandi G, 2000, J NEW MAT ELECT SYST, V3, P13; Tarascon JM, 2001, NATURE, V414, P359, DOI 10.1038/35104644; Tsefrikas VM, 2006, CHEM REV, V106, P4868, DOI 10.1021/cr050553y; Weitz A, 1998, CHEM-EUR J, V4, P234, DOI 10.1002/(SICI)1521-3765(19980210)4:2<234::AID-CHEM234>3.0.CO;2-5; Wu YT, 2006, CHEM REV, V106, P4843, DOI 10.1021/cr050554q; XIE QS, 1992, J AM CHEM SOC, V114, P3978, DOI 10.1021/ja00036a056; Zhang LL, 2009, CHEM SOC REV, V38, P2520, DOI 10.1039/b813846j	28	165	165	4	154	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 19	2011	333	6045					1008	1011		10.1126/science.1208686	http://dx.doi.org/10.1126/science.1208686			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808TD	21852497				2022-12-28	WOS:000294000400053
J	Krumholz, HM				Krumholz, Harlan M.			Real-world Imperative of Outcomes Research	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							QUALITY		[Krumholz, Harlan M.] Yale Univ, Sch Med, Dept Internal Med, Sect Cardiovasc Med, New Haven, CT 06510 USA; [Krumholz, Harlan M.] Yale Univ, Sch Med, Dept Internal Med, Robert Wood Johnson Clin Scholars Program, New Haven, CT 06510 USA; [Krumholz, Harlan M.] Yale Univ, Sch Publ Hlth, Sect Hlth Policy & Adm, New Haven, CT USA; [Krumholz, Harlan M.] Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, New Haven, CT 06504 USA	Yale University; Yale University; Yale University; Yale University	Krumholz, HM (corresponding author), 1 Church St,Ste 200, New Haven, CT 06510 USA.	harlan.krumholz@yale.edu	, Harlan/AAI-2875-2020		NHLBI NIH HHS [U01-HL105270-02] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL105270] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		[Anonymous], 2001, CROSSING QUALITY CHA, DOI DOI 10.17226/10027; Bueno H, 2010, JAMA-J AM MED ASSOC, V303, P2141, DOI 10.1001/jama.2010.748; Codman EA, 1913, T CLIN C SURG N AM, V4, P3; Inst Med, 2010, EVALUATION OF BIOMARKERS AND SURROGATE ENDPOINTS IN CHRONIC DISEASE, P1; Krumholz HM, 2010, CIRC-CARDIOVASC QUAL, V3, P332, DOI 10.1161/CIRCOUTCOMES.110.958017; Lavis JN, 2002, MILBANK Q, V80, P125, DOI 10.1111/1468-0009.00005; MCNEIL BJ, 1981, NEW ENGL J MED, V305, P982, DOI 10.1056/NEJM198110223051704; Nightingale F., 1871, INTRO NOTES LYING IN; WENNBERG J, 1973, SCIENCE, V182, P1102, DOI 10.1126/science.182.4117.1102	9	24	24	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 17	2011	306	7					754	755		10.1001/jama.2011.1170	http://dx.doi.org/10.1001/jama.2011.1170			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	807LP	21846857				2022-12-28	WOS:000293900000025
J	Wang, YC; McPherson, K; Marsh, T; Gortmaker, SL; Brown, M				Wang, Y. Claire; McPherson, Klim; Marsh, Tim; Gortmaker, Steven L.; Brown, Martin			Obesity 2 Health and economic burden of the projected obesity trends in the USA and the UK	LANCET			English	Article							BODY-MASS INDEX; COST-EFFECTIVENESS; MEDICAL COSTS; OVERWEIGHT; RISK; FUTURE; POPULATION; PREVALENCE; CONSEQUENCES; EXPENDITURES	Rising prevalence of obesity is a worldwide health concern because excess weight gain within populations forecasts an increased burden from several diseases, most notably cardiovascular diseases, diabetes, and cancers. In this report, we used a simulation model to project the probable health and economic consequences in the next two decades from a continued rise in obesity in two ageing populations the USA and the UK. These trends project 65 million more obese adults in the USA and 11 million more obese adults in the UK by 2030, consequently accruing an additional 6-8.5 million cases of diabetes, 5.7-7.3 million cases of heart disease and stroke, 492000-669000 additional cases of cancer, and 26-55 million quality-adjusted life years forgone for USA and UK combined. The combined medical costs associated with treatment of these preventable diseases are estimated to increase by $48-66 billion/year in the USA and by 1.9-2 pound billion/year in the UK by 2030. Hence, effective policies to promote healthier weight also have economic benefits.	[Wang, Y. Claire] Columbia Univ, Dept Hlth Policy & Management, Mailman Sch Publ Hlth, New York, NY 10032 USA; [McPherson, Klim] Univ Oxford, New Coll, Oxford, England; [Gortmaker, Steven L.] Harvard Univ, Dept Soc Human Dev & Hlth, Harvard Sch Publ Hlth, Boston, MA 02115 USA; [Marsh, Tim; Brown, Martin] Natl Heart Forum, London, England	Columbia University; University of Oxford; Harvard University; Harvard T.H. Chan School of Public Health	Wang, YC (corresponding author), Columbia Univ, Dept Hlth Policy & Management, Mailman Sch Publ Hlth, New York, NY 10032 USA.	ycw2102@columbia.edu			National Collaborative on Childhood Obesity Research; RWJF [260639, 61468, 66284]; CDC [U48/DP00064-00S1, 1U48DP001946]; NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO [U48DP001946, U48DP000064] Funding Source: NIH RePORTER	National Collaborative on Childhood Obesity Research; RWJF; CDC(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work was done under auspices of the Collaborative Obesity Modeling Network as part of the Envision Project, supported by the National Collaborative on Childhood Obesity Research, which coordinates childhood obesity research across the National Institutes of Health, Centers for Disease Control and Prevention (CDC), Department of Agriculture, and the Robert Wood Johnson Foundation (RWJF). This work was supported in part by grants from RWJF (numbers 260639 and 61468 and 66284), CDC (U48/DP00064-00S1 and 1U48DP001946). This work is solely the responsibility of the authors and does not represent official views of the CDC or any of the other funders.	Allender S, 2008, EUROPEAN CARDIOVASCU; Anandacoomarasamy A, 2009, OBESITY, V17, P2114, DOI 10.1038/oby.2009.121; Andreyeva T, 2004, OBES RES, V12, P1936, DOI 10.1038/oby.2004.243; Bell JF, 2011, OBESITY, V19, P228, DOI 10.1038/oby.2010.104; Bibbins-Domingo K, 2007, NEW ENGL J MED, V357, P2371, DOI 10.1056/NEJMsa073166; Brown ML, 2001, ANNU REV PUBL HEALTH, V22, P91, DOI 10.1146/annurev.publhealth.22.1.91; Butland BJ, 2007, FORESIGHT TACKLING O; Camargo CA, 1999, ARCH INTERN MED, V159, P2582, DOI 10.1001/archinte.159.21.2582; CancerStats, 2011, INC 2008; Carter R, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-419; Cecchini M, 2010, LANCET, V376, P1775, DOI 10.1016/S0140-6736(10)61514-0; Centers for Disease Control and Prevention, NAT HLTH NUTR EX SUR; Colditz G A, 1992, Am J Clin Nutr, V55, p503S, DOI 10.1093/ajcn/55.2.503s; Colditz GA, 1999, MED SCI SPORT EXER, V31, pS663, DOI 10.1097/00005768-199911001-00026; Comptroller and Auditor General, 2001, TACKL OB ENGL APP 6; Department of Health, HLTH SURV ENGL; Finkelstein EA, 2004, OBES RES, V12, P18, DOI 10.1038/oby.2004.4; Finkelstein EA, 2005, ANNU REV PUBL HEALTH, V26, P239, DOI 10.1146/annurev.publhealth.26.021304.144628; Finkelstein EA, 2003, HEALTH AFFAIR, V22, pW219; Finkelstein EA, 2008, OBESITY, V16, P1843, DOI 10.1038/oby.2008.290; Finkelstein EA, 2010, J OCCUP ENVIRON MED, V52, P971, DOI 10.1097/JOM.0b013e3181f274d2; Finkelstein EA, 2009, HEALTH AFFAIR, V28, pW822, DOI 10.1377/hlthaff.28.5.w822; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Fishman G. S., 1995, MONTE CARLO CONCEPTS; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Fry J, 2005, P NUTR SOC, V64, P359, DOI 10.1079/PNS2005443; Garber AM, 1997, J HEALTH ECON, V16, P1, DOI 10.1016/S0167-6296(96)00506-1; GIOVANNUCCI E, 1994, AM J EPIDEMIOL, V140, P989, DOI 10.1093/oxfordjournals.aje.a117206; Gortmaker SL, 2011, LANCET, V378, P838, DOI 10.1016/S0140-6736(11)60815-5; Guh DP, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-88; Hall KD, 2011, LANCET, V378, P826, DOI 10.1016/S0140-6736(11)60812-X; [Internet] Centers for Disease Control and Prevention, NAT HLTH INT SURV; Kim S, 2003, ANN EPIDEMIOL, V13, P666, DOI 10.1016/S1047-2797(03)00054-1; Kopelman P, 2007, OBES REV, V8, pVI; Leach, 2010, DATA DOCUMENTATION D; Lee RH, 2008, J HEALTH ECON, V27, P809, DOI 10.1016/j.jhealeco.2007.09.011; LEVY E, 1995, INT J OBESITY, V19, P788; Lloyd-Jones D, 2009, CIRCULATION, V119, pE21, DOI 10.1161/CIRCULATIONAHA.108.191261; McCormick B, 2007, OBES REV, V8, P161, DOI 10.1111/j.1467-789X.2007.00337.x; McPherson K, 2007, FORESIGHT TACKLING O; McPherson K, 2008, PLOS MED, V5, P183, DOI 10.1371/journal.pmed.0050037; Muennig P, 2006, AM J PUBLIC HEALTH, V96, P1662, DOI 10.2105/AJPH.2005.068874; Narbro K, 1996, INT J OBESITY, V20, P895; Nichols MS, 2011, INT J OBESITY, V35, P916, DOI 10.1038/ijo.2011.64; *NIH, 2006, INC PREV 2006 CHART; Office for National Statistics, NAT PROJ; Ogden CL, 2010, JAMA-J AM MED ASSOC, V303, P242, DOI 10.1001/jama.2009.2012; Olshansky SJ, 2005, NEW ENGL J MED, V352, P1138, DOI 10.1056/NEJMsr043743; Oster G, 2000, AM J MANAG CARE, V6, P681; Popkin BM, 2006, OBES REV, V7, P271, DOI 10.1111/j.1467-789X.2006.00230.x; Preis SR, 2009, CIRCULATION, V120, P212, DOI 10.1161/CIRCULATIONAHA.108.846519; Rappange DR, 2008, PHARMACOECONOMICS, V26, P815, DOI 10.2165/00019053-200826100-00003; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; Rich-Edwards JW, 2002, EPIDEMIOLOGY, V13, P184, DOI 10.1097/00001648-200203000-00013; Rokholm B, 2010, OBES REV, V11, P835, DOI 10.1111/j.1467-789X.2010.00810.x; ROSSNER S, 1991, J INTERN MED, V230, P135; Roux L, 2004, OBES RES, V12, P173, DOI 10.1038/oby.2004.23; Sassi F, 2010, OBESITY EC PREVENTIO; Scarborogh P, 2009, CORONARY HEART STAT; Scarborough P, 2009, UK STROKE STAT; Schmid A, 2005, SOZ PRAVENTIV MED, V50, P87, DOI 10.1007/s00038-004-4067-x; Schwartz M B, 2003, Obes Rev, V4, P57, DOI 10.1046/j.1467-789X.2003.00093.x; SEGAL L, 1994, PHARMACOECONOMICS, V5, P45, DOI 10.2165/00019053-199400051-00009; SEIDELL JC, 1995, INT J OBESITY, V19, pS13; Stothard KJ, 2009, JAMA-J AM MED ASSOC, V301, P636, DOI 10.1001/jama.2009.113; Sun J, 2007, ANN EPIDEMIOL, V17, P51, DOI 10.1016/j.annepidem.2006.06.003; Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1; The Health and Social Care Information Centre, PRESCR DIAB ENGL 200; Thorpe KE, 2004, HEALTH AFFAIR, V23, pW4480, DOI 10.1377/hlthaff.W4.480; Tirosh A, 2011, NEW ENGL J MED, V364, P1315, DOI 10.1056/NEJMoa1006992; Trogdon JG, 2008, OBES REV, V9, P489, DOI 10.1111/j.1467-789X.2008.00472.x; US Census Bureau, US POP PROJ; van Baal PHM, 2008, PLOS MED, V5, P242, DOI 10.1371/journal.pmed.0050029; Wang YC, 2007, OBESITY, V15, P2855, DOI 10.1038/oby.2007.339; Wang YF, 2008, OBESITY, V16, P2323, DOI 10.1038/oby.2008.351; Withrow D, 2011, OBES REV, V12, P131, DOI 10.1111/j.1467-789X.2009.00712.x	76	1725	1760	7	313	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG-SEP	2011	378	9793					815	825		10.1016/S0140-6736(11)60814-3	http://dx.doi.org/10.1016/S0140-6736(11)60814-3			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	816FY	21872750				2022-12-28	WOS:000294585300037
J	Pang, PC; Chiu, PCN; Lee, CL; Chang, LY; Panico, M; Morris, HR; Haslam, SM; Khoo, KH; Clark, GF; Yeung, WSB; Dell, A				Pang, Poh-Choo; Chiu, Philip C. N.; Lee, Cheuk-Lun; Chang, Lan-Yi; Panico, Maria; Morris, Howard R.; Haslam, Stuart M.; Khoo, Kay-Hooi; Clark, Gary F.; Yeung, William S. B.; Dell, Anne			Human Sperm Binding Is Mediated by the Sialyl-Lewis(x) Oligosaccharide on the Zona Pellucida	SCIENCE			English	Article							MASS-SPECTROMETRIC ANALYSIS; EXPRESSION; GLYCANS; FUCOSE; SERUM	Human fertilization begins when spermatozoa bind to the extracellular matrix coating of the oocyte, known as the zona pellucida (ZP). One spermatozoan then penetrates this matrix and fuses with the egg cell, generating a zygote. Although carbohydrate sequences on the ZP have been implicated in sperm binding, the nature of the ligand was unknown. Here, ultrasensitive mass spectrometric analyses revealed that the sialyl-Lewis(x) sequence [NeuAc alpha 2-3Gal beta 1-4(Fuc alpha 1-3)GlcNAc], a well-known selectin ligand, is the most abundant terminal sequence on the N- and O-glycans of human ZP. Sperm-ZP binding was largely inhibited by glycoconjugates terminated with sialyl-Lewis(x) sequences or by antibodies directed against this sequence. Thus, the sialyl-Lewis(x) sequence represents the major carbohydrate ligand for human sperm-egg binding.	[Clark, Gary F.] Univ Missouri, Dept Obstet Gynecol & Womens Hlth, Sch Med, Columbia, MO 65201 USA; [Pang, Poh-Choo; Morris, Howard R.; Haslam, Stuart M.; Dell, Anne] Univ London Imperial Coll Sci Technol & Med, Div Mol Biosci, Fac Nat Sci, London SW7 2AZ, England; [Chiu, Philip C. N.; Lee, Cheuk-Lun; Yeung, William S. B.] Univ Hong Kong, Dept Obstet & Gynaecol, Ctr Reprod Dev & Growth, Hong Kong, Hong Kong, Peoples R China; [Chang, Lan-Yi; Khoo, Kay-Hooi] Acad Sinica, Inst Biol Chem, Taipei 11529, Taiwan	University of Missouri System; University of Missouri Columbia; Imperial College London; University of Hong Kong; Academia Sinica - Taiwan	Clark, GF (corresponding author), Univ Missouri, Dept Obstet Gynecol & Womens Hlth, Sch Med, Columbia, MO 65201 USA.	clarkgf@health.missouri.edu; a.dell@imperial.ac.uk	Chiu, Chi Ngong/C-4245-2009; Khoo, Kay-Hooi/E-1989-2019; Lee, Cheuk Lun/AGX-5720-2022	Chiu, Chi Ngong/0000-0001-6217-1970; Khoo, Kay-Hooi/0000-0003-2906-406X; Dell, Anne/0000-0003-1380-2347; Lee, Cheuk Lun/0000-0003-1553-3478	Biotechnology and Biological Sciences Research Council (BBSRC) [BBF0083091]; Royal Society; Breeden-Adams Foundation; Life Sciences Mission Enhancement Reproductive Biology Program; state of Missouri; University Research Committee, University of Hong Kong; Taiwan National Science Council [NSC99-3112-B-001-025]	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Royal Society(Royal Society of London); Breeden-Adams Foundation; Life Sciences Mission Enhancement Reproductive Biology Program; state of Missouri; University Research Committee, University of Hong Kong(University of Hong Kong); Taiwan National Science Council(Ministry of Science and Technology, Taiwan)	This work was supported by the Biotechnology and Biological Sciences Research Council (BBSRC), grant BBF0083091 (to A. D., H. R. M., and S. M. H.); a Royal Society International Joint Project Award (to A. D. and K-H. K.); the Breeden-Adams Foundation and a Life Sciences Mission Enhancement Reproductive Biology Program funded by the state of Missouri (to G. F. C.); and the University Research Committee, University of Hong Kong (to P.C.N. and W.S.B.Y). The proteomics and sulfoglycomics data were acquired at the National Research Program for Genomic Medicine (NRPGM) Core Facilities for Proteomics and Glycomics funded by the Taiwan National Science Council (NSC99-3112-B-001-025). An intellectual property disclosure has been filed with the University of Missouri that covers technology described in this paper.	Babu P, 2009, GLYCOCONJUGATE J, V26, P975, DOI 10.1007/s10719-008-9146-4; BrinkmanVanderLinden ECM, 1996, GLYCOCONJUGATE J, V13, P27, DOI 10.1007/BF01049676; Chiu PCN, 2008, BIOL REPROD, V79, P869, DOI 10.1095/biolreprod.108.069344; CLARK GF, 1995, HUM REPROD, V10, P31, DOI 10.1093/humrep/10.suppl_1.31; Ferens-Sieczkowska M, 2001, Z NATURFORSCH C, V56, P122; Fukuda M, 1999, J CELL BIOL, V147, P467, DOI 10.1083/jcb.147.3.467; FUKUDA M, 1985, J BIOL CHEM, V260, P2957; HUANG TTF, 1982, GAMETE RES, V5, P355, DOI 10.1002/mrd.1120050406; IMAI Y, 1993, NATURE, V361, P555; Jimenez-Movilla M, 2004, HUM REPROD, V19, P1842, DOI 10.1093/humrep/deh311; Khoo KH, 2010, METHOD ENZYMOL, V478, P3, DOI 10.1016/S0076-6879(10)78001-0; LASKY LA, 1992, SCIENCE, V258, P964, DOI 10.1126/science.1439808; LUCAS H, 1994, HUM REPROD, V9, P1532, DOI 10.1093/oxfordjournals.humrep.a138744; MAGNANI J L, 1991, Glycobiology, V1, P318, DOI 10.1093/glycob/1.4.318; Mechref Y, 2009, J PROTEOME RES, V8, P2656, DOI 10.1021/pr8008385; Mengerink KJ, 2001, GLYCOBIOLOGY, V11, p37R, DOI 10.1093/glycob/11.4.37R; North SJ, 2010, METHOD ENZYMOL, V478, P27, DOI 10.1016/S0076-6879(10)78002-2; Pang PC, 2007, J BIOL CHEM, V282, P36593, DOI 10.1074/jbc.M705134200; Patankar MS, 1997, MOL HUM REPROD, V3, P501, DOI 10.1093/molehr/3.6.501; PATANKAR MS, 1993, J BIOL CHEM, V268, P21770; Rosen SD, 2004, ANNU REV IMMUNOL, V22, P129, DOI 10.1146/annurev.immunol.21.090501.080131; Schweigert FJ, 2006, HUM REPROD, V21, P2960, DOI 10.1093/humrep/del257; STOOLMAN LM, 1983, J CELL BIOL, V96, P722, DOI 10.1083/jcb.96.3.722; Varki A., 2009, ESSENTIALS GLYCOBIOL; Wassarman PM, 2001, NAT CELL BIOL, V3, pE59, DOI 10.1038/35055178	25	240	258	4	82	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 23	2011	333	6050					1761	1764		10.1126/science.1207438	http://dx.doi.org/10.1126/science.1207438			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	823KQ	21852454	Green Submitted			2022-12-28	WOS:000295121500047
J	Colic, E; Dieperink, H; Titlestad, K; Tepel, M				Colic, Edin; Dieperink, Hans; Titlestad, Kjell; Tepel, Martin			Management of an acute outbreak of diarrhoea-associated haemolytic uraemic syndrome with early plasma exchange in adults from southern Denmark: an observational study	LANCET			English	Article							THROMBOTIC THROMBOCYTOPENIC PURPURA; ESCHERICHIA-COLI; SHIGA-TOXIN; RISK	Background Diarrhoea-associated haemolytic uraemic syndrome in adults is a life-threatening, but rare multisystem disorder that is characterised by acute haemolytic anaemia, thrombocytopenia, and renal insufficiency. We aimed to assess the success of management of this disorder with plasma exchange therapy. Methods Patients diagnosed with diarrhoea-associated haemolytic uraemic syndrome in southern Denmark were treated with daily plasma exchange by centrifugation and substitution with fresh frozen plasma. Stool culture and serological testing was done to identify the cause of disease, and the success of management with plasma exchange therapy was assessed from change in platelet count, glomerular filtration rate, and lactate dehydrogenase. Findings During May 25-28, 2011, five patients with a median age of 62 years (range 44-70) presented with diarrhoea-associated haemolytic uraemic syndrome, which was caused by an unusual Shiga-toxin-producing Escherichia coli serotype O104:H4. Strains of E coli showed a high resistance to third-generation cephalosporins because the strains had extended-spectrum beta lactamases. After plasma exchange, median platelet count and glomerular filtration rate increased, median lactate dehydrogenase concentration decreased, and neurological status improved. The time interval from onset of bloody diarrhoea to start of plasma exchange had an inverse correlation with reduction of lactate dehydrogenase concentrations by plasma exchange (p=0.02). All patients were discharged with normal neurological status at 7 days (range 5-8) after starting plasma exchange. Interpretation Early plasma exchange might ameliorate the course of diarrhoea-associated haemolytic uraemic syndrome in adults. However, this finding should be verified in randomised controlled trials	[Colic, Edin; Dieperink, Hans; Tepel, Martin] Odense Univ Hosp, Dept Nephrol, DK-5000 Odense C, Denmark; [Titlestad, Kjell] Odense Univ Hosp, Dept Clin Immunol, DK-5000 Odense C, Denmark; [Tepel, Martin] Univ So Denmark, Inst Mol Med Cardiovasc & Renal Res, Odense, Denmark	University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital; University of Southern Denmark	Tepel, M (corresponding author), Odense Univ Hosp, Dept Nephrol, Winslowpk 21-3, DK-5000 Odense C, Denmark.	mtepel@health.sdu.dk	Tepel, Martin/GRS-9581-2022	Tepel, Martin/0000-0002-0086-0997				Bianchi V, 2002, BLOOD, V100, P710, DOI 10.1182/blood-2002-02-0344; Bielaszewska M, 2011, LANCET INFECT DIS, V11, P671, DOI 10.1016/S1473-3099(11)70165-7; Cohen JA, 1998, J CLIN APHERESIS, V13, P16, DOI 10.1002/(SICI)1098-1101(1998)13:1<16::AID-JCA3>3.0.CO;2-C; Dundas S, 2001, CLIN INFECT DIS, V33, P923, DOI 10.1086/322598; European Centre for Disease Prevention and Control and European Food Safety Authority, 2011, SHIG TOX VER PROD ES; Frank C, 2011, NEW ENGL J MED, V365, P1771, DOI 10.1056/NEJMoa1106483; Garg AX, 2003, JAMA-J AM MED ASSOC, V290, P1360, DOI 10.1001/jama.290.10.1360; Johnson KE, 2006, CLIN INFECT DIS, V43, P1587, DOI 10.1086/509573; Karpac CA, 2008, BRIT J HAEMATOL, V141, P696, DOI 10.1111/j.1365-2141.2008.07116.x; Lapeyraque AL, 2011, NEW ENGL J MED, V364, P2561, DOI 10.1056/NEJMc1100859; Michael M., 2009, COCHRANE DB SYST REV, V1; Piercefield EW, 2010, ARCH INTERN MED, V170, P1656, DOI 10.1001/archinternmed.2010.346; ROCK GA, 1991, NEW ENGL J MED, V325, P393, DOI 10.1056/NEJM199108083250604; Ruggenenti P, 2001, KIDNEY INT, V60, P831, DOI 10.1046/j.1523-1755.2001.060003831.x; Sanchez S, 2010, VET MICROBIOL, V143, P420, DOI 10.1016/j.vetmic.2009.11.016; Tarr PI, 2005, LANCET, V365, P1073, DOI 10.1016/S0140-6736(05)71144-2; Wong CS, 2000, NEW ENGL J MED, V342, P1930, DOI 10.1056/NEJM200006293422601	17	84	88	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 17	2011	378	9796					1089	1093		10.1016/S0140-6736(11)61145-8	http://dx.doi.org/10.1016/S0140-6736(11)61145-8			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	829BE	21871657				2022-12-28	WOS:000295548900025
J	Clemans-Cope, L; Waidmann, T				Clemans-Cope, Lisa; Waidmann, Timothy			Improving Care for Dual Eligibles through Innovations in Financing	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Clemans-Cope, Lisa; Waidmann, Timothy] Urban Inst, Ctr Hlth Policy, Washington, DC 20037 USA	Urban Institute	Clemans-Cope, L (corresponding author), Urban Inst, Ctr Hlth Policy, Washington, DC 20037 USA.		Waidmann, Timothy/X-8811-2019	Waidmann, Timothy/0000-0001-7221-5068				Frank RG, 2008, HEALTH AFFAIR, V27, P33, DOI 10.1377/hlthaff.27.1.33; Rosenbaum S, 2009, SUPPORTING ALTERNATI; ROUSSEAU D, 2010, DUAL ELIGI BLES MEDI	3	8	8	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 15	2011	365	11								10.1056/NEJMp1108571	http://dx.doi.org/10.1056/NEJMp1108571			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	819UR	21879892				2022-12-28	WOS:000294857300004
J	Chen, XK; Gabitto, M; Peng, YQ; Ryba, NJP; Zuker, CS				Chen, Xiaoke; Gabitto, Mariano; Peng, Yueqing; Ryba, Nicholas J. P.; Zuker, Charles S.			A Gustotopic Map of Taste Qualities in the Mammalian Brain	SCIENCE			English	Article							BITTER TASTE; GUSTATORY CORTEX; CORTICAL-NEURONS; UMAMI TASTE; RECEPTORS; CELLS; RESPONSES; STIMULI; SWEET; MOUSE	The taste system is one of our fundamental senses, responsible for detecting and responding to sweet, bitter, umami, salty, and sour stimuli. In the tongue, the five basic tastes are mediated by separate classes of taste receptor cells each finely tuned to a single taste quality. We explored the logic of taste coding in the brain by examining how sweet, bitter, umami, and salty qualities are represented in the primary taste cortex of mice. We used in vivo two-photon calcium imaging to demonstrate topographic segregation in the functional architecture of the gustatory cortex. Each taste quality is represented in its own separate cortical field, revealing the existence of a gustotopic map in the brain. These results expose the basic logic for the central representation of taste.	[Chen, Xiaoke; Gabitto, Mariano; Peng, Yueqing; Zuker, Charles S.] Columbia Univ, Coll Phys & Surg, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Chen, Xiaoke; Gabitto, Mariano; Peng, Yueqing; Zuker, Charles S.] Columbia Univ, Coll Phys & Surg, Dept Neurosci, New York, NY 10032 USA; [Ryba, Nicholas J. P.] Natl Inst Dent & Craniofacial Res, Bethesda, MD 20892 USA; [Zuker, Charles S.] Univ Calif San Diego, Dept Neurobiol, La Jolla, CA 92093 USA; [Zuker, Charles S.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA	Columbia University; Howard Hughes Medical Institute; Columbia University; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); University of California System; University of California San Diego; University of California System; University of California San Diego	Zuker, CS (corresponding author), Columbia Univ, Coll Phys & Surg, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, New York, NY 10032 USA.	cz2195@columbia.edu	chen, xiaoke/E-5385-2011	Ryba, Nicholas/0000-0002-2060-8393	Human Frontier Science Program fellowship; National Institute of Dental and Craniofacial Research; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000561] Funding Source: NIH RePORTER	Human Frontier Science Program fellowship(Human Frontier Science Program); National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We thank A. Devor and Y. Dan for their hospitality and technical help with our early intrinsic imaging attempts, R. Barreto for valuable help with imaging and data analysis, S. Hunter-Smith for help with viral tracing experiments, and R. Axel, K. Scott, D. Steddler, R. Bruno, and members of the Zuker lab for helpful comments. Supported by a Human Frontier Science Program fellowship (X. C.) and by the Intramural Research Program of the National Institute of Dental and Craniofacial Research. C.S.Z. is an investigator of the Howard Hughes Medical Institute.	Accolla R, 2007, J NEUROSCI, V27, P1396, DOI 10.1523/JNEUROSCI.5188-06.2007; Adler E, 2000, CELL, V100, P693, DOI 10.1016/S0092-8674(00)80705-9; Arai T, 2010, NEUROSCIENCE, V165, P1476, DOI 10.1016/j.neuroscience.2009.11.051; Caicedo A, 2002, J PHYSIOL-LONDON, V544, P501, DOI 10.1113/jphysiol.2002.027862; Carleton A, 2010, TRENDS NEUROSCI, V33, P326, DOI 10.1016/j.tins.2010.04.002; Cearley CN, 2008, MOL THER, V16, P1710, DOI 10.1038/mt.2008.166; Chandrashekar J, 2000, CELL, V100, P703, DOI 10.1016/S0092-8674(00)80706-0; Chandrashekar J, 2006, NATURE, V444, P288, DOI 10.1038/nature05401; Chandrashekar J, 2010, NATURE, V464, P297, DOI 10.1038/nature08783; Fenno L, 2011, ANNU REV NEUROSCI, V34, P389, DOI 10.1146/annurev-neuro-061010-113817; Fontanini A, 2009, ANN NY ACAD SCI, V1170, P403, DOI 10.1111/j.1749-6632.2009.03922.x; Gilbertson TA, 2001, J NEUROSCI, V21, P4931, DOI 10.1523/JNEUROSCI.21-13-04931.2001; Huang AL, 2006, NATURE, V442, P934, DOI [10.1038/nature05084, 10.1038/nature050084]; Ishimaru Y, 2006, P NATL ACAD SCI USA, V103, P12569, DOI 10.1073/pnas.0602702103; IWASAKI K, 1985, PHYSIOL BEHAV, V34, P531, DOI 10.1016/0031-9384(85)90045-9; Kadohisa M, 2005, CHEM SENSES, V30, P401, DOI 10.1093/chemse/bji036; Katz DB, 2001, J NEUROSCI, V21, P4478, DOI 10.1523/JNEUROSCI.21-12-04478.2001; Katz DB, 2008, J NEUROSCI, V28, P11802, DOI 10.1523/JNEUROSCI.3613-08.2008; Kerr JND, 2007, J NEUROSCI, V27, P13316, DOI 10.1523/JNEUROSCI.2210-07.2007; Kinnamon SC, 1996, CURR OPIN NEUROBIOL, V6, P506, DOI 10.1016/S0959-4388(96)80057-2; Komiyama T, 2010, NATURE, V464, P1182, DOI 10.1038/nature08897; Li XD, 2002, P NATL ACAD SCI USA, V99, P4692, DOI 10.1073/pnas.072090199; Matsunami H, 2000, NATURE, V404, P601, DOI 10.1038/35007072; MERZENICH MM, 1975, J NEUROPHYSIOL, V38, P231, DOI 10.1152/jn.1975.38.2.231; Mueller KL, 2005, NATURE, V434, P225, DOI 10.1038/nature03352; Nelson G, 2002, NATURE, V416, P199, DOI 10.1038/nature726; Nelson G, 2001, CELL, V106, P381, DOI 10.1016/S0092-8674(01)00451-2; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; Sato T, 1997, CHEM SENSES, V22, P287, DOI 10.1093/chemse/22.3.287; Simon SA, 2006, NAT REV NEUROSCI, V7, P890, DOI 10.1038/nrn2006; Soares ES, 2007, PHYSIOL BEHAV, V92, P629, DOI 10.1016/j.physbeh.2007.05.038; Stapleton JR, 2006, J NEUROSCI, V26, P4126, DOI 10.1523/JNEUROSCI.0092-06.2006; Stettler DD, 2009, NEURON, V63, P854, DOI 10.1016/j.neuron.2009.09.005; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; Sugita M, 2005, SCIENCE, V309, P781, DOI 10.1126/science.1110787; TUSA RJ, 1978, J COMP NEUROL, V177, P213, DOI 10.1002/cne.901770204; WOOLSEY TA, 1970, BRAIN RES, V17, P205, DOI 10.1016/0006-8993(70)90079-X; Wu SV, 2005, PHYSIOL GENOMICS, V22, P139, DOI 10.1152/physiolgenomics.00030.2005; YAMAMOTO T, 1984, PROG NEUROBIOL, V23, P273, DOI 10.1016/0301-0082(84)90007-8; Yarmolinsky DA, 2009, CELL, V139, P234, DOI 10.1016/j.cell.2009.10.001; Yoshimura H, 2004, NEUROREPORT, V15, P17, DOI 10.1097/00001756-200401190-00005; Zhang YF, 2003, CELL, V112, P293, DOI 10.1016/S0092-8674(03)00071-0; Zhao GQ, 2003, CELL, V115, P255, DOI 10.1016/S0092-8674(03)00844-4	43	226	236	5	89	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 2	2011	333	6047					1262	1266		10.1126/science.1204076	http://dx.doi.org/10.1126/science.1204076			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	813YM	21885776	Green Accepted			2022-12-28	WOS:000294406400046
J	Magnus, CJ; Lee, PH; Atasoy, D; Su, HH; Looger, LL; Sternson, SM				Magnus, Christopher J.; Lee, Peter H.; Atasoy, Deniz; Su, Helen H.; Looger, Loren L.; Sternson, Scott M.			Chemical and Genetic Engineering of Selective Ion Channel-Ligand Interactions	SCIENCE			English	Article							NEURONAL NICOTINIC RECEPTOR; IN-VIVO; ACETYLCHOLINE-RECEPTORS; PROTEIN; MUTATIONS; LOOP; DESIGN; DOMAIN; DESENSITIZATION; IDENTIFICATION	Ionic flux mediates essential physiological and behavioral functions in defined cell populations. Cell type-specific activators of diverse ionic conductances are needed for probing these effects. We combined chemistry and protein engineering to enable the systematic creation of a toolbox of ligand-gated ion channels (LGICs) with orthogonal pharmacologic selectivity and divergent functional properties. The LGICs and their small-molecule effectors were able to activate a range of ionic conductances in genetically specified cell types. LGICs constructed for neuronal perturbation could be used to selectively manipulate neuron activity in mammalian brains in vivo. The diversity of ion channel tools accessible from this approach will be useful for examining the relationship between neuronal activity and animal behavior, as well as for cell biological and physiological applications requiring chemical control of ion conductance.	[Magnus, Christopher J.; Lee, Peter H.; Atasoy, Deniz; Su, Helen H.; Looger, Loren L.; Sternson, Scott M.] Howard Hughes Med Inst, Ashburn, VA 20147 USA	Howard Hughes Medical Institute	Sternson, SM (corresponding author), Howard Hughes Med Inst, Janelia Farm Res Campus,19700 Helix Dr, Ashburn, VA 20147 USA.	sternsons@janelia.hhmi.org	Atasoy, Deniz/B-3414-2018; Atasoy, Deniz/AAR-7917-2020	Atasoy, Deniz/0000-0002-3325-8820; Lee, Peter H/0000-0003-4177-4099	Howard Hughes Medical Institute	Howard Hughes Medical Institute(Howard Hughes Medical Institute)	Supported by the Howard Hughes Medical Institute. C.J.M. performed the electrophysiology and the imaging; P. H. L. synthesized the molecules and performed the MP screen; D. A. performed the behavioral experiments; H. H. S. made the mutant channels and other constructs; L. L. L. made the homology model; and S. M. S. developed the mutant ion channel screen, planned the experiments, analyzed data, and wrote the paper with comments from all authors. We thank S. Winfrey and H. White for cell culture support. S. M. S., P. H. L., and L. L. L. are inventors on a patent application by the Howard Hughes Medical Institute regarding combined use of these ligand-gated ion channels and small-molecule agonists.	Aponte Y, 2011, NAT NEUROSCI, V14, P351, DOI 10.1038/nn.2739; Armbruster BN, 2007, P NATL ACAD SCI USA, V104, P5163, DOI 10.1073/pnas.0700293104; Atasoy D, 2008, J NEUROSCI, V28, P7025, DOI 10.1523/JNEUROSCI.1954-08.2008; BERTRAND D, 1993, P NATL ACAD SCI USA, V90, P6971, DOI 10.1073/pnas.90.15.6971; Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; Bodnar AL, 2005, J MED CHEM, V48, P905, DOI 10.1021/jm049363q; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Breitinger HG, 2001, J BIOL CHEM, V276, P29657, DOI 10.1074/jbc.M100446200; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; Dent JA, 2006, J MOL EVOL, V62, P523, DOI 10.1007/s00239-005-0018-2; EISELE JL, 1993, NATURE, V366, P479, DOI 10.1038/366479a0; Ferguson SM, 2011, NAT NEUROSCI, V14, P22, DOI 10.1038/nn.2703; GALZI JL, 1991, FEBS LETT, V294, P198, DOI 10.1016/0014-5793(91)80668-S; GALZI JL, 1992, NATURE, V359, P500, DOI 10.1038/359500a0; Gosgnach S, 2006, NATURE, V440, P215, DOI 10.1038/nature04545; Grutter T, 2005, P NATL ACAD SCI USA, V102, P18207, DOI 10.1073/pnas.0509024102; Gunthorpe MJ, 2001, J BIOL CHEM, V276, P10977, DOI 10.1074/jbc.M009575200; HWANG YW, 1987, J BIOL CHEM, V262, P13081; Jansen M, 2008, J GEN PHYSIOL, V131, P137, DOI 10.1085/jgp.200709896; Kaelin CB, 2004, ENDOCRINOLOGY, V145, P5798, DOI 10.1210/en.2004-0956; Kelley SP, 2003, NATURE, V424, P321, DOI 10.1038/nature01788; Keramidas A, 2000, BIOPHYS J, V79, P247, DOI 10.1016/S0006-3495(00)76287-4; Lerchner W, 2007, NEURON, V54, P35, DOI 10.1016/j.neuron.2007.02.030; Lester HA, 2004, TRENDS NEUROSCI, V27, P329, DOI 10.1016/j.tins.2004.04.002; Li X, 2005, P NATL ACAD SCI USA, V102, P17816, DOI 10.1073/pnas.0509030102; Lin Q, 2001, J AM CHEM SOC, V123, P11608, DOI 10.1021/ja011423j; MORGAN JI, 1991, ANNU REV NEUROSCI, V14, P421, DOI 10.1146/annurev.ne.14.030191.002225; Rayes D, 2005, MOL PHARMACOL, V68, P1475, DOI 10.1124/mol.105.015438; REVAH F, 1991, NATURE, V353, P846, DOI 10.1038/353846a0; SEGUELA P, 1993, J NEUROSCI, V13, P596; Slimko EM, 2002, J NEUROSCI, V22, P7373; Tan EM, 2006, NEURON, V51, P157, DOI 10.1016/j.neuron.2006.06.018; Tasneem A, 2005, GENOME BIOL, V6; Temburni MK, 2000, J PHYSIOL-LONDON, V525, P21, DOI 10.1111/j.1469-7793.2000.00021.x; Vinson PN, 1997, J NEUROSCI METH, V73, P61, DOI 10.1016/S0165-0270(96)02213-3; Walker DP, 2006, BIOORGAN MED CHEM, V14, P8219, DOI 10.1016/j.bmc.2006.09.019; Wulff P, 2007, NAT NEUROSCI, V10, P923, DOI 10.1038/nn1927; Xu J, 2006, J NEUROSCI, V26, P9780, DOI 10.1523/JNEUROSCI.0840-06.2006; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744	39	185	189	4	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 2	2011	333	6047					1292	1296		10.1126/science.1206606	http://dx.doi.org/10.1126/science.1206606			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	813YM	21885782	Green Accepted			2022-12-28	WOS:000294406400055
J	Suhre, K; Shin, SY; Petersen, AK; Mohney, RP; Meredith, D; Wagele, B; Altmaier, E; Deloukas, P; Erdmann, J; Grundberg, E; Hammond, CJ; de Angelis, MH; Kastenmuller, G; Kottgen, A; Kronenberg, F; Mangino, M; Meisinger, C; Meitinger, T; Mewes, HW; Milburn, MV; Prehn, C; Raffler, J; Ried, JS; Romisch-Margl, W; Samani, NJ; Small, KS; Wichmann, HE; Zhai, GJ; Illig, T; Spector, TD; Adamski, J; Soranzo, N; Gieger, C				Suhre, Karsten; Shin, So-Youn; Petersen, Ann-Kristin; Mohney, Robert P.; Meredith, David; Waegele, Brigitte; Altmaier, Elisabeth; Deloukas, Panos; Erdmann, Jeanette; Grundberg, Elin; Hammond, Christopher J.; Hrabe de Angelis, Martin; Kastenmueller, Gabi; Koettgen, Anna; Kronenberg, Florian; Mangino, Massimo; Meisinger, Christa; Meitinger, Thomas; Mewes, Hans-Werner; Milburn, Michael V.; Prehn, Cornelia; Raffler, Johannes; Ried, Janina S.; Roemisch-Margl, Werner; Samani, Nilesh J.; Small, Kerrin S.; Wichmann, H. -Erich; Zhai, Guangju; Illig, Thomas; Spector, Tim D.; Adamski, Jerzy; Soranzo, Nicole; Gieger, Christian		CARDIoGRAM	Human metabolic individuality in biomedical and pharmaceutical research	NATURE			English	Article							GENOME-WIDE ASSOCIATION; GENETIC-VARIATION; KIDNEY-FUNCTION; LOCI; TRANSPORTER; VARIANTS; METAANALYSIS; CONTRIBUTE; RISK; TOOL	Genome-wide association studies (GWAS) have identified many risk loci for complex diseases, but effect sizes are typically small and information on the underlying biological processes is often lacking. Associations with metabolic traits as functional intermediates can overcome these problems and potentially inform individualized therapy. Here we report a comprehensive analysis of genotype-dependent metabolic phenotypes using a GWAS with non-targeted metabolomics. We identified 37 genetic loci associated with blood metabolite concentrations, of which 25 show effect sizes that are unusually high for GWAS and account for 10-60% differences in metabolite levels per allele copy. Our associations provide new functional insights for many disease-related associations that have been reported in previous studies, including those for cardiovascular and kidney disorders, type 2 diabetes, cancer, gout, venous thromboembolism and Crohn's disease. The study advances our knowledge of the genetic basis of metabolic individuality in humans and generates many new hypotheses for biomedical and pharmaceutical research.	[Suhre, Karsten; Waegele, Brigitte; Altmaier, Elisabeth; Kastenmueller, Gabi; Raffler, Johannes; Roemisch-Margl, Werner] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Bioinformat & Syst Biol, D-85764 Neuherberg, Germany; [Suhre, Karsten; Raffler, Johannes] Univ Munich, Fac Biol, D-82152 Planegg Martinsried, Germany; [Suhre, Karsten] Qatar Fdn, Weill Cornell Med Coll Qatar, Dept Physiol & Biophys, Doha, Qatar; [Shin, So-Youn; Deloukas, Panos; Grundberg, Elin; Soranzo, Nicole] Wellcome Trust Sanger Inst, Cambridge CB10 1HH, England; [Petersen, Ann-Kristin; Ried, Janina S.; Gieger, Christian] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Genet Epidemiol, D-85764 Neuherberg, Germany; [Mohney, Robert P.; Milburn, Michael V.] Metabolon Inc, Res Triangle Pk, NC 27709 USA; [Meredith, David] Oxford Brookes Univ, Sch Life Sci, Oxford OX3 0BP, England; [Waegele, Brigitte; Mewes, Hans-Werner] Tech Univ Munich, Dept Genome Oriented Bioinformat, Life & Food Sci Ctr Weihenstephan, D-85354 Freising Weihenstephan, Germany; [Erdmann, Jeanette] Univ Lubeck, Med Klin 2, D-23538 Lubeck, Germany; [Grundberg, Elin; Hammond, Christopher J.; Mangino, Massimo; Small, Kerrin S.; Zhai, Guangju; Spector, Tim D.] Kings Coll London, Dept Twin Res & Genet Epidemiol, London SE1 7EH, England; [Hrabe de Angelis, Martin; Prehn, Cornelia; Adamski, Jerzy] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Genome Anal Ctr, Inst Expt Genet, D-85764 Neuherberg, Germany; [Hrabe de Angelis, Martin; Adamski, Jerzy] Tech Univ Munich, Life & Food Sci Ctr Weihenstephan, Inst Expt Genet, D-85354 Freising Weihenstephan, Germany; [Koettgen, Anna] Univ Hosp Freiburg, Div Renal, D-79106 Freiburg, Germany; [Kronenberg, Florian] Innsbruck Med Univ, Dept Med Genet Mol & Clin Pharmacol, Div Genet Epidemiol, A-6020 Innsbruck, Austria; [Meisinger, Christa] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol 2, D-85764 Neuherberg, Germany; [Meitinger, Thomas] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Human Genet, D-85764 Neuherberg, Germany; [Meitinger, Thomas] Tech Univ Munich, Klinikum Rechts Isar, Inst Human Genet, D-81675 Munich, Germany; [Samani, Nilesh J.] Univ Leicester, Dept Cardiovasc Sci, Leicester LE1 7RH, Leics, England; [Samani, Nilesh J.] Glenfield Hosp, Leicester NIHR Biomed Res Unit Cardiovasc Dis, Leicester LE1 7RH, Leics, England; [Wichmann, H. -Erich] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol 1, D-85764 Neuherberg, Germany; [Wichmann, H. -Erich] Univ Munich, Chair Epidemiol, Inst Med Informat Biometry & Epidemiol, D-80539 Munich, Germany; [Wichmann, H. -Erich] Klinikum Grosshadern, D-81377 Munich, Germany; [Illig, Thomas] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Res Unit Mol Epidemiol, D-85764 Neuherberg, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Wellcome Trust Sanger Institute; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Metabolon; Oxford Brookes University; Technical University of Munich; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Lubeck; University of London; King's College London; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; University of Freiburg; Medical University of Innsbruck; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; University of Leicester; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Suhre, K (corresponding author), German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Bioinformat & Syst Biol, Ingolstadter Landstr 1, D-85764 Neuherberg, Germany.	karsten@suhre.fr; ns6@sanger.ac.uk	Boehm, Bernhard Otto/F-8750-2015; Suhre, Karsten/AAF-1778-2020; Meredith, David/F-3664-2010; Stark, Klaus/D-3813-2009; Munzel, Thomas/A-2912-2014; Gudnason, Vilmundur/K-6885-2015; Erdmann, Jeanette/A-4417-2009; Kastenmüller, Gabi/ABF-5987-2020; Erdmann, Jeanette/P-7513-2014; Deloukas, Panos/B-2922-2013; Willenborg, Christina/D-2668-2012; Peters, Annette/A-6117-2011; Meisinger, Christine/B-5358-2014; Wichmann, Heinz Erich/AAA-5695-2022; Kronenberg, Florian/B-1736-2008; Mangino, Massimo/F-5134-2011; Meitinger, Thomas/O-1318-2015; Kottgen, Anna/D-2920-2012; de Angelis, Martin Hrabe/F-5531-2012; Mewes, Hans-Werner/A-8204-2019	Suhre, Karsten/0000-0001-9638-3912; Stark, Klaus/0000-0002-7832-1942; Munzel, Thomas/0000-0001-5503-4150; Gudnason, Vilmundur/0000-0001-5696-0084; Erdmann, Jeanette/0000-0002-4486-6231; Deloukas, Panos/0000-0001-9251-070X; Willenborg, Christina/0000-0001-5217-6882; Peters, Annette/0000-0001-6645-0985; Kronenberg, Florian/0000-0003-2229-1120; Mangino, Massimo/0000-0002-2167-7470; de Angelis, Martin Hrabe/0000-0002-7898-2353; Meisinger, Christa/0000-0002-9026-6544; Adamski, Jerzy/0000-0001-9259-0199; Kastenmuller, Gabi/0000-0002-2368-7322; Prehn, Cornelia/0000-0002-1274-4715; Melander, Olle/0000-0002-2581-484X; Kleber, Marcus/0000-0003-0663-7275; Zeller, Tanja/0000-0003-3379-2641; Meitinger, Thomas/0000-0002-8838-8403; Soranzo, Nicole/0000-0003-1095-3852; Preuss, Michael/0000-0001-5266-8465; Small, Kerrin/0000-0003-4566-0005; Van Duijn, Cornelia/0000-0002-2374-9204; Mewes, Hans-Werner/0000-0002-9713-6398; Raffler, Johannes/0000-0003-2495-4020; Gieger, Christian/0000-0001-6986-9554	Helmholtz Zentrum Munchen; National Research Center for Environmental Health; German Federal Ministry of Education, Science, Research and Technology; State of Bavaria; German Federal Ministry of Education and Research (BMBF) [0315494A, 03IS2061B, 0315442A]; German National Genome Research Network [01GS0823]; Munich Center of Health Sciences (MC Health) aspart of LMUinnovativ; Leibniz Supercomputing Centre of the Bavarian Academy of Sciences and Humanities [h1231]; Wellcome Trust; European Community [HEALTH-F2-2008-201865-GEFOS, QLG2-CT-2002-01254]; Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre; Biotechnology and Biological Sciences Research Council (BBSRC) [G20234]; ENGAGE project [HEALTH-F4-2007-201413]; Leicester NIHR Biomedical Research Unit in Cardiovascular Disease; National Eye Institute via an NIH/CIDR; Oxford Brookes University; DFG [Graduiertenkolleg GRK 1563]; German Research Foundation (DFG) [KO-3598/2-1]; Genomics of Lipid-associated Disorders (GOLD) of the Austrian Genome Research Programme (GEN-AU); Wellcome Trust [091746/Z/10/Z]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC055016, N01HC055015, N01HC055018, N01HC055019, N01HC055020, N01HC055022, N01HC055021] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL098055, R01HL087647, R01HL087676, P01HL087018] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080732] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [N01AG012100] Funding Source: NIH RePORTER	Helmholtz Zentrum Munchen(Helmholtz Association); National Research Center for Environmental Health; German Federal Ministry of Education, Science, Research and Technology; State of Bavaria; German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); German National Genome Research Network; Munich Center of Health Sciences (MC Health) aspart of LMUinnovativ; Leibniz Supercomputing Centre of the Bavarian Academy of Sciences and Humanities; Wellcome Trust(Wellcome Trust); European Community(European Commission); Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre(National Institute for Health Research (NIHR)); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); ENGAGE project(General Electric); Leicester NIHR Biomedical Research Unit in Cardiovascular Disease; National Eye Institute via an NIH/CIDR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Oxford Brookes University; DFG(German Research Foundation (DFG)); German Research Foundation (DFG)(German Research Foundation (DFG)); Genomics of Lipid-associated Disorders (GOLD) of the Austrian Genome Research Programme (GEN-AU); Wellcome Trust(Wellcome Trust); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We acknowledge the contributions of P. Lichtner, G. Eckstein, G. Fischer, T. Strom and all other members of the Helmholtz Zentrum Munchen genotyping staff in generating the SNP data set, as well as all members of field staff who were involved in the planning and conduct of the MONICA (Monitoring trends and determinants on cardiovascular diseases) and KORA (Kooperative Gesundheitsforschung in der Region Augsburg) studies. The KORA group consists of H. E. Wichmann (speaker), A. Peters, R. Holle, J. John, C. M., T. I. and their co-workers, who are responsible for the design and conduct of the KORA studies. For TwinsUK, we thank the staff from the genotyping facilities at the Wellcome Trust Sanger Institute for sample preparation, quality control and genotyping. G. Fischer (KORA) and G. Surdulescu (TwinsUK) selected the samples; sample handling and shipment was organized by H. Chavez (KORA) and D. Hodgkiss (TwinsUK); and U. Goebel (Helmholtz) provided administrative support. Special thanks go to D. Garcia-West for his role in facilitating this study. We are grateful to the CARDIoGRAM investigators for access to their data set. Finally, we thank all study participants of the KORA and the TwinsUK studies for donating their blood and time. The KORA research platform and the MONICA studies were initiated and financed by the Helmholtz Zentrum Munchen, National Research Center for Environmental Health, funded by the German Federal Ministry of Education, Science, Research and Technology and by the State of Bavaria. This study was supported by a grant from the German Federal Ministry of Education and Research (BMBF) to the German Center for Diabetes Research (DZD e.V.). Part of this work was financed by the German National Genome Research Network (NGFNPlus: 01GS0823). Computing resources were made available by the Leibniz Supercomputing Centre of the Bavarian Academy of Sciences and Humanities (HLRB project h1231) and the DEISA Extreme Computing Initiative (project MeMGenA). Part of this research was supported within the Munich Center of Health Sciences (MC Health) aspart of LMUinnovativ. The TwinsUK study was funded by the Wellcome Trust; the European Community's Seventh Framework Programme (FP7/2007-2013)/grant agreement HEALTH-F2-2008-201865-GEFOS and (FP7/2007-2013); and the FP-5 GenomEUtwin Project (QLG2-CT-2002-01254). The study also receives support from the Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre award to Guy's & St Thomas' NHS Foundation Trust in partnership with King's College London. T.D.S. is an NIHR Senior Investigator. The project also received support from a Biotechnology and Biological Sciences Research Council (BBSRC) project grant (G20234). Both studies received support from ENGAGE project grant agreement HEALTH-F4-2007-201413. N.J.S. holds a British Heart Foundation Chair, is an NIHR Senior Investigator and is supported by the Leicester NIHR Biomedical Research Unit in Cardiovascular Disease. The authors acknowledge the funding and support of the National Eye Institute via an NIH/CIDR genotyping project (PI: T. Young). Genotypingwas also performed by CIDR as part of an NEI/NIH project grant. D. M. received support from the Early Career Researcher Scheme at Oxford Brookes University. J.R. is supported by DFG Graduiertenkolleg 'GRK 1563, Regulation and Evolution of Cellular Systems' (RECESS); E. A., by BMBF grant 0315494A (project SysMBo); W.R.-M., by BMBF grant 03IS2061B (project Gani_Med); and B. W., by Era-Net grant 0315442A (project PathoGenoMics). A.; K. is supported by the Emmy Noether Programme of the German Research Foundation (DFG grant KO-3598/2-1) and F. K., by grants from the 'Genomics of Lipid-associated Disorders (GOLD)' of the Austrian Genome Research Programme (GEN-AU). N.S. is supported by the Wellcome Trust (core grant number 091746/Z/10/Z).	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Altmaier E, 2008, ENDOCRINOLOGY, V149, P3478, DOI 10.1210/en.2007-1747; Andrew T, 2001, Twin Res, V4, P464, DOI 10.1375/1369052012803; Aulchenko YS, 2009, NAT GENET, V41, P47, DOI 10.1038/ng.269; BLOMBACK B, 1962, NATURE, V193, P883, DOI 10.1038/193883a0; Caulfield MJ, 2008, PLOS MED, V5, P1509, DOI 10.1371/journal.pmed.0050197; Chambers JC, 2010, NAT GENET, V42, P373, DOI 10.1038/ng.566; Chen Y, 2009, PHARMACOGENET GENOM, V19, P497, DOI 10.1097/FPC.0b013e32832cc7e9; Davies NJ, 2009, CANCER RES, V69, P4769, DOI 10.1158/0008-5472.CAN-08-4533; Deeken JF, 2010, PHARMACOGENOMICS J, V10, P191, DOI 10.1038/tpj.2009.57; Doring A, 2008, NAT GENET, V40, P430, DOI 10.1038/ng.107; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; Gieger C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000282; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Huang RS, 2007, P NATL ACAD SCI USA, V104, P9758, DOI 10.1073/pnas.0703736104; Illig T, 2010, NAT GENET, V42, P137, DOI 10.1038/ng.507; Johnson AD, 2009, HUM MOL GENET, V18, P2700, DOI 10.1093/hmg/ddp202; Klein T. E., 2001, Pharmacogenomics Journal, V1, P167; Koepsell H, 2004, PFLUG ARCH EUR J PHY, V447, P666, DOI 10.1007/s00424-003-1089-9; Kottgen A, 2010, NAT GENET, V42, P376, DOI 10.1038/ng.568; Kolz M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000504; Lankisch TO, 2008, CANCER EPIDEM BIOMAR, V17, P695, DOI 10.1158/1055-9965.EPI-07-2517; Lawton KA, 2008, PHARMACOGENOMICS, V9, P383, DOI 10.2217/14622416.9.4.383; Link E, 2008, NEW ENGL J MED, V359, P789, DOI 10.1056/NEJMoa0801936; MARTIN SC, 1992, THROMB RES, V68, P467, DOI 10.1016/0049-3848(92)90059-J; Meredith D, 2008, XENOBIOTICA, V38, P1072, DOI [10.1080/00498250802010868, 10.1080/00498250802010868 ]; Meredith D, 2004, J BIOL CHEM, V279, P15795, DOI 10.1074/jbc.M313922200; Mootha VK, 2010, NAT GENET, V42, P97, DOI 10.1038/ng0210-97; Newgard CB, 2010, NAT MED, V16, P388, DOI 10.1038/nm0410-388; Ohta T, 2009, TOXICOL PATHOL, V37, P521, DOI 10.1177/0192623309336152; Panneerselvam K, 1996, J BIOL CHEM, V271, P9417, DOI 10.1074/jbc.271.16.9417; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Raychaudhuri S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000534; Richards JB, 2008, LANCET, V371, P1505, DOI 10.1016/S0140-6736(08)60599-1; Sanna S, 2009, HUM MOL GENET, V18, P2711, DOI 10.1093/hmg/ddp203; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; Shu Y, 2008, CLIN PHARMACOL THER, V83, P273, DOI 10.1038/sj.clpt.6100275; Soranzo N, 2009, NAT GENET, V41, P1182, DOI 10.1038/ng.467; Soranzo N, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000445; Sreekumar A, 2009, NATURE, V457, P910, DOI 10.1038/nature07762; Suhre K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013953; Taguchi T, 2005, AM J PHYSIOL-ENDOC M, V288, pE534, DOI 10.1152/ajpendo.00451.2004; Teo YY, 2007, BIOINFORMATICS, V23, P2741, DOI 10.1093/bioinformatics/btm443; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Tregouet DA, 2009, BLOOD, V113, P5298, DOI 10.1182/blood-2008-11-190389; Wichmann HE, 2005, GESUNDHEITSWESEN, V67, pS26, DOI 10.1055/s-2005-858226; Yuan X, 2008, AM J HUM GENET, V83, P520, DOI 10.1016/j.ajhg.2008.09.012; Zhai GJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002025	50	707	715	4	250	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 1	2011	477	7362					54	U60		10.1038/nature10354	http://dx.doi.org/10.1038/nature10354			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	813XT	21886157	Green Accepted			2022-12-28	WOS:000294404300029
J	Noguchi, T; Nakamura, T; Kimura, M; Zolensky, ME; Tanaka, M; Hashimoto, T; Konno, M; Nakato, A; Ogami, T; Fujimura, A; Abe, M; Yada, T; Mukai, T; Ueno, M; Okada, T; Shirai, K; Ishibashi, Y; Okazaki, R				Noguchi, T.; Nakamura, T.; Kimura, M.; Zolensky, M. E.; Tanaka, M.; Hashimoto, T.; Konno, M.; Nakato, A.; Ogami, T.; Fujimura, A.; Abe, M.; Yada, T.; Mukai, T.; Ueno, M.; Okada, T.; Shirai, K.; Ishibashi, Y.; Okazaki, R.			Incipient Space Weathering Observed on the Surface of Itokawa Dust Particles	SCIENCE			English	Article							S-TYPE ASTEROIDS; IRRADIATION; SIMULATION; ORIGIN	The reflectance spectra of the most abundant meteorites, ordinary chondrites, are different from those of the abundant S-type (mnemonic for siliceous) asteroids. This discrepancy has been thought to be due to space weathering, which is an alteration of the surfaces of airless bodies exposed to the space environment. Here we report evidence of space weathering on particles returned from the S-type asteroid 25143 Itokawa by the Hayabusa spacecraft. Surface modification was found in 5 out of 10 particles, which varies depending on mineral species. Sulfur-bearing Fe-rich nanoparticles exist in a thin (5 to 15 nanometers) surface layer on olivine, low-Ca pyroxene, and plagioclase, which is suggestive of vapor deposition. Sulfur-free Fe-rich nanoparticles exist deeper inside (<60 nanometers) ferromagnesian silicates. Their texture suggests formation by metamictization and in situ reduction of Fe2+.	[Noguchi, T.; Kimura, M.] Ibaraki Univ, Coll Sci, Mito, Ibaraki 3108512, Japan; [Nakamura, T.; Nakato, A.; Ogami, T.] Tohoku Univ, Dept Earth Sci, Grad Sch Sci, Aoba Ku, Sendai, Miyagi 9808578, Japan; [Zolensky, M. E.] NASA, Lyndon B Johnson Space Ctr, Astromat Res & Explorat Sci Directorate, Houston, TX 77058 USA; [Tanaka, M.] Natl Inst Mat Sci, Synchrotron Xray Stn SPring 8, Sayo, Hyogo 6795148, Japan; [Hashimoto, T.; Konno, M.] Hitachi High Technol, Hitachinaka, Ibaraki 3128504, Japan; [Fujimura, A.; Abe, M.; Yada, T.; Mukai, T.; Ueno, M.; Okada, T.; Shirai, K.; Ishibashi, Y.] Japan Aerosp Explorat Agcy, Inst Space & Astronaut Sci, Chuo Ku, Kanagawa 2525210, Japan; [Okazaki, R.] Kyushu Univ, Dept Earth & Planetary Sci, Fukuoka 8128581, Japan	Ibaraki University; Tohoku University; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; National Institute for Materials Science; Hitachi Limited; Japan Aerospace Exploration Agency (JAXA); Institute of Space & Astronautical Science (ISAS); Kyushu University	Noguchi, T (corresponding author), Ibaraki Univ, Coll Sci, 2-1-1 Bunkyo, Mito, Ibaraki 3108512, Japan.	tngc@mx.ibaraki.ac.jp	Mukai, Toshifumi/ABD-3297-2021	Zolensky, Michael/0000-0002-3181-1303; Noguchi, Takaaki/0000-0001-7211-2595	NASA; Grants-in-Aid for Scientific Research [22540488, 22224010] Funding Source: KAKEN	NASA(National Aeronautics & Space Administration (NASA)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Special thanks to the Hayabusa project team for sample return. We are grateful to Y. Suzuki, S. Tsujimoto, R. Sagae, R. Hinoki, and M. Kawamoto for supporting N2 purge sample preparation at the Institute of Space and Astronautical Sciences of the Japan Aerospace Exploration Agency and Ibaraki University, and for STEM observation at Hitachi High-Technologies. Thanks to H. Hidaka, we could compare the rims of the Itokawa particles and those of space-weathered lunar soil. M. Zolensky was supported by NASA's Muses-C/Hayabusa Program.	Abe M, 2006, SCIENCE, V312, P1334, DOI 10.1126/science.1125718; Binzel RP, 1996, SCIENCE, V273, P946, DOI 10.1126/science.273.5277.946; Chapman CR, 2004, ANNU REV EARTH PL SC, V32, P539, DOI 10.1146/annurev.earth.32.101802.120453; Chapman CR, 1996, METEORIT PLANET SCI, V31, P699, DOI 10.1111/j.1945-5100.1996.tb02107.x; Clark B. E., 2002, ASTEROIDS, VIII, P255; Ewing RC, 2003, REV MINERAL GEOCHEM, V53, P387, DOI 10.2113/0530387; HAPKE B, 1975, MOON PLANETS, V13, P339, DOI 10.1007/BF00567525; Hapke B, 2001, J GEOPHYS RES-PLANET, V106, P10039, DOI 10.1029/2000JE001338; Hiroi T, 2006, NATURE, V443, P56, DOI 10.1038/nature05073; Keller L. P., 2001, LUNAR PLANET SCI, VXXXII, P2097; Keller L. P., 1998, LUNAR PLANET SCI, VXXXIX, P1762; Keller LP, 1997, GEOCHIM COSMOCHIM AC, V61, P2331, DOI 10.1016/S0016-7037(97)00085-9; Loeffler MJ, 2009, J GEOPHYS RES-PLANET, V114, DOI 10.1029/2008JE003249; Lucey PG, 2011, ICARUS, V212, P451, DOI 10.1016/j.icarus.2011.01.022; Miyamoto H, 2007, SCIENCE, V316, P1011, DOI 10.1126/science.1134390; Murchie S, 2002, ICARUS, V155, P145, DOI 10.1006/icar.2001.6756; Nagao K, 2011, SCIENCE, V333, P1128, DOI 10.1126/science.1207785; Nakamura T, 2011, SCIENCE, V333, P1113, DOI 10.1126/science.1207758; Nesvorny D, 2006, ICARUS, V181, P107, DOI 10.1016/j.icarus.2005.10.022; Noble S.K., 2011, LUNAR PLANET SCI, V42, P1382; Noble SK, 2007, ICARUS, V192, P629, DOI 10.1016/j.icarus.2007.07.021; Noble SK, 2010, METEORIT PLANET SCI, V45, P2007, DOI 10.1111/j.1945-5100.2010.01151.x; Noble SK, 2005, METEORIT PLANET SCI, V40, P397, DOI 10.1111/j.1945-5100.2005.tb00390.x; Pieters CM, 2000, METEORIT PLANET SCI, V35, P1101, DOI 10.1111/j.1945-5100.2000.tb01496.x; Sasaki S, 2001, NATURE, V410, P555, DOI 10.1038/35069013; Strazzulla G, 2005, ICARUS, V174, P31, DOI 10.1016/j.icarus.2004.09.013; Taylor LA, 2001, J GEOPHYS RES-PLANET, V106, P27985, DOI 10.1029/2000JE001402; Thomas-Osip JE, 2008, EARTH PLANETS SPACE, V60, P39, DOI 10.1186/BF03352760; Vernazza P, 2009, NATURE, V458, P993, DOI 10.1038/nature07956; Willman M, 2008, ICARUS, V195, P663, DOI 10.1016/j.icarus.2008.02.007; Yano H, 2006, SCIENCE, V312, P1350, DOI 10.1126/science.1126164; Zhang S., 2010, LUNAR PLANET SCI, V41, P1432	32	220	224	4	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 26	2011	333	6046					1121	1125		10.1126/science.1207794	http://dx.doi.org/10.1126/science.1207794			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811VM	21868670				2022-12-28	WOS:000294244300041
J	Blaser, M				Blaser, Martin			Stop the killing of beneficial bacteria	NATURE			English	Editorial Material							HELICOBACTER-PYLORI; GUT MICROBIOTA		NYU, Dept Med, Langone Med Ctr, New York, NY 10016 USA	New York University; NYU Langone Medical Center	Blaser, M (corresponding author), NYU, Dept Med, Langone Med Ctr, 550 1St Ave, New York, NY 10016 USA.	martin.blaser@med.nyu.edu						Arnold IC, 2011, J CLIN INVEST, V121, P3088, DOI 10.1172/JCI45041; Blaser MJ, 2009, NAT REV MICROBIOL, V7, P887, DOI 10.1038/nrmicro2245; Chang JY, 2008, J INFECT DIS, V197, P435, DOI 10.1086/525047; Chen Y, 2007, ARCH INTERN MED, V167, P821, DOI 10.1001/archinte.167.8.821; Dethlefsen L, 2011, P NATL ACAD SCI USA, V108, P4554, DOI 10.1073/pnas.1000087107; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; Ley RE, 2008, NAT REV MICROBIOL, V6, P776, DOI 10.1038/nrmicro1978; Sharland M, 2007, J ANTIMICROB CHEMOTH, V60, pI15, DOI 10.1093/jac/dkm153; Sjolund M, 2003, ANN INTERN MED, V139, P483, DOI 10.7326/0003-4819-139-6-200309160-00011	9	261	275	1	110	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 25	2011	476	7361					393	394		10.1038/476393a	http://dx.doi.org/10.1038/476393a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	811KT	21866137	Bronze			2022-12-28	WOS:000294209400011
J	Diamond, A; Lee, K				Diamond, Adele; Lee, Kathleen			Interventions Shown to Aid Executive Function Development in Children 4 to 12 Years Old	SCIENCE			English	Review							WORKING-MEMORY; ACADEMIC-ACHIEVEMENT; SELF-REGULATION; EXERCISE; HEALTH; SKILLS; ENHANCEMENT; OUTCOMES; PROGRAM; BRAIN	To be successful takes creativity, flexibility, self-control, and discipline. Central to all those are executive functions, including mentally playing with ideas, giving a considered rather than an impulsive response, and staying focused. Diverse activities have been shown to improve children's executive functions: computerized training, noncomputerized games, aerobics, martial arts, yoga, mindfulness, and school curricula. All successful programs involve repeated practice and progressively increase the challenge to executive functions. Children with worse executive functions benefit most from these activities; thus, early executive-function training may avert widening achievement gaps later. To improve executive functions, focusing narrowly on them may not be as effective as also addressing emotional and social development (as do curricula that improve executive functions) and physical development (shown by positive effects of aerobics, martial arts, and yoga).	[Diamond, Adele; Lee, Kathleen] Univ British Columbia, Vancouver, BC V6T 2A1, Canada; [Diamond, Adele; Lee, Kathleen] Childrens Hosp, Vancouver, BC V6T 2A1, Canada	University of British Columbia; University of British Columbia	Diamond, A (corresponding author), Univ British Columbia, Vancouver, BC V6T 2A1, Canada.	adele.diamond@ubc.ca	Fahimifar, Sepideh/M-5303-2019	Diamond, Adele/0000-0002-1453-6434	National Institute on Drug Abuse [DA19685]; National Institute of Mental Health [MH 071893]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH071893] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA019685] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	A.D. gratefully acknowledges grant support from the National Institute on Drug Abuse (R01 grant no. DA19685) and the National Institute of Mental Health (R01 grant no. MH 071893) during the writing of this paper.	Arnsten AFT, 1998, SCIENCE, V280, P1711, DOI 10.1126/science.280.5370.1711; Bergman-Nutley S., 2011, THESIS KAROLINSKA I; Blair C, 2007, CHILD DEV, V78, P647, DOI 10.1111/j.1467-8624.2007.01019.x; Bodrova E., 2012, APPROACHES EARLY CHI, V6th ed., P241; Budde H, 2008, NEUROSCI LETT, V441, P219, DOI 10.1016/j.neulet.2008.06.024; Cacioppo JT., 2008, LONELINESS HUMAN NAT; Castelli DM, 2007, J SPORT EXERCISE PSY, V29, P239, DOI 10.1123/jsep.29.2.239; Chaddock L, 2011, J INT NEUROPSYCH SOC, V17, P975, DOI 10.1017/S1355617711000567; Coe DP, 2006, MED SCI SPORT EXER, V38, P1515, DOI 10.1249/01.mss.0000227537.13175.1b; COHEN PA, 1982, AM EDUC RES J, V19, P237, DOI 10.2307/1162567; Davis CL, 2011, HEALTH PSYCHOL, V30, P91, DOI 10.1037/a0021766; Diamond A, 2007, SCIENCE, V318, P1387, DOI 10.1126/science.1151148; Dunn JR, 2010, JAMA-J AM MED ASSOC, V303, P1199, DOI 10.1001/jama.2010.332; Eakin L, 2004, J Atten Disord, V8, P1, DOI 10.1177/108705470400800101; Flook L, 2010, J APPL SCH PSYCHOL, V26, P70, DOI 10.1080/15377900903379125; Gathercole SE, 2004, APPL COGNITIVE PSYCH, V18, P1, DOI 10.1002/acp.934; GREENWOOD CR, 1989, J EDUC PSYCHOL, V81, P371, DOI 10.1037/0022-0663.81.3.371; Hillman CH, 2008, NAT REV NEUROSCI, V9, P58, DOI 10.1038/nrn2298; Holmes J, 2010, APPL COGNITIVE PSYCH, V24, P827, DOI 10.1002/acp.1589; Holmes J, 2009, DEVELOPMENTAL SCI, V12, pF9, DOI 10.1111/j.1467-7687.2009.00848.x; Kamijo K, 2011, DEVELOPMENTAL SCI, V14, P1046, DOI 10.1111/j.1467-7687.2011.01054.x; Klingberg T, 2005, J AM ACAD CHILD PSY, V44, P177, DOI 10.1097/00004583-200502000-00010; Kusche C. A., 1994, PATH CURRICULUM; KUSCHE CA, 1993, J CLIN CHILD PSYCHOL, V22, P172, DOI 10.1207/s15374424jccp2202_5; Lakes KD, 2004, J APPL DEV PSYCHOL, V25, P283, DOI 10.1016/j.appdev.2004.04.002; Li-Grining C. P., 2011, SOC RES CHILD DEV BI; Lillard A, 2006, SCIENCE, V313, P1893, DOI 10.1126/science.1132362; Lloyd K., 2011, NAMTA J, V36, P165; Mackey AP, 2011, DEVELOPMENTAL SCI, V14, P582, DOI 10.1111/j.1467-7687.2010.01005.x; Manjunath N. K., 2001, Indian Journal of Physiology and Pharmacology, V45, P351; Mastropieri M.A., 2001, LEARNING DISABILITIE, V16, P18, DOI [https://doi.org/10.1111/0938-8982.00003, DOI 10.1111/0938-8982.00003]; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Moffitt TE, 2011, P NATL ACAD SCI USA, V108, P2693, DOI 10.1073/pnas.1010076108; Montessori M., 1949, ABSORBENT MIND; Nutley SB, 2011, DEVELOPMENTAL SCI, V14, P591, DOI 10.1111/j.1467-7687.2010.01022.x; O'Shaughnessy TE, 2003, REM SPEC EDUC, V24, P27, DOI 10.1177/074193250302400103; Prince M, 2007, LANCET, V370, P859, DOI 10.1016/S0140-6736(07)61238-0; Rauscher FH, 1997, NEUROL RES, V19, P2; Raver CC, 2008, EARLY CHILD RES Q, V23, P10, DOI 10.1016/j.ecresq.2007.09.001; Raver CC, 2011, CHILD DEV, V82, P362, DOI 10.1111/j.1467-8624.2010.01561.x; Riggs NR, 2006, PREV SCI, V7, P91, DOI 10.1007/s11121-005-0022-1; Rueda MR, 2005, P NATL ACAD SCI USA, V102, P14931, DOI 10.1073/pnas.0506897102; Thorell LB, 2009, DEVELOPMENTAL SCI, V12, P106, DOI 10.1111/j.1467-7687.2008.00745.x; TRULSON ME, 1986, HUM RELAT, V39, P1131, DOI 10.1177/001872678603901204; TUCKMAN BW, 1986, HEALTH PSYCHOL, V5, P197, DOI 10.1037/0278-6133.5.3.197; Uhrich TA, 2007, PERCEPT MOTOR SKILL, V104, P1035, DOI 10.2466/PMS.104.3.1035-1041; Vygotsky L.S, 1978, MIND SOC DEV HIGHER, DOI DOI 10.2307/J.CTVJF9VZ4.11; Webster-Stratton C, 2004, INFANT YOUNG CHILD, V17, P96, DOI 10.1097/00001163-200404000-00002	48	1455	1487	56	1120	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 19	2011	333	6045					959	964		10.1126/science.1204529	http://dx.doi.org/10.1126/science.1204529			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	808TD	21852486	Green Accepted			2022-12-28	WOS:000294000400040
J	Lorsch, JR; Nichols, DG				Lorsch, Jon R.; Nichols, David G.			Organizing Graduate Life Sciences Education around Nodes and Connections	CELL			English	Editorial Material									[Lorsch, Jon R.; Nichols, David G.] Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA; [Nichols, David G.] Johns Hopkins Univ, Sch Med, Dept Anesthesiol Crit Care Med, Baltimore, MD 21205 USA; [Nichols, David G.] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Lorsch, JR (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA.	jlorsch@jhmi.edu; dnichols@jhmi.edu		Lorsch, Jon/0000-0002-4521-4999				Alberts B, 2004, P NATL ACAD SCI USA, V101, P11177, DOI 10.1073/pnas.0404433101; ALPERN RJ, 2009, AAMC HHMI REPORT SCI; Attwood TK, 2009, BIOCHEM J, V424, P317, DOI 10.1042/BJ20091474; CONNELLY T, 2009, ENSURING US LEADS CO; Costello LC, 2009, ACAD MED, V84, P459, DOI 10.1097/ACM.0b013e31819a7c6b; Feldon DF, 2010, SCIENCE, V329, P282, DOI 10.1126/science.1191269; Humphrey JD, 2005, ADV PHYSIOL EDUC, V29, P98, DOI 10.1152/advan.00053.2004; Kirschner MW, 2005, CELL, V121, P503, DOI 10.1016/j.cell.2005.05.005; Sharp P.A., 2011, 3 REVOLUTION CONVERG; STRYER L, 2003, BIO2010 TRANSFORMING; Wiener CM, 2010, ACAD MED, V85, P498, DOI 10.1097/ACM.0b013e3181ccbebf	11	8	8	0	15	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 19	2011	146	4					506	509		10.1016/j.cell.2011.08.004	http://dx.doi.org/10.1016/j.cell.2011.08.004			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	809HY	21854978	Bronze			2022-12-28	WOS:000294043600006
J	Shonkoff, JP				Shonkoff, Jack P.			Protecting Brains, Not Simply Stimulating Minds	SCIENCE			English	Editorial Material							STRESS REACTIVITY; SELF-REGULATION; PRESCHOOL; BEHAVIOR; CHILDREN	Curricular enhancements in early childhood education that are guided by the science of learning must be augmented by protective interventions informed by the biology of adversity. The same neuroplasticity that leaves emotional regulation, behavioral adaptation, and executive functioning skills vulnerable to early disruption by stressful environments also enables their successful development through focused interventions during sensitive periods in their maturation. The early childhood field should therefore combine cognitive-linguistic enrichment with greater attention to preventing, reducing, or mitigating the consequences of significant adversity on the developing brain. Guided by this enhanced theory of change, scientists, practitioners, and policy-makers must work together to design, implement, and evaluate innovative strategies to produce substantially greater impacts than those achieved by existing programs.	Harvard Univ, Ctr Dev Child, Cambridge, MA 02138 USA	Harvard University	Shonkoff, JP (corresponding author), Harvard Univ, Ctr Dev Child, 50 Church St, Cambridge, MA 02138 USA.	jack_shonkoff@harvard.edu						[Anonymous], 2009, SOCIAL POLICY REPORT, DOI DOI 10.1002/J.2379-3988.2009.TB00061.X; Barr CS, 2004, ARCH GEN PSYCHIAT, V61, P1146, DOI 10.1001/archpsyc.61.11.1146; Best JR, 2010, CHILD DEV, V81, P1641, DOI 10.1111/j.1467-8624.2010.01499.x; Clements DH, 2007, J RES MATH EDUC, V38, P136, DOI 10.2307/30034954; Diamond A, 2007, SCIENCE, V318, P1387, DOI 10.1126/science.1151148; Fox SE, 2010, CHILD DEV, V81, P28, DOI 10.1111/j.1467-8624.2009.01380.x; Gelman R., 2009, PRESCHOOL PATHWAYS S; Gilliam WS, 2006, INFANT YOUNG CHILD, V19, P228, DOI 10.1097/00001163-200607000-00007; Hamre BK, 2004, EARLY CHILD RES Q, V19, P297, DOI 10.1016/j.ecresq.2004.04.006; Karoly LA., 2005, EARLY CHILDHOOD INTE; Loman MM, 2010, NEUROSCI BIOBEHAV R, V34, P867, DOI 10.1016/j.neubiorev.2009.05.007; Lupien SJ, 2009, NAT REV NEUROSCI, V10, P434, DOI 10.1038/nrn2639; Nachmias M, 1996, CHILD DEV, V67, P508, DOI 10.2307/1131829; Olfson M, 2010, J AM ACAD CHILD PSY, V49, P13, DOI 10.1016/j.jaac.2009.09.003; Parker D.R., 2009, LEARN DISABIL RES PR, V24, P204, DOI [10.1111/j.1540-5826.2009.00294.x, DOI 10.1111/J.1540-5826.2009.00294.X]; Pine DS, 1999, BIOL PSYCHIAT, V46, P1555, DOI 10.1016/S0006-3223(99)00115-8; Raver CC, 2011, CHILD DEV, V82, P362, DOI 10.1111/j.1467-8624.2010.01561.x; Raver CC, 2004, CHILD DEV, V75, P346, DOI 10.1111/j.1467-8624.2004.00676.x; Rimm-Kaufman SE, 2000, EARLY CHILD RES Q, V15, P147, DOI 10.1016/S0885-2006(00)00049-1; Shonkoff J. P., 2000, NEURONS NEIGHBORHOOD; Shonkoff JP, 2010, NEURON, V67, P689, DOI 10.1016/j.neuron.2010.08.032; Shonkoff JP, 2010, CHILD DEV, V81, P357, DOI 10.1111/j.1467-8624.2009.01399.x; Sotres-Bayon F, 2004, LEARN MEMORY, V11, P525, DOI 10.1101/lm.79504	23	157	166	3	69	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 19	2011	333	6045					982	983		10.1126/science.1206014	http://dx.doi.org/10.1126/science.1206014			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	808TD	21852492				2022-12-28	WOS:000294000400046
J	Zhao, LY; He, R; Rim, KT; Schiros, T; Kim, KS; Zhou, H; Gutierrez, C; Chockalingam, SP; Arguello, CJ; Palova, L; Nordlund, D; Hybertsen, MS; Reichman, DR; Heinz, TF; Kim, P; Pinczuk, A; Flynn, GW; Pasupathy, AN				Zhao, Liuyan; He, Rui; Rim, Kwang Taeg; Schiros, Theanne; Kim, Keun Soo; Zhou, Hui; Gutierrez, Christopher; Chockalingam, S. P.; Arguello, Carlos J.; Palova, Lucia; Nordlund, Dennis; Hybertsen, Mark S.; Reichman, David R.; Heinz, Tony F.; Kim, Philip; Pinczuk, Aron; Flynn, George W.; Pasupathy, Abhay N.			Visualizing Individual Nitrogen Dopants in Monolayer Graphene	SCIENCE			English	Article							SCANNING TUNNELING MICROSCOPE; X-RAY SPECTROSCOPY; DOPED GRAPHENE; FILMS; SCATTERING; GRAPHITE	In monolayer graphene, substitutional doping during growth can be used to alter its electronic properties. We used scanning tunneling microscopy, Raman spectroscopy, x-ray spectroscopy, and first principles calculations to characterize individual nitrogen dopants in monolayer graphene grown on a copper substrate. Individual nitrogen atoms were incorporated as graphitic dopants, and a fraction of the extra electron on each nitrogen atom was delocalized into the graphene lattice. The electronic structure of nitrogen-doped graphene was strongly modified only within a few lattice spacings of the site of the nitrogen dopant. These findings show that chemical doping is a promising route to achieving high-quality graphene films with a large carrier concentration.	[Zhao, Liuyan; He, Rui; Kim, Keun Soo; Zhou, Hui; Gutierrez, Christopher; Chockalingam, S. P.; Arguello, Carlos J.; Heinz, Tony F.; Kim, Philip; Pinczuk, Aron; Pasupathy, Abhay N.] Columbia Univ, Dept Phys, New York, NY 10027 USA; [Rim, Kwang Taeg; Palova, Lucia; Reichman, David R.; Flynn, George W.] Columbia Univ, Dept Chem, New York, NY 10027 USA; [Schiros, Theanne] Columbia Univ, Energy Frontier Res Ctr, New York, NY 10027 USA; [Kim, Keun Soo] Sejong Univ, Dept Phys, Seoul 143747, South Korea; [Kim, Keun Soo] Sejong Univ, Graphene Res Inst, Seoul 143747, South Korea; [Nordlund, Dennis] SLAC Natl Accelerator Lab, Stanford Synchrotron Radiat Light Source, Menlo Pk, CA 94025 USA; [Hybertsen, Mark S.] Brookhaven Natl Lab, Ctr Funct Nanomat, Upton, NY 11973 USA; [Heinz, Tony F.] Columbia Univ, Dept Elect Engn, New York, NY 10027 USA; [Pinczuk, Aron] Columbia Univ, Dept Appl Phys & Appl Math, New York, NY 10027 USA	Columbia University; Columbia University; Columbia University; Sejong University; Sejong University; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; United States Department of Energy (DOE); Brookhaven National Laboratory; Columbia University; Columbia University	Pasupathy, AN (corresponding author), Columbia Univ, Dept Phys, 538 W 120th St, New York, NY 10027 USA.	pasupathy@phys.columbia.edu	Hybertsen, Mark S./AAX-3175-2021; Heinz, Tony/K-7797-2015; Kim, Philip/N-1886-2013; Li, jiayu/H-3827-2014; Kim, Keun Soo/C-1601-2013; He, Rui/B-2021-2012; Nordlund, Dennis/A-8902-2008; bartelsdoe, ludwig/F-8008-2011	Hybertsen, Mark S./0000-0003-3596-9754; Heinz, Tony/0000-0003-1365-9464; Kim, Philip/0000-0002-8255-0086; Li, jiayu/0000-0003-2639-213X; Nordlund, Dennis/0000-0001-9524-6908; Gutierrez, Christopher/0000-0002-8307-6419; Kim, Keun Soo/0000-0002-4901-6156; Schiros, Theanne/0000-0002-1725-1573; Zhao, Liuyan/0000-0001-9512-3537; He, Rui/0000-0002-2368-7269	U.S. Department of Energy (DOE), Office of Science, Office of Basic Energy Sciences [DE_SC0001085]; Air Force Office of Scientific Research [FA9550-11-1-0010]; DOE [DE-FG02-88ER13937, DE-FG02-07ER15842, DE-AC02-98CH10886]; Office of Naval Research under Graphene Multidisciplinary University Research Initiative; Defense Advanced Research Projects Agency; NSF [CHE-0641523, CHE-07-01483]; New York State Office of Science, Technology and Academic Research; Ministry of Education, Science and Technology [2011-0018395]	U.S. Department of Energy (DOE), Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); DOE(United States Department of Energy (DOE)); Office of Naval Research under Graphene Multidisciplinary University Research Initiative; Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NSF(National Science Foundation (NSF)); New York State Office of Science, Technology and Academic Research; Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This material is based on work supported as part of the Center for Re-Defining Photovoltaic Efficiency Through Molecule Scale Control, an Energy Frontier Research Center funded by the U.S. Department of Energy (DOE), Office of Science, Office of Basic Energy Sciences under award no. DE_SC0001085. Support was also provided by the Air Force Office of Scientific Research under grant no. FA9550-11-1-0010 (A.N.P); by the DOE under grants DE-FG02-88ER13937 (G. W. F) and DE-FG02-07ER15842 (T. H.) for research carried out in part at the Center for Functional Nanomaterials, Brookhaven National Laboratory, contract no. DE-AC02-98CH10886 (M. S. H.) and at the National Synchrotron Light Source, contract no. DE-AC02-98CH10886; by the Office of Naval Research under Graphene Multidisciplinary University Research Initiative (A. P. and P. K.); by the Defense Advanced Research Projects Agency Carbon Electronics for RF Applications program (P. K.); by the NSF under grant no. CHE-0641523 (A. P.); by the New York State Office of Science, Technology and Academic Research and by the Priority Research Centers Program (2011-0018395) through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (K. S. K.). Equipment and material support was provided by the NSF under grant CHE-07-01483 (G. W. F.). Portions of this research were carried out at the Stanford Synchrotron Radiation Lightsource (SSRL), a Directorate of SLAC National Accelerator Laboratory and an Office of Science User Facility operated for the DOE Office of Science by Stanford University. We thank C. Jaye and D. Fischer for assistance in using National Synchrotron Light Source beamline U7A, H. Ogasawara for assistance at SSRL beamline 13-2, and C. Marianetti and D. Prezzi for useful discussions. The authors declare no competing financial interests. Requests for materials should be addressed to A.N.P.	Ashcroft N.W., 1976, SOLID STATE PHYS; Castro Neto AH, 2009, REV MOD PHYS, V81, P109, DOI 10.1103/RevModPhys.81.109; Cockayne E, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.195425; Das A, 2008, NAT NANOTECHNOL, V3, P210, DOI 10.1038/nnano.2008.67; Deng DH, 2011, CHEM MATER, V23, P1188, DOI 10.1021/cm102666r; Deshpande A, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.205411; Dresselhaus MS, 2010, PHILOS T R SOC A, V368, P5355, DOI 10.1098/rsta.2010.0213; Endo M, 2001, J APPL PHYS, V90, P5670, DOI 10.1063/1.1409581; Ferrari AC, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.187401; Giannozzi P, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/39/395502; Gierz I, 2008, NANO LETT, V8, P4603, DOI 10.1021/nl802996s; Giovannetti G, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.026803; Hellgren N, 2005, THIN SOLID FILMS, V471, P19, DOI 10.1016/j.tsf.2004.03.027; Hellgren N, 2001, APPL PHYS LETT, V79, P4348, DOI 10.1063/1.1428108; Jorio A, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/33/334204; Khomyakov PA, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.195425; Kim KS, 2009, NATURE, V457, P706, DOI 10.1038/nature07719; Lherbier A, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.036808; Li GH, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.176804; Li XL, 2009, J AM CHEM SOC, V131, P15939, DOI 10.1021/ja907098f; Li XS, 2009, SCIENCE, V324, P1312, DOI 10.1126/science.1171245; Lin YC, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3368697; Lucchese MM, 2010, CARBON, V48, P1592, DOI 10.1016/j.carbon.2009.12.057; Meyer JC, 2011, NAT MATER, V10, P209, DOI 10.1038/NMAT2941; Panchokarla LS, 2009, ADV MATER, V21, P4726, DOI 10.1002/adma.200901285; Point S, 2005, DIAM RELAT MATER, V14, P891, DOI 10.1016/j.diamond.2004.10.011; Qu LT, 2010, ACS NANO, V4, P1321, DOI 10.1021/nn901850u; Rutter GM, 2007, SCIENCE, V317, P219, DOI 10.1126/science.1142882; Shimoyama I, 2000, PHYS REV B, V62, pR6053, DOI 10.1103/PhysRevB.62.R6053; Sun ZZ, 2010, NATURE, V468, P549, DOI 10.1038/nature09579; TERSOFF J, 1985, PHYS REV B, V31, P805, DOI 10.1103/PhysRevB.31.805; Wang XR, 2009, SCIENCE, V324, P768, DOI 10.1126/science.1170335; Wang Y, 2010, ACS NANO, V4, P1790, DOI 10.1021/nn100315s; Wei DC, 2009, NANO LETT, V9, P1752, DOI 10.1021/nl803279t; Yan J, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.166802; Zhang YB, 2008, NAT PHYS, V4, P627, DOI 10.1038/nphys1022; Zhang YB, 2010, NAT PHYS, V6, P74, DOI 10.1038/nphys1502; Zheng B, 2010, ACS NANO, V4, P4165, DOI 10.1021/nn1002425	38	701	712	8	701	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 19	2011	333	6045					999	1003		10.1126/science.1208759	http://dx.doi.org/10.1126/science.1208759			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808TD	21852495	Green Submitted			2022-12-28	WOS:000294000400051
J	Freedman, ND; Silverman, DT; Hollenbeck, AR; Schatzkin, A; Abnet, CC				Freedman, Neal D.; Silverman, Debra T.; Hollenbeck, Albert R.; Schatzkin, Arthur; Abnet, Christian C.			Association Between Smoking and Risk of Bladder Cancer Among Men and Women	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACTIVE CIGARETTE-SMOKING; LUNG-CANCER; REPRODUCTIVE FACTORS; POOLED ANALYSIS; UNITED-STATES; COHORT; POPULATION; METAANALYSIS; OCCUPATION; MORTALITY	Context Previous studies indicate that the population attributable risk (PAR) of bladder cancer for tobacco smoking is 50% to 65% in men and 20% to 30% in women and that current cigarette smoking triples bladder cancer risk relative to never smoking. During the last 30 years, incidence rates have remained stable in the United States in men (123.8 per 100 000 person-years to 142.2 per 100 000 person-years) and women (32.5 per 100 000 person-years to 33.2 per 100 000 person-years); however, changing smoking prevalence and cigarette composition warrant revisiting risk estimates for smoking and bladder cancer. Objective To evaluate the association between tobacco smoking and bladder cancer. Design, Setting, and Participants Men (n=281 394) and women (n=186 134) of the National Institutes of Health-AARP (NIH-AARP) Diet and Health Study cohort completed a lifestyle questionnaire and were followed up between October 25, 1995, and December 31, 2006. Previous prospective cohort studies of smoking and incident bladder cancer were identified by systematic review and relative risks were estimated from fixed-effects models with heterogeneity assessed by the I-2 statistic. Main Outcome Measures Hazard ratios (HRs), PARs, and number needed to harm (NNH). Results During 4 518 941 person-years of follow-up, incident bladder cancer occurred in 3896 men (144.0 per 100 000 person-years) and 627 women (34.5 per 100 000 person-years). Former smokers (119.8 per 100 000 person-years; HR, 2.22; 95% confidence interval [CI], 2.03-2.44; NNH, 1250) and current smokers (177.3 per 100 000 person-years; HR, 4.06; 95% CI, 3.66-4.50; NNH, 727) had higher risks of bladder cancer than never smokers (39.8 per 100 000 person-years). In contrast, the summary risk estimate for current smoking in 7 previous studies (initiated between 1963 and 1987) was 2.94 (95% CI, 2.45-3.54; I-2=0.0%). The PAR for ever smoking in our study was 0.50 (95% CI, 0.45-0.54) in men and 0.52 (95% CI, 0.45-0.59) in women. Conclusion Compared with a pooled estimate of US data from cohorts initiated between 1963 and 1987, relative risks for smoking in the more recent NIH-AARP Diet and Health Study cohort were higher, with PARs for women comparable with those for men.	[Freedman, Neal D.; Silverman, Debra T.; Schatzkin, Arthur; Abnet, Christian C.] NCI, Div Canc Epidemiol & Genet, NIH, US Dept HHS, Rockville, MD 20852 USA; [Hollenbeck, Albert R.] AARP, Washington, DC USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); American Association of Retired Persons (AARP)	Freedman, ND (corresponding author), NCI, Div Canc Epidemiol & Genet, NIH, US Dept HHS, 6120 Execut Blvd,EPS 320,MSC 7232, Rockville, MD 20852 USA.	freedmanne@mail.nih.gov	Freedman, Neal David/B-9741-2015; Abnet, Christian C/C-4111-2015; Hollenbeck, Albert/AAG-9461-2020	Freedman, Neal David/0000-0003-0074-1098; Abnet, Christian C/0000-0002-3008-7843; 	National Institutes of Health, National Cancer Institute, Division of Cancer Epidemiology and Genetics; Florida Department of Health; NATIONAL CANCER INSTITUTE [ZIACP010196] Funding Source: NIH RePORTER	National Institutes of Health, National Cancer Institute, Division of Cancer Epidemiology and Genetics(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics); Florida Department of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the Intramural Research Program of the National Institutes of Health, National Cancer Institute, Division of Cancer Epidemiology and Genetics. Cancer incidence data from Arizona were collected by the Arizona Cancer Registry; from Georgia by the Georgia Center for Cancer Statistics; from California by the California Department of Health Services, Cancer Surveillance Section; from Michigan by the Michigan Cancer Surveillance Program; from Florida by the Florida Cancer Data System under contract to the Florida Department of Health; from Louisiana by the Louisiana Tumor Registry; from New Jersey by the New Jersey State Cancer Registry; from North Carolina by the North Carolina Central Cancer Registry; from Pennsylvania by the Division of Health Statistics and Research, Pennsylvania Department of Health; and from Texas by the Texas Cancer Registry.	Alberg AJ, 2007, AM J EPIDEMIOL, V165, P660, DOI 10.1093/aje/kwk047; [Anonymous], INT TOOL ACC SEER CA; Assaf AR, 2002, J WOMEN HEALTH GEN-B, V11, P899, DOI 10.1089/154099902762203731; Baris D, 2009, JNCI-J NATL CANCER I, V101, P1553, DOI 10.1093/jnci/djp361; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Brennan P, 2000, INT J CANCER, V86, P289, DOI 10.1002/(SICI)1097-0215(20000415)86:2<289::AID-IJC21>3.0.CO;2-M; Breslow N E, 1980, IARC Sci Publ, P5; BRUZZI P, 1985, AM J EPIDEMIOL, V122, P904, DOI 10.1093/oxfordjournals.aje.a114174; Butler TL, 2008, INT J EPIDEMIOL, V37, P260, DOI 10.1093/ije/dym165; Cantwell MM, 2006, INT J CANCER, V119, P2398, DOI 10.1002/ijc.22175; Chyou P H, 1993, Ann Epidemiol, V3, P211; Colt JS, 2004, CANCER CAUSE CONTROL, V15, P759, DOI 10.1023/B:CACO.0000043426.28741.a2; Cook MB, 2009, CANCER EPIDEM BIOMAR, V18, P1174, DOI 10.1158/1055-9965.EPI-08-1118; COX DR, 1972, J R STAT SOC B, V34, P187; D'Avanzo Barbara, 1995, Annals of Epidemiology, V5, P427, DOI 10.1016/1047-2797(95)00057-7; Davis-Dao CA, 2011, CANCER EPIDEM BIOMAR, V20, P1156, DOI 10.1158/1055-9965.EPI-11-0017; Devesa SS, 2005, INT J CANCER, V117, P294, DOI 10.1002/ijc.21183; Dryson E, 2008, INT J CANCER, V122, P1340, DOI 10.1002/ijc.23194; Dube S. R., 2010, Morbidity and Mortality Weekly Report, V59, P1135; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Freedman ND, 2008, LANCET ONCOL, V9, P649, DOI 10.1016/S1470-2045(08)70154-2; Fritz AG., 2000, INT CLASSIFICATION D, V3rd; Fuchs CS, 1996, ARCH INTERN MED, V156, P2255, DOI 10.1001/archinte.156.19.2255; Gallicchio L, 2006, PREV MED, V42, P200, DOI 10.1016/j.ypmed.2005.12.014; Garrett Bridgette E., 2011, Morbidity and Mortality Weekly Report, V60, P109; HARTGE P, 1990, J NATL CANCER I, V82, P1636, DOI 10.1093/jnci/82.20.1636; HARTGE P, 1987, J NATL CANCER I, V78, P1119; Hemelt M, 2009, INT J CANCER, V124, P412, DOI 10.1002/ijc.23856; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hoffmann D, 2001, CHEM RES TOXICOL, V14, P767, DOI 10.1021/tx000260u; Hotaling J, 2010, J UROLOGY, V183, pE449, DOI 10.1016/j.juro.2010.02.660; IARC, 2004, IARC MON EV CARC RIS, V83; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jemal A, 2003, INT J CANCER, V105, P101, DOI 10.1002/ijc.11020; Limsui D, 2010, JNCI-J NATL CANCER I, V102, P1012, DOI 10.1093/jnci/djq201; McGrath M, 2006, AM J EPIDEMIOL, V163, P236, DOI 10.1093/aje/kwj028; Michaud D, 2005, J REGISTRY MANAGE, V2, P70; Michaud DS, 2001, EPIDEMIOLOGY, V12, P719, DOI 10.1097/00001648-200111000-00022; MILLS PK, 1991, AM J EPIDEMIOL, V133, P230, DOI 10.1093/oxfordjournals.aje.a115867; Moore SC, 2008, INT J OBESITY, V32, P730, DOI 10.1038/sj.ijo.0803801; MUNGER RG, 1992, AM J EPIDEMIOL, V136, P192, DOI 10.1093/oxfordjournals.aje.a116485; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; PETITTI DB, 1981, AM J PUBLIC HEALTH, V71, P308, DOI 10.2105/AJPH.71.3.308; Puente D, 2006, CANCER CAUSE CONTROL, V17, P71, DOI 10.1007/s10552-005-0389-0; RIMM EB, 1995, BRIT MED J, V310, P555, DOI 10.1136/bmj.310.6979.555; Rodriguez BL, 1996, CIRCULATION, V94, P952, DOI 10.1161/01.CIR.94.5.952; Rodriguez BL, 2002, STROKE, V33, P230, DOI 10.1161/hs0102.101081; Samanic CM, 2008, OCCUP ENVIRON MED, V65, P347, DOI 10.1136/oem.2007.035816; Samanic C, 2006, CANCER EPIDEM BIOMAR, V15, P1348, DOI 10.1158/1055-9965.EPI-06-0021; Schatzkin A, 2001, AM J EPIDEMIOL, V154, P1119, DOI 10.1093/aje/154.12.1119; Silverman DT, 2006, CANC EPIDEMIOLOGY PR, V3, P1101; Spiegelman D, 2007, CANCER CAUSE CONTROL, V18, P571, DOI 10.1007/s10552-006-0090-y; Thun MJ, 1997, JNCI-J NATL CANCER I, V89, P1580, DOI 10.1093/jnci/89.21.1580; Tripathi A, 2002, CANCER-AM CANCER SOC, V95, P2316, DOI 10.1002/cncr.10975; U.S. Department of Health and Human Services, 2004, HLTH CONS SMOK REP S; Warner KE, 2005, AM J PUBLIC HEALTH, V95, P976, DOI 10.2105/AJPH.2004.046904; WYNDER EL, 1994, CANCER RES, V54, P5284	57	555	567	1	39	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 17	2011	306	7					737	745		10.1001/jama.2011.1142	http://dx.doi.org/10.1001/jama.2011.1142			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	807LP	21846855	Green Accepted, Bronze			2022-12-28	WOS:000293900000023
J	Vivante, A; Afek, A; Frenkel-Nir, Y; Tzur, D; Farfel, A; Golan, E; Chaiter, Y; Shohat, T; Skorecki, K; Calderon-Margalit, R				Vivante, Asaf; Afek, Arnon; Frenkel-Nir, Yael; Tzur, Dorit; Farfel, Alon; Golan, Eliezer; Chaiter, Yoram; Shohat, Tamy; Skorecki, Karl; Calderon-Margalit, Ronit			Persistent Asymptomatic Isolated Microscopic Hematuria in Israeli Adolescents and Young Adults and Risk for End-Stage Renal Disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CHRONIC KIDNEY-DISEASE; FOLLOW-UP; CHILDREN; PROTEINURIA; SCHOOLCHILDREN; EPIDEMIOLOGY; POPULATION; EXCRETION	Context Few data are available on long-term outcomes among adolescents and young adults with persistent asymptomatic isolated microscopic hematuria. Objective To evaluate the risk of end-stage renal disease (ESRD) in adolescents and young adults with persistent asymptomatic isolated microscopic hematuria. Design, Setting, and Participants Nationwide, population-based, retrospective cohort study using medical data from 1 203 626 persons aged 16 through 25 years (60% male) examined for fitness for military service between 1975 and 1997 were linked to the Israeli treated ESRD registry. Incident cases of treated ESRD from January 1, 1980, to May 31, 2010, were included. Cox proportional hazards models were used to estimate the hazard ratio (HR) of treated ESRD among those diagnosed as having persistent asymptomatic isolated microscopic hematuria. Main Outcome Measures Treated ESRD onset, defined as the date of initiation of dialysis treatment or the date of renal transplantation, whichever came first. Results Persistent asymptomatic isolated microscopic hematuria was diagnosed in 3690 of 1 203 626 eligible individuals (0.3%). During 21.88 (SD, 6.74) years of follow-up, treated ESRD developed in 26 individuals (0.70%) with and 539 (0.045%) without persistent asymptomatic isolated microscopic hematuria, yielding incidence rates of 34.0 and 2.05 per 100 000 person-years, respectively, and a crude HR of 19.5 (95% confidence interval [CI], 13.1-28.9). A multivariate model adjusted for age, sex, paternal country of origin, year of enrollment, body mass index, and blood pressure at baseline did not substantially alter the risk associated with persistent asymptomatic isolated microscopic hematuria (HR, 18.5 [95% CI, 12.4-27.6]). A substantially increased risk for treated ESRD attributed to primary glomerular disease was found for individuals with persistent asymptomatic isolated microscopic hematuria compared with those without the condition (incidence rates, 19.6 vs 0.55 per 100 000 person-years, respectively; HR, 32.4 [95% CI, 18.9-55.7]). The fraction of treated ESRD attributed to microscopic hematuria was 4.3% (95% CI, 2.9%-6.4%). Conclusion Presence of persistent asymptomatic isolated microscopic hematuria in persons aged 16 through 25 years was associated with significantly increased risk of treated ESRD for a period of 22 years, although the incidence and absolute risk remain quite low.	[Vivante, Asaf; Frenkel-Nir, Yael; Tzur, Dorit; Farfel, Alon; Chaiter, Yoram] Israeli Def Forces Med Corps, IL-52621 Tel Hashomer, Israel; [Vivante, Asaf] Edmond & Lily Safra Childrens Hosp, Talpiot Med Leadership Program, Dept Pediat, Chaim Sheba Med Ctr, IL-52621 Tel Hashomer, Israel; [Vivante, Asaf; Afek, Arnon; Golan, Eliezer; Shohat, Tamy] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel; [Skorecki, Karl] Technion Israel Inst Technol, Dept Nephrol, Haifa, Israel; [Skorecki, Karl] Technion Israel Inst Technol, Rappaport Fac Med, Haifa, Israel; [Skorecki, Karl] Technion Israel Inst Technol, Res Inst, Haifa, Israel; [Golan, Eliezer] Meir Med Ctr, Dept Nephrol & Hypertens, Kefar Sava, Israel; [Golan, Eliezer] Israel Renal Registry, Kefar Sava, Israel; [Shohat, Tamy; Calderon-Margalit, Ronit] Minist Hlth, Israel Ctr Dis Control, Jerusalem, Israel; [Calderon-Margalit, Ronit] Hadassah Hebrew Univ, Braun Sch Publ Hlth, Jerusalem, Israel; [Skorecki, Karl] Dept Nephrol, Haifa, Israel	Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Technion Israel Institute of Technology; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Technion Israel Institute of Technology; Tel Aviv University; Sackler Faculty of Medicine; Hebrew University of Jerusalem; Hadassah University Medical Center	Vivante, A (corresponding author), Israeli Def Forces Med Corps, IL-52621 Tel Hashomer, Israel.	asafvivante@gmail.com	Hug, Balthasar L./G-1568-2010	Chaiter, Yoram/0000-0003-2058-6873				American Academy of Pediatrics, 2000, PEDIATRICS, V105, P645; ANDERSEN PK, 1982, ANN STAT, V10, P1100, DOI 10.1214/aos/1176345976; Assadi FK, 2005, PEDIATR NEPHROL, V20, P1131, DOI 10.1007/s00467-005-1928-3; Calderon-Margalit R, 2008, NEPHROL DIAL TRANSPL, V23, P659, DOI 10.1093/ndt/gfm597; Chow KM, 2004, QJM-INT J MED, V97, P739, DOI 10.1093/qjmed/hch125; Cohen RA, 2003, NEW ENGL J MED, V348, P2330, DOI 10.1056/NEJMcp012694; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; DODGE WF, 1976, J PEDIATR-US, V88, P327, DOI 10.1016/S0022-3476(76)81012-8; Donadio JV, 2002, NEW ENGL J MED, V347, P738, DOI 10.1056/NEJMra020109; Eardley KS, 2004, QJM-INT J MED, V97, P297, DOI 10.1093/qjmed/hch049; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Gordon Carrie, 2005, Adolesc Med Clin, V16, P229, DOI 10.1016/j.admecli.2004.09.005; Hogg RJ, 2009, CLIN J AM SOC NEPHRO, V4, P509, DOI 10.2215/CJN.01210308; Hudson BG, 2003, NEW ENGL J MED, V348, P2543, DOI 10.1056/NEJMra022296; Israeli E, 2006, AM J HYPERTENS, V19, P708, DOI 10.1016/j.amjhyper.2006.01.012; Keith DS, 2004, ARCH INTERN MED, V164, P659, DOI 10.1001/archinte.164.6.659; Kelly JD, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a3021; Kovacevic Z, 2008, INT J CLIN PRACT, V62, P406, DOI 10.1111/j.1742-1241.2007.01659.x; Kumar P, 2008, CLEV CLIN J MED, V75, P227, DOI 10.3949/ccjm.75.3.227; Lee YM, 2006, ACTA PAEDIATR, V95, P849, DOI 10.1080/08035250600652005; MURAKAMI M, 1991, PEDIATR NEPHROL, V5, P50, DOI 10.1007/BF00852844; Nieuwhof C, 1996, KIDNEY INT, V49, P222, DOI 10.1038/ki.1996.30; Park YH, 2005, PEDIATR NEPHROL, V20, P1126, DOI 10.1007/s00467-005-1915-8; Practice Co Medicine A Committee BFS, 2007, PEDIATRICS, V120, P1376, DOI DOI 10.1542/peds.2007-2901; Shen P, 2007, INT J CLIN PRACT, V61, P789, DOI 10.1111/j.1742-1241.2006.01159.x; SUTTON JM, 1990, JAMA-J AM MED ASSOC, V263, P2475, DOI 10.1001/jama.263.18.2475; TOPHAM PS, 1994, Q J MED, V87, P329; Tryggvason K, 2006, J AM SOC NEPHROL, V17, P813, DOI 10.1681/ASN.2005070737; Tu WH, 2010, NAT REV UROL, V7, P189, DOI 10.1038/nrurol.2010.27; VEHASKARI VM, 1979, J PEDIATR-US, V95, P676, DOI 10.1016/S0022-3476(79)80710-6; Voskarides K, 2007, J AM SOC NEPHROL, V18, P3004, DOI 10.1681/ASN.2007040444; WOOLHANDLER S, 1989, JAMA-J AM MED ASSOC, V262, P1214, DOI 10.1001/jama.262.9.1214; Yamagata K, 1996, CLIN NEPHROL, V45, P281	33	128	140	2	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 17	2011	306	7					729	736		10.1001/jama.2011.1141	http://dx.doi.org/10.1001/jama.2011.1141			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	807LP	21846854	Bronze			2022-12-28	WOS:000293900000022
J	Friedman, JR; Lackner, LL; West, M; DiBenedetto, JR; Nunnari, J; Voeltz, GK				Friedman, Jonathan R.; Lackner, Laura L.; West, Matthew; DiBenedetto, Jared R.; Nunnari, Jodi; Voeltz, Gia K.			ER Tubules Mark Sites of Mitochondrial Division	SCIENCE			English	Article							ENDOPLASMIC-RETICULUM; MAMMALIAN-CELLS; MEMBRANE; FISSION; RECRUITMENT; DYNAMICS; DNM1P; DRP1; MFF	Mitochondrial structure and distribution are regulated by division and fusion events. Mitochondrial division is regulated by Dnm1/Drp1, a dynamin-related protein that forms helices around mitochondria to mediate fission. Little is known about what determines sites of mitochondrial fission within the mitochondrial network. The endoplasmic reticulum (ER) and mitochondria exhibit tightly coupled dynamics and have extensive contacts. We tested whether ER plays a role in mitochondrial division. We found that mitochondrial division occurred at positions where ER tubules contacted mitochondria and mediated constriction before Drp1 recruitment. Thus, ER tubules may play an active role in defining the position of mitochondrial division sites.	[Friedman, Jonathan R.; West, Matthew; DiBenedetto, Jared R.; Voeltz, Gia K.] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA; [Lackner, Laura L.; Nunnari, Jodi] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA	University of Colorado System; University of Colorado Boulder; University of California System; University of California Davis	Voeltz, GK (corresponding author), Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA.	gia.voeltz@colorado.edu	Friedman, Jonathan/GWV-4047-2022	Friedman, Jonathan/0000-0001-8155-2429	NIH [R01 GM083977, GM08759, R01 GM062942]; Searle Scholar award; American Heart Innovative Research Grant; Biological Sciences Initiative; University of Colorado; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008759, R01GM083977, R01GM062942] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Searle Scholar award; American Heart Innovative Research Grant; Biological Sciences Initiative; University of Colorado; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by NIH grant R01 GM083977 and a Searle Scholar award (to G.K.V.), NIH training grant GM08759 (to J.R.F.), NIH grant R01 GM062942 and an American Heart Innovative Research Grant (to J.N.), and grants from the Biological Sciences Initiative (BURST grant) and the Undergraduate Research Opportunity Program at the University of Colorado (to J.R.D.). We thank the Boulder 3D Electron Microscopy facility for shared equipment and helpful suggestions.	Cho DH, 2010, CELL MOL LIFE SCI, V67, P3435, DOI 10.1007/s00018-010-0435-2; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; de Brito OM, 2010, EMBO J, V29, P2715, DOI 10.1038/emboj.2010.177; Friedman JR, 2010, J CELL BIOL, V190, P363, DOI 10.1083/jcb.200911024; Gandre-Babbe S, 2008, MOL BIOL CELL, V19, P2402, DOI 10.1091/mbc.E07-12-1287; Ingerman E, 2005, J CELL BIOL, V170, P1021, DOI 10.1083/jcb.200506078; Kornmann B, 2009, SCIENCE, V325, P477, DOI 10.1126/science.1175088; Labrousse AM, 1999, MOL CELL, V4, P815, DOI 10.1016/S1097-2765(00)80391-3; Lackner LL, 2009, BBA-MOL BASIS DIS, V1792, P1138, DOI 10.1016/j.bbadis.2008.11.011; Legesse-Miller A, 2003, MOL BIOL CELL, V14, P1953, DOI 10.1091/mbc.E02-10-0657; Mears JA, 2011, NAT STRUCT MOL BIOL, V18, P20, DOI 10.1038/nsmb.1949; Otera H, 2010, J CELL BIOL, V191, P1141, DOI 10.1083/jcb.201007152; Sesaki H, 1999, J CELL BIOL, V147, P699, DOI 10.1083/jcb.147.4.699; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047; West M, 2011, J CELL BIOL, V193, P333, DOI 10.1083/jcb.201011039; Yoon Y, 2001, MOL BIOL CELL, V12, P2894, DOI 10.1091/mbc.12.9.2894; Yoon Y, 2011, ANTIOXID REDOX SIGN, V14, P439, DOI 10.1089/ars.2010.3286	18	1209	1238	4	212	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 21	2011	334	6054					358	362		10.1126/science.1207385	http://dx.doi.org/10.1126/science.1207385			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	835RC	21885730	Green Accepted			2022-12-28	WOS:000296052500048
J	Tamiya, N; Noguchi, H; Nishi, A; Reich, MR; Ikegami, N; Hashimoto, H; Shibuya, K; Kawachi, I; Campbell, JC				Tamiya, Nanako; Noguchi, Haruko; Nishi, Akihiro; Reich, Michael R.; Ikegami, Naoki; Hashimoto, Hideki; Shibuya, Kenji; Kawachi, Ichiro; Campbell, John Creighton			Japan: Universal Health Care at 50 years 4 Population ageing and wellbeing: lessons from Japan's long-term care insurance policy	LANCET			English	Article							DAUGHTERS-IN-LAW; FAMILY CAREGIVERS; SERVICES; HOME; BURDEN; US; PROVISION; SURVIVAL; GERMANY; REFORM	Japan's population is ageing rapidly because of long life expectancy and a low birth rate, while traditional supports for elderly people are eroding. In response, the Japanese Government initiated mandatory public long-term care insurance (LTCI) in 2000, to help older people to lead more independent lives and to relieve the burdens of family carers. LTCI operates on social insurance principles, with benefits provided irrespective of income or family situation; it is unusually generous in terms of both coverage and benefits. Only services are provided, not cash allowances, and recipients can choose their services and providers. Analysis of national survey data before and after the programme started shows increased use of formal care at lower cost to households, with mixed results for the wellbeing of carers. Challenges to the success of the system include dissatisfaction with home-based care, provision of necessary support for family carers, and fiscal sustainability. Japan's strategy for long-term care could offer lessons for other nations.	[Tamiya, Nanako; Nishi, Akihiro] Univ Tsukuba, Dept Hlth Serv Res, Grad Sch Human Care Sci, Ibaraki, Japan; [Noguchi, Haruko] Natl Inst Populat & Social Secur Res, Tokyo, Japan; [Nishi, Akihiro; Kawachi, Ichiro] Harvard Univ, Sch Publ Hlth, Dept Soc Human Dev & Hlth, Boston, MA 02115 USA; [Reich, Michael R.] Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA; [Nishi, Akihiro] Univ Tokyo, Grad Sch Med, Dept Publ Hlth, Tokyo, Japan; [Shibuya, Kenji] Univ Tokyo, Grad Sch Med, Dept Global Hlth Policy, Tokyo, Japan; [Hashimoto, Hideki] Univ Tokyo, Dept Hlth Econ & Epidemiol Res, Tokyo, Japan; [Campbell, John Creighton] Univ Tokyo, Inst Gerontol, Tokyo, Japan; [Nishi, Akihiro] Harvard Univ, Inst Quantitat Social Sci, Cambridge, MA 02138 USA; [Ikegami, Naoki] Keio Univ, Sch Med, Dept Hlth Policy & Management, Tokyo, Japan; [Campbell, John Creighton] Univ Michigan, Dept Polit Sci, Ann Arbor, MI 48109 USA	University of Tsukuba; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; University of Tokyo; University of Tokyo; University of Tokyo; University of Tokyo; Harvard University; Keio University; University of Michigan System; University of Michigan	Campbell, JC (corresponding author), Hiroo 5-23-2 1005,Shibuya Ku, Tokyo 1500012, Japan.	jccamp@umich.edu	Noguchi, Haruko/ABF-3059-2020	Noguchi, Haruko/0000-0002-4437-8238; Shibuya, Kenji/0000-0003-2528-7530; Nishi, Akihiro/0000-0003-1629-5985; Reich, Michael R./0000-0003-3338-0612	Bill & Melinda Gates Foundation; China Medical Board; Ministry of Health, Labour and Welfare [H22-seisaku-shitei-033]; Pfizer Health Research Foundation; Nakajima Foundation in Japan	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); China Medical Board; Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Pfizer Health Research Foundation; Nakajima Foundation in Japan	This work is in part funded by the generous support from the Bill & Melinda Gates Foundation and the China Medical Board, partly by a research grant from the Ministry of Health, Labour and Welfare (H22-seisaku-shitei-033), and partly by a research grant from Pfizer Health Research Foundation to NT. AN acknowledges support from the Nakajima Foundation in Japan for his academic endeavours at Harvard University. We thank Keizo Takemi, Thomas Inui, Yan Guo, Bong-Min Yang, and Hidehiko Ichimura for their valuable comments; Masayo Kashiwagi, Mikiya Sato, Li-Mei Chen, Hideto Takahashi, Gohei Kato, Pedro Olivares-Tirado, Tomoko Ito, and postgraduate students in the Department of Health Services Research, University of Tsukuba, for their academic support; Susan Hubbard for her technical edits; Hiyuko Fujita, Tomoko Suzuki, and Tadashi Yamamoto (Japan Center for International Exchange) for their administrative support; and Ruth Campbell for steady support. The views and opinions expressed by the independent authors in this report are provided in their personal capacity and are their sole responsibility.	[Anonymous], 2010, WORLD HLTH STAT 2010; Arai Y, 2004, INT J GERIATR PSYCH, V19, P1205, DOI 10.1002/gps.1153; Asai MO, 2005, SOC WORK, V50, P111, DOI 10.1093/sw/50.2.111; Brodsky J, 2003, KEY POLICY ISSUES LO; Cabinet Office, INT COMP SURV LIF TH; Cabinet Office, EX SUMM INT COMP LIF; Campbell J.C., 1992, POLICIES CHANGE JAPA; Campbell JC, 2003, SOC POLICY ADMIN, V37, P21, DOI 10.1111/1467-9515.00321; Campbell JC, 2000, HEALTH AFFAIR, V19, P26, DOI 10.1377/hlthaff.19.3.26; Campbell JC, 2002, AGING SOCIAL POLICY; Campbell JC, 2009, INT SOC SECUR REV, V62, P63, DOI 10.1111/j.1468-246X.2009.01346.x; Campbell JC, 2010, HEALTH AFFAIR, V29, P87, DOI 10.1377/hlthaff.2009.0548; Christensen K, 2009, LANCET, V374, P1196, DOI 10.1016/S0140-6736(09)61460-4; Colombo F, 2011, HELP WANTED PROVIDIN; Freeman S, 2010, ARCH GERONTOL GERIAT, V50, P282, DOI 10.1016/j.archger.2009.04.008; Gallagher-Thompson D, 2007, PSYCHOL AGING, V22, P37, DOI 10.1037/0882-7974.22.1.37; Hashizume Y, 2000, PUBLIC HEALTH NURS, V17, P25, DOI 10.1046/j.1525-1446.2000.00025.x; Hayashi F, 1997, UNDERSTANDING SAVING; Hirakawa Y, 2004, ARCH GERONTOL GERIAT, V38, P101, DOI 10.1016/j.archger.2003.08.005; Hirakawa Y, 2008, ARCH GERONTOL GERIAT, V46, P367, DOI 10.1016/j.archger.2007.05.011; Horioka CY, 1999, ECON LETT, V65, P365, DOI 10.1016/S0165-1765(99)00166-4; Houde SC, 2007, J GERONTOL NURS, V33, P7, DOI 10.3928/00989134-20070101-04; Huber M., 2009, FACTS FIGURES LONG T; Ishibashi T, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-224; Iwamoto Y, 2010, J JPN INT ECON, V24, P99, DOI 10.1016/j.jjie.2009.12.009; Jackson R., 2010, GLOBAL AGING PREPARE; Jones R, 2007, INEQUALITY POVERTY S; Kato Gohei, 2009, BMC Geriatr, V9, P58, DOI 10.1186/1471-2318-9-58; Kogel T, 2004, J POPUL ECON, V17, P45, DOI 10.1007/s00148-003-0180-z; Kubota M, 2000, ACTA MED OKAYAMA, V54, P75; Kumamoto K, 2006, INT J GERIATR PSYCH, V21, P163, DOI 10.1002/gps.1445; Kuzuya M, 2006, J AM GERIATR SOC, V54, P1364, DOI 10.1111/j.1532-5415.2006.00860.x; Long S. O., 2000, SOC SCI JPN J, V3, P21, DOI DOI 10.1093/SSJJ/3.1.21; Long SO, 2009, SOC SCI JPN J, V12, P1, DOI 10.1093/ssjj/jyn064; Ministry of Health Labour and Welfare (M H LW), MONTHL REP LONG TERM; Ministry of Health Labour and Welfare (M H LW), 2005 SURV EMPL MAN W; Ministry of Health labour and Welfare (MH LW), DAT SOC WELF POL CER; Ministry of Health Labour and Welfare (MHLW), REP VAR CURR STAT LT; Ministry of Health Labour and Welfare (MHLW), ANN REP LTCI; Ministry of Health Labour and Welfare (MHLW), COMPR SURV PEOPL LIV; Ministry of Internal Affairs and Communications Statistics Bureau Director-General for Policy Planning (Statistial Standards) Statistical Research and Training Institute, B BOARD CENS 1010; Ministry of Justice, 1997, LONG TERM CAR INS AC; Muennig PA, 2010, HEALTH AFFAIR, V29, P2105, DOI 10.1377/hlthaff.2010.0073; Murozumi M, STRUCTURE INCOME ELD; National Institute of Population and Social Security Research (IPSS), POP STAT JAP 2008; Nishi A, 2010, BMC GERIATR, V10, DOI 10.1186/1471-2318-10-61; Nishiwaki T, 2007, TOHOKU J EXP MED, V211, P15, DOI 10.1620/tjem.211.15; OECD, 2009, **DROPPED REF**, DOI DOI 10.1017/S1474747205002064; Organisation for Economic Co-operation and Development (OECD), 2011, OECD HLTH DAT 2011 S; Price Policy Division Quality-of-Life Policy Bureau, REP LONG TERM CAR MA; RODRIGUES R, 2010, PAYING LONG TERM CAR; Rothgang H, 2010, SOC POLICY ADMIN, V44, P436, DOI 10.1111/j.1467-9515.2010.00722.x; Shimizutani Satoshi, 2005, KEIZAI BUNSEKI, V175, P1; Sorensen S, 2002, GERONTOLOGIST, V42, P356, DOI 10.1093/geront/42.3.356; Sugisawa H, 2004, EVALUATION LONG TERM; Suzuki W, 2008, SINGAP ECON REV, V53, P121, DOI 10.1142/S0217590808002872; Swedish Association of Local Authorities and Regions, 2006, CAR ELD SWED TOD; Tachibanaki T., 2010, NEW PARADOX JAPANESE; Tamiya N, 2011, COMPREHENSIVE ASSESS; Theobald H, 2010, J ASIAN WOMENS STUDI, V8, P1; Tomita N, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-345; Tsutsui T, 2007, J AM GERIATR SOC, V55, P1458, DOI 10.1111/j.1532-5415.2007.01281.x; *UN DEP EC SOC AFF, WORLD EC SOC SURV 20; United Nations Population Division, WORLD POP PROSP 2010; US-Japan Collaborative Project on LTCI System and Caregiving, 2010, OLD AD FAM HOM CAR C; Wang C, 2008, GERONTOLOGIST, V48, P548; Watts J, 2000, LANCET, V355, P1249, DOI 10.1016/S0140-6736(05)74686-9; Yamada M, 2008, HEALTH SOC CARE COMM, V16, P400, DOI 10.1111/j.1365-2524.2007.00752.x; Yamamoto N, 1997, J HEALTH SOC BEHAV, V38, P164, DOI 10.2307/2955423; Yoshihara K, 2008, HIST JAPANESE HLTH P	70	315	316	17	247	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 24	2011	378	9797					1183	1192		10.1016/S0140-6736(11)61176-8	http://dx.doi.org/10.1016/S0140-6736(11)61176-8			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	829RH	21885099				2022-12-28	WOS:000295601500026
J	Barry, CL; Huskamp, HA				Barry, Colleen L.; Huskamp, Haiden A.			Moving beyond Parity - Mental Health and Addiction Care under the ACA	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Barry, Colleen L.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; [Huskamp, Haiden A.] Harvard Univ, Sch Med, Boston, MA USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Harvard University; Harvard Medical School	Barry, CL (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA.				NIDA NIH HHS [R01 DA026414] Funding Source: Medline; NIMH NIH HHS [R01 MH080797] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH080797] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA026414] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Alakeson V, 2010, HEALTH AFFAIR, V29, P867, DOI 10.1377/hlthaff.2010.0080; Colton Craig W, 2006, Prev Chronic Dis, V3, pA42; Garfield RL, 2011, AM J PSYCHIAT, V168, P486, DOI 10.1176/appi.ajp.2010.10060792; Gilbody S, 2006, ARCH INTERN MED, V166, P2314, DOI 10.1001/archinte.166.21.2314; Mojtabai R, 2007, PSYCHIAT SERV, V58, P1261, DOI 10.1176/appi.ps.58.10.1261	5	145	145	0	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 15	2011	365	11					973	975		10.1056/NEJMp1108649	http://dx.doi.org/10.1056/NEJMp1108649			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	819UR	21848453	Green Accepted			2022-12-28	WOS:000294857300001
J	Carette, JE; Raaben, M; Wong, AC; Herbert, AS; Obernosterer, G; Mulherkar, N; Kuehne, AI; Kranzusch, PJ; Griffin, AM; Ruthel, G; Dal Cin, P; Dye, JM; Whelan, SP; Chandran, K; Brummelkamp, TR				Carette, Jan E.; Raaben, Matthijs; Wong, Anthony C.; Herbert, Andrew S.; Obernosterer, Gregor; Mulherkar, Nirupama; Kuehne, Ana I.; Kranzusch, Philip J.; Griffin, April M.; Ruthel, Gordon; Dal Cin, Paola; Dye, John M.; Whelan, Sean P.; Chandran, Kartik; Brummelkamp, Thijn R.			Ebola virus entry requires the cholesterol transporter Niemann-Pick C1	NATURE			English	Article							VESICULAR STOMATITIS-VIRUS; HEMORRHAGIC-FEVER; ZAIRE-EBOLAVIRUS; HUMAN-CELLS; IDENTIFICATION; GENE; GLYCOPROTEIN; MECHANISM; RECEPTOR; ANTIBODY	Infections by the Ebola and Marburg filoviruses cause a rapidly fatal haemorrhagic fever in humans for which no approved antivirals are available(1). Filovirus entry is mediated by the viral spike glycoprotein (GP), which attaches viral particles to the cell surface, delivers them to endosomes and catalyses fusion between viral and endosomal membranes(2). Additional host factors in the endosomal compartment are probably required for viral membrane fusion; however, despite considerable efforts, these critical host factors have defied molecular identification(3-5). Here we describe a genome-wide haploid genetic screen in human cells to identify host factors required for Ebola virus entry. Our screen uncovered 67 mutations disrupting all six members of the homotypic fusion and vacuole protein-sorting (HOPS) multisubunit tethering complex, which is involved in the fusion of endosomes to lysosomes(6), and 39 independent mutations that disrupt the endo/lysosomal cholesterol transporter protein Niemann-Pick C1 (NPC1)(7). Cells defective for the HOPS complex or NPC1 function, including primary fibroblasts derived from human Niemann-Pick type C1 disease patients, are resistant to infection by Ebola virus and Marburg virus, but remain fully susceptible to a suite of unrelated viruses. We show that membrane fusion mediated by filovirus glycoproteins and viral escape from the vesicular compartment require the NPC1 protein, independent of its known function in cholesterol transport. Our findings uncover unique features of the entry pathway used by filoviruses and indicate potential antiviral strategies to combat these deadly agents.	[Carette, Jan E.; Obernosterer, Gregor; Brummelkamp, Thijn R.] Whitehead Inst Biomed Res, Cambridge Ctr 9, Cambridge, MA 02142 USA; [Raaben, Matthijs; Kranzusch, Philip J.; Griffin, April M.; Whelan, Sean P.] Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA; [Wong, Anthony C.; Mulherkar, Nirupama; Chandran, Kartik] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA; [Herbert, Andrew S.; Kuehne, Ana I.; Ruthel, Gordon; Dye, John M.] USA, Med Res Inst Infect Dis, Ft Detrick, MD 21702 USA; [Dal Cin, Paola] Ctr Adv Mol Diagnost, Boston, MA 02115 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Harvard University; Harvard Medical School; Yeshiva University; Albert Einstein College of Medicine	Brummelkamp, TR (corresponding author), Netherlands Canc Inst, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	John.M.Dye1@us.army.mil; sean_whelan@hms.harvard.edu; kartik.chandran@einstein.yu.edu; t.brummelkamp@nki.nl	Ruthel, Gordon/GYU-9133-2022	Whelan, Sean/0000-0003-1564-8590; Raaben, Matthijs/0000-0001-5989-289X; Dye, John/0000-0002-0883-5016; Ruthel, Gordon/0000-0001-9193-5589; Carette, Jan/0000-0002-5187-8070	NIH [R01 AI088027, AI081842, U54 AI057159, R21 HG004938]; DTRA Project [CBM.VAXPLAT.05.10.RD.005]; Whitehead Fellows Program; Burroughs Wellcome Investigators in the Pathogenesis of Infectious Disease Award; NIH at the Albert Einstein College of Medicine [T32 GM007288, T32 AI070117]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R21HG004938] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI088027, R56AI081842, T32AI070117, U54AI057159, R01AI081842] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007288] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DTRA Project; Whitehead Fellows Program; Burroughs Wellcome Investigators in the Pathogenesis of Infectious Disease Award(Burroughs Wellcome Fund); NIH at the Albert Einstein College of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank M. Kielian, H. Ploegh, V. Prasad and D. Sabatini for critical reading of the manuscript and valuable advice; C. Guimaraes, V. Blomen and T. Peterson for suggestions; M. Bogyo for providing the CTSB/CATL activity probe (GB111); T.-Y. Chang for the gift of NPC1-null CHO cells; D. Lyles for the antibody to VSV M; M. Nibert for providing reovirus; J. de la Torre for providing rVSV-GP-BDV; J. Wojcechowskyj for providing RVF; E. Muhlberger for providing Ebola cDNA; and M. Ericsson for support with electron microscopy. This research was supported by NIH grants R01 AI088027 (K. C.), AI081842 and U54 AI057159 (NERCE-BEID) (S. P. W.), and R21 HG004938 (T. R. B.), and by the DTRA Project, CBM.VAXPLAT.05.10.RD.005 (J. M. D.). T. R. B. was additionally supported by the Whitehead Fellows Program. S. P. W. is a recipient of a Burroughs Wellcome Investigators in the Pathogenesis of Infectious Disease Award. A. C. W. was additionally supported by NIH-funded training programs T32 GM007288 and T32 AI070117 at the Albert Einstein College of Medicine. Opinions, interpretations, conclusions and recommendations are those of the authors and are not necessarily endorsed by the US Army.	Alvarez CP, 2002, J VIROL, V76, P6841, DOI 10.1128/JVI.76.13.6841-6844.2002; Blum G, 2005, NAT CHEM BIOL, V1, P203, DOI 10.1038/nchembio728; Bray M, 1998, J INFECT DIS, V178, P651, DOI 10.1086/515386; Carette JE, 2011, NAT BIOTECHNOL, V29, P542, DOI 10.1038/nbt.1857; Carette JE, 2010, BLOOD, V115, P4039, DOI 10.1182/blood-2009-07-231845; Carette JE, 2009, SCIENCE, V326, P1231, DOI 10.1126/science.1178955; Carstea ED, 1997, SCIENCE, V277, P228, DOI 10.1126/science.277.5323.228; Cenedella RJ, 2009, LIPIDS, V44, P477, DOI 10.1007/s11745-009-3305-7; Chandran K, 2005, SCIENCE, V308, P1643, DOI 10.1126/science.1110656; Cruz JC, 2000, J BIOL CHEM, V275, P4013, DOI 10.1074/jbc.275.6.4013; Cureton DK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000394; Dell'Angelica EC, 2004, CURR OPIN CELL BIOL, V16, P458, DOI 10.1016/j.ceb.2004.05.001; Ebert DH, 2002, J BIOL CHEM, V277, P24609, DOI 10.1074/jbc.M201107200; Ehrlich M, 2004, CELL, V118, P591, DOI 10.1016/j.cell.2004.08.017; Feldmann H, 2011, LANCET, V377, P849, DOI 10.1016/S0140-6736(10)60667-8; Geisbert TW, 2003, AM J PATHOL, V163, P2347, DOI 10.1016/S0002-9440(10)63591-2; Geisbert TW, 2003, AM J PATHOL, V163, P2371, DOI 10.1016/S0002-9440(10)63592-4; Goldman SDB, 2010, J BIOL CHEM, V285, P4983, DOI 10.1074/jbc.M109.037622; Kondratowicz AS, 2011, P NATL ACAD SCI USA, V108, P8426, DOI 10.1073/pnas.1019030108; Kranzusch PJ, 2010, P NATL ACAD SCI USA, V107, P20069, DOI 10.1073/pnas.1007152107; Kuhn JH, 2006, J BIOL CHEM, V281, P15951, DOI 10.1074/jbc.M601796200; Lee JE, 2009, FUTURE VIROL, V4, P621, DOI 10.2217/FVL.09.56; LEFRANCOIS L, 1982, VIROLOGY, V121, P157, DOI 10.1016/0042-6822(82)90125-8; Lloyd-Evans E, 2008, NAT MED, V14, P1247, DOI 10.1038/nm.1876; Maruyama T, 1999, J VIROL, V73, P6024, DOI 10.1128/JVI.73.7.6024-6030.1999; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Muhlberger E, 1999, J VIROL, V73, P2333; Nanbo A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001121; Naureckiene S, 2000, SCIENCE, V290, P2298, DOI 10.1126/science.290.5500.2298; Nickerson DP, 2009, CURR OPIN CELL BIOL, V21, P543, DOI 10.1016/j.ceb.2009.05.007; PENTCHEV PG, 1986, J BIOL CHEM, V261, P2772; Poteryaev D, 2010, CELL, V141, P497, DOI 10.1016/j.cell.2010.03.011; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; RODRIGUEZLAFRASSE C, 1990, BIOCHIM BIOPHYS ACTA, V1043, P123, DOI 10.1016/0005-2760(90)90284-5; Saeed MF, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001110; Sbrissa D, 2007, J BIOL CHEM, V282, P23878, DOI 10.1074/jbc.M611678200; Schornberg K, 2006, J VIROL, V80, P4174, DOI 10.1128/JVI.80.8.4174-4178.2006; Sobo K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000851; Takada A, 2001, J VIROL, V75, P2324, DOI 10.1128/JVI.75.5.2324-2330.2001; Takada A, 1997, P NATL ACAD SCI USA, V94, P14764, DOI 10.1073/pnas.94.26.14764; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tang YY, 2009, J VIROL, V83, P7982, DOI 10.1128/JVI.00259-09; Tiede S, 2005, NAT MED, V11, P1109, DOI 10.1038/nm1305; Warfield KL, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-108; Whelan SPJ, 2000, J VIROL, V74, P8268, DOI 10.1128/JVI.74.18.8268-8276.2000; WHELAN SPJ, 1995, P NATL ACAD SCI USA, V92, P8388, DOI 10.1073/pnas.92.18.8388; Wilson JA, 2000, SCIENCE, V287, P1664, DOI 10.1126/science.287.5458.1664; Wong AC, 2010, J VIROL, V84, P163, DOI 10.1128/JVI.01832-09; Wool-Lewis RJ, 1998, J VIROL, V72, P3155, DOI 10.1128/JVI.72.4.3155-3160.1998	49	847	896	6	265	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 15	2011	477	7364					340	U115		10.1038/nature10348	http://dx.doi.org/10.1038/nature10348			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819TD	21866103	Green Accepted			2022-12-28	WOS:000294852400033
J	Guttman, M; Donaghey, J; Carey, BW; Garber, M; Grenier, JK; Munson, G; Young, G; Lucas, AB; Ach, R; Bruhn, L; Yang, XP; Amit, I; Meissner, A; Regev, A; Rinn, JL; Root, DE; Lander, ES				Guttman, Mitchell; Donaghey, Julie; Carey, Bryce W.; Garber, Manuel; Grenier, Jennifer K.; Munson, Glen; Young, Geneva; Lucas, Anne Bergstrom; Ach, Robert; Bruhn, Laurakay; Yang, Xiaoping; Amit, Ido; Meissner, Alexander; Regev, Aviv; Rinn, John L.; Root, David E.; Lander, Eric S.			lincRNAs act in the circuitry controlling pluripotency and differentiation	NATURE			English	Article							EMBRYONIC STEM-CELLS; LONG NONCODING RNAS; SELF-RENEWAL; GENE-EXPRESSION; DEVELOPMENTAL REGULATORS; CHROMATIN-STRUCTURE; VISCERAL ENDODERM; MOUSE EMBRYO; XIST RNA; ES CELLS	Although thousands of large intergenic non-coding RNAs (lincRNAs) have been identified in mammals, few have been functionally characterized, leading to debate about their biological role. To address this, we performed loss-of-function studies on most lincRNAs expressed in mouse embryonic stem (ES) cells and characterized the effects on gene expression. Here we show that knockdown of lincRNAs has major consequences on gene expression patterns, comparable to knockdown of well-known ES cell regulators. Notably, lincRNAs primarily affect gene expression in trans. Knockdown of dozens of lincRNAs causes either exit from the pluripotent state or upregulation of lineage commitment programs. We integrate lincRNAs into the molecular circuitry of ES cells and show that lincRNA genes are regulated by key transcription factors and that lincRNA transcripts bind to multiple chromatin regulatory proteins to affect shared gene expression programs. Together, the results demonstrate that lincRNAs have key roles in the circuitry controlling ES cell state.	[Guttman, Mitchell; Donaghey, Julie; Garber, Manuel; Grenier, Jennifer K.; Munson, Glen; Young, Geneva; Yang, Xiaoping; Amit, Ido; Meissner, Alexander; Regev, Aviv; Rinn, John L.; Root, David E.; Lander, Eric S.] Broad Inst MIT & Harvard, Cambridge Ctr 7, Cambridge, MA 02142 USA; [Guttman, Mitchell; Carey, Bryce W.; Regev, Aviv; Lander, Eric S.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Carey, Bryce W.] Whitehead Inst Biomed Res, Cambridge Ctr 9, Cambridge, MA 02142 USA; [Lucas, Anne Bergstrom; Ach, Robert; Bruhn, Laurakay] Agilent Technol, Genom Res & Dev, Santa Clara, CA 95051 USA; [Meissner, Alexander; Rinn, John L.] Harvard Univ, Cambridge, MA 02138 USA; [Lander, Eric S.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02114 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute; Agilent Technologies; Harvard University; Harvard University; Harvard Medical School	Guttman, M (corresponding author), Broad Inst MIT & Harvard, Cambridge Ctr 7, Cambridge, MA 02142 USA.	mguttman@mit.edu; lander@broadinstitute.org		Rinn, John/0000-0002-7231-7539	NHGRI, a Center for Excellence for Genomic Science; Merkin Foundation for Stem Cell Research; Broad Institute of MIT; Broad Institute of Harvard; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067] Funding Source: NIH RePORTER	NHGRI, a Center for Excellence for Genomic Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Merkin Foundation for Stem Cell Research; Broad Institute of MIT; Broad Institute of Harvard; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank D. Rivera, T. Green, T. Bhimdi, G. Verstappen, C. Surka, S. Silver, A. Brown, D. Lam and O. Ram for technical help; C. Gifford, S. Markoulaki and R. Jaenisch for providing cell lines used in this study; P. Tsang, B. Curry, A. Tsalenko and Agilent Technologies for microarray and technical help; B. Challis and Active Motif for antibodies; G. Geiss, R. Boykin and Nanostring technologies for technical help; E. Wang and C. Burge for help with RNA immunoprecipitation experiments and helpful discussions; P. Gupta, A. Gnirke, J. Cassady, E. Lieberman-Aiden, M. Cabili and M. Thompson for discussions and ideas; and L. Gaffney for assistance with figures. M. Guttman is a Vertex scholar. This work was funded by NHGRI, a Center for Excellence for Genomic Science, the Merkin Foundation for Stem Cell Research, and funds from the Broad Institute of MIT and Harvard.	Aiba K, 2006, STEM CELLS, V24, P889, DOI 10.1634/stemcells.2005-0332; Aiba K, 2009, DNA RES, V16, P73, DOI 10.1093/dnares/dsn035; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bilodeau S, 2009, GENE DEV, V23, P2484, DOI 10.1101/gad.1837309; Bock C, 2011, CELL, V144, P439, DOI 10.1016/j.cell.2010.12.032; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Cloos PAC, 2008, GENE DEV, V22, P1115, DOI 10.1101/gad.1652908; De Santa F, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000384; Dejosez M, 2008, CELL, V133, P1162, DOI 10.1016/j.cell.2008.05.047; Dey BK, 2008, MOL CELL BIOL, V28, P5312, DOI 10.1128/MCB.00128-08; Ebisuya M, 2008, NAT CELL BIOL, V10, P1106, DOI 10.1038/ncb1771; Fazzio TG, 2008, CELL, V134, P162, DOI 10.1016/j.cell.2008.05.031; Gaspar-Maia A, 2009, NATURE, V460, P863, DOI 10.1038/nature08212; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Guttman M, 2010, NAT BIOTECHNOL, V28, P503, DOI 10.1038/nbt.1633; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Hu G, 2009, GENE DEV, V23, P837, DOI 10.1101/gad.1769609; Huarte M, 2010, CELL, V142, P409, DOI 10.1016/j.cell.2010.06.040; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Jiang H, 2011, CELL, V144, P513, DOI 10.1016/j.cell.2011.01.020; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Katz Y, 2010, NAT METHODS, V7, P1009, DOI 10.1038/NMETH.1528; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Koerner MV, 2009, DEVELOPMENT, V136, P1771, DOI 10.1242/dev.030403; Koziol MJ, 2010, CURR OPIN GENET DEV, V20, P142, DOI 10.1016/j.gde.2010.03.003; Kunarso G, 2010, NAT GENET, V42, P631, DOI 10.1038/ng.600; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Langmead B, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r83; Licatalosi DD, 2008, NATURE, V456, P464, DOI 10.1038/nature07488; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Mattick JS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000459; Meissner Alexander, 2009, V482, P3, DOI 10.1007/978-1-59745-060-7_1; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Morrisey EE, 1998, GENE DEV, V12, P3579, DOI 10.1101/gad.12.22.3579; Nakatake Y, 2006, MOL CELL BIOL, V26, P7772, DOI 10.1128/MCB.00468-06; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; Pasini D, 2007, MOL CELL BIOL, V27, P3769, DOI 10.1128/MCB.01432-06; Plath K, 2002, ANNU REV GENET, V36, P233, DOI 10.1146/annurev.genet.36.042902.092433; Ponjavic J, 2007, GENOME RES, V17, P556, DOI 10.1101/gr.6036807; Ponjavic J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000617; Pruitt KD, 2009, NUCLEIC ACIDS RES, V37, pD32, DOI 10.1093/nar/gkn721; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Shen XH, 2008, MOL CELL, V32, P491, DOI 10.1016/j.molcel.2008.10.016; Sherwood RI, 2007, DEV BIOL, V304, P541, DOI 10.1016/j.ydbio.2007.01.011; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Smith AG, 2001, ANNU REV CELL DEV BI, V17, P435, DOI 10.1146/annurev.cellbio.17.1.435; Sproul D, 2005, NAT REV GENET, V6, P775, DOI 10.1038/nrg1688; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Torres-Padilla ME, 2007, NATURE, V445, P214, DOI 10.1038/nature05458; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Ule J, 2003, SCIENCE, V302, P1212, DOI 10.1126/science.1090095; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Wang Z, 2009, METHODS, V48, P287, DOI 10.1016/j.ymeth.2009.02.021; Wutz A, 2002, NAT GENET, V30, P167, DOI 10.1038/ng820; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Yuan P, 2009, GENE DEV, V23, P2507, DOI 10.1101/gad.1831909; Zappulla DC, 2004, P NATL ACAD SCI USA, V101, P10024, DOI 10.1073/pnas.0403641101; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	72	1492	1601	4	237	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 15	2011	477	7364					295	U60		10.1038/nature10398	http://dx.doi.org/10.1038/nature10398			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819TD	21874018	Green Accepted, Green Submitted			2022-12-28	WOS:000294852400023
J	Hoover, K; Grove, M; Gardner, M; Hughes, DP; McNeil, J; Slavicek, J				Hoover, Kelli; Grove, Michael; Gardner, Matthew; Hughes, David P.; McNeil, James; Slavicek, James			A Gene for an Extended Phenotype	SCIENCE			English	Article							NUCLEAR POLYHEDROSIS-VIRUS; LYMANTRIA-DISPAR; GYPSY-MOTH; BACULOVIRUS INFECTION; SERIAL PASSAGE; EXPRESSION; MUTANTS		[Hoover, Kelli; Grove, Michael; Gardner, Matthew; Hughes, David P.; McNeil, James] Penn State Univ, Dept Entomol, University Pk, PA 16802 USA; [Hoover, Kelli; Grove, Michael; Gardner, Matthew; Hughes, David P.; McNeil, James] Penn State Univ, Ctr Chem Ecol, University Pk, PA 16802 USA; [Gardner, Matthew] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Hughes, David P.] Penn State Univ, Dept Biol, University Pk, PA 16802 USA; [Hughes, David P.] Penn State Univ, Ctr Infect Dis Dynam, University Pk, PA 16802 USA; [Slavicek, James] US Forest Serv, USDA, Delaware, OH 43015 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Harvard University; Harvard Medical School; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; United States Department of Agriculture (USDA); United States Forest Service	Hoover, K (corresponding author), Penn State Univ, Dept Entomol, University Pk, PA 16802 USA.	kxh25@psu.edu		Gardner, Matthew/0000-0003-2872-7597	U.S. Forest Service	U.S. Forest Service(United States Department of Agriculture (USDA)United States Forest Service)	We thank B. Reed and B. Klinestiver for assistance and N. Hayes-Plazolles for construction of recombinant viruses. Project funded by Joint Venture Agreement with U.S. Forest Service. Data were deposited in the Dryad Repository: http://dx.doi.org/10.5061/dryad.36530.	Andersen SB, 2009, AM NAT, V174, P424, DOI 10.1086/603640; Choi O, 2003, GLYCOBIOLOGY, V13, P539, DOI 10.1093/glycob/cwg071; DAMICO V, 1995, ENVIRON ENTOMOL, V24, P1144, DOI 10.1093/ee/24.5.1144; Dawkins R., 1982, pi; HOFMANN O, 1891, INSEKTENOTENDE PILZE; OREILLY DR, 1992, INSECT BIOCHEM MOLEC, V22, P313, DOI 10.1016/0965-1748(92)90069-Q; PARK EJ, 1993, J INSECT PHYSIOL, V39, P791, DOI 10.1016/0022-1910(93)90055-V; Slavicek JM, 1999, BIOL CONTROL, V16, P91, DOI 10.1006/bcon.1999.0734; Slavicek JM, 2001, BIOL CONTROL, V22, P159, DOI 10.1006/bcon.2001.0969; SLAVICEK JM, 1995, BIOL CONTROL, V5, P251, DOI 10.1006/bcon.1995.1031	10	154	159	3	178	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 9	2011	333	6048					1401	1401		10.1126/science.1209199	http://dx.doi.org/10.1126/science.1209199			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817KU	21903803				2022-12-28	WOS:000294672200030
J	Grenfell, P; Nutland, W; McManus, S; Datta, J; Soldan, K; Wellings, K				Grenfell, P.; Nutland, W.; McManus, S.; Datta, J.; Soldan, K.; Wellings, K.			Views and experiences of men who have sex with men on the ban on blood donation: a cross sectional survey with qualitative interviews	BRITISH MEDICAL JOURNAL			English	Article							EVER HAD SEX; RISK; PARTNERSHIPS; BRITAIN; NO	Objective To explore compliance with the UK blood services' criterion that excludes men who have had penetrative sex with a man from donating blood, and to assess the possible effects of revising this policy. Design A random location, cross sectional survey followed by qualitative interviews. Setting Britain. Participants 1028 of 32 373 men in the general population reporting any male sexual contact completed the survey. Additional questions were asked of a general population sample (n=3914). Thirty men who had had penetrative sex with a man participated in the qualitative interviews (19 who had complied with the blood services' exclusion criterion and 11 who had not complied). Main outcome measure Compliance with the blood services' lifetime exclusion criterion for men who have had penetrative sex with a man. Results 10.6% of men with experience of penetrative sex with a man reported having donated blood in Britain while ineligible under the exclusion criterion, and 2.5% had donated in the previous 12 months. Ineligible donation was less common among men who had had penetrative sex with a man recently (in previous 12 months) than among men for whom this last occurred longer ago. Reasons for non-compliance with the exclusion included self categorisation as low risk, discounting the sexual experience that barred donation, belief in the infallibility of blood screening, concerns about confidentiality, and misunderstanding or perceived inequity of the rule. Although blood donation was rarely viewed as a "right," potential donors were seen as entitled to a considered assessment of risk. A one year deferral since last male penetrative sex was considered by study participants to be generally feasible, equitable, and acceptable. Conclusions A minority of men who have sex with men who are ineligible to donate blood under the current donor exclusion in Britain have nevertheless done so in the past 12 months. Many of the reasons identified for non-compliance seem amenable to intervention. A clearly rationalised and communicated one year donor deferral is likely to be welcomed by most men who have sex with men.	[Grenfell, P.; Nutland, W.; Datta, J.; Wellings, K.] London Sch Hyg & Trop Med, Fac Publ Hlth & Policy, Dept Social & Environm Hlth Res, London WC1H 9SH, England; [McManus, S.] Natl Ctr Social Res, London EC1V 0AX, England; [Soldan, K.] Hlth Protect Agcy, London NW9 5EQ, England	University of London; London School of Hygiene & Tropical Medicine; Health Protection Agency	Wellings, K (corresponding author), London Sch Hyg & Trop Med, Fac Publ Hlth & Policy, Dept Social & Environm Hlth Res, London WC1H 9SH, England.	Kaye.Wellings@lshtm.ac.uk	Grenfell, Pippa/Q-8711-2018; McManus, Sally/S-4697-2019; McManus, Sally/HGD-4860-2022	Grenfell, Pippa/0000-0003-0917-7980; McManus, Sally/0000-0003-2711-0819; Soldan, Kate/0000-0002-0361-3174	Department of Health	Department of Health	All authors have completed the Unified Competing Interest form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare that WN worked for Terrence Higgins Trust until 2009 and continues to undertake consultancy work for the organisation; KS is employed by the UK Health Protection Agency and is the budget holder for other funding received from the Department of Health for work unrelated to this submission. There is no personal or financial gain attached to this publication.	*BLODC, 2010, REGL BLODG; Brooks JP, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b318; Coste J, 2005, VOX SANG, V88, P289, DOI 10.1111/j.1423-0410.2005.00636_1.x; *CRUZ ROJ ESP CTR, 2010, DON SANGR QUIEN PUED; Farmer T, 2006, QUAL HEALTH RES, V16, P377, DOI 10.1177/1049732305285708; *FDA BLOOD PROD AD, 2000, 67 M THURSD SEPT 14; Franklin IM, 2007, TRANSFUSION MED, V17, P161, DOI 10.1111/j.1365-3148.2007.00754.x; Galarneau C, 2010, AM J BIOETHICS, V10, P29, DOI [10.1080/15265160903487619, 10.1080/15265161.2010.520590]; GUNSON HH, 1988, VOX SANG, V54, P34, DOI 10.1111/j.1423-0410.1988.tb01609.x; Health Protection Agency, 2009, HIV UK 2009 REP; HURLEY R, 2009, BRIT MED J, V338, pD779; Johnson AM, 2001, LANCET, V358, P1835, DOI 10.1016/S0140-6736(01)06883-0; Leiss W, 2008, TRANSFUS MED REV, V22, P35, DOI 10.1016/j.tmrv.2007.09.002; *MARK RES SOC, DAT PROT ACT 1998 MA; MARTUCCI J, 2009, SOC STUD SCI, V4, P215; MCMANUS S, 2006, EXCLUSION MEN WHO HA; Mercer CH, 2004, AIDS, V18, P1453, DOI 10.1097/01.aids.0000131331.36386.de; *NAT BLOOD SERV EN, 2010, WHO CANT GIV BLOOD; *NAT BLOOD SERV EN, 2010, EXCL MEN WHO HAV SEX; O'Cathain A, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4587; ORTON S, 1994, SURVEY METHODS CTR N, P15; Roehr B, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b311; *S AFR NAT BLOOD S, 2010, PRED TIPS; Sanchez AM, 2005, TRANSFUSION, V45, P404, DOI 10.1111/j.1537-2995.2005.03421.x; Seed CR, 2010, TRANSFUSION, V50, P2722, DOI 10.1111/j.1537-2995.2010.02793.x; Silverman D., 2017, DOING QUALITATIVE RE, V5th; *SOC, 2009, SUMM AN SEL CRIT BLO; Soldan K, 2005, Euro Surveill, V10, P9, DOI 10.2807/esm.10.02.00520-en; *TASM ANT TRIB, 2009, ANT DEC CAIN; TATCHELL P, 2009, GUARDIAN        1130; *TNS RES INT, 2010, BMRB OMN; Wainberg MA, 2010, CAN MED ASSOC J, V182, P1321, DOI 10.1503/cmaj.091476	32	55	56	0	16	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 8	2011	343								d5604	10.1136/bmj.d5604	http://dx.doi.org/10.1136/bmj.d5604			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	819RV	21903692	hybrid, Green Submitted, Green Published, Green Accepted			2022-12-28	WOS:000294848300005
J	Lerner, BH				Lerner, Barron H.			Drunk Driving, Distracted Driving, Moralism, and Public Health	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Columbia Univ, Med Ctr, New York, NY 10027 USA	Columbia University	Lerner, BH (corresponding author), Columbia Univ, Med Ctr, New York, NY 10027 USA.							[Anonymous], 1904, Q J INEBRIETY, V26, P308; Committee for the Study of Traffic Safety, 2011, ACH TRAFF SAF GOALS; Lerner BH, 2011, ONE FOR THE ROAD: DRUNK DRIVING SINCE 1900, P1; Lightner C, 1990, GIVING SORROW WORDS; Redelmeier DA, 1997, NEW ENGL J MED, V336, P453, DOI 10.1056/NEJM199702133360701	5	10	10	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 8	2011	365	10					879	881		10.1056/NEJMp1106640	http://dx.doi.org/10.1056/NEJMp1106640			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	816JX	21899449				2022-12-28	WOS:000294595600003
J	Narayan, KMV; Ali, MK; del Rio, C; Koplan, JP; Curran, J				Narayan, K. M. Venkat; Ali, Mohammed K.; del Rio, Carlos; Koplan, Jeffrey P.; Curran, James			Global Noncommunicable Diseases - Lessons from the HIV-AIDS Experience	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PREVENTION		[Narayan, K. M. Venkat; Ali, Mohammed K.; del Rio, Carlos; Curran, James] Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Koplan, Jeffrey P.] Emory Univ, Global Hlth Inst, Atlanta, GA 30322 USA	Emory University; Rollins School Public Health; Emory University	Narayan, KMV (corresponding author), Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA.		Franzeck, Fabian C/B-5055-2011; Narayan, K.M. Venkat/J-9819-2012; del Rio, Carlos/B-3763-2012; Ali, Mohammed K/N-9833-2013	Narayan, K.M. Venkat/0000-0001-8621-5405; del Rio, Carlos/0000-0002-0153-3517; Ali, Mohammed/0000-0001-7266-2503				Daar AS, 2009, SCIENCE, V324, P1642, DOI 10.1126/science.324_1642; Dabhadkar KC, 2011, ANNU REV PUBL HEALTH, V32, P23, DOI 10.1146/annurev-publhealth-031210-101214; Nations U, 2001, UN GEN ASS 26 SPEC S; Rabkin M, 2011, GLOB PUBLIC HEALTH, V6, P247, DOI 10.1080/17441692.2011.552068; 2004, BMJ, V328, P894	5	34	34	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 8	2011	365	10					876	878		10.1056/NEJMp1107189	http://dx.doi.org/10.1056/NEJMp1107189			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	816JX	21899448	Bronze			2022-12-28	WOS:000294595600002
J	Mullan, Z; Benham, L; Cumber, H; Dehnel, T; Clark, S				Mullan, Zoe; Benham, Laura; Cumber, Hannah; Dehnel, Tim; Clark, Stephanie			To err is human	LANCET			English	Editorial Material									[Mullan, Zoe; Benham, Laura; Cumber, Hannah; Dehnel, Tim; Clark, Stephanie] The Lancet, London NW1 7BY, England		Mullan, Z (corresponding author), The Lancet, London NW1 7BY, England.	zoe.mullan@lancet.com							0	1	1	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 3	2011	378	9794					861	861		10.1016/S0140-6736(11)61175-6	http://dx.doi.org/10.1016/S0140-6736(11)61175-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	818XZ	21890036				2022-12-28	WOS:000294791300010
J	Zeig-Owens, R; Webber, MP; Hall, CB; Schwartz, T; Jaber, N; Weakley, J; Rohan, TE; Cohen, HW; Derman, O; Aldrich, TK; Kelly, K; Prezant, DJ				Zeig-Owens, Rachel; Webber, Mayris P.; Hall, Charles B.; Schwartz, Theresa; Jaber, Nadia; Weakley, Jessica; Rohan, Thomas E.; Cohen, Hillel W.; Derman, Olga; Aldrich, Thomas K.; Kelly, Kerry; Prezant, David J.			Early assessment of cancer outcomes in New York City firefighters after the 9/11 attacks: an observational cohort study	LANCET			English	Article							WALDENSTROM MACROGLOBULINEMIA; DISEASE; RISK; INFLAMMATION; REGISTRY; WORKERS; HEALTH; ASTHMA	Background The attacks on the World Trade Center (WTC) on Sept 11, 2001 (9/11) created the potential for occupational exposure to known and suspected carcinogens. We examined cancer incidence and its potential association with exposure in the first 7 years after 9/11 in firefighters with health information before 9/11 and minimal loss to follow-up. Methods We assessed 9853 men who were employed as firefighters on Jan 1, 1996. On and after 9/11, person-time for 8927 firefighters was classified as WTC-exposed; all person-time before 9/11, and person-time after 9/11 for 926 non-WTC-exposed firefighters, was classified as non-WTC exposed. Cancer cases were confirmed by matches with state tumour registries or through appropriate documentation. We estimated the ratio of incidence rates in WTC-exposed firefighters to non-exposed firefighters, adjusted for age, race and ethnic origin, and secular trends, with the US National Cancer Institute Surveillance Epidemiology and End Results (SEER) reference population. CIs were estimated with overdispersed Poisson models. Additional analyses included corrections for potential surveillance bias and modified cohort inclusion criteria. Findings Compared with the general male population in the USA with a similar demographic mix, the standardised incidence ratios (SIRs) of the cancer incidence in WTC-exposed firefighters was 1.10 (95% CI 0.98-1.25). When compared with non-exposed firefighters, the SIR of cancer incidence in WTC-exposed firefighters was 1.19 (95% CI 0.96-1.47) corrected for possible surveillance bias and 1.32 (1.07-1.62) without correction for surveillance bias. Secondary analyses showed similar effect sizes. Interpretation We reported a modest excess of cancer cases in the WTC-exposed cohort. We remain cautious in our interpretation of this finding because the time since 9/11 is short for cancer outcomes, and the reported excess of cancers is not limited to specific organ types. As in any observational study, we cannot rule out the possibility that effects in the exposed group might be due to unidentified confounders. Continued follow-up will be important and should include cancer screening and prevention strategies.	[Webber, Mayris P.] 9 Metrotech Ctr, Fire Dept City New York, Bur Hlth Serv, Brooklyn, NY 11201 USA; [Zeig-Owens, Rachel; Schwartz, Theresa; Weakley, Jessica; Derman, Olga] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA; [Webber, Mayris P.; Hall, Charles B.; Rohan, Thomas E.; Cohen, Hillel W.] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA; [Aldrich, Thomas K.; Prezant, David J.] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Pulm Med, Bronx, NY 10467 USA	Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine	Webber, MP (corresponding author), 9 Metrotech Ctr, Fire Dept City New York, Bur Hlth Serv, Brooklyn, NY 11201 USA.	webberm@fdny.nyc.gov	Hall, Charles B./AAX-8216-2020; Zeig-Owens, Rachel/HIA-8364-2022	Cohen, Hillel/0000-0002-4524-0898; Hall, Charles/0000-0001-9982-8120	National Institute for Occupational Safety and Health [3U10-OH008242, 3U10-OH008243]; NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH [U10OH008242, U10OH008243] Funding Source: NIH RePORTER	National Institute for Occupational Safety and Health(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH)); NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH))	This study was funded by National Institute for Occupational Safety and Health grant numbers: 3U10-OH008242 and 3U10-OH008243. We thank L J Wei for his analytical support.	Allavena P, 2008, CURR OPIN GENET DEV, V18, P3, DOI 10.1016/j.gde.2008.01.003; Andriole GL, 2009, NEW ENGL J MED, V360, P1310, DOI 10.1056/NEJMoa0810696; [Anonymous], CANC TRENDS PROGR RE; Bars MP, 2006, CHEST, V129, P979, DOI 10.1378/chest.129.4.979; Bates MN, 2007, AM J IND MED, V50, P339, DOI 10.1002/ajim.20446; Chaturvedi AK, 2010, J CLIN ONCOL, V28, P2719, DOI 10.1200/JCO.2009.27.0454; Claudio L, 2001, ENVIRON HEALTH PERSP, V109, pA528, DOI 10.2307/3454848; de la Hoz RE, 2010, CURR ALLERGY ASTHM R, V10, P287, DOI 10.1007/s11882-010-0120-4; *FIR DEP CIT NY, CIT PERF IND CAL YEA; Frank B, 2010, INT J CANCER, V127, P2822, DOI 10.1002/ijc.25299; Fritz APC., 2013, INT CLASSIFICATION D; Guarino V, 2010, MOL CELL ENDOCRINOL, V321, P94, DOI 10.1016/j.mce.2009.10.003; Huh SJ, 2010, AM J PATHOL, V176, P2948, DOI 10.2353/ajpath.2010.090963; Kang D, 2008, AM J IND MED, V51, P329, DOI 10.1002/ajim.20549; Koshiol J, 2008, ARCH INTERN MED, V168, P1903, DOI 10.1001/archinternmed.2008.4; Kristinsson SY, 2010, JNCI-J NATL CANCER I, V102, P557, DOI 10.1093/jnci/djq043; Landrigan PJ, 2004, ENVIRON HEALTH PERSP, V112, P731, DOI 10.1289/ehp.6702; Lee G, 2009, CURR OPIN PULM MED, V15, P303, DOI 10.1097/MCP.0b013e32832c975a; LeMasters GK, 2006, J OCCUP ENVIRON MED, V48, P1189, DOI 10.1097/01.jom.0000246229.68697.90; Lioy PJ, 2002, ENVIRON HEALTH PERSP, V110, P703, DOI 10.1289/ehp.02110703; Little R.J.A., 2002, STAT ANAL MISSING DA; Ma FC, 2006, J OCCUP ENVIRON MED, V48, P883, DOI 10.1097/01.jom.0000235862.12518.04; Maslow, 2011, COUNC STAT TERR EP C; McGee JK, 2003, ENVIRON HEALTH PERSP, V111, P972, DOI 10.1289/ehp.5930; Milham S, 2009, MED HYPOTHESES, V73, P788, DOI 10.1016/j.mehy.2009.04.020; Moline JM, 2009, J OCCUP ENVIRON MED, V51, P896, DOI 10.1097/JOM.0b013e3181ad49c8; *NY STAT CANC REG, NEW YORK STAT CANC R; Prezant DJ, 1999, J OCCUP ENVIRON MED, V41, P469, DOI 10.1097/00043764-199906000-00013; *SEER PROGR, 2010, 1969 2008 SEER STAT; Singh Rajendra K, 2010, J Cancer Sci Ther, V2, P89; *TECHN COMM FIR SE, 2006, 1582 NFPA TECHN COMM; Webber MP, 2009, ENVIRON HEALTH PERSP, V117, P975, DOI 10.1289/ehp.0800291; Weiden MD, 2010, CHEST, V137, P566, DOI 10.1378/chest.09-1580; Wheeler K, 2007, ENVIRON HEALTH PERSP, V115, P1584, DOI 10.1289/ehp.10248; ZEIGOWENS R, 2011, COUNC STAT TERR EP C	35	105	105	0	28	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 3	2011	378	9794					898	905		10.1016/S0140-6736(11)60989-6	http://dx.doi.org/10.1016/S0140-6736(11)60989-6			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	818XZ	21890054	Green Accepted			2022-12-28	WOS:000294791300030
J	Deng, T; Wang, XM; Fortelius, M; Li, Q; Wang, Y; Tseng, ZJJ; Takeuchi, GT; Saylor, JE; Saila, LK; Xie, GP				Deng, Tao; Wang, Xiaoming; Fortelius, Mikael; Li, Qiang; Wang, Yang; Tseng, Zhijie J.; Takeuchi, Gary T.; Saylor, Joel E.; Saila, Laura K.; Xie, Guangpu			Out of Tibet: Pliocene Woolly Rhino Suggests High-Plateau Origin of Ice Age Megaherbivores	SCIENCE			English	Article							EVOLUTION; MAMMALIA; BOVIDAE; FAUNAS; BASIN	Ice Age megafauna have long been known to be associated with global cooling during the Pleistocene, and their adaptations to cold environments, such as large body size, long hair, and snow-sweeping structures, are best exemplified by the woolly mammoths and woolly rhinos. These traits were assumed to have evolved as a response to the ice sheet expansion. We report a new Pliocene mammal assemblage from a high-altitude basin in the western Himalayas, including a primitive woolly rhino. These new Tibetan fossils suggest that some megaherbivores first evolved in Tibet before the beginning of the Ice Age. The cold winters in high Tibet served as a habituation ground for the megaherbivores, which became preadapted for the Ice Age, successfully expanding to the Eurasian mammoth steppe.	[Deng, Tao; Wang, Xiaoming; Fortelius, Mikael; Li, Qiang] Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Evolutionary Systemat Vertebrates, Beijing 100044, Peoples R China; [Wang, Xiaoming; Tseng, Zhijie J.] Nat Hist Museum Los Angeles Cty, Dept Vertebrate Paleontol, Los Angeles, CA 90007 USA; [Fortelius, Mikael; Saila, Laura K.] Univ Helsinki, Dept Geosci & Geog, FIN-00014 Helsinki, Finland; [Wang, Yang] Florida State Univ, Dept Earth Ocean & Atmospher Sci, Tallahassee, FL 32306 USA; [Wang, Yang] Natl High Magnet Field Lab, Tallahassee, FL 32306 USA; [Tseng, Zhijie J.] Univ So Calif, Dept Biol Sci, Integrat & Evolutionary Biol Program, Los Angeles, CA 90089 USA; [Takeuchi, Gary T.] George C Page Museum, Los Angeles, CA 90036 USA; [Saylor, Joel E.] Univ Texas Austin, Jackson Sch Geosci, Dept Geol Sci, Austin, TX 78712 USA; [Xie, Guangpu] Gansu Prov Museum, Lanzhou 730050, Peoples R China	Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; University of Helsinki; State University System of Florida; Florida State University; State University System of Florida; Florida State University; University of Southern California; University of Texas System; University of Texas Austin	Wang, XM (corresponding author), Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Evolutionary Systemat Vertebrates, Beijing 100044, Peoples R China.	xwang@nhm.org	Wang, Xiaoming/I-9033-2019; Saylor, Joel/AAC-9183-2020; Saylor, Joel/L-3954-2018	Saylor, Joel/0000-0001-7746-862X; Fortelius, Mikael/0000-0002-4851-783X; Wang, Xiaoming/0000-0003-1610-3840	Chinese National Natural Science Foundation [40702004, 40730210]; Chinese Academy of Sciences [KZCX2-YW-Q09]; National Geographic Society [W22-08]; NSF [EAR-0446699, EAR-0958704, EAR-0444073, EAR-0958602, EAR-0438115, EAR-0517806]; Directorate For Geosciences [0958602] Funding Source: National Science Foundation; Division Of Earth Sciences [0958704] Funding Source: National Science Foundation	Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); National Geographic Society(National Geographic Society); NSF(National Science Foundation (NSF)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank M. Zhao, J. Liu, S.-k. Hou, C.-f. Zhang, W.-q. Feng, F.-q. Shi, S.-l. Wu, and Z.-d. Zhang for their participation in the fieldwork; Z.-d. Qiu for logistical planning and general guidance; E. H. Lindsay for access to collections under his care; Y.-f. Xu for assistance in isotope analysis; W.-l. Shen for illustration; H. W. Thomas for preparation of Zanda fossils; and R.-D. Kahlke for discussion of early records of Coelodonta. W. Shifeng provided Global Positioning System coordinates for his paleomagnetic sections, and P. Blisniuk offered useful consultation on fossil localities. Fieldwork was supported by the Chinese National Natural Science Foundation (grant no. 40702004 to Q. L. and grant no. 40730210 to T. D.), Chinese Academy of Sciences (KZCX2-YW-Q09), National Geographic Society (grant no. W22-08 to Q. L.), and NSF (grants EAR-0446699 and EAR-0958704 to X. W., EAR-0444073 and EAR-0958602 to Y.W., and EAR-0438115 to P. DeCelles). Isotope analysis was performed at the Florida State University Stable Isotope Laboratory, supported by NSF (grant EAR-0517806).	Antoine Pierre-Olivier, 2002, Memoires du Museum National d'Histoire Naturelle, V188, P1; Deng T, 2006, COUR FOR SEKENBG, V256, P43; [邓涛 Deng Tao], 2002, [地质通报, Geological Bulletin of China], V21, P604; Fortelius M., 1983, Journal of Vertebrate Paleontology, V3, P125; Giaourtsakis I., 2009, BEITR PALAONTOL, V31, P157; Guerin C., 1989, CRANIUM, V2, P3; HAASE E, 1914, TIERE VERZEIT; Hassanin A, 2004, MOL PHYLOGENET EVOL, V33, P896, DOI 10.1016/j.ympev.2004.08.009; Kahlke R-D., 1999, HIST ORIGIN EVOLUTIO; Kahlke RD, 2008, QUATERNARY SCI REV, V27, P1951, DOI 10.1016/j.quascirev.2008.07.013; KAHLKE RD, 2010, QUATERNAIRE HORS SER, V3, P21; Orlando L, 2003, MOL PHYLOGENET EVOL, V28, P485, DOI 10.1016/S1055-7903(03)00023-X; Prothero D. R., 1989, EVOLUTION PERISSODAC, P321; Qiu Z.X., 2004, PALAEONTOL SIN NEW C, P1; Rezaei HR, 2010, MOL PHYLOGENET EVOL, V54, P315, DOI 10.1016/j.ympev.2009.10.037; Saylor JE, 2009, AM J SCI, V309, P1, DOI 10.2475/01.2009.01; THEW N, 2000, CAHIER ARCHEOLOGIE J, P93; Vangengeim E A, 1966, TRUDY GEOLOGICHESKOG, V152, P92; VERESHCHAGIN NK, 1954, DOKL AKAD NAUK SSSR+, V99, P455; Wang XM, 2007, PALAEOGEOGR PALAEOCL, V254, P363, DOI 10.1016/j.palaeo.2007.06.007; Zachos JC, 2008, NATURE, V451, P279, DOI 10.1038/nature06588; Zeuner F., 1934, Bericht der Naturforschenden Gesellschaft zu Freiburg i Br, V34, P21; ZHENG SH, 1985, VERTEBRAT PALASIATIC, V23, P89; ZONG GF, 1985, VERTEBRAT PALASIATIC, V23, P161	24	126	156	6	95	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 2	2011	333	6047					1285	1288		10.1126/science.1206594	http://dx.doi.org/10.1126/science.1206594			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	813YM	21885780				2022-12-28	WOS:000294406400053
J	Panatier, A; Vallee, J; Haber, M; Murai, KK; Lacaille, JC; Robitaille, R				Panatier, Aude; Vallee, Joanne; Haber, Michael; Murai, Keith K.; Lacaille, Jean-Claude; Robitaille, Richard			Astrocytes Are Endogenous Regulators of Basal Transmission at Central Synapses	CELL			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; LONG-TERM POTENTIATION; GLIAL-CELLS; HIPPOCAMPAL ASTROCYTES; RAT HIPPOCAMPUS; SYNAPTIC-TRANSMISSION; DENDRITIC SPINES; D-SERINE; IN-SITU; CALCIUM OSCILLATIONS	Basal synaptic transmission involves the release of neurotransmitters at individual synapses in response to a single action potential. Recent discoveries show that astrocytes modulate the activity of neuronal networks upon sustained and intense synaptic activity. However, their ability to regulate basal synaptic transmission remains ill defined and controversial. Here, we show that astrocytes in the hippocampal CA1 region detect synaptic activity induced by single-synaptic stimulation. Astrocyte activation occurs at functional compartments found along astrocytic processes and involves metabotropic glutamate subtype 5 receptors. In response, astrocytes increase basal synaptic transmission, as revealed by the blockade of their activity with a Ca(2+) chelator. Astrocytic modulation of basal synaptic transmission is mediated by the release of purines and the activation of presynaptic A(2A) receptors by adenosine. Our work uncovers an essential role for astrocytes in the regulation of elementary synaptic communication and provides insight into fundamental aspects of brain function.	[Panatier, Aude; Vallee, Joanne; Lacaille, Jean-Claude; Robitaille, Richard] Univ Montreal, Dept Physiol, Montreal, PQ H3C 3J7, Canada; [Panatier, Aude; Vallee, Joanne; Lacaille, Jean-Claude; Robitaille, Richard] Univ Montreal, Grp Rech Syst Nerveux Cent, Montreal, PQ H3C 3J7, Canada; [Haber, Michael; Murai, Keith K.] McGill Univ, Ctr Res Neurosci, Dept Neurol & Neurosurg, Res Inst,Hlth Ctr,Montreal Gen Hosp, Montreal, PQ H3G 1A4, Canada	Universite de Montreal; Universite de Montreal; McGill University	Lacaille, JC (corresponding author), Univ Montreal, Dept Physiol, POB 6128,Stn Ctr Ville, Montreal, PQ H3C 3J7, Canada.	jean-claude.lacaille@umontreal.ca; richard.robitaille@umontreal.ca		Panatier, Aude/0000-0002-6107-4463; Robitaille, Richard/0000-0001-6628-0146	NSERC Discovery Group; FRSQ (Groupe de recherche sur le Systeme Nerveux Central); CIHR [MOP-14137, MOP-10848]	NSERC Discovery Group; FRSQ (Groupe de recherche sur le Systeme Nerveux Central)(Fonds de la Recherche en Sante du Quebec); CIHR(Canadian Institutes of Health Research (CIHR))	We thank Dr. A. Serrano for helpful discussions and suggestions; Dr. J. Boehm for helpful comments on different versions of the manuscript; and Dr. K.M. Harris for her comments, discussion and for reading different versions of the manuscript. We also thank Ms. Pierrette Fournel for her technical support. This work was supported by grants from NSERC Discovery Group; by an infrastructure grant from FRSQ (Groupe de recherche sur le Systeme Nerveux Central) to J.-C.L. and R.R.; and by the CIHR main operating fund to R.R. (MOP-14137) and J.-C.L. (MOP-10848). A.P. was a Long-Term Fellow of the Human Frontier Science Program Organization; R.R. was a Chercheur-National of the FRSQ; K.K.M. held the Canada Research Chair in Molecular Control of Synaptic Structure (Tier II); and J.-C.L. held the Canada Research Chair in Cellular and Molecular Neurophysiology (Tier I).	Araque A, 1999, TRENDS NEUROSCI, V22, P208, DOI 10.1016/S0166-2236(98)01349-6; Araque A, 2002, J NEUROSCI, V22, P2443, DOI 10.1523/JNEUROSCI.22-07-02443.2002; Ayala JE, 2008, NEUROPHARMACOLOGY, V54, P804, DOI 10.1016/j.neuropharm.2007.12.009; Belair EL, 2010, J PHYSIOL-LONDON, V588, P1039, DOI 10.1113/jphysiol.2009.178988; Bergles DE, 1997, NEURON, V19, P1297, DOI 10.1016/S0896-6273(00)80420-1; Bushong EA, 2004, INT J DEV NEUROSCI, V22, P73, DOI 10.1016/j.ijdevneu.2003.12.008; Bushong EA, 2002, J NEUROSCI, V22, P183, DOI 10.1523/JNEUROSCI.22-01-00183.2002; Cai ZH, 2000, GLIA, V29, P70, DOI 10.1002/(SICI)1098-1136(20000101)29:1<70::AID-GLIA7>3.0.CO;2-V; Carter AG, 2004, NEURON, V44, P483, DOI 10.1016/j.neuron.2004.10.013; Cunha RA, 2001, NEUROCHEM INT, V38, P107, DOI 10.1016/S0197-0186(00)00034-6; D'Ascenzo M, 2007, P NATL ACAD SCI USA, V104, P1995, DOI 10.1073/pnas.0609408104; Diogenes MJ, 2007, HIPPOCAMPUS, V17, P577, DOI 10.1002/hipo.20294; Fellin T, 2004, NEURON, V43, P729, DOI 10.1016/j.neuron.2004.08.011; Goldberg JH, 2003, NEURON, V40, P807, DOI 10.1016/S0896-6273(03)00714-1; Gordon GRJ, 2009, NEURON, V64, P391, DOI 10.1016/j.neuron.2009.10.021; Gourine AV, 2010, SCIENCE, V329, P571, DOI 10.1126/science.1190721; Grosche J, 1999, NAT NEUROSCI, V2, P139, DOI 10.1038/5692; Haber M, 2006, J NEUROSCI, V26, P8881, DOI 10.1523/JNEUROSCI.1302-06.2006; Halassa MM, 2007, J NEUROSCI, V27, P6473, DOI 10.1523/JNEUROSCI.1419-07.2007; Halassa MM, 2010, ANNU REV PHYSIOL, V72, P335, DOI 10.1146/annurev-physiol-021909-135843; Hama K, 2004, J NEUROCYTOL, V33, P277, DOI 10.1023/B:NEUR.0000044189.08240.a2; Henneberger C, 2010, NATURE, V463, P232, DOI 10.1038/nature08673; Holbro N, 2009, P NATL ACAD SCI USA, V106, P15055, DOI 10.1073/pnas.0905110106; Honsek SD, 2012, HIPPOCAMPUS, V22, P29, DOI 10.1002/hipo.20843; Kang J, 1998, NAT NEUROSCI, V1, P683, DOI 10.1038/3684; Latour I, 2001, HIPPOCAMPUS, V11, P132, DOI 10.1002/hipo.1031; Lujan R, 1996, EUR J NEUROSCI, V8, P1488, DOI 10.1111/j.1460-9568.1996.tb01611.x; Matsui K, 2005, J NEUROSCI, V25, P7538, DOI 10.1523/JNEUROSCI.1927-05.2005; Matsui K, 2004, J NEUROSCI, V24, P8932, DOI 10.1523/JNEUROSCI.2650-04.2004; Matsui K, 2003, NEURON, V40, P1173, DOI 10.1016/S0896-6273(03)00788-8; Matthias K, 2003, J NEUROSCI, V23, P1750; Nett WJ, 2002, J NEUROPHYSIOL, V87, P528, DOI 10.1152/jn.00268.2001; Panatier A, 2006, CELL, V125, P775, DOI 10.1016/j.cell.2006.02.051; Pascual O, 2005, SCIENCE, V310, P113, DOI 10.1126/science.1116916; Pasti L, 1997, J NEUROSCI, V17, P7817; Perea G, 2005, J NEUROSCI, V25, P2192, DOI 10.1523/JNEUROSCI.3965-04.2005; Perea G, 2007, SCIENCE, V317, P1083, DOI 10.1126/science.1144640; Porter JT, 1996, J NEUROSCI, V16, P5073; RAASTAD M, 1992, EUR J NEUROSCI, V4, P113, DOI 10.1111/j.1460-9568.1992.tb00114.x; Rebola N, 2005, NEUROSCIENCE, V133, P79, DOI 10.1016/j.neuroscience.2005.01.054; Reid CA, 2001, J NEUROSCI, V21, P2206, DOI 10.1523/JNEUROSCI.21-07-02206.2001; Santello M, 2011, NEURON, V69, P988, DOI 10.1016/j.neuron.2011.02.003; Serrano A, 2008, GLIA, V56, P1648, DOI 10.1002/glia.20717; Serrano A, 2006, J NEUROSCI, V26, P5370, DOI 10.1523/JNEUROSCI.5255-05.2006; Smith MA, 2003, J PHYSIOL-LONDON, V548, P245, DOI 10.1113/jphysiol.2002.036376; Tartaglia N, 2001, J BIOL CHEM, V276, P37585, DOI 10.1074/jbc.M101683200; Todd KJ, 2010, J NEUROSCI, V30, P11870, DOI 10.1523/JNEUROSCI.3165-10.2010; Ventura R, 1999, J NEUROSCI, V19, P6897, DOI 10.1523/JNEUROSCI.19-16-06897.1999; Volterra A, 2005, NAT REV NEUROSCI, V6, P626, DOI 10.1038/nrn1722; Wang XH, 2006, NAT NEUROSCI, V9, P816, DOI 10.1038/nn1703; Witcher MR, 2007, GLIA, V55, P13, DOI 10.1002/glia.20415; Yang YL, 2003, P NATL ACAD SCI USA, V100, P15194, DOI 10.1073/pnas.2431073100; YUSTE R, 1995, NATURE, V375, P682, DOI 10.1038/375682a0; Zhang Q, 2004, P NATL ACAD SCI USA, V101, P9441, DOI 10.1073/pnas.0401960101	54	397	401	1	43	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 2	2011	146	5					785	798		10.1016/j.cell.2011.07.022	http://dx.doi.org/10.1016/j.cell.2011.07.022			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	814SM	21855979	Bronze			2022-12-28	WOS:000294477500018
J	Rausenberger, J; Tscheuschler, A; Nordmeier, W; Wust, F; Timmer, J; Schafer, E; Fleck, C; Hiltbrunner, A				Rausenberger, Julia; Tscheuschler, Anke; Nordmeier, Wiebke; Wuest, Florian; Timmer, Jens; Schaefer, Eberhard; Fleck, Christian; Hiltbrunner, Andreas			Photoconversion and Nuclear Trafficking Cycles Determine Phytochrome A's Response Profile to Far-Red Light	CELL			English	Article							HIGH-IRRADIANCE RESPONSE; SINAPIS-ALBA L; ARABIDOPSIS PHYTOCHROMES; ELONGATED HYPOCOTYL1; A PHOTORECEPTOR; FHY1; PHOTOMORPHOGENESIS; ACCUMULATION; SEEDLINGS; PROTEINS	Phytochrome A (phyA) is the only photoreceptor in plants, initiating responses in far-red light and, as such, essential for survival in canopy shade. Although the absorption and the ratio of active versus total phyA are maximal in red light, far-red light is the most efficient trigger of phyA-dependent responses. Using a joint experimental-theoretical approach, we unravel the mechanism underlying this shift of the phyA action peak from red to far-red light and show that it relies on specific molecular interactions rather than on intrinsic changes to phyA's spectral properties. According to our model, the dissociation rate of the phyA-FHY1/FHL nuclear import complex is a principle determinant of the phyA action peak. The findings suggest how higher plants acquired the ability to sense far-red light from an ancestral photoreceptor tuned to respond to red light.	[Rausenberger, Julia; Fleck, Christian] Univ Freiburg, Ctr Biol Syst Anal ZBSA, D-79104 Freiburg, Germany; [Rausenberger, Julia; Tscheuschler, Anke; Wuest, Florian; Schaefer, Eberhard] Univ Freiburg, Fac Biol, D-79104 Freiburg, Germany; [Timmer, Jens] Univ Freiburg, Freiburg Inst Adv Studies FRIAS, D-79104 Freiburg, Germany; [Timmer, Jens; Schaefer, Eberhard] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, D-79104 Freiburg, Germany; [Nordmeier, Wiebke; Hiltbrunner, Andreas] Univ Tubingen, Ctr Plant Mol Biol ZMBP, D-72076 Tubingen, Germany; [Timmer, Jens] Linkoping Univ, Dept Clin & Expt Med, SE-58183 Linkoping, Sweden	University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg; Eberhard Karls University of Tubingen; Linkoping University	Fleck, C (corresponding author), Univ Freiburg, Ctr Biol Syst Anal ZBSA, D-79104 Freiburg, Germany.	christian.fleck@fdm.uni-freiburg.de; andreas.hiltbrunner@zmbp.uni-tuebingen.de	Fleck, Christian/D-1620-2012	Hiltbrunner, Andreas/0000-0003-0438-5297; Wust, Florian/0000-0002-9941-5550; Fleck, Christian/0000-0002-6371-4495	DFG [SFB592, GRK1305, EXC294]; BMBF-Freiburg Initiative in Systems Biology (FRISYS) [0313921]	DFG(German Research Foundation (DFG)); BMBF-Freiburg Initiative in Systems Biology (FRISYS)(Federal Ministry of Education & Research (BMBF))	We are grateful to Dr. M. Zeidler and the ABRC for providing fhy1-3 and fhl-1 seeds. We thank Prof. J. Paszkowski for the kind gift of the pWCO35 plasmid, Dr. S. Kircher for support for FRAP/FLIP analyses, M. Krenz and C. Konig for technical assistance, and Prof. C. Fankhauser and Prof. R. Ulm for critically reading the manuscript. This work was supported by grants from the DFG to E.S. (SFB592) and to E.S. and J.T. (GRK1305, EXC294) and the BMBF-Freiburg Initiative in Systems Biology 0313921 (FRISYS) to C.F., J.T., and E.S.	Bae G, 2008, ANNU REV PLANT BIOL, V59, P281, DOI 10.1146/annurev.arplant.59.032607.092859; Casal JJ, 2003, PHOTOCH PHOTOBIO SCI, V2, P625, DOI 10.1039/b300094j; Clodong S, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100128; Debrieux D, 2010, PLANT MOL BIOL, V73, P687, DOI 10.1007/s11103-010-9649-9; Desnos T, 2001, GENE DEV, V15, P2980, DOI 10.1101/gad.205401; Devlin PF, 2007, J EXP BOT, V58, P3071, DOI 10.1093/jxb/erm251; Dieterle M, 2001, GENE DEV, V15, P939, DOI 10.1101/gad.197201; Eichenberg K, 2000, FEBS LETT, V470, P107, DOI 10.1016/S0014-5793(00)01301-6; Frey S, 2007, CELL, V130, P512, DOI 10.1016/j.cell.2007.06.024; Genoud T, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000143; HARTMANN KM, 1967, Z NATURFORSCH PT B, VB 22, P1172, DOI 10.1515/znb-1967-1117; Hennig L, 1999, PLANT PHYSIOL, V121, P571, DOI 10.1104/pp.121.2.571; Hennig L, 2000, PLANT CELL ENVIRON, V23, P727, DOI 10.1046/j.1365-3040.2000.00587.x; Hiltbrunner A, 2005, CURR BIOL, V15, P2125, DOI 10.1016/j.cub.2005.10.042; Hiltbrunner A, 2006, PLANT CELL PHYSIOL, V47, P1023, DOI 10.1093/pcp/pcj087; Hu W, 2009, MOL PLANT, V2, P166, DOI 10.1093/mp/ssn086; Kim L, 2000, PLANT J, V22, P125, DOI 10.1046/j.1365-313x.2000.00729.x; Mancinelli Alberto L., 1994, P211; Mathews S, 2005, J HERED, V96, P197, DOI 10.1093/jhered/esi032; MOHR H, 1957, PLANTA, V49, P389, DOI 10.1007/BF01947483; Oyama T, 1997, GENE DEV, V11, P2983, DOI 10.1101/gad.11.22.2983; QUAIL PH, 1994, PLANT CELL, V6, P468, DOI 10.1105/tpc.6.4.468; Rockwell NC, 2006, ANNU REV PLANT BIOL, V57, P837, DOI 10.1146/annurev.arplant.56.032604.144208; Rosler J, 2007, P NATL ACAD SCI USA, V104, P10737, DOI 10.1073/pnas.0703855104; SCHAFER E, 1974, J MATH BIOL, V1, P9, DOI 10.1007/BF02339485; SCHAFER E, 1975, J MATH BIOL, V2, P41, DOI 10.1007/BF00276015; SCHAFER E, 1975, PHOTOCHEM PHOTOBIOL, V22, P193, DOI 10.1111/j.1751-1097.1975.tb06736.x; Shen YP, 2009, PLANT CELL, V21, P494, DOI 10.1105/tpc.108.061259; Shinomura T, 1996, P NATL ACAD SCI USA, V93, P8129, DOI 10.1073/pnas.93.15.8129; Shinomura T, 2000, PLANT PHYSIOL, V122, P147, DOI 10.1104/pp.122.1.147; Sorokina Oxana, 2009, J Biol Eng, V3, P15, DOI 10.1186/1754-1611-3-15; Su YS, 2007, PLANT CELL, V19, P2124, DOI 10.1105/tpc.107.051516; von Dassow G, 2000, NATURE, V406, P188, DOI 10.1038/35018085; WHITELAM GC, 1993, PLANT CELL, V5, P757, DOI 10.1105/tpc.5.7.757; Yang SW, 2009, PLANT CELL, V21, P1341, DOI 10.1105/tpc.109.067215; Zeidler M, 2001, PLANT CELL PHYSIOL, V42, P1193, DOI 10.1093/pcp/pce177; Zhou QQ, 2005, PLANT J, V43, P356, DOI 10.1111/j.1365-313X.2005.02453.x	37	113	121	2	42	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 2	2011	146	5					813	825		10.1016/j.cell.2011.07.023	http://dx.doi.org/10.1016/j.cell.2011.07.023			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	814SM	21884939	Bronze			2022-12-28	WOS:000294477500020
J	Ruder, WC; Lu, T; Collins, JJ				Ruder, Warren C.; Lu, Ting; Collins, James J.			Synthetic Biology Moving into the Clinic	SCIENCE			English	Review							GENE NETWORKS; MAMMALIAN-CELLS; MOLECULAR-BASIS; BACTERIA; RNA; COMMUNICATION; CONSTRUCTION; PROTEINS; SYSTEMS; DESIGN	Synthetic biology is an emerging field focused on engineering biomolecular systems and cellular capabilities for a variety of applications. Substantial progress began a little over a decade ago with the creation of synthetic gene networks inspired by electrical engineering. Since then, the field has designed and built increasingly complex circuits and constructs and begun to use these systems in a variety of settings, including the clinic. These efforts include the development of synthetic biology therapies for the treatment of infectious diseases and cancer, as well as approaches in vaccine development, microbiome engineering, cell therapy, and regenerative medicine. Here, we highlight advances in the biomedical application of synthetic biology and discuss the field's clinical potential.	[Collins, James J.] Boston Univ, Howard Hughes Med Inst, Dept Biomed Engn, Boston, MA 02115 USA; Boston Univ, Ctr BioDynam, Boston, MA 02115 USA; Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA	Boston University; Howard Hughes Medical Institute; Boston University; Harvard University	Collins, JJ (corresponding author), Boston Univ, Howard Hughes Med Inst, Dept Biomed Engn, Boston, MA 02115 USA.	jcollins@bu.edu			National Institutes of Health; Howard Hughes Medical Institute	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	We thank C. Bashor for help with the figures. This work was supported by funding from the National Institutes of Health and the Howard Hughes Medical Institute.	AMIDI M, 2010, SYST SYNTH BIOL, P1; Anderson JC, 2006, J MOL BIOL, V355, P619, DOI 10.1016/j.jmb.2005.10.076; Chen CH, 2007, SCIENCE, V316, P597, DOI [10.1126/science. 1138595, 10.1126/science.1138595]; Chen YY, 2010, P NATL ACAD SCI USA, V107, P8531, DOI 10.1073/pnas.1001721107; Coleman JR, 2008, SCIENCE, V320, P1784, DOI 10.1126/science.1155761; Danino T, 2010, NATURE, V463, P326, DOI 10.1038/nature08753; Deans TL, 2007, CELL, V130, P363, DOI 10.1016/j.cell.2007.05.045; Duan FP, 2008, APPL ENVIRON MICROB, V74, P7437, DOI 10.1128/AEM.01019-08; Duan FP, 2010, P NATL ACAD SCI USA, V107, P11260, DOI 10.1073/pnas.1001294107; Dwyer DJ, 2009, CURR OPIN MICROBIOL, V12, P482, DOI 10.1016/j.mib.2009.06.018; Ellis T, 2009, NAT BIOTECHNOL, V27, P465, DOI 10.1038/nbt.1536; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Farrar MD, 2005, J APPL MICROBIOL, V98, P1191, DOI 10.1111/j.1365-2672.2005.02565.x; Friedland AE, 2009, SCIENCE, V324, P1199, DOI 10.1126/science.1172005; Fung E, 2005, NATURE, V435, P118, DOI 10.1038/nature03508; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Kemmer C, 2010, NAT BIOTECHNOL, V28, P355, DOI 10.1038/nbt.1617; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Levskaya A, 2009, NATURE, V461, P997, DOI 10.1038/nature08446; Lu TK, 2007, P NATL ACAD SCI USA, V104, P11197, DOI 10.1073/pnas.0704624104; Lu TK, 2009, P NATL ACAD SCI USA, V106, P4629, DOI 10.1073/pnas.0800442106; Mukherji S, 2009, NAT REV GENET, V10, P859, DOI 10.1038/nrg2697; Munoz IG, 2011, NUCLEIC ACIDS RES, V39, P729, DOI 10.1093/nar/gkq801; Nandagopal N, 2011, SCIENCE, V333, P1244, DOI 10.1126/science.1207084; Rao S, 2005, P NATL ACAD SCI USA, V102, P11993, DOI 10.1073/pnas.0504881102; Redondo P, 2008, NATURE, V456, P107, DOI 10.1038/nature07343; Rinaudo K, 2007, NAT BIOTECHNOL, V25, P795, DOI 10.1038/nbt1307; Smolke CD, 2011, CELL, V144, P855, DOI 10.1016/j.cell.2011.02.020; Tabor JJ, 2009, CELL, V137, P1272, DOI 10.1016/j.cell.2009.04.048; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Wernig M, 2008, NAT BIOTECHNOL, V26, P916, DOI 10.1038/nbt1483; Windbichler N, 2011, NATURE, V473, P212, DOI 10.1038/nature09937; Wintermute EH, 2010, GENE DEV, V24, P2603, DOI 10.1101/gad.1985210; Xavier JB, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.16; Xiang SL, 2006, NAT BIOTECHNOL, V24, P697, DOI 10.1038/nbt1211; You LC, 2004, NATURE, V428, P868, DOI 10.1038/nature02491	38	275	290	7	211	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 2	2011	333	6047					1248	1252		10.1126/science.1206843	http://dx.doi.org/10.1126/science.1206843			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	813YM	21885773				2022-12-28	WOS:000294406400041
J	Devoogdt, N; Christiaens, MR; Geraerts, I; Truijen, S; Smeets, A; Leunen, K; Neven, P; Van Kampen, M				Devoogdt, Nele; Christiaens, Marie-Rose; Geraerts, Inge; Truijen, Steven; Smeets, Ann; Leunen, Karin; Neven, Patrick; Van Kampen, Marijke			Effect of manual lymph drainage in addition to guidelines and exercise therapy on arm lymphoedema related to breast cancer: randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							QUALITY-OF-LIFE; SURGERY; EDEMA; PHYSIOTHERAPY; MORBIDITY; DIAGNOSIS; SURVIVORS; RISK	Objective To determine the preventive effect of manual lymph drainage on the development of lymphoedema related to breast cancer. Design Randomised single blinded controlled trial. Setting University Hospitals Leuven, Leuven, Belgium. Participants 160 consecutive patients with breast cancer and unilateral axillary lymph node dissection. The randomisation was stratified for body mass index (BMI) and axillary irradiation and treatment allocation was concealed. Randomisation was done independently from recruitment and treatment. Baseline characteristics were comparable between the groups. Intervention For six months the intervention group (n=79) performed a treatment programme consisting of guidelines about the prevention of lymphoedema, exercise therapy, and manual lymph drainage. The control group (n=81) performed the same programme without manual lymph drainage. Main outcome measures Cumulative incidence of arm lymphoedema and time to develop arm lymphoedema, defined as an increase in arm volume of 200 mL or more in the value before surgery. Results Four patients in the intervention group and two in the control group were lost to follow-up. At 12 months after surgery, the cumulative incidence rate for arm lymphoedema was comparable between the intervention group (24%) and control group (19%) (odds ratio 1.3, 95% confidence interval 0.6 to 2.9; P=0.45). The time to develop arm lymphoedema was comparable between the two group during the first year after surgery (hazard ratio 1.3, 0.6 to 2.5; P=0.49). The sample size calculation was based on a presumed odds ratio of 0.3, which is not included in the 95% confidence interval. This odds ratio was calculated as (presumed cumulative incidence of lymphoedema in intervention group/presumed cumulative incidence of no lymphoedema in intervention group)x(presumed cumulative incidence of no lymphoedema in control group/presumed cumulative incidence of lymphoedema in control group) or (10/90)x(70/30). Conclusion Manual lymph drainage in addition to guidelines and exercise therapy after axillary lymph node dissection for breast cancer is unlikely to have a medium to large effect in reducing the incidence of arm lymphoedema in the short term.	[Devoogdt, Nele; Geraerts, Inge; Van Kampen, Marijke] Katholieke Univ Leuven, Dept Rehabil Sci, Louvain, Belgium; [Devoogdt, Nele; Geraerts, Inge; Van Kampen, Marijke] Univ Hosp Leuven, Dept Physiotherapy, Louvain, Belgium; [Devoogdt, Nele; Truijen, Steven] Artesis Univ Coll Antwerp, Dept Hlth Care, Antwerp, Belgium; [Christiaens, Marie-Rose; Smeets, Ann; Leunen, Karin; Neven, Patrick] Univ Hosp Leuven, Multidisciplinary Breast Ctr, Louvain, Belgium; [Christiaens, Marie-Rose; Smeets, Ann; Leunen, Karin; Neven, Patrick] Katholieke Univ Leuven, Fac Med, Louvain, Belgium	KU Leuven; KU Leuven; University Hospital Leuven; KU Leuven; University Hospital Leuven; KU Leuven	Devoogdt, N (corresponding author), Katholieke Univ Leuven, Dept Rehabil Sci, Louvain, Belgium.	nele.devoogdt@uzleuven.be	smeets, ann/AAP-9191-2020; Devoogdt, Nele/H-1840-2014; Devoogdt, Nele/AAB-3933-2020; truijen, steven/G-4179-2016	Devoogdt, Nele/0000-0002-8117-7080; truijen, steven/0000-0002-0604-1431; Geraerts, Inge/0000-0003-3617-6334	agency for Innovation by Science and Technology (Applied Biomedical Research) [IWT 60519]	agency for Innovation by Science and Technology (Applied Biomedical Research)	This study was funded by the agency for Innovation by Science and Technology (Applied Biomedical Research) (IWT 60519). The funding source had no role in study design, data collection, data analysis, data interpretation, or writing of the report.	Armer Jane M., 2005, Lymphatic Research and Biology, V3, P208, DOI 10.1089/lrb.2005.3.208; Armer JM, 2005, CANCER INVEST, V23, P76, DOI 10.1081/CNV-200048707; Berry DA, 2005, NEW ENGL J MED, V353, P1784, DOI 10.1056/NEJMoa050518; Box RC, 2002, BREAST CANCER RES TR, V75, P51, DOI 10.1023/A:1016591121762; Chan Y H, 2004, Singapore Med J, V45, P249; Chan Y. H., 2004, SMJ Singapore Medical Journal, V45, P149; Cheville A, 2010, BRIT MED J, V340, DOI 10.1136/bmj.b5235; Clark B, 2005, QJM-INT J MED, V98, P343, DOI 10.1093/qjmed/hci053; Devoogdt N, 2010, INT ANGIOL, V29, P401; Erickson VS, 2001, J NATL CANCER I, V93, P96, DOI 10.1093/jnci/93.2.96; Ferrandez JC, 1996, J MAL VASCUL, V21, P283; Fleissig A, 2006, BREAST CANCER RES TR, V95, P279, DOI 10.1007/s10549-005-9025-7; FOLDI E, 1989, ANN PLAS SURG, V22, P505; Gebruers N, 2007, CLIN PHYSIOL FUNCT I, V27, P17, DOI 10.1111/j.1475-097X.2007.00708.x; Gergich NLS, 2008, CANCER-AM CANCER SOC, V112, P2809, DOI 10.1002/cncr.23494; Hayes S, 2008, LYMPHOLOGY, V41, P18; Hayes SB, 2008, INT J RADIAT ONCOL, V72, P1449, DOI 10.1016/j.ijrobp.2008.02.080; Karki A, 2005, J REHABIL MED, V37, P180, DOI 10.1080/16501970410024181; Kuter DJ, 2004, ONCOLOGIST, V9, P207, DOI 10.1634/theoncologist.9-2-207; Lacomba MT, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b5396; LEDUC A, 1979, ACTA CHIR BELG, V78, P189; Mellor Russell H, 2004, Breast J, V10, P496, DOI 10.1111/j.1075-122X.2004.21458.x; Norman SA, 2009, J CLIN ONCOL, V27, P390, DOI 10.1200/JCO.2008.17.9291; O'Mahony S, 2006, AM J ROENTGENOL, V186, P1349, DOI 10.2214/AJR.04.1341; Partsch H, 1988, 11 INT C LYMPH; Paskett ED, 2007, CANCER EPIDEM BIOMAR, V16, P775, DOI 10.1158/1055-9965.EPI-06-0168; Ridner Sheila H, 2002, Oncol Nurs Forum, V29, P1285, DOI 10.1188/02.ONF.1285-1293; Rietman JS, 2003, EUR J SURG ONCOL, V29, P229, DOI 10.1053/ejso.2002.1403; Stanton Anthony W. B., 2009, Lymphatic Research and Biology, V7, P29, DOI 10.1089/lrb.2008.1026; van der Veen P, 2001, BREAST, V10, P225, DOI 10.1054/brst.2000.0256; Ware JE, 2000, SPINE, V25, P3130, DOI 10.1097/00007632-200012150-00008	31	50	57	1	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 1	2011	343								d5326	10.1136/bmj.d5326	http://dx.doi.org/10.1136/bmj.d5326			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	816LF	21885537	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000294600500001
J	Sekeres, MA; Steensma, DP				Sekeres, Mikkael A.; Steensma, David P.			The Road Warriors	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Sekeres, Mikkael A.] Cleveland Clin, Taussig Canc Inst, Cleveland, OH 44106 USA; [Steensma, David P.] Dana Farber Canc Inst, Boston, MA 02115 USA	Cleveland Clinic Foundation; Harvard University; Dana-Farber Cancer Institute	Sekeres, MA (corresponding author), Cleveland Clin, Taussig Canc Inst, Cleveland, OH 44106 USA.	sekerem@ccf.org		Steensma, David/0000-0001-5130-9284; Sekeres, Mikkael/0000-0003-2009-6524					0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 24	2011	306	8					805	806		10.1001/jama.2011.1191	http://dx.doi.org/10.1001/jama.2011.1191			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	810VY	21862735				2022-12-28	WOS:000294157300001
J	Musacchio, A				Musacchio, Andrea			Travel Notes from the Equatorial Circle	CELL			English	Editorial Material							MICROTUBULE; INSTABILITY; CAPTURE		[Musacchio, Andrea] Max Planck Inst Mol Physiol, Dept Mechanist Cell Biol, D-44227 Dortmund, Germany; [Musacchio, Andrea] European Inst Oncol, Dept Expt Oncol, I-20139 Milan, Italy	Max Planck Society; IRCCS European Institute of Oncology (IEO)	Musacchio, A (corresponding author), Max Planck Inst Mol Physiol, Dept Mechanist Cell Biol, Otto Hahn Str 11, D-44227 Dortmund, Germany.	andrea.musacchio@mpi-dortmund.mpg.de		Musacchio, Andrea/0000-0003-2362-8784				Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; Gassmann R, 2008, GENE DEV, V22, P2385, DOI 10.1101/gad.1687508; Kapoor TM, 2006, SCIENCE, V311, P388, DOI 10.1126/science.1122142; KIRSCHNER M, 1986, CELL, V45, P329, DOI 10.1016/0092-8674(86)90318-1; Kitajima TS, 2011, CELL, V146, P568, DOI 10.1016/j.cell.2011.07.031; Magidson V, 2011, CELL, V146, P555, DOI 10.1016/j.cell.2011.07.012; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; MITCHISON TJ, 1985, J CELL BIOL, V101, P766, DOI 10.1083/jcb.101.3.766; Tanaka TU, 2010, EMBO J, V29, P4070, DOI 10.1038/emboj.2010.294; Wollman R, 2005, CURR BIOL, V15, P828, DOI 10.1016/j.cub.2005.03.019	10	0	0	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 19	2011	146	4					499	501		10.1016/j.cell.2011.08.001	http://dx.doi.org/10.1016/j.cell.2011.08.001			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	809HY	21854975	Bronze			2022-12-28	WOS:000294043600003
J	Ram, J; Gupta, N				Ram, Jagat; Gupta, Nishant			Bilateral spontaneous anterior dislocation of crystalline lens in an infant	LANCET			English	Editorial Material									[Ram, Jagat; Gupta, Nishant] Post Grad Inst Med Educ & Res, Dept Ophthalmol, Adv Eye Ctr, Chandigarh 160012, India	Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh	Ram, J (corresponding author), Post Grad Inst Med Educ & Res, Dept Ophthalmol, Adv Eye Ctr, Chandigarh 160012, India.	drjagatram@gmail.com							0	4	4	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 22	2011	378	9801					1501	1501		10.1016/S0140-6736(11)60313-9	http://dx.doi.org/10.1016/S0140-6736(11)60313-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	838VC	21872322	Bronze			2022-12-28	WOS:000296319600024
J	Lanyon, BP; Hempel, C; Nigg, D; Muller, M; Gerritsma, R; Zahringer, F; Schindler, P; Barreiro, JT; Rambach, M; Kirchmair, G; Hennrich, M; Zoller, P; Blatt, R; Roos, CF				Lanyon, B. P.; Hempel, C.; Nigg, D.; Mueller, M.; Gerritsma, R.; Zaehringer, F.; Schindler, P.; Barreiro, J. T.; Rambach, M.; Kirchmair, G.; Hennrich, M.; Zoller, P.; Blatt, R.; Roos, C. F.			Universal Digital Quantum Simulation with Trapped Ions	SCIENCE			English	Article							PHASE-TRANSITION; COMPUTATION; COMPUTER	A digital quantum simulator is an envisioned quantum device that can be programmed to efficiently simulate any other local system. We demonstrate and investigate the digital approach to quantum simulation in a system of trapped ions. With sequences of up to 100 gates and 6 qubits, the full time dynamics of a range of spin systems are digitally simulated. Interactions beyond those naturally present in our simulator are accurately reproduced, and quantitative bounds are provided for the overall simulation quality. Our results demonstrate the key principles of digital quantum simulation and provide evidence that the level of control required for a full-scale device is within reach.	[Lanyon, B. P.; Hempel, C.; Mueller, M.; Gerritsma, R.; Zaehringer, F.; Rambach, M.; Kirchmair, G.; Zoller, P.; Blatt, R.; Roos, C. F.] Austrian Acad Sci, Inst Quantenopt & Quanteninformat, A-6020 Innsbruck, Austria; [Lanyon, B. P.; Hempel, C.; Nigg, D.; Gerritsma, R.; Zaehringer, F.; Schindler, P.; Barreiro, J. T.; Rambach, M.; Kirchmair, G.; Hennrich, M.; Blatt, R.; Roos, C. F.] Univ Innsbruck, Inst Expt Phys, A-6020 Innsbruck, Austria; [Mueller, M.; Zoller, P.] Univ Innsbruck, Inst Theoret Phys, A-6020 Innsbruck, Austria	Austrian Academy of Sciences; University of Innsbruck; University of Innsbruck	Lanyon, BP (corresponding author), Austrian Acad Sci, Inst Quantenopt & Quanteninformat, Otto Hittmair Pl 1, A-6020 Innsbruck, Austria.	ben.lanyon@uibk.ac.at	Schindler, Philipp/AAB-4803-2019; Blatt, Rainer/H-9527-2014; Barreiro, Julio T/P-2540-2018; Kirchmair, Gerhard/J-5218-2013; Müller, Markus/AAV-2927-2020; Zoller, Peter/O-1639-2014; Roos, Christian F/D-8475-2011; Rambach, Markus/K-4472-2019; Schindler, Philipp/E-1485-2017; Hempel, Cornelius/I-2388-2013; Hennrich, Markus/D-2475-2009; Müller, Markus/I-6530-2012	Schindler, Philipp/0000-0002-9461-9650; Barreiro, Julio T/0000-0002-1957-8211; Kirchmair, Gerhard/0000-0003-4286-8839; Müller, Markus/0000-0002-2813-3097; Zoller, Peter/0000-0003-4014-1505; Roos, Christian F/0000-0001-7121-8259; Rambach, Markus/0000-0002-4659-3804; Schindler, Philipp/0000-0002-9461-9650; Hempel, Cornelius/0000-0002-4053-722X; Hennrich, Markus/0000-0003-2955-7980; lanyon, benjamin/0000-0002-7379-4572	Austrian Science Fund (FWF) [SFB F40 FOQUS]; Institut fur Quanteninformation GmbH; Intelligence Advanced Research Projects Activity; European Commission; ERC	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Institut fur Quanteninformation GmbH; Intelligence Advanced Research Projects Activity; European Commission(European CommissionEuropean Commission Joint Research Centre); ERC(European Research Council (ERC)European Commission)	We thank W. Dur, A. Aspuru-Guzik, and M. Brownnutt for discussions. We acknowledge financial support by the Austrian Science Fund (FWF) [SFB F40 FOQUS], the Institut fur Quanteninformation GmbH, Intelligence Advanced Research Projects Activity, and the European Commission for support via the integrated project AQUTE, two Marie Curie International Incoming Fellowships, and the ERC advanced grant CRYTERION.	Auerbach A., 1994, INTERACTING ELECT QU; Barreiro JT, 2011, NATURE, V470, P486, DOI 10.1038/nature09801; Benhelm J, 2008, NAT PHYS, V4, P463, DOI 10.1038/nphys961; Brown KR, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.050504; Buluta I, 2009, SCIENCE, V326, P108, DOI 10.1126/science.1177838; Dur W, 2000, PHYS REV A, V62, DOI 10.1103/PhysRevA.62.062314; FEYNMAN RP, 1982, INT J THEOR PHYS, V21, P467, DOI 10.1007/BF02650179; Friedenauer A, 2008, NAT PHYS, V4, P757, DOI 10.1038/nphys1032; Gerritsma R, 2010, NATURE, V463, P68, DOI 10.1038/nature08688; Gilchrist A, 2005, PHYS REV A, V71, DOI 10.1103/PhysRevA.71.062310; Islam R, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1374; Jane E, 2003, QUANTUM INF COMPUT, V3, P15; Kassal I, 2011, ANNU REV PHYS CHEM, V62, P185, DOI 10.1146/annurev-physchem-032210-103512; Kim K, 2010, NATURE, V465, P590, DOI 10.1038/nature09071; Lanyon BP, 2010, NAT CHEM, V2, P106, DOI [10.1038/NCHEM.483, 10.1038/nchem.483]; Leibfried D, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.247901; Lloyd S, 2002, PHYS REV A, V65, DOI 10.1103/PhysRevA.65.010101; Lloyd S, 1996, SCIENCE, V273, P1073, DOI 10.1126/science.273.5278.1073; Monz T, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.040501; Nayak C, 2008, REV MOD PHYS, V80, P1083, DOI 10.1103/RevModPhys.80.1083; NIELSEN MA, 2001, QUANTUM COMPUTATION; Porras D, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.207901; Schindler P, 2011, SCIENCE, V332, P1059, DOI 10.1126/science.1203329; Simon J, 2011, NATURE, V472, P307, DOI 10.1038/nature09994; Somaroo S, 1999, PHYS REV LETT, V82, P5381, DOI 10.1103/PhysRevLett.82.5381; Steane AM, 1999, NATURE, V399, P124, DOI 10.1038/20127; Trotter H.F., 1959, P AM MATH SOC, V10, P545, DOI [10.1090/S0002-9939-1959-0108732-6, DOI 10.1090/S0002-9939-1959-0108732-6, 10.1090/s0002-9939-1959-0108732-6]	33	416	422	0	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 7	2011	334	6052					57	61		10.1126/science.1208001	http://dx.doi.org/10.1126/science.1208001			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	829KW	21885735	Green Submitted			2022-12-28	WOS:000295580300037
J	Sasaki, S				Sasaki, Satoshi			The value of the National Health and Nutrition Survey in Japan	LANCET			English	Editorial Material							STROKE		Univ Tokyo, Sch Publ Hlth, Dept Social & Prevent Epidemiol, Bunkyo Ku, Tokyo 1130033, Japan	University of Tokyo	Sasaki, S (corresponding author), Univ Tokyo, Sch Publ Hlth, Dept Social & Prevent Epidemiol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	stssasak@m.u-tokyo.ac.jp						Iwaoka H, 2001, J NUTR SCI VITAMINOL, V47, P222, DOI 10.3177/jnsv.47.222; Katanoda K, 2002, J NUTR SCI VITAMINOL, V48, P423, DOI 10.3177/jnsv.48.423; Liu LJ, 2001, STROKE, V32, P1745, DOI 10.1161/01.STR.32.8.1745; SASAKI N, 1964, GERIATRICS, V19, P735; Tanaka M, 2012, INT J CANCER, V130, P930, DOI 10.1002/ijc.26080; Ueshima H, 2007, J ATHEROSCLER THROMB, V14, P278, DOI 10.5551/jat.E529	6	21	23	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 1	2011	378	9798					1205	1206		10.1016/S0140-6736(11)61220-8	http://dx.doi.org/10.1016/S0140-6736(11)61220-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	831IO	21885109				2022-12-28	WOS:000295723600008
J	Zhao, YX; Araki, S; Jiahui, WH; Teramoto, T; Chang, YF; Nakano, M; Abdelfattah, AS; Fujiwara, M; Ishihara, T; Nagai, T; Campbell, RE				Zhao, Yongxin; Araki, Satoko; Jiahui, Wu; Teramoto, Takayuki; Chang, Yu-Fen; Nakano, Masahiro; Abdelfattah, Ahmed S.; Fujiwara, Manabi; Ishihara, Takeshi; Nagai, Takeharu; Campbell, Robert E.			An Expanded Palette of Genetically Encoded Ca2+ Indicators	SCIENCE			English	Article							GREEN FLUORESCENT PROTEINS; GCAMP2	Engineered fluorescent protein (FP) chimeras that modulate their fluorescence in response to changes in calcium ion (Ca2+) concentration are powerful tools for visualizing intracellular signaling activity. However, despite a decade of availability, the palette of single FP-based Ca2+ indicators has remained limited to a single green hue. We have expanded this palette by developing blue, improved green, and red intensiometric indicators, as well as an emission ratiometric indicator with an 11,000% ratio change. This series enables improved single-color Ca2+ imaging in neurons and transgenic Caenorhabditis elegans. In HeLa cells, Ca2+ was imaged in three subcellular compartments, and, in conjunction with a cyan FP-yellow FP-based indicator, Ca2+ and adenosine 5'-triphosphate were simultaneously imaged. This palette of indicators paints the way to a colorful new era of Ca2+ imaging.	[Zhao, Yongxin; Jiahui, Wu; Abdelfattah, Ahmed S.; Campbell, Robert E.] Univ Alberta, Dept Chem, Edmonton, AB T6G 2G2, Canada; [Araki, Satoko; Chang, Yu-Fen; Nakano, Masahiro; Nagai, Takeharu] Hokkaido Univ, Res Inst Elect Sci, Kita Ku, Sapporo, Hokkaido 0010020, Japan; [Teramoto, Takayuki; Fujiwara, Manabi; Ishihara, Takeshi] Kyushu Univ, Fac Sci, Dept Biol, Higashi Ku, Fukuoka 8128581, Japan; [Nagai, Takeharu] Japan Sci & Technol Agcy, PRESTO, Chiyoda Ku, Tokyo 1020075, Japan	University of Alberta; Hokkaido University; Kyushu University; Japan Science & Technology Agency (JST)	Campbell, RE (corresponding author), Univ Alberta, Dept Chem, Edmonton, AB T6G 2G2, Canada.	robert.e.campbell@ualberta.ca	Nakano, Masahiro/A-5249-2012; Zhao, Yongxin/AAE-3708-2020; Zhao, Yongxin/F-1874-2015	Nakano, Masahiro/0000-0002-1558-3259; Zhao, Yongxin/0000-0003-4188-5725; Zhao, Yongxin/0000-0003-4188-5725; Abdelfattah, Ahmed/0000-0001-8131-1772; Wu, Jiahui (Chris)/0000-0003-2406-6728; Campbell, Robert E./0000-0003-0604-092X; Teramoto, Takayuki/0000-0001-7060-7148; Nagai, Takeharu/0000-0003-2650-9895	Alberta Innovates; Japan society for the Promotion of Science (JSPS); Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada; Ministry of Education, Culture, Sports, Science, and Technology of Japan [20115003, 221S0003]; PRESTO from the Japan Science and Technology Agency; FIRST from JSPS; Grants-in-Aid for Scientific Research [11J07159] Funding Source: KAKEN	Alberta Innovates; Japan society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); PRESTO from the Japan Science and Technology Agency; FIRST from JSPS; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank L. L. Looger for GCaMP3 cDNA (Addgene plasmid 22692) and H. Imamura for AT1.03 and mitAT1.03 plasmids. Technical advice or support was provided by J. H. Weiner, Q. Tran, K. Saito, T. Matsuda, N. Sato, N. Yonezawa, the Nikon Imaging Center at Hokkaido University, and the University of Alberta Molecular Biology Service Unit. Sequences have been deposited in GenBank (accession nos. JN258409 to JN258415). Plasmid requests will be handled through Addgene and covered under the Uniform Biological Material Transfer Agreement. This work was supported by Alberta Innovates (Y.Z.); Japan society for the Promotion of Science (JSPS), Canadian Institutes of Health Research, and Natural Sciences and Engineering Research Council of Canada (R. E. C.); Ministry of Education, Culture, Sports, Science, and Technology of Japan Grants in Aid for Scientific Research (KAKENHI) 20115003 and 221S0003 (T. I.); and PRESTO from the Japan Science and Technology Agency and FIRST from JSPS (T. N.). R. E. C. holds a Tier II Canada Research Chair in Bioanalytical Chemistry.	Akerboom J, 2009, J BIOL CHEM, V284, P6455, DOI 10.1074/jbc.M807657200; Barrett CML, 2003, BIOCHEM BIOPH RES CO, V304, P279, DOI 10.1016/S0006-291X(03)00583-7; Imamura H, 2009, P NATL ACAD SCI USA, V106, P15651, DOI 10.1073/pnas.0904764106; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Nagai T, 2001, P NATL ACAD SCI USA, V98, P3197, DOI 10.1073/pnas.051636098; Nakai J, 2001, NAT BIOTECHNOL, V19, P137, DOI 10.1038/84397; Nakano M, 2011, ACS CHEM BIOL, V6, P709, DOI 10.1021/cb100313n; Shaner NC, 2008, NAT METHODS, V5, P545, DOI 10.1038/nmeth.1209; Shinkai Y, 2011, J NEUROSCI, V31, P3007, DOI 10.1523/JNEUROSCI.4691-10.2011; Tallini YN, 2006, P NATL ACAD SCI USA, V103, P4753, DOI 10.1073/pnas.0509378103; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Tsien RY, 1999, CALCIUM AS A CELLULAR REGULATOR, P28; Wang Q, 2008, STRUCTURE, V16, P1817, DOI 10.1016/j.str.2008.10.008; Zhang F, 2010, NAT PROTOC, V5, P439, DOI 10.1038/nprot.2009.226; Zhao HM, 2006, NAT PROTOC, V1, P1865, DOI 10.1038/nprot.2006.309	15	867	889	3	175	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 30	2011	333	6051					1888	1891		10.1126/science.1208592	http://dx.doi.org/10.1126/science.1208592			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	826PJ	21903779	Green Accepted			2022-12-28	WOS:000295365800056
J	Holmes, D				Holmes, David			Profile Keizo Takemi: a catalytic charisma	LANCET			English	Biographical-Item																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 17	2011	378	9796					1065	1065		10.1016/S0140-6736(11)61387-1	http://dx.doi.org/10.1016/S0140-6736(11)61387-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	829BE	21885104	Bronze			2022-12-28	WOS:000295548900013
J	Reya, T				Reya, Tannishtha			Illuminating Immune Privilege - A Role for Regulatory T Cells in Preventing Rejection	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Calif San Diego, Sch Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Reya, T (corresponding author), Univ Calif San Diego, Sch Med, La Jolla, CA 92093 USA.							Brunstein CG, 2011, BLOOD, V117, P1061, DOI 10.1182/blood-2010-07-293795; DIIANNI M, 2011, BLOOD, V117, P3921, DOI [DOI 10.1182/blood-2010-10-311894, DOI 10.1182/BLOOD-2010-10-311894]; Fujisaki J, 2011, NATURE, V474, P216, DOI 10.1038/nature10160; Hoffmann P, 2002, J EXP MED, V196, P389, DOI 10.1084/jem.20020399	4	3	3	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 8	2011	365	10					956	957		10.1056/NEJMcibr1107781	http://dx.doi.org/10.1056/NEJMcibr1107781			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	816JX	21899457				2022-12-28	WOS:000294595600015
J	Willbold, M; Elliott, T; Moorbath, S				Willbold, Matthias; Elliott, Tim; Moorbath, Stephen			The tungsten isotopic composition of the Earth's mantle before the terminal bombardment	NATURE			English	Article							IONIZATION MASS-SPECTROMETRY; CORE FORMATION; SIDEROPHILE ELEMENTS; CHROMIUM ISOTOPES; DIFFERENTIATION; TERRESTRIAL; ROCKS; ACCRETION; FRACTIONATION; CONSTRAINTS	Many precious, 'iron-loving' metals, such as gold, are surprisingly abundant in the accessible parts of the Earth, given the efficiency with which core formation should have removed them to the planet's deep interior(1). One explanation of their over-abundance is a 'late veneer'-a flux of meteorites added to the Earth after core formation as a 'terminal' bombardment that culminated in the cratering of the Moon(2). Some 3.8 billion-year-old rocks from Isua, Greenland, are derived from sources that retain an isotopic memory of events pre-dating this cataclysmic meteorite shower(3,4). These Isua samples thus provide a window on the composition of the Earth before such a late veneer and allow a direct test of its importance in modifying the composition of the planet. Using high-precision (less than 6 parts per million, 2 standard deviations) tungsten isotope analyses of these rocks, here we show that they have a isotopic tungsten ratio W-182/W-184 that is significantly higher (about 13 parts per million) than modern terrestrial samples. This finding is in good agreement with the expected influence of a late veneer. We also show that alternative interpretations, such as partial remixing of a deep-mantle reservoir formed in the Hadean eon(5,6) (more than four billion years ago) or core-mantle interaction(7), do not explain the W isotope data well. The decrease in mantle W-182/W-184 occurs during the Archean eon (about four to three billion years ago), potentially on the same timescale as a notable decrease in Nd-142/Nd-144 (refs 3 and 6). We speculate that both observations can be explained if late meteorite bombardment triggered the onset of the current style of mantle convection.	[Willbold, Matthias; Elliott, Tim] Univ Bristol, Sch Earth Sci, Bristol Isotope Grp, Bristol BS8 1RJ, Avon, England; [Moorbath, Stephen] Univ Oxford, Dept Earth Sci, Oxford OX1 3AN, England	University of Bristol; University of Oxford	Willbold, M (corresponding author), Univ Bristol, Sch Earth Sci, Bristol Isotope Grp, Wills Mem Bldg,Queens Rd, Bristol BS8 1RJ, Avon, England.	m.willbold@bristol.ac.uk		Willbold, Matthias/0000-0003-2178-2470; Elliott, Tim/0000-0002-0984-0191	NERC [NE/DO12805/1, NE/H011927/1]; STFC [ST/F002734/1]; DFG [WI 3579/1-1]; NERC [NE/D012805/1] Funding Source: UKRI; Natural Environment Research Council [NE/H011927/1, NE/D012805/1] Funding Source: researchfish; Science and Technology Facilities Council [ST/F002734/1] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); DFG(German Research Foundation (DFG)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	We thank the IODP, C. Storey (University of Portsmouth) and M. D. Norman (ANU Canberra) for providing sample material. We thank C. Coath for assistance with mass spectrometric analyses and T. Kleine and F. Moynier for comments. We acknowledge funding from NERC (NE/DO12805/1, NE/H011927/1), STFC (ST/F002734/1), and DFG (WI 3579/1-1).	Arevalo R, 2008, EARTH PLANET SC LETT, V272, P656, DOI 10.1016/j.epsl.2008.05.031; Bennett VC, 2007, SCIENCE, V318, P1907, DOI 10.1126/science.1145928; Bottke WF, 2010, SCIENCE, V330, P1527, DOI 10.1126/science.1196874; Boyet M, 2005, SCIENCE, V309, P576, DOI 10.1126/science.1113634; Brandon AD, 2005, EARTH PLANET SC LETT, V232, P211, DOI 10.1016/j.epsl.2005.01.034; Brenan JM, 2009, NAT GEOSCI, V2, P798, DOI 10.1038/NGEO658; Carlson RW, 2008, PHILOS T R SOC A, V366, P4077, DOI 10.1098/rsta.2008.0166; Caro G, 2006, GEOCHIM COSMOCHIM AC, V70, P164, DOI 10.1016/j.gca.2005.08.015; Caro G, 2005, NATURE, V436, P246, DOI 10.1038/nature03827; Chou C.-L., 1978, P 9 LUN PLAN SCI C, V9, P163; Frei R, 2005, EARTH PLANET SC LETT, V236, P28, DOI 10.1016/j.epsl.2005.05.024; Iizuka T, 2010, EARTH PLANET SC LETT, V291, P189, DOI 10.1016/j.epsl.2010.01.012; Kamber BS, 2003, CONTRIB MINERAL PETR, V145, P25, DOI 10.1007/s00410-002-0429-7; Kleine T, 2004, GEOCHIM COSMOCHIM AC, V68, P2935, DOI 10.1016/j.gca.2004.01.009; Kleine T, 2008, EARTH PLANET SC LETT, V270, P106, DOI 10.1016/j.epsl.2008.03.013; Kleine T, 2009, GEOCHIM COSMOCHIM AC, V73, P5150, DOI 10.1016/j.gca.2008.11.047; Lorand JP, 2010, EARTH PLANET SC LETT, V289, P298, DOI 10.1016/j.epsl.2009.11.017; Maier WD, 2009, NATURE, V460, P620, DOI 10.1038/nature08205; MARCANTONIO F, 1995, EARTH PLANET SC LETT, V133, P397, DOI 10.1016/0012-821X(95)00092-Q; Montelli R, 2004, SCIENCE, V303, P338, DOI 10.1126/science.1092485; MOORBATH S, 1975, EARTH PLANET SC LETT, V27, P229, DOI 10.1016/0012-821X(75)90034-5; Morgan JW, 2001, METEORIT PLANET SCI, V36, P1257, DOI 10.1111/j.1945-5100.2001.tb01959.x; Moynier F, 2010, P NATL ACAD SCI USA, V107, P10810, DOI 10.1073/pnas.0913605107; Moynier F, 2009, EARTH PLANET SC LETT, V286, P35, DOI 10.1016/j.epsl.2009.06.014; Quitte G, 2002, GEOSTANDARD NEWSLETT, V26, P149, DOI 10.1111/j.1751-908X.2002.tb00883.x; Rudge JF, 2010, NAT GEOSCI, V3, P439, DOI 10.1038/NGEO872; Sahoo YV, 2006, ANALYST, V131, P434, DOI 10.1039/b511557d; Schersten A, 2004, NATURE, V427, P234, DOI 10.1038/nature02221; Schoenberg R, 2002, NATURE, V418, P403, DOI 10.1038/nature00923; Trinquier A, 2008, J ANAL ATOM SPECTROM, V23, P1565, DOI 10.1039/b809755k; Walker RJ, 2009, CHEM ERDE-GEOCHEM, V69, P101, DOI 10.1016/j.chemer.2008.10.001; Willbold M, 2009, EARTH PLANET SC LETT, V279, P44, DOI 10.1016/j.epsl.2008.12.029; Yin QZ, 2002, NATURE, V418, P949, DOI 10.1038/nature00995	35	193	196	3	108	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 8	2011	477	7363					195	U91		10.1038/nature10399	http://dx.doi.org/10.1038/nature10399			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	816MC	21901010				2022-12-28	WOS:000294603900032
J	Karisch, R; Fernandez, M; Taylor, P; Virtanen, C; St-Germain, JR; Jin, LL; Harris, IS; Mori, J; Mak, TW; Senis, YA; Ostman, A; Moran, MF; Neel, BG				Karisch, Robert; Fernandez, Minerva; Taylor, Paul; Virtanen, Carl; St-Germain, Jonathan R.; Jin, Lily L.; Harris, Isaac S.; Mori, Jun; Mak, Tak W.; Senis, Yotis A.; Ostman, Arne; Moran, Michael F.; Neel, Benjamin G.			Global Proteomic Assessment of the Classical Protein-Tyrosine Phosphatome and "Redoxome''	CELL			English	Article							SPECTROMETRY-BASED PROTEOMICS; EPIDERMAL-GROWTH-FACTOR; MASS-SPECTROMETRY; REVERSIBLE OXIDATION; IN-VIVO; CANCER; CELLS; 1B; INACTIVATION; CYSTEINE	Protein-tyrosine phosphatases (PTPs), along with protein-tyrosine kinases, play key roles in cellular signaling. All Class I PTPs contain an essential active site cysteinyl residue, which executes a nucleophilic attack on substrate phosphotyrosyl residues. The high reactivity of the catalytic cysteine also predisposes PTPs to oxidation by reactive oxygen species, such as H2O2. Reversible PTP oxidation is emerging as an important cellular regulatory mechanism and might contribute to diseases such as cancer. We exploited these unique features of PTP enzymology to develop proteomic methods, broadly applicable to cell and tissue samples, that enable the comprehensive identification and quantification of expressed classical PTPs (PTPome) and the oxidized subset of the PTPome (oxPTPome). We find that mouse and human cells and tissues, including cancer cells, display distinctive PTPomes and oxPTPomes, revealing additional levels of complexity in the regulation of protein-tyrosine phosphorylation in normal and malignant cells.	[Karisch, Robert; Neel, Benjamin G.] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2M9, Canada; [Karisch, Robert; Fernandez, Minerva; Virtanen, Carl; Harris, Isaac S.; Mak, Tak W.; Neel, Benjamin G.] Univ Hlth Network, Campbell Family Canc Res Inst, Ontario Canc Inst, Toronto, ON M5G 1L7, Canada; [Karisch, Robert; Fernandez, Minerva; Virtanen, Carl; Harris, Isaac S.; Mak, Tak W.; Neel, Benjamin G.] Univ Hlth Network, Princess Margaret Hosp, Toronto, ON M5G 1L7, Canada; [Taylor, Paul; St-Germain, Jonathan R.; Jin, Lily L.; Moran, Michael F.] Univ Toronto, Program Mol Struct & Funct, Hosp Sick Children, Toronto, ON M5G 1L7, Canada; [Taylor, Paul; St-Germain, Jonathan R.; Jin, Lily L.; Moran, Michael F.] Univ Toronto, Dept Mol Genet, Toronto, ON M5G 1L7, Canada; [Taylor, Paul; St-Germain, Jonathan R.; Jin, Lily L.; Moran, Michael F.] Univ Toronto, McLaughlin Ctr Mol Med, Toronto, ON M5G 1L7, Canada; [Taylor, Paul; St-Germain, Jonathan R.; Jin, Lily L.; Moran, Michael F.] Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5G 1L7, Canada; [Mori, Jun; Senis, Yotis A.] Univ Birmingham, Ctr Cardiovasc Sci, Inst Biomed Res, Sch Clin & Expt Med,Coll Med & Dent Sci, Birmingham B15 2TT, W Midlands, England; [Ostman, Arne] Karolinska Inst, Canc Ctr Karolinska, Dept Pathol & Oncol, S-17176 Stockholm, Sweden	University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University of Toronto; University of Birmingham; Karolinska Institutet	Karisch, R (corresponding author), Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2M9, Canada.	rkarisch@uhnresearch.ca	Senis, Yotis/AAD-7183-2021; Moran, Michael/GYD-3631-2022	Senis, Yotis/0000-0002-0947-9957; Harris, Isaac/0000-0002-6855-2763	National Institutes of Health [R37CA49152]; Human Frontiers of Science Program [RGP0039/2009-C]; Canadian Institutes of Health Research (CIHR); Canadian Cancer Society Research Institute; Swedish Research Council; EU; Ontario Ministry of Health and Long Term Care; Princess Margaret Hospital Foundation; Natural Sciences and Engineering Council of Canada; British Heart Foundation [FS/08/034/25085] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R37CA049152] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontiers of Science Program(Human Frontier Science Program); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); Swedish Research Council(Swedish Research CouncilEuropean Commission); EU(European Commission); Ontario Ministry of Health and Long Term Care(Ministry of Health and Long-Term Care, Ontario); Princess Margaret Hospital Foundation; Natural Sciences and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); British Heart Foundation(British Heart Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr. Petr Heneberg for qPCR and Dr. Suzanne Trudel (Ontario Cancer Institute/Princess Margaret Hospital) for the MM cell lines. This work was supported by National Institutes of Health Grant R37CA49152 (B.G.N.), the Human Frontiers of Science Program Grant RGP0039/2009-C (B.G.N.), the Canadian Institutes of Health Research (CIHR; M.F.M.), the Canadian Cancer Society Research Institute (M.F.M.), the Swedish Research Council (A.O.), and the EU-funded PTPNET Research Training Network (A.O.). Additional support was provided by the Ontario Ministry of Health and Long Term Care and the Princess Margaret Hospital Foundation. B.G.N. and M.F.M. are Canada Research Chairs, Tier 1. Y.A.S. is a British Heart Foundation (BHF) Intermediate Research Fellow (FS/08/034/25085) and J.M. is a BHF Post Doctoral Fellow (PG/07/034/22775). R.K. and I.S.H. are the recipients of graduate fellowships from the CIHR and the Natural Sciences and Engineering Council of Canada, respectively. A.O. is a coinventor of the monoclonal oxidized PTP active site antibody and receives royalties for sales of the antibody.	Agazie YM, 2003, ONCOGENE, V22, P6909, DOI 10.1038/sj.onc.1206798; Ahn NG, 2007, ACS CHEM BIOL, V2, P39, DOI 10.1021/cb600357d; Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Andersen JN, 2001, MOL CELL BIOL, V21, P7117, DOI 10.1128/MCB.21.21.7117-7136.2001; Arnold RS, 2001, P NATL ACAD SCI USA, V98, P5550, DOI 10.1073/pnas.101505898; Boivin B, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3137pl2; Bourdeau A, 2005, CURR OPIN CELL BIOL, V17, P203, DOI 10.1016/j.ceb.2005.02.001; BURRIDGE K, 1995, ANAL BIOCHEM, V232, P56, DOI 10.1006/abio.1995.9961; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Chan G, 2008, CANCER METAST REV, V27, P179, DOI 10.1007/s10555-008-9126-y; Chen CY, 2009, BIOCHEMISTRY-US, V48, P1399, DOI 10.1021/bi801973z; den Hertog J, 2005, ARCH BIOCHEM BIOPHYS, V434, P11, DOI 10.1016/j.abb.2004.05.024; Denu JM, 1998, CURR OPIN CHEM BIOL, V2, P633, DOI 10.1016/S1367-5931(98)80095-1; Elschenbroich S, 2011, MOL BIOSYST, V7, P292, DOI 10.1039/c0mb00159g; Finkel T, 1998, CURR OPIN CELL BIOL, V10, P248, DOI 10.1016/S0955-0674(98)80147-6; Gerber SA, 2003, P NATL ACAD SCI USA, V100, P6940, DOI 10.1073/pnas.0832254100; Gianni D, 2008, MOL BIOL CELL, V19, P2984, DOI 10.1091/mbc.E08-02-0138; Gingras MC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005105; Groen A, 2005, J BIOL CHEM, V280, P10298, DOI 10.1074/jbc.M412424200; Gross S, 2002, J BIOL CHEM, V277, P48139, DOI 10.1074/jbc.M208228200; Gstaiger M, 2009, NAT REV GENET, V10, P617, DOI 10.1038/nrg2633; Hsu MF, 2010, J BIOL CHEM, V285, P7919, DOI 10.1074/jbc.M109.057513; Huyer G, 1997, J BIOL CHEM, V272, P843, DOI 10.1074/jbc.272.2.843; Julien SG, 2011, NAT REV CANCER, V11, P35, DOI 10.1038/nrc2980; Kumar S, 2004, P NATL ACAD SCI USA, V101, P7943, DOI 10.1073/pnas.0402323101; Lahiry P, 2010, NAT REV GENET, V11, P60, DOI 10.1038/nrg2707; Lee SR, 1998, J BIOL CHEM, V273, P15366, DOI 10.1074/jbc.273.25.15366; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Li QA, 2006, MOL CELL BIOL, V26, P140, DOI 10.1128/MCB.26.1.140-154.2006; Li S, 2003, ARCH BIOCHEM BIOPHYS, V410, P269, DOI 10.1016/S0003-9861(02)00696-3; Liou GY, 2010, FREE RADICAL RES, V44, P479, DOI 10.3109/10715761003667554; Lou YW, 2008, FEBS J, V275, P69, DOI 10.1111/j.1742-4658.2007.06173.x; Meng TC, 2004, J BIOL CHEM, V279, P37716, DOI 10.1074/jbc.M404606200; Meng TC, 2002, MOL CELL, V9, P387, DOI 10.1016/S1097-2765(02)00445-8; Mevik BH, 2007, J STAT SOFTW, V18, P1, DOI 10.18637/jss.v018.i02; MIZUNO K, 1993, MOL CELL BIOL, V13, P5513, DOI 10.1128/MCB.13.9.5513; Myers MP, 2001, J BIOL CHEM, V276, P47771, DOI 10.1074/jbc.C100583200; Nelson KJ, 2010, METHOD ENZYMOL, V473, P95, DOI 10.1016/S0076-6879(10)73004-4; Ostman A, 2006, NAT REV CANCER, V6, P307, DOI 10.1038/nrc1837; Pandey A, 2002, ONCOGENE, V21, P8029, DOI 10.1038/sj.onc.1205988; Pearce AC, 2004, J BIOL CHEM, V279, P53955, DOI 10.1074/jbc.M410355200; Persson C, 2005, METHODS, V35, P37, DOI 10.1016/j.ymeth.2004.07.006; Persson C, 2004, P NATL ACAD SCI USA, V101, P1886, DOI 10.1073/pnas.0304403101; Picotti P, 2009, CELL, V138, P795, DOI 10.1016/j.cell.2009.05.051; Poole LB, 2008, CURR OPIN CHEM BIOL, V12, P18, DOI 10.1016/j.cbpa.2008.01.021; Rhee S G, 2000, Sci STKE, V2000, ppe1; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Salmeen A, 2005, ANTIOXID REDOX SIGN, V7, P560, DOI 10.1089/ars.2005.7.560; Salmeen A, 2003, NATURE, V423, P769, DOI 10.1038/nature01680; Sattler M, 2000, J BIOL CHEM, V275, P24273, DOI 10.1074/jbc.M002094200; Seo YH, 2009, P NATL ACAD SCI USA, V106, P16163, DOI 10.1073/pnas.0903015106; Singh DK, 2005, CELL, V121, P281, DOI 10.1016/j.cell.2005.02.036; St-Germain JR, 2009, P NATL ACAD SCI USA, V106, P20127, DOI 10.1073/pnas.0910957106; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; Tanner JJ, 2011, ANTIOXID REDOX SIGN, V15, P77, DOI 10.1089/ars.2010.3611; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Tonks NK, 2005, CELL, V121, P667, DOI 10.1016/j.cell.2005.05.016; van Montfort RLM, 2003, NATURE, V423, P773, DOI 10.1038/nature01681; Walther TC, 2010, J CELL BIOL, V190, P491, DOI 10.1083/jcb.201004052; Weerapana E, 2010, NATURE, V468, P790, DOI 10.1038/nature09472; Weibrecht I, 2007, FREE RADICAL BIO MED, V43, P100, DOI 10.1016/j.freeradbiomed.2007.03.021; Woo HA, 2010, CELL, V140, P517, DOI 10.1016/j.cell.2010.01.009; Yates JR, 2009, ANNU REV BIOMED ENG, V11, P49, DOI 10.1146/annurev-bioeng-061008-124934; Zhang Y, 2005, MOL CELL PROTEOMICS, V4, P1240, DOI 10.1074/mcp.M500089-MCP200; ZHANG ZY, 1994, P NATL ACAD SCI USA, V91, P1624, DOI 10.1073/pnas.91.5.1624	65	130	131	0	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 2	2011	146	5					826	840		10.1016/j.cell.2011.07.020	http://dx.doi.org/10.1016/j.cell.2011.07.020			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	814SM	21884940	Bronze, Green Accepted			2022-12-28	WOS:000294477500021
J	Liu, Z; Scannell, DR; Eisen, MB; Tjian, R				Liu, Zhe; Scannell, Devin R.; Eisen, Michael B.; Tjian, Robert			Control of Embryonic Stem Cell Lineage Commitment by Core Promoter Factor, TAF3	CELL			English	Article							TRANSCRIPTION FACTORS; ENDODERM DIFFERENTIATION; PLURIPOTENCY; EXPRESSION; THOUSANDS; PATHWAY; REGIONS; GENOME; ROLES; MODEL	Deciphering the molecular basis of pluripotency is fundamental to our understanding of development and embryonic stem cell function. Here, we report that TAF3, a TBP-associated core promoter factor, is highly enriched in ES cells. In this context, TAF3 is required for endoderm lineage differentiation and prevents premature specification of neuroectoderm and mesoderm. In addition to its role in the core promoter recognition complex TFIID, genome-wide binding studies reveal that TAF3 localizes to a subset of chromosomal regions bound by CTCF/cohesin that are selectively associated with genes upregulated by TAF3. Notably, CTCF directly recruits TAF3 to promoter distal sites and TAF3-dependent DNA looping is observed between the promoter distal sites and core promoters occupied by TAF3/CTCF/cohesin. Together, our findings support a new role of TAF3 in mediating long-range chromatin regulatory interactions that safeguard the finely-balanced transcriptional programs underlying pluripotency.	[Liu, Zhe; Scannell, Devin R.; Eisen, Michael B.; Tjian, Robert] Univ Calif Berkeley, Howard Hughes Med Inst, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Tjian, Robert] Univ Calif Berkeley, LKS Biomed & Hlth Sci Ctr, CIRM Ctr Excellence, Berkeley, CA 94720 USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Tjian, R (corresponding author), Univ Calif Berkeley, Howard Hughes Med Inst, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.	jmlim@berkeley.edu		Scannell, Devin/0000-0002-8188-5992; Eisen, Michael/0000-0002-7528-738X	NATIONAL CANCER INSTITUTE [R37CA025417] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NCI NIH HHS [R37 CA025417-34, R37 CA025417] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Arnold SJ, 2009, NAT REV MOL CELL BIO, V10, P91, DOI 10.1038/nrm2618; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; BRADLEY A, 1984, NATURE, V309, P255, DOI 10.1038/309255a0; Daley GQ, 2008, CELL, V132, P544, DOI 10.1016/j.cell.2008.02.009; Deato MDE, 2008, MOL CELL, V32, P96, DOI 10.1016/j.molcel.2008.09.009; Deato MDE, 2007, GENE DEV, V21, P2137, DOI 10.1101/gad.1583407; Farnham PJ, 2009, NAT REV GENET, V10, P605, DOI 10.1038/nrg2636; Gadue P, 2006, P NATL ACAD SCI USA, V103, P16806, DOI 10.1073/pnas.0603916103; Gangloff YG, 2001, MOL CELL BIOL, V21, P5109, DOI 10.1128/MCB.21.15.5109-5121.2001; Goodrich JA, 2010, NAT REV GENET, V11, P549, DOI 10.1038/nrg2847; Grapin-Botton A, 2007, MECH DEVELOP, V124, P253, DOI 10.1016/j.mod.2007.01.001; Hart DO, 2009, DEV DYNAM, V238, P2540, DOI 10.1002/dvdy.22083; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Khattra J, 2007, GENOME RES, V17, P108, DOI 10.1101/gr.5488207; Li LJ, 2010, P NATL ACAD SCI USA, V107, P1402, DOI 10.1073/pnas.0905657107; Li XY, 2008, PLOS BIOL, V6, P365, DOI 10.1371/journal.pbio.0060027; MacArthur S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-7-r80; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Naar AM, 2001, ANNU REV BIOCHEM, V70, P475, DOI 10.1146/annurev.biochem.70.1.475; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Seguin CA, 2008, CELL STEM CELL, V3, P182, DOI 10.1016/j.stem.2008.06.018; Tada S, 2005, DEVELOPMENT, V132, P4363, DOI 10.1242/dev.02005; Tam PPL, 2007, NAT REV GENET, V8, P368, DOI 10.1038/nrg2084; TJIAN R, 1994, CELL, V77, P5, DOI 10.1016/0092-8674(94)90227-5; Verheijen MHG, 1999, J BIOL CHEM, V274, P1487, DOI 10.1074/jbc.274.3.1487; Vermeulen M, 2007, CELL, V131, P58, DOI 10.1016/j.cell.2007.08.016; Yao J, 2011, GENE DEV, V25, P569, DOI 10.1101/gad.2021411; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	30	129	131	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 2	2011	146	5					720	731		10.1016/j.cell.2011.08.005	http://dx.doi.org/10.1016/j.cell.2011.08.005			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	814SM	21884934	Bronze, Green Accepted			2022-12-28	WOS:000294477500013
J	Classen, DC; Bates, DW				Classen, David C.; Bates, David W.			Finding the Meaning in Meaningful Use	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							HEALTH INFORMATION-TECHNOLOGY; PHYSICIAN ORDER ENTRY; MEDICATION ERRORS; AMBULATORY-CARE; RECORD USE; QUALITY; BENEFITS; IMPACT; COSTS		[Classen, David C.] Univ Utah, Sch Med, Dept Internal Med, Salt Lake City, UT 84112 USA; [Bates, David W.] Brigham & Womens Hosp, Div Gen Med & Primary Care, Boston, MA 02115 USA	Utah System of Higher Education; University of Utah; Harvard University; Brigham & Women's Hospital	Classen, DC (corresponding author), Univ Utah, Sch Med, Dept Internal Med, Salt Lake City, UT 84112 USA.		Bates, David/AAE-7283-2019					[Anonymous], 2011 HEALTHC INF MAN; Bates DW, 1998, JAMA-J AM MED ASSOC, V280, P1311, DOI 10.1001/jama.280.15.1311; Black AD, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000387; Blumenthal D, 2010, NEW ENGL J MED, V363, P501, DOI 10.1056/NEJMp1006114; Blumenthal D, 2010, NEW ENGL J MED, V362, P382, DOI 10.1056/NEJMp0912825; Blumenthal D, 2009, NEW ENGL J MED, V360, P1477, DOI 10.1056/NEJMp0901592; Buntin MB, 2011, HEALTH AFFAIR, V30, P464, DOI 10.1377/hlthaff.2011.0178; Chaudhry B, 2006, ANN INTERN MED, V144, P742, DOI 10.7326/0003-4819-144-10-200605160-00125; Classen David, 2010, J Patient Saf, V6, P15, DOI 10.1097/PTS.0b013e3181d108db; Dexter PR, 2004, JAMA-J AM MED ASSOC, V292, P2366, DOI 10.1001/jama.292.19.2366; Evans RS, 1998, NEW ENGL J MED, V338, P232, DOI 10.1056/NEJM199801223380406; Goldzweig CL, 2009, HEALTH AFFAIR, V28, pW282, DOI 10.1377/hlthaff.28.2.w282; Greenhalgh T, 2009, MILBANK Q, V87, P729, DOI 10.1111/j.1468-0009.2009.00578.x; Healthcare Information and Management Systems Society Analytics, HOSP READ MEET SOM C; HSIAO CJ, 2009, ELECT MED RECORD ELE; Karsh BT, 2010, J AM MED INFORM ASSN, V17, P617, DOI 10.1136/jamia.2010.005637; Koppel R, 2010, JAMA-J AM MED ASSOC, V303, P1918, DOI 10.1001/jama.2010.590; Liang LL, 2010, CONNECTED HLTH USING; Linder JA, 2007, ARCH INTERN MED, V167, P1400, DOI 10.1001/archinte.167.13.1400; Malenka DJ, 2005, HEALTH AFFAIR, V24, P928, DOI 10.1377/hlthaff.24.4.928; Metzger J, 2008, LEAPFROG GROUPS CPOE; Metzger J, 2010, HEALTH AFFAIR, V29, P655, DOI 10.1377/hlthaff.2010.0160; ORNSTEIN C, 2003, LOS ANGELES TIM 0122, pB1; Potts AL, 2004, PEDIATRICS, V113, P59, DOI 10.1542/peds.113.1.59; Romano MJ, 2011, ARCH INTERN MED, V171, P897, DOI 10.1001/archinternmed.2010.527; Saverno KR, 2011, J AM MED INFORM ASSN, V18, P32, DOI 10.1136/jamia.2010.007609; Sittig DF, 2010, JAMA-J AM MED ASSOC, V303, P450, DOI 10.1001/jama.2010.61; Stewart WF, 2007, HEALTH AFFAIR, V26, pW181, DOI 10.1377/hlthaff.26.2.w181; Zhou L, 2009, J AM MED INFORM ASSN, V16, P457, DOI 10.1197/jamia.M3128	29	52	53	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 1	2011	365	9					855	858		10.1056/NEJMsb1103659	http://dx.doi.org/10.1056/NEJMsb1103659			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	813YC	21879906				2022-12-28	WOS:000294405200016
J	Herrera, AF; Soriano, G; Bellizzi, AM; Hornick, JL; Ho, VT; Ballen, KK; Baden, LR; Cutler, CS; Antin, JH; Soiffer, RJ; Marty, FM				Herrera, Alex F.; Soriano, Gabriela; Bellizzi, Andrew M.; Hornick, Jason L.; Ho, Vincent T.; Ballen, Karen K.; Baden, Lindsey R.; Cutler, Corey S.; Antin, Joseph H.; Soiffer, Robert J.; Marty, Francisco M.			Cord Colitis Syndrome in Cord-Blood Stem-Cell Transplantation	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							VERSUS-HOST-DISEASE; BONE-MARROW-TRANSPLANTATION; UNRELATED DONORS; CHRONIC GRAFT; HEMATOLOGIC MALIGNANCIES; MYCOPHENOLATE-MOFETIL; HEPATIC COMPLICATIONS; PERIPHERAL-BLOOD; ADULT PATIENTS; RECIPIENTS	Background Diarrhea is a frequent complication of hematopoietic stem-cell transplantation (HSCT). Important causes of diarrhea after HSCT include acute graft-versus-host disease (GVHD), infections, and medications. After the transplantation and engraftment of hematopoietic stem cells from umbilical-cord blood, we observed a new syndrome of culture-negative, antibiotic-responsive diarrhea not attributable to any known cause. Methods We conducted a retrospective cohort study of all patients undergoing cord-blood HSCT at our center between March 2003 and March 2010. The cord colitis syndrome was defined as a persistent diarrheal illness in such patients that was not due to acute GVHD, viral or bacterial infection, or another identifiable cause. Clinical and histopathological features of patients meeting the case definition were further analyzed. Results Among 104 patients who underwent cord-blood HSCT at our center, the cord colitis syndrome developed in 11 (10.6%). The 1-year Kaplan-Meier cumulative probability of meeting the case definition for the syndrome was 0.16. The median time to onset after transplantation was 131 days (range, 88 to 314). All patients had a response to a 10-to-14-day course of empirical therapy with metronidazole, alone or in combination with a fluoroquinolone. Five of the 11 patients (45%) had recurrent diarrhea shortly after discontinuation of antibiotics, and all patients who had a relapse had a response to reinitiation of antibiotic therapy. On histologic examination, all patients with the cord colitis syndrome had chronic active colitis, with granulomatous inflammation present in 7 of 11 patients (64%). Conclusions The cord colitis syndrome is clinically and histopathologically distinct from acute GVHD and other causes of diarrhea in patients who have undergone cord-blood HSCT and is relatively common in this patient population. The syndrome should be considered in such patients who have diarrhea that is not attributable to other causes.	[Herrera, Alex F.; Soriano, Gabriela] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Bellizzi, Andrew M.; Hornick, Jason L.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Baden, Lindsey R.; Marty, Francisco M.] Brigham & Womens Hosp, Div Infect Dis, Boston, MA 02115 USA; [Ho, Vincent T.; Cutler, Corey S.; Antin, Joseph H.; Soiffer, Robert J.] Dana Farber Canc Inst, Div Hematol Malignancies, Boston, MA 02115 USA; [Ballen, Karen K.] Massachusetts Gen Hosp, Bone Marrow Transplant Unit, Boston, MA 02114 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts General Hospital	Herrera, AF (corresponding author), Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA.	afherrera@partners.org	Marty, Francisco M./H-7088-2019	Marty, Francisco M./0000-0002-3708-8734; Hobbs, Gabriela/0000-0002-0199-9333; Hornick, Jason/0000-0001-6475-8345; Bellizzi, Andrew/0000-0002-8264-6379				Asplund S, 1998, MODERN PATHOL, V11, P513; Ballen KK, 2007, BIOL BLOOD MARROW TR, V13, P82, DOI 10.1016/j.bbmt.2006.08.041; Baudard M, 2002, BONE MARROW TRANSPL, V30, P287, DOI 10.1038/sj.bmt.1703633; Boeckh M, 2003, BIOL BLOOD MARROW TR, V9, P543, DOI 10.1016/S1083-8791(03)00287-8; Bow EJ, 1997, J CLIN ONCOL, V15, P2254, DOI 10.1200/JCO.1997.15.6.2254; Brunstein CG, 2007, BLOOD, V110, P3064, DOI 10.1182/blood-2007-04-067215; Cutler C, 2011, BONE MARROW TRANSPL, V46, P659, DOI 10.1038/bmt.2010.192; Davila ML, 2006, CURR OPIN GASTROEN, V22, P44; Deeg HJ, 1998, BLOOD, V91, P1833, DOI 10.1182/blood.V91.6.1833.1833_1833_1844; Dubberke ER, 2010, CLIN TRANSPLANT, V24, P192, DOI 10.1111/j.1399-0012.2009.01035.x; Jalal H, 2005, J CLIN MICROBIOL, V43, P2575, DOI 10.1128/JCM.43.6.2575-2580.2005; KEEVER CA, 1995, BONE MARROW TRANSPL, V15, P407; Klein AK, 2001, BIOL BLOOD MARROW TR, V7, P454, DOI 10.1016/S1083-8791(01)80013-6; Laughlin MJ, 2004, NEW ENGL J MED, V351, P2265, DOI 10.1056/NEJMoa041276; Legrand F, 2011, BONE MARROW TRANSPL, V46, P858, DOI 10.1038/bmt.2010.200; Liakopoulou E, 2005, BONE MARROW TRANSPL, V36, P691, DOI 10.1038/sj.bmt.1705127; Marty FM, 2007, BLOOD, V110, P490, DOI 10.1182/blood-2007-01-069294; MCDONALD GB, 1986, GASTROENTEROLOGY, V90, P770, DOI 10.1016/0016-5085(86)91137-6; MCDONALD GB, 1986, GASTROENTEROLOGY, V90, P460, DOI 10.1016/0016-5085(86)90949-2; PRZEPIORKA D, 1995, BONE MARROW TRANSPL, V15, P825; Rocha V, 2004, NEW ENGL J MED, V351, P2276, DOI 10.1056/NEJMoa041469; Roddie C, 2009, CLIN INFECT DIS, V49, P1061, DOI 10.1086/605557; Rubin David T, 2005, Rev Gastroenterol Disord, V5 Suppl 3, pS10; SALE GE, 1979, AM J SURG PATHOL, V3, P291, DOI 10.1097/00000478-197908000-00001; Shafran I, 2010, DIGEST DIS SCI, V55, P1079, DOI 10.1007/s10620-009-1111-y; SHULMAN HM, 1980, AM J MED, V69, P204, DOI 10.1016/0002-9343(80)90380-0; SULLIVAN KM, 1981, BLOOD, V57, P267, DOI 10.1182/blood.V57.2.267.267; Szabolcs P, 2003, EXP HEMATOL, V31, P708, DOI 10.1016/S0301-472X(03)00160-7; Takahashi S, 2004, BLOOD, V104, P3813, DOI 10.1182/blood-2004-03-1001; Takahashi S, 2007, BLOOD, V109, P1322, DOI 10.1182/blood-2006-04-020172; Takami A, 2006, INT J HEMATOL, V83, P80, DOI 10.1532/IJH97.05111; van Kraaij MGJ, 2000, BONE MARROW TRANSPL, V26, P299, DOI 10.1038/sj.bmt.1702484; WARREN S, 1954, JAMA-J AM MED ASSOC, V154, P189, DOI 10.1001/jama.1954.02940370001001; WILLIAMS WJ, 1964, GUT, V5, P510, DOI 10.1136/gut.5.6.510	34	44	44	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 1	2011	365	9					815	824		10.1056/NEJMoa1104959	http://dx.doi.org/10.1056/NEJMoa1104959			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	813YC	21879899				2022-12-28	WOS:000294405200008
J	Patel, K				Patel, Kinesh			STARTING OUT Confessions of a technophile	BRITISH MEDICAL JOURNAL			English	Editorial Material												kinesh_patel@yahoo.co.uk							0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 31	2011	343								d5483	10.1136/bmj.d5483	http://dx.doi.org/10.1136/bmj.d5483			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	816LE	21880679				2022-12-28	WOS:000294600400007
J	Spence, D				Spence, Des			FROM THE FRONTLINE Bad medicine: melanoma	BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk						*CANC RES UK, 2011, SURV HIGHL NEED BETT; Cancer Research UK, 2011, SKIN CANC UK INC STA; Holick MF, 2008, BRIT MED J, V336, P1318, DOI 10.1136/bmj.39581.411424.80; Levell NJ, 2009, BRIT J DERMATOL, V161, P630, DOI 10.1111/j.1365-2133.2009.09299.x; Sondak VK, 2011, NAT REV CLIN ONCOL, V8, P513, DOI 10.1038/nrclinonc.2011.119; *UK NAT STAT, UPD CANC TRENDS ENGL; Welch HG, 2005, BRIT MED J, V331, P481, DOI 10.1136/bmj.38516.649537.E0	7	5	5	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 31	2011	343								d5477	10.1136/bmj.d5477	http://dx.doi.org/10.1136/bmj.d5477			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	816LE	21880678				2022-12-28	WOS:000294600400006
J	Green, DR; Galluzzi, L; Kroemer, G				Green, Douglas R.; Galluzzi, Lorenzo; Kroemer, Guido			Mitochondria and the Autophagy-Inflammation-Cell Death Axis in Organismal Aging	SCIENCE			English	Review							MEMBRANE PERMEABILIZATION; REGULATES AUTOPHAGY; SIGNALING PATHWAYS; DISEASE; MITOPHAGY; MECHANISMS; PARKIN; DEGRADATION; PROTEASOME	Alterations of mitochondrial functions are linked to multiple degenerative or acute diseases. As mitochondria age in our cells, they become progressively inefficient and potentially toxic, and acute damage can trigger the permeabilization of mitochondrial membranes to initiate apoptosis or necrosis. Moreover, mitochondria have an important role in pro-inflammatory signaling. Autophagic turnover of cellular constituents, be it general or specific for mitochondria (mitophagy), eliminates dysfunctional or damaged mitochondria, thus counteracting degeneration, dampening inflammation, and preventing unwarranted cell loss. Decreased expression of genes that regulate autophagy or mitophagy can cause degenerative diseases in which deficient quality control results in inflammation and the death of cell populations. Thus, a combination of mitochondrial dysfunction and insufficient autophagy may contribute to multiple aging-associated pathologies.	[Green, Douglas R.] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA; [Galluzzi, Lorenzo; Kroemer, Guido] Inst Gustave Roussy, INSERM, U848, F-94805 Villejuif, France; [Galluzzi, Lorenzo] Univ Paris 11, F-94805 Villejuif, France; [Kroemer, Guido] Ctr Rech Cordeliers, F-75005 Paris, France; [Kroemer, Guido] Hop Europeen Georges Pompidou, AP HP, F-75908 Paris, France; [Kroemer, Guido] Univ Paris 05, F-75270 Paris, France	St Jude Children's Research Hospital; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Green, DR (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA.	douglas.green@stjude.org; kroemer@orange.fr	Galluzzi, Lorenzo/K-2709-2012; Galluzzi, Lorenzo/AAG-6294-2019; Galluzzi, Lorenzo/AAG-6432-2019; Kroemer, Guido/AAY-9859-2020; Galluzzi, Lorenzo/AAH-3286-2021; Green, Douglas R/N-8083-2018; KROEMER, Guido/B-4263-2013	Galluzzi, Lorenzo/0000-0003-2257-8500; Green, Douglas R/0000-0002-7332-1417; KROEMER, Guido/0000-0002-9334-4405	NIH; American Lebanese Syrian Associated Charities; European Union (EU); Agence Nationale de la Recherche; Association pour la Recherche sur le Cancer; AXA Chair for Longevity Research; Fondation pour la Recherche Medicale; Institut National du Cancer; Ligue Nationale Contre le Cancer; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047891, R01AI040646] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM096208, R37GM052735] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); European Union (EU)(CGIAREuropean Commission); Agence Nationale de la Recherche(French National Research Agency (ANR)); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); AXA Chair for Longevity Research(AXA Research Fund); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Institut National du Cancer(Institut National du Cancer (INCA) France); Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We apologize to all colleagues whose work we could not cite owing to space limitations. D.R.G. receives grants from the NIH and from the American Lebanese Syrian Associated Charities. L.G. is financed by the European Union (EU) (APO-SYS). G.K. is supported by Agence Nationale de la Recherche, Association pour la Recherche sur le Cancer, AXA Chair for Longevity Research, Fondation pour la Recherche Medicale, Institut National du Cancer, EU, and Ligue Nationale Contre le Cancer (equipe labelisee).	Bossy-Wetzel E, 2008, TRENDS NEUROSCI, V31, P609, DOI 10.1016/j.tins.2008.09.004; Carreira RS, 2010, AUTOPHAGY, V6, P462, DOI 10.4161/auto.6.4.11553; Chen D, 2010, J BIOL CHEM, V285, P38214, DOI 10.1074/jbc.M110.101469; Colell A, 2007, CELL, V129, P983, DOI 10.1016/j.cell.2007.03.045; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Gottlieb RA, 2010, ANNU REV PHYSIOL, V72, P45, DOI 10.1146/annurev-physiol-021909-135757; Hailey DW, 2010, CELL, V141, P656, DOI 10.1016/j.cell.2010.04.009; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Hotchkiss RS, 2009, NEW ENGL J MED, V361, P1570, DOI 10.1056/NEJMra0901217; Kono H, 2008, NAT REV IMMUNOL, V8, P279, DOI 10.1038/nri2215; Korolchuk VI, 2009, MOL CELL, V33, P517, DOI 10.1016/j.molcel.2009.01.021; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Lee JY, 2010, J CELL BIOL, V189, P671, DOI 10.1083/jcb.201001039; Lee JH, 2010, CELL, V141, P1146, DOI 10.1016/j.cell.2010.05.008; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Lipinski MM, 2010, P NATL ACAD SCI USA, V107, P14164, DOI 10.1073/pnas.1009485107; Lipinski MM, 2010, DEV CELL, V18, P1041, DOI 10.1016/j.devcel.2010.05.005; Mackenzie E. R., 2006, COMPLEMENTARY ALTERN, P136; Madeo F, 2010, NAT CELL BIOL, V12, P842, DOI 10.1038/ncb0910-842; Martinez-Vicente M, 2010, NAT NEUROSCI, V13, P567, DOI 10.1038/nn.2528; Mattson MP, 2008, NEURON, V60, P748, DOI 10.1016/j.neuron.2008.10.010; Michiorri S, 2010, CELL DEATH DIFFER, V17, P962, DOI 10.1038/cdd.2009.200; Moreau K, 2010, CURR OPIN CELL BIOL, V22, P206, DOI 10.1016/j.ceb.2009.12.002; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Novak I, 2010, EMBO REP, V11, P45, DOI 10.1038/embor.2009.256; Perry VH, 2007, NAT REV IMMUNOL, V7, P161, DOI 10.1038/nri2015; Radoshevich L, 2010, CELL, V142, P590, DOI 10.1016/j.cell.2010.07.018; Saitoh T, 2010, J CELL BIOL, V189, P925, DOI 10.1083/jcb.201002021; Sandoval H, 2008, NATURE, V454, P232, DOI 10.1038/nature07006; Singh SB, 2010, NAT CELL BIOL, V12, P1154, DOI 10.1038/ncb2119; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; Tait SWG, 2010, DEV CELL, V18, P802, DOI [10.1016/j.devcel.2010.03.014, 10.1016/j.devce1.2010.03.014]; Tanaka A, 2010, J CELL BIOL, V191, P1367, DOI 10.1083/jcb.201007013; Wallace DC, 2010, ANNU REV PATHOL-MECH, V5, P297, DOI 10.1146/annurev.pathol.4.110807.092314; Winslow AR, 2010, J CELL BIOL, V190, P1023, DOI 10.1083/jcb.201003122; Xue L, 2001, CURR BIOL, V11, P361, DOI 10.1016/S0960-9822(01)00100-2; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028; Zheng SQ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000838; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	41	768	802	7	250	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 26	2011	333	6046					1109	1112		10.1126/science.1201940	http://dx.doi.org/10.1126/science.1201940			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811VM	21868666	Green Accepted			2022-12-28	WOS:000294244300037
J	Kirkby, J; Curtius, J; Almeida, J; Dunne, E; Duplissy, J; Ehrhart, S; Franchin, A; Gagne, S; Ickes, L; Kurten, A; Kupc, A; Metzger, A; Riccobono, F; Rondo, L; Schobesberger, S; Tsagkogeorgas, G; Wimmer, D; Amorim, A; Bianchi, F; Breitenlechner, M; David, A; Dommen, J; Downard, A; Ehn, M; Flagan, RC; Haider, S; Hansel, A; Hauser, D; Jud, W; Junninen, H; Kreissl, F; Kvashin, A; Laaksonen, A; Lehtipalo, K; Lima, J; Lovejoy, ER; Makhmutov, V; Mathot, S; Mikkila, J; Minginette, P; Mogo, S; Nieminen, T; Onnela, A; Pereira, P; Petaja, T; Schnitzhofer, R; Seinfeld, JH; Sipila, M; Stozhkov, Y; Stratmann, F; Tome, A; Vanhanen, J; Viisanen, Y; Vrtala, A; Wagner, PE; Walther, H; Weingartner, E; Wex, H; Winkler, PM; Carslaw, KS; Worsnop, DR; Baltensperger, U; Kulmala, M				Kirkby, Jasper; Curtius, Joachim; Almeida, Joao; Dunne, Eimear; Duplissy, Jonathan; Ehrhart, Sebastian; Franchin, Alessandro; Gagne, Stephanie; Ickes, Luisa; Kuerten, Andreas; Kupc, Agnieszka; Metzger, Axel; Riccobono, Francesco; Rondo, Linda; Schobesberger, Siegfried; Tsagkogeorgas, Georgios; Wimmer, Daniela; Amorim, Antonio; Bianchi, Federico; Breitenlechner, Martin; David, Andre; Dommen, Josef; Downard, Andrew; Ehn, Mikael; Flagan, Richard C.; Haider, Stefan; Hansel, Armin; Hauser, Daniel; Jud, Werner; Junninen, Heikki; Kreissl, Fabian; Kvashin, Alexander; Laaksonen, Ari; Lehtipalo, Katrianne; Lima, Jorge; Lovejoy, Edward R.; Makhmutov, Vladimir; Mathot, Serge; Mikkila, Jyri; Minginette, Pierre; Mogo, Sandra; Nieminen, Tuomo; Onnela, Antti; Pereira, Paulo; Petaja, Tuukka; Schnitzhofer, Ralf; Seinfeld, John H.; Sipila, Mikko; Stozhkov, Yuri; Stratmann, Frank; Tome, Antonio; Vanhanen, Joonas; Viisanen, Yrjo; Vrtala, Aron; Wagner, Paul E.; Walther, Hansueli; Weingartner, Ernest; Wex, Heike; Winkler, Paul M.; Carslaw, Kenneth S.; Worsnop, Douglas R.; Baltensperger, Urs; Kulmala, Markku			Role of sulphuric acid, ammonia and galactic cosmic rays in atmospheric aerosol nucleation	NATURE			English	Article							ION-INDUCED NUCLEATION; PARTICLE FORMATION; MASS-SPECTROMETER; UPPER TROPOSPHERE; GAS-PHASE; NANOPARTICLES; H2SO4; STRATOSPHERE; ORGANICS; CLIMATE	Atmospheric aerosols exert an important influence on climate(1) through their effects on stratiform cloud albedo and lifetime(2) and the invigoration of convective storms(3). Model calculations suggest that almost half of the global cloud condensation nuclei in the atmospheric boundary layer may originate from the nucleation of aerosols from trace condensable vapours(4), although the sensitivity of the number of cloud condensation nuclei to changes of nucleation rate may be small(5,6). Despite extensive research, fundamental questions remain about the nucleation rate of sulphuric acid particles and the mechanisms responsible, including the roles of galactic cosmic rays and other chemical species such as ammonia(7). Here we present the first results from the CLOUD experiment at CERN. We find that atmospherically relevant ammonia mixing ratios of 100 parts per trillion by volume, or less, increase the nucleation rate of sulphuric acid particles more than 100-1,000-fold. Time-resolved molecular measurements reveal that nucleation proceeds by a base-stabilization mechanism involving the stepwise accretion of ammonia molecules. Ions increase the nucleation rate by an additional factor of between two and more than ten at ground-level galactic-cosmic-ray intensities, provided that the nucleation rate lies below the limiting ion-pair production rate. We find that ion-induced binary nucleation of H2SO4-H2O can occur in the midtroposphere but is negligible in the boundary layer. However, even with the large enhancements in rate due to ammonia and ions, atmospheric concentrations of ammonia and sulphuric acid are insufficient to account for observed boundary-layer nucleation.	[Curtius, Joachim; Almeida, Joao; Ehrhart, Sebastian; Ickes, Luisa; Kuerten, Andreas; Rondo, Linda; Wimmer, Daniela; Kreissl, Fabian] Goethe Univ Frankfurt, Inst Atmospher & Environm Sci, D-60438 Frankfurt, Germany; [Almeida, Joao; Amorim, Antonio; Lima, Jorge; Mogo, Sandra; Pereira, Paulo; Tome, Antonio] Univ Lisbon, SIM, P-1749016 Lisbon, Portugal; [Almeida, Joao; Amorim, Antonio; Lima, Jorge; Mogo, Sandra; Pereira, Paulo; Tome, Antonio] Univ Beira Interior, P-1749016 Lisbon, Portugal; [Dunne, Eimear; Carslaw, Kenneth S.] Univ Leeds, Sch Earth & Environm, Leeds LS2 9JT, W Yorkshire, England; [Duplissy, Jonathan; Franchin, Alessandro; Gagne, Stephanie; Schobesberger, Siegfried; Ehn, Mikael; Junninen, Heikki; Lehtipalo, Katrianne; Mikkila, Jyri; Nieminen, Tuomo; Petaja, Tuukka; Sipila, Mikko; Vanhanen, Joonas; Worsnop, Douglas R.; Kulmala, Markku] Univ Helsinki, Dept Phys, FI-00014 Helsinki, Finland; [Duplissy, Jonathan; Gagne, Stephanie; Sipila, Mikko] Univ Helsinki, Helsinki Inst Phys, FI-00014 Helsinki, Finland; [Kirkby, Jasper; Duplissy, Jonathan; David, Andre; Haider, Stefan; Mathot, Serge; Minginette, Pierre; Onnela, Antti] CERN, CH-1211 Geneva, Switzerland; [Kupc, Agnieszka; Vrtala, Aron; Wagner, Paul E.; Winkler, Paul M.] Univ Vienna, Fac Phys, A-1090 Vienna, Austria; [Metzger, Axel; Breitenlechner, Martin; Hansel, Armin; Hauser, Daniel; Jud, Werner; Schnitzhofer, Ralf] Univ Innsbruck, Inst Ion & Appl Phys, A-6020 Innsbruck, Austria; [Metzger, Axel; Breitenlechner, Martin; Hansel, Armin; Hauser, Daniel; Jud, Werner; Schnitzhofer, Ralf] Ionicon Analyt GmbH, A-6020 Innsbruck, Austria; [Riccobono, Francesco; Bianchi, Federico; Dommen, Josef; Walther, Hansueli; Weingartner, Ernest; Baltensperger, Urs] Paul Scherrer Inst, Lab Atmospher Chem, CH-5232 Villigen, Switzerland; [Tsagkogeorgas, Georgios; Stratmann, Frank; Wex, Heike] Leibniz Inst Tropospher Res, D-04318 Leipzig, Germany; [Bianchi, Federico] Univ Milan, Dept Inorgan Metallorgan & Analyt Chem, I-20133 Milan, Italy; [Downard, Andrew; Flagan, Richard C.; Seinfeld, John H.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; [Kvashin, Alexander; Makhmutov, Vladimir; Stozhkov, Yuri] PN Lebedev Phys Inst, Solar & Cosm Ray Res Lab, Moscow 119991, Russia; [Laaksonen, Ari] Univ Eastern Finland, FI-70211 Kuopio, Finland; [Lovejoy, Edward R.] NOAA, Earth Syst Res Lab, Boulder, CO 80305 USA; [Viisanen, Yrjo] Finnish Meteorol Inst, FI-00101 Helsinki, Finland; [Worsnop, Douglas R.] Aerodyne Res Inc, Billerica, MA 01821 USA	Goethe University Frankfurt; Universidade de Lisboa; Universidade da Beira Interior; University of Leeds; University of Helsinki; Helsinki Institute of Physics; University of Helsinki; European Organization for Nuclear Research (CERN); University of Vienna; University of Innsbruck; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Leibniz Institut fur Tropospharenforschung (TROPOS); University of Milan; California Institute of Technology; Russian Academy of Sciences; Russian Academy of Science Lebedev Physical Institute; University of Eastern Finland; National Oceanic Atmospheric Admin (NOAA) - USA; Finnish Meteorological Institute; Aerodyne Research	Kirkby, J (corresponding author), CERN, CH-1211 Geneva, Switzerland.	jasper.kirkby@cern.ch	Amorim, Antonio/C-8460-2013; Schobesberger, Siegfried/L-4454-2014; Tome, Antonio R/A-5681-2013; Ehn, Mikael/N-2571-2016; Nieminen, Tuomo J/D-1618-2011; Yuri, Stozhkov/ABG-7096-2021; Worsnop, Douglas R/D-2817-2009; Kirkby, Jasper/A-4973-2012; Bianchi, Federico/G-8428-2012; Wex, Heike/X-5882-2018; Viisanen, Yrjö/CAG-3818-2022; Curtius, Joachim/A-2681-2011; Hansel, Armin/F-3915-2010; Sipilä, Mikko/G-3024-2010; Franchin, Alessandro/AAH-3069-2019; Tinoco Mendes, Andre David/D-4314-2011; Laaksonen, Ari/B-5094-2011; Makhmutov, Vladimir/N-2086-2015; Carslaw, Ken S/C-8514-2009; Petäjä, Tuukka/A-8009-2008; Franchin, Alessandro/GVR-8219-2022; Nieminen, Tuomo/AAB-8686-2020; Kürten, Andreas/O-3851-2019; Duplissy, Jonathan/A-1723-2010; Breitenlechner, Martin/AAA-3402-2021; Mogo, Sandra/B-6967-2008; Kulmala, Markku T/I-7671-2016; Franchin, Alessandro/K-1765-2013; Weingartner, Ernest/B-6793-2009; Stozhkov, Yuri/M-7433-2015; Dunne, Eimear M/H-1567-2014; Ickes, Luisa/U-1196-2018; Junninen, Heikki/C-2157-2014	Amorim, Antonio/0000-0003-0638-2321; Schobesberger, Siegfried/0000-0002-5777-4897; Tome, Antonio R/0000-0001-9144-7120; Ehn, Mikael/0000-0002-0215-4893; Worsnop, Douglas R/0000-0002-8928-8017; Kirkby, Jasper/0000-0003-2341-9069; Bianchi, Federico/0000-0003-2996-3604; Wex, Heike/0000-0003-2129-9323; Viisanen, Yrjö/0000-0002-9660-3281; Curtius, Joachim/0000-0003-3153-4630; Hansel, Armin/0000-0002-1062-2394; Sipilä, Mikko/0000-0002-8594-7003; Tinoco Mendes, Andre David/0000-0001-5854-7699; Laaksonen, Ari/0000-0002-1657-2383; Makhmutov, Vladimir/0000-0002-2242-1055; Carslaw, Ken S/0000-0002-6800-154X; Petäjä, Tuukka/0000-0002-1881-9044; Nieminen, Tuomo/0000-0002-2713-715X; Kürten, Andreas/0000-0002-8955-4450; Duplissy, Jonathan/0000-0001-8819-0264; Mogo, Sandra/0000-0002-1423-2668; Kulmala, Markku T/0000-0003-3464-7825; Weingartner, Ernest/0000-0002-2427-4634; Stozhkov, Yuri/0000-0003-1917-0328; Dunne, Eimear M/0000-0001-7085-8473; Ickes, Luisa/0000-0001-8772-4164; Ehrhart, Sebastian/0000-0002-6517-5341; Winkler, Paul/0000-0001-6861-6029; Jud, Werner/0000-0003-4267-0435; Breitenlechner, Martin/0000-0002-2382-6660; Lehtipalo, Katrianne/0000-0002-1660-2706; Junninen, Heikki/0000-0001-7178-9430; Kupc/Straus, Agnieszka/0000-0002-7996-2506	EC [215072]; ERC [227463]; German Federal Ministry of Education and Research [01LK0902A]; Swiss National Science Foundation [206621_125025, 206620_130527]; Academy of Finland Center of Excellence [1118615]; Austrian Science Fund (FWF) [P19546, L593]; Russian Academy of Sciences; Russian Foundation for Basic Research [N08-02-91006-CERN]; CERN; Austrian Science Fund (FWF) [P 19546, L 593] Funding Source: researchfish	EC(European CommissionEuropean Commission Joint Research Centre); ERC(European Research Council (ERC)European Commission); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Academy of Finland Center of Excellence(Academy of Finland); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Russian Academy of Sciences(Russian Academy of Sciences); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); CERN; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	We thank CERN for supporting CLOUD with important technical and financial resources, and for providing a particle beam from the CERN Proton Synchrotron. We also thank J.-L. Agostini, S. Atieh, J. Baechler, D. Bloess, G. Bowden, A. Braem, T. Callamand, A. Castel, L.-P. De Menezes, G. Favre, L. Ferreira, L. Gatignon, D. Gregorio, M. Guinchard, E. Ivanova, F. Josa, I. Krasin, R. Kristic, A. Kuzmin, O. Maksumov, S. Mizin, R. Richter, R. Sitals, A. Vacca, R. Veenhof, A. Wasem and M. Wilhelmsson for their contributions to the experiment. This research has received funding from the EC Seventh Framework Programme under grant agreement no. 215072 (Marie Curie Initial Training Network, 'CLOUD-ITN') and ERC-Advanced Grant 'ATMNUCLE' no. 227463, the German Federal Ministry of Education and Research (project no. 01LK0902A), the Swiss National Science Foundation (project nos 206621_125025 and 206620_130527), the Academy of Finland Center of Excellence program(project no. 1118615), the Austrian Science Fund (FWF; project nos P19546 and L593), and the Russian Academy of Sciences and Russian Foundation for Basic Research (grant N08-02-91006-CERN).	ARNOLD F, 1980, NATURE, V284, P610, DOI 10.1038/284610a0; Ball SM, 1999, J GEOPHYS RES-ATMOS, V104, P23709, DOI 10.1029/1999JD900411; Berndt T, 2010, ATMOS CHEM PHYS, V10, P7101, DOI 10.5194/acp-10-7101-2010; Boy M, 2005, ATMOS CHEM PHYS, V5, P863, DOI 10.5194/acp-5-863-2005; Brunelli NA, 2009, AEROSOL SCI TECH, V43, P53, DOI 10.1080/02786820802464302; COFFMAN DJ, 1995, J GEOPHYS RES-ATMOS, V100, P7147, DOI 10.1029/94JD03253; Duplissy J, 2010, ATMOS CHEM PHYS, V10, P1635, DOI 10.5194/acp-10-1635-2010; Eichkorn S, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015044; Feingold G, 2009, CLOUDS IN THE PERTURBED CLIMATE SYSTEM: THEIR RELATIONSHIP TO ENERGY BALANCE, ATMOSPHERIC DYNAMICS, AND PRECIPITATION, P319; Froyd KD, 2003, J PHYS CHEM A, V107, P9812, DOI 10.1021/jp0278059; Graus M, 2010, J AM SOC MASS SPECTR, V21, P1037, DOI 10.1016/j.jasms.2010.02.006; Iida K, 2009, AEROSOL SCI TECH, V43, P81, DOI 10.1080/02786820802488194; IPCC (Intergovernmental Panel on Climate Change), 2007, CLIM CHANG 2007 PHYS; Junninen H, 2010, ATMOS MEAS TECH, V3, P1039, DOI 10.5194/amt-3-1039-2010; Kazil J, 2007, ATMOS CHEM PHYS, V7, P3447, DOI 10.5194/acp-7-3447-2007; Kerminen VM, 2010, ATMOS CHEM PHYS, V10, P10829, DOI 10.5194/acp-10-10829-2010; Kerminen VM, 2002, J AEROSOL SCI, V33, P609, DOI 10.1016/S0021-8502(01)00194-X; Kirkby J, 2007, SURV GEOPHYS, V28, P333, DOI 10.1007/s10712-008-9030-6; Kuang C, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009253; Kulmala M, 2007, SCIENCE, V318, P89, DOI 10.1126/science.1144124; Kulmala M, 2008, ATMOS RES, V90, P132, DOI 10.1016/j.atmosres.2008.01.005; Kurten T, 2008, ATMOS CHEM PHYS, V8, P4095, DOI 10.5194/acp-8-4095-2008; Lee SH, 2003, SCIENCE, V301, P1886, DOI 10.1126/science.1087236; Lovejoy ER, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD004460; Merikanto J, 2009, ATMOS CHEM PHYS, V9, P8601, DOI 10.5194/acp-9-8601-2009; Metzger A, 2010, P NATL ACAD SCI USA, V107, P6646, DOI 10.1073/pnas.0911330107; Murphy SM, 2007, ATMOS CHEM PHYS, V7, P2313, DOI 10.5194/acp-7-2313-2007; Norman M, 2007, INT J MASS SPECTROM, V265, P382, DOI 10.1016/j.ijms.2007.06.010; Paasonen P, 2009, BOREAL ENVIRON RES, V14, P616; Pierce JR, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL037946; RAES F, 1986, J AEROSOL SCI, V17, P466, DOI 10.1016/0021-8502(86)90135-7; Rosenfeld D, 2008, SCIENCE, V321, P1309, DOI 10.1126/science.1160606; Sipila M, 2010, SCIENCE, V327, P1243, DOI 10.1126/science.1180315; Smith JN, 2010, P NATL ACAD SCI USA, V107, P6634, DOI 10.1073/pnas.0912127107; Sorokin A, 2007, ATMOS ENVIRON, V41, P3740, DOI 10.1016/j.atmosenv.2007.01.017; Spracklen DV, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL033038; Svensmark H, 1997, J ATMOS SOL-TERR PHY, V59, P1225, DOI 10.1016/S1364-6826(97)00001-1; Turco RP, 1998, GEOPHYS RES LETT, V25, P635, DOI 10.1029/98GL00253; Vanhanen J, 2011, AEROSOL SCI TECH, V45, P533, DOI 10.1080/02786826.2010.547889; Wang L, 2010, NAT GEOSCI, V3, P238, DOI 10.1038/NGEO778; Zhang RY, 2010, SCIENCE, V328, P1366, DOI 10.1126/science.1189732; Zhang RY, 2009, P NATL ACAD SCI USA, V106, P17650, DOI 10.1073/pnas.0910125106; Zhang RY, 2004, SCIENCE, V304, P1487, DOI 10.1126/science.1095139; ZIEREIS H, 1986, NATURE, V321, P503, DOI 10.1038/321503a0	44	843	864	17	679	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 25	2011	476	7361					429	U77		10.1038/nature10343	http://dx.doi.org/10.1038/nature10343			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811KT	21866156	Green Submitted			2022-12-28	WOS:000294209400031
J	Barr, HL; Britton, J; Smyth, AR; Fogarty, AW				Barr, Helen L.; Britton, John; Smyth, Alan R.; Fogarty, Andrew W.			Association between socioeconomic status, sex, and age at death from cystic fibrosis in England and Wales (1959 to 2008): cross sectional study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PSEUDOMONAS-AERUGINOSA; GENDER-DIFFERENCES; PULMONARY-FUNCTION; UNITED-KINGDOM; SURVIVAL; MORTALITY; CHILDREN; ADULTS; CARE; OUTCOMES	Objective To determine the trend in the association between socioeconomic status and sex and median age at death from cystic fibrosis in England and Wales, over the past 50 years. Design Series of annual cross sectional studies of all registered deaths with a diagnosis of cystic fibrosis in England and Wales, from 1959 to 2008. Methods We obtained national mortality data for cystic fibrosis from the Office for National Statistics. From 1959 to 2000, the Registrar General's Social Class coded socioeconomic status as manual or non-manual. From 2001 onwards, the National Statistics Socioeconomic Classification was implemented and socioeconomic status was split into three groups: professional and managerial, intermediate, and routine and manual. We calculated median age at death for every study year. We calculated the effects of sex and socioeconomic status on the odds of death above the median age at death for every study decade using logistic regression. Results From 1959 to 2008, 6750 deaths were attributed to cystic fibrosis in England and Wales. Males were more likely to die above the annual median age at death than females (from 1959 to 1999, adjusted odds ratio for socioeconomic status 1.28, 95% confidence intervals 1.13 to 1.45; from 2000 to 2008, 1.57, 1.18 to 2.08). Individuals in the highest socioeconomic class were also more likely to die above the median age of death than those in the lowest socioeconomic class (from 1959 to 2000, adjusted odds ratio for sex 2.50, 2.16 to 2.90; from 2001 to 2008, 1.89, 1.20 to 2.97). Conclusions Socioeconomic status and sex remain strong determinants of survival from cystic fibrosis in England and Wales, and the magnitude of these effects does not appear to have substantially reduced over time.	[Barr, Helen L.] Univ Nottingham, Div Resp Med, Nottingham Resp Biomed Res Unit, Nottingham NG5 1PB, England; [Britton, John; Fogarty, Andrew W.] Univ Nottingham, Div Epidemiol & Publ Hlth, Nottingham Resp Biomed Res Unit, Nottingham NG5 1PB, England; [Smyth, Alan R.] Univ Nottingham, Nottingham Univ Hosp NHS Trust, Nottingham Resp Biomed Res Unit, Div Child Hlth,Queens Med Ctr, Nottingham NG5 1PB, England	University of Nottingham; University of Nottingham; Nottingham University Hospital NHS Trust; University of Nottingham	Barr, HL (corresponding author), Univ Nottingham, Div Resp Med, Nottingham Resp Biomed Res Unit, City Hosp Campus, Nottingham NG5 1PB, England.	helen.barr@nottingham.ac.uk	Britton, John R/G-9705-2011	Smyth, Alan/0000-0001-5494-5438	Medical Research Council; University of Nottingham; National Institute for Health Research [CL-2011-12-501] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Nottingham; National Institute for Health Research(National Institute for Health Research (NIHR))	This research was funded by the Medical Research Council and the University of Nottingham.	Adler AI, 2008, DIABETES CARE, V31, P1789, DOI 10.2337/dc08-0466; Armstrong D, 2003, J CLIN MICROBIOL, V41, P2266, DOI 10.1128/JCM.41.5.2266-2267.2003; Arrington-Sanders R, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-5; Balmer DF, 2008, J CYST FIBROS, V7, P543, DOI 10.1016/j.jcf.2008.06.004; Bell SC, 2008, CYSTIC FIBROSIS STAN; Borowitz D, 2009, J PEDIATR-US, V155, pS73, DOI 10.1016/j.jpeds.2009.09.001; BRITTON JR, 1989, BRIT MED J, V298, P483, DOI 10.1136/bmj.298.6672.483; Cheng K, 1996, LANCET, V348, P639, DOI 10.1016/S0140-6736(96)05169-0; Coakley RD, 2008, J CLIN INVEST, V118, P4025, DOI 10.1172/JCI33893; Collins CE, 1999, ARCH DIS CHILD, V81, P241, DOI 10.1136/adc.81.3.241; Corey M, 1997, J PEDIATR-US, V131, P809, DOI 10.1016/S0022-3476(97)70025-8; COREY M, 1988, J CLIN EPIDEMIOL, V41, P583, DOI 10.1016/0895-4356(88)90063-7; Cystic Fibrosis Trust, 2008, UK CF REG ANN REP 20; DEMKO CA, 1995, J CLIN EPIDEMIOL, V48, P1041, DOI 10.1016/0895-4356(94)00230-N; Dodge JA, 2007, EUR RESPIR J, V29, P522, DOI 10.1183/09031936.00099506; Dodge J A, 1993, Paediatr Perinat Epidemiol, V7, P157, DOI 10.1111/j.1365-3016.1993.tb00390.x; DODGE JA, 1988, BRIT MED J, V297, P1599; Elborn JS, 2009, J CYST FIBROS, V8, P348, DOI 10.1016/j.jcf.2009.05.004; ELBORN JS, 1991, THORAX, V46, P881, DOI 10.1136/thx.46.12.881; Emerson J, 2002, PEDIATR PULM, V34, P91, DOI 10.1002/ppul.10127; Farrell PM, 2005, J PEDIATR-US, V147, pS30, DOI 10.1016/j.jpeds.2005.08.012; FITZSIMMONS SC, 1993, J PEDIATR-US, V122, P1, DOI 10.1016/S0022-3476(05)83478-X; Frederiksen B, 1996, PEDIATR PULM, V21, P153, DOI 10.1002/(SICI)1099-0496(199603)21:3<153::AID-PPUL1>3.0.CO;2-R; George PM, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1008; HENLEY LD, 1990, PEDIATRICS, V85, P1008; HENRY RL, 1992, PEDIATR PULM, V12, P158, DOI 10.1002/ppul.1950120306; HILL DJS, 1985, MED J AUSTRALIA, V143, P230, DOI 10.5694/j.1326-5377.1985.tb122953.x; HUANG NN, 1987, AM J MED, V82, P871, DOI 10.1016/0002-9343(87)90147-1; Jackson Anthony, 1996, Journal of the Royal College of Physicians of London, V30, P305; JOHANSEN HK, 1991, LANCET, V337, P631, DOI 10.1016/0140-6736(91)92449-C; Jones AM, 2001, LANCET, V358, P557, DOI 10.1016/S0140-6736(01)05714-2; KEREM E, 1992, NEW ENGL J MED, V326, P1187, DOI 10.1056/NEJM199204303261804; Lebecque P, 2009, J CYST FIBROS, V8, P26, DOI 10.1016/j.jcf.2008.07.005; Mahadeva R, 1998, BMJ-BRIT MED J, V316, P1771, DOI 10.1136/bmj.316.7147.1771; Merelle ME, 2001, EUR RESPIR J, V18, P306, DOI 10.1183/09031936.01.00080101; NOLAN T, 1986, PEDIATRICS, V77, P229; O'Connor GT, 2003, PEDIATRICS, V111, DOI 10.1542/peds.111.4.e333; OPCS, 1966, CLASS OCC; PENKETH ARL, 1987, THORAX, V42, P526, DOI 10.1136/thx.42.7.526; PHELAN P, 1984, ARCH DIS CHILD, V59, P71, DOI 10.1136/adc.59.1.71; Rose D, 2003, RES GUIDE NATL STAT; Rose David, 1998, ESRC REV GOVT SOCIAL; Rosenfeld M, 1997, AM J EPIDEMIOL, V145, P794; Royal College of Physicians, 1991, J R COLL PHYSICIANS, V25, P12; RUBIN BK, 1990, NEW ENGL J MED, V323, P782, DOI 10.1056/NEJM199009203231203; Saiman L, 2003, JAMA-J AM MED ASSOC, V290, P1749, DOI 10.1001/jama.290.13.1749; Schaedel C, 2002, PEDIATR PULM, V33, P483, DOI 10.1002/ppul.10100; Schechter MS, 2009, J PEDIATR-US, V155, P634, DOI 10.1016/j.jpeds.2009.04.059; Schechter MS, 1998, J PEDIATR-US, V132, P260, DOI 10.1016/S0022-3476(98)70442-1; Schechter MS, 2001, AM J RESP CRIT CARE, V163, P1331, DOI 10.1164/ajrccm.163.6.9912100; Schechter MS, 2009, J PEDIAT, V155, p[634, e1]; Selvadurai HC, 2004, ARCH DIS CHILD, V89, P928, DOI 10.1136/adc.2003.034249; VALERIUS NH, 1991, LANCET, V338, P725, DOI 10.1016/0140-6736(91)91446-2; van Koolwijk LME, 2002, ACTA PAEDIATR, V91, P972, DOI 10.1080/080352502760272687; WALTERS S, 1993, BRIT MED J, V306, P549, DOI 10.1136/bmj.306.6877.549; WALTERS S, 1994, THORAX, V49, P300, DOI 10.1136/thx.49.4.300; Walters S, 2002, J ROY SOC MED, V95, P32; World Health Organization, 1965, MAN INT STAT CLASS D; World Health Organization, 1994, INT STAT CLASS DIS R; World Health Organization, 1957, MAN INT STAT CLASS D; World Health Organization, 1977, MAN INT STAT CLASS D; Yankaskas JR, 2004, CHEST, V125, p1S, DOI 10.1378/chest.125.1_suppl.1S; Zeitlin PL, 2008, J CLIN INVEST, V118, P3841, DOI 10.1172/JCI37778	63	65	65	0	15	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 23	2011	343								d4662	10.1136/bmj.d4662	http://dx.doi.org/10.1136/bmj.d4662			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	813ZK	21862532	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000294409600001
J	Krum, H; Teerlink, JR				Krum, Henry; Teerlink, John R.			Heart Failure 2 Medical therapy for chronic heart failure	LANCET			English	Article							CARDIAC MYOSIN ACTIVATOR; VENTRICULAR EJECTION FRACTION; ANGIOTENSIN-RECEPTOR BLOCKER; CONVERTING ENZYME-INHIBITOR; DOUBLE-BLIND; VASOPRESSIN ANTAGONIST; OMECAMTIV MECARBIL; EXERCISE CAPACITY; SYSTOLIC FUNCTION; RANDOMIZED TRIAL	Understanding of contemporary pharmacological therapy for chronic heart failure continues to evolve. In this Review, we discuss how findings from clinical trials have caused the roles of old therapies to be expanded and past treatment algorithms to be challenged. Several trials investigating preserved ejection fraction as a measure of heart failure had disappointing results, although important studies are in progress. Many novel therapeutic approaches for heart failure have emerged and are discussed in this review. The pharmacological treatments for heart failure continue to change, with many exciting possibilities for the future.	[Teerlink, John R.] San Francisco VA Med Ctr, Cardiol Sect, San Francisco, CA 94121 USA; [Krum, Henry] Monash Univ, Monash Ctr Cardiovasc Res & Educ Therapeut, Melbourne, Vic 3004, Australia; [Teerlink, John R.] Univ Calif San Francisco, Sch Med, San Francisco, CA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; Monash University; University of California System; University of California San Francisco	Teerlink, JR (corresponding author), San Francisco VA Med Ctr, Cardiol Sect, San Francisco, CA 94121 USA.	john.teerlink@ucsf.edu	Teerlink, John R/D-2986-2012		Amgen; Vifor; Novartis; Servier; Bayer; Cytokinetics; Bristol-Myers Squibb; National Institutes of Health	Amgen(Amgen); Vifor; Novartis(Novartis); Servier(Servier); Bayer(Bayer AG); Cytokinetics; Bristol-Myers Squibb(Bristol-Myers Squibb); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	HK has received research grants from Amgen, Vifor, Novartis and Servier; and consulting fees from Novartis, Bayer and Amgen. JRT has received research grants from Amgen and Cytokinetics, Bristol-Myers Squibb, National Institutes of Health, and Novartis; and consulting fees from Amgen and Cytokinetics, and Novartis.	Anker SD, 2009, NEW ENGL J MED, V361, P2436, DOI 10.1056/NEJMoa0908355; Berry DA, 2006, NAT REV DRUG DISCOV, V5, P27, DOI 10.1038/nrd1927; Bohm M, 2010, LANCET, V376, P886, DOI 10.1016/S0140-6736(10)61259-7; Borlaug BA, 2011, EUR HEART J, V32, P670, DOI 10.1093/eurheartj/ehq426; Bristow MR, 1996, CIRCULATION, V94, P2807, DOI 10.1161/01.CIR.94.11.2807; Cleland JGF, 2006, EUR J HEART FAIL, V8, P105, DOI 10.1016/j.ejheart.2005.12.003; Cleland JGF, 2006, EUR HEART J, V27, P2338, DOI 10.1093/eurheartj/ehl250; Cleland JGF, 2011, LANCET, V378, P676, DOI 10.1016/S0140-6736(11)61126-4; Cohn JN, 2001, NEW ENGL J MED, V345, P1667, DOI 10.1056/NEJMoa010713; Davison BA, 2011, CLIN RES CARDIOL, V100, P745, DOI 10.1007/s00392-011-0304-5; DiFrancesco D, 2010, CIRC RES, V106, P434, DOI 10.1161/CIRCRESAHA.109.208041; Fukuta H, 2005, CIRCULATION, V112, P357, DOI 10.1161/CIRCULATIONAHA.104.519876; Gheorghiade M, 2004, JAMA-J AM MED ASSOC, V291, P1963, DOI 10.1001/jama.291.16.1963; Gheorghiade M, 2008, J AM COLL CARDIOL, V51, P2276, DOI 10.1016/j.jacc.2008.03.015; Gheorghiade M, 2007, JAMA-J AM MED ASSOC, V297, P1332, DOI 10.1001/jama.297.12.1332; Gheorghiade M, 2011, EUR J HEART FAIL, V13, P100, DOI 10.1093/eurjhf/hfq209; Greenberg BH, 2009, J CARD FAIL, V15, pS67, DOI 10.1016/j.cardfail.2009.06.206; Gu J, 2010, J CLIN PHARMACOL, V50, P401, DOI 10.1177/0091270009343932; Guazzi M, 2007, J AM COLL CARDIOL, V50, P2136, DOI 10.1016/j.jacc.2007.07.078; Guazzi M, 2011, CIRC-HEART FAIL, V4, P8, DOI 10.1161/CIRCHEARTFAILURE.110.944694; Hasenfuss G, 2011, EUR HEART J, V32, P1838, DOI 10.1093/eurheartj/ehr026; Hjalmarson A, 1999, LANCET, V353, P2001; Jankowska EA, 2010, EUR HEART J, V31, P1872, DOI 10.1093/eurheartj/ehq158; Kass DA, 2007, CIRC RES, V101, P1084, DOI 10.1161/CIRCRESAHA.107.162511; Kass DA, 2011, CIRC-HEART FAIL, V4, P2, DOI 10.1161/CIRCHEARTFAILURE.110.960062; Kjekshus J, 2007, NEW ENGL J MED, V357, P2248, DOI 10.1056/NEJMoa0706201; Konstam MA, 2007, JAMA-J AM MED ASSOC, V297, P1319, DOI 10.1001/jama.297.12.1319; Konstam MA, 2009, LANCET, V374, P1840, DOI 10.1016/S0140-6736(09)61913-9; Krum H, 2011, MED J AUSTRALIA, V194, P405, DOI 10.5694/j.1326-5377.2011.tb03031.x; Krum H, 2011, EUR J HEART FAIL, V13, P107, DOI 10.1093/eurjhf/hfq212; Krum H, 2009, LANCET, V373, P941, DOI 10.1016/S0140-6736(09)60236-1; Lakhdar R, 2008, J CARD FAIL, V14, P181, DOI 10.1016/j.cardfail.2007.11.008; Lechat P, 1999, LANCET, V353, P9; LECHAT P, 1994, CIRCULATION, V90, P1765, DOI 10.1161/01.CIR.90.4.1765; Lewis GD, 2007, CIRCULATION, V116, P1555, DOI 10.1161/CIRCULATIONAHA.107.716373; Lewis GD, 2007, CIRCULATION, V115, P59, DOI 10.1161/CIRCULATIONAHA.106.626226; Liggett SB, 2000, PHARMACOLOGY, V61, P167, DOI 10.1159/000028397; Liggett SB, 2006, P NATL ACAD SCI USA, V103, P11288, DOI 10.1073/pnas.0509937103; Lowes BD, 2005, J CARD FAIL, V11, P659, DOI 10.1016/j.cardfail.2005.10.013; Ma TKW, 2010, BRIT J PHARMACOL, V160, P1273, DOI 10.1111/j.1476-5381.2010.00750.x; MacMahon S, 1997, LANCET, V349, P375; Malik FI, 2011, SCIENCE, V331, P1439, DOI 10.1126/science.1200113; Marchioli R, 2009, CURR ATHEROSCLER REP, V11, P440, DOI 10.1007/s11883-009-0066-y; Massie BM, 2008, NEW ENGL J MED, V359, P2456, DOI 10.1056/NEJMoa0805450; McKelvie RS, 2011, CAN J CARDIOL, V27, P319, DOI 10.1016/j.cjca.2011.03.011; McMurray JJV, 2003, LANCET, V362, P767, DOI 10.1016/S0140-6736(03)14283-3; McMurray JJV, 2008, CIRC-HEART FAIL, V1, P17, DOI 10.1161/CIRCHEARTFAILURE.107.740704; Mebazaa A, 2007, JAMA-J AM MED ASSOC, V297, P1883, DOI 10.1001/jama.297.17.1883; Metra M, 2009, EUR HEART J, V30, P3015, DOI 10.1093/eurheartj/ehp338; Ruilope LM, 2010, LANCET, V375, P1255, DOI 10.1016/S0140-6736(09)61966-8; Nieminen MS, 2008, EUR J HEART FAIL, V10, P1246, DOI 10.1016/j.ejheart.2008.09.006; Packer M, 2002, CIRCULATION, V106, P2194, DOI 10.1161/01.CIR.0000035653.72855.BF; Packer M, 1999, CIRCULATION, V100, P2312, DOI 10.1161/01.CIR.100.23.2312; Packer M, 2002, CIRCULATION, V106, P920, DOI 10.1161/01.CIR.0000029801.86489.50; Packer M, 1996, NEW ENGL J MED, V334, P1349, DOI 10.1056/NEJM199605233342101; PACKER M, 1991, NEW ENGL J MED, V325, P1468, DOI 10.1056/NEJM199111213252103; Perry G, 1997, NEW ENGL J MED, V336, P525; Pitt B, 2003, NEW ENGL J MED, V348, P1309, DOI 10.1056/NEJMoa030207; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Pitt B, 2011, EUR HEART J, V32, P820, DOI 10.1093/eurheartj/ehq502; Poole-Wilson P, 1998, EUR HEART J, V19, P481; Poole-Wilson PA, 2003, LANCET, V362, P7, DOI 10.1016/S0140-6736(03)13800-7; RYDEN L, 1990, LANCET, V336, P1; Shah RV, 2010, J CARD FAIL, V16, P260, DOI 10.1016/j.cardfail.2009.11.007; Shen YT, 2010, CIRC-HEART FAIL, V3, P522, DOI 10.1161/CIRCHEARTFAILURE.109.930321; Solomon SD, 2011, EUR HEART J, V32, P1227, DOI 10.1093/eurheartj/ehq522; Swedberg K, 2010, LANCET, V376, P875, DOI 10.1016/S0140-6736(10)61198-1; Tavazzi L, 2008, LANCET, V372, P1231, DOI 10.1016/S0140-6736(08)61240-4; Tavazzi L, 2008, LANCET, V372, P1223, DOI 10.1016/S0140-6736(08)61239-8; Taylor AL, 2004, NEW ENGL J MED, V351, P2049, DOI 10.1056/NEJMoa042934; Teerlink JR, 2011, LANCET, V378, P667, DOI 10.1016/S0140-6736(11)61219-1; Teerlink JR, 2010, LANCET, V376, P847, DOI 10.1016/S0140-6736(10)61314-1; Teerlink JR, 2009, HEART FAIL REV, V14, P289, DOI 10.1007/s10741-009-9135-0; van Veldhuisen DJ, 2009, J AM COLL CARDIOL, V53, P2150, DOI 10.1016/j.jacc.2009.02.046; Willenheimer R, 2005, CIRCULATION, V112, P2426, DOI 10.1161/CIRCULATIONAHA.105.582320; Yusuf S, 2003, LANCET, V362, P777, DOI 10.1016/S0140-6736(03)14285-7; Zannad F, 2011, NEW ENGL J MED, V364, P11, DOI 10.1056/NEJMoa1009492; Zhou JM, 2010, EUR J HEART FAIL, V12, P181, DOI 10.1093/eurjhf/hfp193	78	56	64	1	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 20	2011	378	9792					713	721		10.1016/S0140-6736(11)61038-6	http://dx.doi.org/10.1016/S0140-6736(11)61038-6			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	815EW	21856485				2022-12-28	WOS:000294509900031
J	Gormley, WT				Gormley, William T., Jr.			From Science to Policy in Early Childhood Education	SCIENCE			English	Review							HOME-VISITING PROGRAMS; FOLLOW-UP; ABUSE	This paper examines the relationship between scientific research and public policy. After explaining why the simple conversion of research into public law is unlikely, several factors are identified that can promote the use of research by public officials. Examples of use and non-use are cited from early childhood education, where empirical evidence on program effects is relatively strong. Some specific suggestions are offered for improving the connection between science and public policy.	Georgetown Univ, Publ Policy Inst, Washington, DC 20057 USA	Georgetown University	Gormley, WT (corresponding author), Georgetown Univ, Publ Policy Inst, 305 Old N, Washington, DC 20057 USA.	gormleyw@georgetown.edu						ASCHER W, 2010, KNOWLEDGE ENV POLICY, P63; Baumgartner FrankR., 2009, LOBBYING POLICY CHAN; Bogenschneider K, 2011, EVIDENCE-BASED POLICYMAKING: INSIGHTS FROM POLICY-MINDED RESEARCHERS AND RESEARCH-MINDED POLICYMAKERS, P193; BUSHOUSE B, 2009, UNIVERSAL PRESCHOOL, P36; CAMPBELL D, 2007, PEWS POLLING PLACES, P111; Chong D, 2007, ANNU REV POLIT SCI, V10, P103, DOI 10.1146/annurev.polisci.10.072805.103054; Esterling KevinM., 2004, POLITICAL EC EXPERTI; GORMLEY W, ARGUING KIDS ISSUE F; Gormley WT, 2008, SCIENCE, V320, P1723, DOI 10.1126/science.1156019; GORMLEY WT, 1995, EVERYBODYS CHILDREN; Howard KS, 2009, FUTURE CHILD, V19, P119, DOI 10.1353/foc.0.0032; Karch A, 2010, POLICY STUD J, V38, P217, DOI 10.1111/j.1541-0072.2010.00359.x; KINGDON JW, 1995, AGENDAS ALTERNATIVES, P94; Manuel T, 2009, REFINING CORE STORY; Melhuish EC, 2008, SCIENCE, V321, P1161, DOI 10.1126/science.1158808; MOONEY CZ, 1992, AM POLIT QUART, V20, P345, DOI 10.1177/1532673X9202000305; MUCCIARIONI G, 2006, DELIBERATIVE CHOICES; NELKIN D, 1979, B ATOM SCI, V35, P20, DOI 10.1080/00963402.1979.11458618; Olds DL, 2007, PEDIATRICS, V120, pE832, DOI 10.1542/peds.2006-2111; Olds DL, 1997, JAMA-J AM MED ASSOC, V278, P637, DOI 10.1001/jama.278.8.637; Olds DL, 2004, PEDIATRICS, V114, P1560, DOI 10.1542/peds.2004-0961; ORSZAG P, 2009, BUIDLING RIGOROUS EV; Puma M., 2010, HEAD START IMPACT ST; RADEN A, 2001, UNIVERSAL PREKINDERG, P19; Reynolds AJ, 2011, SCIENCE, V333, P360, DOI 10.1126/science.1203618; Rigby E, 2007, POLICY STUD J, V35, P653, DOI 10.1111/j.1541-0072.2007.00241.x; Schweinhart L.J., 2005, LIFETIME EFFECTS HIG; Shonkoff J. P., 2000, NEURONS NEIGHBORHOOD; Sweet MA, 2004, CHILD DEV, V75, P1435, DOI 10.1111/j.1467-8624.2004.00750.x; Van Riper Tom, FORBES; Wagner MM, 1999, FUTURE CHILD, V9, P91, DOI 10.2307/1602723; WEAVER RK, 2000, ENDING WELFARE WE KN, P135; WEISS C, 1980, SOCIAL SCI RES DECIS, P83; WHITEMAN D, 1985, WESTERN POLIT QUART, V38, P294, DOI 10.2307/448631; Zigler E., 1992, HEAD START INSIDE ST	35	25	25	3	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 19	2011	333	6045					978	981		10.1126/science.1206150	http://dx.doi.org/10.1126/science.1206150			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	808TD	21852491				2022-12-28	WOS:000294000400045
J	Avidan, MS; Jacobsohn, E; Glick, D; Burnside, BA; Zhang, L; Villafranca, A; Karl, L; Kamal, S; Torres, B; O'Connor, M; Evers, AS; Gradwohl, S; Lin, N; Palanca, BJ; Mashour, GA				Avidan, Michael S.; Jacobsohn, Eric; Glick, David; Burnside, Beth A.; Zhang, Lini; Villafranca, Alex; Karl, Leah; Kamal, Saima; Torres, Brian; O'Connor, Michael; Evers, Alex S.; Gradwohl, Stephen; Lin, Nan; Palanca, Ben J.; Mashour, George A.		BAG-RECALL Res Grp	Prevention of Intraoperative Awareness in a High-Risk Surgical Population	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GENERAL-ANESTHESIA; BISPECTRAL INDEX; EXPLANATION; INFORMATION; ISOFLURANE; DESFLURANE; MORTALITY; RECALL; RATES; AGE	BACKGROUND Unintended intraoperative awareness, which occurs when general anesthesia is not achieved or maintained, affects up to 1% of patients at high risk for this complication. We tested the hypothesis that a protocol incorporating the electroencephalogram-derived bispectral index (BIS) is superior to a protocol incorporating standard monitoring of end-tidal anesthetic-agent concentration (ETAC) for the prevention of awareness. METHODS We conducted a prospective, randomized, evaluator-blinded trial at three medical centers. We randomly assigned 6041 patients at high risk for awareness to BIS-guided anesthesia (with an audible alert if the BIS value was <40 or >60, on a scale of 0 to 100, with 0 indicating the suppression of detectable brain electrical activity and 100 indicating the awake state) or ETAC-guided anesthesia (with an audible alert if the ETAC was <0.7 or >1.3 minimum alveolar concentration). In addition to audible alerts, the protocols included structured education and checklists. Superiority of the BIS protocol was assessed with the use of a one-sided Fisher's exact test. RESULTS A total of 7 of 2861 patients (0.24%) in the BIS group, as compared with 2 of 2852 (0.07%) in the ETAC group, who were interviewed postoperatively had definite intraoperative awareness (a difference of 0.17 percentage points; 95% confidence interval [CI], -0.03 to 0.38; P = 0.98). Thus, the superiority of the BIS protocol was not demonstrated. A total of 19 cases of definite or possible intraoperative awareness (0.66%) occurred in the BIS group, as compared with 8 (0.28%) in the ETAC group (a difference of 0.38 percentage points; 95% CI, 0.03 to 0.74; P = 0.99), with the superiority of the BIS protocol again not demonstrated. There was no difference between the groups with respect to the amount of anesthesia administered or the rate of major postoperative adverse outcomes. CONCLUSIONS The superiority of the BIS protocol was not established; contrary to expectations, fewer patients in the ETAC group than in the BIS group experienced awareness. (Funded by the Foundation for Anesthesia Education and Research and others; BAG-RECALL ClinicalTrials.gov number, NCT00682825.)	[Avidan, Michael S.; Burnside, Beth A.; Zhang, Lini; Kamal, Saima; Torres, Brian; Evers, Alex S.; Gradwohl, Stephen; Palanca, Ben J.] Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63110 USA; [Lin, Nan] Washington Univ, Dept Math, Sch Med, St Louis, MO 63130 USA; [Jacobsohn, Eric; Villafranca, Alex] Univ Manitoba, Dept Anesthesiol, Winnipeg, MB, Canada; [Glick, David; Karl, Leah; O'Connor, Michael] Univ Chicago, Dept Anesthesiol, Chicago, IL 60637 USA; [Mashour, George A.] Univ Michigan, Dept Anesthesiol, Sch Med, Ann Arbor, MI 48109 USA	Washington University (WUSTL); Washington University (WUSTL); University of Manitoba; University of Chicago; University of Michigan System; University of Michigan	Avidan, MS (corresponding author), Washington Univ, Sch Med, Dept Anesthesiol, Campus Box 8054,660 S Euclid Ave, St Louis, MO 63110 USA.	avidanm@anest.wustl.edu	Palanca, Ben Julian/AAW-4006-2021; Whitlock, Elizabeth L./N-1860-2014; Villafranca, Alexander/B-1509-2017	Palanca, Ben Julian/0000-0001-7535-5701; Whitlock, Elizabeth L./0000-0002-6868-4301; Villafranca, Alexander/0000-0002-8991-2043; Avidan, Michael/0000-0001-6248-044X; Pal, Nirvik/0000-0002-2147-3689; Evers, Alex/0000-0002-0342-0575; Searleman, Adam/0000-0003-1084-2415	Foundation for Anesthesia Education and Research [CFM-08/15/2007]; American Society of Anesthesiologists; Winnipeg Regional Health Authority; University of Manitoba Department of Anesthesia	Foundation for Anesthesia Education and Research; American Society of Anesthesiologists; Winnipeg Regional Health Authority; University of Manitoba Department of Anesthesia	Supported by a grant (CFM-08/15/2007, to Dr. Avidan) awarded by the Foundation for Anesthesia Education and Research and the American Society of Anesthesiologists and by a grant from the Winnipeg Regional Health Authority and University of Manitoba Department of Anesthesia (to Dr. Jacobsohn). Departmental support was also provided by the Department of Anesthesiology at Washington University in St. Louis and the Department of Anesthesiology at University of Chicago.	Alkire MT, 2008, SCIENCE, V322, P876, DOI 10.1126/science.1149213; [Anonymous], 2006, ANESTHESIOLOGY, V104, P847; Avidan MS, 2008, NEW ENGL J MED, V358, P1097, DOI 10.1056/NEJMoa0707361; Avidan Michael S, 2009, BMC Anesthesiol, V9, P8, DOI 10.1186/1471-2253-9-8; Bates DW, 2001, J AM MED INFORM ASSN, V8, P299, DOI 10.1136/jamia.2001.0080299; Block FE, 1999, J CLIN MONITOR COMP, V15, P75; Boutron I, 2008, ANN INTERN MED, V148, P295, DOI 10.7326/0003-4819-148-4-200802190-00008; BRICE DD, 1970, BRIT J ANAESTH, V42, P535, DOI 10.1093/bja/42.6.535; Brown EN, 2010, NEW ENGL J MED, V363, P2638, DOI 10.1056/NEJMra0808281; de Vries EN, 2010, NEW ENGL J MED, V363, P1928, DOI 10.1056/NEJMsa0911535; Eger EI, 2001, ANESTH ANALG, V93, P947, DOI 10.1097/00000539-200110000-00029; Emanuel EJ, 2007, JAMA-J AM MED ASSOC, V298, P1323, DOI 10.1001/jama.298.11.1323; Ghoneim MM, 2009, ANESTH ANALG, V108, P527, DOI 10.1213/ane.0b013e318193c634; GONSOWSKI CT, 1995, ANESTH ANALG, V80, P568, DOI 10.1097/00000539-199503000-00024; Haynes Alex B, 2009, N Engl J Med, V360, P491, DOI 10.1056/NEJMsa0810119; Kertai MD, 2011, ANESTHESIOLOGY, V114, P545, DOI 10.1097/ALN.0b013e31820c2b57; Kertai MD, 2010, ANESTHESIOLOGY, V112, P1116, DOI 10.1097/ALN.0b013e3181d5e0a3; Kirschner N, 2008, ANN INTERN MED, V148, P956, DOI 10.7326/0003-4819-148-12-200806170-00222; Landrigan CP, 2010, NEW ENGL J MED, V363, P2124, DOI 10.1056/NEJMsa1004404; Leslie K, 2010, ANESTH ANALG, V110, P823, DOI 10.1213/ANE.0b013e3181b8b6ca; Mashour George A, 2009, BMC Anesthesiol, V9, P7, DOI 10.1186/1471-2253-9-7; Mashour GA, 2010, ANESTH ANALG, V110, P813, DOI 10.1213/ANE.0b013e3181b6267d; Moher David, 2012, Int J Surg, V10, P28, DOI 10.1016/j.ijsu.2011.10.001; Myles PS, 2004, LANCET, V363, P1757, DOI 10.1016/S0140-6736(04)16300-9; Nickalls RWD, 2003, BRIT J ANAESTH, V91, P170, DOI 10.1093/bja/aeg132; NUSSMEIER NA, 1988, ANESTH ANALG, V67, P982; Orszag PR, 2010, NEW ENGL J MED, V363, P601, DOI 10.1056/NEJMp1006571; PHILLIPS AA, 1993, CAN J ANAESTH, V40, P922, DOI 10.1007/BF03010093; Pronovost P, 2006, NEW ENGL J MED, V355, P2725, DOI 10.1056/NEJMoa061115; Pronovost PJ, 2007, NEW ENGL J MED, V356, P1268; Punjasawadwong Y, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003843.pub2; Ranta S, 1996, ACTA ANAESTH SCAND, V40, P554, DOI 10.1111/j.1399-6576.1996.tb04487.x; Schulz KF, 2010, ANN INTERN MED, V152, P726, DOI 10.7326/0003-4819-152-11-201006010-00232; The Joint Commission, 2004, SENT EV AL PREV MAN; WALDER B, 1993, J CLIN MONITOR, V9, P364, DOI 10.1007/BF01618679; Weinstein MC, 2010, NEW ENGL J MED, V362, P460, DOI 10.1056/NEJMsb0911104	36	341	358	2	50	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 18	2011	365	7					591	600		10.1056/NEJMoa1100403	http://dx.doi.org/10.1056/NEJMoa1100403			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	808ER	21848460	Green Published, Bronze			2022-12-28	WOS:000293960500006
J	Wake, M; Tobin, S; Girolametto, L; Ukoumunne, OC; Gold, L; Levickis, P; Sheehan, J; Goldfeld, S; Reilly, S				Wake, Melissa; Tobin, Sherryn; Girolametto, Luigi; Ukoumunne, Obioha C.; Gold, Lisa; Levickis, Penny; Sheehan, Jane; Goldfeld, Sharon; Reilly, Sheena			Outcomes of population based language promotion for slow to talk toddlers at ages 2 and 3 years: Let's Learn Language cluster randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CHILD LANGUAGE; DISORDERS; DELAY; COMMUNICATION; INTERVENTION; IMPAIRMENT; SPEECH; SKILLS	Objective To determine the benefits of a low intensity parent-toddler language promotion programme delivered to toddlers identified as slow to talk on screening in universal services. Design Cluster randomised trial nested in a population based survey. Setting Three local government areas in Melbourne, Australia. Participants Parents attending 12 month well child checks over a six month period completed a baseline questionnaire. At 18 months, children at or below the 20th centile on an expressive vocabulary checklist entered the trial. Intervention Maternal and child health centres (clusters) were randomly allocated to intervention (modified "You Make the Difference" programme over six weekly sessions) or control ("usual care") arms. Main outcome measures The primary outcome was expressive language (Preschool Language Scale-4) at 2 and 3 years; secondary outcomes were receptive language at 2 and 3 years, vocabulary checklist raw score at 2 and 3 years, Expressive Vocabulary Test at 3 years, and Child Behavior Checklist/1.5-5 raw score at 2 and 3 years. Results 1217 parents completed the baseline survey; 1138 (93.5%) completed the 18 month checklist, when 301 (26.4%) children had vocabulary scores at or below the 20th centile and were randomised (158 intervention, 143 control). 115 (73%) intervention parents attended at least one session (mean 4.5 sessions), and most reported high satisfaction with the programme. Interim outcomes at age 2 years were similar in the two groups. Similarly, at age 3 years, adjusted mean differences (intervention-control) were -2.4 (95% confidence interval -6.2 to 1.4; P=0.21) for expressive language; -0.3 (-4.2 to 3.7; P=0.90) for receptive language; 4.1 (-2.3 to 10.6; P=0.21) for vocabulary checklist; -0.5 (-4.4 to 3.4; P=0.80) for Expressive Vocabulary Test; -0.1 (-1.6 to 1.4; P=0.86) for externalising behaviour problems; and -0.1 (-1.3 to 1.2; P=0. 92) for internalising behaviour problems. Conclusion This community based programme targeting slow to talk toddlers was feasible and acceptable, but little evidence was found that it improved language or behaviour either immediately or at age 3 years.	[Wake, Melissa] Royal Childrens Hosp, Ctr Community Child Hlth, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Wake, Melissa; Tobin, Sherryn; Levickis, Penny; Sheehan, Jane; Goldfeld, Sharon; Reilly, Sheena] Univ Melbourne, Parkville, Vic 3052, Australia; [Girolametto, Luigi] Univ Toronto, Dept Speech Language Pathol, Toronto, ON M5G 1V7, Canada; [Ukoumunne, Obioha C.] Univ Exeter, Peninsula Coll Med & Dent, PenCLAHRC, Exeter, Devon, England; [Gold, Lisa] Deakin Univ, Burwood, Vic 3125, Australia	Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne; University of Toronto; University of Exeter; University of Plymouth; Deakin University	Wake, M (corresponding author), Royal Childrens Hosp, Ctr Community Child Hlth, Murdoch Childrens Res Inst, Flemington Rd, Parkville, Vic 3052, Australia.	melissa.wake@rch.org.au	Levickis, Penny/M-3579-2019; Wake, Melissa/J-1396-2012; Reilly, Sheena/A-7035-2016; Reilly, Sheena/D-5120-2012; Levickis, Penny/K-8968-2019; Levickis, Penny/N-9394-2018	Levickis, Penny/0000-0003-0534-733X; Wake, Melissa/0000-0001-7501-9257; Reilly, Sheena/0000-0001-6506-4767; Reilly, Sheena/0000-0001-6506-4767; Levickis, Penny/0000-0003-0534-733X; Goldfeld, Sharon/0000-0001-6520-7094; Gold, Lisa/0000-0002-2733-900X; Sheehan, Jane/0000-0001-8799-5108	Australian National Health and Medical Research Council (NHMRC) [384491, 546405, 425855, 436914, 491210]; Victorian government	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Victorian government	The trial was funded by the Australian National Health and Medical Research Council (NHMRC) strategic award 384491. The following authors were supported by the NHMRC during the trial: MW (population health career development grant 546405); LGold (population health capacity building grant 425855), SG and OU (population health capacity building grant 436914), and SR (practitioner research fellowship 491210). Murdoch Childrens Research Institute's research is supported by the Victorian government's Operational Infrastructure Support Program. The researchers were independent of the funders.	Achenbach T. M., 2000, MANUAL ASEBA PRESCHO; *AUSTR BUR STAT, 2001, SOC IND AR; Beitchman J, 1999, TRANSITIONS ADULTHOO; Buschmann A, 2008, ARCH DIS CHILD, V94, P80; Campbell MJ, 2000, STAT METHODS MED RES, V9, P81, DOI 10.1191/096228000676246354; CAULFIELD MB, 1989, J ABNORM CHILD PSYCH, V17, P187, DOI 10.1007/BF00913793; Clegg J, 2005, J CHILD PSYCHOL PSYC, V46, P128, DOI 10.1111/j.1469-7610.2004.00342.x; Dale PS, 2000, J CHILD LANG, V27, P619, DOI 10.1017/S0305000900004281; Dale PS, 2003, J SPEECH LANG HEAR R, V46, P544, DOI 10.1044/1092-4388(2003/044); de Koning HJ, 2004, J MED SCREEN, V11, P109, DOI 10.1258/0969141041732229; Desmarais C, 2007, INT J LANG COMM DIS, V1, P30; Dollaghan C. A., 2007, HDB EVIDENCE BASED P; Dowd T, 2007, NEONAT PAEDIAT CHILD, V10, P13; Feldman HM, 2005, CHILD DEV, V76, P856, DOI 10.1111/j.1467-8624.2005.00882.x; Fenson L, 2000, APPL PSYCHOLINGUIST, V21, P95, DOI 10.1017/S0142716400001053; Fenson L, 2000, CHILD DEV, V71, P323, DOI 10.1111/1467-8624.00147; Girolametto L., 1996, J CHILDRENS COMMUNIC, V17, P39, DOI [10.1177/152574019501700205, DOI 10.1177/152574019501700205]; Glogowska M, 2000, BRIT MED J, V321, P923, DOI 10.1136/bmj.321.7266.923; Goldstein H, 1995, MULTILEVEL STAT MODE, V2nd; Huebner CE, 2005, J APPL DEV PSYCHOL, V26, P296, DOI 10.1016/j.appdev.2005.02.006; Landry SH, 2008, DEV PSYCHOL, V44, P1335, DOI 10.1037/a0013030; Law J, 2004, J SPEECH LANG HEAR R, V47, P924, DOI 10.1044/1092-4388(2004/069); Law J, 2003, Cochrane Database Syst Rev, pCD004110, DOI 10.1002/14651858.CD004110; Manolson HA, 1995, YOU MAKE DIFFERENCE; Miniscalco C, 2005, ACTA PAEDIATR, V94, P1798, DOI 10.1080/08035250500244242; Nelson HD, 2006, PEDIATRICS, V117, pE298, DOI 10.1542/peds.2005-1467; Perera R, 2007, BRIT MED J, V334, P127, DOI 10.1136/bmj.39045.396817.68; Reilly S, 2007, PEDIATRICS, V120, pE1441, DOI 10.1542/peds.2007-0045; Reilly S, 2006, J PAEDIATR CHILD H, V42, P764, DOI 10.1111/j.1440-1754.2006.00974.x; Rescorla L, 2009, J SPEECH LANG HEAR R, V52, P16, DOI 10.1044/1092-4388(2008/07-0171); Robertson SB, 1999, J SPEECH LANG HEAR R, V42, P1234, DOI 10.1044/jslhr.4205.1234; Robey RR, 1998, J SPEECH LANG HEAR R, V41, P1227, DOI 10.1044/jslhr.4106.1227; Roy P., 2005, SURE START LANGUAGE; Schafer JL., 1997, ANAL INCOMPLETE MULT, DOI 10.1201/9781439821862; Sheehan J, 2009, EARLY CHILDHOOD SERV, V3, P33; Tomblin JB, 1997, J SPEECH LANG HEAR R, V40, P1245, DOI 10.1044/jslhr.4006.1245; Tomblin JB, 2000, J CHILD PSYCHOL PSYC, V41, P473, DOI 10.1111/1469-7610.00632; van Agt HME, 2007, PEDIATRICS, V120, P1317, DOI 10.1542/peds.2006-3145; Warren SF, 2007, MENT RETARD DEV D R, V13, P70, DOI 10.1002/mrdd.20139; Wetherby AM, 2001, CSBS DEV PROFILE INF; Zimmerman I.L., 2002, PRESCHOOL LANGUAGE S	41	65	66	1	32	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 18	2011	343								d4741	10.1136/bmj.d4741	http://dx.doi.org/10.1136/bmj.d4741			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	811LE	21852344	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000294210800001
J	Delmore, JE; Issa, GC; Lemieux, ME; Rahl, PB; Shi, JW; Jacobs, HM; Kastritis, E; Gilpatrick, T; Paranal, RM; Qi, J; Chesi, M; Schinzel, AC; McKeown, MR; Heffernan, TP; Vakoc, CR; Bergsagel, PL; Ghobrial, IM; Richardson, PG; Young, RA; Hahn, WC; Anderson, KC; Kung, AL; Bradner, JE; Mitsiades, CS				Delmore, Jake E.; Issa, Ghayas C.; Lemieux, Madeleine E.; Rahl, Peter B.; Shi, Junwei; Jacobs, Hannah M.; Kastritis, Efstathios; Gilpatrick, Timothy; Paranal, Ronald M.; Qi, Jun; Chesi, Marta; Schinzel, Anna C.; McKeown, Michael R.; Heffernan, Timothy P.; Vakoc, Christopher R.; Bergsagel, P. Leif; Ghobrial, Irene M.; Richardson, Paul G.; Young, Richard A.; Hahn, William C.; Anderson, Kenneth C.; Kung, Andrew L.; Bradner, James E.; Mitsiades, Constantine S.			BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc	CELL			English	Article							B-CELL LINE; MULTIPLE-MYELOMA; BCL-2 FAMILY; TRANSCRIPTION FACTORS; TRANSGENIC MICE; SOLID TUMORS; BONE-MARROW; EXPRESSION; CANCER; ACTIVATION	MYC contributes to the pathogenesis of a majority of human cancers, yet strategies to modulate the function of the c-Myc oncoprotein do not exist. Toward this objective, we have targeted MYC transcription by interfering with chromatin-dependent signal transduction to RNA polymerase, specifically by inhibiting the acetyl-lysine recognition domains (bromodomains) of putative coactivator proteins implicated in transcriptional initiation and elongation. Using a selective small-molecule bromodomain inhibitor, JQ1, we identify BET bromodomain proteins as regulatory factors for c-Myc. BET inhibition by JQ1 downregulates MYC transcription, followed by genome-wide downregulation of Myc-dependent target genes. In experimental models of multiple myeloma, a Myc-dependent hematologic malignancy, JQ1 produces a potent antiproliferative effect associated with cell-cycle arrest and cellular senescence. Efficacy of JQ1 in three murine models of multiple myeloma establishes the therapeutic rationale for BET bromodomain inhibition in this disease and other malignancies characterized by pathologic activation of c-Myc.	[Delmore, Jake E.; Issa, Ghayas C.; Jacobs, Hannah M.; Kastritis, Efstathios; Gilpatrick, Timothy; Paranal, Ronald M.; Qi, Jun; Schinzel, Anna C.; McKeown, Michael R.; Heffernan, Timothy P.; Ghobrial, Irene M.; Richardson, Paul G.; Hahn, William C.; Anderson, Kenneth C.; Bradner, James E.; Mitsiades, Constantine S.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Lemieux, Madeleine E.; Kung, Andrew L.] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02215 USA; [Lemieux, Madeleine E.; Kung, Andrew L.] Childrens Hosp Boston, Boston, MA 02215 USA; [Rahl, Peter B.; Young, Richard A.] Whitehead Inst Biomed Res, Cambridge Ctr 9, Cambridge, MA 02142 USA; [Shi, Junwei; Vakoc, Christopher R.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Chesi, Marta; Bergsagel, P. Leif] Mayo Clin Arizona, Ctr Comprehens Canc, Scottsdale, AZ 85259 USA; [Ghobrial, Irene M.; Richardson, Paul G.; Anderson, Kenneth C.; Bradner, James E.; Mitsiades, Constantine S.] Harvard Univ, Dept Med, Sch Med, Boston, MA 02115 USA; [Young, Richard A.] MIT, Dept Biol, Cambridge, MA 02142 USA; [Hahn, William C.] Broad Inst Harvard & MIT, Cambridge Ctr 7, Cambridge, MA 02142 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Boston Children's Hospital; Massachusetts Institute of Technology (MIT); Whitehead Institute; Cold Spring Harbor Laboratory; Mayo Clinic; Mayo Clinic Phoenix; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Bradner, JE (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, 450 Brookline Ave, Boston, MA 02215 USA.	james_bradner@dfci.harvard.edu; constantine_mitsiades@dfci.harvard.edu	Kastritis, Efstathios/AAD-3656-2019; Kastritis, Efstathios/AAE-4483-2020; Dimopoulos, Meletios Athanasios/AAD-4130-2019; Kung, Andrew L/AEU-0826-2022; Bergsagel, Peter Leif/A-7842-2011; Kung, Andrew/AAL-2384-2020; Young, Richard A/F-6495-2012	Kastritis, Efstathios/0000-0001-8191-5832; Kung, Andrew L/0000-0002-9091-488X; Bergsagel, Peter Leif/0000-0003-1523-7388; Young, Richard A/0000-0001-8855-8647; Vakoc, Christopher/0000-0002-1158-7180; Lemieux, Madeleine/0000-0001-6355-8691	Chambers Medical Foundation; Stepanian Fund for Myeloma Research; Richard J. Corman Foundation; American Cancer Society [120272-PF-11-042-01-DMC]; Burroughs-Wellcome Fund; Smith Family Award; Damon-Runyon Cancer Research Foundation; MMRF;  [NIH-K08CA128972];  [NIH-R01CA050947];  [NIH-R01HG002668];  [NIH-R01CA46455]; NATIONAL CANCER INSTITUTE [R01CA133966, R01CA050947, K08CA128972, R01CA136671] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002668] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG020686] Funding Source: NIH RePORTER	Chambers Medical Foundation; Stepanian Fund for Myeloma Research; Richard J. Corman Foundation; American Cancer Society(American Cancer Society); Burroughs-Wellcome Fund(Burroughs Wellcome Fund); Smith Family Award; Damon-Runyon Cancer Research Foundation; MMRF; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We are grateful to S. Lowe for sharing unpublished information; A. Azab, D. McMillin, C. Ott, and A. Roccaro for technical support; E. Fox for microarray data; J. Daley and S. Lazo-Kallanian for flow cytometry; the MMRF, MMRC, and Broad Institute for establishing the MM Genomics Portal (http://www.broadinstitute.org/mmgp/). This research was supported by NIH-K08CA128972 (J.E.B.), NIH-R01CA050947 (C.S.M.), NIH-R01HG002668 (R.A.Y.), and NIH-R01CA46455 (R.A.Y.); the Chambers Medical Foundation (P.G.R., C.S.M.); the Stepanian Fund for Myeloma Research (P.G.R., C.S.M.); and the Richard J. Corman Foundation (P.G.R., C.S.M.); an American Cancer Society Postdoctoral Fellowship, 120272-PF-11-042-01-DMC (P.B.R.); the Burroughs-Wellcome Fund, the Smith Family Award, the Damon-Runyon Cancer Research Foundation, and the MMRF (to J.E.B.).	AMATI B, 1993, CELL, V72, P233, DOI 10.1016/0092-8674(93)90663-B; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bidwell GL, 2009, J CONTROL RELEASE, V135, P2, DOI 10.1016/j.jconrel.2008.11.015; Bisgrovet DA, 2007, P NATL ACAD SCI USA, V104, P13690, DOI 10.1073/pnas.0705053104; BLACKWOOD EM, 1991, SCIENCE, V251, P1211, DOI 10.1126/science.2006410; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Chesi M, 2008, CANCER CELL, V13, P167, DOI 10.1016/j.ccr.2008.01.007; Chng WJ, 2011, LEUKEMIA, V25, P1026, DOI 10.1038/leu.2011.53; Claudio JO, 2002, BLOOD, V100, P2175, DOI 10.1182/blood-2002-01-0008; Dang CV, 2009, CELL CYCLE, V8, P3243, DOI 10.4161/cc.8.20.9522; Dang CV, 2009, CLIN CANCER RES, V15, P6479, DOI 10.1158/1078-0432.CCR-09-0889; Darnell JE, 2002, NAT REV CANCER, V2, P740, DOI 10.1038/nrc906; DEAN M, 1983, NATURE, V305, P443, DOI 10.1038/305443a0; Dey A, 2009, MOL BIOL CELL, V20, P4899, DOI 10.1091/mbc.E09-05-0380; Dhalluin C, 1999, NATURE, V399, P491, DOI 10.1038/20974; Dib Amel, 2008, J Natl Cancer Inst Monogr, P25, DOI 10.1093/jncimonographs/lgn011; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Frank SR, 2003, EMBO REP, V4, P575, DOI 10.1038/sj.embor.embor861; Frye SV, 2010, NAT CHEM BIOL, V6, P159, DOI 10.1038/nchembio.296; Fukazawa T, 2010, ANTICANCER RES, V30, P4193; GOMI M, 1990, CANCER RES, V50, P1873; Hammoudeh DI, 2009, J AM CHEM SOC, V131, P7390, DOI 10.1021/ja900616b; Harada N, 1998, LEUKEMIA, V12, P1817, DOI 10.1038/sj.leu.2401168; HARRIS AW, 1988, J EXP MED, V167, P353, DOI 10.1084/jem.167.2.353; HAYNES SR, 1992, NUCLEIC ACIDS RES, V20, P2603, DOI 10.1093/nar/20.10.2603; Hideshima T, 2007, NAT REV CANCER, V7, P585, DOI 10.1038/nrc2189; Hurt EM, 2004, CANCER CELL, V5, P191, DOI 10.1016/S1535-6108(04)00019-4; Jain M, 2002, SCIENCE, V297, P102, DOI 10.1126/science.1071489; Jeong KC, 2010, MOL BIOSYST, V6, P1503, DOI 10.1039/c002534h; Keats JJ, 2007, CANCER CELL, V12, P131, DOI 10.1016/j.ccr.2007.07.003; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kim YH, 2006, ONCOGENE, V25, P130, DOI 10.1038/sj.onc.1208997; LEDER A, 1986, CELL, V45, P485, DOI 10.1016/0092-8674(86)90280-1; Legartova S, 2009, NEOPLASMA, V56, P404, DOI 10.4149/neo_2009_05_404; Malo N, 2006, NAT BIOTECHNOL, V24, P167, DOI 10.1038/nbt1186; Matsumura I, 2003, CELL CYCLE, V2, P333, DOI 10.4161/cc.2.4.428; Mattioli M, 2005, ONCOGENE, V24, P2461, DOI 10.1038/sj.onc.1208447; McMillin DW, 2010, NAT MED, V16, P483, DOI 10.1038/nm.2112; Mitsiades CS, 2004, CANCER CELL, V5, P221, DOI 10.1016/S1535-6108(04)00050-9; Mitsiades N, 2002, P NATL ACAD SCI USA, V99, P14374, DOI 10.1073/pnas.202445099; Nair SK, 2003, CELL, V112, P193, DOI 10.1016/S0092-8674(02)01284-9; Nicodeme E, 2010, NATURE, V468, P1119, DOI 10.1038/nature09589; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; PALUMBO AP, 1989, CANCER RES, V49, P4701; Pomerantz MM, 2009, NAT GENET, V41, P882, DOI 10.1038/ng.403; Pomerantz MM, 2009, CANCER RES, V69, P5568, DOI 10.1158/0008-5472.CAN-09-0387; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Rahman S, 2011, MOL CELL BIOL, V31, P2641, DOI 10.1128/MCB.01341-10; Schlosser I, 2005, ONCOGENE, V24, P520, DOI 10.1038/sj.onc.1208198; Schreiber SL, 2002, CELL, V111, P771, DOI 10.1016/S0092-8674(02)01196-0; Schuhmacher M, 2001, NUCLEIC ACIDS RES, V29, P397, DOI 10.1093/nar/29.2.397; Shaffer AL, 2008, NATURE, V454, P226, DOI 10.1038/nature07064; Shou YP, 2000, P NATL ACAD SCI USA, V97, P228, DOI 10.1073/pnas.97.1.228; Soucek L, 2002, CANCER RES, V62, P3507; Soucek L, 1998, ONCOGENE, V17, P2463, DOI 10.1038/sj.onc.1202199; STEWART TA, 1984, CELL, V38, P627, DOI 10.1016/0092-8674(84)90257-5; Trimarchi JM, 2002, NAT REV MOL CELL BIO, V3, P11, DOI 10.1038/nrm714; Trudel S, 2007, CLIN CANCER RES, V13, P621, DOI 10.1158/1078-0432.CCR-06-1526; Vervoorts J, 2003, EMBO REP, V4, P484, DOI 10.1038/sj.embor.embor821; Wu CH, 2007, P NATL ACAD SCI USA, V104, P13028, DOI 10.1073/pnas.0701953104; Zeller KI, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r69; Zhan FH, 2007, BLOOD, V109, P1692, DOI 10.1182/blood-2006-07-037077; Zuber J, 2011, NATURE, V478, P524, DOI 10.1038/nature10334	63	2000	2153	9	270	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 16	2011	146	6					903	916		10.1016/j.cell.2011.08.017	http://dx.doi.org/10.1016/j.cell.2011.08.017			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	825GB	21889194	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000295258100013
J	Hidalgo, C; Donoso, P				Hidalgo, Cecilia; Donoso, Paulina			Getting to the Heart of Mechanotransduction	SCIENCE			English	Editorial Material							RYANODINE RECEPTOR; NADPH OXIDASE; AXIAL STRETCH; CARDIOMYOCYTES; DEPENDENCE; CHANNELS; INCREASE; CALCIUM; DISEASE		[Hidalgo, Cecilia] Univ Chile, Physiol & Biophys Program, Inst Biomed Sci, Brain Neurosci Inst, Santiago, Chile; Univ Chile, Ctr Mol Studies Cell, Fac Med, Santiago, Chile	Universidad de Chile; Universidad de Chile	Hidalgo, C (corresponding author), Univ Chile, Physiol & Biophys Program, Inst Biomed Sci, Brain Neurosci Inst, Santiago, Chile.	chidalgo@med.uchile.cl						Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Caldiz CI, 2007, J PHYSIOL-LONDON, V584, P895, DOI 10.1113/jphysiol.2007.141689; Cingolani HE, 2011, PFLUG ARCH EUR J PHY, V462, P29, DOI 10.1007/s00424-011-0930-9; Gyorke S, 2008, CARDIOVASC RES, V77, P245, DOI 10.1093/cvr/cvm038; Iribe G, 2008, PROG BIOPHYS MOL BIO, V97, P298, DOI 10.1016/j.pbiomolbio.2008.02.012; Iribe G, 2009, CIRC RES, V104, P787, DOI 10.1161/CIRCRESAHA.108.193334; Knoll R, 2003, J MOL MED, V81, P750, DOI 10.1007/s00109-003-0488-x; Marengo JJ, 1998, BIOPHYS J, V74, P1263, DOI 10.1016/S0006-3495(98)77840-3; Meissner G, 2010, CURR TOP MEMBR, V66, P91, DOI 10.1016/S1063-5823(10)66005-X; Petroff MGV, 2001, NAT CELL BIOL, V3, P867, DOI 10.1038/ncb1001-867; Prosser BL, 2011, SCIENCE, V333, P1440, DOI 10.1126/science.1202768; Prosser BL, 2010, J GEN PHYSIOL, V136, P135, DOI 10.1085/jgp.201010406; Sanchez G, 2005, J MOL CELL CARDIOL, V39, P982, DOI 10.1016/j.yjmcc.2005.08.010; Sanchez G, 2008, CARDIOVASC RES, V77, P380, DOI 10.1093/cvr/cvm011; Ullrich ND, 2009, AM J PHYSIOL-HEART C, V297, pH1992, DOI 10.1152/ajpheart.00602.2009; Williams IA, 2007, AM J PHYSIOL-HEART C, V293, pH1969, DOI 10.1152/ajpheart.00489.2007	16	8	8	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 9	2011	333	6048					1388	1390		10.1126/science.1212183	http://dx.doi.org/10.1126/science.1212183			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817KU	21903799				2022-12-28	WOS:000294672200026
J	Burnham, G				Burnham, Gilbert			Suicide attacks-the rationale and consequences	LANCET			English	Editorial Material									Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Refugee & Disaster Response, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Burnham, G (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Refugee & Disaster Response, Baltimore, MD 21205 USA.	gburnham@jhsph.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD042854] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Atran S, 2003, SCIENCE, V299, P1534, DOI 10.1126/science.1078854; Berko Anat, 2005, Violence Vict, V20, P603, DOI 10.1891/vivi.20.6.603; Bhattacharya J, 2011, INT C IM INF PROC, P1; El Sarraj E, 2002, J PALESTINE STUD, V31, P71; Fair C., 2007, SUICIDE ATTACKS AFGH; Ginges J, 2009, PSYCHOL SCI, V20, P224, DOI 10.1111/j.1467-9280.2009.02270.x; Hafez MM, 2007, SUICIDE BOMBERS IN IRAQ: THE STRATEGY AND IDEOOLOGY OF MARTYRDOM, P1; Hicks MHR, 2011, LANCET, V378, P906, DOI 10.1016/S0140-6736(11)61023-4; McBride M, 2009, STOPPING SUICIDE BOM; Nelson Soraya Sarhaddi, 2007, NATL PUBLIC RAD 1015; Post JM, 2009, PSYCHIATRY, V72, P13, DOI 10.1521/psyc.2009.72.1.13; Rosen Nir, 2006, BELLY GREEN BIRD TRI; Strous RD, 2007, J NERV MENT DIS, V195, P233, DOI 10.1097/01.nmd.0000243822.23374.aa	13	3	3	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 3	2011	378	9794					855	857		10.1016/S0140-6736(11)61258-0	http://dx.doi.org/10.1016/S0140-6736(11)61258-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	818XZ	21890033				2022-12-28	WOS:000294791300007
J	Johnson, CL; Spence, AM				Johnson, Cheryl L.; Spence, Andrew M.			Epigenetic Licensing of Germline Gene Expression by Maternal RNA in C. elegans	SCIENCE			English	Article							CAENORHABDITIS-ELEGANS; INTERFERENCE; MICRORNAS; CHROMATIN; SIRNAS	RNA can act as a regulator of gene expression with roles in transposon silencing, antiviral defense, and cell fate determination. Here, we show that in Caenorhabditis elegans a maternal transcript of the sex-determining gene fem-1 is required to license expression of a wild-type fem-1 allele in the zygotic germ line. Females homozygous for fem-1 deletions produce heterozygous offspring exhibiting germline feminization, reduced fem-1 activity, and transcript accumulation. Injection of fem-1 RNA incapable of encoding a protein into the maternal germ line rescues this defect in the progeny. The defect in zygotic fem-1 expression is heritable, suggesting that the gene is subject to epigenetic silencing that is prevented by maternal fem-1 transcripts. This mechanism may contribute to protecting the identity and integrity of the germ line.	[Johnson, Cheryl L.; Spence, Andrew M.] Univ Toronto, Dept Mol Genet, Collaborat Program Dev Biol, Toronto, ON M5S 1A8, Canada	University of Toronto	Spence, AM (corresponding author), Univ Toronto, Dept Mol Genet, Collaborat Program Dev Biol, 1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada.	andrew.spence@utoronto.ca			National Institutes of Health National Center for Research Resources; Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research	National Institutes of Health National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	We thank J. Culotti for providing idDf3; J. Hodgkin, P. Roy, T. Schedl, A. Cutter, and V. Reinke for helpful discussions and suggestions; and P. Roy, B. Lavoie, and H. Lipshitz for comments on the manuscript. Some nematode strains used in this study were provided by the Caenorhabditis Genetics Center (CGC), which is supported by the National Institutes of Health National Center for Research Resources. C. L. J. acknowledges a Postgraduate Scholarship from the Natural Sciences and Engineering Research Council of Canada. This research was supported by grants from the Canadian Institutes of Health Research to A.M.S.	Ambros V, 2003, CURR BIOL, V13, P807, DOI 10.1016/S0960-9822(03)00287-2; Ciosk R, 2006, SCIENCE, V311, P851, DOI 10.1126/science.1122491; Claycomb JM, 2009, CELL, V139, P123, DOI 10.1016/j.cell.2009.09.014; Dernburg AF, 2000, GENE DEV, V14, P1578; DONIACH T, 1984, DEV BIOL, V106, P223, DOI 10.1016/0012-1606(84)90077-0; ELLIS RE, 1995, GENETICS, V139, P561; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Gent JI, 2009, GENETICS, V183, P1297, DOI 10.1534/genetics.109.109686; Gu WF, 2009, MOL CELL, V36, P231, DOI 10.1016/j.molcel.2009.09.020; HAACK H, 1991, MOL GEN GENET, V228, P482, DOI 10.1007/BF00260643; Han T, 2009, P NATL ACAD SCI USA, V106, P18674, DOI 10.1073/pnas.0906378106; HODGKIN J, 1986, GENETICS, V114, P15; Kelly WG, 1998, DEVELOPMENT, V125, P2451; KIMBLE J, 1984, DEV BIOL, V105, P234, DOI 10.1016/0012-1606(84)90279-3; Maine EM, 2005, CURR BIOL, V15, P1972, DOI 10.1016/j.cub.2005.09.049; Robert VJP, 2005, GENE DEV, V19, P782, DOI 10.1101/gad.332305; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; Seydoux G, 1996, NATURE, V382, P713, DOI 10.1038/382713a0; She XY, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000624; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Zarkower D, 2006, WORMBOOK, V1, P1, DOI DOI 10.1895/WORMBOOK.1.84.1	21	30	31	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 2	2011	333	6047					1311	1314		10.1126/science.1208178	http://dx.doi.org/10.1126/science.1208178			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	813YM	21885785				2022-12-28	WOS:000294406400060
J	Latham, JA; Chosed, RJ; Wang, SZ; Dent, SYR				Latham, John A.; Chosed, Renee J.; Wang, Shanzhi; Dent, Sharon Y. R.			Chromatin Signaling to Kinetochores: Transregulation of Dam1 Methylation by Histone H2B Ubiquitination	CELL			English	Article							RNA-POLYMERASE-II; REGULATES H3 METHYLATION; SACCHAROMYCES-CEREVISIAE; CELL-CYCLE; CHROMOSOME SEGREGATION; PAF1 COMPLEX; TRANSCRIPTIONAL ELONGATION; LYSINE-4 METHYLATION; PROTEIN INTERACTIONS; GENE-EXPRESSION	Histone H3K4 trimethylation by the Set1/MLL family of proteins provides a hallmark for transcriptional activity from yeast to humans. In S. cerevisiae, H3K4 methylation is mediated by the Set1-containing COMPASS complex and is regulated in trans by prior ubiquitination of histone H2BK123. All of the events that regulate H2BK123ub and H3K4me are thought to occur at gene promoters. Here we report that this pathway is indispensable for methylation of the only other known substrate of Set1, K233 in Dam1, at kinetochores. Deletion of RAD6, BRE1, or Paf1 complex members abolishes Dam1 methylation, as does mutation of H2BK123. Our results demonstrate that Set1-mediated methylation is regulated by a general pathway regardless of substrate that is composed of transcriptional regulatory factors functioning independently of transcription. Moreover, our data identify a node of regulatory crosstalk in trans between a histone modification and modification on a nonhistone protein, demonstrating that changing chromatin states can signal functional changes in other essential cellular proteins and machineries.	[Latham, John A.; Wang, Shanzhi; Dent, Sharon Y. R.] Univ Texas MD Anderson Canc Ctr, Program Genes & Dev, Smithville, TX 78957 USA; [Latham, John A.; Chosed, Renee J.; Dent, Sharon Y. R.] Univ Texas MD Anderson Canc Ctr, Ctr Canc Epigenet, Smithville, TX 78957 USA; [Latham, John A.; Chosed, Renee J.; Dent, Sharon Y. R.] Univ Texas MD Anderson Canc Ctr, Dept Mol Carcinogenesis, Smithville, TX 78957 USA; [Wang, Shanzhi] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Dent, SYR (corresponding author), Univ Texas MD Anderson Canc Ctr, Program Genes & Dev, Smithville, TX 78957 USA.	sroth@mdanderson.org	Dent, Sharon YR/F-1746-2011	Dent, Sharon YR/0000-0002-4824-3269; Chosed, Renee/0000-0002-0442-0833	American Legion Auxiliary; Odyssey Program; Theodore N. Law Endowment for Scientific Achievement at the University of Texas M.D. Anderson Cancer Center; NIH [GM51189]; Robert A. Welch Foundation [G1371]; Cancer Center Support [NCI CA16672]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051189] Funding Source: NIH RePORTER	American Legion Auxiliary; Odyssey Program; Theodore N. Law Endowment for Scientific Achievement at the University of Texas M.D. Anderson Cancer Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); Cancer Center Support; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	J.A.L. was supported in part by a fellowship by the American Legion Auxiliary. Funding for R.J.C. as an Odyssey Fellow was supported by the Odyssey Program and the Theodore N. Law Endowment for Scientific Achievement at the University of Texas M.D. Anderson Cancer Center. Aspects of this work were supported by NIH grant GM51189 and a grant from the Robert A. Welch Foundation (G1371) to S.Y.R.D. DNA sequencing for this project was done in the UTMDACC DNA Analysis Facility, supported by Cancer Center Support Grant NCI CA16672. We thank the members of the Dent lab, especially Andria Schibler, Rebecca Lewis, Jill Butler, and Marenda Wilson-Pham for their suggestions as well as Fred Winston, Mitch Smith, and Kevin Morano for insightful comments. We are also grateful to Drs. Ambro van Hoof, Mary Ann Osley, Sue Biggins, Brian Strahl, and Peter Nagy for generously providing yeast strains, plasmids, and antibodies.	Adelman K, 2006, MOL CELL BIOL, V26, P250, DOI 10.1128/MCB.26.1.250-260.2006; Allis CD, 2007, CELL, V131, P633, DOI 10.1016/j.cell.2007.10.039; Andrews PD, 2004, DEV CELL, V6, P253, DOI 10.1016/S1534-5807(04)00025-5; Basrai MA, 1996, MOL CELL BIOL, V16, P2838; Berdasco M, 2010, DEV CELL, V19, P698, DOI 10.1016/j.devcel.2010.10.005; Betz JL, 2002, MOL GENET GENOMICS, V268, P272, DOI 10.1007/s00438-002-0752-8; Bouck DC, 2005, P NATL ACAD SCI USA, V102, P5408, DOI 10.1073/pnas.0405925102; CHAN CSM, 1993, GENETICS, V135, P677; Chaudhary K, 2007, ONCOGENE, V26, P7499, DOI 10.1038/sj.onc.1210582; Cheeseman IM, 2001, J CELL BIOL, V155, P1137, DOI 10.1083/jcb.200109063; Cheeseman LM, 2002, CELL, V111, P163, DOI 10.1016/S0092-8674(02)00973-X; Cheng HL, 2004, MOL CELL BIOL, V24, P2932, DOI 10.1128/MCB.24.7.2932-2943.2004; CISMOWSKI MJ, 1995, MOL CELL BIOL, V15, P2983; Crotti LB, 2004, EMBO J, V23, P1804, DOI 10.1038/sj.emboj.7600161; Daniel JA, 2004, J BIOL CHEM, V279, P1867, DOI 10.1074/jbc.C300494200; Dehe PM, 2006, J BIOL CHEM, V281, P35404, DOI 10.1074/jbc.M603099200; Dichtl E, 2004, RNA, V10, P965, DOI 10.1261/rna.7090104; DOHENY KF, 1993, CELL, V73, P761, DOI 10.1016/0092-8674(93)90255-O; DOHMEN RJ, 1991, P NATL ACAD SCI USA, V88, P7351, DOI 10.1073/pnas.88.16.7351; Dou YL, 2006, NAT STRUCT MOL BIOL, V13, P713, DOI 10.1038/nsmb1128; Dover J, 2002, J BIOL CHEM, V277, P28368, DOI 10.1074/jbc.C200348200; Emanuele MJ, 2007, CELL, V130, P893, DOI 10.1016/j.cell.2007.07.023; Emre NCT, 2005, MOL CELL, V17, P585, DOI 10.1016/j.molcel.2005.01.007; Feng Q, 2002, CURR BIOL, V12, P1052, DOI 10.1016/S0960-9822(02)00901-6; Foreman PK, 1996, GENETICS, V144, P1387; FRANCISCO L, 1994, CELL MOL BIOL RES, V40, P207; Furuyama T, 2009, CELL, V138, P104, DOI 10.1016/j.cell.2009.04.049; Glinsky GV, 2006, CELL CYCLE, V5, P1208, DOI 10.4161/cc.5.11.2796; Hanisch A, 2006, EMBO J, V25, P5504, DOI 10.1038/sj.emboj.7601426; Hemmerich P, 2000, P NATL ACAD SCI USA, V97, P12583, DOI 10.1073/pnas.97.23.12583; Henry KW, 2003, GENE DEV, V17, P2648, DOI 10.1101/gad.1144003; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Jaehning JA, 2010, BBA-GENE REGUL MECH, V1799, P379, DOI 10.1016/j.bbagrm.2010.01.001; Janke C, 2002, EMBO J, V21, P181, DOI 10.1093/emboj/21.1.181; Kim J, 2005, MOL CELL, V20, P759, DOI 10.1016/j.molcel.2005.11.012; Kim J, 2009, J BIOL CHEM, V284, P20582, DOI 10.1074/jbc.M109.017442; Kim J, 2009, CELL, V137, P459, DOI 10.1016/j.cell.2009.02.027; Krogan NJ, 2003, MOL CELL, V11, P721, DOI 10.1016/S1097-2765(03)00091-1; Lampson MA, 2011, TRENDS CELL BIOL, V21, P133, DOI 10.1016/j.tcb.2010.10.007; Lan WJ, 2004, CURR BIOL, V14, P273, DOI 10.1016/j.cub.2004.01.055; Latham JA, 2007, NAT STRUCT MOL BIOL, V14, P1017, DOI 10.1038/nsmb1307; Lee JS, 2007, CELL, V131, P1084, DOI 10.1016/j.cell.2007.09.046; Lens SMA, 2010, NAT REV CANCER, V10, P825, DOI 10.1038/nrc2964; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li YM, 2002, GENE DEV, V16, P183, DOI 10.1101/gad.959402; Liu ZX, 2009, MOL BIOL CELL, V20, P757, DOI 10.1091/mbc.E08-09-0983; Lyakhovich A, 2004, ONCOGENE, V23, P3097, DOI 10.1038/sj.onc.1207449; McCleland ML, 2003, GENE DEV, V17, P101, DOI 10.1101/gad.1040903; Meluh PB, 1998, CELL, V94, P607, DOI 10.1016/S0092-8674(00)81602-5; Milne TA, 2010, MOL CELL, V38, P853, DOI 10.1016/j.molcel.2010.05.011; Miranda JJL, 2005, NAT STRUCT MOL BIOL, V12, P138, DOI 10.1038/nsmb896; Mizuguchi G, 2007, CELL, V129, P1153, DOI 10.1016/j.cell.2007.04.026; Moniaux N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007077; Mueller JE, 2006, GENETICS, V173, P557, DOI 10.1534/genetics.106.055400; Muntean AG, 2010, CANCER CELL, V17, P609, DOI 10.1016/j.ccr.2010.04.012; Nakanishi S, 2009, J CELL BIOL, V186, P371, DOI 10.1083/jcb.200906005; Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3; Ng HH, 2003, J BIOL CHEM, V278, P33625, DOI 10.1074/jbc.C300270200; Ng HH, 2002, GENE DEV, V16, P1518, DOI 10.1101/gad.1001502; Ooi CE, 1996, EMBO J, V15, P3515, DOI 10.1002/j.1460-2075.1996.tb00720.x; Porter SE, 2002, EUKARYOT CELL, V1, P830, DOI 10.1128/EC.1.5.830-842.2002; Qian C, 2006, CELL MOL LIFE SCI, V63, P2755, DOI 10.1007/s00018-006-6274-5; Robzyk K, 2000, SCIENCE, V287, P501, DOI 10.1126/science.287.5452.501; Schneider J, 2005, MOL CELL, V19, P849, DOI 10.1016/j.molcel.2005.07.024; Shang C, 2003, MOL BIOL CELL, V14, P3342, DOI 10.1091/mbc.E02-11-0765; Shekhar MPV, 2002, CANCER RES, V62, P2115; Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422; Sun ZW, 2002, NATURE, V418, P104, DOI 10.1038/nature00883; Tenney K, 2005, J CELL BIOCHEM, V95, P429, DOI 10.1002/jcb.20421; VALAY JG, 1995, J MOL BIOL, V249, P535, DOI 10.1006/jmbi.1995.0316; Vitaliano-Prunier A, 2008, NAT CELL BIOL, V10, P1365, DOI 10.1038/ncb1796; Weake VM, 2008, MOL CELL, V29, P653, DOI 10.1016/j.molcel.2008.02.014; Westermann S, 2005, MOL CELL, V17, P277, DOI 10.1016/j.molcel.2004.12.019; Wood A, 2003, J BIOL CHEM, V278, P34739, DOI 10.1074/jbc.C300269200; Wood A, 2003, MOL CELL, V11, P267, DOI 10.1016/S1097-2765(02)00802-X; Xiao TJ, 2005, MOL CELL BIOL, V25, P637, DOI 10.1128/MCB.25.2.637-651.2005; Xiao TJ, 2003, GENE DEV, V17, P654, DOI 10.1101/gad.1055503; Zhang K, 2005, CELL, V122, P723, DOI 10.1016/j.cell.2005.06.021; Zhu B, 2005, MOL CELL, V20, P601, DOI 10.1016/j.molcel.2005.09.025	79	51	52	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 2	2011	146	5					709	719		10.1016/j.cell.2011.07.025	http://dx.doi.org/10.1016/j.cell.2011.07.025			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	814SM	21884933	Bronze, Green Accepted			2022-12-28	WOS:000294477500012
J	Macfarlane, AM				Macfarlane, Allison M.			The Overlooked Back End of the Nuclear Fuel Cycle	SCIENCE			English	Editorial Material									George Mason Univ, Dept Environm Sci & Policy, Fairfax, VA 22030 USA	George Mason University	Macfarlane, AM (corresponding author), George Mason Univ, Dept Environm Sci & Policy, Fairfax, VA 22030 USA.	amac-farl@gmu.edu						Alvarez R., 2003, SCI GLOB SECUR, V11, P1; BARRETT L, 2011, STATEMENT HOUSE COMM; *BLUE RIBB COMM AM, 2011, DISP SUBC R IN PRESS; CHU S, 2011, COMMUNICATION   0211; GOLDFINGER C, 2011, COMMUNICATION   0401; *GOV JAP, 2011, E R H NUCL IAEA MIN; *IAEA, 2011, FACT FIND REP GREAT; *JAIF INC, 2011, INF STAT NUCL POW PL; *JAP AEC, 2005, FRAM NUCL EN POL; Macfarlane A. M., 2006, UNCERTAINTY UNDERGRO, P393, DOI [DOI 10.7551/MITPRESS/6965.003.0035, 10.7551/mitpress/6965.003.0035]; *NAT RES COUNC, 2003, ON STEP TIM STAG DEV; National Research Council, 2006, SAF SEC COMM SPENT N; *NUCL REG COMM, SPENT FUEL STOR POOL	13	19	19	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 2	2011	333	6047					1225	1226		10.1126/science.1207054	http://dx.doi.org/10.1126/science.1207054			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	813YM	21885760				2022-12-28	WOS:000294406400028
J	Cebul, RD; Love, TE; Jain, AK; Hebert, CJ				Cebul, Randall D.; Love, Thomas E.; Jain, Anil K.; Hebert, Christopher J.			Electronic Health Records and Quality of Diabetes Care	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							AMBULATORY-CARE; MEDICAL HOME; PRACTICE FACILITATORS; SYSTEMS; PERFORMANCE; SAVINGS; IMPACT	Background Available studies have shown few quality-related advantages of electronic health records (EHRs) over traditional paper records. We compared achievement of and improvement in quality standards for diabetes at practices using EHRs with those at practices using paper records. All practices, including many safety-net primary care practices, belonged to a regional quality collaborative and publicly reported performance. Methods We used generalized estimating equations to calculate the percentage-point difference between EHR-based and paper-based practices with respect to achievement of composite standards for diabetes care (including four component standards) and outcomes (five standards), after adjusting for covariates and accounting for clustering. In addition to insurance type (Medicare, commercial, Medicaid, or uninsured), patient-level covariates included race or ethnic group (white, black, Hispanic, or other), age, sex, estimated household income, and level of education. Analyses were conducted separately for the overall sample and for safety-net practices. Results From July 2009 through June 2010, data were reported for 27,207 adults with diabetes seen at 46 practices; safety-net practices accounted for 38% of patients. After adjustment for covariates, achievement of composite standards for diabetes care was 35.1 percentage points higher at EHR sites than at paper-based sites (P<0.001), and achievement of composite standards for outcomes was 15.2 percentage points higher (P = 0.005). EHR sites were associated with higher achievement on eight of nine component standards. Such sites were also associated with greater improvement in care (a difference of 10.2 percentage points in annual improvement, P<0.001) and outcomes (a difference of 4.1 percentage points in annual improvement, P = 0.02). Across all insurance types, EHR sites were associated with significantly higher achievement of care and outcome standards and greater improvement in diabetes care. Results confined to safety-net practices were similar. Conclusions These findings support the premise that federal policies encouraging the meaningful use of EHRs may improve the quality of care across insurance types.	[Cebul, Randall D.; Love, Thomas E.] Case Western Reserve Univ, Ctr Hlth Care Res & Policy, MetroHlth Med Ctr, Cleveland, OH 44109 USA; [Cebul, Randall D.; Love, Thomas E.] Case Western Reserve Univ, MetroHlth Med Ctr, Dept Med, Cleveland, OH 44109 USA; [Cebul, Randall D.; Love, Thomas E.] Case Western Reserve Univ, MetroHlth Med Ctr, Dept Epidemiol & Biostat, Cleveland, OH 44109 USA; [Jain, Anil K.] Cleveland Clin, Div Informat Technol, Cleveland, OH USA; [Jain, Anil K.] Cleveland Clin, Inst Med, Cleveland, OH USA; [Hebert, Christopher J.] Ohio Permanente Med Grp, Dept Med, Cleveland, OH USA	Case Western Reserve University; MetroHealth System; Case Western Reserve University; MetroHealth System; Case Western Reserve University; MetroHealth System; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Permanente Medical Groups	Cebul, RD (corresponding author), Case Western Reserve Univ, Ctr Hlth Care Res & Policy, MetroHlth Med Ctr, Rammelkamp Res & Educ Bldg,2500 MetroHlth Dr, Cleveland, OH 44109 USA.	rdc@case.edu		Koppel, Ross/0000-0002-8235-9900	Robert Wood Johnson Foundation	Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF))	All the authors report being active participants in Better Health Greater Cleveland, a regional collaborative supported by the Robert Wood Johnson Foundation and other sources.	Aligning Forces for Quality (AF4Q), AL FORC QUAL AF4Q QU; American Health Information Community Quality Workgroup, EX SUMM END STAT VIS; [Anonymous], 2010, R LANG ENV STAT COMP; [Anonymous], HLTH CAR REF PAT CTR; Bates DW, 2010, J GEN INTERN MED, V25, P174, DOI 10.1007/s11606-010-1252-x; Better Health Greater Cleveland, 2010, EX SUMM; Black AD, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000387; Chaudhry B, 2006, ANN INTERN MED, V144, P742, DOI 10.7326/0003-4819-144-10-200605160-00125; Clancy CM, 2009, HEALTH AFFAIR, V28, P478, DOI 10.1377/hlthaff.28.2.478; DesRoches CM, 2008, NEW ENGL J MED, V359, P50, DOI 10.1056/NEJMsa0802005; Friedberg MW, 2009, ANN INTERN MED, V151, P456, DOI 10.7326/0003-4819-151-7-200910060-00006; Gilfillan RJ, 2010, AM J MANAG CARE, V16, P607; Grant RW, 2005, DIABETES CARE, V28, P337, DOI 10.2337/diacare.28.2.337; HealthCare.gov, ACC CAR ORG IMPR CAR; Hillestad R, 2005, HEALTH AFFAIR, V24, P1103, DOI 10.1377/hlthaff.24.5.1103; Koppel R, 2005, JAMA-J AM MED ASSOC, V293, P1197, DOI 10.1001/jama.293.10.1197; Linder JA, 2007, ARCH INTERN MED, V167, P1400, DOI 10.1001/archinte.167.13.1400; Love TE, 2008, J GEN INTERN MED, V23, P383, DOI 10.1007/s11606-007-0454-3; Ma J, 2005, ARCH INTERN MED, V165, P1354, DOI 10.1001/archinte.165.12.1354; Nagykaldi Z, 2005, FAM MED, V37, P581; Nagykaldi Z, 2006, J AM BOARD FAM MED, V19, P506, DOI 10.3122/jabfm.19.5.506; National Committee on Quality Assurance (NCQA), STAT HLTH CAR QUAL 2; National Coordinator for Health Information Technology, HITECH PRIOR GRANTS; Nolan T, 2006, JAMA-J AM MED ASSOC, V295, P1168, DOI 10.1001/jama.295.10.1168; Reid RJ, 2010, HEALTH AFFAIR, V29, P835, DOI 10.1377/hlthaff.2010.0158; Reid RJ, 2009, AM J MANAG CARE, V15, pE71; Romano MJ, 2011, ARCH INTERN MED, V171, P897, DOI 10.1001/archinternmed.2010.527; Tang PC, 2007, J AM MED INFORM ASSN, V14, P10, DOI 10.1197/jamia.M2198; Trivedi AN, 2011, HEALTH AFFAIR, V30, P707, DOI 10.1377/hlthaff.2011.0074; Wang SJ, 2003, AM J MED, V114, P397, DOI 10.1016/S0002-9343(03)00057-3; [No title captured]	31	224	225	0	37	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 1	2011	365	9					825	833		10.1056/NEJMsa1102519	http://dx.doi.org/10.1056/NEJMsa1102519			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	813YC	21879900				2022-12-28	WOS:000294405200009
J	Dajani, R				Dajani, Rana			The Arab Spring offers hope but no quick fix	NATURE			English	Editorial Material									Hashemite Univ, Zarqa, Jordan	Hashemite University	Dajani, R (corresponding author), Hashemite Univ, Zarqa, Jordan.	rdajani@hu.edu.jo	Dajani, Rana/C-3466-2014	Dajani, Rana/0000-0002-4355-9977					0	2	2	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 1	2011	477	7362					7	7		10.1038/477007a	http://dx.doi.org/10.1038/477007a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	813XT	21886121	Bronze			2022-12-28	WOS:000294404300003
J	Germain, RN; Paul, WE				Germain, Ronald N.; Paul, William E.			Baruj Benacerraf (1920-2011) OBITUARY	NATURE			English	Biographical-Item									[Germain, Ronald N.; Paul, William E.] NIAID, Lab Syst Biol, NIH, Bethesda, MD 20892 USA; [Germain, Ronald N.; Paul, William E.] NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Germain, RN (corresponding author), NIAID, Lab Syst Biol, NIH, Bethesda, MD 20892 USA.	rgermain@nih.gov; wpaul@niaid.nih.gov	Germain, Ronald/ABE-7090-2020; Germain, Ronald N./Z-1945-2019		NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000493] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))			0	1	1	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 1	2011	477	7362					34	34		10.1038/477034a	http://dx.doi.org/10.1038/477034a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	813XT	21886149	Bronze			2022-12-28	WOS:000294404300021
J	Sankaran, VG; Xu, J; Byron, R; Greisman, HA; Fisher, C; Weatherall, DJ; Sabath, DE; Groudine, M; Orkin, SH; Premawardhena, A; Bender, MA				Sankaran, Vijay G.; Xu, Jian; Byron, Rachel; Greisman, Harvey A.; Fisher, Chris; Weatherall, David J.; Sabath, Daniel E.; Groudine, Mark; Orkin, Stuart H.; Premawardhena, Anuja; Bender, M. A.			A Functional Element Necessary for Fetal Hemoglobin Silencing	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DELTA-BETA-THALASSEMIA; GAMMA-GLOBIN GENE; SICKLE-CELL-DISEASE; FACTOR KLF1 CAUSES; HEREDITARY PERSISTENCE; SRI-LANKA; BCL11A; EXPRESSION; DELETION; SEQUENCES	Background An improved understanding of the regulation of the fetal hemoglobin genes holds promise for the development of targeted therapeutic approaches for fetal hemoglobin induction in the beta-hemoglobinopathies. Although recent studies have uncovered trans-acting factors necessary for this regulation, limited insight has been gained into the cis-regulatory elements involved. Methods We identified three families with unusual patterns of hemoglobin expression, suggestive of deletions in the locus of the beta-globin gene (beta-globin locus). We performed array comparative genomic hybridization to map these deletions and confirmed breakpoints by means of polymerase-chain-reaction assays and DNA sequencing. We compared these deletions, along with previously mapped deletions, and studied the trans-acting factors binding to these sites in the beta-globin locus by using chromatin immunoprecipitation. Results We found a new (delta beta)(0)-thalassemia deletion and a rare hereditary persistence of fetal hemoglobin deletion with identical downstream breakpoints. Comparison of the two deletions resulted in the identification of a small intergenic region required for gamma-globin (fetal hemoglobin) gene silencing. We mapped a Kurdish beta(0)-thalassemia deletion, which retains the required intergenic region, deletes other surrounding sequences, and maintains fetal hemoglobin silencing. By comparing these deletions and other previously mapped deletions, we elucidated a 3.5-kb intergenic region near the 5' end of the delta-globin gene that is necessary for gamma-globin silencing. We found that a critical fetal hemoglobin silencing factor, BCL11A, and its partners bind within this region in the chromatin of adult erythroid cells. Conclusions By studying three families with unusual deletions in the beta-globin locus, we identified an intergenic region near the delta-globin gene that is necessary for fetal hemoglobin silencing. (Funded by the National Institutes of Health and others.)	[Sankaran, Vijay G.; Xu, Jian; Orkin, Stuart H.] Childrens Hosp, Dept Med, Boston, MA 02115 USA; [Xu, Jian; Orkin, Stuart H.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Sankaran, Vijay G.] Broad Inst, Cambridge, MA USA; [Byron, Rachel; Groudine, Mark; Bender, M. A.] Fred Hutchinson Canc Ctr, Seattle, WA 98109 USA; [Greisman, Harvey A.; Sabath, Daniel E.; Bender, M. A.] Univ Washington, Seattle, WA 98195 USA; [Fisher, Chris; Weatherall, David J.] Weatherall Inst Mol Med, Oxford, England; [Premawardhena, Anuja] Univ Kelaniya, Ragama Gampaha, Sri Lanka	Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Oxford; University Kelaniya	Sankaran, VG (corresponding author), Childrens Hosp, Dept Med, 300 Longwood Ave, Boston, MA 02115 USA.	sankaran@broadinstitute.org; mbender@fhcrc.org	Premawardhena, Anuja/GLN-5388-2022	Premawardhena, Anuja/0000-0003-0605-9081	Cooley's Anemia Foundation; National Institutes of Health [DK44746, HL032259]; Howard Hughes Medical Institute; Wellcome Trust; March of Dimes; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065440, R01HL032259] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK044746, R01DK044746] Funding Source: NIH RePORTER	Cooley's Anemia Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Wellcome Trust(Wellcome TrustEuropean Commission); March of Dimes(March of Dimes); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by grants from the Cooley's Anemia Foundation (to Dr. Sankaran), the National Institutes of Health (DK44746, to Drs. Bender and Groudine, and HL032259, to Dr. Orkin), the Howard Hughes Medical Institute (to Drs. Xu and Orkin), and the Wellcome Trust and March of Dimes (to Dr. Weatherall).	ANAGNOU NP, 1995, J BIOL CHEM, V270, P10256, DOI 10.1074/jbc.270.17.10256; Arnaud L, 2010, AM J HUM GENET, V87, P721, DOI 10.1016/j.ajhg.2010.10.010; Bauer DE, 2011, CURR OPIN PEDIATR, V23, P1, DOI 10.1097/MOP.0b013e3283420fd0; Benz EJ, 2005, NEW ENGL J MED, V352, P524; Benz EJ, 2004, NEW ENGL J MED, V351, P1490, DOI 10.1056/NEJMp048198; BOLLEKENS JA, 1991, HEMATOL ONCOL CLIN N, V5, P399, DOI 10.1016/S0889-8588(18)30422-2; Borg J, 2010, NAT GENET, V42, P801, DOI 10.1038/ng.630; Bottardi S, 2009, MOL CELL BIOL, V29, P1526, DOI 10.1128/MCB.01523-08; Bradner JE, 2010, P NATL ACAD SCI USA, V107, P12617, DOI 10.1073/pnas.1006774107; Calzolari R, 1999, EMBO J, V18, P949, DOI 10.1093/emboj/18.4.949; Chakalova L, 2005, BLOOD, V105, P2154, DOI 10.1182/blood-2003-11-4069; de Silva S, 2000, LANCET, V355, P786, DOI 10.1016/S0140-6736(99)08246-X; Gaensler KML, 2003, P NATL ACAD SCI USA, V100, P3374, DOI 10.1073/pnas.0634132100; Galarneau G, 2010, NAT GENET, V42, P1049, DOI 10.1038/ng.707; Giardine B, 2007, HUM MUTAT, V28, DOI 10.1002/humu.9479; HENTHORN PS, 1986, P NATL ACAD SCI USA, V83, P5194, DOI 10.1073/pnas.83.14.5194; HUISMAN THJ, 1974, ANN NY ACAD SCI, V232, P107, DOI 10.1111/j.1749-6632.1974.tb20576.x; Joly P, 2009, BLOOD CELL MOL DIS, V43, P53, DOI 10.1016/j.bcmd.2009.01.017; Lettre G, 2008, P NATL ACAD SCI USA, V105, P11869, DOI 10.1073/pnas.0804799105; Menzel S, 2007, NAT GENET, V39, P1197, DOI 10.1038/ng2108; ONER C, 1995, BRIT J HAEMATOL, V89, P306, DOI 10.1111/j.1365-2141.1995.tb03305.x; Premawardhena A, 2005, LANCET, V366, P1467, DOI 10.1016/S0140-6736(05)67396-5; Sankaran VG, 2010, NEW ENGL J MED, V363, P2258, DOI 10.1056/NEJMcibr1010767; Sankaran VG, 2009, NATURE, V460, P1093, DOI 10.1038/nature08243; Sankaran VG, 2008, SCIENCE, V322, P1839, DOI 10.1126/science.1165409; Thein SL, 2009, HUM MOL GENET, V18, pR216, DOI 10.1093/hmg/ddp401; Uda M, 2008, P NATL ACAD SCI USA, V105, P1620, DOI 10.1073/pnas.0711566105; Weatherall D.J., 2001, THALASSAEMIA SYNDROM, Vfourth; Xu J, 2010, GENE DEV, V24, P783, DOI 10.1101/gad.1897310; Zhou VW, 2011, NAT REV GENET, V12, P7, DOI 10.1038/nrg2905	30	131	137	0	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 1	2011	365	9					807	814		10.1056/NEJMoa1103070	http://dx.doi.org/10.1056/NEJMoa1103070			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	813YC	21879898	Bronze, Green Accepted			2022-12-28	WOS:000294405200007
J	Bosch, X				Bosch, Xavier			Systemic Lupus Erythematosus and the Neutrophil	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Barcelona, Dept Internal Med, Hosp Clin, Inst Invest Biomed August Pi & Sunyer, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Bosch, X (corresponding author), Univ Barcelona, Dept Internal Med, Hosp Clin, Inst Invest Biomed August Pi & Sunyer, Barcelona, Spain.							Garcia-Romo GS, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001201; Lahita RG, 2011, SYSTEMIC LUPUS ERYTHEMATOSUS, 5TH EDITION, P1; Lande R, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001180; Obermoser G, 2010, LUPUS, V19, P1012, DOI 10.1177/0961203310371161; Villanueva E, 2011, J IMMUNOL, V187, P538, DOI 10.4049/jimmunol.1100450	5	72	77	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 25	2011	365	8					758	760		10.1056/NEJMcibr1107085	http://dx.doi.org/10.1056/NEJMcibr1107085			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	811JM	21864171				2022-12-28	WOS:000294205300016
J	Anker, SD; Koehler, F; Abraham, WT				Anker, Stefan D.; Koehler, Friedrich; Abraham, William T.			Heart Failure 4 Telemedicine and remote management of patients with heart failure	LANCET			English	Article							SYSTEM; HOME; MORTALITY; PRESSURE; IMPACT; TRIAL	Advances in telecommunication technologies have created new opportunities to provide telemedical care as an adjunct to medical management of patients with heart failure. Meta-analyses suggest that telemedicine can reduce morbidity and mortality in such patients; however, two prospective clinical trials not included in the analyses do not support these findings. Therefore, the effectiveness of telemedicine in heart failure is not established. Telemedicine approaches range from computer-based support systems to programmes led by nurses and physicians. Standardisation and appropriate classification of telemedical systems are needed to enable accurate interpretation of clinical trials. Here we propose a classification of four generations of telemedicine in heart failure. Not all approaches are the same and not every patient with heart failure will need telemedicine. Crisis prevention and treatment, and stabilisation and self-empowerment of patients are focuses of telemedicine in heart failure. The profile of patients who can potentially benefit from telemedicine is unknown and should be investigated in adequately powered randomised clinical trials. We are optimistic that telemedicine is an efficient approach and will become an important feature of management in heart failure.	[Anker, Stefan D.] Charite, Dept Cardiol, Campus Virchow Klinikum, Charite Med Sch, D-13353 Berlin, Germany; [Anker, Stefan D.] IRCCS San Raffaele, Ctr Clin & Basic Res, Rome, Italy; [Koehler, Friedrich] Charite, Ctr Cardiovasc Telemed, D-13353 Berlin, Germany; [Koehler, Friedrich] Charite, Dept Cardiol & Angiol, D-13353 Berlin, Germany; [Abraham, William T.] Ohio State Univ, Div Cardiovasc Med, Davis Heart & Lung Res Inst, Columbus, OH 43210 USA	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Center Clinical & Basic Research; IRCCS San Raffaele Pisana; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University System of Ohio; Ohio State University	Anker, SD (corresponding author), Charite, Dept Cardiol, Campus Virchow Klinikum, Charite Med Sch, D-13353 Berlin, Germany.	s.anker@cachexia.de		Koehler, Friedrich/0000-0003-0441-4123	Robert Bosch Healthcare GmbH; SHL Telemedicine; Thermo Fisher Scientific; St Jude Medical GmbH; German Federal Ministry of Economics and Technology [01MG531]; Biotronik; CardioMEMS; Medtronic; St Jude Medical	Robert Bosch Healthcare GmbH; SHL Telemedicine; Thermo Fisher Scientific; St Jude Medical GmbH; German Federal Ministry of Economics and Technology(Federal Ministry for Economic Affairs and Energy (BMWi)); Biotronik; CardioMEMS; Medtronic(Medtronic); St Jude Medical(St. Jude Medical)	SDA has received fees for consultancy from Robert Bosch Healthcare GmbH, SHL Telemedicine, Thermo Fisher Scientific, and St Jude Medical GmbH, and honoraria for speaking from Thermo Fisher Scientific, SHL Telemedicine, and St Jude Medical GmbH. FK has received grant support for development of telemedical technology and treatment trials from the German Federal Ministry of Economics and Technology (grant number 01MG531). WTA has received fees for consultancy from Biotronik, CardioMEMS, Medtronic, and St Jude Medical.	Abraham WT, 2011, LANCET, V377, P658, DOI 10.1016/S0140-6736(11)60101-3; Abraham WT, 2011, AM HEART J, V161, P558, DOI 10.1016/j.ahj.2010.10.041; Adamson PB, 2011, J CARD FAIL, V17, P3, DOI 10.1016/j.cardfail.2010.08.002; Agency for Healthcare Research and Quality, 2011, AMB CAR SENS COND; ALLELY EB, 1995, J MED SYST, V19, P207, DOI 10.1007/BF02257174; Bourge RC, 2008, J AM COLL CARDIOL, V51, P1073, DOI 10.1016/j.jacc.2007.10.061; Chaudhry SI, 2010, NEW ENGL J MED, V363, P2301, DOI 10.1056/NEJMoa1010029; Clark RA, 2007, BMJ-BRIT MED J, V334, P942, DOI 10.1136/bmj.39156.536968.55; Clarke M, 2011, J TELEMED TELECARE, V17, P7, DOI 10.1258/jtt.2010.100113; Cleland JGF, 2005, J AM COLL CARDIOL, V45, P1654, DOI 10.1016/j.jacc.2005.01.050; Cleland JGF, 2010, JAMA-J AM MED ASSOC, V304, P1383, DOI 10.1001/jama.2010.1387; ClinicalTrials. gov. Diagnostic outcome trial in heart failure (DOT-HF Trial), 2010, DIAGN OUTC TRIAL HEA; ClinicalTrials.gov. Heart failure (HF) assessment with B-type natriuretic peptide (BNP) in the home (HABIT), HEART FAIL HF ASS B; ClinicalTrials. gov. Heart: failure (HF) outpatient monitoring evaluation (HOME), 2011, HEART FAIL HF OUTP M; ClinicalTrials. gov. Left atrial pressure monitoring to optimize heart failure therapy (LAPTOP-HF), 2011, LEFT ATR PRESS MON O; Conraads VM, 2011, EUR HEART J, V32, P2266, DOI 10.1093/eurheartj/ehr050; Desai AS, 2010, NEW ENGL J MED, V363, P2364, DOI 10.1056/NEJMe1011769; Dickstein K, 2010, EUR J HEART FAIL, V12, P1143, DOI [10.1093/eurjhf/hfq192, 10.1093/europace/euq392]; Hoeks LBEA, 2011, DIABETIC MED, V28, P386, DOI 10.1111/j.1464-5491.2010.03177.x; Hood L, 2011, NAT REV CLIN ONCOL, V8, P184, DOI 10.1038/nrclinonc.2010.227; Inglis SC, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007228.pub2; Jankowska EA, 2010, EUR J HEART FAIL, V12, P966, DOI 10.1093/eurjhf/hfq108; Kielblock B, 2007, DEUT MED WOCHENSCHR, V132, P417, DOI 10.1055/s-2007-970350; Klersy C, 2009, J AM COLL CARDIOL, V54, P1683, DOI 10.1016/j.jacc.2009.08.017; Koehler F, 2011, CIRCULATION, V123, P1873, DOI 10.1161/CIRCULATIONAHA.111.018473; Maisel A, 2008, EUR J HEART FAIL, V10, P824, DOI 10.1016/j.ejheart.2008.07.014; Ritzema J, 2010, CIRCULATION, V121, P1086, DOI 10.1161/CIRCULATIONAHA.108.800490; Santschi V, 2007, EUR J CLIN PHARMACOL, V63, P1179, DOI 10.1007/s00228-007-0364-7; Winkler S, 2011, INT J CARDIOL, V153, P55, DOI 10.1016/j.ijcard.2010.08.038; Yu CM, 2005, CIRCULATION, V112, P841, DOI 10.1161/CIRCULATIONAHA.104.492207; Zhang JF, 2009, EUR J HEART FAIL, V11, P420, DOI 10.1093/eurjhf/hfp033	31	202	209	2	34	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 20	2011	378	9792					731	739		10.1016/S0140-6736(11)61229-4	http://dx.doi.org/10.1016/S0140-6736(11)61229-4			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	815EW	21856487				2022-12-28	WOS:000294509900033
J	Chen, IC; Hill, JK; Ohlemuller, R; Roy, DB; Thomas, CD				Chen, I-Ching; Hill, Jane K.; Ohlemueller, Ralf; Roy, David B.; Thomas, Chris D.			Rapid Range Shifts of Species Associated with High Levels of Climate Warming	SCIENCE			English	Article							EXTINCTION RISK; IMPACTS; FACE	The distributions of many terrestrial organisms are currently shifting in latitude or elevation in response to changing climate. Using a meta-analysis, we estimated that the distributions of species have recently shifted to higher elevations at a median rate of 11.0 meters per decade, and to higher latitudes at a median rate of 16.9 kilometers per decade. These rates are approximately two and three times faster than previously reported. The distances moved by species are greatest in studies showing the highest levels of warming, with average latitudinal shifts being generally sufficient to track temperature changes. However, individual species vary greatly in their rates of change, suggesting that the range shift of each species depends on multiple internal species traits and external drivers of change. Rapid average shifts derive from a wide diversity of responses by individual species.	[Chen, I-Ching; Hill, Jane K.; Thomas, Chris D.] Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England; [Chen, I-Ching] Acad Sinica, Biodivers Res Ctr, Taipei 115, Taiwan; [Ohlemueller, Ralf] Univ Durham, Sch Biol & Biomed Sci, Durham DH1 3LE, England; [Ohlemueller, Ralf] Univ Durham, Inst Hazard Risk & Resilience, Durham DH1 3LE, England; [Roy, David B.] Ctr Ecol & Hydrol, Wallingford OX10 8BB, Oxon, England	University of York - UK; Academia Sinica - Taiwan; Durham University; Durham University; UK Centre for Ecology & Hydrology (UKCEH)	Thomas, CD (corresponding author), Univ York, Dept Biol, Wentworth Way, York YO10 5DD, N Yorkshire, England.	chris.thomas@york.ac.uk	Roy, David/A-6619-2009; CHEN, I-CHING/Y-1535-2019; Hill, Jane K/G-5151-2011; Hill, Jane K./AAJ-3374-2021; Thomas, Chris D/A-1460-2014; Chen, I-Ching/GWU-9667-2022; Thomas, Chris D/A-1894-2012	Roy, David/0000-0002-5147-0331; CHEN, I-CHING/0000-0002-1909-7290; Hill, Jane K./0000-0003-1871-7715; Thomas, Chris D/0000-0003-2822-1334; Thomas, Chris D/0000-0003-2822-1334; Ohlemuller, Ralf/0000-0001-9102-6481	Ministry of Education in Taiwan; UK Overseas Research Scholarship Award; Natural Environment Research Council; Natural Environment Research Council [CEH010021] Funding Source: researchfish	Ministry of Education in Taiwan(Ministry of Education, Taiwan); UK Overseas Research Scholarship Award; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank A. Bergamini, R. Hickling, R. Wilson, and B. Zuckerberg for data; H.-J. Shiu for statistical assistance; S.-F. Shen, the Ministry of Education in Taiwan, a UK Overseas Research Scholarship Award, and the Natural Environment Research Council for support; and anonymous referees for comments on the manuscript. We are particularly grateful to the many thousands of volunteers responsible for collecting most of the original records of species. All data sources are listed in the supporting online material.	Angert AL, 2011, ECOL LETT, V14, P677, DOI 10.1111/j.1461-0248.2011.01620.x; Carpenter KE, 2008, SCIENCE, V321, P560, DOI 10.1126/science.1159196; Chen IC, 2011, GLOBAL ECOL BIOGEOGR, V20, P34, DOI 10.1111/j.1466-8238.2010.00594.x; Easterling DR, 2000, SCIENCE, V289, P2068, DOI 10.1126/science.289.5487.2068; Fischlin A., 2007, CONTRIBUTION WORKING, P211; Foden W, 2007, DIVERS DISTRIB, V13, P645, DOI 10.1111/j.1472-4642.2007.00391.x; Forero-Medina G, 2011, CONSERV BIOL, V25, P163, DOI 10.1111/j.1523-1739.2010.01572.x; Hickling R, 2006, GLOBAL CHANGE BIOL, V12, P450, DOI 10.1111/j.1365-2486.2006.01116.x; Loarie SR, 2009, NATURE, V462, P1052, DOI 10.1038/nature08649; Menendez R, 2006, P ROY SOC B-BIOL SCI, V273, P1465, DOI 10.1098/rspb.2006.3484; Menzel A, 2006, GLOBAL CHANGE BIOL, V12, P1969, DOI 10.1111/j.1365-2486.2006.01193.x; Nathan R, 2011, ECOL LETT, V14, P211, DOI 10.1111/j.1461-0248.2010.01573.x; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 1999, NATURE, V399, P579, DOI 10.1038/21181; Pounds JA, 2006, NATURE, V439, P161, DOI 10.1038/nature04246; Pounds JA, 1999, NATURE, V398, P611, DOI 10.1038/19297; Raxworthy CJ, 2008, GLOBAL CHANGE BIOL, V14, P1703, DOI 10.1111/j.1365-2486.2008.01596.x; Root TL, 2005, P NATL ACAD SCI USA, V102, P7465, DOI 10.1073/pnas.0502286102; Rosenzweig C, 2008, NATURE, V453, P353, DOI 10.1038/nature06937; Rosenzweig C, 2007, AR4 CLIMATE CHANGE 2007: IMPACTS, ADAPTATION, AND VULNERABILITY, P79; Sekercioglu CH, 2008, CONSERV BIOL, V22, P140, DOI 10.1111/j.1523-1739.2007.00852.x; Sinervo B, 2010, SCIENCE, V328, P894, DOI 10.1126/science.1184695; Suggitt AJ, 2011, OIKOS, V120, P1, DOI 10.1111/j.1600-0706.2010.18270.x; Thackeray SJ, 2010, GLOBAL CHANGE BIOL, V16, P3304, DOI 10.1111/j.1365-2486.2010.02165.x; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thomas CD, 2006, TRENDS ECOL EVOL, V21, P415, DOI 10.1016/j.tree.2006.05.012; Thomas CD, 2010, DIVERS DISTRIB, V16, P488, DOI 10.1111/j.1472-4642.2010.00642.x; Warren MS, 2001, NATURE, V414, P65, DOI 10.1038/35102054; Williams SE, 2003, P ROY SOC B-BIOL SCI, V270, P1887, DOI 10.1098/rspb.2003.2464	29	2867	2961	92	2085	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 19	2011	333	6045					1024	1026		10.1126/science.1206432	http://dx.doi.org/10.1126/science.1206432			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808TD	21852500				2022-12-28	WOS:000294000400057
J	Baur, LA				Baur, Louise A.			The art of medicine Changing perceptions of obesity-recollections of a paediatrician	LANCET			English	Editorial Material									[Baur, Louise A.] Univ Sydney, Discipline Paediat & Child Hlth, Sydney, NSW 2006, Australia; [Baur, Louise A.] Univ Sydney, Sydney Med Sch, Sydney Sch Publ Hlth, Sydney, NSW 2006, Australia; [Baur, Louise A.] Childrens Hosp Westmead, Westmead, NSW 2145, Australia	University of Sydney; University of Sydney; University of Sydney	Baur, LA (corresponding author), Univ Sydney, Discipline Paediat & Child Hlth, Sydney, NSW 2006, Australia.	louiseb3@chw.edu.au	Baur, Louise/AAE-3413-2021	Baur, Louise/0000-0002-4521-9482					0	3	5	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG-SEP	2011	378	9793					762	763		10.1016/S0140-6736(11)61365-2	http://dx.doi.org/10.1016/S0140-6736(11)61365-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	816FY	21877330				2022-12-28	WOS:000294585300017
J	Anand, S				Anand, Sudhir			Human security and universal health insurance	LANCET			English	Editorial Material									Univ Oxford, Dept Econ, Oxford OX1 3UQ, England	University of Oxford	Anand, S (corresponding author), Univ Oxford, Dept Econ, Oxford OX1 3UQ, England.	sudhir.anand@economics.ox.ac.uk						Anand S, 1992, COMM SEC FOR C OSL N; Chen Lincoln C., 2004, HLTH HUMAN SECURITY; Commission on Human Security, 2003, HUMAN SECURITY NOW P; El-Axir M.H., J MATER PROCESS TECH, V196, P120, DOI [10.1016/j.jmatprotec.2007.05.028, DOI 10.1016/J.JMATPROTEC.2007.05.028]; Matsumae T, 1995, COMMON SECURITY ASIA; Obuchi, 1999, ASIAN CRISIS HUMAN S, P17; Rawls J., 1971, THEORY JUSTICE; Sen A., 1999, COMMODITIES CAPABILI; SEN A, 2000, INT S HUM SEC TOK JU; Takemi K, 1995, COMMON SECURITY ASIA, P71; Yamamoto T, 1999, ASIAN CRISIS HUMAN S, P7	11	11	11	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 7	2012	379	9810					9	10		10.1016/S0140-6736(11)61148-3	http://dx.doi.org/10.1016/S0140-6736(11)61148-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	873WC	21885097	Green Published, Bronze			2022-12-28	WOS:000298913000010
J	Lehner, N; Howk, JC				Lehner, Nicolas; Howk, J. Christopher			A Reservoir of Ionized Gas in the Galactic Halo to Sustain Star Formation in the Milky Way	SCIENCE			English	Article							HIGH-VELOCITY CLOUDS; LOCAL GROUP; COMPLEX-C; DISTANCES; GALAXY; ACCRETION; FEEDBACK; WARM; RAIN; OVI	Without a source of new gas, our Galaxy would exhaust its supply of gas through the formation of stars. Ionized gas clouds observed at high velocity may be a reservoir of such gas, but their distances are key for placing them in the galactic halo and unraveling their role. We have used the Hubble Space Telescope to blindly search for ionized high-velocity clouds (iHVCs) in the foreground of galactic stars. We show that iHVCs with 90 <= vertical bar v(LSR)vertical bar less than or similar to 170 kilometers per second (where v(LSR) is the velocity in the local standard of rest frame) are within one galactic radius of the Sun and have enough mass to maintain star formation, whereas iHVCs with vertical bar v(LSR)vertical bar greater than or similar to 170 kilometers per second are at larger distances. These may be the next wave of infalling material.	[Lehner, Nicolas; Howk, J. Christopher] Univ Notre Dame, Dept Phys, Notre Dame, IN 46556 USA	University of Notre Dame	Lehner, N (corresponding author), Univ Notre Dame, Dept Phys, 225 Nieuwland Sci Hall, Notre Dame, IN 46556 USA.	nlehner@nd.edu	Howk, Jay/D-2577-2013	Lehner, Nicolas/0000-0001-9158-0829; Howk, J. Christopher/0000-0002-2591-3792	NASA [NAS5-26555]; NASA from STScI [HST-GO-11592.01-A]	NASA(National Aeronautics & Space Administration (NASA)); NASA from STScI	This work was based on observations made with the NASA/European Space Agency Hubble Space Telescope, obtained at the Space Telescope Science Institute (STScI), which is operated by the Association of Universities for Research in Astronomy, under NASA contract NAS5-26555. We greatly appreciate funding support from NASA grant HST-GO-11592.01-A from STScI. We are grateful to P. Chayer for computing several stellar spectra for us. The data reported in this paper are tabulated in the SOM and archived at the Multimission Archive at STScI (MAST, http://archive.stsci.edu/).	Bauermeister A, 2010, ASTROPHYS J, V717, P323, DOI 10.1088/0004-637X/717/1/323; Benjamin RA, 1997, ASTROPHYS J, V481, P764, DOI 10.1086/304078; Blitz L, 1999, ASTROPHYS J, V514, P818, DOI 10.1086/306963; Chiappini C, 2001, ASTROPHYS J, V554, P1044, DOI 10.1086/321427; Collins JA, 2009, ASTROPHYS J, V705, P962, DOI 10.1088/0004-637X/705/1/962; Fox AJ, 2006, ASTROPHYS J SUPPL S, V165, P229, DOI 10.1086/504800; Fraternali F, 2008, MON NOT R ASTRON SOC, V386, P935, DOI 10.1111/j.1365-2966.2008.13071.x; Heitsch F, 2009, ASTROPHYS J, V698, P1485, DOI 10.1088/0004-637X/698/2/1485; Kalberla PMW, 2005, ASTRON ASTROPHYS, V440, P775, DOI 10.1051/0004-6361:20041864; Keres D, 2009, ASTROPHYS J LETT, V700, pL1, DOI 10.1088/0004-637X/700/1/L1; Lehner N, 2010, ASTROPHYS J LETT, V709, pL138, DOI 10.1088/2041-8205/709/2/L138; Lehner N, 2001, MON NOT R ASTRON SOC, V323, P904, DOI 10.1046/j.1365-8711.2001.04276.x; Leitner SN, 2011, ASTROPHYS J, V734, DOI 10.1088/0004-637X/734/1/48; Marinacci F, 2011, MON NOT R ASTRON SOC, V415, P1534, DOI 10.1111/j.1365-2966.2011.18810.x; MURPHY EM, 1995, ASTROPHYS J, V447, P642, DOI 10.1086/175906; Nicastro F, 2003, NATURE, V421, P719, DOI 10.1038/nature01369; Oppenheimer BD, 2010, MON NOT R ASTRON SOC, V406, P2325, DOI 10.1111/j.1365-2966.2010.16872.x; Peek JEG, 2007, ASTROPHYS J, V656, P907, DOI 10.1086/510189; Richter P, 2009, ASTROPHYS J, V695, P1631, DOI 10.1088/0004-637X/695/2/1631; Robitaille TP, 2010, ASTROPHYS J LETT, V710, pL11, DOI 10.1088/2041-8205/710/1/L11; Sembach KR, 2003, ASTROPHYS J SUPPL S, V146, P165, DOI 10.1086/346231; Shull JM, 2009, ASTROPHYS J, V699, P754, DOI 10.1088/0004-637X/699/1/754; Thom C, 2008, ASTROPHYS J, V684, P364, DOI 10.1086/589960; Tripp T. M., ASTROPHYS J; Wakker BP, 2008, ASTROPHYS J, V672, P298, DOI 10.1086/523845; Wakker BP, 2007, ASTROPHYS J, V670, pL113, DOI 10.1086/524222; Wakker BP, 1997, ANNU REV ASTRON ASTR, V35, P217, DOI 10.1146/annurev.astro.35.1.217; Zech WF, 2008, ASTROPHYS J, V679, P460, DOI 10.1086/587135; Zsargo J, 2003, ASTROPHYS J, V586, P1019, DOI 10.1086/367766	30	104	104	1	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 18	2011	334	6058					955	958		10.1126/science.1209069	http://dx.doi.org/10.1126/science.1209069			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849CA	21868626	Green Submitted			2022-12-28	WOS:000297101800049
J	Gardner, BM; Walter, P				Gardner, Brooke M.; Walter, Peter			Unfolded Proteins Are Ire1-Activating Ligands That Directly Induce the Unfolded Protein Response	SCIENCE			English	Article							ENDOPLASMIC-RETICULUM; MESSENGER-RNA; TRANSCRIPTION FACTOR; REVEALS; SPECIFICITY; IRE1P; BIP; MECHANISM; PATHWAY; BINDING	The unfolded protein response (UPR) detects the accumulation of unfolded proteins in the endoplasmic reticulum (ER) and adjusts the protein-folding capacity to the needs of the cell. Under conditions of ER stress, the transmembrane protein Ire1 oligomerizes to activate its cytoplasmic kinase and ribonuclease domains. It is unclear what feature of ER stress Ire1 detects. We found that the core ER-lumenal domain (cLD) of yeast Ire1 binds to unfolded proteins in yeast cells and to peptides primarily composed of basic and hydrophobic residues in vitro. Mutation of amino acid side chains exposed in a putative peptide-binding groove of Ire1 cLD impaired peptide binding. Peptide binding caused Ire1 cLD oligomerization in vitro, suggesting that direct binding to unfolded proteins activates the UPR.	[Gardner, Brooke M.; Walter, Peter] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Walter, Peter] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Walter, P (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA.	peter@walterlab.ucsf.edu		Gardner, Brooke/0000-0001-7999-8827	National Science Foundation	National Science Foundation(National Science Foundation (NSF))	We thank J. Weissman, G. Narlikar, and D. Mullins for insightful comments; S. Neher and A. Korennykh for their invaluable guidance; and the Walter Lab, especially H. Li, E. van Anken, D. Pincus, C. Gallagher, and M. Diaz for their assistance and scientific discussions. Purified Kar2 was a generous gift from J. Brodsky. We are grateful to the Massachussetts Institute of Technology Biopolymers Institute for synthesizing the peptide arrays. B. G. was supported by a National Science Foundation predoctoral fellowship. P. W. is an investigator of the Howard Hughes Medical Institute.	Aragon T, 2009, NATURE, V457, P736, DOI 10.1038/nature07641; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; BLONDELGUINDI S, 1993, CELL, V75, P717, DOI 10.1016/0092-8674(93)90492-9; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Cox JS, 1996, CELL, V87, P391, DOI 10.1016/S0092-8674(00)81360-4; Credle JJ, 2005, P NATL ACAD SCI USA, V102, P18773, DOI 10.1073/pnas.0509487102; deCrouyChanel A, 1996, J BIOL CHEM, V271, P15486, DOI 10.1074/jbc.271.26.15486; FINGER A, 1993, EUR J BIOCHEM, V218, P565, DOI 10.1111/j.1432-1033.1993.tb18410.x; FLYNN GC, 1989, SCIENCE, V245, P385, DOI 10.1126/science.2756425; ISHIWATAKIMATA Y, MOL BIOL CELL, DOI DOI 10.1091/MBC.E11-04-0295; Kawahara T, 1997, MOL BIOL CELL, V8, P1845, DOI 10.1091/mbc.8.10.1845; Kimata Y, 2004, J CELL BIOL, V167, P445, DOI 10.1083/jcb.200405153; Kimata Y, 2007, J CELL BIOL, V179, P75, DOI 10.1083/jcb.200704166; Li H, 2010, P NATL ACAD SCI USA, V107, P16113, DOI 10.1073/pnas.1010580107; Okamura K, 2000, BIOCHEM BIOPH RES CO, V279, P445, DOI 10.1006/bbrc.2000.3987; Peterson JH, 2003, J BIOL CHEM, V278, P46155, DOI 10.1074/jbc.M309082200; Pincus D, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000415; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rudiger S, 1997, EMBO J, V16, P1501, DOI 10.1093/emboj/16.7.1501; Shen XH, 2001, CELL, V107, P893, DOI 10.1016/S0092-8674(01)00612-2; Sidrauski C, 1997, CELL, V90, P1031, DOI 10.1016/S0092-8674(00)80369-4; Tirasophon W, 1998, GENE DEV, V12, P1812, DOI 10.1101/gad.12.12.1812; Wang XZ, 1998, EMBO J, V17, P5708, DOI 10.1093/emboj/17.19.5708; Zhou JH, 2006, P NATL ACAD SCI USA, V103, P14343, DOI 10.1073/pnas.0606480103	24	476	498	5	86	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 30	2011	333	6051					1891	1894		10.1126/science.1209126	http://dx.doi.org/10.1126/science.1209126			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	826PJ	21852455	Green Accepted, Bronze			2022-12-28	WOS:000295365800057
J	Greinacher, A; Friesecke, S; Abel, P; Dressel, A; Stracke, S; Fiene, M; Ernst, F; Selleng, K; Weissenborn, K; Schmidt, BMW; Schiffer, M; Felix, SB; Lerch, MM; Kielstein, JT; Mayerle, J				Greinacher, Andreas; Friesecke, Sigrun; Abel, Peter; Dressel, Alexander; Stracke, Sylvia; Fiene, Michael; Ernst, Friedlinde; Selleng, Kathleen; Weissenborn, Karin; Schmidt, Bernhard M. W.; Schiffer, Mario; Felix, Stephan B.; Lerch, Markus M.; Kielstein, Jan T.; Mayerle, Julia			Treatment of severe neurological deficits with IgG depletion through immunoadsorption in patients with Escherichia coli O104:H4-associated haemolytic uraemic syndrome: a prospective trial	LANCET			English	Article							THROMBOTIC THROMBOCYTOPENIC PURPURA; FACTOR-CLEAVING PROTEASE; PLASMA-EXCHANGE; CARDIAC DYSFUNCTION; MANIFESTATIONS; RECEPTOR; TOXINS; VIII	Background In May 2011, an outbreak of Shiga toxin-producing enterohaemorrhagic E coli O104:H4 in northern Germany led to a high proportion of patients developing post-enteritis haemolytic uraemic syndrome and thrombotic microangiopathy that were unresponsive to therapeutic plasma exchange or complement-blocking antibody (eculizumab). Some patients needed ventilatory support due to severe neurological complications, which arose 1 week after onset of enteritis, suggesting an antibody-mediated mechanism. Therefore, we aimed to assess immunoadsorption as rescue therapy. Methods In our prospective non-controlled trial, we enrolled patients with severe neurological symptoms and confirmed recent E coli 0104:H4 infection without other acute bacterial infection or raised procalcitonin concentrations. We did IgG immunoadsorption processing of 12 L plasma volumes on 2 consecutive days, followed by IgG replacement (0.5 g/kg intravenous IgG). We calculated a composite neurological symptom score (lowest score was best) every day and assessed changes before and after immunoadsorption. Findings We enrolled 12 patients who initially presented with enteritis and subsequent renal failure; 10 (83%) of 12 patients needed renal replacement therapy by a median of 8.0 days (range 5-12). Neurological complications (delirium, stimulus sensitive myoclonus, aphasia, and epileptic seizures in 50% of patients) occurred at a median of 8.0 days (range 5-15) and mandated mechanical ventilation in nine patients. Composite neurological symptom scores increased in the 3 days before immunoadsorption to 3.0 (SD 1.1, p=0.038), and improved to 1.0 (1.2, p=0.0006) 3 days after immunoadsorption. In non-intubated patients, improvement was apparent during immunoadsorption (eg, disappearance of aphasia). Five patients who were intubated were weaned within 48 h, two within 4 days, and two patients needed continued ventilation for respiratory problems. All 12 patients survived and ten had complete neurological and renal function recovery. Interpretation Antibodies are probably involved in the pathogenesis of severe neurological symptoms in patients with E coli O104:H4-induced haemolytic uraemic syndrome. Immunoadsorption can safely be used to rapidly ameliorate these severe neurological complications.	[Greinacher, Andreas; Selleng, Kathleen] Ernst Moritz Arndt Univ Greifswald, Inst Immunol & Transfus Med, D-17475 Greifswald, Germany; [Friesecke, Sigrun; Abel, Peter; Felix, Stephan B.] Ernst Moritz Arndt Univ Greifswald, Klin Innere Med B, D-17475 Greifswald, Germany; [Dressel, Alexander] Ernst Moritz Arndt Univ Greifswald, Neurol Klin, D-17475 Greifswald, Germany; [Stracke, Sylvia; Fiene, Michael; Ernst, Friedlinde; Lerch, Markus M.; Mayerle, Julia] Ernst Moritz Arndt Univ Greifswald, Klin Innere Med A, D-17475 Greifswald, Germany; [Weissenborn, Karin] Hannover Med Sch, Dept Neurol, D-3000 Hannover, Germany; [Schmidt, Bernhard M. W.; Schiffer, Mario; Kielstein, Jan T.] Hannover Med Sch, Dept Hypertens & Nephrol, D-3000 Hannover, Germany	Ernst Moritz Arndt Universitat Greifswald; Ernst Moritz Arndt Universitat Greifswald; Ernst Moritz Arndt Universitat Greifswald; Ernst Moritz Arndt Universitat Greifswald; Hannover Medical School; Hannover Medical School	Greinacher, A (corresponding author), Ernst Moritz Arndt Univ Greifswald, Inst Immunol & Transfus Med, Klinikum Sauerbruchstr, D-17475 Greifswald, Germany.	greinach@uni-greifswald.de	Stracke, Sylvia/ABB-8871-2020; Kielstein, Jan T./I-2956-2019; Lerch, Markus M./E-2206-2016; Schiffer, Mario/U-7050-2019; Mayerle, Julia/W-7907-2019; Dressel, Alexander/F-9142-2015	Kielstein, Jan T./0000-0001-8110-9064; Lerch, Markus M./0000-0002-9643-8263; Schiffer, Mario/0000-0002-8414-1470; Abel, Peter/0000-0002-5591-450X; Mayerle, Julia/0000-0002-3666-6459; Dressel, Alexander/0000-0002-9055-4327	Greifswald University; Hannover Medical School; Fresenius Medical Care; Universitatsmedizin Greifswald; Medizinische Hochschule Hannover (Germany); German Federal Ministry for Education and Research (Center for Innovation Competence Humoral Immune Reactions in Cardiovascular Disease [ZIK HIKE]) [FKZ 03Z2CN11, FKZ 03Z2CN12]; Greifswald Approach to Individualised Medicine [FKZ: BMBF/PTJ Berlin 03152061A]	Greifswald University; Hannover Medical School; Fresenius Medical Care; Universitatsmedizin Greifswald; Medizinische Hochschule Hannover (Germany); German Federal Ministry for Education and Research (Center for Innovation Competence Humoral Immune Reactions in Cardiovascular Disease [ZIK HIKE])(Federal Ministry of Education & Research (BMBF)); Greifswald Approach to Individualised Medicine	Greifswald University and Hannover Medical School.; SBF and JTK received research support and speaker fees from Fresenius Medical Care. All other authors declare that they have no conflicts of interest.; This study was supported by the Universitatsmedizin Greifswald and the Medizinische Hochschule Hannover (Germany). The infrastructure necessary for the development of the concept was supported by the German Federal Ministry for Education and Research (Center for Innovation Competence Humoral Immune Reactions in Cardiovascular Disease [ZIK HIKE]; grant numbers FKZ 03Z2CN11 and FKZ 03Z2CN12) and by Greifswald Approach to Individualised Medicine (Gani_Med; grant number FKZ: BMBF/PTJ Berlin 03152061A). We thank the nurses and technicians who supported this study.	Arepally GM, 2006, NEW ENGL J MED, V355, P809, DOI 10.1056/NEJMcp052967; BALE JF, 1980, AM J DIS CHILD, V134, P869, DOI 10.1001/archpedi.1980.02130210053014; Besbas N, 2006, KIDNEY INT, V70, P423, DOI 10.1038/sj.ki.5001581; CIMOLAI N, 1992, PEDIATRICS, V90, P616; Cooper MS, 2003, NEW ENGL J MED, V348, P727, DOI 10.1056/NEJMra020529; Dundas S, 1999, LANCET, V354, P1327, DOI 10.1016/S0140-6736(99)01251-9; Felix SB, 2008, AUTOIMMUNITY, V41, P484, DOI 10.1080/08916930802031173; Fernandez-Brando RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019136; Frank C, 2011, NEW ENGL J MED, DOI [10.1056/NEJM0a110648, DOI 10.1056/NEJMOA110648]; Furlan M, 1998, NEW ENGL J MED, V339, P1578, DOI 10.1056/NEJM199811263392202; George JN, 2008, EUR J HAEMATOL, V80, P277, DOI 10.1111/j.1600-0609.2008.01040.x; George JN, 2009, KIDNEY INT, V75, pS8, DOI 10.1038/ki.2008.609; Greinacher A, 2009, J THROMB HAEMOST, V7, P9, DOI 10.1111/j.1538-7836.2009.03385.x; Greinacher A, 2009, BLOOD, V113, P4970, DOI 10.1182/blood-2008-08-173062; Karpman D, 2010, SEMIN THROMB HEMOST, V36, P575, DOI 10.1055/s-0030-1262879; Klingel R, 2009, ATHEROSCLEROSIS SUPP, V10, P129, DOI 10.1016/S1567-5688(09)71827-6; Lammle B, 2005, J THROMB HAEMOST, V3, P1663, DOI 10.1111/j.1538-7836.2005.01425.x; Lapeyraque AL, N ENGL J MED, V364, P2561; LINDBERG AA, 1987, J BIOL CHEM, V262, P1779; Mistry B, 2004, AM J KIDNEY DIS, V44, DOI 10.1053/j.ajkd.2004.05.046; MOAKE JL, 1984, BLOOD, V64, P592; Moake JL, 2002, NEW ENGL J MED, V347, P589, DOI 10.1056/NEJMra020528; MOAKE JL, 1982, NEW ENGL J MED, V307, P1432, DOI 10.1056/NEJM198212023072306; Nolasco LH, 2005, BLOOD, V106, P4199, DOI 10.1182/blood-2005-05-2111; ROCK GA, 1991, NEW ENGL J MED, V325, P393, DOI 10.1056/NEJM199108083250604; Sandvig K, 2002, FEBS LETT, V529, P49, DOI 10.1016/S0014-5793(02)03182-4; Staudt A, 2010, CLIN PHARMACOL THER, V87, P452, DOI 10.1038/clpt.2009.246; Staudt A, 2002, CIRCULATION, V106, P2448, DOI 10.1161/01.CIR.0000036746.49449.64; Stummvoll GH, 2011, LUPUS, V20, P115, DOI 10.1177/0961203310389487; Tsai HM, 1998, NEW ENGL J MED, V339, P1585, DOI 10.1056/NEJM199811263392203; Warkentin TE, 2001, NEW ENGL J MED, V344, P1286, DOI 10.1056/NEJM200104263441704; Warkentin TE, 2009, BLOOD, V113, P4963, DOI 10.1182/blood-2008-10-186064	32	100	101	0	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 24	2011	378	9797					1166	1173		10.1016/S0140-6736(11)61253-1	http://dx.doi.org/10.1016/S0140-6736(11)61253-1			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	829RH	21890192				2022-12-28	WOS:000295601500024
J	Planavsky, NJ; McGoldrick, P; Scott, CT; Li, C; Reinhard, CT; Kelly, AE; Chu, XL; Bekker, A; Love, GD; Lyons, TW				Planavsky, Noah J.; McGoldrick, Peter; Scott, Clinton T.; Li, Chao; Reinhard, Christopher T.; Kelly, Amy E.; Chu, Xuelei; Bekker, Andrey; Love, Gordon D.; Lyons, Timothy W.			Widespread iron-rich conditions in the mid-Proterozoic ocean	NATURE			English	Article							FERRUGINOUS CONDITIONS; SULFUR; SULFATE; CARBON; CHEMISTRY; EVOLUTION; SEAWATER; DEPOSITS; MODEL	The chemical composition of the ocean changed markedly with the oxidation of the Earth's surface(1), and this process has profoundly influenced the evolutionary and ecological history of life(2,3). The early Earth was characterized by a reducing ocean-atmosphere system, whereas the Phanerozoic eon (less than 542 million years ago) is known for a stable and oxygenated biosphere conducive to the radiation of animals. The redox characteristics of surface environments during Earth's middle age (1.8-1 billion years ago) are less well known, but it is generally assumed that the mid-Proterozoic was home to a globally sulphidic (euxinic) deep ocean(2,3). Here we present iron data from a suite of mid-Proterozoic marine mudstones. Contrary to the popular model, our results indicate that ferruginous (anoxic and Fe2+-rich) conditions were both spatially and temporally extensive across diverse palaeogeographic settings in the mid-Proterozoic ocean, inviting new models for the temporal distribution of iron formations and the availability of bioessential trace elements during a critical window for eukaryotic evolution.	[Planavsky, Noah J.; Scott, Clinton T.; Li, Chao; Reinhard, Christopher T.; Kelly, Amy E.; Love, Gordon D.; Lyons, Timothy W.] Univ Calif Riverside, Dept Earth Sci, Riverside, CA 92521 USA; [McGoldrick, Peter] Univ Tasmania, CODES ARC Ctr Excellence Ore Deposits, Hobart, Tas 7001, Australia; [Li, Chao] China Univ Geosci, State Key Lab Biogeol & Environm Geol, Wuhan 430074, Peoples R China; [Chu, Xuelei] Chinese Acad Sci, Inst Geol & Geophys, Beijing 100029, Peoples R China; [Bekker, Andrey] Univ Manitoba, Dept Geol Sci, Winnipeg, MB R3T 2N2, Canada	University of California System; University of California Riverside; University of Tasmania; China University of Geosciences; Chinese Academy of Sciences; Institute of Geology & Geophysics, CAS; University of Manitoba	Lyons, TW (corresponding author), Univ Calif Riverside, Dept Earth Sci, Riverside, CA 92521 USA.	timothy.lyons@ucr.edu	Chu, Xuelei/AAE-6623-2022	Chu, Xuelei/0000-0002-2155-7081; Bekker, Andrey/0000-0002-1154-0585; Li, Chao/0000-0001-9861-661X	National Science Foundation (NSF); Geological Society of America; American Philosophical Society; NSF Division of Earth Sciences; NASA; Astrobiology Institute; UTAS Visiting Fellows programme; Agouron Institute; Natural Sciences and Engineering Research Council of Canada; Australian Research Council	National Science Foundation (NSF)(National Science Foundation (NSF)); Geological Society of America; American Philosophical Society; NSF Division of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); NASA(National Aeronautics & Space Administration (NASA)); Astrobiology Institute; UTAS Visiting Fellows programme; Agouron Institute(Pfizer); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Australian Research Council(Australian Research Council)	We thank P. Emsbo, S. Bull and D. Winston for formative discussions, P. Fralick for constructive comments, and S. Bates and J. Owens for assistance with the analyses. This work was supported by funding from the National Science Foundation (NSF) Graduate Research Fellowship programme, Geological Society of America and American Philosophical Society, to N.J.P.; from the NSF Division of Earth Sciences, the NASA Exobiology Program and Astrobiology Institute and the UTAS Visiting Fellows programme to T. W. L.; from the Agouron Institute to T. W. L. and G. D. L; and from Natural Sciences and Engineering Research Council of Canada to A. B. P.McG. was supported through the Australian Research Council's Centre of Excellence programme.	Anbar AD, 2002, SCIENCE, V297, P1137, DOI 10.1126/science.1069651; Bekker A, 2008, EARTH PLANET SC LETT, V271, P278, DOI 10.1016/j.epsl.2008.04.021; Bekker A, 2010, ECON GEOL, V105, P467, DOI 10.2113/gsecongeo.105.3.467; Brocks JJ, 2005, NATURE, V437, P866, DOI 10.1038/nature04068; Canfield DE, 2005, ANNU REV EARTH PL SC, V33, P1, DOI 10.1146/annurev.earth.33.092203.122711; Canfield DE, 1998, NATURE, V396, P450, DOI 10.1038/24839; Canfield DE, 2008, SCIENCE, V321, P949, DOI 10.1126/science.1154499; Chu XL, 2007, GEOCHIM COSMOCHIM AC, V71, P4668, DOI 10.1016/j.gca.2007.07.017; David LA, 2011, NATURE, V469, P93, DOI 10.1038/nature09649; Gellatly AM, 2005, GEOCHIM COSMOCHIM AC, V69, P3813, DOI 10.1016/j.gca.2005.01.019; Holland HD, 2005, ECON GEOL, V100, P1489, DOI 10.2113/100.8.1489; Johnston DT, 2008, GEOCHIM COSMOCHIM AC, V72, P4278, DOI 10.1016/j.gca.2008.06.004; Johnston DT, 2010, EARTH PLANET SC LETT, V290, P64, DOI 10.1016/j.epsl.2009.11.059; Kendall B, 2010, NAT GEOSCI, V3, P647, DOI 10.1038/NGEO942; Kendall B, 2009, GEOCHIM COSMOCHIM AC, V73, P2534, DOI 10.1016/j.gca.2009.02.013; Kump LR, 2005, EARTH PLANET SC LETT, V235, P654, DOI 10.1016/j.epsl.2005.04.040; Li C, 2010, SCIENCE, V328, P80, DOI 10.1126/science.1182369; Lyons TW, 2009, GEOBIOLOGY, V7, P489, DOI 10.1111/j.1472-4669.2009.00222.x; Lyons TW, 2009, ANNU REV EARTH PL SC, V37, P507, DOI 10.1146/annurev.earth.36.031207.124233; Lyons TW, 2000, GEOCHIM COSMOCHIM AC, V64, P427, DOI 10.1016/S0016-7037(99)00323-3; McGoldrick P., 2010, SOC EC GEOL SPEC PUB, V15, P1; Poulton SW, 2011, ELEMENTS, V7, P107, DOI 10.2113/gselements.7.2.107; Poulton SW, 2010, NAT GEOSCI, V3, P486, DOI 10.1038/NGEO889; Poulton SW, 2005, CHEM GEOL, V214, P209, DOI 10.1016/j.chemgeo.2004.09.003; Poulton SW, 2004, NATURE, V431, P173, DOI 10.1038/nature02912; Raiswell R, 2008, AM J SCI, V308, P105, DOI 10.2475/02.2008.01; Reinhard CT, 2009, SCIENCE, V326, P713, DOI 10.1126/science.1176711; Scott C, 2008, NATURE, V452, P456, DOI 10.1038/nature06811; Scott CT, 2011, GEOLOGY, V39, P119, DOI 10.1130/G31571.1; Shen Y, 2003, NATURE, V423, P632, DOI 10.1038/nature01651; Slack JF, 2007, EARTH PLANET SC LETT, V255, P243, DOI 10.1016/j.epsl.2006.12.018; Swanson-Hysell NL, 2010, SCIENCE, V328, P608, DOI 10.1126/science.1184508; Wilson JP, 2010, PRECAMBRIAN RES, V179, P135, DOI 10.1016/j.precamres.2010.02.019	33	325	342	6	229	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 22	2011	477	7365					448	U95		10.1038/nature10327	http://dx.doi.org/10.1038/nature10327			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822WH	21900895				2022-12-28	WOS:000295080500037
J	Cote, M; Misasi, J; Ren, T; Bruchez, A; Lee, K; Filone, CM; Hensley, L; Li, Q; Ory, D; Chandran, K; Cunningham, J				Cote, Marceline; Misasi, John; Ren, Tao; Bruchez, Anna; Lee, Kyungae; Filone, Claire Marie; Hensley, Lisa; Li, Qi; Ory, Daniel; Chandran, Kartik; Cunningham, James			Small molecule inhibitors reveal Niemann-Pick C1 is essential for Ebola virus infection	NATURE			English	Article							STEROL-SENSING DOMAIN; CHOLESTEROL ACCUMULATION; ZAIRE EBOLAVIRUS; VIRAL ENTRY; BINDING; GLYCOPROTEIN; PROTEIN; TRAFFICKING; EVENTS; IDENTIFICATION	Ebola virus (EboV) is a highly pathogenic enveloped virus that causes outbreaks of zoonotic infection in Africa. The clinical symptoms are manifestations of the massive production of pro-inflammatory cytokines in response to infection(1) and in many outbreaks, mortality exceeds 75%. The unpredictable onset, ease of transmission, rapid progression of disease, high mortality and lack of effective vaccine or therapy have created a high level of public concern about EboV(2). Here we report the identification of a novel benzylpiperazine adamantane diamide-derived compound that inhibits EboV infection. Using mutant cell lines and informative derivatives of the lead compound, we show that the target of the inhibitor is the endosomal membrane protein Niemann-Pick C1 (NPC1). We find that NPC1 is essential for infection, that it binds to the virus glycoprotein (GP), and that antiviral compounds interfere with GP binding to NPC1. Combined with the results of previous studies of GP structure and function, our findings support a model of EboV infection in which cleavage of the GP1 subunit by endosomal cathepsin proteases removes heavily glycosylated domains to expose the amino-terminal domain(3-7), which is a ligand for NPC1 and regulates membrane fusion by the GP2 subunit(8). Thus, NPC1 is essential for EboV entry and a target for antiviral therapy.	[Cote, Marceline; Misasi, John; Bruchez, Anna; Filone, Claire Marie; Li, Qi; Chandran, Kartik; Cunningham, James] Brigham & Womens Hosp, Dept Med, Div Hematol, Boston, MA 02115 USA; [Misasi, John] Childrens Hosp, Dept Med, Div Infect Dis, Boston, MA 02115 USA; [Ren, Tao; Lee, Kyungae] Harvard Univ, Sch Med, New England Reg Ctr Excellence Biodefense & Emerg, Boston, MA 02115 USA; [Filone, Claire Marie; Hensley, Lisa] USA, Med Res Inst Infect Dis, Div Virol, Frederick, MD 21702 USA; [Ory, Daniel] Washington Univ, Sch Med, Diabet Cardiovasc Dis Ctr, St Louis, MO 63110 USA; [Cunningham, James] Harvard Univ, Sch Med, Dept Microbiol & Immunol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Washington University (WUSTL); Harvard University; Harvard Medical School	Cunningham, J (corresponding author), Brigham & Womens Hosp, Dept Med, Div Hematol, Boston, MA 02115 USA.	jcunningham@rics.bwh.harvard.edu	Cote, Marceline/AAA-6386-2021	Hensley, Lisa/0000-0003-1188-4342; Filone, Claire Marie/0000-0002-4041-3948; Bruchez, Anna/0000-0003-1695-5349; Misasi, John/0000-0001-7169-2639	PIDS-Sanofi-Pasteur Fellowship [K12-HD052896, 5K08AI079381, 5-T32-HL007623]; Fonds de la Recherche en Sante du Quebec; US Army Medical Research and Material Command;  [U54 AI057159];  [R01 CA104266]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD052896] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA104266] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007623] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057159, K08AI079381, R01AI088027] Funding Source: NIH RePORTER	PIDS-Sanofi-Pasteur Fellowship; Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec); US Army Medical Research and Material Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank B. Considine, A. Nilsson and S. Wilkes for assistance, S. Chiang for critical reading of the manuscript, G. Beltz, N. Gray, S. Grinstein, Y. Iannou, R. Infante, J. Kornhuber, F. Sharom and S. Whelan for discussion. This work was supported by grants from U54 AI057159, R01 CA104266 to J. C., PIDS-Sanofi-Pasteur Fellowship, K12-HD052896 and 5K08AI079381 to J. M., 5-T32-HL007623 to A.B., and fellowship from Fonds de la Recherche en Sante du Quebec to M. C.; C. M. F. was supported by the Postgraduate Research Participation Program at the US Army Medical Research and Material Command administered by the Oak Ridge Institute for Science and Education through an interagency agreement between the US Department of Energy and USAMRMC.	Ban HS, 2010, J AM CHEM SOC, V132, P11870, DOI 10.1021/ja104739t; Brindley MA, 2007, J VIROL, V81, P7702, DOI 10.1128/JVI.02433-06; Chandran K, 2005, SCIENCE, V308, P1643, DOI 10.1126/science.1110656; Chevallier J, 2008, J BIOL CHEM, V283, P27871, DOI 10.1074/jbc.M801463200; Du XM, 2011, J CELL BIOL, V192, P121, DOI 10.1083/jcb.201004142; Dube D, 2010, P NATL ACAD SCI USA, V107, P16637, DOI 10.1073/pnas.1008509107; Dube D, 2009, J VIROL, V83, P2883, DOI 10.1128/JVI.01956-08; Geisbert TW, 2004, NAT MED, V10, pS110, DOI 10.1038/nm1142; Gelsthorpe ME, 2008, J BIOL CHEM, V283, P8229, DOI 10.1074/jbc.M708735200; Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456; Hood CL, 2010, J VIROL, V84, P2972, DOI 10.1128/JVI.02151-09; Huynh KK, 2008, J BIOL CHEM, V283, P35745, DOI 10.1074/jbc.M806232200; Kaletsky RL, 2007, J VIROL, V81, P13378, DOI 10.1128/JVI.01170-07; Ko DC, 2001, MOL BIOL CELL, V12, P601, DOI 10.1091/mbc.12.3.601; Kolter T, 2010, FEBS LETT, V584, P1700, DOI 10.1016/j.febslet.2009.10.021; Kuhn JH, 2006, J BIOL CHEM, V281, P15951, DOI 10.1074/jbc.M601796200; Lee JE, 2008, NATURE, V454, P177, DOI 10.1038/nature07082; Millard EE, 2000, J BIOL CHEM, V275, P38445, DOI 10.1074/jbc.M003180200; Millard EE, 2005, J BIOL CHEM, V280, P28581, DOI 10.1074/jbc.M414024200; Nanbo A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001121; Ohgami N, 2004, P NATL ACAD SCI USA, V101, P12473, DOI 10.1073/pnas.0405255101; Saeed MF, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001110; Schornberg K, 2006, J VIROL, V80, P4174, DOI 10.1128/JVI.80.8.4174-4178.2006; Sobo K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000851; SONEOKA Y, 1995, NUCLEIC ACIDS RES, V23, P628, DOI 10.1093/nar/23.4.628; Towner JS, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000212; Towner JS, 2005, VIROLOGY, V332, P20, DOI 10.1016/j.virol.2004.10.048; Weidmann M, 2004, J CLIN VIROL, V30, P94, DOI 10.1016/j.jcv.2003.09.004; Wong AC, 2010, J VIROL, V84, P163, DOI 10.1128/JVI.01832-09; Zampieri CA, 2007, NAT IMMUNOL, V8, P1159, DOI 10.1038/ni1519	30	489	524	1	172	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 15	2011	477	7364					344	U122		10.1038/nature10380	http://dx.doi.org/10.1038/nature10380			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819TD	21866101	Green Accepted			2022-12-28	WOS:000294852400034
J	Park, D; Han, CZ; Elliott, MR; Kinchen, JM; Trampont, PC; Das, S; Collins, S; Lysiak, JJ; Hoehn, KL; Ravichandran, KS				Park, Daeho; Han, Claudia Z.; Elliott, Michael R.; Kinchen, Jason M.; Trampont, Paul C.; Das, Soumita; Collins, Sheila; Lysiak, Jeffrey J.; Hoehn, Kyle L.; Ravichandran, Kodi S.			Continued clearance of apoptotic cells critically depends on the phagocyte Ucp2 protein	NATURE			English	Article							MITOCHONDRIAL UNCOUPLING-PROTEIN; PHOSPHATIDYLSERINE RECEPTOR; PROTON LEAK; ENGULFMENT; OBESITY; GENE	Rapid and efficient removal of apoptotic cells by phagocytes is important during development, tissue homeostasis and in immune responses(1-5). Efficient clearance depends on the capacity of a single phagocyte to ingest multiple apoptotic cells successively, and to process the corpse-derived cellular material(6). However, the factors that influence continued clearance by phagocytes are not known. Here we show that the mitochondrial membrane potential of the phagocyte critically controls engulfment capacity, with lower potential enhancing engulfment and vice versa. The mitochondrial membrane protein Ucp2, which acts to lower the mitochondrial membrane potential(7-9), was upregulated in phagocytes engulfing apoptotic cells. Loss of Ucp2 reduced phagocytic capacity, whereas Ucp2 overexpression enhanced engulfment. Mutational and pharmacological studies indicated a direct role for Ucp2-mediated mitochondrial function in phagocytosis. Macrophages from Ucp2-deficient mice(10,11) were impaired in phagocytosis in vitro, and Ucp2-deficient mice showed profound in vivo defects in clearing dying cells in the thymus and testes. Collectively, these data indicate that mitochondrial membrane potential and Ucp2 are key molecular determinants of apoptotic cell clearance. As Ucp2 is linked to metabolic diseases and atherosclerosis(11,12), this newly discovered role for Ucp2 in apoptotic cell clearance has implications for the complex aetiology and pathogenesis of these diseases.	[Park, Daeho; Han, Claudia Z.; Elliott, Michael R.; Kinchen, Jason M.; Trampont, Paul C.; Ravichandran, Kodi S.] Univ Virginia, Ctr Cell Clearance, Charlottesville, VA 22908 USA; [Park, Daeho; Han, Claudia Z.; Elliott, Michael R.; Kinchen, Jason M.; Trampont, Paul C.; Ravichandran, Kodi S.] Univ Virginia, Beirne B Carter Ctr Immunol Res, Charlottesville, VA 22908 USA; [Han, Claudia Z.; Kinchen, Jason M.; Ravichandran, Kodi S.] Univ Virginia, Dept Microbiol, Charlottesville, VA 22908 USA; [Das, Soumita] Univ Virginia, Dept Med, Charlottesville, VA 22908 USA; [Collins, Sheila] Sanford Burnham Med Res Inst, Diabet & Obes Res Ctr, Orlando, FL 32827 USA; [Lysiak, Jeffrey J.] Univ Virginia, Dept Urol, Charlottesville, VA 22908 USA; [Hoehn, Kyle L.] Univ Virginia, Dept Pharmacol, Charlottesville, VA 22908 USA; [Hoehn, Kyle L.] Univ Virginia, CVRC, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia; University of Virginia; University of Virginia; Sanford Burnham Prebys Medical Discovery Institute; University of Virginia; University of Virginia; University of Virginia	Ravichandran, KS (corresponding author), Univ Virginia, Ctr Cell Clearance, Charlottesville, VA 22908 USA.	ravi@virginia.edu	Kinchen, Jason/ABC-5663-2021	Hoehn, Kyle/0000-0002-0214-3238; Trampont, Paul/0000-0002-3643-8472; Elliott, Michael/0000-0002-0642-482X; Kinchen, Jason/0000-0001-8430-2265; Ravichandran, Kodi/0000-0001-9049-1410	National Institute of General Medical Sciences; National Institute of Child Health and Development; American Heart Association; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD057242] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI055432] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064709, T32GM008136] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Child Health and Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); American Heart Association(American Heart Association); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Schwartz and members of the K. S. R. laboratory for discussions. This work was supported by grants from the National Institute of General Medical Sciences (to K. S. R.), and ARRA funding from National Institute of Child Health and Development (to J.J.L. and K. S. R.). K. S. R. is a Bill Benter Senior Fellow of the American Asthma Foundation. J.M.K. is supported by an American Heart Association Award.	Andrews ZB, 2008, NATURE, V454, P846, DOI 10.1038/nature07181; Arsenijevic D, 2000, NAT GENET, V26, P435, DOI 10.1038/82565; Azzu V, 2010, TRENDS BIOCHEM SCI, V35, P298, DOI 10.1016/j.tibs.2009.11.001; Blanc J, 2003, CIRCULATION, V107, P388, DOI 10.1161/01.CIR.0000051722.66074.60; Echtay KS, 2000, BIOCHEMISTRY-US, V39, P3311, DOI 10.1021/bi992448m; Elliott MR, 2010, J CELL BIOL, V189, P1059, DOI 10.1083/jcb.201004096; Elliott MR, 2009, NATURE, V461, P282, DOI 10.1038/nature08296; Enerback S, 1997, NATURE, V387, P90, DOI 10.1038/387090a0; Fleury C, 1997, NAT GENET, V15, P269, DOI 10.1038/ng0397-269; Gregory CD, 2011, J PATHOL, V223, P177, DOI 10.1002/path.2792; Kobayashi N, 2007, IMMUNITY, V27, P927, DOI 10.1016/j.immuni.2007.11.011; Krauss S, 2002, P NATL ACAD SCI USA, V99, P118, DOI 10.1073/pnas.012410699; Krauss S, 2005, NAT REV MOL CELL BIO, V6, P248, DOI 10.1038/nrm1592; Lugli E, 2005, CYTOM PART A, V68A, P28, DOI 10.1002/cyto.a.20188; Miyanishi M, 2007, NATURE, V450, P435, DOI 10.1038/nature06307; Moukdar F, 2009, J LIPID RES, V50, P59, DOI 10.1194/jlr.M800273-JLR200; Munoz LE, 2010, NAT REV RHEUMATOL, V6, P280, DOI 10.1038/nrrheum.2010.46; Park D, 2007, NATURE, V450, P430, DOI 10.1038/nature06329; Park D, 2009, CURR BIOL, V19, P346, DOI 10.1016/j.cub.2009.01.042; Pi J, 2010, DIABETES OBES METAB, V12, P141, DOI 10.1111/j.1463-1326.2010.01269.x; Ravichandran KS, 2007, NAT REV IMMUNOL, V7, P964, DOI 10.1038/nri2214; REERS M, 1991, BIOCHEMISTRY-US, V30, P4480, DOI 10.1021/bi00232a015; Sokal A, 1998, ARCH BIOCHEM BIOPHYS, V349, P113, DOI 10.1006/abbi.1997.0445; Tabas I, 2010, NAT REV IMMUNOL, V10, P36, DOI 10.1038/nri2675; Urbankova E, 2003, INT J BIOCHEM CELL B, V35, P212, DOI 10.1016/S1357-2725(02)00131-0; Zhang CY, 2006, CELL METAB, V3, P417, DOI 10.1016/j.cmet.2006.04.010	28	147	152	1	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 8	2011	477	7363					220	U126		10.1038/nature10340	http://dx.doi.org/10.1038/nature10340			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	816MC	21857682	Green Accepted			2022-12-28	WOS:000294603900038
J	Dhaliwal, G				Dhaliwal, Gurpreet			The Mechanics of Reasoning	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Dhaliwal, Gurpreet] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Dhaliwal, Gurpreet] San Francisco VA Med Ctr, San Francisco, CA USA	University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center	Dhaliwal, G (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.	gurpreet.dhaliwal@ucsf.edu						[Anonymous], STUMP CHUMPS; O'Shea DC, 2002, OPT ENG, V41, P1462, DOI 10.1117/1.1494997; PETERSON MC, 1992, WESTERN J MED, V156, P163	3	3	3	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 7	2011	306	9					918	919		10.1001/jama.2011.1027	http://dx.doi.org/10.1001/jama.2011.1027			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	815QT	21900128				2022-12-28	WOS:000294542600001
J	Dang, EV; Barbi, J; Yang, HY; Jinasena, D; Yu, H; Zheng, Y; Bordman, Z; Fu, J; Kim, Y; Yen, HR; Luo, WB; Zeller, K; Shimoda, L; Topalian, SL; Semenza, GL; Dang, CV; Pardoll, DM; Pan, F				Dang, Eric V.; Barbi, Joseph; Yang, Huang-Yu; Jinasena, Dilini; Yu, Hong; Zheng, Ying; Bordman, Zachary; Fu, Juan; Kim, Young; Yen, Hung-Rong; Luo, Weibo; Zeller, Karen; Shimoda, Larissa; Topalian, Suzanne L.; Semenza, Gregg L.; Dang, Chi V.; Pardoll, Drew M.; Pan, Fan			Control of T(H)17/T-reg Balance by Hypoxia-Inducible Factor 1	CELL			English	Article							REGULATORY T-CELLS; TGF-BETA; CUTTING EDGE; DIFFERENTIATION; EFFECTOR; ACTIVATION; TH17; INDUCTION; MTOR; AUTOIMMUNITY	T cell differentiation into distinct functional effector and inhibitory subsets is regulated, in part, by the cytokine environment present at the time of antigen recognition. Here, we show that hypoxia-inducible factor 1 (HIF-1), a key metabolic sensor, regulates the balance between regulatory T cell (T-reg) and T(H)17 differentiation. HIF-1 enhances T(H)17 development through direct transcriptional activation of ROR gamma t and via tertiary complex formation with ROR gamma t and p300 recruitment to the IL-17 promoter, thereby regulating T(H)17 signature genes. Concurrently, HIF-1 attenuates T-reg development by binding Foxp3 and targeting it for proteasomal degradation. Importantly, this regulation occurs under both normoxic and hypoxic conditions. Mice with HIF-1 alpha-deficient T cells are resistant to induction of T(H)17-dependent experimental autoimmune encephalitis associated with diminished T(H)17 and increased T-reg cells. These findings highlight the importance of metabolic cues in T cell fate determination and suggest that metabolic modulation could ameliorate certain T cell-based immune pathologies.	[Dang, Eric V.; Barbi, Joseph; Yang, Huang-Yu; Jinasena, Dilini; Yu, Hong; Zheng, Ying; Bordman, Zachary; Yen, Hung-Rong; Pardoll, Drew M.; Pan, Fan] Johns Hopkins Univ, Sch Med, Immunol & Hematopoiesis Div, Dept Oncol & Med,Sidney Kimmel Comprehens Canc Ct, Baltimore, MD 21231 USA; [Fu, Juan; Kim, Young] Johns Hopkins Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21231 USA; [Luo, Weibo; Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Vasc Program, Inst Cell Engn,Dept Pediat, Baltimore, MD 21231 USA; [Luo, Weibo; Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Vasc Program, Inst Cell Engn,Dept Med, Baltimore, MD 21231 USA; [Luo, Weibo; Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Vasc Program, Inst Cell Engn,Dept Oncol, Baltimore, MD 21231 USA; [Luo, Weibo; Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Vasc Program, Inst Cell Engn,Dept Radiat Oncol, Baltimore, MD 21231 USA; [Luo, Weibo; Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Vasc Program, Inst Cell Engn,Dept Biol Chem, Baltimore, MD 21231 USA; [Luo, Weibo; Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21231 USA; [Zeller, Karen; Dang, Chi V.] Johns Hopkins Univ, Sch Med, Div Hematol, Dept Med, Baltimore, MD 21231 USA; [Shimoda, Larissa] Johns Hopkins Univ, Sch Med, Div Pulm & Crit Care Med, Dept Med, Baltimore, MD 21231 USA; [Topalian, Suzanne L.] Johns Hopkins Univ, Sch Med, Dept Surg, Baltimore, MD 21231 USA; [Yang, Huang-Yu] Chang Gung Univ, Coll Med, Dept Nephrol, Chang Gung Mem Hosp, Tao Yuan 333, Taiwan; [Yen, Hung-Rong] Chang Gung Univ, Coll Med, Dept Pediat, Chang Gung Mem Hosp,Ctr Tradit Chinese Med, Tao Yuan 333, Taiwan	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University	Pardoll, DM (corresponding author), Johns Hopkins Univ, Sch Med, Immunol & Hematopoiesis Div, Dept Oncol & Med,Sidney Kimmel Comprehens Canc Ct, Baltimore, MD 21231 USA.	dmpardol@jhmi.edu; fpan1@jhmi.edu	Dang, Chi/Y-3375-2019; Yen, Hung-Rong/M-1373-2013	Yen, Hung-Rong/0000-0002-0131-1658; YANG, HUANG-YU/0000-0001-6826-9717; Luo, Weibo/0000-0002-1992-0320; Dang, Chi/0000-0002-4031-2522; Dang, Eric/0000-0002-2389-6167	NIH; Melanoma Research Alliance; Janey Fund and Seraph Foundation; Stewart Trust; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI089830] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Melanoma Research Alliance; Janey Fund and Seraph Foundation; Stewart Trust; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the members of the D. Pardoll, F. Pan, J. Powell, and C. Drake laboratories for helpful discussions. We are grateful to Drs. J. Liu (Department of Pharmacology at Johns Hopkins), A. Rudensky (Memorial Sloan Kettering Cancer Center), and D. Littman (NYU) for helpful suggestions and/or reagent contribution. We thank Dr. H. Wei (Dr. Semenza's laboratory) for the HIF1<SUP>fl/fl</SUP> mice and genotyping primer sequences. This work was supported by grants from NIH and the Melanoma Research Alliance, the Janey Fund and Seraph Foundation, and gifts from Bill and Betty Topecer and Dorothy Needle. F.P. is a recipient of the Stewart Trust Scholar Award.	Ahern PP, 2010, IMMUNITY, V33, P279, DOI 10.1016/j.immuni.2010.08.010; Arany Z, 1996, P NATL ACAD SCI USA, V93, P12969, DOI 10.1073/pnas.93.23.12969; Barnes MJ, 2009, IMMUNITY, V31, P401, DOI 10.1016/j.immuni.2009.08.011; Bauquet AT, 2009, NAT IMMUNOL, V10, P167, DOI 10.1038/ni.1690; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Davidson TS, 2007, J IMMUNOL, V178, P4022, DOI 10.4049/jimmunol.178.7.4022; Delgoffe GM, 2011, NAT IMMUNOL, V12, P295, DOI 10.1038/ni.2005; Delgoffe GM, 2009, IMMUNOLOGY, V127, P459, DOI 10.1111/j.1365-2567.2009.03125.x; Delgoffe GM, 2009, IMMUNITY, V30, P832, DOI 10.1016/j.immuni.2009.04.014; Dong C, 2008, NAT REV IMMUNOL, V8, P337, DOI 10.1038/nri2295; Durant L, 2010, IMMUNITY, V32, P605, DOI 10.1016/j.immuni.2010.05.003; Fife BT, 2009, NAT IMMUNOL, V10, P1185, DOI 10.1038/ni.1790; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Getnet D, 2010, MOL IMMUNOL, V47, P1595, DOI 10.1016/j.molimm.2010.02.001; Harris TJ, 2007, J IMMUNOL, V179, P4313, DOI 10.4049/jimmunol.179.7.4313; Hot A, 2011, ANN RHEUM DIS, V70, P727, DOI 10.1136/ard.2010.143768; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Koch CJ, 2002, METHOD ENZYMOL, V352, P3; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Littman DR, 2010, CELL, V140, P845, DOI 10.1016/j.cell.2010.02.021; Luger D, 2008, J EXP MED, V205, P799, DOI 10.1084/jem.20071258; Lukashev D, 2006, J IMMUNOL, V177, P4962, DOI 10.4049/jimmunol.177.8.4962; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; O'Quinn DB, 2008, ADV IMMUNOL, V99, P115, DOI 10.1016/S0065-2776(08)00605-6; Pan F, 2005, EMBO J, V24, P2104, DOI 10.1038/sj.emboj.7600685; Pan F, 2009, SCIENCE, V325, P1142, DOI 10.1126/science.1176077; Pouyssegur J, 2006, BIOL CHEM, V387, P1337, DOI 10.1515/BC.2006.167; Rajewsky K, 2008, CURR OPIN IMMUNOL, V20, P127, DOI 10.1016/j.coi.2008.04.005; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Schraml BU, 2009, NATURE, V460, P405, DOI 10.1038/nature08114; SEMENZA GL, 2007, SCI STKE, pCM8, DOI DOI 10.1126/STKE.4072007CM8; Shi LZ, 2011, J EXP MED, V208, P1367, DOI 10.1084/jem.20110278; Thompson PR, 2004, NAT STRUCT MOL BIOL, V11, P308, DOI 10.1038/nsmb740; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557; Wu SG, 2009, NAT MED, V15, P1016, DOI 10.1038/nm.2015; Xu Q, 2005, ONCOGENE, V24, P5552, DOI 10.1038/sj.onc.1208719; Yang XO, 2008, IMMUNITY, V29, P44, DOI 10.1016/j.immuni.2008.05.007; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Yang XXO, 2007, J BIOL CHEM, V282, P9358, DOI 10.1074/jbc.C600321200; Youn HD, 2000, EMBO J, V19, P4323, DOI 10.1093/emboj/19.16.4323; Zhang HF, 2008, P NATL ACAD SCI USA, V105, P19579, DOI 10.1073/pnas.0809763105; Zheng Y, 2010, NATURE, V463, P808, DOI 10.1038/nature08750; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	48	1016	1077	7	97	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 2	2011	146	5					772	784		10.1016/j.cell.2011.07.033	http://dx.doi.org/10.1016/j.cell.2011.07.033			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	814SM	21871655	Green Accepted, Bronze			2022-12-28	WOS:000294477500017
J	Olah, Z; Bereczky, Z; Szarvas, M; Boda, Z				Olah, Zsolt; Bereczky, Zsuzsanna; Szarvas, Mariann; Boda, Zoltan			Coagulation: cascade!	LANCET			English	Editorial Material							HEPARIN-INDUCED THROMBOCYTOPENIA; ANTIPHOSPHOLIPID SYNDROME; PLATELET ACTIVATION		[Olah, Zsolt; Szarvas, Mariann; Boda, Zoltan] Univ Debrecen, Dept Med 2, H-4012 Debrecen, Hungary; [Bereczky, Zsuzsanna] Univ Debrecen, Clin Res Ctr, H-4012 Debrecen, Hungary	University of Debrecen; University of Debrecen	Olah, Z (corresponding author), Univ Debrecen, Dept Med 2, Nagyerdei Krt 98, H-4012 Debrecen, Hungary.	zsolah@med.unideb.hu						Bounameaux C, 2007, EUR J HAEMATOL, V79, P550, DOI 10.1111/j.1600-0609.2007.00959.x; Greinacher A, 2005, THROMB HAEMOSTASIS, V94, P132, DOI 10.1160/TH04-12-0825; Hoppensteadt DA, 2008, HEMATOL ONCOL CLIN N, V22, P1, DOI 10.1016/j.hoc.2007.11.001; Regnault V, 2003, BLOOD, V101, P1419, DOI 10.1182/blood-2002-02-0620; Warkentin TE, 1997, ANN INTERN MED, V127, P804, DOI 10.7326/0003-4819-127-9-199711010-00005	5	2	3	0	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 20	2011	378	9792					740	740		10.1016/S0140-6736(11)60875-1	http://dx.doi.org/10.1016/S0140-6736(11)60875-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	815EW	21856488				2022-12-28	WOS:000294509900034
J	Dutta, D; Shatalin, K; Epshtein, V; Gottesman, ME; Nudler, E				Dutta, Dipak; Shatalin, Konstantin; Epshtein, Vitaly; Gottesman, Max E.; Nudler, Evgeny			Linking RNA Polymerase Backtracking to Genome Instability in E. coli	CELL			English	Article							REPLICATION FORK PROGRESSION; TERMINATION FACTOR-RHO; COUPLING FACTOR MFD; UNITS IN-VIVO; ESCHERICHIA-COLI; DNA-REPLICATION; TRANSCRIPTION TERMINATION; ELONGATION-FACTORS; BACILLUS-SUBTILIS; REPAIR	Frequent codirectional collisions between the replisome and RNA polymerase (RNAP) are inevitable because the rate of replication is much faster than that of transcription. Here we show that, in E. coli, the outcome of such collisions depends on the productive state of transcription elongation complexes (ECs). Codirectional collisions with backtracked (arrested) ECs lead to DNA double-strand breaks (DSBs), whereas head-on collisions do not. A mechanistic model is proposed to explain backtracking-mediated DSBs. We further show that bacteria employ various strategies to avoid replisome collisions with backtracked RNAP, the most general of which is translation that prevents RNAP backtracking. If translation is abrogated, DSBs are suppressed by elongation factors that either prevent backtracking or reactivate backtracked ECs. Finally, termination factors also contribute to genomic stability by removing arrested ECs. Our results establish RNAP backtracking as the intrinsic hazard to chromosomal integrity and implicate active ribosomes and other anti-backtracking mechanisms in genome maintenance.	[Dutta, Dipak; Shatalin, Konstantin; Epshtein, Vitaly; Nudler, Evgeny] NYU, Sch Med, Dept Biochem, New York, NY 10016 USA; [Gottesman, Max E.] Columbia Univ, Med Ctr, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Gottesman, Max E.] Columbia Univ, Med Ctr, Dept Microbiol, New York, NY 10032 USA	New York University; Columbia University; Columbia University	Nudler, E (corresponding author), NYU, Sch Med, Dept Biochem, New York, NY 10016 USA.	evgeny.nudler@nyumc.org		Nudler, Evgeny/0000-0002-8811-3071	NIH [R01 GM58750, R01 GM32719]; BGRF; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058750] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BGRF; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Yuri Nedyalkov, Linqi Wang, Catherine Potenski, Grigory Mogilnitskiy, and Robert Washburn for technical assistance, Lynn Thomason for plasmid pCODIR (pHW27), Susan Rosenberg for SMR8476 strain, and Hanna Klein and Danny Reinberg for critical reading of the manuscript. This work was supported by grants from the NIH, R01 GM58750 (E.N.) and R01 GM32719 (M. E. G.). We also thank Timur Artemyev and BGRF for their support.	Alff-Steinberger C, 2000, J THEOR BIOL, V206, P307, DOI 10.1006/jtbi.2000.2126; Azvolinsky A, 2006, GENE DEV, V20, P3104, DOI 10.1101/gad.1478906; Birren B, 1993, PULSE FIELD GEL ELEC; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Borukhov S, 2005, MOL MICROBIOL, V55, P1315, DOI 10.1111/j.1365-2958.2004.04481.x; Boubakri H, 2010, EMBO J, V29, P145, DOI 10.1038/emboj.2009.308; BREWER BJ, 1988, CELL, V53, P679, DOI 10.1016/0092-8674(88)90086-4; Cardinale CJ, 2008, SCIENCE, V320, P935, DOI 10.1126/science.1152763; Cheung ACM, 2011, NATURE, V471, P249, DOI 10.1038/nature09785; CONDON C, 1995, MICROBIOL REV, V59, P623, DOI 10.1128/MMBR.59.4.623-645.1995; del Solar G, 1998, MICROBIOL MOL BIOL R, V62, P434, DOI 10.1128/MMBR.62.2.434-464.1998; Deshpande AM, 1996, SCIENCE, V272, P1030, DOI 10.1126/science.272.5264.1030; Dillingham MS, 2008, MICROBIOL MOL BIOL R, V72, P642, DOI 10.1128/MMBR.00020-08; Epshtein V, 2003, SCIENCE, V300, P801, DOI 10.1126/science.1083219; Epshtein V, 2010, NATURE, V463, P245, DOI 10.1038/nature08669; FRENCH S, 1992, SCIENCE, V258, P1362, DOI 10.1126/science.1455232; Galhardo RS, 2007, CRIT REV BIOCHEM MOL, V42, P399, DOI 10.1080/10409230701648502; Greive SJ, 2005, J BIOL CHEM, V280, P36397, DOI 10.1074/jbc.M507146200; Gusarov I, 2005, P NATL ACAD SCI USA, V102, P13855, DOI 10.1073/pnas.0504307102; Kettenberger H, 2004, MOL CELL, V16, P955, DOI 10.1016/j.molcel.2004.11.040; Komissarova N, 1997, J BIOL CHEM, V272, P15329, DOI 10.1074/jbc.272.24.15329; Kornberg A., 1992, DNA REPLICATION; Kostrzynska M, 2002, J MICROBIOL METH, V48, P43, DOI 10.1016/S0167-7012(01)00335-9; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; KUZMINOV A, 1995, MOL MICROBIOL, V16, P373, DOI 10.1111/j.1365-2958.1995.tb02403.x; McGlynn P, 2000, CELL, V101, P35, DOI 10.1016/S0092-8674(00)80621-2; Merrikh H, 2011, NATURE, V470, P554, DOI 10.1038/nature09758; Mirkin EV, 2007, MICROBIOL MOL BIOL R, V71, P13, DOI 10.1128/MMBR.00030-06; Nudler E, 2003, METHOD ENZYMOL, V371, P160; Nudler E, 1997, CELL, V89, P33, DOI 10.1016/S0092-8674(00)80180-4; Nudler E, 2009, ANNU REV BIOCHEM, V78, P335, DOI 10.1146/annurev.biochem.76.052705.164655; Park JS, 2002, CELL, V109, P757, DOI 10.1016/S0092-8674(02)00769-9; Park S, 2003, J BACTERIOL, V185, P1942, DOI 10.1128/JB.185.6.1942-1950.2003; Pennington JM, 2007, NAT GENET, V39, P797, DOI 10.1038/ng2051; Perederina A, 2004, CELL, V118, P297, DOI 10.1016/j.cell.2004.06.030; Pomerantz RT, 2010, SCIENCE, V327, P590, DOI 10.1126/science.1179595; Pomerantz RT, 2008, NATURE, V456, P762, DOI 10.1038/nature07527; Prado F, 2005, EMBO J, V24, P1267, DOI 10.1038/sj.emboj.7600602; Proshkin S, 2010, SCIENCE, V328, P504, DOI 10.1126/science.1184939; Rees WA, 1997, J MOL BIOL, V273, P797, DOI 10.1006/jmbi.1997.1327; RICHARDSON JP, 1991, CELL, V64, P1047, DOI 10.1016/0092-8674(91)90257-Y; Roberts JW, 2008, ANNU REV MICROBIOL, V62, P211, DOI 10.1146/annurev.micro.61.080706.093422; Rocha EPC, 2003, NAT GENET, V34, P377, DOI 10.1038/ng1209; Rudolph CJ, 2007, DNA REPAIR, V6, P981, DOI 10.1016/j.dnarep.2007.02.017; SELBY CP, 1994, MICROBIOL REV, V58, P317, DOI 10.1128/MMBR.58.3.317-329.1994; Sigurdsson S, 2010, MOL CELL, V38, P202, DOI 10.1016/j.molcel.2010.02.026; Tehranchi AK, 2010, CELL, V141, P595, DOI 10.1016/j.cell.2010.03.036; Torres M, 2001, EMBO J, V20, P3811, DOI 10.1093/emboj/20.14.3811; Trautinger BW, 2005, MOL CELL, V19, P247, DOI 10.1016/j.molcel.2005.06.004; Trautinger BW, 2002, EMBO J, V21, P6944, DOI 10.1093/emboj/cdf654; Vilette D, 1996, MOL GEN GENET, V252, P398, DOI 10.1007/BF02173004; Wang D, 2009, SCIENCE, V324, P1203, DOI 10.1126/science.1168729; Wang JD, 2007, P NATL ACAD SCI USA, V104, P5608, DOI 10.1073/pnas.0608999104; Washburn RS, 2011, P NATL ACAD SCI USA, V108, P792, DOI 10.1073/pnas.1009564108; Washburn RS, 2003, J MOL BIOL, V329, P655, DOI 10.1016/S0022-2836(03)00465-0; Yao NY, 2010, CELL, V141, P1088, DOI 10.1016/j.cell.2010.05.042; ZWIEFKA A, 1993, BIOCHEMISTRY-US, V32, P3564, DOI 10.1021/bi00065a007	57	233	237	1	31	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 19	2011	146	4					533	543		10.1016/j.cell.2011.07.034	http://dx.doi.org/10.1016/j.cell.2011.07.034			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	809HY	21854980	Green Accepted, Bronze			2022-12-28	WOS:000294043600009
J	Iheanacho, I				Iheanacho, Ike			DRUG TALES AND OTHER STORIES A dead cert: what we might learn at the bookmakers	BRITISH MEDICAL JOURNAL			English	Editorial Material												iiheanacho@bmjgroup.com							0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 17	2011	343								d5178	10.1136/bmj.d5178	http://dx.doi.org/10.1136/bmj.d5178			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	811LB	21849379				2022-12-28	WOS:000294210500004
J	Kesselheim, AS; Rajkumar, R				Kesselheim, Aaron S.; Rajkumar, Rahul			Who Owns Federally Funded Research? The Supreme Court and the Bayh-Dole Act	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Kesselheim, Aaron S.] Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02115 USA; [Kesselheim, Aaron S.; Rajkumar, Rahul] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Kesselheim, Aaron S.] Harvard Univ, Sch Med, Boston, MA USA; [Rajkumar, Rahul] McKinsey & Co Inc, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Kesselheim, AS (corresponding author), Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, 75 Francis St, Boston, MA 02115 USA.		Kesselheim, Aaron/R-6793-2017	Kesselheim, Aaron/0000-0002-8867-2666				Eisenberg RS, 1996, VA LAW REV, V82, P1663, DOI 10.2307/1073686; HAWKINSON JA, 2011, TECH            0610; Mello MM, 2005, NEW ENGL J MED, V352, P2202, DOI 10.1056/NEJMsa044115; Sampat BN, 2006, RES POLICY, V35, P772, DOI 10.1016/j.respol.2006.04.009	4	3	4	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 29	2011	365	13					1167	1169		10.1056/NEJMp1109168	http://dx.doi.org/10.1056/NEJMp1109168			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	825YO	21879888	Bronze			2022-12-28	WOS:000295318400002
J	Hashimoto, H; Ikegami, N; Shibuya, K; Izumida, N; Noguchi, H; Yasunaga, H; Miyata, H; Acuin, JM; Reich, MR				Hashimoto, Hideki; Ikegami, Naoki; Shibuya, Kenji; Izumida, Nobuyuki; Noguchi, Haruko; Yasunaga, Hideo; Miyata, Hiroaki; Acuin, Jose M.; Reich, Michael R.			Japan: Universal Health Care at 50 years 3 Cost containment and quality of care in Japan: is there a trade-off?	LANCET			English	Article							POSTOPERATIVE COMPLICATIONS; SURGEON VOLUMES; CANCER; STAY; RISK; MORTALITY; REFORM; IMPACT; TIME	Japan's health indices such as life expectancy at birth are among the best in the world. However, at 8.5% the proportion of gross domestic product spent on health is 20th among Organisation for Economic Co-operation and Development countries in 2008 and half as much as that in the USA. Costs have been contained by the nationally uniform fee schedule, in which the global revision rate is set first and item-by-item revisions are then made. Although the structural and process dimensions of quality seem to be poor, the characteristics of the health-care system are primarily attributable to how physicians and hospitals have developed in the country, and not to the cost-containment policy. However, outcomes such as postsurgical mortality rates are as good as those reported for other developed countries. Japan's basic policy has been a combination of tight control of the conditions of payment, but a laissezfaire approach to how services are delivered; this combination has led to a scarcity of professional governance and accountability. In view of the structural problems facing the health-care system, the balance should be shifted towards increased freedom of payment conditions by simplification of reimbursement rules, but tightened control of service delivery by strengthening of regional health planning, both of which should be supported through public monitoring of providers' performance. Japan's experience of good health and low cost suggests that the priority in health policy should initially be improvement of access and prevention of impoverishment from health care, after which efficiency and quality of services should then be pursued.	[Hashimoto, Hideki] Univ Tokyo, Sch Publ Hlth, Dept Hlth Econ & Epidemiol Res, Bunkyo Ku, Tokyo 1310033, Japan; [Shibuya, Kenji] Univ Tokyo, Dept Global Hlth Policy, Tokyo 1310033, Japan; [Yasunaga, Hideo] Univ Tokyo, Dept Hlth Management & Policy, Tokyo 1310033, Japan; [Miyata, Hiroaki] Univ Tokyo, Dept Healthcare Qual Assessment, Tokyo 1310033, Japan; [Ikegami, Naoki] Keio Univ, Dept Hlth Policy & Management, Tokyo, Japan; [Izumida, Nobuyuki; Noguchi, Haruko] Natl Inst Populat & Social Secur Res, Tokyo, Japan; [Acuin, Jose M.] De la SalleHlth Sci Inst, Dasmarinas City, Philippines; [Reich, Michael R.] Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA	University of Tokyo; University of Tokyo; University of Tokyo; University of Tokyo; Keio University; Harvard University; Harvard T.H. Chan School of Public Health	Hashimoto, H (corresponding author), Univ Tokyo, Sch Publ Hlth, Dept Hlth Econ & Epidemiol Res, Bunkyo Ku, Tokyo 1310033, Japan.	hidehashimoto-circ@umin.ac.jp	Noguchi, Haruko/ABF-3059-2020	Noguchi, Haruko/0000-0002-4437-8238; Shibuya, Kenji/0000-0003-2528-7530; Yasunaga, Hideo/0000-0002-6017-469X; Reich, Michael R./0000-0003-3338-0612	Bill & Melinda Gates Foundation; China Medical Board; Ministry of Health, Labour and Welfare [H22-seisaku-shitei-033]; Japan Society for the Promotion of Science (JSPS)	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); China Medical Board; Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We thank Keizo Takemi, Sudhir Anand, and Takahiro Higashi for their valuable comments, Shinya Matsuda, Hiroya Ogata, and Zaiken Nishida, and David Evans and Mitsuhiko Noda for reference, Susan Hubbard for her technical edits, and Hiyuko Fujita, Tomoko Suzuki, and Tadashi Yamamoto (Japan Centre for International Exchange) for their administrative support. This work is in part funded by the Bill & Melinda Gates Foundation and the China Medical Board, and in part by a research grant from the Ministry of Health, Labour and Welfare (H22-seisaku-shitei-033), and by a research grant from the Japan Society for the Promotion of Science (JSPS) (Funding Program for Innovative R&D on Science and Technology; FIRST program, initiated by the Council for Science and Technology Policy). The views and opinions expressed by the independent authors in this publication are provided in their personal capacity and are their sole responsibility.	[Anonymous], 2007, HCUP US DAT HEALTHC; Campbell J, 1998, ART BALANCE HLTH POL; Centers for Disease Control and Prevention, US NAT HLTH NUTR EX; Chino M, 2005, SURVEY COMPLEXITY TI; Coleman MP, 2008, LANCET ONCOL, V9, P730, DOI 10.1016/S1470-2045(08)70179-7; Department of Health Economics University of Kyoto Graduate School of Medicine, 2010, QUAL IMPR PROJ; Donabedian A., 1980, EXPLORATIONS QUALITY; Federation of Health Insurance Societies, 2007, ZUH DE MIR IR HOSH; Hirose M, 2003, HEALTH POLICY, V66, P29, DOI 10.1016/S0168-8510(03)00043-5; Idezuki Yasuo, 2009, Nihon Geka Gakkai Zasshi, V110, P115; Ikai, 2010, BYOUIN NO SEIKI NO R; Ikeda N, 2011, LANCET, V378, P1094, DOI 10.1016/S0140-6736(11)61055-6; Ikegami N, 1999, HEALTH AFFAIR, V18, P56, DOI 10.1377/hlthaff.18.3.56; Ikegami N, 2004, HEALTH AFFAIR, V23, P26, DOI 10.1377/hlthaff.23.3.26; IKEGAMI N, 1994, GERONTOLOGIST, V34, P628, DOI 10.1093/geront/34.5.628; Ikegami N, 2011, LANCET, V378, P1106, DOI 10.1016/S0140-6736(11)60828-3; Ikegami N, 2009, J HEALTH POLIT POLIC, V34, P361, DOI 10.1215/03616878-2009-003; Institute of Medicine, 2001, CROSSING QUALITY CHA; Japan Council for Quality Health Care Division of Adverse Event Prevention, 2008, PROJ COLL MED NEAR M; Kita T, 2004, EUR HEART J SUPPL, V6, pA8, DOI 10.1016/j.ehjsup.2004.01.003; Kohro T, 2008, INT HEART J, V49, P193, DOI 10.1536/ihj.49.193; Koike S, 2010, HEALTH POLICY, V98, P236, DOI 10.1016/j.healthpol.2010.06.021; Leflar Robert B, 2009, Yale J Health Policy Law Ethics, V9, P1; Makuuchi Haruo, 2009, Nihon Geka Gakkai Zasshi, V110, P133; Matsuda S., 2008, Eurohealth, V14, P25; Matsumoto Masatoshi, 2005, Aust J Rural Health, V13, P219, DOI 10.1111/j.1440-1584.2005.00705.x; Miyata H, 2008, J THORAC CARDIOV SUR, V135, P1306, DOI 10.1016/j.jtcvs.2007.10.079; Motomura N, 2008, ANN THORAC SURG, V86, P1866, DOI 10.1016/j.athoracsur.2008.08.001; Murata A, 2011, MED CARE, V49, P313, DOI 10.1097/MLR.0b013e3182028954; National Institute of Population and Social Security Research, SEL DEM IND JAP; OECD, 2011, OECD HLTH DAT 2011; OECD, 2003, SOC GLANC 2002 OECD; Roberts MJ., 2004, GETTING HLTH REFORM; Seino Y, 2010, J DIABETES INVEST, V1, P212, DOI 10.1111/j.2040-1124.2010.00074.x; Statistics and Information Department Minister's Secretariat Ministry of Health labour and Welfare, 2008, KANJ CHOUS 2008; Statistics and Information Department Minister's Secretariat Ministry of Health Labour and Welfare, 2009, BYOIN HOUK 2008; Statistics and Information Department Minister's Secretariat Ministry of Health Labour and Welfare, 2008, JUR KOUD CHOUS 2008; Takagi Y, 1996, CONTAINING HLTH CARE, P278; Takagi Y, 1997, IRYOHOSHO TO IRYOHI, P78; United Nations Population Division, WORLD POP PROSP 2010; Wagstaff A, 2005, 3790 WORLD BANK; Wilson A, 2002, BRIT J GEN PRACT, V52, P1012; Yasunaga H, 2008, INT J UROL, V15, P688, DOI 10.1111/j.1442-2042.2008.02098.x; Yasunaga H, 2010, UROLOGY, V76, P548, DOI 10.1016/j.urology.2010.03.021; Yasunaga H, 2008, RISK MANAG HEALTHC P, V1, P39, DOI 10.2147/RMHP.S4755; Yasunaga H, 2009, SURG TODAY, V39, P955, DOI 10.1007/s00595-008-4052-8; Yasunaga H, 2008, RISK MANAG HEALTHC P, V1, P1, DOI 10.2147/RMHP.S4379; Yasunaga H, 2009, J OBSTET GYNAECOL RE, V35, P699, DOI 10.1111/j.1447-0756.2009.01027.x; Yasunaga H, 2009, SURG TODAY, V39, P663, DOI 10.1007/s00595-008-3848-x; Yasunaga H, 2009, SURG TODAY, V39, P566, DOI 10.1007/s00595-008-3832-5; Yasunaga H, 2009, J ORTHOP SCI, V14, P10, DOI 10.1007/s00776-008-1294-7; Yasunaga H, 2008, NEUROL MED-CHIR, V48, P531, DOI 10.2176/nmc.48.531	52	131	132	2	29	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 24	2011	378	9797					1174	1182		10.1016/S0140-6736(11)60987-2	http://dx.doi.org/10.1016/S0140-6736(11)60987-2			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	829RH	21885098				2022-12-28	WOS:000295601500025
J	Reich, MR; Ikegami, N; Shibuya, K; Takemi, K				Reich, Michael R.; Ikegami, Naoki; Shibuya, Kenji; Takemi, Keizo			50 years of pursuing a healthy society in Japan	LANCET			English	Editorial Material							LIFE EXPECTANCY		[Reich, Michael R.] Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA; [Ikegami, Naoki] Keio Univ, Dept Hlth Policy & Management, Tokyo, Japan; [Shibuya, Kenji] Univ Tokyo, Grad Sch Med, Dept Global Hlth Policy, Tokyo, Japan; [Takemi, Keizo] Japan Ctr Int Exchange, Tokyo, Japan	Harvard University; Harvard T.H. Chan School of Public Health; Keio University; University of Tokyo	Reich, MR (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA.	michael_reich@harvard.edu		Shibuya, Kenji/0000-0003-2528-7530				Hashimoto H, 2011, LANCET, V378, P1174, DOI 10.1016/S0140-6736(11)60987-2; HUDDLE NORIE, 1975, ISLAND DREAMS ENV CR; Ikeda N, 2011, LANCET, V378, P1094, DOI 10.1016/S0140-6736(11)61055-6; Ikegami N, 2011, LANCET, V378, P1106, DOI 10.1016/S0140-6736(11)60828-3; Japanese Ministry of Health Labour and Welfare, ABR LIF TABL JAP 200; Japanese Ministry of Health Labour and Welfare, 2010, VITAL STAT, P14; Kelly William W., 2006, JAPAN DYNAMICS E ASI, P63; Llano R, 2011, LANCET, V378, P1255, DOI 10.1016/S0140-6736(11)61048-9; Lock M., 1980, E ASIAN MED URBAN JA; OECD, 2011, OECD HLTH DAT 2011; Shibuya K, 2011, LANCET, V378, P1265, DOI 10.1016/S0140-6736(11)61098-2; Sugiura Y, 2010, BIOSCI TRENDS, V4, P9; Takemi K, 2008, LANCET, V372, P13, DOI 10.1016/S0140-6736(08)60971-X; Tamiya N, 2011, LANCET, V378, P1183, DOI 10.1016/S0140-6736(11)61176-8; United Nations Population Division, WORLD POP PROSP 2010; Vogel E. F., 1979, JAPAN NUMBER ONE LES; World Bank, WORLD BANK NAT ACC D; Yamaguchi M, 2010, CHICAGO TRIBUNE 0726; YANAGISHITA M, 1988, DEMOGRAPHY, V25, P611, DOI 10.2307/2061325	19	32	34	1	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 17	2011	378	9796					1051	1053		10.1016/S0140-6736(11)60274-2	http://dx.doi.org/10.1016/S0140-6736(11)60274-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	829BE	21885101				2022-12-28	WOS:000295548900004
J	Winter, HS; Gervais, DA; Branda, JA				Winter, Harland S.; Gervais, Debra A.; Branda, John A.			Case 27-2011: A 17-Year-Old Boy with Abdominal Pain and Weight Loss	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CROHNS-DISEASE; TUBERCULOSIS; DIAGNOSIS; CHILDREN; HISTOPLASMOSIS; INFECTION; SYMPTOMS		[Winter, Harland S.] Massachusetts Gen Hosp, Dept Pediat Gastroenterol, Boston, MA 02114 USA; [Gervais, Debra A.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Branda, John A.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Winter, Harland S.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Gervais, Debra A.] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Branda, John A.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Winter, HS (corresponding author), Massachusetts Gen Hosp, Dept Pediat Gastroenterol, Boston, MA 02114 USA.		Branda, John/ABD-5620-2020					Arlet JB, 2004, EUR J CLIN MICROBIOL, V23, P342, DOI 10.1007/s10096-003-1089-x; BHARGAVA DK, 1992, AM J GASTROENTEROL, V87, P109; BHARGAVA DK, 1985, GASTROINTEST ENDOSC, V31, P68, DOI 10.1016/S0016-5107(85)71995-5; CAPPELL MS, 1988, DIGEST DIS SCI, V33, P353, DOI 10.1007/BF01535762; Chiappini E, 2009, J PEDIATR GASTR NUTR, V49, P550, DOI 10.1097/MPG.0b013e3181b0f908; Heikenen JB, 1999, INFLAMM BOWEL DIS, V5, P158, DOI 10.1097/00054725-199908000-00002; Ichikawa T, 2009, CLIN GASTROENTEROL H, V7, pXX, DOI 10.1016/j.cgh.2009.02.015; KANOF ME, 1988, GASTROENTEROLOGY, V95, P1523, DOI 10.1016/S0016-5085(88)80072-6; Kotru M, 2004, ANN HEMATOL, V83, P95, DOI 10.1007/s00277-003-0788-9; Lee YJ, 2006, ENDOSCOPY, V38, P592, DOI 10.1055/s-2006-924996; Levy AD, 2009, RADIOGRAPHICS, V29, P347, DOI 10.1148/rg.292085189; MANOHAR A, 1990, GUT, V31, P1130, DOI 10.1136/gut.31.10.1130; Menczer J, 2003, GYNECOL ONCOL, V88, P58, DOI 10.1006/gyno.2002.6853; Sharma Y R, 2004, Kathmandu Univ Med J (KUMJ), V2, P137	14	5	5	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 8	2011	365	10					940	950		10.1056/NEJMcpc1102200	http://dx.doi.org/10.1056/NEJMcpc1102200			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	816JX	21899455				2022-12-28	WOS:000294595600012
J	Von Korff, M; Kolodny, A; Deyo, RA; Chou, R				Von Korff, Michael; Kolodny, Andrew; Deyo, Richard A.; Chou, Roger			Long-Term Opioid Therapy Reconsidered	ANNALS OF INTERNAL MEDICINE			English	Article							CHRONIC NONCANCER PAIN; OLDER-ADULTS; RECEIVING OPIOIDS; UNITED-STATES; ASSOCIATION; MORTALITY; OVERDOSE; HEALTH; MISUSE	In the past 20 years, primary care physicians have greatly increased prescribing of long-term opioid therapy. However, the rise in opioid prescribing has outpaced the evidence regarding this practice. Increased opioid availability has been accompanied by an epidemic of opioid abuse and overdose. The rate of opioid addiction among patients receiving long-term opioid therapy remains unclear, but research suggests that opioid misuse is not rare. Recent studies report increased risks for serious adverse events, including fractures, cardiovascular events, and bowel obstruction, although further research on medical risks is needed. New data indicate that opioid-related risks may increase with dose. From a societal perspective, higher-dose regimens account for the majority of opioids dispensed, so cautious dosing may reduce both diversion potential and patient risks for adverse effects. Limiting long-term opioid therapy to patients for whom it provides decisive benefits could also reduce risks. Given the warning signs and knowledge gaps, greater caution and selectivity are needed in prescribing long-term opioid therapy. Until stronger evidence becomes available, clinicians should err on the side of caution when considering this treatment.	[Von Korff, Michael] Grp Hlth Res Inst, Seattle, WA 98101 USA; Maimonides Hosp, Brooklyn, NY 11219 USA; Oregon Hlth & Sci Univ, Portland, OR 97239 USA; Kaiser Permanente Ctr Hlth Res, Portland, OR USA	Maimonides Medical Center; Oregon Health & Science University; Kaiser Permanente	Von Korff, M (corresponding author), Grp Hlth Res Inst, 1730 Minor Ave,Suite 1600, Seattle, WA 98101 USA.	vonkorff.m@ghc.org		Chou, Roger/0000-0001-9889-8610; VonKorff, Michael/0000-0001-5386-8477	Group Health Foundation; National Institute of Drug Abuse [R01 DA022557]; National Institute of Aging, National Institutes of Health [R01AG034181]; NATIONAL INSTITUTE ON AGING [R01AG034181] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA022557] Funding Source: NIH RePORTER	Group Health Foundation; National Institute of Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Institute of Aging, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Grant Support: By the Group Health Foundation and by the National Institute of Drug Abuse (R01 DA022557) and National Institute of Aging (R01AG034181), National Institutes of Health.	Banta-Green CJ, 2009, DRUG ALCOHOL DEPEN, V104, P34, DOI 10.1016/j.drugalcdep.2009.03.021; Bohnert ASB, 2011, JAMA-J AM MED ASSOC, V305, P1315, DOI 10.1001/jama.2011.370; Boscarino JA, 2010, ADDICTION, V105, P1776, DOI 10.1111/j.1360-0443.2010.03052.x; Butler SF, 2009, J ADDICT MED, V3, P66, DOI 10.1097/ADM.0b013e31818e41da; Carman WJ, 2011, PHARMACOEPIDEMIOL DR; Chou R, 2009, J PAIN, V10, P147, DOI 10.1016/j.jpain.2008.10.007; Chou R, 2009, J PAIN, V10, P113, DOI 10.1016/j.jpain.2008.10.008; Croft P BF, 2010, CHRONIC PAIN EPIDEMI, P9, DOI DOI 10.1093/ACPROF:OSO/9780199235766.001.0001; Dunn KM, 2010, ANN INTERN MED, V152, P85, DOI 10.7326/0003-4819-152-2-201001190-00006; Ferrell B, 2009, J AM GERIATR SOC, V57, P1331, DOI 10.1111/j.1532-5415.2009.02376.x; Fleming MF, 2007, J PAIN, V8, P573, DOI 10.1016/j.jpain.2007.02.432; Gomes T, 2011, ARCH INTERN MED, V171, P686, DOI 10.1001/archinternmed.2011.117; Haddox JD, 1997, CLIN J PAIN, V13, P6; Martell BA, 2007, ANN INTERN MED, V146, P116, DOI 10.7326/0003-4819-146-2-200701160-00006; Moore TM, 2009, PAIN MED, V10, P1426, DOI 10.1111/j.1526-4637.2009.00743.x; Naliboff BD, 2011, J PAIN, V12, P288, DOI 10.1016/j.jpain.2010.09.003; Office of National Drug Control Policy, EP RESP AM PRESCR DR; Papaleontiou M, 2010, J AM GERIATR SOC, V58, P1353, DOI 10.1111/j.1532-5415.2010.02920.x; Paulozzi LJ, 2008, PHARMACOEPIDEM DR S, V17, P997, DOI 10.1002/pds.1626; Physicians for Responsible Opioid Prescribing, CAUT EV BAS OP PRESC; Reid MC, 2010, PAIN MED, V11, P1063, DOI 10.1111/j.1526-4637.2010.00883.x; Solomon DH, 2010, ARCH INTERN MED, V170, P1968, DOI 10.1001/archinternmed.2010.391; Starrels JL, 2010, ANN INTERN MED, V152, P712, DOI 10.7326/0003-4819-152-11-201006010-00004; Sullivan MD, 2010, PAIN, V149, P345, DOI 10.1016/j.pain.2010.02.037; Sung HE, 2005, J ADOLESCENT HEALTH, V37, P44, DOI 10.1016/j.jadohealth.2005.02.013; Vuong C, 2010, ENDOCR REV, V31, P98, DOI 10.1210/er.2009-0009	26	166	165	0	13	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 6	2011	155	5					325	328		10.7326/0003-4819-155-5-201109060-00011	http://dx.doi.org/10.7326/0003-4819-155-5-201109060-00011			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	815PX	21893626	Green Accepted			2022-12-28	WOS:000294538900007
J	Magnusson, R; Patterson, D				Magnusson, Roger; Patterson, David			Role of law in global response to non-communicable diseases	LANCET			English	Editorial Material									[Magnusson, Roger] Univ Sydney, Sydney Law Sch, Sydney, NSW 2006, Australia; [Patterson, David] Int Dev Law Org, Rome, Italy	University of Sydney	Magnusson, R (corresponding author), Univ Sydney, Sydney Law Sch, Sydney, NSW 2006, Australia.	roger.magnusson@sydney.edu.au						Beaglehole R, 2011, LANCET, V378, P449, DOI 10.1016/S0140-6736(11)60879-9; Beaglehole R, 2011, LANCET, V377, P1438, DOI 10.1016/S0140-6736(11)60393-0; *INT DEV LAW ORG, HLTH LAW; Lencucha R, 2010, LANCET, V376, P852, DOI 10.1016/S0140-6736(10)61256-1; Malone R, 2010, BOTTOM LINE PUBLIC H, P155; MAULIA E, 2009, JAKARTA POST JA 1014; MITCHELL AD, 2010, IMPLICATIONS WORLD T; Organization WH, 2016, GLOBAL STATUS REPORT; *SEACTS, WHAT WE DO; *TOBACCOCONTROLLAW, CAMP TOB FREE KIDS	10	18	18	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 3	2011	378	9794					859	860		10.1016/S0140-6736(11)60975-6	http://dx.doi.org/10.1016/S0140-6736(11)60975-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	818XZ	21890035				2022-12-28	WOS:000294791300009
J	Melius, JM				Melius, James M.			Medical care for workers exposed to the WTC disaster	LANCET			English	Editorial Material							HEALTH		NYS Laborers Hlth Fund, Albany, NY 12211 USA		Melius, JM (corresponding author), NYS Laborers Hlth Fund, Albany, NY 12211 USA.	melius@nysliuna.org						Herbert R, 2006, ENVIRON HEALTH PERSP, V114, P1853, DOI 10.1289/ehp.9592; Landrigan PJ, 2004, ENVIRON HEALTH PERSP, V112, P731, DOI 10.1289/ehp.6702; Moline JM, 2009, J OCCUP ENVIRON MED, V51, P896, DOI 10.1097/JOM.0b013e3181ad49c8; Savitz DA, 2008, MT SINAI J MED, V75, P77, DOI 10.1002/msj.20023; Webber MP, 2009, ENVIRON HEALTH PERSP, V117, P975, DOI 10.1289/ehp.0800291; Wheeler K, 2007, ENVIRON HEALTH PERSP, V115, P1584, DOI 10.1289/ehp.10248; Zeig-Owens R, 2011, LANCET, V378, P898, DOI 10.1016/S0140-6736(11)60989-6	7	2	2	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 3	2011	378	9794					854	855		10.1016/S0140-6736(11)61297-X	http://dx.doi.org/10.1016/S0140-6736(11)61297-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	818XZ	21890032				2022-12-28	WOS:000294791300006
J	Nabel, CS; Kohli, RM				Nabel, Christopher S.; Kohli, Rahul M.			Demystifying DNA Demethylation	SCIENCE			English	Editorial Material							5-METHYLCYTOSINE; GLYCOSYLASE; CONVERSION; GENOME; TET1		[Nabel, Christopher S.] Univ Penn, Perelman Sch Med, Dept Med, Philadelphia, PA 19104 USA; Univ Penn, Perelman Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Nabel, CS (corresponding author), Univ Penn, Perelman Sch Med, Dept Med, Philadelphia, PA 19104 USA.	rkohli@upenn.edu		Kohli, Rahul/0000-0002-7689-5678	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI089242] Funding Source: NIH RePORTER; NIAID NIH HHS [K08 AI089242] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bennett MT, 2006, J AM CHEM SOC, V128, P12510, DOI 10.1021/ja0634829; Bhutani N, 2010, NATURE, V463, P1042, DOI 10.1038/nature08752; Cortazar D, 2011, NATURE, V470, P419, DOI 10.1038/nature09672; Cortellino S, 2011, CELL, V146, P67, DOI 10.1016/j.cell.2011.06.020; Globisch D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015367; Guo JU, 2011, CELL, V145, P423, DOI 10.1016/j.cell.2011.03.022; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Iqbal K, 2011, P NATL ACAD SCI USA, V108, P3642, DOI 10.1073/pnas.1014033108; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Kohli RM, 2010, NAT CHEM BIOL, V6, P866, DOI 10.1038/nchembio.471; Pfaffeneder T, 2011, ANGEW CHEM INT EDIT, V50, P7008, DOI 10.1002/anie.201103899; Rai K, 2008, CELL, V135, P1201, DOI 10.1016/j.cell.2008.11.042; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Wu SC, 2010, NAT REV MOL CELL BIO, V11, P607, DOI 10.1038/nrm2950	15	57	64	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 2	2011	333	6047					1229	1230		10.1126/science.1211917	http://dx.doi.org/10.1126/science.1211917			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	813YM	21885763				2022-12-28	WOS:000294406400031
J	Brakenhoff, RH				Brakenhoff, Ruud H.			Another NOTCH for Cancer	SCIENCE			English	Editorial Material							TUMOR-SUPPRESSOR FUNCTION; SQUAMOUS-CELL CARCINOMA; COLORECTAL CANCERS; HUMAN BREAST; NECK; HEAD; SKIN		Vrije Univ Amsterdam, Med Ctr, Dept Otolaryngol Head & Neck Surg, NL-1007 MB Amsterdam, Netherlands	Vrije Universiteit Amsterdam	Brakenhoff, RH (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Otolaryngol Head & Neck Surg, NL-1007 MB Amsterdam, Netherlands.	rh.brakenhoff@vumc.nl						Agrawal N, 2011, SCIENCE, V333, P1154, DOI 10.1126/science.1206923; Bonner JA, 2006, NEW ENGL J MED, V354, P567, DOI 10.1056/NEJMoa053422; Dotto GP, 2008, ONCOGENE, V27, P5115, DOI 10.1038/onc.2008.225; Ezratty EJ, 2011, CELL, V145, P1129, DOI 10.1016/j.cell.2011.05.030; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Iglehart JD, 2009, NEW ENGL J MED, V361, P189, DOI 10.1056/NEJMe0903044; Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; Klinakis A, 2011, NATURE, V473, P230, DOI 10.1038/nature09999; Leemans CR, 2011, NAT REV CANCER, V11, P9, DOI 10.1038/nrc2982; Nicolas M, 2003, NAT GENET, V33, P416, DOI 10.1038/ng1099; Proweller A, 2006, CANCER RES, V66, P7438, DOI 10.1158/0008-5472.CAN-06-0793; Ranganathan P, 2011, NAT REV CANCER, V11, P338, DOI 10.1038/nrc3035; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720	15	22	24	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 26	2011	333	6046					1102	1103		10.1126/science.1210986	http://dx.doi.org/10.1126/science.1210986			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811VM	21868662				2022-12-28	WOS:000294244300032
J	Ebihara, M; Sekimoto, S; Shirai, N; Hamajima, Y; Yamamoto, M; Kumagai, K; Oura, Y; Ireland, TR; Kitajima, F; Nagao, K; Nakamura, T; Naraoka, H; Noguchi, T; Okazaki, R; Tsuchiyama, A; Uesugi, M; Yurimoto, H; Zolensky, ME; Abe, M; Fujimura, A; Mukai, T; Yada, Y				Ebihara, M.; Sekimoto, S.; Shirai, N.; Hamajima, Y.; Yamamoto, M.; Kumagai, K.; Oura, Y.; Ireland, T. R.; Kitajima, F.; Nagao, K.; Nakamura, T.; Naraoka, H.; Noguchi, T.; Okazaki, R.; Tsuchiyama, A.; Uesugi, M.; Yurimoto, H.; Zolensky, M. E.; Abe, M.; Fujimura, A.; Mukai, T.; Yada, Y.			Neutron Activation Analysis of a Particle Returned from Asteroid Itokawa	SCIENCE			English	Article							HAYABUSA SPACECRAFT; ORDINARY CHONDRITES; COMPONENTS; CHONDRULES; MINERALS; HISTORY; ORIGIN; METAL	A single grain (similar to 3 micrograms) returned by the Hayabusa spacecraft was analyzed by neutron activation analysis. This grain is mainly composed of olivine with minor amounts of plagioclase, troilite, and metal. Our results establish that the Itokawa sample has similar chemical characteristics (iron/scandium and nickel/cobalt ratios) to chondrites, confirming that this grain is extraterrestrial in origin and has primitive chemical compositions. Estimated iridium/nickel and iridium/cobalt ratios for metal in the Itokawa samples are about five times lower than CI carbonaceous chondrite values. A similar depletion of iridium was observed in chondrule metals of ordinary chondrites. These metals must have condensed from the nebular where refractory siderophile elements already condensed and were segregated.	[Ebihara, M.; Shirai, N.; Kumagai, K.; Oura, Y.] Tokyo Metropolitan Univ, Dept Chem, Tokyo 1920397, Japan; [Sekimoto, S.] Kyoto Univ, Inst Res Reactor, Osaka 59004, Japan; [Hamajima, Y.; Yamamoto, M.] Kanazawa Univ, Low Level Radioact Lab, Tatsunokuchi, Japan; [Ireland, T. R.] Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT, Australia; [Kitajima, F.; Naraoka, H.; Okazaki, R.] Kyushu Univ, Dept Earth & Planetary Sci, Fukuoka 812, Japan; [Nagao, K.] Univ Tokyo, Geochem Res Ctr, Tokyo, Japan; [Nakamura, T.] Tohoku Univ, Dept Earth & Planetary Mat Sci, Sendai, Miyagi 980, Japan; [Noguchi, T.] Ibaraki Univ, Coll Sci, Mito, Ibaraki, Japan; [Tsuchiyama, A.] Osaka Univ, Dept Earth & Space Sci, Toyonaka, Osaka 560, Japan; [Uesugi, M.; Abe, M.; Fujimura, A.; Mukai, T.; Yada, Y.] Japan Aerosp Explorat Agcy, Inst Space & Astronaut Sci, Kanagawa, Japan; [Yurimoto, H.] Hokkaido Univ, Sapporo, Hokkaido, Japan; [Zolensky, M. E.] NASA, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA	Tokyo Metropolitan University; Kyoto University; Kanazawa University; Australian National University; Kyushu University; University of Tokyo; Tohoku University; Ibaraki University; Osaka University; Japan Aerospace Exploration Agency (JAXA); Institute of Space & Astronautical Science (ISAS); Hokkaido University; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER	Ebihara, M (corresponding author), Tokyo Metropolitan Univ, Dept Chem, Tokyo 1920397, Japan.	ebihara-mitsuru@tmu.ac.jp	HAMAJIMA, Yasunori/L-3802-2015; Ireland, Trevor R/A-4993-2008; Yurimoto, Hisayoshi/S-9938-2018; Ireland, Trevor R./GSJ-1884-2022; Mukai, Toshifumi/ABD-3297-2021	HAMAJIMA, Yasunori/0000-0002-8485-4606; Ireland, Trevor R/0000-0001-7617-3889; Yurimoto, Hisayoshi/0000-0003-0702-0533; Zolensky, Michael/0000-0002-3181-1303; Noguchi, Takaaki/0000-0001-7211-2595; Uesugi, Masayuki/0000-0001-6261-9034; Naraoka, Hiroshi/0000-0002-2373-8759	Ministry of Education, Culture, Science and Technology of Japan; NASA; Grants-in-Aid for Scientific Research [22224010] Funding Source: KAKEN	Ministry of Education, Culture, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NASA(National Aeronautics & Space Administration (NASA)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a grant-in-aid defrayed by the Ministry of Education, Culture, Science and Technology of Japan. M.E.Z. was supported by NASA.	Abe M, 2006, SCIENCE, V312, P1334, DOI 10.1126/science.1125718; ALLEN RO, 1973, GEOCHIM COSMOCHIM AC, V37, P1435, DOI 10.1016/0016-7037(73)90081-1; Eggins SM, 1998, EARTH PLANET SC LETT, V154, P53, DOI 10.1016/S0012-821X(97)00195-7; Fujiwara A, 2006, SCIENCE, V312, P1330, DOI 10.1126/science.1125841; GROSSMAN JN, 1982, GEOCHIM COSMOCHIM AC, V46, P1081, DOI 10.1016/0016-7037(82)90061-8; GROSSMAN JN, 1985, GEOCHIM COSMOCHIM AC, V49, P925, DOI 10.1016/0016-7037(85)90308-4; JONES JH, 1995, EXPT TRACE ELEMENT P, P73; Kong P, 1997, GEOCHIM COSMOCHIM AC, V61, P2317, DOI 10.1016/S0016-7037(97)00087-2; Mason B., 1970, SMITHSONIAN CONTRIBU, V3, P1; MEYER C, 2008, 27672 NASA JOHNS SPA; Nakamura T, 2011, SCIENCE, V333, P1113, DOI 10.1126/science.1207758; Okada T, 2006, SCIENCE, V312, P1338, DOI 10.1126/science.1125731; RUBIN AE, 1990, GEOCHIM COSMOCHIM AC, V54, P1217, DOI 10.1016/0016-7037(90)90148-E; Rudnick R.L., 2004, TREATISE GEOCHEMISTR, P1, DOI DOI 10.1016/B0-08-043751-6/03016-4; WASSON JT, 1988, PHILOS T R SOC A, V325, P535, DOI 10.1098/rsta.1988.0066; WASSON JT, 1985, METEORITES THEIR REC, P1; Yano H, 2006, SCIENCE, V312, P1350, DOI 10.1126/science.1126164	17	58	59	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 26	2011	333	6046					1119	1121		10.1126/science.1207865	http://dx.doi.org/10.1126/science.1207865			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811VM	21868669				2022-12-28	WOS:000294244300040
J	Corral, GH				Herrera Corral, Gerardo			Stand up against the anti-technology terrorists	NATURE			English	Editorial Material									Natl Polytech Inst Mexico, Res & Adv Studies Ctr, Mexico City, DF, Mexico	Instituto Politecnico Nacional - Mexico	Corral, GH (corresponding author), Natl Polytech Inst Mexico, Res & Adv Studies Ctr, Mexico City, DF, Mexico.	gherrera@fis.cinvestav.mx							0	2	2	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 25	2011	476	7361					373	373		10.1038/476373a	http://dx.doi.org/10.1038/476373a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	811KT	21866118	Bronze			2022-12-28	WOS:000294209400003
J	Bell, CM; Brener, SS; Gunraj, N; Huo, C; Bierman, AS; Scales, DC; Bajcar, J; Zwarenstein, M; Urbach, DR				Bell, Chaim M.; Brener, Stacey S.; Gunraj, Nadia; Huo, Cindy; Bierman, Arlene S.; Scales, Damon C.; Bajcar, Jana; Zwarenstein, Merrick; Urbach, David R.			Association of ICU or Hospital Admission With Unintentional Discontinuation of Medications for Chronic Diseases	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ADVERSE DRUG EVENTS; LONG-TERM MEDICATION; INTENSIVE-CARE-UNIT; ELDERLY-PATIENTS; ANTIHYPERTENSIVE THERAPY; ATRIAL-FIBRILLATION; STATIN THERAPY; PATIENT SAFETY; CANADIANS USE; HEALTH-CARE	Context Patients discharged from acute care hospitals may be at risk for unintentional discontinuation of medications prescribed for chronic diseases. The intensive care unit (ICU) may pose an even greater risk because of the focus on acute events and the presence of multiple transitions in care. Objective To evaluate rates of potentially unintentional discontinuation of medications following hospital or ICU admission. Design, Setting, and Patients A population-based cohort study using administrative records from 1997 to 2009 of all hospitalizations and outpatient prescriptions in Ontario, Canada; it included 396 380 patients aged 66 years or older with continuous use of at least 1 of 5 evidence-based medication groups prescribed for long-term use: (1) statins, (2) antiplatelet/anticoagulant agents, (3) levothyroxine, (4) respiratory inhalers, and (5) gastric acid-suppressing drugs. Rates of medication discontinuation were compared across 3 groups: patients admitted to the ICU, patients hospitalized without ICU admission, and nonhospitalized patients (controls). Odds ratios (ORs) were calculated and adjusted for patient demographics, clinical factors, and health services use. Main Outcome Measures The primary outcome was failure to renew the prescription within 90 days after hospital discharge. Results Patients admitted to the hospital (n=187 912) were more likely to experience potentially unintentional discontinuation of medications than controls (n=208 468) across all medication groups examined. The adjusted ORs (AORs) ranged from 1.18 (95% CI, 1.14-1.23) for discontinuing levothyroxine in 12.3% of hospitalized patients (n=6831) vs 11.0% of controls (n=7114) to an AOR of 1.86 (95% CI, 1.771.97) for discontinuing antiplatelet/anticoagulant agents in 19.4% of hospitalized patients (n=5564) vs 11.8% of controls (n=2535). With ICU exposure, the AORs ranged from 1.48 (95% CI, 1.39-1.57) for discontinuing statins in 14.6% of ICU patients (n=1484) to an AOR of 2.31 (95% CI, 2.07-2.57) for discontinuing antiplatelet/anticoagulant agents in 22.8% of ICU patients (n=522) vs the control group. Admission to an ICU was associated with an additional risk of medication discontinuation in 4 of 5 medication groups vs hospitalizations without an ICU admission. One-year follow-up of patients who discontinued medications showed an elevated AOR for the secondary composite outcome of death, emergency department visit, or emergent hospitalization of 1.07 (95% CI, 1.03-1.11) in the statins group and of 1.10 (95% CI, 1.03-1.16) in the antiplatelet/anticoagulant agents group. Conclusions Patients prescribed medications for chronic diseases were at risk for potentially unintentional discontinuation after hospital admission. Admission to the ICU was generally associated with an even higher risk of medication discontinuation. JAMA. 2011;306(8):840-847 www.jama.com	[Bell, Chaim M.; Brener, Stacey S.] Univ Toronto, St Michaels Hosp, Keenan Res Ctr, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada; [Bell, Chaim M.; Brener, Stacey S.; Bierman, Arlene S.; Zwarenstein, Merrick; Urbach, David R.] Univ Toronto, Dept Hlth Policy Management & Evaluat, Toronto, ON M5B 1W8, Canada; [Bell, Chaim M.; Brener, Stacey S.; Bierman, Arlene S.] Univ Toronto, Dept Med, Toronto, ON M5B 1W8, Canada; [Urbach, David R.] Univ Toronto, Dept Surg, Toronto, ON M5B 1W8, Canada; [Scales, Damon C.] Univ Toronto, Interdept Div Critical Care, Toronto, ON M5B 1W8, Canada; [Bierman, Arlene S.] Univ Toronto, Lawrence S Bloomberg Fac Nursing, Toronto, ON M5B 1W8, Canada; [Bajcar, Jana] Univ Toronto, Leslie Dan Fac Pharm, Toronto, ON M5B 1W8, Canada; [Bell, Chaim M.] Univ Toronto, Ctr Patient Safety, Toronto, ON M5B 1W8, Canada; [Urbach, David R.] Univ Toronto, Univ Hlth Network, Toronto, ON M5B 1W8, Canada; [Bell, Chaim M.; Gunraj, Nadia; Huo, Cindy; Bierman, Arlene S.; Scales, Damon C.; Zwarenstein, Merrick; Urbach, David R.] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Scales, Damon C.] Sunnybrook Hlth Sci Ctr, Dept Crit Care Med, Toronto, ON M4N 3M5, Canada; [Bajcar, Jana] Sunnybrook Hlth Sci Ctr, Dept Pharm, Toronto, ON M4N 3M5, Canada	University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Bell, CM (corresponding author), Univ Toronto, St Michaels Hosp, Keenan Res Ctr, Li Ka Shing Knowledge Inst, 30 Bond St, Toronto, ON M5B 1W8, Canada.	bellc@smh.toronto.on.ca	Greiver, Michelle/N-8764-2015; Zwarenstein, Merrick F/P-5210-2014; Bell, Chaim/C-4611-2015	Greiver, Michelle/0000-0001-8957-0285; Zwarenstein, Merrick F/0000-0003-0162-7027; Bell, Chaim/0000-0002-3778-9469	sanofi-aventis; AstraZeneca; Centre for Medical Technology Policy; Canadian Institutes of Health Research [67113]; Ontario Ministry of Health and Long-Term Care; Canadian Institutes of Health Research	sanofi-aventis(Sanofi-Aventis); AstraZeneca(AstraZeneca); Centre for Medical Technology Policy; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Ministry of Health and Long-Term Care(Ministry of Health and Long-Term Care, Ontario); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Bajcar reported that she has been a consultant to Merck Frosst Canada and AstraZeneca; has received payment from sanofi-aventis for lectures; and has received payment from AstraZeneca for manuscript preparation. Dr Zwarenstein reported that he has been consultant on trial design for Johnson & Johnson; and has received financial support from the Centre for Medical Technology Policy for teaching pragmatic trial design. No other disclosures were reported.; The study was funded by operating grant 67113 from the Canadian Institutes of Health Research. This study was supported by the Institute for Clinical Evaluative Sciences, which is funded by an annual grant from the Ontario Ministry of Health and Long-Term Care. Drs Bell and Scales received funding as Canadian Institutes of Health Research New Investigators. Dr Bell now holds a Canadian Institutes of Health Research/Canadian Patient Safety Institute Chair in Patient Safety and Continuity of Care.	Avorn J, 1998, JAMA-J AM MED ASSOC, V279, P1458, DOI 10.1001/jama.279.18.1458; Bajcar Jana M, 2005, Res Social Adm Pharm, V1, P408; Bajcar JM, 2010, BMC FAM PRACT, V11, DOI 10.1186/1471-2296-11-75; Ball C, 2003, BRIT MED J, V327, P1014, DOI 10.1136/bmj.327.7422.1014; Bauer TT, 2001, INTENS CARE MED, V27, P3, DOI 10.1007/PL00020870; Bell CM, 2006, J GEN INTERN MED, V21, P937, DOI 10.1007/BF02743141; Bell CM, 2006, ARCH INTERN MED, V166, P2525, DOI 10.1001/archinte.166.22.2525; Benner JS, 2002, JAMA-J AM MED ASSOC, V288, P455, DOI 10.1001/jama.288.4.455; Boockvar K, 2004, ARCH INTERN MED, V164, P545, DOI 10.1001/archinte.164.5.545; Brown JC, RAPID RESPONSE TEAMS; Calkins DR, 1997, ARCH INTERN MED, V157, P1026, DOI 10.1001/archinte.157.9.1026; COCHRANE RA, 1992, BRIT MED J, V305, P694, DOI 10.1136/bmj.305.6855.694; Coffey Maitreya, 2009, Healthc Q, V12 Spec No Patient, P102; Cook D, 1998, NEW ENGL J MED, V338, P791, DOI 10.1056/NEJM199803193381203; Cornish PL, 2005, ARCH INTERN MED, V165, P424, DOI 10.1001/archinte.165.4.424; DeVault KR, 1999, AM J GASTROENTEROL, V94, P1434; Etchells E, 2004, CAN MED ASSOC J, V170, P333; Fodor JG, 2000, CAN MED ASSOC J, V162, P1441; Ganz DA, 2000, J GEN INTERN MED, V15, P776, DOI 10.1046/j.1525-1497.2000.91022.x; Gillen D, 1999, GUT, V44, P468, DOI 10.1136/gut.44.4.468; Gleason KM, 2010, J GEN INTERN MED, V25, P441, DOI 10.1007/s11606-010-1256-6; Graves T, 1997, ARCH INTERN MED, V157, P2205, DOI 10.1001/archinte.157.19.2205; Green CJ, 1997, CAN J CARDIOL, V13, P811; GURWITZ JH, 1993, AM J PUBLIC HEALTH, V83, P711, DOI 10.2105/AJPH.83.5.711; Hajjar Emily R, 2007, Am J Geriatr Pharmacother, V5, P345, DOI 10.1016/j.amjopharm.2007.12.002; Harrington RA, 2004, CHEST, V126, p513S, DOI 10.1378/chest.126.3_suppl.513S; Hart RG, 2003, ANN INTERN MED, V138, P831, DOI 10.7326/0003-4819-138-10-200305200-00011; Himmel W, 1996, EUR J CLIN PHARMACOL, V50, P253, DOI 10.1007/s002280050103; Institute for Health Improvement, HOW TO GUID PREV ADV; Jackevicius CA, 2002, JAMA-J AM MED ASSOC, V288, P462, DOI 10.1001/jama.288.4.462; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; Juurlink D, 2006, CANADIAN I HLTH INFO; Katz SJ, 2002, HEALTH AFFAIR, V21, P19, DOI 10.1377/hlthaff.21.3.19; Katz SJ, 1998, HEALTH AFFAIR, V17, P225, DOI 10.1377/hlthaff.17.1.225; Kaushal R, 2001, ARCH PEDIAT ADOL MED, V155, P1002, DOI 10.1001/archpedi.155.9.1002; Kripalani S, 2007, J HOSP MED, V2, P314, DOI 10.1002/jhm.228; Kripalani S, 2007, JAMA-J AM MED ASSOC, V297, P831, DOI 10.1001/jama.297.8.831; Landefeld CS, 2003, ANN INTERN MED, V139, P421, DOI 10.7326/0003-4819-139-5_Part_2-200309021-00008; Levy Adrian R, 2003, Can J Clin Pharmacol, V10, P67; MacLean DR, 1999, CAN J CARDIOL, V15, P434; Maslove DM, 2009, J GEN INTERN MED, V24, P995, DOI 10.1007/s11606-009-1053-2; MONANE M, 1994, ARCH INTERN MED, V154, P433, DOI 10.1001/archinte.154.4.433; Monane M, 1997, AM J HYPERTENS, V10, P697, DOI 10.1016/S0895-7061(97)00056-3; Moore C, 2003, J GEN INTERN MED, V18, P646, DOI 10.1046/j.1525-1497.2003.20722.x; O'Donnell Denis E, 2003, Can Respir J, V10 Suppl A, p11A; Perkins GD, 2006, AM J RESP CRIT CARE, V173, P281, DOI 10.1164/rccm.200508-1302OC; PETERSEN LA, 1994, ANN INTERN MED, V121, P866, DOI 10.7326/0003-4819-121-11-199412010-00008; Racz M, 2005, J AM GERIATR SOC, V53, pS245, DOI 10.1111/j.1532-5415.2005.53350.x; Rudd P, 1998, AM J MANAG CARE, V4, P957; Schneeweiss S, 2002, J CLIN EPIDEMIOL, V55, P833, DOI 10.1016/S0895-4356(02)00437-7; Schneeweiss S, 2001, AM J EPIDEMIOL, V154, P854, DOI 10.1093/aje/154.9.854; Schnipper JL, 2009, ARCH INTERN MED, V169, P771, DOI 10.1001/archinternmed.2009.51; Schnipper JL, 2006, ARCH INTERN MED, V166, P565, DOI 10.1001/archinte.166.5.565; SCHWARTZ D, 1962, AM J PUBLIC HEALTH N, V52, P2018, DOI 10.2105/AJPH.52.12.2018; Sibon I, 2004, NEUROLOGY, V62, P1187, DOI 10.1212/01.WNL.0000118288.04483.02; Tam VC, 2005, CAN MED ASSOC J, V173, P510, DOI 10.1503/cmaj.045311; Waldum HL, 1996, GUT, V39, P649, DOI 10.1136/gut.39.5.649	57	181	185	0	17	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 24	2011	306	8					840	847		10.1001/jama.2011.1206	http://dx.doi.org/10.1001/jama.2011.1206			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	810VY	21862745				2022-12-28	WOS:000294157300021
J	Sanghavi, DM				Sanghavi, Darshak M.			The art of medicine Unexpected life lessons from cardiac anatomy and physiology	LANCET			English	Editorial Material									Univ Massachusetts, Sch Med, Div Pediat Cardiol, Worcester, MA 01655 USA	University of Massachusetts System; University of Massachusetts Worcester	Sanghavi, DM (corresponding author), Univ Massachusetts, Sch Med, Div Pediat Cardiol, Worcester, MA 01655 USA.	darshak.sanghavi@umassmemorial.org						MCRAE D, 2007, EVERY SECOND COUNTS; Miller GW, 2000, KING HEARTS TRUE STO; RUHLMAN M, 2003, WALK WATER MIRACLE S; Sacks O., 1995, ANTHR MARS	4	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 20	2011	378	9792					658	659		10.1016/S0140-6736(11)61322-6	http://dx.doi.org/10.1016/S0140-6736(11)61322-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	815EW	21866584				2022-12-28	WOS:000294509900014
J	Metcalf, CJE; Graham, AL; Huijben, S; Barclay, VC; Long, GH; Grenfell, BT; Read, AF; Bjornstad, ON				Metcalf, C. J. E.; Graham, A. L.; Huijben, S.; Barclay, V. C.; Long, G. H.; Grenfell, B. T.; Read, A. F.; Bjornstad, O. N.			Partitioning Regulatory Mechanisms of Within-Host Malaria Dynamics Using the Effective Propagation Number	SCIENCE			English	Article							BLOOD-STAGE MALARIA; PLASMODIUM-CHABAUDI; IMMUNE-RESPONSES; PARASITES; ALPHA(+)-THALASSEMIA; COMPETITION; CHILDREN; ANEMIA; MODEL; MICE	Immune clearance and resource limitation (via red blood cell depletion) shape the peaks and troughs of malaria parasitemia, which in turn affect disease severity and transmission. Quantitatively partitioning the relative roles of these effects through time is challenging. Using data from rodent malaria, we estimated the effective propagation number, which reflects the relative importance of contrasting within-host control mechanisms through time and is sensitive to the inoculating parasite dose. Our analysis showed that the capacity of innate responses to restrict initial parasite growth saturates with parasite dose and that experimentally enhanced innate immunity can affect parasite density indirectly via resource depletion. Such a statistical approach offers a tool to improve targeting of drugs or vaccines for human therapy by revealing the dynamics and interactions of within-host regulatory mechanisms.	[Metcalf, C. J. E.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Graham, A. L.; Grenfell, B. T.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Huijben, S.; Barclay, V. C.; Read, A. F.; Bjornstad, O. N.] Penn State Univ, Ctr Infect Dis Dynam, State Coll, PA USA; [Long, G. H.] Univ Sheffield, Dept Anim & Plant Sci, Western Bank, Sheffield S10 2TN, S Yorkshire, England; [Grenfell, B. T.; Read, A. F.; Bjornstad, O. N.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA	University of Oxford; Princeton University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; University of Sheffield; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC)	Metcalf, CJE (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.	charlotte.metcalf@zoo.ox.ac.uk	Graham, Andrea L./A-8808-2010; Huijben, Silvie/Q-3837-2019; Graham, Andrea L./P-7296-2019; Bjornstad, Ottar N/I-4518-2012; Graham, Andrea/GON-8450-2022; Long, Gráinne H/B-3635-2012	Graham, Andrea L./0000-0002-6580-2755; Graham, Andrea L./0000-0002-6580-2755; Long, Gráinne H/0000-0001-5080-9885; Huijben, Silvie/0000-0002-3537-1915	Wellcome Trust; Darwin Trust of the University of Edinburgh; UK Biotechnology and Biological Sciences Research Council; National Institute of General Medical Sciences [R01GM089932]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD047879] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089932] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); Darwin Trust of the University of Edinburgh; UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Our empirical work was funded by the Wellcome Trust (A.F.R., V.C.B., G.H.L.), the Darwin Trust of the University of Edinburgh (S.H.), and the UK Biotechnology and Biological Sciences Research Council (A.L.G., G.H.L.), and the theoretical work by the Bill and Melinda Gates Foundation (C.J.E.M., B.T.G., O.N.B.), the RAPIDD program of the Science and Technology Directorate (B.T.G., A.L.G., A.F.R.), and National Institute of General Medical Sciences grant R01GM089932 (B.G., O.N.B., A.F.R.). We thank N. Mideo and P. Klepac for extensive discussion. All authors discussed the results and implications and commented on the manuscript at all stages. C.J.E.M. and O.N.B. developed the statistical approach; A.F.R., V.B., and S.H. designed and performed the dose-dependent and CD4<SUP>+</SUP> T cell-depleted mice experiments; A.L.G. and G.H.L. designed and performed the innate immunity experiments. The authors declare no competing interests.	ANDERSON R M, 1991; [Anonymous], 1978, RODENT MALARIA; ANTIA R, 1994, J THEOR BIOL, V168, P141, DOI 10.1006/jtbi.1994.1094; Antia R, 2008, P ROY SOC B-BIOL SCI, V275, P1449, DOI 10.1098/rspb.2008.0198; Baer K, 2007, PLOS PATHOG, V3, P1651, DOI 10.1371/journal.ppat.0030171; Ball CL, 2007, B MATH BIOL, V69, P2361, DOI 10.1007/s11538-007-9223-z; Barclay VC, 2008, P ROY SOC B-BIOL SCI, V275, P1171, DOI 10.1098/rspb.2007.1713; Bjornstad ON, 2002, ECOL MONOGR, V72, P169, DOI 10.1890/0012-9615(2002)072[0169:DOMEES]2.0.CO;2; CARTER R, 1975, ANN TROP MED PARASIT, V69, P187, DOI 10.1080/00034983.1975.11687000; Chang KH, 2004, J INFECT DIS, V189, P735, DOI 10.1086/381458; Chao DL, 2004, IMMUNOL CELL BIOL, V82, P55, DOI 10.1111/j.1440-1711.2004.01207.x; Dietz K, 2006, AM J TROP MED HYG, V75, P46, DOI 10.4269/ajtmh.2006.75.46; GLYNN JR, 1995, PARASITOLOGY, V110, P7, DOI 10.1017/S0031182000080999; Handel A, 2010, J R SOC INTERFACE, V7, P35, DOI 10.1098/rsif.2009.0067; Haydon DT, 2003, P ROY SOC B-BIOL SCI, V270, P289, DOI 10.1098/rspb.2002.2203; HELLRIEGEL B, 1992, P ROY SOC B-BIOL SCI, V250, P249, DOI 10.1098/rspb.1992.0156; Hetzel C, 1996, PARASITOLOGY, V113, P25, DOI 10.1017/S0031182000066245; Huijben S, 2010, THESIS U EDINBURGH; JARRA W, 1989, PARASITOLOGY, V99, P157, DOI 10.1017/S0031182000058583; Kochin BF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010444; Lamikanra AA, 2007, BLOOD, V110, P18, DOI 10.1182/blood-2006-09-018069; Long GH, 2006, PARASITOLOGY, V133, P673, DOI 10.1017/S003118200600117X; Long GH, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-128; Lythgoe KA, 2007, P NATL ACAD SCI USA, V104, P8095, DOI 10.1073/pnas.0606206104; McQueen PG, 2004, P NATL ACAD SCI USA, V101, P9161, DOI 10.1073/pnas.0308256101; Mideo N, 2008, AM NAT, V172, pE214, DOI 10.1086/591684; Miller MR, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000946; Mockenhaupt FP, 2004, BLOOD, V104, P2003, DOI 10.1182/blood-2003-11-4090; Molineaux L, 2002, T ROY SOC TROP MED H, V96, P205, DOI 10.1016/S0035-9203(02)90308-1; Molineaux L, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P221; Nowak MA., 2000, VIRUS DYNAMICS MATH; Othoro C, 1999, J INFECT DIS, V179, P279, DOI 10.1086/314548; Perelson AS, 2002, NAT REV IMMUNOL, V2, P28, DOI 10.1038/nri700; Pilyugin SS, 2000, B MATH BIOL, V62, P869, DOI 10.1006/bulm.2000.0181; Ribeiro RM, 2010, J VIROL, V84, P6096, DOI 10.1128/JVI.00127-10; Russell MS, 2007, J IMMUNOL, V179, P211, DOI 10.4049/jimmunol.179.1.211; Saenz RA, 2010, J VIROL, V84, P3974, DOI 10.1128/JVI.02078-09; Savill NJ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000416; Stephens R, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001208; Stevenson MM, 2004, NAT REV IMMUNOL, V4, P169, DOI 10.1038/nri1311; Su Z, 2002, J INFECT DIS, V186, P1321, DOI 10.1086/344576; Walther M, 2006, J IMMUNOL, V177, P5736, DOI 10.4049/jimmunol.177.8.5736; Wambua S, 2006, BRIT J HAEMATOL, V133, P206, DOI 10.1111/j.1365-2141.2006.06006.x	43	59	59	0	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 19	2011	333	6045					984	988		10.1126/science.1204588	http://dx.doi.org/10.1126/science.1204588			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808TD	21852493	Green Accepted			2022-12-28	WOS:000294000400047
J	Moazed, D				Moazed, Danesh			Mechanisms for the Inheritance of Chromatin States	CELL			English	Article							ORIGIN RECOGNITION COMPLEX; POLYCOMB RESPONSE ELEMENT; SILENCING PROTEIN SIR2; DNA-BINDING PROTEIN; ASSEMBLY FACTOR-I; SACCHAROMYCES-CEREVISIAE; TELOMERIC HETEROCHROMATIN; EPIGENETIC INHERITANCE; HISTONE H3; SIR2/SIR4 COMPLEX		Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Moazed, D (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Cell Biol, Boston, MA 02115 USA.	danesh@hms.harvard.edu			National Institutes of Health; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061641] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	I thank the members of my laboratory and colleagues in the transcription and chromatin fields for discussion. Research in my lab is supported by the National Institutes of Health and the Howard Hughes Medical Institute.	Altaf M, 2007, MOL CELL, V28, P1002, DOI 10.1016/j.molcel.2007.12.002; APARICIO OM, 1991, CELL, V66, P1279, DOI 10.1016/0092-8674(91)90049-5; Bayne EH, 2010, CELL, V140, P666, DOI 10.1016/j.cell.2010.01.038; Beisel C, 2011, NAT REV GENET, V12, P123, DOI 10.1038/nrg2932; BELL SP, 1993, SCIENCE, V262, P1844, DOI 10.1126/science.8266072; BRAND AH, 1985, CELL, V41, P41, DOI 10.1016/0092-8674(85)90059-5; Busturia A, 1997, DEVELOPMENT, V124, P4343; Cavalli G, 1998, CELL, V93, P505, DOI 10.1016/S0092-8674(00)81181-2; Chan SWL, 2006, PLOS BIOL, V4, P1923, DOI 10.1371/journal.pbio.0040363; Cheng TH, 2000, GENE DEV, V14, P452; Dodd IB, 2007, CELL, V129, P813, DOI 10.1016/j.cell.2007.02.053; FOSS M, 1993, SCIENCE, V262, P1838, DOI 10.1126/science.8266071; Gardner KA, 1999, GENETICS, V151, P31; Gasser SM, 2001, GENE, V279, P1, DOI 10.1016/S0378-1119(01)00741-7; Gerace EL, 2010, MOL CELL, V39, P360, DOI 10.1016/j.molcel.2010.07.017; Gottschling DE, 2004, COLD SH Q B, V69, P507, DOI 10.1101/sqb.2004.69.507; Grewal SIS, 1996, CELL, V86, P95, DOI 10.1016/S0092-8674(00)80080-X; Grewal SIS, 2003, SCIENCE, V301, P798, DOI 10.1126/science.1086887; Guenther MG, 2010, SCIENCE, V329, P150, DOI 10.1126/science.1193995; Hansen KH, 2008, NAT CELL BIOL, V10, P1291, DOI 10.1038/ncb1787; Hauenschild A, 2008, PLOS BIOL, V6, P2130, DOI 10.1371/journal.pbio.0060261; HECHT A, 1995, CELL, V80, P583, DOI 10.1016/0092-8674(95)90512-X; Hekimoglu B, 2009, RNA BIOL, V6, P129, DOI 10.4161/rna.6.2.8178; Hogga I, 2002, DEVELOPMENT, V129, P4915; HOLLIDAY R, 1987, SCIENCE, V238, P163, DOI 10.1126/science.3310230; Holmes SG, 1996, GENE DEV, V10, P1021, DOI 10.1101/gad.10.8.1021; Hoppe GJ, 2002, MOL CELL BIOL, V22, P4167, DOI 10.1128/MCB.22.12.4167-4180.2002; Iida T, 2008, MOL CELL, V31, P178, DOI 10.1016/j.molcel.2008.07.003; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; JACKSON V, 1985, BIOCHEMISTRY-US, V24, P6930, DOI 10.1021/bi00345a027; JACKSON V, 1974, BIOCHEMISTRY-US, V13, P3952, DOI 10.1021/bi00716a021; JOHNSON LM, 1992, EMBO J, V11, P2201, DOI 10.1002/j.1460-2075.1992.tb05279.x; Kaufman PD, 2010, CURR OPIN CELL BIOL, V22, P284, DOI 10.1016/j.ceb.2010.02.002; Kaufman PD, 1998, MOL CELL BIOL, V18, P4793, DOI 10.1128/MCB.18.8.4793; Kaufman PD, 1997, GENE DEV, V11, P345, DOI 10.1101/gad.11.3.345; KAYNE PS, 1988, CELL, V55, P27, DOI 10.1016/0092-8674(88)90006-2; Klar AJS, 1998, TRENDS GENET, V14, P299, DOI 10.1016/S0168-9525(98)01535-2; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kuriyan J, 2007, NATURE, V450, P983, DOI 10.1038/nature06524; Landry J, 2000, P NATL ACAD SCI USA, V97, P5807, DOI 10.1073/pnas.110148297; LASSAR AB, 1989, CELL, V58, P823, DOI 10.1016/0092-8674(89)90935-5; Liou GG, 2005, CELL, V121, P515, DOI 10.1016/j.cell.2005.03.035; Luo KH, 2002, GENE DEV, V16, P1528, DOI 10.1101/gad.988802; Margueron R, 2010, NAT REV GENET, V11, P285, DOI 10.1038/nrg2752; MCNALLY FJ, 1991, MOL CELL BIOL, V11, P5648, DOI 10.1128/MCB.11.11.5648; Moazed D, 2001, MOL CELL, V8, P489, DOI 10.1016/S1097-2765(01)00340-9; Moazed D, 1997, P NATL ACAD SCI USA, V94, P2186, DOI 10.1073/pnas.94.6.2186; Moazed D, 2009, NATURE, V457, P413, DOI 10.1038/nature07756; MORETTI P, 1994, GENE DEV, V8, P2257, DOI 10.1101/gad.8.19.2257; Motamedi MR, 2004, CELL, V119, P789, DOI 10.1016/j.cell.2004.11.034; Muller J, 2006, CURR OPIN GENET DEV, V16, P476, DOI 10.1016/j.gde.2006.08.005; Muller HJ, 1930, J GENET, V22, P299, DOI 10.1007/BF02984195; Ng HH, 2002, GENE DEV, V16, P1518, DOI 10.1101/gad.1001502; Noma K, 2004, NAT GENET, V36, P1174, DOI 10.1038/ng1452; Onishi M, 2007, MOL CELL, V28, P1015, DOI 10.1016/j.molcel.2007.12.004; PILLUS L, 1989, CELL, V59, P637, DOI 10.1016/0092-8674(89)90009-3; Ptashne M, 1998, CURR BIOL, V8, pR812, DOI 10.1016/S0960-9822(07)00508-8; Ptashne M, 2001, GENES SIGNALS; Ptashne M, 2007, CURR BIOL, V17, pR233, DOI 10.1016/j.cub.2007.02.030; Radman-Livaja M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001075; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Rudner AD, 2005, MOL CELL BIOL, V25, P4514, DOI 10.1128/MCB.25.11.4514-4528.2005; Rusche LN, 2003, ANNU REV BIOCHEM, V72, P481, DOI 10.1146/annurev.biochem.72.121801.161547; Rusche LN, 2002, MOL BIOL CELL, V13, P2207, DOI 10.1091/mbc.E02-03-0175; Schaefer CB, 2007, SCIENCE, V316, P398, DOI 10.1126/science.1137544; Schmitt S, 2005, GENE DEV, V19, P697, DOI 10.1101/gad.326205; Sengupta AK, 2004, DEVELOPMENT, V131, P1959, DOI 10.1242/dev.01084; SHORE D, 1987, CELL, V51, P721, DOI 10.1016/0092-8674(87)90095-X; Simmer F, 2010, EMBO REP, V11, P112, DOI 10.1038/embor.2009.273; Sing A, 2009, CELL, V138, P885, DOI 10.1016/j.cell.2009.08.020; SOGO JM, 1986, J MOL BIOL, V189, P189, DOI 10.1016/0022-2836(86)90390-6; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; StrahlBolsinger S, 1997, GENE DEV, V11, P83, DOI 10.1101/gad.11.1.83; Suganuma T, 2008, CELL, V135, P604, DOI 10.1016/j.cell.2008.10.036; Tanny JC, 2001, P NATL ACAD SCI USA, V98, P415, DOI 10.1073/pnas.031563798; Triolo T, 1996, NATURE, V381, P251, DOI 10.1038/381251a0; van Leeuwen F, 2002, CELL, V109, P745, DOI 10.1016/S0092-8674(02)00759-6; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Woo CJ, 2010, CELL, V140, P99, DOI 10.1016/j.cell.2009.12.022; Xu EY, 2006, MOL CELL, V23, P219, DOI 10.1016/j.molcel.2006.05.035; Zhang ZG, 2000, NATURE, V408, P221, DOI 10.1038/35041601; Zordan RE, 2006, P NATL ACAD SCI USA, V103, P12807, DOI 10.1073/pnas.0605138103	83	162	162	0	30	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 19	2011	146	4					510	518		10.1016/j.cell.2011.07.013	http://dx.doi.org/10.1016/j.cell.2011.07.013			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	809HY	21854979	Bronze, Green Accepted			2022-12-28	WOS:000294043600007
J	Hall, KD; Sacks, G; Chandramohan, D; Chow, CC; Wang, YC; Gortmaker, SL; Swinburn, BA				Hall, Kevin D.; Sacks, Gary; Chandramohan, Dhruva; Chow, Carson C.; Wang, Y. Claire; Gortmaker, Steven L.; Swinburn, Boyd A.			Obesity 3 Quantification of the effect of energy imbalance on bodyweight	LANCET			English	Article							LOW-FAT DIET; WEIGHT-LOSS MAINTENANCE; VERY-LOW-CARBOHYDRATE; RANDOMIZED CONTROLLED-TRIAL; DOUBLY LABELED WATER; LOW-CALORIE DIET; BODY-WEIGHT; METABOLIC ADAPTATION; PHYSICAL-ACTIVITY; RISK-FACTORS	Obesity interventions can result in weight loss, but accurate prediction of the bodyweight time course requires properly accounting for dynamic energy imbalances. In this report, we describe a mathematical modelling approach to adult human metabolism that simulates energy expenditure adaptations during weight loss. We also present a web-based simulator for prediction of weight change dynamics. We show that the bodyweight response to a change of energy intake is slow, with half times of about 1 year. Furthermore, adults with greater adiposity have a larger expected weight loss for the same change of energy intake, and to reach their steady-state weight will take longer than it would for those with less initial body fat. Using a population-averaged model, we calculated the energy-balance dynamics corresponding to the development of the US adult obesity epidemic. A small persistent average daily energy imbalance gap between intake and expenditure of about 30 kJ per day underlies the observed average weight gain. However, energy intake must have risen to keep pace with increased expenditure associated with increased weight. The average increase of energy intake needed to sustain the increased weight (the maintenance energy gap) has amounted to about 09 MJ per day and quantifies the public health challenge to reverse the obesity epidemic.	[Hall, Kevin D.; Chandramohan, Dhruva; Chow, Carson C.] NIDDKD, Lab Biol Modeling, NIH, Bethesda, MD 20892 USA; [Sacks, Gary; Swinburn, Boyd A.] Deakin Univ, WHO Collaborating Ctr Obes Prevent, Melbourne, Vic, Australia; [Wang, Y. Claire] Columbia Univ, Sch Publ Hlth, New York, NY USA; [Gortmaker, Steven L.] Harvard Univ, Dept Soc Human Dev & Hlth, Harvard Sch Publ Hlth, Boston, MA 02115 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Deakin University; World Health Organization; Columbia University; Harvard University; Harvard T.H. Chan School of Public Health	Hall, KD (corresponding author), NIDDKD, Lab Biol Modeling, NIH, 12A S Dr,Room 4007, Bethesda, MD 20892 USA.	kevinh@niddk.nih.gov	Sacks, Gary/I-5731-2014; Hall, Kevin/F-2383-2010; Chow, Carson C/A-7970-2009	Sacks, Gary/0000-0001-9736-1539; Hall, Kevin/0000-0003-4062-3133; 	National Institutes of Health, NIDDK; Robert Wood Johnson Foundation [260639, 61468, 66284]; US Centers for Disease Control and Prevention [U48/DP00064-00S1, 1U48DP001946]; Office of Behavioral and Social Sciences Research of the National Institutes for Health [HHSN276200700356P]; NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO [U48DP001946, U48DP000064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK013036, ZIADK013022] Funding Source: NIH RePORTER	National Institutes of Health, NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); US Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Office of Behavioral and Social Sciences Research of the National Institutes for Health; NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by the Intramural Research Program of the National Institutes of Health, NIDDK, and grants from the Robert Wood Johnson Foundation (#260639, #61468, and #66284), the US Centers for Disease Control and Prevention (U48/DP00064-00S1 and 1U48DP001946) and the Office of Behavioral and Social Sciences Research of the National Institutes for Health (#HHSN276200700356P). The funders had no role in the formulation of the major concepts, data analysis, data interpretation, or writing of the report. The authors received no payment for writing the report.	ALPERT SS, 1990, AM J CLIN NUTR, V52, P784, DOI 10.1093/ajcn/52.5.784; Alpert SS, 2005, J THEOR BIOL, V233, P1, DOI 10.1016/j.jtbi.2004.08.029; ALPERT SS, 1979, AM J CLIN NUTR, V32, P1710, DOI 10.1093/ajcn/32.8.1710; [Anonymous], 2000, NHLBI OB ED IN EXP P; ANTONETTI VW, 1973, AM J CLIN NUTR, V26, P64, DOI 10.1093/ajcn/26.1.64; Austin GL, 2011, AM J CLIN NUTR, V93, P836, DOI 10.3945/ajcn.110.000141; BERLIN NI, 1962, METABOLISM, V11, P302; BLACKBURN G, 1995, OBES RES, V3, pS211, DOI 10.1002/j.1550-8528.1995.tb00466.x; Blaxter K, 1989, ENERGY METABOLISM AN; Blundell JE, 2003, P NUTR SOC, V62, P651, DOI 10.1079/PNS2003286; Bradley U, 2009, DIABETES, V58, P2741, DOI 10.2337/db09-0098; Brehm BJ, 2003, J CLIN ENDOCR METAB, V88, P1617, DOI 10.1210/jc.2002-021480; Brehm BJ, 2005, J CLIN ENDOCR METAB, V90, P1475, DOI 10.1210/jc.2004-1540; Brinkworth GD, 2009, AM J CLIN NUTR, V90, P23, DOI 10.3945/ajcn.2008.27326; Buchholz AC, 2004, AM J CLIN NUTR, V79, P899; Butland BJ, 2007, FORESIGHT TACKLING O; Butte NF, 2007, OBESITY, V15, P3056, DOI 10.1038/oby.2007.364; Chow CC, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000045; Christiansen E, 2005, J THEOR BIOL, V234, P99, DOI 10.1016/j.jtbi.2004.11.012; Christiansen E, 2002, EUR J CLIN INVEST, V32, P826, DOI 10.1046/j.1365-2362.2002.01036.x; DEFRONZO RA, 1981, DIABETOLOGIA, V21, P165, DOI 10.1007/BF00252649; Dulloo AG, 2007, INT J OBESITY, V31, P201, DOI 10.1038/sj.ijo.0803537; Duyff R. L., 2006, AM DIETETIC ASS COMP; ELIA M, 1987, METABOLISM, V36, P251, DOI 10.1016/0026-0495(87)90184-3; Ellis KJ, 2000, ANN NY ACAD SCI, V904, P374; Feinman RD, 2003, METAB SYNDR RELAT D, V1, P209, DOI 10.1089/154041903322716688; Fine Eugene J, 2004, Nutr Metab (Lond), V1, P15, DOI 10.1186/1743-7075-1-15; Finkelstein EA, 2010, ARCH INTERN MED, V170, P2028, DOI 10.1001/archinternmed.2010.449; Flatt JP, 2004, OBES RES, V12, P2013, DOI 10.1038/oby.2004.252; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Flegal KM, 1998, INT J OBESITY, V22, P39, DOI 10.1038/sj.ijo.0800541; FORBES GB, 1987, NUTR REV, V45, P225; Foster GD, 2010, ANN INTERN MED, V153, P147, DOI 10.7326/0003-4819-153-3-201008030-00005; Foster GD, 2003, NEW ENGL J MED, V348, P2082, DOI 10.1056/NEJMoa022207; Gardner CD, 2007, JAMA-J AM MED ASSOC, V297, P969, DOI 10.1001/jama.297.9.969; Gerstein DE, 2004, J AM DIET ASSOC, V104, P1151, DOI 10.1016/j.jada.2004.04.027; Greenberg I, 2009, J AM COLL NUTR, V28, P159, DOI 10.1080/07315724.2009.10719767; Gustavsen GW, 2011, APPL ECON, V43, P707, DOI 10.1080/00036840802599776; Hall KD, 2008, INT J OBESITY, V32, P573, DOI 10.1038/sj.ijo.0803720; Hall KD, 2007, INT J OBESITY, V31, P1378, DOI 10.1038/sj.ijo.0803608; Hall KD, 2007, BRIT J NUTR, V97, P1059, DOI 10.1017/S0007114507691946; Hall KD, 2006, AM J PHYSIOL-ENDOC M, V291, pE23, DOI 10.1152/ajpendo.00523.2005; Hall KD, 2011, AM J CLIN NUTR, V94, P66, DOI 10.3945/ajcn.111.014399; Hall KD, 2010, BRIT J NUTR, V104, P4, DOI 10.1017/S0007114510000206; Hall KD, 2010, IEEE ENG MED BIOL, V29, P36, DOI 10.1109/MEMB.2009.935465; Hall KD, 2010, AM J CLIN NUTR, V91, P816, DOI 10.3945/ajcn.2009.28922; Hall KD, 2010, AM J PHYSIOL-ENDOC M, V298, pE449, DOI 10.1152/ajpendo.00559.2009; Hall KD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007940; Hall KD, 2008, AM J CLIN NUTR, V88, P1495, DOI 10.3945/ajcn.2008.26333; Heilbronn LK, 2006, JAMA-J AM MED ASSOC, V295, P1539, DOI 10.1001/jama.295.13.1539; Heymsfield SB, 2007, AM J CLIN NUTR, V85, P346, DOI 10.1093/ajcn/85.2.346; Hill JO, 2006, ENDOCR REV, V27, P750, DOI 10.1210/er.2006-0032; Hill JO, 2009, AM J CLIN NUTR, V89, P477, DOI 10.3945/ajcn.2008.26566; Hill JO, 2003, SCIENCE, V299, P853, DOI 10.1126/science.1079857; Jensen MD, 2007, METABOLISM, V56, P68, DOI 10.1016/j.metabol.2006.08.022; Johansson G, 2008, INT J OBESITY, V32, P1031, DOI 10.1038/ijo.2008.42; Johnston CS, 2006, AM J CLIN NUTR, V83, P1055, DOI 10.1093/ajcn/83.5.1055; Jordan PN, 2008, AM J CLIN NUTR, V87, P692, DOI 10.1093/ajcn/87.3.692; KEKWICK A, 1956, LANCET, V271, P155; King NA, 2008, INT J OBESITY, V32, P177, DOI 10.1038/sj.ijo.0803712; King NA, 2007, OBESITY, V15, P1373, DOI 10.1038/oby.2007.164; KINSELL LW, 1964, METABOLISM, V13, P195, DOI 10.1016/0026-0495(64)90098-8; Kozusko FP, 2002, MATH COMPUT MODEL, V35, P973, DOI 10.1016/S0895-7177(02)00064-X; Kozusko FP, 2001, B MATH BIOL, V63, P393, DOI 10.1006/bulm.2001.0229; KUCZMARSKI RJ, 1994, JAMA-J AM MED ASSOC, V272, P205, DOI 10.1001/jama.272.3.205; LEIBEL RL, 1995, NEW ENGL J MED, V332, P621, DOI 10.1056/NEJM199503093321001; LEIBEL RL, 1992, AM J CLIN NUTR, V55, P350, DOI 10.1093/ajcn/55.2.350; Levine JA, 2004, AM J PHYSIOL-ENDOC M, V286, pE675, DOI 10.1152/ajpendo.00562.2003; Lin BH, 2011, EC HUM BIOL IN PRESS; Major GC, 2007, INT J OBESITY, V31, P204, DOI 10.1038/sj.ijo.0803523; Manninen AH, 2004, J INT SOC SPORT NUTR, V1, DOI 10.1186/1550-2783-1-2-21; McAuley KA, 2005, DIABETOLOGIA, V48, P8, DOI 10.1007/s00125-004-1603-4; NHLBI, 2005, 055213 NHLBI; NHS, 2006, 274537 NHS DEP HLTH; Noakes M, 2005, AM J CLIN NUTR, V81, P1298; Noakes M, 2006, NUTR METAB, V3, DOI 10.1186/1743-7075-3-7; Pasanisi F, 2001, NUTR METAB CARDIOVAS, V11, P401; PAYNE PR, 1977, ANN HUM BIOL, V4, P525, DOI 10.1080/03014467700002521; Pereira MA, 2004, JAMA-J AM MED ASSOC, V292, P2482, DOI 10.1001/jama.292.20.2482; RABAST U, 1981, ANN NUTR METAB, V25, P341, DOI 10.1159/000176515; RABAST U, 1979, INT J OBESITY, V3, P201; RAVUSSIN E, 1986, J CLIN INVEST, V78, P1568, DOI 10.1172/JCI112749; RUNCIE J, 1974, BRIT MED J, V2, P352, DOI 10.1136/bmj.2.5915.352; Sacks FM, 2009, NEW ENGL J MED, V360, P859, DOI 10.1056/NEJMoa0804748; Sacks G, 2011, INT J OBESITY, V35, P1001, DOI 10.1038/ijo.2010.228; SCHOELLER DA, 1990, NUTR REV, V48, P373, DOI 10.1111/j.1753-4887.1990.tb02882.x; Schoeller DA, 2005, J AM DIET ASSOC, V105, pS24, DOI 10.1016/j.jada.2005.02.025; SCHOELLER DA, 1991, ANNU REV NUTR, V11, P355, DOI 10.1146/annurev.nu.11.070191.002035; Shai I, 2008, NEW ENGL J MED, V359, P229, DOI 10.1056/NEJMoa0708681; Simon P, 2008, MENU LABELING POTENT; Smith T.A., 2010, TAXING CALORIC SWEET; Song BJ, 2007, J MATH BIOL, V54, P27, DOI 10.1007/s00285-006-0037-7; Stern L, 2004, ANN INTERN MED, V140, P778, DOI 10.7326/0003-4819-140-10-200405180-00007; STUNKARD A, 1959, ARCH INTERN MED, V103, P79, DOI 10.1001/archinte.1959.00270010085011; Svetkey LP, 2008, JAMA-J AM MED ASSOC, V299, P1139, DOI 10.1001/jama.299.10.1139; Swinburn BA, 2006, AM J CLIN NUTR, V83, P859, DOI 10.1093/ajcn/83.4.859; Swinburn B, 2010, AM J CLIN NUTR, V91, P817, DOI 10.3945/ajcn.2009.29041; Swinburn B, 2009, AM J CLIN NUTR, V90, P1453, DOI 10.3945/ajcn.2009.28595; Swinburn BA, 2009, AM J CLIN NUTR, V89, P1723, DOI 10.3945/ajcn.2008.27061; Tay J, 2008, J AM COLL CARDIOL, V51, P59, DOI 10.1016/j.jacc.2007.08.050; Thomas DM, 2010, AM J CLIN NUTR, V92, P1326, DOI 10.3945/ajcn.2010.29687; Thomas DM, 2009, MATH BIOSCI ENG, V6, P873, DOI 10.3934/mbe.2009.6.873; Tremblay A, 2009, BRIT J NUTR, V102, P488, DOI 10.1017/S0007114508207245; VAZQUEZ JA, 1992, METABOLISM, V41, P406, DOI 10.1016/0026-0495(92)90076-M; Volek Js, 2004, Nutr Metab (Lond), V1, P13, DOI 10.1186/1743-7075-1-13; Wang YC, 2006, PEDIATRICS, V118, pE1721, DOI 10.1542/peds.2006-0682; WEINSIER RL, 1993, INT J OBESITY, V17, P693; WERNER SC, 1955, NEW ENGL J MED, V252, P661, DOI 10.1056/NEJM195504212521604; WESTERTERP KR, 1995, BRIT J NUTR, V73, P337, DOI 10.1079/BJN19950037; Westerterp-Plantenga MS, 2009, ANNU REV NUTR, V29, P21, DOI 10.1146/annurev-nutr-080508-141056; Weyer C, 2000, J CLIN ENDOCR METAB, V85, P1087, DOI 10.1210/jc.85.3.1087; Wing RR, 2005, AM J CLIN NUTR, V82, p222S, DOI 10.1093/ajcn/82.1.222S; Wing RR, 2001, ANNU REV NUTR, V21, P323, DOI 10.1146/annurev.nutr.21.1.323; Winkler JT, 2005, OBES REV, V6, P199, DOI 10.1111/j.1467-789X.2005.00186.x; Wycherley TP, 2010, J INTERN MED, V267, P452, DOI 10.1111/j.1365-2796.2009.02174.x; Yancy WS, 2004, ANN INTERN MED, V140, P769, DOI 10.7326/0003-4819-140-10-200405180-00006; YANG MU, 1981, INT J OBESITY, V5, P231; YANG MU, 1976, J CLIN INVEST, V58, P722, DOI 10.1172/JCI108519	118	687	696	1	124	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG-SEP	2011	378	9793					826	837		10.1016/S0140-6736(11)60812-X	http://dx.doi.org/10.1016/S0140-6736(11)60812-X			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	816FY	21872751	Green Accepted			2022-12-28	WOS:000294585300038
J	Mehilli, J; Pache, J; Abdel-Wahab, M; Schulz, S; Byrne, RA; Tiroch, K; Hausleiter, J; Seyfarth, M; Ott, I; Ibrahim, T; Fusaro, M; Laugwitz, KL; Massberg, S; Neumann, FJ; Richardt, G; Schomig, A; Kastrati, A				Mehilli, Julinda; Pache, Juergen; Abdel-Wahab, Mohamed; Schulz, Stefanie; Byrne, Robert A.; Tiroch, Klaus; Hausleiter, Joerg; Seyfarth, Melchior; Ott, Ilka; Ibrahim, Tareq; Fusaro, Massimiliano; Laugwitz, Karl-Ludwig; Massberg, Steffen; Neumann, Franz-Josef; Richardt, Gert; Schoemig, Albert; Kastrati, Adnan		Is Drug-Eluting-Stenting	Drug-eluting versus bare-metal stents in saphenous vein graft lesions (ISAR-CABG): a randomised controlled superiority trial	LANCET			English	Article							PERCUTANEOUS CORONARY INTERVENTION; BYPASS GRAFTS; FOLLOW-UP; INTRAVASCULAR ULTRASOUND; IMPLANTATION; METAANALYSIS; OUTCOMES; ANGIOPLASTY; PREVENTION; THERAPIES	Background Comparative assessment of clinical outcomes after use of drug-eluting stents versus bare-metal stents for treatment of aortocoronary saphenous vein graft lesions has not been undertaken in large randomised trials. We aimed to undertake a comparison in a randomised trial powered for clinical endpoints. Methods In this randomised superiority trial, patients with de-novo saphenous vein graft lesions were assigned by computer-generated sequence (1:1:1:3) to receive either drug-eluting stents (one of three types: permanent-polymer paclitaxel-eluting stents, permanent-polymer sirolimus-eluting stents, or biodegradable-polymer sirolimus-eluting stents) or bare-metal stents. Randomisation took place immediately after crossing of the lesion with a guidewire, and was stratified for each participating centre. Investigators assessing data were masked to treatment allocation; patients were not masked to allocation. The primary endpoint was the combined incidence of death, myocardial infarction, and target lesion revascularisation at 1 year. Analysis was by intention to treat. This trial is registered at ClinicalTrials.gov, number NCT00611910. Findings 610 patients were allocated to treatment groups (303 drug-eluting stent, 307 bare-metal stent). Drug-eluting stents reduced the incidence of the primary endpoint compared with bare-metal stents (44 [15%] vs 66 [22%] patients; hazard ratio [HR] 0.64, 95% CI 0.44-0.94; p=0.02). Target lesion revascularisation rate was reduced by drug-eluting stents (19 [7%] vs 37 [13%] patients; HR 0.49, 95% CI 0.28-0.86; p=0.01). No significant differences were seen between drug-eluting stents and bare-metal stents regarding all-cause mortality (15 [5%] vs 14 [5%] patients; HR 1.08, 95% Cl 0.52-2.24; p=0.83), myocardial infarction (12 [4%] vs 18 [6%]; HR 0.66, 95% CI 0.32-1.37; p=0.27), or definite or probable stent thrombosis (2 [1%] in both groups; HR 1.00,95% CI 0.14-7.10; p=0.99). Interpretation In patients undergoing percutaneous coronary intervention for de-novo saphenous vein graft lesions, drug-eluting stents are the preferred treatment option because they reduce the risk of adverse events compared with bare-metal stents.	[Mehilli, Julinda; Pache, Juergen; Schulz, Stefanie; Byrne, Robert A.; Hausleiter, Joerg; Ott, Ilka; Fusaro, Massimiliano; Massberg, Steffen; Schoemig, Albert; Kastrati, Adnan] Tech Univ Munich, Deutsch Herzzentrum, D-80636 Munich, Germany; [Ibrahim, Tareq; Laugwitz, Karl-Ludwig; Schoemig, Albert] Tech Univ Munich, Klinikum Rechts Isar, Med Klin 1, D-80636 Munich, Germany; [Tiroch, Klaus; Seyfarth, Melchior] Helios Kliniken Wuppertal, Med Klin 3, Wuppertal, Germany; [Abdel-Wahab, Mohamed; Richardt, Gert] Herzzentrum Segeberger Kliniken, Bad Segeberg, Germany; [Neumann, Franz-Josef] Herz Zentrum, Bad Krozingen, Germany	German Heart Center Berlin; German Heart Centre Munich; Technical University of Munich; Technical University of Munich; Helios Kliniken; Segeberger Kliniken Group	Mehilli, J (corresponding author), Tech Univ Munich, Deutsch Herzzentrum, D-80636 Munich, Germany.	mehilli@dhm.mhn.de	Hausleiter, Jörg/V-4206-2019; Mehilli, Julinda/F-2629-2016; , Kastrati/Y-2389-2019; Massberg, Steffen/AAN-6054-2021; Byrne, Robert/C-3902-2016; Schupke, Stefanie/G-8382-2016	Byrne, Robert/0000-0001-5224-6393; Kufner, Sebastian/0000-0002-8091-4552; Schupke, Stefanie/0000-0002-0294-2283	Deutsches Herzzentrum	Deutsches Herzzentrum	Deutsches Herzzentrum.	Ali RC, 2009, J AM GERIATR SOC, V57, P1990, DOI 10.1111/j.1532-5415.2009.02483.x; Baim DS, 2002, CIRCULATION, V105, P1285, DOI 10.1161/01.CIR.0000012783.63093.0C; Brilakis ES, 2011, JACC-CARDIOVASC INTE, V4, P176, DOI 10.1016/j.jcin.2010.10.003; Brilakis ES, 2010, JACC-CARDIOVASC INTE, V3, P1068, DOI 10.1016/j.jcin.2010.07.009; Brilakis ES, 2009, J AM COLL CARDIOL, V53, P919, DOI 10.1016/j.jacc.2008.11.029; Brodie BR, 2009, JACC-CARDIOVASC INTE, V2, P1105, DOI 10.1016/j.jcin.2009.08.020; BRYAN AJ, 1994, CURR OPIN CARDIOL, V9, P641, DOI 10.1097/00001573-199411000-00002; Byrne RA, 2009, EUR HEART J, V30, P2441, DOI 10.1093/eurheartj/ehp352; Byrne RA, 2009, DRUG SAFETY, V32, P749, DOI 10.2165/11316500-000000000-00000; Coolong A, 2008, CIRCULATION, V117, P790, DOI 10.1161/CIRCULATIONAHA.106.651232; Depre C, 1998, AM J CLIN PATHOL, V110, P378, DOI 10.1093/ajcp/110.3.378; FitzGibbon GM, 1996, J AM COLL CARDIOL, V28, P616, DOI 10.1016/0735-1097(96)00206-9; Ge L, 2005, J AM COLL CARDIOL, V45, P989, DOI 10.1016/j.jacc.2004.11.060; GRAMBSCH P, 1994, STAT MED, V13, P1619, DOI 10.1002/sim.4780131603; Hoffmann R, 1996, J AM COLL CARDIOL, V28, P1134, DOI 10.1016/S0735-1097(96)00278-1; Hong MK, 2001, J AM COLL CARDIOL, V38, P150, DOI 10.1016/S0735-1097(01)01324-9; Joyal D, 2010, AM HEART J, V160, P179, DOI 10.1016/j.ahj.2010.04.015; Kastrati A, 2007, NEW ENGL J MED, V356, P1030, DOI 10.1056/NEJMoa067484; Lee MS, 2010, AM J CARDIOL, V105, P1076, DOI 10.1016/j.amjcard.2009.12.006; Mamas MA, 2011, J INTERV CARDIOL, V24, P172, DOI 10.1111/j.1540-8183.2010.00620.x; Morrison DA, 2002, J AM COLL CARDIOL, V40, P1951, DOI 10.1016/S0735-1097(02)02560-3; Newby LK, 2006, CIRCULATION, V113, P203, DOI 10.1161/CIRCULATIONAHA.105.505636; Savage MP, 1997, NEW ENGL J MED, V337, P740, DOI 10.1056/NEJM199709113371103; Shishehbor MH, 2009, AM HEART J, V158, P637, DOI 10.1016/j.ahj.2009.08.003; Stettler C, 2007, LANCET, V370, P937, DOI 10.1016/S0140-6736(07)61444-5; Vermeersch P, 2007, J AM COLL CARDIOL, V50, P261, DOI 10.1016/j.jacc.2007.05.010; Vermeersch P, 2006, J AM COLL CARDIOL, V48, P2423, DOI 10.1016/j.jacc.2006.09.021; Webb JG, 1999, J AM COLL CARDIOL, V34, P468, DOI 10.1016/S0735-1097(99)00196-5; Weintraub WS, 1997, CIRCULATION, V95, P868; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	30	129	136	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 17	2011	378	9796					1071	1078		10.1016/S0140-6736(11)61255-5	http://dx.doi.org/10.1016/S0140-6736(11)61255-5			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	829BE	21872918				2022-12-28	WOS:000295548900023
J	Jennings, CC				Jennings, Christopher C.			Fallback Cuts or Super-Committee Concoction - Choosing Health Care's Policy Poison	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Jennings Policy Strategies, Washington, DC USA		Jennings, CC (corresponding author), Jennings Policy Strategies, Washington, DC USA.								0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 15	2011	365	11								10.1056/NEJMp1109865	http://dx.doi.org/10.1056/NEJMp1109865			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	819UR	21879890				2022-12-28	WOS:000294857300005
J	Robbins, DW; Hartwig, JF				Robbins, Daniel W.; Hartwig, John F.			A Simple, Multidimensional Approach to High-Throughput Discovery of Catalytic Reactions	SCIENCE			English	Article							CROSS-COUPLING REACTIONS; BORONIC ACIDS; INTERMOLECULAR HYDROAMINATION; COMBINATORIAL LIBRARIES; HOMOGENEOUS CATALYSTS; LABELING STRATEGY; CHIRAL CATALYSTS; ALKYNES; EFFICIENT; ALKENES	Transition metal complexes catalyze many important reactions that are employed in medicine, materials science, and energy production. Although high-throughput methods for the discovery of catalysts that would mirror related approaches for the discovery of medicinally active compounds have been the focus of much attention, these methods have not been sufficiently general or accessible to typical synthetic laboratories to be adopted widely. We report a method to evaluate a broad range of catalysts for potential coupling reactions with the use of simple laboratory equipment. Specifically, we screen an array of catalysts and ligands with a diverse mixture of substrates and then use mass spectrometry to identify reaction products that, by design, exceed the mass of any single substrate. With this method, we discovered a copper-catalyzed alkyne hydroamination and two nickel-catalyzed hydroarylation reactions, each of which displays excellent functional-group tolerance.	[Robbins, Daniel W.; Hartwig, John F.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Hartwig, JF (corresponding author), Univ Illinois, Dept Chem, 1209 W Calif St, Urbana, IL 61801 USA.	jhartwig@illinois.edu			NIH [GM-55382]; U.S. Department of Energy [DE-FG02-07ER15843]; Boehringer Ingelheim; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055382, R29GM055382, R37GM055382] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Energy(United States Department of Energy (DOE)); Boehringer Ingelheim(Boehringer Ingelheim); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the NIH (grant GM-55382) and the U.S. Department of Energy (grant DE-FG02-07ER15843) for financial support and the Univ. of Illinois and the American Chemical Society Division of Organic Chemistry (sponsored by Boehringer Ingelheim) for fellowship support (D.W.R.). We also thank P. Hergenrother (Univ. of Illinois), M. Burke (Univ. of Illinois), and S. Herzon (Yale Univ.) for helpful discussions.	Alex K, 2008, CHEMSUSCHEM, V1, P333, DOI 10.1002/cssc.200700160; Beeler AB, 2007, J AM CHEM SOC, V129, P1413, DOI 10.1021/ja0674744; Billingsley K, 2007, J AM CHEM SOC, V129, P3358, DOI 10.1021/ja068577p; Boussie TR, 2003, J AM CHEM SOC, V125, P4306, DOI 10.1021/ja020868k; Chen P, 2003, ANGEW CHEM INT EDIT, V42, P2832, DOI 10.1002/anie.200200560; Cole BM, 1996, ANGEW CHEM INT EDIT, V35, P1668, DOI 10.1002/anie.199616681; Copeland GT, 2001, J AM CHEM SOC, V123, P6496, DOI 10.1021/ja0108584; ELEUTERIO HS, 1991, J MOL CATAL, V65, P55, DOI 10.1016/0304-5102(91)85082-D; Fagan PJ, 2000, J AM CHEM SOC, V122, P5043, DOI 10.1021/ja000094c; FISCHER K, 1973, ANGEW CHEM INT EDIT, V12, P943, DOI 10.1002/anie.197309431; Francis MB, 1999, ANGEW CHEM INT EDIT, V38, P937, DOI 10.1002/(SICI)1521-3773(19990401)38:7<937::AID-ANIE937>3.0.CO;2-O; Geysen HM, 1996, CHEM BIOL, V3, P679, DOI 10.1016/S1074-5521(96)90136-2; Haak E, 1999, ANGEW CHEM INT EDIT, V38, P3389, DOI 10.1002/(SICI)1521-3773(19991115)38:22<3389::AID-ANIE3389>3.0.CO;2-E; Hamid MHSA, 2009, J AM CHEM SOC, V131, P1766, DOI 10.1021/ja807323a; Han JB, 2010, J AM CHEM SOC, V132, P916, DOI 10.1021/ja908883n; Hayashi T, 2001, J AM CHEM SOC, V123, P9918, DOI 10.1021/ja0165234; Hinderling C, 2000, INT J MASS SPECTROM, V195, P377, DOI 10.1016/S1387-3806(99)00229-8; Kanan MW, 2004, NATURE, V431, P545, DOI 10.1038/nature02920; Kinoshita H, 2010, J AM CHEM SOC, V132, P6412, DOI 10.1021/ja100346w; Kinzel T, 2010, J AM CHEM SOC, V132, P14073, DOI 10.1021/ja1073799; Knapp DM, 2009, J AM CHEM SOC, V131, P6961, DOI 10.1021/ja901416p; Lam PYS, 1998, TETRAHEDRON LETT, V39, P2941, DOI 10.1016/S0040-4039(98)00504-8; Lin PS, 2008, CHEM-EUR J, V14, P11296, DOI 10.1002/chem.200801858; Markert C, 2008, J AM CHEM SOC, V130, P3234, DOI 10.1021/ja0740317; Molander GA, 2009, J ORG CHEM, V74, P973, DOI 10.1021/jo802590b; Muller CA, 2008, ANGEW CHEM INT EDIT, V47, P3363, DOI 10.1002/anie.200705081; Muller TE, 2008, CHEM REV, V108, P3795, DOI 10.1021/cr0306788; Nakao Y, 2004, J AM CHEM SOC, V126, P13904, DOI 10.1021/ja0448723; Negishi EI, 2008, ACCOUNTS CHEM RES, V41, P1474, DOI 10.1021/ar800038e; Negishi E, 2010, J ORG CHEM, V75, P3151, DOI 10.1021/jo1003218; Rozenman MM, 2007, J AM CHEM SOC, V129, P14933, DOI 10.1021/ja074155j; Shimizu K. D., 1997, ANGEW CHEM INT EDIT, V36, P1704; Stambuli JP, 2003, CURR OPIN CHEM BIOL, V7, P420, DOI 10.1016/S1367-5931(03)00056-5; Szewczyk JW, 2001, ANGEW CHEM INT EDIT, V40, P216, DOI 10.1002/1521-3773(20010105)40:1<216::AID-ANIE216>3.0.CO;2-K; Teichert A, 2008, ANGEW CHEM INT EDIT, V47, P3360, DOI 10.1002/anie.200705082; Wieland J, 2010, NAT CHEM, V2, P832, DOI [10.1038/nchem.800, 10.1038/NCHEM.800]; Zhou L, 2008, ADV SYNTH CATAL, V350, P2226, DOI 10.1002/adsc.200800447	37	171	172	3	164	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 9	2011	333	6048					1423	1427		10.1126/science.1207922	http://dx.doi.org/10.1126/science.1207922			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817KU	21903809	Green Submitted, Green Accepted			2022-12-28	WOS:000294672200036
J	Arias, CA; Panesso, D; McGrath, DM; Qin, X; Mojica, MF; Miller, C; Diaz, L; Tran, TT; Rincon, S; Barbu, EM; Reyes, J; Roh, JH; Lobos, E; Sodergren, E; Pasqualini, R; Arap, W; Quinn, JP; Shamoo, Y; Murray, BE; Weinstock, GM				Arias, Cesar A.; Panesso, Diana; McGrath, Danielle M.; Qin, Xiang; Mojica, Maria F.; Miller, Corwin; Diaz, Lorena; Tran, Truc T.; Rincon, Sandra; Barbu, E. Magda; Reyes, Jinnethe; Roh, Jung H.; Lobos, Elizabeth; Sodergren, Erica; Pasqualini, Renata; Arap, Wadih; Quinn, John P.; Shamoo, Yousif; Murray, Barbara E.; Weinstock, George M.			Genetic Basis for In Vivo Daptomycin Resistance in Enterococci	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							STAPHYLOCOCCUS-AUREUS; VANCOMYCIN-RESISTANT; PHOSPHOLIPID-COMPOSITION; SUSCEPTIBILITY; INFECTIONS; EXPRESSION; LIAFSR; LIARS	Background Daptomycin is a lipopeptide with bactericidal activity that acts on the cell membrane of enterococci and is often used off-label to treat patients infected with vancomycin-resistant enterococci. However, the emergence of resistance to daptomycin during therapy threatens its usefulness. Methods We performed whole-genome sequencing and characterization of the cell envelope of a clinical pair of vancomycin-resistant Enterococcus faecalis isolates from the blood of a patient with fatal bacteremia; one isolate (S613) was from blood drawn before treatment and the other isolate (R712) was from blood drawn after treatment with daptomycin. The minimal inhibitory concentrations (MICs) of these two isolates were 1 and 12 mu g per milliliter, respectively. Gene replacements were made to exchange the alleles found in isolate S613 with those in isolate R712. Results Isolate R712 had in-frame deletions in three genes. Two genes encoded putative enzymes involved in phospholipid metabolism, GdpD (which denotes glycerophosphoryl diester phosphodiesterase) and Cls (which denotes cardiolipin synthetase), and one gene encoded a putative membrane protein, LiaF (which denotes lipid II cycle-interfering antibiotics protein but whose exact function is not known). LiaF is predicted to be a member of a three-component regulatory system (LiaFSR) involved in the stress-sensing response of the cell envelope to antibiotics. Replacement of the liaF allele of isolate S613 with the liaF allele from isolate R712 quadrupled the MIC of daptomycin, whereas replacement of the gdpD allele had no effect on MIC. Replacement of both the liaF and gdpD alleles of isolate S613 with the liaF and gdpD alleles of isolate R712 raised the daptomycin MIC for isolate S613 to 12 mu g per milliliter. As compared with isolate S613, isolate R712 - the daptomycin-resistant isolate - had changes in the structure of the cell envelope and alterations in membrane permeability and membrane potential. Conclusions Mutations in genes encoding LiaF and a GdpD-family protein were necessary and sufficient for the development of resistance to daptomycin during the treatment of vancomycin-resistant enterococci. (Funded by the National Institute of Allergy and Infectious Diseases and the National Institutes of Health.)	[Arias, Cesar A.; Panesso, Diana; Mojica, Maria F.; Diaz, Lorena; Tran, Truc T.; Roh, Jung H.; Murray, Barbara E.] Univ Texas Med Sch, Dept Internal Med, Div Infect Dis, Houston, TX 77030 USA; [Murray, Barbara E.] Univ Texas Med Sch, Dept Microbiol & Mol Genet, Houston, TX 77030 USA; [McGrath, Danielle M.; Barbu, E. Magda; Pasqualini, Renata; Arap, Wadih] Univ Texas MD Anderson Canc Ctr, David H Koch Ctr, Houston, TX 77030 USA; [Qin, Xiang] Baylor Coll Med, Ctr Human Genome, Houston, TX 77030 USA; [Miller, Corwin; Shamoo, Yousif] Rice Univ, Inst Biosci & Bioengn, Houston, TX USA; [Tran, Truc T.] Univ Houston, Coll Pharm, Houston, TX 77030 USA; [Arias, Cesar A.; Panesso, Diana; Diaz, Lorena; Rincon, Sandra; Reyes, Jinnethe] Univ El Bosque, Mol Genet & Antimicrobial Resistance Unit, Bogota, Colombia; [Mojica, Maria F.] Ctr Med Res & Training, Cali, Colombia; [Lobos, Elizabeth; Sodergren, Erica; Weinstock, George M.] Washington Univ, St Louis, MO 63130 USA; [Quinn, John P.] Chicago Infect Dis Inst, Chicago, IL USA; [Quinn, John P.] Pfizer Worldwide Res & Dev, Groton, CT USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine; Rice University; University of Houston System; University of Houston; Universidad El Bosque; Washington University (WUSTL); Pfizer	Arias, CA (corresponding author), Univ Texas Med Sch, Dept Internal Med, Div Infect Dis, 6431 Fannin St,Rm MSB 2-112, Houston, TX 77030 USA.	cesar.arias@uth.tmc.edu	Weinstock, George M/C-6314-2013	Weinstock, George M/0000-0002-2997-4592; Rincon, Sandra/0000-0002-8482-4554; Mojica Medina, Maria Fernanda/0000-0002-1380-9824; Shamoo, Yousif/0000-0001-9241-8962	National Institute of Allergy and Infectious Diseases [R00 AI72961, R01 AI067861, R37 AI47923, R01 AI080714]; National Institutes of Health [1U54 HG004968]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG004968] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R00AI072961, R01AI080714, R01AI093749, R01AI067861, R37AI047923] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by grants from the National Institute of Allergy and Infectious Diseases (Pathway to Independence Award R00 AI72961, to Dr. Arias; R01 AI067861 and R37 AI47923, to Dr. Murray; and R01 AI080714, to Dr. Shamoo) and a grant for genome sequencing from the National Institutes of Health (1U54 HG004968, to Dr. Weinstock).	[Anonymous], 2008, ETEST TECHNICAL MANU; Boucher HW, 2009, CLIN INFECT DIS, V48, P1, DOI 10.1086/595011; Canton R, 2010, J ANTIMICROB CHEMOTH, V65, P1126, DOI 10.1093/jac/dkq087; *CLIN LAB STAND I, 2011, M100S21 CLSI; Cui L, 2009, ANTIMICROB AGENTS CH, V53, P1231, DOI 10.1128/AAC.01173-08; Depardieu F, 2003, MOL MICROBIOL, V50, P1069, DOI 10.1046/j.1365-2958.2003.03771.x; DiazGranados CA, 2005, CLIN INFECT DIS, V41, P327, DOI 10.1086/430909; DOSSANTO.JM, 1970, J BACTERIOL, V104, P611, DOI 10.1128/JB.104.2.611-619.1970; Eldholm V, 2010, J BACTERIOL, V192, P1761, DOI 10.1128/JB.01489-09; Ernst CM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000660; Friedman L, 2006, ANTIMICROB AGENTS CH, V50, P2137, DOI 10.1128/AAC.00039-06; Green Myke R, 2006, J Oncol Pharm Pract, V12, P179, DOI 10.1177/1078155206069165; Hayat MA, 2000, PRINCIPLES AND TECHNIQUES OF ELECTRON MICROSCOPY: BIOLOGICAL APPLICATIONS, FOURTH EDITION, P1; Jones T, 2008, ANTIMICROB AGENTS CH, V52, P269, DOI 10.1128/AAC.00719-07; Jordan S, 2006, J BACTERIOL, V188, P5153, DOI 10.1128/JB.00310-06; Kilelee E, 2010, ANTIMICROB AGENTS CH, V54, P4476, DOI 10.1128/AAC.00191-10; Koppelman CM, 2001, J BACTERIOL, V183, P6144, DOI 10.1128/JB.183.20.6144-6147.2001; Kristich CJ, 2007, PLASMID, V57, P131, DOI 10.1016/j.plasmid.2006.08.003; Leuko S, 2004, APPL ENVIRON MICROB, V70, P6884, DOI 10.1128/AEM.70.11.6884-6886.2004; Lewis JS, 2005, ANTIMICROB AGENTS CH, V49, P2152, DOI 10.1128/AAC.49.5.2152.2005; Mascher T, 2004, ANTIMICROB AGENTS CH, V48, P2888, DOI 10.1128/AAC.48.8.2888-2896.2004; Mileykovskaya E, 2009, BBA-BIOMEMBRANES, V1788, P2084, DOI 10.1016/j.bbamem.2009.04.003; Mukhopadhyay K, 2007, MICROBIOL-SGM, V153, P1187, DOI 10.1099/mic.0.2006/003111-0; Munoz-Price LS, 2005, CLIN INFECT DIS, V41, P565, DOI 10.1086/432121; Mwangi MM, 2007, P NATL ACAD SCI USA, V104, P9451, DOI 10.1073/pnas.0609839104; Panesso D, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-20; Romantsov T, 2007, MOL MICROBIOL, V64, P1455, DOI 10.1111/j.1365-2958.2007.05727.x; Schwan TG, 2003, J BACTERIOL, V185, P1346, DOI 10.1128/JB.185.4.1346-1356.2003; SHIBUYA I, 1985, J BACTERIOL, V161, P1086, DOI 10.1128/JB.161.3.1086-1092.1985; Suntharalingam P, 2009, J BACTERIOL, V191, P2973, DOI 10.1128/JB.01563-08; Wolf D, 2010, J BACTERIOL, V192, P4680, DOI 10.1128/JB.00543-10; Yang SJ, 2009, J INFECT DIS, V200, P1916, DOI 10.1086/648473; Yang SJ, 2009, ANTIMICROB AGENTS CH, V53, P2636, DOI 10.1128/AAC.01415-08; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	34	233	235	1	39	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 8	2011	365	10					892	900		10.1056/NEJMoa1011138	http://dx.doi.org/10.1056/NEJMoa1011138			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	816JX	21899450	Green Published, Green Accepted			2022-12-28	WOS:000294595600005
J	Blank, S				Blank, Steve			Embrace failure to start up success	NATURE			English	Editorial Material												sblank@kandsranch.com							0	16	16	1	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 8	2011	477	7363					133	133		10.1038/477133a	http://dx.doi.org/10.1038/477133a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	816MC	21900972	Bronze			2022-12-28	WOS:000294603900004
J	Boyce, N				Boyce, Niall			Profile JoAnn Difede: emotional engagement with victims of trauma	LANCET			English	Biographical-Item																		DIFEDE J, PUBLICATION LIST	1	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 3	2011	378	9794					869	869		10.1016/S0140-6736(11)61402-5	http://dx.doi.org/10.1016/S0140-6736(11)61402-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	818XZ	21890039	Bronze			2022-12-28	WOS:000294791300014
J	Feeney, JM; Wallack, MK				Feeney, James M.; Wallack, Marc K.			Taking the terror out of terrorism: mortality data after 9/11	LANCET			English	Editorial Material							WORLD-TRADE-CENTER; SEPTEMBER 11; SYMPTOMS; HEALTH		[Feeney, James M.] St Francis Hosp & Med Ctr, Hartford, CT 06103 USA; [Wallack, Marc K.] Metropolitan Hosp Ctr, New York, NY 10029 USA	Saint Francis Hospital & Medical Center; Metropolitan Hospital Center	Feeney, JM (corresponding author), St Francis Hosp & Med Ctr, Hartford, CT 06103 USA.	feeneymd@yahoo.com						Aldrich TK, 2010, NEW ENGL J MED, V362, P1263, DOI 10.1056/NEJMoa0910087; Berninger A, 2010, PUBLIC HEALTH REP, V125, P556, DOI 10.1177/003335491012500411; Brackbill RM, 2009, JAMA-J AM MED ASSOC, V302, P502, DOI 10.1001/jama.2009.1121; Cushman JG, 2003, J TRAUMA, V54, P147, DOI 10.1097/00005373-200301000-00018; Feeney JM, 2005, ARCH SURG-CHICAGO, V140, P1068, DOI 10.1001/archsurg.140.11.1068; Frykberg ER, 2002, J TRAUMA, V53, P201, DOI 10.1097/00005373-200208000-00001; Goldman H, 2010, BLOOMBERG NEWS  0912; Jordan HT, 2011, LANCET, V378, P879, DOI 10.1016/S0140-6736(11)60966-5; Reibman J, 2005, ENVIRON HEALTH PERSP, V113, P406, DOI 10.1289/ehp.7375; US Congress Senate, 1996, PERM SUBC INV HEAR G, P21; Warga C, 2011, NEW YORK DAILY  0618; Weiden MD, 2010, CHEST, V137, P566, DOI 10.1378/chest.09-1580	12	3	4	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 3	2011	378	9794					851	852		10.1016/S0140-6736(11)61309-3	http://dx.doi.org/10.1016/S0140-6736(11)61309-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	818XZ	21890030				2022-12-28	WOS:000294791300004
J	Rubinsztein, DC; Marino, G; Kroemer, G				Rubinsztein, David C.; Marino, Guillermo; Kroemer, Guido			Autophagy and Aging	CELL			English	Review							LIFE-SPAN EXTENSION; BETA-CELL MASS; CALORIC RESTRICTION; MEDIATED AUTOPHAGY; MAMMALIAN AUTOPHAGY; DIETARY RESTRICTION; PROTEIN-SYNTHESIS; LONGEVITY; DISEASE; STRESS	Genetic inhibition of autophagy induces degenerative changes in mammalian tissues that resemble those associated with aging, and normal and pathological aging are often associated with a reduced autophagic potential. Pharmacological or genetic manipulations that increase life span in model organisms often stimulate autophagy, and its inhibition compromises the longevity-promoting effects of caloric restriction, Sirtuin 1 activation, inhibition of insulin/insulin growth factor signaling, or the administration of rapamycin, resveratrol, or spermidine. Here, we discuss the probable cause and effect relationship between perturbed autophagy and aging, as well as possible molecular mechanisms that may mediate the anti-aging effects of autophagy.	[Rubinsztein, David C.] Univ Cambridge, Addenbrookes Hosp, Dept Med Genet, Cambridge Inst Med Res, Cambridge CB2 0XY, England; [Marino, Guillermo; Kroemer, Guido] INSERM, U848, F-94805 Villejuif, France; [Marino, Guillermo; Kroemer, Guido] Inst Gustave Roussy, F-94805 Villejuif, France; [Marino, Guillermo] Univ Paris Sud, F-94805 Villejuif, France; [Kroemer, Guido] Ctr Rech Cordeliers, F-75006 Paris, France; [Kroemer, Guido] Hop Europeen Georges Pompidou, AP HP, F-75015 Paris, France; [Kroemer, Guido] Univ Paris 05, Fac Med, F-75006 Paris, France	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Rubinsztein, DC (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Med Genet, Cambridge Inst Med Res, Hills Rd, Cambridge CB2 0XY, England.	dcr1000@hermes.cam.ac.uk; kroemer@orange.fr	Kroemer, Guido/AAY-9859-2020; KROEMER, Guido/B-4263-2013; GARCÍA, GUILLERMO MARIÑO/AAI-8015-2020; Rubinsztein, David C/C-3472-2011; marino, guillermo/HGB-8664-2022; GARCÍA, GUILLERMO MARIÑO/J-1726-2012	KROEMER, Guido/0000-0002-9334-4405; GARCÍA, GUILLERMO MARIÑO/0000-0003-1960-1677	Ligue Nationale contre le Cancer (Equipes labellisee); Agence Nationale pour la Recherche; AXA Chair for Longevity Research; European Commission (Apo-Sys, ArtForce, ChemoRes, Apop-Train); Fondation Bettencourt-Schueller; Fondation pour la Recherche Medicale; LabEx Immuno-Oncology; Institut National du Cancer; Canceropole Ile-de-France; Wellcome Trust; Wellcome Trust/Medical Research Council Strategic Award on Neurodegenerative Diseases; Medical Research Council; National Institute for Health Research Biomedical Research Centre at Addenbrooke's Hospital; Medical Research Council [MC_G1000734, G0600194] Funding Source: researchfish; MRC [MC_G1000734, G0600194] Funding Source: UKRI	Ligue Nationale contre le Cancer (Equipes labellisee); Agence Nationale pour la Recherche(French National Research Agency (ANR)); AXA Chair for Longevity Research(AXA Research Fund); European Commission (Apo-Sys, ArtForce, ChemoRes, Apop-Train)(European CommissionEuropean Commission Joint Research Centre); Fondation Bettencourt-Schueller; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); LabEx Immuno-Oncology; Institut National du Cancer(Institut National du Cancer (INCA) France); Canceropole Ile-de-France(Region Ile-de-France); Wellcome Trust(Wellcome Trust); Wellcome Trust/Medical Research Council Strategic Award on Neurodegenerative Diseases(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research Biomedical Research Centre at Addenbrooke's Hospital(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We apologize to all colleagues whose work we could not cite owing to space limitations. G.K. is supported by the Ligue Nationale contre le Cancer (Equipes labellisee), Agence Nationale pour la Recherche, AXA Chair for Longevity Research, European Commission (Apo-Sys, ArtForce, ChemoRes, Apop-Train), Fondation Bettencourt-Schueller, Fondation pour la Recherche Medicale, the LabEx Immuno-Oncology, Institut National du Cancer, and Canceropole Ile-de-France. D.C.R. is supported by the Wellcome Trust (Senior Fellowship), a Wellcome Trust/Medical Research Council Strategic Award on Neurodegenerative Diseases, Medical Research Council, and the National Institute for Health Research Biomedical Research Centre at Addenbrooke's Hospital.	Alimonti A, 2010, J CLIN INVEST, V120, P681, DOI 10.1172/JCI40535; Alvers AL, 2009, AGING CELL, V8, P353, DOI 10.1111/j.1474-9726.2009.00469.x; Bjedov I, 2010, CELL METAB, V11, P35, DOI 10.1016/j.cmet.2009.11.010; Blagosklonny MV, 2009, CELL CYCLE, V8, P1883, DOI 10.4161/cc.8.12.8815; Canto C, 2010, CELL METAB, V11, P213, DOI 10.1016/j.cmet.2010.02.006; Carames B, 2010, ARTHRITIS RHEUM-US, V62, P791, DOI 10.1002/art.27305; Cardenas C, 2010, CELL, V142, P270, DOI 10.1016/j.cell.2010.06.007; Castilho RM, 2009, CELL STEM CELL, V5, P279, DOI 10.1016/j.stem.2009.06.017; Chen C, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000559; Colell A, 2007, CELL, V129, P983, DOI 10.1016/j.cell.2007.03.045; Colman RJ, 2009, SCIENCE, V325, P201, DOI 10.1126/science.1173635; Dang WW, 2009, NATURE, V459, P802, DOI 10.1038/nature08085; de Kreutzenberg SV, 2010, DIABETES, V59, P1006, DOI 10.2337/db09-1187; Decuypere J.-P., 2011, J AGING RES, DOI [10.4061/2011/920178, DOI 10.4061/2011/920178]; Demontis F, 2010, CELL, V143, P813, DOI 10.1016/j.cell.2010.10.007; Dwivedi M, 2009, AUTOPHAGY, V5, P604, DOI 10.4161/auto.5.5.8157; Ebato C, 2008, CELL METAB, V8, P325, DOI 10.1016/j.cmet.2008.08.009; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; Eisenberg T, 2009, NAT CELL BIOL, V11, P1305, DOI 10.1038/ncb1975; Elgendy M, 2011, MOL CELL, V42, P23, DOI 10.1016/j.molcel.2011.02.009; Fleming A, 2011, NAT CHEM BIOL, V7, P9, DOI 10.1038/NCHEMBIO.500; Furuta N, 2010, MOL BIOL CELL, V21, P1001, DOI 10.1091/mbc.E09-08-0693; Gautier CA, 2008, P NATL ACAD SCI USA, V105, P11364, DOI 10.1073/pnas.0802076105; Gottlieb RA, 2010, ANNU REV PHYSIOL, V72, P45, DOI 10.1146/annurev-physiol-021909-135757; Grandison RC, 2009, NATURE, V462, P1061, DOI 10.1038/nature08619; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; Hands SL, 2009, AGING-US, V1, P586, DOI 10.18632/aging.100070; Hansen M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040024; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Hartleben B, 2010, J CLIN INVEST, V120, P1084, DOI 10.1172/JCI39492; Inuzuka Y, 2009, CIRCULATION, V120, P1695, DOI 10.1161/CIRCULATIONAHA.109.871137; Jagannath C, 2009, NAT MED, V15, P267, DOI 10.1038/nm.1928; Jia KL, 2007, AUTOPHAGY, V3, P597, DOI 10.4161/auto.4989; Jia KL, 2009, P NATL ACAD SCI USA, V106, P14564, DOI 10.1073/pnas.0813319106; Jiang M, 2010, AM J PATHOL, V176, P1181, DOI 10.2353/ajpath.2010.090594; Jung HS, 2008, CELL METAB, V8, P318, DOI 10.1016/j.cmet.2008.08.013; Kapahi P, 2010, CELL METAB, V11, P453, DOI 10.1016/j.cmet.2010.05.001; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Komatsu M, 2007, P NATL ACAD SCI USA, V104, P14489, DOI 10.1073/pnas.0701311104; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Komatsu M, 2010, NAT CELL BIOL, V12, P213, DOI 10.1038/ncb2021; Korolchuk VI, 2011, NAT CELL BIOL, V13, P453, DOI 10.1038/ncb2204; Korolchuk VI, 2009, MOL CELL, V33, P517, DOI 10.1016/j.molcel.2009.01.021; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Kroemer G, 2008, NAT REV MOL CELL BIO, V9, P1004, DOI 10.1038/nrm2529; Kume S, 2010, J CLIN INVEST, V120, P1043, DOI 10.1172/JCI41376; Le Bourg E, 2009, BBA-GEN SUBJECTS, V1790, P1030, DOI 10.1016/j.bbagen.2009.01.004; Lee IH, 2008, P NATL ACAD SCI USA, V105, P3374, DOI 10.1073/pnas.0712145105; Lee JS, 2009, NAT CELL BIOL, V11, P1355, DOI 10.1038/ncb1980; Lee JY, 2010, EMBO J, V29, P969, DOI 10.1038/emboj.2009.405; Lee JH, 2010, SCIENCE, V327, P1223, DOI 10.1126/science.1182228; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Li YH, 2008, CANCER RES, V68, P6889, DOI 10.1158/0008-5472.CAN-08-0161; Liang CC, 2010, J BIOL CHEM, V285, P3499, DOI 10.1074/jbc.M109.072389; Lipinski MM, 2010, P NATL ACAD SCI USA, V107, P14164, DOI 10.1073/pnas.1009485107; Madeo F, 2010, NAT CELL BIOL, V12, P842, DOI 10.1038/ncb0910-842; Maiuri MC, 2009, CELL DEATH DIFFER, V16, P87, DOI 10.1038/cdd.2008.131; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; Masiero E, 2009, CELL METAB, V10, P507, DOI 10.1016/j.cmet.2009.10.008; Matecic M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000921; Mathew R, 2009, CELL, V137, P1062, DOI 10.1016/j.cell.2009.03.048; Mattson MP, 2005, J NUTR BIOCHEM, V16, P129, DOI 10.1016/j.jnutbio.2004.12.007; Melendez A, 2003, SCIENCE, V301, P1387, DOI 10.1126/science.1087782; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Morselli E, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2009.8; Morselli E, 2011, J CELL BIOL, V192, P615, DOI 10.1083/jcb.201008167; Mortensen M, 2011, J EXP MED, V208, P455, DOI 10.1084/jem.20101145; Murphy CT, 2007, P NATL ACAD SCI USA, V104, P19046, DOI 10.1073/pnas.0709613104; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Nakai A, 2007, NAT MED, V13, P619, DOI 10.1038/nm1574; Orvedahl A, 2007, CELL HOST MICROBE, V1, P23, DOI 10.1016/j.chom.2006.12.001; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Pickford F, 2008, J CLIN INVEST, V118, P2190, DOI 10.1172/JCI33585; Ravikumar B, 2005, NAT GENET, V37, P771, DOI 10.1038/ng1591; Ravikumar B, 2010, PHYSIOL REV, V90, P1383, DOI 10.1152/physrev.00030.2009; Ristow M, 2010, EXP GERONTOL, V45, P410, DOI 10.1016/j.exger.2010.03.014; Rogina B, 2004, P NATL ACAD SCI USA, V101, P15998, DOI 10.1073/pnas.0404184101; Saitoh T, 2010, J CELL BIOL, V189, P925, DOI 10.1083/jcb.201002021; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Saunders LR, 2009, SCIENCE, V323, P1021, DOI 10.1126/science.1170007; Selman C, 2009, SCIENCE, V326, P140, DOI 10.1126/science.1177221; Sheaffer KL, 2008, CURR BIOL, V18, P1355, DOI 10.1016/j.cub.2008.07.097; Sheng R, 2010, AUTOPHAGY, V6, P482, DOI 10.4161/auto.6.4.11737; Simonsen A, 2008, AUTOPHAGY, V4, P176, DOI 10.4161/auto.5269; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Syntichaki P, 2007, NATURE, V445, P922, DOI 10.1038/nature05603; Tasdemir E, 2008, NAT CELL BIOL, V10, P676, DOI 10.1038/ncb1730; Tavernarakis N, 2008, AUTOPHAGY, V4, P870, DOI 10.4161/auto.6730; Toth ML, 2008, AUTOPHAGY, V4, P330, DOI 10.4161/auto.5618; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Uhl M, 2009, CELL DEATH DIFFER, V16, P991, DOI 10.1038/cdd.2009.8; Vicencio JM, 2009, CELL DEATH DIFFER, V16, P1006, DOI 10.1038/cdd.2009.34; Vijg J, 2008, NATURE, V454, P1065, DOI 10.1038/nature07216; Wang T, 2009, J CELL BIOL, V186, P703, DOI 10.1083/jcb.200904090; Wang XW, 2008, NAT CELL BIOL, V10, P1090, DOI 10.1038/ncb1769; Wang YM, 2006, MECH AGEING DEV, V127, P48, DOI 10.1016/j.mad.2005.09.005; Williams A, 2008, NAT CHEM BIOL, V4, P295, DOI 10.1038/nchembio.79; Witte AV, 2009, P NATL ACAD SCI USA, V106, P1255, DOI 10.1073/pnas.0808587106; Wu JJ, 2009, AGING-US, V1, P425, DOI 10.18632/aging.100038; Yang L, 2010, CELL METAB, V11, P467, DOI 10.1016/j.cmet.2010.04.005; Young ARJ, 2009, GENE DEV, V23, P798, DOI 10.1101/gad.519709; Zhang C, 2008, NAT MED, V14, P959, DOI 10.1038/nm.1851; Zheng SQ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000838; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663; Zid BM, 2009, CELL, V139, P149, DOI 10.1016/j.cell.2009.07.034	108	1462	1535	26	409	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 2	2011	146	5					682	695		10.1016/j.cell.2011.07.030	http://dx.doi.org/10.1016/j.cell.2011.07.030			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	814SM	21884931	Bronze			2022-12-28	WOS:000294477500010
J	Smolle, M; Workman, JL				Smolle, Michaela; Workman, Jerry L.			Signaling through Chromatin: Setting the Scene at Kinetochores	CELL			English	Editorial Material							TRANSCRIPTION ELONGATION; BUR1 KINASE; COMPLEX; SPT5	Histone H3 lysine 4 trimethylation needed for transcription is mediated by the Set1 methyltransferase and requires prior monoubiquitination of histone H2B. In this issue, Latham et al. (2011) report that dimethylation of the yeast kinetochore protein Dam1 by Set1 similarly requires H2B monoubiquitination. Thus, H2B ubiquitination signals for methylation beyond chromatin.	[Smolle, Michaela; Workman, Jerry L.] Stowers Inst Med Res, Kansas City, MO 64110 USA	Stowers Institute for Medical Research	Workman, JL (corresponding author), Stowers Inst Med Res, Kansas City, MO 64110 USA.	jlw@stowers.org		Smolle, Michaela/0000-0001-8900-1541	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047867] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM047867] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Choi ES, 2011, J BIOL CHEM, V286, P23600, DOI 10.1074/jbc.M111.228510; Keogh MC, 2003, MOL CELL BIOL, V23, P7005, DOI 10.1128/MCB.23.19.7005-7018.2003; Lampson MA, 2011, TRENDS CELL BIOL, V21, P133, DOI 10.1016/j.tcb.2010.10.007; Laribee RN, 2007, P NATL ACAD SCI USA, V104, P5836, DOI 10.1073/pnas.0607996104; Latham JA, 2011, CELL, V146, P709, DOI 10.1016/j.cell.2011.07.025; Liu Y, 2009, MOL CELL BIOL, V29, P4852, DOI 10.1128/MCB.00609-09; Pinsky BA, 2006, MOL CELL BIOL, V26, P2648, DOI 10.1128/MCB.26.7.2648-2660.2006; Weake VM, 2008, MOL CELL, V29, P653, DOI 10.1016/j.molcel.2008.02.014; Zhang K, 2005, CELL, V122, P723, DOI 10.1016/j.cell.2005.06.021; Zhou K, 2009, P NATL ACAD SCI USA, V106, P6956, DOI 10.1073/pnas.0806302106	10	0	0	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 2	2011	146	5					671	672		10.1016/j.cell.2011.08.011	http://dx.doi.org/10.1016/j.cell.2011.08.011			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	814SM	21884927	Bronze			2022-12-28	WOS:000294477500006
J	Morford, SL; Houlton, BZ; Dahlgren, RA				Morford, Scott L.; Houlton, Benjamin Z.; Dahlgren, Randy A.			Increased forest ecosystem carbon and nitrogen storage from nitrogen rich bedrock	NATURE			English	Article							MENDOCINO TRIPLE JUNCTION; FORK MOUNTAIN SCHIST; COAST RANGES; ISOTOPIC COMPOSITION; NORTHERN CALIFORNIA; GEOLOGIC NITROGEN; CASCADIA MARGIN; GLOBAL PATTERNS; UPLIFT RATES; SOIL	Nitrogen (N) limits the productivity of many ecosystems worldwide, thereby restricting the ability of terrestrial ecosystems to offset the effects of rising atmospheric CO2 emissions naturally(1,2). Understanding input pathways of bioavailable N is therefore paramount for predicting carbon (C) storage on land, particularly in temperate and boreal forests(3,4). Paradigms of nutrient cycling and limitation posit that new N enters terrestrial ecosystems solely from the atmosphere. Here we show that bedrock comprises a hitherto overlooked source of ecologically available N to forests. We report that the N content of soils and forest foliage on N-rich metasedimentary rocks (350-950 mg N kg(-1)) is elevated by more than 50% compared with similar temperate forest sites underlain by N-poor igneous parent material (30-70 mg N kg(-1)). Natural abundance N isotopes attribute this difference to rock-derived N: N-15/N-14 values for rock, soils and plants are indistinguishable in sites underlain by N-rich lithology, in marked contrast to sites on N-poor substrates. Furthermore, forests associated with N-rich parent material contain on average 42% more carbon in above-ground tree biomass and 60% more carbon in the upper 30 cm of the soil than similar sites underlain by N-poor rocks. Our results raise the possibility that bedrock N input may represent an important and overlooked component of ecosystem N and C cycling elsewhere.	[Morford, Scott L.; Houlton, Benjamin Z.; Dahlgren, Randy A.] Univ Calif Davis, Dept Land Air & Water Resources, Davis, CA 95616 USA	University of California System; University of California Davis	Morford, SL (corresponding author), Univ Calif Davis, Dept Land Air & Water Resources, Davis, CA 95616 USA.	slmorford@ucdavis.edu		Dahlgren, Randy/0000-0002-8961-875X; Houlton, Benjamin/0000-0002-1414-0261	David and Lucile Packard Foundation; Andrew W. Mellon Foundation; Kearney Foundation of Soil Science	David and Lucile Packard Foundation(The David & Lucile Packard Foundation); Andrew W. Mellon Foundation; Kearney Foundation of Soil Science	We thank the United States Forest Service (USFS) for access and insight, particularly D. Young and B. Rust of the Shasta-Trinity National Forest; C. Ramirez, C. Clark and D. Beardsley of USFS Region 5 Remote Sensing Office; and M. North of the Pacific Southwest Research Station for discussion of FIA modelling. I. Fisher, E. Hendel, K. Mayfield and S. Prentice assisted with sample preparation and fieldwork, and E. Brown assisted in processing strontium isotope samples. D. Beaudette provided assistance in analysing soil data. This work was supported by grants from the David and Lucile Packard Foundation (to B.Z.H. and R.A.D.) the Andrew W. Mellon Foundation (to B.Z.H.) and the Kearney Foundation of Soil Science (to R.A.D.).	Aalto KR, 2006, GEOL SOC AM SPEC PAP, V410, P451, DOI 10.1130/2006.2410(22); AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Amundson R, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001903; Beaudette D. E., 2010, 1KM SCALE GRIDDED SO; BISHOP DG, 1977, GEOLOGY, V5, P595, DOI 10.1130/0091-7613(1977)5<595:SFMSAB>2.0.CO;2; Blake G. R., 1986, METHODS SOIL ANAL PH, V9, P364; Blake M. S., 1992, OF92271 US GEOL SURV; BLATT H, 1975, GEOL SOC AM BULL, V86, P1085, DOI 10.1130/0016-7606(1975)86<1085:POEIMA>2.0.CO;2; BRADY PV, 1994, GEOCHIM COSMOCHIM AC, V58, P1853, DOI 10.1016/0016-7037(94)90543-6; Brauer K, 2005, CHEM GEOL, V218, P361, DOI 10.1016/j.chemgeo.2005.01.004; California Department of Forestry and Fire Protection, 2009, FIR PER 1923 2008 WI; Capo RC, 1998, GEODERMA, V82, P197, DOI 10.1016/S0016-7061(97)00102-X; CARLSON RM, 1978, ANAL CHEM, V50, P1528, DOI 10.1021/ac50033a035; CASEY WH, 1992, GEOCHIM COSMOCHIM AC, V56, P3825, DOI 10.1016/0016-7037(92)90173-G; Cleveland CC, 1999, GLOBAL BIOGEOCHEM CY, V13, P623, DOI 10.1029/1999GB900014; CORNWELL SM, 1968, NATURE, V217, P768, DOI 10.1038/217768a0; Dahlgren RA, 2005, SOIL SCI PLANT NUTR, V51, P719, DOI 10.1111/j.1747-0765.2005.tb00099.x; DAHLGREN RA, 1994, NATURE, V368, P838, DOI 10.1038/368838a0; de Vries W, 2008, NATURE, V451, pE1, DOI 10.1038/nature06579; Environmental Systems Research Group, 2010, ARCGIS DESKT V 9 3; Eshel G, 2004, SOIL SCI SOC AM J, V68, P736, DOI 10.2136/sssaj2004.0736; Forest Inventory and Analysis Program, 2008, FOR INV AN DAT DAT D; Fox J., 2019, R COMPANION APPL REG; Fu PD, 2002, COMPUT ELECTRON AGR, V37, P25, DOI 10.1016/S0168-1699(02)00115-1; Galloway J. N., 2004, TREATISE GEOCHEMISTR, V8, P557; GALLOWAY JN, 1995, GLOBAL BIOGEOCHEM CY, V9, P235, DOI 10.1029/95GB00158; Gesch D., 2007, DIGITAL ELEVATION MO, P99; Hobbie EA, 2000, OECOLOGIA, V122, P273, DOI 10.1007/PL00008856; Holloway JM, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2002GB001862; Holloway JM, 1998, NATURE, V395, P785, DOI 10.1038/27410; Houlton BZ, 2009, P NATL ACAD SCI USA, V106, P21713, DOI 10.1073/pnas.0912111106; Irwin W., 1974, GQ1111 US GEOL SURV; JAYKO AS, 1989, J STRUCT GEOL, V11, P375, DOI 10.1016/0191-8141(89)90016-3; Jenkins JC, 2003, FOREST SCI, V49, P12; Jennings C. W., 1960, GEOLOGIC MAP CALIFOR; Keeler-Wolf T., 1990, General Technical Report - Pacific Southwest Research Station, USDA Forest Service; KELSEY HM, 1994, J GEOPHYS RES-SOL EA, V99, P12245, DOI 10.1029/93JB03236; LANPHERE MA, 1978, AM J SCI, V278, P798, DOI 10.2475/ajs.278.6.798; LeBauer DS, 2008, ECOLOGY, V89, P371, DOI 10.1890/06-2057.1; LI YH, 1991, GEOCHIM COSMOCHIM AC, V55, P3223, DOI 10.1016/0016-7037(91)90485-N; Lock J, 2006, GEOL SOC AM BULL, V118, P1232, DOI 10.1130/B25885.1; Lorenz K, 2010, CARBON SEQUESTRATION IN FOREST ECOSYSTEMS, P1, DOI 10.1007/978-90-481-3266-9; Magnani F, 2007, NATURE, V447, P848, DOI 10.1038/nature05847; Martinelli LA, 1999, BIOGEOCHEMISTRY, V46, P45, DOI 10.1023/A:1006100128782; McGaughey R.J., 2004, STAND VISUALIZATION; MCKINNEY CR, 1950, REV SCI INSTRUM, V21, P724, DOI 10.1063/1.1745698; MERRITTS D, 1989, GEOLOGY, V17, P1020, DOI 10.1130/0091-7613(1989)017<1020:IQURAT>2.3.CO;2; MITCHELL CE, 1994, J GEOPHYS RES-SOL EA, V99, P12257, DOI 10.1029/94JB00279; National Atmospheric Deposition Program, 2009, 200901 NAT ATM DEP P; *OR STAT U PRISM G, 2006, US AV MONTHL ANN PRE; Oren R, 2001, NATURE, V411, P469, DOI 10.1038/35078064; Reineke LH, 1933, J AGRIC RES, V46, P0627; Reinhardt E. D., 2003, FIRE FUELS EXTENSION; Riebe CS, 2004, EARTH PLANET SC LETT, V218, P421, DOI 10.1016/S0012-821X(03)00673-3; Smith E. M., 1996, PRACTICE SILVICULTUR; SOIL SURVEY STAFF, 2010, SOIL SURV GEOGR SSUR; SOLLINS P, 1980, ECOL MONOGR, V50, P261, DOI 10.2307/2937252; STEVENSON FJ, 1959, SCIENCE, V130, P221, DOI 10.1126/science.130.3369.221; Strand R.G., 1962, GEOLOGIC MAP CALIFOR; STRATHOUSE SM, 1980, J ENVIRON QUAL, V9, P54, DOI 10.2134/jeq1980.00472425000900010014x; The PRISM Group at Oregon State University, 2006, US AV MONTHL ANN MAX; Thomas RQ, 2010, NAT GEOSCI, V3, P13, DOI 10.1038/NGEO721; TIMMER VR, 1978, SOIL SCI SOC AM J, V42, P125, DOI 10.2136/sssaj1978.03615995004200010027x; Townsend AR, 1996, ECOL APPL, V6, P806, DOI 10.2307/2269486; USDA Forest Service, 2010, 2007 SHAST TRIN NAT; USDA Forest Service, 2009, EX VEG CALVEG GEOD; USDA Forest Service, 2010, 2007 MEND NAT FOR VE; USDA Forest Service, 2004, TRIN SERP SOIL SURV; USDA Forest Service, 2010, 2007 6 RIV NAT FOR V; VERRALL RE, 1975, J SOLUTION CHEM, V4, P319, DOI 10.1007/BF00650390; VITOUSEK PM, 1991, BIOGEOCHEMISTRY, V13, P87; WALKER TW, 1976, GEODERMA, V15, P1, DOI 10.1016/0016-7061(76)90066-5; Walvoord MA, 2003, SCIENCE, V302, P1021, DOI 10.1126/science.1086435; Wang YP, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL041009; Zhang BC, 2016, J BASIC MICROB, V56, P670, DOI 10.1002/jobm.201500751; [No title captured]	76	102	106	14	236	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 1	2011	477	7362					78	U88		10.1038/nature10415	http://dx.doi.org/10.1038/nature10415			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	813XT	21886160				2022-12-28	WOS:000294404300034
J	Villeda, SA; Luo, J; Mosher, KI; Zou, BD; Britschgi, M; Bieri, G; Stan, TM; Fainberg, N; Ding, ZQ; Eggel, A; Lucin, KM; Czirr, E; Park, JS; Couillard-Despres, S; Aigner, L; Li, G; Peskind, ER; Kaye, JA; Quinn, JF; Galasko, DR; Xie, XMS; Rando, TA; Wyss-Coray, T				Villeda, Saul A.; Luo, Jian; Mosher, Kira I.; Zou, Bende; Britschgi, Markus; Bieri, Gregor; Stan, Trisha M.; Fainberg, Nina; Ding, Zhaoqing; Eggel, Alexander; Lucin, Kurt M.; Czirr, Eva; Park, Jeong-Soo; Couillard-Despres, Sebastien; Aigner, Ludwig; Li, Ge; Peskind, Elaine R.; Kaye, Jeffrey A.; Quinn, Joseph F.; Galasko, Douglas R.; Xie, Xinmin S.; Rando, Thomas A.; Wyss-Coray, Tony			The ageing systemic milieu negatively regulates neurogenesis and cognitive function	NATURE			English	Article							ADULT HIPPOCAMPAL NEUROGENESIS; NEURAL STEM-CELLS; LONG-TERM POTENTIATION; PROGENITOR CELLS; SELF-RENEWAL; AGED MICE; MEMORY; BRAIN; NEURONS; MODEL	In the central nervous system, ageing results in a precipitous decline in adult neural stem/progenitor cells and neurogenesis, with concomitant impairments in cognitive functions(1). Interestingly, such impairments can be ameliorated through systemic perturbations such as exercise(1). Here, using heterochronic parabiosis we show that blood-borne factors present in the systemic milieu can inhibit or promote adult neurogenesis in an age-dependent fashion in mice. Accordingly, exposing a young mouse to an old systemic environment or to plasma from old mice decreased synaptic plasticity, and impaired contextual fear conditioning and spatial learning and memory. We identify chemokines-including CCL11 (also known as eotaxin)-the plasma levels of which correlate with reduced neurogenesis in heterochronic parabionts and aged mice, and the levels of which are increased in the plasma and cerebrospinal fluid of healthy ageing humans. Lastly, increasing peripheral CCL11 chemokine levels in vivo in young mice decreased adult neurogenesis and impaired learning and memory. Together our data indicate that the decline in neurogenesis and cognitive impairments observed during ageing can be in part attributed to changes in blood-borne factors.	[Villeda, Saul A.; Luo, Jian; Mosher, Kira I.; Britschgi, Markus; Bieri, Gregor; Stan, Trisha M.; Fainberg, Nina; Ding, Zhaoqing; Eggel, Alexander; Lucin, Kurt M.; Czirr, Eva; Park, Jeong-Soo; Rando, Thomas A.; Wyss-Coray, Tony] Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [Villeda, Saul A.; Mosher, Kira I.; Wyss-Coray, Tony] Stanford Univ, Sch Med, Neurosci IDP Program, Stanford, CA 94305 USA; [Zou, Bende; Xie, Xinmin S.] AfaSci Res Lab, Redwood City, CA 94063 USA; [Bieri, Gregor] Ecole Polytech Fed Lausanne, Swiss Fed Inst Technol, Sch Life Sci, CH-1015 Lausanne, Switzerland; [Stan, Trisha M.; Ding, Zhaoqing; Wyss-Coray, Tony] Stanford Univ, Sch Med, Immunol IDP Program, Stanford, CA 94305 USA; [Couillard-Despres, Sebastien; Aigner, Ludwig] Paracelsus Med Univ, Inst Mol Regenerat Med, A-5020 Salzburg, Austria; [Li, Ge; Peskind, Elaine R.] Univ Washington, Sch Med, Dept Psychiat & Behav Sci, Seattle, WA 98108 USA; [Peskind, Elaine R.] Vet Affairs NW Network Mental Illness Res Educ &, Seattle, WA 98108 USA; [Kaye, Jeffrey A.; Quinn, Joseph F.] Oregon Hlth & Sci Univ, Layton Aging & Alzheimers Dis Ctr, Portland, OR 97201 USA; [Kaye, Jeffrey A.; Quinn, Joseph F.] Portland VA Med Ctr, Portland, OR 97207 USA; [Galasko, Douglas R.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Rando, Thomas A.; Wyss-Coray, Tony] VA Palo Alto Hlth Care Syst, Ctr Tissue Regenerat Repair & Restorat, Palo Alto, CA 94304 USA; [Rando, Thomas A.] Stanford Univ, Sch Med, Glenn Labs Biol Aging, Stanford, CA 94305 USA	Stanford University; Stanford University; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Stanford University; Paracelsus Private Medical University; University of Washington; University of Washington Seattle; Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Portland VA Medical Center; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University	Wyss-Coray, T (corresponding author), Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA.	twc@stanford.edu	Wyss-Coray, Tony/AAF-3380-2019; Luo, Jian/B-8449-2014; Eggel, Alexander/J-8177-2019	Wyss-Coray, Tony/0000-0001-5893-0831; Luo, Jian/0000-0002-2064-8467; Eggel, Alexander/0000-0001-8746-3339; Quinn, Joseph/0000-0001-7305-2256; Aigner, Ludwig/0000-0002-1653-8046; Mosher, Kira/0000-0002-3041-3186; Rando, Thomas/0000-0001-5843-8564; Xie, Xinmin Simon/0000-0002-4049-6499; Britschgi, Markus/0000-0001-6151-4257; Couillard-Despres, Sebastien/0000-0002-8486-6412; Kaye, Jeffrey/0000-0002-9971-3478	Department of Veterans Affairs; National Institutes of Health Institute on Aging [R01 AG027505, P30AG08017]; California Initiative for Regenerative Medicine; National Institutes of Health [R01 MH078194]; Larry L. Hillblom Foundation [2008-A-023-FEL]; Feodor-Lynen postdoctoral fellowship; Swiss National Science Foundation; National Science Foundation; Kirschstein NRSA [AG034045-01, 1 F31 NS066676-01A1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007290] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056849] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH078194] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS066676] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG027505, P30AG008017, P50AG005136, F31AG034045] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000392] Funding Source: NIH RePORTER	Department of Veterans Affairs(US Department of Veterans Affairs); National Institutes of Health Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Initiative for Regenerative Medicine; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Larry L. Hillblom Foundation; Feodor-Lynen postdoctoral fellowship; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Science Foundation(National Science Foundation (NSF)); Kirschstein NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank A. Brunet for critically reading the manuscript; M. Buckwalter for parabiosis instruction; T.-T. Huang for irradiation instruction; R. Corniola and C. Clelland for behavioural advice, S. Bauer Huang, H. Johns, J. Sun, H. Hefner, H. Alabsi and I. Villeda for technical assistance. This work was supported by grants from Anonymous (T.W.-C.), Department of Veterans Affairs (T.W.-C.), National Institutes of Health Institute on Aging (R01 AG027505, T.W.-C.), a California Initiative for Regenerative Medicine Award (T.W.-C.), National Institutes of Health (R01 MH078194, X.S.X.), National Institutes of Health Institute on Aging (P30AG08017, J.A.K.), a National Institutes of Health Director's Pioneer Award (T.A.R.), a Larry L. Hillblom Foundation postdoctoral fellowship (K.M.L.; 2008-A-023-FEL), a Feodor-Lynen postdoctoral fellowship (E.C.), a Swiss National Science Foundation postdoctoral fellowship (A.E.), a National Science Foundation predoctoral fellowship (S.A.V.; K.I.M.; T.M.S.), and Kirschstein NRSA predoctoral fellowships (1 F31 AG034045-01, S.A.V.; 1 F31 NS066676-01A1, Z.D.).	Ajami B, 2007, NAT NEUROSCI, V10, P1538, DOI 10.1038/nn2014; Alamed J, 2006, NAT PROTOC, V1, P1671, DOI 10.1038/nprot.2006.275; Alvarez-Buylla A, 2004, NEURON, V41, P683, DOI 10.1016/S0896-6273(04)00111-4; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; Buckwalter MS, 2006, AM J PATHOL, V169, P154, DOI 10.2353/ajpath.2006.051272; Carpentier PA, 2009, NEURON, V64, P79, DOI 10.1016/j.neuron.2009.08.038; Clelland CD, 2009, SCIENCE, V325, P210, DOI 10.1126/science.1173215; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Couillard-Despres S, 2008, MOL IMAGING, V7, P28, DOI 10.2310/7290.2008.0004; Couillard-Despres S, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-31; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; Fumagalli M, 2009, NAT CELL BIOL, V11, P921, DOI 10.1038/ncb0809-921; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Li G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005424; Lie DC, 2005, NATURE, V437, P1370, DOI 10.1038/nature04108; Lucin KM, 2009, NEURON, V64, P110, DOI 10.1016/j.neuron.2009.08.039; Luo J, 2007, J CLIN INVEST, V117, P3306, DOI 10.1172/JCI31763; Molofsky AV, 2006, NATURE, V443, P448, DOI 10.1038/nature05091; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Moriyama M, 2011, J NEUROSCI, V31, P3981, DOI 10.1523/JNEUROSCI.3617-10.2011; Raber J, 2011, HIPPOCAMPUS, V21, P72, DOI 10.1002/hipo.20724; RAPP PR, 1994, CURR OPIN NEUROL, V7, P294, DOI 10.1097/00019052-199408000-00003; Renault VM, 2009, CELL STEM CELL, V5, P527, DOI 10.1016/j.stem.2009.09.014; Saxe MD, 2006, P NATL ACAD SCI USA, V103, P17501, DOI 10.1073/pnas.0607207103; Shen Q, 2004, SCIENCE, V304, P1338, DOI 10.1126/science.1095505; van Praag H, 2005, J NEUROSCI, V25, P8680, DOI 10.1523/JNEUROSCI.1731-05.2005; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; XIE XM, 1994, PFLUG ARCH EUR J PHY, V427, P481, DOI 10.1007/BF00374264; Zhang CL, 2008, NATURE, V451, P1004, DOI 10.1038/nature06562; Zhang J, 2008, AM J CLIN PATHOL, V129, P526, DOI 10.1309/W01Y0B808EMEH12L; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	32	1090	1142	3	219	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 1	2011	477	7362					90	U157		10.1038/nature10357	http://dx.doi.org/10.1038/nature10357			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	813XT	21886162	Green Accepted			2022-12-28	WOS:000294404300037
J	Luo, ZX; Yuan, CX; Meng, QJ; Ji, Q				Luo, Zhe-Xi; Yuan, Chong-Xi; Meng, Qing-Jin; Ji, Qiang			A Jurassic eutherian mammal and divergence of marsupials and placentals	NATURE			English	Article							TRIBOSPHENIC MAMMALS; DUAL ORIGIN; EVOLUTION; MONGOLIA; BIOTA; AGE	Placentals are the most abundant mammals that have diversified into every niche for vertebrates and dominated the world's terrestrial biotas in the Cenozoic. A critical event in mammalian history is the divergence of eutherians, the clade inclusive of all living placentals, from the metatherian-marsupial clade(1-8). Here we report the discovery of a new eutherian of 160 Myr from the Jurassic of China, which extends the first appearance of the eutherian-placental clade by about 35 Myr from the previous record, reducing and resolving a discrepancy between the previous fossil record and the molecular estimate for the placental-marsupial divergence(9-13). This mammal has scansorial forelimb features, and provides the ancestral condition for dental and other anatomical features of eutherians.	[Luo, Zhe-Xi] CarnegieMuseum Nat Hist, Pittsburgh, PA 15213 USA; [Yuan, Chong-Xi; Ji, Qiang] Chinese Acad Geol Sci, Beijing 100037, Peoples R China; [Meng, Qing-Jin] Beijing Museum Nat Hist, Beijing 100050, Peoples R China	Chinese Academy of Geological Sciences	Luo, ZX (corresponding author), CarnegieMuseum Nat Hist, Pittsburgh, PA 15213 USA.	luoz@carnegiemnh.org	Luo, Zhe-XI/AAU-2263-2021; Meng, Q./GSI-6185-2022		National Science Foundation (USA); National Natural Science Foundation-China; Chinese Academy of Geological Sciences; Ministry of Science and Technology of China	National Science Foundation (USA)(National Science Foundation (NSF)); National Natural Science Foundation-China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Geological Sciences; Ministry of Science and Technology of China(Ministry of Science and Technology, China)	We thank A.R. Tabrum for his meticulous preparation of the fossil, Y.-Q. Zhang for casting, and M. A. Klingler for assistance with graphics. During this work, we benefited from discussion with Y.-Q. Liu on field geology and dating, and with R. J. Asher, K. C. Beard, R. L. Cifelli, M. R. Dawson, T. Martin and J. R. Wible for discussion on mammal phylogeny. J. Wible and M. Dawson helped to improve the manuscript. Support was given to Z.-X.L. from the National Science Foundation (USA), to C.-X.Y. from the National Natural Science Foundation-China and the Chinese Academy of Geological Sciences, and to Q. J. from the 973 Project of the Ministry of Science and Technology of China and funding from the Chinese Academy of Geological Sciences.	Argot C, 2001, J MORPHOL, V247, P51, DOI 10.1002/1097-4687(200101)247:1<51::AID-JMOR1003>3.0.CO;2-#; Asher RJ, 2004, MOL PHYLOGENET EVOL, V33, P240, DOI 10.1016/j.ympev.2004.05.004; Averianov AO, 2010, J SYST PALAEONTOL, V8, P301, DOI 10.1080/14772011003603499; Averianov AO, 2001, ACTA PALAEONTOL POL, V46, P431; Benton Michael J., 2009, P35; Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; Chang SC, 2009, EARTH PLANET SC LETT, V279, P212, DOI 10.1016/j.epsl.2008.12.045; Cifelli Richard L., 1997, Journal of Mammalian Evolution, V4, P241, DOI 10.1023/A:1027394430433; Cifelli RL, 1996, NATURE, V379, P715, DOI 10.1038/379715a0; Crompton A. W., 1978, STUDIES DEV FUNCTION, P249; Hu YM, 2010, P ROY SOC B-BIOL SCI, V277, P229, DOI 10.1098/rspb.2009.0203; Ji Q, 2002, NATURE, V416, P816, DOI 10.1038/416816a; KIELAN-JAWOROWSKA Z, 2004, MAMMALS AGE DINOSAUR; KIELANJAWOROWSKA Z, 1989, ZOOL SCR, V18, P347, DOI 10.1111/j.1463-6409.1989.tb00460.x; Kirk EC, 2008, J HUM EVOL, V55, P278, DOI 10.1016/j.jhevol.2008.02.008; Kitazoe Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000384; Liu YQ, 2006, CHINESE SCI BULL, V51, P2634, DOI 10.1007/s11434-006-2165-2; Luo ZX, 2007, NATURE, V450, P1011, DOI 10.1038/nature06277; Luo ZX, 2007, NATURE, V450, P93, DOI 10.1038/nature06221; Luo ZX, 2003, SCIENCE, V302, P1934, DOI 10.1126/science.1090718; Luo ZX, 2001, NATURE, V409, P53, DOI 10.1038/35051023; Martin T, 2005, J VERTEBR PALEONTOL, V25, P414, DOI 10.1671/0272-4634(2005)025[0414:MADOAP]2.0.CO;2; Phillips MJ, 2009, P NATL ACAD SCI USA, V106, P17089, DOI 10.1073/pnas.0904649106; Rich Thomas H., 1999, Records of the Queen Victoria Museum, V106, P1; Rougier GW, 2007, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2007)507[1:NJMFPA]2.0.CO;2; Rougier GW, 1998, NATURE, V396, P459, DOI 10.1038/24856; Sigogneau-Russell D, 2001, CR ACAD SCI II A, V333, P141, DOI 10.1016/S1251-8050(01)01612-3; van Rheede T, 2006, MOL BIOL EVOL, V23, P587, DOI 10.1093/molbev/msj064; Wible JR, 2009, B AM MUS NAT HIST, P1, DOI 10.1206/623.1; Wilson GP, 2010, J VERTEBR PALEONTOL, V30, P872, DOI 10.1080/02724631003762948	30	349	375	1	156	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 25	2011	476	7361					442	445		10.1038/nature10291	http://dx.doi.org/10.1038/nature10291			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811KT	21866158				2022-12-28	WOS:000294209400034
J	Ryan, C; Leonardi, CL; Krueger, JG; Kimball, AB; Strober, BE; Gordon, KB; Langley, RG; de Lemos, JA; Daoud, Y; Blankenship, D; Kazi, S; Kaplan, DH; Friedewald, VE; Menter, A				Ryan, Caitriona; Leonardi, Craig L.; Krueger, James G.; Kimball, Alexa B.; Strober, Bruce E.; Gordon, Kenneth B.; Langley, Richard G.; de Lemos, James A.; Daoud, Yahya; Blankenship, Derek; Kazi, Salahuddin; Kaplan, Dan H.; Friedewald, Vincent E.; Menter, Alan			Association Between Biologic Therapies for Chronic Plaque Psoriasis and Cardiovascular Events A Meta-analysis of Randomized Controlled Trials	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							INTERLEUKIN-12/23 MONOCLONAL-ANTIBODY; DOUBLE-BLIND; PHASE-III; INFLIXIMAB INDUCTION; EFFICACY; MODERATE; SAFETY; ETANERCEPT; USTEKINUMAB; MONOTHERAPY	Context Ustekinumab and briakinumab, monoclonal antibodies to the shared p40 subunit of interleukin (IL)-12 and IL-23, have shown efficacy in treating chronic plaque psoriasis (CPP). Preliminary reports of major adverse cardiovascular events (MACEs) in psoriasis patients receiving anti-IL-12/23 agents have prompted concern. Objective To evaluate a possible association between biologic therapies for CPP and MACEs via meta-analysis. Data Sources Randomized controlled trials (RCTs) of anti-IL-12/23 (ustekinumab and briakinumab) agents and anti-tumor necrosis factor alpha (TNF-alpha) agents (adalimumab, etanercept, and infliximab) used in treating CPP were reviewed using the Cochrane Central Register of Controlled Trials, ClinicalTrials.gov, and Ovid MEDLINE from database inception to May 2011. The results of registered nonpublished completed studies were procured through abstract publications or poster presentations. Study Selection Randomized, placebo-controlled, double-blind, monotherapy studies (with safety outcome data for MACE) of IL-12/23 antibodies and anti-TNF-alpha agents in adults. Studies of psoriatic arthritis were excluded. Data Extraction Two investigators independently searched data while 6 investigators reviewed the abstracted data. Results A total of 22 RCTs comprising 10 183 patients met the predefined inclusion criteria. The primary outcome measure was MACE, a composite end point of myocardial infarction, cerebrovascular accident, or cardiovascular death during the placebocontrolled phase of treatment in patients receiving at least 1 dose of study agent or placebo. Absolute risk differences were used as an effect measure. There was no evidence of statistical heterogeneity across the studies using the I-2 statistic (I-2=0), allowing for combination of trial results using the Mantel-Haenszel fixed-effects method. During the placebo-controlled phases of the anti-IL-12/23 studies, 10 of 3179 patients receiving anti-IL-12/23 therapies experienced MACEs compared with zero events in 1474 patients receiving placebo (Mantel-Haenszel risk difference, 0.012 events/ person-year; 95% confidence interval [CI], -0.001 to 0.026; P=.12). In the anti-TNF-alpha trials, only 1 of 3858 patients receiving anti-TNF-alpha agents experienced a MACE compared with 1 of 1812 patients receiving placebo (Mantel-Haenszel risk difference, -0.0005 events/person-year; 95% CI, -0.010 to 0.009; P=.94). Conclusions Compared with placebo, there was no significant difference in the rate of MACEs observed in patients receiving anti-IL-12/IL-23 antibodies or anti-TNF-alpha treatments. This study may have been underpowered to identify a significant difference. JAMA. 2011;306(8):864-871 www.jama.com	[Ryan, Caitriona; Menter, Alan] Baylor Res Inst, Dept Dermatol, Dallas, TX 75246 USA; [Leonardi, Craig L.] St Louis Univ, Dept Dermatol, St Louis, MO 63103 USA; [Krueger, James G.] Rockefeller Univ, Lab Investigat Dermatol, New York, NY 10021 USA; [Kimball, Alexa B.] Massachusetts Gen Hosp, Dept Dermatol, Boston, MA 02114 USA; [Strober, Bruce E.] Univ Connecticut, Dept Dermatol, Farmington, CT USA; [Gordon, Kenneth B.] Univ Chicago, Pritzker Sch Med, Div Dermatol, Chicago, IL 60637 USA; [Langley, Richard G.] Dalhousie Univ, Dept Dermatol, Halifax, NS, Canada; [de Lemos, James A.] Univ Texas SW Med Ctr Dallas, Donald W Reynolds Cardiovasc Res Ctr, Dallas, TX 75390 USA; [de Lemos, James A.] Univ Texas SW Med Ctr Dallas, Div Cardiol, Dallas, TX 75390 USA; [Daoud, Yahya; Blankenship, Derek] Baylor Univ, Med Ctr, Dept Res & Improvement Educ, Dallas, TX USA; [Kazi, Salahuddin] VA N Texas Hlth Care Syst, Dept Rheumatol, Dallas, TX USA; [Kaplan, Dan H.] Univ Minnesota, Dept Dermatol, Ctr Immunol, Minneapolis, MN 55455 USA; [Friedewald, Vincent E.] Univ Notre Dame, Dept Cardiol, Notre Dame, IN 46556 USA	Baylor Scott & White Health; Baylor University Medical Center; Saint Louis University; Rockefeller University; Harvard University; Massachusetts General Hospital; University of Connecticut; University of Chicago; Dalhousie University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Baylor University; Baylor University Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA North Texas Health Care System; University of Minnesota System; University of Minnesota Twin Cities; University of Notre Dame	Ryan, C (corresponding author), Baylor Res Inst, Dept Dermatol, 3900 Junius St,Ste 125, Dallas, TX 75246 USA.	caitriona.ryan@baylorhealth.edu	Kaplan, Daniel H/N-2779-2013; de Lemos, James/ABD-6669-2021; Strober, Bruce/AAQ-6953-2020; Kimball, Alexandra B./M-6347-2019	Kaplan, Daniel H/0000-0002-7851-7320; Strober, Bruce/0000-0002-8394-2057; Kimball, Alexandra B./0000-0001-9405-0479; Ryan, Caitriona/0000-0003-1915-546X	Abbott; Centocor; Amgen; Eli Lilly; Baylor Research Institute; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056632] Funding Source: NIH RePORTER	Abbott(Abbott Laboratories); Centocor; Amgen(Amgen); Eli Lilly(Eli Lilly); Baylor Research Institute; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Ryan reports acting as a speaker for Jansen-Cilag and Pfizer; serving as an advisory board member for Galderma; and receiving grant support from Abbott. Dr Leonardi reports acting as a consultant for Abbott, Amgen, Centocor, Pfizer, and Eli Lilly; investigating for Abbott, Amgen, Celgene, Centocor, Genentech, Eli Lilly, Galderma, Genzyme, GlaxoSmithKline, Incyte, Pfizer, Incyte, Schering Plough, Sirtris, Stiefel, Novartis, Novo Nordisk, Vascular Biogenics, and Wyeth (now Pfizer); and serving on speakers' bureaus for Abbott, Amgen, and Centocor. Dr Krueger reports being a consultant to or participant on advisory boards for Amgen, Wyeth (now Pfizer), and Centocor. Dr Kimball reports acting as a consultant and investigator for Abbott, Amgen, Centocor, Idera, VBL, Neostrata, Galderma; investigating for Pfizer, Boehringer Ingleheim, Stiefel, Cytochroma, and Schering Plough; speaking for Johnson and Johnson; receiving fellowship funding from Centocor; and consulting for Novartis, Lilly, Celgene, Combinatorix, Canfite, Serentis, Incyte, Array Biopharma, and Warner Chilcott. Dr Strober reports acting as a consultant for Amgen, Abbott, Centocor, Pfizer, Celgene, and Novartis; as a speaker for Amgen, Abbott, and Centocor; and receiving grant support from Amgen, Abbott, and Centocor. Dr Gordon reports receiving research support or honoraria from Abbott, Amgen, Centocor, and Eli Lilly, and consulting for Abbott, Amgen, Centocor, Eli Lilly, Merck, and Pfizer. Dr Langley reports acting as an investigator, scientific advisory board member, or speaker for Abbott, Amgen, Biogen-IDEC, Celgene, Centocor, Leo, Schering, Merck, Novartis, Ortho Biotec, and Pfizer. Dr de Lemos reports consulting for Johnson and Johnson and AstraZeneca. Dr Kazi reports acting as a speaker for Centocor and Genentech. Dr Friedewald reports acting as a consultant for AstraZeneca. Dr Menter reports receiving research support and consulting or lecturing for Abbott, Amgen, Astellas, Asubio, Celgene, Centocor, DUSA, Eli Lilly, Galderma, Genentech, Novartis, Novo-Nordisk, Merck-Serono, Pfizer, Promius, Stiefel, Syntrix Biosystems, Warner Chilcott, and Wyeth (now Pfizer). All other authors report no disclosures.; No external funding was received for this study. Statistical support was funded internally by Baylor Research Institute discretionary funds. Mr Daoud and Dr Blankenship are full-time employees of Baylor Research Institute and were reimbursed for their time spent working on this project.	[Anonymous], 2010, LANCET, V376, P1196, DOI 10.1016/S0140-6736(10)61862-4; [Anonymous], 2004, LANCET, V364, P1287; Asahina A, 2010, J DERMATOL, V37, P299, DOI 10.1111/j.1346-8138.2009.00748.x; Bagel J, 2010, FALL CLIN DERM C OCT; Boyman O, 2006, SCIENCE, V311, P1924, DOI 10.1126/science.1122927; Bresalier RS, 2005, NEW ENGL J MED, V352, P1092, DOI 10.1056/NEJMoa050493; Chaudhari U, 2001, LANCET, V357, P1842, DOI 10.1016/S0140-6736(00)04954-0; Chen SA, 2010, J INNATE IMMUN, V2, P325, DOI 10.1159/000314626; Cheng X, 2008, CLIN IMMUNOL, V127, P89, DOI 10.1016/j.clim.2008.01.009; Derry S, 2001, BMC MED RES METHODOL, V1; Dieppe PA, 2004, BRIT MED J, V329, P867, DOI 10.1136/bmj.329.7471.867; Eid RE, 2009, CIRCULATION, V119, P1424, DOI 10.1161/CIRCULATIONAHA.108.827618; FINKELMAN FD, 1993, J IMMUNOL, V151, P1235; Gelfand JM, 2006, JAMA-J AM MED ASSOC, V296, P1735, DOI 10.1001/jama.296.14.1735; Gordon K, 2010, WINT CLIN DERM C JAN; Gordon KB, 2006, J AM ACAD DERMATOL, V55, P598, DOI 10.1016/j.jaad.2006.05.027; Gottlieb AB, 2004, J AM ACAD DERMATOL, V51, P534, DOI 10.1016/j.jaad.2004.02.021; Gottlieb AB, 2003, ARCH DERMATOL, V139, P1627, DOI 10.1001/archderm.139.12.1627; Griffiths CEM, 2010, NEW ENGL J MED, V362, P118, DOI 10.1056/NEJMoa0810652; Hashmi S, 2006, CORONARY ARTERY DIS, V17, P699, DOI 10.1097/01.mca.0000236288.94553.b4; Hauer AD, 2005, CIRCULATION, V112, P1054, DOI 10.1161/CIRCULATIONAHA.104.533463; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Igarashi A, 2010, C PSOR INT NETW JUL; Juni P, 2004, LANCET, V364, P2021, DOI 10.1016/S0140-6736(04)17514-4; Kamimura D, 2006, J IMMUNOL, V177, P306, DOI 10.4049/jimmunol.177.1.306; Kimball AB, 2008, ARCH DERMATOL, V144, P200, DOI 10.1001/archdermatol.2007.63; Konstam MA, 2001, CIRCULATION, V104, P2280, DOI 10.1161/hc4401.100078; Krueger GG, 2007, NEW ENGL J MED, V356, P580, DOI 10.1056/NEJMoa062382; Langley RG, 2010, ANN M CAN DERM ASS J; Langley RG, 2011, ANN AM ACAD DERM M F; Lee TS, 1999, ARTERIOSCL THROM VAS, V19, P734, DOI 10.1161/01.ATV.19.3.734; Leonardi CL, 2003, NEW ENGL J MED, V349, P2014, DOI 10.1056/NEJMoa030409; Leonardi CL, 2008, LANCET, V371, P1665, DOI 10.1016/S0140-6736(08)60725-4; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; MAY LT, 1993, J IMMUNOL, V151, P3225; Menter A, 2010, J EUR ACAD DERMATOL, V24, P1371, DOI 10.1111/j.1468-3083.2010.03656.x; Menter A, 2010, WINT CLIN DERM C JAN; Menter A, 2008, J AM ACAD DERMATOL, V58, P106, DOI 10.1016/j.jaad.2007.09.010; Menter A, 2007, J AM ACAD DERMATOL, V56, P31, DOI 10.1016/j.jaad.2006.07.017; Mitka M, 2010, JAMA-J AM MED ASSOC, V303, P2341, DOI 10.1001/jama.2010.788; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1016/j.ijsu.2010.02.007, 10.1136/bmj.b2535]; Nathan D, 2009, DIABETOLOGIA, V52, P17, DOI 10.1007/s00125-008-1157-y; Neimann AL, 2006, J AM ACAD DERMATOL, V55, P829, DOI 10.1016/j.jaad.2006.08.040; Papp KA, 2005, BRIT J DERMATOL, V152, P1304, DOI 10.1111/j.1365-2133.2005.06688.x; Papp KA, 2008, LANCET, V371, P1675, DOI 10.1016/S0140-6736(08)60726-6; Phelan JD, 2008, J IMMUNOL, V180, P44, DOI 10.4049/jimmunol.180.1.44; Prodanowich S, 2005, J AM ACAD DERMATOL, V52, P262, DOI 10.1016/j.jaad.2004.06.017; Reddy M, 2010, J DERMATOL, V37, P413, DOI 10.1111/j.1346-8138.2010.00802.x; Reich K, 2005, LANCET, V366, P1367, DOI 10.1016/S0140-6736(05)67566-6; Smith E, 2010, CIRCULATION, V121, P1746, DOI 10.1161/CIRCULATIONAHA.109.924886; Strober BE, 2010, WINT CLIN DERM C JAN; Taleb S, 2009, J EXP MED, V206, P2067, DOI 10.1084/jem.20090545; Tyring S, 2006, LANCET, V367, P29, DOI 10.1016/S0140-6736(05)67763-X; van de Kerkhof PCM, 2008, BRIT J DERMATOL, V159, P1177, DOI 10.1111/j.1365-2133.2008.08771.x; Wang MJ, 2007, AM J PHYSIOL-HEART C, V293, pH2101, DOI 10.1152/ajpheart.00125.2007; Wu J, 2011, ANN M AM AC DERM FEB; Wyss CA, 2010, EUR HEART J, V31, P1457, DOI 10.1093/eurheartj/ehq084; Xie JJ, 2010, CYTOKINE, V49, P185, DOI 10.1016/j.cyto.2009.09.007; Youn JI, 2010, E AS DERM C SEPT 30	59	227	230	3	20	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 24	2011	306	8					864	871		10.1001/jama.2011.1211	http://dx.doi.org/10.1001/jama.2011.1211			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	810VY	21862748				2022-12-28	WOS:000294157300024
J	Marrakchi, S; Guigue, P; Renshaw, BR; Puel, A; Pei, XY; Fraitag, S; Zribi, J; Bal, E; Cluzeau, C; Chrabieh, M; Towne, JE; Douangpanya, J; Pons, C; Mansour, S; Serre, V; Makni, H; Mahfoudh, N; Fakhfakh, F; Bodemer, C; Feingold, J; Hadj-Rabia, S; Favre, M; Genin, E; Sahbatou, M; Munnich, A; Casanova, JL; Sims, JE; Turki, H; Bachelez, H; Smahi, A				Marrakchi, Slaheddine; Guigue, Philippe; Renshaw, Blair R.; Puel, Anne; Pei, Xue-Yuan; Fraitag, Sylvie; Zribi, Jihen; Bal, Elodie; Cluzeau, Celine; Chrabieh, Maya; Towne, Jennifer E.; Douangpanya, Jason; Pons, Christian; Mansour, Sourour; Serre, Valerie; Makni, Hafedh; Mahfoudh, Nadia; Fakhfakh, Faiza; Bodemer, Christine; Feingold, Josue; Hadj-Rabia, Smail; Favre, Michel; Genin, Emmanuelle; Sahbatou, Mourad; Munnich, Arnold; Casanova, Jean-Laurent; Sims, John E.; Turki, Hamida; Bachelez, Herve; Smahi, Asma			Interleukin-36-Receptor Antagonist Deficiency and Generalized Pustular Psoriasis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NF-KAPPA-B; AUTOINFLAMMATORY DISEASE; FAMILY; MEMBERS; IDENTIFICATION; PATHOGENESIS; ASSOCIATION; IMMUNITY; LOCUS	BACKGROUND Generalized pustular psoriasis is a life-threatening disease of unknown cause. It is characterized by sudden, repeated episodes of high-grade fever, generalized rash, and disseminated pustules, with hyperleukocytosis and elevated serum levels of C-reactive protein, which may be associated with plaque-type psoriasis. METHODS We performed homozygosity mapping and direct sequencing in nine Tunisian multiplex families with autosomal recessive generalized pustular psoriasis. We assessed the effect of mutations on protein expression and conformation, stability, and function. RESULTS We identified significant linkage to an interval of 1.2 megabases on chromosome 2q13-q14.1 and a homozygous missense mutation in IL36RN, encoding an interleukin-36-receptor antagonist (interleukin-36Ra), an antiinflammatory cytokine. This mutation predicts the substitution of a proline residue for leucine at amino acid position 27 (L27P). Homology-based structural modeling of human interleukin-36Ra suggests that the proline at position 27 affects both the stability of interleukin-36Ra and its interaction with its receptor, interleukin-1 receptor-like 2 (interleukin-1 receptor-related protein 2). Biochemical analyses showed that the L27P variant was poorly expressed and less potent than the nonvariant interleukin-36Ra in inhibiting a cytokine-induced response in an interleukin-8 reporter assay, leading to enhanced production of inflammatory cytokines (interleukin-8 in particular) by keratinocytes from the patients. CONCLUSIONS Aberrant interleukin-36Ra structure and function lead to unregulated secretion of inflammatory cytokines and generalized pustular psoriasis. (Funded by Agence Nationale de la Recherche and Societe Francaise de Dermatologie.)	[Marrakchi, Slaheddine; Zribi, Jihen; Makni, Hafedh; Mahfoudh, Nadia; Fakhfakh, Faiza; Turki, Hamida] Sfax Univ, Hedi Chaker Hosp, Dept Dermatol, Sfax, Tunisia; [Marrakchi, Slaheddine; Guigue, Philippe; Fraitag, Sylvie; Bal, Elodie; Cluzeau, Celine; Mansour, Sourour; Serre, Valerie; Bodemer, Christine; Feingold, Josue; Hadj-Rabia, Smail; Munnich, Arnold; Smahi, Asma] Sorbonne Paris Cite Univ Paris Descartes, Hop Necker Enfants Malades, Genet Lab, INSERM,Unit 781, Paris, France; [Puel, Anne; Chrabieh, Maya; Casanova, Jean-Laurent] Sorbonne Paris Cite Univ Paris Descartes, Hop Necker Enfants Malades, Lab Human Genet Infect Dis, INSERM,Unit 980, Paris, France; [Fraitag, Sylvie] Hop Necker Enfants Malad, Dept Pathol, Paris, France; [Pons, Christian; Favre, Michel] Inst Pasteur, Unite Genet Papillomavirus & Canc Humain, Paris, France; [Genin, Emmanuelle] Sorbonne Paris Cite Univ Paris Diderot, Inst Univ Hematol, INSERM, UMRS 946, Paris, France; [Bachelez, Herve] Sorbonne Paris Cite Univ Paris Diderot, Hop St Louis, AP HP, INSERM,Unit 976, Paris, France; [Sahbatou, Mourad] Ctr Etud Polymorphisme Humain, Fdn Jean Dausset, F-75010 Paris, France; [Renshaw, Blair R.; Towne, Jennifer E.; Douangpanya, Jason; Sims, John E.] Dept Inflammat Res, Seattle, WA USA; [Pei, Xue-Yuan] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England; [Casanova, Jean-Laurent] Rockefeller Univ, St Giles Lab Human Genet Infect Dis, New York, NY 10021 USA	Universite de Sfax; Hopital Hedi Chaker; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Foundation Jean Dausset-CEPH; University of Cambridge; Rockefeller University	Smahi, A (corresponding author), Hop Necker Enfants Malad, INSERM, U781, 149 Rue Sevres, F-75015 Paris, France.	asma.smahi@inserm.fr	chrabieh, maya/H-7370-2017; Casanova, Jean-Laurent/I-3418-2017; Puel, Anne/H-7305-2017; Cluzeau, Celine/E-6873-2016; Smahi, Asma/J-4184-2017; Genin, Emmanuelle/C-4974-2013	chrabieh, maya/0000-0003-0772-4805; Puel, Anne/0000-0003-2603-0323; Cluzeau, Celine/0000-0002-7791-6223; Smahi, Asma/0000-0002-6002-0981; Genin, Emmanuelle/0000-0003-4117-2813; Hadj-Rabia, Smail/0000-0001-6801-7106; Sims, John/0000-0002-5667-9185; Mansour, Sourour/0000-0003-1959-1341; bachelez, herve/0000-0003-3567-9095; Casanova, Jean-Laurent/0000-0002-7782-4169	Agence Nationale de la Recherche; Societe Francaise de Dermatologie	Agence Nationale de la Recherche(French National Research Agency (ANR)); Societe Francaise de Dermatologie	Supported by grants from the Agence Nationale de la Recherche and the Societe Francaise de Dermatologie.	Aksentijevich I, 2009, NEW ENGL J MED, V360, P2426, DOI 10.1056/NEJMoa0807865; Augey F, 2006, EUR J DERMATOL, V16, P669, DOI 10.1684/ejd.2006.0003; BAKER H, 1968, BRIT J DERMATOL, V80, P771, DOI 10.1111/j.1365-2133.1968.tb11947.x; Blumberg H, 2007, J EXP MED, V204, P2603, DOI 10.1084/jem.20070157; Blumberg H, 2010, J IMMUNOL, V185, P4354, DOI 10.4049/jimmunol.1000313; Carrie A, 1999, NAT GENET, V23, P25, DOI 10.1038/12623; Casanova JL, 2011, ANNU REV IMMUNOL, V29, P447, DOI 10.1146/annurev-immunol-030409-101335; Chang SE, 2003, INT J DERMATOL, V42, P754; Debets R, 2001, J IMMUNOL, V167, P1440, DOI 10.4049/jimmunol.167.3.1440; Dinarello C, 2010, NAT IMMUNOL, V11, P973, DOI 10.1038/ni1110-973; Dinarello CA, 2009, NEW ENGL J MED, V360, P2467, DOI 10.1056/NEJMe0811014; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Dunn EF, 2003, BIOCHEMISTRY-US, V42, P10938, DOI 10.1021/bi0341197; Genin E, 2004, J MED GENET, V41, P445, DOI 10.1136/jmg.2003.017962; Griffiths CEM, 2007, LANCET, V370, P263, DOI 10.1016/S0140-6736(07)61128-3; Henderson C, 2010, CLIN IMMUNOL, V135, P210, DOI 10.1016/j.clim.2010.02.013; HUBLER WR, 1984, ARCH DERMATOL, V120, P1174, DOI 10.1001/archderm.120.9.1174; Iizuka H, 2003, ARCH DERMATOL RES, V295, pS55, DOI 10.1007/s00403-002-0372-5; Kumar S, 2000, J BIOL CHEM, V275, P10308, DOI 10.1074/jbc.275.14.10308; Liu Y, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000041; Lowes MA, 2007, NATURE, V445, P866, DOI 10.1038/nature05663; Muto M, 2003, ARCH DERMATOL RES, V295, pS60, DOI 10.1007/s00403-002-0373-4; Nair RP, 2009, NAT GENET, V41, P199, DOI 10.1038/ng.311; Naldi L, 2007, CLIN DERMATOL, V25, P510, DOI 10.1016/j.clindermatol.2007.08.003; Puel A, 2004, CURR OPIN IMMUNOL, V16, P34, DOI 10.1016/j.coi.2003.11.013; Reddy S, 2009, NEW ENGL J MED, V360, P2438, DOI 10.1056/NEJMoa0809568; Sims JE, 2010, NAT REV IMMUNOL, V10, P89, DOI 10.1038/nri2691; Smith DE, 2000, J BIOL CHEM, V275, P1169, DOI 10.1074/jbc.275.2.1169; Strange A, 2010, NAT GENET, V42, P985, DOI 10.1038/ng.694; TAKEMATSU H, 1992, ACTA DERM-VENEREOL, V72, P443; Taylor SL, 2002, GENOMICS, V79, P726, DOI 10.1006/geno.2002.6752; Towne JE, 2004, J BIOL CHEM, V279, P13677, DOI 10.1074/jbc.M400117200; ZELICKSON BD, 1991, ARCH DERMATOL, V127, P1339, DOI 10.1001/archderm.127.9.1339	33	603	648	1	55	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 18	2011	365	7					620	628		10.1056/NEJMoa1013068	http://dx.doi.org/10.1056/NEJMoa1013068			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	808ER	21848462				2022-12-28	WOS:000293960500009
J	Thombs, BD; Arthurs, E; El-Baalbaki, G; Meijer, A; Ziegelstein, RC; Steele, RJ				Thombs, Brett D.; Arthurs, Erin; El-Baalbaki, Ghassan; Meijer, Anna; Ziegelstein, Roy C.; Steele, Russell J.			Risk of bias from inclusion of patients who already have diagnosis of or are undergoing treatment for depression in diagnostic accuracy studies of screening tools for depression: systematic review	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ACUTE MYOCARDIAL-INFARCTION; CORONARY-HEART-DISEASE; PRIMARY-CARE SETTINGS; POSTNATAL-DEPRESSION; HEALTH QUESTIONNAIRE; DETECT DEPRESSION; PALLIATIVE CARE; NATIONAL TRENDS; SPECTRUM BIAS; SCALE	Objectives To investigate the proportion of original studies included in systematic reviews and meta-analyses on the diagnostic accuracy of screening tools for depression that appropriately exclude patients who already have a diagnosis of or are receiving treatment for depression and to determine whether these systematic reviews and meta-analyses evaluate possible bias from the inclusion of such patients. Design Systematic review. Data sources Medline, PsycINFO, CINAHL, Embase, ISI, SCOPUS, and Cochrane databases were searched from 1 January 2005 to 29 October 2009. Eligibility criteria for selecting studies Systematic reviews and meta-analyses in any language that reported on the diagnostic accuracy of screening tools for depression. Results Only eight of 197 (4%) unique publications from 17 systematic reviews and meta-analyses specifically excluded patients who already had a diagnosis of or were receiving treatment for depression. No systematic reviews or meta-analyses commented on possible bias from the inclusion of such patients, even though 10 reviews used quality assessment tools with items to rate risk of bias from composition of the sample of patients. Conclusions Studies of the accuracy of screening tools for depression rarely exclude patients who already have a diagnosis of or are receiving treatment for depression, a potential bias that is not evaluated in systematic reviews and meta-analyses. This could result in inflated estimates of accuracy on which clinical practice and preventive care guidelines are often based, a problem that takes on greater importance as the rate of diagnosed and treated depression in the population increases.	[Thombs, Brett D.; Arthurs, Erin; El-Baalbaki, Ghassan] Jewish Gen Hosp, Lady Davis Inst Med Res, Montreal, PQ H3T 1E4, Canada; [Thombs, Brett D.; Arthurs, Erin; El-Baalbaki, Ghassan] McGill Univ, Montreal, PQ H3T 1E4, Canada; [Meijer, Anna] Univ Groningen, Univ Med Ctr Groningen, Interdisciplinary Ctr Psychiat Epidemiol, NL-9713 GZ Groningen, Netherlands; [Ziegelstein, Roy C.] Johns Hopkins Univ, Sch Med, Baltimore, MD 21224 USA; [Steele, Russell J.] McGill Univ, Dept Math & Stat, Montreal, PQ H3A 2K6, Canada	Lady Davis Institute; McGill University; McGill University; University of Groningen; Johns Hopkins University; McGill University	Thombs, BD (corresponding author), Jewish Gen Hosp, Lady Davis Inst Med Res, Montreal, PQ H3T 1E4, Canada.	brett.thombs@mcgill.ca	Steele, Russell J/G-6926-2017	Thombs, Brett D./0000-0002-5644-8432	Canadian Institutes of Health Research; Fonds de la Recherche en Sante Quebec; National Center for Complementary and Alternative Medicine [R24AT004641]; Johns Hopkins Center for Innovative Medicine; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R24AT004641] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de la Recherche en Sante Quebec(Fonds de la Recherche en Sante du Quebec); National Center for Complementary and Alternative Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); Johns Hopkins Center for Innovative Medicine; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)	This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors. BDT is supported by a New Investigator Award from the Canadian Institutes of Health Research and an Etablissement de Jeunes Chercheurs award from the Fonds de la Recherche en Sante Quebec. RCZ is supported by the National Center for Complementary and Alternative Medicine (grant No R24AT004641) and the Miller Family Scholar Program of the Johns Hopkins Center for Innovative Medicine. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Center for Complementary and Alternative Medicine or the National Institutes of Health.	Allen J, 2009, J CLIN NURS, V18, P949, DOI 10.1111/j.1365-2702.2008.02731.x; [Anonymous], 2003, AM J NURS, V103, P108; Arroll B, 2005, BRIT MED J, V331, P884, DOI 10.1136/bmj.38607.464537.7C; Arroll B, 2003, BMJ-BRIT MED J, V327, P1144, DOI 10.1136/bmj.327.7424.1144; Aydin N, 2004, SOC PSYCH PSYCH EPID, V39, P483, DOI 10.1007/s00127-004-0770-4; Baas KD, 2009, BRIT J PSYCHIAT, V194, P399, DOI 10.1192/bjp.bp.107.046052; Beck Cheryl T, 2005, J Transcult Nurs, V16, P331, DOI 10.1177/1043659605278940; Benazon NR, 2005, PSYCHOSOM MED, V67, P916, DOI 10.1097/01.psy.0000188399.80167.aa; Berg AO, 2003, AM J NURS, V103, P101; Cochrane Methods Working Group on Systematic Reviews of Screening and Diagnostic Tests, 1996, COCHR METH WORK GROU; Corson K, 2004, AM J MANAG CARE, V10, P839; Coyne JC, 2004, GEN HOSP PSYCHIAT, V26, P121, DOI 10.1016/j.genhosppsych.2003.08.012; Dell DL, 2002, CLIN UPDATES WOMENS, V1; Edlund W, 2004, AM ACAD NEUROLOGY CL; Evans DL, 2005, BIOL PSYCHIAT, V58, P175, DOI 10.1016/j.biopsych.2005.05.001; Gaynes B N, 2005, Evid Rep Technol Assess (Summ), P1; Gehi A, 2005, ARCH INTERN MED, V165, P2508, DOI 10.1001/archinte.165.21.2508; Gibson J, 2009, ACTA PSYCHIAT SCAND, V119, P350, DOI 10.1111/j.1600-0447.2009.01363.x; Gilbody S, 2008, CAN MED ASSOC J, V178, P997, DOI 10.1503/cmaj.070281; Gilbody S, 2007, J GEN INTERN MED, V22, P1596, DOI 10.1007/s11606-007-0333-y; Goldrick BA, 2003, AM J NURS, V103, P105, DOI 10.1097/00000446-200303000-00043; Harbour R, 2001, BRIT MED J, V323, P334, DOI 10.1136/bmj.323.7308.334; Harris RP, 2001, AM J PREV MED, V20, P21, DOI 10.1016/S0749-3797(01)00261-6; Hewitt CE, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13360; Institute for Scientific Information, 2011, J CITATION REPORTS; JAESCHKE R, 1994, JAMA-J AM MED ASSOC, V271, P389, DOI 10.1001/jama.271.5.389; Kalpakjian CZ, 2009, J SPINAL CORD MED, V32, P6, DOI 10.1080/10790268.2009.11760748; KHAN K, 2001, UNDERTAKING SYSTEMAT; Lichtman JH, 2008, CIRCULATION, V118, P1768, DOI 10.1161/CIRCULATIONAHA.108.190769; Lijmer JG, 1999, JAMA-J AM MED ASSOC, V282, P1061, DOI 10.1001/jama.282.11.1061; Lloyd-Williams M, 2001, J PAIN SYMPTOM MANAG, V22, P990, DOI 10.1016/S0885-3924(01)00358-X; Lloyd-Williams M, 2000, J PAIN SYMPTOM MANAG, V20, P259, DOI 10.1016/S0885-3924(00)00182-2; Marcus SC, 2010, ARCH GEN PSYCHIAT, V67, P1265, DOI 10.1001/archgenpsychiatry.2010.151; Maunsell E, 1996, J CLIN ONCOL, V14, P2747, DOI 10.1200/JCO.1996.14.10.2747; Mirkhil S, 2009, CLIN J PAIN, V25, P340, DOI 10.1097/AJP.0b013e31819299e3; Mitchell AJ, 2008, BRIT J CANCER, V98, P1934, DOI 10.1038/sj.bjc.6604396; Mitchell AJ, 2007, BRIT J GEN PRACT, V57, P144; Mitchell AJ, 2010, J AFFECT DISORDERS, V125, P10, DOI 10.1016/j.jad.2009.08.019; Mitchell AJ, 2009, LANCET, V374, P609, DOI 10.1016/S0140-6736(09)60879-5; Morse R, 2006, CLIN EFF NURS, V9, P188; Mulherin SA, 2002, ANN INTERN MED, V137, P598, DOI 10.7326/0003-4819-137-7-200210010-00011; National Collaborating Center for Mental Health, 2010, NICE GUID MAN TREATM; National Comprehensive Cancer Network, 2011, DISTR MAN NCCN CLIN; National Institute for Health and Clinical Excellence, 2007, ANT POSTN MENT HLTH; NHS Public Health Resource Unit, 2011, 12 QUEST HELP YOU MA; O'Connor EA, 2009, ANN INTERN MED, V151, P793, DOI 10.7326/0003-4819-151-11-200912010-00007; OConnell D, 2019, NEWCASTLE OTTAWA SCA; Olfson M, 2010, AM J PSYCHIAT, V167, P1456, DOI 10.1176/appi.ajp.2010.10040570; Olfson M, 2009, ARCH GEN PSYCHIAT, V66, P848, DOI 10.1001/archgenpsychiatry.2009.81; Pai MMM, 2004, EVID BASED MED, V141, pA11, DOI DOI 10.1136/EBM.9.4.101; Patsopoulos NA, 2005, JAMA-J AM MED ASSOC, V293, P2362, DOI 10.1001/jama.293.19.2362; Pignone M, 2001, SYSTEMATIC EVIDENCE; Raffle AE, 2007, SCREENING EVIDENCE P; RANSOHOFF DF, 1978, NEW ENGL J MED, V299, P926, DOI 10.1056/NEJM197810262991705; REID MC, 1995, JAMA-J AM MED ASSOC, V274, P645, DOI 10.1001/jama.274.8.645; Rutjes Anne W S, 2006, CMAJ, V174, P469, DOI 10.1503/cmaj.050090; Scottish Intercollegiate Guidelines Network, 2002, SIGN 60 POSTN DEPR P; Thekkumpurath P, 2008, J PAIN SYMPTOM MANAG, V36, P520, DOI 10.1016/j.jpainsymman.2007.11.010; Thombs BD, 2008, JAMA-J AM MED ASSOC, V300, P2161, DOI 10.1001/jama.2008.667; Thombs BD, 2007, PSYCHOSOMATICS, V48, P185, DOI 10.1176/appi.psy.48.3.185; Tiemens BG, 1999, GEN HOSP PSYCHIAT, V21, P87, DOI 10.1016/S0163-8343(98)00077-2; UK National Screening Committee, 2000, 2 DEP HLTH ENGL UK N; US Preventive Serv Task Force, 2009, ANN INTERN MED, V151, P784, DOI 10.7326/0003-4819-151-11-200912010-00006; Vittayanont Arnont, 2006, Journal of the Medical Association of Thailand, V89, P1; Wancata J, 2006, ACTA PSYCHIAT SCAND, V114, P398, DOI 10.1111/j.1600-0447.2006.00888.x; Webster J, 2003, BJOG-INT J OBSTET GY, V110, P842, DOI 10.1016/S1470-0328(03)02977-X; Whiting P, 2004, ANN INTERN MED, V140, P189, DOI 10.7326/0003-4819-140-3-200402030-00010; Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25; Whooley MA, 2008, JAMA-J AM MED ASSOC, V300, P2379, DOI 10.1001/jama.2008.711; Wickberg B, 1996, ACTA PSYCHIAT SCAND, V94, P181, DOI 10.1111/j.1600-0447.1996.tb09845.x; Williams JW, 2002, GEN HOSP PSYCHIAT, V24, P225, DOI 10.1016/S0163-8343(02)00195-0; Williams SB, 2009, PEDIATRICS, V123, pE716, DOI 10.1542/peds.2008-2415; Willis BH, 2008, FAM PRACT, V25, P390, DOI 10.1093/fampra/cmn051; Wittkampf KA, 2007, GEN HOSP PSYCHIAT, V29, P388, DOI 10.1016/j.genhosppsych.2007.06.004; Yonkers KA, 2009, PSYCHIAT SERV, V60, P322, DOI 10.1176/appi.ps.60.3.322	75	67	67	2	15	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 18	2011	343								d4825	10.1136/bmj.d4825	http://dx.doi.org/10.1136/bmj.d4825			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	811LE	21852353	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000294210800002
J	Wainberg, MA; Zaharatos, GJ; Brenner, BG				Wainberg, Mark A.; Zaharatos, Gerasimos J.; Brenner, Bluma G.			MECHANISMS OF DISEASE Development of Antiretroviral Drug Resistance	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							IMMUNODEFICIENCY-VIRUS TYPE-1; HIV-1 SUBTYPE-C; TO-CHILD TRANSMISSION; SINGLE-DOSE NEVIRAPINE; REVERSE-TRANSCRIPTASE INHIBITORS; NON-B SUBTYPES; VIROLOGICAL FAILURE; IN-VITRO; K65R RESISTANCE; SOUTHERN BRAZIL		[Wainberg, Mark A.; Zaharatos, Gerasimos J.; Brenner, Bluma G.] McGill Univ, Jewish Gen Hosp, Lady Davis Inst, AIDS Ctr, Montreal, PQ H3T 1E2, Canada	Lady Davis Institute; McGill University	Wainberg, MA (corresponding author), McGill Univ, Jewish Gen Hosp, Lady Davis Inst, AIDS Ctr, 3755 Cote St Catherine Rd, Montreal, PQ H3T 1E2, Canada.	mark.wainberg@mcgill.ca	Franzeck, Fabian C/B-5055-2011; Brenner, Bluma/I-8714-2019	Brenner, Bluma/0000-0002-2084-728X				Aghokeng AF, 2005, AIDS RES HUM RETROV, V21, P430, DOI 10.1089/aid.2005.21.430; Akouamba BS, 2005, EMERG INFECT DIS, V11, P1230, DOI 10.3201/eid1108.040877; Arien KK, 2007, NAT REV MICROBIOL, V5, P141, DOI 10.1038/nrmicro1594; Ayele W, 2010, AIDS RES HUM RETROV, V26, P805, DOI 10.1089/aid.2009.0152; Barth RE, 2008, AIDS, V22, P2210, DOI 10.1097/QAD.0b013e328313bf87; Brennan CA, 2007, AIDS RES HUM RETROV, V23, P1434, DOI 10.1089/aid.2007.0121; Brenner B, 2003, AIDS, V17, pF1, DOI 10.1097/00002030-200301030-00001; Brenner BG, 2006, AIDS, V20, pF9, DOI 10.1097/01.aids.0000232228.88511.0b; Brenner BG, 2011, J MED VIROL, V83, P751, DOI 10.1002/jmv.22047; Brenner Bluma G., 2009, HIV Therapy, V3, P583, DOI [10.2217/hiv.09.40, 10.2217/HIV.09.40]; Brenner BG, 2007, CURR OPIN HIV AIDS, V2, P94, DOI 10.1097/COH.0b013e32801682e2; Calazans A, 2005, J INFECT DIS, V191, P1961, DOI 10.1086/430002; Ceccherini-Silberstein F, 2009, AIDS REV, V11, P17; Chaix ML, 2006, J INFECT DIS, V193, P482, DOI 10.1086/499966; Charpentier C, 2008, HIV MED, V9, P765, DOI 10.1111/j.1468-1293.2008.00628.x; Charpentier C, 2011, ANTIMICROB AGENTS CH, V55, P1293, DOI 10.1128/AAC.00942-10; Clotet B, 2008, J ANTIMICROB CHEMOTH, V61, P13, DOI 10.1093/jac/dkm432; Coutsinos Dimitrios, 2010, Antiviral Chemistry & Chemotherapy, V20, P117, DOI 10.3851/IMP1443; Coutsinos D, 2009, J VIROL, V83, P2029, DOI 10.1128/JVI.01349-08; D'Aquila RT, 2011, AIDS RES HUM RETROV, V27, P201, DOI 10.1089/aid.2010.0077; Descamps D, 2005, JAIDS-J ACQ IMM DEF, V38, P545, DOI 10.1097/01.qai.0000155201.51232.2e; Descamps D, 1997, J VIROL, V71, P8893, DOI 10.1128/JVI.71.11.8893-8898.1997; Deshpande A, 2007, AIDS RES HUM RETROV, V23, P335, DOI 10.1089/aid.2006.0183; Deshpande A, 2010, AIDS RES HUM RETROV, V26, P343, DOI 10.1089/aid.2009.0217; Doualla-Bell F, 2006, ANTIMICROB AGENTS CH, V50, P4182, DOI 10.1128/AAC.00714-06; Doualla-Bell F, 2006, ANTIMICROB AGENTS CH, V50, P2210, DOI 10.1128/AAC.01447-05; Doualla-Bell F, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-25; Dumans AT, 2004, J INFECT DIS, V189, P1232, DOI 10.1086/382483; Eshleman SH, 2006, JAIDS-J ACQ IMM DEF, V42, P518, DOI 10.1097/01.qai.0000221676.22069.b8; Fleury HJ, 2006, AIDS RES HUM RETROV, V22, P357, DOI 10.1089/aid.2006.22.357; Flys T, 2005, J INFECT DIS, V192, P24, DOI 10.1086/430742; Flys TS, 2006, JAIDS-J ACQ IMM DEF, V42, P610, DOI 10.1097/01.qai.0000221686.67810.20; Fransen S, 2009, J VIROL, V83, P11440, DOI 10.1128/JVI.01168-09; Fransen S, 2009, ANTIMICROB AGENTS CH, V53, P4522, DOI 10.1128/AAC.00651-09; Garrido C, 2010, AIDS REV, V12, P243; Gonzalez LMF, 2004, ANTIMICROB AGENTS CH, V48, P3552, DOI 10.1128/AAC.48.9.3552-3555.2004; Gottlieb GS, 2009, CLIN INFECT DIS, V48, P476, DOI 10.1086/596504; Grossman Z, 2004, ANTIMICROB AGENTS CH, V48, P2159, DOI 10.1128/AAC.48.6.2159-2165.2004; Grossman Z, 2004, AIDS, V18, P909, DOI 10.1097/00002030-200404090-00008; Gupta RK, 2005, AIDS, V19, P1916, DOI 10.1097/01.aids.0000189860.36688.e5; Harrigan PR, 2008, AIDS, V22, P2501, DOI 10.1097/QAD.0b013e328318f16c; Hemelaar J, 2011, AIDS, V25, P679, DOI 10.1097/QAD.0b013e328342ff93; Holguin A, 2008, CURR HIV RES, V6, P327, DOI 10.2174/157016208785132455; Hosseinipour MC, 2009, AIDS, V23, P1127, DOI 10.1097/QAD.0b013e32832ac34e; Hsu LY, 2005, JAIDS-J ACQ IMM DEF, V38, P5, DOI 10.1097/00126334-200501010-00002; Invernizzi CF, 2009, J INFECT DIS, V200, P1202, DOI 10.1086/605894; Johnson JA, 2005, J INFECT DIS, V192, P16, DOI 10.1086/430741; Johnston KM, 2010, AIDS, V24, P1929, DOI 10.1097/QAD.0b013e32833af85d; Buzon MJ, 2010, AIDS, V24, P17, DOI 10.1097/QAD.0b013e328331c81e; Kantor R, 2005, PLOS MED, V2, P325, DOI 10.1371/journal.pmed.0020112; Kantor Rami, 2005, MedGenMed, V7, P71, DOI 10.1186/1758-2652-7-1-71; Kantor R, 2006, CURR OPIN INFECT DIS, V19, P594, DOI 10.1097/QCO.0b013e3280109122; Kinomoto M, 2005, CLIN INFECT DIS, V41, P243, DOI 10.1086/431197; Lai MT, 2010, ANTIMICROB AGENTS CH, V54, P4812, DOI 10.1128/AAC.00829-10; Li JF, 2011, J INFECT DIS, V203, P798, DOI 10.1093/infdis/jiq126; Lisovsky I, 2010, ANTIMICROB AGENTS CH, V54, P2878, DOI 10.1128/AAC.01828-09; Locateli D, 2007, J MED VIROL, V79, P1455, DOI 10.1002/jmv.20955; Loemba H, 2002, ANTIMICROB AGENTS CH, V46, P2087, DOI 10.1128/AAC.46.7.2087-2094.2002; Maiga AI, 2009, ANTIVIR THER, V14, P123; Malet I, 2008, ANTIMICROB AGENTS CH, V52, P1351, DOI 10.1128/AAC.01228-07; Marconi VC, 2008, CLIN INFECT DIS, V46, P1589, DOI 10.1086/587109; Martinez-Cajas JL, 2008, AIDS REV, V10, P212; Miller MD, 2007, AIDS, V21, P265, DOI 10.1097/QAD.0b013e32801199ee; Montaner JSG, 2010, LANCET, V376, P532, DOI 10.1016/S0140-6736(10)60936-1; Nachega JB, 2007, ANN INTERN MED, V146, P564, DOI 10.7326/0003-4819-146-8-200704170-00007; Novitsky V, 2007, AIDS RES HUM RETROV, V23, P868, DOI 10.1089/aid.2006.0298; Ntemgwa ML, 2009, ANTIMICROB AGENTS CH, V53, P3611, DOI 10.1128/AAC.00154-09; Orrell C, 2009, ANTIVIR THER, V14, P523; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Phillips AN, 2011, AIDS, V25, P843, DOI 10.1097/QAD.0b013e328344037a; Pillay V, 2008, AIDS RES HUM RETROV, V24, P1449, DOI 10.1089/aid.2008.0180; Poveda E, 2004, AIDS RES HUM RETROV, V20, P347, DOI 10.1089/088922204322996590; Quercia R, 2009, J VIROL, V83, P10245, DOI 10.1128/JVI.00894-09; Rajesh L, 2009, AIDS RES HUM RETROV, V25, P1179, DOI 10.1089/aid.2009.0110; REWARI BB, 2010, J ACQUIR IMMUNE 1001; Rey D, 2009, J ANTIMICROB CHEMOTH, V63, P380, DOI 10.1093/jac/dkn471; Richard N, 2004, AIDS RES HUM RETROV, V20, P355, DOI 10.1089/088922204323048104; Ross L, 2009, AIDS RES HUM RETROV, V25, P665, DOI 10.1089/aid.2008.0302; Shafer RW, 2006, J INFECT DIS, V194, pS51, DOI 10.1086/505356; Shah M, 2011, AIDS, V25, P1093, DOI 10.1097/QAD.0b013e32834670b9; Soares EAJM, 2005, AIDS, V19, pS81, DOI 10.1097/01.aids.0000191497.00928.e4; Soares EAJM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000730; Soares EAJM, 2003, JAIDS-J ACQ IMM DEF, V34, P520, DOI 10.1097/00126334-200312150-00012; Soares RO, 2010, J MOL GRAPH MODEL, V29, P137, DOI 10.1016/j.jmgm.2010.05.007; Sprinz E, 2009, AIDS RES HUM RETROV, V25, P861, DOI 10.1089/aid.2009.0012; Sukasema C, 2008, INT J ANTIMICROB AG, V31, P277, DOI 10.1016/j.ijantimicag.2007.10.029; Sylla M, 2008, ANTIVIR THER, V13, P141; Tebit DM, 2008, JAIDS-J ACQ IMM DEF, V49, P17, DOI 10.1097/QAI.0b013e318182d2bc; Tebit DM, 2011, LANCET INFECT DIS, V11, P45, DOI 10.1016/S1473-3099(10)70186-9; Thomas TK, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001015; Toni TD, 2005, AIDS RES HUM RETROV, V21, P1031, DOI 10.1089/aid.2005.21.1031; Tuaillon E, 2004, JAIDS-J ACQ IMM DEF, V37, P1543, DOI 10.1097/00126334-200412150-00001; Turner D, 2009, J MED VIROL, V81, P1509, DOI 10.1002/jmv.21567; van Oosterhout JJG, 2009, TROP MED INT HEALTH, V14, P856, DOI 10.1111/j.1365-3156.2009.02309.x; VANMAARSEVEEN N, 2006, ANTIRETROVIRAL RESIS, P19; Varghese V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010992; Velazquez-Campoy A, 2002, BIOCHEMISTRY-US, V41, P8613, DOI 10.1021/bi020160i; von Wyl V, 2008, CLIN INFECT DIS, V46, P1299, DOI 10.1086/528863; Xu HT, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-14; Zeh C, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000430; ZOLFO M, 2010, AIDS RES HUM RE 1123	101	155	161	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 18	2011	365	7					637	646		10.1056/NEJMra1004180	http://dx.doi.org/10.1056/NEJMra1004180			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	808ER	21848464				2022-12-28	WOS:000293960500011
J	Ommaya, AK; Kupersmith, J				Ommaya, Alexander K.; Kupersmith, Joel			Challenges Facing the US Patient-Centered Outcomes Research Institute	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CLINICAL-RESEARCH ENTERPRISE		[Ommaya, Alexander K.; Kupersmith, Joel] US Dept Vet Affairs, Off Res & Dev, Washington, DC 20420 USA	US Department of Veterans Affairs	Ommaya, AK (corresponding author), US Dept Vet Affairs, Off Res & Dev, 810 Vermont Ave NW, Washington, DC 20420 USA.	alex.ommaya@va.gov						Crowley WF, 2004, JAMA-J AM MED ASSOC, V291, P1120, DOI 10.1001/jama.291.9.1120; Institute of Medicine of the National Academies, CLIN RES ROUNDT; Kupersmith J, 2005, J INVEST MED, V53, P67; Lee DH, 2011, ARCH INTERN MED, V171, P18, DOI 10.1001/archinternmed.2010.482; Stafford RS, 2010, ARCH INTERN MED, V170, P851, DOI 10.1001/archinternmed.2010.130; Sung NS, 2003, JAMA-J AM MED ASSOC, V289, P1278, DOI 10.1001/jama.289.10.1278; Tunis SKA., 2002, ROLE PURCHASERS PAYE; Wilensky GR, 2006, HEALTH AFFAIR, V25, pW572, DOI 10.1377/hlthaff.25.w572	8	6	6	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 17	2011	306	7					756	757		10.1001/jama.2011.1171	http://dx.doi.org/10.1001/jama.2011.1171			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	807LP	21846858				2022-12-28	WOS:000293900000026
J	Warren, B; Spitzer, P				Warren, Bernie; Spitzer, Peter			The art of medicine Laughing to longevity-the work of elder clowns	LANCET			English	Editorial Material									[Warren, Bernie] Univ Windsor, Sch Dramat Art, Windsor, ON N9B 3P4, Canada; [Spitzer, Peter] Humour Fdn, Bowral, NSW, Australia	University of Windsor	Warren, B (corresponding author), Univ Windsor, Sch Dramat Art, Windsor, ON N9B 3P4, Canada.	merv123@uwindsor.ca						[Anonymous], FOOLS HLTH; Dementia Collaborative Research Centres, SYDN MULT INT LAUGHT; Killick J., 2003, J DEMENTIA CARE, V11, P24; Spitzer P, 2011, CREATIVE APPROACHES, P32; Warren B, 2009, COME YOUR SENSES CRE, P37; Warren B., 2008, USING CREATIVE ARTS, P213	6	26	31	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 13	2011	378	9791					562	563		10.1016/S0140-6736(11)61280-4	http://dx.doi.org/10.1016/S0140-6736(11)61280-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	812UX	21847805	Bronze			2022-12-28	WOS:000294319500014
J	Herwaldt, BL; Linden, JV; Bosserman, E; Young, C; Olkowska, D; Wilson, M				Herwaldt, Barbara L.; Linden, Jeanne V.; Bosserman, Elizabeth; Young, Carolyn; Olkowska, Danuta; Wilson, Marianna			Transfusion-Associated Babesiosis in the United States: A Description of Cases	ANNALS OF INTERNAL MEDICINE			English	Article							TRANSMITTED BABESIOSIS; BLOOD-TRANSFUSION; WASHINGTON-STATE; TRANSMISSION; MICROTI; MINNESOTA; INFECTION; DISEASE; INFANT	Background: Babesiosis is a potentially life-threatening disease caused by intraerythrocytic parasites, which usually are tickborne but also are transmissible by transfusion. Tickborne transmission of Babesia microti mainly occurs in 7 states in the Northeast and the upper Midwest of the United States. No Babesia test for screening blood donors has been licensed. Objective: To ascertain and summarize data on U. S. transfusion-associated Babesia cases identified since the first described case in 1979. Design: Case series. Setting: United States. Patients: Case patients were transfused during 1979-2009 and had posttransfusion Babesia infection diagnosed by 2010, without reported evidence that another transmission route was more likely than transfusion. Implicated donors had laboratory evidence of infection. Potential cases were excluded if all pertinent donors tested negative. Measurements: Distributions of ascertained cases according to Babesia species and period and state of transfusion. Results: 159 transfusion-associated B. microti cases were included; donors were implicated for 136 (86%). The case patients' median age was 65 years (range, <1 to 94 years). Most cases were associated with red blood cell components; 4 were linked to whole blood-derived platelets. Cases occurred in all 4 seasons and in 22 (of 31) years, but 77% (122 cases) occurred during 2000-2009. Cases occurred in 19 states, but 87% (138 cases) were in the 7 main B. microti-endemic states. In addition, 3 B. duncani cases were documented in western states. Limitation: The extent to which cases were not diagnosed, investigated, reported, or ascertained is unknown. Conclusion: Donor-screening strategies that mitigate the risk for transfusion transmission are needed. Babesiosis should be included in the differential diagnosis of unexplained posttransfusion hemolytic anemia or fever, regardless of the season or U. S. region.	[Herwaldt, Barbara L.] Ctr Dis Control & Prevent, Div Parasit Dis & Malaria, Atlanta, GA 30333 USA; New York State Dept Hlth, Wadsworth Ctr, Albany, NY USA; Rhode Isl Blood Ctr, Providence, RI USA	Centers for Disease Control & Prevention - USA; State University of New York (SUNY) System; Wadsworth Center	Herwaldt, BL (corresponding author), Ctr Dis Control & Prevent, Div Parasit Dis & Malaria, 1600 Clifton Rd NE,Mailstop A06, Atlanta, GA 30333 USA.	bherwaldt@cdc.gov						Asad S, 2009, TRANSFUSION, V49, P2564, DOI 10.1111/j.1537-2995.2009.02380.x; Bachowski G, 2009, TRANSFUSION, V49, p35A; Blue D, 2009, TRANSFUSION, V49, P8, DOI 10.1111/j.1537-2995.2008.01883.x; Brennan MB, 2010, 5 DEC INT C HEALTHC; CABLE RG, 2001, BLOOD SAFETY SURVEIL, P399; Cangelosi JJ, 2008, VOX SANG, V95, P331, DOI 10.1111/j.1423-0410.2008.01094.x; Cirino CM, 2008, ANN INTERN MED, V148, P794, DOI 10.7326/0003-4819-148-10-200805200-00018; Conrad PA, 2006, INT J PARASITOL, V36, P779, DOI 10.1016/j.ijpara.2006.03.008; Dobroszycki J, 1999, JAMA-J AM MED ASSOC, V281, P927, DOI 10.1001/jama.281.10.927; Evenson DA, 1998, J CLIN APHERESIS, V13, P32, DOI 10.1002/(SICI)1098-1101(1998)13:1<32::AID-JCA7>3.3.CO;2-1; Food and Drug Administration, 2010, M BLOOD PROD ADV COM; Fox LAM, 2006, PEDIATR INFECT DIS J, V25, P169, DOI 10.1097/01.inf.0000195438.09628.b0; GERBER MA, 1994, J INFECT DIS, V170, P231, DOI 10.1093/infdis/170.1.231; GORDON S, 1984, CHEST, V86, P633, DOI 10.1378/chest.86.4.633; GRABOWSKI EF, 1982, ANN INTERN MED, V96, P466, DOI 10.7326/0003-4819-96-4-446; Gubernot DM, 2009, TRANSFUSION, V49, P2759, DOI 10.1111/j.1537-2995.2009.02429.x; Gubernot DM, 2009, CLIN INFECT DIS, V48, P25, DOI 10.1086/595010; Herman JH, 2010, J CLIN APHERESIS, V25, P358, DOI 10.1002/jca.20262; Herwaldt BL, 2004, EMERG INFECT DIS, V10, P622, DOI 10.3201/eid1004.030377; Herwaldt BL, 1997, J INFECT DIS, V175, P1259, DOI 10.1086/593812; Herwaldt BL, 2003, EMERG INFECT DIS, V9, P184; Herwaldt BL, 1996, ANN INTERN MED, V124, P643, DOI 10.7326/0003-4819-124-7-199604010-00004; Herwaldt BL, 2002, TRANSFUSION, V42, P1154, DOI 10.1046/j.1537-2995.2002.00189.x; JACOBY GA, 1980, NEW ENGL J MED, V303, P1098, DOI 10.1056/NEJM198011063031906; Kain KC, 2001, CAN MED ASSOC J, V164, P1721; Kjemtrup AM, 2002, TRANSFUSION, V42, P1482, DOI 10.1046/j.1537-2995.2002.00245.x; Kurkjian K, 2010, ANN C COUNC STAT TER; Laird TW, 2005, MIL MED, V170, P295, DOI 10.7205/MILMED.170.4.295; Leiby DA, 2011, CLIN MICROBIOL REV, V24, P14, DOI 10.1128/CMR.00022-10; Linden JV, 2010, TRANSFUSION, V50, p39A; Linden JV, 2000, TRANSFUSION, V40, p96S; Linden JV, 2000, TRANSFUSION, V40, P285, DOI 10.1046/j.1537-2995.2000.40030285.x; Lux JZ, 2003, EMERG INFECT DIS, V9, P116, DOI 10.3201/eid0901.020149; MARCUS LC, 1982, JAMA-J AM MED ASSOC, V248, P465, DOI 10.1001/jama.248.4.465; MINTZ ED, 1991, TRANSFUSION, V31, P365, DOI 10.1046/j.1537-2995.1991.31491213305.x; Ngo V, 2009, EMERG INFECT DIS, V15, P785, DOI 10.3201/eid1505.081562; Nicholson GT, 2010, CONGENIT HEART DIS, V5, P607, DOI 10.1111/j.1747-0803.2010.00384.x; Pantanowitz L, 2002, TRANSFUS MED REV, V16, P131, DOI 10.1053/tmrv.2002.31462; Perdrizet GA, 2000, TRANSPLANTATION, V70, P205; PRZYJEMSKI CJ, 1981, NEW ENGL J MED, V304, P733; QUICK RE, 1993, ANN INTERN MED, V119, P284, DOI 10.7326/0003-4819-119-4-199308150-00006; Raju M, 2007, PEDIATR INFECT DIS J, V26, P181, DOI 10.1097/01.inf.0000250622.11505.8f; SMITH RP, 1986, JAMA-J AM MED ASSOC, V256, P2726, DOI 10.1001/jama.256.19.2726; Stramer SL, 2009, TRANSFUSION, V49, p1S, DOI 10.1111/j.1537-2995.2009.02279.x; Tonnetti L, 2009, TRANSFUSION, V49, P2557, DOI 10.1111/j.1537-2995.2009.02317.x; WESTERN KA, 1970, NEW ENGL J MED, V283, P854, DOI 10.1056/NEJM197010152831607; WITTNER M, 1982, ANN INTERN MED, V96, P601, DOI 10.7326/0003-4819-96-5-601; Wormser GP, 2011, AM SURGEON, V77, P345; Wudhikarn K, 2011, AM J MED, V124, P800, DOI 10.1016/j.amjmed.2011.03.009; Young C, 2009, TRANSFUSION, V49, P2548, DOI 10.1111/j.1537-2995.2009.02494.x; Zhao Y, 2009, TRANSFUSION, V49, P2583, DOI 10.1111/j.1537-2995.2009.02454.x	51	204	213	0	17	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 18	2011	155	8					509	U83		10.7326/0003-4819-155-8-201110180-00362	http://dx.doi.org/10.7326/0003-4819-155-8-201110180-00362			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	835WB	21893613				2022-12-28	WOS:000296066300016
J	Jett, JR; Midthun, DE				Jett, James R.; Midthun, David E.			Screening for Lung Cancer: For Patients at Increased Risk for Lung Cancer, It Works	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							SUSCEPTIBILITY LOCUS; PREDICTION MODEL; SMOKING; MORTALITY; OBSTRUCTION; DEPENDENCE; PROSTATE; VOLUME; SCANS	Screening for lung cancer is not currently recommended, even in persons at high risk for this condition. Most patients with lung cancer present with symptomatic disease that is usually at an incurable, advanced stage. The recently reported NLST (National Lung Screening Trial) showed a 20% decrease in deaths from lung cancer in high-risk persons undergoing screening with low-dose computed tomography of the chest compared with chest radiography. The high-risk group included in the trial comprised asymptomatic persons aged 55 to 74 years, with smoking history of at least 30 pack-years. Screening with low-dose computed tomography detected more cases of early-stage lung cancer and fewer cases of advanced-stage cancer, confirming that screening has shifted the stage of cancer at diagnosis and provides more persons with the opportunity for curative treatment. Although computed tomography screening has risks and limitations, the 20% decrease in deaths is the single most dramatic decrease ever reported for deaths from lung cancer, with the possible exception of smoking cessation. Physicians should offer computed tomography screening for lung cancer to patients who fit the high-risk profile defined in the NLST.	[Jett, James R.] Natl Jewish Hlth, Dept Med, Denver, CO 80206 USA; Mayo Clin, Rochester, MN USA	National Jewish Health; Mayo Clinic	Jett, JR (corresponding author), Natl Jewish Hlth, Dept Med, J307A,1400 Jackson St, Denver, CO 80206 USA.	jettj@njhealth.org						Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Amos CI, 2008, NAT GENET, V40, P616, DOI 10.1038/ng.109; Ashraf H, 2009, THORAX, V64, P388, DOI 10.1136/thx.2008.102475; Bach PB, 2003, JNCI-J NATL CANCER I, V95, P470, DOI 10.1093/jnci/95.6.470; Baldwin DR, 2011, THORAX, V66, P308, DOI 10.1136/thx.2010.152066; Boeri M, 2011, P NATL ACAD SCI USA, V108, P3713, DOI 10.1073/pnas.1100048108; Boyle P, 2011, ANN ONCOL, V22, P383, DOI 10.1093/annonc/mdq361; Cassidy A, 2008, BRIT J CANCER, V98, P270, DOI 10.1038/sj.bjc.6604158; Cox LS, 2003, CANCER, V98, P2495, DOI 10.1002/cncr.11813; de Gonzalez AB, 2008, J MED SCREEN, V15, P153, DOI 10.1258/jms.2008.008052; de Gonzalez AB, 2009, ARCH INTERN MED, V169, P2071, DOI 10.1001/archinternmed.2009.440; Doll R, 2004, BMJ-BRIT MED J, V328, P1519, DOI 10.1136/bmj.38142.554479.AE; Ebbert JO, 2007, J THORAC ONCOL, V2, P249, DOI 10.1097/JTO.0b013e318031bca4; Goldstraw P, 2007, J THORAC ONCOL, V2, P706, DOI 10.1097/JTO.0b013e31812f3c1a; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; Maldonado F, 2010, CHEST, V138, P1295, DOI 10.1378/chest.09-2567; McKay JD, 2008, NAT GENET, V40, P1404, DOI 10.1038/ng.254; Mettler FA, 2008, RADIOLOGY, V248, P254, DOI 10.1148/radiol.2481071451; Ostroff Rachel M, 2010, PLoS One, V5, pe15003, DOI 10.1371/journal.pone.0015003; Raz DJ, 2007, J THORAC ONCOL, V2, P125, DOI 10.1097/JTO.0b013e31802f1cb1; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Spitz MR, 2008, CANCER PREV RES, V1, P250, DOI 10.1158/1940-6207.CAPR-08-0060; Tammemagi CM, 2011, JNCI-J NATL CANCER I, V103, P1058, DOI 10.1093/jnci/djr173; Tammemagi MC, 2009, J THORAC ONCOL, V4, P710, DOI 10.1097/JTO.0b013e31819e77ce; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; TOCKMAN MS, 1987, ANN INTERN MED, V106, P512, DOI 10.7326/0003-4819-106-4-512; Townsend CO, 2005, CANCER-AM CANCER SOC, V103, P2154, DOI 10.1002/cncr.21045; van Klaveren RJ, 2009, NEW ENGL J MED, V361, P2221, DOI 10.1056/NEJMoa0906085; Wang YF, 2008, NAT GENET, V40, P1407, DOI 10.1038/ng.273; Wasswa-Kintu S, 2005, THORAX, V60, P570, DOI 10.1136/thx.2004.037135; Yee J, 2009, J CLIN ONCOL, V27, P2787, DOI 10.1200/JCO.2008.19.4233	31	18	18	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 18	2011	155	8					540	542		10.7326/0003-4819-155-8-201110180-00367	http://dx.doi.org/10.7326/0003-4819-155-8-201110180-00367			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	835WB	21893615				2022-12-28	WOS:000296066300020
J	Abi-Rached, L; Jobin, MJ; Kulkarni, S; McWhinnie, A; Dalva, K; Gragert, L; Babrzadeh, F; Gharizadeh, B; Luo, M; Plummer, FA; Kimani, J; Carrington, M; Middleton, D; Rajalingam, R; Beksac, M; Marsh, SGE; Maiers, M; Guethlein, LA; Tavoularis, S; Little, AM; Green, RE; Norman, PJ; Parham, P				Abi-Rached, Laurent; Jobin, Matthew J.; Kulkarni, Subhash; McWhinnie, Alasdair; Dalva, Klara; Gragert, Loren; Babrzadeh, Farbod; Gharizadeh, Baback; Luo, Ma; Plummer, Francis A.; Kimani, Joshua; Carrington, Mary; Middleton, Derek; Rajalingam, Raja; Beksac, Meral; Marsh, Steven G. E.; Maiers, Martin; Guethlein, Lisbeth A.; Tavoularis, Sofia; Little, Ann-Margaret; Green, Richard E.; Norman, Paul J.; Parham, Peter			The Shaping of Modern Human Immune Systems by Multiregional Admixture with Archaic Humans	SCIENCE			English	Article							HLA-B ALLELES; HAPLOTYPE MAP; MHC; HISTORY; POLYMORPHISM; POPULATION; DIVERSITY; EVOLUTION; MIGRATION; SELECTION	Whole genome comparisons identified introgression from archaic to modern humans. Our analysis of highly polymorphic human leukocyte antigen (HLA) class I, vital immune system components subject to strong balancing selection, shows how modern humans acquired the HLA-B*73 allele in west Asia through admixture with archaic humans called Denisovans, a likely sister group to the Neandertals. Virtual genotyping of Denisovan and Neandertal genomes identified archaic HLA haplotypes carrying functionally distinctive alleles that have introgressed into modern Eurasian and Oceanian populations. These alleles, of which several encode unique or strong ligands for natural killer cell receptors, now represent more than half the HLA alleles of modern Eurasians and also appear to have been later introduced into Africans. Thus, adaptive introgression of archaic alleles has significantly shaped modern human immune systems.	[Abi-Rached, Laurent; Kulkarni, Subhash; Guethlein, Lisbeth A.; Norman, Paul J.; Parham, Peter] Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA; [Abi-Rached, Laurent; Kulkarni, Subhash; Guethlein, Lisbeth A.; Norman, Paul J.; Parham, Peter] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Jobin, Matthew J.] Santa Clara Univ, Dept Anthropol, Santa Clara, CA 95050 USA; [Jobin, Matthew J.] Stanford Univ, Dept Anthropol, Stanford, CA 94305 USA; [McWhinnie, Alasdair; Marsh, Steven G. E.; Little, Ann-Margaret] Royal Free Hosp, Anthony Nolan Res Inst, London NW3 2QG, England; [Dalva, Klara; Beksac, Meral] Ankara Univ, Dept Hematol, TR-06520 Ankara, Turkey; [Gragert, Loren; Maiers, Martin] Natl Marrow Donor Program, Minneapolis, MN 55413 USA; [Babrzadeh, Farbod; Gharizadeh, Baback] Stanford Univ, Sch Med, Stanford Genome Technol Ctr, Palo Alto, CA 94304 USA; [Luo, Ma; Plummer, Francis A.] Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB R3E 3R2, Canada; [Luo, Ma; Plummer, Francis A.] Univ Manitoba, Dept Med Microbiol, Winnipeg, MB R3E 0J9, Canada; [Kimani, Joshua] Univ Nairobi, Dept Med Microbiol, Nairobi 00202, Kenya; [Carrington, Mary] NCI, Canc & Inflammat Program, Expt Immunol Lab, SAIC Frederick Inc, Frederick, MD 21702 USA; [Carrington, Mary] Ragon Inst MGH MIT & Harvard, Boston, MA 02129 USA; [Middleton, Derek] Univ Liverpool, Royal Liverpool Univ Hosp, Sch Infect & Host Def, Div Immunol, Liverpool L7 8XP, Merseyside, England; [Rajalingam, Raja] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, UCLA Immunogenet Ctr, Los Angeles, CA 90095 USA; [Marsh, Steven G. E.; Little, Ann-Margaret] UCL, UCL Canc Inst, London WC1E 6BT, England; [Tavoularis, Sofia] Canadian Blood Serv, Head Off, HLA Lab, Ottawa, ON K1G 4J5, Canada; [Green, Richard E.] Univ Calif Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95064 USA	Stanford University; Stanford University; Santa Clara University; Stanford University; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; Ankara University; National Marrow Donor Program; Stanford University; Public Health Agency of Canada; University of Manitoba; University of Nairobi; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute; Royal Liverpool & Broadgreen University Hospitals NHS Trust; Royal Liverpool University Hospital; University of Liverpool; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of London; University College London; Canadian Blood Services; University of California System; University of California Santa Cruz	Parham, P (corresponding author), Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA.	peropa@stanford.edu	Abi-Rached, Laurent/H-7236-2012; Beksac, Meral/D-6411-2013; dalva, klara/AAN-7704-2020; Kulkarni, Subhash/I-4159-2017	Beksac, Meral/0000-0003-1797-8657; dalva, klara/0000-0001-6917-6870; Kulkarni, Subhash/0000-0002-2298-0623; Maiers, Martin/0000-0002-0198-2064; Norman, Paul/0000-0001-8370-7703	NIH [AI031168]; Yerkes Center [RR000165]; NSF [CNS-0619926, TG-DBS100006]; National Cancer Institute (NCI), NIH [HHSN261200800001E]; NCI, NIH, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC010792] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Yerkes Center; NSF(National Science Foundation (NSF)); National Cancer Institute (NCI), NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI, NIH, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank individual investigators and the Bone Marrow Donors Worldwide (BMDW) organization for kindly providing HLA class I typing data, as well as bone marrow registries from Australia, Austria, Belgium, Canada, Cyprus, Czech Republic, France, Ireland, Israel, Italy, Lithuania, Norway, Poland, Portugal, Singapore, Spain, Sweden, Switzerland, Turkey, United Kingdom, and United States for contributing typing data through BMDW. We thank E. Watkin for technical support. We are indebted to the large genome sequencing centers for early access to the gorilla genome data. We used sequence reads generated at the Wellcome Trust Sanger Institute as part of the gorilla reference genome sequencing project. These data can be obtained from the National Center for Biotechnology Information (NCBI) Trace Archive (www.ncbi.nlm.nih.gov/Traces). We also used reads generated by Washington University School of Medicine; these data were produced by the Genome Institute at Washington University School of Medicine in St. Louis and can be obtained from the NCBI Trace Archive (www.ncbi.nlm.nih.gov/Traces/). Funded by NIH grant AI031168, Yerkes Center base grant RR000165, NSF awards (CNS-0619926, TG-DBS100006), by federal funds from the National Cancer Institute (NCI), NIH (contract HHSN261200800001E), and by the Intramural Research Program of the NCI, NIH, Center for Cancer Research. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U. S. government. Sequence data have been deposited in GenBank under accession nos. JF974053 to 70.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Behar DM, 2008, AM J HUM GENET, V82, P1130, DOI 10.1016/j.ajhg.2008.04.002; BELICH MP, 1992, NATURE, V357, P326, DOI 10.1038/357326a0; Cao K, 2001, HUM IMMUNOL, V62, P1009, DOI 10.1016/S0198-8859(01)00298-1; Castric V, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000168; Cruciani F, 2002, AM J HUM GENET, V70, P1197, DOI 10.1086/340257; de Bakker PIW, 2006, NAT GENET, V38, P1166, DOI 10.1038/ng1885; DECAMPOSLIMA PO, 1993, SCIENCE, V260, P98, DOI 10.1126/science.7682013; DeGiorgio M, 2009, P NATL ACAD SCI USA, V106, P16057, DOI 10.1073/pnas.0903341106; Ferrer-Admetlla A, 2008, J IMMUNOL, V181, P1315, DOI 10.4049/jimmunol.181.2.1315; Gibbons A, 2011, SCIENCE, V331, P392, DOI 10.1126/science.331.6016.392; Gonzalez-Galarza FF, 2011, NUCLEIC ACIDS RES, V39, pD913, DOI 10.1093/nar/gkq1128; Graef T, 2009, J EXP MED, V206, P2557, DOI 10.1084/jem.20091010; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Hansasuta P, 2004, EUR J IMMUNOL, V34, P1673, DOI 10.1002/eji.200425089; Jobin MJ, 2008, BIOINFORMATICS, V24, P2936, DOI 10.1093/bioinformatics/btn540; Moesta AK, 2008, J IMMUNOL, V180, P3969, DOI 10.4049/jimmunol.180.6.3969; Moodley Y, 2009, SCIENCE, V323, P527, DOI 10.1126/science.1166083; Norman PJ, 2007, NAT GENET, V39, P1092, DOI 10.1038/ng2111; Parham P, 2005, NAT REV IMMUNOL, V5, P201, DOI 10.1038/nri1570; PARHAM P, 1994, TISSUE ANTIGENS, V43, P302, DOI 10.1111/j.1399-0039.1994.tb02344.x; PETZLERLER ML, 1993, TISSUE ANTIGENS, V41, P227; Reich D, 2010, NATURE, V468, P1053, DOI 10.1038/nature09710; Robinson J, 2011, NUCLEIC ACIDS RES, V39, pD1171, DOI 10.1093/nar/gkq998; Semino O, 2002, AM J HUM GENET, V70, P265, DOI 10.1086/338306; VILCHES C, 1994, IMMUNOGENETICS, V40, P166, DOI 10.1007/BF00188185; VILCHES C, 1994, IMMUNOGENETICS, V40, P313, DOI 10.1007/BF00189983; WATKINS DI, 1992, NATURE, V357, P329, DOI 10.1038/357329a0; Yawata M, 2008, BLOOD, V112, P2369, DOI 10.1182/blood-2008-03-143727; Yotova V, 2011, MOL BIOL EVOL, V28, P1957, DOI 10.1093/molbev/msr024	30	319	327	8	246	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 7	2011	334	6052					89	94		10.1126/science.1209202	http://dx.doi.org/10.1126/science.1209202			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	829KW	21868630	Green Accepted, Green Submitted			2022-12-28	WOS:000295580300046
J	Alfoldi, J; Di Palma, F; Grabherr, M; Williams, C; Kong, LS; Mauceli, E; Russell, P; Lowe, CB; Glor, RE; Jaffe, JD; Ray, DA; Boissinot, S; Shedlock, AM; Botka, C; Castoe, TA; Colbourne, JK; Fujita, MK; Moreno, RG; ten Hallers, BF; Haussler, D; Heger, A; Heiman, D; Janes, DE; Johnson, J; de Jong, PJ; Koriabine, MY; Lara, M; Novick, PA; Organ, CL; Peach, SE; Poe, S; Pollock, DD; de Queiroz, K; Sanger, T; Searle, S; Smith, JD; Smith, Z; Swofford, R; Turner-Maier, J; Wade, J; Young, S; Zadissa, A; Edwards, SV; Glenn, TC; Schneider, CJ; Losos, JB; Lander, ES; Breen, M; Ponting, CP; Lindblad-Toh, K				Alfoeldi, Jessica; Di Palma, Federica; Grabherr, Manfred; Williams, Christina; Kong, Lesheng; Mauceli, Evan; Russell, Pamela; Lowe, Craig B.; Glor, Richard E.; Jaffe, Jacob D.; Ray, David A.; Boissinot, Stephane; Shedlock, Andrew M.; Botka, Christopher; Castoe, Todd A.; Colbourne, John K.; Fujita, Matthew K.; Moreno, Ricardo Godinez; ten Hallers, Boudewijn F.; Haussler, David; Heger, Andreas; Heiman, David; Janes, Daniel E.; Johnson, Jeremy; de Jong, Pieter J.; Koriabine, Maxim Y.; Lara, Marcia; Novick, Peter A.; Organ, Chris L.; Peach, Sally E.; Poe, Steven; Pollock, David D.; de Queiroz, Kevin; Sanger, Thomas; Searle, Steve; Smith, Jeremy D.; Smith, Zachary; Swofford, Ross; Turner-Maier, Jason; Wade, Juli; Young, Sarah; Zadissa, Amonida; Edwards, Scott V.; Glenn, Travis C.; Schneider, Christopher J.; Losos, Jonathan B.; Lander, Eric S.; Breen, Matthew; Ponting, Chris P.; Lindblad-Toh, Kerstin			The genome of the green anole lizard and a comparative analysis with birds and mammals	NATURE			English	Article							CHICKEN; EVOLUTION	The evolution of the amniotic egg was one of the great evolutionary innovations in the history of life, freeing vertebrates from an obligatory connection to water and thus permitting the conquest of terrestrial environments(1). Among amniotes, genome sequences are available for mammals and birds(2-4), but not for non-avian reptiles. Here we report the genome sequence of the North American green anole lizard, Anolis carolinensis. We find that A. carolinensis microchromosomes are highly syntenic with chicken microchromosomes, yet do not exhibit the high GC and low repeat content that are characteristic of avian microchromosomes(2). Also, A. carolinensis mobile elements are very young and diverse-more so than in any other sequenced amniote genome. The GC content of this lizard genome is also unusual in its homogeneity, unlike the regionally variable GC content found in mammals and birds(5). We describe and assign sequence to the previously unknown A. carolinensis X chromosome. Comparative gene analysis shows that amniote egg proteins have evolved significantly more rapidly than other proteins. An anole phylogeny resolves basal branches to illuminate the history of their repeated adaptive radiations.	[Alfoeldi, Jessica; Di Palma, Federica; Grabherr, Manfred; Mauceli, Evan; Russell, Pamela; Jaffe, Jacob D.; Heiman, David; Johnson, Jeremy; Lara, Marcia; Peach, Sally E.; Swofford, Ross; Turner-Maier, Jason; Young, Sarah; Lander, Eric S.; Lindblad-Toh, Kerstin] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Williams, Christina; Breen, Matthew] N Carolina State Univ, Dept Mol Biomed Sci, Coll Vet Med, Raleigh, NC 27606 USA; [Kong, Lesheng; Fujita, Matthew K.; Heger, Andreas; Ponting, Chris P.] Univ Oxford, MRC, Funct Genom Unit, Dept Physiol Anat & Genet, Oxford OX1 3QX, England; [Lowe, Craig B.] Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA; [Glor, Richard E.] Univ Rochester, Rochester, NY 14607 USA; [Ray, David A.; Smith, Jeremy D.] Mississippi State Univ, Dept Biochem Mol Biol Entomol & Plant Pathol, Mississippi State, MS 39762 USA; [Boissinot, Stephane] CUNY, Dept Biol, Queens Coll, New York, NY 11367 USA; [Shedlock, Andrew M.] Coll Charleston, Dept Biol, Charleston, SC 29424 USA; [Shedlock, Andrew M.] Coll Charleston, Grad Program Marine Genom, Charleston, SC 29424 USA; [Botka, Christopher] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Castoe, Todd A.; Pollock, David D.] Univ Colorado, Sch Med, Dept Biochem & Mol Genet, Aurora, CO 80045 USA; [Colbourne, John K.; Smith, Zachary] Indiana Univ, Ctr Genom & Bioinformat, Bloomington, IN 47405 USA; [Fujita, Matthew K.; Moreno, Ricardo Godinez; Janes, Daniel E.; Organ, Chris L.; Sanger, Thomas; Edwards, Scott V.; Losos, Jonathan B.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Fujita, Matthew K.; Moreno, Ricardo Godinez; Janes, Daniel E.; Organ, Chris L.; Sanger, Thomas; Edwards, Scott V.; Losos, Jonathan B.] Harvard Univ, Museum Comparat Zool, Cambridge, MA 02138 USA; [ten Hallers, Boudewijn F.; de Jong, Pieter J.; Koriabine, Maxim Y.] Childrens Hosp, Oakland Res Inst, Oakland, CA 94609 USA; [Haussler, David] Univ Calif Santa Cruz, Ctr Biomol Sci & Engn, Santa Cruz, CA 95064 USA; [Novick, Peter A.] Queensborough Community Coll, Dept Biol Sci & Geol, Bayside, NY 11364 USA; [Poe, Steven] Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA; [Pollock, David D.] Univ Colorado, Program Computat Biosci, Sch Med, Aurora, CO 80045 USA; [de Queiroz, Kevin] Smithsonian Inst, Natl Museum Nat Hist, Dept Vertebrate Zool, Washington, DC 20560 USA; [Wade, Juli] Michigan State Univ, Dept Psychol, Program Neurosci, E Lansing, MI 48824 USA; [Wade, Juli] Michigan State Univ, Dept Zool, Program Neurosci, E Lansing, MI 48824 USA; [Glenn, Travis C.] Univ Georgia, Dept Environm Hlth Sci, Athens, GA 30602 USA; [Glenn, Travis C.] Univ Georgia, Georgia Genom Facil, Athens, GA 30602 USA; [Schneider, Christopher J.] Boston Univ, Dept Biol, Boston, MA 02215 USA; [Breen, Matthew] N Carolina State Univ, Ctr Comparat Med & Translat Res, Raleigh, NC 27695 USA; [Breen, Matthew] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27514 USA; [Lindblad-Toh, Kerstin] Uppsala Univ, Dept Med Biochem & Microbiol, Sci Life Lab Uppsala, S-75123 Uppsala, Sweden	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of North Carolina; North Carolina State University; University of Oxford; Stanford University; University of Rochester; Mississippi State University; City University of New York (CUNY) System; Queens College NY (CUNY); College of Charleston; College of Charleston; Harvard University; Harvard Medical School; University of Colorado System; University of Colorado Anschutz Medical Campus; Indiana University System; Indiana University Bloomington; Harvard University; Harvard University; Children's Hospital Los Angeles; Children's Hospital Oakland Research Institute; University of California System; University of California Santa Cruz; University of New Mexico; University of Colorado System; University of Colorado Anschutz Medical Campus; Smithsonian Institution; Smithsonian National Museum of Natural History; Michigan State University; Michigan State University; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Boston University; University of North Carolina; North Carolina State University; University of North Carolina; University of North Carolina Chapel Hill; Uppsala University	Alfoldi, J (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.	jalfoldi@broadinstitute.org; kersli@broadinstitute.org	Kong, Lesheng/O-8933-2015; Glor, Richard/N-4656-2013; Ponting, Chris/AAV-2621-2021; Pollock, David D/M-4740-2016; Glenn, Travis C/A-2390-2008; Edwards, Scott V./D-9071-2018; wade, juli/F-4993-2012; Colbourne, John K/L-7748-2014	Kong, Lesheng/0000-0002-9225-3421; Glor, Richard/0000-0002-3359-1631; Pollock, David D/0000-0002-7627-4214; Glenn, Travis C/0000-0001-7725-3637; Edwards, Scott V./0000-0003-2535-6217; Colbourne, John K/0000-0002-6966-2972; Heger, Andreas/0000-0001-7720-0447; Grabherr, Manfred/0000-0001-8792-6508; Heiman, David/0000-0001-7895-4259; Swofford, Ross/0000-0003-3676-8479; Ray, David/0000-0002-3340-3987; Di-Palma, Federica/0000-0002-4394-0102; Boissinot, Stephane/0000-0002-8760-1284; Zadissa, Amonida/0000-0001-5310-8830; Ponting, Chris/0000-0003-0202-7816; Breen, Matthew/0000-0002-8901-4155; Russell, Pamela/0000-0003-2997-6392	National Human Genome Research Institute (NHGRI); NSF [DEB-0844624, DEB-0920892]; David and Lucile Packard Foundation; Biotechnology and Biological Sciences Research Council [BB/F007590/1] Funding Source: researchfish; Medical Research Council [MC_U137761446] Funding Source: researchfish; BBSRC [BB/F007590/1] Funding Source: UKRI; MRC [MC_U137761446] Funding Source: UKRI; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067] Funding Source: NIH RePORTER	National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NSF(National Science Foundation (NSF)); David and Lucile Packard Foundation(The David & Lucile Packard Foundation); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	Generation of the A. carolinensis sequence at the Broad Institute of MIT and Harvard was supported by grants from the National Human Genome Research Institute (NHGRI); S. P. and R. E. G. were supported by NSF grants DEB-0844624 and DEB-0920892. All sequence data was produced by the Genome Sequencing Platform of the Broad Institute. We would also like to thank the David and Lucile Packard Foundation for their early support of anole genomics, R. Andrews for her advice on lizard egg biology, C. Hickman and B. Temple and the Herpetology group at the University of Georgia's Savannah River Ecology Lab for assistance with sample collection, and L. Gaffney and L. Virnoche for assistance with figure and text preparation.	Axelsson E, 2005, GENOME RES, V15, P120, DOI 10.1101/gr.3021305; Benton MJ, 2007, MOL BIOL EVOL, V24, P26, DOI 10.1093/molbev/msl150; Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; Burt DW, 2002, CYTOGENET GENOME RES, V96, P97, DOI 10.1159/000063018; Colosimo PF, 2005, SCIENCE, V307, P1928, DOI 10.1126/science.1107239; Dalloul RA, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000475; Duret L, 2006, GENE, V385, P71, DOI 10.1016/j.gene.2006.04.030; Farinazzo A, 2009, J CHROMATOGR A, V1216, P1241, DOI 10.1016/j.chroma.2008.11.051; Fujita MK, 2011, GENOME BIOL EVOL, V3, P974, DOI 10.1093/gbe/evr072; Furano AV, 2004, TRENDS GENET, V20, P9, DOI 10.1016/j.tig.2003.11.006; Gorman G. C., 1973, CYTOTAXONOMY VERTEBR, P349; Hellsten U, 2010, SCIENCE, V328, P633, DOI 10.1126/science.1183670; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Kordis D, 2009, CYTOGENET GENOME RES, V127, P94, DOI 10.1159/000294999; Losos JB, 2009, ORGANISM ENVIRON, V10, P1; Lowe CB, 2010, J HERED, V101, P437, DOI 10.1093/jhered/esq016; Mann K, 2007, PROTEOMICS, V7, P3558, DOI 10.1002/pmic.200700397; Novick PA, 2011, GENOME BIOL EVOL, V3, P1, DOI 10.1093/gbe/evq080; Novick PA, 2009, MOL BIOL EVOL, V26, P1811, DOI 10.1093/molbev/msp090; Organ CL, 2008, INTEGR COMP BIOL, V48, P512, DOI 10.1093/icb/icn041; Potrzebowski L, 2008, PLOS BIOL, V6, P709, DOI 10.1371/journal.pbio.0060080; Shedlock AM, 2007, P NATL ACAD SCI USA, V104, P2767, DOI 10.1073/pnas.0606204104; Sumida S. S., 1997, AMNIOTE ORIGINS COMP; VIETS BE, 1994, J EXP ZOOL, V270, P45, DOI 10.1002/jez.1402700106; Warren WC, 2010, NATURE, V464, P757, DOI 10.1038/nature08819; Williams EE, 1983, LIZARD ECOLOGY STUDI	26	446	458	3	157	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 29	2011	477	7366					587	591		10.1038/nature10390	http://dx.doi.org/10.1038/nature10390			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825ZM	21881562	Green Submitted, Green Accepted, hybrid			2022-12-28	WOS:000295320900039
J	Wang, Z; Young, RL; Xue, HL; Wagner, GP				Wang, Zhe; Young, Rebecca L.; Xue, Huiling; Wagner, Guenter P.			Transcriptomic analysis of avian digits reveals conserved and derived digit identities in birds	NATURE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; RNA-SEQ DATA; GENE-EXPRESSION; WING DIGITS; HOX GENES; R-PACKAGE; EVOLUTION; HOMOLOGY; LIMB; PATTERNS	Morphological characters are the result of developmental gene expression. The identity of a character is ultimately grounded in the gene regulatory network directing development and thus whole-genome gene expression data can provide evidence about character identity. This approach has been successfully used to assess cell-type identity(1-3). Here we use transcriptomic data to address a long-standing uncertainty in evolutionary biology, the identity of avian wing digits(4,5). Embryological evidence clearly identifies the three wing digits as developing from digit positions 2, 3 and 4 (ref. 6), whereas palaeontological data suggest that they are digits I, II and III7. We compare the transcriptomes of the wing and foot digits and find a strong signal that unites the first wing digit with the first foot digit, even though the first wing digit develops from embryological position 2. Interestingly, our transcriptomic data of the posterior digits show a higher degree of differentiation among forelimb digits compared with hindlimb digits. These data show that in the stem lineage of birds the first digit underwent a translocation from digit position 1 to position 2, and further indicate that the posterior wing digits have unique identities contrary to any model of avian digit identity proposed so far(5,8).	[Wang, Zhe; Young, Rebecca L.; Wagner, Guenter P.] Yale Univ, Yale Syst Biol Inst, West Haven, CT 06516 USA; [Wang, Zhe; Young, Rebecca L.; Wagner, Guenter P.] Yale Univ, Dept Ecol & Evolutionary Biol, West Haven, CT 06516 USA; [Xue, Huiling] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA	Yale University; Yale University; Yale University	Wagner, GP (corresponding author), Yale Univ, Yale Syst Biol Inst, West Haven, CT 06516 USA.	gunter.wagner@yale.edu	Young, Rebecca/ABB-4869-2021	Young, Rebecca/0000-0002-6230-1912; Wang, Zhe/0000-0002-8166-1059; Wagner, Gunter/0000-0002-3097-002X	Yale Science Development Fund	Yale Science Development Fund	The authors thank J. Noonan for discussions on this project, K. Cooper for experimental assistance and N. Carriero for read-mapping assistance and C. Tabin for providing us with the Hoxd12 probe. The authors are also grateful for the technical support for this project by the Yale Center for Genomic Analysis. The financial support by the Yale Science Development Fund is gratefully acknowledged.	Abellan A, 2009, J COMP NEUROL, V516, P166, DOI 10.1002/cne.22102; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Arendt D, 2008, NAT REV GENET, V9, P868, DOI 10.1038/nrg2416; AVEROF M, 1995, NATURE, V376, P420, DOI 10.1038/376420a0; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BURKE AC, 1995, DEVELOPMENT, V121, P333; Burke AC, 1997, SCIENCE, V278, P666, DOI 10.1126/science.278.5338.666; Cherbas L, 2011, GENOME RES, V21, P301, DOI 10.1101/gr.112961.110; Dahn RD, 2000, SCIENCE, V289, P438, DOI 10.1126/science.289.5478.438; Firulli BA, 2005, NAT GENET, V37, P373, DOI 10.1038/ng1525; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Hargrave Murray, 2006, Methods Mol Biol, V326, P103; Mansfield JH, 2010, J EXP ZOOL PART B, V314B, P629, DOI 10.1002/jez.b.21364; McMahon Ariel R, 2010, BMC Res Notes, V3, P167, DOI 10.1186/1756-0500-3-167; Montavon T, 2008, GENE DEV, V22, P346, DOI 10.1101/gad.1631708; Nelson CE, 1996, DEVELOPMENT, V122, P1449; Novershtern N, 2011, CELL, V144, P296, DOI 10.1016/j.cell.2011.01.004; Palmer C, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-115; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sugino K, 2006, NAT NEUROSCI, V9, P99, DOI 10.1038/nn1618; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Suzuki T, 2008, P NATL ACAD SCI USA, V105, P4185, DOI 10.1073/pnas.0707899105; Tamura K, 2011, SCIENCE, V331, P753, DOI 10.1126/science.1198229; Tickle C, 2006, NAT REV MOL CELL BIO, V7, P45, DOI 10.1038/nrm1830; Tzchori I, 2009, DEVELOPMENT, V136, P1375, DOI 10.1242/dev.026476; Uejima A, 2010, DEV GROWTH DIFFER, V52, P223, DOI 10.1111/j.1440-169X.2009.01161.x; Vargas AO, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003325; Vargas AO, 2005, J EXP ZOOL PART B, V304B, P86, DOI 10.1002/jez.b.21023; Wagner GP, 2005, THEOR BIOSCI, V124, P165, DOI 10.1016/j.thbio.2005.07.002; Wagner GP, 1999, P NATL ACAD SCI USA, V96, P5111, DOI 10.1073/pnas.96.9.5111; Wagner GP, 2007, NAT REV GENET, V8, P473, DOI 10.1038/nrg2099; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Welten MCM, 2005, EVOL DEV, V7, P18, DOI 10.1111/j.1525-142X.2005.05003.x; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Young RL, 2011, DEV DYNAM, V240, P1042, DOI 10.1002/dvdy.22595; Young RL, 2011, J EXP ZOOL PART B, V316B, P165, DOI 10.1002/jez.b.21396; Zhu LR, 2008, HUM MUTAT, V29, P99, DOI 10.1002/humu.20606	38	52	52	1	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 29	2011	477	7366					583	U345		10.1038/nature10391	http://dx.doi.org/10.1038/nature10391			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825ZM	21892187				2022-12-28	WOS:000295320900038
J	Halperin, E; Russell, AG; Trzesniewski, KH; Gross, JJ; Dweck, CS				Halperin, Eran; Russell, Alexandra G.; Trzesniewski, Kali H.; Gross, James J.; Dweck, Carol S.			Promoting the Middle East Peace Process by Changing Beliefs About Group Malleability	SCIENCE			English	Article							IMPLICIT THEORIES; ATTITUDES	Four studies showed that beliefs about whether groups have a malleable versus fixed nature affected intergroup attitudes and willingness to compromise for peace. Using a nationwide sample (N = 500) of Israeli Jews, the first study showed that a belief that groups were malleable predicted positive attitudes toward Palestinians, which in turn predicted willingness to compromise. In the remaining three studies, experimentally inducing malleable versus fixed beliefs about groups among Israeli Jews (N = 76), Palestinian citizens of Israel (N = 59), and Palestinians in the West Bank (N = 53)-without mentioning the adversary-led to more positive attitudes toward the outgroup and, in turn, increased willingness to compromise for peace.	[Russell, Alexandra G.; Gross, James J.; Dweck, Carol S.] Stanford Univ, Dept Psychol, Stanford, CA 94305 USA; [Halperin, Eran] Interdisciplinary Ctr Herzliya, Lauder Sch Govt Diplomacy & Strategy, IL-46150 Herzliyya, Israel; [Trzesniewski, Kali H.] Univ Calif Davis, Davis, CA 95616 USA	Stanford University; Reichman University; University of California System; University of California Davis	Dweck, CS (corresponding author), Stanford Univ, Dept Psychol, Stanford, CA 94305 USA.	dweck@stanford.edu	Trzesniewski, Kali H/D-3912-2009; Gross, James/AAM-4104-2020	Trzesniewski, Kali H/0000-0001-8165-3107; 	United States-Israel Educational Foundation	United States-Israel Educational Foundation	We thank S. Cohen-Chen, the Midgam Project Company, and the Jerusalem Media and Communication Center for their assistance in data collection for studies 3 and 4, and M. Mikulincer for his comments on early draft of this manuscript. Supported by a Fulbright-Yitzhak Rabin grant from the United States-Israel Educational Foundation (to E.H.).	Ajzen I, 2005, HANDBOOK OF ATTITUDES, P173; Alreshoud A, 1997, J SOC PSYCHOL, V137, P235, DOI 10.1080/00224549709595434; Bar-Tal D, 2009, REV EDUC RES, V79, P557, DOI 10.3102/0034654308330969; BARTAL D, 1990, J SOC ISSUES, V46, P65, DOI 10.1111/j.1540-4560.1990.tb00272.x; Chiu CY, 1997, J PERS SOC PSYCHOL, V73, P19, DOI 10.1037/0022-3514.73.1.19; Chiu CY, 1997, J PERS SOC PSYCHOL, V73, P923, DOI 10.1037/0022-3514.73.5.923; Haslam N, 2000, BRIT J SOC PSYCHOL, V39, P113, DOI 10.1348/014466600164363; Kelman HC, 2007, PEACEMAKING IN INTERNATIONAL CONFLICT: METHODS & TECHNIQUES, P61; KRAUS SJ, 1995, PERS SOC PSYCHOL B, V21, P58, DOI 10.1177/0146167295211007; Preacher KJ, 2007, MULTIVAR BEHAV RES, V42, P185, DOI 10.1080/00273170701341316; Rydell RJ, 2007, PERS SOC PSYCHOL B, V33, P549, DOI 10.1177/0146167206296956; SMOOHA S, 1992, ARABS JEWS ISRAEL	12	159	160	2	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 23	2011	333	6050					1767	1769		10.1126/science.1202925	http://dx.doi.org/10.1126/science.1202925			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	823KQ	21868627				2022-12-28	WOS:000295121500049
J	Gan, XC; Stegle, O; Behr, J; Steffen, JG; Drewe, P; Hildebrand, KL; Lyngsoe, R; Schultheiss, SJ; Osborne, EJ; Sreedharan, VT; Kahles, A; Bohnert, R; Jean, G; Derwent, P; Kersey, P; Belfield, EJ; Harberd, NP; Kemen, E; Toomajian, C; Kover, PX; Clark, RM; Ratsch, G; Mott, R				Gan, Xiangchao; Stegle, Oliver; Behr, Jonas; Steffen, Joshua G.; Drewe, Philipp; Hildebrand, Katie L.; Lyngsoe, Rune; Schultheiss, Sebastian J.; Osborne, Edward J.; Sreedharan, Vipin T.; Kahles, Andre; Bohnert, Regina; Jean, Geraldine; Derwent, Paul; Kersey, Paul; Belfield, Eric J.; Harberd, Nicholas P.; Kemen, Eric; Toomajian, Christopher; Kover, Paula X.; Clark, Richard M.; Raetsch, Gunnar; Mott, Richard			Multiple reference genomes and transcriptomes for Arabidopsis thaliana	NATURE			English	Article							GENETIC ARCHITECTURE; SEQUENCE; MAP; VERNALIZATION; ASSOCIATION; DIVERSITY; REVEALS; STRAINS; COMPLEX; MAIZE	Genetic differences between Arabidopsis thaliana accessions underlie the plant's extensive phenotypic variation, and until now these have been interpreted largely in the context of the annotated reference accession Col-0. Here we report the sequencing, assembly and annotation of the genomes of 18 natural A. thaliana accessions, and their transcriptomes. When assessed on the basis of the reference annotation, one-third of protein-coding genes are predicted to be disrupted in at least one accession. However, re-annotation of each genome revealed that alternative gene models often restore coding potential. Gene expression in seedlings differed for nearly half of expressed genes and was frequently associated with cis variants within 5 kilobases, as were intron retention alternative splicing events. Sequence and expression variation is most pronounced in genes that respond to the biotic environment. Our data further promote evolutionary and functional studies in A. thaliana, especially the MAGIC genetic reference population descended from these accessions.	[Gan, Xiangchao; Mott, Richard] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Stegle, Oliver] Max Planck Inst Intelligent Syst, D-72076 Tubingen, Germany; [Stegle, Oliver] Max Planck Inst Dev Biol, D-72076 Tubingen, Germany; [Behr, Jonas; Drewe, Philipp; Schultheiss, Sebastian J.; Sreedharan, Vipin T.; Kahles, Andre; Bohnert, Regina; Jean, Geraldine; Raetsch, Gunnar] Max Planck Gesell, Friedrich Miescher Lab, D-72076 Tubingen, Germany; [Steffen, Joshua G.; Osborne, Edward J.; Clark, Richard M.] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [Hildebrand, Katie L.; Toomajian, Christopher] Kansas State Univ, Dept Plant Pathol, Manhattan, KS 66506 USA; [Lyngsoe, Rune] Univ Oxford, Dept Stat, Oxford OX1 3TG, England; [Derwent, Paul; Kersey, Paul] European Bioinformat Inst, Cambridge CB10 1SD, England; [Belfield, Eric J.; Harberd, Nicholas P.] Univ Oxford, Dept Plant Sci, Oxford OX1 3RB, England; [Kemen, Eric] Sainsbury Lab, Norwich NR4 7UH, Norfolk, England; [Kover, Paula X.] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England	University of Oxford; Wellcome Centre for Human Genetics; Max Planck Society; Max Planck Society; Eberhard Karls University of Tubingen; Max Planck Society; Utah System of Higher Education; University of Utah; Kansas State University; University of Oxford; European Molecular Biology Laboratory (EMBL); University of Oxford; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University of Bath	Mott, R (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England.	toomajia@ksu.edu; p.x.kover@bath.ac.uk; clark@biology.utah.edu; Gunnar.Raetsch@tuebingen.mpg.de; richard.mott@well.ox.ac.uk	Rätsch, Gunnar/O-5914-2017; Kahles, Andre/ABB-8343-2020; Stegle, Oliver/AAU-9177-2020; Toomajian, Christopher/ABA-2615-2021	Rätsch, Gunnar/0000-0001-5486-8532; Kahles, Andre/0000-0002-3411-0692; Stegle, Oliver/0000-0002-8818-7193; Toomajian, Christopher/0000-0002-6763-0678; Mott, Richard/0000-0002-1022-9330; Steffen, JOSHUA/0000-0002-5345-5207; Kemen, Eric/0000-0002-7924-116X; Gan, Xiangchao/0000-0001-6398-5191; Boss, Philipp/0000-0002-5459-9771; Belfield, Eric/0000-0003-0892-100X; Kersey, Paul/0000-0002-7054-800X; Schultheiss, Sebastian J/0000-0001-8488-906X	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/F022697/1, BB/D016029/2, BB/F020759/1, BB/F019793/1]; Max Planck Society; German Research Foundation [RA1894/1-1, RA1894/2-1]; Volkswagen Stiftung; National Science Foundation (NSF) [0929262, 0820985]; King Abdullah University of Science and Technology (KAUST) [KUK-I1-002-03]; Wellcome Trust [090532/Z/09/Z]; BBSRC [BB/D016029/1, BB/D016029/2, BB/F020759/1, BB/F019793/1, BB/F022697/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F020759/1, BB/F022697/1, BB/D016029/1, BB/F019793/1, BB/D016029/2] Funding Source: researchfish; Direct For Biological Sciences [0929262] Funding Source: National Science Foundation; Div Of Biological Infrastructure [0820985] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007464] Funding Source: NIH RePORTER	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Max Planck Society(Max Planck SocietyFoundation CELLEX); German Research Foundation(German Research Foundation (DFG)); Volkswagen Stiftung(Volkswagen); National Science Foundation (NSF)(National Science Foundation (NSF)); King Abdullah University of Science and Technology (KAUST)(King Abdullah University of Science & Technology); Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. Jiang and C. Brown for technical help; P. Dikjwel, K. Schneeberger and D. Weigel for providing sequence data in advance of publication; and J. Flint, M. Tsiantis, E. Feil, L. Hurst, A. Wachter and D. Weigel for comments on the manuscript. Funding was provided by the Biotechnology and Biological Sciences Research Council (BBSRC) BB/F022697/1 (to R. M. and P. X. K.), BB/D016029/2 (to P. X. K and R. M.), BB/F020759/1 (to N.P.H.) and BB/F019793/1 to P. K. (PI E. Birney), by core funding of the Max Planck Society (to G. R.), the German Research Foundation RA1894/1-1 and RA1894/2-1 (to G. R.), Volkswagen Stiftung (to O.S.), the National Science Foundation (NSF) 0929262 (to R. C. and C. T.) and 0820985 (to R. C., Principal Investigator L. Sieburth), and award no. KUK-I1-002-03 (to N.P.H), made by King Abdullah University of Science and Technology (KAUST). D. Buck, I. Ragoussis and colleagues in the Wellcome Trust Centre for Human Genetics Genomics Core performed most of the genomic sequencing, supported by the Wellcome Trust Core grant 090532/Z/09/Z. Contribution no. 11-388-J from the Kansas Agricultural Experiment Station.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Cao J, 2011, NAT GENET, V43, P956, DOI 10.1038/ng.911; Clark RM, 2007, SCIENCE, V317, P338, DOI 10.1126/science.1138632; Durrant C, 2011, GENOME RES, V21, P1239, DOI 10.1101/gr.118786.110; Gagne JM, 2002, P NATL ACAD SCI USA, V99, P11519, DOI 10.1073/pnas.162339999; Gore MA, 2009, SCIENCE, V326, P1115, DOI 10.1126/science.1177837; Howe GA, 2008, ANNU REV PLANT BIOL, V59, P41, DOI 10.1146/annurev.arplant.59.032607.092825; Hu TT, 2011, NAT GENET, V43, P476, DOI 10.1038/ng.807; Jean Geraldine, 2010, Curr Protoc Bioinformatics, VChapter 11, DOI 10.1002/0471250953.bi1106s32; Johanson U, 2000, SCIENCE, V290, P344, DOI 10.1126/science.290.5490.344; Kaufmann K, 2005, GENE, V347, P183, DOI 10.1016/j.gene.2004.12.014; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Keane TM, 2011, NATURE, V477, P289, DOI 10.1038/nature10413; Keurentjes JJB, 2007, P NATL ACAD SCI USA, V104, P1708, DOI 10.1073/pnas.0610429104; Kover PX, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000551; Lai AG, 2011, GENOME BIOL EVOL, V3, P627, DOI 10.1093/gbe/evr038; Lempe J, 2005, PLOS GENET, V1, P109, DOI 10.1371/journal.pgen.0010006; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Lunter G, 2011, GENOME RES, V21, P936, DOI 10.1101/gr.111120.110; McMullen MD, 2009, SCIENCE, V325, P737, DOI 10.1126/science.1174320; Nordborg M, 2005, PLOS BIOL, V3, P1289, DOI 10.1371/journal.pbio.0030196; Ossowski S, 2008, GENOME RES, V18, P2024, DOI 10.1101/gr.080200.108; Plantegenet S, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.79; Ratcliffe OJ, 2003, PLANT CELL, V15, P1159, DOI 10.1105/tpc.009506; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Schneeberger K, 2011, P NATL ACAD SCI USA, V108, P10249, DOI 10.1073/pnas.1107739108; Schweikert G, 2009, GENOME RES, V19, P2133, DOI 10.1101/gr.090597.108; Sheldon CC, 1999, PLANT CELL, V11, P445, DOI 10.1105/tpc.11.3.445; Silverstein KAT, 2005, PLANT PHYSIOL, V138, P600, DOI 10.1104/pp.105.060079; Song YS, 2005, J COMPUT BIOL, V12, P147, DOI 10.1089/cmb.2005.12.147; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Weigel D, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-107; West MAL, 2007, GENETICS, V175, P1441, DOI 10.1534/genetics.106.064972; Zeller G, 2008, GENOME RES, V18, P918, DOI 10.1101/gr.070169.107; Zhang X, 2011, GENOME RES, V21, P725, DOI 10.1101/gr.115337.110	37	464	471	4	135	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 22	2011	477	7365					419	423		10.1038/nature10414	http://dx.doi.org/10.1038/nature10414			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822WH	21874022	Green Accepted, hybrid, Green Published			2022-12-28	WOS:000295080500031
J	Carlson, KJ; Stout, D; Jashashvili, T; de Ruiter, DJ; Tafforeau, P; Carlson, K; Berger, LR				Carlson, Kristian J.; Stout, Dietrich; Jashashvili, Tea; de Ruiter, Darryl J.; Tafforeau, Paul; Carlson, Keely; Berger, Lee R.			The Endocast of MH1, Australopithecus sediba	SCIENCE			English	Article							ORBITOFRONTAL CORTEX; BRAIN; EVOLUTION; ORGANIZATION; ASYMMETRY; AFRICANUS; REGION; HUMANS	The virtual endocast of MH1 (Australopithecus sediba), obtained from high-quality synchrotron scanning, reveals generally australopith-like convolutional patterns on the frontal lobes but also some foreshadowing of features of the human frontal lobes, such as posterior repositioning of the olfactory bulbs. Principal component analysis of orbitofrontal dimensions on australopith endocasts (MH1, Sts 5, and Sts 60) indicates that among these, MH1 orbitofrontal shape and organization align most closely with human endocasts. These results are consistent with gradual neural reorganization of the orbitofrontal region in the transition from Australopithecus to Homo, but given the small volume of the MH1 endocast, they are not consistent with gradual brain enlargement before the transition.	[Carlson, Kristian J.; Jashashvili, Tea; de Ruiter, Darryl J.; Berger, Lee R.] Univ Witwatersrand, Inst Human Evolut, Palaeosci Ctr, ZA-2050 Johannesburg, South Africa; [Carlson, Kristian J.] Indiana Univ, Dept Anthropol, Bloomington, IN 47405 USA; [Stout, Dietrich] Emory Univ, Dept Anthropol, Atlanta, GA 30322 USA; [Jashashvili, Tea] Georgian Natl Museum, GE-0105 Tbilisi, Georgia; [Jashashvili, Tea] Univ Zurich, Anthropol Inst & Museum, CH-8057 Zurich, Switzerland; [de Ruiter, Darryl J.; Carlson, Keely] Texas A&M Univ, Dept Anthropol, College Stn, TX 77843 USA; [Tafforeau, Paul] European Synchrotron Radiat Facil, F-38043 Grenoble, France; [Berger, Lee R.] Univ Witwatersrand, Sch Geosci, ZA-2050 Johannesburg, South Africa	University of Witwatersrand; Indiana University System; Indiana University Bloomington; Emory University; University of Zurich; Texas A&M University System; Texas A&M University College Station; European Synchrotron Radiation Facility (ESRF); University of Witwatersrand	Carlson, KJ (corresponding author), Univ Witwatersrand, Inst Human Evolut, Palaeosci Ctr, Private Bag 3, ZA-2050 Johannesburg, South Africa.	kristian.carlson@wits.ac.za	Berger, Lee Rogers/AAC-3484-2020	Berger, Lee Rogers/0000-0002-0367-7629; Tafforeau, Paul/0000-0002-5962-1683; Stout, Dietrich/0000-0003-3555-7637; de Ruiter, Darryl/0000-0003-1183-0352	South African Department of Science and Technology; South African National Research Foundation (particularly the African Origins Platform Initiative); Institute for Human Evolution (IHE); University of the Witwatersrand; National Geographic Society; Palaeontological Scientific Trust (PAST); Andrew W. Mellon Foundation; Ford Foundation; United States Diplomatic Mission to South Africa; French Embassy of South Africa; Research Office of the University of the Witwatersrand; Ray A. Rothrock '77 Fellowship; Texas AM University; Oppenheimer and Ackerman families; Sir Richard Branson; Claude Leon Foundation	South African Department of Science and Technology; South African National Research Foundation (particularly the African Origins Platform Initiative)(National Research Foundation - South Africa); Institute for Human Evolution (IHE); University of the Witwatersrand; National Geographic Society(National Geographic Society); Palaeontological Scientific Trust (PAST); Andrew W. Mellon Foundation; Ford Foundation; United States Diplomatic Mission to South Africa; French Embassy of South Africa; Research Office of the University of the Witwatersrand; Ray A. Rothrock '77 Fellowship; Texas AM University; Oppenheimer and Ackerman families; Sir Richard Branson; Claude Leon Foundation	We thank the South African Heritage Resource Agency for permits to work at the Malapa site; the Nash family for granting access to the Malapa site and their continued support of research on the Malapa and John Nash Nature Reserves; the South African Department of Science and Technology, the South African National Research Foundation (particularly the African Origins Platform Initiative), the Institute for Human Evolution (IHE), the University of the Witwatersrand, the University of the Witwatersrand's Vice Chancellor's Discretionary Fund, the National Geographic Society, the Palaeontological Scientific Trust (PAST), the Andrew W. Mellon Foundation, the Ford Foundation, the United States Diplomatic Mission to South Africa, the French Embassy of South Africa, the Research Office of the University of the Witwatersrand, the Ray A. Rothrock '77 Fellowship, the Program to Enhance Scholarly and Creative Activities, and International Research Travel Assistance Grant of Texas A&M University, the Oppenheimer and Ackerman families, and Sir Richard Branson for funding; the University of the Witwatersrand's Schools of Geosciences and Anatomical Sciences and the Bernard Price Institute for Palaeontology for support and facilities; the Gauteng Government, Gauteng Department of Agriculture, Conservation and Environment, and the Cradle of Humankind Management Authority; and our respective institutions for ongoing support. For access to comparative specimens, we thank S. Potze, L. Kgasi, and the Ditsong National Museum of Natural History; B. Billings, D. Lieberman and the Peabody Museum of Archeology and Ethnology (Harvard University); E. Mbua, P. Kiura, V. Iminjili, and the National Museums of Kenya; and the University of Zurich 2009 and 2010 Field Schools. Numerous individuals assisted with ongoing preparation and excavation of the Malapa fossils, including C. Dube, S. Jilah, C. Kemp, M. Kgasi, M. Languza, J. Malaza, G. Mokoma, P. Mukanela, T. Nemvhundi, M. Ngcamphalala, S. Tshabalala, and C. Yates. Other individuals, contributing substantial support to this project include L. Backwell, D. Conforti, B. de Klerk, C. Dlamini, V. Fernandez, J. Kretzen, B. Kuhn, W. Lawrence, B. Louw, B. Nkosi, M. Peltier, L. Pollarolo, C. Steininger, F. Thackeray, H. Visser, and B. Zipfel. T. J. also would like to thank the Claude Leon Foundation for awarding her a postdoctoral fellowship. We acknowledge the ESRF ID17 beamline team, and the ESRF for granting beamtime under proposal ec521. We thank Charlotte Maxeke Johannesburg Academic Hospital and J. Smilg for facilitating computed tomography (CT) scans and Q. Letsoalo for assistance in conducting them; D. Falk, R. Holloway, and R. Clarke for discussions on hominin fossils in South Africa; T. Preuss and J. Rilling for images and discussions of chimpanzee cortical anatomy; M. Dowdeswell for statistical guidance; S. Hurst for permitting use of CT data from Sts 60 and Sterkfontein Type 2 endocasts; and the editor and three anonymous reviewers for their comments. Image data of the MH1 cranium and endocast are curated in the IHE at the University of the Witwatersrand and at ESRF.	Amunts K, 1999, J COMP NEUROL, V412, P319, DOI 10.1002/(SICI)1096-9861(19990920)412:2<319::AID-CNE10>3.0.CO;2-7; Badre D, 2009, NAT REV NEUROSCI, V10, P659, DOI 10.1038/nrn2667; Bailey P, 1950, ISOCORTEX CHIMPANZEE; Bastir M, 2008, ANAT REC, V291, P130, DOI 10.1002/ar.20636; Bastir M, 2010, J HUM EVOL, V58, P424, DOI 10.1016/j.jhevol.2010.03.001; Berger LR, 2010, SCIENCE, V328, P195, DOI 10.1126/science.1184944; CLARK WE, 1936, J ROY ANTHROPOL INST, V66, P249; Connolly CJ, 1950, EXTERNAL MORPHOLOGY; CONROY GC, 1990, SCIENCE, V247, P838, DOI 10.1126/science.2305255; DARROCH JN, 1985, BIOMETRIKA, V72, P241, DOI 10.2307/2336077; Dart RA, 1925, NATURE, V115, P195, DOI 10.1038/115195a0; Falk D, 2005, SCIENCE, V308, P242, DOI 10.1126/science.1109727; FALK D, 1983, SCIENCE, V221, P1072, DOI 10.1126/science.221.4615.1072; Falk D, 2000, J HUM EVOL, V38, P695, DOI 10.1006/jhev.1999.0378; FALK D, 1980, AM J PHYS ANTHROPOL, V53, P525, DOI 10.1002/ajpa.1330530409; Falk D., 2011, PROGR BRAIN RES, V195; Falk D, 2007, AM J PHYS ANTHROPOL, V134, P529, DOI 10.1002/ajpa.20697; Falk D, 2009, YEARB PHYS ANTHROPOL, V52, P49, DOI 10.1002/ajpa.21184; Falk D, 2009, J HUM EVOL, V57, P597, DOI 10.1016/j.jhevol.2008.10.008; Fischl B, 2008, CEREB CORTEX, V18, P1973, DOI 10.1093/cercor/bhm225; Frey S, 2000, P NATL ACAD SCI USA, V97, P8723, DOI 10.1073/pnas.140543497; Holloway R., 2004, BRAIN ENDOCASTS PALE, V3; Holloway R L, 1983, Hum Neurobiol, V2, P105; HOLLOWAY RL, 1982, AM J PHYS ANTHROPOL, V58, P101, DOI 10.1002/ajpa.1330580111; HOLLOWAY RL, 1967, GEN SYST, V12, P3; Kibii JM, 2011, SCIENCE, V333, P1407, DOI 10.1126/science.1202521; Kivell TL, 2011, SCIENCE, V333, P1411, DOI 10.1126/science.1202625; Koechlin E, 2007, SCIENCE, V318, P594, DOI 10.1126/science.1142995; Kringelbach ML, 2004, PROG NEUROBIOL, V72, P341, DOI 10.1016/j.pneurobio.2004.03.006; LEMAY M, 1992, AM J NEURORADIOL, V13, P493; Lieberman DE, 2008, EVOL ANTHROPOL, V17, P55, DOI 10.1002/evan.20154; Pickering R, 2011, SCIENCE, V333, P1421, DOI 10.1126/science.1203697; Rilling JK, 2008, NAT NEUROSCI, V11, P426, DOI 10.1038/nn2072; Rilling JK, 2006, EVOL ANTHROPOL, V15, P65, DOI 10.1002/evan.20095; Schenker NM, 2010, CEREB CORTEX, V20, P730, DOI 10.1093/cercor/bhp138; Semendeferi K, 2001, AM J PHYS ANTHROPOL, V114, P224, DOI 10.1002/1096-8644(200103)114:3<224::AID-AJPA1022>3.3.CO;2-9; Semendeferi K, 1998, AM J PHYS ANTHROPOL, V106, P129, DOI 10.1002/(SICI)1096-8644(199806)106:2<129::AID-AJPA3>3.0.CO;2-L; Semendeferi K, 2011, CEREB CORTEX, V21, P1485, DOI 10.1093/cercor/bhq191; TOBIAS PV, 1987, J HUM EVOL, V16, P741, DOI 10.1016/0047-2484(87)90022-4; VanEssen DC, 1997, NATURE, V385, P313, DOI 10.1038/385313a0; Walker AE, 1936, J ANAT, V71, P105	41	115	119	0	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 9	2011	333	6048					1402	1407		10.1126/science.1203922	http://dx.doi.org/10.1126/science.1203922			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	817KU	21903804				2022-12-28	WOS:000294672200031
J	Lister, S				Lister, Sam			NHS REFORM The politics of NHS reconfiguration	BRITISH MEDICAL JOURNAL			English	Editorial Material									Times, London, England		Lister, S (corresponding author), Times, London, England.	Sam.Lister@thetimes.co.uk						GAINSBURY S, 2011, FINANCIAL TIMES 0715; LISTER S, 2011, TIMES           0617	2	2	2	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 7	2011	343								d5311	10.1136/bmj.d5311	http://dx.doi.org/10.1136/bmj.d5311			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	819RQ	21900346				2022-12-28	WOS:000294847800002
J	Obedin-Maliver, J; Goldsmith, ES; Stewart, L; White, W; Tran, E; Brenman, S; Wells, M; Fetterman, DM; Garcia, G; Lunn, MR				Obedin-Maliver, Juno; Goldsmith, Elizabeth S.; Stewart, Leslie; White, William; Tran, Eric; Brenman, Stephanie; Wells, Maggie; Fetterman, David M.; Garcia, Gabriel; Lunn, Mitchell R.			Lesbian, Gay, Bisexual, and Transgender-Related Content in Undergraduate Medical Education	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							UNITED-STATES; HEALTH; STUDENTS; HOMOSEXUALITY; ADOLESCENTS; IDENTITY; OUTCOMES; ADULTS; RISK; CARE	Context Lesbian, gay, bisexual, and transgender (LGBT) individuals experience health and health care disparities and have specific health care needs. Medical education organizations have called for LGBT-sensitive training, but how and to what extent schools educate students to deliver comprehensive LGBT patient care is unknown. Objectives To characterize LGBT-related medical curricula and associated curricular development practices and to determine deans' assessments of their institutions' LGBT-related curricular content. Design, Setting, and Participants Deans of medical education (or equivalent) at 176 allopathic or osteopathic medical schools in Canada and the United States were surveyed to complete a 13-question, Web-based questionnaire between May 2009 and March 2010. Main Outcome Measure Reported hours of LGBT-related curricular content. Results Of 176 schools, 150 (85.2%) responded, and 132 (75.0%) fully completed the questionnaire. The median reported time dedicated to teaching LGBT-related content in the entire curriculum was 5 hours (interquartile range [IQR], 3-8 hours). Of the 132 respondents, 9 (6.8%; 95% CI, 2.5%-11.1%) reported 0 hours taught during preclinical years and 44 (33.3%; 95% CI, 25.3%-41.4%) reported 0 hours during clinical years. Median US allopathic clinical hours were significantly different from US osteopathic clinical hours (2 hours [IQR, 0-4 hours] vs 0 hours [IQR, 0-2 hours]; P=.008). Although 128 of the schools (97.0%; 95% CI, 94.0%-99.9%) taught students to ask patients if they "have sex with men, women, or both" when obtaining a sexual history, the reported teaching frequency of 16 LGBT-specific topic areas in the required curriculum was lower: at least 8 topics at 83 schools (62.9%; 95% CI, 54.6%-71.1%) and all topics at 11 schools (8.3%; 95% CI, 3.6%-13.0%). The institutions' LGBT content was rated as "fair" at 58 schools (43.9%; 95% CI, 35.5%-52.4%). Suggested successful strategies to increase content included curricular material focusing on LGBT-related health and health disparities at 77 schools (58.3%, 95% CI, 49.9%-66.7%) and faculty willing and able to teach LGBT-related curricular content at 67 schools (50.8%, 95% CI, 42.2%-59.3%). Conclusion The median reported time dedicated to LGBT-related topics in 20092010 was small across US and Canadian medical schools, but the quantity, content covered, and perceived quality of instruction varied substantially. JAMA. 2011;306(9):971-977	[Lunn, Mitchell R.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Lunn, Mitchell R.] Harvard Univ, Sch Med, Boston, MA USA; [Obedin-Maliver, Juno; Goldsmith, Elizabeth S.; Stewart, Leslie; White, William; Tran, Eric; Brenman, Stephanie; Wells, Maggie; Fetterman, David M.; Garcia, Gabriel; Lunn, Mitchell R.] Stanford Univ, Sch Med, Lesbian Gay Bisexual & Transgender Med Educ Res G, Stanford, CA 94305 USA; [Garcia, Gabriel] Stanford Univ, Sch Med, Dept Med, Div Gastroenterol & Hepatol,Off MD Admiss, Stanford, CA 94305 USA; [Fetterman, David M.] Stanford Univ, Sch Med, Off Med Educ, Stanford, CA 94305 USA; [Obedin-Maliver, Juno] Univ Calif San Francisco, Med Ctr, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94143 USA; [Obedin-Maliver, Juno] Univ Calif San Francisco, Sch Med, San Francisco, CA 94143 USA; [Fetterman, David M.] Univ Arkansas Pine Bluff & Fetterman & Associates, San Jose, CA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Stanford University; Stanford University; Stanford University; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Lunn, MR (corresponding author), Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA.	mrlunn@partners.org	Garcia, Gabriel/GWZ-5540-2022	Lunn, Mitchell/0000-0002-0068-0814	Stanford University School of Medicine; Stanford University School of Medicine, Office of the Dean; Stanford University School of Medicine, Office of Diversity and Leadership; Haas Center for Public Service at Stanford University; Stanford University LGBT Community Resources Center	Stanford University School of Medicine; Stanford University School of Medicine, Office of the Dean; Stanford University School of Medicine, Office of Diversity and Leadership; Haas Center for Public Service at Stanford University; Stanford University LGBT Community Resources Center	This work was supported by Stanford University School of Medicine; Stanford University School of Medicine, Office of the Dean; Stanford University School of Medicine, Office of Diversity and Leadership; Haas Center for Public Service at Stanford University; and the Stanford University LGBT Community Resources Center. Drs Obedin-Maliver and Ms Brenman report receipt of support from the Stanford University School of Medicine Medical Scholars Fellowship Program.	Association of American Medical Colleges, 2007, JOINT AAMC GSA AAMC; Bostwick WB, 2010, AM J PUBLIC HEALTH, V100, P468, DOI 10.2105/AJPH.2008.152942; BRADBURN NM, 1978, PUBLIC OPIN QUART, V42, P221, DOI 10.1086/268444; Cohen-Kettenis PT, 2010, ARCH SEX BEHAV, V39, P499, DOI 10.1007/s10508-009-9562-y; Coker TR, 2010, ANNU REV PUBL HEALTH, V31, P457, DOI 10.1146/annurev.publhealth.012809.103636; [Committee on Lesbian Gay Bisexual and Transgender Health Issues and Research Gaps and Opportunities Board on the Health of Select Populations Institute of Medicine], 2011, HLTH LESB GAY BIS TR; Garofalo R, 2006, J ADOLESCENT HEALTH, V38, P230, DOI 10.1016/j.jadohealth.2005.03.023; *GAY LESB MED ASS, 2001, HLTH PEOPL 2010 COMP; Kelley L, 2008, TEACH LEARN MED, V20, P248, DOI 10.1080/10401330802199567; King M, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-127; Kulkin HS, 2007, J HOMOSEXUAL, V53, P71, DOI 10.1080/00918360802101385; Lindley LL, 2003, AIDS EDUC PREV, V15, P413, DOI 10.1521/aeap.15.6.413.24039; Marrazzo JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011139; Park Ina U, 2010, Curr Infect Dis Rep, V12, P126, DOI 10.1007/s11908-010-0090-7; Pathela P, 2006, ANN INTERN MED, V145, P416, DOI 10.7326/0003-4819-145-6-200609190-00005; Ryan C, 2009, PEDIATRICS, V123, P346, DOI 10.1542/peds.2007-3524; Saewye E., 2007, NOT YET EQUAL HLTH L; Sanchez NF, 2006, FAM MED, V38, P21; Smith DM, 2007, J HOMOSEXUAL, V52, P1, DOI 10.1300/J082v52n03_01; Tesar C M, 1998, Fam Med, V30, P283; The American Association for Public Opinion Research Standard Definitions, 2009, FIN DISP CAS COD OUT; WALLICK MM, 1992, ACAD MED, V67, P601, DOI 10.1097/00001888-199209000-00013	22	635	647	2	91	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 7	2011	306	9					971	977		10.1001/jama.2011.1255	http://dx.doi.org/10.1001/jama.2011.1255			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	815QT	21900137	Bronze			2022-12-28	WOS:000294542600015
J	Jahoda, CAB; Christiano, AM				Jahoda, Colin A. B.; Christiano, Angela M.			Niche Crosstalk: Intercellular Signals at the Hair Follicle	CELL			English	Review							STEM-CELLS; SKIN; ACTIVATION	A recent series of papers, including Festa et al. (2011) in this issue, has revealed unexpected interdependent relationships among cell populations residing in and around the hair follicle. These interactions between different lineages of stem cells are crucial for hair follicle growth and cycling and point to a complex crosstalk in stem cell niches.	[Jahoda, Colin A. B.] Univ Durham, Sch Biol & Biomed Sci, Durham DH1 3LE, England; [Christiano, Angela M.] Columbia Univ, Dept Dermatol, New York, NY 10032 USA; [Christiano, Angela M.] Columbia Univ, Dept Genet & Dev, New York, NY 10032 USA	Durham University; Columbia University; Columbia University	Jahoda, CAB (corresponding author), Univ Durham, Sch Biol & Biomed Sci, Durham DH1 3LE, England.	colin.jahoda@durham.ac.uk; amc65@columbia.edu		Jahoda, Colin/0000-0002-1762-1220	Medical Research Council [G1000846]; NYSTEM [SDH C024321]; NIH/NIAMS [R01AR47338, R01AR056016]; MRC [G1000846] Funding Source: UKRI; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056016, R01AR047338] Funding Source: NIH RePORTER	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NYSTEM; NIH/NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We are very grateful to Drs. Claire Higgins, Sivan Harel, and David Bickers for critical comments and help with manuscript preparation. We thank Mr. Brian Soda for expert help with the illustration. We apologize to the many authors whose work we have been unable to cite because of space limitations. C.A.B.J. is supported, in part, by the Medical Research Council, grant number G1000846, and A.M.C. is supported, in part, by NYSTEM grant number SDH C024321 and NIH/NIAMS grant R01AR47338 and R01AR056016.	Botchkarev VA, 1997, J COMP NEUROL, V386, P379, DOI 10.1002/(SICI)1096-9861(19970929)386:3<379::AID-CNE4>3.0.CO;2-Z; Brownell I, 2011, CELL STEM CELL, V8, P552, DOI 10.1016/j.stem.2011.02.021; BULLOUGH WS, 1962, NATURE, V193, P520, DOI 10.1038/193520a0; Christoph T, 2000, BRIT J DERMATOL, V142, P862, DOI 10.1046/j.1365-2133.2000.03464.x; Festa E, 2011, CELL, V146, P761, DOI 10.1016/j.cell.2011.07.019; Fuchs E, 2007, NATURE, V445, P834, DOI 10.1038/nature05659; Fujiwara H, 2011, CELL, V144, P577, DOI 10.1016/j.cell.2011.01.014; Kirilly D, 2007, CELL RES, V17, P15, DOI 10.1038/sj.cr.7310123; Leatherman JL, 2010, NAT CELL BIOL, V12, P806, DOI 10.1038/ncb2086; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Paus R, 2008, MOL CELL ENDOCRINOL, V288, P38, DOI 10.1016/j.mce.2008.02.023; Plikus MV, 2008, NATURE, V451, P340, DOI 10.1038/nature06457; Plikus MV, 2011, SCIENCE, V332, P586, DOI 10.1126/science.1201647; Rabbani P, 2011, CELL, V145, P941, DOI 10.1016/j.cell.2011.05.004; Reichelt J, 2007, EUR J CELL BIOL, V86, P807, DOI 10.1016/j.ejcb.2007.06.004; Sato N., 1999, J CLIN INVEST, V213, P173; Tanimura S, 2011, CELL STEM CELL, V8, P177, DOI 10.1016/j.stem.2010.11.029; Woo WM, 2011, CELL, V146, P334, DOI 10.1016/j.cell.2011.07.001	18	41	43	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 2	2011	146	5					678	681		10.1016/j.cell.2011.08.020	http://dx.doi.org/10.1016/j.cell.2011.08.020			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	814SM	21884930	Bronze			2022-12-28	WOS:000294477500009
J	Lepre, CJ; Roche, H; Kent, DV; Harmand, S; Quinn, RL; Brugal, JP; Texier, PJ; Lenoble, A; Feibel, CS				Lepre, Christopher J.; Roche, Helene; Kent, Dennis V.; Harmand, Sonia; Quinn, Rhonda L.; Brugal, Jean-Philippe; Texier, Pierre-Jean; Lenoble, Arnaud; Feibel, Craig S.			An earlier origin for the Acheulian	NATURE			English	Article							KOOBI-FORA-FORMATION; TURKANA-BASIN; EARLY HOMO; PLEISTOCENE; KENYA; AGE; MAGNETOSTRATIGRAPHY; GEOCHRONOLOGY	The Acheulian is one of the first defined prehistoric technocomplexes and is characterized by shaped bifacial stone tools(1-3). It probably originated in Africa, spreading to Europe and Asia perhaps as early as similar to 1 million years (Myr) ago(4-6). The origin of the Acheulian is thought to have closely coincided with major changes in human brain evolution, allowing for further technological developments(7,8). Nonetheless, the emergence of the Acheulian remains unclear because well-dated sites older than 1.4 Myr ago are scarce. Here we report on the lithic assemblage and geological context for the Kokiselei 4 archaeological site from the Nachukui formation (West Turkana, Kenya) that bears characteristic early Acheulian tools and pushes the first appearance datum for this stone-age technology back to 1.76 Myr ago. Moreover, co-occurrence of Oldowan and Acheulian artefacts at the Kokiselei site complex indicates that the two technologies are not mutually exclusive time-successive components of an evolving cultural lineage, and suggests that the Acheulian was either imported from another location yet to be identified or originated from Oldowan hominins at this vicinity. In either case, the Acheulian did not accompany the first human dispersal from Africa(9,10) despite being available at the time. This may indicate that multiple groups of hominins distinguished by separate stone-tool-making behaviours and dispersal strategies coexisted in Africa at 1.76 Myr ago.	[Lepre, Christopher J.; Kent, Dennis V.] Lamont Doherty Earth Observ, Palisades, NY 10964 USA; [Lepre, Christopher J.; Kent, Dennis V.; Quinn, Rhonda L.; Feibel, Craig S.] Rutgers State Univ, Dept Earth & Planetary Sci, Piscataway, NJ 08854 USA; [Roche, Helene; Harmand, Sonia] Univ Paris Ouest Nanterre, UMR CNRS 7055, F-92023 Nanterre, France; [Quinn, Rhonda L.] Seton Hall Univ, Dept Sociol Anthropol & Social Work, S Orange, NJ 07079 USA; [Brugal, Jean-Philippe] Maison Mediterraneenne Sci Homme, UMR CNRS 6636, F-13094 Aix En Provence 2, France; [Texier, Pierre-Jean; Lenoble, Arnaud] Univ Bordeaux 1, UMR CNRS PACEA 5199, F-33405 Talence, France	Columbia University; Rutgers State University New Brunswick; UDICE-French Research Universities; Universite Paris Saclay; Seton Hall University; UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux	Lepre, CJ (corresponding author), Lamont Doherty Earth Observ, Palisades, NY 10964 USA.	lepre@ldeo.columbia.edu	Harmand, Sonia/AAG-3874-2021	Harmand, Sonia/0000-0003-1765-6180; Quinn, Rhonda/0000-0003-2580-864X; Brugal, Jean-Philip/0000-0002-5138-3545; Lenoble, Arnaud/0000-0001-9023-9741; Lepre, Christopher/0000-0001-9930-9339; Kent, Dennis/0000-0002-7677-2993	French Ministry of Foreign Affairs; National Science Foundation [BCS 02-18511]	French Ministry of Foreign Affairs; National Science Foundation(National Science Foundation (NSF))	We thank the office of the President of Kenya and the National Museums of Kenya for permission to conduct this research, TOTAL Kenya for logistical support, and the WTAP team. Funding was provided by the French Ministry of Foreign Affairs and the National Science Foundation (BCS 02-18511 to C.S.F.). Lamont-Doherty Earth Observatory is acknowledged for ongoing support to the Paleomagnetics Laboratory.	ASFAW B, 1992, NATURE, V360, P732, DOI 10.1038/360732a0; Callow P., 1986, STONE AGE PREHISTORY, P243; CLEMENT BM, 1986, INITIAL REP DEEP SEA, V94, P831; Feibel CS, 1991, FOSSIL UNGULATES GEO, V3, P321; Gabunia L, 2000, SCIENCE, V288, P1019, DOI 10.1126/science.288.5468.1019; Goren-Inbar N, 2000, SCIENCE, V289, P944, DOI 10.1126/science.289.5481.944; Harmand S., 2009, LITHIC MAT PALEOLITH, P3, DOI DOI 10.1007/s10539-012-9308-4; Harris J.M., 1988, CONTRIBUTIONS SCI, V399, P1; ISAACS GL, 1974, NATURE, V249, P624, DOI 10.1038/249624a0; Kidane T, 2007, EARTH PLANET SC LETT, V262, P240, DOI 10.1016/j.epsl.2007.07.047; KIRSCHVINK JL, 1980, GEOPHYS J ROY ASTR S, V62, P699, DOI 10.1111/j.1365-246X.1980.tb02601.x; Klein R.G., 2009, HUMAN CAREER HUMAN B, V3rd; Leakey M. D., 1971, OLDUVAI GORGE EXCAVA; Lepre CJ, 2010, EARTH PLANET SC LETT, V290, P362, DOI 10.1016/j.epsl.2009.12.032; LOURENS L, 2004, GEOLOGIC TIME SCALE, P409, DOI DOI 10.1017/CBO9780511536045.022; McDougall I, 2006, J GEOL SOC LONDON, V163, P205, DOI 10.1144/0016-764904-166; McDougall I, 2008, J GEOL SOC LONDON, V165, P549, DOI 10.1144/0016-76492006-170; Ninkovich D., 1966, EARTH PLANET SC LETT, V1, P476, DOI [DOI 10.1016/0012-821X(66)90052-5, 10.1016/0012-821X(66)90052-5]; Pappu S, 2011, SCIENCE, V331, P1596, DOI 10.1126/science.1200183; Roberts AP, 2010, EARTH PLANET SC LETT, V292, P98, DOI 10.1016/j.epsl.2010.01.025; Roche H, 2003, CR PALEVOL, V2, P663, DOI 10.1016/j.crpv.2003.06.001; Scott GR, 2009, NATURE, V461, P82, DOI 10.1038/nature08214; Spoor F, 2007, NATURE, V448, P688, DOI 10.1038/nature05986; SWISHER CC, 1994, SCIENCE, V263, P1118, DOI 10.1126/science.8108729; TAUXE L, 1983, NATURE, V304, P125, DOI 10.1038/304125a0; Wood B., 1991, HOMINID CRANIAL REMA, V4; Zijderveld J. D. A., 1967, METHODS PALEOMAGNETI, P254, DOI DOI 10.1016/B978-1-4832-2894-5.50049-5; ZIJDERVELD JDA, 1991, EARTH PLANET SC LETT, V107, P697, DOI 10.1016/0012-821X(91)90112-U	28	283	294	1	72	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 1	2011	477	7362					82	85		10.1038/nature10372	http://dx.doi.org/10.1038/nature10372			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	813XT	21886161	Green Published			2022-12-28	WOS:000294404300035
J	Jenkins, DJA; Jones, PJH; Lamarche, B; Kendall, CWC; Faulkner, D; Cermakova, L; Gigleux, I; Ramprasath, V; de Souza, R; Ireland, C; Patel, D; Srichaikul, K; Abdulnour, S; Bashyam, B; Collier, C; Hoshizaki, S; Josse, RG; Leiter, LA; Connelly, PW; Frohlich, J				Jenkins, David J. A.; Jones, Peter J. H.; Lamarche, Benoit; Kendall, Cyril W. C.; Faulkner, Dorothea; Cermakova, Luba; Gigleux, Iris; Ramprasath, Vanu; de Souza, Russell; Ireland, Chris; Patel, Darshna; Srichaikul, Korbua; Abdulnour, Shahad; Bashyam, Balachandran; Collier, Cheryl; Hoshizaki, Sandy; Josse, Robert G.; Leiter, Lawrence A.; Connelly, Philip W.; Frohlich, Jiri			Effect of a Dietary Portfolio of Cholesterol-Lowering Foods Given at 2 Levels of Intensity of Dietary Advice on Serum Lipids in Hyperlipidemia A Randomized Controlled Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY-HEART-DISEASE; TREATMENT PANEL-III; CARDIOVASCULAR-DISEASE; WEIGHT-LOSS; BLOOD CHOLESTEROL; LOW-CARBOHYDRATE; NUT CONSUMPTION; PLANT STEROLS; RISK; WOMEN	Context Combining foods with recognized cholesterol-lowering properties (dietary portfolio) has proven highly effective in lowering serum cholesterol under metabolically controlled conditions. Objective To assess the effect of a dietary portfolio administered at 2 levels of intensity on percentage change in low-density lipoprotein cholesterol (LDL-C) among participants following self-selected diets. Design, Setting, and Participants A parallel-design study of 351 participants with hyperlipidemia from 4 participating academic centers across Canada (Quebec City, Toronto, Winnipeg, and Vancouver) randomized between June 25, 2007, and February 19, 2009, to 1 of 3 treatments lasting 6 months. Intervention Participants received dietary advice for 6 months on either a low-saturated fat therapeutic diet (control) or a dietary portfolio, for which counseling was delivered at different frequencies, that emphasized dietary incorporation of plant sterols, soy protein, viscous fibers, and nuts. Routine dietary portfolio involved 2 clinic visits over 6 months and intensive dietary portfolio involved 7 clinic visits over 6 months. Main Outcome Measures Percentage change in serum LDL-C. Results In the modified intention-to-treat analysis of 345 participants, the overall attrition rate was not significantly different between treatments (18% for intensive dietary portfolio, 23% for routine dietary portfolio, and 26% for control; Fisher exact test, P=.33). The LDL-C reductions from an overall mean of 171 mg/dL (95% confidence interval [CI], 168-174 mg/dL) were -13.8% (95% CI, -17.2% to -10.3%; P<.001) or -26 mg/dL (95% CI, -31 to -21 mg/dL; P<.001) for the intensive dietary portfolio; -13.1% (95% CI, -16.7% to -9.5%; P<.001) or -24 mg/dL (95% CI, -30 to -19 mg/dL; P<.001) for the routine dietary portfolio; and -3.0% (95% CI, -6.1% to 0.1%; P=.06) or -8 mg/dL (95% CI, -13 to -3 mg/dL; P=.002) for the control diet. Percentage LDL-C reductions for each dietary portfolio were significantly more than the control diet (P<.001, respectively). The 2 dietary portfolio interventions did not differ significantly (P=.66). Among participants randomized to one of the dietary portfolio interventions, percentage reduction in LDL-C on the dietary portfolio was associated with dietary adherence (r=-0.34, n=157, P<.001). Conclusion Use of a dietary portfolio compared with the low-saturated fat dietary advice resulted in greater LDL-C lowering during 6 months of follow-up.	[Jenkins, David J. A.; Kendall, Cyril W. C.; Faulkner, Dorothea; de Souza, Russell; Ireland, Chris; Patel, Darshna; Srichaikul, Korbua; Abdulnour, Shahad; Bashyam, Balachandran; Josse, Robert G.; Leiter, Lawrence A.] St Michaels Hosp, Clin Nutr & Risk Factor Modificat Ctr, Toronto, ON M5C 2T2, Canada; [Jenkins, David J. A.; Josse, Robert G.; Leiter, Lawrence A.] St Michaels Hosp, Dept Med, Toronto, ON M5C 2T2, Canada; [Jenkins, David J. A.; Kendall, Cyril W. C.; Faulkner, Dorothea; de Souza, Russell; Ireland, Chris; Patel, Darshna; Srichaikul, Korbua; Bashyam, Balachandran; Josse, Robert G.; Leiter, Lawrence A.] Univ Toronto, Dept Nutr Sci, Toronto, ON, Canada; [Jenkins, David J. A.; Jones, Peter J. H.; Leiter, Lawrence A.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Jones, Peter J. H.; Ramprasath, Vanu] Univ Manitoba, Richardson Ctr Funct Foods & Nutraceut, Winnipeg, MB, Canada; [Lamarche, Benoit; Gigleux, Iris] Univ Laval, Inst Nutraceut & Funct Foods, Quebec City, PQ, Canada; [Cermakova, Luba; Collier, Cheryl; Hoshizaki, Sandy; Frohlich, Jiri] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada; [de Souza, Russell] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Abdulnour, Shahad] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A1, Canada; [Jenkins, David J. A.; Josse, Robert G.; Leiter, Lawrence A.; Connelly, Philip W.] St Michaels Hosp, Keenan Res Ctr, Toronto, ON M5C 2T2, Canada; [Jenkins, David J. A.; Josse, Robert G.; Leiter, Lawrence A.; Connelly, Philip W.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON M5C 2T2, Canada	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; University of Manitoba; Laval University; University of British Columbia; McMaster University; University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto	Jenkins, DJA (corresponding author), St Michaels Hosp, Clin Nutr & Risk Factor Modificat Ctr, 61 Queen St E, Toronto, ON M5C 2T2, Canada.	cyril.kendall@utoronto.ca	Leiter, Lawrence/AAG-4059-2020; Lamarche, Benoit/ABA-4785-2021; de Souza, Russell J/ABB-7735-2021; Connelly, Philip W/B-7583-2012	Lamarche, Benoit/0000-0002-4443-5378; de Souza, Russell J/0000-0001-8945-513X; Connelly, Philip W/0000-0001-7244-6843; Jones, Peter/0000-0001-5887-2846	Loblaw Brands Ltd; Unilever; Barilla; Almond Board of California; Solae; Haine Celestial; Sanitarium Company; Orafti; International Tree Nut Council; Peanut Institute; Canadian Institutes of Health Research (CIHR); Canada Research Chair Endowment (CRCE) of the Federal Government of Canada; Advanced Foods and Materials Network (AFM Net); Danone; Enzymotec; CRCE of the Federal Government of Canada; Viterra Food Processing-Oat and Specialty Grain Milling; St Michael's Hospital Foundation; Unilever (Vlaardingen, the Netherlands); Unilever (Toronto, Ontario, Canada)	Loblaw Brands Ltd; Unilever(Unilever); Barilla; Almond Board of California; Solae; Haine Celestial; Sanitarium Company; Orafti; International Tree Nut Council; Peanut Institute; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canada Research Chair Endowment (CRCE) of the Federal Government of Canada; Advanced Foods and Materials Network (AFM Net); Danone(Danone Nutricia); Enzymotec; CRCE of the Federal Government of Canada; Viterra Food Processing-Oat and Specialty Grain Milling; St Michael's Hospital Foundation; Unilever (Vlaardingen, the Netherlands)(Netherlands Government); Unilever (Toronto, Ontario, Canada)(Unilever)	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Jenkins reported serving on the Scientific Advisory Board of Unilever, Sanitarium Company, California Strawberry Commission, Loblaw Supermarket, Herbal Life International, Nutritional Fundamental for Health, Pacific Health Laboratories, Metagenics, Bayer Consumer Care, Orafti, Dean Foods, Kellogg's, Quaker Oats, Procter & Gamble, Coca-Cola, NuVal Griffin Hospital, Abbott, Pulse Canada, Saskatchewan Pulse Growers, and Canola Council of Canada; receiving honoraria for scientific advice from the Almond Board of California, International Tree Nut Council Nutrition Research and Education Foundation, Barilla, Unilever Canada, Solae, Oldways, Kellogg's, Quaker Oats, Procter & Gamble, Coca-Cola, NuVal Griffin Hospital, Abbott, Canola Council of Canada, Dean Foods, California Strawberry Commission, Haine Celestial, and Alpro Foundation; being on the speakers panel for the Almond Board of California; receiving research grants from Loblaw Brands Ltd, Unilever, Barilla, Almond Board of California, Solae, Haine Celestial, Sanitarium Company, Orafti, International Tree Nut Council, and Peanut Institute; and receiving travel support to meetings from the Almond Board of California, Unilever, Alpro Foundation, and International Tree Nut Council. Dr Jenkins' wife is a director of Glycemic Index Laboratories, Toronto, Ontario, Canada, and his sister, Caroline Brydson, contributed to the diet booklet used in the study, which may in the future be expanded to book form for the general public. Dr Jones reported receiving grants from the Canadian Institutes of Health Research (CIHR), Canada Research Chair Endowment (CRCE) of the Federal Government of Canada, Advanced Foods and Materials Network (AFM Net), Danone, Enzymotec, and Unilever. Dr Jones also serves as president of Nutritional Fundamentals for Health Inc, which markets plant sterols among other nutraceuticals. Dr Lamarche reported receiving grants from CIHR and AFM Net, being a consultant and on speakers bureaus for Danone, and receiving royalties from Atrium Innovations. Dr Kendall reported being on speakers bureaus for Almond Board of California, Solae, and Unilever; and receiving research grants from CIHR, Unilever, Solae, Loblaw Brands Ltd, International Tree Nut Council, and Almond Board of California. Dr Faulkner reported receiving grants from CRCE of the Federal Government of Canada, CIHR, AFM Net, Loblaw Brands Ltd, Unilever, and Solae. Ms Cermakova reported receiving grants from CRCE of the Federal Government of Canada, CIHR, AFM Net, Loblaw Brands Ltd, Unilever, Solae, and Viterra Food Processing-Oat and Specialty Grain Milling. Dr Ramprasath reported receiving grants from CRCE of the Federal Government of Canada, CIHR, AFM Net, Loblaw Brands Ltd, Solae, and Unilever. Dr de Souza reported receiving grants from Coca-Cola, Calorie Control Council, and CIHR. Mr Ireland reported receiving grants from CRCE of the Federal Government of Canada, CIHR, AFM Net, Loblaw Brands Ltd, Solae, and Unilever. Ms Patel reported receiving grants from CRCE of the Federal Government of Canada, CIHR, AFM Net, Loblaw Brands Ltd, Solae, and Unilever. Dr Bashyam reported receiving grants from CIHR, CRCE of the Federal Government of Canada, AFM Net, Loblaw Brands Ltd, Solae, and Unilever. Ms Hoshizaki reported receiving grants from CRCE of the Federal Government of Canada, CIHR, AFM Net, Loblaw Brands Ltd, Unilever, and Solae. No other authors reported any financial disclosures.; This work was supported by the CRCE of the Federal Government of Canada (Drs Jenkins, Jones, and Lamarche), CIHR, AFM Net, Loblaw Brands Ltd, Solae (St Louis, Missouri), and Unilever (Vlaardingen, the Netherlands, and Toronto, Ontario, Canada). Unilever Research and Development provided the donation of margarines used in the study and Can-Oat Milling, a division of Viterra Inc (Portage La Prairie, Manitoba, Canada), provided the generous donation of HiFi medium oat bran used for the study breads and funding for freezer acquisition. St Michael's Hospital Foundation provided funding for the production of the study booklet.	Abumweis SS, 2008, FOOD NUTR RES, V52, DOI [10.3402/fnr.v3452i3400.1811, DOI 10.3402/FNR.V3452I3400.1811]; ANDERSON JW, 1995, NEW ENGL J MED, V333, P276, DOI 10.1056/NEJM199508033330502; Anderson JW, 2000, AM J CLIN NUTR, V71, P472; ANDERSON KM, 1991, CIRCULATION, V83, P356, DOI 10.1161/01.CIR.83.1.356; [Anonymous], 2008, SAS STAT US GUID; Appel LJ, 2005, JAMA-J AM MED ASSOC, V294, P2455, DOI 10.1001/jama.294.19.2455; BETTERIDGE DJ, 1993, POSTGRAD MED J, V69, P359, DOI 10.1136/pgmj.69.811.359; Brown L, 1999, AM J CLIN NUTR, V69, P30; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Dansinger ML, 2005, JAMA-J AM MED ASSOC, V293, P43, DOI 10.1001/jama.293.1.43; DAYTON S, 1969, CIRCULATION, V40, pII1; FINK PC, 1989, J CLIN CHEM CLIN BIO, V27, P261; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Genest J, 2009, CAN J CARDIOL, V25, P567, DOI 10.1016/S0828-282X(09)70715-9; Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E; Halton TL, 2006, NEW ENGL J MED, V355, P1991, DOI 10.1056/NEJMoa055317; Harsha DW, 2004, HYPERTENSION, V43, P393, DOI 10.1161/01.HYP.0000113046.83819.a2; Hu FB, 1998, BMJ-BRIT MED J, V317, P1341, DOI 10.1136/bmj.317.7169.1341; Huang JB, 2011, CAN J CARDIOL, V27, P488, DOI 10.1016/j.cjca.2010.12.077; Jenkins DJA, 2010, J NUTR, V140, p2302S, DOI 10.3945/jn.110.124958; Jenkins DJA, 2005, AM J CLIN NUTR, V81, P380; Jenkins DJA, 2003, JAMA-J AM MED ASSOC, V290, P502, DOI 10.1001/jama.290.4.502; Jenkins DJA, 1999, J AM COLL NUTR, V18, P559, DOI 10.1080/07315724.1999.10718889; Kassis AN, 2008, METABOLISM, V57, P339, DOI 10.1016/j.metabol.2007.10.008; Katan MB, 2003, MAYO CLIN PROC, V78, P965, DOI 10.4065/78.8.965; Kris-Etherton PM, 1999, AM J CLIN NUTR, V70, p504S, DOI 10.1093/ajcn/70.3.504s; Liu SM, 2002, J AM COLL CARDIOL, V39, P49, DOI 10.1016/S0735-1097(01)01695-3; Ludwig DS, 2002, JAMA-J AM MED ASSOC, V287, P2414, DOI 10.1001/jama.287.18.2414; MIETTINEN M, 1972, LANCET, V2, P835; Mills EJ, 2011, QJM-INT J MED, V104, P109, DOI 10.1093/qjmed/hcq165; Ornish D, 1998, JAMA-J AM MED ASSOC, V280, P2001, DOI 10.1001/jama.280.23.2001; Sabate J, 2010, ARCH INTERN MED, V170, P821, DOI 10.1001/archinternmed.2010.79; Sacks FM, 2009, NEW ENGL J MED, V360, P859, DOI 10.1056/NEJMoa0804748; Shai I, 2008, NEW ENGL J MED, V359, P229, DOI 10.1056/NEJMoa0708681; TURPEINEN O, 1979, CIRCULATION, V59, P1; Wolk A, 1999, JAMA-J AM MED ASSOC, V281, P1998, DOI 10.1001/jama.281.21.1998; WOOLEY SC, 1994, BMJ-BRIT MED J, V309, P655; Zhang XL, 2003, J NUTR, V133, P2874, DOI 10.1093/jn/133.9.2874	38	137	140	2	27	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 24	2011	306	8					831	839		10.1001/jama.2011.1202	http://dx.doi.org/10.1001/jama.2011.1202			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	810VY	21862744	Bronze			2022-12-28	WOS:000294157300020
J	Schmermund, A; Voigtlander, T				Schmermund, Axel; Voigtlaender, Thomas			Predictive ability of coronary artery calcium and CRP	LANCET			English	Editorial Material							C-REACTIVE PROTEIN; BEAM COMPUTED-TOMOGRAPHY; HEART-DISEASE; RISK; EVENTS; ATHEROSCLEROSIS; QUANTIFICATION; MORTALITY		[Schmermund, Axel; Voigtlaender, Thomas] CCB, D-60389 Frankfurt, Germany		Schmermund, A (corresponding author), CCB, Prufling 23, D-60389 Frankfurt, Germany.	a.schmermund@ccb.de						Arad Y, 2005, J AM COLL CARDIOL, V46, P166, DOI 10.1016/j.jacc.2005.02.089; Blaha MJ, 2011, LANCET, V378, P684, DOI 10.1016/S0140-6736(11)60784-8; Chang MK, 2002, P NATL ACAD SCI USA, V99, P13043, DOI 10.1073/pnas.192399699; Detrano R, 2008, NEW ENGL J MED, V358, P1336, DOI 10.1056/NEJMoa072100; Erbel R, 2010, J AM COLL CARDIOL, V56, P1397, DOI 10.1016/j.jacc.2010.06.030; Ford ES, 2009, CIRCULATION, V120, P1181, DOI 10.1161/CIRCULATIONAHA.108.835728; Greenland P, 2007, J AM COLL CARDIOL, V49, P378, DOI 10.1016/j.jacc.2006.10.001; Kaptoge S, 2010, LANCET, V375, P132, DOI 10.1016/S0140-6736(09)61717-7; Mohlenkamp S, 2011, J AM COLL CARDIOL, V57, P1455, DOI 10.1016/j.jacc.2010.10.043; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; RUMBERGER JA, 1995, CIRCULATION, V92, P2157, DOI 10.1161/01.CIR.92.8.2157; Schmermund A, 1997, CIRCULATION, V96, P1461, DOI 10.1161/01.CIR.96.5.1461; Wensley F, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d548; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837	14	6	7	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 20	2011	378	9792					641	643		10.1016/S0140-6736(11)61129-X	http://dx.doi.org/10.1016/S0140-6736(11)61129-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	815EW	21856466				2022-12-28	WOS:000294509900005
J	Tsivion, D; Schvartzman, M; Popovitz-Biro, R; von Huth, P; Joselevich, E				Tsivion, David; Schvartzman, Mark; Popovitz-Biro, Ronit; von Huth, Palle; Joselevich, Ernesto			Guided Growth of Millimeter-Long Horizontal Nanowires with Controlled Orientations	SCIENCE			English	Article							SINGLE; ARRAYS; GAN; ELECTRONICS; PHOTONICS; ALIGNMENT; NETWORKS; DEVICES; SILICON; BOTTOM	The large-scale assembly of nanowires with controlled orientation on surfaces remains one challenge preventing their integration into practical devices. We report the vapor-liquid-solid growth of aligned, millimeter-long, horizontal GaN nanowires with controlled crystallographic orientations on different planes of sapphire. The growth directions, crystallographic orientation, and faceting of the nanowires vary with each surface orientation, as determined by their epitaxial relationship with the substrate, as well as by a graphoepitaxial effect that guides their growth along surface steps and grooves. Despite their interaction with the surface, these horizontally grown nanowires display few structural defects, exhibiting optical and electronic properties comparable to those of vertically grown nanowires. This paves the way to highly controlled nanowire structures with potential applications not available by other means.	[Tsivion, David; Schvartzman, Mark; Joselevich, Ernesto] Weizmann Inst Sci, Dept Mat & Interfaces, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Joselevich, E (corresponding author), Weizmann Inst Sci, Dept Mat & Interfaces, IL-76100 Rehovot, Israel.	ernesto.joselevich@weizmann.ac.il		Schvartzman, Mark/0000-0002-5912-525X; Joselevich, Ernesto/0000-0002-9919-0734	Israel Science Foundation; Kimmel Center for Nanoscale Science; Moskowitz Center for Nano and Bio-Nano Imaging; Djanogly Foundation; Alhadeff Foundation; Perlman Foundation	Israel Science Foundation(Israel Science Foundation); Kimmel Center for Nanoscale Science; Moskowitz Center for Nano and Bio-Nano Imaging; Djanogly Foundation; Alhadeff Foundation; Perlman Foundation	We thank L. Zeiri for assistance in PL measurements; M. Bar-Sadan and L. Houben for assistance with TEM simulations; and W. D. Kaplan, M. Baram, H. Meltzman, R. Tenne, and L. Kronik for helpful discussions and critical comments. Supported by the Israel Science Foundation, Kimmel Center for Nanoscale Science, Moskowitz Center for Nano and Bio-Nano Imaging, and the Djanogly, Alhadeff, and Perlman foundations.	Choi JH, 1997, J AM CERAM SOC, V80, P62, DOI 10.1111/j.1151-2916.1997.tb02791.x; Cui Y, 2001, SCIENCE, V293, P1289, DOI 10.1126/science.1062711; Fan ZY, 2008, NANO LETT, V8, P20, DOI 10.1021/nl071626r; Fortuna SA, 2008, NANO LETT, V8, P4421, DOI 10.1021/nl802331m; Gabai R, 2007, ADV MATER, V19, P1325, DOI 10.1002/adma.200601625; GEIS MW, 1979, APPL PHYS LETT, V35, P71, DOI 10.1063/1.90936; Gudiksen MS, 2002, NATURE, V415, P617, DOI 10.1038/415617a; Hochbaum AI, 2010, CHEM REV, V110, P527, DOI 10.1021/cr900075v; Huang Y, 2001, SCIENCE, V291, P630, DOI 10.1126/science.291.5504.630; Huang Y, 2002, NANO LETT, V2, P101, DOI 10.1021/nl015667d; Ismach A, 2004, ANGEW CHEM INT EDIT, V43, P6140, DOI 10.1002/anie.200460356; Ismach A, 2005, J AM CHEM SOC, V127, P11554, DOI 10.1021/ja052759m; Jin S, 2004, NANO LETT, V4, P915, DOI 10.1021/nl049659j; Kang SJ, 2007, NAT NANOTECHNOL, V2, P230, DOI 10.1038/nnano.2007.77; Kempa TJ, 2008, NANO LETT, V8, P3456, DOI 10.1021/nl8023438; Kuykendall T, 2004, NAT MATER, V3, P524, DOI 10.1038/nmat1177; Kuykendall T, 2003, NANO LETT, V3, P1063, DOI 10.1021/nl034422t; Lu W, 2007, NAT MATER, V6, P841, DOI 10.1038/nmat2028; MARUSKA HP, 1969, APPL PHYS LETT, V15, P327, DOI 10.1063/1.1652845; Morkoc H, 2008, HDB NITRIDE SEMICOND, V1; Nikoobakht B, 2004, APPL PHYS LETT, V85, P3244, DOI 10.1063/1.1803951; Schlager JB, 2008, J APPL PHYS, V103, DOI 10.1063/1.2940732; Schwarz KW, 2011, NANO LETT, V11, P316, DOI 10.1021/nl1027815; Smith PA, 2000, APPL PHYS LETT, V77, P1399, DOI 10.1063/1.1290272; WAGNER RS, 1964, APPL PHYS LETT, V4, P89, DOI 10.1063/1.1753975; Waltereit P, 2000, NATURE, V406, P865, DOI 10.1038/35022529; Wu Z, 2009, J MATER CHEM, V19, P463, DOI 10.1039/b816064c; Yan RX, 2009, NAT PHOTONICS, V3, P569, DOI 10.1038/NPHOTON.2009.184; Yang C, 2005, SCIENCE, V310, P1304, DOI 10.1126/science.1118798; Yang PD, 2010, NANO LETT, V10, P1529, DOI 10.1021/nl100665r	30	203	207	11	250	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 19	2011	333	6045					1003	1007		10.1126/science.1208455	http://dx.doi.org/10.1126/science.1208455			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808TD	21852496				2022-12-28	WOS:000294000400052
J	Benz, EJ; Wu, CC; Sohani, AR				Benz, Edward J.; Wu, Carol C.; Sohani, Aliyah R.			A Woman with Anemia and Paraspinal Masses Thalassemia (hemoglobin H disease) with extramedullary hematopoiesis.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							VITAMIN-D DEFICIENCY; PREVALENCE		[Benz, Edward J.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Wu, Carol C.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Sohani, Aliyah R.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Benz, Edward J.] Harvard Univ, Sch Med, Dept Med Pediat & Genet, Boston, MA USA; [Wu, Carol C.] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Sohani, Aliyah R.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Benz, EJ (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.							Bain BJ, 2006, HAEMOGLOBINOPATHY DIAGNOSIS, 2ND EDITION, P1, DOI 10.1002/9780470988787; Chourmouzi D, 2001, EUR RADIOL, V11, P1803, DOI 10.1007/s003300000802; Chui DHK, 2003, BLOOD, V101, P791, DOI 10.1182/blood-2002-07-1975; Goodman BM, 2010, J NATL MED ASSOC, V102, P332, DOI 10.1016/S0027-9684(15)30605-2; Harteveld CL, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-13; Koumbourlis AC, 2001, J PEDIATR-US, V138, P188, DOI 10.1067/mpd.2001.111824; Litonjua AA, 2007, J ALLERGY CLIN IMMUN, V120, P1031, DOI 10.1016/j.jaci.2007.08.028; Marks PW, 2009, HEMATOLOGY BASIC PRI, V455-63; MENTZER WC, 1973, LANCET, V1, P882; ORKIN SH, 1982, NATURE, V300, P768, DOI 10.1038/300768a0; Steensma DP, 2005, BLOOD, V105, P443, DOI 10.1182/blood-2004-07-2792; Vendramini EC, 2006, AM J MED SCI, V332, P68, DOI 10.1097/00000441-200608000-00003; Weatherall DJ, 1996, NAT MED, V2, P847, DOI 10.1038/nm0896-847; Wu JM, 2005, DIAGN CYTOPATHOL, V33, P157, DOI 10.1002/dc.20319	14	2	2	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 18	2011	365	7					648	658		10.1056/NEJMcpc1013925	http://dx.doi.org/10.1056/NEJMcpc1013925			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	808ER	21848466				2022-12-28	WOS:000293960500014
J	Makinen, N; Mehine, M; Tolvanen, J; Kaasinen, E; Li, YL; Lehtonen, HJ; Gentile, M; Yan, J; Enge, M; Taipale, M; Aavikko, M; Katainen, R; Virolainen, E; Bohling, T; Koski, TA; Launonen, V; Sjoberg, J; Taipale, J; Vahteristo, P; Aaltonen, LA				Makinen, Netta; Mehine, Miika; Tolvanen, Jaana; Kaasinen, Eevi; Li, Yilong; Lehtonen, Heli J.; Gentile, Massimiliano; Yan, Jian; Enge, Martin; Taipale, Minna; Aavikko, Mervi; Katainen, Riku; Virolainen, Elina; Bohling, Tom; Koski, Taru A.; Launonen, Virpi; Sjoberg, Jari; Taipale, Jussi; Vahteristo, Pia; Aaltonen, Lauri A.			MED12, the Mediator Complex Subunit 12 Gene, Is Mutated at High Frequency in Uterine Leiomyomas	SCIENCE			English	Article							FG SYNDROME; MEDIATOR; ETIOLOGY; FEATURES; COMPLEX	Uterine leiomyomas, or fibroids, are benign tumors that affect millions of women worldwide and that can cause considerable morbidity. To study the genetic basis of this tumor type, we examined 18 uterine leiomyomas derived from 17 different patients by exome sequencing and identified tumor-specific mutations in the mediator complex subunit 12 (MED12) gene in 10. Through analysis of 207 additional tumors, we determined that MED12 is altered in 70% (159 of 225) of tumors from a total of 80 patients. The Mediator complex is a 26-subunit transcriptional regulator that bridges DNA regulatory sequences to the RNA polymerase II initiation complex. All mutations resided in exon 2, suggesting that aberrant function of this region of MED12 contributes to tumorigenesis.	[Makinen, Netta; Mehine, Miika; Tolvanen, Jaana; Kaasinen, Eevi; Li, Yilong; Lehtonen, Heli J.; Taipale, Minna; Aavikko, Mervi; Katainen, Riku; Koski, Taru A.; Launonen, Virpi; Taipale, Jussi; Vahteristo, Pia; Aaltonen, Lauri A.] Univ Helsinki, Genome Scale Biol Res Program, Dept Med Genet, FIN-00014 Helsinki, Finland; [Gentile, Massimiliano] Ctr Sci Ltd, Espoo 02101, Finland; [Yan, Jian; Enge, Martin; Taipale, Minna; Taipale, Jussi] Karolinska Inst, Sci Life Lab, Dept Biosci & Nutr, S-14183 Stockholm, Sweden; [Virolainen, Elina; Bohling, Tom] Univ Helsinki, Haartman Inst, Dept Pathol, FIN-00014 Helsinki, Finland; [Bohling, Tom] Helsinki Univ Cent Hosp, Lab Hosp Dist Helsinki & Uusimaa, Helsinki 00029, Finland; [Sjoberg, Jari] Helsinki Univ Cent Hosp, Dept Obstet & Gynecol, Helsinki 00029, Finland	University of Helsinki; Karolinska Institutet; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital	Aaltonen, LA (corresponding author), Univ Helsinki, Genome Scale Biol Res Program, Dept Med Genet, FIN-00014 Helsinki, Finland.	lauri.aaltonen@helsinki.fi	Aaltonen, Lauri/A-5375-2010; Enge, Martin/GYQ-5073-2022; Gentile, Massimo/R-3270-2016; Katainen, Riku/GYR-0921-2022; Yan, Jian/B-2631-2018; Kaukomaa, Jaana/G-1040-2016	Aaltonen, Lauri/0000-0001-6839-4286; Gentile, Massimo/0000-0002-5256-0726; Yan, Jian/0000-0002-1267-2870; Katainen, Riku/0000-0003-4575-4239; Enge, Martin/0000-0001-8748-8931; Taipale, Minna/0000-0002-1905-2551; Kaukomaa, Jaana/0000-0003-1183-4943; Makinen, Netta/0000-0003-0104-7794; Kaasinen, Eevi/0000-0002-1333-8049	Academy of Finland (Center of Excellence in Translational Genome-Scale Biology) [6302352, 1124270, 212901, 214323]; European Commission [2005-518200]; GENICA Genomic Instability in Cancer and Precancer [201630]; Sigrid Juselius Foundation; Cancer Society of Finland	Academy of Finland (Center of Excellence in Translational Genome-Scale Biology)(Academy of Finland); European Commission(European CommissionEuropean Commission Joint Research Centre); GENICA Genomic Instability in Cancer and Precancer; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Cancer Society of Finland	We thank S. Nieminen, I.-L. Svedberg, M. Kuris, and I. Vuoristo for technical assistance. This work was supported by grants from the Academy of Finland (Center of Excellence in Translational Genome-Scale Biology grant 6302352, and grants 1124270, 212901, and 214323), European Commission Projects TCAC in Cancer (project number 2005-518200) and GENICA Genomic Instability in Cancer and Precancer (project number 201630), Sigrid Juselius Foundation, and the Cancer Society of Finland. Primer sequences are provided in the Supporting Online Material. The gene expression data presented have been deposited in the Gene Expression Omnibus database (www.ncbi.nlm.nih.gov/geo) and are accessible with the accession number GSE30673.	Akoulitchev S, 2000, NATURE, V407, P102, DOI 10.1038/35024111; Borggrefe T, 2002, J BIOL CHEM, V277, P44202, DOI 10.1074/jbc.M207195200; Bourbon HM, 2008, NUCLEIC ACIDS RES, V36, P3993, DOI 10.1093/nar/gkn349; Chen GL, 2007, BLOOD, V110, P1410, DOI 10.1182/blood-2006-09-018655; Donner AJ, 2007, MOL CELL, V27, P121, DOI 10.1016/j.molcel.2007.05.026; Elmlund H, 2006, P NATL ACAD SCI USA, V103, P15788, DOI 10.1073/pnas.0607483103; Graham JM, 2010, AM J MED GENET C, V154C, P477, DOI 10.1002/ajmg.c.30284; Harper PS, 2011, HUM GENET, V130, P169, DOI 10.1007/s00439-011-1013-x; Hennig Y, 1996, MOL HUM REPROD, V2, P277, DOI 10.1093/molehr/2.4.277; Jacoby VL, 2009, OBSTET GYNECOL, V114, P1041, DOI 10.1097/AOG.0b013e3181b9d222; Kim S, 2006, J BIOL CHEM, V281, P14066, DOI 10.1074/jbc.M602696200; Malik S, 2000, TRENDS BIOCHEM SCI, V25, P277, DOI 10.1016/S0968-0004(00)01596-6; Okolo S, 2008, BEST PRACT RES CL OB, V22, P571, DOI 10.1016/j.bpobgyn.2008.04.002; Parker WH, 2007, FERTIL STERIL, V87, P725, DOI 10.1016/j.fertnstert.2007.01.093; Rocha PP, 2010, DEVELOPMENT, V137, P2723, DOI 10.1242/dev.053660; Rump P, 2011, CLIN GENET, V79, P183, DOI 10.1111/j.1399-0004.2010.01449.x; Schwartz CE, 2007, J MED GENET, V44, P472, DOI 10.1136/jmg.2006.048637; Stewart EA, 2001, LANCET, V357, P293, DOI 10.1016/S0140-6736(00)03622-9; Taatjes DJ, 2002, SCIENCE, V295, P1058, DOI 10.1126/science.1065249; Taatjes DJ, 2010, TRENDS BIOCHEM SCI, V35, P315, DOI 10.1016/j.tibs.2010.02.004; Takagi Y, 2006, J BIOL CHEM, V281, P80, DOI 10.1074/jbc.M508253200; Velagaleti GVN, 2010, CANCER GENET CYTOGEN, V202, P11, DOI 10.1016/j.cancergencyto.2010.06.002; Wallach EE, 2004, OBSTET GYNECOL, V104, P393, DOI 10.1097/01.AOG.0000136079.62513.39; Zhou HY, 2006, MOL CELL BIOL, V26, P8667, DOI 10.1128/MCB.00443-06	24	414	435	0	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 14	2011	334	6053					252	255		10.1126/science.1208930	http://dx.doi.org/10.1126/science.1208930			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832UI	21868628				2022-12-28	WOS:000295833600054
J	Lovibond, K; Jowett, S; Barton, P; Caulfield, M; Heneghan, C; Hobbs, FDR; Hodgkinson, J; Mant, J; Martin, U; Williams, B; Wonderling, D; McManus, RJ				Lovibond, Kate; Jowett, Sue; Barton, Pelham; Caulfield, Mark; Heneghan, Carl; Hobbs, F. D. Richard; Hodgkinson, James; Mant, Jonathan; Martin, Una; Williams, Bryan; Wonderling, David; McManus, Richard J.			Cost-effectiveness of options for the diagnosis of high blood pressure in primary care: a modelling study	LANCET			English	Article							TARGET ORGAN DAMAGE; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; GENERAL-POPULATION; HYPERTENSION; HOME; MORTALITY; STROKE; RISK; GUIDELINES	Background The diagnosis of hypertension has traditionally been based on blood-pressure measurements in the clinic, but home and ambulatory measurements better correlate with cardiovascular outcome, and ambulatory monitoring is more accurate than both clinic and home monitoring in diagnosing hypertension. We aimed to compare the cost-effectiveness of different diagnostic strategies for hypertension. Methods We did a Markov model-based probabilistic cost-effectiveness analysis. We used a hypothetical primary-care population aged 40 years or older with a screening blood-pressure measurement greater than 140/90 mm Hg and risk-factor prevalence equivalent to the general population. We compared three diagnostic strategies-further blood pressure measurement in the clinic, at home, and with an ambulatory monitor-in terms of lifetime costs, quality-adjusted life years, and cost-effectiveness. Findings Ambulatory monitoring was the most cost-effective strategy for the diagnosis of hypertension for men and women of all ages. It was cost-saving for all groups (from -56 pound [95% CI -105 to -10] in men aged 75 years to -323 pound [-389 to -222] in women aged 40 years) and resulted in more quality-adjusted life years for men and women older than 50 years (from 0.006 [0.000 to 0.015] for women aged 60 years to 0.022 [0.012 to 0.035] for men aged 70 years). This finding was robust when assessed with a wide range of deterministic sensitivity analyses around the base case, but was sensitive if home monitoring was judged to have equal test performance to ambulatory monitoring or if treatment was judged effective irrespective of whether an individual was hypertensive. Interpretation Ambulatory monitoring as a diagnostic strategy for hypertension after an initial raised reading in the clinic would reduce misdiagnosis and save costs. Additional costs from ambulatory monitoring are counterbalanced by cost savings from better targeted treatment. Ambulatory monitoring is recommended for most patients before the start of antihypertensive drugs.	[Martin, Una; McManus, Richard J.] Univ Birmingham, Sch Clin & Expt Med, Birmingham B15 2TT, W Midlands, England; [Lovibond, Kate; Wonderling, David] Royal Coll Physicians, Natl Clin Guideline Ctr, London NW1 4LE, England; [Caulfield, Mark] Queen Mary Univ London, Barts London Sch Med & Dent, William Harvey Res Inst, London, England; [Caulfield, Mark] Queen Mary Univ London, Barts London Sch Med & Dent, NIHR Cardiovasc Biomed Res Unit, London, England; [Heneghan, Carl; Hobbs, F. D. Richard] Univ Oxford, Dept Primary Care Hlth Sci, Oxford, England; [Mant, Jonathan] Univ Cambridge, Gen Practice & Primary Care Res Unit, Cambridge, England; [Williams, Bryan] Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England; [Williams, Bryan] Glenfield Hosp, Leicester NIHR Biomed Res Unit Cardiovasc Dis, Leicester, Leics, England	University of Birmingham; Royal College of Physicians; University of London; Queen Mary University London; University of London; Queen Mary University London; University of Oxford; University of Cambridge; University of Leicester; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital	McManus, RJ (corresponding author), Univ Birmingham, Sch Clin & Expt Med, Birmingham B15 2TT, W Midlands, England.	s.jowett@bham.ac.uk; r.j.mcmanus@bham.ac.uk	Hodgkinson, James/AAY-3410-2020; Jowett, Sue/AAO-4198-2021; Hug, Balthasar L./G-1568-2010	Hodgkinson, James/0000-0002-7583-5278; Jowett, Sue/0000-0001-8936-3745; Caulfield, Mark/0000-0001-9295-3594; Wonderling, David/0000-0003-0315-6273; Williams, Bryan/0000-0002-8094-1841; hobbs, richard/0000-0001-7976-7172; Mant, Jonathan/0000-0002-9531-0268	Microlife; BpTRU; National Institute for Health and Clinical Excellence; National Institute for Health Research (NIHR) [RP-PG-0407-10347]; National Institute for Health Research [CDF/01/017, NF-SI-0509-10222] Funding Source: researchfish	Microlife; BpTRU; National Institute for Health and Clinical Excellence; National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	FDRH has received research support in terms of blood pressure devices from Microlife and BpTRU. All other authors declare that they have no conflicts of interest.; The National Clinical Guideline Centre (KL and DW) is funded by the National Institute for Health and Clinical Excellence. The views expressed in this publication are those of the authors and not necessarily those of the Institute. This article presents independent research commissioned by the National Institute for Health Research (NIHR) under its Programme Grants for Applied Research funding scheme (RP-PG-0407-10347). The views expressed in this article are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. RJM was funded by an NIHR Career Development Fellowship. BW and FDRH are NIHR senior investigators.	Afridi I, 2003, J HYPERTENS, V21, P1983, DOI 10.1097/01.hjh.0000084751-37215.d2; ANDERSON KM, 1991, AM HEART J, V121, P293, DOI 10.1016/0002-8703(91)90861-B; Asayama K, 2005, EUR HEART J, V26, P2026, DOI 10.1093/eurheartj/ehi330; Bobrie G, 2001, ARCH INTERN MED, V161, P2205, DOI 10.1001/archinte.161.18.2205; Briggs AH, 2006, DECISION MODELLING H, P77; British Hypertension Society, VAL DEV SUIT HOM US; Bronnum-Hansen H, 2001, J CLIN EPIDEMIOL, V54, P1244, DOI 10.1016/S0895-4356(01)00405-X; Bronnum-Hansen H, 2001, STROKE, V32, P2131, DOI 10.1161/hs0901.094253; Craig R MJ., 2006, JOINT HLTH SURVEYS U; DENNIS M, 1990, STROKE, V21, P848, DOI 10.1161/01.STR.21.6.848; *DEP HLTH, 2004, HLTH SURV ENGL 2003; Dolan E, 2005, HYPERTENSION, V46, P156, DOI 10.1161/01.HYP.0000170138.56903.7a; Ewald B, 2002, MED J AUSTRALIA, V176, P580, DOI 10.5694/j.1326-5377.2002.tb04588.x; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; Fravel MA, 2008, PHARMACOTHERAPY, V28, P1341, DOI 10.1592/phco.28.11.1341; Fukunaga H, 2008, J HYPERTENS, V26, P685, DOI 10.1097/HJH.0b013e3282f42285; Hansen TW, 2005, HYPERTENSION, V45, P499, DOI 10.1161/01.HYP.0000160402.39597.3b; Hodgkinson J, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d3621; Imai, 1996, Blood Press Monit, V1, P251; Information Centre for Health and Social Care, QUAL OUTC FRAM 2006; JOHNSTON ME, 1984, J CHRON DIS, V37, P417, DOI 10.1016/0021-9681(84)90025-0; Joint Formulary Committee, 2010, BRIT NAT FORM 60; Koehler E, 2009, AM STAT, V63, P155, DOI 10.1198/tast.2009.0030; Krakoff LR, 2006, HYPERTENSION, V47, P29, DOI 10.1161/01.HYP.0000197195.84725.66; Law MR, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1665; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Little P, 2002, BMJ-BRIT MED J, V325, P254, DOI 10.1136/bmj.325.7358.254; Mancia G, 2007, J HYPERTENS, V25, P1751, DOI 10.1097/HJH.0b013e3282f0580f; Mule G, 2002, J CARDIOVASC RISK, V9, P123, DOI 10.1097/00043798-200204000-00008; *NAT COLL CTR CHRO, 2006, HYP MAN AD PRIM CAR; National Centre for Social Research and University College London, 2010, DEP EP PUBL HLTH HLT; National Clinical Guideline Centre for Acute and Chronic Conditions, STABL ANG DRAFT FULL; National Institute for Health and Clinical Excellence (NICE), 2009, GUID METH TECHN APPR; National Institute for Health and Clinical Excellence (NICE), 2008, CARD RISK ASS MOD BL; [NICE (NICE) NIfHaCE], 2008, SOC VAL JUDG PRINC D; NICE, 2017, HYP IMPR BLOOD PRESS; NICE, 2011, CLIN GUID 127 HYP UP; NICE, 2010, CLOP MOD REL DIS PRE; Office for National Statistics (ONS), ENGL WAL INT LIF TAB; Office for National Statistics (ONS), MORT STAT DEATHS REG; Ohkubo T, 1998, J HYPERTENS, V16, P971, DOI 10.1097/00004872-199816070-00010; Ohkubo T, 2000, J HYPERTENS, V18, P847, DOI 10.1097/00004872-200018070-00005; Palmer S, 2002, COST EFFECTIVENESS M; Personal Social Services Research Unit, UN COSTS HLTH SOC CA; Phillips LS, 2001, ANN INTERN MED, V135, P825, DOI 10.7326/0003-4819-135-9-200111060-00012; PIERDOMENICO SD, 1995, EUR HEART J, V16, P692, DOI 10.1093/oxfordjournals.eurheartj.a060975; Redon J, 1998, HYPERTENSION, V31, P712, DOI 10.1161/01.HYP.31.2.712; Rosengren A, 1998, J INTERN MED, V244, P495, DOI 10.1111/j.1365-2796.1998.00394.x; Staessen JA, 1999, JAMA-J AM MED ASSOC, V282, P539, DOI 10.1001/jama.282.6.539; Stergiou GS, 2005, AM J HYPERTENS, V18, P772, DOI 10.1016/j.amjhyper.2005.01.003; The Department of Health, NHS REF COSTS 2008 0; The NHS Information Centre Prescribing Support Unit, 2009, PRESCR COST AN ENGL; TRAZZI S, 1991, J HYPERTENS, V9, P115, DOI 10.1097/00004872-199102000-00003; Tsunoda S, 2002, HYPERTENS RES, V25, P167, DOI 10.1291/hypres.25.167; *US DEP HHS, 7 REP JOINT NAT COMM; Vasan RS, 2002, JAMA-J AM MED ASSOC, V287, P1003, DOI 10.1001/jama.287.8.1003; Verdecchia P, 2001, BLOOD PRESS MONIT, V6, P323, DOI 10.1097/00126097-200112000-00011; Wald NJ, 2003, BMJ-BRIT MED J, V326, P1419, DOI 10.1136/bmj.326.7404.1419; Ward S, 2007, HEALTH TECHNOL ASSES, V11, P1, DOI 10.3310/hta11140; Williams B, 2004, J HUM HYPERTENS, V18, P139, DOI 10.1038/sj.jhh.1001683; Youman P, 2003, PHARMACOECONOMICS, V21, P43, DOI 10.2165/00019053-200321001-00005	61	228	240	1	31	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 1	2011	378	9798					1219	1230		10.1016/S0140-6736(11)61184-7	http://dx.doi.org/10.1016/S0140-6736(11)61184-7			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	831IO	21868086				2022-12-28	WOS:000295723600024
J	Kho, C; Lee, A; Jeong, D; Oh, JG; Chaanine, AH; Kizana, E; Park, WJ; Hajjar, RJ				Kho, Changwon; Lee, Ahyoung; Jeong, Dongtak; Oh, Jae Gyun; Chaanine, Antoine H.; Kizana, Eddy; Park, Woo Jin; Hajjar, Roger J.			SUMO1-dependent modulation of SERCA2a in heart failure	NATURE			English	Article							SARCOPLASMIC-RETICULUM CA2+-ATPASE; SERUM RESPONSE FACTOR; GENE-TRANSFER; VENTRICULAR-FUNCTION; PROTEIN; SUMO-1; CARDIOMYOCYTES; SUMOYLATION; EXPRESSION; CELLS	The calcium-transporting ATPase ATP2A2, also known as SERCA2a, is a critical ATPase responsible for Ca(2+) re-uptake during excitation-contraction coupling. Impaired Ca(2+) uptake resulting from decreased expression and reduced activity of SERCA2a is a hallmark of heart failure(1). Accordingly, restoration of SERCA2a expression by gene transfer has proved to be effective in improving cardiac function in heart-failure patients(2), as well as in animal models(3). The small ubiquitin-related modifier (SUMO) can be conjugated to lysine residues of target proteins(4), and is involved in many cellular processes(5). Here we show that SERCA2a is SUMOylated at lysines 480 and 585 and that this SUMOylation is essential for preserving SERCA2a ATPase activity and stability in mouse and human cells. The levels of SUMO1 and the SUMOylation of SERCA2a itself were greatly reduced in failing hearts. SUMO1 restitution by adeno-associated-virus-mediated gene delivery maintained the protein abundance of SERCA2a and markedly improved cardiac function in mice with heart failure. This effect was comparable to SERCA2A gene delivery. Moreover, SUMO1 overexpression in isolated cardiomyocytes augmented contractility and accelerated Ca(2+) decay. Transgene-mediated SUMO1 overexpression rescued cardiac dysfunction induced by pressure overload concomitantly with increased SERCA2a function. By contrast, downregulation of SUMO1 using small hairpin RNA (shRNA) accelerated pressure-overload-induced deterioration of cardiac function and was accompanied by decreased SERCA2a function. However, knockdown of SERCA2a resulted in severe contractile dysfunction both in vitro and in vivo, which was not rescued by overexpression of SUMO1. Taken together, our data show that SUMOylation is a critical post-translational modification that regulates SERCA2a function, and provide a platform for the design of novel therapeutic strategies for heart failure.	[Kho, Changwon; Lee, Ahyoung; Jeong, Dongtak; Chaanine, Antoine H.; Hajjar, Roger J.] Mt Sinai Sch Med, Cardiovasc Res Ctr, New York, NY 10029 USA; [Oh, Jae Gyun; Park, Woo Jin] Gwangju Inst Sci & Technol, Coll Life Sci, Kwangju 500712, South Korea; [Kizana, Eddy] Westmead Hosp, Westmead Millennium Inst, Sydney Med Sch, Westmead, NSW 2145, Australia; [Kizana, Eddy] Westmead Hosp, Dept Cardiol, Westmead, NSW 2145, Australia	Icahn School of Medicine at Mount Sinai; Gwangju Institute of Science & Technology (GIST); University of Sydney; Westmead Institute for Medical Research; University of Sydney	Hajjar, RJ (corresponding author), Mt Sinai Sch Med, Cardiovasc Res Ctr, 1 Gustave L Levy Pl,Box 1030, New York, NY 10029 USA.	roger.hajjar@mssm.edu	Jeong, Dongtak/AAK-4194-2020; Jeong, Dongtak/ABA-7745-2020; Dongtak, Jeong/AGZ-5435-2022	Jeong, Dongtak/0000-0003-4153-3498; Kizana, Eddy/0000-0002-7266-6720	NIH [RO1 HL083156, HL080498, HL093183, P20HL100396]; Global Research Laboratory of the Korean Ministry of Science and Technology [M6-0605-00-0001]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL078731, R01HL093183, R01HL088434, T32HL007824, R01HL083156, P20HL100396, R01HL080498] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Global Research Laboratory of the Korean Ministry of Science and Technology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work is supported by NIH RO1 HL083156, HL080498, HL093183 and P20HL100396 (R.J.H.). W.J.P. is funded by Global Research Laboratory Program (M6-0605-00-0001) of the Korean Ministry of Science and Technology.	Adachi T, 2004, NAT MED, V10, P1200, DOI 10.1038/nm1119; Baba D, 2005, NATURE, V435, P979, DOI 10.1038/nature03634; Brady M, 2003, CARDIOVASC RES, V60, P347, DOI 10.1016/S0008-6363(03)00529-7; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Drewett V, 2001, J BIOL CHEM, V276, P33444, DOI 10.1074/jbc.M103877200; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Hajjar RJ, 1997, CIRC RES, V81, P145, DOI 10.1161/01.RES.81.2.145; Hajjar RJ, 1998, P NATL ACAD SCI USA, V95, P5251, DOI 10.1073/pnas.95.9.5251; Jeong D, 2006, CIRC RES, V99, P307, DOI 10.1161/01.RES.0000234780.06115.2c; Jessup M, 2011, CIRCULATION, V124, P304, DOI 10.1161/CIRCULATIONAHA.111.022889; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Kawase Y, 2008, J AM COLL CARDIOL, V51, P1112, DOI 10.1016/j.jacc.2007.12.014; Kim MJ, 2008, FASEB J, V22, P3785, DOI 10.1096/fj.08-113910; Kizana E, 2009, GENE THER, V16, P1163, DOI 10.1038/gt.2009.64; Knyushko TV, 2005, BIOCHEMISTRY-US, V44, P13071, DOI 10.1021/bi051226n; Lee AY, 2004, PROTEOMICS, V4, P3437, DOI 10.1002/pmic.200400997; Matsuzaki K, 2003, BIOCHEM BIOPH RES CO, V306, P32, DOI 10.1016/S0006-291X(03)00910-0; MEYER M, 1995, CIRCULATION, V92, P778, DOI 10.1161/01.CIR.92.4.778; Mooney SM, 2010, BIOCHEMISTRY-US, V49, P1, DOI 10.1021/bi901263m; Okura T, 1996, J IMMUNOL, V157, P4277; Pacher P, 2008, NAT PROTOC, V3, P1422, DOI 10.1038/nprot.2008.138; Plemper RK, 1999, TRENDS BIOCHEM SCI, V24, P266, DOI 10.1016/S0968-0004(99)01420-6; Porterfield JE, 2009, J APPL PHYSIOL, V107, P1693, DOI 10.1152/japplphysiol.91322.2008; Ryu KY, 2008, P NATL ACAD SCI USA, V105, P4016, DOI 10.1073/pnas.0800096105; Sampson DA, 2001, J BIOL CHEM, V276, P21664, DOI 10.1074/jbc.M100006200; Schillinger W, 2003, CARDIOVASC RES, V57, P921, DOI 10.1016/S0008-6363(02)00826-X; Tiscornia G, 2003, P NATL ACAD SCI USA, V100, P1844, DOI 10.1073/pnas.0437912100; Van Rechem C, 2010, MOL CELL BIOL, V30, P4045, DOI 10.1128/MCB.00582-09; Vlasblom R, 2004, CARDIOVASC RES, V63, P537, DOI 10.1016/j.cardiores.2004.04.005; Wang J, 2004, J BIOL CHEM, V279, P49091, DOI 10.1074/jbc.M407494200; Wang J, 2010, CIRC RES, V107, P19, DOI 10.1161/CIRCRESAHA.110.220491; Zolotukhin S, 1999, GENE THER, V6, P973, DOI 10.1038/sj.gt.3300938	32	248	263	0	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 29	2011	477	7366					601	U263		10.1038/nature10407	http://dx.doi.org/10.1038/nature10407			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825ZM	21900893	Green Accepted			2022-12-28	WOS:000295320900042
J	Kario, K; Nishizawa, M; Hoshide, S; Shimpo, M; Ishibashi, Y; Kunii, O; Shibuya, K				Kario, Kazuomi; Nishizawa, Masafumi; Hoshide, Satoshi; Shimpo, Masahisa; Ishibashi, Yukishige; Kunii, Osamu; Shibuya, Kenji			Development of a disaster cardiovascular prevention network	LANCET			English	Editorial Material							EARTHQUAKE; HEART; STRESS		[Kario, Kazuomi; Nishizawa, Masafumi; Hoshide, Satoshi; Shimpo, Masahisa] Jichi Med Univ, Sch Med, Dept Med, Div Cardiovasc Med, Shimotsuke, Tochigi 3290498, Japan; [Nishizawa, Masafumi] Shizugawa Hosp, Dept Med, Shizugawa, Japan; [Ishibashi, Yukishige] Ishibashi Clin, Tokyo, Japan; [Ishibashi, Yukishige] Primary Care All Team, Tokyo, Japan; [Kunii, Osamu] United Nations Childrens Fund, Somalia Support Ctr, Nairobi, Kenya; [Shibuya, Kenji] Univ Tokyo, Dept Global Hlth Policy, Tokyo, Japan	Jichi Medical University; University of Tokyo	Kario, K (corresponding author), Jichi Med Univ, Sch Med, Dept Med, Div Cardiovasc Med, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, Japan.	kkario@jichi.ac.jp		Shibuya, Kenji/0000-0003-2528-7530				[Anonymous], 2011, LANCET, V377, P968, DOI 10.1016/S0140-6736(11)60368-1; Inui A, 1998, ARCH INTERN MED, V158, P274, DOI 10.1001/archinte.158.3.274; [Japanese Ministry of Health Labour and Welfare Ministry of Education Culture Sports Science and Technology], 2011, STAT SURV RES DIS AF; Kario K, 1997, J AM GERIATR SOC, V45, P610, DOI 10.1111/j.1532-5415.1997.tb03096.x; Kario K, 1997, J AM COLL CARDIOL, V29, P926, DOI 10.1016/S0735-1097(97)00002-8; Kario K, 2003, HYPERTENS RES, V26, P355, DOI 10.1291/hypres.26.355; Kario K., 2005, JMAJ - Japan Medical Association Journal, V48, P363; Kario K, 1998, J AM GERIATR SOC, V46, P537, DOI 10.1111/j.1532-5415.1998.tb02485.x; McCurry J, 2011, LANCET, V378, P15, DOI 10.1016/S0140-6736(11)61002-7; Mokdad Ali H, 2005, Prev Chronic Dis, V2 Spec no, pA04; Pickering T G, 2001, Curr Hypertens Rep, V3, P249, DOI 10.1007/s11906-001-0047-1; Shibuya K, 2011, LANCET, V378, P1265, DOI 10.1016/S0140-6736(11)61098-2	12	26	26	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 24	2011	378	9797					1125	1127		10.1016/S0140-6736(11)61187-2	http://dx.doi.org/10.1016/S0140-6736(11)61187-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	829RH	21885110				2022-12-28	WOS:000295601500008
J	Forster, P; Renfrew, C				Forster, Peter; Renfrew, Colin			Mother Tongue and Y Chromosomes	SCIENCE			English	Editorial Material							MTDNA VARIATION; EXPANSION; ADMIXTURE; ISLANDS; ESKIMOS		[Forster, Peter] Univ Cambridge, Murray Edwards Coll, Cambridge CB3 0DF, England; [Forster, Peter] Inst Forens Genet, D-48161 Munster, Germany; [Renfrew, Colin] Univ Cambridge, McDonald Inst Archaeol Res, Cambridge CB2 3ER, England	University of Cambridge; University of Cambridge	Forster, P (corresponding author), Univ Cambridge, Murray Edwards Coll, Cambridge CB3 0DF, England.	pf223@cam.ac.uk						Bosch E, 2003, HUM GENET, V112, P353, DOI 10.1007/s00439-003-0913-9; CAVALLISFORZA LL, 1988, P NATL ACAD SCI USA, V85, P6002, DOI 10.1073/pnas.85.16.6002; Chaubey G, 2011, MOL BIOL EVOL, V28, P1013, DOI 10.1093/molbev/msq288; de Filippo C, 2011, MOL BIOL EVOL, V28, P1255, DOI 10.1093/molbev/msq312; Forster P, 2004, TRACES ANCESTRY STUD, P99; Helgason A, 2001, AM J HUM GENET, V68, P723, DOI 10.1086/318785; Kayser M, 2008, MOL BIOL EVOL, V25, P1362, DOI 10.1093/molbev/msn078; Kemp BM, 2010, P NATL ACAD SCI USA, V107, P6759, DOI 10.1073/pnas.0905753107; Matsumura S, 2008, P ROY SOC B-BIOL SCI, V275, P1501, DOI 10.1098/rspb.2007.1724; Renfrew Cohn, 2002, EXAMINING FARMING LA; Saillard J, 2000, AM J HUM GENET, V67, P718, DOI 10.1086/303038; Sengupta S, 2006, AM J HUM GENET, V78, P202, DOI 10.1086/499411; Stoneking M, 2010, CURR BIOL, V20, pR188, DOI 10.1016/j.cub.2009.11.052; Wood ET, 2005, EUR J HUM GENET, V13, P867, DOI 10.1038/sj.ejhg.5201408; Zerjal T, 2003, AM J HUM GENET, V72, P717, DOI 10.1086/367774	15	27	27	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 9	2011	333	6048					1390	1391		10.1126/science.1205331	http://dx.doi.org/10.1126/science.1205331			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817KU	21903800				2022-12-28	WOS:000294672200027
J	Johnston, MI; Fauci, AS				Johnston, Margaret I.; Fauci, Anthony S.			HIV Vaccine Development - Improving on Natural Immunity	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Johnston, Margaret I.; Fauci, Anthony S.] NIAID, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Johnston, MI (corresponding author), NIAID, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.		Franzeck, Fabian C/B-5055-2011					Chen L, 2009, SCIENCE, V326, P1123, DOI 10.1126/science.1175868; Mikell I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001251; Nabel GJ, 2010, NAT MED, V16, P1389, DOI 10.1038/nm1210-1389; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Walker LM, 2010, CURR OPIN IMMUNOL, V22, P358, DOI 10.1016/j.coi.2010.02.012	5	35	40	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 8	2011	365	10					873	875		10.1056/NEJMp1107621	http://dx.doi.org/10.1056/NEJMp1107621			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	816JX	21899447	Bronze			2022-12-28	WOS:000294595600001
J	Lord, SJ; Staub, LP; Bossuyt, PMM; Irwig, LM				Lord, S. J.; Staub, L. P.; Bossuyt, P. M. M.; Irwig, L. M.			Target practice: choosing target conditions for test accuracy studies that are relevant to clinical practice	BMJ-BRITISH MEDICAL JOURNAL			English	Article									[Lord, S. J.; Staub, L. P.] Univ Sydney, Clin Trials Ctr, Natl Hlth & Med Res Council, Camperdown, NSW 2050, Australia; [Lord, S. J.; Irwig, L. M.] Univ Sydney, Screening & Test Evaluat Program, Sch Publ Hlth, Sydney, NSW 2006, Australia; [Bossuyt, P. M. M.] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol & Biostat, NL-1105 AZ Amsterdam, Netherlands	University of Sydney; University of Sydney; University of Amsterdam; Academic Medical Center Amsterdam	Lord, SJ (corresponding author), Univ Sydney, Clin Trials Ctr, Natl Hlth & Med Res Council, 92-94 Parramatta Rd,Locked Bag 77, Camperdown, NSW 2050, Australia.	sally.lord@ctc.usyd.edu.au	Bossuyt, Patrick M/AAR-1183-2021; Bossuyt, Patrick M./B-4557-2016; Lord, Sally/GZM-7796-2022	Bossuyt, Patrick M/0000-0003-4427-0128; Bossuyt, Patrick M./0000-0003-4427-0128; Lord, Sally/0000-0003-2763-5949; Staub, Lukas/0000-0002-2815-9107	Australian National Health and Medical Research Council [571044, 402764]	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported through an Australian National Health and Medical Research Council Project Grant (No 571044) and Program Grant (No 402764).	Anderson DR, 2007, JAMA-J AM MED ASSOC, V298, P2743, DOI 10.1001/jama.298.23.2743; AUTRET A, 1987, LANCET, V1, P888; Bossuyt PM, 2003, BRIT MED J, V326, P41, DOI 10.1136/bmj.326.7379.41; Esserman L, 2010, J NATL CANCER I, V102, P582, DOI 10.1093/jnci/djq119; Glassroth J, 2007, JAMA-J AM MED ASSOC, V298, P2788, DOI 10.1001/jama.298.23.2788; Halligan S, 2005, RADIOLOGY, V237, P893, DOI 10.1148/radiol.2373050176; Hassan C, 2010, ALIMENT PHARM THER, V31, P210, DOI 10.1111/j.1365-2036.2009.04160.x; Irwig L, 2002, BRIT MED J, V324, P669, DOI 10.1136/bmj.324.7338.669; Lameris W, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b2431; Morrow DA, 2009, NEW ENGL J MED, V361, P913, DOI 10.1056/NEJMe0905790; Mulherin SA, 2002, ANN INTERN MED, V137, P598, DOI 10.7326/0003-4819-137-7-200210010-00011; Rothwell PM, 2003, LANCET, V361, P107, DOI 10.1016/S0140-6736(03)12228-3; Schoenfeld AJ, J TRAUMA, V113, P109; Snijders PJF, 2003, J PATHOL, V201, P1, DOI 10.1002/path.1433; Szczepura A, 2006, HEALTH TECHNOL ASSES, V10, P1; Wardlaw JM, 2006, LANCET, V367, P1503, DOI 10.1016/S0140-6736(06)68650-9; Welch HG, 2010, J NATL CANCER I, V102, P605, DOI 10.1093/jnci/djq099; Whiting P, 2004, ANN INTERN MED, V140, P189, DOI 10.7326/0003-4819-140-3-200402030-00010; Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25	19	35	35	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 8	2011	343								d4684	10.1136/bmj.d4684	http://dx.doi.org/10.1136/bmj.d4684			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	V41KR	21903693	Bronze, Green Submitted			2022-12-28	WOS:000209545600001
J	Spence, D				Spence, Des			FROM THE FRONTLINE No trivial pursuit	BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk							0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 7	2011	343								d5648	10.1136/bmj.d5648	http://dx.doi.org/10.1136/bmj.d5648			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	819RQ	21900353				2022-12-28	WOS:000294847800011
J	Desch, K; Li, J; Kim, S; Laventhal, N; Metzger, K; Siemieniak, D; Ginsburg, D				Desch, Karl; Li, Jun; Kim, Scott; Laventhal, Naomi; Metzger, Kristen; Siemieniak, David; Ginsburg, David			Analysis of Informed Consent Document Utilization in a Minimal-Risk Genetic Study	ANNALS OF INTERNAL MEDICINE			English	Review							CLINICAL-TRIALS; QUALITY; IMPROVEMENT; PARTICIPATION; ASSOCIATION; READABILITY; NETWORK; FORMS	Background: The signed informed consent document certifies that the process of informed consent has taken place and provides research participants with comprehensive information about their role in the study. Despite efforts to optimize the informed consent document, only limited data are available about the actual use of consent documents by participants in biomedical research. Objective: To examine the use of online consent documents in a minimal-risk genetic study. Design: Prospective sibling cohort enrolled as part of a genetic study of hematologic and common human traits. Setting: University of Michigan Campus, Ann Arbor, Michigan. Participants: Volunteer sample of healthy persons with 1 or more eligible siblings aged 14 to 35 years. Enrollment was through targeted e-mail to student lists. A total of 1209 persons completed the study. Measurements: Time taken by participants to review a 2833-word online consent document before indicating consent and identification of a masked hyperlink near the end of the document. Results: The minimum predicted reading time was 566 seconds. The median time to consent was 53 seconds. A total of 23% of participants consented within 10 seconds, and 93% of participants consented in less than the minimum predicted reading time. A total of 2.5% of participants identified the masked hyperlink. Limitation: The online consent process was not observed directly by study investigators, and some participants may have viewed the consent document more than once. Conclusion: Few research participants thoroughly read the consent document before agreeing to participate in this genetic study. These data suggest that current informed consent documents, particularly for low-risk studies, may no longer serve the intended purpose of protecting human participants, and the role of these documents should be reassessed.	Univ Michigan, Ann Arbor, MI 48109 USA; City Chicago, Dept Publ Hlth, Chicago, IL USA	University of Michigan System; University of Michigan; Chicago Department of Public Health	Ginsburg, D (corresponding author), 5028 Life Sci Inst, 210 Washtenaw Ave, Ann Arbor, MI 48109 USA.	ginsburg@umich.edu		Laventhal, Naomi/0000-0002-8110-7621; Li, Jun/0000-0001-6727-0812	National Institutes of Health [R37HL039693, K12HD028820]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD028820] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL039693, R01HL039693] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	By National Institutes of Health grants R37HL039693 (Dr. Ginsburg) and K12HD028820 (Dr. Desch). Dr. Ginsburg is a Howard Hughes Investigator, and Dr. Kim is a Greenwall Faculty Scholar in Bioethics.	Albala Ilene, 2010, IRB, V32, P7; [Anonymous], 1979, FED REG, V44, P23191; Appelbaum PS, 2007, NEW ENGL J MED, V357, P1834, DOI 10.1056/NEJMcp074045; Beauchamp Tom L., 2001, PRINCIPLES BIOMEDICA, P63; Berger O, 2009, ANN ONCOL, V20, P379, DOI 10.1093/annonc/mdn623; Burman W, 2009, CLIN INFECT DIS, V49, P328, DOI 10.1086/605454; CASSILETH BR, 1980, NEW ENGL J MED, V302, P896, DOI 10.1056/NEJM198004173021605; Finch SA, 2009, ARCH PEDIAT ADOL MED, V163, P1130, DOI 10.1001/archpediatrics.2009.206; Flesch R, 1948, J APPL PSYCHOL, V32, P221, DOI 10.1037/h0057532; Flory J, 2004, JAMA-J AM MED ASSOC, V292, P1593, DOI 10.1001/jama.292.13.1593; Granick J, 2007, WIRED; Henry James, 2009, IRB, V31, P1; HOWARD JM, 1981, CONTROL CLIN TRIALS, V2, P287, DOI 10.1016/0197-2456(81)90019-2; Jefford MH, 2007, J CLIN ONCOL, V25, DOI 10.1200/JCO.2006.10.3341; Jefford M, 2008, LANCET ONCOL, V9, P485, DOI 10.1016/S1470-2045(08)70128-1; Joffe S, 2001, LANCET, V358, P1772, DOI 10.1016/S0140-6736(01)06805-2; Kim S, 2009, NATURE, V457, P534, DOI 10.1038/457534a; Kim SYH., 2010, EVALUATION CAPACITY; Krousel-Wood M, 2006, J INVEST MED, V54, P174, DOI 10.2310/6650.2006.05031; Lantos J, 2009, ARCH PEDIAT ADOL MED, V163, P1163, DOI 10.1001/archpediatrics.2009.225; LAVELLEJONES C, 1993, BRIT MED J, V306, P885, DOI 10.1136/bmj.306.6882.885; Legemaate Johan, 1994, Eur J Health Law, V1, P161, DOI 10.1163/157180994X00268; LEGGE GE, 1985, VISION RES, V25, P239, DOI 10.1016/0042-6989(85)90117-8; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Mailman MD, 2007, NAT GENET, V39, P1181, DOI 10.1038/ng1007-1181; Manolio TA, 2010, NEW ENGL J MED, V363, P166, DOI 10.1056/NEJMra0905980; Marco CA, 2008, J EMERG MED, V34, P269, DOI 10.1016/j.jemermed.2007.06.026; MEISEL A, 1977, AM J PSYCHIAT, V134, P285; Mello MM, 2010, NEW ENGL J MED, V363, P204, DOI 10.1056/NEJMp1005203; Michigan University, 2011, ETHN U MICH STUD; Ness RB, 2007, JAMA-J AM MED ASSOC, V298, P2164, DOI 10.1001/jama.298.18.2164; Paasche-Orlow MK, 2003, NEW ENGL J MED, V348, P721, DOI 10.1056/NEJMsa021212; Paris A, 2010, BRIT J CLIN PHARMACO, V69, P231, DOI 10.1111/j.1365-2125.2009.03565.x; Sharp SM, 2004, AM J CLIN ONCOL-CANC, V27, P570, DOI 10.1097/01.coc.0000135925.83221.b3; Stunkel Leanne, 2010, IRB, V32, P1; Tu JV, 2004, NEW ENGL J MED, V350, P1414, DOI 10.1056/NEJMsa031697; University of Michigan Medical School, 2011, INF CONS TEMPL WHATS; Varnhagen CK, 2005, ETHICS BEHAV, V15, P37, DOI 10.1207/s15327019eb1501_3; Vila JJ, 2006, REV ESP ENFERM DIG, V98, P101, DOI 10.4321/s1130-01082006000200005; Weir BS, 2006, NAT REV GENET, V7, P771, DOI 10.1038/nrg1960; Zetola NM, 2007, JAMA-J AM MED ASSOC, V297, P1061, DOI 10.1001/jama.297.10.1061	41	19	19	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 6	2011	155	5					316	U85		10.7326/0003-4819-155-5-201109060-00009	http://dx.doi.org/10.7326/0003-4819-155-5-201109060-00009			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	815PX	21893624	Green Accepted			2022-12-28	WOS:000294538900005
J	Kirby, T				Kirby, Tony			Profile Mechthild Prinz: using DNA to identify the victims of 9/11	LANCET			English	Biographical-Item																			0	0	0	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 3	2011	378	9794					868	868		10.1016/S0140-6736(11)61401-3	http://dx.doi.org/10.1016/S0140-6736(11)61401-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	818XZ	21890038				2022-12-28	WOS:000294791300013
J	Nutsch, K; Hsieh, C				Nutsch, Katherine; Hsieh, Chyi			When T Cells Run Out of Breath: The HIF-1 alpha Story	CELL			English	Editorial Material							DIFFERENTIATION; T(H)17	In this issue, Dang et al. (2011) report a role for the hypoxia-induced transcription factor HIF-1 alpha in regulating the differentiation of T cell subsets that impact both inflammation and its resolution. Their findings illustrate how metabolic signals can alter the balance between inflammation and tolerance and present a potential therapeutic opportunity for the treatment of diseases associated with chronic inflammation.	[Nutsch, Katherine; Hsieh, Chyi] Washington Univ, Sch Med, Div Rheumatol, Dept Med, St Louis, MO 63110 USA	Washington University (WUSTL)	Hsieh, C (corresponding author), Washington Univ, Sch Med, Div Rheumatol, Dept Med, St Louis, MO 63110 USA.	chsieh@dom.wustl.edu						Abraham C, 2009, NEW ENGL J MED, V361, P2066, DOI 10.1056/NEJMra0804647; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Delgoffe GM, 2011, NAT IMMUNOL, V12, P295, DOI 10.1038/ni.2005; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; Shi LZ, 2011, J EXP MED, V208, P1367, DOI 10.1084/jem.20110278; Solt LA, 2011, NATURE, V472, P491, DOI 10.1038/nature10075; Yang XO, 2008, IMMUNITY, V29, P44, DOI 10.1016/j.immuni.2008.05.007	10	11	16	1	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 2	2011	146	5					673	674		10.1016/j.cell.2011.08.018	http://dx.doi.org/10.1016/j.cell.2011.08.018			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	814SM	21884928	Bronze			2022-12-28	WOS:000294477500007
J	Tendal, B; Nuesch, E; Higgins, JPT; Juni, P; Gotzsche, PC				Tendal, Britta; Nueesch, Eveline; Higgins, Julian P. T.; Jueni, Peter; Gotzsche, Peter C.			Multiplicity of data in trial reports and the reliability of meta-analyses: empirical study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PANIC DISORDER; RANDOMIZED-TRIALS; PLACEBO; IMIPRAMINE; OSTEOARTHRITIS; COMBINATION; CHONDROITIN; FLUVOXAMINE; EXPOSURE; OUTCOMES	Objectives To examine the extent of multiplicity of data in trial reports and to assess the impact of multiplicity on meta-analysis results. Design Empirical study on a cohort of Cochrane systematic reviews. Data sources All Cochrane systematic reviews published from issue 3 in 2006 to issue 2 in 2007 that presented a result as a standardised mean difference (SMD). We retrieved trial reports contributing to the first SMD result in each review, and downloaded review protocols. We used these SMDs to identify a specific outcome for each meta-analysis from its protocol. Review methods Reviews were eligible if SMD results were based on two to ten randomised trials and if protocols described the outcome. We excluded reviews if they only presented results of subgroup analyses. Based on review protocols and index outcomes, two observers independently extracted the data necessary to calculate SMDs from the original trial reports for any intervention group, time point, or outcome measure compatible with the protocol. From the extracted data, we used Monte Carlo simulations to calculate all possible SMDs for every meta-analysis. Results We identified 19 eligible meta-analyses (including 83 trials). Published review protocols often lacked information about which data to choose. Twenty-four (29%) trials reported data for multiple intervention groups, 30 (36%) reported data for multiple time points, and 29 (35%) reported the index outcome measured on multiple scales. In 18 meta-analyses, we found multiplicity of data in at least one trial report; the median difference between the smallest and largest SMD results within a meta-analysis was 0.40 standard deviation units (range 0.04 to 0.91). Conclusions Multiplicity of data can affect the findings of systematic reviews and meta-analyses. To reduce the risk of bias, reviews and meta-analyses should comply with prespecified protocols that clearly identify time points, intervention groups, and scales of interest.	[Tendal, Britta; Gotzsche, Peter C.] Rigshosp, Nord Cochrane Ctr, DK-2100 Copenhagen O, Denmark; [Nueesch, Eveline; Jueni, Peter] Univ Bern, Inst Social & Prevent Med, CH-3012 Bern, Switzerland; [Nueesch, Eveline; Jueni, Peter] Univ Hosp Bern, CTU Bern, Bern, Switzerland; [Higgins, Julian P. T.] MRC, Biostat Unit, Cambridge CB2 2BW, England	Rigshospitalet; University of Bern; University of Bern; University Hospital of Bern; MRC Biostatistics Unit	Tendal, B (corresponding author), Rigshosp, Nord Cochrane Ctr, Blegdamsvej 9, DK-2100 Copenhagen O, Denmark.	bt@cochrane.dk	Juni, Peter/Q-8700-2016; Higgins, Julian PT/H-4008-2011	Juni, Peter/0000-0002-5985-0670; Higgins, Julian PT/0000-0002-8323-2514	IMK Charitable Fund; MRC [MC_U105285807] Funding Source: UKRI; Medical Research Council [MC_U105285807] Funding Source: researchfish	IMK Charitable Fund; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was part of a PhD (BT) funded by IMK Charitable Fund. The funding source had no role in the design and conduct of the study; data collection, management, analysis, and interpretation; preparation, review, and approval of the manuscript; or the decision to submit the paper for publication.	Abbass AA, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004687; Afolabi BB, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004350.pub2; Ahmad G, 2007, COCHRANE DB SYST REV, V2; Barlow DH, 2000, JAMA-J AM MED ASSOC, V283, P2529, DOI 10.1001/jama.283.19.2529; Bender R, 2008, J CLIN EPIDEMIOL, V61, P857, DOI 10.1016/j.jclinepi.2008.03.004; Buckley LA, 2007, COCHRANE DB SYST REV, V3; Chan AW, 2004, CAN MED ASSOC J, V171, P735, DOI 10.1503/cmaj.1041086; Chan AW, 2004, JAMA-J AM MED ASSOC, V291, P2457, DOI 10.1001/jama.291.20.2457; Chan AW, 2005, BMJ-BRIT MED J, V330, P753, DOI 10.1136/bmj.38356.424606.8F; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; DEBEURS E, 1995, AM J PSYCHIAT, V152, P683; Devesa P. Martinez, 2007, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD005233.PUB2; FAHY TJ, 1992, J AFFECT DISORDERS, V25, P63, DOI 10.1016/0165-0327(92)90094-M; Furukawa T. A., 2007, COCHRANE DB SYST REV, V1; Gava I, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005333.pub2; Harbord RM, 2008, J CLIN EPIDEMIOL, V61, P1095, DOI 10.1016/j.jclinepi.2007.09.013; Hopewell S, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000006.pub3; Hunot V, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001848; Ipser JC, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005473.pub2; Juni P, 2009, LANCET, V374, P1221, DOI 10.1016/S0140-6736(09)61765-7; LARUN L, 2006, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD004691.PUB2; Liberati A, 2009, BMJ-BRIT MED J, V339, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; MAVISSAKALIAN M, 1986, AM J PSYCHIAT, V143, P1106; Mistiaen P, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004510.pub3; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1016/j.ijsu.2010.02.007, 10.1136/bmj.b2535]; Moher D, 2007, PLOS MED, V4, P447, DOI 10.1371/journal.pmed.0040078; Moore M, 2006, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CDC002870.PUB2; Mytton J, 2006, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD004606.PUB2; O'Kearney RT, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004856; Orlando R, 2007, COCHRANE DB SYST REV, V1; Reichenbach S, 2007, ANN INTERN MED, V146, P580, DOI 10.7326/0003-4819-146-8-200704170-00009; Sharp DM, 1996, J ANXIETY DISORD, V10, P219, DOI 10.1016/0887-6185(96)00008-4; Tendal B, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3128; Trinh KV, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004870.pub3; Uman LS, 2006, COCHRANE DB SYST REV, V4; Vedula SS, 2009, NEW ENGL J MED, V361, P1963, DOI 10.1056/NEJMsa0906126; Wandel S, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4675; Woodford H, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004585.pub2; Yousefi-Nooraie R, 2007, COCHRANE DB SYST REV, V2; ZITRIN CM, 1983, ARCH GEN PSYCHIAT, V40, P125	40	29	29	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 30	2011	343								d4829	10.1136/bmj.d4829	http://dx.doi.org/10.1136/bmj.d4829			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	816LA	21878462	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000294599900001
J	Jorgensen, RA				Jorgensen, Richard A.			A Window on the Sophistication of Plants	SCIENCE			English	Editorial Material									Cinvestav Irapuato, Langebio, Guanajuato 36821, Mexico	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional	Jorgensen, RA (corresponding author), Cinvestav Irapuato, Langebio, Guanajuato 36821, Mexico.	rajorgensen@langebio.cinvestav.mx		Jorgensen, Richard/0000-0002-0382-2371				Brosnan CA, 2007, P NATL ACAD SCI USA, V104, P14741, DOI 10.1073/pnas.0706701104; Lucas WJ, 2009, TRENDS CELL BIOL, V19, P495, DOI 10.1016/j.tcb.2009.07.003; Turck F, 2008, ANNU REV PLANT BIOL, V59, P573, DOI 10.1146/annurev.arplant.59.032607.092755; Xu XM, 2011, SCIENCE, V333, P1141, DOI 10.1126/science.1205727; ZEEVAART JA, 1962, SCIENCE, V137, P723, DOI 10.1126/science.137.3532.723	5	0	0	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 26	2011	333	6046					1103	1104		10.1126/science.1211194	http://dx.doi.org/10.1126/science.1211194			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811VM	21868663				2022-12-28	WOS:000294244300033
J	Clements, DH; Sarama, J				Clements, Douglas H.; Sarama, Julie			Early Childhood Mathematics Intervention	SCIENCE			English	Review							YOUNG-CHILDREN; CURRICULUM; KNOWLEDGE; TEACHERS	Preschool and primary grade children have the capacity to learn substantial mathematics, but many children lack opportunities to do so. Too many children not only start behind their more advantaged peers, but also begin a negative trajectory in mathematics. Interventions designed to facilitate their mathematical learning during ages 3 to 5 years have a strong positive effect on these children's lives for many years thereafter.	[Clements, Douglas H.; Sarama, Julie] SUNY Buffalo, Grad Sch Educ, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Clements, DH (corresponding author), SUNY Buffalo, Grad Sch Educ, Buffalo, NY 14260 USA.	clements@buffalo.edu; jsarama@buffalo.edu		Clements, Douglas/0000-0003-1800-5099	Institute of Education Sciences (U.S. Department of Education) [R305K05157]; NSF [DRL-1019925]	Institute of Education Sciences (U.S. Department of Education)(US Department of Education); NSF(National Science Foundation (NSF))	This article was based on work supported in part by the Institute of Education Sciences (U.S. Department of Education) under grant R305K05157. Work on the research was also supported in part by the NSF under grant DRL-1019925. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the funding agencies. A short section of this review includes research that, although concerned with a scale-up model rather than particular curricula, includes an intervention of which a minor component has been published by the authors, who thus could have a vested interest in the results. An external auditor oversaw research designs, data collections, and analyses of all these studies, and other researchers independently confirmed findings and procedures.	[Anonymous], ISSUES ED; Bennett N., 1984, QUALITY PUPIL LEARNI; Bobis J, 2005, MATH EDUC RES J, V16, P27, DOI 10.1007/BF03217400; Butterworth B, 2011, SCIENCE, V332, P1049, DOI 10.1126/science.1201536; CARPENTER TP, 1988, J RES MATH EDUC, V19, P385, DOI 10.2307/749173; Carpenter TP, 1998, J RES MATH EDUC, V29, P3, DOI 10.2307/749715; Case R, 1999, DEVELOPMENTAL HEALTH AND THE WEALTH OF NATIONS, P125; Clements D., 2009, LEARNING TEACHING EA; Clements DH, 2008, AM EDUC RES J, V45, P443, DOI 10.3102/0002831207312908; Clements DH, 2007, J RES MATH EDUC, V38, P35, DOI 10.2307/30034927; Clements DH, 2007, J RES MATH EDUC, V38, P136, DOI 10.2307/30034954; Clements DH, 2011, J RES MATH EDUC, V42, P127; Cross C. T., 2009, MATH EARL CHILD LEAR; Duncan GJ, 2007, DEV PSYCHOL, V43, P1428, DOI 10.1037/0012-1649.43.6.1428; Greenes C, 2004, EARLY CHILD RES Q, V19, P159, DOI 10.1016/j.ecresq.2004.01.010; GRIFFIN SA, 1994, CLASSROOM LESSONS IN, P25; Henry VJ, 2008, J RES MATH EDUC, V39, P153, DOI 10.2307/30034895; HIEBERT J, 1993, AM EDUC RES J, V30, P393, DOI 10.3102/00028312030002393; Hiebert J., 2007, 2 HDB RES MATH TEACH, V1, P371; JORDAN NC, 1992, DEV PSYCHOL, V28, P644, DOI 10.1037/0012-1649.28.4.644; Klein A., 2008, J RES EDUC EFF, V1, P155, DOI [10.1080/19345740802114533, DOI 10.1080/19345740802114533]; Munn P., 2006, INT J EARLY CHILDHOO, V38, P99, DOI DOI 10.1007/BF03165980; National Mathematics Advisory Panel, 2008, FDN SUCC FIN REP NAT; Sadler PM, 2007, SCIENCE, V317, P457, DOI 10.1126/science.1144214; Sarama J, 2009, STUD MATH THINK LEAR, P1; Sarama J., 2008, J RES EDUC EFF, V1, P89, DOI [10.1080/19345740801941332, DOI 10.1080/19345740801941332]; SIEGLER RS, 1995, COGNITIVE PSYCHOL, V28, P225, DOI 10.1006/cogp.1995.1006; SIMON MA, 1995, J RES MATH EDUC, V26, P114, DOI 10.2307/749205; Starkey P, 2004, EARLY CHILD RES Q, V19, P99, DOI 10.1016/j.ecresq.2004.01.002; STIPEK D, 1995, CHILD DEV, V66, P209, DOI 10.1111/j.1467-8624.1995.tb00866.x; *US DEP HHS, 2005, HEAD START IMP STUD; Wright B., 1991, MATH ED RES J, V3, P1; Wright R. J., 1994, EDUC STUD MATH, V26, P25, DOI DOI 10.1007/BF01273299; Wright R. J., 2002, TEACHING NUMBER ADV; Young-Loveridge JM, 2004, EARLY CHILD RES Q, V19, P82, DOI 10.1016/j.ecresq.2004.01.001	35	160	162	2	66	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 19	2011	333	6045					968	970		10.1126/science.1204537	http://dx.doi.org/10.1126/science.1204537			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	808TD	21852488				2022-12-28	WOS:000294000400042
J	Thomas, C; Moraga, I; Levin, D; Krutzik, PO; Podoplelova, Y; Trejo, A; Lee, C; Yarden, G; Vleck, SE; Glenn, JS; Nolan, GP; Piehler, J; Schreiber, G; Garcia, KC				Thomas, Christoph; Moraga, Ignacio; Levin, Doron; Krutzik, Peter O.; Podoplelova, Yulia; Trejo, Angelica; Lee, Choongho; Yarden, Ganit; Vleck, Susan E.; Glenn, Jeffrey S.; Nolan, Garry P.; Piehler, Jacob; Schreiber, Gideon; Garcia, K. Christopher			Structural Linkage between Ligand Discrimination and Receptor Activation by Type I Interferons	CELL			English	Article							CRYSTAL-STRUCTURE; MUTATIONAL ANALYSIS; COMPLEX REVEALS; BINDING-SITE; AFFINITY; IFNAR1; IFN-ALPHA-2; MUTANT; ALPHA; GAMMA	Type I Interferons (IFNs) are important cytokines for innate immunity against viruses and cancer. Sixteen human type I IFN variants signal through the same cell-surface receptors, IFNAR1 and IFNAR2, yet they can evoke markedly different physiological effects. The crystal structures of two human type I IFN ternary signaling complexes containing IFN alpha 2 and IFN omega reveal recognition modes and heterotrimeric architectures that are unique among the cytokine receptor superfamily but conserved between different type I IFNs. Receptor-ligand cross-reactivity is enabled by conserved receptor-ligand "anchor points" interspersed among ligand-specific interactions that "tune" the relative IFN-binding affinities, in an apparent extracellular "ligand proofreading" mechanism that modulates biological activity. Functional differences between IFNs are linked to their respective receptor recognition chemistries, in concert with a ligand-induced conformational change in IFNAR1, that collectively control signal initiation and complex stability, ultimately regulating differential STAT phosphorylation profiles, receptor internalization rates, and downstream gene expression patterns.	[Thomas, Christoph; Moraga, Ignacio; Garcia, K. Christopher] Stanford Univ, Howard Hughes Med Inst, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Thomas, Christoph; Moraga, Ignacio; Garcia, K. Christopher] Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA; [Krutzik, Peter O.; Trejo, Angelica; Nolan, Garry P.] Stanford Univ, Sch Med, Baxter Lab Stem Cell Biol, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Lee, Choongho; Vleck, Susan E.; Glenn, Jeffrey S.] Stanford Univ, Sch Med, Div Gastroenterol & Hepatol, Dept Med, Stanford, CA 94305 USA; [Levin, Doron; Yarden, Ganit; Schreiber, Gideon] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; [Podoplelova, Yulia; Piehler, Jacob] Univ Osnabruck, Div Biophys, D-49076 Osnabruck, Germany	Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University; Stanford University; Weizmann Institute of Science; University Osnabruck	Garcia, KC (corresponding author), Stanford Univ, Howard Hughes Med Inst, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA.	kcgarcia@stanford.edu	Nolan, Garry/AAE-7903-2019; Lee, Choongho/AAZ-9876-2020	Moraga, Ignacio/0000-0001-9909-0701; Nolan, Garry/0000-0002-8862-9043; Thomas, Christoph/0000-0001-7441-1089	International Human Frontier Science Program Organization; European Community [223608];  [NIH-RO1-AI51321];  [NIH-RO1-AI087917]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087917, R37AI051321, R01AI051321] Funding Source: NIH RePORTER	International Human Frontier Science Program Organization(Human Frontier Science Program); European Community(European Commission); ; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Natalia Goriatcheva for expert technical assistance, the staff at SSRL and ALS for their assistance, and David Canner for preparing the Proteopedia pages. K. C. G. is an Investigator of the Howard Hughes Medical Institute. This work was also supported by NIH-RO1-AI51321 (K. C. G.) and NIH-RO1-AI087917 (J.S.G.), C. T. is supported by a long-term postdoctoral fellowship of the International Human Frontier Science Program Organization. G. S. and J.P. are supported by the European Community's FP7/2007-2013 under GA no. 223608 (IFNaction).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bleicher L, 2008, FEBS LETT, V582, P2985, DOI 10.1016/j.febslet.2008.07.046; Bogdan C, 2000, CURR OPIN IMMUNOL, V12, P419, DOI 10.1016/S0952-7915(00)00111-4; Borden EC, 2007, NAT REV DRUG DISCOV, V6, P975, DOI 10.1038/nrd2422; Cajean-Feroldi C, 2004, BIOCHEMISTRY-US, V43, P12498, DOI 10.1021/bi049111r; Chill JH, 2003, STRUCTURE, V11, P791, DOI 10.1016/S0969-2126(03)00120-5; Cho NJ, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000331; Coelho LFL, 2005, P NATL ACAD SCI USA, V102, P11917, DOI 10.1073/pnas.0502188102; Dong G, 2009, IMMUNITY, V30, P21, DOI 10.1016/j.immuni.2008.10.018; Dukkipati A, 2008, PROTEIN EXPRES PURIF, V62, P160, DOI 10.1016/j.pep.2008.08.004; GABORIAUD C, 1990, FEBS LETT, V269, P1, DOI 10.1016/0014-5793(90)81103-U; Garcia-Sastre A, 2006, SCIENCE, V312, P879, DOI 10.1126/science.1125676; Horton HM, 1999, CANCER RES, V59, P4064; ISAACS A, 1957, PROC R SOC SER B-BIO, V147, P258, DOI 10.1098/rspb.1957.0048; Jaitin DA, 2006, MOL CELL BIOL, V26, P1888, DOI 10.1128/MCB.26.5.1888-1897.2006; Jaks E, 2007, J MOL BIOL, V366, P525, DOI 10.1016/j.jmb.2006.11.053; Jones BC, 2008, STRUCTURE, V16, P1333, DOI 10.1016/j.str.2008.06.005; Josephson K, 2001, IMMUNITY, V15, P35, DOI 10.1016/S1074-7613(01)00169-8; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kalie E, 2008, J BIOL CHEM, V283, P32925, DOI 10.1074/jbc.M806019200; Kalie E, 2007, J BIOL CHEM, V282, P11602, DOI 10.1074/jbc.M610115200; Krutzik PO, 2006, NAT METHODS, V3, P361, DOI 10.1038/NMETH872; Lamken P, 2005, J MOL BIOL, V350, P476, DOI 10.1016/j.jmb.2005.05.008; Levin D, 2011, MOL CELL BIOL, V31, P3252, DOI 10.1128/MCB.05251-11; Li ZL, 2008, J MOL BIOL, V377, P715, DOI 10.1016/j.jmb.2007.12.005; Marijanovic Z, 2007, BIOCHEM J, V407, P141, DOI 10.1042/BJ20070605; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miknis ZJ, 2010, J MOL BIOL, V404, P650, DOI 10.1016/j.jmb.2010.09.068; Moraga I, 2009, MOL CELL BIOL, V29, P4778, DOI 10.1128/MCB.01808-08; Nudelman I, 2010, BIOCHEMISTRY-US, V49, P5117, DOI 10.1021/bi100041f; Pestka S, 2004, IMMUNOL REV, V202, P8, DOI 10.1111/j.0105-2896.2004.00204.x; Piehler J, 2000, J BIOL CHEM, V275, P40425, DOI 10.1074/jbc.M006854200; Quadt-Akabayov SR, 2006, PROTEIN SCI, V15, P2656, DOI 10.1110/ps.062283006; Radhakrishnan R, 1996, STRUCTURE, V4, P1453, DOI 10.1016/S0969-2126(96)00152-9; Roisman LC, 2005, J MOL BIOL, V353, P271, DOI 10.1016/j.jmb.2005.08.042; Roisman LC, 2001, P NATL ACAD SCI USA, V98, P13231, DOI 10.1073/pnas.221290398; Schindler C, 2008, SEMIN CELL DEV BIOL, V19, P311, DOI 10.1016/j.semcdb.2008.08.010; Strunk JJ, 2008, J MOL BIOL, V377, P725, DOI 10.1016/j.jmb.2008.01.017; Uze G, 2007, CURR TOP MICROBIOL, V316, P71; van Boxel-Dezaire AHH, 2006, IMMUNITY, V25, P361, DOI 10.1016/j.immuni.2006.08.014; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; WALTER MR, 1995, NATURE, V376, P230, DOI 10.1038/376230a0; Walter MR, 2004, ADV PROTEIN CHEM, V68, P171; Wang XQ, 2009, ANNU REV IMMUNOL, V27, P29, DOI 10.1146/annurev.immunol.24.021605.090616; Zdanov A, 2010, CYTOKINE GROWTH F R, V21, P325, DOI 10.1016/j.cytogfr.2010.08.003	45	251	263	0	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 19	2011	146	4					621	632		10.1016/j.cell.2011.06.048	http://dx.doi.org/10.1016/j.cell.2011.06.048			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	809HY	21854986	Green Accepted, Bronze			2022-12-28	WOS:000294043600016
J	Swinburn, BA; Sacks, G; Hall, KD; McPherson, K; Finegood, DT; Moodie, ML; Gortmaker, SL				Swinburn, Boyd A.; Sacks, Gary; Hall, Kevin D.; McPherson, Klim; Finegood, Diane T.; Moodie, Marjory L.; Gortmaker, Steven L.			Obesity 1 The global obesity pandemic: shaped by global drivers and local environments	LANCET			English	Article							CHILDHOOD OBESITY; PHYSICAL-ACTIVITY; WEIGHT-GAIN; MISSING HERITABILITY; FOOD-INDUSTRY; UNITED-STATES; BODY-SIZE; TRENDS; HEALTH; POLICY	The simultaneous increases in obesity in almost all countries seem to be driven mainly by changes in the global food system, which is producing more processed, affordable, and effectively marketed food than ever before. This passive overconsumption of energy leading to obesity is a predictable outcome of market economies predicated on consumption-based growth. The global food system drivers interact with local environmental factors to create a wide variation in obesity prevalence between populations. Within populations, the interactions between environmental and individual factors, including genetic makeup, explain variability in body size between individuals. However, even with this individual variation, the epidemic has predictable patterns in subpopulations. In low-income countries, obesity mostly affects middle-aged adults (especially women) from wealthy, urban environments; whereas in high-income countries it affects both sexes and all ages, but is disproportionately greater in disadvantaged groups. Unlike other major causes of preventable death and disability, such as tobacco use, injuries, and infectious diseases, there are no exemplar populations in which the obesity epidemic has been reversed by public health measures. This absence increases the urgency for evidence-creating policy action, with a priority on reduction of the supply-side drivers.	[Swinburn, Boyd A.; Sacks, Gary] Deakin Univ, WHO Collaborating Ctr Obes Prevent, Melbourne, Vic 3125, Australia; [Hall, Kevin D.] NIDDKD, NIH, Washington, DC USA; [McPherson, Klim] Univ Oxford, New Coll, Oxford, England; [Finegood, Diane T.] Simon Fraser Univ, Dept Biomed Physiol & Kinesiol, Vancouver, BC, Canada; [Gortmaker, Steven L.] Harvard Univ, Dept Soc Human Dev & Hlth, Harvard Sch Publ Hlth, Boston, MA 02115 USA	Deakin University; World Health Organization; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of Oxford; Simon Fraser University; Harvard University; Harvard T.H. Chan School of Public Health	Swinburn, BA (corresponding author), Deakin Univ, WHO Collaborating Ctr Obes Prevent, Melbourne, Vic 3125, Australia.	boyd.swinburn@deakin.edu.au	NSABIMANA, Samuel/U-5620-2017; Hall, Kevin/F-2383-2010; Sacks, Gary/I-5731-2014	Hall, Kevin/0000-0003-4062-3133; Sacks, Gary/0000-0001-9736-1539; Moodie, Marjory/0000-0001-6890-5250	National Collaborative on Childhood Obesity Research; RWJF [260639, 61468, 66284]; CDC [U48/DP00064-00S1, 1U48DP001946]; NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO [U48DP000064, U48DP001946] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK013036] Funding Source: NIH RePORTER	National Collaborative on Childhood Obesity Research; RWJF; CDC(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was done under auspices of the Collaborative Obesity Modeling Network as part of the Envision Project, supported by the National Collaborative on Childhood Obesity Research, which coordinates childhood obesity research across the National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), Department of Agriculture, and the Robert Wood Johnson Foundation (RWJF). This work was supported in part by grants from RWJF (grant numbers 260639, 61468 and 66284), CDC (U48/DP00064-00S1 and 1U48DP001946), including the Nutrition and Obesity Policy, Research and Evaluation Network, and the Office of Behavioral and Social Sciences Research of NIH. This work is solely the responsibility of the authors and does not represent official views of the Centers for Disease Control and Prevention or any of the other funders.	Ahmed F, 2010, NATURE, V468, pS20, DOI 10.1038/468S20a; Anand P, 2009, KYKLOS, V62, P182, DOI 10.1111/j.1467-6435.2009.00430.x; [Anonymous], 2000, FoodReview, V23, P8; [Anonymous], NUTR CONTENT US FOOD; [Anonymous], 1948, JAMA-J AM MED ASSOC, V138, P972; [Australian Institute of Health and Welfare (AIHW) National Heart Foundation of Australia], 2004, CARD DIS SER AIHW, V23; BARKER DJP, 1989, LANCET, V2, P577; Bell AC, 2002, OBES RES, V10, P277, DOI 10.1038/oby.2002.38; Blundell JE, 1996, CIBA F SYMP, V201, P138; Bogardus C, 2009, OBESITY, V17, P209, DOI 10.1038/oby.2008.613; Bouchard C, 2008, OBESITY, V16, pS5, DOI 10.1038/oby.2008.528; Bray GA, 2004, PHYSIOL BEHAV, V82, P115, DOI 10.1016/j.physbeh.2004.04.033; Brownell KD, 2009, NEW ENGL J MED, V360, P1805, DOI 10.1056/NEJMp0902392; Brownell KD, 2009, MILBANK Q, V87, P259, DOI 10.1111/j.1468-0009.2009.00555.x; Burke C., 2010, CHILDRENS FOOD BEVER; Butland B, 2007, FORESIGHT TACKLING O; Chaput JP, 2008, SLEEP, V31, P517, DOI 10.1093/sleep/31.4.517; Cohen DA, 2008, DIABETES, V57, P1768, DOI 10.2337/db08-0163; Comuzzie AG, 1998, SCIENCE, V280, P1374, DOI 10.1126/science.280.5368.1374; Corporate Europe Observatory, 2010, RED LIGHT CONS INF F; Cross-Government Obesity Unit, 2008, HLTH WEIGHT HLTH LIV; Cutler DM, 2003, J ECON PERSPECT, V17, P93, DOI 10.1257/089533003769204371; de Silva-Sanigorski AM, 2010, AM J CLIN NUTR, V91, P831, DOI 10.3945/ajcn.2009.28826; Department of Economic and Social Affairs Population Division, 2009, WORLD POP PROSP 2008; Economic Research Service US Department of Agriculture, FOOD AV PER CAP DAT; Egger Garry, 2010, PLANET OBESITY WERE; European Union, 2009, EU PLEDG 2009 MON RE; Ezzati M, 2004, COMP QUANTIFICATION; Finegood DT., 2011, HDB SOCIAL SCI OBESI, P208, DOI DOI 10.1093/OXFORDHB/9780199736362.013.0013; Finkelstein EA, 2005, ANNU REV PUBL HEALTH, V26, P239, DOI 10.1146/annurev.publhealth.26.021304.144628; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Food and Agriculture Organization of the United Nations, 2010, GLOB HUNG DECL STILL; Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935; Franco M, 2007, AM J EPIDEMIOL, V166, P1374, DOI 10.1093/aje/kwm226; Frank LD, 2004, AM J PREV MED, V27, P87, DOI 10.1016/j.amepre.2004.04.011; Freebairn J, 2010, AUST ECON REV, V43, P54, DOI 10.1111/j.1467-8462.2009.00581.x; Geneau R, 2010, LANCET, V376, P1689, DOI 10.1016/S0140-6736(10)61414-6; Gortmaker SL, 2011, LANCET, V378, P838, DOI 10.1016/S0140-6736(11)60815-5; Hall KD, 2011, LANCET, V378, P826, DOI 10.1016/S0140-6736(11)60812-X; Hall KD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007940; Hayashi F, 2006, BRIT J NUTR, V96, P1154, DOI 10.1017/BJN20061921; Hebebrand J, 2010, OBESITY FACTS, V3, P294, DOI 10.1159/000321537; Hoad V, 2010, AUST NZ J PUBL HEAL, V34, P214, DOI 10.1111/j.1753-6405.2010.00509.x; Institute of Medicine, 2006, FOOD MARK CHILDR YOU; [International Association for the Study of Obesity International Obesity Taskforce], GLOB OB PREV AD; [International Association for the Study of Obesity International Obesity Taskforce], GLOB CHILDH OV; Jackson Tim, 2009, PROSPERITY GROWTH TR; Jacobs P, 2004, EC HLTH MED CARE; James P, 2010, PREVENTING CHILDHOOD, P212; Jan S, 2006, INT J PEDIATR OBES, V1, P131, DOI 10.1080/17477160600881312; JENCKS C, 1980, AM SOCIOL REV, V45, P723, DOI 10.2307/2094892; Kitchen PJ, 2004, J ADVERTISING RES, V44, P19, DOI 10.1017/S0021849904040048; Koplan J., 2005, PREVENTING CHILDHOOD; Kuchler F, 2004, CHOICES MAGAZINE, P41; Kumanyika S, 2002, INT J OBESITY, V26, P425, DOI 10.1038/sj.ijo.0801938; Lange UC, 2010, BIOESSAYS, V32, P659, DOI 10.1002/bies.201000030; Larsen Thomas Meinert, 2010, N Engl J Med, V363, P2102, DOI 10.1056/NEJMoa1007137; Levy DT, 2010, OBES REV, V12, P387; Lobstein T., 2004, OBES REV S1, V5, P4, DOI [https://doi.org/10.1111/j.1467-789X.2004.00133.x, DOI 10.1111/J.1467-789X.2004.00133.X]; Lobstein T., 2007, FORESIGHT TACKLING O; Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P1, DOI 10.1596/978-0-8213-6262-4; Ludwig DS, 2008, JAMA-J AM MED ASSOC, V300, P1808, DOI 10.1001/jama.300.15.1808; Matsushita Y, 2004, OBES RES, V12, P205, DOI 10.1038/oby.2004.27; Mavoa HM, 2008, ASIA PAC J CLIN NUTR, V17, P375; Mazzocchi M., 2009, FAT EC NUTR HLTH EC; McCabe MP, 2001, ADOLESCENCE, V36, P225; McCarthy M, 2004, LANCET, V364, P2169, DOI 10.1016/S0140-6736(04)17613-7; McCormick B, 2007, OBES REV, V8, P161, DOI 10.1111/j.1467-789X.2007.00337.x; Mcmichael A.J., 2003, ATL HLTH CLIM; McMichael AJ, 2007, LANCET, V370, P1253, DOI 10.1016/S0140-6736(07)61256-2; Mendez MA, 2005, AM J CLIN NUTR, V81, P714; Monteiro CA, 2004, B WORLD HEALTH ORGAN, V82, P940; Monteiro CA, 2007, AM J PUBLIC HEALTH, V97, P1808, DOI 10.2105/AJPH.2006.099630; Moodie R, 2006, INT J PEDIATR OBES, V1, P133, DOI 10.1080/17477160600845044; Morley B, 2008, AUST NZ J PUBL HEAL, V32, P341, DOI 10.1111/j.1753-6405.2008.00252.x; Mytton O, 2007, J EPIDEMIOL COMMUN H, V61, P689, DOI 10.1136/jech.2006.047746; *NAT OB TASKF, 2003, HLTH WEIGHT 2008 AUS; National Health and Medical Research Council (NHMRC), 1997, EC ISS PREV TREATM O; National Preventative Health Taskforce, 2009, AUSTR HLTH COUNTR 20; Keke K, 2007, NAURU NCD RISK FACTO; Ni Mhurchu C, 2010, AM J CLIN NUTR, V91, P736, DOI 10.3945/ajcn.2009.28742; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Olshansky SJ, 2005, NEW ENGL J MED, V352, P1138, DOI 10.1056/NEJMsr043743; Philipson TJ, 2003, PERSPECT BIOL MED, V46, pS87; Popkin BM, 1998, PUBLIC HEALTH NUTR, V1, P5, DOI 10.1079/PHN19980004; Putnam J., 2002, FoodReview, V25, P2; Putnam J., 2000, FoodReview, V23, P2; RITTEL HWJ, 1973, POLICY SCI, V4, P155, DOI 10.1007/BF01405730; Rodgers JL, 2010, AM PSYCHOL, V65, P1, DOI 10.1037/a0018326; Rokholm B, 2010, OBES REV, V11, P835, DOI 10.1111/j.1467-789X.2010.00810.x; Rush Elaine, 2004, N Z Med J, V117, pU1203; Sacks G, 2011, INT J OBESITY, V35, P1001, DOI 10.1038/ijo.2010.228; Sacks G, 2009, OBES REV, V10, P76, DOI 10.1111/j.1467-789X.2008.00524.x; Sanigorski AM, 2008, INT J OBESITY, V32, P1060, DOI 10.1038/ijo.2008.79; Sassi F., 2009, OBESITY EPIDEMIC ANA; Sassi F., 2010, OBESITY EC PREVENTIO; Scarborough P, 2011, BRIT J NUTR, V105, P1399, DOI 10.1017/S0007114510005076; Stein AD, 2007, AM J CLIN NUTR, V85, P869, DOI 10.1093/ajcn/85.3.869; Stender S, 2006, NEW ENGL J MED, V354, P1650, DOI 10.1056/NEJMc052959; Stewart Susan T, 2009, N Engl J Med, V361, P2252, DOI 10.1056/NEJMsa0900459; Swinburn B, 2008, HDB OBESITY CLIN APP, P177; Swinburn B, 2008, PUBLIC HEALTH NUTR, V11, P881, DOI 10.1017/S136898000800284X; Swinburn B, 2009, AM J CLIN NUTR, V90, P1453, DOI 10.3945/ajcn.2009.28595; Tickner J. A., 1999, PRECAUTIONARY PRINCI; UK Office of Communications, 2010, HFSS ADV RESTR FIN R; Vandenbroeck I.P., 2007, TACKLING OBESITIES F; Wang YC, 2011, LANCET, V378, P815, DOI 10.1016/S0140-6736(11)60814-3; Wang Y, 2006, INT J PEDIATR OBES, V1, P11, DOI 10.1080/17477160600586747; Weiss RA, 2004, NAT MED, V10, pS70, DOI 10.1038/nm1150; White House Task Force on Childhood Obesity, 2010, SOLV PROBL CHILDH OB; WHO, 1986, 1 INT C HLTH PROM OT, DOI DOI 10.1093/HEAPRO/1.4.405; Wilkinson RG, 2006, SOC SCI MED, V62, P1768, DOI 10.1016/j.socscimed.2005.08.036; World Cancer Research Fund & American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P; World Health Organization, 2004, GLOB STRAT DIET PHYS; World Health Organization, 2005, RED RISKS PROM HLTH; World Health Organization (WHO), 2008, FRAM MON EV IMPL GLO; Yach D, 2010, GLOBALIZATION HEALTH, V6, DOI 10.1186/1744-8603-6-10; Yajnik CS, 2010, DIABETES CARE, V33, P1146, DOI 10.2337/dc10-0407	119	2669	2756	15	557	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG-SEP	2011	378	9793					804	814		10.1016/S0140-6736(11)60813-1	http://dx.doi.org/10.1016/S0140-6736(11)60813-1			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	816FY	21872749				2022-12-28	WOS:000294585300036
J	Murray, CJL				Murray, Christopher J. L.			Why is Japanese life expectancy so high?	LANCET			English	Editorial Material									Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98121 USA	Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle	Murray, CJL (corresponding author), Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98121 USA.	cjlm@uw.edu						Gakidou E, 2010, LANCET, V376, P959, DOI 10.1016/S0140-6736(10)61257-3; Ikeda N, 2008, B WORLD HEALTH ORGAN, V86, P978, DOI 10.2471/BLT.07.050195; Ikeda N, 2011, LANCET, V378, P1094, DOI 10.1016/S0140-6736(11)61055-6; Kulkarni SC, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-16; Organisation for Economic Co-operation and Development, 2011, STATEXTRACTS HLTH EX; Roth GA, 2011, B WORLD HEALTH ORGAN, V89, P89; World Health Organization, 2000, WORLD HLTH REP 2000	7	20	21	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 24	2011	378	9797					1124	1125		10.1016/S0140-6736(11)61221-X	http://dx.doi.org/10.1016/S0140-6736(11)61221-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	829RH	21885112				2022-12-28	WOS:000295601500007
J	D'Costa, VM; King, CE; Kalan, L; Morar, M; Sung, WWL; Schwarz, C; Froese, D; Zazula, G; Calmels, F; Debruyne, R; Golding, GB; Poinar, HN; Wright, GD				D'Costa, Vanessa M.; King, Christine E.; Kalan, Lindsay; Morar, Mariya; Sung, Wilson W. L.; Schwarz, Carsten; Froese, Duane; Zazula, Grant; Calmels, Fabrice; Debruyne, Regis; Golding, G. Brian; Poinar, Hendrik N.; Wright, Gerard D.			Antibiotic resistance is ancient	NATURE			English	Article							YUKON-TERRITORY; PERMAFROST; RESISTOME; SEDIMENTS; BACTERIA; MAMMALS; ICE	The discovery of antibiotics more than 70 years ago initiated a period of drug innovation and implementation in human and animal health and agriculture. These discoveries were tempered in all cases by the emergence of resistant microbes(1,2). This history has been interpreted to mean that antibiotic resistance in pathogenic bacteria is a modern phenomenon; this view is reinforced by the fact that collections of microbes that predate the antibiotic era are highly susceptible to antibiotics(3). Here we report targeted metagenomic analyses of rigorously authenticated ancient DNA from 30,000-year-old Beringian permafrost sediments and the identification of a highly diverse collection of genes encoding resistance to beta-lactam, tetracycline and glycopeptide antibiotics. Structure and function studies on the complete vancomycin resistance element VanA confirmed its similarity to modern variants. These results show conclusively that antibiotic resistance is a natural phenomenon that predates the modern selective pressure of clinical antibiotic use.	[D'Costa, Vanessa M.; Kalan, Lindsay; Morar, Mariya; Poinar, Hendrik N.; Wright, Gerard D.] McMaster Univ, Michael G DeGroote Inst Infect Dis Res, Hamilton, ON L8N 3Z5, Canada; [D'Costa, Vanessa M.; Kalan, Lindsay; Morar, Mariya; Wright, Gerard D.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8N 3Z5, Canada; [King, Christine E.; Schwarz, Carsten; Poinar, Hendrik N.] McMaster Univ, Dept Anthropol, McMaster Ancient DNA Ctr, Hamilton, ON L8S 4L9, Canada; [King, Christine E.; Sung, Wilson W. L.; Golding, G. Brian; Poinar, Hendrik N.] McMaster Univ, Dept Biol, Hamilton, ON L8S 4K1, Canada; [Froese, Duane; Calmels, Fabrice] Univ Alberta, Dept Earth & Atmospher Sci, Edmonton, AB T6G 2E3, Canada; [Zazula, Grant] Yukon Govt, Dept Tourism & Culture, Yukon Palaeontol Program, Whitehorse, YT Y1A 2C6, Canada; [Debruyne, Regis] Museum Natl Hist Nat, UMR Ecoanthropol 7206, F-75231 Paris 05, France	McMaster University; McMaster University; McMaster University; McMaster University; University of Alberta; Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Universite Paris Cite	Wright, GD (corresponding author), McMaster Univ, Michael G DeGroote Inst Infect Dis Res, Hamilton, ON L8N 3Z5, Canada.	poinarh@mcmaster.ca; wrightge@mcmaster.ca	Wright, G/ABB-7666-2021; Debruyne, Régis/G-7839-2011	Debruyne, Régis/0000-0002-7002-3940; Wright, Gerard/0000-0002-9129-7131; Sung, Wilson/0000-0002-4703-5118; Kalan, Lindsay/0000-0003-4980-5128	Canada Research Chairs; Canadian Institutes of Health Research [MOP-79488]; Natural Sciences and Engineering Research Council of Canada	Canada Research Chairs(Canada Research ChairsCGIAR); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	We thank A. Guarne for assistance in X-ray data collection. This work was supported by Canada Research Chairs to D. F., H.N.P. and G. D. W., a Canadian Institutes of Health Research operating grant to G. D. W.(MOP-79488) and a scholarship to V. M. D., and by grants from the Natural Sciences and Engineering Research Council of Canada to D. F. and H.N.P. and scholarship to C.E.K.	Baltz R. H., 2005, SIM NEWS, V55, P186; Brock F, 2010, QUAT GEOCHRONOL, V5, P625, DOI 10.1016/j.quageo.2010.06.003; Courvalin P, 2006, CLIN INFECT DIS, V42, pS25, DOI 10.1086/491711; D'Costa VM, 2006, SCIENCE, V311, P374, DOI 10.1126/science.1120800; Dantas G, 2008, SCIENCE, V320, P100, DOI 10.1126/science.1155157; Demuro M, 2008, QUAT GEOCHRONOL, V3, P346, DOI 10.1016/j.quageo.2007.12.003; DOYLE D, 1991, MOL MICROBIOL, V5, P2923, DOI 10.1111/j.1365-2958.1991.tb01852.x; Froese DG, 2009, GSA TODAY, V19, P4, DOI DOI 10.1130/GSATG54A.1; Froese DG, 2006, QUATERNARY SCI REV, V25, P1542, DOI 10.1016/j.quascirev.2006.01.028; Gilichinsky David, 2008, P83, DOI 10.1007/978-3-540-74335-4_6; Haile J, 2009, P NATL ACAD SCI USA, V106, P22352, DOI 10.1073/pnas.0912510106; Hall BG, 2004, DRUG RESIST UPDATE, V7, P111, DOI 10.1016/j.drup.2004.02.003; HARINGTON CR, 1973, CAN J EARTH SCI, V10, P697, DOI 10.1139/e73-069; HUGHES VM, 1983, NATURE, V302, P725, DOI 10.1038/302725a0; Livermore DM, 2009, J ANTIMICROB CHEMOTH, V64, P29, DOI 10.1093/jac/dkp255; Mindlin SZ, 2008, RUSS J GENET+, V44, P27, DOI 10.1134/S1022795408010043; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Sommer MOA, 2009, SCIENCE, V325, P1128, DOI 10.1126/science.1176950; Willerslev E, 2004, TRENDS ECOL EVOL, V19, P141, DOI 10.1016/j.tree.2003.11.010; Wright GD, 2007, NAT REV MICROBIOL, V5, P175, DOI 10.1038/nrmicro1614; Zazula GD, 2003, NATURE, V423, P603, DOI 10.1038/423603a	21	1378	1453	50	1050	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 22	2011	477	7365					457	461		10.1038/nature10388	http://dx.doi.org/10.1038/nature10388			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822WH	21881561				2022-12-28	WOS:000295080500039
J	Staiger, DO; Auerbach, DI; Buerhaus, PI				Staiger, Douglas O.; Auerbach, David I.; Buerhaus, Peter I.			Health Care Reform and the Health Care Workforce - The Massachusetts Experience	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Staiger, Douglas O.] Dartmouth Coll, Dept Econ, Hanover, NH 03755 USA; [Staiger, Douglas O.] Natl Bur Econ Res, Cambridge, MA 02138 USA; [Auerbach, David I.] RAND, Boston, MA USA; [Buerhaus, Peter I.] Vanderbilt Univ, Med Ctr, Ctr Interdisciplinary Hlth Workforce Studies, Inst Med & Publ Hlth, Nashville, TN USA	Dartmouth College; National Bureau of Economic Research; RAND Corporation; Vanderbilt University	Staiger, DO (corresponding author), Dartmouth Coll, Dept Econ, Hanover, NH 03755 USA.							[Anonymous], 2010, COMM REP STAT REF DO; Long SK, 2010, HEALTH AFFAIR, V29, P1234, DOI 10.1377/hlthaff.2010.0337; SteelFisher GK, 2009, NEW ENGL J MED, V361, DOI 10.1056/NEJMp0909851; Weissman JS, 2009, NEW ENGL J MED, V361, P2012, DOI 10.1056/NEJMp0909295	4	17	17	1	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 22	2011	365	12								10.1056/NEJMp1106616	http://dx.doi.org/10.1056/NEJMp1106616			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	822WR	21899443				2022-12-28	WOS:000295081600001
J	McCartney, M				McCartney, Margaret			PERSONAL VIEW Adult and child asylum seekers should be treated with humanity	BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				McCartney M, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4106	1	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 7	2011	343								d5571	10.1136/bmj.d5571	http://dx.doi.org/10.1136/bmj.d5571			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	819RQ	21900348				2022-12-28	WOS:000294847800005
J	Orbach, RL				Orbach, Raymond L.			John Harmen Marburger III (1941-2011)	SCIENCE			English	Biographical-Item									Univ Texas Austin, Energy Inst, Austin, TX 78705 USA	University of Texas System; University of Texas Austin	Orbach, RL (corresponding author), Univ Texas Austin, Energy Inst, Austin, TX 78705 USA.							MARBURGER JH, PUBLICATION LIST, DOI DOI 10.1098/RSTB.2010.0133	1	0	0	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 2	2011	333	6047					1233	1233		10.1126/science.1212357	http://dx.doi.org/10.1126/science.1212357			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	813YM	21885766				2022-12-28	WOS:000294406400034
J	Linden, JA				Linden, Judith A.			Care of the Adult Patient after Sexual Assault	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; HIV POSTEXPOSURE PROPHYLAXIS; PHYSICAL INJURY; FEMALE VICTIMS; FORENSIC EVIDENCE; RISK-FACTORS; RAPE; WOMEN; SEROCONVERSION; TRANSMISSION	A 20-year-old woman presents to the emergency department with a report of having been sexually assaulted 24 hours earlier. She reports that a man she had met at a campus party walked her to her apartment, where he assaulted and raped her, including vaginal penetration. She did not report the assault to the police but confided in a friend, who encouraged her to seek medical care. How should this patient be evaluated and treated?	[Linden, Judith A.] Boston Med Ctr, Dept Emergency Med, Boston, MA 02118 USA; [Linden, Judith A.] Boston Univ, Sch Med, Boston, MA 02118 USA	Boston Medical Center; Boston University	Linden, JA (corresponding author), Boston Med Ctr, Dept Emergency Med, 1 Boston Med Ctr Pl,Dowling 1 S, Boston, MA 02118 USA.	jlinden@bu.edu		Linden, Judith/0000-0002-2677-3410				Acierno R, 1999, J ANXIETY DISORD, V13, P541, DOI 10.1016/S0887-6185(99)00030-4; American College of Emergency Physicians, MAN PAT COMPL SEX AS; [Anonymous], 2004, 206554 NCJ DEP JUST; Balsam KF, 2005, J CONSULT CLIN PSYCH, V73, P477, DOI 10.1037/0022-006X.73.3.477; Boily MC, 2009, LANCET INFECT DIS, V9, P118, DOI 10.1016/S1473-3099(09)70021-0; Campbell R, 2005, TRAUMA VIOLENCE ABUS, V6, P313, DOI 10.1177/1524838005280328; Campbell R, 2009, CRIM JUSTICE BEHAV, V36, P712, DOI 10.1177/0093854809335054; Cardo DM, 1997, NEW ENGL J MED, V337, P1485, DOI 10.1056/NEJM199711203372101; CARTWRIGHT PS, 1987, OBSTET GYNECOL, V70, P44; Coker AL, 1998, J INTERPERS VIOLENCE, V13, P605, DOI 10.1177/088626098013005004; CONNOR EM, 1994, NEW ENGL J MED, V331, P1173, DOI 10.1056/NEJM199411033311801; Crandall CS, 2003, IMPACT EVALUATION SE; Du Mont J, 2008, SEX TRANSM DIS, V35, P973, DOI 10.1097/OLQ.0b013e3181824f3c; Feldhaus KM, 2000, ANN EMERG MED, V36, P23, DOI 10.1067/mem.2000.107660; Fisher BS, 2000, 182369 NCJ NAT I JUS; Foa EB, 2006, J TRAUMA STRESS, V19, P29, DOI 10.1002/jts.20096; Gray-Eurom K, 2002, ANN EMERG MED, V39, P39, DOI 10.1067/mem.2002.118013; Hertzen H, 2002, LANCET, V360, P1803; Hilden M, 2005, FORENSIC SCI INT, V154, P200, DOI 10.1016/j.forsciint.2004.10.010; Holmes MM, 1996, AM J OBSTET GYNECOL, V175, P320, DOI 10.1016/S0002-9378(96)70141-2; KAUFMAN A, 1980, AM J PSYCHIAT, V137, P221; Krebs CP, 2009, J AM COLL HEALTH, V57, P639, DOI 10.3200/JACH.57.6.639-649; Landovitz RJ, 2009, NEW ENGL J MED, V361, P1768, DOI 10.1056/NEJMcp0904189; Lawyer S, 2010, J AM COLL HEALTH, V58, P453, DOI 10.1080/07448480903540515; Ledray L E, 1997, J Emerg Nurs, V23, P75, DOI 10.1016/S0099-1767(97)90070-2; Linden JA, 2005, ACAD EMERG MED, V12, P640, DOI 10.1197/j.aem.2005.01.015; McGregor MJ, 1999, CAN MED ASSOC J, V160, P1565; MURPHY S, 1989, BRIT MED J, V299, P718, DOI 10.1136/bmj.299.6701.718; National Victim Center, 1992, RAP AM REP NAT; Nugent-Boracove ME, 2006, TESTING EFFICACY SAN; Palmer Cheryn M, 2004, Sex Health, V1, P55, DOI 10.1071/SH03004; Paras ML, 2009, JAMA-J AM MED ASSOC, V302, P550, DOI 10.1001/jama.2009.1091; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; RAMBOW B, 1992, ANN EMERG MED, V21, P727, DOI 10.1016/S0196-0644(05)82788-X; Rich JD, 2002, JAMA-J AM MED ASSOC, V288, P164, DOI 10.1001/jama.288.2.164; Riggs N, 2000, ANN EMERG MED, V35, P358, DOI 10.1016/S0196-0644(00)70054-0; Sachs CJ, 2002, ACAD EMERG MED, V9, P146, DOI 10.1197/aemj.9.2.146; Scalzo TP, 2006, RAPE SEXUAL ASSAULT; Sievers Valerie, 2003, J Emerg Nurs, V29, P511, DOI 10.1016/j.jen.2003.08.010; Sommers MS, 2007, TRAUMA VIOLENCE ABUS, V8, P270, DOI 10.1177/1524838007303194; Spohn C, 2001, SOC PROBL, V48, P206, DOI 10.1525/sp.2001.48.2.206; Sugar NF, 2004, AM J OBSTET GYNECOL, V190, P71, DOI 10.1016/S0002-9378(03)00912-8; The American Congress of Obstetricians and Gynecologists, SCREEN TOOLS SEX ASS; Thoennes, 2006, EXTENT NATURE CONSEQ; Tjaden P., 2000, 183781 NCJ NAT I JUS; Vandercam B, 1992, Acta Urol Belg, V60, P77; Vickerman KA, 2009, CLIN PSYCHOL REV, V29, P431, DOI 10.1016/j.cpr.2009.04.004; Wiebe ER, 2000, CAN MED ASSOC J, V162, P641; Workowski Kimberly A., 2011, Morbidity and Mortality Weekly Report, V60, P18; Workowski Kimberly A, 2010, MMWR Recomm Rep, V59, P1; World Health Organization, 2003, GUID MED CAR VICT SE	51	60	60	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 1	2011	365	9					834	841		10.1056/NEJMcp1102869	http://dx.doi.org/10.1056/NEJMcp1102869			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	813YC	21879901				2022-12-28	WOS:000294405200010
J	Baerlocher, C; Weber, T; McCusker, LB; Palatinus, L; Zones, SI				Baerlocher, Christian; Weber, Thomas; McCusker, Lynne B.; Palatinus, Lukas; Zones, Stacey I.			Unraveling the Perplexing Structure of the Zeolite SSZ-57	SCIENCE			English	Article							POWDER DIFFRACTION	Previous high-resolution x-ray powder diffraction and transmission electron microscopy studies of the zeolite SSZ-57 could not fully elucidate the structural basis for its puzzling adsorption behavior, which appears to be intermediate between that of a medium-(10-ring) and a large-pore (12-ring) zeolite. Now by applying advanced crystallographic techniques (structure solution in four-dimensional space and interpretation of three-dimensional diffuse scattering by Monte Carlo simulation) and crystal chemistry considerations to high-quality single-crystal x-ray diffraction data collected on a microcrystal (about 2 micrometers by 2 micrometers by 8 micrometers), we have been able to derive a comprehensive description of its silicate framework structure. The framework is related to that of ZSM-11 but is commensurately modulated along the c axis (P (4) over bar m2, a = b = 20.091 angstrom, c = 110.056 angstrom) to yield a structure with a 12-ring:10-ring ratio of 1:15. Disorder of the 12-rings results in a three-dimensional 10-ring channel system with large isolated pockets. The structure helps to clarify the material's catalytic activity.	[Baerlocher, Christian; Weber, Thomas; McCusker, Lynne B.] ETH, Lab Crystallog, CH-8093 Zurich, Switzerland; [Palatinus, Lukas] Acad Sci Czech Republic, Inst Phys, Dept Struct Anal, Prague 18221, Czech Republic; [Zones, Stacey I.] Chevron Energy Technol Co, Richmond, CA 94802 USA	Swiss Federal Institutes of Technology Domain; ETH Zurich; Czech Academy of Sciences; Institute of Physics of the Czech Academy of Sciences; Chevron	McCusker, LB (corresponding author), ETH, Lab Crystallog, CH-8093 Zurich, Switzerland.	mccusker@mat.ethz.ch	Palatinus, Lukas/E-8358-2012; Palatinus, Lukas/AAG-6913-2019	Palatinus, Lukas/0000-0002-8987-8164; McCusker, Lynne/0000-0003-0074-1733; Weber, Thomas/0000-0003-1429-9915	Swiss National Science Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	We thank S. Elomari for synthesizing the SSZ-57 sample. Crystallographic experiments were conducted at the X06SA beamline at the Swiss Light Source, Paul Scherrer Institute, Villigen, Switzerland. We thank the staff there for assistance with the data collection. This work was funded in part by the Swiss National Science Foundation. Additional information on the indexing, the structure solution, the model construction and the Monte Carlo simulations is available in the supporting online material.	Baerlocher C., 2007, ATLAS ZEOLITE FRAMEW; Baerlocher Ch., 1977, DLS 76 DISTANCE LEAS; Baerlocher C, 2007, SCIENCE, V315, P1113, DOI 10.1126/science.1137920; Brenner S, 1997, J APPL CRYSTALLOGR, V30, P1167, DOI 10.1107/S0021889897011291; Broennimann C, 2006, J SYNCHROTRON RADIAT, V13, P120, DOI 10.1107/S0909049505038665; Burton AW, 2007, STUD SURF SCI CATAL, V170, P690; Carpenter JR, 2010, J CATAL, V269, P64, DOI 10.1016/j.jcat.2009.10.016; Dusek M., 2006, JANA2006; Elomari S., 2003, US Pat., Patent No. [6 544 495, 6544495]; Elomari S., 2003, U. S. Patent, Patent No. [6,616,830, 6616830]; Gies H., CATALOG DISORDER ZEO; Gramm F, 2006, NATURE, V444, P79, DOI 10.1038/nature05200; Kim J, 2011, ACS CATAL, V1, P337, DOI 10.1021/cs100160g; KOKOTAILO GT, 1978, NATURE, V275, P119, DOI 10.1038/275119a0; Koo JB, 2010, J CATAL, V276, P327, DOI 10.1016/j.jcat.2010.09.024; Oszlanyi G, 2004, ACTA CRYSTALLOGR A, V60, P134, DOI 10.1107/S0108767303027569; Oszlanyi G, 2008, ACTA CRYSTALLOGR A, V64, P123, DOI 10.1107/S0108767307046028; Palatinus L, 2008, J APPL CRYSTALLOGR, V41, P975, DOI 10.1107/S0021889808028185; Palatinus L, 2004, ACTA CRYSTALLOGR A, V60, P604, DOI 10.1107/S0108767304022433; Palatinus L, 2007, J APPL CRYSTALLOGR, V40, P786, DOI 10.1107/S0021889807029238; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Smaalen S. v., 2007, INCOMMENSURATE CRYST; Zones SI, 2007, J CATAL, V250, P41, DOI 10.1016/j.jcat.2007.05.005; Zones SI, 2011, SOLID STATE SCI, V13, P706, DOI 10.1016/j.solidstatesciences.2010.08.004	24	59	63	2	125	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 26	2011	333	6046					1134	1137		10.1126/science.1207466	http://dx.doi.org/10.1126/science.1207466			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811VM	21868674				2022-12-28	WOS:000294244300045
J	Xu, XM; Wang, J; Xuan, ZY; Goldshmidt, A; Borrill, PGM; Hariharan, N; Kim, JY; Jackson, D				Xu, Xianfeng Morgan; Wang, Jing; Xuan, Zhenyu; Goldshmidt, Alexander; Borrill, Philippa G. M.; Hariharan, Nisha; Kim, Jae Yean; Jackson, David			Chaperonins Facilitate KNOTTED1 Cell-to-Cell Trafficking and Stem Cell Function	SCIENCE			English	Article							INTERCELLULAR MOVEMENT; HOMEODOMAIN PROTEIN; MESSENGER-RNA; ARABIDOPSIS; PLASMODESMATA; GENE; PREFOLDIN; TRANSPORT; REQUIRES	Cell-to-cell communication in plants includes the selective trafficking of transcription factors and other signals through plasmodesmata. The KNOTTED1 (KN1) homeobox (KNOX) family transcription factors, which use this pathway, are essential for stem cell establishment and/or maintenance. Here we show that KN1 trafficking requires the chaperonin complex, which belongs to a group of cytosolic chaperones that fold specific substrate proteins. Genetic and physical interaction data show a functional relevance for chaperonins in KNOX family-dependent stem cell maintenance. Furthermore, tissue-specific complementation assays indicate a mechanistic basis for chaperonin function during the posttranslocational refolding process. Our study shows that chaperonins are essential for the cell-to-cell trafficking of a subset of mobile transcription factors and demonstrates the importance of chaperonin-dependent protein trafficking for plant stem cell function.	[Xu, Xianfeng Morgan; Wang, Jing; Xuan, Zhenyu; Goldshmidt, Alexander; Borrill, Philippa G. M.; Hariharan, Nisha; Kim, Jae Yean; Jackson, David] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Jackson, D (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	jacksond@cshl.edu	Borrill, Philippa/B-3199-2012	Goldshmidt, Alexander/0000-0001-7468-6779; Xuan, Zhenyu/0000-0001-9344-8493; Borrill, Philippa/0000-0002-7623-8256	Vaadia-Binational Agricultural Research and Development [FI-413]; Cold Spring Harbor Laboratory; Rural Development Administration, Korea [PJ008109]; NSF [1027003]; Division Of Integrative Organismal Systems [1027003] Funding Source: National Science Foundation	Vaadia-Binational Agricultural Research and Development; Cold Spring Harbor Laboratory; Rural Development Administration, Korea(Rural Development Administration (RDA), Republic of Korea); NSF(National Science Foundation (NSF)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank the Arabidopsis Biological Resource Center, K. Barton, P. Benfey, Y. Gu, J.-Y. Lee, and D. Chitwood for seeds and plasmids. We also thank M. Regulski for assisting with the Illumina sequencing library; T. Mulligan for plant care; and R. Martienssen, Z. Lippman, F Kragler, and members of the Jackson lab for discussion and comments on the manuscript. X. M. X. is a LSRF Fellow of the Life Sciences Research Foundation and a Chapman Fellow of the Chapman Foundation. A.G. is supported by the Vaadia-Binational Agricultural Research and Development Postdoctoral Fellowship Award FI-413. P.G.M.B. and N.H. were supported by the Cold Spring Harbor Laboratory's Undergraduate Research Program. J.Y.K. is currently supported by the Next-Generation BioGreen 21 Program (SSAC grant PJ008109), Rural Development Administration, Korea. This research is supported by the NSF (award 1027003). Author contributions: X.M.X. performed the imaging, RT-PCRs, immunoprecipitations (Ips), and genetic and transgenic analyses. J.W. started the screen and performed mutant cloning. Z.X. processed the Illumina sequencing data. P.G.M.B. assisted with the IP assays. N.H. analyzed the cct3-1 embryos. A.G. took the scanning electron microscopy images. J.Y.K. generated the starting line for mutagenesis. X.M.X. and D.J. analyzed the data and wrote the manuscript. All of the authors read and approved the manuscript.	Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Aoki K, 2002, P NATL ACAD SCI USA, V99, P16342, DOI 10.1073/pnas.252427999; Bouyer D, 2008, PLOS BIOL, V6, P1166, DOI 10.1371/journal.pbio.0060141; Carlsbecker A, 2010, NATURE, V465, P316, DOI 10.1038/nature08977; CRONSHAW J, 1980, J HISTOCHEM CYTOCHEM, V28, P375, DOI 10.1177/28.4.6445380; Dunoyer P, 2010, SCIENCE, V328, P912, DOI 10.1126/science.1185880; Fernandez-Calvino L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018880; Gu Y, 2008, P NATL ACAD SCI USA, V105, P18064, DOI 10.1073/pnas.0808652105; HAKE S, 1986, NATURE, V320, P621, DOI 10.1038/320621a0; Horwich AL, 2007, ANNU REV CELL DEV BI, V23, P115, DOI 10.1146/annurev.cellbio.23.090506.123555; Jakel S, 2002, EMBO J, V21, P377, DOI 10.1093/emboj/21.3.377; Kanrar S, 2006, PLANTA, V224, P1163, DOI 10.1007/s00425-006-0298-9; Kim I, 2005, CURR OPIN PLANT BIOL, V8, P593, DOI 10.1016/j.pbi.2005.09.013; Kim JY, 2005, GENE DEV, V19, P788, DOI 10.1101/gad.332805; Kim JY, 2003, DEVELOPMENT, V130, P4351, DOI 10.1242/dev.00618; Kragler F, 1998, PLANT J, V15, P367, DOI 10.1046/j.1365-313X.1998.00219.x; Kurata T, 2005, CURR OPIN PLANT BIOL, V8, P600, DOI 10.1016/j.pbi.2005.09.005; Long JA, 1996, NATURE, V379, P66, DOI 10.1038/379066a0; Lucas WJ, 2009, TRENDS CELL BIOL, V19, P495, DOI 10.1016/j.tcb.2009.07.003; LUCAS WJ, 1995, SCIENCE, V270, P1980, DOI 10.1126/science.270.5244.1980; Martin-Benito J, 2002, EMBO J, V21, P6377, DOI 10.1093/emboj/cdf640; Maule AJ, 2008, CURR OPIN PLANT BIOL, V11, P680, DOI 10.1016/j.pbi.2008.08.002; Nakajima K, 2001, NATURE, V413, P307, DOI 10.1038/35095061; OPPENHEIMER DG, 1991, CELL, V67, P483, DOI 10.1016/0092-8674(91)90523-2; Peremyslov VV, 1999, P NATL ACAD SCI USA, V96, P14771, DOI 10.1073/pnas.96.26.14771; Plath K, 2000, J CELL BIOL, V151, P167, DOI 10.1083/jcb.151.1.167; Vollbrecht E, 2000, DEVELOPMENT, V127, P3161; Weissman JS, 1996, CELL, V84, P481, DOI 10.1016/S0092-8674(00)81293-3; Winter N, 2007, PLANT CELL, V19, P3001, DOI 10.1105/tpc.107.044354; Wright KM, 2007, TRAFFIC, V8, P21, DOI 10.1111/j.1600-0854.2006.00510.x; Xu XM, 2010, CURR OPIN PLANT BIOL, V13, P684, DOI 10.1016/j.pbi.2010.09.003	31	100	114	3	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 26	2011	333	6046					1141	1144		10.1126/science.1205727	http://dx.doi.org/10.1126/science.1205727			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811VM	21868675				2022-12-28	WOS:000294244300047
J	Cleland, JGF; Teerlink, JR; Senior, R; Nifontov, EM; Mc Murray, JJV; Lang, CC; Tsyrlin, VA; Greenberg, BH; Mayet, J; Francis, DP; Shaburishvili, T; Monaghan, M; Saltzberg, M; Neyses, L; Wasserman, SM; Lee, JH; Saikali, KG; Clarke, CP; Goldman, JH; Wolff, AA; Malik, FI				Cleland, John G. F.; Teerlink, John R.; Senior, Roxy; Nifontov, Evgeny M.; Mc Murray, John J. V.; Lang, Chim C.; Tsyrlin, Vitaly A.; Greenberg, Barry H.; Mayet, Jamil; Francis, Darrel P.; Shaburishvili, Tamaz; Monaghan, Mark; Saltzberg, Mitchell; Neyses, Ludwig; Wasserman, Scott M.; Lee, Jacqueline H.; Saikali, Khalil G.; Clarke, Cyril P.; Goldman, Jonathan H.; Wolff, Andrew A.; Malik, Fady I.			The effects of the cardiac myosin activator, omecamtiv mecarbil, on cardiac function in systolic heart failure: a double-blind, placebo-controlled, crossover, dose-ranging phase 2 trial	LANCET			English	Article							RESYNCHRONIZATION THERAPY; CONSCIOUS DOGS; MILRINONE; MORTALITY	Background Many patients with heart failure remain symptomatic and have a poor prognosis despite existing treatments. Decreases in myocardial contractility and shortening of ventricular systole are characteristic of systolic heart failure and might be improved by a new therapeutic class, cardiac myosin activators. We report the first study of the cardiac myosin activator, omecamtiv mecarbil, in patients with systolic heart failure. Methods We undertook a double-blind, placebo-controlled, crossover, dose-ranging, phase 2 trial investigating the effects of omecamtiv mecarbil (formerly CK-1827452), given intravenously for 2, 24, or 72 h to patients with stable heart failure and left ventricular systolic dysfunction receiving guideline-indicated treatment. Clinical assessment (including vital signs, echocardiograms, and electrocardiographs) and testing of plasma drug concentrations took place during and after completion of each infusion. The primary aim was to assess safety and tolerability of omecamtiv mecarbil. This study is registered at ClinicalTrials.gov, NCT00624442. Findings 45 patients received 151 infusions of active drug or placebo. Placebo-corrected, concentration-dependent increases in left ventricular ejection time (up to an 80 ms increase from baseline) and stroke volume (up to 9.7 mL) were recorded, associated with a small reduction in heart rate (up to 2.7 beats per min; p<0.0001 for all three measures). Higher plasma concentrations were also associated with reductions in end-systolic (decrease of 15 mL at >500 ng/mL, p=0.0026) and end-diastolic volumes (16 mL, p=0.0096) that might have been more pronounced with increased duration of infusion. Cardiac ischaemia emerged at high plasma concentrations (two patients, plasma concentrations roughly 1750 ng/mL and 1350 ng/mL). For patients tolerant of all study drug infusions, no consistent pattern of adverse events with either dose or duration emerged. Interpretation Omecamtiv mecarbil improved cardiac function in patients with heart failure caused by left ventricular dysfunction and could be the first in class of a new therapeutic agent.	[Cleland, John G. F.] Univ Hull, Dept Cardiol, Hull York Med Sch, Kingston Upon Hull HU6 7RX, N Humberside, England; [Teerlink, John R.] Univ Calif San Francisco, Cardiol Sect, San Francisco Vet Affairs Med Ctr, San Francisco, CA 94143 USA; [Senior, Roxy] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England; [Senior, Roxy] Royal Brompton Hosp, London SW3 6LY, England; [Senior, Roxy] Northwick Pk Hosp & Clin Res Ctr, Harrow HA1 3UJ, Middx, England; [Nifontov, Evgeny M.] St Petersburg State Med Univ, St Petersburg, Russia; [Mc Murray, John J. V.] Univ Glasgow, Western Infirm, Glasgow G11 6NT, Lanark, Scotland; [Mc Murray, John J. V.] Univ Glasgow, British Heart Fdn, Glasgow Cardiovasc Res Ctr, Glasgow G11 6NT, Lanark, Scotland; [Lang, Chim C.] Univ Dundee, Ctr Cardiovasc & Lung Biol, Div Med Sci, Dundee DD1 4HN, Scotland; [Tsyrlin, Vitaly A.] Almazov Fed Heart Blood & Endocrinol Ctr, St Petersburg, Russia; [Greenberg, Barry H.] Univ Calif San Diego Med Ctr, San Diego, CA USA; [Mayet, Jamil; Francis, Darrel P.] St Marys Hosp, London, England; [Shaburishvili, Tamaz] Diagnost Serv Clin, Tbilisi, Georgia; [Monaghan, Mark] Kings Coll Hosp London, London, England; [Saltzberg, Mitchell] Jefferson Med Coll, Christiana Care Hlth Syst, Newark, DE USA; [Neyses, Ludwig; Clarke, Cyril P.] Univ Manchester, Manchester, Lancs, England; [Neyses, Ludwig] Manchester Royal Infirm, Manchester Acad Hlth Sci Ctr, Manchester M13 9WL, Lancs, England; [Wasserman, Scott M.] Amgen Inc, Thousand Oaks, CA 91320 USA; [Clarke, Cyril P.] ICON Dev Solut, UK Clin Res Unit, Manchester, Lancs, England; [Goldman, Jonathan H.] ICON Med Imaging, Warrington, PA USA; [Lee, Jacqueline H.; Saikali, Khalil G.; Wolff, Andrew A.; Malik, Fady I.] Cytokinetics Inc, San Francisco, CA USA	University of Hull; University of York - UK; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; Imperial College London; Royal Brompton Hospital; Imperial College London; Pavlov First Saint Petersburg State Medical University; University of Glasgow; University of Glasgow; University of Dundee; Almazov National Medical Research Centre; University of California System; University of California San Diego; Imperial College London; King's College Hospital NHS Foundation Trust; King's College Hospital; Christiana Care Health System; Jefferson University; University of Manchester; University of Manchester; Amgen; ICON plc; ICON plc	Cleland, JGF (corresponding author), Univ Hull, Dept Cardiol, Hull York Med Sch, Castle Hill Hosp, Med Res Bldg, Kingston Upon Hull HU16 5JQ, East Yorkshire, England.	j.g.cleland@hull.ac.uk	mcmurray, John/B-2467-2013; Nifontov, Evgeniy M/A-5954-2017; Cleland, John G./AAZ-4185-2020; Teerlink, John R/D-2986-2012; Neyses, Ludwig/AGY-7446-2022	mcmurray, John/0000-0002-6317-3975; Cleland, John G./0000-0002-1471-7016; Lang, Chim/0000-0002-4530-3078	Cytokinetics; Amgen; Cytokinetics Inc.; British Heart Foundation [FS/10/38/28268] Funding Source: researchfish	Cytokinetics; Amgen(Amgen); Cytokinetics Inc.; British Heart Foundation(British Heart Foundation)	JGFC, JRT, JJVM, and BHG have received research grants and consulting fees from Cytokinetics and Amgen, which is a licensee of omecamtiv mecarbil. RS, EMN, CCL, VAT, JM, DPF, TS, MM, MS, and LN have received research grants and consulting fees from Cytokinetics. SMW is an employee of Amgen. CPC is an employee of ICON Development Solutions (formerly Medeval, Manchester, UK). (HG is an employee of ICON Clinical Research, and formerly of ICON Medical Imaging, the echocardiogram core laboratory for this study. JHL, KGS, AAW, and FIM are employees of Cytokinetics, the sponsor of this study.; Funding: Cytokinetics Inc.	Asai K, 1998, AM J PHYSIOL-HEART C, V275, pH2219, DOI 10.1152/ajpheart.1998.275.6.H2219; Banfor PN, 2008, AM J PHYSIOL-HEART C, V294, pH238, DOI 10.1152/ajpheart.01181.2007; Cleland JGF, 2005, NEW ENGL J MED, V352, P1539, DOI 10.1056/NEJMoa050496; Cohn JN, 1998, NEW ENGL J MED, V339, P1810, DOI 10.1056/NEJM199812173392503; Cuffe MS, 2002, JAMA-J AM MED ASSOC, V287, P1541, DOI 10.1001/jama.287.12.1541; Doughty RN, 2004, CIRCULATION, V109, P201, DOI 10.1161/01.CIR.0000108928.25690.94; GWATHMEY JK, 1987, CIRC RES, V61, P70, DOI 10.1161/01.RES.61.1.70; KONSTAM MA, 1993, CIRCULATION, V88, P2277, DOI 10.1161/01.CIR.88.5.2277; Malik FI, 2011, SCIENCE, V331, P1439, DOI 10.1126/science.1200113; McMurray JJV, 2010, NEW ENGL J MED, V362, P228, DOI 10.1056/NEJMcp0909392; Morimoto S, 2008, CARDIOVASC RES, V77, P659, DOI 10.1093/cvr/cvm084; Moss AJ, 2009, NEW ENGL J MED, V361, P1329, DOI 10.1056/NEJMoa0906431; Neubauer S, 2007, NEW ENGL J MED, V356, P1140, DOI 10.1056/NEJMra063052; Shen YT, 2010, CIRC-HEART FAIL, V3, P522, DOI 10.1161/CIRCHEARTFAILURE.109.930321; Solomon SD, 2010, CIRCULATION, V122, P985, DOI 10.1161/CIRCULATIONAHA.110.955039; Teerlink JR, 2011, LANCET, V378, P667, DOI 10.1016/S0140-6736(11)61219-1	16	221	234	0	30	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 20	2011	378	9792					676	683		10.1016/S0140-6736(11)61126-4	http://dx.doi.org/10.1016/S0140-6736(11)61126-4			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	815EW	21856481				2022-12-28	WOS:000294509900027
J	Day, KP; Fowkes, FJI				Day, Karen P.; Fowkes, Freya J. I.			Quantifying Malaria Dynamics Within the Host	SCIENCE			English	Editorial Material							PLASMODIUM-FALCIPARUM		[Day, Karen P.] NYU, Sch Med, Dept Microbiol, Div Parasitol, New York, NY 10016 USA; [Fowkes, Freya J. I.] Macfarlane Burnet Inst, Ctr Populat Hlth, Melbourne, Vic 3004, Australia	New York University; Burnet Institute	Day, KP (corresponding author), NYU, Sch Med, Dept Microbiol, Div Parasitol, New York, NY 10016 USA.	karen.day@nyumc.org	Day, Karen/F-3697-2015	Day, Karen/0000-0002-6115-6135; Fowkes, Freya/0000-0001-5832-9464				Bruce MC, 2000, SCIENCE, V287, P845, DOI 10.1126/science.287.5454.845; Dyer M, 2003, AM J TROP MED HYG, V68, P403, DOI 10.4269/ajtmh.2003.68.403; Earle W. C., 1962, COURSE NATURALLY ACQ; Fowkes FJI, 2008, PLOS MED, V5, P494, DOI 10.1371/journal.pmed.0050056; GLYNN JR, 1995, PARASITOLOGY, V110, P7, DOI 10.1017/S0031182000080999; Metcalf CJE, 2011, SCIENCE, V333, P984, DOI 10.1126/science.1204588; Mockenhaupt FP, 1999, J INFECT DIS, V180, P925, DOI 10.1086/314959; Pinzon-Charry A, 2010, J CLIN INVEST, V120, P2967, DOI 10.1172/JCI39222; Rogier C, 1996, AM J TROP MED HYG, V54, P613, DOI 10.4269/ajtmh.1996.54.613; Wambua S, 2006, BRIT J HAEMATOL, V133, P206, DOI 10.1111/j.1365-2141.2006.06006.x	10	4	4	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 19	2011	333	6045					943	944		10.1126/science.1210775	http://dx.doi.org/10.1126/science.1210775			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808TD	21852478	Green Published			2022-12-28	WOS:000294000400032
J	Hines, P; Mccartney, M; Mervis, J; Wible, B				Hines, Pamela; Mccartney, Melissa; Mervis, Jeffrey; Wible, Brad			Laying the Foundation for Lifetime Learning INTRODUCTION	SCIENCE			English	Editorial Material																			0	7	7	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 19	2011	333	6045					951	951		10.1126/science.333.6045.951	http://dx.doi.org/10.1126/science.333.6045.951			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	808TD	21852482				2022-12-28	WOS:000294000400036
J	Klahr, D; Zimmerman, C; Jirout, J				Klahr, David; Zimmerman, Corinne; Jirout, Jamie			Educational Interventions to Advance Children's Scientific Thinking	SCIENCE			English	Review							METASTRATEGIC KNOWLEDGE; SCIENCE; DISCOVERY; INSTRUCTION; ELEMENTARY; CONCEPTIONS; PSYCHOLOGY; LITERACY; INFANTS; SKILLS	The goal of science education interventions is to nurture, enrich, and sustain children's natural and spontaneous interest in scientific knowledge and procedures. We present taxonomy for classifying different types of research on scientific thinking from the perspective of cognitive development and associated attempts to teach science. We summarize the literature on the early-unschooled-development of scientific thinking, and then focus on recent research on how best to teach science to children from preschool to middle school. We summarize some of the current disagreements in the field of science education and offer some suggestions on ways to continue to advance the science of science instruction.	[Klahr, David; Jirout, Jamie] Carnegie Mellon Univ, Dept Psychol, Pittsburgh, PA 15213 USA; [Zimmerman, Corinne] Illinois State Univ, Dept Psychol, Normal, IL 61790 USA	Carnegie Mellon University; Illinois State University	Klahr, D (corresponding author), Carnegie Mellon Univ, Dept Psychol, Pittsburgh, PA 15213 USA.		Jirout, Jamie/I-1745-2019	Jirout, Jamie/0000-0003-4832-930X	NSF [SBE-0836012]; Institute of Education Sciences [R305B040063, R305A100404]	NSF(National Science Foundation (NSF)); Institute of Education Sciences(US Department of EducationInstitute of Education Sciences (IES))	The opinions expressed are those of the authors. This work was partially funded by grants from NSF (SBE-0836012) and the Institute of Education Sciences (R305B040063 and R305A100404). Thanks to several anonymous reviewers for comments and suggestions.	American Association for the Advancement of Science (AAAS), 1993, BENCHM SCI LIT; Baillargeon R, 2004, CURR DIR PSYCHOL SCI, V13, P89, DOI 10.1111/j.0963-7214.2004.00281.x; Bransford D., 2000, PEOPLE LEARN; Brown AnnL., 1992, J LEARN SCI, V2, P141, DOI [10.1207/s15327809jls0202_2, DOI 10.1207/S15327809JLS0202_2]; Chalufour, 2003, DISCOVERING NATURE Y; Chen Z, 1999, CHILD DEV, V70, P1098, DOI 10.1111/1467-8624.00081; Chi MTH, 2005, J LEARN SCI, V14, P161, DOI 10.1207/s15327809jls1402_1; Cohen L.B., 2006, HDB CHILD PSYCHOL, P214; Conezio K, 2002, YOUNG CHILDREN, V57, P12; Dean D, 2007, SCI EDUC, V91, P384, DOI 10.1002/sce.20194; DeLoache JS, 2010, PSYCHOL SCI, V21, P1570, DOI 10.1177/0956797610384145; Diamond A, 2007, SCIENCE, V318, P1387, DOI 10.1126/science.1151148; Duschl R. A., 2007, TAKING SCI SCH LEARN, DOI DOI 10.17226/11625; French L, 2004, EARLY CHILD RES Q, V19, P138, DOI 10.1016/j.ecresq.2004.01.004; Geary D. C., 2005, ORIGIN MIND EVOLUTIO, DOI DOI 10.1037/10871-000; Gelman R, 2004, EARLY CHILD RES Q, V19, P150, DOI 10.1016/j.ecresq.2004.01.009; Gopnik A., 1999, SCI CRIB MINDS BRAIN; Gredeback G, 2004, INFANCY, V6, P165, DOI 10.1207/s15327078in0602_2; Gropen J., 2011, C SOC RES ED EFF WAS; Inagaki K., 2002, ESSAYS DEV PSYCHOL, P19; Jaakkola T, 2008, J COMPUT ASSIST LEAR, V24, P271, DOI 10.1111/j.1365-2729.2007.00259.x; Jirout J., 2011, BIENN M SOC RES CHIL; Keselman A, 2003, J RES SCI TEACH, V40, P898, DOI 10.1002/tea.10115; Kirschner PA, 2006, EDUC PSYCHOL-US, V41, P75, DOI 10.1207/s15326985ep4102_1; Kitchener R. F., 1993, SCI EDUC, V2, P137, DOI DOI 10.1007/BF00592203; Klahr D, 2003, CHILD DEV, V74, P1275, DOI 10.1111/1467-8624.00607; Klahr D, 1999, PSYCHOL BULL, V125, P524, DOI 10.1037/0033-2909.125.5.524; Klahr D, 2007, J RES SCI TEACH, V44, P183, DOI 10.1002/tea.20152; Kuhn D, 1998, COGNITIVE DEV, V13, P227, DOI 10.1016/S0885-2014(98)90040-5; Kuhn D., 2005, ED THINKING; LOEWENSTEIN G, 1994, PSYCHOL BULL, V116, P75, DOI 10.1037/0033-2909.116.1.75; Lorch RF, 2010, J EDUC PSYCHOL, V102, P90, DOI 10.1037/a0017972; Mayer RE, 2004, AM PSYCHOL, V59, P14, DOI 10.1037/0003-066X.59.1.14; Metz KE, 2011, J LEARN SCI, V20, P50, DOI 10.1080/10508406.2011.529325; Michaels S., 2008, READY SET SCI PUTTIN; National Research Council, 2000, INQ NAT SCI ED STAND; National Research Council, 2001, KNOWING WHAT STUDENT; Newcombe NS, 2009, AM PSYCHOL, V64, P538, DOI 10.1037/a0014813; Pearson PD, 2010, SCIENCE, V328, P459, DOI 10.1126/science.1182595; Penner DE, 1996, CHILD DEV, V67, P2709, DOI 10.1111/j.1467-8624.1996.tb01884.x; Peterson SM, 2009, DISCOURSE PROCESS, V46, P369, DOI 10.1080/01638530902959448; Piaget J., 1955, CHILDS CONSTRUCTION; Roth WM, 2008, EDUC RES REV-NETH, V3, P30, DOI 10.1016/j.edurev.2007.10.002; Salden RJCM, 2010, INSTR SCI, V38, P289, DOI 10.1007/s11251-009-9107-8; Samarapungavan A, 1996, COGNITIVE DEV, V11, P491, DOI 10.1016/S0885-2014(96)90015-5; Shavelson R. J., 2002, SCI RES ED, DOI [10.17226/10236, DOI 10.17226/10236]; Siegler R., 2006, HDB CHILD PSYCHOL; Siler S, 2010, LECT NOTES COMPUT SC, V6095, P198; Tobias S., 2009, CONSTRUCTIVIST THEOR; Tu T., 2006, EARLY CHILD EDUC J, V33, P245, DOI [DOI 10.1007/S10643-005-0049-8, 10.1007/s10643-005-]; Vosniadou, 2013, INT HDB RES CONCEPTU, DOI 10.4324/9780203154472; Zimmerman C, 2007, DEV REV, V27, P172, DOI 10.1016/j.dr.2006.12.001; Zohar A, 2008, LEARN INSTR, V18, P337, DOI 10.1016/j.learninstruc.2007.07.001	53	71	73	15	116	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 19	2011	333	6045					971	975		10.1126/science.1204528	http://dx.doi.org/10.1126/science.1204528			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	808TD	21852489				2022-12-28	WOS:000294000400043
J	Mercer, TR; Neph, S; Dinger, ME; Crawford, J; Smith, MA; Shearwood, AMJ; Haugen, E; Bracken, CP; Rackham, O; Stamatoyannopoulos, JA; Filipovska, A; Mattick, JS				Mercer, Tim R.; Neph, Shane; Dinger, Marcel E.; Crawford, Joanna; Smith, Martin A.; Shearwood, Anne-Marie J.; Haugen, Eric; Bracken, Cameron P.; Rackham, Oliver; Stamatoyannopoulos, John A.; Filipovska, Aleksandra; Mattick, John S.			The Human Mitochondrial Transcriptome	CELL			English	Article							MESSENGER-RNAS; HUMAN GENOME; IN-VIVO; DNA; PROTEIN; POLYADENYLATION; SEQUENCE; REVEALS; IMPORT; ORIGIN	The human mitochondrial genome comprises a distinct genetic system transcribed as precursor poly-cistronic transcripts that are subsequently cleaved to generate individual mRNAs, tRNAs, and rRNAs. Here, we provide a comprehensive analysis of the human mitochondrial transcriptome across multiple cell lines and tissues. Using directional deep sequencing and parallel analysis of RNA ends, we demonstrate wide variation in mitochondrial transcript abundance and precisely resolve transcript processing and maturation events. We identify previously undescribed transcripts, including small RNAs, and observe the enrichment of several nuclear RNAs in mitochondria. Using high-throughput in vivo DNaseI footprinting, we establish the global profile of DNA-binding protein occupancy across the mitochondrial genome at single-nucleotide resolution, revealing regulatory features at mitochondrial transcription initiation sites and functional insights into disease-associated variants. This integrated analysis of the mitochondrial transcriptome reveals unexpected complexity in the regulation, expression, and processing of mitochondrial RNA and provides a resource for future studies of mitochondrial function (accessed at http://mitochondria.matticklab.com).	[Neph, Shane; Haugen, Eric; Stamatoyannopoulos, John A.] Univ Washington, Sch Med, Dept Genome Sci & Med, Seattle, WA 98195 USA; [Mercer, Tim R.; Dinger, Marcel E.; Crawford, Joanna; Smith, Martin A.; Mattick, John S.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Shearwood, Anne-Marie J.; Rackham, Oliver; Filipovska, Aleksandra] Univ Western Australia, Med Res Ctr, Perth, WA 6000, Australia; [Shearwood, Anne-Marie J.; Rackham, Oliver; Filipovska, Aleksandra] Univ Western Australia, Western Australian Inst Med Res, Perth, WA 6000, Australia; [Bracken, Cameron P.] SA Pathol, Ctr Canc Biol, Div Human Immunol, Adelaide, SA 5000, Australia	University of Washington; University of Washington Seattle; University of Queensland; University of Western Australia; University of Western Australia; Centre for Cancer Biology; SA Pathology	Stamatoyannopoulos, JA (corresponding author), Univ Washington, Sch Med, Dept Genome Sci & Med, Seattle, WA 98195 USA.	jstam@u.washington.edu; afilipov@waimr.uwa.edu.au; j.mattick@uq.edu.au	Smith, Martin A./L-5265-2019; Mercer, Tim/AAK-5060-2020; Mattick, John S/I-7789-2012; Mattick, John/ABH-6130-2020; Dinger, Marcel/N-1398-2019; Rackham, Oliver/E-1264-2013; Rackham, Oliver/AGO-0005-2022; Crawford, Joanna/F-9135-2013	Smith, Martin A./0000-0003-2259-1713; Mercer, Tim/0000-0001-8780-894X; Mattick, John S/0000-0002-7680-7527; Mattick, John/0000-0002-7680-7527; Rackham, Oliver/0000-0002-5301-9624; Rackham, Oliver/0000-0002-5301-9624; Crawford, Joanna/0000-0003-0786-6889; Haugen, Eric/0000-0001-7444-8981; Bracken, Cameron/0000-0001-7722-625X; Dinger, Marcel/0000-0003-4423-934X; Filipovska, Aleksandra/0000-0002-6998-8403	Australian Research Council; National Health and Medical Research Council of Australia; Queensland Government Department of Employment, Economic Development and Innovation; Australian Stem Cell Centre; NIH [U54HG004592, U54HG004592-S1]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG004592] Funding Source: NIH RePORTER	Australian Research Council(Australian Research Council); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Queensland Government Department of Employment, Economic Development and Innovation; Australian Stem Cell Centre; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by grants and fellowships from the Australian Research Council, the National Health and Medical Research Council of Australia, the Queensland Government Department of Employment, Economic Development and Innovation, the Australian Stem Cell Centre, and NIH Grants U54HG004592 and U54HG004592-S1. We thank Rob King from GeneWorks (Adelaide, SA) for advice with RNA sequencing; Andreas Gruber from the Institute for Theoretical Chemistry in Vienna for providing his software for merging and fragmenting alignment files; Robert Thurman, Alex Reynolds, and Dave Shechner for help with DNaseI hypersensitivity analysis; and Illumina (Hayward, CA) for providing early access to thehuman "Body Map" RNA sequencing atlas.	ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Bhat A, 2007, HUM GENET, V120, P821, DOI 10.1007/s00439-006-0272-4; Cannino G, 2007, MITOCHONDRION, V7, P359, DOI 10.1016/j.mito.2007.07.001; Crimi M, 2003, EUR J HUM GENET, V11, P896, DOI 10.1038/sj.ejhg.5201056; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Entelis NS, 2001, ADV DRUG DELIVER REV, V49, P199, DOI 10.1016/S0169-409X(01)00135-1; Entelis NS, 1998, P NATL ACAD SCI USA, V95, P2838, DOI 10.1073/pnas.95.6.2838; FISHER RP, 1992, J BIOL CHEM, V267, P3358; FISHER RP, 1987, CELL, V50, P247, DOI 10.1016/0092-8674(87)90220-0; Fuste JM, 2010, MOL CELL, V37, P67, DOI 10.1016/j.molcel.2009.12.021; German MA, 2008, NAT BIOTECHNOL, V26, P941, DOI 10.1038/nbt1417; Gesell T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-248; GHIVIZZANI SC, 1994, MOL CELL BIOL, V14, P7717, DOI 10.1128/MCB.14.12.7717; Guan MX, 1998, MOL CELL BIOL, V18, P5868, DOI 10.1128/MCB.18.10.5868; HANCOCK K, 1992, J BIOL CHEM, V267, P23963; Haussecker D, 2010, RNA, V16, P673, DOI 10.1261/rna.2000810; HAUSWIRTH WW, 1985, NUCLEIC ACIDS RES, V13, P8093, DOI 10.1093/nar/13.22.8093; Hesselberth JR, 2009, NAT METHODS, V6, P283, DOI [10.1038/NMETH.1313, 10.1038/nmeth.1313]; Holt IJ, 2007, MITOCHONDRION, V7, P311, DOI 10.1016/j.mito.2007.06.004; Jacquier A, 2009, NAT REV GENET, V10, P833, DOI 10.1038/nrg2683; Karginov FV, 2010, MOL CELL, V38, P781, DOI 10.1016/j.molcel.2010.06.001; Khogali SS, 2001, LANCET, V357, P1265, DOI 10.1016/S0140-6736(00)04422-6; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lane N, 2010, NATURE, V467, P929, DOI 10.1038/nature09486; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee YS, 2009, GENE DEV, V23, P2639, DOI 10.1101/gad.1837609; Lin H, 2008, BIOINFORMATICS, V24, P2431, DOI 10.1093/bioinformatics/btn416; Lu JX, 2010, MITOCHONDRION, V10, P69, DOI 10.1016/j.mito.2009.09.007; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Morin RD, 2008, BIOTECHNIQUES, V45, P81, DOI 10.2144/000112900; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Nagaike T, 2005, J BIOL CHEM, V280, P19721, DOI 10.1074/jbc.M500804200; NOLL M, 1974, NUCLEIC ACIDS RES, V1, P1573, DOI 10.1093/nar/1.11.1573; OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Pedersen JS, 2006, PLOS COMPUT BIOL, V2, P251, DOI 10.1371/journal.pcbi.0020033; Percival Donald B., 1993, SPECTRAL ANAL PHYS A; Piechota J, 2006, ACTA BIOCHIM POL, V53, P157; Rossmanith W, 2009, CELL CYCLE, V8, P1650, DOI 10.4161/cc.8.11.8502; Rubio MAT, 2008, P NATL ACAD SCI USA, V105, P9186, DOI 10.1073/pnas.0804283105; Sabo PJ, 2006, NAT METHODS, V3, P511, DOI 10.1038/NMETH890; SBISA E, 1992, FEBS LETT, V296, P311, DOI 10.1016/0014-5793(92)80311-4; Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007; Shin C, 2010, MOL CELL, V38, P789, DOI 10.1016/j.molcel.2010.06.005; Slomovic S, 2005, MOL CELL BIOL, V25, P6427, DOI 10.1128/MCB.25.15.6427-6435.2005; Suissa S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000474; Sylvestre J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-r44; Szczesny RJ, 2010, NUCLEIC ACIDS RES, V38, P279, DOI 10.1093/nar/gkp903; Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606; Temperley R, 2010, SCIENCE, V327, P301, DOI 10.1126/science.1180674; Temperley RJ, 2010, BBA-BIOENERGETICS, V1797, P1081, DOI 10.1016/j.bbabio.2010.02.036; Temperley RJ, 2003, HUM MOL GENET, V12, P2341, DOI 10.1093/hmg/ddg238; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Wang G, 2010, CELL, V142, P456, DOI 10.1016/j.cell.2010.06.035; Washietl S, 2005, NAT BIOTECHNOL, V23, P1383, DOI 10.1038/nbt1144; Yakubovskaya E, 2010, CELL, V141, P982, DOI 10.1016/j.cell.2010.05.018; Zhang CX, 2009, CURR OPIN MOL THER, V11, P641	58	522	539	2	68	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 19	2011	146	4					645	658		10.1016/j.cell.2011.06.051	http://dx.doi.org/10.1016/j.cell.2011.06.051			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	809HY	21854988	Bronze, Green Accepted			2022-12-28	WOS:000294043600018
J	Solomon, DA; Kim, T; Diaz-Martinez, LA; Fair, J; Elkahloun, AG; Harris, BT; Toretsky, JA; Rosenberg, SA; Shukla, N; Ladanyi, M; Samuels, Y; James, CD; Yu, HT; Kim, JS; Waldman, T				Solomon, David A.; Kim, Taeyeon; Diaz-Martinez, Laura A.; Fair, Joshlean; Elkahloun, Abdel G.; Harris, Brent T.; Toretsky, Jeffrey A.; Rosenberg, Steven A.; Shukla, Neerav; Ladanyi, Marc; Samuels, Yardena; James, C. David; Yu, Hongtao; Kim, Jung-Sik; Waldman, Todd			Mutational Inactivation of STAG2 Causes Aneuploidy in Human Cancer	SCIENCE			English	Article							TUMOR-SUPPRESSOR GENE; CHROMOSOME INSTABILITY; COPY NUMBER; COHESIN; OVEREXPRESSION; HETEROZYGOSITY; TUMORIGENESIS; EXPRESSION	Most cancer cells are characterized by aneuploidy, an abnormal number of chromosomes. We have identified a clue to the mechanistic origins of aneuploidy through integrative genomic analyses of human tumors. A diverse range of tumor types were found to harbor deletions or inactivating mutations of STAG2, a gene encoding a subunit of the cohesin complex, which regulates the separation of sister chromatids during cell division. Because STAG2 is on the X chromosome, its inactivation requires only a single mutational event. Studying a near-diploid human cell line with a stable karyotype, we found that targeted inactivation of STAG2 led to chromatid cohesion defects and aneuploidy, whereas in two aneuploid human glioblastoma cell lines, targeted correction of the endogenous mutant alleles of STAG2 led to enhanced chromosomal stability. Thus, genetic disruption of cohesin is a cause of aneuploidy in human cancer.	[Solomon, David A.; Kim, Taeyeon; Fair, Joshlean; Toretsky, Jeffrey A.; Kim, Jung-Sik; Waldman, Todd] Georgetown Univ, Sch Med, Dept Oncol, Lombardi Comprehens Canc Ctr, Washington, DC 20057 USA; [Diaz-Martinez, Laura A.; Yu, Hongtao] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Diaz-Martinez, Laura A.; Yu, Hongtao] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Elkahloun, Abdel G.; Samuels, Yardena] NHGRI, Canc Genet Branch, NIH, Bethesda, MD 20892 USA; [Harris, Brent T.] Georgetown Univ, Sch Med, Dept Neurol, Washington, DC 20057 USA; [Harris, Brent T.] Georgetown Univ, Sch Med, Dept Pathol, Washington, DC 20057 USA; [Rosenberg, Steven A.] NCI, Surg Branch, NIH, Bethesda, MD 20892 USA; [Shukla, Neerav; Ladanyi, Marc] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA; [James, C. David] Univ Calif San Francisco, Helen Diller Comprehens Canc Ctr, Brain Tumor Res Ctr, Dept Neurol Surg, San Francisco, CA 94143 USA	Georgetown University; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Georgetown University; Georgetown University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Memorial Sloan Kettering Cancer Center; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center	Waldman, T (corresponding author), Georgetown Univ, Sch Med, Dept Oncol, Lombardi Comprehens Canc Ctr, Washington, DC 20057 USA.	waldmant@georgetown.edu	James, Charles D/E-2721-2012; Ladanyi, Marc/AAG-8585-2019	James, Charles D/0000-0002-1027-203X; Yu, Hongtao/0000-0002-8861-049X; Diaz-Martinez, Laura/0000-0002-7226-7068; Samuels, Yardena/0000-0002-3349-7266	NIH [R01CA115699, R21CA143282]; SPORE grant [CA097257]; American Cancer Society [RSG0619101]; National Human Genome Research Institute, NIH; NATIONAL CANCER INSTITUTE [R01CA138212, R01CA133662, R21CA143282, ZIABC010984, R01CA169345, P50CA097257] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZICHG200365, ZIAHG200337] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SPORE grant; American Cancer Society(American Cancer Society); National Human Genome Research Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank K. Creswell, S. Sen, and Applied Genetics Laboratories for technical assistance; and M. White and the Brain Tumor Tissue Bank of Canada, S. Baker, F. Bunz, J.-M. Peters, and the Children's Oncology Group for reagents and tumor samples. This research was supported by NIH grants R01CA115699 (T. W.), R21CA143282 (T. W.), SPORE grant CA097257 (C.D.J.), and American Cancer Society grant RSG0619101 (T. W.). Georgetown University has filed a patent application relating to the application of the mutations described in this work to the diagnosis and treatment of cancer. Y.S. is supported by the Intramural Research Programs of the National Human Genome Research Institute, NIH. Primer sequences are in table S6. For copy number arrays: the scanned array images and processed data sets have been deposited in the Gene Expression Omnibus (www.ncbi.nlm.nih.gov/geo, dataset GSE13021). For expression microarrays: the scanned array images and processed data sets have been deposited in the Gene Expression Omnibus (www.ncbi.nlm.nih.gov/geo, dataset GSE28214)	Baker DJ, 2009, CANCER CELL, V16, P475, DOI 10.1016/j.ccr.2009.10.023; Barber TD, 2008, P NATL ACAD SCI USA, V105, P3443, DOI 10.1073/pnas.0712384105; Cahill DP, 1998, NATURE, V392, P300, DOI 10.1038/32688; Gorringe KL, 2009, GENE CHROMOSOME CANC, V48, P931, DOI 10.1002/gcc.20694; Haering CH, 2008, NATURE, V454, P297, DOI 10.1038/nature07098; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Jallepalli PV, 2001, CELL, V105, P445, DOI 10.1016/S0092-8674(01)00340-3; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kim JS, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn566; Kinzler KW, 1997, NATURE, V386, P761, DOI 10.1038/386761a0; Lara-Pezzi E, 2004, J BIOL CHEM, V279, P6553, DOI 10.1074/jbc.M307663200; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; LOEB LA, 1991, CANCER RES, V51, P3075; Nasmyth K, 2002, SCIENCE, V297, P559, DOI 10.1126/science.1074757; Rajagopalan H, 2004, NATURE, V428, P77, DOI 10.1038/nature02313; Rocquain J, 2010, AM J HEMATOL, V85, P717, DOI 10.1002/ajh.21798; Solomon DA, 2008, CANCER RES, V68, P2564, DOI 10.1158/0008-5472.CAN-07-6388; Solomon DA, 2008, CANCER RES, V68, P10300, DOI 10.1158/0008-5472.CAN-08-3272; Sotillo R, 2007, CANCER CELL, V11, P9, DOI 10.1016/j.ccr.2006.10.019; Walter MJ, 2009, P NATL ACAD SCI USA, V106, P12950, DOI 10.1073/pnas.0903091106; Wang ZGC, 2004, CANCER RES, V64, P64, DOI 10.1158/0008-5472.CAN-03-2570; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; Zhang NG, 2008, P NATL ACAD SCI USA, V105, P13033, DOI 10.1073/pnas.0801610105	24	325	327	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 19	2011	333	6045					1039	1043		10.1126/science.1203619	http://dx.doi.org/10.1126/science.1203619			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808TD	21852505	Green Accepted			2022-12-28	WOS:000294000400062
J	Heagerty, AM				Heagerty, Anthony M.			Secondary prevention of heart disease and stroke: work to do	LANCET			English	Editorial Material							RANDOMIZED-TRIAL; BLOOD-PRESSURE; METAANALYSIS; INDIVIDUALS; GUIDELINES; MANAGEMENT		Univ Manchester, Cardiovasc Res Grp, Manchester M13 9NT, Lancs, England	University of Manchester	Heagerty, AM (corresponding author), Univ Manchester, Cardiovasc Res Grp, Manchester M13 9NT, Lancs, England.	tony.heagerty@manchester.ac.uk		Heagerty, Anthony/0000-0002-9043-2119				Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Catapano AL, 2011, ATHEROSCLEROSIS, V217, P1, DOI 10.1016/j.atherosclerosis.2011.06.011; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; MacMahon S, 2001, LANCET, V358, P1033, DOI 10.1016/S0140-6736(01)06178-5; Mancia G, 2009, J HYPERTENS, V27, P2121, DOI 10.1097/HJH.0b013e328333146d; Mihaylova B, 2005, LANCET, V365, P1779, DOI 10.1016/S0140-6736(05)63014-0; Sever PS, 2003, LANCET, V361, P1149, DOI 10.1016/S0140-6736(03)12948-0; Yusuf S, 2011, LANCET, DOI [10.1016/S0140-6736(11)61302-0, DOI 10.1016/S0140-6736(11)61302-0]	8	1	1	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 1	2011	378	9798					1200	1202		10.1016/S0140-6736(11)61302-0	http://dx.doi.org/10.1016/S0140-6736(11)61302-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	831IO	21872919				2022-12-28	WOS:000295723600005
J	Kim, JJ				Kim, Jon Jin			Immunoadsorption for haemolytic uraemic syndrome	LANCET			English	Editorial Material							COMPLEMENT		Evelina Childrens Hosp, London SE1 7EH, England		Kim, JJ (corresponding author), Evelina Childrens Hosp, London SE1 7EH, England.	jonjinkim@doctors.org.uk		Kim, Jon Jin/0000-0003-4307-8513				Fernandez-Brando RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019136; Frank C, 2011, NEW ENGL J MED, V365, P1771, DOI 10.1056/NEJMoa1106483; Greinacher A, 2011, LANCET, V378, P1166, DOI 10.1016/S0140-6736(11)61253-1; Lapeyraque AL, 2011, NEW ENGL J MED, V364, P2561, DOI 10.1056/NEJMc1100859; Morigi M, 2011, J IMMUNOL, V187, P172, DOI 10.4049/jimmunol.1100491; Nathanson S, 2010, CLIN J AM SOC NEPHRO, V5, P1218, DOI 10.2215/CJN.08921209; Orth D, 2009, J IMMUNOL, V182, P6394, DOI 10.4049/jimmunol.0900151; *R KOCH I, 2011, EHEC HUS O104 H4 OUT; Rasko DA, 2011, NEW ENGL J MED, V365, P709, DOI 10.1056/NEJMoa1106920; Zoja C, 2010, PEDIATR NEPHROL, V25, P2231, DOI 10.1007/s00467-010-1522-1	10	3	4	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 24	2011	378	9797					1120	1122		10.1016/S0140-6736(11)61342-1	http://dx.doi.org/10.1016/S0140-6736(11)61342-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	829RH	21890191				2022-12-28	WOS:000295601500005
J	Arie, S				Arie, Sophie			INTERNATIONAL HEALTH How should GAVI build on its success?	BRITISH MEDICAL JOURNAL			English	Editorial Material												mail@sophiearie.com						GAVI Alliance, GAVI ALL PROGR REP 2; GAVI Alliance, 2011, COUNTR EL POL; *GLAXOSMITHKLINE, 2011, OUR COMM INCR ACC VA; *UNICEF, VACC SUPPL 2011; World Health Organization, 2011, IMM VACC BIOL	5	5	5	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 8	2011	343								d5182	10.1136/bmj.d5182	http://dx.doi.org/10.1136/bmj.d5182			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	819RV	21903688				2022-12-28	WOS:000294848300001
J	Prada-Delgado, O; Barge-Caballero, E				Prada-Delgado, Oscar; Barge-Caballero, Eduardo			Ortner's Syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Prada-Delgado, Oscar; Barge-Caballero, Eduardo] Complexo Hosp Univ A Coruna, La Coruna, Spain	Complejo Hospitalario Universitario A Coruna; Universidade da Coruna	Prada-Delgado, O (corresponding author), Complexo Hosp Univ A Coruna, La Coruna, Spain.	oscarprade@hotmail.com							0	6	6	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 8	2011	365	10					939	939		10.1056/NEJMicm1014167	http://dx.doi.org/10.1056/NEJMicm1014167			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	816JX	21899454				2022-12-28	WOS:000294595600010
J	Brotherton, SE; Etzel, SI				Brotherton, Sarah E.; Etzel, Sylvia I.			Graduate Medical Education, 2010-2011	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Brotherton, Sarah E.; Etzel, Sylvia I.] Amer Med Assoc, Div Grad Med Educ, Chicago, IL 60654 USA	American Medical Association	Brotherton, SE (corresponding author), Amer Med Assoc, Div Grad Med Educ, 515 N State St, Chicago, IL 60654 USA.	sarah.brotherton@ama-assn.org	Deville, Curtiland/B-2819-2013	Deville, Curtiland/0000-0003-4846-6486					0	72	72	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 7	2011	306	9					1015	1030		10.1001/jama.2011.1236	http://dx.doi.org/10.1001/jama.2011.1236			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	815QT	21900146				2022-12-28	WOS:000294542600024
J	Downing, JR				Downing, James R.			A New FOXO Pathway Required for Leukemogenesis	CELL			English	Editorial Material							HEMATOPOIETIC STEM-CELLS; TUMOR SUPPRESSORS; LEUKEMIA	In cancer, the FOXO family of transcription factors functions as tumor suppressors and is directly inactivated by oncogenic signaling through the PI3K/AKT pathway. Now, Skykes et al. (2011) identify a paradoxical requirement for FOXOs in the maintenance of leukemia-initiating cells.	St Jude Childrens Hosp, Dept Pathol, Memphis, TN 38105 USA	St Jude Children's Research Hospital	Downing, JR (corresponding author), St Jude Childrens Hosp, Dept Pathol, 262 Danny Thomas Pl, Memphis, TN 38105 USA.	james.downing@stjude.org	Downing, James R./N-8102-2018					Fu Z, 2008, ONCOGENE, V27, P2312, DOI 10.1038/onc.2008.24; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Kharas MG, 2010, BLOOD, V115, P1406, DOI 10.1182/blood-2009-06-229443; Lee JY, 2010, CELL STEM CELL, V7, P593, DOI 10.1016/j.stem.2010.09.015; Martelli AM, 2010, ONCOTARGET, V1, P89, DOI 10.18632/oncotarget.114; Miyamoto K, 2007, CELL STEM CELL, V1, P101, DOI 10.1016/j.stem.2007.02.001; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Sykes SM, 2011, CELL, V146, P697, DOI 10.1016/j.cell.2011.07.032; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703	10	9	9	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 2	2011	146	5					669	670		10.1016/j.cell.2011.08.019	http://dx.doi.org/10.1016/j.cell.2011.08.019			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	814SM	21884926	Bronze			2022-12-28	WOS:000294477500005
J	Erickson, B; Singh, R; Winters, P				Erickson, Brent; Singh, Rina; Winters, Paul			Synthetic Biology: Regulating Industry Uses of New Biotechnologies	SCIENCE			English	Editorial Material							GENOME	In our view, synthetic biology is an extension of the continuum of genetic science that has been used safely for more than 40 years by the biotechnology industry in the development of commercial products. Examples of synthetic biology use by biotechnology companies illustrate the potential to substantially reduce research and development time and to increase speed to market. Improvements in the speed and cost of DNA synthesis are enabling scientists to design modified bacterial chromosomes that can be used in the production of renewable chemicals, biofuels, bioproducts, renewable specialty chemicals, pharmaceutical intermediates, fine chemicals, food ingredients, and health care products. Regulatory options should support innovation and commercial development of new products while protecting the public from potential harms.	[Erickson, Brent; Singh, Rina; Winters, Paul] BIO, Washington, DC 20024 USA		Singh, R (corresponding author), BIO, Washington, DC 20024 USA.	rsingh@bio.org	Winters, Paul/AGS-8510-2022	Winters, Paul/0000-0003-1039-3867				ALDRICH SC, 2007, GENOME SYNTHESIS DES; [Anonymous], 2010, SCREEN FRAM GUID PRO; Balmer A., 2008, SYNTHETIC BIOL SOCIA; *BIOBRICKS FDN, BIOBRICKS FDN FAQ; *BIOBRICKS FDN, BIOBRICKS FDN TECHN; Friends of the Earth, 2010, SYNTH SOL CLIM CRIS; Garfinkel MS, 2008, BIRTH DEATH BENCH CL, P163; Gibson DG, 2008, SCIENCE, V319, P1215, DOI 10.1126/science.1151721; Gibson DG, 2010, SCIENCE, V329, P52, DOI 10.1126/science.1190719; GIBSON L, 2010, BIOMASS POWER T 0209; Gutmann A., 2010, NEW DIRECTIONS ETHIC; Hart Research Associates, 2010, AW IMPR SYNTH BIOL R; International Association Synthetic Biology, 2009, COD COND BEST PRACT; Isaacs FJ, 2011, SCIENCE, V333, P348, DOI 10.1126/science.1205822; *NIH OFF BIOT ACT, 2011, NIH GUID RES INV REC; Savile CK, 2010, SCIENCE, V329, P305, DOI 10.1126/science.1188934; Singh R, 2011, ORG PROCESS RES DEV, V15, P175, DOI 10.1021/op100312a; *UN OFF GEN, DIS THINK ZON 7 REV; VERGANO D, 2010, US TODAY        0521, P20; *W WILS INT CTR SC, 2011, MAPP EM SYNTH BIOL L; WADE N, 2011, NY TIMES        0715, pA14; Whited GM, 2010, IND BIOTECHNOLOGY, P152, DOI [10.1089/ind.2010.6.152, DOI 10.1089/IND.2010.6.152]; 6 PARTY S SYNTHETIC	23	23	27	1	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 2	2011	333	6047					1254	1256		10.1126/science.1211066	http://dx.doi.org/10.1126/science.1211066			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	813YM	21885775				2022-12-28	WOS:000294406400043
J	Festa, E; Fretz, J; Berry, R; Schmidt, B; Rodeheffer, M; Horowitz, M; Horsley, V				Festa, Eric; Fretz, Jackie; Berry, Ryan; Schmidt, Barbara; Rodeheffer, Matthew; Horowitz, Mark; Horsley, Valerie			Adipocyte Lineage Cells Contribute to the Skin Stem Cell Niche to Drive Hair Cycling	CELL			English	Article							SCARRING ALOPECIA; ADIPOSE-TISSUE; IN-VIVO; DIFFERENTIATION; MICE; ACTIVATION; PRECURSORS; FOLLICLE; MOUSE; GLAND	In mammalian skin, multiple types of resident cells are required to create a functional tissue and support tissue homeostasis and regeneration. The cells that compose the epithelial stem cell niche for skin homeostasis and regeneration are not well defined. Here, we identify adipose precursor cells within the skin and demonstrate that their dynamic regeneration parallels the activation of skin stem cells. Functional analysis of adipocyte lineage cells in mice with defects in adipogenesis and in transplantation experiments revealed that intradermal adipocyte lineage cells are necessary and sufficient to drive follicular stem cell activation. Furthermore, we implicate PDGF expression by immature adipocyte cells in the regulation of follicular stem cell activity. These data highlight adipogenic cells as skin niche cells that positively regulate skin stem cell activity, and suggest that adipocyte lineage cells may alter epithelial stem cell function clinically.	[Festa, Eric; Rodeheffer, Matthew; Horsley, Valerie] Yale Univ, Dept Mol Cell & Dev Biol, New Haven, CT 06520 USA; [Fretz, Jackie; Horowitz, Mark] Yale Univ, Dept Orthopaed & Rehabil, New Haven, CT 06520 USA; [Rodeheffer, Matthew] Yale Univ, Comparat Med Sect, New Haven, CT 06520 USA; [Rodeheffer, Matthew; Horsley, Valerie] Yale Univ, Yale Stem Cell Ctr, New Haven, CT 06520 USA; [Berry, Ryan; Schmidt, Barbara] Yale Univ, Mol Cell Biol Genet & Dev Program, New Haven, CT 06520 USA	Yale University; Yale University; Yale University; Yale University; Yale University	Horsley, V (corresponding author), Yale Univ, Dept Mol Cell & Dev Biol, 219 Prospect St, New Haven, CT 06520 USA.	valerie.horsley@yale.edu		Fretz, Jackie/0000-0002-6605-869X	NIH [AR054775, AR060295]; Connecticut Department of Public Health [09SCAYALE30]; NIH (NIDDK) [AR052690, AR046032, DK084970]; NIH (NIAMS) [AR052690, AR046032, DK084970]; NIDDK/NIH [5P30DK045735-18, DK090489]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052690, P30AR046032, R01AR060295, K99AR054775, R00AR054775] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090489, R24DK084970, R24DK092759, P30DK045735] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Connecticut Department of Public Health; NIH (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH (NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDDK/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Dr. Mengqing Xiang for the vector encoding the Ebf1 in situ hybridization probe and Drs. Ana Tadeu and Natalie Roberts for assistance with experiments. Horsley lab members and Drs. Michael Rendl and Tudorita Tumbar provided critical reading of the manuscript and valuable discussions. V.H. is a Pew Scholar in Biomedical Research and is funded by the NIH (AR054775 and AR060295) and the Connecticut Department of Public Health (09SCAYALE30). M.H. is funded by AR052690, AR046032 and DK084970 from NIH (NIDDK and NIAMS). M.R. is supported by 5P30DK045735-18 and DK090489 from NIDDK/NIH.	Bendixen AC, 2001, P NATL ACAD SCI USA, V98, P2443, DOI 10.1073/pnas.041493198; Biernaskie J, 2009, CELL STEM CELL, V5, P610, DOI 10.1016/j.stem.2009.10.019; Blanpain C, 2006, ANNU REV CELL DEV BI, V22, P339, DOI 10.1146/annurev.cellbio.22.010305.104357; Butcher EO, 1934, ANAT REC, V61, P5, DOI 10.1002/ar.1090610103; CHASE HB, 1953, ANAT REC, V116, P75, DOI 10.1002/ar.1091160107; Chen HC, 2002, J CLIN INVEST, V109, P175, DOI 10.1172/JCI0213880; Couldrey C, 2002, DEV DYNAM, V223, P459, DOI 10.1002/dvdy.10065; Fukumoto D, 2009, J DERMATOL, V36, P499, DOI 10.1111/j.1346-8138.2009.00685.x; Greco V, 2009, CELL STEM CELL, V4, P155, DOI 10.1016/j.stem.2008.12.009; GREENBERG AS, 1991, J BIOL CHEM, V266, P11341; HANSEN LS, 1984, ANAT REC, V210, P569, DOI 10.1002/ar.1092100404; Herrmann T, 2003, J CELL BIOL, V161, P1105, DOI 10.1083/jcb.200207080; Hesslein DGT, 2009, BONE, V44, P537, DOI 10.1016/j.bone.2008.11.021; Horsley V, 2008, CELL, V132, P299, DOI 10.1016/j.cell.2007.11.047; Horsley V, 2006, CELL, V126, P597, DOI 10.1016/j.cell.2006.06.048; Jin KX, 2010, J NEUROSCI, V30, P11902, DOI 10.1523/JNEUROSCI.2187-10.2010; Joe AWB, 2010, NAT CELL BIOL, V12, P153, DOI 10.1038/ncb2015; Jong MC, 1998, J CLIN INVEST, V101, P145, DOI 10.1172/JCI791; Karlsson L, 1999, DEVELOPMENT, V126, P2611; Karnik P, 2009, J INVEST DERMATOL, V129, P1243, DOI 10.1038/jid.2008.369; Landskroner-Eiger S, 2010, DEV BIOL, V344, P968, DOI 10.1016/j.ydbio.2010.06.019; Le Lay S, 2010, AUTOPHAGY, V6, P754, DOI 10.4161/auto.6.6.12574; LIN HH, 1995, NATURE, V376, P263, DOI 10.1038/376263a0; Lurie R, 1996, CUTIS, V57, P151; Mao-Qiang M, 2004, J INVEST DERMATOL, V123, P305, DOI 10.1111/j.0022-202X.2004.23235.x; Moitra J, 1998, GENE DEV, V12, P3168, DOI 10.1101/gad.12.20.3168; Naveiras O, 2009, NATURE, V460, P259, DOI 10.1038/nature08099; OCHI M, 1988, AM J PHYSIOL, V254, pR740, DOI 10.1152/ajpregu.1988.254.5.R740; Park BS, 2010, BIOMED RES-TOKYO, V31, P27, DOI 10.2220/biomedres.31.27; PIACQUADIO DJ, 1994, J AM ACAD DERMATOL, V30, P1028, DOI 10.1016/S0190-9622(09)80150-3; Plikus MV, 2008, NATURE, V451, P340, DOI 10.1038/nature06457; Rendl M, 2005, PLOS BIOL, V3, P1910, DOI 10.1371/journal.pbio.0030331; Rodeheffer MS, 2008, CELL, V135, P240, DOI 10.1016/j.cell.2008.09.036; Rosen ED, 2000, ANNU REV CELL DEV BI, V16, P145, DOI 10.1146/annurev.cellbio.16.1.145; Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902; Stone SJ, 2004, J BIOL CHEM, V279, P11767, DOI 10.1074/jbc.M311000200; Sundberg JP, 2000, AM J PATHOL, V156, P2067, DOI 10.1016/S0002-9440(10)65078-X; Tomita Y, 2006, J DERMATOL SCI, V43, P105, DOI 10.1016/j.jdermsci.2006.03.012; Tsai SY, 2010, STEM CELLS, V28, P221, DOI 10.1002/stem.281; Uezumi A, 2010, NAT CELL BIOL, V12, P143, DOI 10.1038/ncb2014; Voog J, 2010, CELL STEM CELL, V6, P103, DOI 10.1016/j.stem.2010.01.011; Wright HM, 2000, J BIOL CHEM, V275, P1873, DOI 10.1074/jbc.275.3.1873; Zhang YV, 2009, CELL STEM CELL, V5, P267, DOI 10.1016/j.stem.2009.06.004	43	380	392	10	53	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 2	2011	146	5					761	771		10.1016/j.cell.2011.07.019	http://dx.doi.org/10.1016/j.cell.2011.07.019			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	814SM	21884937	Green Accepted, Bronze			2022-12-28	WOS:000294477500016
J	Merikangas, KR; Cui, LH; Richardson, AK; Isler, H; Khoromi, S; Nakamura, E; Lamers, F; Rossler, W; Ajdacic-Gross, V; Gamma, A; Angst, J				Merikangas, Kathleen R.; Cui, Lihong; Richardson, Amanda Kalaydjian; Isler, Hansruedi; Khoromi, Suzan; Nakamura, Erin; Lamers, Femke; Roessler, Wulf; Ajdacic-Gross, Vladeta; Gamma, Alex; Angst, Jules			Magnitude, impact, and stability of primary headache subtypes: 30 year prospective Swiss cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							TENSION-TYPE HEADACHE; FOLLOW-UP; ZURICH COHORT; MENTAL-DISORDERS; UNITED-STATES; MIGRAINE; PREVALENCE; EPIDEMIOLOGY; COMORBIDITY; CLASSIFICATION	Objective To determine the prevalence, impact, and stability of different subtypes of headache in a 30 year prospective follow-up study of a general population sample. Design Prospective cohort study. Setting Canton of Zurich, Switzerland. Participants 591 people aged 19-20 from a cohort of 4547 residents of Zurich, Switzerland, interviewed seven times across 30 years of follow-up. Main outcome measures Prevalence of headache; stability of the predominant subtype of headache over time; and age of onset, severity, impact, family history, use of healthcare services, and drugs for headache subtypes. Results The average one year prevalences of subtypes of headache were 0.9% (female: male ratio of 2.8) for migraine with aura, 10.9% (female: male ratio of 2.2) for migraine without aura, and 11.5% (female: male ratio of 1.2) for tension-type headache. Cumulative 30 year prevalences of headache subtypes were 3.0% for migraine with aura, 36.0% for migraine without aura, and 29.3% for tension-type headache. Despite the high prevalence of migraine without aura, most cases were transient and only about 20% continued to have migraine for more than half of the follow-up period. 69% of participants with migraine and 58% of those with tension-type headache manifested the same predominant subtype over time. However, the prospective stability of the predominant headache subtypes was quite low, with substantial crossover among the subtypes and no specific ordinal pattern of progression. A gradient of severity of clinical correlates and service use was present across headache subtypes; the greatest effect was for migraine with aura followed by migraine without aura, and then tension-type headache and unclassified headaches. Conclusions These findings highlight the importance of prospective follow-up of people with headache. The substantial longitudinal overlap among subtypes of headache shows the developmental heterogeneity of headache syndromes. Studies of the causes of headache that apply diagnostic nomenclature based on distinctions between discrete headache subtypes may not capture the true nature of headache in the general population.	[Merikangas, Kathleen R.; Cui, Lihong; Richardson, Amanda Kalaydjian; Khoromi, Suzan; Nakamura, Erin; Lamers, Femke] NIMH, NIH, Intramural Res Program, Genet Epidemiol Res Branch, Bethesda, MD 20892 USA; [Isler, Hansruedi] Hochhaus Schanze, CH-8032 Zurich, Switzerland; [Roessler, Wulf; Ajdacic-Gross, Vladeta; Gamma, Alex; Angst, Jules] Univ Zurich, Hosp Psychiat, Zurich, Switzerland	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University of Zurich	Merikangas, KR (corresponding author), NIMH, NIH, Intramural Res Program, Genet Epidemiol Res Branch, Bethesda, MD 20892 USA.	Kathleen.Merikangas@nih.gov	Lamers, Femke/G-5161-2012	Merikangas, Kathkeen/0000-0002-4667-2414; Ajdacic-Gross, Vladeta/0000-0002-7032-9237; Rossler, Wulf/0000-0003-0049-4533; Lamers, Femke/0000-0003-4344-5766	Swiss National Science Foundation [3200-050881.97/1]; National Institute of Mental Health [ZIAMH002807-07]; Netherlands Organisation for Scientific Research (NWO); NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002807] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by grant 3200-050881.97/1 of the Swiss National Science Foundation and National Institute of Mental Health, Intramural Research Program grant No ZIAMH002807-07 for collaborative analyses of the Zurich Cohort Study. FL is supported by a Rubicon fellowship from the Netherlands Organisation for Scientific Research (NWO). The views and opinions expressed in this report are those of the authors and should not be construed to represent the views of any of the sponsoring organisations, agencies, or US government.	American Psychiatric Association, 1987, DIAGN STAT MAN MENT; American Psychiatric Association, 1980, DIAGN STAT MAN 3; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; Angst J, 2005, EPIDEMIOL PSICHIAT S, V14, P68, DOI 10.1017/S1121189X00006278; Angst J, 2010, AM J PSYCHIAT, V167, P1194, DOI 10.1176/appi.ajp.2010.09071011; Anttila P, 2006, PEDIATRICS, V117, pE1197, DOI 10.1542/peds.2005-2274; Bille B, 1997, CEPHALALGIA, V17, P488, DOI 10.1046/j.1468-2982.1997.1704488.x; BINDER J, 1982, PSYCHOTHER PSYCHOSOM, V38, P128, DOI 10.1159/000287621; BRESLAU N, 1993, J PSYCHIAT RES, V27, P211, DOI 10.1016/0022-3956(93)90009-Q; Cady R, 2002, HEADACHE, V42, P204, DOI 10.1046/j.1526-4610.2002.02053.x; Derogatis L. R., 1977, SCL 90 MANUAL SCORIN; Dunn G, 1999, BRIT J PSYCHIAT, V174, P95, DOI 10.1192/bjp.174.2.95; Eich D, 2003, ACTA PSYCHIAT SCAND, V108, P11, DOI 10.1034/j.1600-0447.108.s418.3.x; Guidetti V, 1998, CEPHALALGIA, V18, P449, DOI 10.1046/j.1468-2982.1998.1807449.x; HONKASALO ML, 1995, HEADACHE, V35, P70, DOI 10.1111/j.1526-4610.1995.hed3502070.x; Jensen R, 2008, LANCET NEUROL, V7, P354, DOI 10.1016/S1474-4422(08)70062-0; Kallela M, 1999, CEPHALALGIA, V19, P151, DOI 10.1046/j.1468-2982.1999.1903151.x; Kienbacher C, 2006, CEPHALALGIA, V26, P820, DOI 10.1111/j.1468-2982.2006.01108.x; LARSSON B, 1995, HEADACHE, V35, P513, DOI 10.1111/j.1526-4610.1995.hed3509513.x; Ligthart L, 2006, TWIN RES HUM GENET, V9, P54, DOI 10.1375/183242706776403019; Lipton RB, 2005, AM J MED, V118, p3S, DOI 10.1016/j.amjmed.2005.01.014; Lipton RB, 2001, HEADACHE, V41, P646, DOI 10.1046/j.1526-4610.2001.041007646.x; Lipton RB, 2002, NEUROLOGY, V58, pS27, DOI 10.1212/WNL.58.9_suppl_6.S27; Lyngberg AC, 2005, EUR J EPIDEMIOL, V20, P1007, DOI 10.1007/s10654-005-3778-5; Lyngberg AC, 2005, NEUROLOGY, V65, P580, DOI 10.1212/01.wnl.0000172918.74999.8a; Lyngberg AC, 2005, AM J EPIDEMIOL, V161, P1066, DOI 10.1093/aje/kwi139; Manzoni GC, 2004, NEUROL SCI, V25, pS67, DOI 10.1007/s10072-004-0255-y; MERIKANGAS KR, 1994, EUR ARCH PSY CLIN N, V244, P145, DOI 10.1007/BF02191890; MERIKANGAS KR, 1990, ARCH GEN PSYCHIAT, V47, P849; RASMUSSEN BK, 1994, CURR OPIN NEUROL, V7, P264, DOI 10.1097/00019052-199406000-00015; Rasmussen BK, 1997, CEPHALALGIA, V17, P487, DOI 10.1046/j.1468-2982.1997.1704487.x; Rossler W, 2011, EUR ARCH PSY CLIN N, V261, P11, DOI 10.1007/s00406-010-0123-0; Russell MB, 2002, HEADACHE, V42, P332, DOI 10.1046/j.1526-4610.2002.02102.x; Russell MB, 2007, AM J MED GENET B, V144B, P982, DOI 10.1002/ajmg.b.30497; Saunders K, 2008, NEUROLOGY, V70, P538, DOI 10.1212/01.wnl.0000297192.84581.21; Shapiro RE, 2007, CEPHALALGIA, V27, P991, DOI 10.1111/j.1468-2982.2007.01396.x; Stang P, 1998, J GEN INTERN MED, V13, P296, DOI 10.1046/j.1525-1497.1998.00094.x; Stewart WF, 2008, J OCCUP ENVIRON MED, V50, P736, DOI 10.1097/JOM.0b013e31818180cb; STEWART WF, 1992, JAMA-J AM MED ASSOC, V267, P64, DOI 10.1001/jama.267.1.64; Stovner LJ, 2007, CEPHALALGIA, V27, P193, DOI 10.1111/j.1468-2982.2007.01288.x; Swartz KL, 2000, ARCH GEN PSYCHIAT, V57, P945, DOI 10.1001/archpsyc.57.10.945; Wessman M, 2007, LANCET NEUROL, V6, P521, DOI 10.1016/S1474-4422(07)70126-6	42	27	27	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 25	2011	343								d5076	10.1136/bmj.d5076	http://dx.doi.org/10.1136/bmj.d5076			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	813ZQ	21868455	Green Accepted, Green Published, hybrid, Green Submitted			2022-12-28	WOS:000294410400003
J	Stuckler, D; Basu, S; McKee, M				Stuckler, David; Basu, Sanjay; McKee, Martin			Commentary: UN high level meeting on non-communicable diseases: an opportunity for whom?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							NONCOMMUNICABLE DISEASES; ALCOHOL TAX; HEALTH; MORTALITY		[Stuckler, David] Univ Cambridge, Dept Sociol, Cambridge CB23RQ, England; [Basu, Sanjay] Univ Calif San Francisco, Dept Sociol, San Francisco, CA USA; [McKee, Martin] London Sch Hyg & Trop Med, London, England	University of Cambridge; University of California System; University of California San Francisco; University of London; London School of Hygiene & Tropical Medicine	Stuckler, D (corresponding author), Univ Cambridge, Dept Sociol, Cambridge CB23RQ, England.	ds450@cam.ac.uk	McKee, Marc D/E-2187-2011; Mckee, Martin/E-6673-2018; Stuckler, David/H-2261-2012	McKee, Marc D/0000-0001-8349-965X; Mckee, Martin/0000-0002-0121-9683; Stuckler, David/0000-0002-1288-8401				Alwan AD, 2011, B WORLD HEALTH ORGAN, V89, P546, DOI 10.2471/BLT.11.091074; [Anonymous], SCARCE DONOR FUNDING; Barnes PJ, 2007, PLOS MED, V4, P779, DOI 10.1371/journal.pmed.0040112; BEAGLEHOLE R, UNPUB LANCET; Beaglehole R, 2007, LANCET, V370, P2152, DOI 10.1016/S0140-6736(07)61700-0; Beaglehole R, 2011, LANCET, V377, P1438, DOI 10.1016/S0140-6736(11)60393-0; Bibbins-Domingo K, 2010, NEW ENGL J MED, V362, P590, DOI 10.1056/NEJMoa0907355; BOSELEY S, 2010, GUARDIAN        1221; CAPEWELL S, UNPUB RAPID MORTALIT; Delamothe T, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b2102; FREUDENBERG N, 2011, CORP HLTH WATCH 0727; Geneau R, 2010, LANCET, V376, P1689, DOI 10.1016/S0140-6736(10)61414-6; Horton R, 2005, LANCET, V366, P1514, DOI 10.1016/S0140-6736(05)67454-5; Jamison DT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1; KOSTOVA D, 2010, 15781 NBER WORKING P; Labonte R, 2011, GLOBALIZATION HEALTH, V7, DOI 10.1186/1744-8603-7-21; LAYTON L, 2011, WASHINTON POST  0709; Mccoy D, 2009, LANCET, V373, P1645, DOI 10.1016/S0140-6736(09)60571-7; McDaniel PA, 2006, TOB CONTROL, V15, P215, DOI 10.1136/tc.2005.014977; MCNEIL D, 2009, NY TIMES        0216; Narayan KMV, 2010, NEW ENGL J MED, V363, P1196, DOI 10.1056/NEJMp1002024; Ooms G, 2010, GLOBALIZATION HEALTH, V6, DOI 10.1186/1744-8603-6-17; Organization WH, 2009, GLOB HLTH RISKS MORT; POKHAREL K, 2011, WALL ST J; Siegel K., 2011, SICK SOC RESPONDING; Stuckler D, 2008, LANCET, V372, P1563, DOI 10.1016/S0140-6736(08)61656-6; Stuckler D, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001020; *UN, 2010, PREV CONTR NONC DIS; Wagenaar AC, 2010, AM J PUBLIC HEALTH, V100, P2270, DOI 10.2105/AJPH.2009.186007; Wagenaar AC, 2009, AM J PUBLIC HEALTH, V99, P1464, DOI 10.2105/AJPH.2007.131326; World Health Organization, 2009, MORT BURD DIS EST WH; YACH D, 2004, TOWARDS WHO LONG TER; Zhang B, 2006, AM J PREV MED, V30, P474, DOI 10.1016/j.amepre.2006.02.001	33	29	29	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 23	2011	343								d5336	10.1136/bmj.d5336	http://dx.doi.org/10.1136/bmj.d5336			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	813ZK	21865280	Green Accepted			2022-12-28	WOS:000294409600022
J	Holzmeister, J; Leclercq, C				Holzmeister, Johannes; Leclercq, Christophe			Heart Failure 3 Implantable cardioverter defibrillators and cardiac resynchronisation therapy	LANCET			English	Article							LEFT-VENTRICULAR DYSSYNCHRONY; LONG-TERM SURVIVAL; CARE-HF TRIAL; RESYNCHRONIZATION THERAPY; SPECKLE-TRACKING; PROPHYLACTIC IMPLANTATION; AUTOMATIC DEFIBRILLATOR; MYOCARDIAL-INFARCTION; SYSTOLIC DYSFUNCTION; DISEASE PROGRESSION	Implantable cardioverter defibrillators and cardiac resynchronisation therapy (CRT) have become standard of care in modern treatment for heart failure. Results from trials have provided ample evidence that CRT, in addition to its proven benefits in patients with symptomatic heart failure (New York Heart Association [NYHA] class III), might also reduce morbidity and mortality in those with mildly symptomatic heart failure (NYHA class II). As a result, the 2010 European Society of Cardiology guidelines now recommend CRT for both patient populations. In this review we summarise and critically assess the landmark randomised clinical trials REVERSE, MADIT-CRT, and RAFT. Furthermore, we discuss the rationale and available evidence for other emerging indications of CRT, including its use in patients with a mildly reduced left ventricular ejection fraction (>35%), in those with a narrow QRS complex (<= 120 ms), and in those with concomitant bradyarrhythmic pacemaker indications. We also focus on patients who do not respond to CRT, and on CRT optimisation.	[Holzmeister, Johannes] Univ Zurich Hosp, Dept Cardiol & Cardiac Surg, CH-8091 Zurich, Switzerland; [Leclercq, Christophe] CHU Pontchaillou, Dept Cardiol & Malad Vasc, Rennes, France	University of Zurich; University Zurich Hospital; CHU Rennes	Holzmeister, J (corresponding author), Univ Zurich Hosp, Dept Cardiol, CH-8091 Zurich, Switzerland.	johannes.holzmeister@usz.ch			St Jude Medical; Biotronik; Medtronic; Boston Scientific; Sorin; Boston Scimed	St Jude Medical(St. Jude Medical); Biotronik; Medtronic(Medtronic); Boston Scientific(Boston Scientific); Sorin; Boston Scimed	JH has received consulting fees from St Jude Medical and Biotronik; has received research grants and speaker honoraria from Biotronik, St Jude Medical, Medtronic, and Boston Scientific; and is a co-principal investigator in EchoCRT. CL has received consulting fees from St Jude Medical, Sorin, Medtronic, and Biotronik; has received research grants and speaker honoraria from St Jude Medical, Sorin, Medtronic, Boston Scimed, and Biotronik; and was a principal investigator in Septal CRT, which was sponsored by Boston Scientific.	Abraham WT, 2010, AM HEART J, V159, P944, DOI 10.1016/j.ahj.2010.02.034; Abraham WT, 2004, CIRCULATION, V110, P2864, DOI 10.1161/01.CIR.0000146336.92331.D1; Abraham WT, 2002, NEW ENGL J MED, V346, P1845, DOI 10.1056/NEJMoa013168; Achilli A, 2003, J AM COLL CARDIOL, V42, P2117, DOI 10.1016/j.jacc.2003.08.024; Achtelik M, 2000, PACE, V23, P1741; Adabag AS, 2010, NAT REV CARDIOL, V7, P216, DOI 10.1038/nrcardio.2010.3; Ailawadi G, 2010, HEART RHYTHM, V7, P619, DOI 10.1016/j.hrthm.2010.01.014; Bansch D, 2002, CIRCULATION, V105, P1453, DOI 10.1161/01.CIR.0000012350.99718.AD; Bardy GH, 2005, NEW ENGL J MED, V352, P225, DOI 10.1056/NEJMoa043399; Bax JJ, 2004, J AM COLL CARDIOL, V44, P1, DOI 10.1016/j.jacc.2004.02.055; Becker M, 2010, JACC-CARDIOVASC IMAG, V3, P472, DOI 10.1016/j.jcmg.2009.11.016; Bernard A, 2011, INT J CARDIOL, V148, P289, DOI 10.1016/j.ijcard.2009.11.007; Beshai JF, 2007, NEW ENGL J MED, V357, P2461, DOI 10.1056/NEJMoa0706695; Bigger JT, 1997, NEW ENGL J MED, V337, P1569, DOI 10.1056/NEJM199711273372201; Bleeker GB, 2006, J AM COLL CARDIOL, V48, P2243, DOI 10.1016/j.jacc.2006.07.067; Bleeker GB, 2006, CIRCULATION, V113, P969, DOI 10.1161/CIRCULATIONAHA.105.543678; Bordachar P, 2010, J AM COLL CARDIOL, V56, P747, DOI 10.1016/j.jacc.2010.04.038; Boriani G, 2006, AM HEART J, V151, P1050, DOI 10.1016/j.ahj.2005.08.019; Bristow MR, 2004, NEW ENGL J MED, V350, P2140, DOI 10.1056/NEJMoa032423; Cazeau S, 2001, NEW ENGL J MED, V344, P873, DOI 10.1056/NEJM200103223441202; Chakir K, 2008, CIRCULATION, V117, P1369, DOI 10.1161/CIRCULATIONAHA.107.706291; Chung ES, 2008, CIRCULATION, V117, P2608, DOI 10.1161/CIRCULATIONAHA.107.743120; Chung ES, 2010, EUR J HEART FAIL, V12, P581, DOI 10.1093/eurjhf/hfq009; Cleland JGF, 2005, NEW ENGL J MED, V352, P1539, DOI 10.1056/NEJMoa050496; Cleland JGF, 2006, EUR HEART J, V27, P1928, DOI 10.1093/eurheartj/ehl099; Connolly SJ, 2000, EUR HEART J, V21, P2071, DOI 10.1053/euhj.2000.2476; Delgado V, 2008, J AM COLL CARDIOL, V51, P1944, DOI 10.1016/j.jacc.2008.02.040; Derval N, 2010, J AM COLL CARDIOL, V56, P782, DOI 10.1016/j.jacc.2010.07.006; Dickstein K, 2008, EUR HEART J, V29, P2388, DOI 10.1093/eurheartj/ehn309; Dickstein K, 2010, EUR HEART J, V31, P2677, DOI 10.1093/eurheartj/ehq337; Ellenbogen KA, 2010, CIRCULATION, V122, P2660, DOI 10.1161/CIRCULATIONAHA.110.992552; Fonarow GC, 2007, J AM COLL CARDIOL, V50, P768, DOI 10.1016/j.jacc.2007.04.064; Forleo GB, 2011, HEART RHYTHM, V8, P31, DOI 10.1016/j.hrthm.2010.09.076; Frohlich G, 2010, EUR HEART J, V31, P1477, DOI 10.1093/eurheartj/ehq065; Fung JWH, 2006, J CARDIOVASC ELECTR, V17, P1288, DOI 10.1111/j.1540-8167.2006.00612.x; Gasparini M, 2008, EUR HEART J, V29, P1644, DOI 10.1093/eurheartj/ehn133; Gervais R, 2009, EUR J HEART FAIL, V11, P699, DOI 10.1093/eurjhf/hfp074; Ghio S, 2009, EUR J HEART FAIL, V11, P480, DOI 10.1093/eurjhf/hfp034; Gorcsan J, 2010, CIRCULATION, V122, P1910, DOI 10.1161/CIRCULATIONAHA.110.954768; Gras D, 2007, EUROPACE, V9, P516, DOI 10.1093/europace/eum080; Hauser RG, 2009, HEART RHYTHM, V6, P605, DOI 10.1016/j.hrthm.2009.02.024; Healey JS, 2007, EUR HEART J, V28, P1746, DOI 10.1093/eurheartj/ehl438; Hohnloser SH, 2004, NEW ENGL J MED, V351, P2481, DOI 10.1056/NEJMoa041489; Holzmeister Johannes, 2009, Curr Heart Fail Rep, V6, P49; Kadish A, 2004, NEW ENGL J MED, V350, P2151, DOI 10.1056/NEJMoa033088; Khan NK, 2007, EUR J HEART FAIL, V9, P491, DOI 10.1016/j.ejheart.2006.11.003; Koplan BA, 2009, J AM COLL CARDIOL, V53, P355, DOI 10.1016/j.jacc.2008.09.043; Lambiase PD, 2004, HEART, V90, P44, DOI 10.1136/heart.90.1.44; Leclercq C, 2002, J AM COLL CARDIOL, V39, P194, DOI 10.1016/S0735-1097(01)01747-8; Leclercq C, 2008, J AM COLL CARDIOL, V51, P1455, DOI 10.1016/j.jacc.2007.11.074; Leclercq C, 2007, PACE, V30, pS23; Leclercq C, 2011, EUR HEART J, V32, P1580, DOI 10.1093/eurheartj/ehr016; Linde C, 2009, J AM COLL CARDIOL, V53, pA183, DOI 10.1016/j.jacc.2009.08.011; Linde C, 2008, J AM COLL CARDIOL, V52, P1834, DOI 10.1016/j.jacc.2008.08.027; MAURER G, 1984, J AM COLL CARDIOL, V3, P986, DOI 10.1016/S0735-1097(84)80357-5; MIROWSKI M, 1980, NEW ENGL J MED, V303, P322, DOI 10.1056/NEJM198008073030607; Moss AJ, 1996, NEW ENGL J MED, V335, P1933, DOI 10.1056/NEJM199612263352601; Moss AJ, 2002, NEW ENGL J MED, V346, P877, DOI 10.1056/NEJMoa013474; Moss AJ, 2010, CIRC J, V74, P1038, DOI 10.1253/circj.CJ-10-0243; Moss AJ, 2009, NEW ENGL J MED, V361, P1329, DOI 10.1056/NEJMoa0906431; Mullens W, 2009, J AM COLL CARDIOL, V53, P765, DOI 10.1016/j.jacc.2008.11.024; Paparella G, 2010, PACE, V33, P841, DOI 10.1111/j.1540-8159.2010.02701.x; Pouleur AC, 2011, EUR HEART J, V32, P1720, DOI 10.1093/eurheartj/ehr185; Rao RK, 2007, CIRCULATION, V115, P2136, DOI 10.1161/CIRCULATIONAHA.106.634444; Singh JP, 2011, CIRCULATION, V123, P1159, DOI 10.1161/CIRCULATIONAHA.110.000646; Singh JP, 2006, HEART RHYTHM, V3, P1285, DOI 10.1016/j.hrthm.2006.07.034; Solomon SD, 2010, CIRCULATION, V122, P985, DOI 10.1161/CIRCULATIONAHA.110.955039; Solomon SD, 2005, NEW ENGL J MED, V352, P2581, DOI 10.1056/NEJMoa043938; Spragg DD, 2003, CIRCULATION, V108, P929, DOI 10.1161/01.CIR.0000088782.99568.CA; Stern J, 2007, PACE, V30, P603, DOI 10.1111/j.1540-8159.2007.00719.x; Suffoletto MS, 2006, CIRCULATION, V113, P960, DOI 10.1161/CIRCULATIONAHA.105.571455; Sutton MSJ, 2009, CIRCULATION, V120, P1858, DOI 10.1161/CIRCULATIONAHA.108.818724; Sutton MGS, 2003, CIRCULATION, V107, P1985, DOI 10.1161/01.CIR.0000065226.24159.E9; Tanaka H, 2010, EUR HEART J, V31, P1690, DOI 10.1093/eurheartj/ehq213; Tang ASL, 2010, NEW ENGL J MED, V363, P2385, DOI 10.1056/NEJMoa1009540; Theuns DAMJ, 2010, EUROPACE, V12, P1564, DOI 10.1093/europace/euq329; Tops LF, 2006, J AM COLL CARDIOL, V48, P1642, DOI 10.1016/j.jacc.2006.05.072; Tournoux FB, 2007, PACE, V30, P1021, DOI 10.1111/j.1540-8159.2007.00803.x; Truong QA, 2008, JACC-CARDIOVASC IMAG, V1, P772, DOI 10.1016/j.jcmg.2008.07.014; van Geldorp IE, 2010, EUROPACE, V12, P223, DOI 10.1093/europace/eup378; Vatankulu MA, 2009, AM J CARDIOL, V103, P1280, DOI 10.1016/j.amjcard.2009.01.023; Ypenburg C, 2008, J AM COLL CARDIOL, V52, P1402, DOI 10.1016/j.jacc.2008.06.046; Yu CM, 2006, J AM COLL CARDIOL, V48, P2251, DOI 10.1016/j.jacc.2006.07.054; Zareba W, 2011, CIRCULATION, V123, P1061, DOI 10.1161/CIRCULATIONAHA.110.960898	84	34	35	0	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 20	2011	378	9792					722	730		10.1016/S0140-6736(11)61228-2	http://dx.doi.org/10.1016/S0140-6736(11)61228-2			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	815EW	21856486				2022-12-28	WOS:000294509900032
J	Wray, GA				Wray, Gregory A.			CNCing Is Believing	SCIENCE			English	Editorial Material									[Wray, Gregory A.] Duke Univ, Dept Biol, Durham, NC 27708 USA; [Wray, Gregory A.] Duke Univ, Inst Genome Sci & Policy, Durham, NC 27708 USA	Duke University; Duke University	Wray, GA (corresponding author), Duke Univ, Dept Biol, Durham, NC 27708 USA.	gwray@duke.edu						Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Blanchette M, 2004, GENOME RES, V14, P2412, DOI 10.1101/gr.2800104; Gould SJ, 2002, STRUCTURE EVOLUTIONA; Levinton, 2001, GENETICS PALEONTOLOG, DOI 10.1017/CBO9780511612961; Li W. - H., 2006, MOL EVOLUTION; Lowe CB, 2011, SCIENCE, V333, P1019, DOI 10.1126/science.1202702; McLysaght A, 2002, NAT GENET, V31, P200, DOI 10.1038/ng884; Pollard KS, 2006, PLOS GENET, V2, P1599, DOI 10.1371/journal.pgen.0020168; SEPKOSKI JJ, 1984, PALEOBIOLOGY, V10, P246, DOI 10.1017/S0094837300008186; Visel A, 2008, NAT GENET, V40, P158, DOI 10.1038/ng.2007.55	10	0	0	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 19	2011	333	6045					946	947		10.1126/science.1210771	http://dx.doi.org/10.1126/science.1210771			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808TD	21852480				2022-12-28	WOS:000294000400034
J	Mangalmurti, SS; Murtagh, L; Mello, MM				Mangalmurti, Sandeep S.; Murtagh, Lindsey; Mello, Michelle M.			Medical Malpractice in the Military	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ADVERSE EVENTS; NEGLIGENT CARE; FERES DOCTRINE; ERRORS; CLAIMS; RETENTION; COLORADO; UTAH		[Mangalmurti, Sandeep S.] Univ Chicago, Med Ctr, Dept Med, Chicago, IL 60637 USA; [Murtagh, Lindsey; Mello, Michelle M.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA	University of Chicago; University of Chicago Medical Center; Harvard University; Harvard T.H. Chan School of Public Health	Mangalmurti, SS (corresponding author), Univ Chicago, Med Ctr, Dept Med, Chicago, IL 60637 USA.							BRENNAN TA, 1991, NEW ENGL J MED, V324, P370, DOI 10.1056/NEJM199102073240604; Brou DG, 2007, MIL LAW REV, V192, P1; CAIN BP, 1986, GEORGIA LAW REV, V20, P497; CAROLLO R, 1997, DAYTON DAILY NEW 105; Carpenter Jennifer L., 2003, U HAWAII LAW REV, V26, P35; *DEP VET AFF, VA BEN SERV MEMB ENT; Figley Paul, 2010, AM U L REV, V60, P393; Gallagher TH, 2006, ARCH INTERN MED, V166, P1605, DOI 10.1001/archinte.166.15.1605; Gawande A, 2004, NEW ENGL J MED, V351, P2471, DOI 10.1056/NEJMp048317; *GEN ACC OFF, 1987, BETT US MALPR DAT CO; HICKSON GB, 1992, JAMA-J AM MED ASSOC, V267, P1359, DOI 10.1001/jama.267.10.1359; Holmes SL, 2009, MIL MED, V174, P529, DOI 10.7205/MILMED-D-01-6508; HULL A, 2007, WASHINGTON POST 0305, pA1; Institute of Medicine, 2007, 21 CENT SYST EV VET; LOCALIO AR, 1991, NEW ENGL J MED, V325, P245, DOI 10.1056/NEJM199107253250405; Mello MM, 2006, MILBANK Q, V84, P459, DOI 10.1111/j.1468-0009.2006.00455.x; Mello MM, 2002, TEX LAW REV, V80, P1595; MILLER CT, 2008, NATL PUBLIC RAD 0608; MOALLEM L, 2011, HASTINGS LAW J  0427; President's Commission on Care for America's Returning Wounded Warriors, 2007, SERV SUPP SIMPL SUBC; PRIEST D, 2007, WASHINGTON POST 0627, pA1; ROCHE WF, 2008, LOS ANGELES TIM 0420, pA1; Studdert DM, 2006, NEW ENGL J MED, V354, P2024, DOI 10.1056/NEJMsa054479; Studdert DM, 2000, MED CARE, V38, P250, DOI 10.1097/00005650-200003000-00002; Thomas EJ, 2000, MED CARE, V38, P261, DOI 10.1097/00005650-200003000-00003; Turley J, 2003, GEORGE WASH LAW REV, V71, P1; TURLEY J, 2007, US TODAY        0412, pA13; *VET DIS BEN COMM, 2007, HON CALL DUT VET DIS; *VET EQ RIGHTS PRO, OV WHO WE AR	29	2	2	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 18	2011	365	7					664	670		10.1056/NEJMhle1104066	http://dx.doi.org/10.1056/NEJMhle1104066			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	808ER	21848468				2022-12-28	WOS:000293960500017
J	Neuteboom, RF; Lequin, MH; de Wit, MCY; Catsman-Berrevoets, CE				Neuteboom, Rinze F.; Lequin, Maarten H.; de Wit, Marie-Claire Y.; Catsman-Berrevoets, Coriene E.			Lumbar puncture in paediatric stroke	LANCET			English	Editorial Material							ARTERIAL ISCHEMIC-STROKE; ARTERIOPATHY; CHILDHOOD		[Neuteboom, Rinze F.; de Wit, Marie-Claire Y.; Catsman-Berrevoets, Coriene E.] Erasmus MC, Erasmus Univ Hosp Rotterdam, Dept Paediat Neurol, Rotterdam, Netherlands; [Lequin, Maarten H.] Erasmus MC, Erasmus Univ Hosp Rotterdam, Dept Paediat Radiol, Rotterdam, Netherlands; Sophia Childrens Univ Hosp, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC - Sophia Children's Hospital	Neuteboom, RF (corresponding author), Sophia Childrens Hosp Erasmus MC, Dept Paediat Neurol, POB 2060, NL-3000 CB Rotterdam, Netherlands.	r.neuteboom@erasmusmc.nl	de Wit, Marie-Claire/X-4168-2019					Amlie-Lefond C, 2008, LANCET NEUROL, V7, P425, DOI 10.1016/S1474-4422(08)70086-3; Braun KPJ, 2009, BRAIN, V132, P544, DOI 10.1093/brain/awn313; Lanthier S, 2005, NEUROLOGY, V64, P660, DOI 10.1212/01.WNL.0000151851.66154.27; Nagel MA, 2008, NEUROLOGY, V70, P853, DOI 10.1212/01.wnl.0000304747.38502.e8; Riou EM, 2008, PEDIATR NEUROL, V38, P1, DOI 10.1016/j.pediatrneurol.2007.09.005	5	4	4	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG-SEP	2011	378	9793					848	848		10.1016/S0140-6736(11)60892-1	http://dx.doi.org/10.1016/S0140-6736(11)60892-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	816FY	21872753				2022-12-28	WOS:000294585300040
J	Motohashi, Y				Motohashi, Yutaka			Suicide in Japan	LANCET			English	Editorial Material									Akita Univ, Grad Sch Med, Dept Publ Hlth, Akita 0108543, Japan	Akita University	Motohashi, Y (corresponding author), Akita Univ, Grad Sch Med, Dept Publ Hlth, 1-1-1 Hndo, Akita 0108543, Japan.	motohasi@med.akita-u.ac.jp						Cabinet Office Government of Japan, 2007, COMPR SUIC PREV PRIN; Cabinet Office Government of Japan, 2008, PLAN ACC SUIC PREV M; Cabinet Office Government of Japan, 2011, WHIT PAP SUIC PREV P; Cabinet Office Government of Japan, 2006, BAS LAW SUIC COUNT; Department of Public Health Akita University School of Medicine, 2006, AKITA J PUBLIC HLTH, V4, P83; Japan Ministry of Health Labor and Welfare, 2011, VIT STAT JAP 2009; Kaga Makiko, 2009, Leg Med (Tokyo), V11 Suppl 1, pS18, DOI 10.1016/j.legalmed.2009.01.015; Motohashi Y, 2007, SUICIDE CAN BE PREVE; Motohashi Y, 2007, SUICIDE LIFE-THREAT, V37, P593, DOI 10.1521/suli.2007.37.5.593; Motohashi Yutaka, 2004, Environ Health Prev Med, V9, P3, DOI 10.1265/ehpm.9.3; Watanabe R, 2006, RES REPORT SOCIOECON	11	27	29	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 7	2012	379	9823					1282	1283		10.1016/S0140-6736(11)61130-6	http://dx.doi.org/10.1016/S0140-6736(11)61130-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	922FB	21885102				2022-12-28	WOS:000302531100008
J	Cipriani, A; Barbui, C; Salanti, G; Rendell, J; Brown, R; Stockton, S; Purgato, M; Spineli, LM; Goodwin, GM; Geddes, JR				Cipriani, Andrea; Barbui, Corrado; Salanti, Georgia; Rendell, Jennifer; Brown, Rachel; Stockton, Sarah; Purgato, Marianna; Spineli, Loukia M.; Goodwin, Guy M.; Geddes, John R.			Comparative efficacy and acceptability of antimanic drugs in acute mania: a multiple-treatments meta-analysis	LANCET			English	Article							COST-EFFECTIVENESS; DISORDER; GUIDELINES; COMBINATION; MONOTHERAPY; RELAPSE; UPDATE; MOOD; RISK	Background Conventional meta-analyses have shown inconsistent results for efficacy of pharmacological treatments for acute mania. We did a multiple-treatments meta-analysis, which accounted for both direct and indirect comparisons, to assess the effects of all antimanic drugs. Methods We systematically reviewed 68 randomised controlled trials (16 073 participants) from Jan 1, 1980, to Nov 25, 2010, which compared any of the following pharmacological drugs at therapeutic dose range for the treatment of acute mania in adults: aripiprazole, asenapine, carbamazepine, valproate, gabapentin, haloperidol, lamotrigine, lithium, olanzapine, quetiapine, risperidone, topiramate, and ziprasidone. The main outcomes were the mean change on mania rating scales and the number of patients who dropped out of the allocated treatment at 3 weeks. Analysis was done by intention to treat. Findings Haloperidol (standardised mean difference [SMD] -0.56 [95% CI -0.69 to -0.43]), risperidone (-0.50 [-0.63 to -0.38]), olanzapine (-0.43 [-0.54 to -0.32], lithium (-0.37 [-0.63 to -0.11]), quetiapine (-0.37 [-0.51 to -0.23]), aripiprazole (-0.37 [-0.51 to -0.23]), carbamazepine (-0.36 [-0.60 to -0.11], asenapine (-0.30 [-0.53 to -0.07]), valproate (-0.20 [-0.37 to -0.04]), and ziprasidone (-0.20 [-0.37 to -0.03]) were significantly more effective than placebo, whereas gabapentin, lamotrigine, and topiramate were not. Haloperidol had the highest number of significant differences and was significantly more effective than lithium (SMD -0.19 [95% CI -0.36 to -0.01]), quetiapine (-0.19 [-0.37 to 0.01]), aripiprazole (-0.19 [-0.36 to -0.02]), carbamazepine (-0.20 [-0.36 to -0.01]), asenapine (-0.26 [-0.52 to 0.01]), valproate (-0.36 [-0.56 to -0.15]), ziprasidone (-0.36 [-0.56 to -0.15]), lamotrigine (-0.48 [-0.77 to -0.19]), topiramate (-0.63 [-0.84 to -0.43]), and gabapentin (-0.88 [-1.40 to -0.36]). Risperidone and olanzapine had a very similar profile of comparative efficacy, being more effective than valproate, ziprasidone, lamotrigine, topiramate, and gabapentin. Olanzapine, risperidone, and quetiapine led to significantly fewer discontinuations than did lithium, lamotrigine, placebo, topiramate, and gabapentin. Interpretation Overall, antipsychotic drugs were significantly more effective than mood stabilisers. Risperidone, olanzapine, and haloperidol should be considered as among the best of the available options for the treatment of manic episodes. These results should be considered in the development of clinical practice guidelines.	[Cipriani, Andrea] Univ Verona, WHO Collaborating Ctr Res & Training Mental Hlth, Dept Publ Hlth & Community Med,Policlin G B Rossi, Dept Med & Publ Hlth,Sect Psychiat & Clin Psychol, I-37134 Verona, Italy; [Salanti, Georgia; Spineli, Loukia M.] Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, GR-45110 Ioannina, Greece; [Rendell, Jennifer; Brown, Rachel; Stockton, Sarah; Goodwin, Guy M.; Geddes, John R.] Univ Oxford, Dept Psychiat, Oxford, England	University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; University of Ioannina; University of Oxford	Cipriani, A (corresponding author), Univ Verona, WHO Collaborating Ctr Res & Training Mental Hlth, Dept Publ Hlth & Community Med,Policlin G B Rossi, Dept Med & Publ Hlth,Sect Psychiat & Clin Psychol, Piazzale LA Scuro 10, I-37134 Verona, Italy.	andrea.cipriani@univr.it	Geddes, John/B-8240-2011; Cipriani, Andrea/P-6944-2015; Spineli, Loukia/S-9443-2019; Bannuru, Raveendhara/G-2601-2011; Goodwin, Guy/ABE-6084-2020	Geddes, John/0000-0002-5281-5960; Cipriani, Andrea/0000-0001-5179-8321; Spineli, Loukia/0000-0001-9515-582X; Bannuru, Raveendhara/0000-0002-8069-5783; Salanti, Georgia/0000-0002-3830-8508	Bailly Thomas charity; Medical Research Council; NIHR; Servier; UK Medical Research Council; UK Economic and Social Research Council; National Institute for Health Research; Stanley Medical Research Institute; European Research Council [260559 IMMA]; National Institute for Health Research [NF-SI-0510-10102] Funding Source: researchfish	Bailly Thomas charity; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIHR(National Institute for Health Research (NIHR)); Servier(Servier); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); Stanley Medical Research Institute; European Research Council(European Research Council (ERC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	GMG holds or has held grants from Bailly Thomas charity, Medical Research Council, NIHR, Servier; has received honoraria from AstraZeneca, BMS, Lundbeck, Sanofi-Aventis, Servier, holds shares in P1vital ltd; has served on advisory boards for AstraZeneca, BMS, Boehringer Ingelheim, Cephalon, Janssen-Cilag, Lilly, Lundbeck, P1Vital, Servier, Shering Plough, Wyeth, and acted as an expert witness for Lilly and Servier. JRG currently receives research funding from UK Medical Research Council, UK Economic and Social Research Council, the National Institute for Health Research, and the Stanley Medical Research Institute. He was expert witness for Dr Reddys Laboratories and is Chief Investigator on the CEQUEL trial to which GlaxoSmithKline have contributed and supplied investigational drugs and placebo. AC, CB, MP, RB, JR, GS, LMS, and SS declare that they have no conflicts of interest.; We thank the following authors and pharmaceutical companies for providing additional information on included studies: John Gallagher (AstraZeneca); Wally Landsberg and Paula Fyans (Bristol-Myers Squibb); Jean-Yves Loze (Otsuka Pharmaceutical Europe Ltd); Doug Williamson (Eli Lilly); and Onur Karayal and Douglas Vanderburg (Pfizer). We also thank Eduard Vieta and Aysegul Yildiz for their help in checking the references of studies to be included. GS and LMS acknowledge research funding support from the European Research Council (Grant Agreement Number 260559 IMMA).	Ades AE, 2006, PHARMACOECONOMICS, V24, P1, DOI 10.2165/00019053-200624010-00001; Caldwell DM, 2005, BMJ-BRIT MED J, V331, P897, DOI 10.1136/bmj.331.7521.897; Cipriani A, 2009, LANCET, V373, P746, DOI 10.1016/S0140-6736(09)60046-5; Correll CU, 2010, BIPOLAR DISORD, V12, P116, DOI 10.1111/j.1399-5618.2010.00798.x; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dias S, 2010, STAT MED, V29, P932, DOI 10.1002/sim.3767; Geddes JR, 2010, LANCET, V375, P385, DOI 10.1016/S0140-6736(09)61828-6; Goodwin GM, 2009, J PSYCHOPHARMACOL, V23, P346, DOI 10.1177/0269881109102919; Grunze H, 2009, WORLD J BIOL PSYCHIA, V10, P85, DOI 10.1080/15622970902823202; Higgins J., 2009, COCHRANE HDB SYSTEMA; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Kahn RS, 2008, LANCET, V371, P1085, DOI 10.1016/S0140-6736(08)60486-9; Leucht S, 2009, LANCET, V373, P31, DOI 10.1016/S0140-6736(08)61764-X; Licht RW, 2001, EUR ARCH PSY CLIN N, V251, P66, DOI 10.1007/BF03035131; Lu G, 2004, STAT MED, V23, P3105, DOI 10.1002/sim.1875; Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8; National Institute for Health and Clinical Excellence (NICE), 2006, NICE CLIN GUID; Purgato M, 2010, EPIDEMIOL PSICHIAT S, V19, P296; Rummel-Kluge C, 2010, SCHIZOPHR RES, V123, P225, DOI 10.1016/j.schres.2010.07.012; Salanti G, 2008, STAT METHODS MED RES, V17, P279, DOI 10.1177/0962280207080643; Salanti G, 2011, J CLIN EPIDEMIOL, V64, P163, DOI 10.1016/j.jclinepi.2010.03.016; Salanti G, 2009, J CLIN EPIDEMIOL, V62, P857, DOI 10.1016/j.jclinepi.2008.10.001; Scherk H, 2007, ARCH GEN PSYCHIAT, V64, P442, DOI 10.1001/archpsyc.64.4.442; Soares-Weiser K, 2007, HEALTH TECHNOL ASSES, V11, P1; Tamayo JM, 2010, INT J NEUROPSYCHOPH, V13, P813, DOI 10.1017/S1461145709991246; World Health Organization, WHO MOD LIST ESS MED; Yatham LN, 2009, BIPOLAR DISORD, V11, P225, DOI 10.1111/j.1399-5618.2009.00672.x; Yildiz A, 2011, NEUROPSYCHOPHARMACOL, V36, P375, DOI 10.1038/npp.2010.192; YOUNG RC, 1978, BRIT J PSYCHIAT, V133, P429, DOI 10.1192/bjp.133.5.429	30	350	360	0	61	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 8	2011	378	9799					1306	1315		10.1016/S0140-6736(11)60873-8	http://dx.doi.org/10.1016/S0140-6736(11)60873-8			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	831IU	21851976				2022-12-28	WOS:000295724300025
J	Jacquemont, S; Reymond, A; Zufferey, F; Harewood, L; Walters, RG; Kutalik, Z; Martinet, D; Shen, YP; Valsesia, A; Beckmann, ND; Thorleifsson, G; Belfiore, M; Bouquillon, S; Campion, D; de Leeuw, N; de Vries, BBA; Esko, T; Fernandez, BA; Fernandez-Aranda, F; Fernandez-Real, JM; Gratacos, M; Guilmatre, A; Hoyer, J; Jarvelin, MR; Kooy, RF; Kurg, A; Le Caignec, C; Mannik, K; Platt, OS; Sanlaville, D; Van Haelst, MM; Gomez, SV; Walha, F; Wu, BL; Yu, YG; Aboura, A; Addor, MC; Alembik, Y; Antonarakis, SE; Arveiler, B; Barth, M; Bednarek, N; Bena, F; Bergmann, S; Beri, M; Bernardini, L; Blaumeiser, B; Bonneau, D; Bottani, A; Boute, O; Brunner, HG; Cailley, D; Callier, P; Chiesa, J; Chrast, J; Coin, L; Coutton, C; Cuisset, JM; Cuvellier, JC; David, A; de Freminville, B; Delobel, B; Delrue, MA; Demeer, B; Descamps, D; Didelot, G; Dieterich, K; Disciglio, V; Doco-Fenzy, M; Drunat, S; Duban-Bedu, B; Dubourg, C; Moustafa, JSE; Elliott, P; Faas, BHW; Faivre, L; Faudet, A; Fellmann, F; Ferrarini, A; Fisher, R; Flori, E; Forer, L; Gaillard, D; Gerard, M; Gieger, C; Gimelli, S; Gimelli, G; Grabe, HJ; Guichet, A; Guillin, O; Hartikainen, AL; Heron, D; Hippolyte, L; Holder, M; Homuth, G; Isidor, B; Jaillard, S; Jaros, Z; Jimenez-Murcia, S; Helas, GJ; Jonveaux, P; Kaksonen, S; Keren, B; Kloss-Brandstatter, A; Knoers, NVAM; Koolen, DA; Kroisel, PM; Kronenberg, F; Labalme, A; Landais, E; Lapi, E; Layet, V; Legallic, S; Leheup, B; Leube, B; Lewis, S; Lucas, J; MacDermot, KD; Magnusson, P; Marshall, C; Mathieu-Dramard, M; McCarthy, MI; Meitinger, T; Mencarelli, MA; Merla, G; Moerman, A; Mooser, V; Morice-Picard, F; Mucciolo, M; Nauck, M; Ndiaye, NC; Nordgren, A; Pasquier, L; Petit, F; Pfundt, R; Plessis, G; Rajcan-Separovic, E; Ramelli, GP; Rauch, A; Ravazzolo, R; Reis, A; Renieri, A; Richart, C; Ried, JS; Rieubland, C; Roberts, W; Roetzer, KM; Rooryck, C; Rossi, M; Saemundsen, E; Satre, V; Schurmann, C; Sigurdsson, E; Stavropoulos, DJ; Stefansson, H; Tengstrom, C; Thorsteinsdottir, U; Tinahones, FJ; Touraine, R; Vallee, L; van Binsbergen, E; Van der Aa, N; Vincent-Delorme, C; Visvikis-Siest, S; Vollenweider, P; Volzke, H; Vulto-van Silfhout, AT; Waeber, G; Wallgren-Pettersson, C; Witwicki, RM; Zwolinksi, S; Andrieux, J; Estivill, X; Gusella, JF; Gustafsson, O; Metspalu, A; Scherer, SW; Stefansson, K; Blakemore, AIF; Beckmann, JS; Froguel, P				Jacquemont, Sebastien; Reymond, Alexandre; Zufferey, Flore; Harewood, Louise; Walters, Robin G.; Kutalik, Zoltan; Martinet, Danielle; Shen, Yiping; Valsesia, Armand; Beckmann, Noam D.; Thorleifsson, Gudmar; Belfiore, Marco; Bouquillon, Sonia; Campion, Dominique; de Leeuw, Nicole; de Vries, Bert B. A.; Esko, Tonu; Fernandez, Bridget A.; Fernandez-Aranda, Fernando; Manuel Fernandez-Real, Jose; Gratacos, Monica; Guilmatre, Audrey; Hoyer, Juliane; Jarvelin, Marjo-Riitta; Kooy, R. Frank; Kurg, Ants; Le Caignec, Cedric; Maennik, Katrin; Platt, Orah S.; Sanlaville, Damien; Van Haelst, Mieke M.; Villatoro Gomez, Sergi; Walha, Faida; Wu, Bai-lin; Yu, Yongguo; Aboura, Azzedine; Addor, Marie-Claude; Alembik, Yves; Antonarakis, Stylianos E.; Arveiler, Benoit; Barth, Magalie; Bednarek, Nathalie; Bena, Frederique; Bergmann, Sven; Beri, Mylene; Bernardini, Laura; Blaumeiser, Bettina; Bonneau, Dominique; Bottani, Armand; Boute, Odile; Brunner, Han G.; Cailley, Dorothee; Callier, Patrick; Chiesa, Jean; Chrast, Jacqueline; Coin, Lachlan; Coutton, Charles; Cuisset, Jean-Marie; Cuvellier, Jean-Christophe; David, Albert; de Freminville, Benedicte; Delobel, Bruno; Delrue, Marie-Ange; Demeer, Benedicte; Descamps, Dominique; Didelot, Gerard; Dieterich, Klaus; Disciglio, Vittoria; Doco-Fenzy, Martine; Drunat, Severine; Duban-Bedu, Benedicte; Dubourg, Christele; Moustafa, Julia S. El-Sayed; Elliott, Paul; Faas, Brigitte H. W.; Faivre, Laurence; Faudet, Anne; Fellmann, Florence; Ferrarini, Alessandra; Fisher, Richard; Flori, Elisabeth; Forer, Lukas; Gaillard, Dominique; Gerard, Marion; Gieger, Christian; Gimelli, Stefania; Gimelli, Giorgio; Grabe, Hans J.; Guichet, Agnes; Guillin, Olivier; Hartikainen, Anna-Liisa; Heron, Delphine; Hippolyte, Loyse; Holder, Muriel; Homuth, Georg; Isidor, Bertrand; Jaillard, Sylvie; Jaros, Zdenek; Jimenez-Murcia, Susana; Helas, Geraldine Joly; Jonveaux, Philippe; Kaksonen, Satu; Keren, Boris; Kloss-Brandstaetter, Anita; Knoers, Nine V. A. M.; Koolen, David A.; Kroisel, Peter M.; Kronenberg, Florian; Labalme, Audrey; Landais, Emilie; Lapi, Elisabetta; Layet, Valerie; Legallic, Solenn; Leheup, Bruno; Leube, Barbara; Lewis, Suzanne; Lucas, Josette; MacDermot, Kay D.; Magnusson, Pall; Marshall, Christian; Mathieu-Dramard, Michele; McCarthy, Mark I.; Meitinger, Thomas; Mencarelli, Maria Antonietta; Merla, Giuseppe; Moerman, Alexandre; Mooser, Vincent; Morice-Picard, Fanny; Mucciolo, Mafalda; Nauck, Matthias; Ndiaye, Ndeye Coumba; Nordgren, Ann; Pasquier, Laurent; Petit, Florence; Pfundt, Rolph; Plessis, Ghislaine; Rajcan-Separovic, Evica; Ramelli, Gian Paolo; Rauch, Anita; Ravazzolo, Roberto; Reis, Andre; Renieri, Alessandra; Richart, Cristobal; Ried, Janina S.; Rieubland, Claudine; Roberts, Wendy; Roetzer, Katharina M.; Rooryck, Caroline; Rossi, Massimiliano; Saemundsen, Evald; Satre, Veronique; Schurmann, Claudia; Sigurdsson, Engilbert; Stavropoulos, Dimitri J.; Stefansson, Hreinn; Tengstrom, Carola; Thorsteinsdottir, Unnur; Tinahones, Francisco J.; Touraine, Renaud; Vallee, Louis; van Binsbergen, Ellen; Van der Aa, Nathalie; Vincent-Delorme, Catherine; Visvikis-Siest, Sophie; Vollenweider, Peter; Voelzke, Henry; Vulto-van Silfhout, Anneke T.; Waeber, Gerard; Wallgren-Pettersson, Carina; Witwicki, Robert M.; Zwolinksi, Simon; Andrieux, Joris; Estivill, Xavier; Gusella, James F.; Gustafsson, Omar; Metspalu, Andres; Scherer, Stephen W.; Stefansson, Kari; Blakemore, Alexandra I. F.; Beckmann, Jacques S.; Froguel, Philippe			Mirror extreme BMI phenotypes associated with gene dosage at the chromosome 16p11.2 locus	NATURE			English	Article							COPY NUMBER VARIATION; BODY-MASS INDEX; DEPENDENT PROBE AMPLIFICATION; CIRCULAR BINARY SEGMENTATION; TIME QUANTITATIVE PCR; HIDDEN-MARKOV MODEL; SNP GENOTYPING DATA; FAILURE-TO-THRIVE; RELATIVE QUANTIFICATION; METABOLIC SYNDROME	Both obesity and being underweight have been associated with increased mortality(1,2). Underweight, defined as a body mass index (BMI) <= 18.5 kg per m(2) in adults and <= -2 standard deviations from the mean in children, is the main sign of a series of heterogeneous clinical conditions including failure to thrive(3-5), feeding and eating disorder and/or anorexia nervosa(6,7). In contrast to obesity, few genetic variants underlying these clinical conditions have been reported(8,9). We previously showed that hemizygosity of a similar to 600-kilobase (kb) region on the short arm of chromosome 16 causes a highly penetrant form of obesity that is often associated with hyperphagia and intellectual disabilities(10). Here we show that the corresponding reciprocal duplication is associated with being underweight. We identified 138 duplication carriers (including 132 novel cases and 108 unrelated carriers) from individuals clinically referred for developmental or intellectual disabilities (DD/ID) or psychiatric disorders, or recruited from population-based cohorts. These carriers show significantly reduced postnatal weight and BMI. Half of the boys younger than five years are underweight with a probable diagnosis of failure to thrive, whereas adult duplication carriers have an 8.3-fold increased risk of being clinically underweight. We observe a trend towards increased severity in males, as well as a depletion of male carriers among non-medically ascertained cases. These features are associated with an unusually high frequency of selective and restrictive eating behaviours and a significant reduction in head circumference. Each of the observed phenotypes is the converse of one reported in carriers of deletions at this locus. The phenotypes correlate with changes in transcript levels for genes mapping within the duplication but not in flanking regions. The reciprocal impact of these 16p11.2 copy-number variants indicates that severe obesity and being underweight could have mirror aetiologies, possibly through contrasting effects on energy balance.	[Jacquemont, Sebastien; Zufferey, Flore; Martinet, Danielle; Beckmann, Noam D.; Belfiore, Marco; Addor, Marie-Claude; Fellmann, Florence; Ferrarini, Alessandra; Hippolyte, Loyse; Beckmann, Jacques S.] CHU Vaudois, Serv Med Genet, CH-1011 Lausanne, Switzerland; [Reymond, Alexandre; Harewood, Louise; Walha, Faida; Chrast, Jacqueline; Didelot, Gerard; Witwicki, Robert M.] Univ Lausanne, Ctr Integrat Genom, CH-1015 Lausanne, Switzerland; [Walters, Robin G.; Van Haelst, Mieke M.; Coin, Lachlan; Moustafa, Julia S. El-Sayed; Blakemore, Alexandra I. F.; Froguel, Philippe] Univ London Imperial Coll Sci Technol & Med, Dept Genom Common Dis, London W12 0NN, England; [Kutalik, Zoltan; Valsesia, Armand; Bergmann, Sven; Beckmann, Jacques S.] Univ Lausanne, Dept Med Genet, CH-1005 Lausanne, Switzerland; [Kutalik, Zoltan; Valsesia, Armand; Bergmann, Sven] Univ Lausanne, Swiss Inst Bioinformat, CH-1015 Lausanne, Switzerland; [Shen, Yiping; Platt, Orah S.; Wu, Bai-lin; Yu, Yongguo] Childrens Hosp Boston, Boston, MA 02115 USA; [Shen, Yiping; Gusella, James F.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Valsesia, Armand] Univ Lausanne, Ludwig Inst Canc Res, CH-1015 Lausanne, Switzerland; [Thorleifsson, Gudmar; Stefansson, Hreinn; Thorsteinsdottir, Unnur; Gustafsson, Omar; Stefansson, Kari] deCODE Genet, IS-101 Reykjavik, Iceland; [Bouquillon, Sonia; Andrieux, Joris] CHRU Lille, Hop Jeanne de Flandre, Med Genet Lab, F-59000 Lille, France; [Campion, Dominique; Guilmatre, Audrey; Guillin, Olivier; Legallic, Solenn] Univ Rouen, INSERM U614, F-76000 Rouen, France; [Campion, Dominique; Guilmatre, Audrey; Guillin, Olivier; Legallic, Solenn] Ctr Hosp Rouvray, F-76000 Rouen, France; [de Leeuw, Nicole; de Vries, Bert B. A.; Brunner, Han G.; Faas, Brigitte H. W.; Koolen, David A.; Pfundt, Rolph; Vulto-van Silfhout, Anneke T.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, Nijmegen Ctr Mol Life Sci, NL-6500 HB Nijmegen, Netherlands; [de Leeuw, Nicole; de Vries, Bert B. A.; Brunner, Han G.; Faas, Brigitte H. W.; Koolen, David A.; Pfundt, Rolph; Vulto-van Silfhout, Anneke T.] Radboud Univ Nijmegen, Med Ctr, Inst Genet & Metab Disorders, NL-6500 HB Nijmegen, Netherlands; [Esko, Tonu; Kurg, Ants; Maennik, Katrin; Metspalu, Andres] Univ Tartu, Inst Mol & Cell Biol, EE-51010 Tartu, Estonia; [Esko, Tonu; Metspalu, Andres] Univ Tartu, Estonian Genome Ctr, EE-51010 Tartu, Estonia; [Fernandez, Bridget A.] Mem Univ Newfoundland, Discipline Genet & Med, St John, NF A1B 3V6, Canada; [Fernandez-Aranda, Fernando; Jimenez-Murcia, Susana] Univ Hosp Bellvitge IDIBELL, Ciber Fisiopatol Obesidad & Nutr CIBEROBN, Dept Psychiat, Barcelona 08907, Spain; [Manuel Fernandez-Real, Jose] Hosp Univ Girona Dr Josep Trueta, Dept Diabet Endocrinol & Nutr, Ciber Fisiopatol Obesidad & Nutr CIBEROBN, Inst Invest Biomed Girona,Inst Salud Carlos III, Girona 17007, Spain; [Gratacos, Monica; Villatoro Gomez, Sergi; Estivill, Xavier] CIBER Epidemiol & Salud Publ CIBERESP, Ctr Genom Regulat CRG UPF, Genes & Dis Program, Barcelona 08003, Catalonia, Spain; [Hoyer, Juliane; Reis, Andre] Univ Erlangen Nurnberg, Inst Human Genet, D-91054 Erlangen, Germany; [Jarvelin, Marjo-Riitta] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Biostat, London W2 1PG, England; [Jarvelin, Marjo-Riitta] Natl Inst Hlth & Welf, Dept Child & Adolescent Hlth, Oulu 90101, Finland; [Jarvelin, Marjo-Riitta] Univ Oulu, Inst Hlth Sci, FIN-90570 Oulu, Finland; [Jarvelin, Marjo-Riitta] 90014 Univ Oulu, Univ Oulu, Bioctr Oulu, Oulu, Finland; [Kooy, R. Frank; Blaumeiser, Bettina; Van der Aa, Nathalie] Univ Antwerp, Dept Med Genet, B-2650 Antwerp, Belgium; [Kooy, R. Frank; Blaumeiser, Bettina; Van der Aa, Nathalie] Univ Antwerp Hosp, B-2650 Antwerp, Belgium; [Le Caignec, Cedric; David, Albert; Isidor, Bertrand] CHU Nantes, Serv Genet Med, Nantes, France; [Sanlaville, Damien; Labalme, Audrey; Rossi, Massimiliano] CHU Lyon, Hosp Civils Lyon, Serv Cytogenet Constitut, F-69000 Lyon, France; [Sanlaville, Damien; Labalme, Audrey; Rossi, Massimiliano] UCBL1, TIGER Team, Neurosci Res Ctr, F-69000 Lyon, France; [Van Haelst, Mieke M.; Knoers, Nine V. A. M.; van Binsbergen, Ellen] Univ Med Ctr, Dept Med Genet, NL-3584 EA Utrecht, Netherlands; [Wu, Bai-lin] Fudan Univ, Childrens Hosp, Shanghai 200032, Peoples R China; [Wu, Bai-lin] Fudan Univ, Inst Biomed Sci, Shanghai 200032, Peoples R China; [Yu, Yongguo] Shanghai Childrens Med Ctr, Shanghai 200127, Peoples R China; [Aboura, Azzedine; Drunat, Severine; Gerard, Marion] Robert DEBRE Univ Hosp, APHP, Dept Genet, F-75019 Paris, France; [Alembik, Yves; Flori, Elisabeth] CHU Strasbourg, Hop Hautepierre, Serv Genet Med, F-67000 Strasbourg, France; [Antonarakis, Stylianos E.; Bena, Frederique; Bottani, Armand; Gimelli, Stefania] Univ Hosp Geneva, Serv Genet Med, CH-1205 Geneva, Switzerland; [Arveiler, Benoit; Delrue, Marie-Ange; Morice-Picard, Fanny; Rooryck, Caroline] Univ Bordeaux 2, Lab Malad Rares Genet & Metab, F-33076 Bordeaux, France; [Arveiler, Benoit; Cailley, Dorothee; Delrue, Marie-Ange; Morice-Picard, Fanny; Rooryck, Caroline] CHU Bordeaux, Serv Genet Med, F-33076 Bordeaux, France; [Barth, Magalie; Bonneau, Dominique; Guichet, Agnes] CHU Angers, Serv Genet, F-49933 Angers, France; [Bednarek, Nathalie] CHU Hop Alix de Champagne, Serv Pediat, F-51100 Reims, France; [Beri, Mylene; Jonveaux, Philippe] CHU Nancy, Genet Lab, F-54511 Vandoeuvre Les Nancy, France; [Bernardini, Laura] IRCCS Casa Sollievo della Sofferenza Hosp, Mendel Lab, I-71013 San Giovanni Rotondo, Italy; [Boute, Odile; Holder, Muriel; Moerman, Alexandre; Petit, Florence] CHRU Lille, Hop Jeanne de Flandre, Serv Genet Clin, F-59037 Lille, France; [Chiesa, Jean] CHU Caremeau, Lab Cytogenet, F-30029 Nimes, France; [Coutton, Charles; Satre, Veronique] CHU Grenoble, Lab Genet Chromosom, F-38043 Grenoble, France; [Cuisset, Jean-Marie; Cuvellier, Jean-Christophe; Vallee, Louis] CHRU Lille, Hop Roger Salengro, Serv Neurol Pediat, F-59037 Lille, France; [de Freminville, Benedicte; Touraine, Renaud] CHU St Etienne, Serv Genet, CHU Hop Nord, F-42055 St Etienne, France; [Delobel, Bruno; Duban-Bedu, Benedicte] GHICL, Hop St Vincent de Paul, Ctr Genet Chromosom, F-59160 Lille, France; [Demeer, Benedicte; Mathieu-Dramard, Michele] CHRU Amiens, Serv Genet Med, F-80000 Amiens, France; [Descamps, Dominique] Ctr Hosp Bethune, F-62408 Bethune, France; [Dieterich, Klaus] CHU Grenoble, Serv Genet Clin, F-38043 Grenoble, France; [Disciglio, Vittoria; Mencarelli, Maria Antonietta; Mucciolo, Mafalda; Renieri, Alessandra] Univ Siena, Dept Biotechnol, I-53100 Siena, Italy; [Doco-Fenzy, Martine; Gaillard, Dominique; Landais, Emilie] CHU REIMS, IFR 53, HMB, Serv Genet, F-51092 Reims, France; [Dubourg, Christele; Jaillard, Sylvie] Univ Rennes 1, IFR GFAS 140, UMR CNRS 6061, F-35043 Rennes, France; [Dubourg, Christele] CHU, Serv Genet Mol, F-35033 Rennes, France; [Elliott, Paul] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Biostat, MRC HPA Ctr Environm & Hlth, London W2 1PG, England; [Faivre, Laurence] CHU Dijon, Ctr Genet, F-21079 Dijon, France; [Faudet, Anne; Keren, Boris] APHP GH Pitie Salpetriere, Dept Genet & Cytogenet, F-75013 Paris, France; [Fisher, Richard; Zwolinksi, Simon] Int Ctr Life, Inst Human Genet, Newcastle Upon Tyne NE1 4EP, Tyne & Wear, England; [Forer, Lukas; Kloss-Brandstaetter, Anita; Kronenberg, Florian] Innsbruck Med Univ, Div Genet Epidemiol, Dept Med Genet Mol & Clin Pharmacol, A-6020 Innsbruck, Austria; [Gieger, Christian; Ried, Janina S.] German Res Ctr Environm Hlth, Helmholtz Ctr Munich, Inst Genet Epidemiol, D-85764 Neuherberg, Germany; [Gimelli, Giorgio] G Gaslini Inst Children, Lab Citogenet, I-16147 Genoa, Italy; [Grabe, Hans J.] Ernst Moritz Arndt Univ Greifswald, Dept Psychiat & Psychotherapy, D-17475 Greifswald, Germany; [Grabe, Hans J.] Ernst Moritz Arndt Univ Greifswald, Dept Psychiat & Psychotherapy, D-18437 Stralsund, Germany; [Hartikainen, Anna-Liisa] Univ Oulu, Dept Obstet & Gynecol, Inst Clin Med, FIN-90570 Oulu, Finland; [Heron, Delphine] Univ Paris 06, Embryol AP HP, F-75005 Paris, France; [Heron, Delphine] Hop La Pitie Salpetriere, Dept Genet Cytogenet, F-75013 Paris, France; [Homuth, Georg; Schurmann, Claudia] Ernst Moritz Arndt Univ Greifswald, Interfac Inst Genet & Funct Genom, D-17487 Greifswald, Germany; [Jaillard, Sylvie; Lucas, Josette] CHU Rennes, Lab Cytogenet & Biol Cellulaire, F-35033 Rennes, France; [Jaros, Zdenek] Landesklinikum Waldviertel Zwettl, Abt Kinder & Jugendheilkunde, A-3910 Zwettl, Austria; [Helas, Geraldine Joly] CHU Rouen, Dept Genet, F-76183 Rouen, France; [Kaksonen, Satu] Habilitat Unit Folkhalsan, SF-00250 Helsinki, Finland; [Knoers, Nine V. A. M.] Univ Med Ctr, Dept Human Genet, NL-3584 EA Utrecht, Netherlands; [Kroisel, Peter M.; Roetzer, Katharina M.] Med Univ Graz, Inst Human Genet, A-8010 Graz, Austria; [Layet, Valerie] Childrens Hosp Anna Meyer, Med Genet Unit, I-50139 Florence, Italy; [Layet, Valerie] Grp Hosp Havre, Unite Genet, F-76600 Le Havre, France; [Leheup, Bruno] CHU Nancy, Serv Med Infantile & Genet Clin 3, F-54511 Vandoeuvre Les Nancy, France; [Leheup, Bruno] Univ Lorraine UHP Nancy, PRES, F-54511 Vandoeuvre Les Nancy, France; [Leube, Barbara] Heinrich Heine Univ Hosp Duesseldorf, Inst Human Genet & Anthropol, D-40001 Dusseldorf, Germany; [Lewis, Suzanne] Univ British Columbia, Dept Med Genet, Vancouver, BC V6H 3N1, Canada; [Lewis, Suzanne] Child & Family Res Inst, Vancouver, BC V6H 3N1, Canada; [MacDermot, Kay D.] Northwick Pk & St Marks Hosp, NW Thames Reg Genet Serv, Harrow HA1 3UJ, Middx, England; [Magnusson, Pall] Landspitali Univ Hosp, IS-105 Reykjavik, Iceland; [Marshall, Christian] Hosp Sick Children, Ctr Appl Genom, Toronto, ON M5G 1X8, Canada; [McCarthy, Mark I.] Univ Oxford, Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab, Oxford OX3 7LJ, England; [McCarthy, Mark I.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [McCarthy, Mark I.] Churchill Hosp, Oxford NIHR Biomed Res Ctr, Oxford OX3 7LJ, England; [Meitinger, Thomas] German Res Ctr Environm Hlth, Hemholtz Ctr Munich, Inst Human Genet, D-85764 Neuherberg, Germany; [Meitinger, Thomas] Tech Univ Munich, Inst Human Genet, D-85764 Neuherberg, Germany; [Merla, Giuseppe] IRCCS Casa Sollievo della Sofferenza Hosp, Med Genet Unit, I-71013 San Giovanni Rotondo, Italy; [Mooser, Vincent] GlaxoSmithKline R&D, Genet, King Of Prussia, PA 19406 USA; [Nauck, Matthias] Ernst Moritz Arndt Univ Greifswald, Inst Clin Chem & Lab Med, D-17475 Greifswald, Germany; [Ndiaye, Ndeye Coumba; Visvikis-Siest, Sophie] Univ Henri Poincare, Cardiovasc Genet Res Unit, EA4373, F-54000 Nancy, France; [Nordgren, Ann] Karolinska Inst, Dept Mol Med & Surg, S-17176 Stockholm, Sweden; [Pasquier, Laurent] CLAD Ouest, Serv Genet, F-35203 Rennes 2, France; [Plessis, Ghislaine] CHU Clemenceau, Serv Genet, F-14033 Caen, France; [Rajcan-Separovic, Evica] Univ British Columbia, Dept Pathol, Vancouver, BC V5Z 4H4, Canada; [Rajcan-Separovic, Evica] Child & Family Res Inst, Vancouver, BC V5Z 4H4, Canada; [Ramelli, Gian Paolo] Osped San Giovanni Bellinzona, Div Pediat, CH-6500 Bellinzona, Switzerland; [Rauch, Anita] Univ Zurich, Inst Med Genet, CH-8603 Schwerzenbach, Switzerland; [Ravazzolo, Roberto] Univ Genoa, Dept Pediat, I-16126 Genoa, Italy; [Ravazzolo, Roberto] Univ Genoa, G Gaslini Inst, CEBR, I-16126 Genoa, Italy; [Richart, Cristobal] Univ Rovira & Virgili, Univ Hosp Juan XXIII, Ciber Fisiopatol Obesidad & Nutr CIBEROBN, Dept Internal Med,Inst Salud Carlos III, Tarragona 43005, Spain; [Rieubland, Claudine] Univ Bern, Inselspital, Dept Paediat, Div Human Genet, CH-3010 Bern, Switzerland; [Roberts, Wendy] Hosp Sick Children, Autism Res Unit, Toronto, ON M5G 1X8, Canada; [Saemundsen, Evald] State Diagnost & Counseling Ctr, IS-200 Kopavogur, Iceland; [Sigurdsson, Engilbert] Landspitali Univ Hosp, IS-101 Reykjavik, Iceland; [Stavropoulos, Dimitri J.] Hosp Sick Children, Dept Pediat Lab Med, Toronto, ON M5G 1X8, Canada; [Tengstrom, Carola] Rinnekoti Res Fdn, Genet Serv, SF-02980 Espoo, Finland; [Thorsteinsdottir, Unnur] Univ Iceland, Fac Med, IS-101 Reykjavik, Iceland; [Tinahones, Francisco J.] Clin Hosp Virgen de la Victoria, Ciber Fisiopatol Obesidad & Nutr CIBEROBN, Dept Endocrinol & Nutr, Inst Salud Carlos III, Malaga 29010, Spain; [Vincent-Delorme, Catherine] CH Arras CHRU Lille, Ctr Malad Rares, F-59000 Lille, France; [Vollenweider, Peter; Waeber, Gerard] CHU Vaudois, Dept Internal Med, CH-1011 Lausanne, Switzerland; [Voelzke, Henry] Ernst Moritz Arndt Univ Greifswald, Inst Community Med, D-17475 Greifswald, Germany; [Wallgren-Pettersson, Carina] Univ Helsinki, Dept Med Genet, Helsinki 00251, Finland; [Wallgren-Pettersson, Carina] Folkhalsan Inst Genet, Helsinki 00251, Finland; [Gustafsson, Omar] Oslo Univ Hosp, Dept Psychiat, N-0407 Oslo, Norway; [Scherer, Stephen W.] Univ Toronto, Hosp Sick Children, Toronto, ON M5G 1L7, Canada; [Froguel, Philippe] Inst Pasteur, Inst Biol, CNRS 8090, F-59800 Lille, France; [Disciglio, Vittoria] Azienda Osped Univ Senese, UOC Genet Med, Siena, Italy; [Meitinger, Thomas] Tech Univ Munich, Klinikum Rechts Isar, Inst Human Genet, D-81675 Munich, Germany	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Imperial College London; University of Lausanne; Swiss Institute of Bioinformatics; University of Lausanne; Harvard University; Boston Children's Hospital; Harvard University; Massachusetts General Hospital; Ludwig Institute for Cancer Research; University of Lausanne; Universite de Lille - ISITE; CHU Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rouen Normandie; Radboud University Nijmegen; Radboud University Nijmegen; University of Tartu; University of Tartu; Memorial University Newfoundland; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; Universitat de Girona; Girona University Hospital Dr. Josep Trueta; Institut d'Investigacio Biomedica de Girona (IDIBGI); Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; University of Erlangen Nuremberg; Imperial College London; Finland National Institute for Health & Welfare; University of Oulu; University of Oulu; University of Antwerp; University of Antwerp; Nantes Universite; CHU de Nantes; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Utrecht University; Utrecht University Medical Center; Fudan University; Fudan University; Shanghai Jiao Tong University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Geneva; UDICE-French Research Universities; Universite de Bordeaux; CHU Bordeaux; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; CHU de Reims; CHU de Nancy; IRCCS Casa Sollievo Della Sofferenza; Istituto CSS Mendel; Universite de Lille - ISITE; CHU Lille; Universite de Montpellier; CHU de Nimes; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Universite de Lille - ISITE; CHU Lille; CHU de St Etienne; Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); University of Siena; CHU de Reims; Universite de Reims Champagne-Ardenne; Universite de Rennes; CHU Rennes; Imperial College London; CHU Dijon Bourgogne; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Newcastle University - UK; Medical University of Innsbruck; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Genoa; IRCCS Istituto Giannina Gaslini; Ernst Moritz Arndt Universitat Greifswald; Ernst Moritz Arndt Universitat Greifswald; University of Oulu; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Ernst Moritz Arndt Universitat Greifswald; CHU Rennes; CHU de Rouen; Utrecht University; Utrecht University Medical Center; Medical University of Graz; University of Florence; Azienda Ospedaliera Universitaria (AOU) MEYER; CHU de Nancy; Universite de Lorraine; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; University of British Columbia; Child & Family Research Institute; Imperial College London; Landspitali National University Hospital; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; IRCCS Casa Sollievo Della Sofferenza; GlaxoSmithKline; Ernst Moritz Arndt Universitat Greifswald; Universite de Lorraine; Karolinska Institutet; CHU de Caen NORMANDIE; University of British Columbia; Child & Family Research Institute; Regional Hospital of Bellinzona & Valleys, San Giovanni; University of Zurich; University of Genoa; University of Genoa; IRCCS Istituto Giannina Gaslini; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; Universitat Rovira i Virgili; University of Bern; University Hospital of Bern; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Landspitali National University Hospital; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Iceland; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Ernst Moritz Arndt Universitat Greifswald; University of Helsinki; University of Oslo; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; University of Siena; University Hospital of Siena; Technical University of Munich	Beckmann, JS (corresponding author), CHU Vaudois, Serv Med Genet, CH-1011 Lausanne, Switzerland.	Jacques.Beckmann@chuv.ch	Brunner, Han/C-9928-2013; JIMENEZ-MURCIA, SUSANA/L-9786-2014; ROORYCK, Caroline/M-4565-2014; COUTTON, Charles/G-2859-2014; Touraine, Renaud/AAV-1605-2020; Tinahones, Francisco José/AAB-2882-2020; Sanlaville, Damien/M-4716-2014; Reis, André/D-2309-2009; Rauch, Anita/C-5568-2014; dieterich, klaus/R-8418-2019; Coin, Lachlan/O-4976-2019; Isidor, Bertrand/L-2435-2015; Walters, Robin G/E-6069-2010; de Leeuw, N./L-4480-2015; Coin, Lachlan JM/A-9001-2014; Scherer, Stephen W./B-3785-2013; Antonarakis, Stylianos E/N-8866-2014; RICHART, CRISTOBAL C/S-9158-2017; FERNANDEZ-ARANDA, FERNANDO/AGY-1597-2022; Arveiler, Benoit/M-3721-2014; Meitinger, Thomas/O-1318-2015; Faas, Brigitte/L-4301-2015; Kooy, Frank/F-5276-2014; Beckmann, Jacques S/A-9772-2008; Nordgren, Ann C/N-4057-2013; Renieri, Alessandra/K-5950-2016; Isidor, Bertrand/AAJ-3456-2021; jaillard, sylvie/L-9314-2015; AT, Vulto-van Silfhout/H-4199-2015; Mencarelli, Maria Antonietta/AAC-5615-2022; Koolen, D.A./L-4448-2015; Mucciolo, Mafalda/AAB-8222-2019; Schurmann, Claudia/L-1204-2016; Fernández-Real, Jose Manuel/AGH-3599-2022; Visvikis-Siest, Sophie/H-2324-2014; DISCIGLIO, VITTORIA/K-3376-2018; Forer, Lukas/ABE-6007-2020; Pasquier, Laurent/AAN-4081-2020; Rossi, Massimiliano/AAO-5615-2020; Valsesia, Armand/F-1724-2010; Estivill, Xavier/A-3125-2013; Kutalik, Zoltan/HHZ-5697-2022; Stefansson, Kari/AAE-7187-2019; Kurg, Ants/AAM-1292-2020; Pfundt, Rolph/L-4576-2015; Fernandez-Aranda, Fernando/L-9762-2014; FROGUEL, Philippe/O-6799-2017; Kronenberg, Florian/B-1736-2008; Colaus, PsyColaus/K-6607-2013; Kurg, Ants/J-2616-2015; Jacquemont, Sebastien/AAS-5060-2021; Bonneau, Dominique/K-6110-2015; Forer, Lukas/AAX-9577-2021; Nordgren, Ann/AAQ-9142-2021; Bernardini, Laura/H-5360-2016; merla, giuseppe/K-4627-2012; MORICE-PICARD, Fanny/M-5125-2014; Le Caignec, Cedric/K-8467-2015; Estivill, Xavier/E-2957-2012; Sigurdsson, Engilbert/D-2486-2014; Blakemore, Alexandra I F/D-2253-2009; McCarthy, Mark/M-3763-2015; SATRE, Veronique/G-2864-2014	JIMENEZ-MURCIA, SUSANA/0000-0002-3596-8033; Sanlaville, Damien/0000-0001-9939-2849; Reis, André/0000-0002-6301-6363; Rauch, Anita/0000-0003-2930-3163; dieterich, klaus/0000-0002-4362-4062; Coin, Lachlan/0000-0002-4300-455X; Isidor, Bertrand/0000-0001-6480-126X; Walters, Robin G/0000-0002-9179-0321; Coin, Lachlan JM/0000-0002-4300-455X; Scherer, Stephen W./0000-0002-8326-1999; Antonarakis, Stylianos E/0000-0001-8907-5823; RICHART, CRISTOBAL C/0000-0003-0852-6739; FERNANDEZ-ARANDA, FERNANDO/0000-0002-2968-9898; Kooy, Frank/0000-0003-2024-0485; Beckmann, Jacques S/0000-0002-9741-1900; Nordgren, Ann C/0000-0003-3285-4281; Renieri, Alessandra/0000-0002-0846-9220; Isidor, Bertrand/0000-0001-6480-126X; jaillard, sylvie/0000-0002-0593-0261; Mencarelli, Maria Antonietta/0000-0001-5131-3718; Mucciolo, Mafalda/0000-0003-2228-8271; Schurmann, Claudia/0000-0003-4158-9192; Fernández-Real, Jose Manuel/0000-0002-7442-9323; Visvikis-Siest, Sophie/0000-0001-8104-8425; DISCIGLIO, VITTORIA/0000-0002-3518-9224; Pasquier, Laurent/0000-0003-3985-1286; Rossi, Massimiliano/0000-0002-5797-8152; Estivill, Xavier/0000-0002-0723-2256; Kutalik, Zoltan/0000-0001-8285-7523; Kurg, Ants/0000-0002-0829-1987; Fernandez-Aranda, Fernando/0000-0002-2968-9898; FROGUEL, Philippe/0000-0003-2972-0784; Kronenberg, Florian/0000-0003-2229-1120; Jacquemont, Sebastien/0000-0001-6838-8767; Forer, Lukas/0000-0003-2139-7329; Nordgren, Ann/0000-0003-3285-4281; Bernardini, Laura/0000-0002-3554-2817; merla, giuseppe/0000-0001-5078-928X; Le Caignec, Cedric/0000-0002-0598-653X; Sigurdsson, Engilbert/0000-0001-9404-7982; Blakemore, Alexandra I F/0000-0003-0661-564X; El-Sayed Moustafa, Julia Sarah/0000-0001-6963-6654; Bonneau, Dominique/0000-0002-6886-0969; Valsesia, Armand/0000-0003-0746-9664; Harewood, Louise/0000-0002-6398-6714; Elliott, Paul/0000-0002-7511-5684; Lewis, Suzanne/0000-0002-6300-5381; Meitinger, Thomas/0000-0002-8838-8403; McCarthy, Mark/0000-0002-4393-0510; Stefansson, Hreinn/0000-0002-9331-6666; Esko, Tonu/0000-0003-1982-6569; Rooryck, Caroline/0000-0002-9789-3591; Villatoro, Sergio/0000-0001-6940-2866; Rajcan-Separovic, Evica/0000-0002-4528-7135; SATRE, Veronique/0000-0001-7852-8591; petit, florence/0000-0002-1368-1023; Bergmann, Sven/0000-0002-6785-9034; yu, yongguo/0000-0002-4472-0910; Waeber, Gerard/0000-0003-4193-788X; Jarvelin, Marjo-Riitta/0000-0002-2149-0630; Reymond, Alexandre/0000-0003-1030-8327; Gieger, Christian/0000-0001-6986-9554; Kloss-Brandstatter, Anita/0000-0002-0873-6704; Coutton, Charles/0000-0002-8873-8098; Tinahones, Francisco J/0000-0001-6871-4403; Faivre, Laurence/0000-0001-9770-444X; Fellmann, Florence/0000-0003-3156-4768	Leenaards Foundation; Jerome Lejeune Foundation; Telethon Action Suisse Foundation; Swiss National Science Foundation; European Commission [037627, QLG1-CT-2000-01643]; Ludwig Institute for Cancer Research; Swiss Institute of Bioinformatics; Imperial College Department of Medicine; Comprehensive Biomedical Research Centre; Imperial College Healthcare NHS Trust; National Institute for Health Research; Wellcome Trust; Medical Research Council; Instituto de Salud Carlos III (ISCIII)-FIS; German Mental Retardation Network; German Federal Ministry of Education and Research [NGFNplus 01GS08160]; European Union [PI081714, PS09/01778, 201413, 245536, HEALTH-2007-2.2.1-10-223423]; Belgian National Fund for Scientific Research, Flanders; Dutch Organisation for Health Research and Development (ZON-MW) [917-86-319]; Hersenstichting Nederland (B.B.A.d.V.); Chinese National Natural Science Foundation [81000346]; Simons Foundation Autism Research Initiative; Autism Speaks; NIH [GM061354, MH071425]; Oesterreichische Nationalbank (OENB) [13059]; Children's Tumor Foundation; Harvard Medical School; Fudan University; Chinese National '973' project on Population and Health [2010CB529601]; Science and Technology Council of Shanghai [09JC1402400]; Michael Smith Foundation for Health; CIHR [MOP 74502]; Estonian Government [SF0180142s08, SF0180026s09, SF0180027s10]; Helmholtz Zentrum Munich; State of Bavaria; German National Genome Research Network [01GS0823]; German Federal Ministry of Education and Research (BMBF); Munich Center of Health Sciences (MC Health, LMUinnovativ); Genome Canada; McLaughlin Centre; Academy of Finland [104781, 120315, 129269, 1114194]; University Hospital Oulu; Biocenter; University of Oulu, Finland [75617]; NHLBI [5R01HL087679-02, 1RL1MH083268-01]; NIH/NIMH [5R01MH63706:02]; ENGAGE project; Medical Research Council, UK [G0500539, G0600705]; Academy of Finland; Biocentrum Helsinki;  [SAF2008-02278];  [HEALTH-F4-2007-201413]; MRC [G0600705, G0801056] Funding Source: UKRI; Diabetes UK [08/0003775] Funding Source: researchfish; Medical Research Council [G0600705, G0801056, G0801056B] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087679] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM061354] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH071425, RL1MH083268, R01MH063706] Funding Source: NIH RePORTER	Leenaards Foundation; Jerome Lejeune Foundation; Telethon Action Suisse Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Commission(European CommissionEuropean Commission Joint Research Centre); Ludwig Institute for Cancer Research; Swiss Institute of Bioinformatics; Imperial College Department of Medicine; Comprehensive Biomedical Research Centre; Imperial College Healthcare NHS Trust; National Institute for Health Research(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Instituto de Salud Carlos III (ISCIII)-FIS(Instituto de Salud Carlos III); German Mental Retardation Network; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); European Union(European Commission); Belgian National Fund for Scientific Research, Flanders(Fonds de la Recherche Scientifique - FNRS); Dutch Organisation for Health Research and Development (ZON-MW)(Netherlands Organization for Health Research and Development); Hersenstichting Nederland (B.B.A.d.V.); Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Simons Foundation Autism Research Initiative; Autism Speaks; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oesterreichische Nationalbank (OENB); Children's Tumor Foundation; Harvard Medical School; Fudan University; Chinese National '973' project on Population and Health(National Basic Research Program of China); Science and Technology Council of Shanghai; Michael Smith Foundation for Health(Michael Smith Foundation for Health Research); CIHR(Canadian Institutes of Health Research (CIHR)); Estonian Government; Helmholtz Zentrum Munich; State of Bavaria; German National Genome Research Network; German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Munich Center of Health Sciences (MC Health, LMUinnovativ); Genome Canada(Genome Canada); McLaughlin Centre; Academy of Finland(Academy of Finland); University Hospital Oulu; Biocenter; University of Oulu, Finland; NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH/NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); ENGAGE project(General Electric); Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Academy of Finland(Academy of Finland); Biocentrum Helsinki; ; ; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Diabetes UK(Diabetes UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank the Vital-IT high-performance computing centre of the Swiss Institute of Bioinformatics. S.J. is recipient of a bourse de releve academique de la Faculte de Biologie et Medecine de l'Universite de Lausanne. This work was supported by the Leenaards Foundation Prize (S.J., D. M. and A. Reymond), the Jerome Lejeune Foundation (A. Reymond), the Telethon Action Suisse Foundation (A. Reymond), the Swiss National Science Foundation (A. Reymond, J.S.B., S. B. and S. E. A.), a Swiss National Science Foundation Sinergia grant (S.J., D. M., S. B., J.S.B. and A. Reymond), the European Commission an EU ploidy Integrated Project grant 037627 (A. Reymond, S. B., X. E., H. G. B. and S. E. A.), the Ludwig Institute for Cancer Research (A. V.), the Swiss Institute of Bioinformatics (S. B. and Z.K.), an Imperial College Department of Medicine PhD studentship (J.S.E.-S.M), the Comprehensive Biomedical Research Centre, Imperial College Healthcare NHS Trust, and the National Institute for Health Research (P. E.), the Wellcome Trust and the Medical Research Council (A. I. F. B. and P. F.), the Instituto de Salud Carlos III (ISCIII)-FIS, the German Mental Retardation Network funded through a grant of the German Federal Ministry of Education and Research (NGFNplus 01GS08160) (A. Reis), European Union-FEDER (PI081714, PS09/01778) (F. F. A., M. G. and X. E.), SAF2008-02278 (C. R.), the Belgian National Fund for Scientific Research, Flanders (N.V.A. and R. F. K.), the Dutch Organisation for Health Research and Development (ZON-MW grant 917-86-319) and Hersenstichting Nederland (B.B.A.d.V.), grant 81000346 from the Chinese National Natural Science Foundation (Y.G.Y.), the Simons Foundation Autism Research Initiative, Autism Speaks and NIH grant GM061354 (J.F.G.), and Oesterreichische Nationalbank (OENB) grant 13059 (A.K.-B.). Y.S. holds a Young Investigator Award from the Children's Tumor Foundation and a Catalyst Award from Harvard Medical School. B. L. W. holds a Fudan Scholar Research Award from Fudan University, a grant from Chinese National '973' project on Population and Health (2010CB529601) and a grant from the Science and Technology Council of Shanghai (09JC1402400). E. R. S. and S. L., recipients of the Michael Smith Foundation for Health Research Scholar award, acknowledge the CIHR MOP 74502 operational grant. The Estonian Genome Center of the University of Tartu (EGCUT) received support from the EU Centre of Excellence in Genomics and FP7 grants 201413 and 245536, and from Estonian Government SF0180142s08, SF0180026s09 and SF0180027s10 (A. M., K. M. and A. K.). D. S. thanks the Direction Generale de l'Organisation des Soins from the French Ministry of Health for their support in the development of several array-CGH platforms, and the Centres Labellises Anomalies du Development in France. The Helmholtz Zentrum Munich and the State of Bavaria financed the KORA study, also supported by the German National Genome Research Network (NGFN-2 and NGFN Plus: 01GS0823), the German Federal Ministry of Education and Research (BMBF), and the Munich Center of Health Sciences (MC Health, LMUinnovativ). CIBEROBN and CIBERESP are initiatives of ISCIII (Spain). S. W. S. holds the GlaxoSmithKline-Canadian Institutes of Health Chair in Genetics and Genomics at the University of Toronto and the Hospital for Sick Children, and is supported by Genome Canada and the McLaughlin Centre. Funding for deCODE came in part from NIH grant MH071425 (K. S.), EU grant HEALTH-2007-2.2.1-10-223423 (Project PsychCNV) and EU grant IMI-JU-NewMeds.; NFBC1966 received financial supportfrom the Academy of Finland (project grants 104781, 120315, 129269, 1114194, Center of Excellence in Complex Disease Genetics and SALVE), University Hospital Oulu, Biocenter, University of Oulu, Finland (75617), the European Commission (EURO-BLCS, Framework 5 award QLG1-CT-2000-01643), NHLBI grant 5R01HL087679-02 through the STAMPEED program (1RL1MH083268-01), NIH/NIMH (5R01MH63706:02), ENGAGE project and grant agreement HEALTH-F4-2007-201413, and the Medical Research Council, UK (G0500539, G0600705, PrevMetSyn/SALVE). The DNA extractions, sample quality controls, biobank up-keeping and aliquotting was performed in the National Public Health Institute, Biomedicum Helsinki, Finland and supported financially by the Academy of Finland and Biocentrum Helsinki. We thank M. Hass, Z. Jaros, M. Jussila, M. Koiranen, P. Rantakallio, M. C. Rudolf, V. Soo, O. Tornwall, S. Vaara, T. Ylitalo and the French DHOS national CGH network for their help, as well as all participating patients and clinicians. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT, P39; Baxter PS, 2009, PEDIATRICS, V124, P590, DOI 10.1542/peds.2008-2784; Bengtsson H, 2008, BIOINFORMATICS, V24, P759, DOI 10.1093/bioinformatics/btn016; Bengtsson H, 2009, BIOINFORMATICS, V25, P861, DOI 10.1093/bioinformatics/btp074; Bochukova EG, 2010, NATURE, V463, P666, DOI 10.1038/nature08689; Bravender T, 2010, EUR EAT DISORD REV, V18, P79, DOI 10.1002/erv.994; Bunyan DJ, 2004, BRIT J CANCER, V91, P1155, DOI 10.1038/sj.bjc.6602121; Coin LJM, 2010, NAT METHODS, V7, P541, DOI [10.1038/NMETH.1466, 10.1038/nmeth.1466]; Colella S, 2007, NUCLEIC ACIDS RES, V35, P2013, DOI 10.1093/nar/gkm076; Corbett SS, 2004, J CHILD PSYCHOL PSYC, V45, P641, DOI 10.1111/j.1469-7610.2004.00253.x; Courchesne E, 2003, JAMA-J AM MED ASSOC, V290, P337, DOI 10.1001/jama.290.3.337; Crespi B, 2010, P NATL ACAD SCI USA, V107, P1736, DOI 10.1073/pnas.0906080106; de Gonzalez AB, 2010, NEW ENGL J MED, V363, P2211, DOI 10.1056/NEJMoa1000367; de Onis M, 2004, JAMA-J AM MED ASSOC, V291, P2600, DOI 10.1001/jama.291.21.2600; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; de Onis M, 2007, J NUTR, V137, P144, DOI 10.1093/jn/137.1.144; Diskin SJ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn556; Fernandez L, 2005, CLIN GENET, V68, P373, DOI 10.1111/j.1399-0004.2005.00493.x; FerroLuzzi A, 1995, WHO TECH REP SER, V854, P1; Firmann M, 2008, BMC CARDIOVASC DISOR, V8, DOI 10.1186/1471-2261-8-6; Flegal KM, 2007, JAMA-J AM MED ASSOC, V298, P2028, DOI 10.1001/jama.298.17.2028; Fredriks M., 1997, GROWTH DIAGRAMS 1997, P233; Girirajan S, 2010, HUM MOL GENET, V19, pR176, DOI 10.1093/hmg/ddq366; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Henrichsen CN, 2009, NAT GENET, V41, P424, DOI 10.1038/ng.345; Huang Jing, 2004, Human Genomics, V1, P287; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; Kuczmarski RJ, 2000, ADV DATA, V314, P1; Li YF, 2008, OBESITY, V16, P1809, DOI 10.1038/oby.2008.296; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marioni JC, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r228; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; McCarthy SE, 2009, NAT GENET, V41, P1223, DOI 10.1038/ng.474; Mei ZG, 2002, AM J CLIN NUTR, V75, P978, DOI 10.1093/ajcn/75.6.978; Mei ZG, 2008, J PEDIATR-US, V153, P622, DOI 10.1016/j.jpeds.2008.05.048; Merla G, 2006, AM J HUM GENET, V79, P332, DOI 10.1086/506371; Molina J, 2008, HUM MOL GENET, V17, P2486, DOI 10.1093/hmg/ddn148; MORRIS JA, 1988, BRIT MED J, V296, P1313, DOI 10.1136/bmj.296.6632.1313; Nelis M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005472; Olsen EM, 2007, ARCH DIS CHILD, V92, P109, DOI 10.1136/adc.2005.080333; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Prader A, 1989, Helv Paediatr Acta Suppl, V52, P1; Pramyothin P, 2010, CURR OPIN ENDOCRINOL, V17, P460, DOI 10.1097/MED.0b013e32833de61c; Ricard G, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000543; ROLLANDCACHERA MF, 1991, EUR J CLIN NUTR, V45, P13; Rudolf MCJ, 2005, ARCH DIS CHILD, V90, P925, DOI 10.1136/adc.2004.050179; Sabatti C, 2009, NAT GENET, V41, P35, DOI 10.1038/ng.271; Scherag S, 2010, EUR CHILD ADOLES PSY, V19, P211, DOI 10.1007/s00787-009-0085-9; Schouten JP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf056; Sempe M., 1979, AUXOLOGIE METHODE SE; Shinawi M, 2010, J MED GENET, V47, P332, DOI 10.1136/jmg.2009.073015; Slater HR, 2003, J MED GENET, V40, P907, DOI 10.1136/jmg.40.12.907; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Venkatraman ES, 2007, BIOINFORMATICS, V23, P657, DOI 10.1093/bioinformatics/btl646; Walters RG, 2010, NATURE, V463, P671, DOI 10.1038/nature08727; Wang B, 2007, SCIENCE, V316, P1194, DOI 10.1126/science.1139476; Wang K, 2011, MOL PSYCHIATR, V16, P949, DOI 10.1038/mp.2010.107; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287	61	304	311	2	85	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 6	2011	478	7367					97	U111		10.1038/nature10406	http://dx.doi.org/10.1038/nature10406			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	829JN	21881559	Green Accepted, Green Submitted			2022-12-28	WOS:000295575400042
J	Jobs, E; Ingelsson, E; Riserus, U; Nerpin, E; Jobs, M; Sundstrom, J; Basu, S; Larsson, A; Lind, L; Arnlov, J				Jobs, Elisabeth; Ingelsson, Erik; Riserus, Ulf; Nerpin, Elisabet; Jobs, Magnus; Sundstrom, Johan; Basu, Samar; Larsson, Anders; Lind, Lars; Arnlov, Johan			Association Between Serum Cathepsin S and Mortality in Older Adults	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CYSTATIN-C; TUMOR INVASION; ADIPOSE-TISSUE; EXPRESSION; ATHEROSCLEROSIS; CYSTEINE; PROGRESSION; PROTEASES; CHOLESTEROL; DEFICIENCY	Context Experimental data suggest that cathepsin S, a cysteine protease, is involved in the complex pathways leading to cardiovascular disease and cancer. However, prospective data concerning a potential association between circulating cathepsin S levels and mortality are lacking. Objective To investigate associations between circulating cathepsin S levels and mortality in 2 independent cohorts of elderly men and women. Design, Setting, and Participants Prospective study using 2 community-based cohorts, the Uppsala Longitudinal Study of Adult Men (ULSAM; n=1009; mean age: 71 years; baseline period: 1991-1995; median follow-up: 12.6 years; end of follow-up: 2006) and the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS; n=987; 50% women; mean age: 70 years; baseline period: 2001-2004; median follow-up: 7.9 years; end of follow-up: 2010). Serum samples were used to measure cathepsin S. Main Outcome Measure Total mortality. Results During follow-up, 413 participants died in the ULSAM cohort (incidence rate: 3.59/100 person-years at risk) and 100 participants died in the PIVUS cohort (incidence rate: 1.32/100 person-years at risk). In multivariable Cox regression models adjusted for age, systolic blood pressure, diabetes, smoking status, body mass index, total cholesterol, high-density lipoprotein cholesterol, antihypertensive treatment, lipid-lowering treatment, and history of cardiovascular disease, higher serum cathepsin S was associated with an increased risk for mortality (ULSAM cohort: hazard ratio [HR] for 1-unit increase of cathepsin S, 1.04 [95% CI, 1.01-1.06], P=.009; PIVUS cohort: HR for 1-unit increase of cathepsin S, 1.03 [95% CI, 1.00-1.07], P=.04). In the ULSAM cohort, serum cathepsin S also was associated with cardiovascular mortality (131 deaths; HR for quintile 5 vs quintiles 1-4, 1.62 [95% CI, 1.11-2.37]; P=.01) and cancer mortality (148 deaths; HR for 1-unit increase of cathepsin S, 1.05 [95% CI, 1.01-1.10]; P=.01). Conclusions Among elderly individuals in 2 independent cohorts, higher serum cathepsin S levels were associated with increased mortality risk. Additional research is needed to delineate the role of cathepsin S and whether its measurement might have clinical utility. JAMA. 2011;306(10):1113-1121 www.jama.com	[Jobs, Elisabeth; Ingelsson, Erik; Nerpin, Elisabet; Arnlov, Johan] Uppsala Univ, Dept Publ Hlth & Caring Sci, Sect Geriatr, Uppsala, Sweden; [Riserus, Ulf] Uppsala Univ, Sect Clin Nutr & Metab, Uppsala, Sweden; [Basu, Samar] Uppsala Univ, Sect Oxidat Stress & Inflammat, Uppsala, Sweden; [Sundstrom, Johan; Larsson, Anders; Lind, Lars] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Ingelsson, Erik] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Jobs, Elisabeth; Nerpin, Elisabet; Jobs, Magnus; Arnlov, Johan] Dalarna Univ, Sch Hlth & Social Studies, Falun, Sweden; [Basu, Samar] Univ Auvergne, Fac Pharm, Lab Biochem Mol Biol & Nutr, Dauvergne, France	Uppsala University; Uppsala University; Uppsala University; Uppsala University; Karolinska Institutet; Dalarna University; Universite Clermont Auvergne (UCA)	Arnlov, J (corresponding author), Uppsala Sci Pk, SE-75185 Uppsala, Sweden.	johan.arnlov@pubcare.uu.se	Sundstrom, Johan/R-2139-2019; Sundström, Johan/A-6286-2009; Ärnlöv, Johan/AAF-2746-2019	Sundstrom, Johan/0000-0003-2247-8454; Sundström, Johan/0000-0003-2247-8454; Ärnlöv, Johan/0000-0002-6933-4637	Swedish Research Council [2006-6555]; Swedish Heart-Lung Foundation; Thureus Foundation; Dalarna University; Uppsala University	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Thureus Foundation; Dalarna University; Uppsala University	This study was supported by grant 2006-6555 from the Swedish Research Council and by funding from the Swedish Heart-Lung Foundation, the Thureus Foundation, Dalarna University, and Uppsala University.	Aoki T, 2008, STROKE, V39, P2603, DOI 10.1161/STROKEAHA.107.513648; Bengtsson E, 2008, FRONT BIOSCI, V13, P5780; Burden RE, 2008, MOL CANCER THER, V7, P538, DOI 10.1158/1535-7163.MCT-07-0528; Burden RE, 2009, CLIN CANCER RES, V15, P6042, DOI 10.1158/1078-0432.CCR-09-1262; Byberg L, 1998, ARTERIOSCL THROM VAS, V18, P258, DOI 10.1161/01.ATV.18.2.258; Chan LLY, 2010, J LEUKOCYTE BIOL, V88, P303, DOI 10.1189/jlb.1009659; Chen JC, 2010, J MED CHEM, V53, P4545, DOI [10.1021/jm100089c, 10.1021/jm100089e]; Cheng Xian-Wu, 2008, Zhonghua Xinxueguanbing Zazhi, V36, P51; Chrysant SG, 2010, WORLD J CARDIOL, V2, P43, DOI 10.4330/wjc.v2.i3.43; de Nooijer R, 2009, ARTERIOSCL THROM VAS, V29, P188, DOI 10.1161/ATVBAHA.108.181578; Fernandez PL, 2001, INT J CANCER, V95, P51, DOI 10.1002/1097-0215(20010120)95:1<51::AID-IJC1009>3.0.CO;2-J; Flannery T, 2003, AM J PATHOL, V163, P175, DOI 10.1016/S0002-9440(10)63641-3; Flannery T, 2006, INT J CANCER, V119, P854, DOI 10.1002/ijc.21911; Geraghty P, 2007, J BIOL CHEM, V282, P33389, DOI 10.1074/jbc.M706884200; Gupta S, 2008, EXPERT OPIN THER TAR, V12, P291, DOI 10.1517/14728222.12.3.291; Ingelsson E, 2008, EUR J CLIN INVEST, V38, P502, DOI 10.1111/j.1365-2362.2008.01962.x; Jobs E, 2010, J CLIN ENDOCR METAB, V95, P4460, DOI 10.1210/jc.2010-0328; Jormsjo S, 2002, AM J PATHOL, V161, P939, DOI 10.1016/S0002-9440(10)64254-X; Kitamura H, 2005, IMMUNITY, V23, P491, DOI 10.1016/j.immuni.2005.09.010; Kos J, 2001, BRIT J CANCER, V85, P1193, DOI 10.1054/bjoc.2001.2057; Lee-Dutra A, 2011, EXPERT OPIN THER PAT, V21, P311, DOI 10.1517/13543776.2011.553800; Lind L, 2005, ARTERIOSCL THROM VAS, V25, P2368, DOI 10.1161/01.ATV.0000184769.22061.da; Lindstedt L, 2003, BIOCHEM BIOPH RES CO, V312, P1019, DOI 10.1016/j.bbrc.2003.11.020; Liu JA, 2004, ARTERIOSCL THROM VAS, V24, P1359, DOI 10.1161/01.ATV.0000134530.27208.41; Liu J, 2006, ATHEROSCLEROSIS, V186, P411, DOI 10.1016/j.atherosclerosis.2005.08.001; Liuzzo JP, 1999, MOL MED, V5, P320, DOI 10.1007/BF03402068; Martin SL, 2010, PEDIATR PULM, V45, P860, DOI 10.1002/ppul.21274; Nakagawa TY, 1999, IMMUNITY, V10, P207, DOI 10.1016/S1074-7613(00)80021-7; Naour N, 2010, J CLIN ENDOCR METAB, V95, P1861, DOI 10.1210/jc.2009-1894; Ovchinnikova O, 2009, AM J PATHOL, V174, P693, DOI 10.2353/ajpath.2009.080561; Pan JH, 2004, CIRCULATION, V109, P3149, DOI 10.1161/01.CIR.0000134704.84454.D2; Rodgers KJ, 2006, ARTERIOSCL THROM VAS, V26, P851, DOI 10.1161/01.ATV.0000203526.75772.4b; Schwarz G, 2002, J INVEST DERMATOL, V119, P44, DOI 10.1046/j.1523-1747.2002.01800.x; Shlipak MG, 2005, NEW ENGL J MED, V352, P2049, DOI 10.1056/NEJMoa043161; Spielmann N, 2008, CLIN GENET, V74, P155, DOI 10.1111/j.1399-0004.2008.01043.x; Sukhova GK, 2003, J CLIN INVEST, V111, P897, DOI 10.1172/JCI200314915; Sukhova GK, 1998, J CLIN INVEST, V102, P576, DOI 10.1172/JCI181; Taleb S, 2006, J CLIN ENDOCR METAB, V91, P1042, DOI 10.1210/jc.2005-1601; Taleb S, 2005, FASEB J, V19, P1540, DOI 10.1096/fj.05-3673fje; Taleb S, 2006, ENDOCRINOLOGY, V147, P4950, DOI 10.1210/en.2006-0386; Urbonaviciene G, 2011, ATHEROSCLEROSIS, V216, P440, DOI 10.1016/j.atherosclerosis.2011.02.016; Wang B, 2006, J BIOL CHEM, V281, P6020, DOI 10.1074/jbc.M509134200; Ward C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012543; Williams AS, 2009, PULM PHARMACOL THER, V22, P27, DOI 10.1016/j.pupt.2008.11.002; Wu CK, 2010, J AM COLL CARDIOL, V56, P1930, DOI 10.1016/j.jacc.2010.04.069; Yang YX, 2010, J PROTEOME RES, V9, P6801, DOI 10.1021/pr101027g; Zethelius B, 2008, NEW ENGL J MED, V358, P2107, DOI 10.1056/NEJMoa0707064	47	60	61	1	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 14	2011	306	10					1113	1121		10.1001/jama.2011.1246	http://dx.doi.org/10.1001/jama.2011.1246			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	819DS	21878432	Bronze			2022-12-28	WOS:000294806200025
J	Pickering, R; Dirks, PHGM; Jinnah, Z; de Ruiter, DJ; Churchill, SE; Herries, AIR; Woodhead, JD; Hellstrom, JC; Berger, LR				Pickering, Robyn; Dirks, Paul H. G. M.; Jinnah, Zubair; de Ruiter, Darryl J.; Churchill, Steven E.; Herries, Andy I. R.; Woodhead, Jon D.; Hellstrom, John C.; Berger, Lee R.			Australopithecus sediba at 1.977 Ma and Implications for the Origins of the Genus Homo	SCIENCE			English	Article							SOUTH-AFRICA	Newly exposed cave sediments at the Malapa site include a flowstone layer capping the sedimentary unit containing the Australopithecus sediba fossils. Uranium-lead dating of the flowstone, combined with paleomagnetic and stratigraphic analysis of the flowstone and underlying sediments, provides a tightly constrained date of 1.977 +/- 0.002 million years ago (Ma) for these fossils. This refined dating suggests that Au. sediba from Malapa predates the earliest uncontested evidence for Homo in Africa.	[Pickering, Robyn; Woodhead, Jon D.; Hellstrom, John C.] Univ Melbourne, Sch Earth Sci, Melbourne, Vic 3010, Australia; [Dirks, Paul H. G. M.] James Cook Univ, Sch Earth & Environm Sci, Townsville, Qld 4811, Australia; [Dirks, Paul H. G. M.; Jinnah, Zubair; Berger, Lee R.] Univ Witwatersrand, Sch Geosci, ZA-2050 Wits, South Africa; [Pickering, Robyn; Dirks, Paul H. G. M.; de Ruiter, Darryl J.; Churchill, Steven E.; Berger, Lee R.] Univ Witwatersrand, Inst Human Evolut, ZA-2050 Wits, South Africa; [de Ruiter, Darryl J.] Texas A&M Univ, Dept Anthropol, College Stn, TX 77843 USA; [Churchill, Steven E.] Duke Univ, Dept Evolutionary Anthropol, Durham, NC 27708 USA; [Herries, Andy I. R.] La Trobe Univ, Australian Archaeomagnetism Lab, Fac Humanities & Social Sci, Sch Hist & European Studies,Archaeol Program, Melbourne, Vic, Australia	University of Melbourne; James Cook University; University of Witwatersrand; University of Witwatersrand; Texas A&M University System; Texas A&M University College Station; Duke University; La Trobe University	Pickering, R (corresponding author), Univ Melbourne, Sch Earth Sci, Melbourne, Vic 3010, Australia.	r.pickering@unimelb.edu.au	Churchill, Steven/AAA-9386-2022; Hellstrom, John C/B-1770-2008; Berger, Lee Rogers/AAC-3484-2020; Woodhead, Jon/C-2227-2012	Hellstrom, John C/0000-0001-9427-3525; Berger, Lee Rogers/0000-0002-0367-7629; Woodhead, Jon/0000-0002-7614-0136; Jinnah, Zubair/0000-0002-1317-7361; de Ruiter, Darryl/0000-0003-1183-0352; Herries, Andy/0000-0002-2905-2002	South African Department of Science and Technology; South African National Research Foundation; Institute for Human Evolution; University of the Witwatersrand; National Geographic Society; Palaeontological Scientific Trust; Andrew W. Mellon Foundation; Ford Foundation; U.S. Diplomatic Mission to South Africa; French Embassy of South Africa; Oppenheimer and Ackerman families; Sir Richard Branson; Texas AM University; Swiss National Research Foundation [PBBEP2-126195]; Australian Research Council [DP0877603]; University of Melbourne; Liverpool University Geomagnetism Laboratory; AfricaArray; James Cook University; BHPBilliton Geosciences	South African Department of Science and Technology; South African National Research Foundation(National Research Foundation - South Africa); Institute for Human Evolution; University of the Witwatersrand; National Geographic Society(National Geographic Society); Palaeontological Scientific Trust; Andrew W. Mellon Foundation; Ford Foundation; U.S. Diplomatic Mission to South Africa; French Embassy of South Africa; Oppenheimer and Ackerman families; Sir Richard Branson; Texas AM University; Swiss National Research Foundation(Swiss National Science Foundation (SNSF)); Australian Research Council(Australian Research Council); University of Melbourne(University of Melbourne); Liverpool University Geomagnetism Laboratory; AfricaArray; James Cook University; BHPBilliton Geosciences	We thank the South African Heritage Resources and the Nash family. Funding was received from the South African Department of Science and Technology, South African National Research Foundation, Institute for Human Evolution, University of the Witwatersrand, University of the Witwatersrand's Vice Chancellor's Discretionary Fund, National Geographic Society, Palaeontological Scientific Trust, Andrew W. Mellon Foundation, Ford Foundation, U.S. Diplomatic Mission to South Africa, French Embassy of South Africa, Oppenheimer and Ackerman families, and Sir Richard Branson. Thanks also to the University of the Witwatersrand's Schools of Geosciences and Anatomical Sciences, Bernard Price Institute for Palaeontology; Gauteng Government, Gauteng Department of Agriculture, Conservation and Environment, Cradle of Humankind Management Authority; E. Mbua, P. Kiura, and V. Iminjili at the National Museums of Kenya for access to comparative specimens; and the University of Zurich 2010 Field School. For the fossil preparation, we thank C. Dube, C. Kemp, M. Kgasi, M. Languza, J. Malaza, G. Mokoma, P. Mukanela, T. Nemvhundi, M. Ngcamphalala, S. Jirah, S. Tshabalala, and C. Yates. Others who have given significant support are B. de Klerk, W. Lawrence, C. Steininger, B. Kuhn, L. Pollarolo, J. Kretzen, D. Conforti, C. Dlamini, H. Visser, B. Nkosi, B. Louw, L. Backwell, F. Thackeray, M. Peltier, and M. Klinkmuller. Further acknowledgements are given to Texas A&M University (The Ray A. Rothrock '77 Fellowship, the Program to Enhance Scholarly and Creative Activities, and the International Research Travel Assistance Grant of Texas A&M University), Swiss National Research Foundation (PBBEP2-126195), Australian Research Council (DP0877603), University of Melbourne (McKenzie Fellowship), Liverpool University Geomagnetism Laboratory staff, AfricaArray, James Cook University, and the BHPBilliton Geosciences staff development program.	Balter M, 2010, SCIENCE, V328, P154, DOI 10.1126/science.328.5975.154; Berger LR, 2010, SCIENCE, V328, P195, DOI 10.1126/science.1184944; Carlson BA, 2011, SCIENCE, V332, P583, DOI 10.1126/science.1201524; Channell JET, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2001JB000491; Cherry M, 2010, NATURE, V463, P726, DOI 10.1038/463726a; Dirks PHGM, 2010, SCIENCE, V328, P205, DOI 10.1126/science.1184950; Ferring R, 2011, P NATL ACAD SCI USA, V108, P10432, DOI 10.1073/pnas.1106638108; Herries AIR, 2011, J HUM EVOL, V60, P523, DOI 10.1016/j.jhevol.2010.09.001; Kibii JM, 2011, SCIENCE, V333, P1407, DOI 10.1126/science.1202521; Kimbel WH, 1997, AM J PHYS ANTHROPOL, V103, P235, DOI 10.1002/(SICI)1096-8644(199706)103:2<235::AID-AJPA8>3.3.CO;2-V; Kimbel William H., 2009, P31, DOI 10.1007/978-1-4020-9980-9_4; Kivell TL, 2011, SCIENCE, V333, P1411, DOI 10.1126/science.1202625; Pickering R, 2011, EARTH PLANET SC LETT, V306, P23, DOI 10.1016/j.epsl.2011.03.019; Pickering R, 2010, J HUM EVOL, V59, P70, DOI 10.1016/j.jhevol.2010.03.014; Pickering R, 2010, QUAT GEOCHRONOL, V5, P544, DOI 10.1016/j.quageo.2009.12.004; Roberts AP, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034719; White TD, 1995, PALEOCLIMATE AND EVOLUTION, WITH EMPHASIS ON HUMAN ORIGINS, P369; Wood B, 1999, SCIENCE, V284, P65, DOI 10.1126/science.284.5411.65; Wood B., 1991, HOMINID CRANIAL REMA, V4; Woodhead J, 2006, QUAT GEOCHRONOL, V1, P208, DOI 10.1016/j.quageo.2006.08.002; Zipfel B, 2011, SCIENCE, V333, P1417, DOI 10.1126/science.1202703	21	126	137	2	81	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 9	2011	333	6048					1421	1423		10.1126/science.1203697	http://dx.doi.org/10.1126/science.1203697			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	817KU	21903808				2022-12-28	WOS:000294672200035
J	Matsunaga, N; Kawadu, T; Nishiyama, S; Nagayama, T; Kobayashi, N; Tamura, M; Bono, G; Feast, MW; Nagata, T				Matsunaga, Noriyuki; Kawadu, Takahiro; Nishiyama, Shogo; Nagayama, Takahiro; Kobayashi, Naoto; Tamura, Motohide; Bono, Giuseppe; Feast, Michael W.; Nagata, Tetsuya			Three classical Cepheid variable stars in the nuclear bulge of the Milky Way	NATURE			English	Article							GALACTIC-CENTER; FORMATION HISTORY; PERIOD DISTRIBUTION; DISK GALAXIES; POPULATION; PC; PSEUDOBULGES; VARIABILITY; DISTANCE; MODELS	The nuclear bulge is a region with a radius of about 200 parsecs around the centre of the Milky Way(1). It contains stars with ages(2-4) ranging from a few million years to over a billion years, yet its star-formation history and the triggering process for star formation remain to be resolved. Recently, episodic star formation, powered by changes in the gas content, has been suggested(5). Classical Cepheid variable stars have pulsation periods that decrease with increasing age(6), so it is possible to probe the star-formation history on the basis of the distribution of their periods(7,8). Here we report the presence of three classical Cepheids in the nuclear bulge with pulsation periods of approximately 20 days, within 40 parsecs (projected distance) of the central black hole. No Cepheids with longer or shorter periods were found. We infer that there was a period about 25 million years ago, and possibly lasting until recently, in which star formation increased relative to the period of 30-70 million years ago.	[Matsunaga, Noriyuki; Kobayashi, Naoto] Univ Tokyo, Inst Astron, Kiso Observ, Kiso, Nagano 3970101, Japan; [Kawadu, Takahiro; Nagata, Tetsuya] Kyoto Univ, Dept Astron, Sakyo Ku, Kyoto 6068502, Japan; [Nishiyama, Shogo; Tamura, Motohide] Natl Astron Observ Japan, Tokyo 1818588, Japan; [Nagayama, Takahiro] Nagoya Univ, Dept Astrophys, Chikusa Ku, Aichi 4648602, Japan; [Kobayashi, Naoto] Univ Tokyo, Inst Astron, Tokyo 1810015, Japan; [Bono, Giuseppe] Univ Roma Tor Vergata, Dipartimento Fis, I-00133 Rome, Italy; [Bono, Giuseppe] Osserv Astron Roma, INAF, I-00040 Monte Porzio Catone, Italy; [Feast, Michael W.] Univ Cape Town, Dept Astron, Astrophys Cosmol & Grav Ctr, ZA-7701 Rondebosch, South Africa; [Feast, Michael W.] S African Astron Observ, ZA-7935 Observatory, South Africa	University of Tokyo; Kyoto University; National Institutes of Natural Sciences (NINS) - Japan; National Astronomical Observatory of Japan (NAOJ); Nagoya University; University of Tokyo; University of Rome Tor Vergata; Istituto Nazionale Astrofisica (INAF); University of Cape Town; National Research Foundation - South Africa; South African Astronomical Observatory	Matsunaga, N (corresponding author), Univ Tokyo, Inst Astron, Kiso Observ, 10762-30 Mitake, Kiso, Nagano 3970101, Japan.	matsunaga@ioa.s.u-tokyo.ac.jp		Feast, Michael/0000-0002-8908-1630; Nishiyama, S./0000-0002-9440-7172; Kobayashi, Naoto/0000-0003-4578-2619	Japan Society for the Promotion of Science (JSPS); National Research Foundation (NRF) of South Africa; Grants-in-Aid for Scientific Research [23840044] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Research Foundation (NRF) of South Africa(National Research Foundation - South Africa); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank the IRSF/SIRIUS team in Nagoya University, the National Astronomical Observatory of Japan, Kyoto University and the University of Tokyo, and the staff of the South African Astronomical Observatory (SAAO) for their support during our near-IR observations. This work was supported by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (JSPS). M. W. F. acknowledges the support from National Research Foundation (NRF) of South Africa.	Alcock C, 1999, ASTRON J, V117, P920, DOI 10.1086/300736; Antonello E, 2002, ASTRON ASTROPHYS, V388, P477, DOI 10.1051/0004-6361:20020553; BINNEY J, 2009, P IAU S, V254, P145; Bono G, 2000, ASTROPHYS J, V543, P955, DOI 10.1086/317156; Bono G, 2005, ASTROPHYS J, V621, P966, DOI 10.1086/427744; Davies B, 2009, ASTROPHYS J, V694, P46, DOI 10.1088/0004-637X/694/1/46; Fernie J.D., 1995, IBVS, V4148, P1; Figer DF, 2004, ASTROPHYS J, V601, P319, DOI 10.1086/380392; Gillessen S, 2009, ASTROPHYS J, V692, P1075, DOI 10.1088/0004-637X/692/2/1075; Groenewegen MAT, 2008, ASTRON ASTROPHYS, V481, P441, DOI 10.1051/0004-6361:20079101; Kormendy J, 2004, ANNU REV ASTRON ASTR, V42, P603, DOI 10.1146/annurev.astro.42.053102.134024; Kormendy J, 2006, ASTROPHYS J, V642, P765, DOI 10.1086/501341; Kroupa P, 2001, MON NOT R ASTRON SOC, V322, P231, DOI 10.1046/j.1365-8711.2001.04022.x; Launhardt R, 2002, ASTRON ASTROPHYS, V384, P112, DOI 10.1051/0004-6361:20020017; Matsunaga N, 2009, MON NOT R ASTRON SOC, V399, P1709, DOI 10.1111/j.1365-2966.2009.15393.x; Meschin I, 2009, ASTRON J, V137, P3619, DOI 10.1088/0004-6256/137/3/3619; Nishiyama S, 2006, ASTROPHYS J, V647, P1093, DOI 10.1086/505529; Peeples MS, 2007, ACTA ASTRONOM, V57, P173; Rafelski M, 2007, ASTROPHYS J, V659, P1241, DOI 10.1086/512062; Schinnerer E, 2007, ASTRON ASTROPHYS, V462, pL27, DOI 10.1051/0004-6361:20066711; Serabyn E, 1996, NATURE, V382, P602, DOI 10.1038/382602a0; Stark AA, 2004, ASTROPHYS J, V614, pL41, DOI 10.1086/425304; Trippe S, 2008, ASTRON ASTROPHYS, V492, P419, DOI 10.1051/0004-6361:200810191; van Leeuwen F, 2007, MON NOT R ASTRON SOC, V379, P723, DOI 10.1111/j.1365-2966.2007.11972.x; van Loon JT, 2003, MON NOT R ASTRON SOC, V338, P857, DOI 10.1046/j.1365-8711.2003.06134.x; Yusef-Zadeh F, 2009, ASTROPHYS J, V702, P178, DOI 10.1088/0004-637X/702/1/178	26	69	69	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 8	2011	477	7363					188	190		10.1038/nature10359	http://dx.doi.org/10.1038/nature10359			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	816MC	21866100	Green Submitted			2022-12-28	WOS:000294603900030
J	Reis, JP; Loria, CM; Sorlie, PD; Park, Y; Hollenbeck, A; Schatzkin, A				Reis, Jared P.; Loria, Catherine M.; Sorlie, Paul D.; Park, Yikyung; Hollenbeck, Albert; Schatzkin, Arthur			Lifestyle Factors and Risk for New-Onset Diabetes A Population-Based Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							HEALTH-AMERICAN-ASSOCIATION; MODERATE ALCOHOL INTAKE; RETIRED-PERSONS DIET; INSULIN SENSITIVITY; CIGARETTE-SMOKING; NATIONAL-INSTITUTES; PHYSICAL-ACTIVITY; OLDER-ADULTS; BODY-WEIGHT; MELLITUS	Background: Epidemiologic data on the combined influence of several lifestyle factors on diabetes risk are rare, particularly among older adults. Objective: To examine how combinations of lifestyle risk factors relate to the 11-year risk for incident diabetes. Design: Population-based prospective cohort study. Setting: National Institutes of Health (NIH)-AARP Diet and Health Study. Participants: 114 996 men and 92 483 women, aged 50 to 71 years in 1995 to 1996, without evidence of heart disease, cancer, or diabetes. Measurements: A comprehensive survey of demographic characteristics and lifestyle factors, including dietary intake, body weight and height, physical activity, smoking, and alcohol consumption at baseline (1995 to 1996). Low-risk groups were formed by dichotomizing each lifestyle factor. Incident self-reported, physician-diagnosed diabetes was identified with a follow-up survey in 2004 to 2006. Results: 11 031 men (9.6%) and 6969 women (7.5%) developed new-onset diabetes. For each additional lifestyle factor in the low-risk group, the odds for diabetes were 31% lower (odds ratio [OR], 0.69 [95% CI, 0.68 to 0.71]) among men and 39% lower (OR, 0.61 [CI, 0.60 to 0.63]) among women. Men and women whose diet score, physical activity level, smoking status, and alcohol use were all in the low-risk group had ORs for diabetes of 0.61 (CI, 0.56 to 0.66) and 0.43 (CI, 0.34 to 0.55), respectively. When absence of overweight or obesity was added, the respective ORs were 0.28 (CI, 0.23 to 0.34) and 0.16 (CI, 0.10 to 0.24) for men and women. Results did not differ by family history of diabetes or level of adiposity. Limitation: The study was observational, with potential for residual confounding. Conclusion: Lifestyle factors, when considered in combination, are associated with a substantial reduction in risk for diabetes.	[Reis, Jared P.] NHLBI, Div Cardiovasc Sci, Bethesda, MD 20892 USA; NCI, Rockville, MD 20852 USA; AARP, Washington, DC 20049 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); American Association of Retired Persons (AARP)	Reis, JP (corresponding author), NHLBI, Div Cardiovasc Sci, 6701 Rockledge Dr, Bethesda, MD 20892 USA.	reisjp@mail.nih.gov	Hollenbeck, Albert/AAG-9461-2020	Park, Yikyung/0000-0002-6281-489X	NIH; NATIONAL CANCER INSTITUTE [ZIACP010196] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The NIH-AARP Diet and Health Study was supported by the Intramural Research Program of the NIH.	Ajani UA, 2000, ARCH INTERN MED, V160, P1025, DOI 10.1001/archinte.160.7.1025; [Anonymous], 2011, 2011 NAT DIAB FACT S; Asthana A, 2010, AM HEART J, V160, P458, DOI 10.1016/j.ahj.2010.06.006; ATTVALL S, 1993, J INTERN MED, V233, P327, DOI 10.1111/j.1365-2796.1993.tb00680.x; BARRETTCONNOR E, 1989, ANN INTERN MED, V111, P783, DOI 10.7326/0003-4819-111-10-783; Biggs ML, 2010, JAMA-J AM MED ASSOC, V303, P2504, DOI 10.1001/jama.2010.843; Centers for Disease Control and Prevention, 2008, 2007 NAT DIAB FACT S; Davies MJ, 2002, JAMA-J AM MED ASSOC, V287, P2559, DOI 10.1001/jama.287.19.2559; Division of Cancer Control and Population Sciences, 2010, DIET HIST QUEST OLD; FACCHINI F, 1994, DIABETES CARE, V17, P115, DOI 10.2337/diacare.17.2.115; Hodge AM, 2004, DIABETES CARE, V27, P2701, DOI 10.2337/diacare.27.11.2701; Hu FB, 2001, NEW ENGL J MED, V345, P790, DOI 10.1056/NEJMoa010492; Imhof A, 2001, LANCET, V357, P763, DOI 10.1016/S0140-6736(00)04170-2; Kiechl S, 1996, BRIT MED J, V313, P1040; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Lazarus R, 1997, AM J EPIDEMIOL, V145, P909, DOI 10.1093/oxfordjournals.aje.a009050; Lynch J, 1996, ARCH INTERN MED, V156, P1307, DOI 10.1001/archinte.156.12.1307; MANSON JE, 1991, LANCET, V338, P774, DOI 10.1016/0140-6736(91)90664-B; Mozaffarian D, 2009, ARCH INTERN MED, V169, P798, DOI 10.1001/archinternmed.2009.21; Nakanishi N, 2000, ANN INTERN MED, V133, P183, DOI 10.7326/0003-4819-133-3-200008010-00009; Okura Y, 2004, J CLIN EPIDEMIOL, V57, P1096, DOI 10.1016/j.jclinepi.2004.04.005; PATE RR, 1995, JAMA-J AM MED ASSOC, V273, P402, DOI 10.1001/jama.273.5.402; RIMM EB, 1993, AM J PUBLIC HEALTH, V83, P211, DOI 10.2105/AJPH.83.2.211; Salmeron J, 2001, AM J CLIN NUTR, V73, P1019; Schatzkin A, 2001, AM J EPIDEMIOL, V154, P1119, DOI 10.1093/aje/154.12.1119; Schienkiewitz A, 2006, AM J CLIN NUTR, V84, P427; Sierksma A, 2002, EUR J CLIN NUTR, V56, P1130, DOI 10.1038/sj.ejcn.1601459; Somm E, 2008, ENDOCRINOLOGY, V149, P6289, DOI 10.1210/en.2008-0361; STEVENS J, 1990, AM J EPIDEMIOL, V132, P1156, DOI 10.1093/oxfordjournals.aje.a115758; Subar AF, 2000, AM J EPIDEMIOL, V152, P279, DOI 10.1093/aje/152.3.279; Thompson FE, 2008, PUBLIC HEALTH NUTR, V11, P183, DOI 10.1017/S1368980007000419; US Department of Health and Human Services and USDA, 2005, DIET GUID AM 2005; Wei M, 2000, DIABETES CARE, V23, P18, DOI 10.2337/diacare.23.1.18; Willett WC, 1998, OXFORD SCHOLARSHIP O; Willi C, 2007, JAMA-J AM MED ASSOC, V298, P2654, DOI 10.1001/jama.298.22.2654; Yeh HC, 2010, ANN INTERN MED, V152, P10, DOI 10.7326/0003-4819-152-1-201001050-00005	36	75	77	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 6	2011	155	5					292	U45		10.7326/0003-4819-155-5-201109060-00006	http://dx.doi.org/10.7326/0003-4819-155-5-201109060-00006			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	815PX	21893622	Green Accepted			2022-12-28	WOS:000294538900002
J	Jordan, HT; Brackbill, RM; Cone, JE; Debchoudhury, I; Farfel, MR; Greene, CM; Hadler, JL; Kennedy, J; Li, JH; Liff, J; Stayner, L; Stellman, SD				Jordan, Hannah T.; Brackbill, Robert M.; Cone, James E.; Debchoudhury, Indira; Farfel, Mark R.; Greene, Carolyn M.; Hadler, James L.; Kennedy, Joseph; Li, Jiehui; Liff, Jonathan; Stayner, Leslie; Stellman, Steven D.			Mortality among survivors of the Sept 11, 2001, World Trade Center disaster: results from the World Trade Center Health Registry cohort	LANCET			English	Article							POSTTRAUMATIC STRESS SYMPTOMS; NEW-YORK-CITY; TERRORIST ATTACKS; LOWER MANHATTAN; FIREFIGHTERS; SEPTEMBER-11; RESIDENTS; WORKERS; RESCUE; RECOVERY	Background The Sept 11, 2001 (9/11) World Trade Center (WTC) disaster has been associated with several subacute and chronic health effects, but whether excess mortality after 9/11 has occurred is unknown. We tested whether excess mortality has occurred in people exposed to the WTC disaster. Methods In this observational cohort study, deaths occurring in 2003-09 in WTC Health Registry participants residing in New York City were identified through linkage to New York City vital records and the National Death Index. Eligible participants were rescue and recovery workers and volunteers; lower Manhattan area residents, workers, school staff and students; and commuters and passers-by on 9/11. Study participants were categorised as rescue and recovery workers (including volunteers), or non-rescue and non-recovery participants. Standardised mortality ratios (SMR) were calculated with New York City rates from 2000-09 as the reference. Within the cohort, proportional hazards were used to examine the relation between a three-tiered WTC-related exposure level (high, intermediate, or low) and total mortality. Findings We identified 156 deaths in 13 337 rescue and recovery workers and 634 deaths in 28 593 non-rescue and non-recovery participants. All-cause SMRs were significantly lower than that expected for rescue and recovery participants (SMR 0.45, 95% Cl 0.38-0.53) and non-rescue and non-recovery participants (0.61, 0.56-0.66). No significantly increased SMRs for diseases of the respiratory system or heart, or for haematological malignancies were found. In non-rescue and non-recovery participants, both intermediate and high levels of WTC-related exposure were significantly associated with mortality when compared with low exposure (adjusted hazard ratio 1.22, 95% CI 1.01-1.48, for intermediate exposure and 1.56, 1.15-2.12, for high exposure). High levels of exposure in non-rescue and non-recovery individuals, when compared with low exposed non-rescue and non-recovery individuals, were associated with heart-disease-related mortality (adjusted hazard ratio 2.06, 1.10-3.86). In rescue and recovery participants, level of WTC-related exposure was not significantly associated with all-cause mortality (adjusted hazard ratio 1.25, 95% Cl 0.56-2.78, for high exposure and 1.03, 0.52-2.06, for intermediate exposure when compared with low exposure). Interpretation This exploratory study of mortality in a well defined cohort of 9/11 survivors provides a baseline for continued surveillance. Additional follow-up is needed to establish whether these associations persist and whether a similar association over time will occur in rescue and recovery participants.	[Cone, James E.] New York City Dept Hlth & Mental Hyg, World Trade Ctr Hlth Registry, Long Isl City, NY 11101 USA; [Liff, Jonathan] Emory Univ, Rollins Sch Publ Hlth, Dept Epidemiol, Atlanta, GA 30322 USA; [Stayner, Leslie] Univ Illinois, Sch Publ Hlth, Div Epidemiol & Biostat, Chicago, IL USA; [Stellman, Steven D.] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA	New York City Department of Health & Mental Hygiene; Emory University; Rollins School Public Health; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Columbia University	Cone, JE (corresponding author), New York City Dept Hlth & Mental Hyg, World Trade Ctr Hlth Registry, 42-09 28th St,7th Floor, Long Isl City, NY 11101 USA.	jcone@health.nyc.gov	Berger, Emily/N-7268-2017	Berger, Emily/0000-0001-5550-807X; Li, Jiehui/0000-0002-7812-8878	Agency for Toxic Substances and Disease Registry (ATSDR) of the US Centers for Disease Control and Prevention (CDC) [U50/ATU272750]; National Center for Environmental Health (NCEH); National Institute for Occupational Safety and Health (NIOSH) [1U50/OH009739]; New York City Department of Health and Mental Hygiene (NYC DOHMH); NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH [U50OH009739] Funding Source: NIH RePORTER	Agency for Toxic Substances and Disease Registry (ATSDR) of the US Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Center for Environmental Health (NCEH); National Institute for Occupational Safety and Health (NIOSH)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH)); New York City Department of Health and Mental Hygiene (NYC DOHMH); NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH))	This study was supported by Cooperative Agreement U50/ATU272750 from the Agency for Toxic Substances and Disease Registry (ATSDR) of the US Centers for Disease Control and Prevention (CDC), which included support from the National Center for Environmental Health (NCEH); Cooperative Agreement 1U50/OH009739 from the National Institute for Occupational Safety and Health (NIOSH); and the New York City Department of Health and Mental Hygiene (NYC DOHMH). We thank the World Trade Center Health Registry participants; Grade Han for her role in establishing the methods for gathering mortality data; Mary Schubauer-Berigan and James Yiin for their assistance with the LTAS statistical software; and Robert Bilgrad for his assistance with obtaining and interpreting National Death Index results. The views expressed in this article are those of the authors and do not necessarily represent the views of ATSDR, NIOSH, NCEH, or NYC DOHMH.	Aldrich TK, 2010, NEW ENGL J MED, V362, P1263, DOI 10.1056/NEJMoa0910087; Allegra JR, 2005, J URBAN HEALTH, V82, P358, DOI 10.1093/jurban/jti087; Banauch GI, 2003, AM J RESP CRIT CARE, V168, P54, DOI 10.1164/rccm.200211-1329OC; Berninger A, 2010, PUBLIC HEALTH REP, V125, P556, DOI 10.1177/003335491012500411; Brackbill RM, 2009, JAMA-J AM MED ASSOC, V302, P502, DOI 10.1001/jama.2009.1121; Burnell M, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-61; Checkoway H, 1998, EPIDEMIOL REV, V20, P100, DOI 10.1093/oxfordjournals.epirev.a017965; DiGrande L, 2008, J TRAUMA STRESS, V21, P264, DOI 10.1002/jts.20345; Dominici F, 2006, JAMA-J AM MED ASSOC, V295, P1127, DOI 10.1001/jama.295.10.1127; Fang J, 1996, NEW ENGL J MED, V335, P1545, DOI 10.1056/NEJM199611213352101; Farfel M, 2008, J URBAN HEALTH, V85, P880, DOI 10.1007/s11524-008-9317-4; Galea S, 2003, AM J EPIDEMIOL, V158, P514, DOI 10.1093/aje/kwg187; Gullette ECD, 1997, JAMA-J AM MED ASSOC, V277, P1521, DOI 10.1001/jama.277.19.1521; Herbert R, 2006, ENVIRON HEALTH PERSP, V114, P1853, DOI 10.1289/ehp.9592; Karpati A., 2004, HLTH DISPARITIES NEW; Landrigan PJ, 2004, ENVIRON HEALTH PERSP, V112, P731, DOI 10.1289/ehp.6702; Li CY, 1999, OCCUP MED-OXFORD, V49, P225, DOI 10.1093/occmed/49.4.225; Lin S, 2010, ARCH ENVIRON OCCUP H, V65, P12, DOI 10.1080/19338240903390230; Lindsted KD, 1996, J CLIN EPIDEMIOL, V49, P783, DOI 10.1016/0895-4356(96)00009-1; Lioy PJ, 2002, ENVIRON HEALTH PERSP, V110, P703, DOI 10.1289/ehp.02110703; Moline JM, 2009, J OCCUP ENVIRON MED, V51, P896, DOI 10.1097/JOM.0b013e3181ad49c8; Pinsky PF, 2007, AM J EPIDEMIOL, V165, P874, DOI 10.1093/aje/kwk075; Pleil JD, 2004, P NATL ACAD SCI USA, V101, P11685, DOI 10.1073/pnas.0404499101; Reibman J, 2005, ENVIRON HEALTH PERSP, V113, P406, DOI 10.1289/ehp.7375; Robinson CF, 2006, J OCCUP ENVIRON MED, V48, P662, DOI 10.1097/01.jom.0000229968.74906.8f; Sadetzki S, 2000, AM J EPIDEMIOL, V151, P266, DOI 10.1093/oxfordjournals.aje.a010202; SCHUBAUERBERIGA.M, AM J IND ME IN PRESS; Stellman JM, 2008, ENVIRON HEALTH PERSP, V116, P1248, DOI 10.1289/ehp.11164; Weiden MD, 2010, CHEST, V137, P566, DOI 10.1378/chest.09-1580; Wheeler K, 2007, ENVIRON HEALTH PERSP, V115, P1584, DOI 10.1289/ehp.10248; World Health Organization, 2004, ICD 10 INT STAT CLAS, V2nd	31	48	48	0	15	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 3	2011	378	9794					879	887		10.1016/S0140-6736(11)60966-5	http://dx.doi.org/10.1016/S0140-6736(11)60966-5			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	818XZ	21890052	Green Submitted			2022-12-28	WOS:000294791300028
J	Tsuchiyama, A; Uesugi, M; Matsushima, T; Michikami, T; Kadono, T; Nakamura, T; Uesugi, K; Nakano, T; Sandford, SA; Noguchi, R; Matsumoto, T; Matsuno, J; Nagano, T; Imai, Y; Takeuchi, A; Suzuki, Y; Ogami, T; Katagiri, J; Ebihara, M; Ireland, TR; Kitajima, F; Nagao, K; Naraoka, H; Noguchi, T; Okazaki, R; Yurimoto, H; Zolensky, ME; Mukai, T; Abe, M; Yada, T; Fujimura, A; Yoshikawa, M; Kawaguchi, J				Tsuchiyama, Akira; Uesugi, Masayuki; Matsushima, Takashi; Michikami, Tatsuhiro; Kadono, Toshihiko; Nakamura, Tomoki; Uesugi, Kentaro; Nakano, Tsukasa; Sandford, Scott A.; Noguchi, Ryo; Matsumoto, Toru; Matsuno, Junya; Nagano, Takashi; Imai, Yuta; Takeuchi, Akihisa; Suzuki, Yoshio; Ogami, Toshihiro; Katagiri, Jun; Ebihara, Mitsuru; Ireland, Trevor R.; Kitajima, Fumio; Nagao, Keisuke; Naraoka, Hiroshi; Noguchi, Takaaki; Okazaki, Ryuji; Yurimoto, Hisayoshi; Zolensky, Michael E.; Mukai, Toshifumi; Abe, Masanao; Yada, Toru; Fujimura, Akio; Yoshikawa, Makoto; Kawaguchi, Junichiro			Three-Dimensional Structure of Hayabusa Samples: Origin and Evolution of Itokawa Regolith	SCIENCE			English	Article							ASTEROID ITOKAWA; SURFACE	Regolith particles on the asteroid Itokawa were recovered by the Hayabusa mission. Their three-dimensional (3D) structure and other properties, revealed by x-ray microtomography, provide information on regolith formation. Modal abundances of minerals, bulk density (3.4 grams per cubic centimeter), and the 3D textures indicate that the particles represent a mixture of equilibrated and less-equilibrated LL chondrite materials. Evidence for melting was not seen on any of the particles. Some particles have rounded edges. Overall, the particles' size and shape are different from those seen in particles from the lunar regolith. These features suggest that meteoroid impacts on the asteroid surface primarily form much of the regolith particle, and that seismic-induced grain motion in the smooth terrain abrades them over time.	[Tsuchiyama, Akira; Noguchi, Ryo; Matsumoto, Toru; Matsuno, Junya; Nagano, Takashi; Imai, Yuta] Osaka Univ, Dept Earth & Space Sci, Toyonaka, Osaka 5600043, Japan; [Uesugi, Masayuki; Mukai, Toshifumi; Abe, Masanao; Yada, Toru; Fujimura, Akio; Yoshikawa, Makoto; Kawaguchi, Junichiro] Japan Aerosp Explorat Agcy, Sagamihara, Kanagawa 2525210, Japan; [Matsushima, Takashi; Katagiri, Jun] Univ Tsukuba, Dept Engn Mech & Energy, Grad Sch Syst & Informat Engn, Tsukuba, Ibaraki 3058573, Japan; [Michikami, Tatsuhiro] Fukushima Natl Coll Technol, Fukushima 9708034, Japan; [Kadono, Toshihiko] Osaka Univ, Inst Laser Engn, Suita, Osaka 5650871, Japan; [Nakamura, Tomoki; Ogami, Toshihiro] Tohoku Univ, Dept Earth & Planetary Mat Sci, Aoba Ku, Sendai, Miyagi 9808578, Japan; [Uesugi, Kentaro; Takeuchi, Akihisa; Suzuki, Yoshio] Japan Synchrotron Radiat Res Inst JASRI SPring 8, Sayo, Hyogo 6795198, Japan; [Nakano, Tsukasa] Natl Inst Adv Ind Sci & Technol, Geol Survey Japan, Tsukuba, Ibaraki 3058568, Japan; [Sandford, Scott A.] NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; [Ebihara, Mitsuru] Tokyo Metropolitan Univ, Grad Sch Sci & Engn, Hachioji, Tokyo 1920397, Japan; [Ireland, Trevor R.] Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT 0200, Australia; [Kitajima, Fumio; Naraoka, Hiroshi; Okazaki, Ryuji] Kyushu Univ, Dept Earth & Planetary Sci, Higashi Ku, Fukuoka 8128581, Japan; [Nagao, Keisuke] Univ Tokyo, Geochem Res Ctr, Bunkyo Ku, Tokyo 1130033, Japan; [Noguchi, Takaaki] Ibaraki Univ, Coll Sci, Mito, Ibaraki 3100056, Japan; [Yurimoto, Hisayoshi] Hokkaido Univ, Kita Ku, Sapporo, Hokkaido 0600808, Japan; [Zolensky, Michael E.] NASA, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA	Osaka University; Japan Aerospace Exploration Agency (JAXA); University of Tsukuba; Osaka University; Tohoku University; Japan Synchrotron Radiation Research Institute; National Institute of Advanced Industrial Science & Technology (AIST); National Aeronautics & Space Administration (NASA); NASA Ames Research Center; Tokyo Metropolitan University; Australian National University; Kyushu University; University of Tokyo; Ibaraki University; Hokkaido University; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER	Tsuchiyama, A (corresponding author), Osaka Univ, Dept Earth & Space Sci, Toyonaka, Osaka 5600043, Japan.	akira@ess.sci.osaka-u.ac.jp	Mukai, Toshifumi/ABD-3297-2021; Ireland, Trevor R./GSJ-1884-2022; Ireland, Trevor R/A-4993-2008; Yurimoto, Hisayoshi/S-9938-2018	Ireland, Trevor R/0000-0001-7617-3889; Yurimoto, Hisayoshi/0000-0003-0702-0533; Zolensky, Michael/0000-0002-3181-1303; Uesugi, Masayuki/0000-0001-6261-9034; Noguchi, Takaaki/0000-0001-7211-2595; Naraoka, Hiroshi/0000-0002-2373-8759; Michikami, Tatsuhiro/0000-0003-3096-5789	Japan Ministry of Education, Culture, Sports, Science, and Technology [19104012]; NASA; Grants-in-Aid for Scientific Research [22740300, 22224010, 22340158] Funding Source: KAKEN	Japan Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NASA(National Aeronautics & Space Administration (NASA)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank the Hayabusa sample curation team and the Hayabusa project team. A. Tsuchiyama was supported by a grant-in-aid of the Japan Ministry of Education, Culture, Sports, Science, and Technology (19104012). M.E.Z. and S.A.S. were supported by NASA's Muses-C/Hayabusa Program. The tomography experiment was performed under the approval of the SPring-8 Proposal Review Committee (2010B1531).	Abe M, 2006, SCIENCE, V312, P1334, DOI 10.1126/science.1125718; Binzel RP, 2001, METEORIT PLANET SCI, V36, P1167, DOI 10.1111/j.1945-5100.2001.tb01950.x; CAPACCIONI F, 1984, NATURE, V308, P832, DOI 10.1038/308832a0; Consolmagno GJ, 2008, CHEM ERDE-GEOCHEM, V68, P1, DOI 10.1016/j.chemer.2008.01.003; Duran J., 1999, INTRO PHYS GRANULAR; Ebihara M, 2011, SCIENCE, V333, P1119, DOI 10.1126/science.1207865; Fujiwara A, 2006, SCIENCE, V312, P1330, DOI 10.1126/science.1125841; FUJIWARA A, 1978, NATURE, V272, P602, DOI 10.1038/272602a0; Heiken GH., 1991, LUNAR SOURCEBOOK; Hutchison R., 2004, METEORITES PETROLOGI; Kadono T, 2010, J GEOPHYS RES-PLANET, V115, DOI 10.1029/2009JE003385; Katagiri J., 2010, EARTH SPACE 2010 ENG, P254; Michel P, 2009, ICARUS, V200, P503, DOI 10.1016/j.icarus.2008.04.002; Michikami T., 2005, LUN PLAN SCI C, VXXXVI, P1729; Michikami T, 2008, EARTH PLANETS SPACE, V60, P13, DOI 10.1186/BF03352757; Michikami T, 2010, ICARUS, V207, P277, DOI 10.1016/j.icarus.2009.10.008; Miyamoto H, 2007, SCIENCE, V316, P1011, DOI 10.1126/science.1134390; Nakamura T, 2011, SCIENCE, V333, P1113, DOI 10.1126/science.1207758; Noguchi T, 2011, SCIENCE, V333, P1121, DOI 10.1126/science.1207794; Robinson MS, 2001, NATURE, V413, P396, DOI 10.1038/35096518; Scheeres DJ, 2010, ICARUS, V210, P968, DOI 10.1016/j.icarus.2010.07.009; Yano H, 2006, SCIENCE, V312, P1350, DOI 10.1126/science.1126164; Yurimoto H, 2011, SCIENCE, V333, P1116, DOI 10.1126/science.1207776	23	215	218	2	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 26	2011	333	6046					1125	1128		10.1126/science.1207807	http://dx.doi.org/10.1126/science.1207807			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811VM	21868671				2022-12-28	WOS:000294244300042
J	Rinkevich, Y; Lindau, P; Ueno, H; Longaker, MT; Weissman, IL				Rinkevich, Yuval; Lindau, Paul; Ueno, Hiroo; Longaker, Michael T.; Weissman, Irving L.			Germ-layer and lineage-restricted stem/progenitors regenerate the mouse digit tip	NATURE			English	Article							HEMATOPOIETIC STEM-CELLS; REGULATORY ELEMENTS; BLOOD-CELLS; MICE; LIMB; EXPRESSION; SKIN; RECOMBINATION; ENDOTHELIUM; PRECURSORS	The regrowth of amputated limbs and the distal tips of digits represent models of tissue regeneration in amphibians, fish and mice. For decades it had been assumed that limb regeneration derived from the blastema, an undifferentiated pluripotent cell population thought to be derived from mature cells via dedifferentiation. Here we show that a wide range of tissue stem/progenitor cells contribute towards the restoration of the mouse distal digit. Genetic fate mapping and clonal analysis of individual cells revealed that these stem cells are lineage restricted, mimicking digit growth during development. Transplantation of cyan-fluorescent-protein-expressing haematopoietic stem cells, and parabiosis between genetically marked mice, confirmed that the stem/progenitor cells are tissue resident, including the cells involved in angiogenesis. These results, combined with those from appendage regeneration in other vertebrate subphyla, collectively demonstrate that tissue stem cells rather than pluripotent blastema cells are an evolutionarily conserved cellular mode for limb regeneration after amputation.	[Rinkevich, Yuval; Lindau, Paul; Ueno, Hiroo; Longaker, Michael T.; Weissman, Irving L.] Stanford Univ, Sch Med, Stanford Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Longaker, Michael T.] Stanford Univ, Sch Med, Dept Surg Plast & Reconstruct Surg, Hagey Lab Pediat Regenerat Med, Stanford, CA 94305 USA; [Weissman, Irving L.] Stanford Univ, Ludwig Ctr Canc Stem Cell Res, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Rinkevich, Y (corresponding author), Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Lorry I Lokey Res Bldg, Stanford, CA 94028 USA.	ryuval@stanford.edu	Rinkevich, Yuval/B-7854-2018; Rinkevich, Yuval/B-7647-2018	Rinkevich, Yuval/0000-0001-6290-7271; Rinkevich, Yuval/0000-0002-9022-7668	California Institute of Regenerative Medicine [RC1 00354]; Smith Family Trust; Oak Foundation; Hagey Laboratory for Pediatric Regenerative Medicine; Human Frontier Science Program (HFSP); Machiah Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL099999, U01HL099995] Funding Source: NIH RePORTER	California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); Smith Family Trust; Oak Foundation; Hagey Laboratory for Pediatric Regenerative Medicine; Human Frontier Science Program (HFSP)(Human Frontier Science Program); Machiah Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank A. Mosley for assistance with animal care and parabiosis experiments; A. Sweet-Cordero for providing Sox9Cre and Prx1Cre mice; R. Schweitzer for providing ScxCre mice; and L. Luo for providing mTmG reporter mice. We thank D. Montoro for assistance with histochemical stains and G. Paz for assistance with figure preparations. This work was supported in part by a grant from the California Institute of Regenerative Medicine (RC1 00354) and from the Smith Family Trust (to I.L.W.), the Oak Foundation and the Hagey Laboratory for Pediatric Regenerative Medicine (to M.T.L.). Y.R. is supported by a Human Frontier Science Program (HFSP) Long Term Fellowship, and the Machiah Foundation Fellowship.	Akiyama H, 2005, P NATL ACAD SCI USA, V102, P14665, DOI 10.1073/pnas.0504750102; Alvarado AS, 2000, BIOESSAYS, V22, P578, DOI 10.1002/(SICI)1521-1878(200006)22:6<578::AID-BIES11>3.0.CO;2-#; BORGENS RB, 1982, SCIENCE, V217, P747, DOI 10.1126/science.7100922; Bratincsak A, 2007, STEM CELLS, V25, P2820, DOI 10.1634/stemcells.2007-0301; Brockes JP, 2005, SCIENCE, V310, P1919, DOI 10.1126/science.1115200; Chan CKF, 2009, NATURE, V457, P490, DOI 10.1038/nature07547; Christen B, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-5; Djouad F, 2009, NAT REV RHEUMATOL, V5, P392, DOI 10.1038/nrrheum.2009.104; Faustman DL, 2006, SCIENCE, V314, DOI 10.1126/science.1129811; Fernando WA, 2011, DEV BIOL, V350, P301, DOI 10.1016/j.ydbio.2010.11.035; Forde A, 2002, GENESIS, V33, P191, DOI 10.1002/gene.10117; Forsberg EC, 2006, STEM CELL REV, V2, P23, DOI 10.1007/s12015-006-0005-z; Gargioli C, 2004, DEVELOPMENT, V131, P2669, DOI 10.1242/dev.01155; Hamrick MW, 2001, EVOL DEV, V3, P355, DOI 10.1046/j.1525-142X.2001.01032.x; Han M, 2008, DEV BIOL, V315, P125, DOI 10.1016/j.ydbio.2007.12.025; ILLINGWORTH CM, 1974, J PEDIATR SURG, V9, P853, DOI 10.1016/S0022-3468(74)80220-4; Indra AK, 1999, NUCLEIC ACIDS RES, V27, P4324, DOI 10.1093/nar/27.22.4324; Ito M, 2007, NATURE, V447, P316, DOI 10.1038/nature05766; Kimmel RA, 2000, GENE DEV, V14, P1377; Kragl M, 2009, NATURE, V460, P60, DOI 10.1038/nature08152; LIVERSAGE RA, 1991, HIST REGENERATION RE; Logan M, 2002, GENESIS, V33, P77, DOI 10.1002/gene.10092; Monvoisin A, 2006, DEV DYNAM, V235, P3413, DOI 10.1002/dvdy.20982; Morgan T.H., 1901, REGENERATION; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; NEUFELD DA, 1993, PROG CLIN BIOL RES, V383, P243; Nowak JA, 2008, CELL STEM CELL, V3, P33, DOI 10.1016/j.stem.2008.05.009; Pryce BA, 2007, DEV DYNAM, V236, P1677, DOI 10.1002/dvdy.21179; Purhonen S, 2008, P NATL ACAD SCI USA, V105, P6620, DOI 10.1073/pnas.0710516105; REGINELLI AD, 1995, DEVELOPMENT, V121, P1065; RINKEVICH B, 1995, P NATL ACAD SCI USA, V92, P7695, DOI 10.1073/pnas.92.17.7695; Rinkevich Y, 2007, PLOS BIOL, V5, P900, DOI 10.1371/journal.pbio.0050071; ROSENTHAL LJ, 1979, PEDIATRICS, V64, P1; Said S, 2004, ANAT REC PART A, V278A, P443, DOI 10.1002/ar.a.20034; SCHOTTE OE, 1959, BIOL BULL, V117, P546, DOI 10.2307/1538866; Tamura K, 2010, DEV GROWTH DIFFER, V52, P89, DOI 10.1111/j.1440-169X.2009.01144.x; Tsonis PA, 2008, CURR STEM CELL RES T, V3, P53, DOI 10.2174/157488808783489408; Tu S, 2011, DEV CELL, V20, P725, DOI 10.1016/j.devcel.2011.04.013; Vasioukhin V, 1999, P NATL ACAD SCI USA, V96, P8551, DOI 10.1073/pnas.96.15.8551; VIDAL P, 1993, J HAND SURG-BRIT EUR, V18B, P230, DOI 10.1016/0266-7681(93)90116-W; Voskoboynik A, 2007, FASEB J, V21, P1335, DOI 10.1096/fj.06-7337com; Wagers AJ, 2004, CELL, V116, P639, DOI 10.1016/S0092-8674(04)00208-9; Wagers AJ, 2002, SCIENCE, V297, P2256, DOI 10.1126/science.1074807; Weissman IL, 2000, CELL, V100, P157, DOI 10.1016/S0092-8674(00)81692-X; Wright DE, 2001, SCIENCE, V294, P1933, DOI 10.1126/science.1064081; Zaidi N, 2007, ANN NY ACAD SCI, V1117, P62, DOI 10.1196/annals.1402.074	46	282	287	1	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 25	2011	476	7361					409	U53		10.1038/nature10346	http://dx.doi.org/10.1038/nature10346			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811KT	21866153	Green Accepted			2022-12-28	WOS:000294209400027
J	Cohen, D				Cohen, Deborah			NON-COMMUNICABLE DISEASES Will industry influence derail UN summit?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									BMJ, London WC1H 9JR, England		Cohen, D (corresponding author), BMJ, London WC1H 9JR, England.	dcohen@bmj.com						Abegunde DO, 2007, LANCET, V370, P1929, DOI 10.1016/S0140-6736(07)61696-1; Beaglehole R, LANCET IN PRESS; Corporate Europe Observatory, 2010, RED LIGHT CONSUMER I; Esterl M, 2011, WALL STREET J   0628; Stuckler D, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5336; World Economic Forum, 2011, GLOB RISKS 2011; World Heart Federation, ANN REP 2009; World Public Health Nutrition Association, UN SUMM NONC DIS	8	13	13	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 23	2011	343								d5328	10.1136/bmj.d5328	http://dx.doi.org/10.1136/bmj.d5328			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	813ZK	21865279				2022-12-28	WOS:000294409600008
J	Ginther, DK; Schaffer, WT; Schnell, J; Masimore, B; Liu, FY; Haak, LL; Kington, R				Ginther, Donna K.; Schaffer, Walter T.; Schnell, Joshua; Masimore, Beth; Liu, Faye; Haak, Laurel L.; Kington, Raynard			Race, Ethnicity, and NIH Research Awards	SCIENCE			English	Article								We investigated the association between a U. S. National Institutes of Health (NIH) R01 applicant's self-identified race or ethnicity and the probability of receiving an award by using data from the NIH IMPAC II grant database, the Thomson Reuters Web of Science, and other sources. Although proposals with strong priority scores were equally likely to be funded regardless of race, we find that Asians are 4 percentage points and black or African-American applicants are 13 percentage points less likely to receive NIH investigator-initiated research funding compared with whites. After controlling for the applicant's educational background, country of origin, training, previous research awards, publication record, and employer characteristics, we find that black applicants remain 10 percentage points less likely than whites to be awarded NIH research funding. Our results suggest some leverage points for policy intervention.	[Ginther, Donna K.] Univ Kansas, Inst Policy & Social Res, Dept Econ, Lawrence, KS 66045 USA; [Ginther, Donna K.] Univ Kansas, Inst Policy & Social Res, Ctr Sci Technol & Econ Policy, Lawrence, KS 66045 USA; [Schaffer, Walter T.; Kington, Raynard] NIH, Bethesda, MD 20892 USA; [Schnell, Joshua; Masimore, Beth; Liu, Faye; Haak, Laurel L.] Thomson Reuters, Discovery Log, Rockville, MD 20850 USA	University of Kansas; University of Kansas; National Institutes of Health (NIH) - USA; Clarivate	Ginther, DK (corresponding author), Univ Kansas, Inst Policy & Social Res, Dept Econ, Lawrence, KS 66045 USA.	dginther@ku.edu	Schnell, Joshua/J-4000-2012; Haak, Laurel L./C-4986-2008; Schaffer, Walter/E-5982-2010; Ginther, Donna/W-9055-2019; Ginther, Donna K/F-7317-2016; Schnell, Joshua/J-3142-2019	Schnell, Joshua/0000-0001-9241-7441; Haak, Laurel L./0000-0001-5109-3700; Schaffer, Walter/0000-0002-2276-4656; Ginther, Donna/0000-0002-0881-7969; Ginther, Donna K/0000-0002-0881-7969; Schnell, Joshua/0000-0001-9241-7441	NSF [SES-0353703]; NIH [1R01AG36820-01, HHSN276200800458U, HHSN276200900100U, 07-6008 OD OER]; NATIONAL INSTITUTE ON AGING [R01AG036820] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	D.K.G. acknowledges financial support from NSF grant SES-0353703 and NIH grant 1R01AG36820-01. D. K. G. and Discovery Logic, a Thomson Reuters company, acknowledge support from NIH contracts HHSN276200800458U and HHSN276200900100U, made possible through an NIH Evaluation Set-Aside Award to W. T. S. (07-6008 OD OER). We thank C. Bollinger, S. Kahn, and W. McGarvey for helpful discussions. The analytical files used in the studies described here contain personal information from individuals who have submitted applications and in some cases have received awards from NIH. Many of these application records have been matched to records included in the Survey of Earned Doctorates as maintained by the National Science Foundation and to records included in the Faculty Roster maintained by the Association of American Medical Colleges. The information is therefore protected by the Privacy Act of 1974 as amended (5 U. S. C. 552a) and the National Science Foundation Act of 1950 as amended (42 U. S. C. 1873(i). More complete information can be found in the NSF/SRS Restricted-Use Data Procedures Guide available at www.nsf.gov/statistics/license/forms/pdf/srs_license_guide_august_2008.pdf and the NSF Data and Tools Web site at www.nsf.gov/statistics/database.cfm. Researchers interested in access should call W. T. S. at 301-402-2725 to discuss the security clearance requirements necessary for using the data. A de-identified version of the data files will be posted at http://report.nih.gov/investigators_and_trainees/index.aspx and archived by Science.	*AM ASS MED, 2008, COLL FAC REP; Bollinger CR, 2003, REV ECON STAT, V85, P578, DOI 10.1162/003465303322369731; Committee on Science Engineering and Public Policy, 2010, EXP UND MIN PART AM; DiPrete TA, 2006, ANNU REV SOCIOL, V32, P271, DOI 10.1146/annurev.soc.32.061604.123127; Ginther D.K., 2009, DIVERSITY ACAD BIOME; MERTON RK, 1968, SCIENCE, V159, P56, DOI 10.1126/science.159.3810.56; National Science Foundation Division of Science Resources Statistics, 2009, 09305 NSF DIV SCI RE; Nelson DJ., 2007, NATL ANAL MINORITIES; IMPAC 2	9	555	554	2	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 19	2011	333	6045					1015	1019		10.1126/science.1196783	http://dx.doi.org/10.1126/science.1196783			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	808TD	21852498	Green Published, Green Accepted, Green Submitted			2022-12-28	WOS:000294000400055
J	De Maeseneer, J; Roberts, RG; Demarzo, M; Heath, I; Sewankambo, N; Kidd, MR; van Weel, C; Egilman, D; Boelen, C; Willems, S				De Maeseneer, Jan; Roberts, Richard G.; Demarzo, Marcelo; Heath, Iona; Sewankambo, Nelson; Kidd, Michael R.; van Weel, Chris; Egilman, David; Boelen, Charles; Willems, Sara			Tackling NCDs: a different approach is needed	LANCET			English	Editorial Material							HEALTH-CARE; DEVELOPING-COUNTRIES; GLOBAL HEALTH; DISEASES		[De Maeseneer, Jan] Univ Ghent, Fac Med & Hlth Sci, Secretariat Network Unity Hlth, B-9000 Ghent, Belgium; [Willems, Sara] Univ Ghent, Dept Family Med & Primary Hlth Care, B-9000 Ghent, Belgium; [Roberts, Richard G.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Family Med, Madison, WI USA; [Demarzo, Marcelo] Fed Univ Sao Paolo, Dept Prevent Med, Sao Paulo, Brazil; [Heath, Iona] Royal Coll Gen Practitioners, London, England; [Sewankambo, Nelson] Makerere Univ, Coll Hlth Sci, Kampala, Uganda; [Kidd, Michael R.] Flinders Univ S Australia, Fac Hlth Sci, Adelaide, SA 5001, Australia; [van Weel, Chris] Radboud Univ Nijmegen, Med Ctr, Dept Primary & Community Care, NL-6525 ED Nijmegen, Netherlands; [Egilman, David] Brown Univ, Dept Family Med, Providence, RI 02912 USA; [Boelen, Charles] Secretariat Global Consensus Social Accountabil M, Sciez Sur Leman, France	Ghent University; Ghent University; University of Wisconsin System; University of Wisconsin Madison; Makerere University; Flinders University South Australia; Radboud University Nijmegen; Brown University	De Maeseneer, J (corresponding author), Univ Ghent, Fac Med & Hlth Sci, Secretariat Network Unity Hlth, B-9000 Ghent, Belgium.	jan.demaeseneer@ugent.be	van Weel, Chris/D-4375-2009; Willems, Sara/AFU-7707-2022; Demarzo, Marcelo/A-7021-2010; Willems, Sara/AAI-4851-2021	van Weel, Chris/0000-0003-3653-4701; Willems, Sara/0000-0002-6349-7785; Demarzo, Marcelo/0000-0002-7447-1839; Sewankambo, Nelson/0000-0001-9362-053X				[Anonymous], 2011, LANCET, V377, P2055; Barreto ML, 2011, LANCET, V377, P1877, DOI 10.1016/S0140-6736(11)60202-X; Beaglehole R, 2011, LANCET, V377, P1438, DOI 10.1016/S0140-6736(11)60393-0; Cavalli A, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000798; De Maeseneer J, 2008, BRIT MED J, V336, P518, DOI 10.1136/bmj.39496.444271.80; Mold J W, 1991, Fam Med, V23, P46; Starfield B, 2011, INT J EQUITY HEALTH, V10, DOI 10.1186/1475-9276-10-15; Starfield Barbara, 2011, Prim Health Care Res Dev, V12, P1, DOI 10.1017/S1463423610000484; Stuckler D, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000241; Unger JP, 2003, INT J HEALTH PLAN M, V18, pS27, DOI 10.1002/hpm.723; van Weel C, 2008, LANCET, V372, P871, DOI 10.1016/S0140-6736(08)61376-8; WHO, 2008, WORLD HLTH REP PRIM	12	48	48	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 19	2012	379	9829					1860	1861		10.1016/S0140-6736(11)61135-5	http://dx.doi.org/10.1016/S0140-6736(11)61135-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	944IW	21899880	Green Published			2022-12-28	WOS:000304194200008
J	Lyu, SY; Su, LW; Chen, YMA				Lyu, Shu-Yu; Su, Lien-Wen; Chen, Yi-Ming Arthur			Effects of education on harm-reduction programmes	LANCET			English	Editorial Material							DRUG-USERS; INFECTION; TAIWAN; HIV-1		[Lyu, Shu-Yu; Chen, Yi-Ming Arthur] Natl Yang Ming Univ, AIDS Prevent & Res Ctr, Taipei 112, Taiwan; [Lyu, Shu-Yu] Taipei Med Univ, Sch Publ Hlth, Taipei, Taiwan; [Su, Lien-Wen] Taipei City Hosp, Dept Addict Sci, Songde Branch, Taipei, Taiwan; [Chen, Yi-Ming Arthur] Natl Yang Ming Univ, Sch Med, Dept Microbiol, Taipei 112, Taiwan	National Yang Ming Chiao Tung University; Taipei Medical University; Taipei City Hospital; National Yang Ming Chiao Tung University	Chen, YMA (corresponding author), Natl Yang Ming Univ, AIDS Prevent & Res Ctr, Taipei 112, Taiwan.	arthur@ym.edu.tw						Beyrer C, 2010, LANCET, V376, P551, DOI 10.1016/S0140-6736(10)60928-2; Chen YJ, 2010, JAIDS-J ACQ IMM DEF, V53, P425, DOI 10.1097/QAI.0b013e3181ccba1a; Chen YMA, 2007, LANCET, V369, P623, DOI 10.1016/S0140-6736(07)60291-8; Degenhardt L, 2010, LANCET, V376, P285, DOI 10.1016/S0140-6736(10)60742-8; Lan YC, 2008, 17 INT AIDS C MEX CI; Morisky Donald E, 2009, Prospects (Paris), V39, P335; Peng EY, 2007, AM PUBL HLTH ASS 135; Strathdee SA, 2010, LANCET, V376, P268, DOI 10.1016/S0140-6736(10)60743-X; Taiwan Centers for Disease Control Department of Health Executive Yuan, 2011, HIV AIDS STAT DRUG S; Taiwan Ministry of Justice, 2011, STAT JUST; Tsai TI, 2010, AIDS EDUC PREV, V22, P546, DOI 10.1521/aeap.2010.22.6.546; Wolfe D, 2010, LANCET, V376, P355, DOI 10.1016/S0140-6736(10)60832-X	12	18	18	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 4	2012	379	9814					E28	E30		10.1016/S0140-6736(11)60786-1	http://dx.doi.org/10.1016/S0140-6736(11)60786-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	891AF	21851974	Bronze, Green Published			2022-12-28	WOS:000300187800002
J	Leeb, M; Wutz, A				Leeb, Martin; Wutz, Anton			Derivation of haploid embryonic stem cells from mouse embryos	NATURE			English	Article							GENETIC SCREENS; LINES; ACTIVATION; EXPRESSION; GENERATION; IDENTITY	Most animals are diploid, but haploid-only and male-haploid (such as honeybee and ant) species have been described(1). The diploid genomes of complex organisms limit genetic approaches in biomedical model species such as mice. To overcome this problem, experimental induction of haploidy has been used in fish(2,3). Haploid development in zebrafish has been applied for genetic screening(2). Recently, haploid pluripotent cell lines from medaka fish (Oryzias latipes) have also been established(3). In contrast, haploidy seems less compatible with development in mammals(4,5). Although haploid cells have been observed in egg cylinder stage parthenogenetic mouse embryos(6), most cells in surviving embryos become diploid. Here we describe haploid mouse embryonic stem cells and show their application in forward genetic screening.	[Leeb, Martin; Wutz, Anton] Univ Cambridge, Wellcome Trust Ctr Stem Cell Res, Cambridge CB2 1QR, England	University of Cambridge	Wutz, A (corresponding author), Univ Cambridge, Wellcome Trust Ctr Stem Cell Res, Tennis Court Rd, Cambridge CB2 1QR, England.	aw512@cam.ac.uk	Leeb, Martin/AAE-7498-2020; Leeb, Martin/N-3861-2015	Leeb, Martin/0000-0001-5114-4782; Leeb, Martin/0000-0001-5114-4782	Wellcome Trust [087530/Z/08/A]; EMBO Long Term Fellowship; MRC [G0800784] Funding Source: UKRI; Medical Research Council [G0800784, G0800784B] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); EMBO Long Term Fellowship(European Molecular Biology Organization (EMBO)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank A. Smith and J. Nichols for critical discussion; K. Jones for advice on cell culture; S. Dietmann for bioinformatics support; and R. Walker for cell sorting. We would also like to thank B. Mansfield and C.-E. Dumeau for their help, and the BSU team at the centre for maintaining the mouse colony. This work was supported by a Wellcome Trust Senior Research Fellowship to A. W. (grant reference 087530/Z/08/A) and an EMBO Long Term Fellowship to M.L.	Buehr M, 2008, CELL, V135, P1287, DOI 10.1016/j.cell.2008.12.007; Cadinanos J, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm446; Carette JE, 2009, SCIENCE, V326, P1231, DOI 10.1126/science.1178955; Cutler G, 2007, GENOME RES, V17, P1743, DOI 10.1101/gr.6754607; Guo G, 2004, NATURE, V429, P891, DOI 10.1038/nature02653; Inoue K, 2010, SCIENCE, V330, P496, DOI 10.1126/science.1194174; Jiang H, 2007, CELL RES, V17, P792, DOI 10.1038/cr.2007.70; KAUFMAN MH, 1983, J EMBRYOL EXP MORPH, V73, P249; KAUFMAN MH, 1978, J EMBRYOL EXP MORPH, V45, P85; Kishigami S, 2007, J REPROD DEVELOP, V53, P1207, DOI 10.1262/jrd.19067; Kong J, 2008, BIOINFORMATICS, V24, P2923, DOI 10.1093/bioinformatics/btn541; Kotecki M, 1999, EXP CELL RES, V252, P273, DOI 10.1006/excr.1999.4656; Latham KE, 2002, BIOL REPROD, V67, P386, DOI 10.1095/biolreprod67.2.386; Leeb M, 2010, GENE DEV, V24, P265, DOI 10.1101/gad.544410; Li MA, 2010, METHOD ENZYMOL, V477, P217, DOI 10.1016/S0076-6879(10)77012-9; Mai QY, 2007, CELL RES, V17, P1008, DOI 10.1038/cr.2007.102; Mikkers H, 2002, NAT GENET, V32, P459, DOI 10.1038/ng1102-459b; Nichols J, 2011, DEVELOPMENT, V138, P3, DOI 10.1242/dev.050831; Nichols J, 2009, DEVELOPMENT, V136, P3215, DOI 10.1242/dev.038893; Nichols J, 2009, NAT MED, V15, P814, DOI 10.1038/nm.1996; Otto SP, 2001, SCIENCE, V292, P2441, DOI 10.1126/science.1062890; Pollard SM, 2006, METHOD ENZYMOL, V418, P151, DOI 10.1016/S0076-6879(06)18010-6; Revazova ES, 2007, CLONING STEM CELLS, V9, P432, DOI 10.1089/clo.2007.0033; Savarese F, 2006, MOL CELL BIOL, V26, P7167, DOI 10.1128/MCB.00810-06; Shen XH, 2008, MOL CELL, V32, P491, DOI 10.1016/j.molcel.2008.10.016; Sukov WR, 2010, CANCER GENET CYTOGEN, V202, P123, DOI 10.1016/j.cancergencyto.2010.07.120; Wiellette E, 2004, GENESIS, V40, P231, DOI 10.1002/gene.20090; Wutz A, 2000, MOL CELL, V5, P695, DOI 10.1016/S1097-2765(00)80248-8; Yi MS, 2009, SCIENCE, V326, P430, DOI 10.1126/science.1175151; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968	30	181	214	0	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 3	2011	479	7371					131	U164		10.1038/nature10448	http://dx.doi.org/10.1038/nature10448			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	840FA	21900896	Green Accepted			2022-12-28	WOS:000296422600046
J	Yusuf, S; Islam, S; Chow, CK; Rangarajan, S; Dagenais, G; Diaz, R; Gupta, R; Kelishadi, R; Iqbal, R; Avezum, A; Kruger, A; Kutty, R; Lanas, F; Liu, LS; Wei, L; Lopez-Jaramillo, P; Oguz, A; Rahman, O; Swidan, H; Yusoff, K; Zatonski, W; Rosengren, A; Teo, KK				Yusuf, Salim; Islam, Shofiqul; Chow, Clara K.; Rangarajan, Sumathy; Dagenais, Gilles; Diaz, Rafael; Gupta, Rajeev; Kelishadi, Roya; Iqbal, Romaina; Avezum, Alvaro; Kruger, Annamarie; Kutty, Raman; Lanas, Fernando; Liu Lisheng; Wei, Li; Lopez-Jaramillo, Patricio; Oguz, Aytekin; Rahman, Omar; Swidan, Hany; Yusoff, Khalid; Zatonski, Witold; Rosengren, Annika; Teo, Koon K.		PURE Study Investigators	Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey	LANCET			English	Article							ACUTE CORONARY SYNDROMES; MYOCARDIAL-INFARCTION; RISK-FACTORS; HEART-FAILURE; SELF-REPORT; STROKE; AVAILABILITY; MEDICINES; VALIDITY; IMPACT	Background Although most cardiovascular disease occurs in low-income and middle-income countries, little is known about the use of effective secondary prevention medications in these communities. We aimed to assess use of proven effective secondary preventive drugs (antiplatelet drugs, beta blockers, angiotensin-converting-enzyme [ACE] inhibitors or angiotensin-receptor blockers [ARBs], and statins) in individuals with a history of coronary heart disease or stroke. Methods In the Prospective Urban Rural Epidemiological (PURE) study, we recruited individuals aged 35-70 years from rural and urban communities in countries at various stages of economic development. We assessed rates of previous cardiovascular disease (coronary heart disease or stroke) and use of proven effective secondary preventive drugs and blood-pressure-lowering drugs with standardised questionnaires, which were completed by telephone interviews, household visits, or on patient's presentation to clinics. We report estimates of drug use at national, community, and individual levels. Findings We enrolled 153 996 adults from 628 urban and rural communities in countries with incomes classified as high (three countries), upper-middle (seven), lower-middle (three), or low (four) between January, 2003, and December, 2009. 5650 participants had a self-reported coronary heart disease event (median 5.0 years previously [IQR 2.0-10.0]) and 2292 had stroke (4.0 years previously [2.0-8.0]). Overall, few individuals with cardiovascular disease took antiplatelet drugs (25.3%), beta blockers (17.4%), ACE inhibitors or ARBs (19.5%), or statins (14.6%). Use was highest in high-income countries (antiplatelet drugs 62.0%, beta blockers 40.0%, ACE inhibitors or ARBs 49.8%, and statins 66.5%), lowest in low-income countries (8.8%, 9.7%, 5.2%, and 3.3%, respectively), and decreased in line with reduction of country economic status (p(trend)<0.0001 for every drug type). Fewest patients received no drugs in high-income countries (11.2%), compared with 45.1% in upper middle-income countries, 69.3% in lower middle-income countries, and 80.2% in low-income countries. Drug use was higher in urban than rural areas (antiplatelet drugs 28.7% urban vs 21.3% rural, beta blockers 23.5% vs 15.6%, ACE inhibitors or ARBs 22.8% vs 15.5%, and statins 19.9% vs 11.6%; all p<0.0001), with greatest variation in poorest countries (p(interaction)<0.0001 for urban vs rural differences by country economic status). Country-level factors (eg, economic status) affected rates of drug use more than did individual-level factors (eg, age, sex, education, smoking status, body-mass index, and hypertension and diabetes statuses). Interpretation Because use of secondary prevention medications is low worldwide-especially in low-income countries and rural areas-systematic approaches are needed to improve the long-term use of basic, inexpensive, and effective drugs.	[Yusuf, Salim; Islam, Shofiqul; Chow, Clara K.; Rangarajan, Sumathy; Teo, Koon K.] Hamilton Hlth Sci, Populat Hlth Res Inst, Hamilton, ON, Canada; [Yusuf, Salim; Islam, Shofiqul; Chow, Clara K.; Rangarajan, Sumathy; Teo, Koon K.] McMaster Univ, Hamilton, ON, Canada; [Dagenais, Gilles] Hosp Laval, Quebec Heart Inst, Ste Foy, PQ, Canada; [Diaz, Rafael] Estudios Clin Latinoamer, Rosario, Argentina; [Gupta, Rajeev] Fortis Escorts Hosp, Jaipur, Rajasthan, India; [Kelishadi, Roya] Isfahan Univ Med Sci, Isfahan Cardiovasc Res Ctr, Esfahan, Iran; [Iqbal, Romaina] Aga Khan Univ, Dept Community Hlth Sci & Med, Karachi, Pakistan; [Avezum, Alvaro] Dante Pazzanese Inst Cardiol, Sao Paulo, Brazil; [Kutty, Raman] Hlth Act People, Trivandrum, Kerala, India; [Lanas, Fernando] Univ La Frontera, Temuco, Chile; [Liu Lisheng; Wei, Li] Chinese Acad Med Sci, Cardiovasc Inst, Natl Ctr Cardiovasc Dis, Beijing 100730, Peoples R China; [Liu Lisheng; Wei, Li] Chinese Acad Med Sci, FuWai Hosp, Beijing 100730, Peoples R China; [Lopez-Jaramillo, Patricio] Fdn Oftalmol Santander FOSCAL, Floridablanca Santander, Colombia; [Oguz, Aytekin] Goztepe Training & Res Hosp, Istanbul, Turkey; [Rahman, Omar] Independent Univ, Dhaka, Bangladesh; [Swidan, Hany] Dubai Hlth Author, Dubai, U Arab Emirates; [Yusoff, Khalid] Univ Teknol MARA Sungai Buloh, Fac Med, Selangor, Malaysia; [Zatonski, Witold] Maria Sklodowska Curie Mem Canc Ctr, Warsaw, Poland; [Zatonski, Witold] Inst Oncol, Warsaw, Poland; [Rosengren, Annika] Univ Gothenburg, Sahlgrenska Acad, Gothenburg, Sweden	McMaster University; Population Health Research Institute; McMaster University; Laval University; Fortis Escorts Hospital; Isfahan University Medical Science; Aga Khan University; Instituto Dante Pazzanese de Cardiologia; Universidad de La Frontera; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Istanbul Goztepe Training and Research Hospital; Independent University Bangladesh (IUB); Maria Sklodowska-Curie National Research Institute of Oncology; Maria Sklodowska-Curie National Research Institute of Oncology; University of Gothenburg	Yusuf, S (corresponding author), Hamilton Gen Hosp, DBCVSRI, Populat Hlth Res Inst, 237 Barton St E, Hamilton, ON L8L 2X2, Canada.	yusufs@mcmaster.ca	Nor-Ashikin, Mohamed Noor Khan/P-2055-2015; Oguz, Aytekin/AAJ-2732-2021; Lanas, Fernando/AAE-8842-2022; Avezum, Alvaro AA/K-6137-2016; Ramli, Anis Safura/U-3548-2018; Nawawi, Hapizah/N-7446-2019; Igumbor, Ehimario U/B-2652-2012; Ramli, Anis Safura/K-3322-2014; Yusoff, Khalid/I-7029-2019; Avezum, Alvaro/AAP-7687-2020; Rahman, Omar/E-1329-2019; Nawawi, Hapizah Mohd/J-8873-2019; Qorbani, Mostafa/M-8171-2017; Kelishadi, Roya/E-6154-2012; Corsi, Daniel J/S-4689-2018; Gomez-Arbelaez, Diego/K-1883-2013	Nor-Ashikin, Mohamed Noor Khan/0000-0002-1325-9236; Oguz, Aytekin/0000-0002-2595-5167; Avezum, Alvaro AA/0000-0002-3073-6890; Ramli, Anis Safura/0000-0002-9517-1413; Nawawi, Hapizah/0000-0003-4462-8484; Igumbor, Ehimario U/0000-0002-6313-6031; Ramli, Anis Safura/0000-0002-9517-1413; Yusoff, Khalid/0000-0001-5669-5188; Rahman, Omar/0000-0002-0606-2507; Nawawi, Hapizah Mohd/0000-0003-4462-8484; Kelishadi, Roya/0000-0001-7455-1495; Levitt, Naomi/0000-0001-6480-8066; Lopez-Jaramillo, Patricio/0000-0002-9122-8742; Gulec, Sadi/0000-0002-2685-2522; Lanas, Fernando/0000-0003-3595-9759; Corsi, Daniel J/0000-0001-7063-3354; Iqbal, Romaina/0000-0002-5364-4366; Jerling, Johann/0000-0003-2600-3536; Yusuf, Salim/0000-0003-4776-5601; Gomez-Arbelaez, Diego/0000-0001-6150-0066; Teo, Koon/0000-0002-3731-0956	Marion W Burke endowed chair of the Heart and Stroke Foundation of Ontario, ON, Canada; National Heart and Medical Research Council of Australia; National Heart Foundation of Australia; Sydney Medical School Foundation; Population Health Research Institute; Canadian Institutes of Health Research; Heart and Stroke Foundation of Ontario; AstraZeneca [Sweden]; AstraZeneca [Canada]; Sanofi-Aventis [France]; Sanofi-Aventis [Canada]; Boehringer Ingelheim [Germany]; Boehringer Ingelheim [Canada]; Servier; GlaxoSmithKline; Bangladesh Independent University; Mitra and Associates in Bangladesh; Unilever Health Institute in Brazil; Public Health Agency of Canada and Champlain Cardiovascular Disease Prevention Network in Canada; Universidad de la Frontera in Chile; National Center for Cardiovascular Diseases in China; Colciencias in Colombia [6566-04-18062]; Indian Council of Medical Research in India; Ministry of Science, Technology and Innovation of Malaysia [07-05-IFN-MEB010]; Universiti Teknologi MARA, Universiti Kebangsaan Malaysia in Malaysia [UKM-Hejim-Komuniti-15-2010]; Polish Ministry of Science and Higher Education [290/W-PURE/2008/0]; Wroclaw Medical University in Poland; North-West University; South Africa and Netherlands Programme for Alternative Development (SANPAD); National Research Foundation; Medical Research Council of South Africa; South Africa Sugar Association (SASA); Faculty of Community and Health Sciences (UWC) in South Africa; Swedish Council for Working Life and Social Research; Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning; Swedish Heart and Lung Foundation; Swedish Research Council; Swedish State; Vastra Gotaland Region (FOUU) in Sweden; Metabolic Syndrome Society; Astra Zeneca; Sanofi-Aventis in Turkey; Sheikh Hamdan Bin Rashid Al Maktoum Award For Medical Sciences; Dubai Health Authority, Dubai, in the United Arab Emirates	Marion W Burke endowed chair of the Heart and Stroke Foundation of Ontario, ON, Canada; National Heart and Medical Research Council of Australia; National Heart Foundation of Australia(National Heart Foundation of Australia); Sydney Medical School Foundation; Population Health Research Institute; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); AstraZeneca [Sweden](AstraZeneca); AstraZeneca [Canada](AstraZeneca); Sanofi-Aventis [France](Sanofi-Aventis); Sanofi-Aventis [Canada](Sanofi-Aventis); Boehringer Ingelheim [Germany](Boehringer Ingelheim); Boehringer Ingelheim [Canada](Boehringer Ingelheim); Servier(Servier); GlaxoSmithKline(GlaxoSmithKline); Bangladesh Independent University; Mitra and Associates in Bangladesh; Unilever Health Institute in Brazil(Unilever); Public Health Agency of Canada and Champlain Cardiovascular Disease Prevention Network in Canada; Universidad de la Frontera in Chile; National Center for Cardiovascular Diseases in China; Colciencias in Colombia(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Indian Council of Medical Research in India; Ministry of Science, Technology and Innovation of Malaysia(Ministry of Energy, Science, Technology, Environment and Climate Change (MESTECC), Malaysia); Universiti Teknologi MARA, Universiti Kebangsaan Malaysia in Malaysia; Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); Wroclaw Medical University in Poland; North-West University; South Africa and Netherlands Programme for Alternative Development (SANPAD); National Research Foundation; Medical Research Council of South Africa(South African Medical Research Council); South Africa Sugar Association (SASA); Faculty of Community and Health Sciences (UWC) in South Africa; Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning(Swedish Research Council Formas); Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish State; Vastra Gotaland Region (FOUU) in Sweden; Metabolic Syndrome Society; Astra Zeneca(AstraZeneca); Sanofi-Aventis in Turkey; Sheikh Hamdan Bin Rashid Al Maktoum Award For Medical Sciences; Dubai Health Authority, Dubai, in the United Arab Emirates	SY is supported by the Marion W Burke endowed chair of the Heart and Stroke Foundation of Ontario, ON, Canada. CKC is supported by a fellowship co-funded by the National Heart and Medical Research Council of Australia, National Heart Foundation of Australia and Sydney Medical School Foundation. The main PURE study and its components are funded by the Population Health Research Institute, the Canadian Institutes of Health Research, Heart and Stroke Foundation of Ontario, and through unrestricted grants from several pharmaceutical companies (major contributions from AstraZeneca [Sweden and Canada], Sanofi-Aventis [France and Canada], Boehringer Ingelheim [Germany and Canada], Servier, and GlaxoSmithKline), and additional contributions from Novartis and King Pharma and from various national or local organisations in participating countries. These contributions were from the Bangladesh Independent University and Mitra and Associates in Bangladesh; Unilever Health Institute in Brazil; Public Health Agency of Canada and Champlain Cardiovascular Disease Prevention Network in Canada; Universidad de la Frontera in Chile; National Center for Cardiovascular Diseases in China; Colciencias in Colombia (grant number 6566-04-18062); Indian Council of Medical Research in India; Ministry of Science, Technology and Innovation of Malaysia (grant number 07-05-IFN-MEB010) and Universiti Teknologi MARA, Universiti Kebangsaan Malaysia (UKM-Hejim-Komuniti-15-2010) in Malaysia; Polish Ministry of Science and Higher Education (grant number 290/W-PURE/2008/0) and Wroclaw Medical University in Poland; The North-West University, South Africa and Netherlands Programme for Alternative Development (SANPAD), National Research Foundation, Medical Research Council of South Africa, The South Africa Sugar Association (SASA), and Faculty of Community and Health Sciences (UWC) in South Africa; Swedish Council for Working Life and Social Research, Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning, Swedish Heart and Lung Foundation, Swedish Research Council, Grant from the Swedish State under LUA (LakarUtbildningsAvtalet) agreement, and grant from the Vastra Gotaland Region (FOUU) in Sweden; Metabolic Syndrome Society, Astra Zeneca, and Sanofi-Aventis in Turkey; Sheikh Hamdan Bin Rashid Al Maktoum Award For Medical Sciences, Dubai Health Authority, Dubai, in the United Arab Emirates.	ALTMAN R, 1994, BMJ-BRIT MED J, V308, P81, DOI 10.1136/bmj.308.6921.81; Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; Bergmann MM, 1998, AM J EPIDEMIOL, V147, P969; Bhatt DL, 2010, JAMA-J AM MED ASSOC, V304, P1350, DOI 10.1001/jama.2010.1322; Cameron A, 2011, B WORLD HEALTH ORGAN, V89, P412, DOI 10.2471/BLT.10.084327; Dagenais GR, 2006, LANCET, V368, P581, DOI 10.1016/S0140-6736(06)69201-5; Fox KAA, 2007, JAMA-J AM MED ASSOC, V297, P1892, DOI 10.1001/jama.297.17.1892; Haynes RB, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000011.pub3; HEALY B, 1991, NEW ENGL J MED, V325, P274, DOI 10.1056/NEJM199107253250408; Heckbert SR, 2004, AM J EPIDEMIOL, V160, P1152, DOI 10.1093/aje/kwh314; John RM, 2008, SOC SCI MED, V66, P1356, DOI 10.1016/j.socscimed.2007.11.020; Joshi R, 2009, CIRCULATION, V119, P1950, DOI 10.1161/CIRCULATIONAHA.108.819201; Kotseva K, 2009, LANCET, V373, P929, DOI 10.1016/S0140-6736(09)60330-5; Lampe FC, 1999, J CLIN EPIDEMIOL, V52, P73, DOI 10.1016/S0895-4356(98)00146-2; Lonn E, 2010, CIRCULATION, V122, P2078, DOI 10.1161/CIRCULATIONAHA.109.873232; MacQueen KM, 2001, AM J PUBLIC HEALTH, V91, P1929, DOI 10.2105/AJPH.91.12.1929; Mendis S, 2005, B WORLD HEALTH ORGAN, V83, P820; Niens LM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000333; O'Donnell MJ, 2010, LANCET, V376, P112, DOI 10.1016/S0140-6736(10)60834-3; Okura Y, 2004, J CLIN EPIDEMIOL, V57, P1096, DOI 10.1016/j.jclinepi.2004.04.005; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Ramsey F. L., 2002, STAT SLEUTH COURSE M; Sacco RL, 2006, STROKE, V37, P577, DOI 10.1161/01.STR.0000199147.30016.74; Teo K, 2009, AM HEART J, V158, P1, DOI 10.1016/j.ahj.2009.04.019; van Mourik MSM, 2010, BMC CARDIOVASC DISOR, V10, DOI 10.1186/1471-2261-10-25; Wald NJ, 2003, BMJ-BRIT MED J, V326, P1419, DOI 10.1136/bmj.326.7404.1419; World Bank, WE CLASS COUNTR; Xavier D, 2008, LANCET, V371, P1435, DOI 10.1016/S0140-6736(08)60623-6; Yamagishi K, 2009, J CLIN EPIDEMIOL, V62, P667, DOI 10.1016/j.jclinepi.2008.07.016; Yusuf S, 2001, CIRCULATION, V104, P2746, DOI 10.1161/hc4601.099487; YUSUF S, 1985, PROG CARDIOVASC DIS, V27, P335, DOI 10.1016/S0033-0620(85)80003-7; Yusuf S, 2009, LANCET, V373, P1341, DOI 10.1016/S0140-6736(09)60611-5; Yusuf S, 2002, LANCET, V360, P2, DOI 10.1016/S0140-6736(02)09358-3; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9; Yusuf S, 2000, NEW ENGL J MED, V342, P145	35	652	701	2	105	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 1	2011	378	9798					1231	1243		10.1016/S0140-6736(11)61215-4	http://dx.doi.org/10.1016/S0140-6736(11)61215-4			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	831IO	21872920				2022-12-28	WOS:000295723600025
J	Levy, BS; Sidel, VW				Levy, Barry S.; Sidel, Victor W.			Adverse health consequences of US Government responses to the 2001 terrorist attacks	LANCET			English	Review							TRAUMATIC BRAIN-INJURY; MATERNAL MORTALITY; AFGHAN REFUGEES; IRAQ; WAR; DEPLOYMENT; SERVICE; PREVALENCE; SYMPTOMS; CHILDREN	In response to the attacks on Sept 11, 2001 (9/11), and the related security concerns, the USA and its coalition partners began a war in Afghanistan and subsequently invaded Iraq. The wars caused many deaths of non-combatant civilians, further damaged the health-supporting infrastructure and the environment (already adversely affected by previous wars), forced many people to migrate, led to violations of human rights, and diverted resources away from important health needs. After 9/11 and the anthrax outbreak shortly afterwards, the USA and other countries have improved emergency preparedness and response capabilities, but these actions have often diverted attention and resources from more urgent health issues. The documentation and dissemination of information about the adverse health effects of these wars and about the diversion of resources could help to mitigate these consequences and prevent their recurrence.	[Levy, Barry S.] Tufts Univ, Sch Med, Boston, MA 02111 USA; [Sidel, Victor W.] Montefiore Med Ctr, Bronx, NY 10467 USA; [Sidel, Victor W.] Albert Einstein Coll Med, Bronx, NY 10467 USA; [Sidel, Victor W.] Weill Cornell Med Coll, New York, NY USA	Tufts University; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Cornell University	Levy, BS (corresponding author), POB 1230, Sherborn, MA 01770 USA.	blevy@igc.org						Ahmad K, 1999, LANCET, V354, P752, DOI 10.1016/S0140-6736(05)75997-3; ALDERSON A, 2010, TELEGRAPH       0807; Ali MM, 2003, POP STUD-J DEMOG, V57, P217, DOI 10.1080/0032472032000097119; Alkhuzai AH, 2008, NEW ENGL J MED, V358, P484, DOI 10.1056/NEJMsa0707782; ARBOUR L, 2007, HIGH COMMISSIONER HU; Bartlett LA, 2005, LANCET, V365, P864, DOI 10.1016/S0140-6736(05)71044-8; Bartlett LA, 2002, LANCET, V359, P643, DOI 10.1016/S0140-6736(02)07808-X; Belasco Amy, 2010, COST IRAQ AFGHANISTA; Bell RS, 2009, J TRAUMA, V66, pS104, DOI 10.1097/TA.0b013e31819d88c8; BENNIS P, 2005, IPS IRAQ TASK FORCE; Bilmes Linda J., 2008, 3 TRILLION DOLLAR WA; Bilukha OO, 2008, PREHOSP DISASTER MED, V23, P493, DOI 10.1017/S1049023X00006300; Bloche MG, 2005, NEW ENGL J MED, V353, P6, DOI 10.1056/NEJMp058145; Breeze J, 2011, J LARYNGOL OTOL, V125, P13, DOI 10.1017/S0022215110002215; Briner W, 2010, INT J ENV RES PUB HE, V7, P303, DOI 10.3390/ijerph7010303; BROWN P, 2003, GUARDIAN        0425; Burnham G, 2002, LANCET, V359, P639, DOI 10.1016/S0140-6736(02)07780-2; Burnham G, 2006, LANCET, V368, P1421, DOI 10.1016/S0140-6736(06)69491-9; Burnham GM, 2009, SOC SCI MED, V69, P172, DOI 10.1016/j.socscimed.2009.05.021; *CAMP TOB FREE KID, FY2010 TOB MON TOB P; *CAMP TOB FREE KID, STAT TOB REV PREV SP; Carlson KF, 2010, J TRAUMA STRESS, V23, P17, DOI 10.1002/jts.20483; Cavendish J, 2010, B WORLD HEALTH ORGAN, V88, P566, DOI 10.2471/BLT.10.020810; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51 Spec No, P16; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P482; Centers for Disease Control and Prevention (CDC), 2001, MMWR Morb Mortal Wkly Rep, V50, P941; Central Intelligence Agency, WORLD FACTB; COLVILLE R, 1997, REFUGEES MAGAZI 0601; Cumberland S, 2009, B WORLD HEALTH ORGAN, V87, P8, DOI 10.2471/BLT.09.030109; Donaldson RI, 2010, J TRAUMA, V69, P1379, DOI 10.1097/TA.0b013e318203190f; Doocy S, 2011, SOC SCI MED, V72, P273, DOI 10.1016/j.socscimed.2010.10.023; Downes Alexander B, 2008, NY TIMES        0219; Edward A, 2009, B WORLD HEALTH ORGAN, V87, P940, DOI 10.2471/BLT.08.054858; Fear NT, 2010, LANCET, V375, P1783, DOI 10.1016/S0140-6736(10)60672-1; *FED AM SCI, BSL 4 LAB US; FEICKERT A, 2008, CLUSTER MUNITIONS BA; FOWLER J, 2005, CHILD HUNGER IRAQ SA; Franco C, 2009, BIOSECUR BIOTERROR, V7, P291, DOI 10.1089/bsp.2009.0035; Hansen PM, 2008, INT J HEALTH PLAN M, V23, P107, DOI 10.1002/hpm.931; Hansen PM, 2008, INT J QUAL HEALTH C, V20, P375, DOI 10.1093/intqhc/mzn039; HATOUM B, 2001, US JETS DAMAGE KANDA; Hedges Chris, 2008, COLLATERAL DAMAGE AM; Heltemes KJ, 2011, MIL MED, V176, P132, DOI 10.7205/MILMED-D-09-00238; Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Huber D, 2010, B WORLD HEALTH ORGAN, V88, P227, DOI 10.2471/BLT.08.059410; *ICASUALTIES, COAL MIL FAT YEAR; *INT ORG MIGR, IR DISPL 2007 YEAR R; *INT POL GROUP, 2009, WHIT PAP INT POL GRO; *INT SEC ASS FORC, 2011, INT SEC ASS FORC ISA; Katz IT, 2004, NEW ENGL J MED, V351, P2571, DOI 10.1056/NEJMp048296; LATE M, 2006, NATIONS HLTH     OCT, P4; *LENNT, 2006, ENV EFF WARF IMP WAR; Lester P, 2010, J AM ACAD CHILD PSY, V49, P310, DOI 10.1016/j.jaac.2010.01.003; LEVY B, 2003, TERRORISM PUBLIC HLT; LEVY BS, TERRORISM P IN PRESS; LEVY BS, 2010, INFECT DIS MOVEMENT, P104; Litz B.T., 2009, PTSD RES Q, V20, P1; Loewenberg S, 2009, LANCET, V374, P1487, DOI 10.1016/S0140-6736(09)61887-0; Maguen S, 2010, J TRAUMA STRESS, V23, P86, DOI 10.1002/jts.20434; *MAPL, 2010, AFR NAT DOM MAPL NEW; Margesson R, 2007, AFGHAN REFUGEES CURR; MARON DF, 2010, PENTAGON WEIGHS CLEA; MCGINNIS JM, 1993, JAMA-J AM MED ASSOC, V270, P2207, DOI 10.1001/jama.270.18.2207; MCKELVEY T, 2011, NEWSWEEK        0221, P34; Meddings DR, 2004, B WORLD HEALTH ORGAN, V82, P281; Morton MJ, 2008, JAMA-J AM MED ASSOC, V300, P727, DOI 10.1001/jama.300.6.727; Murray CK, 2009, J TRAUMA, V66, pS138, DOI 10.1097/TA.0b013e31819d894c; Naeem Farooq, 2005, J Ayub Med Coll Abbottabad, V17, P23; *NAT COUNT CTR, 2007, REP TERR INC 2006, P34; NORTONTAYLOR R, 2008, GUARDIAN        0419; NYDER AA, 2009, J TRAUMA, V66, P888; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; OZONOFF D, 2008, WAR PUBLIC HLTH, P139; Physicians for Human Rights, 2005, BREAK THEM SYST US P; Purdin S, 2009, INT J GYNECOL OBSTET, V105, P82, DOI 10.1016/j.ijgo.2008.12.021; Quddus A, 2006, INT J INFECT DIS, V10, P242, DOI 10.1016/j.ijid.2005.04.007; Rajabali A, 2009, NAT REV MICROBIOL, V7, P609, DOI 10.1038/nrmicro2176; *REF INT, 2005, IR REF SYR SIL EX LE; *RELIEFWEB, 2008, INT DISPL UP IR; RICHARD EP, 2004, SMALLPOX VACCINATION; Roberts L, 2004, LANCET, V364, P1857, DOI 10.1016/S0140-6736(04)17441-2; ROGERS S, 2009, ACCESS CLEAN WATER; Sayer NA, 2010, PSYCHIAT SERV, V61, P589, DOI 10.1176/ps.2010.61.6.589; SENGUPTA K, 2005, INDEPENDENT     1003; SHANE S, 2010, NY TIMES        0219; SLEVIN P, 2004, WASHINGTON POST 0610; Smith B, 2009, AM J EPIDEMIOL, V170, P1433, DOI 10.1093/aje/kwp287; Stinner DJ, 2010, MIL MED, V175, P1027, DOI 10.7205/MILMED-D-10-00102; Sugerman David E, 2005, Int J Inj Contr Saf Promot, V12, P177, DOI 10.1080/15660970500036481; Tapp Christine, 2008, Confl Health, V2, P1, DOI 10.1186/1752-1505-2-1; TRAN M, 2008, GUARDIAN        0418; Transparency International, 2010, CORR PERC IND 2010 R; Trust for America's Health, 2010, READ NOT 2010 PROT P; *UN ASS MISS AFGH, 2011, AFGH ANN REP 2010 PR; *UN ASS MISS AFGH, 2010, AFGH CIV CAS RIS 31; *UN ED SCI CULT O, 2010, UNESCO LAUNCH IN ID; *UN HIGH COMM REF, 2011 UNHCR COUNTR OP; *UN WORLD FOOD PRO, 2008, WORLD FOOD PROGRAM, P1; *UNICEF, IR STAT; *US DEP DEF, US MIL CAS; Viswanathan K, 2010, B WORLD HEALTH ORGAN, V88, P576, DOI 10.2471/BLT.09.068957; *VOIC AM, 2009, UN QUEST LEG US US D; WEISS P, 2007, TERRORISM PUBLIC HLT, P351; *WHO, AFGH HLTH PROF; WONG E, 2009, NY TIMES        0405; *WORLD BANK, 2011, AFGH COUNTR OV 2011; *WORLD VIS, IR CHILDR CAUGHT WAR; 2009, BBC NEWS        1118; 2007, NAT PUBL RAD    0309; 2005, US TODAY        0728; 2003, CABLE NEWS NETW 1029; 2011, VOA NEWS        0220; 2010, NY TIMES        0615	116	8	8	0	14	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 3	2011	378	9794					944	952		10.1016/S0140-6736(11)60970-7	http://dx.doi.org/10.1016/S0140-6736(11)60970-7			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	818XZ	21890059				2022-12-28	WOS:000294791300035
J	Odman-Govender, CJ; Kelleghan, D				Oedman-Govender, Carolina J.; Kelleghan, Deirdre			Astronomical Perspectives for Young Children	SCIENCE			English	Editorial Material									[Oedman-Govender, Carolina J.] Leiden Univ, NL-2300 Leiden, Netherlands; [Oedman-Govender, Carolina J.] S African Astron Observ, ZA-7935 Observatory, South Africa; [Oedman-Govender, Carolina J.] African Inst Math Sci, ZA-7945 Muizenberg, South Africa	Leiden University; Leiden University - Excl LUMC; National Research Foundation - South Africa; South African Astronomical Observatory	Odman-Govender, CJ (corresponding author), Leiden Univ, NL-2300 Leiden, Netherlands.	carolina@odman.org; skysketcher@gmail.com	Odman, Carolina/U-3779-2018	Odman, Carolina/0000-0002-8968-8563				*INT ASTR UN, ASTR DEV WORLD STRAT	1	0	0	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 26	2011	333	6046					1106	1107		10.1126/science.1196982	http://dx.doi.org/10.1126/science.1196982			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	811VM	21868665				2022-12-28	WOS:000294244300035
J	Furumoto, T; Yamaguchi, T; Ohshima-Ichie, Y; Nakamura, M; Tsuchida-Iwata, Y; Shimamura, M; Ohnishi, J; Hata, S; Gowik, U; Westhoff, P; Brautigam, A; Weber, APM; Izui, K				Furumoto, Tsuyoshi; Yamaguchi, Teppei; Ohshima-Ichie, Yumiko; Nakamura, Masayoshi; Tsuchida-Iwata, Yoshiko; Shimamura, Masaki; Ohnishi, Junichi; Hata, Shingo; Gowik, Udo; Westhoff, Peter; Braeutigam, Andrea; Weber, Andreas P. M.; Izui, Katsura			A plastidial sodium-dependent pyruvate transporter	NATURE			English	Article							MESOPHYLL CHLOROPLASTS; C-4 PHOTOSYNTHESIS; MAIZE; PLANT; EXPRESSION; ENVELOPE; REVEALS; FAMILY; DRIVEN; TAF10	Pyruvate serves as a metabolic precursor for many plastid-localized biosynthetic pathways, such as those for fatty acids(1), terpenoids(2) and branched-chainamino acids(3). In spite of the importance of pyruvate uptake into plastids (organelles within cells of plants and algae), the molecular mechanisms of this uptake have not yet been explored. This is mainly because pyruvate is a relatively small compound that is able to passively permeate lipid bilayers(4), which precludes accurate measurement of pyruvate transport activity in reconstituted liposomes. Using differential transcriptome analyses of C-3 and C-4 plants of the genera Flaveria and Cleome, here we have identified a novel gene that is abundant in C-4 species, named BASS2 (BILE ACID:SODIUM SYMPORTER FAMILY PROTEIN 2). The BASS2 protein is localized at the chloroplast envelope membrane, and is highly abundant in C-4 plants that have the sodium-dependent pyruvate transporter. Recombinant BASS2 shows sodium-dependent pyruvate uptake activity. Sodium influx is balanced by a sodium: proton antiporter (NHD1), which was mimicked in recombinant Escherichia coli cells expressing both BASS2 and NHD1. Arabidopsis thaliana bass2 mutants lack pyruvate uptake into chloroplasts, which affects plastid-localized isopentenyl diphosphate synthesis, as evidenced by increased sensitivity of such mutants to mevastatin, an inhibitor of cytosolic isopentenyl diphosphate biosynthesis. We thus provide molecular evidence for a sodium-coupled metabolite transporter in plastid envelopes. Orthologues of BASS2 can be detected in all the genomes of land plants that have been characterized so far, thus indicating the widespread importance of sodium-coupled pyruvate import into plastids.	[Furumoto, Tsuyoshi; Shimamura, Masaki] Hiroshima Univ, Grad Sch Sci, Higashihiroshima 7398526, Japan; [Furumoto, Tsuyoshi; Yamaguchi, Teppei; Ohshima-Ichie, Yumiko; Nakamura, Masayoshi; Tsuchida-Iwata, Yoshiko; Hata, Shingo; Izui, Katsura] Kyoto Univ, Grad Sch Biostudies, Sakyo Ku, Kyoto 6068502, Japan; [Ohnishi, Junichi] Saitama Univ, Grad Sch Sci & Engn, Sakura Ku, Saitama 3388570, Japan; [Hata, Shingo] Nagoya Univ, Grad Sch Bioagr Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Gowik, Udo; Westhoff, Peter] Univ Dusseldorf, Inst Entwicklungs & Mol Biol Pflanzen, D-40225 Dusseldorf, Germany; [Braeutigam, Andrea; Weber, Andreas P. M.] Univ Dusseldorf, Inst Biochem Pflanzen, D-40225 Dusseldorf, Germany; [Izui, Katsura] Kinki Univ, Fac Biol Oriented Sci & Technol, Wakayama 6496493, Japan	Hiroshima University; Kyoto University; Saitama University; Nagoya University; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Kindai University (Kinki University)	Furumoto, T (corresponding author), Hiroshima Univ, Grad Sch Sci, 1-3-1 Kagamiyama, Higashihiroshima 7398526, Japan.	tfurumoto@hiroshima-u.ac.jp	Nakamura, Masayoshi/D-1979-2017; Bräutigam, Andrea/H-2685-2012; Weber, Andreas Paul Michael/O-3043-2019; Weber, Andreas PM/A-6250-2011	Nakamura, Masayoshi/0000-0002-7107-4942; Bräutigam, Andrea/0000-0002-5309-0527; Weber, Andreas Paul Michael/0000-0003-0970-4672; Weber, Andreas PM/0000-0003-0970-4672; Gowik, Udo/0000-0002-8986-7318; Shimamura, Masaki/0000-0002-5665-5116	Ministry of Education, Science and Culture of Japan; Japan Science Society; German Research Foundation [CRC-TR1, IRTG 1525/1, CRC 590]	Ministry of Education, Science and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science Society; German Research Foundation(German Research Foundation (DFG))	We thank G. Schonknecht, S. Yamaguchi and Y. Kamiya for discussions; N. Das, S. von Caemmerer and R. T. Furbank for critical reading of the manuscript; R. F. Sage, T. Endo, M. Munekage, J. Hibberd and M. Ku for gifts of seeds; T. Kinoshita for technical advice on the BASS2 immunoblot analysis; N. Aoki and S. Koreeda for technical advice on the pyruvate-uptake measurements; A. Izumida for preparation of the F. trinervia cDNA library; and Y. Takahashi for suggesting the dual expression system. This work was supported in part by the Ministry of Education, Science and Culture of Japan (Grants-in-Aid for Scientific Research to T.F. and K.I.), by a Sasakawa Scientific Research Grant from the Japan Science Society to T.F., and by the German Research Foundation (CRC-TR1 and IRTG 1525/1 to A.P.M.W., and CRC 590 to P.W.).	Aoki N, 1997, PLANT CELL PHYSIOL, V38, P1217, DOI 10.1093/oxfordjournals.pcp.a029108; AOKI N, 1992, PLANT CELL PHYSIOL, V33, P805; Brautigam A, 2008, PLANT PHYSIOL, V148, P568, DOI 10.1104/pp.108.121012; Brautigam A, 2011, PLANT PHYSIOL, V155, P142, DOI 10.1104/pp.110.159442; Cellier F, 2004, PLANT J, V39, P834, DOI 10.1111/j.1365-313X.2004.02177.x; FLUGGE UI, 1985, FEBS LETT, V183, P335, DOI 10.1016/0014-5793(85)80805-X; Furumoto T, 2005, PLANT CELL PHYSIOL, V46, P108, DOI 10.1093/pcp/pci006; Furumoto T, 1999, PLANT MOL BIOL, V41, P301, DOI 10.1023/A:1006317120460; Furumoto T, 2007, PLANT PHYSIOL, V144, P1936, DOI 10.1104/pp.107.102541; Gigolashvili T, 2009, PLANT CELL, V21, P1813, DOI 10.1105/tpc.109.066399; Hemmerlin A, 2003, J BIOL CHEM, V278, P26666, DOI 10.1074/jbc.M302526200; HUBER SC, 1977, BIOCHIM BIOPHYS ACTA, V462, P583, DOI 10.1016/0005-2728(77)90103-7; Majeran W, 2008, MOL CELL PROTEOMICS, V7, P1609, DOI 10.1074/mcp.M800016-MCP200; McKown AD, 2005, AM J BOT, V92, P1911, DOI 10.3732/ajb.92.11.1911; OHNISHI J, 1990, FEBS LETT, V269, P122, DOI 10.1016/0014-5793(90)81134-A; OHNISHI JI, 1987, FEBS LETT, V219, P347, DOI 10.1016/0014-5793(87)80250-8; PADAN E, 1989, J BIOL CHEM, V264, P20297; Pavon LR, 2008, J BIOL CHEM, V283, P13520, DOI 10.1074/jbc.M709371200; PROUDLOVE MO, 1981, NEW PHYTOL, V88, P255, DOI 10.1111/j.1469-8137.1981.tb01722.x; Sawada Y, 2009, PLANT CELL PHYSIOL, V50, P1579, DOI 10.1093/pcp/pcp110; SCHULZESIEBERT D, 1984, PLANT PHYSIOL, V76, P465, DOI 10.1104/pp.76.2.465; Schwender J, 2004, CURR OPIN PLANT BIOL, V7, P309, DOI 10.1016/j.pbi.2004.03.016; Sugden Mary C, 2003, Biochem J, V374, pe1, DOI 10.1042/BJ20031105; Suzuki M, 2004, PLANT J, V37, P750, DOI 10.1111/j.1365-313X.2004.02003.x; Tamada Y, 2007, PLANT CELL PHYSIOL, V48, P134, DOI 10.1093/pcp/pcl048; TSUCHIYA T, 1977, J BACTERIOL, V131, P848, DOI 10.1128/JB.131.3.848-853.1977; Weber APM, 2007, PLANT PHYSIOL, V144, P32, DOI 10.1104/pp.107.096677; Weber APM, 2010, CURR OPIN PLANT BIOL, V13, P257, DOI 10.1016/j.pbi.2010.01.007; Weber APM, 2005, ANNU REV PLANT BIOL, V56, P133, DOI 10.1146/annurev.arplant.56.032604.144228	29	177	182	2	133	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 25	2011	476	7361					472	U131		10.1038/nature10250	http://dx.doi.org/10.1038/nature10250			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811KT	21866161	Green Published			2022-12-28	WOS:000294209400041
J	Paul, E; Thiele, EA; Shailam, R; Rosales, AM; Sadow, PM				Paul, Elahna; Thiele, Elizabeth Anne; Shailam, Randheer; Rosales, Ana Maria; Sadow, Peter M.			Case 26-2011: A 7-Year-Old Boy with a Complex Cyst in the Kidney	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TUBEROUS SCLEROSIS COMPLEX; RENAL-CELL CARCINOMA; CONTIGUOUS GENE SYNDROME; DISEASE; ANGIOMYOLIPOMA; EPILEPSY; EMBOLIZATION; PROGNOSIS; TSC2		[Paul, Elahna] Massachusetts Gen Hosp, Dept Pediat Nephrol, Boston, MA 02114 USA; [Thiele, Elizabeth Anne] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Shailam, Randheer] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Rosales, Ana Maria] Massachusetts Gen Hosp, Dept Cardiol, Boston, MA 02114 USA; [Sadow, Peter M.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Paul, Elahna] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Thiele, Elizabeth Anne] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; [Shailam, Randheer] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Rosales, Ana Maria] Harvard Univ, Sch Med, Dept Cardiol, Boston, MA USA; [Sadow, Peter M.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Paul, E (corresponding author), Massachusetts Gen Hosp, Dept Pediat Nephrol, Boston, MA 02114 USA.		Sadow, Peter/E-7691-2015; Sadow, Peter/AAO-9878-2020	Sadow, Peter/0000-0003-1036-6367; Sadow, Peter/0000-0003-1036-6367				BROOKCARTER PT, 1994, NAT GENET, V8, P328, DOI 10.1038/ng1294-328; Casper KA, 2002, RADIOLOGY, V225, P451, DOI 10.1148/radiol.2252011584; Castagnetti M, 2007, J UROLOGY, V178, P2155, DOI 10.1016/j.juro.2007.07.058; Chu-Shore CJ, 2010, EPILEPSIA, V51, P1236, DOI 10.1111/j.1528-1167.2009.02474.x; Chu-Shore CJ, 2009, NEUROLOGY, V72, P1165, DOI 10.1212/01.wnl.0000345365.92821.86; Consugar MB, 2008, KIDNEY INT, V74, P1468, DOI 10.1038/ki.2008.485; Cook A, 2006, J UROLOGY, V175, P1456, DOI 10.1016/S0022-5347(05)00671-3; Cook A, 2006, J UROLOGY, V175, P1460; Crino PB, 2006, NEW ENGL J MED, V355, P1345, DOI 10.1056/NEJMra055323; Ewalt DH, 2005, J UROLOGY, V174, P1764, DOI 10.1097/01.ju.0000177497.31986.64; Fencl F, 2009, PEDIATR NEPHROL, V24, P983, DOI 10.1007/s00467-008-1090-9; Hajj P, 2009, UROLOGY, V74, P631, DOI 10.1016/j.urology.2009.02.078; Henske EP, 2004, CURR MOL MED, V4, P825, DOI 10.2174/1566524043359610; Jimenez RE, 2001, MODERN PATHOL, V14, P157, DOI 10.1038/modpathol.3880275; Lipworth L, 2006, J UROLOGY, V176, P2353, DOI 10.1016/j.juro.2006.07.130; LOWN B, 1952, CIRCULATION, V5, P693, DOI 10.1161/01.CIR.5.5.693; Lyczkowski DA, 2007, J CHILD NEUROL, V22, P1348, DOI 10.1177/0883073807307093; Muzykewicz DA, 2007, EPILEPSY BEHAV, V11, P506, DOI 10.1016/j.yebeh.2007.07.010; OSBORNE JP, 1991, ANN NY ACAD SCI, V615, P125; Pressey JG, 2010, PEDIATR BLOOD CANCER, V54, P1035, DOI 10.1002/pbc.22401; Rakowski SK, 2006, KIDNEY INT, V70, P1777, DOI 10.1038/sj.ki.5001853; Roach ES, 1998, J CHILD NEUROL, V13, P624, DOI 10.1177/088307389801301206; Sampson JR, 1997, AM J HUM GENET, V61, P843, DOI 10.1086/514888; Seyam RM, 2008, UROLOGY, V72, P1077, DOI 10.1016/j.urology.2008.07.049; SHEPHERD CW, 1991, MAYO CLIN PROC, V66, P792, DOI 10.1016/S0025-6196(12)61196-3; Sooriakumaran P, 2010, BJU INT, V105, P101, DOI 10.1111/j.1464-410X.2009.08649.x; Tello R, 1998, EUR J RADIOL, V27, P131, DOI 10.1016/S0720-048X(97)00037-5; Thiele EA, 2010, EPILEPSIA, V51, P90, DOI 10.1111/j.1528-1167.2009.02458.x; Williams JM, 2006, AM J KIDNEY DIS, V47, P95, DOI 10.1053/j.ajkd.2005.09.028; Winterkorn EB, 2007, NEUROLOGY, V68, P62, DOI 10.1212/01.wnl.0000250330.44291.54; Winterkorn EB, 2006, PEDIATR NEPHROL, V21, P1189, DOI 10.1007/s00467-006-0133-3	31	7	8	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 25	2011	365	8					743	751		10.1056/NEJMcpc1103557	http://dx.doi.org/10.1056/NEJMcpc1103557			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	811JM	21864169				2022-12-28	WOS:000294205300012
J	Montalescot, G; Zeymer, U; Silvain, J; Boulanger, B; Cohen, M; Goldstein, P; Ecollan, P; Combes, X; Huber, K; Pollack, C; Benezet, JF; Stibbe, O; Filippi, E; Teiger, E; Cayla, G; Elhadad, S; Adnet, F; Chouihed, T; Gallula, S; Greffet, A; Aout, M; Collet, JP; Vicaut, E				Montalescot, Gilles; Zeymer, Uwe; Silvain, Johanne; Boulanger, Bertrand; Cohen, Marc; Goldstein, Patrick; Ecollan, Patrick; Combes, Xavier; Huber, Kurt; Pollack, Charles, Jr.; Benezet, Jean-Francois; Stibbe, Olivier; Filippi, Emmanuelle; Teiger, Emmanuel; Cayla, Guillaume; Elhadad, Simon; Adnet, Frederic; Chouihed, Tahar; Gallula, Sebastien; Greffet, Agnes; Aout, Mounir; Collet, Jean-Philippe; Vicaut, Eric		ATOLL Investigators	Intravenous enoxaparin or unfractionated heparin in primary percutaneous coronary intervention for ST-elevation myocardial infarction: the international randomised open-label ATOLL trial	LANCET			English	Article							MOLECULAR-WEIGHT HEPARIN; ANTITHROMBIN THERAPY; UNSELECTED PATIENTS; EUROPEAN-SOCIETY; STEEPLE TRIAL; TASK-FORCE; ANTICOAGULATION; EFFICACY; SAFETY; FONDAPARINUX	Background Primary percutaneous coronary intervention (PCI) for ST-elevation myocardial infarction has traditionally been supported by unfractionated heparin, which has never been directly compared with a new anticoagulant using consistent anticoagulation and similar antiplatelet strategies in both groups. We compared traditional heparin treatment with intravenous enoxaparin in primary PCI. Methods In a randomised open-label trial, patients presenting with ST-elevation myocardial infarction were randomly assigned (1:1) to receive an intravenous bolus of 0.5 mg/kg of enoxaparin or unfractionated heparin before primary PCI. Wherever possible, medical teams travelling in mobile intensive care units (ambulances) selected, randomly assigned (using an interactive voice response system at the central randomisation centre), and treated patients. Patients who had received any anticoagulant before randomisation were excluded. Patients and caregivers were not masked to treatment allocation. The primary endpoint was 30-day incidence of death, complication of myocardial infarction, procedure failure, or major bleeding. The main secondary endpoint was the composite of death, recurrent acute coronary syndrome, or urgent revascularisation. Analysis was by intention to treat. This trial is registered at ClinicalTrials.gov, number NCT00718471. Findings 910 patients were assigned to treatment with enoxaparin (n=450) or unfractionated heparin (n=460). The primary endpoint occurred in 126 (28%) patients after anticoagulation with enoxaparin versus 155 (34%) patients on unfractionated heparin (relative risk [RR] 0 83, 95% CI 0.68-1.01, p=0.06). The incidence of death (enoxaparin, 17 [4%] vs heparin, 29 [6%] patients; p=0.08), complication of myocardial infarction (20 [4%] vs 29 [6%]; p=0.21), procedure failure (100 [26%] vs 109 [28%]; p=0.61), and major bleeding (20 [5%] vs 22 [5%]; p=0.79) did not differ between groups. Enoxaparin resulted in a significantly reduced rate of the main secondary endpoint (30 [7%] vs 52 [11%] patients; RR 0.59, 95% CI 0.38-0.91, p=0.015). Death, complication of myocardial infarction, or major bleeding (46 [10%] vs 69 [15%] patients; p=0.03), death or complication of myocardial infarction (35 [8%] vs 57 [12%]; p=0.02), and death, recurrent myocardial infarction, or urgent revascularisation (23 [5%] vs 39 [8%]; p=0.04) were all reduced with enoxaparin. Interpretation Intravenous enoxaparin compared with unfractionated heparin significantly reduced clinical ischaemic outcomes without differences in bleeding and procedural success. Therefore, enoxaparin provided an improvement in net clinical benefit in patients undergoing primary PCI.	[Montalescot, Gilles; Silvain, Johanne; Collet, Jean-Philippe] Univ Paris 06, CHU Pitie Salpetriere, AP HP, Inst Cardiol, Paris, France; [Ecollan, Patrick] Univ Paris 06, CHU Pitie Salpetriere, AP HP, SMUR, Paris, France; [Zeymer, Uwe] Herzzentrum Klinikum Ludwigshafen, Med Klin B, Ludwigshafen, Germany; [Boulanger, Bertrand] CH Bretagne Atlantique, SAMU, Vannes, France; [Filippi, Emmanuelle] CH Bretagne Atlantique, Dept Cardiol, Vannes, France; [Cohen, Marc] Newark Beth Israel Med Ctr, Div Cardiol, Newark, NJ USA; [Goldstein, Patrick] CHU Lille, SAMU, Lille, France; [Combes, Xavier] Henri Mondor Hosp, SAMU, Creteil, France; [Teiger, Emmanuel] Henri Mondor Hosp, Dept Cardiol, Creteil, France; [Huber, Kurt] Wilhelminenhosp, Dept Internal Med Cardiol & Emergency Med, Vienna, Austria; [Pollack, Charles, Jr.] Univ Penn, Penn Hosp, Philadelphia, PA 19104 USA; [Benezet, Jean-Francois] CH Caremeau, SAMU, Nimes, France; [Cayla, Guillaume] CH Caremeau, Dept Cardiol, Nimes, France; [Stibbe, Olivier] CH Lagny, SAMU, Lagny Sur Marne, France; [Elhadad, Simon] CH Lagny, Dept Cardiol, Lagny Sur Marne, France; [Adnet, Frederic] Hop Avicenne, SAMU, F-93009 Bobigny, France; [Chouihed, Tahar] Hop Cent, SAMU, Nancy, France; [Gallula, Sebastien] Hop Lariboisiere, SMUR, F-75475 Paris, France; [Greffet, Agnes] Hop Necker Enfants Malad, SAMU, Paris, France; [Aout, Mounir; Vicaut, Eric] Univ Paris 07, Lariboisiere Hosp, AP HP, Unite Rech Clin, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Newark Beth Israel Medical Center; Universite de Lille - ISITE; CHU Lille; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Wilhelminenspital; University of Pennsylvania; Pennsylvania Medicine; Universite de Montpellier; CHU de Nimes; Universite de Montpellier; CHU de Nimes; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Universite Paris 13; CHU de Nancy; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite	Montalescot, G (corresponding author), CHU Pitie Salpetriere, Inst Coeur, F-75013 Paris, France.	gilles.montalescot@psl.aphp.fr	SILVAIN, Johanne/C-7521-2016	SILVAIN, Johanne/0000-0002-1901-2808; TEIGER, emmanuel/0000-0001-7515-4344	Direction de la Recherche Clinique, Assistance Publique-Hopitaux de Paris; Sanofi-Aventis; Federation Francaise de Cardiologie; Abbott Vascular; AstraZeneca; CLS Behring; Daiichi Sankyo; Eli Lilly; Biotronik; Iroko Cardio; Bristol-Myers Squibb; Merck; Guerbet Medical; Medtronic; Boston Scientific; Cordis; Stago; Fondation de France; INSERM; Societe Francaise de Cardiologie; Medicines Company; Pfizer; Schering-Plough; ITC Edison; Cardiovascular Research Foundation; Cleveland Clinic Research Foundation; Duke Institute; Europa; Lead-up; Institut de Cardiologie de Montreal; Menarini; Nanospheres; Novartis; Portola; TIMI study group; Brahms; Abbott; Amgen; Servier	Direction de la Recherche Clinique, Assistance Publique-Hopitaux de Paris; Sanofi-Aventis(Sanofi-Aventis); Federation Francaise de Cardiologie; Abbott Vascular(Abbott Laboratories); AstraZeneca(AstraZeneca); CLS Behring; Daiichi Sankyo(Daiichi Sankyo Company Limited); Eli Lilly(Eli Lilly); Biotronik; Iroko Cardio; Bristol-Myers Squibb(Bristol-Myers Squibb); Merck(Merck & Company); Guerbet Medical; Medtronic(Medtronic); Boston Scientific(Boston Scientific); Cordis; Stago; Fondation de France(Fondation de France); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Societe Francaise de Cardiologie; Medicines Company; Pfizer(Pfizer); Schering-Plough(Merck & CompanySchering Plough Corporation); ITC Edison; Cardiovascular Research Foundation; Cleveland Clinic Research Foundation; Duke Institute; Europa; Lead-up; Institut de Cardiologie de Montreal; Menarini(Menarini Group); Nanospheres; Novartis(Novartis); Portola; TIMI study group; Brahms; Abbott(Abbott Laboratories); Amgen(Amgen); Servier(Servier)	Funding Direction de la Recherche Clinique, Assistance Publique-Hopitaux de Paris; Sanofi-Aventis.; GC reports receiving a research grant from la Federation Francaise de Cardiologie; consultant fees from Abbott Vascular, AstraZeneca, CLS Behring, Daiichi Sankyo, and Eli Lilly; and lecture fees from Abbott Vascular, AstraZeneca, Biotronik, CLS Behring, Daiichi Sankyo, Eli Lilly, and Iroko Cardio. MC reports receiving grant support and speakers' honoraria from Sanofi-Aventis, Bristol-Myers Squibb, and Merck. J-PC reports receiving research grants from Bristol-Myers Squibb, Sanofi-Aventis, Eli Lilly, Guerbet Medical, Medtronic, Boston Scientific, Cordis, Stago, Fondation de France, INSERM, Federation Francaise de Cardiologie, and Societe Francaise de Cardiologie; consulting fees from Sanofi-Aventis, Eli Lilly, and Bristol-Myers Squibb; and lecture fees from Bristol-Myers Squibb, Sanofi-Aventis, Eli Lilly, and AstraZeneca. PG reports receiving consulting or board fees and lecture fees from AstraZeneca, Boehringer Ingelheim, Daiichi-Sankyo, Eli-Lilly, Sanofi-Aventis, and The Medicines Company. KH reports receiving lecture fees from AstraZeneca, Bayer, Bristol-Myers Squibb, Boehringer Ingelheim, Daiichi Sankyo, Eli Lilly, Pfizer, Sanofi-Aventis, Schering-Plough, and The Medicines Company. GM reports receiving grant support from Abbott Vascular, Boston Scientific, Cordis, Eli Lilly, Federation Francaise de Cardiologie, Fondation de France, Guerbet Medical, INSERM, ITC Edison, Medtronic, Pfizer, Sanofi-Aventis, Societe Francaise de Cardiologie, and Stago; consulting or board fees and lecture fees from AstraZeneca, Bayer, Boehringer Ingelheim, Cardiovascular Research Foundation, Cleveland Clinic Research Foundation, Daiichi-Sankyo, Duke Institute, Eli Lilly, Europa, Lead-up, GlaxoSmithKline, Institut de Cardiologie de Montreal, Menarini, Nanospheres, Novartis, Pfizer, Portola, Sanofi-Aventis, The Medicines Company, and the TIMI study group. CP reports receiving research support and consulting fees from Sanofi-Aventis and The Medicines Company. JS reports receiving research grants from Sanofi-Aventis, Daiichi-Sankyo, Eli Lilly, Brahms, INSERM, Federation Francaise de Cardiologie, and Societe Francaise de Cardiologie; consulting fees from Daiichi-Sankyo and Eli Lilly; and speakers' honoraria from AstraZeneca, Daiichi Sankyo, Eli Lilly, and Servier. ET reports speakers' honoraria from Eli Lilly and Daiichi Sankyo and consulting fees and lectures fees from Medtronic and Cordis. EV reports receiving consulting fees and lecture fees from Abbott, Amgen, Eli Lilly, Pfizer, Sanofi-Aventis, and Servier. UZ reports receiving research grants and speakers' honoraria from Bristol-Myers Squibb, Eli Lilly, and Sanofi-Aventis and consulting fees and lecture fees from AstraZeneca, Bayer, Boehringer Ingelheim, Daiichi Sankyo, Portola, and The Medicines Company. All other authors declare that they have no conflicts of interest.	Antman EM, 2006, NEW ENGL J MED, V354, P1477, DOI 10.1056/NEJMoa060898; Brieger D, 2011, CATHETER CARDIO INTE, V77, P182, DOI 10.1002/ccd.22674; Choussat R, 2002, J AM COLL CARDIOL, V40, P1943, DOI 10.1016/S0735-1097(02)02531-7; Cohen M, 2006, J AM COLL CARDIOL, V48, P1346, DOI 10.1016/j.jacc.2006.05.058; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; Drouet L, 2009, AM HEART J, V158, P177, DOI 10.1016/j.ahj.2009.05.022; Dumaine R, 2007, ARCH INTERN MED, V167, P2423, DOI 10.1001/archinte.167.22.2423; Gallo R, 2009, CATHETER CARDIO INTE, V73, P319, DOI 10.1002/ccd.21764; Gibson CM, 2007, J AM COLL CARDIOL, V49, P2238, DOI 10.1016/j.jacc.2007.01.093; Hirsh J, 2004, CHEST, V126, p188S, DOI 10.1378/chest.126.3_suppl.188S; Jolly SS, 2011, LANCET, V377, P1409, DOI 10.1016/S0140-6736(11)60404-2; Li YJ, 2010, AM HEART J, V159, P684, DOI 10.1016/j.ahj.2009.12.041; Montalescot G, 2003, AM J CARDIOL, V91, P925, DOI 10.1016/S0002-9149(03)00105-X; Montalescot G, 2007, EUR HEART J, V28, P443, DOI 10.1093/eurheartj/ehl472; Montalescot G, 2006, NEW ENGL J MED, V355, P1006, DOI 10.1056/NEJMoa052711; Montalescot G, 2010, JACC-CARDIOVASC INTE, V3, P203, DOI 10.1016/j.jcin.2009.11.012; Montalescot G, 2009, LANCET, V373, P723, DOI 10.1016/S0140-6736(09)60441-4; Petersen JL, 2004, JAMA-J AM MED ASSOC, V292, P89, DOI 10.1001/jama.292.1.89; Sanchez-Pena P, 2005, BRIT J CLIN PHARMACO, V60, P364, DOI 10.1111/j.1365-2125.2005.02452.x; Silber S, 2005, EUR HEART J, V26, P804, DOI 10.1093/eurheartj/ehi138; Silvain J, 2010, J AM COLL CARDIOL, V55, P617, DOI 10.1016/j.jacc.2009.08.077; Smith SC, 2006, CIRCULATION, V113, P156, DOI 10.1161/CIRCULATIONAHA.105.170815; Stone GW, 2008, NEW ENGL J MED, V358, P2218, DOI 10.1056/NEJMoa0708191; White HD, 2009, AM HEART J, V157, P125, DOI 10.1016/j.ahj.2008.08.019; Wijns W, 2010, EUR HEART J, V31, P2501, DOI 10.1093/eurheartj/ehq277; Xiao ZH, 1998, CIRCULATION, V97, P251, DOI 10.1161/01.CIR.97.3.251; Yusuf S, 2006, JAMA-J AM MED ASSOC, V295, P1519; Yusuf S, 2006, NEW ENGL J MED, V354, P1464; Zeymer U, 2008, THROMB HAEMOSTASIS, V99, P150, DOI 10.1160/TH07-07-0449; Zeymer U, 2009, EUROINTERVENTION, V4, P524, DOI 10.4244/EIJV4I4A88	30	195	211	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 20	2011	378	9792					693	703		10.1016/S0140-6736(11)60876-3	http://dx.doi.org/10.1016/S0140-6736(11)60876-3			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	815EW	21856483				2022-12-28	WOS:000294509900029
J	Stone, GW; Ohman, EM				Stone, Gregg W.; Ohman, E. Magnus			Antithrombin alternatives in STEMI	LANCET			English	Editorial Material							PERCUTANEOUS CORONARY INTERVENTION; ELEVATION MYOCARDIAL-INFARCTION; RANDOMIZED CONTROLLED-TRIAL; UNFRACTIONATED HEPARIN; ENOXAPARIN; BIVALIRUDIN; CLOPIDOGREL; REPERFUSION		[Stone, Gregg W.] Columbia Univ, Med Ctr, New York Presbyterian Hosp, New York, NY 10022 USA; [Stone, Gregg W.] Cardiovasc Res Fdn, New York, NY 10022 USA; [Ohman, E. Magnus] Duke Univ, Med Ctr, Durham, NC USA	Columbia University; NewYork-Presbyterian Hospital; Cardiovascular Research Foundation (CRF); Duke University	Stone, GW (corresponding author), Columbia Univ, Med Ctr, New York Presbyterian Hosp, New York, NY 10022 USA.	gs2184@columbia.edu						Antman EM, 2006, NEW ENGL J MED, V354, P1477, DOI 10.1056/NEJMoa060898; Dangas GD, 2011, J AM COLL CARDIOL, V57, P2309, DOI 10.1016/j.jacc.2011.01.038; De Luca G, 2005, JAMA-J AM MED ASSOC, V293, P1759, DOI 10.1001/jama.293.14.1759; Ferguson JJ, 2004, JAMA-J AM MED ASSOC, V292, P45; Gao CJ, 2011, BLOOD, V117, P4946, DOI 10.1182/blood-2010-09-307751; Kimmelstiel C, 2011, CIRC-CARDIOVASC INTE, V4, P171, DOI 10.1161/CIRCINTERVENTIONS.110.959098; Montalescot G, 2011, LANCET, V378, P693, DOI 10.1016/S0140-6736(11)60876-3; Montalescot G, 2006, NEW ENGL J MED, V355, P1006, DOI 10.1056/NEJMoa052711; Montalescot G, 2009, LANCET, V373, P723, DOI 10.1016/S0140-6736(09)60441-4; Pocock SJ, 2010, CIRCULATION, V121, P43, DOI 10.1161/CIRCULATIONAHA.109.878017; Rassen JA, 2010, EUR HEART J, V31, P561, DOI 10.1093/eurheartj/ehp437; Steg PG, 2010, CIRCULATION, V122, P2131, DOI 10.1161/CIRCULATIONAHA.109.927582; Stone GW, 2011, LANCET, V377, P2193, DOI 10.1016/S0140-6736(11)60764-2; Yusuf S, 2006, JAMA-J AM MED ASSOC, V295, P1519	14	6	6	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 20	2011	378	9792					643	645		10.1016/S0140-6736(11)61059-3	http://dx.doi.org/10.1016/S0140-6736(11)61059-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	815EW	21856467				2022-12-28	WOS:000294509900006
J	Teerlink, JR; Clarke, CP; Saikali, KG; Lee, JH; Chen, MM; Escandon, RD; Elliott, L; Bee, R; Habibzadeh, MR; Goldman, JH; Schiller, NB; Malik, FI; Wolff, AA				Teerlink, John R.; Clarke, Cyril P.; Saikali, Khalil G.; Lee, Jacqueline H.; Chen, Michael M.; Escandon, Rafael D.; Elliott, Lyndsey; Bee, Rachel; Habibzadeh, Mohammad Reza; Goldman, Jonathan H.; Schiller, Nelson B.; Malik, Fady I.; Wolff, Andrew A.			Dose-dependent augmentation of cardiac systolic function with the selective cardiac myosin activator, omecamtiv mecarbil: a first-in-man study	LANCET			English	Article							DECOMPENSATED HEART-FAILURE; TIME INTERVALS; DIAGNOSIS; SURVIVE; UPDATE	Background Decreased systolic function is central to the pathogenesis of heart failure in millions of patients worldwide, but mechanism-related adverse effects restrict existing inotropic treatments. This study tested the hypothesis that omecamtiv mecarbil, a selective cardiac myosin activator, will augment cardiac function in human beings. Methods In this dose-escalating, crossover study, 34 healthy men received a 6-h double-blind intravenous infusion of omecamtiv mecarbil or placebo once a week for 4 weeks. Each sequence consisted of three ascending omecamtiv mecarbil doses (ranging from 0.005 to 1.0 mg/kg per h) with a placebo infusion randomised into the sequence. Vital signs, blood samples, electrocardiographs (ECGs), and echocardiograms were obtained before, during, and after each infusion. The primary aim was to establish maximum tolerated dose (the highest infusion rate tolerated by at least eight participants) and plasma concentrations of omecamtiv mecarbil; secondary aims were evaluation of pharmacodynamic and pharmacokinetic characteristics, safety, and tolerability. This study is registered at ClinicalTrials.gov, number NCT01380223. Findings The maximum tolerated dose of omecamtiv mecarbil was 0.5 mg/kg per h. Omecamtiv mecarbil infusion resulted in dose-related and concentration-related increases in systolic ejection time (mean increase from baseline at maximum tolerated dose, 85 [SD 5] ms), the most sensitive indicator of drug effect (r(2)=0.99 by dose), associated with increases in stroke volume (15 [2] mL), fractional shortening (8% [1]), and ejection fraction (7% [1]; all p<0.0001). Omecamtiv mecarbil increased atrial contractile function, and there were no clinically relevant changes in diastolic function. There were no clinically significant dose-related adverse effects on vital signs, serum chemistries, ECGs, or adverse events up to a dose of 0.625 mg/kg per h. The dose-limiting toxic effect was myocardial ischaemia due to excessive prolongation of systolic ejection time. Interpretation These first-in-man data show highly dose-dependent augmentation of left ventricular systolic function in response to omecamtiv mecarbil and support potential clinical use of the drug in patients with heart failure.	[Teerlink, John R.] Univ Calif San Francisco, San Francisco Vet Affairs Med Ctr, Cardiol Sect, San Francisco, CA 94121 USA; [Habibzadeh, Mohammad Reza; Schiller, Nelson B.] Univ Calif San Francisco, Div Cardiol, San Francisco, CA 94121 USA; [Clarke, Cyril P.] ICON Dev Solut, UK Clin Res Unit, Manchester, Lancs, England; [Clarke, Cyril P.] Univ Manchester, Manchester, Lancs, England; [Saikali, Khalil G.; Lee, Jacqueline H.; Chen, Michael M.; Escandon, Rafael D.; Malik, Fady I.; Wolff, Andrew A.] Cytokinetics Inc, San Francisco, CA USA; [Elliott, Lyndsey; Bee, Rachel; Goldman, Jonathan H.] ICON Med Imaging, Warrington, PA USA	University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; University of California System; University of California San Francisco; ICON plc; University of Manchester; ICON plc	Teerlink, JR (corresponding author), Univ Calif San Francisco, San Francisco Vet Affairs Med Ctr, Cardiol Sect, San Francisco, CA 94121 USA.	john.teerlink@ucsf.edu	Teerlink, John R/D-2986-2012		Amgen; Corthera; Cytokinetics; Merck; Novartis; Scios; Bayer; Nile Therapeutics; Cytokinetics (South San Francisco, CA, USA); Cytokinetics Inc.	Amgen(Amgen); Corthera; Cytokinetics; Merck(Merck & Company); Novartis(Novartis); Scios; Bayer(Bayer AG); Nile Therapeutics; Cytokinetics (South San Francisco, CA, USA); Cytokinetics Inc.	JRT has received research grants from Amgen, Corthera, Cytokinetics, Merck, Novartis, and Scios; and consulting fees from Bayer, Corthera, Cytokinetics, Merck, Nile Therapeutics, and Novartis. CPC is an employee of ICON Development Solutions (formerly Medeval). LE and RB are employees of ICON Medical Imaging. KGS, JHL, MMC, RDE, FIM, and AAW are employees of Cytokinetics, the sponsor of this study. MRH and NBS received research grants from ICON Medical Imaging. JHG is an employee of ICON Clinical Research, and formerly of ICON Medical Imaging, the echocardiogram core laboratory for this study.; This study was funded by Cytokinetics (South San Francisco, CA, USA).; Funding Cytokinetics Inc.	Carvalho P, 2009, IEEE ENG MED BIO, P3124, DOI 10.1109/IEMBS.2009.5332565; Cleland JGF, 2006, EUR J HEART FAIL, V8, P105, DOI 10.1016/j.ejheart.2005.12.003; Cleland JGF, 2011, LANCET, V378, P676, DOI 10.1016/S0140-6736(11)61126-4; Cohn JN, 1998, NEW ENGL J MED, V339, P1810, DOI 10.1056/NEJM199812173392503; Dickstein K, 2008, EUR HEART J, V29, P2388, DOI 10.1093/eurheartj/ehn309; Felker GM, 2003, J AM COLL CARDIOL, V41, P997, DOI 10.1016/S0735-1097(02)02968-6; Hasenfuss G, 2011, EUR HEART J, V32, P1838, DOI 10.1093/eurheartj/ehr026; LEWIS RP, 1977, CIRCULATION, V56, P146, DOI 10.1161/01.CIR.56.2.146; Lloyd-Jones D, 2010, CIRCULATION, V121, P948, DOI 10.1161/CIRCULATIONAHA.109.192666; Malik FI, 2011, SCIENCE, V331, P1439, DOI 10.1126/science.1200113; Mebazaa A, 2007, JAMA-J AM MED ASSOC, V297, P1883, DOI 10.1001/jama.297.17.1883; Morgan BP, 2010, ACS MED CHEM LETT, V1, P472, DOI 10.1021/ml100138q; Moyers B, 2007, ANN NONINVAS ELECTRO, V12, P89, DOI 10.1111/j.1542-474X.2007.00146.x; PACKER M, 1993, NEW ENGL J MED, V329, P201, DOI 10.1056/NEJM199307153290310; Pollard TD, 2008, CELL BIOL, V2nd, P705; Shen YT, 2010, CIRC-HEART FAIL, V3, P522, DOI 10.1161/CIRCHEARTFAILURE.109.930321; Smith BP, 2000, PHARMACEUT RES, V17, P1278, DOI 10.1023/A:1026451721686; Suzuki T, 2009, CIRC-HEART FAIL, V2, P334, DOI 10.1161/CIRCHEARTFAILURE.108.802298; Teerlink JR, 2009, HEART FAIL REV, V14, P243, DOI 10.1007/s10741-009-9153-y; Teerlink JR, 2009, HEART FAIL REV, V14, P289, DOI 10.1007/s10741-009-9135-0; Thomas JD, 2006, J AM COLL CARDIOL, V48, P2012, DOI 10.1016/j.jacc.2006.06.071; Thomas L, 2008, EUR J ECHOCARDIOGR, V9, P356, DOI 10.1016/j.euje.2007.06.002; WEISSLER AM, 1968, CIRCULATION, V37, P149, DOI 10.1161/01.CIR.37.2.149	23	176	182	1	16	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 20	2011	378	9792					667	675		10.1016/S0140-6736(11)61219-1	http://dx.doi.org/10.1016/S0140-6736(11)61219-1			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	815EW	21856480				2022-12-28	WOS:000294509900026
J	Gupta, PB; Fillmore, CM; Jiang, GZ; Shapira, SD; Tao, K; Kuperwasser, C; Lander, ES				Gupta, Piyush B.; Fillmore, Christine M.; Jiang, Guozhi; Shapira, Sagi D.; Tao, Kai; Kuperwasser, Charlotte; Lander, Eric S.			Stochastic State Transitions Give Rise to Phenotypic Equilibrium in Populations of Cancer Cells	CELL			English	Article							EMBRYONIC STEM-CELLS; HUMAN BREAST-CANCER; BASAL-LIKE TUMORS; GENE-EXPRESSION; MAMMARY-GLAND; SELF-RENEWAL; IN-VITRO; FLUCTUATING ENVIRONMENTS; STEM/PROGENITOR CELLS; PROGENITOR CELLS	Cancer cells within individual tumors often exist in distinct phenotypic states that differ in functional attributes. While cancer cell populations typically display distinctive equilibria in the proportion of cells in various states, the mechanisms by which this occurs are poorly understood. Here, we study the dynamics of phenotypic proportions in human breast cancer cell lines. We show that subpopulations of cells purified for a given phenotypic state return towards equilibrium proportions over time. These observations can be explained by a Markov model in which cells transition stochastically between states. A prediction of this model is that, given certain conditions, any subpopulation of cells will return to equilibrium phenotypic proportions over time. A second prediction is that breast cancer stem-like cells arise de novo from non-stem-like cells. These findings contribute to our understanding of cancer heterogeneity and reveal how stochasticity in single-cell behaviors promotes phenotypic equilibrium in populations of cancer cells.	[Gupta, Piyush B.; Jiang, Guozhi; Shapira, Sagi D.; Lander, Eric S.] Broad Inst, Cambridge, MA 02142 USA; [Fillmore, Christine M.; Kuperwasser, Charlotte] Tufts Univ, Sch Med, Sackler Sch Grad Biomed Sci, Dept Anat & Cellular Biol, Boston, MA 02111 USA; [Tao, Kai; Kuperwasser, Charlotte] Tufts Med Ctr, Mol Oncol Res Inst, Boston, MA 02111 USA; [Gupta, Piyush B.; Lander, Eric S.] MIT, Dept Biol, Cambridge, MA 02142 USA; [Lander, Eric S.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Tufts University; Tufts Medical Center; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School	Gupta, PB (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02142 USA.	pgupta@wi.mit.edu; lander@broadinstitute.org	Brainson, Christine/AAG-4688-2020	Brainson, Christine/0000-0002-0854-5043	Breast Cancer Research Foundation; Raymond and Beverly Sackler Foundation; Broad Institute	Breast Cancer Research Foundation; Raymond and Beverly Sackler Foundation; Broad Institute	We thank Aviv Regev, Robert Weinberg, Todd Golub, and Gaorav Gupta for valuable discussions and criticism of the manuscript, Supriya Gupta for assistance with gene-expression profiling, and Tom DiCesare for assistance with graphical design. This work was supported by the Breast Cancer Research Foundation, the Raymond and Beverly Sackler Foundation, and the Broad Institute.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Assou S, 2007, STEM CELLS, V25, P961, DOI 10.1634/stemcells.2006-0352; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Blackman B, 2005, BREAST CANCER RES, V7, pR248, DOI 10.1186/bcr988; Bocker W, 2002, LAB INVEST, V82, P737, DOI 10.1097/01.LAB.0000017371.72714.C5; Bonnet D, 1999, BONE MARROW TRANSPL, V23, P203, DOI 10.1038/sj.bmt.1701564; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Bussolati G, 1996, AM J PATHOL, V148, P1895; Calo E, 2010, NATURE, V466, P1110, DOI 10.1038/nature09264; Charafe-Jauffret E, 2006, ONCOGENE, V25, P2273, DOI 10.1038/sj.onc.1209254; Chiou SH, 2008, CLIN CANCER RES, V14, P4085, DOI 10.1158/1078-0432.CCR-07-4404; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; Creighton CJ, 2009, P NATL ACAD SCI USA, V106, P13820, DOI 10.1073/pnas.0905718106; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Deng H, 2011, MED HYPOTHESES, V76, P809, DOI 10.1016/j.mehy.2011.02.024; Di Talia S, 2007, NATURE, V448, P947, DOI 10.1038/nature06072; Diehn M, 2006, J NATL CANCER I, V98, P1755, DOI 10.1093/jnci/djj505; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Drabsch Y, 2007, P NATL ACAD SCI USA, V104, P13762, DOI 10.1073/pnas.0700104104; Dressman M. A., 2001, Pharmacogenomics Journal, V1, P135; Eyler CE, 2008, J CLIN ONCOL, V26, P2839, DOI 10.1200/JCO.2007.15.1829; Fillmore CM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1982; Fillmore CM, 2010, P NATL ACAD SCI USA, V107, P21737, DOI 10.1073/pnas.1007863107; Frobenius G., 1912, MATRIZEN NICHT NEGAT, P456; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gill S, 2001, J CLIN PATHOL, V54, P956, DOI 10.1136/jcp.54.12.956; Govoni KE, 2009, J CELL BIOCHEM, V106, P482, DOI 10.1002/jcb.22035; Gudjonsson T, 2002, GENE DEV, V16, P693, DOI 10.1101/gad.952602; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; Gutierrez GM, 2008, P NATL ACAD SCI USA, V105, P18402, DOI 10.1073/pnas.0805925105; Harris MA, 2008, CANCER RES, V68, P10051, DOI 10.1158/0008-5472.CAN-08-0786; Howard B, 2006, PLOS GENET, V2, P1121, DOI 10.1371/journal.pgen.0020112; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Jones C, 2004, CANCER RES, V64, P3037, DOI 10.1158/0008-5472.CAN-03-2028; Kariagina A, 2007, ENDOCRINOLOGY, V148, P2723, DOI 10.1210/en.2006-1493; Kussell E, 2005, SCIENCE, V309, P2075, DOI 10.1126/science.1114383; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Lee HS, 2007, MOL CELL BIOCHEM, V296, P129, DOI 10.1007/s11010-006-9306-4; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Li XX, 2008, JNCI-J NATL CANCER I, V100, P672, DOI 10.1093/jnci/djn123; Liu GT, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-67; Lu S, 2008, CLIN CANCER RES, V14, P1050, DOI 10.1158/1078-0432.CCR-07-4116; Monaghan P, 1995, EPITHELIAL CELL BIOL, V4, P52; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Parisi S, 2008, J CELL SCI, V121, P2629, DOI 10.1242/jcs.027599; Perron O, 1907, MATH ANN, V64, P248, DOI 10.1007/BF01449896; Perry SS, 2007, BLOOD, V110, P2351, DOI 10.1182/blood-2007-01-069914; Phinney DG, 2005, BIOCHEM BIOPH RES CO, V338, P1759, DOI 10.1016/j.bbrc.2005.10.140; RASBRIDGE SA, 1993, J PATHOL, V169, P245, DOI 10.1002/path.1711690211; Reis JS, 2006, HISTOPATHOLOGY, V49, P10, DOI 10.1111/j.1365-2559.2006.02467.x; Richard JP, 2011, DEVELOPMENT, V138, P1483, DOI 10.1242/dev.063115; Sansone P, 2007, STEM CELLS, V25, P807, DOI 10.1634/stemcells.2006-0442; Shipitsin M, 2007, CANCER CELL, V11, P259, DOI 10.1016/j.ccr.2007.01.013; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Sleeman KE, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1371; Smalley M, 2003, NAT REV CANCER, V3, P832, DOI 10.1038/nrc1212; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Sorlie T, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-127; Stingl J, 2007, NAT REV CANCER, V7, P791, DOI 10.1038/nrc2212; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Suel GM, 2007, SCIENCE, V315, P1716, DOI 10.1126/science.1137455; Suel GM, 2006, NATURE, V440, P545, DOI 10.1038/nature04588; Thattai M, 2004, GENETICS, V167, P523, DOI 10.1534/genetics.167.1.523; Thorel F, 2010, NATURE, V464, P1149, DOI 10.1038/nature08894; Wolf DM, 2005, J THEOR BIOL, V234, P227, DOI 10.1016/j.jtbi.2004.11.020; Woodward WA, 2007, P NATL ACAD SCI USA, V104, P618, DOI 10.1073/pnas.0606599104; Yarosh W, 2008, CANCER RES, V68, P693, DOI 10.1158/0008-5472.CAN-07-5012; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	68	1002	1027	2	89	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 19	2011	146	4					633	644		10.1016/j.cell.2011.07.026	http://dx.doi.org/10.1016/j.cell.2011.07.026			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	809HY	21854987	Bronze, Green Published			2022-12-28	WOS:000294043600017
J	Sheltzer, JM; Blank, HM; Pfau, SJ; Tange, Y; George, BM; Humpton, TJ; Brito, IL; Hiraoka, Y; Niwa, O; Amon, A				Sheltzer, Jason M.; Blank, Heidi M.; Pfau, Sarah J.; Tange, Yoshie; George, Benson M.; Humpton, Timothy J.; Brito, Ilana L.; Hiraoka, Yasushi; Niwa, Osami; Amon, Angelika			Aneuploidy Drives Genomic Instability in Yeast	SCIENCE			English	Article							DOUBLE-STRAND BREAKS; RECOMBINATION; CELLS; PROLIFERATION; EVOLUTION; REPAIR	Aneuploidy decreases cellular fitness, yet it is also associated with cancer, a disease of enhanced proliferative capacity. To investigate one mechanism by which aneuploidy could contribute to tumorigenesis, we examined the effects of aneuploidy on genomic stability. We analyzed 13 budding yeast strains that carry extra copies of single chromosomes and found that all aneuploid strains exhibited one or more forms of genomic instability. Most strains displayed increased chromosome loss and mitotic recombination, as well as defective DNA damage repair. Aneuploid fission yeast strains also exhibited defects in mitotic recombination. Aneuploidy-induced genomic instability could facilitate the development of genetic alterations that drive malignant growth in cancer.	[Sheltzer, Jason M.; Blank, Heidi M.; Pfau, Sarah J.; George, Benson M.; Humpton, Timothy J.; Amon, Angelika] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Sheltzer, Jason M.; Blank, Heidi M.; Pfau, Sarah J.; George, Benson M.; Humpton, Timothy J.; Amon, Angelika] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Tange, Yoshie; Hiraoka, Yasushi] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan; [Brito, Ilana L.] Columbia Univ, Dept Ecol Evolut & Environm Biol, New York, NY 10027 USA; [Hiraoka, Yasushi] Natl Inst Informat & Commun Technol, Kobe Adv ICT Res Ctr, Nishi Ku, Kobe, Hyogo 6512492, Japan; [Niwa, Osami] Rockefeller Univ, New York, NY 10065 USA	Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Osaka University; Columbia University; National Institute of Information & Communications Technology (NICT) - Japan; Rockefeller University	Amon, A (corresponding author), MIT, David H Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	angelika@mit.edu	Hiraoka, Yasushi/B-5111-2009; Humpton, Timothy/AAV-5501-2020; Brito, Ilana/W-1827-2017	Hiraoka, Yasushi/0000-0001-9407-8228; Humpton, Timothy/0000-0002-8030-9539; Pfau, Sarah/0000-0001-7528-0666; Amon, Angelika/0000-0001-9837-0314; Brito, Ilana/0000-0002-2250-3480	NSF;  [GM056800]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM056800, R01GM056800] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Koshland, T. Petes, R. Li, L. Symington, D. Page, T. Matsumoto, and J. Takeda for reagents, and I. Cheeseman, J. Haber, M. Rose, F. Solomon, and the Amon lab for comments on the manuscript. J. M. S. and S. J. P. are supported by NSF Graduate Fellowships and A. A by grant GM056800. A.A. is an HHMI investigator.	Charles JS, 2010, GENETICS, V186, P537, DOI 10.1534/genetics.110.121533; Chen JY, 2005, NAT REV CANCER, V5, P102, DOI 10.1038/nrc1547; Duesberg P, 1998, P NATL ACAD SCI USA, V95, P13692, DOI 10.1073/pnas.95.23.13692; Harfe BD, 2000, MOL CELL, V6, P1491, DOI 10.1016/S1097-2765(00)00145-3; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Lisby M, 2001, P NATL ACAD SCI USA, V98, P8276, DOI 10.1073/pnas.121006298; Matzke MA, 2003, TRENDS GENET, V19, P253, DOI 10.1016/S0168-9525(03)00057-X; Meister P, 2003, NUCLEIC ACIDS RES, V31, P5064, DOI 10.1093/nar/gkg719; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Natarajan AT, 2006, MED INTELL UNIT, P61; Niwa O, 2006, YEAST, V23, P937, DOI 10.1002/yea.1411; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Pavelka N, 2010, NATURE, V468, P321, DOI 10.1038/nature09529; Rattray AJ, 2002, GENETICS, V162, P1063; Shaver AC, 2002, GENETICS, V162, P557; Sniegowski PD, 1997, NATURE, V387, P703, DOI 10.1038/42701; Takeda J, 2008, DNA REPAIR, V7, P1250, DOI 10.1016/j.dnarep.2008.04.006; Thompson SL, 2010, J CELL BIOL, V188, P369, DOI 10.1083/jcb.200905057; Torres EM, 2008, GENETICS, V179, P737, DOI 10.1534/genetics.108.090878; Torres EM, 2007, SCIENCE, V317, P916, DOI 10.1126/science.1142210; Torres EM, 2010, CELL, V143, P71, DOI 10.1016/j.cell.2010.08.038; Weaver BAA, 2006, CURR OPIN CELL BIOL, V18, P658, DOI 10.1016/j.ceb.2006.10.002; Williams BR, 2008, SCIENCE, V322, P703, DOI 10.1126/science.1160058	23	274	281	1	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 19	2011	333	6045					1026	1030		10.1126/science.1206412	http://dx.doi.org/10.1126/science.1206412			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808TD	21852501	Green Accepted, Green Submitted			2022-12-28	WOS:000294000400058
J	McCartney, M				McCartney, Margaret			MEDICINE AND THE MEDIA Anorexia in young children: press coverage was flawed	BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358					0	0	0	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 17	2011	343								d5072	10.1136/bmj.d5072	http://dx.doi.org/10.1136/bmj.d5072			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	811LB	21849378				2022-12-28	WOS:000294210500001
J	Presanis, AM; Pebody, RG; Paterson, BJ; Tom, BDM; Birrell, PJ; Charlett, A; Lipsitch, M; De Angelis, D				Presanis, A. M.; Pebody, R. G.; Paterson, B. J.; Tom, B. D. M.; Birrell, P. J.; Charlett, A.; Lipsitch, M.; De Angelis, D.			Changes in severity of 2009 pandemic A/H1N1 influenza in England: a Bayesian evidence synthesis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							INFECTION; DISEASE	Objective To assess the impact of the 2009 A/H1N1 influenza pandemic in England during the two waves of activity up to end of February 2010 by estimating the probabilities of cases leading to severe events and the proportion of the population infected. Design A Bayesian evidence synthesis of all available relevant surveillance data in England to estimate severity of the pandemic. Data sources All available surveillance systems relevant to the pandemic 2009 A/H1N1 influenza outbreak in England from June 2009 to February 2010. Pre-existing influenza surveillance systems, including estimated numbers of symptomatic cases based on consultations to the health service for influenza-like illness and cross sectional population serological surveys, as well as systems set up in response to the pandemic, including follow-up of laboratory confirmed cases up to end of June 2009 (FF100 and Fluzone databases), retrospective and prospective follow-up of confirmed hospitalised cases, and reported deaths associated with pandemic 2009 A/H1N1 influenza. Main outcome measures Age specific and wave specific probabilities of infection and symptomatic infection resulting in hospitalisation, intensive care admission, and death, as well as infection attack rates (both symptomatic and total). The probabilities of intensive care admission and death given hospitalisation over time are also estimated to evaluate potential changes in severity across waves. Results In the summer wave of A/H1N1 influenza, 0.54% (95% credible interval 0.33% to 0.82%) of the estimated 606 100 (419 300 to 886 300) symptomatic cases were hospitalised, 0.05% (0.03% to 0.08%) entered intensive care, and 0.015% (0.010% to 0.022%) died. These correspond to 3200 (2300 to 4700) hospital admissions, 310 (200 to 480) intensive care admissions, and 90 (80 to 110) deaths in the summer wave. In the second wave, 0.55% (0.28% to 0.89%) of the 1 352 000 (829 900 to 2 806 000) estimated symptomatic cases were hospitalised, 0.10% (0.05% to 0.16%) were admitted to intensive care, and 0.025% (0.013% to 0.040%) died. These correspond to 7500 (5900 to 9700) hospitalisations, 1340 (1030 to 1790) admissions to intensive care, and 240 (310 to 380) deaths. Just over a third (35% (26% to 45%)) of infections were estimated to be symptomatic. The estimated probabilities of infections resulting in severe events were therefore 0.19% (0.12% to 0.29%), 0.02% (0.01% to 0.03%), and 0.005% (0.004% to 0.008%) in the summer wave for hospitalisation, intensive care admission, and death respectively. The corresponding second wave probabilities are 0.19% (0.10% to 0.32%), 0.03% (0.02% to 0.06%), and 0.009% (0.004% to 0.014%). An estimated 30% (20% to 43%) of hospitalisations were detected in surveillance systems in the summer, compared with 20% (15% to 25%) in the second wave. Across the two waves, a mid-estimate of 11.2% (7.4% to 18.9%) of the population of England were infected, rising to 29.5% (16.9% to 64.1%) in 5-14 year olds. Sensitivity analyses to the evidence included suggest this infection attack rate could be as low as 5.9% (4.2% to 8.7%) or as high as 28.4% (26.0% to 30.8%). In terms of the probability that an infection leads to death in the second wave, these correspond, respectively, to a high estimate of 0.017% (0.011% to 0.024%) and a low estimate of 0.0027% (0.0024% to 0.0031%). Conclusions This study suggests a mild pandemic, characterised by case and infection severity ratios increasing between waves. Results suggest low ascertainment rates, highlighting the importance of systems enabling early robust estimation of severity, to inform optimal public health responses, particularly in light of the apparent resurgence of the 2009 A/H1N1 strain in the 2010-11 influenza season.	[Presanis, A. M.; Tom, B. D. M.; Birrell, P. J.; De Angelis, D.] Univ Forvie Site, Inst Publ Hlth, Med Res Council Biostat Unit, Cambridge CB2 0SR, England; [Charlett, A.] Hlth Protect Serv, Hlth Protect Agcy, Modelling & Econ Dept, London NW9 5EQ, England; [Paterson, B. J.] Univ Newcastle, Hunter Med Res Inst, Newcastle, NSW 2300, Australia; [Lipsitch, M.] Harvard Univ, Sch Publ Hlth, Ctr Communicable Dis Dynam, Dept Epidemiol, Boston, MA 02115 USA; [Lipsitch, M.] Harvard Univ, Sch Publ Hlth, Ctr Communicable Dis Dynam, Dept Immunol & Infect Dis, Boston, MA 02115 USA	MRC Biostatistics Unit; University of Cambridge; Health Protection Agency; Hunter Medical Research Institute; University of Newcastle; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Presanis, AM (corresponding author), Univ Forvie Site, Inst Publ Hlth, Med Res Council Biostat Unit, Cambridge CB2 0SR, England.	anne.presanis@mrc-bsu.cam.ac.uk	Paterson, Beverley J/C-6189-2012	Paterson, Beverley J/0000-0001-5108-103X; Tom, Brian/0000-0002-3335-9322; Birrell, Paul/0000-0001-8131-4893; Pebody, Richard/0000-0002-9069-2885; Presanis, Anne/0000-0003-3078-4427; De Angelis, Daniela/0000-0001-6619-6112	UK Medical Research Council [MC_US_A030_0016.01]; UK Health Protection Agency; Models of Infectious Disease Agent Study Consortium from the National Institute of General Medical Sciences [U54GM088558];  [MC_US_A030_0022.01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM088558] Funding Source: NIH RePORTER; Medical Research Council [MC_U105260556, MC_U105261167] Funding Source: researchfish; MRC [MC_U105261167, MC_U105260556] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Health Protection Agency; Models of Infectious Disease Agent Study Consortium from the National Institute of General Medical Sciences; ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	AMP, PJB, and DDA were funded by the UK Medical Research Council (grant MC_US_A030_0016.01). BDMT was also funded by the council (grant MC_US_A030_0022.01). DDA, RGP, BJP, and AC were funded by the UK Health Protection Agency. BJP was funded as a research fellow by the Hunter Medical Research Institute, Australia. ML was supported by the Models of Infectious Disease Agent Study Consortium from the National Institute of General Medical Sciences (award No U54GM088558). The content is the responsibility of the authors and does not necessarily represent the views of the National Institute of General Medical Sciences or the National Institutes of Health. The funders had no role in study design; the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to publish the article.	Bandaranayake D, 2010, SEROPREVALENCE 2009; Bird SM, 2010, LANCET, V376, P684, DOI 10.1016/S0140-6736(10)61333-5; Birrell PJ, 2011, BAYESIAN MODEL UNPUB; Campbell CN, 2010, EPIDEMIOL INFECT, V26, P1, DOI DOI 10.1017/S0950268810002657; Carrat F, 2008, AM J EPIDEMIOL, V167, P775, DOI 10.1093/aje/kwm375; Cowling BJ, 2010, NEW ENGL J MED, V362, P2175, DOI 10.1056/NEJMoa0911530; Degail M, 2010, HLTH PROT C; Donaldson LJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5213; Dowell SF, 2003, EMERG INFECT DIS, V9, P573, DOI 10.3201/eid0905.020556; Evans BG, 2011, HAS ESTIMATION UNPUB; FluWatch, 2009, PAND STUD; Garske T, 2009, BMJ-BRIT MED J, V339, pb2840; Grant A, 2010, COMMUNICATION; Hadler JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011677; Hardelid P, 2010, HEALTH TECHNOL ASSES, V14, P115, DOI 10.3310/hta14550-03; Harris R, 2010, STAT ANAL PRELIMINAR; Health Protection Agency, 2010, EP REP PAND H1N1 200; Health Protection Agency Health Protection Scotland Communicable Disease Surveillance Centre Northern Ireland and National Public Health Service FOR WALES, 2009, 1 FEW 100 FF100 PROJ; Ihekweazu C, 2010, INT C EM INF DIS ATL; Influenzanet, 2009, INFL; Lipsitch M, 2009, NEW ENGL J MED, V361, P112, DOI 10.1056/NEJMp0904380; Lunn D, 2009, STAT MED, V28, P3049, DOI 10.1002/sim.3680; Miller E, 2010, LANCET, V375, P1100, DOI 10.1016/S0140-6736(09)62126-7; Miller MA, 2009, NEW ENGL J MED, V360, P2595, DOI 10.1056/NEJMp0903906; Nishiura H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006852; Pebody RG, 2010, EUROSURVEILLANCE, V15; Presanis AM, 2011, ROLE EACH ITEM UNPUB; Presanis AM, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000207; Reed C, 2009, EMERG INFECT DIS, V15, P2004, DOI 10.3201/eid1512.091413; Wallinga J, 2010, P NATL ACAD SCI USA, V107, P923, DOI 10.1073/pnas.0908491107; Welliver R, 2001, JAMA-J AM MED ASSOC, V285, P748, DOI 10.1001/jama.285.6.748; Wilson N, 2009, EUROSURVEILLANCE, V14; World Health Organization, 2010, PAND H1N1 2009 UPD 1; Wu JT, 2010, CLIN INFECT DIS, V51, P1184, DOI 10.1086/656740; [No title captured]	35	62	62	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 8	2011	343								d5408	10.1136/bmj.d5408	http://dx.doi.org/10.1136/bmj.d5408			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	819RV	21903689	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000294848300003
J	Sachs, GA; Carter, R; Holtz, LR; Smith, F; Stump, TE; Tu, WZ; Callahan, CM				Sachs, Greg A.; Carter, Ravan; Holtz, Laura R.; Smith, Faye; Stump, Timothy E.; Tu, Wanzhu; Callahan, Christopher M.			Cognitive Impairment: An Independent Predictor of Excess Mortality A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							PRIMARY-CARE PATIENTS; NATIONAL DEATH INDEX; ALZHEIMER-DISEASE; ELDERLY PATIENTS; OLDER-ADULTS; DEMENTIA; SURVIVAL; POPULATION; QUESTIONNAIRE; CERTIFICATES	Background: Dementia is a leading cause of death among older adults, but less is known about the mortality risk associated with milder forms of cognitive impairment. Objective: To determine whether cognitive impairment is independently associated with increased long-term mortality in primary care patients aged 60 years and older. Design: Linkage of electronic health records from a cohort recruited between January 1991 and May 1993 with data from the National Death Index through 31 December 2006. Setting: A public safety-net hospital and its community health centers. Patients: 3957 older adults aged 60 to 102 years who were screened at scheduled primary care appointments. Measurements: At baseline, patients were screened for cognitive impairment by using the Short Portable Mental Status Questionnaire and were categorized into groups with no, mild, or moderate to severe cognitive impairment. Baseline data from comprehensive electronic health records were linked with vital status obtained from the National Death Index. Kaplan-Meier survival curves compared time to death for the groups with cognitive impairment. Cox proportional hazards models controlled for mortality risk factors. Results: At baseline, 3157 patients had no cognitive impairment, 533 had mild impairment, and 267 had moderate to severe impairment. Overall, 2385 of the 3957 patients (60.3%) died during the observation period: 1812 (57.4%) patients with no cognitive impairment, 363 (68.1%) patients with mild impairment, and 210 (78.7%) patients with moderate to severe impairment. Both mild and moderate to severe cognitive impairment were associated with increased mortality hazard independent of other mortality risk factors (hazard ratio, 1.184 [95% CI, 1.051 to 1.334] and for mild impairment 1.447 [CI, 1.235 to 1.695] for moderate to severe impairment). Median survival for all 3957 participants was 129 months. Median survival for participants with no, mild, and moderate to severe cognitive impairment was 138, 106, and 63 months, respectively. Limitations: Cognition was assessed only at enrollment by using a screening instrument. Participants were drawn from a single safety-net health system and had low educational and socioeconomic status, which limits generalizability to other populations. Changes in cognition, function, and comorbid conditions were not measured over time. Conclusion: Both mild and moderate to severe cognitive impairment as identified by the Short Portable Mental Status Questionnaire are associated with an increased risk for mortality.	Indiana Univ, Regenstrief Inst, Ctr Aging Res, Indianapolis, IN 46204 USA; Indiana Univ Sch Med, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Regenstrief Institute Inc; Indiana University System; Indiana University Bloomington	Sachs, GA (corresponding author), Indiana Univ Sch Med, Div Gen Internal Med & Geriat, Wishard Mem Hosp, 1001 W 10th St, Indianapolis, IN 46202 USA.	sachsg@iupui.edu			Agency for Healthcare Research and Quality [R21 HS17630]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R21HS017630] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	By grant R21 HS17630 from the Agency for Healthcare Research and Quality.	Attems J, 2005, J ALZHEIMERS DIS, V8, P57; Boult C, 2010, JAMA-J AM MED ASSOC, V304, P1936, DOI 10.1001/jama.2010.1623; Boustani M, 2007, J GEN INTERN MED, V22, P1625, DOI 10.1007/s11606-007-0386-y; Brauner DJ, 2000, JAMA-J AM MED ASSOC, V283, P3230, DOI 10.1001/jama.283.24.3230; Brunnstrom HR, 2009, EUR J NEUROL, V16, P488, DOI 10.1111/j.1468-1331.2008.02503.x; CALLAHAN CM, 1995, J AM GERIATR SOC, V43, P1378, DOI 10.1111/j.1532-5415.1995.tb06617.x; CALLAHAN CM, 1995, ANN INTERN MED, V122, P422, DOI 10.7326/0003-4819-122-6-199503150-00004; CALLAHAN CM, 1994, J AM GERIATR SOC, V42, P839, DOI 10.1111/j.1532-5415.1994.tb06555.x; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Ganguli M, 2005, ARCH NEUROL-CHICAGO, V62, P779, DOI 10.1001/archneur.62.5.779; Ganguli M, 1999, J AM GERIATR SOC, V47, P842, DOI 10.1111/j.1532-5415.1999.tb03842.x; Helzner EP, 2008, NEUROLOGY, V71, P1489, DOI 10.1212/01.wnl.0000334278.11022.42; Holmes HM, 2006, ARCH INTERN MED, V166, P605, DOI 10.1001/archinte.166.6.605; HOOIJER C, 1992, INT J GERIATR PSYCH, V7, P559, DOI 10.1002/gps.930070805; Inouye SK, 2006, NEW ENGL J MED, V354, P1157, DOI 10.1056/NEJMra052321; Kammoun S, 2000, ACTA NEUROL SCAND, V102, P96, DOI 10.1034/j.1600-0404.2000.00314.x; Larson EB, 2004, ANN INTERN MED, V140, P501, DOI 10.7326/0003-4819-140-7-200404060-00008; MAYFIELD D, 1974, AM J PSYCHIAT, V131, P1121; MCDONALD CJ, 1992, M D COMPUT, V9, P206; Mehta KM, 2010, AM J PUBLIC HEALTH, V100, P1917, DOI 10.2105/AJPH.2008.158485; PATTERSON BH, 1986, J NATL CANCER I, V77, P877; PFEIFFER E, 1975, J AM GERIATR SOC, V23, P433, DOI 10.1111/j.1532-5415.1975.tb00927.x; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rait G., 2010, BMJ-BRIT MED J, V341, pc3584; Sampson EL, 2009, J AM GERIATR SOC, V57, P985, DOI 10.1111/j.1532-5415.2009.02265.x; TIERNEY WM, 1991, MED CARE, V29, pJS57; U.S. Department of Health and Human Services, 2011, HHS IN MULT CHRON CO; Wachterman M, 2008, JAMA-J AM MED ASSOC, V300, P2608, DOI 10.1001/jama.2008.768; Walter LC, 2001, JAMA-J AM MED ASSOC, V285, P2750, DOI 10.1001/jama.285.21.2750; Werner P, 2004, INT J GERIATR PSYCH, V19, P479, DOI 10.1002/gps.1120; WILLIAMS BC, 1992, AM J PUBLIC HEALTH, V82, P1145, DOI 10.2105/AJPH.82.8.1145; Wilson RS, 2009, ARCH NEUROL-CHICAGO, V66, P767, DOI 10.1001/archneurol.2009.80; Wolfson C, 2001, NEW ENGL J MED, V344, P1111, DOI 10.1056/NEJM200104123441501; Xie J, 2008, BMJ-BRIT MED J, V336, P258, DOI 10.1136/bmj.39433.616678.25	34	129	131	0	11	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 6	2011	155	5					300	U55		10.7326/0003-4819-155-5-201109060-00007	http://dx.doi.org/10.7326/0003-4819-155-5-201109060-00007			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	815PX	21893623				2022-12-28	WOS:000294538900003
J	Sovik, TT; Aasheim, ET; Taha, O; Engstrom, M; Fagerland, MW; Bjorkman, S; Kristinsson, J; Birkeland, KI; Mala, T; Olbers, T				Sovik, Torgeir T.; Aasheim, Erlend T.; Taha, Osama; Engstrom, My; Fagerland, Morten W.; Bjorkman, Sofia; Kristinsson, Jon; Birkeland, Kare I.; Mala, Tom; Olbers, Torsten			Weight Loss, Cardiovascular Risk Factors, and Quality of Life After Gastric Bypass and Duodenal Switch A Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							SEVERELY OBESE ADULTS; BODY-MASS INDEX; BARIATRIC SURGERY; BILIOPANCREATIC DIVERSION; LONG-TERM; MORTALITY; OVERWEIGHT; HEALTH; TRENDS; INTERVENTION	Background: Gastric bypass and duodenal switch are currently performed bariatric surgical procedures. Uncontrolled studies suggest that duodenal switch induces greater weight loss than gastric bypass. Objective: To determine whether duodenal switch leads to greater weight loss and more favorable improvements in cardiovascular risk factors and quality of life than gastric bypass. Design: Randomized, parallel-group trial. (ClinicalTrials.gov registration number: NCT00327912) Setting: 2 academic medical centers (1 in Norway and 1 in Sweden). Patients: 60 participants with a body mass index (BMI) between 50 and 60 kg/m(2). Intervention: Gastric bypass (n = 31) or duodenal switch (n = 29). Measurements: The primary outcome was the change in BMI after 2 years. Secondary outcomes included anthropometric measures; concentrations of blood lipids, glucose, insulin, C-reactive protein, and vitamins; and health-related quality of life and adverse events. Results: Fifty-eight of 60 participants (97%) completed the study. The mean reductions in BMI were 17.3 kg/m(2) (95% CI, 15.7 to 19.0 kg/m(2)) after gastric bypass and 24.8 kg/m(2) (CI, 23.0 to 26.5 kg/m(2)) after duodenal switch (mean between-group difference, 7.44 kg/m(2) [CI, 5.24 to 9.64 kg/m(2)]; P < 0.001). Total cholesterol concentration decreased by 0.24 mmol/L (CI, -0.03 to 0.50 mmol/L) (9.27 mg/dL [CI, -1.16 to 19.3 mg/dL]) after gastric bypass and 1.07 mmol/L (CI, 0.79 to 1.35 mmol/L) (41.3 mg/dL [CI, 30.5 to 52.1 mg/dL]) after duodenal switch (mean between-group difference, 0.83 mmol/L [CI, 0.48 to 1.18 mmol/L]; 32.0 mg/dL [CI, 18.5 to 45.6 mg/dL]; P <= 0.001). Reductions in low-density lipoprotein cholesterol concentration, anthropometric measures, fat mass, and fat-free mass were also greater after duodenal switch (P <= 0.010 for each between-group comparison). Both groups had reductions in blood pressure and mean concentrations of glucose, insulin, and C-reactive protein, with no between-group differences. The duodenal switch group, but not the gastric bypass group, had reductions in concentrations of vitamin A and 25-hydroxyvitamin D. Most Short Form-36 Health Survey dimensional scores improved in both groups, with greater improvement in 1 of 8 domains (bodily pain) after gastric bypass. From surgery until 2 years, 10 participants (32%) had adverse events after gastric bypass and 18 (62%) after duodenal switch (P = 0.021). Adverse events related to malnutrition occurred only after duodenal switch. Limitation: Clinical experience was greater with gastric bypass than with duodenal switch at the study centers. Conclusion: Duodenal switch surgery was associated with greater weight loss, greater reductions of total and low-density lipoprotein cholesterol concentrations, and more adverse events. Improvements in other cardiovascular risk factors and quality of life were similar after both procedures.	[Sovik, Torgeir T.] Oslo Univ Hosp Aker, Dept Gastrointestinal Surg, N-0424 Oslo, Norway; Univ Oslo, Oslo, Norway; Sahlgrens Univ Hosp, S-41345 Gothenburg, Sweden	University of Oslo; University of Oslo; Sahlgrenska University Hospital	Sovik, TT (corresponding author), Oslo Univ Hosp Aker, Dept Gastrointestinal Surg, POB 4959, N-0424 Oslo, Norway.	t.t.sovik@medisin.uio.no	Birkeland, Kåre I/E-9750-2010; Mala, Tom/J-5418-2019; Fagerland, Morten W/B-1672-2009	Mala, Tom/0000-0003-3058-4775; Bjorkman, Sofia/0000-0001-9384-2562; Aasheim, Erlend Tuseth/0000-0002-6246-6303; Olbers, Torsten/0000-0002-7218-3390	South-Eastern Norway Regional Health Authority; Sahlgrenska University Hospital; National Institute for Health Research [ACF-2011-14-008] Funding Source: researchfish	South-Eastern Norway Regional Health Authority; Sahlgrenska University Hospital; National Institute for Health Research(National Institute for Health Research (NIHR))	By research fellowship grants from the South-Eastern Norway Regional Health Authority (Drs. Sovik and Aasheim) and a postdoctoral research grant from Sahlgrenska University Hospital (Dr. Olbers).	Aasheim Erlend T, 2007, Tidsskr Nor Laegeforen, V127, P38; Aasheim ET, 2011, BRIT J NUTR, V106, P432, DOI 10.1017/S0007114511000201; Aasheim ET, 2010, SURG OBES RELAT DIS, V6, P441, DOI 10.1016/j.soard.2009.11.007; Aasheim ET, 2009, AM J CLIN NUTR, V90, P15, DOI 10.3945/ajcn.2009.27583; Aasheim ET, 2011, SURG OBES RELAT DIS; Abell JE, 2008, AM J PUBLIC HEALTH, V98, P63, DOI 10.2105/AJPH.2006.093781; Adams TD, 2007, NEW ENGL J MED, V357, P753, DOI 10.1056/NEJMoa066603; Andersen JR, 2010, OBES SURG, V20, P340, DOI 10.1007/s11695-009-9837-3; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; BROLIN RE, 1992, ANN SURG, V215, P387, DOI 10.1097/00000658-199204000-00014; Buchwald H, 2004, JAMA-J AM MED ASSOC, V292, P1724, DOI 10.1001/jama.292.14.1724; Buchwald H, 2008, ANN SURG, V248, P541, DOI 10.1097/SLA.0b013e318188e1c2; Buchwald H, 2007, SURGERY, V142, P621, DOI 10.1016/j.surg.2007.07.018; Buchwald H, 2010, ANN SURG, V251, P1034, DOI 10.1097/SLA.0b013e3181deb4d0; Christiansen T, 2007, OBESITY, V15, P413, DOI 10.1038/oby.2007.530; Cools M, 2006, EUR J PEDIATR, V165, P199, DOI 10.1007/s00431-005-0056-1; de Gonzalez AB, 2010, NEW ENGL J MED, V363, P2211, DOI 10.1056/NEJMoa1000367; FerroLuzzi A, 1995, WHO TECH REP SER, V854, P1; Field AE, 2001, ARCH INTERN MED, V161, P1581, DOI 10.1001/archinte.161.13.1581; Flegal KM, 2007, JAMA-J AM MED ASSOC, V298, P2028, DOI 10.1001/jama.298.17.2028; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Flum DR, 2009, NEW ENGL J MED, V361, P445, DOI 10.1056/NEJMoa0901836; GLEYSTEEN JJ, 1990, AM J CLIN NUTR, V51, P774, DOI 10.1093/ajcn/51.5.774; Goodpaster BH, 2010, JAMA-J AM MED ASSOC, V304, P1795, DOI 10.1001/jama.2010.1505; Karlsson J, 2007, INT J OBESITY, V31, P1248, DOI 10.1038/sj.ijo.0803573; Li ZP, 2005, ANN INTERN MED, V142, P532, DOI 10.7326/0003-4819-142-7-200504050-00012; Loge JH, 1998, SCAND J SOC MED, V26, P250; Lydersen S, 2009, STAT MED, V28, P1159, DOI 10.1002/sim.3531; Maggard MA, 2008, JAMA-J AM MED ASSOC, V300, P2286, DOI 10.1001/jama.2008.641; Marceau P, 2007, OBES SURG, V17, P1421, DOI 10.1007/s11695-008-9435-9; Mattsson S, 2006, PHYS MED BIOL, V51, pR203, DOI 10.1088/0031-9155/51/13/R13; Moore LL, 2005, ARCH INTERN MED, V165, P1298, DOI 10.1001/archinte.165.11.1298; Moore LL, 2000, EPIDEMIOLOGY, V11, P269, DOI 10.1097/00001648-200005000-00007; Nguyen NT, 2008, J AM COLL SURGEONS, V207, P928, DOI 10.1016/j.jamcollsurg.2008.08.022; Parikh MS, 2005, OBES SURG, V15, P858, DOI 10.1381/0960892054222632; Pateyjohns IR, 2006, OBESITY, V14, P2064, DOI 10.1038/oby.2006.241; Pihlajamaki J, 2010, METABOLISM, V59, P866, DOI 10.1016/j.metabol.2009.10.004; Prachand VN, 2006, ANN SURG, V244, P611, DOI 10.1097/01.sla.0000239086.30518.2a; Prachand VN, 2010, J GASTROINTEST SURG, V14, P211, DOI 10.1007/s11605-009-1101-6; Regan JP, 2003, OBES SURG, V13, P861, DOI 10.1381/096089203322618669; Scopinaro Nicola, 2005, Surg Obes Relat Dis, V1, P317, DOI 10.1016/j.soard.2005.03.216; Sjostrom L, 2004, NEW ENGL J MED, V351, P2683, DOI 10.1056/NEJMoa035622; Sjostrom L, 2007, NEW ENGL J MED, V357, P741, DOI 10.1056/NEJMoa066254; Sjostrom L, 2009, LANCET ONCOL, V10, P653, DOI 10.1016/S1470-2045(09)70159-7; Sovik TT, 2010, BRIT J SURG, V97, P160, DOI 10.1002/bjs.6802; Strain GW, 2007, SURG OBES RELAT DIS, V3, P31, DOI 10.1016/j.soard.2006.09.002; Sturm R, 2007, PUBLIC HEALTH, V121, P492, DOI 10.1016/j.puhe.2007.01.006; Suter M, 2009, ARCH SURG-CHICAGO, V144, P312, DOI 10.1001/archsurg.2009.19; Topart P, 2010, SURG OBES RELAT DIS, V6, P59, DOI 10.1016/j.soard.2009.04.016; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Zamboni M, 1998, INT J OBESITY, V22, P655, DOI 10.1038/sj.ijo.0800643	51	112	119	0	11	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 6	2011	155	5					281	U34		10.7326/0003-4819-155-5-201109060-00005	http://dx.doi.org/10.7326/0003-4819-155-5-201109060-00005			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	815PX	21893621				2022-12-28	WOS:000294538900001
J	Inhorn, MC; Serour, GI				Inhorn, Marcia C.; Serour, Gamal I.			Islam, medicine, and Arab-Muslim refugee health in America after 9/11	LANCET			English	Review							SELF-RATED HEALTH; IMMIGRANTS; CONFLICT; DONATION; DETROIT; NEEDS; CARE	Islam is the world's second largest religion, representing nearly a quarter of the global population. Here, we assess how Islam as a religious system shapes medical practice, and how Muslims view and experience medical care. Islam has generally encouraged the use of science and biomedicine for the alleviation of suffering, with Islamic authorities having a crucial supportive role. Muslim patients are encouraged to seek medical solutions to their health problems. For example, Muslim couples who are infertile throughout the world are permitted to use assisted reproductive technologies. We focus on the USA, assessing how Islamic attitudes toward medicine influence Muslims' engagement with the US health-care system. Nowadays, the Arab Muslim population is one of the fastest growing ethnic-minority populations in the USA. However, since Sept 11, 2001, Arab Muslim patients and particularly the growing Iraqi refugee population face huge challenges in seeking and receiving medical care, including care that is judged to be religiously appropriate. We assess some of the barriers to care-ie, poverty, language, and discrimination. Arab Muslim patients' religious concerns also suggest the need for cultural competence and sensitivity on the part of health-care practitioners. Here, we emphasise how Islamic conventions might affect clinical care, and make recommendations to improve healthcare access and services for Arab Muslim refugees and immigrants, and Muslim patients in general.	[Inhorn, Marcia C.] Yale Univ, Dept Anthropol, New Haven, CT 06520 USA; [Inhorn, Marcia C.] Yale Univ, Council Middle E Studies, New Haven, CT 06520 USA; [Serour, Gamal I.] Al Azhar Univ, Egyptian Vitro Fertilisat & Embryo Transfer Ctr, Int Islam Ctr Populat Studies & Res, Cairo, Egypt	Yale University; Yale University; Egyptian Knowledge Bank (EKB); Al Azhar University	Inhorn, MC (corresponding author), Yale Univ, Dept Anthropol, 10 Sachem St, New Haven, CT 06520 USA.	marcia.inhorn@yale.edu			National Science Foundation; Cultural Anthropology Program; US Department of Education Fulbright-Hays Faculty Abroad Research Program	National Science Foundation(National Science Foundation (NSF)); Cultural Anthropology Program; US Department of Education Fulbright-Hays Faculty Abroad Research Program	The National Science Foundation, Cultural Anthropology Program, and the US Department of Education Fulbright-Hays Faculty Abroad Research Program funded the research on which this report is based. MCI was the principal investigator for both grants, and is grateful to these funding agencies for their generous support. We thank Jennifer DeChello for her bibliographic assistance.	Abbasi-Shavazi MJ., 2008, J MIDDLE E WOMENS ST, V4, P1, DOI [10.2979/MEW.2008.4.2.1, DOI 10.2979/MEW.2008.4.2.1]; Abdulrahim S, 2010, QUAL HEALTH RES, V20, P1229, DOI 10.1177/1049732310371104; Abdulrahim S, 2009, SOC SCI MED, V68, P2097, DOI 10.1016/j.socscimed.2009.04.017; Aboul-Enein Basil H, 2010, J Cult Divers, V17, P20; Abraham N., 2000, ARAB DETROIT MARGIN; ABULFADL ME, 2001, ORGAN TRANSPLANT EUT; Ahmed SR, 2011, AM J COMMUN PSYCHOL, V48, P181, DOI 10.1007/s10464-011-9424-3; Ajrouch KJ, 2007, INT MIGR REV, V41, P860, DOI 10.1111/j.1747-7379.2007.00103.x; Al-Kassimi M, 2003, CLIN MED, V3, P52, DOI 10.7861/clinmedicine.3-1-52; Ali OM, 2005, PSYCHIAT SERV, V56, P202, DOI 10.1176/appi.ps.56.2.202; ASWAD BC, 1999, ARABS AM BUILDING NE, P177; ATIGHETCHI D, 2008, ISLAMIC BIOETHICS PR; AZAIZEH H, 2007, CAM, V7, P419; BAKER W, 2009, CITIZENSHIP CRISIS A; Brockopp Jonathan E., 2008, MUSLIM MED ETHICS TH; Bukhari Z., 2004, MUSLIMS PLACE AM PUB; Clarke M., 2009, ISLAM NEW KINSHIP RE; Clarke M, 2011, INT J MIDDLE E STUD, V43, P409, DOI 10.1017/S0020743811000596; Dallo FJ, 2012, J IMMIGR MINOR HEALT, V14, P236, DOI 10.1007/s10903-011-9441-1; Davidson JE, 2008, CRIT CARE NURS Q, V31, P119, DOI 10.1097/01.CNQ.0000314472.33883.d4; Deeb L, 2006, PRINC STUD MUSLIM PO, P1; Dufoix Stephane, 2008, DIASPORAS; Ebrahim AFM., 2005, J ISLAM STUD, V16, P376, DOI [10.1093/jis/eti160, DOI 10.1093/JIS/ETI160]; Ebrahimnejad H, 2011, BOST STUD PHILOS HIS, V275, P259, DOI 10.1007/978-90-481-9968-6_17; Eich Thomas, 2002, ISIM NEWSLETTER, V12, P38; El-Sayed AM, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-272; ELHAK AGH, 1980, IN VITRO FERTILIZATI, V1225, P3213; GALLAGHER N, 2005, ENCY RELIG, P3831; GURTIN Z, 2012, ISLAM ASSIS IN PRESS; Hamdy S., 2008, MUSLIM MED ETHICS TH, P78; Herrag M, 2010, AFR HEALTH SCI, V10, P215; Howell S, 2003, ANTHROPOL QUART, V76, P443, DOI 10.1353/anq.2003.0040; INBORN MC, 2011, REPROD BIOM IN PRESS; INBORN MC, 2003, LOCAL BABIES GLOBAL; INBORN MC, 2010, GLOBALIZATION MOTHER, P180; INBORN MC, 2006, J SOC AFF, V23, P13; INBORN MC, 1994, QUEST CONCEPTION GEN; Inhorn M. C., 1995, INFERTILITY PATRIARC; Inhorn MC, 2006, CULT MED PSYCHIAT, V30, P427, DOI 10.1007/s11013-006-9027-x; Inhorn MC, 2010, REPROD BIOMED ONLINE, V21, P848, DOI 10.1016/j.rbmo.2010.09.008; Inhorn MC, 2008, MED ANTHROPOL Q, V22, P416, DOI 10.1111/j.1548-1387.2008.00040.x; Inhorn MC, 2009, INT J GYNECOL OBSTET, V106, P172, DOI 10.1016/j.ijgo.2009.03.034; Inhorn Marcia C., 2010, REPROD GLOBALIZATION, P126; Inhorn MarciaC., 2006, J GENDER RACE JUSTIC, V9, P291; Inhorn MC, 2006, FERTIL STERIL, V85, P844, DOI 10.1016/j.fertnstert.2005.10.029; Inhorn MC, 2004, SOC SCI MED, V59, P2095, DOI 10.1016/j.socscimed.2004.03.012; INHORN MC, 2005, ENCY RELIG, P3834; INHORN MC, 2006, CHRON HIGHER EDUC, pB12; INHORN MC, 2012, NEW ARAB MA IN PRESS; INHORN MC, 2012, ISLAM ASSIS IN PRESS; IQBAL M, 2009, FAITH FERTILITY ATTI, P33; Jamal A., 2008, RACE ARAB AM 9 11 IN, DOI [https://doi.org/10.5860/choice.45-7063, DOI 10.5860/CHOICE.45-7063]; Jamil H, 2008, J IMMIGR MINOR HEALT, V10, P397, DOI 10.1007/s10903-007-9108-0; KAZIM F, 2010, ISLAMIC BIOETHICS CR; KLEINMAN A, 1997, WRITING MARGINS DISC; Kleinman A., 1992, QUAL HEALTH RES, V2, P127, DOI [10.1177/104973239200200202, DOI 10.1177/104973239200200202]; Kridli Suha Al-Oballi, 2002, MCN Am J Matern Child Nurs, V27, P178, DOI 10.1097/00005721-200205000-00010; LEONARD KI, 2003, MUSLIMS US STAT RES; LOTFOLIAN M, 2004, ISLAM TECHNOSCIENTIF; Mahmood S, 2005, POLITICS OF PIETY: THE ISLAMIC REVIVAL AND THE FEMINIST SUBJECT, P1; Marvasti Amir B., 2004, MIDDLE E LIVES AM; McLean M, 2010, MED EDUC, V44, P306, DOI 10.1111/j.1365-2923.2009.03599.x; Moazam F., 2006, BIOETHICS ORGAN TRAN; Mohammadi Nooredin, 2007, Int J Nurs Pract, V13, P310, DOI 10.1111/j.1440-172X.2007.00643.x; Moosa Ebrahim, 2003, VOICES BOUNDARIES, P23; Moran M, 2011, GLOB PUBLIC HEALTH, V6, P467, DOI 10.1080/17441692.2011.578581; Mowafi H, 2011, GLOB PUBLIC HEALTH, V6, P472, DOI 10.1080/17441692.2011.570358; MUHAMMAD I, 2009, SAUDI J KIDNEY DIS T, V20, P154; Naber N, 2000, ETHNIC RACIAL STUD, V23, P37, DOI 10.1080/014198700329123; Najmabadi Afsaneh, 2008, WOM STUD Q, V36, P234; Nasir L. S., 2008, CARING ARAB PATIENTS; Padela AI, 2007, BIOETHICS, V21, P169, DOI 10.1111/j.1467-8519.2007.00540.x; Padela AI, 2011, J MED ETHICS, V37, P40, DOI 10.1136/jme.2010.037614; Pew Research Center, 2011, FUT GLOB MUSL POP PR; Pew Research Centre, 2007, MUSL AM MIDDL CLASS; Pew Research Centre, 2009, MAPP GLOB MUSL POP; Rady MY, 2009, HEC FORUM, V21, P175, DOI 10.1007/s10730-009-9095-8; Read JG, 2005, SOC SCI MED, V61, P77, DOI 10.1016/j.socscimed.2004.11.054; SACHEDINA A, 2009, ISLAMIC BIOMEDICAL E; Sajoo Amyn B., 2004, MUSLIM ETHICS EMERGI; Saliba Therese, 1999, ARABS AM BUILDING NE, P304; SANIEI M, 2012, ISLAM ASSIS IN PRESS; Serour GI, 2008, REPROD BIOMED ONLINE, V17, P34, DOI 10.1016/S1472-6483(10)60328-8; Serour G.I., 1996, MIDDLE EAST FERTIL S, V1, P30; SEROUR GI, 1997, ETHICAL IMPLICATIONS; SEROUR GI, 2006, ASSISTED REPROD, P99; SEROUR GI, 1992, ETHICAL GUIDELINES H; SEROUR GI, 2000, ETHICAL IMPLICATIONS; Shah SM, 2008, J IMMIGR MINOR HEALT, V10, P429, DOI 10.1007/s10903-007-9106-2; Shaheen Jack G., 2008, GUILTY HOLLYWOODS VE; Shara NM, 2010, CURR CARDIOVASC RISK, V4, P181, DOI 10.1007/s12170-010-0096-6; SHEPPARD C, 2011, HARD TIME IRAQI REFU; Simpson JL, 2008, J TRANSCULT NURS, V19, P16, DOI 10.1177/1043659607309146; TAPPAN R, 2012, ISLAM ASSIS IN PRESS; Tober DM, 2007, BODY SOC, V13, P151, DOI 10.1177/1357034X07082257; *US CIT IMM SERV, 2009, FACT SHEET IR REF PR; WALBRIDGE LS, 2000, ARAB DETROIT MARGIN, P321; Yacoub AAA, 2001, FIQH MED RESPONSES I; Yosef ARO, 2008, J TRANSCULT NURS, V19, P284, DOI 10.1177/1043659608317450; WHITE HOUSE BLOG	100	53	53	3	47	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 3	2011	378	9794					935	943		10.1016/S0140-6736(11)61041-6	http://dx.doi.org/10.1016/S0140-6736(11)61041-6			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	818XZ	21890058				2022-12-28	WOS:000294791300034
J	Navarrete, M; Araque, A				Navarrete, Marta; Araque, Alfonso			Basal Synaptic Transmission: Astrocytes Rule!	CELL			English	Editorial Material							GLIAL-CELLS; RELEASE	In this issue, Panatier et al. (2011) show that astrocytes detect synaptic activity induced by single action potentials and upregulate basal synaptic transmission through calcium-dependent mechanisms and purinergic signaling. These results demonstrate the relevance of astrocyte calcium in neurophysiology and confirm that astrocytes are actively involved in synaptic function.	[Navarrete, Marta; Araque, Alfonso] CSIC, Inst Cajal, E-28002 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC)	Araque, A (corresponding author), CSIC, Inst Cajal, E-28002 Madrid, Spain.	araque@cajal.csic.es	Navarrete, Marta/E-9266-2013	Navarrete, Marta/0000-0003-2097-4788; Araque, Alfonso/0000-0003-3840-1144				Fiacco TA, 2004, J NEUROSCI, V24, P722, DOI 10.1523/JNEUROSCI.2859-03.2004; Grosche J, 1999, NAT NEUROSCI, V2, P139, DOI 10.1038/5692; Henneberger C, 2010, NATURE, V463, P232, DOI 10.1038/nature08673; Navarrete M, 2010, NEURON, V68, P113, DOI 10.1016/j.neuron.2010.08.043; Panatier A, 2011, CELL, V146, P785, DOI 10.1016/j.cell.2011.07.022; Pascual O, 2005, SCIENCE, V310, P113, DOI 10.1126/science.1116916; Perea G, 2007, SCIENCE, V317, P1083, DOI 10.1126/science.1144640; Perea G, 2009, TRENDS NEUROSCI, V32, P421, DOI 10.1016/j.tins.2009.05.001; Santello M, 2011, NEURON, V69, P988, DOI 10.1016/j.neuron.2011.02.003; Serrano A, 2006, J NEUROSCI, V26, P5370, DOI 10.1523/JNEUROSCI.5255-05.2006	10	17	17	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 2	2011	146	5					675	677		10.1016/j.cell.2011.08.006	http://dx.doi.org/10.1016/j.cell.2011.08.006			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	814SM	21884929	Bronze			2022-12-28	WOS:000294477500008
J	Dhalla, IA; Persaud, N; Juurlink, DN				Dhalla, Irfan A.; Persaud, Navindra; Juurlink, David N.			Facing up to the prescription opioid crisis	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CHRONIC NONCANCER PAIN; PRACTICE GUIDELINE; NONMALIGNANT PAIN; MORTALITY; ANALGESICS; OXYCODONE; DEATHS; SAFETY		[Dhalla, Irfan A.; Juurlink, David N.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Dhalla, Irfan A.; Juurlink, David N.] Univ Toronto, Dept Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Dhalla, Irfan A.] St Michaels Hosp, Dept Med, Toronto, ON M5B 1W8, Canada; [Dhalla, Irfan A.; Persaud, Navindra] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada; [Dhalla, Irfan A.; Juurlink, David N.] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Persaud, Navindra] St Michaels Hosp, Dept Family & Community Med, Toronto, ON M5B 1W8, Canada; [Persaud, Navindra] Univ Toronto, Dept Family & Community Med, Toronto, ON M5S 1A1, Canada; [Juurlink, David N.] Sunnybrook Res Inst, Toronto, ON, Canada	University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Dhalla, IA (corresponding author), 30 Bond St, Toronto, ON M5B 1W8, Canada.	dhallai@smh.ca						Andersen S, 1996, BRIT J CLIN PRACT, V50, P324; [Anonymous], PHARM SALES 2010; Centers for Disease Control and Prevention, 2010, MMWR-MORBID MORTAL W, V59, P1026; Chou R, 2009, J PAIN, V10, P147, DOI 10.1016/j.jpain.2008.10.007; Dhalla IA, 2011, CAN FAM PHYSICIAN, V57, pE92; Dhalla IA, 2009, CAN MED ASSOC J, V181, P891, DOI 10.1503/cmaj.090784; Furlan AD, 2010, CAN MED ASSOC J, V182, P923, DOI 10.1503/cmaj.100187; Gomes T, 2011, ARCH INTERN MED, V171, P686, DOI 10.1001/archinternmed.2011.117; Hawton K, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b2270; Noble M, 2008, J PAIN SYMPTOM MANAG, V35, P214, DOI 10.1016/j.jpainsymman.2007.03.015; Nuesch E., 2009, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD003115.PUB3; Office for National Statistics, DEATHS REL DRUG POIS; Rintoul AC, 2011, INJURY PREV, V17, P254, DOI 10.1136/ip.2010.029611; Solomon DH, 2010, ARCH INTERN MED, V170, P1968, DOI 10.1001/archinternmed.2010.391; SOUMERAI SB, 1990, JAMA-J AM MED ASSOC, V263, P549, DOI 10.1001/jama.263.4.549; Spence D., 2010, BMJ-BRIT MED J, V340, pc2659; United nations, REP INT NARC CONTR B; United States General Accounting Office, 2003, OX AB DIV EFF ADDR P; US Department of Health and Human Services, 2009, WARN LETT EMBEDA MOR; US Department of Health and Human Services, 2004, WARN LETT DUR FENT T; Warner M, 1999, INCREASE FATAL POISO; Zee AV, 2009, AM J PUBLIC HEALTH, V99, P221, DOI 10.2105/AJPH.2007.131714	22	129	129	0	23	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 23	2011	343								d5142	10.1136/bmj.d5142	http://dx.doi.org/10.1136/bmj.d5142			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	813ZK	21862533	Green Submitted			2022-12-28	WOS:000294409600005
J	Shah, AM; Mann, DL				Shah, Ajay M.; Mann, Douglas L.			Heart Failure 1 In search of new therapeutic targets and strategies for heart failure: recent advances in basic science	LANCET			English	Article							MITOCHONDRIAL PERMEABILITY TRANSITION; CARDIAC-HYPERTROPHY; SYSTEMS BIOLOGY; MYOCARDIAL-INFARCTION; ENERGY-METABOLISM; CA2+; CARDIOMYOCYTES; CONTRIBUTES; EXPRESSION; AUTOPHAGY	Chronic heart failure continues to impose a substantial health-care burden, despite recent treatment advances. The key pathophysiological process that ultimately leads to chronic heart failure is cardiac remodelling in response to chronic disease stresses. Here, we review recent advances in our understanding of molecular and cellular mechanisms that play a part in the complex remodelling process, with a focus on key molecules and pathways that might be suitable targets for therapeutic manipulation. Such pathways include those that regulate cardiac myocyte hypertrophy, calcium homoeostasis, energetics, and cell survival, and processes that take place outside the cardiac myocyte-eg, in the myocardial vasculature and extracellular matrix. We also discuss major gaps in our current understanding, take a critical look at conventional approaches to target discovery that have been used to date, and consider new investigational avenues that might accelerate clinically relevant discovery.	[Shah, Ajay M.] Kings Coll London, British Heart Fdn, Ctr Excellence, London SE5 9NU, England; [Mann, Douglas L.] Washington Univ, Sch Med, St Louis, MO USA	University of London; King's College London; University College London; Washington University (WUSTL)	Shah, AM (corresponding author), Kings Coll London, James Black Ctr, Div Cardiovasc, London SE5 9NU, England.	ajay.shah@kcl.ac.uk	Mann, Douglas Lowell/AAQ-3524-2021	Mann, Douglas/0000-0002-2516-0145; Shah, Ajay/0000-0002-6547-0631	British Heart Foundation; Leducq Fondation Transatlantic Network of Excellence; National Institute for Health Research comprehensive Biomedical Research Centre; National Institute of Health [RO1 HL58081, HL73017, HL089543]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089543, R01HL073017, R01HL058081] Funding Source: NIH RePORTER; British Heart Foundation [RG/08/011/25922] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); Leducq Fondation Transatlantic Network of Excellence; National Institute for Health Research comprehensive Biomedical Research Centre(National Institute for Health Research (NIHR)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); British Heart Foundation(British Heart Foundation)	Research in the authors' laboratories is supported by: the British Heart Foundation, a Leducq Fondation Transatlantic Network of Excellence, and National Institute for Health Research comprehensive Biomedical Research Centre funding (AMS); and by the National Institute of Health (DLM [RO1 HL58081, HL73017, HL089543]).	Adams KF, 2010, HEART FAIL REV, V15, P371, DOI 10.1007/s10741-009-9138-x; Azmi AS, 2010, MOL CANCER THER, V9, P3137, DOI 10.1158/1535-7163.MCT-10-0642; Backs J, 2006, CIRC RES, V98, P15, DOI 10.1161/01.RES.0000197782.21444.8f; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Bostrom P, 2010, CELL, V143, P1072, DOI 10.1016/j.cell.2010.11.036; Carvajal-Vergara X, 2010, NATURE, V465, P808, DOI 10.1038/nature09005; Catalucci D, 2008, FRONT BIOSCI-LANDMRK, V13, P312, DOI 10.2741/2681; Choi YH, 2011, CARDIOVASC THER, V29, P2, DOI 10.1111/j.1755-5922.2010.00191.x; Cook SA, 2009, J MOL CELL CARDIOL, V46, P118, DOI 10.1016/j.yjmcc.2008.11.005; Damilano F, 2011, CIRCULATION, V123, P391, DOI 10.1161/CIRCULATIONAHA.110.950543; Del Re DP, 2010, J CLIN INVEST, V120, P3555, DOI 10.1172/JCI43569; Dewey FE, 2011, CURR OPIN CARDIOL, V26, P314, DOI 10.1097/HCO.0b013e328346597d; Diwan A, 2009, J CLIN INVEST, V119, P203, DOI 10.1172/JCI36445; Dixon JA, 2009, CIRC-HEART FAIL, V2, P262, DOI 10.1161/CIRCHEARTFAILURE.108.814459; Dorn GW, 2007, HYPERTENSION, V49, P962, DOI 10.1161/HYPERTENSIONAHA.106.079426; Dorn GW, 2009, CARDIOVASC RES, V81, P465, DOI 10.1093/cvr/cvn243; Dorn GW, 2005, J CLIN INVEST, V115, P527, DOI 10.1172/JCI200524178; Drozdov I, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-557; Efimov IR, 2010, IEEE ENG MED BIO, P5177, DOI 10.1109/IEMBS.2010.5626151; Erickson JR, 2008, CELL, V133, P462, DOI 10.1016/j.cell.2008.02.048; Frey N, 2003, ANNU REV PHYSIOL, V65, P45, DOI 10.1146/annurev.physiol.65.092101.142243; Frey N, 2004, NAT MED, V10, P1336, DOI 10.1038/nm1132; Gautel M, 2008, ADV EXP MED BIOL, V642, P176; George CH, 2008, CARDIOVASC RES, V77, P302, DOI 10.1093/cvr/cvm006; Heineke J, 2006, NAT REV MOL CELL BIO, V7, P589, DOI 10.1038/nrm1983; Heineke J, 2007, J CLIN INVEST, V117, P3198, DOI 10.1172/JCI32573; Heineke J, 2010, NAT MED, V16, P872, DOI 10.1038/nm.2181; Ho D, 2010, HEART FAIL REV, V15, P495, DOI 10.1007/s10741-010-9183-5; Huang ZM, 2011, FRONT BIOSCI, V17, P3057; Hudson MP, 2006, J AM COLL CARDIOL, V48, P15, DOI 10.1016/j.jacc.2006.02.055; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Ingwall JS, 2009, CARDIOVASC RES, V81, P412, DOI 10.1093/cvr/cvn301; Jaski BE, 2009, J CARD FAIL, V15, P171, DOI 10.1016/j.cardfail.2009.01.013; Kawaguchi M, 2011, CIRCULATION, V123, P594, DOI 10.1161/CIRCULATIONAHA.110.982777; Kohlhaas M, 2010, CIRCULATION, V121, P1606, DOI 10.1161/CIRCULATIONAHA.109.914911; Koitabashi N, 2011, J CLIN INVEST, V121, P2301, DOI 10.1172/JCI44824; Kolwicz SC, 2009, TRENDS CARDIOVAS MED, V19, P201, DOI 10.1016/j.tcm.2009.12.005; Kung G, 2011, CIRC RES, V108, P1017, DOI 10.1161/CIRCRESAHA.110.225730; Lamkanfi M, 2011, NAT REV IMMUNOL, V11, P213, DOI 10.1038/nri2936; Latronico MVG, 2011, EXP BIOL MED, V236, P125, DOI 10.1258/ebm.2010.010269; Lehnart SE, 2009, HEART FAIL REV, V14, P213, DOI 10.1007/s10741-009-9146-x; Liu T, 2009, J BIOENERG BIOMEMBR, V41, P127, DOI 10.1007/s10863-009-9216-8; Lompre AM, 2010, CIRCULATION, V121, P822, DOI 10.1161/CIRCULATIONAHA.109.890954; Madrazo JA, 2008, J MOL CELL CARDIOL, V44, P968, DOI 10.1016/j.yjmcc.2008.03.021; Malik FI, 2011, SCIENCE, V331, P1439, DOI 10.1126/science.1200113; Mann DL, 2005, AM J CARDIOL, V95, p9C, DOI 10.1016/j.amjcard.2005.03.007; Mann DL, 2005, CIRCULATION, V111, P2837, DOI 10.1161/CIRCULATIONAHA.104.500546; Mann DL, 2011, CIRC RES, V108, P1133, DOI 10.1161/CIRCRESAHA.110.226936; Martins PAD, 2010, NAT CELL BIOL, V12, P1220, DOI 10.1038/ncb2126; Molkentin JD, 2009, J MOL CELL CARDIOL, V46, P130, DOI 10.1016/j.yjmcc.2008.09.002; Mudd JO, 2008, NATURE, V451, P919, DOI 10.1038/nature06798; Muraski JA, 2007, NAT MED, V13, P1467, DOI 10.1038/nm1671; Nakagawa T, 2005, NATURE, V434, P652, DOI 10.1038/nature03317; Nakai A, 2007, NAT MED, V13, P619, DOI 10.1038/nm1574; Nakayama H, 2007, J CLIN INVEST, V117, P2431, DOI 10.1172/JCI31060; Nicolaou P, 2009, FRONT BIOSCI-LANDMRK, V14, P3571, DOI 10.2741/3472; Nishida K, 2009, CELL DEATH DIFFER, V16, P31, DOI 10.1038/cdd.2008.163; Patterson C, 2007, CIRCULATION, V115, P1456, DOI 10.1161/CIRCULATIONAHA.106.649863; Pokreisz P, 2009, CIRCULATION, V119, P408, DOI 10.1161/CIRCULATIONAHA.108.822072; Prentice H, 2004, TRENDS CARDIOVAS MED, V14, P282, DOI 10.1016/j.tcm.2004.08.001; Roukos DH, 2010, EXPERT REV MOL DIAGN, V10, P33, DOI 10.1586/ERM.09.69; SABBAH HN, 1991, AM J PHYSIOL, V260, pH1379, DOI 10.1152/ajpheart.1991.260.4.H1379; Sano M, 2007, NATURE, V446, P444, DOI 10.1038/nature05602; Santos CXC, 2011, FREE RADICAL BIO MED, V50, P777, DOI 10.1016/j.freeradbiomed.2011.01.003; Shan J, 2010, J CLIN INVEST, V120, P4375, DOI 10.1172/JCI37649; Sharma UC, 2005, J MOL CELL CARDIOL, V38, P425, DOI 10.1016/j.yjmcc.2004.12.016; Shiojima I, 2005, J CLIN INVEST, V115, P2108, DOI 10.1172/JCI24682; Swedberg K, 2010, LANCET, V376, P875, DOI 10.1016/S0140-6736(10)61198-1; Takeda N, 2010, J CLIN INVEST, V120, P254, DOI 10.1172/JCI40295; Takimoto E, 2005, NAT MED, V11, P214, DOI 10.1038/nm1175; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; Tijsen AJ, 2010, CIRC RES, V106, P1035, DOI 10.1161/CIRCRESAHA.110.218297; Topkara VK, 2010, PERS MED, V7, P531, DOI 10.2217/PME.10.44; Trivedi CM, 2007, NAT MED, V13, P324, DOI 10.1038/nm1552; van Rooij E, 2008, CIRC RES, V103, P919, DOI 10.1161/CIRCRESAHA.108.183426; van Rooij E, 2007, SCIENCE, V316, P575, DOI 10.1126/science.1139089; Weinberg EO, 2002, CIRCULATION, V106, P2961, DOI 10.1161/01.CIR.0000038705.69871.D9; Whelan RS, 2010, ANNU REV PHYSIOL, V72, P19, DOI 10.1146/annurev.physiol.010908.163111; Wittopper K, 2010, J CLIN INVEST, V120, P617, DOI 10.1172/JCI40545; Wu X, 2006, J CLIN INVEST, V116, P675, DOI 10.1172/JCI27374; Zampetaki A, 2010, CIRC RES, V107, P810, DOI 10.1161/CIRCRESAHA.110.226357; Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613; Zhang M, 2010, P NATL ACAD SCI USA, V107, P18121, DOI 10.1073/pnas.1009700107; Zhu HX, 2007, J CLIN INVEST, V117, P1782, DOI 10.1172/JCI27523	84	210	247	0	33	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 20	2011	378	9792					704	712		10.1016/S0140-6736(11)60894-5	http://dx.doi.org/10.1016/S0140-6736(11)60894-5			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	815EW	21856484	Green Accepted			2022-12-28	WOS:000294509900030
J	Li, FB; Ravetch, JV				Li, Fubin; Ravetch, Jeffrey V.			Inhibitory Fc gamma Receptor Engagement Drives Adjuvant and Anti-Tumor Activities of Agonistic CD40 Antibodies	SCIENCE			English	Article							MONOCLONAL-ANTIBODY; IN-VIVO; BREAST-CANCER; CELLS; POLYMORPHISMS; TRASTUZUMAB; LYMPHOMA; EFFICACY; THERAPY; BINDING	CD40, a member of the tumor necrosis factor receptor (TNFR) superfamily, is expressed on antigen-presenting cells (APCs) and is essential for immune activation. Although agonistic CD40 antibodies have been developed for immunotherapy, their clinical efficacy has been limited. We have found that coengagement of the Fc domain of agonistic CD40 monoclonal antibodies (mAbs) with the inhibitory Fc gamma receptor Fc gamma RIIB is required for immune activation. Direct comparison of mAbs to CD40 enhanced for activating Fc gamma R binding, hence capable of cytotoxicity, or for inhibitory Fc gamma RIIB binding, revealed that enhancing Fc gamma RIIB binding conferred immunostimulatory activity and considerably greater anti-tumor responses. This unexpected requirement for Fc gamma RIIB in enhancing CD40-mediated immune activation has direct implications for the design of agonistic antibodies to TNFR as therapeutics.	[Li, Fubin; Ravetch, Jeffrey V.] Rockefeller Univ, Lab Mol Genet & Immunol, New York, NY 10065 USA	Rockefeller University	Ravetch, JV (corresponding author), Rockefeller Univ, Lab Mol Genet & Immunol, New York, NY 10065 USA.	ravetch@rockefeller.edu	Ravetch, Jeffrey/Z-1596-2019; Li, Fubin/H-1285-2012	Ravetch, Jeffrey/0000-0003-2024-9041; 	NIH; Paralyzed Veterans of America research foundation [2757]; NATIONAL CANCER INSTITUTE [R01CA080757] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI051573] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Paralyzed Veterans of America research foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank R. Anthony, A. Pincetic, and S. Bournazos for helpful discussion and comments on the manuscript; M. Nussenzweig, D. Robbiani, and S. Deroubaix for kindly providing B6BL cells; and P. Smith, B. Wang, L. Bozzacco, A. Kamphorst, K. Horiuchi, R. Peraza M. Kibe, I. Londono J. Carroll, J. Brown, and T. Shabaneh for excellent technical support. This work was performed with support from NIH grants to J. V. R. F. L. is supported in part by grant no. 2757 from the Paralyzed Veterans of America research foundation. J. V. R. is a paid consultant and member of the Scientific Advisory Board of Xencor, Inc. A patent has been filed (application no. 61424996) "Modulating adjuvant effect of agonistic TNFR monoclonal antibodies," which relates to modified antibodies, and associated methods and compositions, that both engage a receptor from the TNFR superfamily and enhance its ability to stimulate natural immunological responsiveness through coengagement of the inhibitory Fc receptor FcRIIB. The listed inventors are F.L. and J.V.R.	Beatty GL, 2011, SCIENCE, V331, P1612, DOI 10.1126/science.1198443; Bonifaz LC, 2004, J EXP MED, V199, P815, DOI 10.1084/jem.20032220; Cartron G, 2002, BLOOD, V99, P754, DOI 10.1182/blood.V99.3.754; Chu SY, 2008, MOL IMMUNOL, V45, P3926, DOI 10.1016/j.molimm.2008.06.027; Chuntharapai A, 2001, J IMMUNOL, V166, P4891, DOI 10.4049/jimmunol.166.8.4891; Clynes RA, 2000, NAT MED, V6, P443, DOI 10.1038/74704; HEATH AW, 1994, EUR J IMMUNOL, V24, P1828, DOI 10.1002/eji.1830240816; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Horton HM, 2011, J IMMUNOL, V186, P4223, DOI 10.4049/jimmunol.1003412; McKenzie SE, 1999, J IMMUNOL, V162, P4311; Musolino A, 2008, J CLIN ONCOL, V26, P1789, DOI 10.1200/JCO.2007.14.8957; Nimmerjahn F, 2005, SCIENCE, V310, P1510, DOI 10.1126/science.1118948; Nimmerjahn F, 2005, IMMUNITY, V23, P41, DOI 10.1016/j.immuni.2005.05.010; Nimmerjahn F, 2008, NAT REV IMMUNOL, V8, P34, DOI 10.1038/nri2206; Robbiani DF, 2009, MOL CELL, V36, P631, DOI 10.1016/j.molcel.2009.11.007; Shields RL, 2001, J BIOL CHEM, V276, P6591, DOI 10.1074/jbc.M009483200; Suntharalingam G, 2006, NEW ENGL J MED, V355, P1018, DOI 10.1056/NEJMoa063842; Tamura K, 2011, ANN ONCOL, V22, P1302, DOI 10.1093/annonc/mdq585; Wilson NS, 2011, CANCER CELL, V19, P101, DOI 10.1016/j.ccr.2010.11.012; Xu YY, 2003, J IMMUNOL, V171, P562, DOI 10.4049/jimmunol.171.2.562; Zhang ML, 2006, BLOOD, V108, P705, DOI 10.1182/blood-2005-11-4607	22	238	324	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 19	2011	333	6045					1030	1034		10.1126/science.1206954	http://dx.doi.org/10.1126/science.1206954			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808TD	21852502	Green Accepted			2022-12-28	WOS:000294000400059
J	Magidson, V; O'Connell, CB; Loncarek, J; Paul, R; Mogilner, A; Khodjakov, A				Magidson, Valentin; O'Connell, Christopher B.; Loncarek, Jadranka; Paul, Raja; Mogilner, Alex; Khodjakov, Alexey			The Spatial Arrangement of Chromosomes during Prometaphase Facilitates Spindle Assembly	CELL			English	Article							EGG EXTRACT SPINDLES; NEWT LUNG-CELLS; MITOTIC-SPINDLE; MICROTUBULE ATTACHMENT; ELECTRON-MICROSCOPY; CHROMOKINESIN KID; METAPHASE PLATE; MITOSIS; CONGRESSION; KINETOCHORES	Error-free chromosome segregation requires stable attachment of sister kinetochores to the opposite spindle poles (amphitelic attachment). Exactly how amphitelic attachments are achieved during spindle assembly remains elusive. We employed photoactivatable GFP and high-resolution live-cell confocal microscopy to visualize complete 3D movements of individual kinetochores throughout mitosis in non-transformed human cells. Combined with electron microscopy, molecular perturbations, and immunofluorescence analyses, this approach reveals unexpected details of chromosome behavior. Our data demonstrate that unstable lateral interactions between kinetochores and microtubules dominate during early prometaphase. These transient interactions lead to the reproducible arrangement of chromosomes in an equatorial ring on the surface of the nascent spindle. A computational model predicts that this toroidal distribution of chromosomes exposes kinetochores to a high density of microtubules which facilitates subsequent formation of amphitelic attachments. Thus, spindle formation involves a previously overlooked stage of chromosome prepositioning which promotes formation of amphitelic attachments.	[Magidson, Valentin; O'Connell, Christopher B.; Loncarek, Jadranka; Khodjakov, Alexey] New York State Dept Hlth, Wadsworth Ctr, Albany, NY 12201 USA; [Paul, Raja; Mogilner, Alex] Univ Calif Davis, Dept Math, Davis, CA 95616 USA; [Paul, Raja; Mogilner, Alex] Univ Calif Davis, Dept Neurobiol Physiol & Behav, Davis, CA 95616 USA; [Khodjakov, Alexey] Rensselaer Polytech Inst, Troy, NY 12180 USA	State University of New York (SUNY) System; Wadsworth Center; University of California System; University of California Davis; University of California System; University of California Davis; Rensselaer Polytechnic Institute	Khodjakov, A (corresponding author), New York State Dept Hlth, Wadsworth Ctr, Albany, NY 12201 USA.	khodj@wadsworth.org		Magidson, Valentin/0000-0002-0780-9123; Loncarek, Jadranka/0000-0003-1879-5473	NIH [GM059363, GM068952]; Kirschstein National Research Service Award [GM077911]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059363, R01GM068952, F32GM077911] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grants GM059363 (A. K.) and GM068952 (A. M.) and a Kirschstein National Research Service Award GM077911 to C.B.O. We acknowledge use of the Wadsworth Center's electron microscopy core facility and the Ordway Research Institute's Flow Cytometry Core. A special thanks to Dr. Duane Compton (Dartmouth Medical School) for his generous donation of anti-KID serum. V. M., C.B.O., and A. K. designed the experiments. V. M., C.B.O., and J.L. performed the experiments. R. P. and A. M. developed the computational model. V. M. designed the MatLab tools to visualize and numerically analyze kinetochore/centrosome trajectories. All authors analyzed and interpreted the data. The manuscript was written primarily by C.B.O. and A. K. with significant input from V. M. and other authors.	Allison DC, 1999, J CELL BIOL, V145, P1, DOI 10.1083/jcb.145.1.1; Bakhoum SF, 2009, CURR BIOL, V19, P1937, DOI 10.1016/j.cub.2009.09.055; Blangy A, 1995, CELL, V83, P1159, DOI 10.1016/0092-8674(95)90142-6; Cahu J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003936; Cai S, 2009, NAT CELL BIOL, V11, P832, DOI 10.1038/ncb1890; CHALY N, 1988, J CELL SCI, V91, P325; DeLuca JG, 2002, J CELL BIOL, V159, P549, DOI 10.1083/jcb.200208159; DeLuca JG, 2005, MOL BIOL CELL, V16, P519, DOI 10.1091/mbc.E04-09-0852; Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; Goshima G, 2005, MOL BIOL CELL, V16, P3896, DOI 10.1091/mbc.E05-02-0118; Jaqaman K, 2010, J CELL BIOL, V188, P665, DOI 10.1083/jcb.200909005; Kapitein LC, 2005, NATURE, V435, P114, DOI 10.1038/nature03503; Kapoor TM, 2006, SCIENCE, V311, P388, DOI 10.1126/science.1122142; Khodjakov A, 1999, CELL MOTIL CYTOSKEL, V43, P179, DOI 10.1002/(SICI)1097-0169(1999)43:3<179::AID-CM1>3.3.CO;2-W; KIRSCHNER M, 1986, CELL, V45, P329, DOI 10.1016/0092-8674(86)90318-1; Kitajima TS, 2011, CELL, V146, P568, DOI 10.1016/j.cell.2011.07.031; Lenart P, 2005, NATURE, V436, P812, DOI 10.1038/nature03810; Levesque AA, 2001, J CELL BIOL, V154, P1135, DOI 10.1083/jcb.200106093; MAGIDSON V, 2007, LASER MANIPULATIONS, P237; Maresca TJ, 2010, J CELL SCI, V123, P825, DOI 10.1242/jcs.064790; MOLEBAJER J, 1975, CYTOBIOS, V13, P117; MOSGOLLER W, 1991, HUM GENET, V88, P27, DOI 10.1007/BF00204924; NAGELE R, 1995, SCIENCE, V270, P1831, DOI 10.1126/science.270.5243.1831; Nezi LG, 2009, CURR OPIN CELL BIOL, V21, P785, DOI 10.1016/j.ceb.2009.09.007; O'Connell CB, 2009, J CELL BIOL, V187, P43, DOI 10.1083/jcb.200903076; Paul R, 2009, P NATL ACAD SCI USA, V106, P15708, DOI 10.1073/pnas.0908261106; RIEDER CL, 1990, J CELL BIOL, V110, P81, DOI 10.1083/jcb.110.1.81; Rieder CL, 1999, METHOD CELL BIOL, V61, P297; RIEDER CL, 1994, J CELL BIOL, V124, P223, DOI 10.1083/jcb.124.3.223; RIEDER CL, 1986, J CELL BIOL, V103, P581, DOI 10.1083/jcb.103.2.581; ROOS UP, 1973, CHROMOSOMA, V40, P43, DOI 10.1007/BF00319836; Rosenblatt J, 2005, NAT CELL BIOL, V7, P219, DOI 10.1038/ncb0305-219; Silkworth WT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006564; SKIBBENS RV, 1993, J CELL BIOL, V122, P859, DOI 10.1083/jcb.122.4.859; Stumpff J, 2008, DEV CELL, V14, P252, DOI 10.1016/j.devcel.2007.11.014; Tokai N, 1996, EMBO J, V15, P457, DOI 10.1002/j.1460-2075.1996.tb00378.x; Tokai-Nishizumi N, 2005, MOL BIOL CELL, V16, P5455, DOI 10.1091/mbc.E05-03-0244; Toso A, 2009, J CELL BIOL, V184, P365, DOI 10.1083/jcb.200809055; Uetake Y, 2010, CURR BIOL, V20, P1666, DOI 10.1016/j.cub.2010.08.018; Uteng M, 2008, J CELL BIOL, V182, P715, DOI 10.1083/jcb.200801125; Walczak CE, 2010, NAT REV MOL CELL BIO, V11, P91, DOI 10.1038/nrm2832; Whitehead CM, 1996, CELL MOTIL CYTOSKEL, V35, P298, DOI 10.1002/(SICI)1097-0169(1996)35:4<298::AID-CM3>3.0.CO;2-3; Wollman R, 2005, CURR BIOL, V15, P828, DOI 10.1016/j.cub.2005.03.019; Yang Z, 2008, NAT CELL BIOL, V10, P748, DOI 10.1038/ncb1738	44	210	211	0	38	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 19	2011	146	4					555	567		10.1016/j.cell.2011.07.012	http://dx.doi.org/10.1016/j.cell.2011.07.012			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	809HY	21854981	Green Accepted, Bronze			2022-12-28	WOS:000294043600011
J	Chillag, SA; Greenberg, S				Chillag, Shawn A.; Greenberg, Stephen			An Unusual Cause of Trigger Finger	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Chillag, Shawn A.; Greenberg, Stephen] Univ S Carolina, Columbia, SC 29208 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Chillag, SA (corresponding author), Univ S Carolina, Columbia, SC 29208 USA.	shawn.chillag@uscmed.sc.edu							0	1	1	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 18	2011	365	7					E14	E14		10.1056/NEJMicm1012468	http://dx.doi.org/10.1056/NEJMicm1012468			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	808ER	21848455				2022-12-28	WOS:000293960500013
J	Ramos-Casals, M; Stone, JH; Cid, MC; Bosch, X				Ramos-Casals, Manuel; Stone, John H.; Cid, Maria C.; Bosch, Xavier			The cryoglobulinaemias	LANCET			English	Article							HEPATITIS-C VIRUS; MONOCLONAL-ANTIBODY TREATMENT; SYSTEMIC-LUPUS-ERYTHEMATOSUS; B-CELL-PROLIFERATION; MIXED CRYOGLOBULINEMIA; INTERFERON-ALPHA; PERIPHERAL NEUROPATHY; CLINICAL-SIGNIFICANCE; MORPHOLOGIC SPECTRUM; VIROLOGICAL RESPONSE	Cryoglobulins are immunoglobulins that precipitate in vitro at temperatures less than 37 degrees C and produce organ damage through two main pathways: vascular sludging (hyperviscosity syndrome, mainly in type I cryoglobulinaemia) and immune-mediated mechanisms (principally vasculitis, in mixed cryoglobulinaemia). Cryoglobulinaemia is associated with many illnesses, which can be broadly grouped into infections, autoimmune disorders, and malignancies; the most common cause is infection with hepatitis C virus. Mixed cryoglobulinaemic syndrome is diagnosed when a patient has typical organ involvement (mainly skin, kidney, or peripheral nerve) and circulating cryoglobulins. Cutaneous purpura is the most common manifestation of cryoglobulinaemic vasculitis. The most frequently affected internal organs are the peripheral nerves, kidneys, and joints. The course varies widely and prognosis is influenced by both cryoglobulinaemic damage to vital organs and by comorbidities associated with underlying diseases. More than 90% of cases of cryoglobulinaemia have a known underlying cause; therefore treatment is focused on the cause of the disorder rather than merely symptomatic relief. Studies suggest that both combined or sequential antiviral therapies and targeted biological treatments might be more effective than monotherapy.	[Bosch, Xavier] Univ Barcelona, Inst Invest Biomed August Pi & Sunyer, Hosp Clin, Dept Internal Med,Inst Clin Med Dermatol 1, E-08036 Barcelona, Spain; [Ramos-Casals, Manuel] Univ Barcelona, Inst Invest Biomed August Pi & Sunyer, Josep Font Lab Autoimmune Dis, Hosp Clin,Inst Clin Med Dermatol 1, E-08036 Barcelona, Spain; [Cid, Maria C.] Univ Barcelona, Inst Invest Biomed August Pi & Sunyer, Dept Autoimmune Dis, Vasculitis Res Unit,Hosp Clin,Inst Clin Med Derma, E-08036 Barcelona, Spain; [Stone, John H.] Massachusetts Gen Hosp, Rheumatol Unit, Boston, MA 02114 USA	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Harvard University; Massachusetts General Hospital	Bosch, X (corresponding author), Univ Barcelona, Inst Invest Biomed August Pi & Sunyer, Hosp Clin, Dept Internal Med,Inst Clin Med Dermatol 1, E-08036 Barcelona, Spain.	xavbosch@clinic.ub.es	Cid, Maria C./J-4553-2016; Franzeck, Fabian C/B-5055-2011	Cid, Maria C./0000-0002-4730-0938; Ramos-Casals, Manuel/0000-0001-5709-6734	Centocor; Bristol-Myers Squibb; Roche; Genentech	Centocor; Bristol-Myers Squibb(Bristol-Myers Squibb); Roche(Roche Holding); Genentech(Roche HoldingGenentech)	MCC has received consultancy fees, research grants and speaker's fees from Centocor; and speaker's fees from Bristol-Myers Squibb and Roche. JS has received consultancy fees from Genentech. XB and MR-C declare that they have no conflicts of interest.	Adinolfi LE, 1996, ITAL J GASTROENTEROL, V28, P1; Alpers CE, 2008, CURR OPIN NEPHROL HY, V17, P243, DOI 10.1097/MNH.0b013e3282f8afe2; Amital H, 2005, CLIN EXP RHEUMATOL, V23, P616; Antonelli A, 2004, QJM-INT J MED, V97, P499, DOI 10.1093/qjmed/hch088; Antonelli A, 2004, RHEUMATOLOGY, V43, P238, DOI 10.1093/rheumatology/keh011; Baimpa E, 2009, MEDICINE, V88, P284, DOI 10.1097/MD.0b013e3181b76ab5; Bakker AJ, 2003, CLIN CHEM LAB MED, V41, P85, DOI 10.1515/CCLM.2003.015; BAMBARA LM, 1991, CLIN EXP RHEUMATOL, V9, P96; Basse G, 2006, CLIN NEPHROL, V66, P395; Basu N, 2010, ANN RHEUM DIS, V69, P1744, DOI 10.1136/ard.2009.119032; Beddhu S, 2002, MEDICINE, V81, P398, DOI 10.1097/00005792-200209000-00005; Bonnet F, 2003, J RHEUMATOL, V30, P2005; Brito-Zeron P, 2007, RHEUMATOLOGY, V46, P1359, DOI 10.1093/rheumatology/kem079; BROUET JC, 1974, AM J MED, V57, P775, DOI 10.1016/0002-9343(74)90852-3; Bryce AH, 2006, AM J HEMATOL, V81, P511, DOI 10.1002/ajh.20643; Cacoub P, 2005, ARTHRITIS RHEUM-US, V52, P911, DOI 10.1002/art.20958; Casato M, 2003, J VIRAL HEPATITIS, V10, P455, DOI 10.1046/j.1365-2893.2003.00462.x; Charles ED, 2008, BLOOD, V111, P1344, DOI 10.1182/blood-2007-07-101717; CHEN PP, 1988, SPRINGER SEMIN IMMUN, V10, P35, DOI 10.1007/BF02054022; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; Cid MC, 1999, ARTHRITIS RHEUM-US, V42, P1051, DOI 10.1002/1529-0131(199905)42:5<1051::AID-ANR26>3.0.CO;2-Q; Cohen P, 1997, CLIN EXP RHEUMATOL, V15, P523; D'Amico G, 1998, KIDNEY INT, V54, P650, DOI 10.1046/j.1523-1755.1998.00028.x; Dammacco F, 2010, BLOOD, V116, P343, DOI 10.1182/blood-2009-10-245878; Dammacco Franco, 2007, Dig Liver Dis, V39 Suppl 1, pS8, DOI 10.1016/S1590-8658(07)80004-1; De Vita S, 2011, ANN RHEUM DIS, V70, P1183, DOI 10.1136/ard.2011.150755; De Vita S, 2010, ARTHRITIS RHEUM-US, V62, P908, DOI 10.1002/art.27310; Della Rossa A, 2003, SEMIN THROMB HEMOST, V29, P473; Della Rossa A, 2010, SCAND J RHEUMATOL, V39, P167, DOI 10.3109/03009740903313639; Dimitrakopoulos AN, 1999, ANN INTERN MED, V130, P226, DOI 10.7326/0003-4819-130-3-199902020-00027; Fabris P, 2003, J MED VIROL, V69, P339, DOI 10.1002/jmv.10294; Feld JJ, 2005, NATURE, V436, P967, DOI 10.1038/nature04082; Ferri C, 2006, CURR OPIN RHEUMATOL, V18, P54; Ferri C, 2004, SEMIN ARTHRITIS RHEU, V33, P355, DOI 10.1016/j.semarthrit.2003.10.001; Ferri C, 1997, BRIT J RHEUMATOL, V36, P360; FERRI C, 1991, CLIN EXP RHEUMATOL, V9, P621; FERRI C, 1991, ARTHRITIS RHEUM, V34, P1606; Ferri C, 2008, ORPHANET J RARE DIS, V3, DOI 10.1186/1750-1172-3-25; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Garcia-Carrasco M, 2001, SEMIN ARTHRITIS RHEU, V30, P366, DOI 10.1053/sarh.2001.20265; Gea-Banacloche JC, 2010, SEMIN HEMATOL, V47, P187, DOI 10.1053/j.seminhematol.2010.01.002; Gemignani F, 2002, J PERIPHER NERV SYST, V7, P59, DOI 10.1046/j.1529-8027.2002.02007.x; Geri G, 2010, ANN RHEUM DIS, V69, P2177, DOI 10.1136/ard.2010.132001; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Giordano TP, 2007, JAMA-J AM MED ASSOC, V297, P2010, DOI 10.1001/jama.297.18.2010; Gish RG, 2007, J HEPATOL, V47, P51, DOI 10.1016/j.jhep.2007.02.018; Gopalani A, 2001, AM J MED SCI, V322, P57, DOI 10.1097/00000441-200108000-00001; Gordon ACH, 1998, J INFECTION, V36, P229, DOI 10.1016/S0163-4453(98)80022-4; Hadziyannis SJ, 2004, ANN INTERN MED, V140, P346, DOI 10.7326/0003-4819-140-5-200403020-00010; Hezode C, 2009, NEW ENGL J MED, V360, P1839, DOI 10.1056/NEJMoa0807650; HIESSE C, 1989, AM J NEPHROL, V9, P150, DOI 10.1159/000167955; Joshi S, 2007, DIGEST DIS SCI, V52, P2410, DOI 10.1007/s10620-006-9355-2; Kayali Z, 2002, HEPATOLOGY, V36, P978, DOI 10.1053/jhep.2002.35620; Knight GB, 2010, ARTHRITIS RHEUM-US, V62, P2152, DOI 10.1002/art.27490; Kosmas N, 2006, J MED VIROL, V78, P1257, DOI 10.1002/jmv.20695; LaCivita L, 1995, ARTHRITIS RHEUM, V38, P1859; Lamprecht P, 2003, ANN RHEUM DIS, V62, P1230, DOI 10.1136/ard.2002.004929; Landau DA, 2008, ARTHRITIS RHEUM-US, V58, P604, DOI 10.1002/art.23305; Landau DA, 2010, J RHEUMATOL, V37, P615, DOI 10.3899/jrheum.090790; LERNER AB, 1947, AM J MED SCI, V214, P410, DOI 10.1097/00000441-194710000-00009; LUNEL F, 1994, GASTROENTEROLOGY, V106, P1291, DOI 10.1016/0016-5085(94)90022-1; MAIRE MA, 1989, AUTOIMMUNITY, V2, P155, DOI 10.3109/08916938909019952; Matignon M, 2009, MEDICINE, V88, P341, DOI 10.1097/MD.0b013e3181c1750f; McColl MD, 1997, LEUKEMIA LYMPHOMA, V26, P127, DOI 10.3109/10428199709109167; McHutchinson J, 2007, HEPATOLOGY, V46, P1317; MELTZER M, 1966, AM J MED, V40, P828, DOI 10.1016/0002-9343(66)90199-9; Menke M. N., 2007, CLIN MALIGNANT HEMAT, P937; Mizuochi T, 2001, BLOOD, V97, P3537, DOI 10.1182/blood.V97.11.3537; Monti G, 2005, ARCH INTERN MED, V165, P101, DOI 10.1001/archinte.165.1.101; Monti G, 2007, Dig Liver Dis, V39 Suppl 1, pS112, DOI 10.1016/S1590-8658(07)80022-3; Monti G, 1995, CLIN EXP RHEUMATOL, V13, pS129; Morgello S, 2005, SEMIN LIVER DIS, V25, P118, DOI 10.1055/s-2005-864787; Nelson DR, 2009, CLIN GASTROENTEROL H, V7, P212, DOI 10.1016/j.cgh.2008.10.035; Nemni R, 2003, J NEUROL NEUROSUR PS, V74, P1267, DOI 10.1136/jnnp.74.9.1267; Perlemuter G, 2003, J RHEUMATOL, V30, P1473; Persico M, 2003, AM J GASTROENTEROL, V98, P884, DOI 10.1016/S0002-9270(03)00003-0; Petrarca A, 2010, BLOOD, V116, P335, DOI 10.1182/blood-2009-11-253948; Pileri P, 1998, SCIENCE, V282, P938, DOI 10.1126/science.282.5390.938; Pioltelli P, 1995, CLIN EXP RHEUMATOL, V13, pS187; Poynard T, 2002, J VIRAL HEPATITIS, V9, P295, DOI 10.1046/j.1365-2893.2002.00364.x; Quartuccio L, 2007, RHEUMATOLOGY, V46, P1657, DOI 10.1093/rheumatology/kem209; Quartuccio L, 2006, RHEUMATOLOGY, V45, P842, DOI 10.1093/rheumatology/kel004; Ramos-Casals M, 2007, J VIRAL HEPATITIS, V14, P736, DOI 10.1111/j.1365-2893.2007.00866.x; Ramos-Casals M, 2005, LUPUS, V14, pS64, DOI 10.1191/0961203305lu2122oa; Ramos-Casals M, 2005, MEDICINE, V84, P81, DOI 10.1097/01.md.0000157397.30055.c9; Ramos-Casals M, 2005, AUTOIMMUN REV, V4, P8, DOI 10.1016/j.autrev.2004.04.004; Ramos-Casals M, 2004, J RHEUMATOL, V31, P495; Ramos-Casals M, 2000, LUPUS, V9, P83, DOI 10.1191/096120300678828127; Ramos-Casals M, 2006, SEMIN ARTHRITIS RHEU, V36, P189, DOI 10.1016/j.semarthrit.2006.08.005; Retamozo S, 2011, AUTOIMMUNE DISEASES: ACUTE AND COMPLEX SITUATIONS, P133, DOI 10.1007/978-0-85729-358-9_10; Rieu V, 2002, RHEUMATOLOGY, V41, P290, DOI 10.1093/rheumatology/41.3.290; Roccatello D, 2004, NEPHROL DIAL TRANSPL, V19, P3054, DOI 10.1093/ndt/gfh469; Roccatello D, 2007, AM J KIDNEY DIS, V49, P69, DOI 10.1053/j.ajkd.2006.09.015; Rosa D, 2005, P NATL ACAD SCI USA, V102, P18544, DOI 10.1073/pnas.0509402102; Russo MW, 2003, GASTROENTEROLOGY, V124, P1711, DOI 10.1016/S0016-5085(03)00394-9; Saadoun D, 2007, RHEUMATOLOGY, V46, P1234, DOI 10.1093/rheumatology/kem132; Saadoun D, 2008, BLOOD, V111, P5334, DOI 10.1182/blood-2007-11-122713; Saadoun D, 2008, CURR OPIN RHEUMATOL, V20, P23, DOI 10.1097/BOR.0b013e3282f1330c; Saadoun D, 2006, ARTHRITIS RHEUM-US, V54, P3696, DOI 10.1002/art.22168; Saadoun D, 2006, ARCH INTERN MED, V166, P2101, DOI 10.1001/archinte.166.19.2101; Saadoun D, 2010, BLOOD, V116, P326, DOI 10.1182/blood-2009-10-248518; Saccardo E, 2007, Dig Liver Dis, V39 Suppl 1, pS52; Safadi R, 1997, AM J GASTROENTEROL, V92, P710; Sansonno D, 2007, RHEUMATOLOGY, V46, P572, DOI 10.1093/rheumatology/kel425; Sansonno D, 2003, BLOOD, V101, P3818, DOI 10.1182/blood-2002-10-3162; Sansonno D, 2005, LANCET INFECT DIS, V5, P227, DOI 10.1016/S1473-3099(05)70053-0; Sansonno D, 1997, HEPATOLOGY, V25, P1237, DOI 10.1002/hep.510250529; Sansonno D, 2004, EUR J IMMUNOL, V34, P126, DOI 10.1002/eji.200324328; Sansonno D, 2003, CLIN EXP IMMUNOL, V133, P275, DOI 10.1046/j.1365-2249.2003.02204.x; SANSONNO D, 1995, HEPATOLOGY, V21, P305; Sansonno D, 2009, J IMMUNOL, V183, P6013, DOI 10.4049/jimmunol.0902038; Santoro L, 2006, J NEUROL NEUROSUR PS, V77, P626, DOI 10.1136/jnnp.2005.081570; Sargur R, 2010, ANN CLIN BIOCHEM, V47, P8, DOI 10.1258/acb.2009.009180; Sene D, 2007, RHEUMATOLOGY, V46, P65, DOI 10.1093/rheumatology/kel177; Sene D, 2004, J RHEUMATOL, V31, P2199; Sene D, 2009, ARTHRITIS RHEUM-US, V60, P3848, DOI 10.1002/art.25000; Shihabi ZK, 1996, ELECTROPHORESIS, V17, P1607, DOI 10.1002/elps.1150171020; Spizzo G, 2010, BRIT J HAEMATOL, V150, P235, DOI 10.1111/j.1365-2141.2010.08184.x; Sumida K, 2010, CLIN NEPHROL, V74, P446, DOI 10.2379/CN106395; Taieb G, 2010, REV NEUROL-FRANCE, V166, P509, DOI 10.1016/j.neurol.2009.10.019; Talamo G, 2008, AM J HEMATOL, V83, P883, DOI 10.1002/ajh.21258; TARANTINO A, 1995, KIDNEY INT, V47, P618, DOI 10.1038/ki.1995.78; Tedeschi A, 2007, BLOOD REV, V21, P183, DOI 10.1016/j.blre.2006.12.002; Terrier B, 2010, ARTHRIT CARE RES, V62, P1787, DOI 10.1002/acr.20318; Terrier B, 2010, GUT, V59, P1709, DOI 10.1136/gut.2010.218123; TISSOT JD, 1994, J IMMUNOL METHODS, V173, P63, DOI 10.1016/0022-1759(94)90284-4; Trejo O, 2001, MEDICINE, V80, P252, DOI 10.1097/00005792-200107000-00004; Trejo O, 2003, SEMIN ARTHRITIS RHEU, V33, P19, DOI 10.1053/sarh.2003.50020; Trendelenburg M, 1998, ANN RHEUM DIS, V57, P3, DOI 10.1136/ard.57.1.3; Treon SP, 2009, BLOOD, V114, P2375, DOI 10.1182/blood-2009-05-174359; Tzioufas AG, 1996, ARTHRITIS RHEUM, V39, P767, DOI 10.1002/art.1780390508; Vallat J M, 1981, Acta Neuropathol Suppl, V7, P252; VALLAT JM, 1980, ANN NEUROL, V8, P179, DOI 10.1002/ana.410080208; Vassilopoulos D, 2002, ARTHRITIS RHEUM-US, V46, P585, DOI 10.1002/art.10107; Vermeersch P, 2008, CLIN CHEM, V54, P39, DOI 10.1373/clinchem.2007.090134; Vidaller A, 1999, MED CLIN-BARCELONA, V112, P470; VITALI C, 1994, BRIT J RHEUMATOL, V33, P791; Wener MH, 2004, ARTHRITIS RHEUM-US, V50, P2305, DOI 10.1002/art.20355; Wintrobe MM, 1933, B JOHNS HOPKINS HOSP, V52, P156; Zaja F, 2003, BLOOD, V101, P3827, DOI 10.1182/blood-2002-09-2856; Zignego AL, 2007, DIGEST LIVER DIS, V39, P2, DOI 10.1016/j.dld.2006.06.008	141	312	351	1	16	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 28	2012	379	9813					348	360		10.1016/S0140-6736(11)60242-0	http://dx.doi.org/10.1016/S0140-6736(11)60242-0			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	889BA	21868085				2022-12-28	WOS:000300047300042
J	Gaziano, TA				Gaziano, Thomas A.			Accurate hypertension diagnosis is key in efficient control	LANCET			English	Editorial Material							GUIDELINES; DISEASE		Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital	Gaziano, TA (corresponding author), Brigham & Womens Hosp, Div Cardiovasc, 75 Francis St, Boston, MA 02115 USA.	tgaziano@partners.org						Danaei G, 2011, LANCET, V377, P568, DOI 10.1016/S0140-6736(10)62036-3; Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935; Gaziano TA, 2005, CIRCULATION, V112, P3569, DOI 10.1161/CIRCULATIONAHA.105.535922; Lawes CMM, 2008, LANCET, V371, P1513, DOI 10.1016/S0140-6736(08)60655-8; Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P1, DOI 10.1596/978-0-8213-6262-4; Lovibond K, 2011, LANCET, V378, P1219, DOI 10.1016/S0140-6736(11)61184-7; Williams B, 2004, J HUM HYPERTENS, V18, P139, DOI 10.1038/sj.jhh.1001683; Wolf-Maier K, 2004, HYPERTENSION, V43, P10, DOI 10.1161/01.HYP.0000103630.72812.10	8	7	7	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 1	2011	378	9798					1199	1200		10.1016/S0140-6736(11)61299-3	http://dx.doi.org/10.1016/S0140-6736(11)61299-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	831IO	21868084				2022-12-28	WOS:000295723600004
J	Ruggenenti, P; Remuzzi, G				Ruggenenti, Piero; Remuzzi, Giuseppe			A German outbreak of haemolytic uraemic syndrome	LANCET			English	Editorial Material							ESCHERICHIA-COLI		[Ruggenenti, Piero; Remuzzi, Giuseppe] Mario Negri Inst Pharmacol Res, Clin Res Ctr Rare Dis Aldo & Cele Dacco, I-24126 Bergamo, Italy; [Ruggenenti, Piero; Remuzzi, Giuseppe] Osped Riuniti Bergamo, Azienda Osped, Nephrol Unit, I-24100 Bergamo, Italy	Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Ospedali Riuniti di Bergamo	Remuzzi, G (corresponding author), Mario Negri Inst Pharmacol Res, Clin Res Ctr Rare Dis Aldo & Cele Dacco, I-24126 Bergamo, Italy.	Giuseppe.remuzzi@marionegri.it	Remuzzi, Giuseppe/V-9766-2017	Remuzzi, Giuseppe/0000-0002-6194-3446				Bielaszewska M, 2011, LANCET INFECT DIS, V11, P671, DOI 10.1016/S1473-3099(11)70165-7; Colic E, 2011, LANCET, V378, P1089, DOI 10.1016/S0140-6736(11)61145-8; Dolgin E, 2011, NAT MED, V17, P755, DOI 10.1038/nm0711-755; European Centre for Disease Prevention and Control (ECDC), 2011, SHIG TOX PROD E COL; Falagas ME, 2010, LANCET INFECT DIS, V10, P43, DOI 10.1016/S1473-3099(09)70325-1; Frank C, 2011, NEW ENGL J MED, V365, P1771, DOI 10.1056/NEJMoa1106483; Lapeyraque AL, 2011, NEW ENGL J MED, V364, P2561, DOI 10.1056/NEJMc1100859; Lino M, 2011, MICROBIOL-SGM, V157, P1768, DOI 10.1099/mic.0.047365-0; Noris M, 2005, J AM SOC NEPHROL, V16, P1035, DOI 10.1681/ASN.2004100861; Noris M, 2009, NEW ENGL J MED, V361, P1676, DOI 10.1056/NEJMra0902814; Orth D, 2009, J IMMUNOL, V182, P6394, DOI 10.4049/jimmunol.0900151; Qin JJ, 2011, J CLIN MICROBIOL, V49, P3439, DOI 10.1128/JCM.01312-11; Uber AP, 2006, FEMS MICROBIOL LETT, V256, P251, DOI 10.1111/j.1574-6968.2006.00124.x	13	26	26	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 17	2011	378	9796					1057	1058		10.1016/S0140-6736(11)61217-8	http://dx.doi.org/10.1016/S0140-6736(11)61217-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	829BE	21871656				2022-12-28	WOS:000295548900007
J	Prasad, M; Holmboe, ES; Lipner, RS; Hess, BJ; Christie, JD; Bellamy, SL; Rubenfeld, GD; Kahn, JM				Prasad, Meeta; Holmboe, Eric S.; Lipner, Rebecca S.; Hess, Brian J.; Christie, Jason D.; Bellamy, Scarlett L.; Rubenfeld, Gordon D.; Kahn, Jeremy M.			Clinical Protocols and Trainee Knowledge About Mechanical Ventilation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SEVERE SEPSIS; CARE; GUIDELINES; ADHERENCE; OUTCOMES	Context Clinical protocols are associated with improved patient outcomes; however, they may negatively affect medical education by removing trainees from clinical decision making. Objective To study the relationship between critical care training with mechanical ventilation protocols and subsequent knowledge about ventilator management. Design, Setting, and Participants A retrospective cohort equivalence study, linking a national survey of mechanical ventilation protocol availability in accredited US pulmonary and critical care fellowship programs with knowledge about mechanical ventilation among first-time examinees of the American Board of Internal Medicine (ABIM) Critical Care Medicine Certification Examination in 2008 and 2009. Exposure to protocols was defined as high intensity if an examinee's training intensive care unit had 2 or more protocols for at least 3 years and as low intensity if 0 or 1 protocol. Main Outcome Measures Knowledge, measured by performance on examination questions specific to mechanical ventilation management, calculated as a mechanical ventilation score using item response theory. The score is standardized to a mean (SD) of 500 (100), and a clinically important difference is defined as 25. Variables included in adjusted analyses were birth country, residency training country, and overall first-attempt score on the ABIM Internal Medicine Certification Examination. Results Ninety of 129 programs (70%) responded to the survey. Seventy-seven programs (86%) had protocols for ventilation liberation, 66 (73%) for sedation management, and 54 (60%) for lung-protective ventilation at the time of the survey. Eighty-eight (98%) of these programs had trainees who completed the ABIM Critical Care Medicine Certification Examination, totaling 553 examinees. Of these 88 programs, 27 (31%) had 0 protocols, 19 (22%) had 1 protocol, 24 (27%) had 2 protocols, and 18 (20%) had 3 protocols for at least 3 years. Forty-two programs (48%) were classified as high intensity and 46 (52%) as low intensity, with 304 trainees (55%) and 249 trainees (45%), respectively. In bivariable analysis, no difference in mean scores was observed in high-intensity (497; 95% CI, 486-507) vs low-intensity programs (497; 95% CI, 485-509). Mean difference was 0 (95% CI, -16 to 16), with a positive value indicating a higher score in the high-intensity group. In multivariable analyses, no association of training was observed in a high-intensity program with mechanical ventilation score (adjusted mean difference, -5.36; 95% CI, -20.7 to 10.0). Conclusion Among first-time ABIM Critical Care Medicine Certification Examination examinees, training in a high-intensity ventilator protocol environment compared with a low-intensity environment was not associated with worse performance on examination questions about mechanical ventilation management. JAMA. 2011;306(9):935-941	[Prasad, Meeta; Christie, Jason D.] Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA; [Holmboe, Eric S.; Lipner, Rebecca S.; Hess, Brian J.] Amer Board Internal Med, Philadelphia, PA USA; [Christie, Jason D.; Bellamy, Scarlett L.] Univ Penn, Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; [Rubenfeld, Gordon D.] Univ Toronto, Sunnybrook Hlth Sci Ctr, Program Trauma Emergency & Crit Care, Toronto, ON, Canada; [Kahn, Jeremy M.] Univ Pittsburgh, Med Ctr, Dept Crit Care, Clin Res Invest & Syst Modeling Acute Illness CRI, Pittsburgh, PA USA	University of Pennsylvania; American Board of Internal Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Prasad, M (corresponding author), Univ Penn, Sch Med, Dept Med, 3600 Spruce St,8th Floor,W Gates Bldg, Philadelphia, PA 19104 USA.	prasadm@uphs.upenn.edu		Kahn, Jeremy/0000-0001-9688-5576; Bellamy, Scarlett/0000-0002-2906-4046; Christie, Jason/0000-0003-0519-218X	Leonard Davis Institute of the University of Pennsylvania, Philadelphia	Leonard Davis Institute of the University of Pennsylvania, Philadelphia	This work was funded by a grant from the Leonard Davis Institute of the University of Pennsylvania, Philadelphia (Drs Prasad and Kahn).	Adams AS, 1999, INT J QUAL HEALTH C, V11, P187, DOI 10.1093/intqhc/11.3.187; Berenholtz Sean M, 2004, Jt Comm J Qual Saf, V30, P195; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Cabana MD, 1999, JAMA-J AM MED ASSOC, V282, P1458, DOI 10.1001/jama.282.15.1458; Chatburn RL, 2007, RESP CARE, V52, P609; Chiong W, 2007, JAMA-J AM MED ASSOC, V298, P1046, DOI 10.1001/jama.298.9.1046; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Costantini O, 1999, ACAD MED, V74, P1138, DOI 10.1097/00001888-199910000-00019; Dellinger RP, 2008, INTENS CARE MED, V34, P17, DOI 10.1007/s00134-007-0934-2; Dunn D, 1997, MED EDUC, V31, P25, DOI 10.1111/j.1365-2923.1997.tb02583.x; Ely EW, 1996, NEW ENGL J MED, V335, P1864, DOI 10.1056/NEJM199612193352502; Hambleton R.K., 1991, FUNDAMENTALS ITEM RE; Holmboe ES, 2008, ARCH INTERN MED, V168, P1396, DOI 10.1001/archinte.168.13.1396; Kahn JM, 2006, NEW ENGL J MED, V355, P41, DOI 10.1056/NEJMsa053993; Kaplan LJ, 2011, JAMA-J AM MED ASSOC, V305, P296, DOI 10.1001/jama.2010.1997; Kress JP, 2000, NEW ENGL J MED, V342, P1471, DOI 10.1056/NEJM200005183422002; MacIntyre NR, 2001, CHEST, V120, p375S, DOI 10.1378/chest.120.6_suppl.375S; McLean SE, 2006, AM J CRIT CARE, V15, P299; Morris AH, 1998, PRINCIPLES PRACTICE, P1355; Morris Alan H, 2003, Curr Opin Crit Care, V9, P236, DOI 10.1097/00075198-200306000-00012; Papadakis MA, 2008, ANN INTERN MED, V148, P869, DOI 10.7326/0003-4819-148-11-200806030-00009; Prasad M, 2010, J CRIT CARE, V25, P610, DOI 10.1016/j.jcrc.2010.02.014; Resar R, 2005, JT COMM J QUAL PATIE, V31, P243, DOI 10.1016/S1553-7250(05)31031-2; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Steiger JH, 2004, PSYCHOL METHODS, V9, P164, DOI 10.1037/1082-989X.9.2.164; Stoller J K, 2000, Respir Care, V45, P945; Tobin MJ, 2004, AM J RESP CRIT CARE, V169, P661, DOI 10.1164/rccm.2401006; ZEGER SL, 1988, BIOMETRICS, V44, P1049, DOI 10.2307/2531734	28	16	16	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 7	2011	306	9					935	941		10.1001/jama.2011.1226	http://dx.doi.org/10.1001/jama.2011.1226			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	815QT	21900133	Bronze			2022-12-28	WOS:000294542600011
J	Howell, JD				Howell, Joel D.			Maintaining Connections: Some Thoughts on the Value of Intensive Care Unit Rounding for General Medicine Ward Teams	ANNALS OF INTERNAL MEDICINE			English	Editorial Material								When established ward patients are unexpectedly transferred to an intensive care unit (ICU), the ward team should continue to follow them. Although there may be reasons not to do so, the advantages outweigh the obstacles. Great pedagogic value can be gained from following patients after acute decompensation, but a more important reason is that by following patients into the ICU, the ward team can enact for both patients and their families the twin virtues of caring and continuity. Doing so also demonstrates the highest ideals of medicine-that we are focused not on defined areas of turf, but on our patient's well-being. It shows that we are not merely doing narrowly defined "shift work," but that we truly care about our patients. Rounding on established patients who have been transferred into the ICU is the sort of behavior that undergirds the fundamental bases of professionalism. It takes a few minutes from a busy day, but it can be incredibly beneficial for families, patients, and the ideals of medicine.	Univ Michigan, Div Gen Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Howell, JD (corresponding author), Univ Michigan, Div Gen Med, 300 N Ingalls Bldg,Room 7C27, Ann Arbor, MI 48109 USA.	jhowell@umich.edu							0	1	1	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 6	2011	155	5					323	324		10.7326/0003-4819-155-5-201109060-00010	http://dx.doi.org/10.7326/0003-4819-155-5-201109060-00010			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	815PX	21893625				2022-12-28	WOS:000294538900006
J	Wisnivesky, JP; Teitelbaum, SL; Todd, AC; Boffetta, P; Crane, M; Crowley, L; de la Hoz, RE; Dellenbaugh, C; Harrison, D; Herbert, R; Kim, H; Jeon, Y; Kaplan, J; Katz, C; Levin, S; Luft, B; Markowitz, S; Moline, JM; Ozbay, F; Pietrzak, RH; Shapiro, M; Sharma, V; Skloot, G; Southwick, S; Stevenson, LA; Udasin, I; Wallenstein, S; Landrigan, PJ				Wisnivesky, Juan P.; Teitelbaum, Susan L.; Todd, Andrew C.; Boffetta, Paolo; Crane, Michael; Crowley, Laura; de la Hoz, Rafael E.; Dellenbaugh, Cornelia; Harrison, Denise; Herbert, Robin; Kim, Hyun; Jeon, Yunho; Kaplan, Julia; Katz, Craig; Levin, Stephen; Luft, Ben; Markowitz, Steven; Moline, Jacqueline M.; Ozbay, Fatih; Pietrzak, Robert H.; Shapiro, Moshe; Sharma, Vansh; Skloot, Gwen; Southwick, Steven; Stevenson, Lori A.; Udasin, Iris; Wallenstein, Sylvan; Landrigan, Philip J.			Persistence of multiple illnesses in World Trade Center rescue and recovery workers: a cohort study	LANCET			English	Article							POSTTRAUMATIC STRESS SYMPTOMS; RESPIRATORY SYMPTOMS; DISASTER RESCUE; LUNG-FUNCTION; HEALTH; FIREFIGHTERS; ASTHMA; WTC; STRATEGIES; EXPOSURE	Background More than 50000 people participated in the rescue and recovery work that followed the Sept 11, 2001 (9/11) attacks on the World Trade Center (WTC). Multiple health problems in these workers were reported in the early years after the disaster. We report incidence and prevalence rates of physical and mental health disorders during the 9 years since the attacks, examine their associations with occupational exposures, and quantify physical and mental health comorbidities. Methods In this longitudinal study of a large cohort of WTC rescue and recovery workers, we gathered data from 27 449 participants in the WTC Screening, Monitoring, and Treatment Program. The study population included police officers, firefighters, construction workers, and municipal workers. We used the Kaplan-Meier procedure to estimate cumulative and annual incidence of physical disorders (asthma, sinusitis, and gastro-oesophageal reflux disease), mental health disorders (depression, post-traumatic stress disorder [PTSD], and panic disorder), and spirometric abnormalities. Incidence rates were assessed also by level of exposure (days worked at the WTC site and exposure to the dust cloud). Findings 9-year cumulative incidence of asthma was 27.6% (number at risk: 7027), sinusitis 42.3% (5870), and gastro-oesophageal reflux disease 39.3% (5650). In police officers, cumulative incidence of depression was 7.0% (number at risk: 3648), PTSD 9.3% (3761), and panic disorder 8.4% (3780). In other rescue and recovery workers, cumulative incidence of depression was 27.5% (number at risk: 4200), PTSD 31.9% (4342), and panic disorder 21.2% (4953). 9-year cumulative incidence for spirometric abnormalities was 41.8% (number at risk: 5769); three-quarters of these abnormalities were low forced vital capacity. Incidence of most disorders was highest in workers with greatest WTC exposure. Extensive comorbidity was reported within and between physical and mental health disorders. Interpretation 9 years after the 9/11 WTC attacks, rescue and recovery workers continue to have a substantial burden of physical and mental health problems. These findings emphasise the need for continued monitoring and treatment of the WTC rescue and recovery population.	[Wisnivesky, Juan P.] Mt Sinai Sch Med, Dept Med, Div Gen Internal Med, New York, NY 10029 USA; [Wisnivesky, Juan P.; Skloot, Gwen] Mt Sinai Sch Med, Div Pulm & Crit Care Med, New York, NY 10029 USA; [Teitelbaum, Susan L.; Todd, Andrew C.; Crane, Michael; Crowley, Laura; de la Hoz, Rafael E.; Dellenbaugh, Cornelia; Herbert, Robin; Jeon, Yunho; Kaplan, Julia; Levin, Stephen; Shapiro, Moshe; Stevenson, Lori A.; Wallenstein, Sylvan; Landrigan, Philip J.] Mt Sinai Sch Med, Dept Prevent Med, New York, NY 10029 USA; [Boffetta, Paolo] Mt Sinai Sch Med, Inst Translat Epidemiol, New York, NY 10029 USA; [Katz, Craig; Ozbay, Fatih; Sharma, Vansh] Mt Sinai Sch Med, Dept Psychiat, New York, NY 10029 USA; [Harrison, Denise] NYU, Bellevue Hosp Ctr, Sch Med, Dept Med, New York, NY 10016 USA; [Kim, Hyun; Moline, Jacqueline M.] Hofstra N Shore LIJ Sch Med, Dept Populat Hlth, Great Neck, NY USA; [Luft, Ben] SUNY Stony Brook, Dept Med, Port Jefferson, NY USA; [Markowitz, Steven] CUNY Queens Coll, Flushing, NY 11367 USA; [Pietrzak, Robert H.; Southwick, Steven] Yale Univ, Sch Med, Dept Psychiat, West Haven, CT 06516 USA; [Pietrzak, Robert H.; Southwick, Steven] Vet Adm Connecticut Healthcare Syst, Natl Ctr Posttraumat Stress Disorder, West Haven, CT USA; [Udasin, Iris] Univ Med & Dent New Jersey, Piscataway, NJ 08854 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Bellevue Hospital Center; New York University; Hofstra University; Northwell Health; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; City University of New York (CUNY) System; Queens College NY (CUNY); Yale University; Rutgers State University New Brunswick; Rutgers State University Medical Center	Wisnivesky, JP (corresponding author), Mt Sinai Sch Med, Dept Med, Div Gen Internal Med, 1 Gustave L Pl,Box 1087, New York, NY 10029 USA.	juan.wisnivesky@mssm.edu	Boffetta, Paolo/AAI-7767-2021; de la Hoz, Rafael E./AGV-3806-2022	Boffetta, Paolo/0000-0002-3811-2791; de la Hoz, Rafael E./0000-0002-8949-9279; Luft, Benjamin/0000-0001-9008-7004; Kaplan, Julia/0000-0003-4746-1309	Centers for Disease Control and Prevention; National Institute for Occupational Safety and Health [200-2002-0038, 5U1O 0H008232]; American Red Cross Liberty Fund; September 11th Recovery Program; Bear Stearns Charitable Foundation; September 11th Fund; Robin Hood Foundation; NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH [U10OH008232] Funding Source: NIH RePORTER	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Institute for Occupational Safety and Health(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH)); American Red Cross Liberty Fund; September 11th Recovery Program; Bear Stearns Charitable Foundation; September 11th Fund; Robin Hood Foundation; NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH))	We thank the staff of the World Trade Center (WTC) Worker and Volunteer Medical Screening, Medical Monitoring, and Treatment programmes; the labour, community, and volunteer organisation stake-holders; and the WTC rescue and recovery workers, who gave of themselves so readily in response to the WTC attacks and to whom the WTC programmes are dedicated. This work was supported by the Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health (contract 200-2002-0038 and grant 5U1O 0H008232), the American Red Cross Liberty Fund, The September 11th Recovery Program, The Bear Stearns Charitable Foundation, The September 11th Fund, The Robin Hood Foundation Relief Fund, and many others. The contents of this report are solely the responsibility of the authors and do not necessarily represent the official views of Centers for Disease Control or the National Institute for Occupational Safety and Health.	Aldrich TK, 2010, NEW ENGL J MED, V362, P1263, DOI 10.1056/NEJMoa0910087; Brackbill RM, 2009, JAMA-J AM MED ASSOC, V302, P502, DOI 10.1001/jama.2009.1121; BROOKS SM, 1985, CHEST, V88, P376, DOI 10.1378/chest.88.3.376; CHOI BC, 1992, OCCUP MED, V34, P979; Crowley LE, 2011, AM J IND MED, V54, P175, DOI 10.1002/ajim.20924; DiGrande L, 2011, AM J EPIDEMIOL, V173, P271, DOI 10.1093/aje/kwq372; Feldman DM, 2004, CHEST, V125, P1256, DOI 10.1378/chest.125.4.1256; Gavett SH, 2003, ENVIRON HEALTH PERSP, V111, P981, DOI 10.1289/ehp.5931; Herbert R, 2006, ENVIRON HEALTH PERSP, V114, P1853, DOI 10.1289/ehp.9592; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Landrigan PJ, 2004, ENVIRON HEALTH PERSP, V112, P731, DOI 10.1289/ehp.6702; Lioy PJ, 2002, ENVIRON HEALTH PERSP, V110, P703, DOI 10.1289/ehp.02110703; Litz B.T, 1993, PTSD CHECKL PCL REL; Lombardo LJ, 2000, ENVIRON HEALTH PERSP, V108, P697, DOI 10.2307/3454406; Mann JM, 2005, AM J IND MED, V48, P225, DOI 10.1002/ajim.20196; Mauer MP, 2010, OCCUP MED-OXFORD, V60, P145, DOI 10.1093/occmed/kqp176; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Moline JM, 2008, MT SINAI J MED, V75, P67, DOI 10.1002/msj.20022; Murphy J, 2007, STAT MED, V26, P1688, DOI 10.1002/sim.2806; Pellegrino R, 2005, EUR RESPIR J, V26, P948, DOI 10.1183/09031936.05.00035205; Perrin MA, 2007, AM J PSYCHIAT, V164, P1385, DOI 10.1176/appi.ajp.2007.06101645; Prezant DJ, 2002, NEW ENGL J MED, V347, P806, DOI 10.1056/NEJMoa021300; Renck B, 2002, NORD J PSYCHIAT, V56, P7, DOI 10.1080/08039480252803855; Safirstein BH, 2003, CHEST, V123, P301, DOI 10.1378/chest.123.1.301; Savitz DA, 2008, MT SINAI J MED, V75, P77, DOI 10.1002/msj.20023; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Stellman JM, 2008, ENVIRON HEALTH PERSP, V116, P1248, DOI 10.1289/ehp.11164; Tapp LC, 2005, AM J IND MED, V47, P475, DOI 10.1002/ajim.20177; Udasin I, 2011, J OCCUP ENVIRON MED, V53, P49, DOI 10.1097/JOM.0b013e3182028e5c; Weiden MD, 2010, CHEST, V137, P566, DOI 10.1378/chest.09-1580; ZHAN J, 1997, JASA, V92, P945	32	207	210	0	30	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 3	2011	378	9794					888	897		10.1016/S0140-6736(11)61180-X	http://dx.doi.org/10.1016/S0140-6736(11)61180-X			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	818XZ	21890053	Green Accepted			2022-12-28	WOS:000294791300029
J	Cross, M				Cross, Michael			INFORMATION TECHNOLOGY There IT goes again	BRITISH MEDICAL JOURNAL			English	Editorial Material												michaelcross@fastmail.fm						Dunleavy P., 2006, DIGITAL ERA GOVERNAN; Greenhalgh T, 2010, DEVILS DETAIL FINAL; KLEIN R, 1994, BRIT MED J, V308, P215, DOI 10.1136/bmj.308.6923.215; Public Accounts Committee, 2011, NAT PROGR IT NHS UPD; Public Administration Select Committee, 2011, GOV IT REC RIP OFFS; Schoen C, 2009, HEALTH AFFAIR, V28, pW1171, DOI 10.1377/hlthaff.28.6.w1171	6	4	4	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 2	2011	343								d5317	10.1136/bmj.d5317	http://dx.doi.org/10.1136/bmj.d5317			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	816LI	21890565				2022-12-28	WOS:000294600900002
J	Schwille, P				Schwille, Petra			Bottom-Up Synthetic Biology: Engineering in a Tinkerer's World	SCIENCE			English	Editorial Material							ORGANIZATION; LESSONS	How synthetic can "synthetic biology" be? A literal interpretation of the name of this new life science discipline invokes expectations of the systematic construction of biological systems with cells being built module by module-from the bottom up. But can this possibly be achieved, taking into account the enormous complexity and redundancy of living systems, which distinguish them quite remarkably from design features that characterize human inventions? There are several recent developments in biology, in tight conjunction with quantitative disciplines, that may bring this literal perspective into the realm of the possible. However, such bottom-up engineering requires tools that were originally designed by nature's greatest tinkerer: evolution.	Tech Univ Dresden, Biophys BIOTEC, D-01307 Dresden, Germany	Technische Universitat Dresden	Schwille, P (corresponding author), Tech Univ Dresden, Biophys BIOTEC, Tatzberg 47-51, D-01307 Dresden, Germany.	schwille@biotec.tu-dresden.de	Schwille, Petra/A-4983-2010					Bashor CJ, 2010, ANNU REV BIOPHYS, V39, P515, DOI 10.1146/annurev.biophys.050708.133652; Choi HJ, 2005, NANO LETT, V5, P2538, DOI 10.1021/nl051896e; Delebecque CJ, 2011, SCIENCE, V333, P470, DOI 10.1126/science.1206938; Endy D, 2005, NATURE, V438, P449, DOI 10.1038/nature04342; JACOB F, 1977, SCIENCE, V196, P1161, DOI 10.1126/science.860134; Levskaya A, 2009, NATURE, V461, P997, DOI 10.1038/nature08446; Loose M, 2008, SCIENCE, V320, P789, DOI 10.1126/science.1154413; Loose M, 2011, ANNU REV BIOPHYS, V40, P315, DOI 10.1146/annurev-biophys-042910-155332; Nakajima M, 2005, SCIENCE, V308, P414, DOI 10.1126/science.1108451; Nandagopal N, 2011, SCIENCE, V333, P1244, DOI 10.1126/science.1207084; Roux A, 2006, NATURE, V441, P528, DOI 10.1038/nature04718; Ruder WC, 2011, SCIENCE, V333, P1248, DOI 10.1126/science.1206843; Szostak JW, 2001, NATURE, V409, P387, DOI 10.1038/35053176; Taubes G, 2000, SCIENCE, V288, P80, DOI 10.1126/science.288.5463.80; Wollert T, 2009, NATURE, V458, P172, DOI 10.1038/nature07836; Yeh BJ, 2007, NAT CHEM BIOL, V3, P521, DOI 10.1038/nchembio0907-521	16	146	153	2	105	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 2	2011	333	6047					1252	1254		10.1126/science.1211701	http://dx.doi.org/10.1126/science.1211701			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	813YM	21885774				2022-12-28	WOS:000294406400042
J	Borg, LE; Connelly, JN; Boyet, M; Carlson, RW				Borg, Lars E.; Connelly, James N.; Boyet, Maud; Carlson, Richard W.			Chronological evidence that the Moon is either young or did not have a global magma ocean	NATURE			English	Article							NORITIC ANORTHOSITE CLAST; SM-ND; FERROAN ANORTHOSITE-60025; LUNAR; AGE; CRUST; DIFFERENTIATION; PETROLOGY; ORIGIN; MODEL	Chemical evolution of planetary bodies, ranging from asteroids to the large rocky planets, is thought to begin with differentiation through solidification of magma oceans many hundreds of kilometres in depth(1-3). The Earth's Moon is the archetypical example of this type of differentiation. Evidence for a lunar magma ocean is derived largely from the widespread distribution, compositional and mineralogical characteristics, and ancient ages inferred for the ferroan anorthosite (FAN) suite of lunar crustal rocks. The FANs are considered to be primary lunar flotation-cumulate crust that crystallized in the latter stages of magma ocean solidification. According to this theory, FANs represent the oldest lunar crustal rock type(2-4). Attempts to date this rock suite have yielded ambiguous results, however, because individual isochron measurements are typically incompatible with the geochemical make-up of the samples, and have not been confirmed by additional isotopic systems(5-9). By making improvements to the standard isotopic techniques, we report here the age of crystallization of FAN 60025 using the Pb-207-Pb-206, Sm-147-Nd-143 and Sm-146-Nd-142 isotopic systems to be 4,360 +/- 3 million years. This extraordinarily young age requires that either the Moon solidified significantly later than most previous estimates or the long-held assumption that FANs are flotation cumulates of a primordial magma ocean is incorrect. If the latter is correct, then much of the lunar crust may have been produced by non-magma-ocean processes, such as serial magmatism(10).	[Borg, Lars E.] Lawrence Livermore Natl Lab, Div Chem Sci, Livermore, CA 94550 USA; [Connelly, James N.] Univ Copenhagen, Ctr Star & Planet Format, Copenhagen, Denmark; [Boyet, Maud] Univ Blaise Pascal, Clermont Univ, Lab Magmas & Volcans, UMR CNRS 6524, F-63038 Clermont Ferrand, France; [Carlson, Richard W.] Carnegie Inst Sci, Dept Terr Magnetism, Washington, DC 20015 USA	United States Department of Energy (DOE); Lawrence Livermore National Laboratory; University of Copenhagen; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Institut de Recherche pour le Developpement (IRD); Universite Clermont Auvergne (UCA); Universite Jean Monnet; Carnegie Institution for Science	Borg, LE (corresponding author), Lawrence Livermore Natl Lab, Div Chem Sci, 7000 East Ave L-231, Livermore, CA 94550 USA.	borg5@llnl.gov	Connelly, James/O-7996-2015		US Department of Energy by Lawrence Livermore National Laboratory [DE-AC52-07NA27344]; NASA [NNH08ZDA001N, NNX08AH65G]; Danish National Research Foundation; University of Copenhagen	US Department of Energy by Lawrence Livermore National Laboratory(United States Department of Energy (DOE)); NASA(National Aeronautics & Space Administration (NASA)); Danish National Research Foundation(Danmarks Grundforskningsfond); University of Copenhagen	This work was performed under the auspices of the US Department of Energy by Lawrence Livermore National Laboratory under contract number DE-AC52-07NA27344. The portion of the work performed at Lawrence Livermore National Laboratory and the Department of Terrestrial Magnetism were supported by NASA Cosmochemistry grants NNH08ZDA001N and NNX08AH65G, respectively. The Centre for Star and Planet Formation is funded by the Danish National Research Foundation and the University of Copenhagen's programme of excellence. We appreciate comments by A. Brandon.	ALIBERT C, 1994, GEOCHIM COSMOCHIM AC, V58, P2921, DOI 10.1016/0016-7037(94)90125-2; Borg L, 1999, GEOCHIM COSMOCHIM AC, V63, P2679, DOI 10.1016/S0016-7037(99)00130-1; Boyet M, 2005, SCIENCE, V309, P576, DOI 10.1126/science.1113634; Boyet M, 2007, EARTH PLANET SC LETT, V262, P505, DOI 10.1016/j.epsl.2007.08.009; Boyet M, 2010, EARTH PLANET SC LETT, V291, P172, DOI 10.1016/j.epsl.2010.01.010; Brandon AD, 2009, GEOCHIM COSMOCHIM AC, V73, P6421, DOI 10.1016/j.gca.2009.07.015; CARLSON RW, 1988, EARTH PLANET SC LETT, V90, P119, DOI 10.1016/0012-821X(88)90095-7; Connelly JN, 2009, CHEM GEOL, V259, P143, DOI 10.1016/j.chemgeo.2008.11.003; Edmunson J, 2009, GEOCHIM COSMOCHIM AC, V73, P514, DOI 10.1016/j.gca.2008.10.021; Gerstenberger H, 1997, CHEM GEOL, V136, P309, DOI 10.1016/S0009-2541(96)00033-2; HANAN BB, 1987, EARTH PLANET SC LETT, V84, P15, DOI 10.1016/0012-821X(87)90171-3; HESS PC, 1995, EARTH PLANET SC LETT, V134, P501, DOI 10.1016/0012-821X(95)00138-3; JAMES OB, 1991, P LUNAR PLANET SCI, V21, P63; Lapen TJ, 2010, SCIENCE, V328, P347, DOI 10.1126/science.1185395; Lugmair G. W., 1978, LUNAR PLANETARY SCI, V9, P689; Nemchin A, 2009, NAT GEOSCI, V2, P133, DOI 10.1038/NGEO417; Norman MD, 2003, METEORIT PLANET SCI, V38, P645, DOI 10.1111/j.1945-5100.2003.tb00031.x; Nunes P. D., 1974, LUNAR SCI, VV, P559; Nyquist L, 2006, GEOCHIM COSMOCHIM AC, V70, P5990, DOI 10.1016/j.gca.2006.07.042; NYQUIST LE, 1995, GEOCHIM COSMOCHIM AC, V59, P2817, DOI 10.1016/0016-7037(95)00175-Y; NYQUIST LE, 1992, GEOCHIM COSMOCHIM AC, V56, P2213, DOI 10.1016/0016-7037(92)90185-L; Nyquist LE, 2010, LUNAR PLANET SCI, P1383; Rankenburg K, 2006, SCIENCE, V312, P1369, DOI 10.1126/science.1126114; SHIH CY, 1993, GEOCHIM COSMOCHIM AC, V57, P915, DOI 10.1016/0016-7037(93)90178-Y; Shirley D. N., 1983, Journal of Geophysical Research, V88, P519, DOI 10.1029/JB088iS02p0A519; Smith J. A., 1970, P LUNAR PLANET SCI 1, V1, P149; SNYDER GA, 1992, GEOCHIM COSMOCHIM AC, V56, P3809, DOI 10.1016/0016-7037(92)90172-F; TERA F, 1972, EARTH PLANET SC LETT, V17, P36, DOI 10.1016/0012-821X(72)90257-9; Tera F., 1974, P LUNAR PLANET SCI C, V5, P1571; Touboul M, 2007, NATURE, V450, P1206, DOI 10.1038/nature06428; Warren P. H., 1977, REV GEOPHYS SPACE PH, V17, P73; Wilde SA, 2001, NATURE, V409, P175, DOI 10.1038/35051550; Wood J.A., 1970, P AP 11 LUN SCI C, P965	33	158	158	0	73	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 1	2011	477	7362					70	U150		10.1038/nature10328	http://dx.doi.org/10.1038/nature10328			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	813XT	21849974				2022-12-28	WOS:000294404300032
J	Yurimoto, H; Abe, K; Abe, M; Ebihara, M; Fujimura, A; Hashiguchi, M; Hashizume, K; Ireland, TR; Itoh, S; Katayama, J; Kato, C; Kawaguchi, J; Kawasaki, N; Kitajima, F; Kobayashi, S; Meike, T; Mukai, T; Nagao, K; Nakamura, T; Naraoka, H; Noguchi, T; Okazaki, R; Park, C; Sakamoto, N; Seto, Y; Takei, M; Tsuchiyama, A; Uesugi, M; Wakaki, S; Yada, T; Yamamoto, K; Yoshikawa, M; Zolensky, ME				Yurimoto, Hisayoshi; Abe, Ken-ichi; Abe, Masanao; Ebihara, Mitsuru; Fujimura, Akio; Hashiguchi, Minako; Hashizume, Ko; Ireland, Trevor R.; Itoh, Shoichi; Katayama, Juri; Kato, Chizu; Kawaguchi, Junichiro; Kawasaki, Noriyuki; Kitajima, Fumio; Kobayashi, Sachio; Meike, Tatsuji; Mukai, Toshifumi; Nagao, Keisuke; Nakamura, Tomoki; Naraoka, Hiroshi; Noguchi, Takaaki; Okazaki, Ryuji; Park, Changkun; Sakamoto, Naoya; Seto, Yusuke; Takei, Masashi; Tsuchiyama, Akira; Uesugi, Masayuki; Wakaki, Shigeyuki; Yada, Toru; Yamamoto, Kosuke; Yoshikawa, Makoto; Zolensky, Michael E.			Oxygen Isotopic Compositions of Asteroidal Materials Returned from Itokawa by the Hayabusa Mission	SCIENCE			English	Article							ORIGIN	Meteorite studies suggest that each solar system object has a unique oxygen isotopic composition. Chondrites, the most primitive of meteorites, have been believed to be derived from asteroids, but oxygen isotopic compositions of asteroids themselves have not been established. We measured, using secondary ion mass spectrometry, oxygen isotopic compositions of rock particles from asteroid 25143 Itokawa returned by the Hayabusa spacecraft. Compositions of the particles are depleted in O-16 relative to terrestrial materials and indicate that Itokawa, an S-type asteroid, is one of the sources of the LL or L group of equilibrated ordinary chondrites. This is a direct oxygen-isotope link between chondrites and their parent asteroid.	[Yurimoto, Hisayoshi; Abe, Ken-ichi; Hashiguchi, Minako; Itoh, Shoichi; Katayama, Juri; Kato, Chizu; Kawasaki, Noriyuki; Kobayashi, Sachio; Meike, Tatsuji; Park, Changkun; Sakamoto, Naoya; Takei, Masashi; Wakaki, Shigeyuki; Yamamoto, Kosuke] Hokkaido Univ, Sapporo, Hokkaido 0600810, Japan; [Abe, Masanao; Fujimura, Akio; Kawaguchi, Junichiro; Mukai, Toshifumi; Uesugi, Masayuki; Yada, Toru; Yoshikawa, Makoto] Japan Aerosp Explorat Agency, Inst Space & Astronaut Sci, Chuo Ku, Kanagawa 2525210, Japan; [Ebihara, Mitsuru] Tokyo Metropolitan Univ, Grad Sch Sci & Engn, Tokyo 1920397, Japan; [Hashizume, Ko; Tsuchiyama, Akira] Osaka Univ, Dept Earth & Space Sci, Toyonaka, Osaka 5600043, Japan; [Ireland, Trevor R.] Australian Natl Univ, Res Sch Earth Sci, Coll Phys & Math Sci, Canberra, ACT 0200, Australia; [Kitajima, Fumio; Naraoka, Hiroshi; Okazaki, Ryuji] Kyushu Univ, Dept Earth & Planetary Sci, Higashi Ku, Fukuoka 8128581, Japan; [Nagao, Keisuke] Univ Tokyo, Geochem Res Ctr, Tokyo 1130033, Japan; [Nakamura, Tomoki] Tohoku Univ, Dept Earth & Planetary Mat Sci, Aoba Ku, Sendai, Miyagi 9808578, Japan; [Noguchi, Takaaki] Ibaraki Univ, Coll Sci, Mito, Ibaraki 3108512, Japan; [Seto, Yusuke] Kobe Univ, Dept Earth & Planetary Sci, Kobe, Hyogo 6578501, Japan; [Zolensky, Michael E.] NASA, Lyndon B Johnson Space Ctr, KT, Houston, TX 77058 USA	Hokkaido University; Japan Aerospace Exploration Agency (JAXA); Institute of Space & Astronautical Science (ISAS); Tokyo Metropolitan University; Osaka University; Australian National University; Kyushu University; University of Tokyo; Tohoku University; Ibaraki University; Kobe University; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER	Yurimoto, H (corresponding author), Hokkaido Univ, Sapporo, Hokkaido 0600810, Japan.	yuri@ep.sci.hokudai.ac.jp	Yurimoto, Hisayoshi/S-9938-2018; Ireland, Trevor R./GSJ-1884-2022; Kawasaki, Noriyuki/P-9002-2019; Seto, Yusuke/D-5751-2015; Ireland, Trevor R/A-4993-2008; Mukai, Toshifumi/ABD-3297-2021; HASHIGUCHI, Minako/Z-2896-2019; Park, Changkun/E-7281-2019	Yurimoto, Hisayoshi/0000-0003-0702-0533; Kawasaki, Noriyuki/0000-0001-6502-6488; Seto, Yusuke/0000-0002-5423-2136; Ireland, Trevor R/0000-0001-7617-3889; Park, Changkun/0000-0002-1206-6803; Uesugi, Masayuki/0000-0001-6261-9034; Kato, Chizu/0000-0001-6735-2092; Noguchi, Takaaki/0000-0001-7211-2595; Zolensky, Michael/0000-0002-3181-1303; wakaki, Shigeyuki/0000-0003-2472-3169; Itoh, Shoichi/0000-0001-9431-0525; Naraoka, Hiroshi/0000-0002-2373-8759; HASHIGUCHI, MINAKO/0000-0002-0302-2171	Monka-sho grant; NASA; Grants-in-Aid for Scientific Research [22224010, 23654191] Funding Source: KAKEN	Monka-sho grant; NASA(National Aeronautics & Space Administration (NASA)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank the Hayabusa sample curation team and the Hayabusa project team for close cooperation. This study was supported by the Monka-sho grant (H.Y.) and by the NASA Muses-CN/Hayabusa Program (M.E.Z.).	Abe M, 2006, SCIENCE, V312, P1334, DOI 10.1126/science.1125718; Abell PA, 2007, METEORIT PLANET SCI, V42, P2165, DOI 10.1111/j.1945-5100.2007.tb01016.x; Brown P, 2011, METEORIT PLANET SCI, V46, P339, DOI 10.1111/j.1945-5100.2010.01167.x; CLAYTON RN, 1991, GEOCHIM COSMOCHIM AC, V55, P2317, DOI 10.1016/0016-7037(91)90107-G; CLAYTON RN, 1993, ANNU REV EARTH PL SC, V21, P115, DOI 10.1146/annurev.earth.21.1.115; Clayton RN, 2002, NATURE, V415, P860, DOI 10.1038/415860b; Clayton RN, 2005, TREATISE GEOCHEM, V1, P129; CLAYTON RN, 1991, GEOCHEM SOC SPEC PUB, V3, P3; Greenwood RC, 2005, NATURE, V435, P916, DOI 10.1038/nature03612; Krot AN, 2005, TREATISE GEOCHEM, V1, P83; KURAMOTO K, 2005, ASP C SERIES, V341, P181; Lyons JR, 2005, NATURE, V435, P317, DOI 10.1038/nature03557; Nakamura T, 2011, SCIENCE, V333, P1113, DOI 10.1126/science.1207758; Tholen D.J., 1989, ASTEROIDS, VII, P298; Wiechert U, 2001, SCIENCE, V294, P345, DOI 10.1126/science.1063037; Yurimoto H, 2004, SCIENCE, V305, P1763, DOI 10.1126/science.1100989; Yurimoto L, 2003, APPL SURF SCI, V203, P793, DOI 10.1016/S0169-4332(02)00825-5	17	123	124	0	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 26	2011	333	6046					1116	1119		10.1126/science.1207776	http://dx.doi.org/10.1126/science.1207776			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811VM	21868668	Green Published			2022-12-28	WOS:000294244300039
J	Imbach, P; Crowther, M				Imbach, Paul; Crowther, Mark			Thrombopoietin-Receptor Agonists for Primary Immune Thrombocytopenia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PLATELET COUNTS; ADULT PATIENTS; DOUBLE-BLIND; PURPURA; ROMIPLOSTIM; EFFICACY; SAFETY; ITP; ELTROMBOPAG; AUTOANTIBODIES	A 26-year-old woman with a history of chronic primary immune thrombocytopenia presents for evaluation. Her condition was first diagnosed when she was 11 years of age. Her platelet count has typically been less than 10,000 per cubic millimeter. Her symptoms have not responded to glucocorticoids, and she has had only transient responses to intravenous immune globulin. Previous treatments have included a course of cyclosporine, a course of four doses of rituximab, and splenectomy. Her bleeding symptoms have consisted mainly of menorrhagia, resulting in iron-deficiency anemia. She is currently being treated with a thrombopoietin-receptor agonist, which has resulted in an increase in her platelet count to between 50,000 and 200,000 per cubic millimeter and resolution of her excessive menstrual bleeding, with normalization of her hemoglobin level after iron therapy. She is now inquiring about the long-term treatment of her condition.	[Imbach, Paul] Univ Childrens Hosp Basel, Div Pediat Oncol Hematol, CH-4031 Basel, Switzerland; [Crowther, Mark] McMaster Univ, Hamilton, ON, Canada	University of Basel; McMaster University	Imbach, P (corresponding author), Univ Childrens Hosp Basel, Div Pediat Oncol Hematol, CH-4031 Basel, Switzerland.	paul.imbach@unibas.ch			Amgen; GlaxoSmithKline; Boehringer Ingelheim; Bristol-Myers Squibb; Pfizer; Leo	Amgen(Amgen); GlaxoSmithKline(GlaxoSmithKline); Boehringer Ingelheim(Boehringer Ingelheim); Bristol-Myers Squibb(Bristol-Myers Squibb); Pfizer(Pfizer); Leo(LEO Pharma)	Dr. Imbach reports that his institution has received consulting fees from Amgen and GlaxoSmithKline and travel support from CSL Behring. Dr. Crowther reports receiving payment for serving on the advisory boards of Octapharma and CSL Behring and payment for the development of educational presentations from Pfizer and Octapharma, and that his institution has received grant support from Boehringer Ingelheim, Bristol-Myers Squibb, Pfizer, and Leo. No other potential conflict of interest relevant to this article was reported.	Aledort LM, 2004, AM J HEMATOL, V76, P205, DOI 10.1002/ajh.20104; [Anonymous], 2010, ELTR TREATM CHRON IM; [Anonymous], 2011, ROM TREATM CHRON IMM; Archer M, 2008, NEW DRUG B ROMIPLOST; Arnold DM, 2007, ANN INTERN MED, V146, P25, DOI 10.7326/0003-4819-146-1-200701020-00006; Bredlau AL, 2011, PEDIATR DRUGS, V13, P213, DOI 10.2165/11591640-000000000-00000; Bussel JB, 2009, BLOOD, V113, P4822; Bussel JB, 2007, NEW ENGL J MED, V357, P2237, DOI 10.1056/NEJMoa073275; Bussel JB, 2009, LANCET, V373, P641, DOI 10.1016/S0140-6736(09)60402-5; Bussel JB, 2009, SEMIN HEMATOL, V46, pS44, DOI 10.1053/j.seminhematol.2008.12.003; Bussel JB, 2009, BLOOD, V113, P2161, DOI 10.1182/blood-2008-04-150078; Bussel JB, 2008, BLOOD, V112, P3431; Cines DB, 2009, BLOOD, V113, P6511, DOI 10.1182/blood-2009-01-129155; Fanucchi M, 1997, NEW ENGL J MED, V336, P404, DOI 10.1056/NEJM199702063360603; George JN, 1996, BLOOD, V88, P3, DOI 10.1182/blood.V88.1.3.3; Gernsheimer TB, 2010, J THROMB HAEMOST, V8, P1372, DOI 10.1111/j.1538-7836.2010.03830.x; GlaxoSmithKline, PROM PRESCR INF; Imbach P, 2010, VOX SANG, V98, P385, DOI 10.1111/j.1423-0410.2009.01264.x; Jensen J, 2009, NEW DRUG B ELTROMBOP; Kaushansky K, 2005, J CLIN INVEST, V115, P3339, DOI 10.1172/JCI26674; KAUSHANSKY K, 1994, NATURE, V369, P568, DOI 10.1038/369568a0; Kojouri K, 2004, BLOOD, V104, P2623, DOI 10.1182/blood-2004-03-1168; Kuter DJ, 2008, LANCET, V371, P395, DOI 10.1016/S0140-6736(08)60203-2; Kuter DJ, 2007, BRIT J HAEMATOL, V139, P351, DOI 10.1111/j.1365-2141.2007.06807.x; Kuter DJ, 2010, BLOOD, V116, P36, DOI 10.1182/blood.V116.21.68.68; Kuter DJ, 2010, SEMIN HEMATOL, V47, P243, DOI 10.1053/j.seminhematol.2010.02.005; Kuter DJ, 2002, BLOOD, V100, P3457, DOI 10.1182/blood.V100.10.3457; Li JZ, 2001, BLOOD, V98, P3241, DOI 10.1182/blood.V98.12.3241; Liebman H, 2008, BLOOD, V112, P1171; Maddrey WC, 2009, BLOOD, V114, P951, DOI 10.1182/blood.V114.22.2410.2410; McMillan R, 2004, BLOOD, V103, P1364, DOI 10.1182/blood-2003-08-2672; McMillan R, 2000, SEMIN HEMATOL, V37, P239, DOI 10.1016/S0037-1963(00)90102-1; Neunert C, 2011, BLOOD, V117, P4190, DOI 10.1182/blood-2010-08-302984; Neylon AJ, 2003, BRIT J HAEMATOL, V122, P966, DOI 10.1046/j.1365-2141.2003.04547.x; Olsson B, 2003, NAT MED, V9, P1123, DOI 10.1038/nm921; Provan D, 2010, BLOOD, V115, P168, DOI 10.1182/blood-2009-06-225565; Rodeghiero F, 2009, BLOOD, V113, P2386, DOI 10.1182/blood-2008-07-162503; Saleh MN, 2010, BLOOD, V116, P36; Saleh MN, 2009, BLOOD, V114, P1326; Tarantino MD, 2010, BLOOD S, V116, P2511; Wang B, 2004, CLIN PHARMACOL THER, V76, P628, DOI 10.1016/j.clpt.2004.08.010; Zeller B, 2005, ACTA PAEDIATR, V94, P178, DOI 10.1080/08035250410025294	42	75	78	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 25	2011	365	8					734	741		10.1056/NEJMct1014202	http://dx.doi.org/10.1056/NEJMct1014202			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	811JM	21864167				2022-12-28	WOS:000294205300009
J	Kolodner, RD; Cleveland, DW; Putnam, CD				Kolodner, Richard D.; Cleveland, Don W.; Putnam, Christopher D.			Aneuploidy Drives a Mutator Phenotype in Cancer	SCIENCE			English	Editorial Material							MUTATIONS		[Kolodner, Richard D.; Cleveland, Don W.; Putnam, Christopher D.] Univ Calif San Diego, Sch Med, Ludwig Inst Canc Res, La Jolla, CA 92093 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego	Kolodner, RD (corresponding author), Univ Calif San Diego, Sch Med, Ludwig Inst Canc Res, La Jolla, CA 92093 USA.	rkolodner@ucsd.edu; dcleveland@ucsd.edu; cdputnam@ucsd.edu	Cleveland, Don/AAN-9783-2021	Putnam, Christopher/0000-0002-6145-1265; Cleveland, Don/0000-0002-1934-3682	NATIONAL CANCER INSTITUTE [P30CA023100] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026017] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA023100] Funding Source: Medline; NIGMS NIH HHS [R01 GM026017] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Albertson TM, 2009, P NATL ACAD SCI USA, V106, P17101, DOI 10.1073/pnas.0907147106; Carter SL, 2006, NAT GENET, V38, P1043, DOI 10.1038/ng1861; Hanks S, 2004, NAT GENET, V36, P1159, DOI 10.1038/ng1449; Kolodner RD, 2002, SCIENCE, V297, P552, DOI 10.1126/science.1075277; Loeb LA, 2001, CANCER RES, V61, P3230; Perez de Castro I, 2007, CARCINOGENESIS, V28, P899, DOI 10.1093/carcin/bgm019; Sheltzer JM, 2011, SCIENCE, V333, P1026, DOI 10.1126/science.1206412; Snape K, 2011, NAT GENET, V43, P527, DOI 10.1038/ng.822; Solomon DA, 2011, SCIENCE, V333, P1039, DOI 10.1126/science.1203619; Torres EM, 2010, CELL, V143, P71, DOI 10.1016/j.cell.2010.08.038; Weaver BAA, 2007, CANCER CELL, V11, P25, DOI 10.1016/j.ccr.2006.12.003; Williams BR, 2008, SCIENCE, V322, P703, DOI 10.1126/science.1160058; Yang GZ, 2004, CANCER CELL, V6, P139, DOI 10.1016/j.ccr.2004.06.024; Yuen KWY, 2007, P NATL ACAD SCI USA, V104, P3925, DOI 10.1073/pnas.0610642104	14	35	35	1	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 19	2011	333	6045					942	943		10.1126/science.1211154	http://dx.doi.org/10.1126/science.1211154			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808TD	21852477	Green Accepted			2022-12-28	WOS:000294000400031
J	Gai, ZK; Donoghue, PCJ; Zhu, M; Janvier, P; Stampanoni, M				Gai, Zhikun; Donoghue, Philip C. J.; Zhu, Min; Janvier, Philippe; Stampanoni, Marco			Fossil jawless fish from China foreshadows early jawed vertebrate anatomy	NATURE			English	Article							TOMOGRAPHIC MICROSCOPY; INTERNAL ANATOMY; NEURAL CREST; ORIGIN; EVOLUTION; AGNATHANS; PHYLOGENY; LAMPREY; HEAD	Most living vertebrates are jawed vertebrates (gnathostomes), and the living jawless vertebrates (cyclostomes), hagfishes and lampreys, provide scarce information about the profound reorganization of the vertebrate skull during the evolutionary origin of jaws(1-9). The extinct bony jawless vertebrates, or 'ostracoderms', are regarded as precursors of jawed vertebrates and provide insight into this formative episode in vertebrate evolution(8-14). Here, using synchrotron radiation X-ray tomography(15,16), we describe the cranial anatomy of galeaspids, a 435-370-million-year-old 'ostracoderm' group from China and Vietnam(17). The paired nasal sacs of galeaspids are located anterolaterally in the braincase, and the hypophyseal duct opens anteriorly towards the oral cavity. These three structures (the paired nasal sacs and the hypophyseal duct) were thus already independent of each other, like in gnathostomes and unlike in cyclostomes and osteostracans (another 'ostracoderm' group), and therefore have the condition that current developmental models regard as prerequisites for the development of jaws(1-3). This indicates that the reorganization of vertebrate cranial anatomy was not driven deterministically by the evolutionary origin of jaws but occurred stepwise, ultimately allowing the rostral growth of ectomesenchyme that now characterizes gnathostome head development(1-3).	[Gai, Zhikun; Donoghue, Philip C. J.] Univ Bristol, Sch Earth Sci, Bristol BS8 1RJ, Avon, England; [Gai, Zhikun; Zhu, Min] Chinese Acad Sci, Lab Evolutionary Systemat Vertebrates, Inst Vertebrate Paleontol & Paleoanthropol, Beijing 100044, Peoples R China; [Janvier, Philippe] Museum Natl Hist Nat, CNRS, UMR 7207, F-75231 Paris 05, France; [Stampanoni, Marco] Paul Scherrer Inst, Swiss Light Source, CH-5232 Villigen, Switzerland; [Stampanoni, Marco] Univ & ETH Zurich, Inst Biomed Engn, CH-8092 Zurich, Switzerland	University of Bristol; Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Swiss Federal Institutes of Technology Domain; ETH Zurich	Donoghue, PCJ (corresponding author), Univ Bristol, Sch Earth Sci, Bristol BS8 1RJ, Avon, England.	phil.donoghue@bristol.ac.uk; zhumin@ivpp.ac.cn	Stampanoni, Marco/J-4099-2013; min, zhu/AAL-6712-2021; Stampanoni, Marco/GRR-9695-2022; Janvier, Philippe/Q-5268-2019; Donoghue, Philip/A-3873-2008; Zhu, Min/E-8728-2012; Stampanoni, Marco/AAZ-3033-2021	Stampanoni, Marco/0000-0001-7486-6681; Stampanoni, Marco/0000-0001-7486-6681; Donoghue, Philip/0000-0003-3116-7463; Zhu, Min/0000-0002-4786-0898; Stampanoni, Marco/0000-0001-7486-6681	Chinese Academy of Sciences [KZCX2-YW-156]; Chinese Foundation of Natural Sciences [40872020, 40930208]; Major Basic Research Projects of MST of China [2006CB806400]; Paul Scherrer Institut; European Union; Leverhulme Trust; Natural Environmental Research Council; SYNTHESYS Project; Royal Society; NERC [NE/G016623/1] Funding Source: UKRI; Natural Environment Research Council [NE/G016623/1] Funding Source: researchfish	Chinese Academy of Sciences(Chinese Academy of Sciences); Chinese Foundation of Natural Sciences; Major Basic Research Projects of MST of China; Paul Scherrer Institut; European Union(European Commission); Leverhulme Trust(Leverhulme Trust); Natural Environmental Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); SYNTHESYS Project; Royal Society(Royal Society of London); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank F. Marone, S. Bengtson, E.-M. Friis, N. J. Gostling, T. Huldtgren, M. Pawlowska and C.-W. Thomas for assistance in retrieving synchrotron radiation X-ray tomographic microscopy data; Q.-S. Chen and W.-J. Zhao for field work; and S. Powell, F.-X. Wu, B. Choo and R.-D. Zhao for illustrations. This work was supported by the Chinese Academy of Sciences (KZCX2-YW-156), the Chinese Foundation of Natural Sciences (40872020, 40930208), the Major Basic Research Projects (2006CB806400) of MST of China, the Paul Scherrer Institut (P. C. J. D.), European Union FP6 (P. C. J. D.), the Leverhulme Trust (P. C. J. D.), the Natural Environmental Research Council (P. C. J. D.), the SYNTHESYS Project (Z.G.) and a Dorothy Hodgkin studentship from the Royal Society (Z.G.).	Baker CVH, 2005, J EXP ZOOL PART B, V304B, P269, DOI 10.1002/jez.b.21060; Donoghue PCJ, 2001, T ROY SOC EDIN-EARTH, V92, P15, DOI 10.1017/S026359330000002X; Donoghue PCJ, 2005, TRENDS ECOL EVOL, V20, P312, DOI 10.1016/j.tree.2005.04.008; Donoghue PCJ, 2006, NATURE, V442, P680, DOI 10.1038/nature04890; FOREY P, 1993, NATURE, V361, P129, DOI 10.1038/361129a0; FOREY PL, 1995, REV FISH BIOL FISHER, V5, P267, DOI 10.1007/BF00043003; Gai Zhi-Kun, 2005, Vertebrata Palasiatica, V43, P61; GANS C, 1983, SCIENCE, V220, P268, DOI 10.1126/science.220.4594.268; HALSTEAD LB, 1979, NATURE, V282, P833, DOI 10.1038/282833a0; HALSTEAD LB, 1979, NATURE, V282, P831, DOI 10.1038/282831a0; Heimberg AM, 2010, P NATL ACAD SCI USA, V107, P19379, DOI 10.1073/pnas.1010350107; Janvier P, 1996, PALAEONTOLOGY, V39, P259; Janvier P, 2001, SYST ASSOC SPEC VOL, V61, P172; JANVIER P, 1979, ZOOL SCR, V8, P287, DOI 10.1111/j.1463-6409.1979.tb00640.x; Janvier P., 1996, EARLY VERTEBRATES; Janvier Philippe, 2007, P57; Khonsari RH, 2009, ACTA ZOOL-STOCKHOLM, V90, P52, DOI 10.1111/j.1463-6395.2008.00388.x; Kuratani S, 2001, PHILOS T ROY SOC B, V356, P1615, DOI 10.1098/rstb.2001.0976; Kuratani S, 2008, J EXP ZOOL PART B, V310B, P294, DOI 10.1002/jez.b.21190; Mazan S, 2000, EVOL DEV, V2, P186, DOI 10.1046/j.1525-142x.2000.00062.x; PAN J, 1986, YOH SS, P67; Shigetani Y, 2002, SCIENCE, V296, P1316, DOI 10.1126/science.1068310; Smeets W.J.A.J., 1998, P551; Stampanoni M, 2007, AIP CONF PROC, V879, P848; Stensio E.A., 1927, SKRIFTER SVALBARD NO, DOI DOI 10.3402/POLAR.V14I1.6649; Tafforeau P, 2006, APPL PHYS A-MATER, V83, P195, DOI 10.1007/s00339-006-3507-2; Uchida K, 2003, J EXP ZOOL PART B, V300B, P32, DOI 10.1002/jez.b.00044; von Kupffer C., 1900, STUDIEN VERGLEICHEND; Wang Nian-zhong, 1991, P41; Zhu Min, 2006, Vertebrata Palasiatica, V44, P1	30	84	102	3	112	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 18	2011	476	7360					324	327		10.1038/nature10276	http://dx.doi.org/10.1038/nature10276			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811JV	21850106				2022-12-28	WOS:000294206500036
J	Gortmaker, SL; Swinburn, BA; Levy, D; Carter, R; Mabry, PL; Finegood, DT; Huang, T; Marsh, T; Moodie, ML				Gortmaker, Steven L.; Swinburn, Boyd A.; Levy, David; Carter, Rob; Mabry, Patricia L.; Finegood, Diane T.; Huang, Terry; Marsh, Tim; Moodie, Marjory L.			Obesity 4 Changing the future of obesity: science, policy, and action	LANCET			English	Article							PHYSICAL-ACTIVITY INTERVENTIONS; ASSESSING COST-EFFECTIVENESS; SUGAR-SWEETENED BEVERAGES; PUBLIC-HEALTH; CHILDHOOD OVERWEIGHT; WEIGHT MANAGEMENT; CHRONIC DISEASES; PREVENT OBESITY; US CHILDREN; BURDEN	The global obesity epidemic has been escalating for four decades, yet sustained prevention efforts have barely begun. An emerging science that uses quantitative models has provided key insights into the dynamics of this epidemic, and enabled researchers to combine evidence and to calculate the effect of behaviours, interventions, and policies at several levels from individual to population. Forecasts suggest that high rates of obesity will affect future population health and economics. Energy gap models have quantified the association of changes in energy intake and expenditure with weight change, and have documented the effect of higher intake on obesity prevalence. Empirical evidence that shows interventions are effective is limited but expanding. We identify several cost-effective policies that governments should prioritise for implementation. Systems science provides a framework for organising the complexity of forces driving the obesity epidemic and has important implications for policy makers. Many parties (such as governments, international organisations, the private sector, and civil society) need to contribute complementary actions in a coordinated approach. Priority actions include policies to improve the food and built environments, cross-cutting actions (such as leadership, healthy public policies, and monitoring), and much greater funding for prevention programmes. Increased investment in population obesity monitoring would improve the accuracy of forecasts and evaluations. The integration of actions within existing systems into both health and non-health sectors (trade, agriculture, transport, urban planning, and development) can greatly increase the influence and sustainability of policies. We call for a sustained worldwide effort to monitor, prevent, and control obesity.	[Gortmaker, Steven L.] Harvard Univ, Sch Publ Hlth, Dept Soc Human Dev & Hlth, Boston, MA 02115 USA; [Swinburn, Boyd A.] Deakin Univ, WHO Collaborating Ctr Obes Prevent, Melbourne, Vic, Australia; [Carter, Rob; Moodie, Marjory L.] Deakin Univ, Deakin Hlth Econ, Deakin Populat Hlth, Melbourne, Vic, Australia; [Levy, David] Univ Baltimore, Pacific Inst Res & Evaluat, Baltimore, MD 21201 USA; [Levy, David] Univ Baltimore, Dept Econ, Baltimore, MD 21201 USA; [Mabry, Patricia L.] NIH, Off Behav & Social Sci Res, Bethesda, MD 20892 USA; [Finegood, Diane T.] Simon Fraser Univ, Dept Biomed Physiol & Kinesiol, Vancouver, BC, Canada; [Huang, Terry] Univ Nebraska, Dept Hlth Promot Social & Behav Hlth, Med Ctr, Omaha, NE 68182 USA; [Marsh, Tim] Natl Heart Forum, London, England	Harvard University; Harvard T.H. Chan School of Public Health; Deakin University; World Health Organization; Deakin University; Pacific Institute for Research & Evaluation (PIRE); University System of Maryland; University of Baltimore; University System of Maryland; University of Baltimore; National Institutes of Health (NIH) - USA; Simon Fraser University; University of Nebraska System; University of Nebraska Medical Center	Gortmaker, SL (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Soc Human Dev & Hlth, 665 Huntington Ave, Boston, MA 02115 USA.	sgortmak@hsph.harvard.edu	Levy, David/GPS-4945-2022	Huang, Terry/0000-0001-5544-5187; Moodie, Marjory/0000-0001-6890-5250; Mabry, Patricia/0000-0002-6374-8679; Carter, Rob/0000-0002-1586-5619	National Collaborative on Childhood Obesity Research; RWJF [260639, 61468, 66284]; CDC [U48/DP00064-00S1, 1U48DP001946]; Office of Behavioral and Social Sciences Research of NIH [HHSN276200700356P]; NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO [U48DP001946, U48DP000064] Funding Source: NIH RePORTER	National Collaborative on Childhood Obesity Research; RWJF(Robert Wood Johnson Foundation (RWJF)); CDC(Centre National de la Recherche Scientifique (CNRS)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Office of Behavioral and Social Sciences Research of NIH; NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	We thank William Dietz and Angie Cradock for comments and suggestions. This work was done under the auspices of the Collaborative Obesity Modeling Network as part of the Envision Project, supported by the National Collaborative on Childhood Obesity Research, which coordinates childhood obesity research across the National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), Department of Agriculture, and the Robert Wood Johnson Foundation (RWJF). This work was supported in part by grants from RWJF (#260639, #61468 and #66284), CDC (U48/DP00064-00S1 and 1U48DP001946), including the Nutrition and Obesity Policy, Research and Evaluation Network, and the Office of Behavioral and Social Sciences Research of NIH (#HHSN276200700356P). This work is solely the responsibility of the authors and does not represent official views of the CDC or any of the other funders.	Ahmed F, 2010, NATURE, V468, pS20, DOI 10.1038/468S20a; Ananthapavan J, 2010, SURG OBES RELAT DIS, V6, P377, DOI 10.1016/j.soard.2010.02.040; [Anonymous], 2010, POP BAS PREV STRAT C; Australian Health Ministers' Advisory Council (Breast Cancer Screening Evaluation; Committee), 1990, BREAST CANC SCREEN A; Beaglehole R, 2007, LANCET, V370, P2152, DOI 10.1016/S0140-6736(07)61700-0; Beaglehole R, 2011, LANCET, V377, P1438, DOI 10.1016/S0140-6736(11)60393-0; Bleich S, 2008, ANNU REV PUBL HEALTH, V29, P273, DOI 10.1146/annurev.publhealth.29.020907.090954; Bleich SN, 2009, AM J CLIN NUTR, V89, P372, DOI 10.3945/ajcn.2008.26883; Bouchard C, 2008, OBESITY, V16, pS5, DOI 10.1038/oby.2008.528; Brownell KD, 2009, NEW ENGL J MED, V361, P1599, DOI 10.1056/NEJMhpr0905723; CAIRNS G, 2009, EXTENT NATURE EFFECT; Carter R, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-419; Carter Rob, 2008, Expert Rev Pharmacoecon Outcomes Res, V8, P593, DOI 10.1586/14737167.8.6.593; Cattaneo A, 2010, OBES REV, V11, P389, DOI 10.1111/j.1467-789X.2009.00639.x; Cecchini M, 2010, LANCET, V376, P1775, DOI 10.1016/S0140-6736(10)61514-0; Centers for Disease Control and Prevention, OV OB; Chou SY, 2008, J LAW ECON, V51, P599, DOI 10.1086/590132; Ciampa PJ, 2010, ARCH PEDIAT ADOL MED, V164, P1098, DOI 10.1001/archpediatrics.2010.232; Colquitt JL, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003641.pub3; Committee on Food Marketing and the Diets of Children and Youth, 2006, FOOD MARK CHILDR YOU; Cook TD, 2002, EXPT QUASIEXPERIMENT, P1, DOI 10.1198/jasa.2005.s22; Crowle J, 2010, CHILDHOOD OBESITY EC; Cutler DM, 2003, J ECON PERSPECT, V17, P93, DOI 10.1257/089533003769204371; Eriksson J, 2003, INT J OBESITY, V27, P722, DOI 10.1038/sj.ijo.0802278; Finegood DT, 2011, OXFORD HDB IN PRESS; Finkelstein EA, 2008, OBESITY, V16, P1843, DOI 10.1038/oby.2008.290; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Flegal KM, 2010, AM J CLIN NUTR, V91, P1020, DOI 10.3945/ajcn.2009.28589; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Flodmark CE, 2006, INT J OBESITY, V30, P579, DOI 10.1038/sj.ijo.0803290; Foresight, 2007, TACKL OB FUT CHOIC; George B, 2001, PHARMACOECONOMICS, V19, P1103, DOI 10.2165/00019053-200119110-00004; Gillman MW, 2008, OBESITY, V16, P1651, DOI 10.1038/oby.2008.260; Goris JM, 2010, PUBLIC HEALTH NUTR, V13, P1003, DOI 10.1017/S1368980009992850; Gracey M, 2009, LANCET, V374, P65, DOI 10.1016/S0140-6736(09)60914-4; Guide to Community Preventive Services, 2010, OB PREV CONTR INT CO; Haby MM, 2006, INT J OBESITY, V30, P1463, DOI 10.1038/sj.ijo.0803469; Hall KD, 2011, LANCET, V378, P826, DOI 10.1016/S0140-6736(11)60812-X; Hall KD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007940; HAWE P, 1995, HLTH PROMOT J AUST, V5, P4; Head B., 2008, PUBLIC POLICY, V3, P101, DOI DOI 10.1128/MCB.00567-07; Hoehner CM, 2008, AM J PREV MED, V34, P224, DOI 10.1016/j.amepre.2007.11.016; Homer J, 2006, OB POP DYN EXPL HIST; Howard DH, 2010, HEALTH ECON POLICY L, V5, P411, DOI 10.1017/S1744133110000149; Institute of Medicine, 2010, BRIDG EV GAP OB PREV; Irizarry L. M., 2010, PREVENTING CHILDHOOD, P147; Jha P, 2006, DRUG ALCOHOL REV, V25, P597, DOI 10.1080/09595230600944511; Kelly T, 2008, INT J OBESITY, V32, P1431, DOI 10.1038/ijo.2008.102; Kessler D. A., 2009, END OVEREATING TAKIN; Koplan J., 2005, PREVENTING CHILDHOOD; Lang T, 2007, OBES REV, V8, P165, DOI 10.1111/j.1467-789X.2007.00338.x; Let's Move, 2010, WHIT HOUS TASK FORC; Levy DT, 2011, OBES REV, V12, P378, DOI 10.1111/j.1467-789X.2010.00804.x; Levy DT, 2010, AM J PREV MED, V38, pS373, DOI 10.1016/j.amepre.2009.11.018; Lightwood J, 2009, AM J PUBLIC HEALTH, V99, P2230, DOI 10.2105/AJPH.2008.152595; Lobstein T., 2004, OBESITY REV OFFIC S1, V5, P4, DOI [10.1111/j.1467-789X.2004.00133.x, DOI 10.1111/J.1467-789X.2004.00133.X]; Lobstein T, 2007, INT J PEDIATR OBES, V2, P62, DOI 10.1080/17477160601103948; Loveman E, 2011, HEALTH TECHNOL ASSES, V15, P1, DOI 10.3310/hta15020; Loxley W., 2004, PREVENTION SUBSTANCE; Magnus A, 2009, INT J OBESITY, V33, P1094, DOI 10.1038/ijo.2009.156; McCrory MA, 2002, J NUTR, V132, p3830S, DOI 10.1093/jn/132.12.3830S; McKinnon RA, 2009, AM J PREV MED, V36, P351, DOI 10.1016/j.amepre.2008.11.017; Moodie M, 2010, COMMUNITY BASED OBES, P167; Moodie M, 2008, ECON HUM BIOL, V6, P363, DOI 10.1016/j.ehb.2008.06.001; Moodie ML, 2010, OBESITY, V18, P1585, DOI 10.1038/oby.2009.401; *NAT OB TASKF, 2003, HLTH WEIGHT 2008 AUS; *NHMRC NAT BREAST, 2000, PSYCH CLIN PRACT GUI; NIH Obesity Research Task Force, 2011, STRAT PLAN NIH OB RE; Norris SL, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD004096.pub2, 10.1002/14651858.CD004095.pub2, 10.1002/14651858.CD005270]; Olshansky SJ, 2005, NEW ENGL J MED, V352, P1138, DOI 10.1056/NEJMsr043743; Organization W. H, 2009, 2008 2013 ACT PLAN G; Oude Luttikhuis H, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001872.pub2; Padwal RS, 2003, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD004094.pub2, DOI 10.1002/14651858.CD004094.PUB2]; Prentice A, 2004, NUTR REV, V62, pS98, DOI 10.1111/j.1753-4887.2004.tb00095.x; Reilly JJ, 2003, P NUTR SOC, V62, P611, DOI 10.1079/PNS2003276; Rokholm B, 2010, OBES REV, V11, P835, DOI 10.1111/j.1467-789X.2010.00810.x; Rychetnik L, 2002, J EPIDEMIOL COMMUN H, V56, P119, DOI 10.1136/jech.56.2.119; Sacks G, 2011, INT J OBESITY, V35, P1001, DOI 10.1038/ijo.2010.228; Sacks G, 2009, OBES REV, V10, P76, DOI 10.1111/j.1467-789X.2008.00524.x; Sacks Gary, 2008, Aust New Zealand Health Policy, V5, P13, DOI 10.1186/1743-8462-5-13; Sallis JF, 2000, MED SCI SPORT EXER, V32, P963, DOI 10.1097/00005768-200009000-00012; Sassi F, 2010, OBESITY EC PREVENTIO; Sassi F., 2009, 48 OECD; Seidell JC, 2005, P NUTR SOC, V64, P1, DOI 10.1079/PNS2004402; Shaw K, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003817.pub3; Stahl T, 2010, INTERSECTORAL ACTION; Stewart ST, 2009, NEW ENGL J MED, V361, P2252, DOI 10.1056/NEJMsa0900459; Stuckler D, 2008, LANCET, V372, P1563, DOI 10.1016/S0140-6736(08)61656-6; Subramanian SV, 2011, AM J CLIN NUTR, V93, P413, DOI 10.3945/ajcn.110.004820; Summerbell CD, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001871.pub4, 10.1002/14651858.CD001871.pub2]; Swinburn B, 2005, OBES REV, V6, P23, DOI 10.1111/j.1467-789X.2005.00184.x; Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1; The Auditor-General, 2008, ACT AFT SCH COMM PRO; Thomas D, 2007, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD005105.PUB2; Thow AM, 2010, B WORLD HEALTH ORGAN, V88, P609, DOI 10.2471/BLT.09.070987; Trueman P, 2010, INT J CLIN PRACT, V64, P775, DOI 10.1111/j.1742-1241.2010.02349.x; U.S. Department of Health and Human Services, 2010, SURG GEN VIS HLTH FI; US Department of Health and Human Services, HLTH PEOPL 2010 NUTR; van Baal PHM, 2008, VALUE HEALTH, V11, P1033, DOI 10.1111/j.1524-4733.2008.00328.x; Van Cleave J, 2010, JAMA-J AM MED ASSOC, V303, P623, DOI 10.1001/jama.2010.104; Vartanian LR, 2007, AM J PUBLIC HEALTH, V97, P667, DOI 10.2105/AJPH.2005.083782; Veerman L., 2010, ASSESSING COST EFFEC; Wang YC, 2008, PEDIATRICS, V121, pE1604, DOI 10.1542/peds.2007-2834; Wang YC, 2006, PEDIATRICS, V118, pE1721, DOI 10.1542/peds.2006-0682; Wang YC, 2011, LANCET, V378, P815, DOI 10.1016/S0140-6736(11)60814-3; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; *WHO, 2010, SET REC MARK FOODS N; World Cancer Research Fund & American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P; World Health Organization, 2011, OB OV FACTSH; World Health Organization, 2008, GLOB BURD DIS 2004 U; World Health Organization, 2009, INT DIET PHYS ACT WH; World Health Organization, CHILD GROWTH STAND; World Health Organization (WHO), 2008, FRAM MON EV IMPL GLO; World Public Health Nutrition Association, 2010, UN STAND COMM NUTR I; Yach D, 2010, GLOBALIZATION HEALTH, V6, DOI 10.1186/1744-8603-6-10	115	609	626	2	262	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG-SEP	2011	378	9793					838	847		10.1016/S0140-6736(11)60815-5	http://dx.doi.org/10.1016/S0140-6736(11)60815-5			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	816FY	21872752	Green Accepted			2022-12-28	WOS:000294585300039
J	Llano, R; Kanamori, S; Kunii, O; Mori, R; Takei, T; Sasaki, H; Nakamura, Y; Kurokawa, K; Hai, Y; Chen, L; Takemi, K; Shibuya, K				Llano, Rayden; Kanamori, Sayako; Kunii, Osamu; Mori, Rintaro; Takei, Teiji; Sasaki, Hatoko; Nakamura, Yasuhide; Kurokawa, Kiyoshi; Hai, Yu; Chen, Lincoln; Takemi, Keizo; Shibuya, Kenji			Japan: Universal Health Care at 50 years 5 Re-invigorating Japan's commitment to global health: challenges and opportunities	LANCET			English	Article							DISEASES; G8	Over the past 50 years, Japan has successfully developed and maintained an increasingly equitable system of universal health coverage in addition to achieving the world's highest life expectancy and one of the lowest infant mortality rates. Against this backdrop, Japan is potentially in a position to become a leading advocate for and supporter of global health. Nevertheless, Japan's engagement with global health has not been outstanding relative to its substantial potential, in part because of government fragmentation, a weak civil society, and lack of transparency and assessment. Japan's development assistance for health, from both governmental and non-governmental sectors, has remained low and Japanese global health leadership has been weak. New challenges arising from changes in governance and global and domestic health needs, including the recent Great East Japan Earthquake, now provide Japan with an opportunity to review past approaches to health policy and develop a new strategy for addressing global and national health. The fragmented functioning of the government with regards to global health policy needs to be reconfigured and should be accompanied by further financial commitment to global health priorities, innovative non-governmental sector initiatives, increased research capacity, and investments in good leadership development as witnessed at the G8 Hokkaido Toyako Summit. Should this strategy development and commitment be achieved, Japan has the potential to make substantial contributions to the health of the world as many countries move toward universal coverage and as Japan itself faces the challenge of maintaining its own health system.	[Shibuya, Kenji] Univ Tokyo, Grad Sch Med, Dept Global Hlth Policy, Bunkyo Ku, Tokyo 1130033, Japan; [Kanamori, Sayako] Minist Foreign Affairs Japan, Global Issues Cooperat Div, Int Cooperat Bur, Tokyo, Japan; [Kunii, Osamu] Nagasaki Univ, Inst Trop Med, Nagasaki 852, Japan; [Takei, Teiji] Minist Hlth Labour & Welf Japan, Ministers Secretariat, Int Affairs Div, Tokyo, Japan; [Nakamura, Yasuhide] Osaka Univ, Grad Sch Human Sci, Global Human Study, Osaka, Japan; [Kurokawa, Kiyoshi] Natl Grad Inst Policy Studies, Tokyo, Japan; [Hai, Yu] Zhejiang Univ, Sch Med, Dept Oncol, Hangzhou, Zhejiang, Peoples R China; [Chen, Lincoln] China Med Board, Cambridge, MA USA; [Takemi, Keizo] Tokai Univ, Sch Polit Sci & Econ, Kanagawa 2591100, Japan	University of Tokyo; Nagasaki University; Osaka University; National Graduate Institute for Policy Studies; Zhejiang University; Tokai University	Shibuya, K (corresponding author), Univ Tokyo, Grad Sch Med, Dept Global Hlth Policy, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	shibuyak@m.u-tokyo.ac.jp		Mori, Rintaro/0000-0001-7656-6156; Shibuya, Kenji/0000-0003-2528-7530	Bill & Melinda Gates Foundation; China Medical Board; Ministry of Health, Labour and Welfare [H21-tikyuukibo-ippan-002, H22-seisaku-shitei-033]; Henry Luce Foundation	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); China Medical Board; Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Henry Luce Foundation	This work is in part funded by the Bill & Melinda Gates Foundation and the China Medical Board and in part by research grants from the Ministry of Health, Labour and Welfare (H21-tikyuukibo-ippan-002 and H22-seisaku-shitei-033). RL received financial support from the Henry Luce Foundation for his fellowship at the University of Tokyo. The views expressed in this report are solely those of the authors and do not necessarily represent the decisions or policies of the Government of Japan or the organisations they represent. We thank Yojiro Ishii (JICA) and Sumie Ishii (JOICFP) for their valuable contributions, David Evans (WHO) and Azrul Azwar (University of Indonesia) for their comments, Andrew Stickley for his technical edits, and Tomoko Suzuki and Tadashi Yamamoto (Japan Centre for International Exchange) for their administrative support.	ARASE D, 1994, PAC AFF, V67, P171, DOI 10.2307/2759416; Commission on Human Security, 2003, HUM SEC NOW; Feinberg R. E., 2003, APEC I MULTILATERAL; Fenner Frank, 2006, NATURE NURTURE CHANC; Frenk J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000089; Garrett L, 2007, FOREIGN AFF, V86, P14; GAVI Alliance, GAVI ALL IFFIM OFF C; Geneau R, 2010, LANCET, V376, P1689, DOI 10.1016/S0140-6736(10)61414-6; Gilson Julie, 2003, JPN FORUM, V15, P193, DOI DOI 10.1080/0955580032000108388; Global Business Coalition on HIV/AIDS, SUM CHEM ANN EXP OL; Government of Japan Cabinet Office, PUBL OP POLL INT COO; Hashimoto H, 2011, LANCET, V378, P1174, DOI 10.1016/S0140-6736(11)60987-2; Horton R, 2010, LANCET, V376, P858, DOI 10.1016/S0140-6736(10)61392-X; IHME, 2010, DEV ASS HLTH EST 199; Ikeda N, 2011, LANCET, V378, P1094, DOI 10.1016/S0140-6736(11)61055-6; Ikegami N, 2011, LANCET, V378, P1106, DOI 10.1016/S0140-6736(11)60828-3; ILO, 2008, SOC HLTH PROT ILO ST; Japan Anti-Tuberculosis Association, 2004, OK INF DIS IN SUMM M; Japan Committee for UNICEF, 2009, ANN REP 2009 JAP COM; Japan International Cooperation Agency, MISS STAT; JOICEF HANDS, 2010, STUD JAP GLOB HLTH A; Kawai M., 2004, J INT DEV, V16, P255, DOI DOI 10.1002/JID.1074; Konrad C, 2006, HUMAN SECURITY PERSP, V1, P22; Koplan JP, 2009, LANCET, V373, P1993, DOI 10.1016/S0140-6736(09)60332-9; Koumura M, 2007, LANCET, V370, P1983, DOI 10.1016/S0140-6736(07)61726-7; Kunii O, 2007, TRENDS PARASITOL, V23, P58, DOI 10.1016/j.pt.2006.12.008; Kurokawa K, 2009, LANCET, V373, P526, DOI 10.1016/S0140-6736(09)60180-X; Latko B, 2011, LANCET, V377, P2161, DOI 10.1016/S0140-6736(10)62006-5; Lu CL, 2010, LANCET, V375, P1375, DOI 10.1016/S0140-6736(10)60233-4; MacDonald R, 2008, LANCET, V372, P99, DOI 10.1016/S0140-6736(08)61004-1; McCurry J, 2011, LANCET, V377, P1061, DOI 10.1016/S0140-6736(11)60413-3; Ministry of Foreign Affairs, JAP ODA WHIT PAP 200; Ministry of Foreign Affairs of Japan, 1994, JAP ODA ANN REP; Ministry of Foreign Affairs of Japan, 2003, JAP OFF DEV ASS CHAR; Ministry of Foreign Affairs of Japan, PRESS C MIN FOR AFF; Mori K, 2010, HEALTH POLICY, V94, P54, DOI 10.1016/j.healthpol.2009.08.008; Mori R, 2012, LANCET, V379, P12, DOI 10.1016/S0140-6736(11)60820-9; Murali M S, 2002, Indian J Med Sci, V56, P16; NPOWEB, NEW CHAR TAX REL LAW; Okita S, 1989, INT COOPERATION HLTH; Ravishankar N, 2009, LANCET, V373, P2113, DOI 10.1016/S0140-6736(09)60881-3; Reich MR, 2008, LANCET, V371, P865, DOI 10.1016/S0140-6736(08)60384-0; Reich MR, 2009, LANCET, V373, P508, DOI 10.1016/S0140-6736(08)61899-1; Samarasinghe SdeA, 1989, INT COOPERATION HLTH; Samb B, 2009, LANCET, V373, P2137, DOI 10.1016/S0140-6736(09)60919-3; Sumitomo Chemical, OL MAN AFR; Sumitomo Chemical, SUM CHEM CSR; Takemi K, 2008, LANCET, V372, P13, DOI 10.1016/S0140-6736(08)60971-X; Tamiya N, 2011, LANCET, V378, P1183, DOI 10.1016/S0140-6736(11)61176-8; Togo K, 2010, JAPAN'S FOREIGN POLICY, 1945-2009: THE QUEST FOR A PROACTIVE POLICY, P1, DOI 10.1163/ej.9789004185012.i-484; Tokyo International Conference on African Development, AB TICAD; Trinidad Dennis D., 2007, Asian Perspective, V31, P95; United Nations, COMP SECR REP SECR G; United Nations Population Division, 2011, WORLD POP PROSP 2010; WHO, 2010, WOR HEALT REP, P1; Woods N, 2008, INT AFF, V84, P1205, DOI 10.1111/j.1468-2346.2008.00765.x; World Bank, WORLD DEV IND 2010; Yamahana I, 2011, ASIA EUR J, V8, P453, DOI 10.1007/s10308-010-0285-4	58	9	9	0	15	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 1	2011	378	9798					1255	1264		10.1016/S0140-6736(11)61048-9	http://dx.doi.org/10.1016/S0140-6736(11)61048-9			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	831IO	21885096				2022-12-28	WOS:000295723600028
J	Fabbiano, G; Wang, JF; Elvis, M; Risaliti, G				Fabbiano, G.; Wang, Junfeng; Elvis, M.; Risaliti, G.			A close nuclear black-hole pair in the spiral galaxy NGC 3393	NATURE			English	Article							ACTIVE GALACTIC NUCLEI; X-RAY SOURCE; SYSTEM; REFLECTION; DISCOVERY; BINARIES; NGC-3393; SUZAKU	The current picture of galaxy evolution(1) advocates co-evolution of galaxies and their nuclear massive black holes, through accretion and galactic merging. Pairs of quasars, each with a massive black hole at the centre of its galaxy, have separations of 6,000 to 300,000 light years (refs 2 and 3; 1 parsec = 3.26 light years) and exemplify the first stages of this gravitational interaction. The final stages of the black-hole merging process, through binary black holes and final collapse into a single black hole with gravitational wave emission, are consistent with the sub-light-year separation inferred from the optical spectra(4) and light-variability(5) of two such quasars. The double active nuclei of a few nearby galaxies with disrupted morphology and intense star formation (such as NGC 6240 with a separation(6) of about 2,600 light years and Mrk 463 with a separation(7) of about 13,000 light years between the nuclei) demonstrate the importance of major mergers of equal-mass spiral galaxies in this evolution; such mergers lead to an elliptical galaxy(8), as in the case of the double-radio-nucleus elliptical galaxy 0402+379 (with a separation of about 24 light years between the nuclei)(9). Minor mergers of a spiral galaxy with a smaller companion should be a more common occurrence, evolving into spiral galaxies with active massive black-hole pairs(10), but have hitherto not been seen. Here we report the presence of two active massive black holes, separated by about 490 light years, in the Seyfert(11) galaxy NGC 3393 (50 Mpc, about 160 million light years). The regular spiral morphology and predominantly old circum-nuclear stellar population(12) of this galaxy, and the closeness of the black holes embedded in the bulge, provide a hitherto missing observational point to the study of galaxy/black hole evolution. Comparison of our observations with current theoretical models of mergers suggests that they are the result of minor merger evolution(10).	[Fabbiano, G.; Wang, Junfeng; Elvis, M.; Risaliti, G.] Harvard Smithsonian Ctr Astrophys CfA, Cambridge, MA 02138 USA; [Risaliti, G.] INAF Arcetri, I-50125 Florence, Italy	Harvard University; Smithsonian Institution; Istituto Nazionale Astrofisica (INAF)	Fabbiano, G (corresponding author), Harvard Smithsonian Ctr Astrophys CfA, 60 Garden St, Cambridge, MA 02138 USA.	gfabbiano@cfa.harvard.edu		Risaliti, Guido/0000-0002-3556-977X	NASA	NASA(National Aeronautics & Space Administration (NASA))	This work was supported by a NASA grant (with Principal Investigator J.W.). We thank P. Gandhi for discussions on the 13 mu m observations. We used the NASA ADS and NED services. This work includes archival Chandra and Hubble Space Telescope data. We acknowledge discussions with T. Di Matteo and L. Mayer at the Aspen Center for Physics 2011 Summer Program.	Boroson TA, 2009, NATURE, V458, P53, DOI 10.1038/nature07779; Callegari S, 2011, ASTROPHYS J, V729, DOI 10.1088/0004-637X/729/2/85; Civano F, 2010, ASTROPHYS J, V717, P209, DOI 10.1088/0004-637X/717/1/209; Colpi M., 2009, ADV SCI LETT SPECIAL; Cooke AJ, 2000, ASTROPHYS J SUPPL S, V129, P517, DOI 10.1086/313422; Cusumano G, 2010, ASTRON ASTROPHYS, V524, DOI 10.1051/0004-6361/201015249; DIAZ AI, 1988, ASTRON ASTROPHYS, V195, P53; ELVIS M, 1994, ASTROPHYS J SUPPL S, V95, P1, DOI 10.1086/192093; Fabbiano G, 2003, ASTROPHYS J, V584, pL5, DOI 10.1086/368174; Fernandes RC, 2004, MON NOT R ASTRON SOC, V355, P273, DOI 10.1111/j.1365-2966.2004.08321.x; Fukazawa Y, 2011, ASTROPHYS J, V727, DOI 10.1088/0004-637X/727/1/19; Gandhi P, 2009, ASTRON ASTROPHYS, V502, P457, DOI 10.1051/0004-6361/200811368; GEORGE IM, 1991, MON NOT R ASTRON SOC, V249, P352, DOI 10.1093/mnras/249.2.352; Green PJ, 2010, ASTROPHYS J, V710, P1578, DOI 10.1088/0004-637X/710/2/1578; Guainazzi M, 2005, MON NOT R ASTRON SOC, V356, P295, DOI 10.1111/j.1365-2966.2004.08448.x; HUTCHINGS JB, 1989, ASTRON J, V97, P1306, DOI 10.1086/115073; Komossa S, 2003, ASTROPHYS J, V582, pL15, DOI 10.1086/346145; Kondratko PT, 2008, ASTROPHYS J, V678, P87, DOI 10.1086/586879; Levenson NA, 2006, ASTROPHYS J, V648, P111, DOI 10.1086/505735; MAGDZIARZ P, 1995, MON NOT R ASTRON SOC, V273, P837, DOI 10.1093/mnras/273.3.837; Magorrian J, 1998, ASTRON J, V115, P2285, DOI 10.1086/300353; Maiolino R, 1998, ASTRON ASTROPHYS, V338, P781; Mayer L, 2007, SCIENCE, V316, P1874, DOI 10.1126/science.1141858; Miyazawa T, 2009, PUBL ASTRON SOC JPN, V61, P1331, DOI 10.1093/pasj/61.6.1331; Palmeri P, 2003, ASTRON ASTROPHYS, V410, P359, DOI 10.1051/0004-6361:20031262; Risaliti G, 2009, MON NOT R ASTRON SOC, V393, pL1, DOI 10.1111/j.1745-3933.2008.00580.x; Rodriguez C, 2006, ASTROPHYS J, V646, P49, DOI 10.1086/504825; Schmitt HR, 2001, ASTROPHYS J SUPPL S, V132, P199, DOI 10.1086/318957; Strohmayer TE, 2003, ASTROPHYS J, V586, pL61, DOI 10.1086/374732; Valtonen MJ, 2008, NATURE, V452, P851, DOI 10.1038/nature06896	30	82	83	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 22	2011	477	7365					431	434		10.1038/nature10364	http://dx.doi.org/10.1038/nature10364			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822WH	21881560	Green Submitted			2022-12-28	WOS:000295080500033
J	Trosterman, A				Trosterman, Adam			The art of medicine Just work	LANCET			English	Editorial Material									Univ Colorado Denver, Aurora, CO 80045 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Trosterman, A (corresponding author), Univ Colorado Denver, Aurora, CO 80045 USA.	adam.trosterman@ucdenver.edu							0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 3	2011	378	9794					870	871		10.1016/S0140-6736(11)61403-7	http://dx.doi.org/10.1016/S0140-6736(11)61403-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	818XZ	21898920	Bronze			2022-12-28	WOS:000294791300015
J	Kutateladze, TG				Kutateladze, Tatiana G.			SnapShot: Histone Readers	CELL			English	Editorial Material							CHROMATIN MODIFICATIONS; BINDING MODULES; LANGUAGE; CODE		Univ Colorado, Dept Pharmacol, Sch Med, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus	Kutateladze, TG (corresponding author), Univ Colorado, Dept Pharmacol, Sch Med, Aurora, CO 80045 USA.			Kutateladze, Tatiana/0000-0001-7375-6990	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM096863] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM096863] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Campos EI, 2009, ANNU REV GENET, V43, P559, DOI 10.1146/annurev.genet.032608.103928; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Turner BM, 2002, CELL, V111, P285, DOI 10.1016/S0092-8674(02)01080-2	9	20	20	0	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 2	2011	146	5							842.e1	10.1016/j.cell.2011.08.022	http://dx.doi.org/10.1016/j.cell.2011.08.022			1	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	814SM	21884941	Green Accepted, Bronze			2022-12-28	WOS:000294477500024
J	Mulley, G				Mulley, Graham			PERSONAL VIEW Social care homes: what the media forget to tell us	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Mulley, Graham] Univ Leeds, Leeds LS2 9JT, W Yorkshire, England	University of Leeds	Mulley, G (corresponding author), Univ Leeds, Leeds LS2 9JT, W Yorkshire, England.	G.mulley@btinternet.com							0	4	4	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 31	2011	343								d5391	10.1136/bmj.d5391	http://dx.doi.org/10.1136/bmj.d5391			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	816LE	21880687				2022-12-28	WOS:000294600400003
J	Dickstein, K				Dickstein, Kenneth			Cardiac myosin activation: will theory and practice coincide?	LANCET			English	Editorial Material							SYSTOLIC HEART-FAILURE; MILRINONE; TRIAL		Univ Bergen, Stavanger Univ Hosp, N-4011 Stavanger, Norway	Stavanger University Hospital; University of Bergen	Dickstein, K (corresponding author), Univ Bergen, Stavanger Univ Hosp, N-4011 Stavanger, Norway.	kenneth.dickstein@med.uib.no						Cleland JGF, 2011, LANCET, V378, P676, DOI 10.1016/S0140-6736(11)61126-4; Cuffe MS, 2002, JAMA-J AM MED ASSOC, V287, P1541, DOI 10.1001/jama.287.12.1541; Dickstein K, 2008, EUR J HEART FAIL, V10, P933, DOI 10.1016/j.ejheart.2008.08.005; Felker GM, 2003, J AM COLL CARDIOL, V41, P997, DOI 10.1016/S0735-1097(02)02968-6; Hasenfuss G, 2011, EUR HEART J, V32, P1838, DOI 10.1093/eurheartj/ehr026; Konstam MA, 2007, JAMA-J AM MED ASSOC, V297, P1319, DOI 10.1001/jama.297.12.1319; Malik FI, 2011, SCIENCE, V331, P1439, DOI 10.1126/science.1200113; McMurray JJV, 2010, NEW ENGL J MED, V362, P228, DOI 10.1056/NEJMcp0909392; O'Connor CM, 2011, NEW ENGL J MED, V365, P32, DOI 10.1056/NEJMoa1100171; Shen YT, 2010, CIRC-HEART FAIL, V3, P522, DOI 10.1161/CIRCHEARTFAILURE.109.930321; Teerlink JR, 2011, LANCET, V378, P667, DOI 10.1016/S0140-6736(11)61219-1; Thomas JD, 2006, J AM COLL CARDIOL, V48, P2012, DOI 10.1016/j.jacc.2006.06.071	12	4	4	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 20	2011	378	9792					639	641		10.1016/S0140-6736(11)61298-1	http://dx.doi.org/10.1016/S0140-6736(11)61298-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	815EW	21856465				2022-12-28	WOS:000294509900004
J	Pielke, R				Pielke, Roger, Jr.			John Marburger (1941-2011) OBITUARY	NATURE			English	Biographical-Item									Univ Colorado, Ctr Sci & Technol Policy Res, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	Pielke, R (corresponding author), Univ Colorado, Ctr Sci & Technol Policy Res, Boulder, CO 80309 USA.	pielke@colorado.edu			Direct For Social, Behav & Economic Scie [0830224] Funding Source: National Science Foundation	Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))			0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 18	2011	476	7360					284	284		10.1038/476284a	http://dx.doi.org/10.1038/476284a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811JV	21850096	Bronze			2022-12-28	WOS:000294206500024
J	Berk, M; Malhi, GS				Berk, Michael; Malhi, Gin S.			Should antipsychotics take pole position in mania treatment?	LANCET			English	Editorial Material							INTERNATIONAL SOCIETY; BIPOLAR; GUIDELINES; MOOD		[Berk, Michael] Deakin Univ, Sch Med, Geelong, Vic 3220, Australia; [Berk, Michael] Univ Melbourne, Ctr Youth Mental Hlth, Orygen Youth Hlth Res Ctr, Parkville, Vic 3052, Australia; [Berk, Michael] Univ Melbourne, Dept Psychiat, Parkville, Vic 3052, Australia; [Berk, Michael] Barwon Hlth, Geelong, Vic, Australia; [Berk, Michael] Swanston Ctr, Geelong Clin, Geelong, Vic, Australia; [Berk, Michael] Mental Hlth Res Inst Victoria, Parkville, Vic, Australia; [Malhi, Gin S.] Royal N Shore Hosp, Dept Psychiat, CADE Clin, Sydney, NSW, Australia; [Malhi, Gin S.] Univ Sydney, Sydney Med Sch, Discipline Psychiat, Sydney, NSW 2006, Australia	Deakin University; Orygen, The National Centre of Excellence in Youth Mental Health; University of Melbourne; University of Melbourne; Royal North Shore Hospital; University of Sydney; University of Sydney	Berk, M (corresponding author), Deakin Univ, Sch Med, Geelong, Vic 3220, Australia.	mikebe@barwonhealth.org.au	Berk, Michael/M-3585-2019; Malhi, Gin/Z-2418-2019; Berk, Michael/M-7891-2013	Berk, Michael/0000-0002-5554-6946; Berk, Michael/0000-0002-5554-6946; Malhi, Gin/0000-0002-4524-9091				Cipriani A, 2011, LANCET, V378, P1306, DOI 10.1016/S0140-6736(11)60873-8; Geddes JR, 2010, LANCET, V375, P385, DOI 10.1016/S0140-6736(09)61828-6; Malhi GS, 2009, BIPOLAR DISORD, V11, P55, DOI 10.1111/j.1399-5618.2009.00711.x; Malhi GS, 2009, AUST NZ J PSYCHIAT, V43, P1093; Ng F, 2009, BIPOLAR DISORD, V11, P559, DOI 10.1111/j.1399-5618.2009.00737.x; Yatham LN, 2009, BIPOLAR DISORD, V11, P225, DOI 10.1111/j.1399-5618.2009.00672.x	6	9	9	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 8	2011	378	9799					1279	1281		10.1016/S0140-6736(11)61060-X	http://dx.doi.org/10.1016/S0140-6736(11)61060-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	831IU	21851975				2022-12-28	WOS:000295724300006
J	Obaro, S; Greenwood, B				Obaro, Stephen; Greenwood, Brian			Malaria and bacteraemia in African children	LANCET			English	Editorial Material							SALMONELLA INFECTIONS; GAMBIAN CHILDREN; IMPAIRMENT; MORTALITY		[Obaro, Stephen] Michigan State Univ, Dept Paediat & Human Dev, Div Paediat Infect Dis, E Lansing, MI 48824 USA; [Greenwood, Brian] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London WC1, England	Michigan State University; University of London; London School of Hygiene & Tropical Medicine	Obaro, S (corresponding author), Michigan State Univ, Dept Paediat & Human Dev, Div Paediat Infect Dis, E Lansing, MI 48824 USA.	stephen.obaro@hc.msu.edu						ALONSO PL, 1991, LANCET, V337, P1499, DOI 10.1016/0140-6736(91)93194-E; Cunnington AJ, 2010, EXPERT REV VACCINES, V9, P409, DOI 10.1586/ERV.10.16; GIGLIOLI G, 1972, B WORLD HEALTH ORGAN, V46, P181; GREEN SDR, 1993, ANN TROP PAEDIATR, V13, P45, DOI 10.1080/02724936.1993.11747624; KAYE D, 1967, AM J MED SCI, V254, P205, DOI 10.1097/00000441-196708000-00011; MABEY DCW, 1987, J INFECT DIS, V155, P1319, DOI 10.1093/infdis/155.6.1319; Mackenzie G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010568; Morpeth SC, 2009, CLIN INFECT DIS, V49, P606, DOI 10.1086/603553; Okiro EA, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-151; Roux CM, 2010, INFECT IMMUN, V78, P1520, DOI 10.1128/IAI.00887-09; SCHWARZER E, 1992, J EXP MED, V176, P1033, DOI 10.1084/jem.176.4.1033; Scott JAG, 2011, LANCET, V378, P1316, DOI 10.1016/S0140-6736(11)60888-X; WILLIAMSON WA, 1978, LANCET, V1, P1328	13	5	5	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 8	2011	378	9799					1281	1282		10.1016/S0140-6736(11)61146-X	http://dx.doi.org/10.1016/S0140-6736(11)61146-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	831IU	21903254				2022-12-28	WOS:000295724300007
J	Iglehart, JK				Iglehart, John K.			The Uncertain Future of Medicare and Graduate Medical Education	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PHYSICIANS											[Anonymous], MOMENT TRUTH, V9, P15; *ASS AM MED COLL, 1996, CONS STAT PHYS WORKF; Association of American Medical Colleges, PHYS SHORT WORS INCR; Association of American Medical Colleges, 2011, REC STUD REP PHYS SH; Congressional Budget Office, 2011, RED DEF SPEND REV OP; Cooper RA, 2002, HEALTH AFFAIR, V21, P140, DOI 10.1377/hlthaff.21.1.140; DALL T, 2011, AC HLTH ANN RES M SE; ERIKSON C, 2011, 7 ANN ASS AM MED COL; Goodman DC, 2008, JAMA-J AM MED ASSOC, V299, P335, DOI 10.1001/jama.299.3.335; GOODMAN DC, 2009, LINK WORKF POL HLTH; Henderson TM., 2010, MEDICAID DIRECT INDI; Hofer AN, 2011, MILBANK Q, V89, P69, DOI 10.1111/j.1468-0009.2011.00620.x; Institute of Medicine, 2011, FUT NURS LEAD CHANG; Josiah Macy Jr. Foundation, 2010, ENS EFF PHYS WORKF A; Medicare Payment Advisory Commission, 2008, REP C REF DEL SYST; *R GRAH CTR, 2009, EFF PROP PRIM CAR IN; Sargen M, 2011, J AM COLL SURGEONS, V212, P991, DOI 10.1016/j.jamcollsurg.2011.03.005	17	50	50	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 6	2011	365	14					1340	1345		10.1056/NEJMhpr1107519	http://dx.doi.org/10.1056/NEJMhpr1107519			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	829KL	21899445				2022-12-28	WOS:000295578700015
J	Montgomery, J				Montgomery, John			High-Throughput Discovery of New Chemical Reactions	SCIENCE			English	Editorial Material							LABELING STRATEGY; CATALYSTS; DNA; SELECTION		Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Montgomery, J (corresponding author), Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA.	jmontg@umich.edu	Montgomery, John/G-7460-2016	Montgomery, John/0000-0002-2229-0585				Beeler AB, 2007, J AM CHEM SOC, V129, P1413, DOI 10.1021/ja0674744; Cole BM, 1996, ANGEW CHEM INT EDIT, V35, P1668, DOI 10.1002/anie.199616681; Francis MB, 1999, ANGEW CHEM INT EDIT, V38, P937, DOI 10.1002/(SICI)1521-3773(19990401)38:7<937::AID-ANIE937>3.0.CO;2-O; Goodell JR, 2009, J ORG CHEM, V74, P6169, DOI 10.1021/jo901073v; Kanan MW, 2004, NATURE, V431, P545, DOI 10.1038/nature02920; Markert C, 2008, J AM CHEM SOC, V130, P3234, DOI 10.1021/ja0740317; Miller SJ, 2004, ACCOUNTS CHEM RES, V37, P601, DOI 10.1021/ar030061c; Miller SJ, 2004, NAT BIOTECHNOL, V22, P1378, DOI 10.1038/nbt1104-1378; Reetz MT, 1998, ANGEW CHEM INT EDIT, V37, P2647, DOI 10.1002/(SICI)1521-3773(19981016)37:19<2647::AID-ANIE2647>3.0.CO;2-I; Robbins DW, 2011, SCIENCE, V333, P1423, DOI 10.1126/science.1207922; Rozenman MM, 2007, J AM CHEM SOC, V129, P14933, DOI 10.1021/ja074155j; Szewczyk JW, 2001, ANGEW CHEM INT EDIT, V40, P216, DOI 10.1002/1521-3773(20010105)40:1<216::AID-ANIE216>3.0.CO;2-K; Taylor SJ, 1998, SCIENCE, V280, P267, DOI 10.1126/science.280.5361.267	13	10	11	0	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 9	2011	333	6048					1387	1388		10.1126/science.1210735	http://dx.doi.org/10.1126/science.1210735			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817KU	21903798				2022-12-28	WOS:000294672200025
J	Zipfel, B; DeSilva, JM; Kidd, RS; Carlson, KJ; Churchill, SE; Berger, LR				Zipfel, Bernhard; DeSilva, Jeremy M.; Kidd, Robert S.; Carlson, Kristian J.; Churchill, Steven E.; Berger, Lee R.			The Foot and Ankle of Australopithecus sediba	SCIENCE			English	Article							EVOLUTION; AFARENSIS; ANATOMY; AFRICA	A well-preserved and articulated partial foot and ankle of Australopithecus sediba, including an associated complete adult distal tibia, talus, and calcaneus, have been discovered at the Malapa site, South Africa, and reported in direct association with the female paratype Malapa Hominin 2. These fossils reveal a mosaic of primitive and derived features that are distinct from those seen in other hominins. The ankle (talocrural) joint is mostly humanlike in form and inferred function, and there is some evidence for a humanlike arch and Achilles tendon. However, Au. sediba is apelike in possessing a more gracile calcaneal body and a more robust medial malleolus than expected. These observations suggest, if present models of foot function are correct, that Au. sediba may have practiced a unique form of bipedalism and some degree of arboreality. Given the combination of features in the Au. sediba foot, as well as comparisons between Au. sediba and older hominins, homoplasy is implied in the acquisition of bipedal adaptations in the hominin foot.	[Zipfel, Bernhard; DeSilva, Jeremy M.; Kidd, Robert S.; Carlson, Kristian J.; Churchill, Steven E.; Berger, Lee R.] Univ Witwatersrand, Inst Human Evolut, ZA-2050 Wits, South Africa; [Zipfel, Bernhard] Univ Witwatersrand, Bernard Price Inst Palaeontol Res, Sch Geosci, ZA-2050 Wits, South Africa; [DeSilva, Jeremy M.] Boston Univ, Dept Anthropol, Boston, MA 02215 USA; [Kidd, Robert S.] Univ Western Sydney, Sch Biomed & Hlth Sci, Campbelltown, NSW 2560, Australia; [Carlson, Kristian J.] Indiana Univ, Dept Anthropol, Bloomington, IN 47405 USA; [Churchill, Steven E.] Duke Univ, Dept Evolutionary Anthropol, Durham, NC 27708 USA; [Berger, Lee R.] Univ Witwatersrand, Sch Geosci, ZA-2050 Wits, South Africa	University of Witwatersrand; University of Witwatersrand; Boston University; Western Sydney University; Indiana University System; Indiana University Bloomington; Duke University; University of Witwatersrand	Zipfel, B (corresponding author), Univ Witwatersrand, Inst Human Evolut, PO Wits, ZA-2050 Wits, South Africa.	bernhard.zipfel@wits.ac.za	Berger, Lee Rogers/AAC-3484-2020; Churchill, Steven/AAA-9386-2022	Berger, Lee Rogers/0000-0002-0367-7629; Zipfel, Bernhard/0000-0002-4251-884X	South African Department of Science and Technology; South African National Research Foundation; Institute for Human Evolution, Univ. of the Witwatersrand; National Geographic Society; Palaeontological Scientific Trust; Andrew W. Mellon Foundation; Ford Foundation; U.S. Diplomatic Mission to South Africa; French Embassy of South Africa; Leakey Foundation; Oppenheimer and Ackerman families; R. Branson; Univ. of the Witwatersrand's Schools of Geosciences and Anatomical Sciences; Bernard Price Institute for Palaeontological Research	South African Department of Science and Technology; South African National Research Foundation(National Research Foundation - South Africa); Institute for Human Evolution, Univ. of the Witwatersrand; National Geographic Society(National Geographic Society); Palaeontological Scientific Trust; Andrew W. Mellon Foundation; Ford Foundation; U.S. Diplomatic Mission to South Africa; French Embassy of South Africa; Leakey Foundation; Oppenheimer and Ackerman families; R. Branson; Univ. of the Witwatersrand's Schools of Geosciences and Anatomical Sciences; Bernard Price Institute for Palaeontological Research	We thank the South African Heritage Resources agency for the permits to work at the Malapa site; the Nash family for granting access to the Malapa site and continued support of research on the Malapa and John Nash nature reserves; the South African Department of Science and Technology, the South African National Research Foundation, the Institute for Human Evolution, Univ. of the Witwatersrand, Univ. of the Witwatersrand's Vice Chancellor's Discretionary Fund, the National Geographic Society, the Palaeontological Scientific Trust, the Andrew W. Mellon Foundation, the Ford Foundation, the U.S. Diplomatic Mission to South Africa, the French Embassy of South Africa, the Leakey Foundation, the Oppenheimer and Ackerman families, and R. Branson for funding; the Univ. of the Witwatersrand's Schools of Geosciences and Anatomical Sciences and the Bernard Price Institute for Palaeontological Research for support and facilities; the Gauteng Government, Gauteng Department of Agriculture, Conservation and Environment and the Cradle of Humankind Management Authority; and our respective universities for ongoing support. We also thank S. Potze, L. Kgasi and the Ditsong Museum of Natural History (Pretoria), E. Mbua, P. Kiura, V. Iminjili and the National Museums of Kenya, A. Kwekason, P. Msemwa and the Tanzania Commission for Science and Technology and B. Billings and the Univ. of the Witwatersrand fossil access advisory panel for access to comparative specimens; Y. Haile-Selassie, L. Jellema and the Cleveland Museum of Natural History, J. Chupasko and the Harvard Museum of Comparative Zoology, D. Pilbeam, M. Morgan and the Harvard Peabody Museum, O. Lovejoy, D. Gebo, M. Wolpoff, and staff of the Smithsonian Institution, American Museum of Natural History, Chicago Field Museum, Powell-Cotton Museum, and The Natural History Museum (London) for access to comparative fossil casts, as well as human and ape skeletal specimens. Additionally, we are grateful to the Univ. of Zurich 2010 Field School. Numerous individuals have been involved in the ongoing preparation and excavation of these fossils, including C. Dube, C. Kemp, M. Kgasi, M. Languza, J. Malaza, G. Mokoma, P. Mukanela, T. Nemvhundi, M. Ngcamphalala, S. Jirah, S. Tshabalala, and C. Yates. Other individuals who have given considerable support to this project include B. de Klerk, W. Lawrence, C. Steininger, B. Kuhn, L. Pollarolo, J. Kretzen, D. Conforti, C. Dlamini, H. Visser, B. Nkosi, B. Louw, L. Backwell, F. Thackeray, M. Peltier, J. McCaffery, and R. McCrae-Samuel. J. Smilg facilitated CT scanning of the specimens. Finally, we thank G. Leggott, D. Bullock, and P. Bullock from Rapid3D-produced 3D printouts and R. Wunderlich, C. Ward, T. Kivell, B. Hanson, and four anonymous reviewers for helpful comments.	Berger LR, 2010, SCIENCE, V328, P195, DOI 10.1126/science.1184944; Berillon G., 2003, Human Evolution, V18, P113, DOI 10.1007/BF02436280; DAY MH, 1964, NATURE, V201, P969, DOI 10.1038/201969a0; DAY MH, 1968, MAN, V3, P440, DOI 10.2307/2798879; DeSilva JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014432; DeSilva JM, 2009, P NATL ACAD SCI USA, V106, P6567, DOI 10.1073/pnas.0900270106; DeSilva JM., 2008, THESIS U MICHIGAN; Dirks PHGM, 2010, SCIENCE, V328, P205, DOI 10.1126/science.1184950; GEBO DL, 1992, AM J PHYS ANTHROPOL, V89, P29, DOI 10.1002/ajpa.1330890105; Harcourt-Smith WEH, 2004, J ANAT, V204, P403, DOI 10.1111/j.0021-8782.2004.00296.x; Jones F. Wood, 1944, STRUCTURE FUNCTION S; Kachlik D, 2008, SURG RADIOL ANAT, V30, P347, DOI 10.1007/s00276-008-0335-4; Kibii JM, 2011, SCIENCE, V333, P1407, DOI 10.1126/science.1202521; Kivell TL, 2011, SCIENCE, V333, P1411, DOI 10.1126/science.1202625; LATIMER B, 1987, AM J PHYS ANTHROPOL, V74, P155, DOI 10.1002/ajpa.1330740204; LATIMER B, 1989, AM J PHYS ANTHROPOL, V78, P369, DOI 10.1002/ajpa.1330780306; LEWIS OJ, 1980, J ANAT, V131, P275; Lovejoy C. O, 1978, EARLY HOMINIDS AFRIC, P403; Morton D.J., 1935, HUMAN FOOT ITS EVOLU; Pickering R, 2011, SCIENCE, V333, P1421, DOI 10.1126/science.1203697; SARMIENTO EE, 1983, INT J PRIMATOL, V4, P127, DOI 10.1007/BF02743754; Sellers WI, 2010, INT J PRIMATOL, V31, P321, DOI 10.1007/s10764-010-9396-4; STERN JT, 1983, AM J PHYS ANTHROPOL, V60, P279, DOI 10.1002/ajpa.1330600302; SUSMAN RL, 1983, FOOT ANKLE, V3, P365, DOI 10.1177/107110078300300605; Wunderlich R.E., 1999, THESIS STATE U NEW Y; Zipfel B, 2009, AM J PHYS ANTHROPOL, V140, P532, DOI 10.1002/ajpa.21103	26	121	126	1	82	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 9	2011	333	6048					1417	1420		10.1126/science.1202703	http://dx.doi.org/10.1126/science.1202703			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	817KU	21903807				2022-12-28	WOS:000294672200034
J	Cavalcanti, RB; Detsky, AS				Cavalcanti, Rodrigo B.; Detsky, Allan S.			The Education and Training of Future Physicians Why Coaches Can't Be Judges	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PERSPECTIVES; PERFORMANCE		Univ Toronto, Dept Med, Toronto, ON, Canada; Univ Hlth Network, Dept Med, Toronto, ON, Canada; [Cavalcanti, Rodrigo B.; Detsky, Allan S.] Mt Sinai Hosp, Dept Med, Toronto, ON M5G 1X5, Canada; [Cavalcanti, Rodrigo B.] Univ Hlth Network, Dr Herbert HoPingKong Ctr Excellence Educ & Pract, Toronto, ON, Canada; [Detsky, Allan S.] Univ Toronto, Dept Hlth Policy Management & Evaluat, Toronto, ON, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto	Detsky, AS (corresponding author), 600 Univ Av,Room 429, Toronto, ON M5G 1X5, Canada.	adetsky@mtsinai.on.ca		Cavalcanti, Rodrigo B/0000-0001-8980-159X				Detsky AS, 2009, JAMA-J AM MED ASSOC, V301, P1379, DOI 10.1001/jama.2009.247; Dudek NL, 2005, ACAD MED, V80, pS84, DOI 10.1097/00001888-200510001-00023; Epstein RM, 2007, NEW ENGL J MED, V356, P387, DOI 10.1056/NEJMra054784; Ericsson KA, 2004, ACAD MED, V79, pS70, DOI 10.1097/00001888-200410001-00022; Govaerts MJB, 2007, ADV HEALTH SCI EDUC, V12, P239, DOI 10.1007/s10459-006-9043-1; Kahn MJ, 2001, TEACH LEARN MED, V13, P9, DOI 10.1207/S15328015TLM1301_3; Kogan JR, 2009, JAMA-J AM MED ASSOC, V302, P1316, DOI 10.1001/jama.2009.1365; McLaughlin K, 2009, MED TEACH, V31, P36, DOI 10.1080/01421590802334309; STANGOR C, 1992, PSYCHOL BULL, V111, P42, DOI 10.1037/0033-2909.111.1.42; Watling CJ, 2010, ACAD MED, V85, P1157, DOI 10.1097/ACM.0b013e3181e19722	10	29	30	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 7	2011	306	9					993	994		10.1001/jama.2011.1232	http://dx.doi.org/10.1001/jama.2011.1232			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	815QT	21900141				2022-12-28	WOS:000294542600019
J	Steinberg, MH				Steinberg, Martin H.			Sickle Cell Disease	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							ACUTE CHEST SYNDROME; RISK-FACTOR; ANEMIA; CHILDREN; HYDROXYUREA; STROKE; ADULTS; PAIN; MORTALITY; DEATH							Steinberg, Martin/0000-0001-8800-8020				ADAMS R, 1992, NEW ENGL J MED, V326, P605, DOI 10.1056/NEJM199202273260905; Adams RJ, 2005, NEW ENGL J MED, V353, P2769; Adams RJ, 1998, NEW ENGL J MED, V339, P5, DOI 10.1056/NEJM199807023390102; Atkins RC, 2003, EXPERT OPIN BIOL TH, V3, P1215, DOI 10.1517/eobt.3.8.1215.21287; Ballas SK, 2005, HEMATOL ONCOL CLIN N, V19, P785, DOI 10.1016/j.hoc.2005.07.008; Boyd JH, 2006, BLOOD, V108, P2923, DOI 10.1182/blood-2006-01-011072; Burnett AL, 2006, UROLOGY, V67, P1043, DOI 10.1016/j.urology.2005.11.045; CHARACHE S, 1995, NEW ENGL J MED, V332, P1317, DOI 10.1056/NEJM199505183322001; Ferster A, 2001, BLOOD, V97, P3628, DOI 10.1182/blood.V97.11.3628; Gladwin MT, 2004, NEW ENGL J MED, V350, P886, DOI 10.1056/NEJMoa035477; Halasa NB, 2007, CLIN INFECT DIS, V44, P1428, DOI 10.1086/516781; Hsieh MM, 2009, NEW ENGL J MED, V361, P2309, DOI 10.1056/NEJMoa0904971; Hulbert ML, 2006, J PEDIATR-US, V149, P710, DOI 10.1016/j.jpeds.2006.06.037; KARK JA, 1994, SEMIN HEMATOL, V31, P181; KARK JA, 1987, NEW ENGL J MED, V317, P781, DOI 10.1056/NEJM198709243171301; PARENT F, 2011, NEW ENGL J MED, V36, P544; PLATT OS, 1994, NEW ENGL J MED, V330, P1639, DOI 10.1056/NEJM199406093302303; Quinn CT, 2010, BLOOD, V115, P3447, DOI 10.1182/blood-2009-07-233700; Rogers ZR, 2005, HEMATOL ONCOL CLIN N, V19, P917, DOI 10.1016/j.hoc.2005.08.003; Smith WR, 2008, ANN INTERN MED, V148, P94, DOI 10.7326/0003-4819-148-2-200801150-00004; Steinberg MH, 2009, DISORDERS OF HEMOGLOBIN: GENETICS, PATHOPHYSIOLOGY, AND CLINICAL MANAGEMENT, 2ND EDITION, P525, DOI 10.1017/CBO9780511596582.029; Steinberg MH, 2010, AM J HEMATOL, V85, P403, DOI 10.1002/ajh.21699; Steinberg MH, 2003, JAMA-J AM MED ASSOC, V289, P1645, DOI 10.1001/jama.289.13.1645; Strouse JJ, 2009, AM J HEMATOL, V84, P548, DOI 10.1002/ajh.21476; Taylor JG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002095; VICHINSKY E, 1994, BLOOD, V83, P3107; Vichinsky EP, 2010, JAMA-J AM MED ASSOC, V303, P1823, DOI 10.1001/jama.2010.562; Vichinsky EP, 2000, NEW ENGL J MED, V342, P1855, DOI 10.1056/NEJM200006223422502; VICHINSKY EP, 1995, NEW ENGL J MED, V333, P206, DOI 10.1056/NEJM199507273330402; Voskaridou E, 2010, BLOOD, V115, P2354, DOI 10.1182/blood-2009-05-221333; Wang WC, 2011, LANCET, V377, P1663, DOI 10.1016/S0140-6736(11)60355-3	31	17	17	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 6	2011	155	5								10.7326/0003-4819-155-5-201109060-01003	http://dx.doi.org/10.7326/0003-4819-155-5-201109060-01003			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	815PX	21893620				2022-12-28	WOS:000294538900021
J	Mondragon-Palomino, O; Danino, T; Selimkhanov, J; Tsimring, L; Hasty, J				Mondragon-Palomino, Octavio; Danino, Tal; Selimkhanov, Jangir; Tsimring, Lev; Hasty, Jeff			Entrainment of a Population of Synthetic Genetic Oscillators	SCIENCE			English	Article							REVEALS PERSISTENT; CIRCADIAN-RHYTHMS; CLOCKS; EXPRESSION; CIRCUITS; BIOLOGY; DESIGN; SYSTEM; LIGHT	Biological clocks are self-sustained oscillators that adjust their phase to the daily environmental cycles in a process known as entrainment. Molecular dissection and mathematical modeling of biological oscillators have progressed quite far, but quantitative insights on the entrainment of clocks are relatively sparse. We simultaneously tracked the phases of hundreds of synthetic genetic oscillators relative to a common external stimulus to map the entrainment regions predicted by a detailed model of the clock. Synthetic oscillators were frequency-locked in wide intervals of the external period and showed higher-order resonance. Computational simulations indicated that natural oscillators may contain a positive-feedback loop to robustly adapt to environmental cycles.	[Mondragon-Palomino, Octavio; Danino, Tal; Selimkhanov, Jangir; Hasty, Jeff] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Selimkhanov, Jangir; Tsimring, Lev; Hasty, Jeff] Univ Calif San Diego, San Diego Ctr Syst Biol, La Jolla, CA 92093 USA; [Hasty, Jeff] Univ Calif San Diego, Div Biol Sci, Mol Biol Sect, La Jolla, CA 92093 USA; [Tsimring, Lev; Hasty, Jeff] Univ Calif San Diego, BioCircuits Inst, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Hasty, J (corresponding author), Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA.	hasty@ucsd.edu		Tsimring, Lev/0000-0003-0709-3548	National Institutes of Health and General Medicine [R01GM69811]; San Diego Center for Systems Biology [P50GM085764]; CONACyT (Mexico) [184646]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM085764, R01GM069811] Funding Source: NIH RePORTER	National Institutes of Health and General Medicine; San Diego Center for Systems Biology; CONACyT (Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health and General Medicine (grant R01GM69811), the San Diego Center for Systems Biology (grant P50GM085764), and CONACyT (Mexico, grant 184646 to O.M.-P.). Single-cell data obtained from automated tracking and lineage reconstruction is available online at http://biodynamics.ucsd.edu/downloads.	Abraham U, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.92; Basu S, 2005, NATURE, V434, P1130, DOI 10.1038/nature03461; Bell-Pedersen D, 2005, NAT REV GENET, V6, P544, DOI 10.1038/nrg1633; Boothroyd CE, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030054; Carr AJF, 2005, NAT CELL BIOL, V7, P319, DOI 10.1038/ncb1232; Danino T, 2010, NATURE, V463, P326, DOI 10.1038/nature08753; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Endy D, 2005, NATURE, V438, P449, DOI 10.1038/nature04342; Fischer-Friedrich E, 2010, P NATL ACAD SCI USA, V107, P6134, DOI 10.1073/pnas.0911708107; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Gibson DG, 2010, SCIENCE, V329, P52, DOI 10.1126/science.1190719; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Grilly C, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100168; Hasty J, 2002, NATURE, V420, P224, DOI 10.1038/nature01257; Johnson CH, 2003, CHRONOBIOL INT, V20, P741, DOI 10.1081/CBI-120024211; Mukherji S, 2009, NAT REV GENET, V10, P859, DOI 10.1038/nrg2697; Pikovsky A., 2003, SYNCHRONIZATION UNIV; Rand DA, 2004, J ROY SOC INTERFACE, V1, P119, DOI 10.1098/rsif.2004.0014; Sprinzak D, 2005, NATURE, V438, P443, DOI 10.1038/nature04335; Stricker J, 2008, NATURE, V456, P516, DOI 10.1038/nature07389; Swain PS, 2002, P NATL ACAD SCI USA, V99, P12795, DOI 10.1073/pnas.162041399; Tamsir A, 2011, NATURE, V469, P212, DOI 10.1038/nature09565; Tass P, 1998, PHYS REV LETT, V81, P3291, DOI 10.1103/PhysRevLett.81.3291; Tigges M, 2009, NATURE, V457, P309, DOI 10.1038/nature07616; Welsh DK, 2004, CURR BIOL, V14, P2289, DOI 10.1016/j.cub.2004.11.057; Whitesides GM, 2001, ANNU REV BIOMED ENG, V3, P335, DOI 10.1146/annurev.bioeng.3.1.335; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Zhang EE, 2010, NAT REV MOL CELL BIO, V11, P764, DOI 10.1038/nrm2995	29	123	129	3	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 2	2011	333	6047					1315	1319		10.1126/science.1205369	http://dx.doi.org/10.1126/science.1205369			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	813YM	21885786	Green Accepted			2022-12-28	WOS:000294406400061
J	Postma, E				Postma, Erik			Comment on "Additive Genetic Breeding Values Correlate with the Load of Partially Deleterious Mutations"	SCIENCE			English	Editorial Material							INBREEDING DEPRESSION; SELECTION	Tomkins et al. (Reports, 14 May 2010, p. 892) reported a strong negative correlation between breeding values and mutational load in cow-pea weevils. Here, I show that this result can be attributed to a statistical artifact. By testing the observed correlation against an incorrect null hypothesis, they find a negative correlation where one does not exist.	Univ Zurich, Inst Evolutionary Biol & Environm Studies, CH-8057 Zurich, Switzerland	University of Zurich	Postma, E (corresponding author), Univ Zurich, Inst Evolutionary Biol & Environm Studies, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	erik.postma@ieu.uzh.ch	Postma, Erik/B-7258-2008	Postma, Erik/0000-0003-0856-1294				Barton NH, 2002, NAT REV GENET, V3, P11, DOI 10.1038/nrg700; Booksmythe I, 2010, CURR BIOL, V20, pR672, DOI 10.1016/j.cub.2010.06.055; Fox CW, 2005, AM J BOT, V92, P1929, DOI 10.3732/ajb.92.11.1929; JOHNSTON MO, 1994, EVOLUTION, V48, P1735, DOI 10.1111/j.1558-5646.1994.tb02209.x; Lynch M, 1998, EVOLUTION, V52, P727, DOI 10.1111/j.1558-5646.1998.tb03697.x; Lynch M., 1998, GENETICS ANAL QUANTI; Postma E, 2006, J EVOLUTION BIOL, V19, P309, DOI 10.1111/j.1420-9101.2005.01007.x; Tomkins JL, 2010, SCIENCE, V328, P892, DOI 10.1126/science.1188013	8	4	4	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 2	2011	333	6047								10.1126/science.1200996	http://dx.doi.org/10.1126/science.1200996			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	813YM	21885758	Green Accepted			2022-12-28	WOS:000294406400025
J	Mechanic, RE				Mechanic, Robert E.			Opportunities and Challenges for Episode-Based Payment	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Brandeis Univ, Heller Sch Social Policy & Management, Waltham, MA 02453 USA	Brandeis University	Mechanic, RE (corresponding author), Brandeis Univ, Heller Sch Social Policy & Management, Waltham, MA 02453 USA.							Casale AS, 2007, ANN SURG, V246, P613, DOI 10.1097/SLA.0b013e318155a996; de Brantes F, 2009, NEW ENGL J MED, V361, P1033, DOI 10.1056/NEJMp0906121; Hussey PS, 2009, HEALTH AFFAIR, V28, P1406, DOI 10.1377/hlthaff.28.5.1406; Mechanic RE, 2009, HEALTH AFFAIR, V28, pW262, DOI 10.1377/hlthaff.28.2.w262	4	57	57	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 1	2011	365	9					777	779		10.1056/NEJMp1105963	http://dx.doi.org/10.1056/NEJMp1105963			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	813YC	21864162				2022-12-28	WOS:000294405200001
J	Sigal, A; Kim, JT; Balazs, AB; Dekel, E; Mayo, A; Milo, R; Baltimore, D				Sigal, Alex; Kim, Jocelyn T.; Balazs, Alejandro B.; Dekel, Erez; Mayo, Avi; Milo, Ron; Baltimore, David			Cell-to-cell spread of HIV permits ongoing replication despite antiretroviral therapy	NATURE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; LYMPHOID-TISSUE; TARGET-CELLS; INFECTION; DYNAMICS; RECOMBINATION; LYMPHOCYTES; RESERVOIRS; VIREMIA; HAART	Latency and ongoing replication(1) have both been proposed to explain the drug-insensitive human immunodeficiency virus (HIV) reservoir maintained during antiretroviral therapy. Here we explore a novel mechanism for ongoing HIV replication in the face of antiretroviral drugs. We propose a model whereby multiple infections(2,3) per cell lead to reduced sensitivity to drugs without requiring drug-resistant mutations, and experimentally validate the model using multiple infections per cell by cell-free HIV in the presence of the drug tenofovir. We then examine the drug sensitivity of cell-to-cell spread of HIV(4-7), a mode of HIV transmission that can lead to multiple infection events per target cell(8-10). Infections originating from cell-free virus decrease strongly in the presence of antiretrovirals tenofovir and efavirenz whereas infections involving cell-to-cell spread are markedly less sensitive to the drugs. The reduction in sensitivity is sufficient to keep multiple rounds of infection from terminating in the presence of drugs. We examine replication from cell-to-cell spread in the presence of clinical drug concentrations using a stochastic infection model and find that replication is intermittent, without substantial accumulation of mutations. If cell-to-cell spread has the same properties in vivo, it may have adverse consequences for the immune system(11-13), lead to therapy failure in individuals with risk factors(14), and potentially contribute to viral persistence and hence be a barrier to curing HIV infection.	[Sigal, Alex; Kim, Jocelyn T.; Balazs, Alejandro B.; Baltimore, David] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Kim, Jocelyn T.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Infect Dis, Los Angeles, CA 90095 USA; [Dekel, Erez; Mayo, Avi] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel; [Milo, Ron] Weizmann Inst Sci, Dept Plant Sci, IL-76100 Rehovot, Israel	California Institute of Technology; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Weizmann Institute of Science; Weizmann Institute of Science	Baltimore, D (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	baltimo@caltech.edu	MAYO, AVI E/K-1736-2012; mayo, avi/N-3756-2019; Sigal, Alex/GWC-7488-2022; Milo, Hilla/C-8767-2016	mayo, avi/0000-0002-4479-3423; Sigal, Alex/0000-0001-8571-2004; Balazs, Alejandro/0000-0002-1767-3944; Kim, Jocelyn/0000-0001-7040-5773; Milo, Ron/0000-0003-1641-2299	Human Frontier Science Program [LT00946]; UCLA [T32 AI089398]; amfAR Postdoctoral Research Fellowship [107756-47-RFVA]; Bill & Melinda Gates Foundation; National Institutes of Health [HHSN266200500035C]; National Institute of Allergy and Infectious Diseases; UCLA CFAR Virology Core Lab [P01-AI-28697]; UCSF-GIVI CFAR [P30-AI-27763]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI089398] Funding Source: NIH RePORTER	Human Frontier Science Program(Human Frontier Science Program); UCLA; amfAR Postdoctoral Research Fellowship; Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); UCLA CFAR Virology Core Lab; UCSF-GIVI CFAR; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank B. K. Chen, A. Del Portillo, J. T. Schiffer, L. Corey, and G. Lustig for discussions. A.S. was supported by the Human Frontier Science Program Long Term Fellowship LT00946. J.T.K. was supported by the UCLA STAR fellowship and T32 AI089398. A.B.B. was supported by the amfAR Postdoctoral Research Fellowship 107756-47-RFVA. This work was supported by the Bill & Melinda Gates Foundation and by the National Institutes of Health (HHSN266200500035C) and a contract from the National Institute of Allergy and Infectious Diseases. We acknowledge the support of the UCLA CFAR Virology Core Lab (P01-AI-28697) and the UCSF-GIVI CFAR (P30-AI-27763).	Bailey JR, 2006, J VIROL, V80, P6441, DOI 10.1128/JVI.00591-06; Buzon MJ, 2010, NAT MED, V16, P460, DOI 10.1038/nm.2111; Chen BK, 1996, J VIROL, V70, P6044, DOI 10.1128/JVI.70.9.6044-6053.1996; Chun TW, 2011, J INFECT DIS, V204, P135, DOI 10.1093/infdis/jir208; Collins KL, 1998, NATURE, V391, P397, DOI 10.1038/34929; Cu-Uvin S, 2010, AIDS, V24, P2486, DOI 10.1097/QAD.0b013e32833e5043; Dang Q, 2004, P NATL ACAD SCI USA, V101, P632, DOI 10.1073/pnas.0307636100; Del Portillo A, 2011, J VIROL, V85, P7169, DOI 10.1128/JVI.00231-11; DIMITROV DS, 1993, J VIROL, V67, P2182, DOI 10.1128/JVI.67.4.2182-2190.1993; Dixit NM, 2005, P NATL ACAD SCI USA, V102, P8198, DOI 10.1073/pnas.0407498102; Dixit NM, 2004, J VIROL, V78, P8942, DOI 10.1128/JVI.78.16.8942-8945.2004; Doitsh G, 2010, CELL, V143, P789, DOI 10.1016/j.cell.2010.11.001; Frenkel LM, 2003, J VIROL, V77, P5721, DOI 10.1128/JVI.77.10.5721-5730.2003; Gratton S, 2000, P NATL ACAD SCI USA, V97, P14566, DOI 10.1073/pnas.97.26.14566; Grossman Z, 1999, NAT MED, V5, P1099, DOI 10.1038/13410; Jung A, 2002, NATURE, V418, P144, DOI 10.1038/418144a; Kieffer TL, 2004, J INFECT DIS, V189, P1452, DOI 10.1086/382488; Levy DN, 2004, P NATL ACAD SCI USA, V101, P4204, DOI 10.1073/pnas.0306764101; Martin N, 2010, J VIROL, V84, P3516, DOI 10.1128/JVI.02651-09; Mathias AA, 2007, JAIDS-J ACQ IMM DEF, V46, P167, DOI 10.1097/QAI.0b013e3181427835; North TW, 2010, J VIROL, V84, P2913, DOI 10.1128/JVI.02356-09; Nowak MA., 2000, VIRUS DYNAMICS MATH; Paredes R, 2010, J INFECT DIS, V201, P662, DOI 10.1086/650543; Pierson T, 2000, ANNU REV IMMUNOL, V18, P665, DOI 10.1146/annurev.immunol.18.1.665; Rhee SY, 2003, NUCLEIC ACIDS RES, V31, P298, DOI 10.1093/nar/gkg100; Ribeiro RM, 2010, J VIROL, V84, P6096, DOI 10.1128/JVI.00127-10; Rong LB, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000533; Sattentau Q, 2008, NAT REV MICROBIOL, V6, P815, DOI 10.1038/nrmicro1972; Sourisseau M, 2007, J VIROL, V81, P1000, DOI 10.1128/JVI.01629-06; Wu Y, 2007, CURR HIV RES, V5, P394	30	368	372	3	75	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 1	2011	477	7362					95	U100		10.1038/nature10347	http://dx.doi.org/10.1038/nature10347			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	813XT	21849975				2022-12-28	WOS:000294404300038
J	Burrows, DN; Kennea, JA; Ghisellini, G; Mangano, V; Zhang, B; Page, KL; Eracleous, M; Romano, P; Sakamoto, T; Falcone, AD; Osborne, JP; Campana, S; Beardmore, AP; Breeveld, AA; Chester, MM; Corbet, R; Covino, S; Cummings, JR; D'Avanzo, P; D'Elia, V; Esposito, P; Evans, PA; Fugazza, D; Gelbord, JM; Hiroi, K; Holland, ST; Huang, KY; Im, M; Israel, G; Jeon, Y; Jeon, YB; Jun, HD; Kawai, N; Kim, JH; Krimm, HA; Marshall, FE; Meszaros, P; Negoro, H; Omodei, N; Park, WK; Perkins, JS; Sugizaki, M; Sung, HI; Tagliaferri, G; Troja, E; Ueda, Y; Urata, Y; Usui, R; Antonelli, LA; Barthelmy, SD; Cusumano, G; Giommi, P; Melandri, A; Perri, M; Racusin, JL; Sbarufatti, B; Siegel, MH; Gehrels, N				Burrows, D. N.; Kennea, J. A.; Ghisellini, G.; Mangano, V.; Zhang, B.; Page, K. L.; Eracleous, M.; Romano, P.; Sakamoto, T.; Falcone, A. D.; Osborne, J. P.; Campana, S.; Beardmore, A. P.; Breeveld, A. A.; Chester, M. M.; Corbet, R.; Covino, S.; Cummings, J. R.; D'Avanzo, P.; D'Elia, V.; Esposito, P.; Evans, P. A.; Fugazza, D.; Gelbord, J. M.; Hiroi, K.; Holland, S. T.; Huang, K. Y.; Im, M.; Israel, G.; Jeon, Y.; Jeon, Y. -B.; Jun, H. D.; Kawai, N.; Kim, J. H.; Krimm, H. A.; Marshall, F. E.; Meszaros, P.; Negoro, H.; Omodei, N.; Park, W. -K.; Perkins, J. S.; Sugizaki, M.; Sung, H. -I.; Tagliaferri, G.; Troja, E.; Ueda, Y.; Urata, Y.; Usui, R.; Antonelli, L. A.; Barthelmy, S. D.; Cusumano, G.; Giommi, P.; Melandri, A.; Perri, M.; Racusin, J. L.; Sbarufatti, B.; Siegel, M. H.; Gehrels, N.			Relativistic jet activity from the tidal disruption of a star by a massive black hole	NATURE			English	Article							X-RAY OUTBURSTS; FLARES; NUCLEUS; EVENTS	Supermassive black holes have powerful gravitational fields with strong gradients that can destroy stars that get too close(1,2), producing a bright flare in ultraviolet and X-ray spectral regions from stellar debris that forms an accretion disk around the black hole(3-7). The aftermath of this process may have been seen several times over the past two decades in the form of sparsely sampled, slowly fading emission from distant galaxies(8-14), but the onset of the stellar disruption event has not hitherto been observed. Here we report observations of a bright X-ray flare from the extragalactic transient Swift J164449.3+573451. This source increased in brightness in the X-ray band by a factor of at least 10,000 since 1990 and by a factor of at least 100 since early 2010. We conclude that we have captured the onset of relativistic jet activity from a supermassive black hole. A companion paper(15) comes to similar conclusions on the basis of radio observations. This event is probably due to the tidal disruption of a star falling into a supermassive black hole, but the detailed behaviour differs from current theoretical models of such events.	[Burrows, D. N.; Kennea, J. A.; Eracleous, M.; Falcone, A. D.; Chester, M. M.; Fugazza, D.; Meszaros, P.; Siegel, M. H.] Penn State Univ, Dept Astron & Astrophys, 525 Davey Lab, University Pk, PA 16802 USA; [Ghisellini, G.; Campana, S.; Covino, S.; D'Avanzo, P.; Tagliaferri, G.; Melandri, A.] INAF Osservatorio Astron Brera, I-23807 Merate, Italy; [Mangano, V.; Romano, P.; Cusumano, G.; Sbarufatti, B.] INAF Ist Astrofis Spaziale & Fis Cosm, I-90146 Palermo, Italy; [Zhang, B.] Univ Nevada, Dept Phys & Astron, Las Vegas, NV 89154 USA; [Page, K. L.; Osborne, J. P.; Beardmore, A. P.; Evans, P. A.] Univ Leicester, Dept Phys & Astron, Leicester LE1 7RH, Leics, England; [Sakamoto, T.; Corbet, R.; Cummings, J. R.; Hiroi, K.; Krimm, H. A.; Perkins, J. S.] CRESST, Greenbelt, MD 20771 USA; [Sakamoto, T.; Corbet, R.; Cummings, J. R.; Hiroi, K.; Krimm, H. A.; Marshall, F. E.; Perkins, J. S.; Troja, E.; Barthelmy, S. D.; Racusin, J. L.; Gehrels, N.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Sakamoto, T.; Corbet, R.; Cummings, J. R.; Perkins, J. S.] Univ Maryland, Baltimore, MD 21250 USA; [Breeveld, A. A.] Univ Coll London, Mullard Space Sci Lab, Dorking RH5 6NT, Surrey, England; [D'Elia, V.; Antonelli, L. A.; Giommi, P.; Perri, M.] ASI Sci Data Ctr, I-00044 Frascati, Italy; [Esposito, P.] INAF Osservatorio Astron Cagliari, I-09012 Capoterra, Italy; [Ueda, Y.] Kyoto Univ, Dept Astron, Sakyo Ku, Kyoto 6068502, Japan; [Holland, S. T.; Krimm, H. A.] Univ Space Res Assoc, Columbia, MD 21044 USA; [Huang, K. Y.] Acad Sinica, Inst Astron & Astrophys, Taipei 106, Taiwan; [Im, M.; Jeon, Y.; Jun, H. D.; Kim, J. H.; Park, W. -K.] Seoul Natl Univ, Dept Phys & Astron, FPRD, Ctr Explorat Origin Universe, Seoul, South Korea; [Israel, G.; Antonelli, L. A.] INAF Osservatorio Astron Roma, I-00040 Monte Porzio Catone, Italy; [Jeon, Y.; Sung, H. -I.] Korea Astron & Space Sci Inst KASI, Taejon 305348, South Korea; [Kawai, N.; Usui, R.] Tokyo Inst Technol, Dept Phys, Meguro Ku, Tokyo 1528551, Japan; [Sugizaki, M.] RIKEN, MAXI Team, Wako, Saitama 3510198, Japan; [Negoro, H.] Nihon Univ, Dept Phys, Chiyoda Ku, Tokyo 1018308, Japan; [Omodei, N.] Stanford Univ, Dept Phys, Kavli Inst Particle Astrophys & Cosmol, WW Hansen Expt Phys Lab, Stanford, CA 94305 USA; [Omodei, N.] Stanford Univ, SLAC Natl Accelerator Lab, Stanford, CA 94305 USA; [Urata, Y.] Natl Cent Univ, Inst Astron, Chungli 32054, Taiwan	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Istituto Nazionale Astrofisica (INAF); Istituto Nazionale Astrofisica (INAF); Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; University of Leicester; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University System of Maryland; University of Maryland Baltimore; University of London; University College London; Agenzia Spaziale Italiana (ASI); Istituto Nazionale Astrofisica (INAF); Kyoto University; Universities Space Research Association (USRA); Academia Sinica - Taiwan; Seoul National University (SNU); Istituto Nazionale Astrofisica (INAF); Korea Astronomy & Space Science Institute (KASI); Tokyo Institute of Technology; RIKEN; Nihon University; Stanford University; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; National Central University	Burrows, DN (corresponding author), Penn State Univ, Dept Astron & Astrophys, 525 Davey Lab, University Pk, PA 16802 USA.	burrows@astro.psu.edu	Troja, Eleonora/AAB-3604-2020; Kim, Ji Hoon/A-8989-2009; Kennea, Jamie/AAF-2090-2019; Esposito, Paolo/ABE-6389-2020; Esposito, Paolo/Q-2639-2019; Racusin, Judith L/D-2935-2012; Zhang, Bing/AAG-2824-2019; Jun, Hyunsung/AAH-3501-2019; Covino, Stefano/AAQ-5188-2021; Gehrels, Neil/D-2971-2012; Barthelmy, Scott D/D-2943-2012; Im, Myungshin/B-3436-2013; Campana, Sergio/AAL-6012-2020; Troja, Eleonora/I-5282-2017; Tagliaferri, Gianpiero/ABD-7556-2021; giommi, paolo/L-1006-2018; Sugizaki, Mutsumi/C-5523-2017	Troja, Eleonora/0000-0002-1869-7817; Kim, Ji Hoon/0000-0002-1418-3309; Kennea, Jamie/0000-0002-6745-4790; Esposito, Paolo/0000-0003-4849-5092; Esposito, Paolo/0000-0003-4849-5092; Covino, Stefano/0000-0001-9078-5507; Im, Myungshin/0000-0002-8537-6714; Campana, Sergio/0000-0001-6278-1576; Troja, Eleonora/0000-0002-1869-7817; Tagliaferri, Gianpiero/0000-0003-0121-0723; Beardmore, Andrew/0000-0001-5186-5950; Jun, Hyunsung/0000-0003-1470-5901; Perri, Matteo/0000-0003-3613-4409; Breeveld, Alice/0000-0002-0001-7270; Gelbord, Jonathan/0000-0001-9092-8619; Israel, GianLuca/0000-0001-5480-6438; Mangano, Vanessa/0000-0003-4262-8616; Sbarufatti, Boris/0000-0001-6620-8347; Zhang, Bing/0000-0002-9725-2524; Page, Kim/0000-0001-5624-2613; Omodei, Nicola/0000-0002-5448-7577; Fugazza, Dino Pierluigi/0000-0001-9942-277X; Cusumano, Giancarlo/0000-0002-8151-1990; Evans, Philip/0000-0002-8465-3353; Romano, Patrizia/0000-0003-0258-7469; giommi, paolo/0000-0002-2265-5003; Ghisellini, Gabriele/0000-0002-0037-1974; Melandri, Andrea/0000-0002-2810-2143; Antonelli, Lucio Angelo/0000-0002-5037-9034; D'Avanzo, Paolo/0000-0001-7164-1508; Sugizaki, Mutsumi/0000-0002-1190-0720; Siegel, Michael/0000-0003-1817-3009; D'Elia, Valerio/0000-0002-7320-5862	NASA (US); NSF (US); DOE (US); UK Space Agency; ASI (Italy); INAF (Italy); INFN (Italy); Autonomous Region of Sardinia; MEXT (Japan); KEK (Japan); JAXA (Japan); CRI/NRF/MEST (Korea); NSC (Taiwan); Academia Sinica (Taiwan); CEA/Irfu (France); IN2P3/CNRS (France); CNES (France); K. A. Wallenberg Foundation (Sweden); Swedish Research Council (Sweden); National Space Board (Sweden); UK Space Agency [ST/J000841/1] Funding Source: researchfish; Division Of Astronomical Sciences [0908362] Funding Source: National Science Foundation	NASA (US)(National Aeronautics & Space Administration (NASA)); NSF (US)(National Science Foundation (NSF)); DOE (US)(United States Department of Energy (DOE)); UK Space Agency; ASI (Italy)(Agenzia Spaziale Italiana (ASI)); INAF (Italy)(Istituto Nazionale Astrofisica (INAF)); INFN (Italy)(Istituto Nazionale di Fisica Nucleare (INFN)); Autonomous Region of Sardinia(Regione Sardegna); MEXT (Japan)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); KEK (Japan)(High Energy Accelerator Research Organization (KEK)); JAXA (Japan); CRI/NRF/MEST (Korea)(Ministry of Education, Science & Technology (MEST), Republic of Korea); NSC (Taiwan)(Ministry of Science and Technology, Taiwan); Academia Sinica (Taiwan)(Academia Sinica - Taiwan); CEA/Irfu (France)(French Atomic Energy Commission); IN2P3/CNRS (France)(Centre National de la Recherche Scientifique (CNRS)); CNES (France)(Centre National D'etudes Spatiales); K. A. Wallenberg Foundation (Sweden)(Knut & Alice Wallenberg Foundation); Swedish Research Council (Sweden)(Swedish Research Council); National Space Board (Sweden); UK Space Agency; Division Of Astronomical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We acknowledge support from the following funding agencies: NASA, NSF and DOE (US); the UK Space Agency; ASI, INAF and INFN (Italy); the Autonomous Region of Sardinia; MEXT, KEK and JAXA (Japan); CRI/NRF/MEST (Korea); NSC and Academia Sinica (Taiwan); CEA/Irfu, IN2P3/CNRS and CNES (France); and the K. A. Wallenberg Foundation, the Swedish Research Council and the National Space Board (Sweden). We thank the Swift, Fermi and MAXI operation teams; and we thank A. Read for help with the most recent XMM slew data. We acknowledge the contribution of pre-publication upper limits by the VERITAS Collaboration. Finally, we acknowledge the use of public data from the Swift and Fermi data archives (http://heasarc.nasa.gov/docs/swift/archive/ and http://fermi.gsfc.nasa.gov/ssc/, respectively), as well as data supplied by the UK Swift Science Data Centre at the University of Leicester. E.T. is a NASA Postdoctoral Fellow.	Aliu E., ASTROPHYS J IN PRESS; Barthelmy SD, 2005, SPACE SCI REV, V120, P143, DOI 10.1007/s11214-005-5096-3; Bogdanovic T, 2004, ASTROPHYS J, V610, P707, DOI 10.1086/421758; BOHLIN RC, 1978, ASTROPHYS J, V224, P132, DOI 10.1086/156357; BRANDT WN, 1995, MON NOT R ASTRON SOC, V273, pL47, DOI 10.1093/mnras/273.1.L47; Brassart M, 2010, ASTRON ASTROPHYS, V511, DOI 10.1051/0004-6361/200913442; Burrows DN, 2005, SPACE SCI REV, V120, P165, DOI 10.1007/s11214-005-5097-2; Donley JL, 2002, ASTRON J, V124, P1308, DOI 10.1086/342280; Esquej P, 2007, ASTRON ASTROPHYS, V462, pL49, DOI 10.1051/0004-6361:20066072; EVANS CR, 1989, ASTROPHYS J, V346, pL13, DOI 10.1086/185567; Evans PA, 2009, MON NOT R ASTRON SOC, V397, P1177, DOI 10.1111/j.1365-2966.2009.14913.x; Gezari S, 2008, ASTROPHYS J, V676, P944, DOI 10.1086/529008; Gezari S, 2009, ASTROPHYS J, V698, P1367, DOI 10.1088/0004-637X/698/2/1367; Ghisellini G, 2009, MON NOT R ASTRON SOC, V397, P985, DOI 10.1111/j.1365-2966.2009.15007.x; Goad MR, 2007, ASTRON ASTROPHYS, V476, P1401, DOI 10.1051/0004-6361:20078436; Grindlay JE, 2004, AIP CONF PROC, V714, P413, DOI 10.1063/1.1781064; Guillochon J, 2009, ASTROPHYS J, V705, P844, DOI 10.1088/0004-637X/705/1/844; Komossa S, 1999, ASTRON ASTROPHYS, V343, P775; KRAFT RP, 1991, ASTROPHYS J, V374, P344, DOI 10.1086/170124; Levan AJ, 2011, SCIENCE, V333, P199, DOI 10.1126/science.1207143; Lodato G, 2009, MON NOT R ASTRON SOC, V392, P332, DOI 10.1111/j.1365-2966.2008.14049.x; Lodato G, 2011, MON NOT R ASTRON SOC, V410, P359, DOI 10.1111/j.1365-2966.2010.17448.x; Maksym WP, 2010, ASTROPHYS J, V722, P1035, DOI 10.1088/0004-637X/722/2/1035; Phinney E. S., 1989, IAU S, V136, P543; REES MJ, 1988, NATURE, V333, P523, DOI 10.1038/333523a0; Romano P, 2011, MON NOT R ASTRON SOC, V410, P1825, DOI 10.1111/j.1365-2966.2010.17564.x; Strubbe LE, 2009, MON NOT R ASTRON SOC, V400, P2070, DOI 10.1111/j.1365-2966.2009.15599.x; Ulmer A, 1999, ASTROPHYS J, V514, P180, DOI 10.1086/306909	29	378	381	0	26	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 25	2011	476	7361					421	424		10.1038/nature10374	http://dx.doi.org/10.1038/nature10374			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811KT	21866154	Green Submitted			2022-12-28	WOS:000294209400029
J	Phillips, R				Phillips, Rob			Jonathan Widom (1955-2011) OBITUARY	NATURE			English	Biographical-Item									CALTECH, Pasadena, CA 91125 USA	California Institute of Technology	Phillips, R (corresponding author), CALTECH, Pasadena, CA 91125 USA.	phillips@pboc.caltech.edu						WIDOM J, PUBLICAITON LIST	1	1	1	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 25	2011	476	7361					400	400		10.1038/476400a	http://dx.doi.org/10.1038/476400a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811KT	21866146	Bronze			2022-12-28	WOS:000294209400020
J	Zauderer, BA; Berger, E; Soderberg, AM; Loeb, A; Narayan, R; Frail, DA; Petitpas, GR; Brunthaler, A; Chornock, R; Carpenter, JM; Pooley, GG; Mooley, K; Kulkarni, SR; Margutti, R; Fox, DB; Nakar, E; Patel, NA; Volgenau, NH; Culverhouse, TL; Bietenholz, MF; Rupen, MP; Max-Moerbeck, W; Readhead, ACS; Richards, J; Shepherd, M; Storm, S; Hull, CLH				Zauderer, B. A.; Berger, E.; Soderberg, A. M.; Loeb, A.; Narayan, R.; Frail, D. A.; Petitpas, G. R.; Brunthaler, A.; Chornock, R.; Carpenter, J. M.; Pooley, G. G.; Mooley, K.; Kulkarni, S. R.; Margutti, R.; Fox, D. B.; Nakar, E.; Patel, N. A.; Volgenau, N. H.; Culverhouse, T. L.; Bietenholz, M. F.; Rupen, M. P.; Max-Moerbeck, W.; Readhead, A. C. S.; Richards, J.; Shepherd, M.; Storm, S.; Hull, C. L. H.			Birth of a relativistic outflow in the unusual gamma-ray transient Swift J164449.3+573451	NATURE			English	Article							TIDAL DISRUPTION; BLACK-HOLES; RADIO-SOURCES; GALAXIES; OUTBURST; STARS	Active galactic nuclei, which are powered by long-term accretion onto central supermassive black holes, produce(1) relativistic jets with lifetimes of at least one million years, and the observation of the birth of such a jet is therefore unlikely. Transient accretion onto a supermassive black hole, for example through the tidal disruption(2,3) of a stray star, thus offers a rare opportunity to study the birth of a relativistic jet. On 25 March 2011, an unusual transient source (Swift J164449.3+573451) was found(4), potentially representing(5,6) such an accretion event. Here we report observations spanning centimetre to millimetre wavelengths and covering the first month of evolution of a luminous radio transient associated with Swift J164449.3+573451. The radio transient coincides(7) with the nucleus of an inactive galaxy. We conclude that we are seeing a newly formed relativistic outflow, launched by transient accretion onto a million-solar-mass black hole. A relativistic outflow is not predicted in this situation, but we show that the tidal disruption of a star naturally explains the observed high-energy properties and radio luminosity and the inferred rate of such events. The weaker beaming in the radio-frequency spectrum relative to c-rays or X-rays suggests that radio searches may uncover similar events out to redshifts of z approximate to 6.	[Zauderer, B. A.; Berger, E.; Soderberg, A. M.; Loeb, A.; Narayan, R.; Petitpas, G. R.; Chornock, R.; Patel, N. A.] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [Frail, D. A.; Rupen, M. P.] Natl Radio Astron Observ, Socorro, NM 87801 USA; [Brunthaler, A.] Max Planck Inst Radioastron, D-53121 Bonn, Germany; [Carpenter, J. M.; Mooley, K.; Kulkarni, S. R.; Max-Moerbeck, W.; Readhead, A. C. S.; Richards, J.; Shepherd, M.] CALTECH, Dept Astron, Pasadena, CA 91125 USA; [Pooley, G. G.] Univ Cambridge, Cavendish Lab, Mullard Radio Observ, Cambridge CB3 0HE, England; [Margutti, R.] INAF Osservatorio Astron Brera, I-23807 Merate, Italy; [Fox, D. B.] Penn State Univ, Dept Astron, University Pk, PA 16802 USA; [Nakar, E.] Tel Aviv Univ, Sch Phys & Astron, IL-69978 Tel Aviv, Israel; [Volgenau, N. H.; Culverhouse, T. L.] CALTECH, Owens Valley Radio Observ, Big Pine, CA 93513 USA; [Bietenholz, M. F.] Hartebeesthoek Radio Astron Observ, ZA-1740 Krugersdorp, South Africa; [Bietenholz, M. F.] York Univ, Dept Phys & Astron, Toronto, ON M3J 1P3, Canada; [Storm, S.] Univ Maryland, Dept Astron, College Pk, MD 20742 USA; [Hull, C. L. H.] Univ Calif Berkeley, Dept Astron, Berkeley, CA 94720 USA	Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; National Radio Astronomy Observatory (NRAO); Max Planck Society; California Institute of Technology; University of Cambridge; Istituto Nazionale Astrofisica (INAF); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Tel Aviv University; California Institute of Technology; National Research Foundation - South Africa; Hartebeesthoek Radio Astronomy Observatory; York University - Canada; University System of Maryland; University of Maryland College Park; University of California System; University of California Berkeley	Zauderer, BA (corresponding author), Harvard Smithsonian Ctr Astrophys, 60 Garden St, Cambridge, MA 02138 USA.	bzauderer@cfa.harvard.edu; eberger@cfa.harvard.edu	Max-Moerbeck, Walter/AAU-5773-2020; Max-Moerbeck, Walter/N-8042-2018	Max-Moerbeck, Walter/0000-0002-5491-5244; Max-Moerbeck, Walter/0000-0002-5491-5244; Narayan, Ramesh/0000-0002-1919-2730; Nakar, Ehud/0000-0002-4534-7089; Carpenter, John/0000-0003-2251-0602	NASA; NSF; Ministry of Universities and Research of Italy; IRG; ISF; Smithsonian Institution; Academia Sinica; California Institute of Technology; University of Chicago; states of California, Illinois and Maryland; University of Cambridge; STFC	NASA(National Aeronautics & Space Administration (NASA)); NSF(National Science Foundation (NSF)); Ministry of Universities and Research of Italy; IRG; ISF(Israel Science Foundation); Smithsonian Institution(Smithsonian Institution); Academia Sinica(Academia Sinica - Taiwan); California Institute of Technology; University of Chicago(University of Chicago); states of California, Illinois and Maryland; University of Cambridge(University of Cambridge); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	E.B. is supported in part by funds from NASA. A.L. is supported in part by NSF and NASA grants. R. M. acknowledges support from a Swift ASI grant and from the Ministry of Universities and Research of Italy. E.N. is partly supported by IRG and ISF grants. The EVLA and the Very Long Baseline Array are operated by the NRAO, a facility of the NSF operated under cooperative agreement by the AUI. The SMA is a joint project between the SAO and the ASIAA, and is funded by the Smithsonian Institution and the Academia Sinica. CARMA development and operations are supported by the NSF under a cooperative agreement, and by the Associates of the California Institute of Technology, the University of Chicago and the states of California, Illinois and Maryland. The AMI arrays are supported by the University of Cambridge and the STFC. This work is partly based on observations with the 100-m telescope of the MPIfR at Effelsberg. This work made use of data supplied by the UK Swift Science Data Centre at the University of Leicester.	BEGELMAN MC, 1984, REV MOD PHYS, V56, P255, DOI 10.1103/RevModPhys.56.255; BERGER E, 2011, 11854 GCN; Bloom JS, 2011, SCIENCE, V333, P203, DOI 10.1126/science.1207150; Bower GC, 2011, ASTROPHYS J LETT, V732, DOI 10.1088/2041-8205/732/1/L12; CENKO SB, 2011, MON NOT R ASTR UNPUB; Chevalier RA, 1998, ASTROPHYS J, V499, P810, DOI 10.1086/305676; CORDES JM, 2003, NE2001 I NEW MODEL G; Frail DA, 2000, ASTROPHYS J, V537, P191, DOI 10.1086/309024; Gezari S, 2008, ASTROPHYS J, V676, P944, DOI 10.1086/529008; Goodman J, 2006, ASTROPHYS J, V636, P510, DOI 10.1086/497903; Greene JE, 2007, ASTROPHYS J, V670, P92, DOI 10.1086/522082; HILLS JG, 1975, NATURE, V254, P295, DOI 10.1038/254295a0; Komossa S, 1999, ASTRON ASTROPHYS, V343, P775; Kumar P, 2009, MON NOT R ASTRON SOC, V395, P472, DOI 10.1111/j.1365-2966.2009.14539.x; Levan AJ, 2011, SCIENCE, V333, P199, DOI 10.1126/science.1207143; READHEAD ACS, 1994, ASTROPHYS J, V426, P51, DOI 10.1086/174038; REES MJ, 1988, NATURE, V333, P523, DOI 10.1038/333523a0; Shivvers I, 2011, ASTROPHYS J, V734, DOI 10.1088/0004-637X/734/1/58; Strubbe LE, 2009, MON NOT R ASTRON SOC, V400, P2070, DOI 10.1111/j.1365-2966.2009.15599.x; VANVELZEN S, 2010, OPTICAL DISCOVERY ST; Wang JX, 2004, ASTROPHYS J, V600, P149, DOI 10.1086/379767	21	290	291	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 25	2011	476	7361					425	428		10.1038/nature10366	http://dx.doi.org/10.1038/nature10366			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811KT	21866155	Green Submitted			2022-12-28	WOS:000294209400030
J	Andersen, JL; Kornbluth, S				Andersen, Joshua L.; Kornbluth, Sally			Meeting the (N-Terminal) End with Acetylation	CELL			English	Editorial Material							CYTOCHROME-C; METABOLISM; APOPTOSIS; RELEASE		[Andersen, Joshua L.; Kornbluth, Sally] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA	Duke University	Kornbluth, S (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA.	kornbluth@duke.edu						Arnesen T, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001074; Buchakjian MR, 2010, NAT REV MOL CELL BIO, V11, P715, DOI 10.1038/nrm2972; Cheng EHY, 1996, NATURE, V379, P554, DOI 10.1038/379554a0; Heiden MGV, 2001, J BIOL CHEM, V276, P19414, DOI 10.1074/jbc.M101590200; Janumyan YM, 2003, EMBO J, V22, P5459, DOI 10.1093/emboj/cdg533; Sheridan C, 2008, MOL CELL, V31, P570, DOI 10.1016/j.molcel.2008.08.002; Shimizu S, 1999, NATURE, V399, P483, DOI 10.1038/20959; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097; Yi CH, 2011, CELL, V146, P607, DOI 10.1016/j.cell.2011.06.050; Zorzano A, 2010, SEMIN CELL DEV BIOL, V21, P566, DOI 10.1016/j.semcdb.2010.01.002	10	2	2	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 19	2011	146	4					503	505		10.1016/j.cell.2011.07.024	http://dx.doi.org/10.1016/j.cell.2011.07.024			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	809HY	21854977	Bronze			2022-12-28	WOS:000294043600005
J	Dietz, WH				Dietz, William H.			Reversing the tide of obesity	LANCET			English	Editorial Material									Ctr Dis Control & Prevent, Div Nutr Phys Act & Obes, Atlanta, GA 30341 USA	Centers for Disease Control & Prevention - USA	Dietz, WH (corresponding author), Ctr Dis Control & Prevent, Div Nutr Phys Act & Obes, Atlanta, GA 30341 USA.	wcd4@cdc.gov						Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P986; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Gortmaker SL, 2011, LANCET, V378, P838, DOI 10.1016/S0140-6736(11)60815-5; Green LW, 2006, AM J PUBLIC HEALTH, V96, P406, DOI 10.2105/AJPH.2005.066035; Hall KD, 2011, LANCET, V378, P826, DOI 10.1016/S0140-6736(11)60812-X; Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1; Wang YC, 2011, LANCET, V378, P815, DOI 10.1016/S0140-6736(11)60814-3	7	25	25	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG-SEP	2011	378	9793					744	746		10.1016/S0140-6736(11)61218-X	http://dx.doi.org/10.1016/S0140-6736(11)61218-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	816FY	21872735				2022-12-28	WOS:000294585300005
J	Kofoed, EM; Vance, RE				Kofoed, Eric M.; Vance, Russell E.			Innate immune recognition of bacterial ligands by NAIPs determines inflammasome specificity	NATURE			English	Article							CELL-DEATH; CASPASE-1; ACTIVATION; FLAGELLIN; INTERLEUKIN-1-BETA; SECRETION; BIRC1E	Inflammasomes are a family of cytosolic multiprotein complexes that initiate innate immune responses to pathogenic microbes by activating the caspase 1 protease(1,2). Although genetic data support a critical role for inflammasomes in immune defence and inflammatory diseases(3), the molecular basis by which individual inflammasomes respond to specific stimuli remains poorly understood. The inflammasome that contains the NLRC4 (NLR family, CARD domain containing 4) protein was previously shown to be activated in response to two distinct bacterial proteins, flagellin(4,5) and PrgJ(6), a conserved component of pathogen-associated type III secretion systems. However, direct binding between NLRC4 and flagellin or PrgJ has never been demonstrated. A homologue of NLRC4, NAIP5 (NLR family, apoptosis inhibitory protein 5), has been implicated in activation of NLRC4 (refs 7-11), but is widely assumed to have only an auxiliary role(1,2), as NAIP5 is often dispensable for NLRC4 activation(7,8). However, Naip5 is a member of a small multigene family(12), raising the possibility of redundancy and functional specialization among Naip genes. Here we show in mice that different NAIP paralogues determine the specificity of the NLRC4 inflammasome for distinct bacterial ligands. In particular, we found that activation of endogenous NLRC4 by bacterial PrgJ requires NAIP2, a previously uncharacterized member of the NAIP gene family, whereas NAIP5 and NAIP6 activate NLRC4 specifically in response to bacterial flagellin. We dissected the biochemical mechanism underlying the requirement for NAIP proteins by use of a reconstituted NLRC4 inflammasome system. We found that NAIP proteins control ligand-dependent oligomerization of NLRC4 and that the NAIP2-NLRC4 complex physically associates with PrgJ but not flagellin, whereas NAIP5-NLRC4 associates with flagellin but not PrgJ. Our results identify NAIPs as immune sensor proteins and provide biochemical evidence for a simple receptor-ligand model for activation of the NAIP-NLRC4 inflammasomes.	[Kofoed, Eric M.; Vance, Russell E.] Univ Calif Berkeley, Dept Mol & Cell Biol, Div Immunol & Pathogenesis, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Vance, RE (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Div Immunol & Pathogenesis, 229 Stanley Hall, Berkeley, CA 94720 USA.	rvance@berkeley.edu			Burroughs Wellcome Fund; Cancer Research Institute; NIH [AI075039, AI080749, AI063302]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080749, R01AI075039, P01AI063302] Funding Source: NIH RePORTER	Burroughs Wellcome Fund(Burroughs Wellcome Fund); Cancer Research Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Work in R.E.V.'s laboratory is supported by Investigator Awards from the Burroughs Wellcome Fund and the Cancer Research Institute and by NIH grants AI075039, AI080749 and AI063302. We thank J. von Moltke, A. Kintzer and B. Krantz for provision of reagents; S. Mariathasan and V. Dixit for the gift of anti-NLRC4 antibodies and Nlrc4<SUP>-/-</SUP> mice; J. D. Sauer and D. Portnoy for development of Listeria strains to deliver PrgJ and FlaA; and E. Michelle Long and W. Dietrich for pCDNA3-NAIP constructs and anti-NAIP antibodies. We thank A. Roberts for her initial efforts to knock down NAIP2, M. Fontana for validating NAIP knockdowns, and J. von Moltke and members of the Barton and Vance laboratories for discussions.	Bergsbaken T, 2009, NAT REV MICROBIOL, V7, P99, DOI 10.1038/nrmicro2070; Broz P, 2010, CELL HOST MICROBE, V8, P471, DOI 10.1016/j.chom.2010.11.007; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Damiano JS, 2004, BIOCHEM J, V381, P213, DOI 10.1042/BJ20031506; Diez E, 2003, NAT GENET, V33, P55, DOI 10.1038/ng1065; Franchi L, 2006, NAT IMMUNOL, V7, P576, DOI 10.1038/ni1346; Growney JD, 2000, GENOME RES, V10, P1158, DOI 10.1101/gr.10.8.1158; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Krantz BA, 2005, SCIENCE, V309, P777, DOI 10.1126/science.1113380; Latz E, 2010, CURR OPIN IMMUNOL, V22, P28, DOI 10.1016/j.coi.2009.12.004; Lightfield KL, 2008, NAT IMMUNOL, V9, P1171, DOI 10.1038/ni.1646; Lightfield KL, 2011, INFECT IMMUN, V79, P1606, DOI 10.1128/IAI.01187-10; Lu CF, 2005, BIOCHEM BIOPH RES CO, V331, P1114, DOI 10.1016/j.bbrc.2005.04.027; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Miao EA, 2006, NAT IMMUNOL, V7, P569, DOI 10.1038/ni1344; Miao EA, 2010, P NATL ACAD SCI USA, V107, P3076, DOI 10.1073/pnas.0913087107; Molofsky AB, 2006, J EXP MED, V203, P1093, DOI 10.1084/jem.20051659; Ren T, 2006, PLOS PATHOG, V2, P175, DOI 10.1371/journal.ppat.0020018; Romanish MT, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030010; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Ting JPY, 2006, NAT REV IMMUNOL, V6, P183, DOI 10.1038/nri1788; Wright EK, 2003, CURR BIOL, V13, P27, DOI 10.1016/S0960-9822(02)01359-3; Zamboni DS, 2006, NAT IMMUNOL, V7, P318, DOI 10.1038/ni1305; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831	26	611	629	1	73	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 29	2011	477	7366					592	U356		10.1038/nature10394	http://dx.doi.org/10.1038/nature10394			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825ZM	21874021	Green Accepted			2022-12-28	WOS:000295320900040
J	McGrath, PT; Xu, YF; Ailion, M; Garrison, JL; Butcher, RA; Bargmann, CI				McGrath, Patrick T.; Xu, Yifan; Ailion, Michael; Garrison, Jennifer L.; Butcher, Rebecca A.; Bargmann, Cornelia I.			Parallel evolution of domesticated Caenorhabditis species targets pheromone receptor genes	NATURE			English	Article							ELEGANS DAUER LARVA; MOLECULAR EVOLUTION; COMPONENT; BEHAVIOR; NEURONS; FOOD	Evolution can follow predictable genetic trajectories(1), indicating that discrete environmental shifts can select for reproducible genetic changes(2-4). Conspecific individuals are an important feature of an animal's environment, and a potential source of selective pressures. Here we show that adaptation of two Caenorhabditis species to growth at high density, a feature common to domestic environments, occurs by reproducible genetic changes to pheromone receptor genes. Chemical communication through pheromones that accumulate during high-density growth causes young nematode larvae to enter the long-lived but non-reproductive dauer stage. Two strains of Caenorhabditis elegans grown at high density have independently acquired multigenic resistance to pheromone-induced dauer formation. In each strain, resistance to the pheromone ascaroside C3 results from a deletion that disrupts the adjacent chemoreceptor genes serpentine receptor class g (srg)-36 and -37. Through misexpression experiments, we show that these genes encode redundant G-protein-coupled receptors for ascaroside C3. Multigenic resistance to dauer formation has also arisen in high-density cultures of a different nematode species, Caenorhabditis briggsae, resulting in part from deletion of an srg gene paralogous to srg-36 and srg-37. These results demonstrate rapid remodelling of the chemoreceptor repertoire as an adaptation to specific environments, and indicate that parallel changes to a common genetic substrate can affect life-history traits across species.	[McGrath, Patrick T.; Xu, Yifan; Garrison, Jennifer L.; Bargmann, Cornelia I.] Rockefeller Univ, Lab Neural Circuits & Behav, Howard Hughes Med Inst, New York, NY 10065 USA; [Ailion, Michael] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [Butcher, Rebecca A.] Univ Florida, Dept Chem, Gainesville, FL 32611 USA	Howard Hughes Medical Institute; Rockefeller University; Utah System of Higher Education; University of Utah; State University System of Florida; University of Florida	Bargmann, CI (corresponding author), Rockefeller Univ, Lab Neural Circuits & Behav, Howard Hughes Med Inst, New York, NY 10065 USA.	cori@rockefeller.edu	Ailion, Michael/ABE-6210-2021	Ailion, Michael/0000-0002-8070-1362; Bargmann, Cornelia/0000-0002-8484-0618	Damon Runyon Fellowship; Medical Scientist Training Program (MSTP) [GM07739]; Paul and Daisy Soros Fellowship; National Institutes of Health (NIH) [K99 GM092859]; HHMI;  [R00GM87533]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K99GM092859, R00GM087533, T32GM007739] Funding Source: NIH RePORTER	Damon Runyon Fellowship; Medical Scientist Training Program (MSTP); Paul and Daisy Soros Fellowship; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI(Howard Hughes Medical Institute); ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank N. Lu for the LSJ2 strain, M. Rockman for a qgIR1(X,CB4856>N2) introgression strain, J. Ragains for ascaroside synthesis, H. Hang for assistance in purifying pheromones and S. Dewell, K. Foster, N. Ringstad, A. Bendesky, Y. Saheki, M. Zimmer, S. Crosson, E. Feinberg, E. Toro, M. Rockman and L. Kruglyak for comments and advice. P. T. M. was funded by a Damon Runyon Fellowship. Y. X. was supported by Medical Scientist Training Program (MSTP) grant GM07739 and a Paul and Daisy Soros Fellowship. J. L. G. was an HHMI fellow of the Helen Hay Whitney Foundation and is funded by National Institutes of Health (NIH) K99 GM092859. R. A. B. is supported by R00GM87533. C. I. B. is an investigator of the Howard Hughes Medical Institute. This work was supported by the HHMI.	BARGMANN CI, 1991, SCIENCE, V251, P1243, DOI 10.1126/science.2006412; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Butcher RA, 2008, P NATL ACAD SCI USA, V105, P14288, DOI 10.1073/pnas.0806676105; Butcher RA, 2007, NAT CHEM BIOL, V3, P420, DOI 10.1038/nchembio.2007.3; Butcher RA, 2009, ORG LETT, V11, P3100, DOI 10.1021/ol901011c; Chalasani SH, 2007, NATURE, V450, P63, DOI 10.1038/nature06292; Chan YF, 2010, SCIENCE, V327, P302, DOI 10.1126/science.1182213; Chronis N, 2007, NAT METHODS, V4, P727, DOI 10.1038/NMETH1075; Cutter AD, 2008, MOL BIOL EVOL, V25, P778, DOI 10.1093/molbev/msn024; de Bono M, 1998, CELL, V94, P679, DOI 10.1016/S0092-8674(00)81609-8; FODOR A, 1983, NEMATOLOGICA, V29, P203, DOI 10.1163/187529283X00456; GOLDEN JW, 1982, SCIENCE, V218, P578, DOI 10.1126/science.6896933; GOLDEN JW, 1984, DEV BIOL, V102, P368, DOI 10.1016/0012-1606(84)90201-X; Hilliard MA, 2005, EMBO J, V24, P63, DOI 10.1038/sj.emboj.7600493; Hilliard MA, 2002, CURR BIOL, V12, P730, DOI 10.1016/S0960-9822(02)00813-8; Hu P.J., 2007, DAUER, DOI [10.1895/wormbook.1.144.1, DOI 10.1895/WORMBOOK.1.144.1]; Jeong PY, 2005, NATURE, V433, P541, DOI 10.1038/nature03201; KAPLAN JM, 1993, P NATL ACAD SCI USA, V90, P2227, DOI 10.1073/pnas.90.6.2227; Kim K, 2009, SCIENCE, V326, P994, DOI 10.1126/science.1176331; Kim UK, 2003, SCIENCE, V299, P1221, DOI 10.1126/science.1080190; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; McGrath PT, 2009, NEURON, V61, P692, DOI 10.1016/j.neuron.2009.02.012; Nei M, 2008, NAT REV GENET, V9, P951, DOI 10.1038/nrg2480; Protas ME, 2006, NAT GENET, V38, P107, DOI 10.1038/ng1700; Srinivasan J, 2008, NATURE, V454, P1115, DOI 10.1038/nature07168; Stern DL, 2009, SCIENCE, V323, P746, DOI 10.1126/science.1158997; Stiernagle Theresa, 2006, WormBook, P1; Sucena E, 2003, NATURE, V424, P935, DOI 10.1038/nature01768; Szewczyk NJ, 2003, BMC BIOTECHNOL, V3, DOI 10.1186/1472-6750-3-19; Thomas JH, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-42; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Viney ME, 2003, DEV GROWTH DIFFER, V45, P389, DOI 10.1046/j.1440-169X.2003.00703.x; Waters CM, 2005, ANNU REV CELL DEV BI, V21, P319, DOI 10.1146/annurev.cellbio.21.012704.131001; Weber KP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013922; Woods R, 2006, P NATL ACAD SCI USA, V103, P9107, DOI 10.1073/pnas.0602917103; Yokoyama S, 2000, PROG RETIN EYE RES, V19, P385, DOI 10.1016/S1350-9462(00)00002-1	36	159	166	1	58	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 15	2011	477	7364					321	U92		10.1038/nature10378	http://dx.doi.org/10.1038/nature10378			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819TD	21849976	Green Accepted			2022-12-28	WOS:000294852400029
J	Kivell, TL; Kibii, JM; Churchill, SE; Schmid, P; Berger, LR				Kivell, Tracy L.; Kibii, Job M.; Churchill, Steven E.; Schmid, Peter; Berger, Lee R.			Australopithecus sediba Hand Demonstrates Mosaic Evolution of Locomotor and Manipulative Abilities	SCIENCE			English	Article							OLDUVAI GORGE; MORPHOLOGICAL AFFINITIES; AFARENSIS HAND; SOUTH-AFRICA; TOOL USE; HOMO; REMAINS; ETHIOPIA; BONES; STERKFONTEIN	Hand bones from a single individual with a clear taxonomic affiliation are scarce in the hominin fossil record, which has hampered understanding the evolution of manipulative abilities in hominins. Here we describe and analyze a nearly complete wrist and hand of an adult female [Malapa Hominin 2 (MH2)] Australopithecus sediba from Malapa, South Africa (1.977 million years ago). The hand presents a suite of Australopithecus-like features, such as a strong flexor apparatus associated with arboreal locomotion, and Homo-like features, such as a long thumb and short fingers associated with precision gripping and possibly stone tool production. Comparisons to other fossil hominins suggest that there were at least two distinct hand morphotypes around the Plio-Pleistocene transition. The MH2 fossils suggest that Au. sediba may represent a basal condition associated with early stone tool use and production.	[Kibii, Job M.; Churchill, Steven E.; Schmid, Peter; Berger, Lee R.] Univ Witwatersrand, Inst Human Evolut, ZA-2050 Wits, South Africa; [Kivell, Tracy L.] Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, D-04103 Leipzig, Germany; [Churchill, Steven E.] Duke Univ, Dept Evolutionary Anthropol, Durham, NC 27708 USA; [Schmid, Peter] Univ Zurich, Anthropol Inst & Museum, CH-8057 Zurich, Switzerland; [Berger, Lee R.] Univ Witwatersrand, Sch Geosci, ZA-2050 Wits, South Africa	University of Witwatersrand; Max Planck Society; Duke University; University of Zurich; University of Witwatersrand	Kibii, JM (corresponding author), Univ Witwatersrand, Inst Human Evolut, Private Bag 3, ZA-2050 Wits, South Africa.	job.kibii@wits.ac.za	Kivell, Tracy/D-1225-2010; Churchill, Steven/AAA-9386-2022; Berger, Lee Rogers/AAC-3484-2020	Berger, Lee Rogers/0000-0002-0367-7629	South African Department of Science and Technology; South African National Research Foundation; Institute for Human Evolution, University of the Witwatersrand; University of the Witwatersrand; National Geographic Society; Palaeontological Scientific Trust; Andrew W. Mellon Foundation; Ford Foundation; U.S. Diplomatic Mission to South Africa; French embassy of South Africa; Oppenheimer and Ackerman families; Sir Richard Branson; Witwatersrand's Schools of Geosciences and Anatomical Sciences; Bernard Price Institute for Palaeontology; Gauteng Government; Gauteng Department of Agriculture, Conservation and Environment; Cradle of Humankind Management Authority	South African Department of Science and Technology; South African National Research Foundation(National Research Foundation - South Africa); Institute for Human Evolution, University of the Witwatersrand; University of the Witwatersrand; National Geographic Society(National Geographic Society); Palaeontological Scientific Trust; Andrew W. Mellon Foundation; Ford Foundation; U.S. Diplomatic Mission to South Africa; French embassy of South Africa; Oppenheimer and Ackerman families; Sir Richard Branson; Witwatersrand's Schools of Geosciences and Anatomical Sciences; Bernard Price Institute for Palaeontology; Gauteng Government; Gauteng Department of Agriculture, Conservation and Environment; Cradle of Humankind Management Authority	We thank the South African Heritage Resources Agency for the permits to work at the Malapa site; the Nash family for granting access to the Malapa site and continued support of research on the Malapa and John Nash nature reserves; the South African Department of Science and Technology, the South African National Research Foundation, the Institute for Human Evolution, University of the Witwatersrand, the University of the Witwatersrand's Vice Chancellor's Discretionary Fund, the National Geographic Society, the Palaeontological Scientific Trust, the Andrew W. Mellon Foundation, the Ford Foundation, the U.S. Diplomatic Mission to South Africa, the French embassy of South Africa, the Oppenheimer and Ackerman families, and Sir Richard Branson for funding; the University of the Witwatersrand's Schools of Geosciences and Anatomical Sciences and the Bernard Price Institute for Palaeontology for support and facilities; the Gauteng Government, Gauteng Department of Agriculture, Conservation and Environment and the Cradle of Humankind Management Authority; our respective universities for ongoing support; E. Mbua, P. Kiura, V. Iminjili, and the National Museums of Kenya, B. Billings, B. Zipfel, and the School of Anatomical Sciences at the University of the Witwatersrand, and S. Potze, L. C. Kgasi and the Ditsong Museum for access to comparative fossil specimens; the staff at the Musee royal de l'Afrique central, Museum fur Naturkunde Berlin, Max-Planck-Institute fur evolution re Anthropologie, Powell-Cotton Museum, Universitat Wien, Naturhistorisches Museum Wien, Cleveland Museum of Natural History, Harvard Museum of Comparative Zoology, and Royal Ontario Museum for access to extant comparative material; and the University of Zurich 2010 Field School. Numerous individuals have been involved in the ongoing preparation and excavation of these fossils, including C. Dube, C. Kemp, M. Kgasi, M. Languza, J. Malaza, G. Mokoma, P. Mukanela, T. Nemvhundi,	Alba DM, 2003, J HUM EVOL, V44, P225, DOI 10.1016/S0047-2484(02)00207-5; Almecija S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011727; Berger LR, 2010, SCIENCE, V328, P195, DOI 10.1126/science.1184944; BUSH ME, 1982, AM J PHYS ANTHROPOL, V57, P651, DOI 10.1002/ajpa.1330570410; Clarke RJ, 1999, S AFR J SCI, V95, P477; Drapeau MSM, 2005, J HUM EVOL, V48, P593, DOI 10.1016/j.jhevol.2005.02.005; Green DJ, 2008, J HUM EVOL, V54, P705, DOI 10.1016/j.jhevol.2007.10.007; Jacofsky M.C., 2009, THESIS ARIZONA STATE; Kuman K, 2000, J HUM EVOL, V38, P827, DOI 10.1006/jhev.1999.0392; LEAKEY LSB, 1964, NATURE, V202, P7, DOI 10.1038/202007a0; Leakey MG, 1998, NATURE, V393, P62, DOI 10.1038/29972; Lorenzo C, 1999, J HUM EVOL, V37, P501, DOI 10.1006/jhev.1999.0341; LOVEJOY CO, 2009, SCIENCE, V326; Marzke MW, 1998, AM J PHYS ANTHROPOL, V105, P315, DOI 10.1002/(SICI)1096-8644(199803)105:3<315::AID-AJPA3>3.3.CO;2-D; Marzke MW, 1999, AM J PHYS ANTHROPOL, V110, P163; Marzke MW, 1997, AM J PHYS ANTHROPOL, V102, P91; MARZKE MW, 1983, J HUM EVOL, V12, P197, DOI 10.1016/S0047-2484(83)80025-6; McPherron SP, 2010, NATURE, V466, P857, DOI 10.1038/nature09248; Moore MW, 2009, J HUM EVOL, V57, P503, DOI 10.1016/j.jhevol.2008.10.006; Moya-Sola S, 2008, FOLIA PRIMATOL, V79, P215, DOI 10.1159/000113458; NAPIER J, 1962, NATURE, V196, P409, DOI 10.1038/196409a0; Napier J. R., 1993, HANDS; Pickering R, 2011, SCIENCE, V333, P1421, DOI 10.1126/science.1203697; RICKLAN DE, 1987, J HUM EVOL, V16, P643, DOI 10.1016/0047-2484(87)90018-2; Rolian C, 2011, J HUM EVOL, V61, P26, DOI 10.1016/j.jhevol.2011.01.008; Semaw S, 2003, J HUM EVOL, V45, P169, DOI 10.1016/S0047-2484(03)00093-9; Shrewsbury MM, 2003, AM J PHYS ANTHROPOL, V121, P30, DOI 10.1002/ajpa.10192; SUSMAN RL, 1994, SCIENCE, V265, P1570, DOI 10.1126/science.8079169; Susman RL, 1998, J HUM EVOL, V35, P23, DOI 10.1006/jhev.1998.0220; SUSMAN RL, 1979, AM J PHYS ANTHROPOL, V51, P311, DOI 10.1002/ajpa.1330510303; Susman RL, 2001, J HUM EVOL, V41, P607, DOI 10.1006/jhev.2001.0510; Tocheri M.W., 2007, THESIS ARIZONA STATE; Tocheri MW, 2008, J ANAT, V212, P544, DOI 10.1111/j.1469-7580.2008.00865.x; Tocheri MW, 2007, SCIENCE, V317, P1743, DOI 10.1126/science.1147143; Tocheri MW, 2003, AM J PHYS ANTHROPOL, V122, P101, DOI 10.1002/ajpa.10235; Trinkaus, 2014, SHANIDAR NEANDERTALS; TRINKAUS E, 1990, AM J PHYS ANTHROPOL, V83, P419, DOI 10.1002/ajpa.1330830403; Walker A., 1993, NARIOKOTOME HOMO ERE; Ward CV, 1999, J HUM EVOL, V36, P69, DOI 10.1006/jhev.1998.0262; Ward CV, 2002, YEARB PHYS ANTHROPOL, V45, P185, DOI 10.1002/ajpa.10185; Zipfel B, 2011, SCIENCE, V333, P1417, DOI 10.1126/science.1202703	41	155	163	2	90	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 9	2011	333	6048					1411	1417		10.1126/science.1202625	http://dx.doi.org/10.1126/science.1202625			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	817KU	21903806				2022-12-28	WOS:000294672200033
J	Zimmerman, PD				Zimmerman, Peter D.			Homeland insecurity	NATURE			English	Editorial Material									Kings Coll London, Dept War Studies, London WC2R 2LS, England	University of London; King's College London	Zimmerman, PD (corresponding author), Kings Coll London, Dept War Studies, London WC2R 2LS, England.	peter.zimmerman@cox.net							0	0	0	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 8	2011	477	7363					153	154		10.1038/477153a	http://dx.doi.org/10.1038/477153a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	816MC	21900991	Bronze			2022-12-28	WOS:000294603900012
J	West, CP; Shanafelt, TD; Kolars, JC				West, Colin P.; Shanafelt, Tait D.; Kolars, Joseph C.			Quality of Life, Burnout, Educational Debt, and Medical Knowledge Among Internal Medicine Residents	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							IN-TRAINING EXAMINATION; UNITED-STATES; CAREER SATISFACTION; PHYSICIANS; PERFORMANCE; STRESS; ASSOCIATION; DISTRESS; STUDENTS; AMERICA	Context Physician distress is common and has been associated with negative effects on patient care. However, factors associated with resident distress and wellbeing have not been well described at a national level. Objectives To measure well-being in a national sample of internal medicine residents and to evaluate relationships with demographics, educational debt, and medical knowledge. Design, Setting, and Participants Study of internal medicine residents using data collected on 2008 and 2009 Internal Medicine In-Training Examination (IM-ITE) scores and the 2008 IM-ITE survey. Participants were 16 394 residents, representing 74.1% of all eligible US internal medicine residents in the 2008-2009 academic year. This total included 7743 US medical graduates and 8571 international medical graduates. Main Outcome Measures Quality of life (QOL) and symptoms of burnout were assessed, as were year of training, sex, medical school location, educational debt, and IM-ITE score reported as percentage of correct responses. Results Quality of life was rated "as bad as it can be" or "somewhat bad" by 2402 of 16 187 responding residents (14.8%). Overall burnout and high levels of emotional exhaustion and depersonalization were reported by 8343 of 16 192 (51.5%), 7394 of 16 154 (45.8%), and 4541 of 15 737 (28.9%) responding residents, respectively. In multivariable models, burnout was less common among international medical graduates than among US medical graduates (45.1% vs 58.7%; odds ratio, 0.70 [99% CI, 0.63-0.77]; P < .001). Greater educational debt was associated with the presence of at least 1 symptom of burnout (61.5% vs 43.7%; odds ratio, 1.72 [99% CI, 1.49-1.99]; P < .001 for debt >$200 000 relative to no debt). Residents reporting QOL "as bad as it can be" and emotional exhaustion symptoms daily had mean IM-ITE scores 2.7 points (99% CI, 1.2-4.3; P < .001) and 4.2 points (99% CI, 2.5-5.9; P < .001) lower than those with QOL "as good as it can be" and no emotional exhaustion symptoms, respectively. Residents reporting debt greater than $200 000 had mean IM-ITE scores 5.0 points (99% CI, 4.4-5.6; P < .001) lower than those with no debt. These differences were similar in magnitude to the 4.1 point (99% CI, 3.9-4.3) and 2.6-point (99% CI, 2.4-2.8) mean differences associated with progressing from first to second and second to third years of training, respectively. Conclusions In this national study of internal medicine residents, suboptimal QOL and symptoms of burnout were common. Symptoms of burnout were associated with higher debt and were less frequent among international medical graduates. Low QOL, emotional exhaustion, and educational debt were associated with lower IM-ITE scores. JAMA. 2011;306(9):952-960	[West, Colin P.] Mayo Clin, Dept Med, Div Gen Internal Med, Rochester, MN 55905 USA; [Shanafelt, Tait D.] Mayo Clin, Div Hematol, Rochester, MN 55905 USA; [West, Colin P.] Mayo Clin, Dept Hlth Sci Res, Div Biomed Stat & Informat, Rochester, MN 55905 USA; [Kolars, Joseph C.] Univ Michigan, Sch Med, Dept Med, Div Gastroenterol, Ann Arbor, MI 48104 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; University of Michigan System; University of Michigan	West, CP (corresponding author), Mayo Clin, Dept Med, Div Gen Internal Med, 200 1st St SW, Rochester, MN 55905 USA.	west.colin@mayo.edu		Kolars, Joseph/0000-0002-2603-188X	Mayo Clinic Department of Medicine	Mayo Clinic Department of Medicine	This work was supported by the Mayo Clinic Department of Medicine Program on Physician Well-being. Data from IM-ITE surveys were used for this study with special permission from the American College of Physicians. Further use of these data without permission is prohibited.	Adashi EY, 2010, ACAD MED, V85, P763, DOI 10.1097/ACM.0b013e3181d5cff7; American College of Physicians, INT MED IN TRAIN EX; Andriole DA, 2010, JAMA-J AM MED ASSOC, V304, P1212, DOI 10.1001/jama.2010.1321; [Anonymous], RES DUT HOURS ENH SL; Brotherton SE, 2009, JAMA-J AM MED ASSOC, V302, P1357, DOI 10.1001/jama.2009.1221; Collier VU, 2002, ANN INTERN MED, V136, P384, DOI 10.7326/0003-4819-136-5-200203050-00011; Dyrbye LN, 2006, MAYO CLIN PROC, V81, P1435, DOI 10.4065/81.11.1435; Dyrbye LN, 2010, JAMA-J AM MED ASSOC, V304, P1173, DOI 10.1001/jama.2010.1318; Dyrbye LN, 2005, MAYO CLIN PROC, V80, P1613, DOI 10.4065/80.12.1613; Eckleberry-Hunt J, 2009, ACAD MED, V84, P269, DOI 10.1097/ACM.0b013e3181938a45; Fahrenkopf AM, 2008, BRIT MED J, V336, P488, DOI 10.1136/bmj.39469.763218.BE; Fiscella K, 2000, JAMA-J AM MED ASSOC, V283, P1751, DOI 10.1001/jama.283.13.1751; Friedlander MJ, 2011, ACAD MED, V86, P415, DOI 10.1097/ACM.0b013e31820dc197; GARIBALDI RA, 1994, ANN INTERN MED, V121, P117, DOI 10.7326/0003-4819-121-2-199407150-00008; Garibaldi RA, 2002, ANN INTERN MED, V137, P505, DOI 10.7326/0003-4819-137-6-200209170-00011; Gozu A, 2009, ACAD MED, V84, P385, DOI 10.1097/ACM.0b013e318197321b; Gudex C, 1996, QUAL LIFE RES, V5, P521, DOI 10.1007/BF00439226; Haas JS, 2000, J GEN INTERN MED, V15, P122, DOI 10.1046/j.1525-1497.2000.02219.x; Jolly P, 2005, HEALTH AFFAIR, V24, P527, DOI 10.1377/hlthaff.24.2.527; Keeton K, 2007, OBSTET GYNECOL, V109, P949, DOI 10.1097/01.AOG.0000258299.45979.37; LeBlanc VR, 2009, ACAD MED, V84, pS25, DOI 10.1097/ACM.0b013e3181b37b8f; LINN LS, 1985, JAMA-J AM MED ASSOC, V254, P2775, DOI 10.1001/jama.254.19.2775; Linzer M, 2001, AM J MED, V111, P170, DOI 10.1016/S0002-9343(01)00814-2; McMahon GT, 2004, NEW ENGL J MED, V350, P2435, DOI 10.1056/NEJMp038221; Mitchell M, 2005, ACAD MED, V80, P376, DOI 10.1097/00001888-200504000-00016; RAFFERTY JP, 1986, J CLIN PSYCHOL, V42, P488, DOI 10.1002/1097-4679(198605)42:3<488::AID-JCLP2270420315>3.0.CO;2-S; Rummans TA, 2006, J CLIN ONCOL, V24, P635, DOI 10.1200/JCO.2006.06.209; Schaufeli W.B., 1996, MASLACH BURNOUT INVE, V3rd, P22; Shanafelt TD, 2003, AM J MED, V114, P513, DOI 10.1016/S0002-9343(03)00117-7; Shanafelt TD, 2002, ANN INTERN MED, V136, P358, DOI 10.7326/0003-4819-136-5-200203050-00008; SPITZER WO, 1981, J CHRON DIS, V34, P585, DOI 10.1016/0021-9681(81)90058-8; Steinbrook R, 2008, NEW ENGL J MED, V359, P2629, DOI 10.1056/NEJMp0808520; Thomas NK, 2004, JAMA-J AM MED ASSOC, V292, P2880, DOI 10.1001/jama.292.23.2880; West CP, 2010, MED EDUC, V44, P1224, DOI 10.1111/j.1365-2923.2010.03803.x; West CP, 2009, J GEN INTERN MED, V24, P1318, DOI 10.1007/s11606-009-1129-z; West Colin P, 2007, Minn Med, V90, P44; West CP, 2009, JAMA-J AM MED ASSOC, V302, P1294, DOI 10.1001/jama.2009.1389; Whelan GP, 2006, ACAD MED, V81, P176, DOI 10.1097/00001888-200602000-00017; Xu G, 1998, ACAD MED, V73, P119, DOI 10.1097/00001888-199802000-00006	39	426	441	2	60	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 7	2011	306	9					952	960		10.1001/jama.2011.1247	http://dx.doi.org/10.1001/jama.2011.1247			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	815QT	21900135	Bronze			2022-12-28	WOS:000294542600013
J	Moosig, F; Gross, WL; Herrmann, K; Bremer, JP; Hellmich, B				Moosig, Frank; Gross, Wolfgang Ludwig; Herrmann, Kristina; Bremer, Jan Phillip; Hellmich, Bernhard			Targeting Interleukin-5 in Refractory and Relapsing Churg-Strauss Syndrome	ANNALS OF INTERNAL MEDICINE			English	Letter							MEPOLIZUMAB		[Moosig, Frank; Gross, Wolfgang Ludwig; Herrmann, Kristina; Bremer, Jan Phillip] Univ Lubeck, D-24576 Bad Bramstedt, Germany; [Moosig, Frank; Gross, Wolfgang Ludwig; Herrmann, Kristina; Bremer, Jan Phillip] Clin Bad Bramstedt, D-24576 Bad Bramstedt, Germany; [Hellmich, Bernhard] Univ Tubingen, D-73207 Tubingen, Germany; [Hellmich, Bernhard] Hosp Plochingen, D-73207 Tubingen, Germany	University of Lubeck; Eberhard Karls University of Tubingen	Moosig, F (corresponding author), Univ Lubeck, D-24576 Bad Bramstedt, Germany.		Gross, Wolfgang Ludwig WG/C-8733-2011; Moosig, Frank/C-8750-2011; Bremer, Phillip/AAE-7842-2020	Moosig, Frank/0000-0002-7341-9844				Hellmich B, 2005, ANN NY ACAD SCI, V1051, P121, DOI 10.1196/annals.1361.053; Kim S, 2010, J ALLERGY CLIN IMMUN, V125, P1336, DOI 10.1016/j.jaci.2010.03.028; Rothenberg ME, 2008, NEW ENGL J MED, V358, P1215, DOI 10.1056/NEJMoa070812; Tatsis E, 1998, ANN INTERN MED, V129, P370, DOI 10.7326/0003-4819-129-5-199809010-00004	4	151	161	1	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 6	2011	155	5					341	343		10.7326/0003-4819-155-5-201109060-00026	http://dx.doi.org/10.7326/0003-4819-155-5-201109060-00026			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	815PX	21893636				2022-12-28	WOS:000294538900020
J	Vaidya, D; Becker, DM; Bittner, V; Mathias, RA; Ouyang, P				Vaidya, Dhananjay; Becker, Diane M.; Bittner, Vera; Mathias, Rasika A.; Ouyang, Pamela			Ageing, menopause, and ischaemic heart disease mortality in England, Wales, and the United States: modelling study of national mortality data	BMJ-BRITISH MEDICAL JOURNAL			English	Article								Objectives To use changes in heart disease mortality rates with age to investigate the plausibility of attributing women's lower heart disease mortality than men to the protective effects of premenopausal sex hormones. Design Modelling study of longitudinal mortality data with models assuming (i) a linear association between mortality rates and age (absolute mortality) or (ii) a logarithmic association (proportional mortality). We fitted models to age and sex specific mortality rates in the census years 1950 to 2000 for three birth cohorts (1916-25, 1926-35, and 1936-45). Data sources UK Office for National Statistics and the US National Center for Health Statistics. Main outcome measure(s) Fit of models to data for England and Wales and for the US. Results For England-Wales data, proportional increases in ischaemic heart disease mortality fitted the data better than absolute increases (improvement in deviance statistics: women, 58 logarithmic units; men, 37). We identified a deceleration in male mortality after age 45 years (decreasing from 30.3% to 5.2% per age-year, P=0.042), although the corresponding difference in women was non-significant (P=0.43, overall trend 7.9% per age-year, P<0.001). By contrast, female breast cancer mortality decelerated significantly after age 45 years (decreasing from 19.3% to 2.6% per age-year, P<0.001). We found similar results in US data. Conclusions Proportional age related changes in ischaemic heart disease mortality, suggesting a loss of reparative reserve, fit longitudinal mortality data from England, Wales, and the United States better than absolute age related changes in mortality. Acceleration in male heart disease mortality at younger ages could explain sex differences rather than any menopausal changes in women.	[Vaidya, Dhananjay; Becker, Diane M.; Mathias, Rasika A.; Ouyang, Pamela] Johns Hopkins Univ Hosp, Sch Med, Baltimore, MD 21287 USA; [Bittner, Vera] Univ Alabama Birmingham, Birmingham, AL USA	Johns Hopkins University; Johns Hopkins Medicine; University of Alabama System; University of Alabama Birmingham	Vaidya, D (corresponding author), Johns Hopkins Univ Hosp, Sch Med, Baltimore, MD 21287 USA.	dvaidya1@jhmi.edu	Vaidya, Dhananjay/AAL-5684-2020	Vaidya, Dhananjay/0000-0002-7164-1601; Bittner, Vera/0000-0001-9456-850X	National Center for Research Resources a component of the National Institutes of Health [UL1 RR 025005]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025005] Funding Source: NIH RePORTER	National Center for Research Resources a component of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	DV was supported by the National Center for Research Resources (grant No UL1 RR 025005), a component of the National Institutes of Health.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Anversa P, 2006, CIRCULATION, V113, P1451, DOI 10.1161/CIRCULATIONAHA.105.595181; BarrettConnor E, 1997, CIRCULATION, V95, P252, DOI 10.1161/01.CIR.95.1.252; Bittner V, 2009, J AM COLL CARDIOL, V54, P2374, DOI 10.1016/j.jacc.2009.10.008; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Chimenti C, 2003, CIRC RES, V93, P604, DOI 10.1161/01.RES.0000093985.76901.AF; DODD GD, 1992, CANCER, V69, P1885, DOI 10.1002/1097-0142(19920401)69:7+<1885::AID-CNCR2820691702>3.0.CO;2-B; FROST WH, 1995, AM J EPIDEMIOL, V141, P4, DOI 10.1093/oxfordjournals.aje.a117343; FURMAN RH, 1968, ANN NY ACAD SCI, V149, P822, DOI 10.1111/j.1749-6632.1968.tb53838.x; Greider CW, 1998, CURR BIOL, V8, pR178, DOI 10.1016/S0960-9822(98)70105-8; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Hobbs F., 2002, DEMOGRAPHIC TRENDS 2; Lawlor DA, 2002, BRIT MED J, V325, P311, DOI 10.1136/bmj.325.7359.311; Matthews KA, 2009, J AM COLL CARDIOL, V54, P2366, DOI 10.1016/j.jacc.2009.10.009; National Cancer Institute, 1987, WORK GUID EARL CANC; National Center for Health Statistics, 2005, HLTH US 2005 CHARTB, P171; Office for National Statistics, 2010, CENT MORT ENGL WAL 1; PIKE MC, 1993, EPIDEMIOL REV, V15, P17, DOI 10.1093/oxfordjournals.epirev.a036102; Rauscher FM, 2003, CIRCULATION, V108, P457, DOI 10.1161/01.CIR.0000082924.75945.48; Samani NJ, 2008, HEART, V94, P537, DOI 10.1136/hrt.2007.136010; Tunstall-Pedoe H, 1998, LANCET, V351, P1425, DOI 10.1016/S0140-6736(97)11321-6; U.S. Preventive Service Task Force, 1989, GUID CLIN PREV SERV	22	46	47	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 6	2011	343								d5170	10.1136/bmj.d5170	http://dx.doi.org/10.1136/bmj.d5170			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	V41KO	21896608	hybrid, Green Submitted, Green Published			2022-12-28	WOS:000209545300001
J	Brown, E; Jaeger, HM				Brown, Eric; Jaeger, Heinrich M.			Through Thick and Thin	SCIENCE			English	Editorial Material							COLLOIDAL DISPERSIONS; SHEAR; SUSPENSIONS; SPHERES		[Brown, Eric] Univ Calif, Sch Nat Sci, Merced, CA 95343 USA; [Jaeger, Heinrich M.] Univ Chicago, James Franck Inst, Chicago, IL 60637 USA	University of California System; University of California Merced; University of Chicago	Brown, E (corresponding author), Univ Calif, Sch Nat Sci, Merced, CA 95343 USA.	h-jaeger@uchicago.edu						BRADY JF, 1985, J FLUID MECH, V155, P105, DOI 10.1017/S0022112085001732; Brown E, 2010, NAT MATER, V9, P220, DOI [10.1038/NMAT2627, 10.1038/nmat2627]; Cheng X, 2011, SCIENCE, V333, P1276, DOI 10.1126/science.1207032; CHOI GN, 1986, J COLLOID INTERF SCI, V113, P101, DOI 10.1016/0021-9797(86)90210-9; Fall A, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.178301; Hoffman RL, 1998, J RHEOL, V42, P111, DOI 10.1122/1.550884; Larson R. G., 1999, STRUCTURE RHEOLOGY C, P443; Maranzano BJ, 2001, J CHEM PHYS, V114, P10514, DOI 10.1063/1.1373687; O'Hern CS, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.011306; Trappe V, 2001, NATURE, V411, P772, DOI 10.1038/35081021; Wagner NJ, 2009, PHYS TODAY, V62, P27, DOI 10.1063/1.3248476	11	39	39	4	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 2	2011	333	6047					1230	1231		10.1126/science.1211155	http://dx.doi.org/10.1126/science.1211155			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	813YM	21885764				2022-12-28	WOS:000294406400032
J	Gee, HY; Noh, SH; Tang, BL; Kim, KH; Lee, MG				Gee, Heon Yung; Noh, Shin Hye; Tang, Bor Luen; Kim, Kyung Hwan; Lee, Min Goo			Rescue of Delta F508-CFTR Trafficking via a GRASP-Dependent Unconventional Secretion Pathway	CELL			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; ENDOPLASMIC-RETICULUM; DYNAMIC REGULATION; BREFELDIN-A; PROTEIN; CFTR; MEMBRANE; STACKING; SURFACE; BINDS	The most prevalent disease-causing mutation of CFTR is the deletion of Phe508 (Delta F508), which leads to defects in conventional Golgi-mediated exocytosis and cell surface expression. We report that Delta F508-CFTR surface expression can be rescued in vitro and in vivo by directing it to an unconventional GRASP-dependent secretion pathway. An integrated molecular and physiological analysis indicates that mechanisms associated with ER stress induce cell surface trafficking of the ER core-glycosylated wild-type and Delta F508-CFTR via the GRASP-dependent pathway. Phosphorylation of a specific site of GRASP and the PDZ-based interaction between GRASP and CFTR are critical for this unconventional surface trafficking. Remarkably, transgenic expression of GRASP in Delta F508-CFTR mice restores CFTR function and rescues mouse survival without apparent toxicity. These findings provide insight into how unconventional protein secretion is activated, and offer a potential therapeutic strategy for the treatment of cystic fibrosis and perhaps diseases stemming from other misfolded proteins.	[Gee, Heon Yung; Noh, Shin Hye; Kim, Kyung Hwan; Lee, Min Goo] Yonsei Univ, Dept Pharmacol, Brain Korea Project Med Sci 21, Severance Biomed Sci Inst,Coll Med, Seoul 120752, South Korea; [Tang, Bor Luen] Natl Univ Singapore, Dept Biochem, Yong Loo Lin Sch Med, Singapore 117597, Singapore	Yonsei University; Yonsei University Health System; National University of Singapore	Lee, MG (corresponding author), Yonsei Univ, Dept Pharmacol, Brain Korea Project Med Sci 21, Severance Biomed Sci Inst,Coll Med, Seoul 120752, South Korea.	mlee@yuhs.ac	Gee, Heon Yung/K-7781-2019; Lee, Min Goo/D-5635-2012; Tang, Bor Luen/E-4548-2012; Lee, Min Goo/AAS-4636-2020	Gee, Heon Yung/0000-0002-8741-6177; Lee, Min Goo/0000-0001-7436-012X; Tang, Bor Luen/0000-0002-1925-636X; Lee, Min Goo/0000-0001-7436-012X; Noh, Shin Hye/0000-0003-3118-9240	Ministry of Education, Science, and Technology, Korea [2011-0001178, 2011-0016484]; Ministry of Health and Welfare, Korea [A030001]; Ministry of Education of Singapore	Ministry of Education, Science, and Technology, Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); Ministry of Health and Welfare, Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); Ministry of Education of Singapore(Ministry of Education, Singapore)	We thank Shmuel Muallem, Hyun Woo Park, and Dong-Su Jang for helpful discussions and editorial assistance, and the Yonsei-Carl Zeiss Advanced Imaging Center, Yonsei Proteome Research Center, and the Mouse Division of Macrogen for technical assistance. This work was supported by grants 2011-0001178 and 2011-0016484 from the National Research Foundation of Korea funded by the Ministry of Education, Science, and Technology, Korea, and A030001 from the Korea Health 21 R&D Project, Ministry of Health and Welfare, Korea. B.L.T. is supported by an AcRF grant from the Ministry of Education of Singapore. H.Y.G. and S.H.N. performed the experiments, analyzed data, and wrote the paper. B.L.T. and K.H.K. assisted in performing experiments. M.G.L. designed and coordinated the study and wrote the paper.	Amaral MD, 2004, J MOL NEUROSCI, V23, P41, DOI 10.1385/JMN:23:1-2:041; Barr FA, 1997, CELL, V91, P253, DOI 10.1016/S0092-8674(00)80407-9; Becq F, 2010, DRUGS, V70, P241, DOI 10.2165/11316160-000000000-00000; Bernales S, 2006, PLOS BIOL, V4, P2311, DOI 10.1371/journal.pbio.0040423; Bernales S, 2006, ANNU REV CELL DEV BI, V22, P487, DOI 10.1146/annurev.cellbio.21.122303.120200; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; Egan ME, 2002, NAT MED, V8, P485, DOI 10.1038/nm0502-485; Gee HY, 2010, J BIOL CHEM, V285, P35519, DOI 10.1074/jbc.M110.162438; Gee HY, 2009, GASTROENTEROLOGY, V137, P607, DOI 10.1053/j.gastro.2009.01.065; Han W, 2006, J BIOL CHEM, V281, P1461, DOI 10.1074/jbc.M509786200; Hatsuzawa K, 2006, MOL BIOL CELL, V17, P3964, DOI 10.1091/mbc.E05-12-1174; HELMS JB, 1992, NATURE, V360, P352, DOI 10.1038/360352a0; Hong Wanjin, 2005, Biochim Biophys Acta, V1744, P493; Jesch SA, 2001, MOL BIOL CELL, V12, P1811, DOI 10.1091/mbc.12.6.1811; Kinseth MA, 2007, CELL, V130, P524, DOI 10.1016/j.cell.2007.06.029; Kunzelmann K, 2001, NEWS PHYSIOL SCI, V16, P167; Lee JH, 2007, J BIOL CHEM, V282, P10414, DOI 10.1074/jbc.M610857200; Luo Y, 2009, BIOCHEM J, V419, P211, DOI 10.1042/BJ20081869; Manjithaya R, 2011, TRENDS CELL BIOL, V21, P67, DOI 10.1016/j.tcb.2010.09.009; Manjithaya R, 2010, J CELL BIOL, V188, P537, DOI 10.1083/jcb.200911149; MILLER SG, 1992, J CELL BIOL, V118, P267, DOI 10.1083/jcb.118.2.267; Namkung W, 2005, GASTROENTEROLOGY, V129, P1979, DOI 10.1053/j.gastro.2005.08.049; Pahl HL, 1999, PHYSIOL REV, V79, P683, DOI 10.1152/physrev.1999.79.3.683; Park HW, 2010, GASTROENTEROLOGY, V139, P620, DOI 10.1053/j.gastro.2010.04.004; Quinton Paul M., 1999, Physiological Reviews, V79, pS3; Rennolds J, 2008, BIOCHEM BIOPH RES CO, V366, P1025, DOI 10.1016/j.bbrc.2007.12.065; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Roxo-Rosa M, 2006, P NATL ACAD SCI USA, V103, P17891, DOI 10.1073/pnas.0608312103; Russell C, 2010, TRAFFIC, V11, P303, DOI 10.1111/j.1600-0854.2009.01026.x; Schotman H, 2008, DEV CELL, V14, P171, DOI 10.1016/j.devcel.2007.12.006; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Shorter J, 1999, EMBO J, V18, P4949, DOI 10.1093/emboj/18.18.4949; Tang BL, 2011, TRAFFIC, V12, P364, DOI 10.1111/j.1600-0854.2011.01161.x; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; Wiseman RL, 2010, CELL, V140, P590, DOI 10.1016/j.cell.2010.02.006; Yoo JS, 2002, J BIOL CHEM, V277, P11401, DOI 10.1074/jbc.M110263200; ZEIHER BG, 1995, J CLIN INVEST, V96, P2051, DOI 10.1172/JCI118253; Zhang KZ, 2005, J CLIN INVEST, V115, P268, DOI 10.1172/JCI200521848	39	217	223	0	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 2	2011	146	5					746	760		10.1016/j.cell.2011.07.021	http://dx.doi.org/10.1016/j.cell.2011.07.021			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	814SM	21884936	Bronze			2022-12-28	WOS:000294477500015
J	Nagao, K; Okazaki, R; Nakamura, T; Miura, YN; Osawa, T; Bajo, K; Matsuda, S; Ebihara, M; Ireland, TR; Kitajima, F; Naraoka, H; Noguchi, T; Tsuchiyama, A; Yurimoto, H; Zolensky, ME; Uesugi, M; Shirai, K; Abe, M; Yada, T; Ishibashi, Y; Fujimura, A; Mukai, T; Ueno, M; Okada, T; Yoshikawa, M; Kawaguchi, J				Nagao, Keisuke; Okazaki, Ryuji; Nakamura, Tomoki; Miura, Yayoi N.; Osawa, Takahito; Bajo, Ken-ichi; Matsuda, Shintaro; Ebihara, Mitsuru; Ireland, Trevor R.; Kitajima, Fumio; Naraoka, Hiroshi; Noguchi, Takaaki; Tsuchiyama, Akira; Yurimoto, Hisayoshi; Zolensky, Michael E.; Uesugi, Masayuki; Shirai, Kei; Abe, Masanao; Yada, Toru; Ishibashi, Yukihiro; Fujimura, Akio; Mukai, Toshifumi; Ueno, Munetaka; Okada, Tatsuaki; Yoshikawa, Makoto; Kawaguchi, Junichiro			Irradiation History of Itokawa Regolith Material Deduced from Noble Gases in the Hayabusa Samples	SCIENCE			English	Article							SOLAR ENERGETIC PARTICLES; ASTEROID ITOKAWA; HELIUM; NEON; SPACECRAFT; ISOTOPES; SYSTEM; ARGON; WIND	Noble gas isotopes were measured in three rocky grains from asteroid Itokawa to elucidate a history of irradiation from cosmic rays and solar wind on its surface. Large amounts of solar helium (He), neon (Ne), and argon (Ar) trapped in various depths in the grains were observed, which can be explained by multiple implantations of solar wind particles into the grains, combined with preferential He loss caused by frictional wear of space-weathered rims on the grains. Short residence time of less than 8 million years was implied for the grains by an estimate on cosmic-ray-produced (21)Ne. Our results suggest that Itokawa is continuously losing its surface materials into space at a rate of tens of centimeters per million years. The lifetime of Itokawa should be much shorter than the age of our solar system.	[Nagao, Keisuke; Bajo, Ken-ichi; Matsuda, Shintaro] Univ Tokyo, Geochem Res Ctr, Bunkyo Ku, Tokyo 1130033, Japan; [Okazaki, Ryuji; Kitajima, Fumio; Naraoka, Hiroshi] Kyushu Univ, Dept Earth & Planetary Sci, Higashi Ku, Fukuoka 812, Japan; [Nakamura, Tomoki] Tohoku Univ, Dept Earth & Planetary Mat Sci, Aoba Ku, Sendai, Miyagi 980, Japan; [Miura, Yayoi N.] Univ Tokyo, Earthquake Res Inst, Bunkyo Ku, Tokyo 1130033, Japan; [Osawa, Takahito] Japan Atom Energy Agcy, Tokai, Ibaraki, Japan; [Ebihara, Mitsuru] Tokyo Metropolitan Univ, Grad Sch Sci & Engn, Hachioji, Tokyo, Japan; [Ireland, Trevor R.] Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT, Australia; [Noguchi, Takaaki] Ibaraki Univ, Coll Sci, Mito, Ibaraki, Japan; [Tsuchiyama, Akira] Osaka Univ, Dept Earth & Space Sci, Toyonaka, Osaka 560, Japan; [Yurimoto, Hisayoshi] Hokkaido Univ, Kita Ku, Sapporo, Hokkaido, Japan; [Zolensky, Michael E.] NASA, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA; [Uesugi, Masayuki; Shirai, Kei; Abe, Masanao; Yada, Toru; Ishibashi, Yukihiro; Fujimura, Akio; Mukai, Toshifumi; Ueno, Munetaka; Okada, Tatsuaki; Yoshikawa, Makoto; Kawaguchi, Junichiro] Japan Aerosp Explorat Agcy JAXA, ISAS, Sagamihara, Kanagawa, Japan	University of Tokyo; Kyushu University; Tohoku University; University of Tokyo; Japan Atomic Energy Agency; Tokyo Metropolitan University; Australian National University; Ibaraki University; Osaka University; Hokkaido University; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; Japan Aerospace Exploration Agency (JAXA); Institute of Space & Astronautical Science (ISAS)	Nagao, K (corresponding author), Univ Tokyo, Geochem Res Ctr, Bunkyo Ku, Tokyo 1130033, Japan.	nagao@eqchem.s.u-tokyo.ac.jp	Mukai, Toshifumi/ABD-3297-2021; Ireland, Trevor R./GSJ-1884-2022; Ireland, Trevor R/A-4993-2008; Yurimoto, Hisayoshi/S-9938-2018	Ireland, Trevor R/0000-0001-7617-3889; Yurimoto, Hisayoshi/0000-0003-0702-0533; Noguchi, Takaaki/0000-0001-7211-2595; Uesugi, Masayuki/0000-0001-6261-9034; Zolensky, Michael/0000-0002-3181-1303; Naraoka, Hiroshi/0000-0002-2373-8759	Grants-in-Aid for Scientific Research [22224010] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Abe M, 2006, SCIENCE, V312, P1334, DOI 10.1126/science.1125718; Brownlee D, 2006, SCIENCE, V314, P1711, DOI 10.1126/science.1135840; Ducati H., 1973, Moon, V8, P210, DOI 10.1007/BF00562758; Fujiwara A, 2006, SCIENCE, V312, P1330, DOI 10.1126/science.1125841; Grimberg A, 2008, GEOCHIM COSMOCHIM AC, V72, P626, DOI 10.1016/j.gca.2007.10.017; Heber VS, 2009, GEOCHIM COSMOCHIM AC, V73, P7414, DOI 10.1016/j.gca.2009.09.013; Kiko J, 1978, P LUNAR PLANET SCI, V9, P1655; MIYAMOTO H, 2006, 37 LUN PLAN SCI C LE; Miyamoto H, 2007, SCIENCE, V316, P1011, DOI 10.1126/science.1134390; Nakamura T, 2011, SCIENCE, V333, P1113, DOI 10.1126/science.1207758; NIER AO, 1990, METEORITICS, V25, P263, DOI 10.1111/j.1945-5100.1990.tb00710.x; Noguchi T, 2011, SCIENCE, V333, P1121, DOI 10.1126/science.1207794; Okada T, 2006, SCIENCE, V312, P1338, DOI 10.1126/science.1125731; OKAZAKI R, 2011, 42 LUN PLAN SCI C WO; Osawa T, 2003, METEORIT PLANET SCI, V38, P1627, DOI 10.1111/j.1945-5100.2003.tb00005.x; Osawa T., 2003, ANTARCTIC METEORITE, V16, P196; Osawa T., 2002, ANTARCT METEORITE RE, V15, P165; Parker EN, 1997, SPACE SCI S, P3; Pepin RO, 2000, METEORIT PLANET SCI, V35, P495, DOI 10.1111/j.1945-5100.2000.tb01431.x; Saito J, 2006, SCIENCE, V312, P1341, DOI 10.1126/science.1125722; Schultz L, 2004, METEORIT PLANET SCI, V39, P1889, DOI 10.1111/j.1945-5100.2004.tb00083.x; SIGNER P, 1977, P LUNAR PLANET SCI C, V8, P3657; Wieler R, 2002, REV MINERAL GEOCHEM, V47, P21, DOI 10.2138/rmg.2002.47.2; WIELER R, 1986, GEOCHIM COSMOCHIM AC, V50, P1997, DOI 10.1016/0016-7037(86)90255-3; WIELER R, 1980, P LUNAR PLANET SCI C, V11, P1369; Yano H, 2006, SCIENCE, V312, P1350, DOI 10.1126/science.1126164	26	119	119	1	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 26	2011	333	6046					1128	1131		10.1126/science.1207785	http://dx.doi.org/10.1126/science.1207785			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811VM	21868672				2022-12-28	WOS:000294244300043
J	Albert, RK; Connett, J; Bailey, WC; Casaburi, R; Cooper, JAD; Criner, GJ; Curtis, JL; Dransfield, MT; Han, MLK; Lazarus, SC; Make, B; Marchetti, N; Martinez, FJ; Madinger, NE; McEvoy, C; Niewoehner, DE; Porsasz, J; Price, CS; Reilly, J; Scanlon, PD; Sciurba, FC; Scharf, SM; Washko, GR; Woodruff, PG; Anthonisen, NR				Albert, Richard K.; Connett, John; Bailey, William C.; Casaburi, Richard; Cooper, J. Allen D., Jr.; Criner, Gerard J.; Curtis, Jeffrey L.; Dransfield, Mark T.; Han, MeiLan K.; Lazarus, Stephen C.; Make, Barry; Marchetti, Nathaniel; Martinez, Fernando J.; Madinger, Nancy E.; McEvoy, Charlene; Niewoehner, Dennis E.; Porsasz, Janos; Price, Connie S.; Reilly, John; Scanlon, Paul D.; Sciurba, Frank C.; Scharf, Steven M.; Washko, George R.; Woodruff, Prescott G.; Anthonisen, Nicholas R.		COPD Clinical Res Network	Azithromycin for Prevention of Exacerbations of COPD	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; FLUTICASONE PROPIONATE; HEALTH OUTCOMES; SALMETEROL; TIOTROPIUM; ERYTHROMYCIN; MANAGEMENT; FREQUENCY; EFFICACY; PLACEBO	Background Acute exacerbations adversely affect patients with chronic obstructive pulmonary disease (COPD). Macrolide antibiotics benefit patients with a variety of inflammatory airway diseases. Methods We performed a randomized trial to determine whether azithromycin decreased the frequency of exacerbations in participants with COPD who had an increased risk of exacerbations but no hearing impairment, resting tachycardia, or apparent risk of prolongation of the corrected QT interval. Results A total of 1577 subjects were screened; 1142 (72%) were randomly assigned to receive azithromycin, at a dose of 250 mg daily (570 participants), or placebo (572 participants) for 1 year in addition to their usual care. The rate of 1-year follow-up was 89% in the azithromycin group and 90% in the placebo group. The median time to the first exacerbation was 266 days (95% confidence interval [CI], 227 to 313) among participants receiving azithromycin, as compared with 174 days (95% CI, 143 to 215) among participants receiving placebo (P < 0.001). The frequency of exacerbations was 1.48 exacerbations per patient-year in the azithromycin group, as compared with 1.83 per patient-year in the placebo group (P = 0.01), and the hazard ratio for having an acute exacerbation of COPD per patient-year in the azithromycin group was 0.73 (95% CI, 0.63 to 0.84; P< 0.001). The scores on the St. George's Respiratory Questionnaire (on a scale of 0 to 100, with lower scores indicating better functioning) improved more in the azithromycin group than in the placebo group (a mean [+/- SD] decrease of 2.8 +/- 12.8 vs. 0.6 +/- 11.4, P = 0.004); the percentage of participants with more than the minimal clinically important difference of -4 units was 43% in the azithromycin group, as compared with 36% in the placebo group (P = 0.03). Hearing decrements were more common in the azithromycin group than in the placebo group (25% vs. 20%, P = 0.04). Conclusions Among selected subjects with COPD, azithromycin taken daily for 1 year, when added to usual treatment, decreased the frequency of exacerbations and improved quality of life but caused hearing decrements in a small percentage of subjects. Although this intervention could change microbial resistance patterns, the effect of this change is not known. (Funded by the National Institutes of Health; ClinicalTrials. gov number, NCT00325897.)	Denver Hlth, Med Serv, Denver, CO USA; [Albert, Richard K.; Price, Connie S.] Univ Colorado Denver, Hlth Sci Ctr, Dept Med, Denver, CO USA; Natl Jewish Hlth, Div Pulm Med, Denver, CO USA; [Madinger, Nancy E.; Price, Connie S.] Univ Colorado Denver, Dept Med, Div Infect Dis, Denver, CO USA; [Connett, John] Univ Minnesota, Sch Publ Hlth, Div Biostat, Minneapolis, MN 55455 USA; [Niewoehner, Dennis E.; Reilly, John] Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA; [Niewoehner, Dennis E.; Reilly, John] Minneapolis Vet Affairs VA Med Ctr, Med Serv, Div Pulm Med, Minneapolis, MN USA; [Bailey, William C.; Cooper, J. Allen D., Jr.; Dransfield, Mark T.] Univ Alabama Birmingham, Dept Med, Div Pulm Allergy & Crit Care Med, Birmingham, AL 35294 USA; [Dransfield, Mark T.] Birmingham VA Med Ctr, Pulm Sect, Birmingham, AL USA; [Casaburi, Richard; Porsasz, Janos] Harbor UCLA Med Ctr, Dept Med, Div Resp & Crit Care Physiol & Med, Torrance, CA 90509 USA; [Criner, Gerard J.; Marchetti, Nathaniel] Temple Univ, Div Pulm & Crit Care Med, Dept Med, Philadelphia, PA 19122 USA; [Curtis, Jeffrey L.; Han, MeiLan K.; Martinez, Fernando J.] Univ Michigan, Dept Med, Div Pulm & Crit Care Med, Ann Arbor, MI 48109 USA; [Curtis, Jeffrey L.] Ann Arbor VA Med Ctr, Div Pulm & Crit Care Med, Ann Arbor, MI USA; [Lazarus, Stephen C.; Woodruff, Prescott G.] Univ Calif San Francisco, Dept Med, Div Pulm & Crit Care Med, San Francisco, CA USA; [Lazarus, Stephen C.; Woodruff, Prescott G.] Univ Calif San Francisco, Inst Cardiovasc Res, San Francisco, CA USA; [McEvoy, Charlene] HealthPartners Res Fdn, Pulm Crit Care & Sleep Dept, St Paul, MN USA; [Scanlon, Paul D.] Mayo Clin, Div Pulm & Crit Care Med, Rochester, MN USA; [Sciurba, Frank C.] Univ Pittsburgh, Dept Med, Div Pulm & Crit Care Med, Pittsburgh, PA USA; [Scharf, Steven M.] Univ Maryland, Dept Med, Div Pulm & Crit Care, Baltimore, MD 21201 USA; [Washko, George R.] Brigham & Womens Hosp, Dept Med, Div Pulm & Crit Care Med, Boston, MA 02115 USA; [Anthonisen, Nicholas R.] Resp Hosp, Winnipeg, MB, Canada	Denver Health Medical Center; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; National Jewish Health; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Alabama System; University of Alabama Birmingham; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Birmingham; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Michigan System; University of Michigan; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Mayo Clinic; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University System of Maryland; University of Maryland Baltimore; Harvard University; Brigham & Women's Hospital; University of Manitoba; Children's Hospital Research Institute of Manitoba	Albert, RK (corresponding author), Dr Albert Denver Hlth, 777 Bannock St,MC 4000, Denver, CO 80204 USA.	ralbert@dhha.org	Wendt, Chris/C-6823-2012; Sciurba, Frank/AAZ-9339-2021	sciurba, frank/0000-0001-7468-2225; Curtis, Jeffrey/0000-0001-5191-4847; Marchetti, Nathaniel/0000-0003-3229-8879	National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health [U10 HL074407, U10 HL074408, U10 HL074409, U10 HL074416, U10 HL074418, U10 HL074422, U10 HL074424, U10 HL074428, U10 HL074431, U10 HL074439, U10 HL074441]; Division of Lung Diseases of the NHLBI; National Center for Research Resources [M01]; Gilead Sciences; Elsevier; Novartis Pharmaceuticals; Forest Pharmaceuticals; Theratechnologies; Breathe Technologies; Medtronic Spinal and Biologics; Boehringer Ingelheim; Philips Respironics; Novartis; Actelion Pharmaceuticals; AstraZeneca; Pfizer; Roche; Osiris Therapeutics; GlaxoSmithKline; Watkins; Louri; Roll and Change; Lawrence R. Dry Associates; Starnes Davis Florie LLP; Walker; Tipps Malone PLC; Moore; Ingram Johnson Steele; Farris; Riley Pitt, LLP; Phillips Pharmaceuticals; Uptake Medical; Dey; Boston Scientific; CSL Behring; Astellas Pharma; Talecris Biotherapeutics; Chiesi Pharmaceuticals; MedImmune-Astra Zeneca; Merck; Pearl Therapeutics; UBC; Mpex Pharmaceuticals and Ikaria; Forest-Almirall; Nycomed-Forest; Bayer; Schering-Plough (Merck); HLS; Comgeniz; fb Communications; BoomComm; Elan; Genzyme; Quark Pharmaceuticals; Sanofi-Aventis; Associates in Medical Marketing and Castle Connolly; National Association for Continuing Education; Med-Ed; Potomac Pharma; Vox Medica; WebMD; Epocrates; Altana-Nycomed; Global; Johnson & Johnson-Centocor Ortho Biotech; MicroPhage; Cubist Pharmaceuticals; Quintiles; Sanofi Pasteur; BioCryst Pharmaceuticals; Accelr8 Technology; Robert Michael; Baxter Healthcare; Altana; Lippincott Williams Wilkins; Wolters Kluwer; Genentech; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000425, M01RR000051, M01RR002635, M01RR016500, M01RR000056] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U10HL074441, U10HL074422, U10HL074416, U10HL074408, U10HL074407, U10HL074439, U10HL074428, U10HL074409, U10HL074418, U10HL074431, K23HL089353, U10HL074424] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Division of Lung Diseases of the NHLBI; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Gilead Sciences(Gilead Sciences); Elsevier; Novartis Pharmaceuticals(Novartis); Forest Pharmaceuticals; Theratechnologies; Breathe Technologies; Medtronic Spinal and Biologics; Boehringer Ingelheim(Boehringer Ingelheim); Philips Respironics; Novartis(Novartis); Actelion Pharmaceuticals; AstraZeneca(AstraZeneca); Pfizer(Pfizer); Roche(Roche Holding); Osiris Therapeutics; GlaxoSmithKline(GlaxoSmithKline); Watkins; Louri; Roll and Change; Lawrence R. Dry Associates; Starnes Davis Florie LLP; Walker; Tipps Malone PLC; Moore; Ingram Johnson Steele; Farris; Riley Pitt, LLP; Phillips Pharmaceuticals; Uptake Medical; Dey; Boston Scientific(Boston Scientific); CSL Behring; Astellas Pharma(Astellas Pharmaceuticals); Talecris Biotherapeutics; Chiesi Pharmaceuticals(Chiesi Pharmaceuticals Inc); MedImmune-Astra Zeneca(AstraZeneca); Merck(Merck & Company); Pearl Therapeutics; UBC; Mpex Pharmaceuticals and Ikaria; Forest-Almirall(Almirall); Nycomed-Forest; Bayer(Bayer AG); Schering-Plough (Merck)(Merck & CompanySchering Plough Corporation); HLS; Comgeniz; fb Communications; BoomComm; Elan; Genzyme(Sanofi-AventisGenzyme Corporation); Quark Pharmaceuticals; Sanofi-Aventis(Sanofi-Aventis); Associates in Medical Marketing and Castle Connolly; National Association for Continuing Education; Med-Ed; Potomac Pharma; Vox Medica; WebMD; Epocrates; Altana-Nycomed; Global; Johnson & Johnson-Centocor Ortho Biotech; MicroPhage; Cubist Pharmaceuticals; Quintiles; Sanofi Pasteur; BioCryst Pharmaceuticals; Accelr8 Technology; Robert Michael; Baxter Healthcare; Altana; Lippincott Williams Wilkins; Wolters Kluwer; Genentech(Roche HoldingGenentech); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by grants (U10 HL074407, U10 HL074408, U10 HL074409, U10 HL074416, U10 HL074418, U10 HL074422, U10 HL074424, U10 HL074428, U10 HL074431, U10 HL074439, and U10 HL074441) from the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health. The COPD Clinical Research Network is supported by a Cooperative Agreement from the Division of Lung Diseases of the NHLBI. At some sites, General Clinical Research Center facilities were used; their M01 grants from the National Center for Research Resources are listed in the Supplementary Appendix.; Dr. Albert reports receiving consulting fees from Gilead Sciences, fees for expert testimony from the Bruce Fagel Law Firm, and royalties from Elsevier, and being named on a patent pending for a device that provides continuous monitoring of the elevation of the head of the bed (Denver Health and the University of Colorado); Dr. Casaburi, receiving payment for service on the advisory boards of Novartis Pharmaceuticals and Forest Pharmaceuticals, consulting fees from Theratechnologies, Breathe Technologies, Medtronic Spinal and Biologics, Boehringer Ingelheim, Philips Respironics, Novartis, and Actelion Pharmaceuticals, lecture fees from Boehringer Ingelheim, AstraZeneca, and Pfizer, holding stock in Inogen, and receiving grant support from Novartis, Roche, Boehringer Ingelheim, Osiris Therapeutics, Forest Pharmaceuticals, and GlaxoSmithKline, Breathe Technologies (pending), and Theratechnologies (pending); Dr. Cooper, receiving fees for expert testimony from Watkins, Louri, Roll and Change; Lawrence R. Dry & Associates; Starnes Davis Florie LLP; Walker, Tipps & Malone PLC; Moore, Ingram Johnson & Steele; and Farris, Riley & Pitt, LLP; and grant support from GlaxoSmithKline and Novartis; Dr. Criner, receiving consulting fees from Phillips Pharmaceuticals, GlaxoSmithKline, Uptake Medical, and Dey, grant support from Philips Respironics, GlaxoSmithKline, Boehringer Ingelheim, Novartis, and AstraZeneca, and royalties from Springer; Dr. Curtis, receiving grant support from Boehringer Ingelheim; Dr. Dransfield, receiving consulting fees from GlaxoSmithKline, Boehringer Ingelheim, and Forest Pharmaceuticals, grant support from GlaxoSmithKline, Boehringer Ingelheim, and Boston Scientific, and lecture fees from GlaxoSmithKline and Boehringer Ingelheim; Dr. Han, receiving payment for service on the advisory boards of CSL Behring, GlaxoSmithKline, and Boehringer Ingelheim, consulting fees from Genentech and Novartis, lecture fees from GlaxoSmithKline, CSL Behring, Boehringer Ingelheim, and Pfizer, royalties from UpToDate, and meeting expenses from AstraZeneca; Dr. Madinger, receiving honoraria in conjunction with the Merck Study Monitoring Antimicrobial Resistance Trends (SMART), the JMI Laboratories Sentry study, and the Eurofins Medinet Trust study; Dr. Make, receiving payment for service on the advisory boards of Forest Pharmaceuticals, AstraZeneca, Novartis, Dey, Nycomed, Philips Respironics, Schering-Plough (now Merck), SeQual, Embryon, Boehringer Ingelheim, Pfizer, and GlaxoSmithKline, consulting fees from Astellas Pharma, Talecris Biotherapeutics, and Chiesi Pharmaceuticals, lecture fees from GlaxoSmithKline, Boehringer Ingelheim, Pfizer, and Forest Pharmaceuticals, payment for manuscript preparation from AstraZeneca, payment for video presentation preparation from Boehringer Ingelheim and Pfizer, payment for document reviews from Spiration, and grant support from AstraZeneca, GlaxoSmithKline, Pfizer, Nabi Biopharmaceuticals, Boehringer Ingelheim, and Sunovion; Dr.; Martinez, receiving payment for service on the advisory boards of GlaxoSmithKline, MedImmune-Astra Zeneca, Merck, Pearl Therapeutics, Novartis, UBC, Mpex Pharmaceuticals and Ikaria, consulting fees from Forest-Almirall, Boehringer Ingelheim, Nycomed-Forest, Roche, Bayer, Schering-Plough (Merck), HLS, Talecris Biotherapeutics, Comgeniz, fb Communications, BoomComm, Actelion Pharmaceuticals, Elan, Genzyme, Quark Pharmaceuticals, Merck, Pfizer, and Sanofi-Aventis, royalties from Associates in Medical Marketing and Castle Connolly, lecture fees from GlaxoSmithKline, National Associaion for Continuing Education, Med-Ed, Potomac Pharma, Pfizer, Boehringer Ingelheim, Schering-Plough (Merck), Vox Medica, WebMD, Epocrates, AstraZeneca, and Altana-Nycomed, payment for development of educational presentations for HIT Global and UpToDate, and grant support from Boehringer Ingelheim, Gilead, Johnson & Johnson-Centocor Ortho Biotech, and Actelion Pharmaceuticals; Dr. McEvoy, receiving grant support from Boston Scientific and GlaxoSmithKline and lecture fees from Boehringer Ingelheim and GlaxoSmithKline; Dr. Niewoehner, receiving consulting fees from Boehringer Ingelheim, AstraZeneca, GlaxoSmithKline, Forest Research, Merck, Sanofi-Aventis, Bayer Schering Pharma, Nycomed, ProtAffin, and Pfizer; Dr. Porszasz, receiving consulting fees from Breathe Technologies, Boehringer Ingelheim, Novartis, and Forest Pharmaceuticals, and grant support from Boehringer Ingelheim, Forest Pharmaceuticals, Breathe Technologies (pending), and Novartis; Dr. Price, receiving consulting fees from Astellas Pharma, Cubist Pharmaceuticals, and Merck, providing expert testimony on transmission of hospital-associated infections, management of musculoskeletal infections, aminoglycoside toxicity, and diagnosis of infection, receiving grant support from MicroPhage, Cubist Pharmaceuticals, Quintiles, Sanofi Pasteur, BioCryst Pharmaceuticals, and Accelr8 Technology, and lecture fees from Robert Michael (a CME vendor), Cubist Pharmaceuticals, and Baxter Healthcare; Dr. Scanlon, receiving grant support from Altana, Boehringer Ingelheim, Dey, Forest Pharmaceuticals, GlaxoSmithKline, Novartis, and Pfizer and royalties from Lippincott Williams & Wilkins and Wolters Kluwer; Dr. Sciurba, receiving consulting fees from Boehringer Ingelheim, AstraZeneca, and GlaxoSmithKline and grant support from Pfizer and GlaxoSmithKline; Dr. Washko, receiving consulting fees from MedImmune and Spiration and being married to an employee of Merck Research Laboratories Division of Clinical Pharmacology; and Dr. Woodruff, receiving consulting fees from MedImmune, grant support from Genentech, and being a coinventor on a patent held jointly by his institution and Genentech. No other potential conflict of interest relevant to this article was reported.	Aaron SD, 2007, ANN INTERN MED, V146, P545, DOI 10.7326/0003-4819-146-8-200704170-00152; Andersson F, 2002, RESP MED, V96, P700, DOI 10.1053/rmed.2002.1334; Arizona Center for Education and Research on Therapeutics, QT DRUG LISTS RISK G; Banerjee D, 2005, RESP MED, V99, P208, DOI 10.1016/j.rmed.2004.06.009; Blasi F, 2010, PULM PHARMACOL THER, V23, P200, DOI 10.1016/j.pupt.2009.12.002; Brusasco V, 2003, THORAX, V58, P399, DOI 10.1136/thorax.58.5.399; Brusasco V, 2005, THORAX, V60, P105; Burge PS, 2000, BMJ-BRIT MED J, V320, P1297, DOI 10.1136/bmj.320.7245.1297; Calverley P, 2003, LANCET, V361, P1660; Calverley P, 2003, LANCET, V361, P449, DOI 10.1016/S0140-6736(03)12459-2; Calverley PMA, 2007, NEW ENGL J MED, V356, P775, DOI 10.1056/NEJMoa063070; Casaburi R, 2002, EUR RESPIR J, V19, P217, DOI 10.1183/09031936.02.00269802; Donaldson GC, 2008, THORAX, V63, P753; Donaldson GC, 2002, THORAX, V57, P847, DOI 10.1136/thorax.57.10.847; Druss BG, 2002, HEALTH AFFAIR, V21, P105, DOI 10.1377/hlthaff.21.4.105; Efron B., 1994, MONOGRAPHS STAT APPL; Gomez J, 2000, Rev Esp Quimioter, V13, P379; He ZY, 2010, RESPIRATION     0928; JONES PW, 1991, RESP MED, V85, P25, DOI 10.1016/S0954-6111(06)80166-6; Kanner RE, 2001, AM J RESP CRIT CARE, V164, P358, DOI 10.1164/ajrccm.164.3.2010017; KIM K, 1987, BIOMETRIKA, V74, P149, DOI 10.2307/2336029; Mahler DA, 1999, CHEST, V115, P957, DOI 10.1378/chest.115.4.957; Martinez Fernando J, 2008, Int J Chron Obstruct Pulmon Dis, V3, P331; Miller Jeffrey D, 2005, COPD, V2, P311, DOI 10.1080/15412550500218221; Niewoehner DE, 2005, ANN INTERN MED, V143, P317, DOI 10.7326/0003-4819-143-5-200509060-00007; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Patel IS, 2002, THORAX, V57, P759, DOI 10.1136/thorax.57.9.759; Phaff SJ, 2006, J ANTIMICROB CHEMOTH, V57, P741, DOI 10.1093/jac/dkl014; Saiman L, 2010, JAMA-J AM MED ASSOC, V303, P1707, DOI 10.1001/jama.2010.563; Seemungal TAR, 1998, AM J RESP CRIT CARE, V157, P1418, DOI 10.1164/ajrccm.157.5.9709032; Seemungal TAR, 2008, AM J RESP CRIT CARE, V178, P1139, DOI 10.1164/rccm.200801-145OC; Sin DD, 2003, JAMA-J AM MED ASSOC, V290, P2301, DOI 10.1001/jama.290.17.2301; Soler-Cataluna JJ, 2005, THORAX, V60, P925, DOI 10.1136/thx.2005.040527; Strassels SA, 2001, CHEST, V119, P344, DOI 10.1378/chest.119.2.344; Suzuki T, 2001, CHEST, V120, P730, DOI 10.1378/chest.120.3.730; Szafranski W, 2003, EUR RESPIR J, V21, P74, DOI 10.1183/09031936.03.00031402; Szafranski W, 2004, EUR RESPIR J, V21, P912; Tashkin DP, 2008, NEW ENGL J MED, V359, P1543, DOI 10.1056/NEJMoa0805800; Tsai CL, 2008, ACAD EMERG MED, V15, P1275, DOI 10.1111/j.1553-2712.2008.00284.x; Vincken W, 2002, EUR RESPIR J, V19, P209, DOI 10.1183/09031936.02.00238702; Welte T, 2009, AM J RESP CRIT CARE, V180, P741, DOI 10.1164/rccm.200904-0492OC; Yamaya M, 2008, J AM GERIATR SOC, V56, P1358, DOI 10.1111/j.1532-5415.2008.01725.x	42	801	834	2	109	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 25	2011	365	8					689	698		10.1056/NEJMoa1104623	http://dx.doi.org/10.1056/NEJMoa1104623			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	811JM	21864166	Green Accepted			2022-12-28	WOS:000294205300004
J	Wu, SS; Yen, HH				Wu, Shun-Sheng; Yen, Hsu-Heng			Pneumatosis Cystoides Intestinalis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Wu, Shun-Sheng; Yen, Hsu-Heng] Changhua Christian Hosp, Changhua, Taiwan	Changhua Christian Hospital	Wu, SS (corresponding author), Changhua Christian Hosp, Changhua, Taiwan.	91646@cch.org.tw							0	8	9	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 25	2011	365	8					E16	E16		10.1056/NEJMicm1013439	http://dx.doi.org/10.1056/NEJMicm1013439			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	811JM	21864163				2022-12-28	WOS:000294205300011
J	Kleykamp, BA; Heishman, SJ				Kleykamp, Bethea A.; Heishman, Stephen J.			The Older Smoker	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							SMOKING-CESSATION; UNITED-STATES; ADULTS		[Kleykamp, Bethea A.] NIDA, Intramural Res Program, Nicotine Psychopharmacol Sect, NIH, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA)	Kleykamp, BA (corresponding author), NIDA, Intramural Res Program, Nicotine Psychopharmacol Sect, NIH, 251 Bayview Blvd,Ste 200, Baltimore, MD 21224 USA.	annie.kleykamp@nih.gov			Intramural NIH HHS [ZIA DA000483-08] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000484, ZIADA000483] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Almeida OP, 2011, NEUROIMAGE, V55, P1480, DOI 10.1016/j.neuroimage.2011.01.063; Brega AG, 2008, AGE AGEING, V37, P521, DOI 10.1093/ageing/afn121; Fiore MC, 2008, TREATING TOBACCO USE; Han B, 2009, ADDICTION, V104, P88, DOI 10.1111/j.1360-0443.2008.02411.x; Hughes JR, 2007, NICOTINE TOB RES, V9, P315, DOI 10.1080/14622200701188919; Husten C G, 1997, Tob Control, V6, P175, DOI 10.1136/tc.6.3.175; Molander L, 2001, CLIN PHARMACOL THER, V69, P57, DOI 10.1067/mcp.2001.113181; Ossip-Klein D J, 1999, Nicotine Tob Res, V1, P299, DOI 10.1080/14622299050011421; Thorne S. L., 2008, Morbidity and Mortality Weekly Report, V57, P1221; Vincent GK, NEXT 4 DECADES OLDER	10	23	23	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 24	2011	306	8					876	877		10.1001/jama.2011.1221	http://dx.doi.org/10.1001/jama.2011.1221			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	810VY	21862749	Green Accepted			2022-12-28	WOS:000294157300027
J	Hawkes, N				Hawkes, Nigel			BODY POLITIC Take dietary truths with a pinch of salt	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes1@btinternet.com						Barton P, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4044; Cooper BEJ, 2012, PUBLIC UNDERST SCI, V21, P664, DOI 10.1177/0963662511401782; He FJ, 2011, LANCET, V378, P380, DOI 10.1016/S0140-6736(11)61174-4; Prasad V, 2011, ARCH INTERN MED, V171, P1675, DOI 10.1001/archinternmed.2011.295; Adler Alma J, 2014, Cochrane Database Syst Rev, pCD009217, DOI [10.1002/14651858.CD009217, 10.1002/14651858.CD009217.pub3]	5	2	2	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 22	2011	343								d5346	10.1136/bmj.d5346	http://dx.doi.org/10.1136/bmj.d5346			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	813ZH	21859794				2022-12-28	WOS:000294408900003
J	Cavallaro, E; Date, K; Medus, C; Meyer, S; Miller, B; Kim, C; Nowicki, S; Cosgrove, S; Sweat, D; Phan, Q; Flint, J; Daly, ER; Adams, J; Hyytia-Trees, E; Gerner-Smidt, P; Hoekstra, RM; Schwensohn, C; Langer, A; Sodha, SV; Rogers, MC; Angulo, FJ; Tauxe, RV; Williams, IT; Behravesh, CB				Cavallaro, Elizabeth; Date, Kashmira; Medus, Carlota; Meyer, Stephanie; Miller, Benjamin; Kim, Clara; Nowicki, Scott; Cosgrove, Shaun; Sweat, David; Phan, Quyen; Flint, James; Daly, Elizabeth R.; Adams, Jennifer; Hyytia-Trees, Eija; Gerner-Smidt, Peter; Hoekstra, Robert M.; Schwensohn, Colin; Langer, Adam; Sodha, Samir V.; Rogers, Michael C.; Angulo, Frederick J.; Tauxe, Robert V.; Williams, Ian T.; Behravesh, Casey Barton		Salmonella Typhimurium Outbreak	Salmonella Typhimurium Infections Associated with Peanut Products	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							OUTBREAK; BUTTER	BACKGROUND Contaminated food ingredients can affect multiple products, each distributed through various channels and consumed in multiple settings. Beginning in November 2008, we investigated a nationwide outbreak of salmonella infections. METHODS A case was defined as laboratory-confirmed infection with the outbreak strain of Salmonella Typhimurium occurring between September 1, 2008, and April 20, 2009. We conducted two case-control studies, product "trace-back," and environmental investigations. RESULTS Among 714 case patients identified in 46 states, 166 (23%) were hospitalized and 9 (1%) died. In study 1, illness was associated with eating any peanut butter (matched odds ratio, 2.5; 95% confidence interval [CI], 1.3 to 5.3), peanut butter-containing products (matched odds ratio, 2.2; 95% CI, 1.1 to 4.7), and frozen chicken products (matched odds ratio, 4.6; 95% CI, 1.7 to 14.7). Investigations of focal clusters and single cases associated with nine institutions identified a single institutional brand of peanut butter (here called brand X) distributed to all facilities. In study 2, illness was associated with eating peanut butter outside the home (matched odds ratio, 3.9; 95% CI, 1.6 to 10.0) and two brands of peanut butter crackers (brand A: matched odds ratio, 17.2; 95% CI, 6.9 to 51.5; brand B: matched odds ratio, 3.6; 95% CI, 1.3 to 9.8). Both cracker brands were made from brand X peanut paste. The outbreak strain was isolated from brand X peanut butter, brand A crackers, and 15 other products. A total of 3918 peanut butter-containing products were recalled between January 10 and April 29, 2009. CONCLUSIONS Contaminated peanut butter and peanut products caused a nationwide salmonellosis outbreak. Ingredient-driven outbreaks are challenging to detect and may lead to widespread contamination of numerous food products.	[Cavallaro, Elizabeth; Date, Kashmira; Adams, Jennifer; Hyytia-Trees, Eija; Gerner-Smidt, Peter; Hoekstra, Robert M.; Schwensohn, Colin; Langer, Adam; Sodha, Samir V.; Angulo, Frederick J.; Tauxe, Robert V.; Williams, Ian T.; Behravesh, Casey Barton] Ctr Dis Control & Prevent, Program Off Sci Educ & Profess Dev, Natl Ctr Emerging & Zoonot Infect Dis, Div Foodborne Waterborne & Environm Dis, Atlanta, GA 30333 USA; [Cavallaro, Elizabeth; Date, Kashmira; Kim, Clara] Ctr Dis Control & Prevent, Program Off Sci Educ & Profess Dev, Epidem Intelligence Serv, Atlanta, GA USA; [Medus, Carlota; Meyer, Stephanie] Minnesota Dept Hlth, St Paul, MN USA; [Miller, Benjamin] Minnesota Dept Agr, St Paul, MN USA; [Kim, Clara; Nowicki, Scott] Ohio Dept Hlth, Columbus, OH USA; [Cosgrove, Shaun] Colorado Dept Publ Hlth & Environm, Denver, CO USA; [Sweat, David] N Carolina Div Publ Hlth, Raleigh, NC USA; [Phan, Quyen] Connecticut Dept Publ Hlth, Hartford, CT USA; [Flint, James] Publ Hlth Agcy Canada, Ottawa, ON, Canada; [Daly, Elizabeth R.] New Hampshire Dept Hlth & Human Serv, Concord, NH USA; [Rogers, Michael C.] US FDA, Silver Spring, MD USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Minnesota Department of Health (MHD); Colorado Department of Public Health & Environment; Public Health Agency of Canada; US Food & Drug Administration (FDA)	Cavallaro, E (corresponding author), Ctr Dis Control & Prevent, Program Off Sci Educ & Profess Dev, Natl Ctr Emerging & Zoonot Infect Dis, Div Foodborne Waterborne & Environm Dis, Atlanta, GA 30333 USA.	ecavallaro@cdc.gov	Langer, Adam Justin/P-1188-2019; BARTON BEHRAVESH, Casey/HDL-8040-2022; Daly, Elizabeth/ABC-1577-2021; Trees, Eija/AAY-7538-2020	Langer, Adam Justin/0000-0001-5980-3359; BARTON BEHRAVESH, Casey/0000-0003-2270-5573; Daly, Elizabeth/0000-0003-3468-5151; Trees, Eija/0000-0001-6694-2445; Hoekstra, Robert Michael/0000-0002-0340-8015; Miller, Benjamin/0000-0003-1647-0122				[Anonymous], 2009, MMWR-MORBID MORTAL W, V58, P85; Behravesh CB, 2011, NEW ENGL J MED, V364, P918, DOI 10.1056/NEJMoa1005741; Burnett SL, 2000, J APPL MICROBIOL, V89, P472, DOI 10.1046/j.1365-2672.2000.01138.x; *CDCP, 2007, FOODB OUTBR DUE CONF; *CDCP, 2008, INV INF OUTBR SALM T; *CONAGRA FOODS, PET PAN PEAN BUTT FR; Council to Improve Foodborne Outbreak Response (CIFOR), 2009, GUID FOODB DIS OUTBR; DOLYLE M, 2009, US PEAN C AM ISL FL; FIALKOW G, CANNED GOOD SHELF LI; *FOOD DRUG ADM, 2009, REP DEP HLTH HUM SER; *FOOD DRUG ADM, 2009, RES CONS IND; *FOOD DRUG ADM, 2009, PEAN BUTT OTH PEAN C; *FOOD DRUG ADM, 2009, FDAS INV WESTC FRUIT; *FOOD DRUG ADM, 2009, NEW APPR TARG SPECT; *FOOD DRUG ADM, 1998, BACT AN MAN BAM SALM; *FOODNET, 2006, POP SURV DAT; Grimont P. A. D., 2007, ANTIGENIC FORMULAE S; Lehmacher A, 1995, EPIDEMIOL INFECT, V115, P501, DOI 10.1017/S0950268800058660; Ma L, 2009, J FOOD PROTECT, V72, P1596, DOI 10.4315/0362-028X-72.8.1596; Park EJ, 2008, J FOOD SCI, V73, pM82, DOI 10.1111/j.1750-3841.2007.00638.x; Ribot EM, 2006, FOODBORNE PATHOG DIS, V3, P59, DOI 10.1089/fpd.2006.3.59; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; Shachar D, 2006, J FOOD PROTECT, V69, P2687, DOI 10.4315/0362-028X-69.11.2687; Sotir MJ, 2010, PEDIATR INFECT DIS J, V29, P284, DOI 10.1097/01.inf.0000369241.58743.90; Sotir MJ, 2009, PEDIATR INFECT DIS J, V28, P1041, DOI 10.1097/INF.0b013e3181af6218; Voetsch AC, 2004, CLIN INFECT DIS, V38, pS127, DOI 10.1086/381578; 2007, MMWR MORB MORTAL WKL, V21, P521; 2009, THOMASNET NEWS  0311	28	74	76	2	43	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 18	2011	365	7					601	610		10.1056/NEJMoa1011208	http://dx.doi.org/10.1056/NEJMoa1011208			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	808ER	21848461				2022-12-28	WOS:000293960500007
J	Wang, NX				Wang, Nai-Xing			China's chemists should avoid the Vanity Fair	NATURE			English	Editorial Material									Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences	Wang, NX (corresponding author), Chinese Acad Sci, Beijing, Peoples R China.	nxwang@mail.ipc.ac.cn							0	5	5	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 18	2011	476	7360					253	253		10.1038/476253a	http://dx.doi.org/10.1038/476253a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	811JV	21850064	Bronze			2022-12-28	WOS:000294206500003
J	Williams, HC; Dellavalle, RP; Garner, S				Williams, Hywel C.; Dellavalle, Robert P.; Garner, Sarah			Acne vulgaris	LANCET			English	Article							TEA TREE OIL; BENZOYL PEROXIDE; DOUBLE-BLIND; PSYCHOLOGICAL MORBIDITY; PROPIONIBACTERIUM-ACNES; PHOTODYNAMIC THERAPY; TOPICAL TRETINOIN; IMPROVE OUTCOMES; GLOBAL ALLIANCE; RISK-FACTORS	Acne is a chronic inflammatory disease of the pilosebaceous unit resulting from androgen-induced increased sebum production, altered keratinisation, inflammation, and bacterial colonisation of hair follicles on the face, neck, chest, and back by Propionibacterium acnes. Although early colonisation with P acnes and family history might have important roles in the disease, exactly what triggers acne and how treatment affects the course of the disease remain unclear. Other factors such as diet have been implicated, but not proven. Facial scarring due to acne affects up to 20% of teenagers. Acne can persist into adulthood, with detrimental effects on self-esteem. There is no ideal treatment for acne, although a suitable regimen for reducing lesions can be found for most patients. Good quality evidence on comparative effectiveness of common topical and systemic acne therapies is scarce. Topical therapies including benzoyl peroxide, retinoids, and antibiotics when used in combination usually improve control of mild to moderate acne. Treatment with combined oral contraceptives can help women with acne. Patients with more severe inflammatory acne usually need oral antibiotics combined with topical benzoyl peroxide to decrease antibiotic-resistant organisms. Oral isotretinoin is the most effective therapy and is used early in severe disease, although its use is limited by teratogenicity and other side-effects. Availability, adverse effects, and cost, limit the use of photodynamic therapy. New research is needed into the therapeutic comparative effectiveness and safety of the many products available, and to better understand the natural history, subtypes, and triggers of acne.	[Williams, Hywel C.] Nottingham Univ Hosp NHS Trust, Ctr Evidence Based Dermatol, Nottingham NG7 2UH, England; [Dellavalle, Robert P.] Univ Colorado Denver, Sch Med, Aurora & VA Eastern Colorado Hlth Care Syst, Dept Dermatol, Denver, CO USA; [Garner, Sarah] Tufts Med Ctr, Ctr Evaluat Value & Risk Hlth, Boston, MA USA; [Garner, Sarah] Commonwealth Fund, New York, NY USA	Nottingham University Hospital NHS Trust; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Tufts Medical Center; Commonwealth Fund	Williams, HC (corresponding author), Nottingham Univ Hosp NHS Trust, Ctr Evidence Based Dermatol, Nottingham NG7 2UH, England.	hywel.williams@nottingham.ac.uk	Feldman, Steven R./AAH-6971-2021; Zouboulis, Christos C./I-4493-2013; Dellavalle, Robert/L-2020-2013; Franzeck, Fabian C/B-5055-2011; Dessinioti, Clio/AAU-2952-2021	Feldman, Steven R./0000-0002-0090-6289; Zouboulis, Christos C./0000-0003-1646-2608; Dellavalle, Robert/0000-0001-8132-088X; williams, hywel/0000-0002-5646-3093				Abulnaja KO, 2009, BRAZ J MED BIOL RES, V42, P501, DOI 10.1590/S0100-879X2009000600005; Alestas T, 2006, J MOL MED, V84, P75, DOI 10.1007/s00109-005-0715-8; [Anonymous], 2005, OBS COMP DIS COR INT; Antoniou C, 2009, PEDIATR DERMATOL, V26, P373, DOI 10.1111/j.1525-1470.2009.00932.x; Arowojolu AO, 2009, COCHRANE DB SYST REV, V3; Ayer J, 2006, POSTGRAD MED J, V82, P500, DOI 10.1136/pgmj.2006.045377; Ballanger F, 2006, DERMATOLOGY, V212, P145, DOI 10.1159/000090655; Barratt H, 2009, BRIT J DERMATOL, V160, P132, DOI 10.1111/j.1365-2133.2008.08819.x; Bataille V, 2002, J INVEST DERMATOL, V119, P1317, DOI 10.1046/j.1523-1747.2002.19621.x; Bergman H, 2009, TELEMED J E-HEALTH, V15, P426, DOI 10.1089/tmj.2008.0128; BOTTOMLEY WW, 1993, DERMATOLOGY, V186, P253, DOI 10.1159/000247364; Bowe WP, 2007, J AM ACAD DERMATOL, V57, P222, DOI 10.1016/j.jaad.2007.03.030; Brown J, 2009, COCHRANE DB SYST REV, V15, DOI DOI 10.1002/14651858.CD000194.PUB2; Brown SK, 1998, LANCET, V351, P1871, DOI 10.1016/S0140-6736(98)01046-0; BUCKNALL JH, 1977, CURR MED RES OPIN, V5, P266, DOI 10.1185/03007997709110177; Charakida A, 2007, BRIT J DERMATOL, V157, P569, DOI 10.1111/j.1365-2133.2007.08083.x; Chen MJ, 2011, HUM REPROD, V26, P227, DOI 10.1093/humrep/deq308; Cheng CE, 2010, PEDIATR DERMATOL, V27, P446, DOI 10.1111/j.1525-1470.2010.01286.x; Chua SL, 2009, CLIN EXP DERMATOL, V34, pe241, DOI 10.1111/j.1365-2230.2008.03111.x; Coenye T., 2008, Infectious Disorders - Drug Targets, V8, P156; Collier CN, 2008, J AM ACAD DERMATOL, V58, P56, DOI 10.1016/j.jaad.2007.06.045; Cordain L, 2002, ARCH DERMATOL, V138, P1584, DOI 10.1001/archderm.138.12.1584; Crockett SD, 2010, AM J GASTROENTEROL, V105, P1986, DOI 10.1038/ajg.2010.124; CUNLIFFE WJ, 1979, BRIT MED J, V1, P1109, DOI 10.1136/bmj.1.6171.1109; CUNLIFFE WJ, 1986, BRIT J DERMATOL, V115, P386, DOI 10.1111/j.1365-2133.1986.tb05757.x; CUNLIFFE WJ, 1969, LANCET, V1, P685, DOI 10.1016/S0140-6736(69)92642-7; Degitz Klaus, 2007, J Dtsch Dermatol Ges, V5, P316, DOI 10.1111/j.1610-0387.2007.06274.x; Del Rosso James Q, 2009, J Clin Aesthet Dermatol, V2, P26; Do JE, 2009, ANN DERMATOL, V21, P125, DOI 10.5021/ad.2009.21.2.125; Downie MMT, 2002, BRIT J DERMATOL, V147, P869, DOI 10.1046/j.1365-2133.2002.04946.x; Dreno B, 2004, EUR J DERMATOL, V14, P391; Eady AE, 2003, AM J CLIN DERMATOL, V4, P813, DOI 10.2165/00128071-200304120-00002; Ehrmann DA, 2005, NEW ENGL J MED, V352, P1223, DOI 10.1056/NEJMra041536; Enshaieh S, 2007, INDIAN J DERMATOL VE, V73, P22; Ernst E, 2000, FORSCH KOMP KLAS NAT, V7, P17, DOI 10.1159/000057164; Fakhouri T, 2009, J DRUGS DERMATOL, V8, P657; Food and Drug Administration HHS, 2010, FED REGISTER, V75, P9767; Friedlander SF, 2010, SEMIN CUTAN MED SURG, V29, P2, DOI 10.1016/j.sder.2010.04.002; Galadari H, 2009, J AM ACAD DERMATOL, V61, P123, DOI 10.1016/j.jaad.2008.10.046; Garner S.E., 2003, EVIDENCE BASED DERMA; Ghodsi SZ, 2009, J INVEST DERMATOL, V129, P2136, DOI 10.1038/jid.2009.47; Gollnick H, 2003, J AM ACAD DERMATOL, V49, pS1, DOI 10.1067/mjd.2003.618; Gollnick HPM, 2009, BRIT J DERMATOL, V161, P1180, DOI 10.1111/j.1365-2133.2009.09209.x; Gollnick HPM, 2008, AM J CLIN DERMATOL, V9, P279, DOI 10.2165/00128071-200809050-00001; GRANT J D, 1965, Mo Med, V62, P459; Green J, 2001, Australas J Dermatol, V42, P98, DOI 10.1046/j.1440-0960.2001.00489.x; Grindlay D, SYSTEMATIC REV ACNE; Haedersdal M, 2008, J EUR ACAD DERMATOL, V22, P267, DOI 10.1111/j.1468-3083.2007.02503.x; Hahm BJ, 2009, J DERMATOL, V36, P255, DOI 10.1111/j.1346-8138.2009.00635.x; Halvorsen JA, 2011, J INVEST DERMATOL, V131, P363, DOI 10.1038/jid.2010.264; Hamilton FL, 2009, BRIT J DERMATOL, V160, P1273, DOI 10.1111/j.1365-2133.2009.09047.x; HANDOJO I, 1979, Southeast Asian Journal of Tropical Medicine and Public Health, V10, P548; Hogewoning AA, 2009, BRIT J DERMATOL, V161, P475, DOI 10.1111/j.1365-2133.2009.09259.x; Holby N, 1997, LANCET, V349, P167, DOI 10.1016/S0140-6736(96)09229-X; HUGHES BR, 1992, CLIN EXP DERMATOL, V17, P165, DOI 10.1111/j.1365-2230.1992.tb00196.x; HULL SM, 1991, CLIN EXP DERMATOL, V16, P210; Iinuma K, 2009, J INVEST DERMATOL, V129, P2113, DOI 10.1038/jid.2009.46; Inglese MJ, 2008, J DERMATOL TREAT, V19, P27, DOI 10.1080/09546630701729895; Ingram JR, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-77; Jacob CI, 2001, J AM ACAD DERMATOL, V45, P109, DOI 10.1067/mjd.2001.113451; Jeremy AHT, 2003, J INVEST DERMATOL, V121, P20, DOI 10.1046/j.1523-1747.2003.12321.x; Khunger N, 2008, INDIAN J DERMATOL VE, V74, pS28; Kim J, 2008, J INVEST DERMATOL, V128, P2353, DOI 10.1038/jid.2008.221; Klaz I, 2006, J INVEST DERMATOL, V126, P1749, DOI 10.1038/sj.jid.5700326; Kontaxakis Vassilis P, 2009, Ann Gen Psychiatry, V8, P2, DOI 10.1186/1744-859X-8-2; Kubota Y, 2010, J DERMATOL, V37, P617, DOI 10.1111/j.1346-8138.2010.00855.x; Kurokawa I, 2009, EXP DERMATOL, V18, P821, DOI 10.1111/j.1600-0625.2009.00890.x; Law MPM, 2010, CLIN EXP DERMATOL, V35, P16, DOI 10.1111/j.1365-2230.2009.03340.x; Lehmann H P, 2001, Evid Rep Technol Assess (Summ), P1; Lehmann HP, 2001, MANAGEMENT ACNE, V01-E019; Li Bo, 2009, Zhongguo Zhen Jiu, V29, P247; Lucky AW, 1998, DERMATOLOGY, V196, P95; LUCKY AW, 1994, ARCH DERMATOL, V130, P308, DOI 10.1001/archderm.130.3.308; LYONS RE, 1978, INT J DERMATOL, V17, P246, DOI 10.1111/j.1365-4362.1978.tb06072.x; Magin P, 2005, BRIT J GEN PRACT, V55, P134; Magin P, 2005, FAM PRACT, V22, P62, DOI 10.1093/fampra/cmh715; Magin PJ, 2006, COMPLEMENT THER MED, V14, P62, DOI 10.1016/j.ctim.2005.10.007; Magin PJ, 2010, J EUR ACAD DERMATOL, V24, P58, DOI 10.1111/j.1468-3083.2009.03354.x; Marcinkiewicz J, 2008, EUR J DERMATOL, V18, P433, DOI 10.1684/ejd.2008.0460; Marqueling AL, 2005, SEMIN CUTAN MED SURG, V24, P92, DOI 10.1016/j.sder.2005.04.003; Meixner D, 2008, J DTSCH DERMATOL GES, V6, P189, DOI 10.1111/j.1610-0387.2007.06492.x; Melnik Bodo, 2007, J Dtsch Dermatol Ges, V5, P110, DOI 10.1111/j.1610-0387.2007.06176.x; Menon C, 2008, DERMATOLOGY, V217, P164, DOI 10.1159/000136655; MILLS CM, 1993, CLIN EXP DERMATOL, V18, P100, DOI 10.1111/j.1365-2230.1993.tb00986.x; Mourelatos K, 2007, BRIT J DERMATOL, V156, P22, DOI 10.1111/j.1365-2133.2006.07517.x; National Institute of health and Clinical Excellence, CLIN KNOWL SUMM ACN; Ozolins M, 2004, LANCET, V364, P2188, DOI 10.1016/S0140-6736(04)17591-0; Papakonstantinou E, 2005, J INVEST DERMATOL, V125, P673, DOI 10.1111/j.0022-202X.2005.23848.x; Patel M, 2010, J DRUGS DERMATOL, V9, P655; PLEWIG G, 1970, ARCH DERMATOL, V101, P580, DOI 10.1001/archderm.101.5.580; Poli F, 2001, J EUR ACAD DERMATOL, V15, P541, DOI 10.1046/j.1468-3083.2001.00357.x; Popescu, 2003, COCHRANE COLLABORATI; RADEMAKER M, 1989, BRIT MED J, V298, P1217, DOI 10.1136/bmj.298.6682.1217; Rademaker M, 2010, AUSTRALAS J DERMATOL, V51, P248, DOI 10.1111/j.1440-0960.2010.00657.x; Rapp DA, 2004, BRIT J DERMATOL, V151, P183, DOI 10.1111/j.1365-2133.2004.06078.x; Rivera AE, 2008, J AM ACAD DERMATOL, V59, P659, DOI 10.1016/j.jaad.2008.05.029; Rosenfield RL, 2008, DERMATOL THER, V21, P354, DOI 10.1111/j.1529-8019.2008.00217.x; Sakamoto FH, 2010, J AM ACAD DERMATOL, V63, P183, DOI 10.1016/j.jaad.2009.09.056; Schafer T, 2001, BRIT J DERMATOL, V145, P100, DOI 10.1046/j.1365-2133.2001.04290.x; Schilling LM, 2009, ARCH DERMATOL, V145, P76, DOI 10.1001/archdermatol.2008.520; Seirafi H, 2007, INT J DERMATOL, V46, P1188, DOI 10.1111/j.1365-4632.2007.03411.x; Shalita AR, 2004, CLIN DERMATOL, V22, P385, DOI 10.1016/j.clindermatol.2004.03.012; Simonart T, 2008, BRIT J DERMATOL, V158, P208, DOI 10.1111/j.1365-2133.2007.08286.x; Simonart T, 2005, BRIT J DERMATOL, V153, P395, DOI 10.1111/j.1365-2133.2005.06614.x; Skidmore R, 2003, ARCH DERMATOL, V139, P459, DOI 10.1001/archderm.139.4.459; Smith RN, 2007, AM J CLIN NUTR, V86, P107, DOI 10.1093/ajcn/86.1.107; Smithard A, 2001, BRIT J DERMATOL, V145, P274, DOI 10.1046/j.1365-2133.2001.04346.x; Spencer EH, 2009, INT J DERMATOL, V48, P339, DOI 10.1111/j.1365-4632.2009.04002.x; Stathakis V, 1997, Australas J Dermatol, V38, P115; Stoll S, 2001, J AM ACAD DERMATOL, V45, P957, DOI 10.1067/mjd.2001.117382; Stotland M, 2009, AM J CLIN DERMATOL, V10, P221, DOI 10.2165/00128071-200910040-00002; Strauss JS, 2007, J AM ACAD DERMATOL, V56, P651, DOI 10.1016/j.jaad.2006.08.048; Sundstrom A, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c5812; Taub AF, 2007, DERMATOL SURG, V33, P1005, DOI 10.1111/j.1524-4725.2007.33215.x; Thiboutot D, 2008, J AM ACAD DERMATOL, V59, P792, DOI 10.1016/j.jaad.2008.06.040; Thiboutot D, 2008, CUTIS, V81, P81; Thiboutot D, 2009, J AM ACAD DERMATOL, V60, pS1, DOI 10.1016/j.jaad.2009.01.019; Thiboutot DM, 2002, ARCH DERMATOL, V138, P1591, DOI 10.1001/archderm.138.12.1591; Thielitz A, 2007, J EUR ACAD DERMATOL, V21, P747, DOI 10.1111/j.1468-3083.2007.02190.x; Tierney EP, 2009, DERMATOL SURG, V35, P1445, DOI 10.1111/j.1524-4725.2009.01258.x; Toossi Parviz, 2008, J Drugs Dermatol, V7, P1149; Tsai MC, 2006, EUR J DERMATOL, V16, P251; TUCKER SB, 1983, CUTIS, V31, P79; UK National Health Service, UK DAT UNC EFF TREAT; US Food and Drug Administration, PROT YOURS; Valeyrie-Allanore L, 2007, DRUG SAFETY, V30, P1011, DOI 10.2165/00002018-200730110-00003; van Zuuren EJ, 2007, J AM ACAD DERMATOL, V56, P107, DOI 10.1016/j.jaad.2006.04.084; Vance K, 2009, DERMATOL CLIN, V27, P133, DOI 10.1016/j.det.2008.11.010; Vazquez ER, 1996, INT J DERMATOL, V35, P643, DOI 10.1111/j.1365-4362.1996.tb03689.x; Wang F, 2009, J AM ACAD DERMATOL, V61, P252, DOI 10.1016/j.jaad.2009.03.013; Wang Kevin C, 2008, Adv Dermatol, V24, P197, DOI 10.1016/j.yadr.2008.09.002; Wei B, 2010, J EUR ACAD DERMATOL, V24, P953, DOI 10.1111/j.1468-3083.2010.03590.x; Weinstock MA, 2009, ARCH DERMATOL, V145, P18, DOI 10.1001/archdermatol.2008.542; Wessels F, 1999, S AFR MED J, V89, P780; Winnington P, 2009, PRACT DERMATOL, V6, P5; Yahya H, 2009, INT J DERMATOL, V48, P498, DOI 10.1111/j.1365-4632.2009.03922.x; Yentzer BA, 2010, CUTIS, V86, P103; Yentzer BA, 2009, J DRUGS DERMATOL, V8, P799; Yosipovitch G, 2007, ACTA DERM-VENEREOL, V87, P135, DOI 10.2340/00015555-0231; Zouboulis CC, 2004, EXP DERMATOL, V13, P31, DOI 10.1111/j.1600-0625.2004.00254.x; Zouboulis CC, 2008, EXP DERMATOL, V17, P542, DOI 10.1111/j.1600-0625.2008.00725.x	141	587	639	32	331	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 28	2012	379	9813					361	372		10.1016/S0140-6736(11)60321-8	http://dx.doi.org/10.1016/S0140-6736(11)60321-8			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	889BA	21880356				2022-12-28	WOS:000300047300043
J	Kovalenko, I; Zdyrko, B; Magasinski, A; Hertzberg, B; Milicev, Z; Burtovyy, R; Luzinov, I; Yushin, G				Kovalenko, Igor; Zdyrko, Bogdan; Magasinski, Alexandre; Hertzberg, Benjamin; Milicev, Zoran; Burtovyy, Ruslan; Luzinov, Igor; Yushin, Gleb			A Major Constituent of Brown Algae for Use in High-Capacity Li-Ion Batteries	SCIENCE			English	Article							LONG CYCLE LIFE; COMPOSITE ELECTRODE; LITHIUM; ANODES; PERFORMANCE; BINDER; NANOWIRES	The identification of similarities in the material requirements for applications of interest and those of living organisms provides opportunities to use renewable natural resources to develop better materials and design better devices. In our work, we harness this strategy to build high-capacity silicon (Si) nanopowder-based lithium (Li)-ion batteries with improved performance characteristics. Si offers more than one order of magnitude higher capacity than graphite, but it exhibits dramatic volume changes during electrochemical alloying and de-alloying with Li, which typically leads to rapid anode degradation. We show that mixing Si nanopowder with alginate, a natural polysaccharide extracted from brown algae, yields a stable battery anode possessing reversible capacity eight times higher than that of the state-of-the-art graphitic anodes.	[Zdyrko, Bogdan; Burtovyy, Ruslan; Luzinov, Igor] Clemson Univ, Sch Mat Sci & Engn, Clemson, SC 29634 USA; [Zdyrko, Bogdan; Burtovyy, Ruslan; Luzinov, Igor] Clemson Univ, Ctr Opt Mat Sci & Engn Technol, Clemson, SC 29634 USA; [Kovalenko, Igor; Magasinski, Alexandre; Hertzberg, Benjamin; Milicev, Zoran; Yushin, Gleb] Georgia Inst Technol, Sch Mat Sci & Engn, Atlanta, GA 30332 USA	Clemson University; Clemson University; University System of Georgia; Georgia Institute of Technology	Luzinov, I (corresponding author), Clemson Univ, Sch Mat Sci & Engn, Clemson, SC 29634 USA.	luzinov@clemson.edu; yushin@gatech.edu	Yushin, Gleb/B-4529-2013	Yushin, Gleb/0000-0002-3274-9265	Georgia Institute of Technology; Honda Initiation Grant; Clemson Univ.; NASA [NNX09CD29P]	Georgia Institute of Technology; Honda Initiation Grant; Clemson Univ.; NASA(National Aeronautics & Space Administration (NASA))	This work was partially supported by Georgia Institute of Technology, Honda Initiation Grant, Clemson Univ., and NASA grant NNX09CD29P. Patent application PCT US 113507 has been filed.	Aurbach D, 2000, J POWER SOURCES, V89, P206, DOI 10.1016/S0378-7753(00)00431-6; Beattie SD, 2008, J ELECTROCHEM SOC, V155, pA158, DOI 10.1149/1.2817828; Bridel JS, 2010, CHEM MATER, V22, P1229, DOI 10.1021/cm902688w; Chan CK, 2008, NAT NANOTECHNOL, V3, P31, DOI 10.1038/nnano.2007.411; Chandrasekaran R, 2010, J ELECTROCHEM SOC, V157, pA1139, DOI 10.1149/1.3474225; Choi JW, 2010, NANO LETT, V10, P1409, DOI 10.1021/nl100258p; de Kerchove AJ, 2007, BIOMACROMOLECULES, V8, P113, DOI 10.1021/bm060670i; Draget KI, 1997, INT J BIOL MACROMOL, V21, P47, DOI 10.1016/S0141-8130(97)00040-8; El Ouatani L, 2009, J POWER SOURCES, V189, P72, DOI 10.1016/j.jpowsour.2008.11.031; Fenoradosoa TA, 2010, J APPL PHYCOL, V22, P131, DOI 10.1007/s10811-009-9432-y; Fransson L, 2001, J POWER SOURCES, V101, P1, DOI 10.1016/S0378-7753(01)00481-5; Gadjourova Z, 2001, NATURE, V412, P520, DOI 10.1038/35087538; Goodenough JB, 2010, CHEM MATER, V22, P587, DOI 10.1021/cm901452z; Guo JC, 2010, CHEM COMMUN, V46, P1428, DOI 10.1039/b918727h; Guy D, 2004, ADV MATER, V16, P553, DOI 10.1002/adma.200306075; Hertzberg B, 2010, J AM CHEM SOC, V132, P8548, DOI 10.1021/ja1031997; Kang K, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3299006; Kim H, 2008, NANO LETT, V8, P3688, DOI 10.1021/nl801853x; Levi MD, 1997, J PHYS CHEM B, V101, P4630, DOI 10.1021/jp9701909; Li J, 2007, ELECTROCHEM SOLID ST, V10, pA17, DOI 10.1149/1.2398725; Magasinski A, 2010, NAT MATER, V9, P353, DOI [10.1038/nmat2725, 10.1038/NMAT2725]; Magasinski A, 2010, ACS APPL MATER INTER, V2, P3004, DOI 10.1021/am100871y; Mazouzi D, 2009, ELECTROCHEM SOLID ST, V12, pA215, DOI 10.1149/1.3212894; Obrovac MN, 2004, ELECTROCHEM SOLID ST, V7, pA93, DOI 10.1149/1.1652421; Ohara S, 2004, J POWER SOURCES, V136, P303, DOI 10.1016/j.jpowsour.2004.03.014; Papageorgiou SK, 2010, CARBOHYD RES, V345, P469, DOI 10.1016/j.carres.2009.12.010; Park MH, 2009, NANO LETT, V9, P3844, DOI 10.1021/nl902058c; PELED E, 1995, ELECTROCHIM ACTA, V40, P2197, DOI 10.1016/0013-4686(95)00163-9; Smidsrod O., 1996, CARBOHYDR EUR, V14, P6; Zhang SS, 2002, J POWER SOURCES, V109, P422, DOI 10.1016/S0378-7753(02)00107-6	30	1355	1403	53	1405	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 7	2011	334	6052					75	79		10.1126/science.1209150	http://dx.doi.org/10.1126/science.1209150			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	829KW	21903777				2022-12-28	WOS:000295580300042
J	Ikeda, N; Saito, E; Kondo, N; Inoue, M; Ikeda, S; Satoh, T; Wada, K; Stickley, A; Katanoda, K; Mizoue, T; Noda, M; Iso, H; Fujino, Y; Sobue, T; Tsugane, S; Naghavi, M; Ezzati, M; Shibuya, K				Ikeda, Nayu; Saito, Eiko; Kondo, Naoki; Inoue, Manami; Ikeda, Shunya; Satoh, Toshihiko; Wada, Koji; Stickley, Andrew; Katanoda, Kota; Mizoue, Tetsuya; Noda, Mitsuhiko; Iso, Hiroyasu; Fujino, Yoshihisa; Sobue, Tomotaka; Tsugane, Shoichiro; Naghavi, Mohsen; Ezzati, Majid; Shibuya, Kenji			Japan: Universal Health Care at 50 Years 1 What has made the population of Japan healthy?	LANCET			English	Article							CORONARY-HEART-DISEASE; LIFE EXPECTANCY; RISK-FACTORS; BLOOD-PRESSURE; TRENDS; STROKE; HYPERTENSION; PREVALENCE; MEN; DISABILITY	People in Japan have the longest life expectancy at birth in the world. Here, we compile the best available evidence about population health in Japan to investigate what has made the Japanese people healthy in the past 50 years. The Japanese population achieved longevity in a fairly short time through a rapid reduction in mortality rates for communicable diseases from the 1950s to the early 1960s, followed by a large reduction in stroke mortality rates. Japan had moderate mortality rates for non-communicable diseases, with the exception of stroke, in the 1950s. The improvement in population health continued after the mid-1960s through the implementation of primary and secondary preventive community public health measures for adult mortality from non-communicable diseases and an increased use of advanced medical technologies through the universal insurance scheme. Reduction in health inequalities with improved average population health was partly attributable to equal educational opportunities and financial access to care. With the achievement of success during the health transition since World War 2, Japan now needs to tackle major health challenges that are emanating from a rapidly ageing population, causes that are not amenable to health technologies, and the effects of increasing social disparities to sustain the improvement in population health.	[Shibuya, Kenji] Univ Tokyo, Grad Sch Med, Dept Global Hlth Policy, Bunkyo Ku, Tokyo 1130033, Japan; [Kondo, Naoki] Univ Yamanashi, Dept Hlth Sci, Interdisciplinary Grad Sch Med & Engn, Yamanashi, Japan; [Inoue, Manami; Tsugane, Shoichiro] Natl Canc Ctr, Res Ctr Canc Prevent & Screening, Epidemiol & Prevent Div, Tokyo 104, Japan; [Ikeda, Shunya] Int Univ Hlth & Welf, Grad Sch, Tokyo, Japan; [Satoh, Toshihiko] Kitasato Univ, Sch Med, Kitasato Clin Res Ctr, Sagamihara, Kanagawa 228, Japan; [Wada, Koji] Kitasato Univ, Sch Med, Dept Prevent Med & Publ Hlth, Sagamihara, Kanagawa 228, Japan; [Katanoda, Kota; Sobue, Tomotaka] Natl Canc Ctr, Ctr Canc Control & Informat Serv, Surveillance Div, Tokyo 104, Japan; [Mizoue, Tetsuya] Natl Ctr Global Hlth & Med, Dept Epidemiol & Int Hlth, Tokyo, Japan; [Noda, Mitsuhiko] Natl Ctr Global Hlth & Med, Dept Diabet & Metab Med, Tokyo, Japan; [Iso, Hiroyasu] Osaka Univ, Grad Sch Med, Dept Social & Environm Med, Osaka, Japan; [Fujino, Yoshihisa] Univ Occupat & Environm Hlth, Dept Prevent Med & Community Hlth, Fukuoka, Japan; [Naghavi, Mohsen] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA; [Ezzati, Majid] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Epidemiol & Biostat, MRC HPA Ctr Environm & Hlth, London, England	University of Tokyo; University of Yamanashi; National Cancer Center - Japan; International University of Health & Welfare; Kitasato University; Kitasato University; National Cancer Center - Japan; National Center for Global Health & Medicine - Japan; National Center for Global Health & Medicine - Japan; Osaka University; University of Occupational & Environmental Health - Japan; Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; Imperial College London	Shibuya, K (corresponding author), Univ Tokyo, Grad Sch Med, Dept Global Hlth Policy, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	shibuyak@m.u-tokyo.ac.jp	Kondo, Naoki/ABC-5865-2020; Sobue, Tomotaka/ABE-4739-2021; Noda, Mitsuhiko/W-3905-2019; Katanoda, Kota/AFV-8519-2022; Kondo, Naoki/K-3898-2012; Fujino, Yoshihisa/F-3054-2010; Tsugane, Shoichiro/A-2424-2015; Ikeda, Nayu/J-9890-2019	Kondo, Naoki/0000-0002-6425-6844; Noda, Mitsuhiko/0000-0003-0413-4631; Katanoda, Kota/0000-0001-8687-1269; Kondo, Naoki/0000-0002-6425-6844; Fujino, Yoshihisa/0000-0002-9126-206X; Tsugane, Shoichiro/0000-0003-4105-2774; Ikeda, Nayu/0000-0002-3424-1991; Shibuya, Kenji/0000-0003-2528-7530; Iso, Hiroyasu/0000-0002-9241-7289	Bill & Melinda Gates Foundation; China Medical Board; Ministry of Health, Labour and Welfare [H22-seisaku-shitei-033]; Japan Society for the Promotion of Science [22390130]; Medical Research Council [G0801056B] Funding Source: researchfish	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); China Medical Board; Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work is in partly funded by the generous support from the Bill & Melinda Gates Foundation and the China Medical Board, a Grant-in-Aid for Scientific Research from the Ministry of Health, Labour and Welfare (H22-seisaku-shitei-033), and a Grant-in-Aid for Scientific Research (grant category B) from the Japan Society for the Promotion of Science (number 22390130). The views and opinions expressed by the authors are provided in their personal capacity and are their sole responsibility. We thank Hironori Imano and Zentaro Yamagata for their valuable contributions; Amarjargal Dagvadorji, Jinghua Li, Hatoko Sasaki, Mengru Wang, and Windy Mariane Virenia Wariki for their technical support; and Tomoko Suzuki and Tadashi Yamamoto for their administrative support.	[Anonymous], 2010, WORLD HLTH STAT 2010; [Anonymous], 1984, ILLNESS CULTURE CONT; Cabinet Office Government of Japan, 2010, WHIT PAP SUIC 2010; Cabinet Office Government of Japan, 2011, PUBL OP SURV PEOPL L; Cabinet Office Government of Japan, 2006, BAS ACT SUIC PREV; Chang SS, 2009, SOC SCI MED, V68, P1322, DOI 10.1016/j.socscimed.2009.01.010; Chen J, 2009, SOC INDIC RES, V94, P535, DOI 10.1007/s11205-009-9448-3; Christensen K, 2009, LANCET, V374, P1196, DOI 10.1016/S0140-6736(09)61460-4; Ezzati M, 2008, PLOS MED, V5, P557, DOI 10.1371/journal.pmed.0050066; Gondo Y, 2007, RONEN SHAKAI KAGAKU, V28, P504; Hamano T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013214; Hasegawa T, 2001, CHALLENGING INEQUITI, P90; Hashimoto H, 2011, LANCET, V378, P1174, DOI 10.1016/S0140-6736(11)60987-2; Hashimoto S, 2010, J EPIDEMIOL, V20, P308, DOI 10.2188/jea.JE20090190; Honjo K, 2000, TOB CONTROL, V9, P193, DOI 10.1136/tc.9.2.193; Horiuchi Shiro, 2011, Jpn J Popul, V9, P162; Ikeda N, 2008, B WORLD HEALTH ORGAN, V86, P978, DOI 10.2471/BLT.07.050195; Ikegami N, 2011, LANCET, V378, P1106, DOI 10.1016/S0140-6736(11)60828-3; Institute for Health Metrics and Evaluation, 2010, I HLTH METR EV DAT; Iso H, 1998, STROKE, V29, P1510, DOI 10.1161/01.STR.29.8.1510; Iso H, 2008, CIRCULATION, V118, P2725, DOI 10.1161/CIRCULATIONAHA.107.750117; Iwasaki T, 1974, Bull Int Union Tuberc, V49, P30; Japan Brain Dock Society, 2008, GUID BRAIN DOCK 2008; JOHANSSON SR, 1987, POP STUD-J DEMOG, V41, P207, DOI 10.1080/0032472031000142776; Kaga Makiko, 2009, Leg Med (Tokyo), V11 Suppl 1, pS18, DOI 10.1016/j.legalmed.2009.01.015; Kagamimori S, 2009, SOC SCI MED, V68, P2152, DOI 10.1016/j.socscimed.2009.03.030; Kato M, 2004, ALIMENT PHARM THERAP, V20, P85, DOI 10.1111/j.1365-2036.2004.01987.x; MARMOT MG, 1989, BRIT MED J, V299, P1547, DOI 10.1136/bmj.299.6715.1547; Ministry of Health Labour and Welfare, 2007, 20 LIF TABL; Ministry of Health Labour and Welfare, 1952, VIT STAT JAP 1950 20; Ministry of Health Labour and Welfare, 1949, VIT STAT JAP 1947 20; Ministry of Health Labour and Welfare, 2011, FACT SHEET ABR LIF T; Ministry of Health labour and Welfare, 1989, MUN LIF TABL 1985 20; Ministry of Health Labour and Welfare, 2009, VIT STAT JAP 2007; Ministry of Health Labour and Welfare, 2009, ACT SEC PROP OP WORK; Ministry of Health Labour and Welfare, 2007, STAND HLTH EX GUID P; Ministry of Health Labour and Welfare, 2009, 2007 COMPR SURV LIV; Ministry of Health Labour and Welfare in Japan, 2010, NAT HLTH NUTR SURV J; Ministry of Internal Affairs and Communications, 2010, POP JAP FIN REP 2005; Ministry of Internal Affairs and Communications, 2010, LAB FORC SURV; Mori T, 2000, EMERG INFECT DIS, V6, P566, DOI 10.3201/eid0606.000602; Murakami Y, 2011, PREV MED, V52, P60, DOI 10.1016/j.ypmed.2010.11.009; Naghavi M, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-9; Nakaya T, 2005, SOC SCI MED, V60, P2865, DOI 10.1016/j.socscimed.2004.11.007; National Police Agency of Japan, 2011, INF SUIC 2010; Nolte Ellen., 2004, DOES HLTH CARE SAVE; OECD, 2008, RIGHTS TRANSL UN GRO; Oeppen J, 2002, SCIENCE, V296, P1029, DOI 10.1126/science.1069675; Ogihara T, 2009, HYPERTENS RES, V32, P3, DOI 10.1038/hr.2008.15; Ohno Y, 1985, World Health Stat Q, V38, P176; OKAYAMA A, 1993, INT J EPIDEMIOL, V22, P1038, DOI 10.1093/ije/22.6.1038; Olshansky SJ, 2001, SCIENCE, V291, P1491, DOI 10.1126/science.291.5508.1491; Organisation for Economic Co-operation and Development (OECD), 2011, OECD HLTH DAT 2011 S; Parkin DM, 2006, INT J CANCER, V118, P3030, DOI 10.1002/ijc.21731; Rajaratnam JK, 2010, LANCET, V375, P1704, DOI 10.1016/S0140-6736(10)60517-X; Reich MR, 2011, LANCET, V378, P1051, DOI 10.1016/S0140-6736(11)60274-2; Riley J, 2001, RISING LIFE EXPECTAN; ROBERTSON TL, 1977, AM J CARDIOL, V39, P244, DOI 10.1016/S0002-9149(77)80198-7; Sakane N, 1997, DIABETOLOGIA, V40, P200, DOI 10.1007/s001250050663; Schoeni RF, 2006, POP STUD-J DEMOG, V60, P39, DOI 10.1080/00324720500462280; Shibuya K, 2011, COMPREHENSIVE ASSESS, P5; SHIMAMOTO T, 1989, CIRCULATION, V79, P503, DOI 10.1161/01.CIR.79.3.503; Shinmura Hiromi, 2008, Nihon Koshu Eisei Zasshi, V55, P170; Statistics Bureau Ministry of Internal Affairs and Communications, 1985, POP JAP 1980 2000; Sugiura Y, 2010, BIOSCI TRENDS, V4, P9; Suzuki M, 1995, Nihon Ronen Igakkai Zasshi, V32, P416; TAKEYA Y, 1984, STROKE, V15, P15, DOI 10.1161/01.STR.15.1.15; Tamiya N, 2011, LANCET, V378, P1183, DOI 10.1016/S0140-6736(11)61176-8; Tominaga S, 1997, INT J CANCER, P2; Tsukuma Hideaki, 2005, Asian Pac J Cancer Prev, V6, P244; UESHIMA H, 1987, J CHRON DIS, V40, P137, DOI 10.1016/0021-9681(87)90065-8; United Nations Population Division, WORLD POP PROSP 2010; [University of California Berkeley (USA) Max Planck Institute for Demographic Research (Germany)], HUM MORT DAT; WHO, 2010, WOR HEALT REP, P1; World Bank, WORLD DEV IND; World Health Organization, 2011, WORLD HLTH STAT 2011; World Health Organization, 2009, WHO REP GLOB TOB EP; World Health Organization (WHO), 2013, WORLD HLTH REPORT 20; Yamakado M., 2010, HIGHLIGHTING JAPAN, V4, P10; YANO K, 1984, AM J EPIDEMIOL, V119, P653, DOI 10.1093/oxfordjournals.aje.a113787; Yong V, 2009, DEMOGR RES, V20, P467, DOI 10.4054/DemRes.2009.20.19; YOSHIDA T, 1995, LANCET, V346, P1433, DOI 10.1016/S0140-6736(95)92452-3	82	262	267	1	12	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 17	2011	378	9796					1094	1105		10.1016/S0140-6736(11)61055-6	http://dx.doi.org/10.1016/S0140-6736(11)61055-6			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	829BE	21885105				2022-12-28	WOS:000295548900026
J	Cook-Deegan, R				Cook-Deegan, Robert			Boosting Health Services Research	SCIENCE			English	Editorial Material							NIH		[Cook-Deegan, Robert] Fdn Brocher, CH-1248 Hermance, Switzerland; [Cook-Deegan, Robert] Duke Univ, Inst Genome Sci & Policy, Durham, NC 27708 USA	Duke University	Cook-Deegan, R (corresponding author), Fdn Brocher, CH-1248 Hermance, Switzerland.	gelp@duke.edu		Cook-Deegan, Robert/0000-0002-8251-4237	NHGRI NIH HHS [P50 HG003391, P50 HG003391-01] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG003391] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Academy Health, 2005, PLAC COORD FUND HLTH; *AHRQ, 2011, BUDG ESTM APPR COMM; Bigos S, 1994, CLIN PRACTICE GUIDEL; Centers for Medicare & Medicaid Services, 2011, NAT HLTH EXP TYP SER; CLANCY CM, 2003, HLTH AFF MILLWOOD S, pW3; *COAL HLTH SERV RE, 2010, 2009 FED FUND HLTH S; Crow MM, 2011, NATURE, V471, P569, DOI 10.1038/471569a; GAUS CR, 2003, HLTH AFF MILLWOOD S, pW3; GRAY BH, 2003, HLTH AFF        0625, pW3; Manton KG, 2009, P NATL ACAD SCI USA, V106, P10981, DOI 10.1073/pnas.0905104106; McGeary M, 2002, ORG STRUCTURE NATL I; *NAT RES COUNC, 2003, ENH VIT NAT I HLTH O; Sisko AM, 2010, HEALTH AFFAIR, V29, P1933, DOI 10.1377/hlthaff.2010.0788; Topel R, 2003, MEASURING GAINS MED; Varmus H, 2001, SCIENCE, V291, P1903, DOI 10.1126/science.1059063; WENNBERG JE, 2003, HLTH AFF MILLWOOD S, pW3; World Health Organization, 2000, WORLD HLTH REP 2000	17	4	4	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 9	2011	333	6048					1384	1385		10.1126/science.1208201	http://dx.doi.org/10.1126/science.1208201			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	817KU	21903796	Green Accepted			2022-12-28	WOS:000294672200023
J	Feero, WG; Green, ED				Feero, W. Gregory; Green, Eric D.			Genomics Education for Health Care Professionals in the 21st Century	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							COMPETENCES; REVOLUTION; GENETICS		[Feero, W. Gregory; Green, Eric D.] NHGRI, NIH, Bethesda, MD 20892 USA; [Feero, W. Gregory] Maine & Dartmouth Family Med Residency, Augusta, GA USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Feero, WG (corresponding author), NHGRI, NIH, 31 Ctr Dr,Bldg 31,Room 4B09, Bethesda, MD 20892 USA.	feerow@mail.nih.gov						[Anonymous], TABLE PHARMACOGENOMI; [Anonymous], AM SKEPTICAL PHYS KN; Collins FS, 1997, JAMA-J AM MED ASSOC, V278, P1285, DOI 10.1001/jama.278.15.1285; Dietz HC, 2010, NEW ENGL J MED, V363, P852, DOI 10.1056/NEJMra0907180; Green ED, 2011, NATURE, V470, P204, DOI 10.1038/nature09764; Jenkins J, 2007, J NURS SCHOLARSHIP, V39, P10, DOI 10.1111/j.1547-5069.2007.00137.x; Kirk M, 2011, J NURS SCHOLARSHIP, V43, P107, DOI 10.1111/j.1547-5069.2011.01388.x; Lander ES, 2011, NATURE, V470, P187, DOI 10.1038/nature09792; Manolio TA, 2010, NEW ENGL J MED, V363, P166, DOI 10.1056/NEJMra0905980; Marshall E, 2011, SCIENCE, V331, P526, DOI 10.1126/science.331.6017.526	10	88	90	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 7	2011	306	9					989	990		10.1001/jama.2011.1245	http://dx.doi.org/10.1001/jama.2011.1245			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	815QT	21900139				2022-12-28	WOS:000294542600017
J	Sorenson, C; Naci, H; Cylus, J; Mossialos, E				Sorenson, Corinna; Naci, Huseyin; Cylus, Jonathan; Mossialos, Elias			Evidence of comparative efficacy should have a formal role in European drug approvals	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CLINICAL-TRIALS		[Sorenson, Corinna; Naci, Huseyin; Cylus, Jonathan; Mossialos, Elias] Univ London London Sch Econ & Polit Sci, LSE Hlth & Social Care, London WC2A 2AE, England; [Cylus, Jonathan; Mossialos, Elias] European Observ Hlth Syst & Policies, London, England	University of London; London School Economics & Political Science; European Observatory on Health Systems & Policies	Cylus, J (corresponding author), Univ London London Sch Econ & Polit Sci, LSE Hlth & Social Care, Houghton St, London WC2A 2AE, England.	j.d.cylus@lse.ac.uk	Mossialos, Elias/ABE-1301-2021	Cylus, Jonathan/0000-0001-8269-1578				[Anonymous], 2004, EMEA11931904; Barbui C, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2291; Chan AW, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d80; Chokshi DA, 2010, HEALTH AFFAIR, V29, P1842, DOI 10.1377/hlthaff.2010.0843; Eichler HG, 2010, NAT REV DRUG DISCOV, V9, P277, DOI 10.1038/nrd3079; *EUR COMM, 2008, FIN CONCL REC HIGH L; *EUR SOC INS PLATF, 2007, RESP EUR COMM PUBL C; European Medicines Agency, 2010, EMA7597842010; European Medicines Agency, 2010, ROAD MAP 2015 EUR ME; Fleurence RL, 2010, HEALTH AFFAIR, V29, P1826, DOI 10.1377/hlthaff.2010.0630; Furberg CD, 2002, JAMA-J AM MED ASSOC, V288, P2981; Gage BF, 2009, NEW ENGL J MED, V361, P1200, DOI 10.1056/NEJMe0906886; Gagne JJ, 2011, JAMA-J AM MED ASSOC, V305, P711, DOI 10.1001/jama.2011.152; Garattini S, 2007, BMJ-BRIT MED J, V335, P803, DOI 10.1136/bmj.39281.615706.94; Garattini S, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c1578; Garattini S, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b1025; Goldberg NH, 2011, JAMA-J AM MED ASSOC, V305, P1786, DOI 10.1001/jama.2011.539; Jefferson T, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7258; Juurlink DN, 2010, JAMA-J AM MED ASSOC, V304, P469, DOI 10.1001/jama.2010.954; Loke YK, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d1309; Luce BR, 2009, ANN INTERN MED, V151, P206, DOI 10.7326/0003-4819-151-3-200908040-00126; Maio V, 2010, J CLIN PHARM THER, V35, P55, DOI 10.1111/j.1365-2710.2009.01047.x; Motola D, 2006, BRIT J CLIN PHARMACO, V62, P610, DOI 10.1111/j.1365-2125.2006.02700.x; Nissen S, 2010, ROSIGLITAZONE CRITIC; Smith R, 2005, PLOS MED, V2, P364, DOI 10.1371/journal.pmed.0020138.g001; Song FJ, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1147; Stafford RS, 2009, NEW ENGL J MED, V361, P1230, DOI 10.1056/NEJMp0906490; Tunis SR, 2003, JAMA-J AM MED ASSOC, V290, P1624, DOI 10.1001/jama.290.12.1624; van Luijn JCF, 2008, ANN PHARMACOTHER, V42, P1605, DOI 10.1345/aph.1L115; van Luijn JCF, 2008, BRIT J CLIN PHARMACO, V65, P716, DOI 10.1111/j.1365-2125.2007.03092.x; van Luijn JCF, 2007, BRIT J CLIN PHARMACO, V63, P159, DOI 10.1111/j.1365-2125.2006.02812.x; van Luijn JCF, 2010, EUR J CLIN PHARMACOL, V66, P445, DOI 10.1007/s00228-010-0808-3	32	32	32	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 6	2011	343								d4849	10.1136/bmj.d4849	http://dx.doi.org/10.1136/bmj.d4849			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	819RF	21896610	Green Accepted			2022-12-28	WOS:000294846500001
J	Aufderheide, TP; Nichol, G; Rea, TD; Brown, SP; Leroux, BG; Pepe, PE; Kudenchuk, PJ; Christenson, J; Daya, MR; Dorian, P; Callaway, CW; Idris, AH; Andrusiek, D; Stephens, SW; Hostler, D; Davis, DP; Dunford, JV; Pirrallo, RG; Stiell, IG; Clement, CM; Craig, A; Van Ottingham, L; Schmidt, TA; Wang, HE; Weisfeldt, ML; Ornato, JP; Sopko, G				Aufderheide, Tom P.; Nichol, Graham; Rea, Thomas D.; Brown, Siobhan P.; Leroux, Brian G.; Pepe, Paul E.; Kudenchuk, Peter J.; Christenson, Jim; Daya, Mohamud R.; Dorian, Paul; Callaway, Clifton W.; Idris, Ahamed H.; Andrusiek, Douglas; Stephens, Shannon W.; Hostler, David; Davis, Daniel P.; Dunford, James V.; Pirrallo, Ronald G.; Stiell, Ian G.; Clement, Catherine M.; Craig, Alan; Van Ottingham, Lois; Schmidt, Terri A.; Wang, Henry E.; Weisfeldt, Myron L.; Ornato, Joseph P.; Sopko, George		ROC Investigators	A Trial of an Impedance Threshold Device in Out-of-Hospital Cardiac Arrest	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CARDIOPULMONARY-RESUSCITATION; PORCINE MODEL; HEMODYNAMICS; SURVIVAL	Background The impedance threshold device (ITD) is designed to enhance venous return and cardiac output during cardiopulmonary resuscitation (CPR) by increasing the degree of negative intrathoracic pressure. Previous studies have suggested that the use of an ITD during CPR may improve survival rates after cardiac arrest. Methods We compared the use of an active ITD with that of a sham ITD in patients with out-of-hospital cardiac arrest who underwent standard CPR at 10 sites in the United States and Canada. Patients, investigators, study coordinators, and all care providers were unaware of the treatment assignments. The primary outcome was survival to hospital discharge with satisfactory function (i.e., a score of <= 3 on the modified Rankin scale, which ranges from 0 to 6, with higher scores indicating greater disability). Results Of 8718 patients included in the analysis, 4345 were randomly assigned to treatment with a sham ITD and 4373 to treatment with an active device. A total of 260 patients (6.0%) in the sham-ITD group and 254 patients (5.8%) in the active-ITD group met the primary outcome (risk difference adjusted for sequential monitoring, -0.1 percentage points; 95% confidence interval, -1.1 to 0.8; P = 0.71). There were also no significant differences in the secondary outcomes, including rates of return of spontaneous circulation on arrival at the emergency department, survival to hospital admission, and survival to hospital discharge. Conclusions Use of the ITD did not significantly improve survival with satisfactory function among patients with out-of-hospital cardiac arrest receiving standard CPR. (Funded by the National Heart, Lung, and Blood Institute and others; ROC PRIMED ClinicalTrials.gov number, NCT00394706.)	[Aufderheide, Tom P.; Pirrallo, Ronald G.] Med Coll Wisconsin, Dept Emergency Med, 9200 W Wisconsin Ave,Pavil 1P, Milwaukee, WI 53226 USA; [Nichol, Graham] Univ Washington, Harborview Ctr Prehosp Emergency Care, Seattle, WA 98195 USA; [Rea, Thomas D.] Univ Washington, Div Gen Med, Seattle, WA 98195 USA; [Kudenchuk, Peter J.] Univ Washington, Div Cardiol, Dept Med, Seattle, WA 98195 USA; [Nichol, Graham; Brown, Siobhan P.; Leroux, Brian G.; Van Ottingham, Lois] Univ Washington, Dept Biostat, Clin Trials Ctr, Seattle, WA 98195 USA; [Pepe, Paul E.; Idris, Ahamed H.] Univ Texas SW Med Ctr Dallas, Dept Surg Emergency Med, Dallas, TX 75390 USA; [Christenson, Jim] Univ British Columbia, Dept Emergency Med, Vancouver, BC V5Z 1M9, Canada; [Andrusiek, Douglas] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V5Z 1M9, Canada; [Christenson, Jim; Andrusiek, Douglas] British Columbia Emergency & Hlth Serv Commiss, Vancouver, BC, Canada; [Daya, Mohamud R.; Schmidt, Terri A.] Oregon Hlth & Sci Univ, Dept Emergency Med, Ctr Policy & Res Emergency Med, Portland, OR 97201 USA; [Dorian, Paul] Univ Toronto, Dept Med, Toronto, ON, Canada; [Craig, Alan] Toronto Emergency Med Serv, Toronto, ON, Canada; [Callaway, Clifton W.; Hostler, David] Univ Pittsburgh, Dept Emergency Med, Pittsburgh, PA USA; [Davis, Daniel P.; Dunford, James V.] Univ Calif San Diego, Dept Emergency Med, San Diego, CA 92103 USA; [Stiell, Ian G.; Clement, Catherine M.] Univ Ottawa, Dept Emergency Med, Ottawa, ON, Canada; [Stiell, Ian G.; Clement, Catherine M.] Univ Ottawa, Ottawa Hosp Res Inst, Ottawa, ON, Canada; [Weisfeldt, Myron L.] Johns Hopkins Med Inst, Dept Med, Baltimore, MD 21205 USA; [Sopko, George] NHLBI, NIH, Bethesda, MD 20892 USA; [Ornato, Joseph P.] Virginia Commonwealth Univ, Dept Emergency Med, Richmond, VA USA	Medical College of Wisconsin; Harborview Medical Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of British Columbia; University of British Columbia; Oregon Health & Science University; University of Toronto; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California San Diego; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; Johns Hopkins University; Johns Hopkins Medicine; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Virginia Commonwealth University	Aufderheide, TP (corresponding author), Med Coll Wisconsin, Dept Emergency Med, 9200 W Wisconsin Ave,Pavil 1P, Milwaukee, WI 53226 USA.	taufderh@mcw.edu	Leroux, Brian G/H-2254-2015; Nichol, Graham/Z-4996-2019; Cheskes, Sheldon/I-4456-2015; Daya, Mohamud R/A-9322-2012	Cheskes, Sheldon/0000-0001-7835-3074; Brown, Siobhan/0000-0002-4774-3122; Idris, Ahamed/0000-0001-7113-6499; Pirrallo, Ronald/0000-0002-8321-3866; Callaway, Clifton/0000-0002-3309-1573; Hostler, David/0000-0002-7711-4001; Stephens, Shannon/0000-0001-5898-5170; Stiell, Ian/0000-0002-2583-6408; Gabriel, Erin/0000-0002-0504-8404	National Heart, Lung, and Blood Institute [5U01 HL077863, HL077881, HL077871, HL077872, HL077866, HL077908, HL077867, HL077887, HL077873, HL077865]; National Institute of Neurological Disorders and Stroke; U.S. Army Medical Research and Materiel Command; Institute of Circulatory and Respiratory Health of the Canadian Institutes of Health Research, Defence Research and Development Canada; Heart and Stroke Foundation of Canada; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL077866, U01HL077908, U01HL077887, U01HL077871, U01HL077867, U01HL077881, U01HL077873, U01HL077863, U01HL077865, U01HL077872] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); U.S. Army Medical Research and Materiel Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); Institute of Circulatory and Respiratory Health of the Canadian Institutes of Health Research, Defence Research and Development Canada(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by a series of cooperative agreements with 10 regional clinical centers and one data coordinating center (5U01 HL077863, HL077881, HL077871, HL077872, HL077866, HL077908, HL077867, HL077887, HL077873, HL077865) from the National Heart, Lung, and Blood Institute in partnership with the National Institute of Neurological Disorders and Stroke, U.S. Army Medical Research and Materiel Command, the Institute of Circulatory and Respiratory Health of the Canadian Institutes of Health Research, Defence Research and Development Canada, the Heart and Stroke Foundation of Canada, and the American Heart Association.	Andreka P, 2006, CURR OPIN CRIT CARE, V12, P198, DOI 10.1097/01.ccx.0000224861.70958.59; [Anonymous], 2005, CIRCULATION, V112, pIV1, DOI 10.1161/CIRCULATIONAHA.105.166550; [Anonymous], 2005, CIRCULATION, V2005, P112; Aufderheide TP, 2008, CRIT CARE MED, V36, pS397, DOI 10.1097/CCM.0b013e31818a7e56; Aufderheide TP, 2008, RESUSCITATION, V78, P179, DOI 10.1016/j.resuscitation.2008.01.028; Aufderheide TP, 2006, CRIT CARE MED, V34, pS466, DOI 10.1097/01.CCM.0000246013.47237.86; Aufderheide TP, 2011, LANCET, V377, P301, DOI 10.1016/S0140-6736(10)62103-4; Aufderheide TP, 2005, CRIT CARE MED, V33, P734, DOI 10.1097/01.CCM.0000155909.09061.12; Aufderheide TP, 2004, CIRCULATION, V109, P1960, DOI 10.1161/01.CIR.0000126594.79136.61; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Eisenberg MS, 2010, JAMA-J AM MED ASSOC, V304, P87, DOI 10.1001/jama.2010.898; Emerson S S, 1990, Oncology (Williston Park), V4, P126; Lai SM, 2001, NEUROEPIDEMIOLOGY, V20, P26, DOI 10.1159/000054754; Lurie KG, 2002, CIRCULATION, V105, P124, DOI 10.1161/hc0102.101391; Mader TJ, 2008, RESUSCITATION, V77, P387, DOI 10.1016/j.resuscitation.2008.01.007; Menegazzi JJ, 2007, PREHOSP EMERG CARE, V11, P179, DOI 10.1080/10903120701206073; Pirrallo RG, 2005, RESUSCITATION, V66, P13, DOI 10.1016/j.resuscitation.2004.12.027; Stiell IG, 2011, NEW ENGL J MED, V365, P787, DOI 10.1056/NEJMoa1010076; Thayne RC, 2005, RESUSCITATION, V67, P103, DOI 10.1016/j.resuscitation.2005.05.009; Tomlinson AE, 2007, RESUSCITATION, V72, P364, DOI 10.1016/j.resuscitation.2006.07.017; WHITEHEAD J, 1986, STAT MED, V5, P459, DOI 10.1002/sim.4780050510; Yannopoulos D, 2005, RESUSCITATION, V64, P363, DOI 10.1016/j.resuscitation.2004.10.009; Yannopoulos D, 2004, RESUSCITATION, V61, P75, DOI 10.1016/j.resuscitation.2003.12.006	24	164	169	1	26	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 1	2011	365	9					798	806		10.1056/NEJMoa1010821	http://dx.doi.org/10.1056/NEJMoa1010821			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	813YC	21879897	Green Accepted, Green Published			2022-12-28	WOS:000294405200006
J	Bouvignies, G; Vallurupalli, P; Hansen, DF; Correia, BE; Lange, O; Bah, A; Vernon, RM; Dahlquist, FW; Baker, D; Kay, LE				Bouvignies, Guillaume; Vallurupalli, Pramodh; Hansen, D. Flemming; Correia, Bruno E.; Lange, Oliver; Bah, Alaji; Vernon, Robert M.; Dahlquist, Frederick W.; Baker, David; Kay, Lewis E.			Solution structure of a minor and transiently formed state of a T4 lysozyme mutant	NATURE			English	Article							RELAXATION DISPERSION NMR; EXCITED PROTEIN STATES; NUCLEAR-MAGNETIC-RESONANCE; CHEMICAL-SHIFTS; HETERONUCLEAR CORRELATION; SPECTROSCOPY; EXCHANGE; FLEXIBILITY; ANGLES; RESOLUTION	Proteins are inherently plastic molecules, whose function often critically depends on excursions between different molecular conformations (conformers)(1-3). However, a rigorous understanding of the relation between a protein's structure, dynamics and function remains elusive. This is because many of the conformers on its energy landscape are only transiently formed and marginally populated (less than a few per cent of the total number of molecules), so that they cannot be individually characterized by most biophysical tools. Here we study a lysozyme mutant from phage T4 that binds hydrophobic molecules(4) and populates an excited state transiently (about 1 ms) to about 3% at 25 degrees C (ref. 5). We show that such binding occurs only via the ground state, and present the atomic-level model of the 'invisible', excited state obtained using a combined strategy of relaxation-dispersion NMR (ref. 6) and CS-Rosetta(7) model building that rationalizes this observation. The model was tested using structure-based design calculations identifying point mutants predicted to stabilize the excited state relative to the ground state. In this way a pair of mutations were introduced, inverting the relative populations of the ground and excited states and altering function. Our results suggest a mechanism for the evolution of a protein's function by changing the delicate balance between the states on its energy landscape. More generally, they show that our approach can generate and validate models of excited protein states.	[Bouvignies, Guillaume; Vallurupalli, Pramodh; Hansen, D. Flemming; Kay, Lewis E.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Bouvignies, Guillaume; Vallurupalli, Pramodh; Hansen, D. Flemming; Kay, Lewis E.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Bouvignies, Guillaume; Vallurupalli, Pramodh; Hansen, D. Flemming; Kay, Lewis E.] Univ Toronto, Dept Chem, Toronto, ON M5S 1A8, Canada; [Correia, Bruno E.; Lange, Oliver; Vernon, Robert M.; Baker, David] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Correia, Bruno E.] Inst Gulbenkian Ciencias, Program Computat Biol, P-2780156 Oeiras, Portugal; [Bah, Alaji; Vernon, Robert M.; Kay, Lewis E.] Hosp Sick Children, Program Mol Struct & Funct, Toronto, ON M5G 1X8, Canada; [Dahlquist, Frederick W.] Univ Calif Santa Barbara, Dept Chem & Biochem, Santa Barbara, CA 93106 USA	University of Toronto; University of Toronto; University of Toronto; University of Washington; University of Washington Seattle; Instituto Gulbenkian de Ciencia; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of California System; University of California Santa Barbara	Kay, LE (corresponding author), Univ Toronto, Dept Mol Genet, 100 Coll St, Toronto, ON M5S 1A8, Canada.	kay@pound.med.utoronto.ca	Baker, David/K-8941-2012; Bouvignies, Guillaume/C-1009-2008; Lange, Oliver/K-5749-2012	Baker, David/0000-0001-7896-6217; Bouvignies, Guillaume/0000-0003-4398-0320; Lange, Oliver/0000-0002-4018-7020; Hansen, Dennis Flemming/0000-0003-0891-220X	European Molecular Biology Organization; Canadian Institutes of Health Research (CIHR); Natural Sciences and Engineering Research Council of Canada; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM092802] Funding Source: NIH RePORTER	European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Forman-Kay for providing laboratory space, and J. Forman-Kay and T. Alber for discussions. G.B. acknowledges The European Molecular Biology Organization and The Canadian Institutes of Health Research (CIHR) for postdoctoral fellowships. L.E.K. holds a Canada Research Chair in Biochemistry. This work was supported by the CIHR and the Natural Sciences and Engineering Research Council of Canada, with computations performed on the GPC supercomputer at the SciNet HPC Consortium.	Baase WA, 2010, PROTEIN SCI, V19, P631, DOI 10.1002/pro.344; Berjanskii MV, 2005, J AM CHEM SOC, V127, P14970, DOI 10.1021/ja054842f; Boehr DD, 2006, SCIENCE, V313, P1638, DOI 10.1126/science.1130258; Bouvignies G, 2010, J BIOMOL NMR, V47, P135, DOI 10.1007/s10858-010-9418-8; Cavalli A, 2007, P NATL ACAD SCI USA, V104, P9615, DOI 10.1073/pnas.0610313104; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; ERIKSSON AE, 1992, NATURE, V355, P371, DOI 10.1038/355371a0; ERIKSSON AE, 1992, SCIENCE, V255, P178, DOI 10.1126/science.1553543; FARROW NA, 1994, J BIOMOL NMR, V4, P727, DOI 10.1007/BF00404280; Feher VA, 1996, NAT STRUCT BIOL, V3, P516, DOI 10.1038/nsb0696-516; Fersht A., 1999, STRUCTURE MECH PROTE, DOI 10.1142/10574; Goddard T. D., 2006, SPARKY 3; Hansen DF, 2008, J BIOMOL NMR, V41, P113, DOI 10.1007/s10858-008-9251-5; Hansen DF, 2008, J AM CHEM SOC, V130, P2667, DOI 10.1021/ja078337p; Henzler-Wildman KA, 2007, NATURE, V450, P838, DOI 10.1038/nature06410; Hu JS, 1997, J AM CHEM SOC, V119, P1803, DOI 10.1021/ja963625z; Hu JS, 1997, J AM CHEM SOC, V119, P6360, DOI 10.1021/ja970067v; JENSEN RA, 1976, ANNU REV MICROBIOL, V30, P409, DOI 10.1146/annurev.mi.30.100176.002205; Karplus M, 2005, P NATL ACAD SCI USA, V102, P6679, DOI 10.1073/pnas.0408930102; Kellogg EH, 2011, PROTEINS, V79, P830, DOI 10.1002/prot.22921; Korzhnev DM, 2004, NATURE, V430, P586, DOI 10.1038/nature02655; Korzhnev DM, 2008, ACCOUNTS CHEM RES, V41, P442, DOI 10.1021/ar700189y; Korzhnev DM, 2010, SCIENCE, V329, P1312, DOI 10.1126/science.1191723; Liu LJ, 2009, J MOL BIOL, V385, P595, DOI 10.1016/j.jmb.2008.10.086; Loken Chris, 2010, Journal of Physics: Conference Series, V256, DOI 10.1088/1742-6596/256/1/012026; Lundstrom P, 2009, NAT PROTOC, V4, P1641, DOI 10.1038/nprot.2009.118; MCCONNELL HM, 1958, J CHEM PHYS, V28, P430, DOI 10.1063/1.1744152; MONTELIONE GT, 1989, J AM CHEM SOC, V111, P3096, DOI 10.1021/ja00190a072; Mulder FAA, 2001, NAT STRUCT BIOL, V8, P932, DOI 10.1038/nsb1101-932; Mulder FAA, 2000, BIOCHEMISTRY-US, V39, P12614, DOI 10.1021/bi001351t; NICHOLSON H, 1992, BIOPOLYMERS, V32, P1431, DOI 10.1002/bip.360321103; Orekhov VY, 2004, J AM CHEM SOC, V126, P1886, DOI 10.1021/ja038620y; Palmer AG, 2001, METHOD ENZYMOL, V339, P204, DOI 10.1016/S0076-6879(01)39315-1; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PRESS WH, 1992, NUMERICAL RECIPES; Religa TL, 2010, SCIENCE, V328, P98, DOI 10.1126/science.1184991; Rodriguez JC, 2004, J BIOMOL NMR, V30, P155, DOI 10.1023/B:JNMR.0000048857.44219.c3; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Schrodinger LLC, 2010, PYMOL MOL GRAPH SYST; Shen Y, 2008, P NATL ACAD SCI USA, V105, P4685, DOI 10.1073/pnas.0800256105; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Skrynnikov NR, 2002, J AM CHEM SOC, V124, P12352, DOI 10.1021/ja0207089; Tang C, 2007, NATURE, V449, P1078, DOI 10.1038/nature06232; Tokuriki N, 2009, SCIENCE, V324, P203, DOI 10.1126/science.1169375; Vallurupalli P, 2008, P NATL ACAD SCI USA, V105, P11766, DOI 10.1073/pnas.0804221105; Vallurupalli P, 2007, P NATL ACAD SCI USA, V104, P18473, DOI 10.1073/pnas.0708296104; Vallurupalli P, 2009, J BIOMOL NMR, V45, P45, DOI 10.1007/s10858-009-9310-6; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Walden WE, 2006, SCIENCE, V314, P1903, DOI 10.1126/science.1133116; Wang C, 2007, J MOL BIOL, V373, P503, DOI 10.1016/j.jmb.2007.07.050	51	221	224	1	98	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 1	2011	477	7362					111	U134		10.1038/nature10349	http://dx.doi.org/10.1038/nature10349			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	813XT	21857680	Green Accepted			2022-12-28	WOS:000294404300042
J	das Neves, MF; Oliveira, S				das Neves, Marisa Fernandes; Oliveira, Susana			Scleroderma	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[das Neves, Marisa Fernandes; Oliveira, Susana] Fernando Fonseca Hosp, Amadora, Portugal	Hospital Professor Doutor Fernando Fonseca, EPE	das Neves, MF (corresponding author), Fernando Fonseca Hosp, Amadora, Portugal.								0	0	0	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 1	2011	365	9					842	842						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	813YC	21879902				2022-12-28	WOS:000294405200011
J	Stiell, IG; Nichol, G; Leroux, BG; Rea, TD; Ornato, JP; Powell, J; Christenson, J; Callaway, CW; Kudenchuk, PJ; Aufderheide, TP; Idris, AH; Daya, MR; Wang, HE; Morrison, LJ; Davis, D; Andrusiek, D; Stephens, S; Cheskes, S; Schmicker, RH; Fowler, R; Vaillancourt, C; Hostler, D; Zive, D; Pirrallo, RG; Vilke, GM; Sopko, G; Weisfeldt, M				Stiell, Ian G.; Nichol, Graham; Leroux, Brian G.; Rea, Thomas D.; Ornato, Joseph P.; Powell, Judy; Christenson, James; Callaway, Clifton W.; Kudenchuk, Peter J.; Aufderheide, Tom P.; Idris, Ahamed H.; Daya, Mohamud R.; Wang, Henry E.; Morrison, Laurie J.; Davis, Daniel; Andrusiek, Douglas; Stephens, Shannon; Cheskes, Sheldon; Schmicker, Robert H.; Fowler, Ray; Vaillancourt, Christian; Hostler, David; Zive, Dana; Pirrallo, Ronald G.; Vilke, Gary M.; Sopko, George; Weisfeldt, Myron		ROC Investigators	Early versus Later Rhythm Analysis in Patients with Out-of-Hospital Cardiac Arrest	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							IMPEDANCE THRESHOLD DEVICE; CARDIOPULMONARY-RESUSCITATION; VENTRICULAR-FIBRILLATION; TRIAL METHODS; LIFE-SUPPORT; SWINE MODEL; DEFIBRILLATION; OUTCOMES; METHODOLOGY; RATIONALE	Background In a departure from the previous strategy of immediate defibrillation, the 2005 resuscitation guidelines from the American Heart Association-International Liaison Committee on Resuscitation suggested that emergency medical service (EMS) personnel could provide 2 minutes of cardiopulmonary resuscitation (CPR) before the first analysis of cardiac rhythm. We compared the strategy of a brief period of CPR with early analysis of rhythm with the strategy of a longer period of CPR with delayed analysis of rhythm. Methods We conducted a cluster-randomized trial involving adults with out-of-hospital cardiac arrest at 10 Resuscitation Outcomes Consortium sites in the United States and Canada. Patients in the early-analysis group were assigned to receive 30 to 60 seconds of EMS-administered CPR and those in the later-analysis group were assigned to receive 180 seconds of CPR, before the initial electrocardiographic analysis. The primary outcome was survival to hospital discharge with satisfactory functional status (a modified Rankin scale score of <= 3, on a scale of 0 to 6, with higher scores indicating greater disability). Results We included 9933 patients, of whom 5290 were assigned to early analysis of cardiac rhythm and 4643 to later analysis. A total of 273 patients (5.9%) in the later-analysis group and 310 patients (5.9%) in the early-analysis group met the criteria for the primary outcome, with a cluster-adjusted difference of -0.2 percentage points (95% confidence interval, -1.1 to 0.7; P = 0.59). Analyses of the data with adjustment for confounding factors, as well as subgroup analyses, also showed no survival benefit for either study group. Conclusions Among patients who had an out-of-hospital cardiac arrest, we found no difference in the outcomes with a brief period, as compared with a longer period, of EMS-administered CPR before the first analysis of cardiac rhythm. (Funded by the National Heart, Lung, and Blood Institute and others; ROC PRIMED ClinicalTrials.gov number, NCT00394706.)	[Stiell, Ian G.; Vaillancourt, Christian] Univ Ottawa, Dept Emergency Med, Ottawa, ON, Canada; [Stiell, Ian G.; Vaillancourt, Christian] Univ Ottawa, Ottawa Hosp Res Inst, Ottawa, ON, Canada; [Nichol, Graham; Leroux, Brian G.; Powell, Judy; Schmicker, Robert H.] Univ Washington, Clin Trials Ctr, Dept Biostat, Seattle, WA 98195 USA; [Nichol, Graham; Rea, Thomas D.; Kudenchuk, Peter J.] Univ Washington, Dept Med, Seattle, WA USA; [Nichol, Graham] Univ Washington, Harborview Ctr Prehosp Emergency Care, Seattle, WA 98195 USA; [Ornato, Joseph P.] Virginia Commonwealth Univ, Dept Emergency Med, Richmond, VA USA; [Christenson, James] Univ British Columbia, Dept Emergency Med, Vancouver, BC V5Z 1M9, Canada; [Andrusiek, Douglas] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V5Z 1M9, Canada; [Christenson, James; Andrusiek, Douglas] British Columbia Emergency & Hlth Serv Commiss, Vancouver, BC, Canada; [Callaway, Clifton W.; Hostler, David] Univ Pittsburgh, Dept Emergency Med, Pittsburgh, PA USA; [Aufderheide, Tom P.; Pirrallo, Ronald G.] Med Coll Wisconsin, Dept Emergency Med, Milwaukee, WI 53226 USA; [Idris, Ahamed H.; Fowler, Ray] Univ Texas SW Med Ctr Dallas, Dept Surg Emergency Med, Dallas, TX 75390 USA; [Daya, Mohamud R.; Zive, Dana] Oregon Hlth & Sci Univ, Dept Emergency Med, Ctr Policy & Res Emergency Med, Portland, OR 97201 USA; [Wang, Henry E.; Stephens, Shannon] Univ Alabama Birmingham, Dept Emergency Med, Birmingham, W Midlands, England; [Morrison, Laurie J.] Univ Toronto, Dept Med, Div Emergency Med, Toronto, ON, Canada; [Cheskes, Sheldon] Univ Toronto, Dept Family & Community Med, Toronto, ON M5S 1A1, Canada; [Morrison, Laurie J.; Cheskes, Sheldon] St Michaels Hosp, Li Ka Shing Knowledge Inst, Rescu Keenan Res Ctr, Toronto, ON M5B 1W8, Canada; [Davis, Daniel; Vilke, Gary M.] Univ Calif San Diego, Dept Emergency Med, San Diego, CA 92103 USA; [Sopko, George] NHLBI, NIH, Bethesda, MD 20892 USA; [Weisfeldt, Myron] Johns Hopkins Med Inst, Dept Med, Baltimore, MD 21205 USA	University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Harborview Medical Center; University of Washington; University of Washington Seattle; Virginia Commonwealth University; University of British Columbia; University of British Columbia; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Medical College of Wisconsin; University of Texas System; University of Texas Southwestern Medical Center Dallas; Oregon Health & Science University; University of Toronto; University of Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of California System; University of California San Diego; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Johns Hopkins University; Johns Hopkins Medicine	Stiell, IG (corresponding author), Univ Ottawa, Dept Emergency Med, Ottawa, ON, Canada.	istiell@ohri.ca	Morrison, Laurie Jean/A-6325-2012; Leroux, Brian G/H-2254-2015; Daya, Mohamud R/A-9322-2012; Cheskes, Sheldon/I-4456-2015; Hug, Balthasar L./G-1568-2010; Nichol, Graham/Z-4996-2019	Morrison, Laurie Jean/0000-0001-8369-9774; Cheskes, Sheldon/0000-0001-7835-3074; Stephens, Shannon/0000-0001-5898-5170; Hostler, David/0000-0002-7711-4001; Idris, Ahamed/0000-0001-7113-6499; Gabriel, Erin/0000-0002-0504-8404; Pirrallo, Ronald/0000-0002-8321-3866; Stiell, Ian/0000-0002-2583-6408; Callaway, Clifton/0000-0002-3309-1573	National Heart, Lung, and Blood Institute [5U01 HL077863, HL077881, HL077871 HL077872, HL077866, HL077908, HL077867, HL077887, HL077873, HL077865]; National Institute of Neurological Disorders and Stroke; Canadian Institutes of Health Research-Institute of Circulatory and Respiratory Health; Heart and Stroke Foundation of Canada; U.S. Army Medical Research and Material Command; Institute of Circulatory and Respiratory Health of the Canadian Institutes of Health Research, Defence Research and Development Canada; American Heart Association; Laerdal Foundation for Acute Medicine; Medtronic Foundation; Sotera Wireless; Medtronic; Jolife; Philips Healthcare; ZOLL Medical; Imricor Medical Systems; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL077866, U01HL077887, U01HL077873, U01HL077865, U01HL077872, U01HL077871, U01HL077881, U01HL077863, U01HL077885, U01HL077908, U01HL077867] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Canadian Institutes of Health Research-Institute of Circulatory and Respiratory Health(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); U.S. Army Medical Research and Material Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); Institute of Circulatory and Respiratory Health of the Canadian Institutes of Health Research, Defence Research and Development Canada(Canadian Institutes of Health Research (CIHR)); American Heart Association(American Heart Association); Laerdal Foundation for Acute Medicine; Medtronic Foundation; Sotera Wireless; Medtronic(Medtronic); Jolife; Philips Healthcare; ZOLL Medical; Imricor Medical Systems; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by grants from the National Heart, Lung, and Blood Institute, the National Institute of Neurological Disorders and Stroke, the Canadian Institutes of Health Research-Institute of Circulatory and Respiratory Health, and the Heart and Stroke Foundation of Canada. The Resuscitation Outcome Consortium is supported by a series of cooperative agreements with 10 regional clinical centers and one data coordinating center (5U01 HL077863, HL077881, HL077871 HL077872, HL077866, HL077908, HL077867, HL077887, HL077873, HL077865) from the National Heart, Lung, and Blood Institute in partnership with the National Institute of Neurological Disorders and Stroke, U.S. Army Medical Research and Material Command, the Institute of Circulatory and Respiratory Health of the Canadian Institutes of Health Research, Defence Research and Development Canada, the Heart and Stroke Foundation of Canada, and the American Heart Association.; Dr. Nichol reports receiving grant support from the Laerdal Foundation for Acute Medicine and Medtronic Foundation and travel fees from Sotera Wireless, being a board member of Medic One Foundation, and participating in research collaborations with Gambro Renal, Lifebridge Medizintechnik, and Sotera Wireless; Dr. Ornato, serving on an advisory board for ZOLL Circulation; Dr. Callaway, that he and his institution receive royalties for patents from Medtronic related to the timing of defibrillation; Dr. Aufderheide, consulting fees from Jolife and Medtronic; Dr. Daya, consulting and lecture fees from Philips Healthcare and owning stock in Amgen, Johnson & Johnson, and Roche; Dr. Morrison, grant support from the Laerdal Foundation for Acute Medicine; Dr. Pirrallo, consulting fees from ZOLL Medical; and Dr. Weisfeldt, that he and his institution receive royalties for patents from Imricor Medical Systems related to an MRI Insensitive Pacemaker. No other potential conflict of interest relevant to this article was reported.	[Anonymous], 2005, CIRCULATION, V112, pIV1, DOI 10.1161/CIRCULATIONAHA.105.166550; Aufderheide TP, 2008, RESUSCITATION, V78, P179, DOI 10.1016/j.resuscitation.2008.01.028; Aufderheide TP, 2011, NEW ENGL J MED, V365, P798, DOI 10.1056/NEJMoa1010821; Baker PW, 2008, RESUSCITATION, V79, P424, DOI 10.1016/j.resuscitation.2008.07.017; Bradley SM, 2010, RESUSCITATION, V81, P155, DOI 10.1016/j.resuscitation.2009.10.026; BRESLOW NE, 1993, J AM STAT ASSOC, V88, P9, DOI 10.1080/01621459.1993.10594284; Cobb LA, 1999, JAMA-J AM MED ASSOC, V281, P1182, DOI 10.1001/jama.281.13.1182; CUMMINS RO, 1991, CIRCULATION, V83, P1832, DOI 10.1161/01.CIR.83.5.1832; Davis DP, 2007, PREHOSP EMERG CARE, V11, P369, DOI 10.1080/10903120701537147; Efron B., 1994, MONOGRAPHS STAT APPL; Hastie T.J., 2017, STAT MODELS S, P249, DOI DOI 10.1201/9780203738535; Jacobs IG, 2009, EMERG MED AUSTRALAS, V21, P430, DOI 10.1111/j.1742-6723.2009.01224.x; Jacobs Ian G, 2005, Emerg Med Australas, V17, P39, DOI 10.1111/j.1742-6723.2005.00694.x; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Link, 2011, CIRCULATION, V123, pE235, DOI 10.1161/CIR.0b013e31820ff4b0; Link MS, 2010, CIRCULATION, V122, pS706, DOI 10.1161/CIRCULATIONAHA.110.970954; Meier P, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-52; Menegazzi JJ, 1993, PREHOSP DISAST MED S, V8, pS15; Newcommon NJ, 2003, STROKE, V34, P377, DOI 10.1161/01.STR.0000055766.99908.58; NICHOL G, 2008, JAMA-J AM MED ASSOC, V300, P1763; Nichol G, 2008, JAMA-J AM MED ASSOC, V300, P1423, DOI 10.1001/jama.300.12.1423; Niemann JT, 2000, ANN EMERG MED, V36, P543, DOI 10.1067/mem.2000.109441; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; Peberdy MA, 2005, RESUSCITATION, V64, P135, DOI 10.1016/j.resuscitation.2004.09.015; Rea TD, 2010, ANN EMERG MED, V55, P249, DOI 10.1016/j.annemergmed.2009.09.018; Rittenberger JC, 2008, RESUSCITATION, V79, P155, DOI 10.1016/j.resuscitation.2008.04.022; Silverman B.W, 1986, DENSITY ESTIMATION; Stiell IG, 2008, RESUSCITATION, V78, P186, DOI 10.1016/j.resuscitation.2008.01.027; Stiell IG, 2004, NEW ENGL J MED, V351, P647, DOI 10.1056/NEJMoa040325; van Alem AP, 2004, AM HEART J, V148, P416, DOI 10.1016/j.ahj.2004.01.031; Wang YL, 2009, CRIT CARE MED, V37, P2250, DOI 10.1097/CCM.0b013e31819ffc6a; Weisfeldt ML, 2002, JAMA-J AM MED ASSOC, V288, P3035, DOI 10.1001/jama.288.23.3035; Wik L, 2003, JAMA-J AM MED ASSOC, V289, P1389, DOI 10.1001/jama.289.11.1389; YAKAITIS RW, 1980, CRIT CARE MED, V8, P157, DOI 10.1097/00003246-198003000-00014	34	192	196	1	28	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 1	2011	365	9					787	797		10.1056/NEJMoa1010076	http://dx.doi.org/10.1056/NEJMoa1010076			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	813YC	21879896	Green Accepted, Green Published			2022-12-28	WOS:000294405200005
J	Krause, T; Lovibond, K; Caulfield, M; McCormack, T; Williams, B				Krause, Taryn; Lovibond, Kate; Caulfield, Mark; McCormack, Terry; Williams, Bryan		Guideline Dev Grp	GUIDELINES Management of hypertension: summary of NICE guidance	BRITISH MEDICAL JOURNAL			English	Editorial Material							RISK		[Krause, Taryn; Lovibond, Kate] Royal Coll Physicians, Natl Clin Guideline Ctr Acute & Chron Condit, London NW1 4LE, England; [Caulfield, Mark] Queen Mary Univ London, Barts & London Sch Med, William Harvey Res Inst, London EC1M 6BQ, England; [Caulfield, Mark] Queen Mary Univ London, NIHR Cardiovasc Biomed Res Unit, London EC1M 6BQ, England; [McCormack, Terry] Spring Vale Med Ctr, Whitby Grp Practice, Whitby YO21 1SD, England; [Williams, Bryan] Univ Leicester, Dept Cardiovasc Sci, Leicester LE3 9QP, Leics, England; [Williams, Bryan] Glenfield Hosp, Leicester NIHR Cardiovasc Biomed Res Unit, Leicester LE3 9QP, Leics, England	Royal College of Physicians; University of London; Queen Mary University London; University of London; Queen Mary University London; University of Leicester; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital	Williams, B (corresponding author), Univ Leicester, Dept Cardiovasc Sci, Leicester LE2 7LX, Leics, England.	bw17@le.ac.uk		Williams, Bryan/0000-0002-8094-1841	National Institute for Health Research [NF-SI-0509-10222] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		ANDERSON KM, 1991, AM HEART J, V121, P293, DOI 10.1016/0002-8703(91)90861-B; Department of Health, HLTH SURV ENGL 2009; Hippisley-Cox J, 2008, BMJ-BRIT MED J, V336, P1475, DOI 10.1136/bmj.39609.449676.25; Hodgkinson J, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d3621; *NAT COLL CTR CHRO, 2006, HYP MAN AD PRIM CAR; *NAT I HLTH CLIN E, 2004, HYP PERS HIGH BLOOD; National Institute for Health and Clinical Excellence, 2011, HYPERT CLIN MAN PRI; National Institute for Health and Clinical Excellence, 2008, LIP MOD CARD RISK AS; National Institute for Health and Clinical Excellence, 2006, HYP MAN HYP AD PRIM; Yusuf S, 2008, NEW ENGL J MED, V358, P1547, DOI 10.1056/NEJMoa0801317	10	223	238	0	18	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 25	2011	343								d4891	10.1136/bmj.d4891	http://dx.doi.org/10.1136/bmj.d4891			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	813ZQ	21868454				2022-12-28	WOS:000294410400001
J	Mayo-Wilson, E; Imdad, A; Herzer, K; Yakoob, MY; Bhutta, ZA				Mayo-Wilson, Evan; Imdad, Aamer; Herzer, Kurt; Yakoob, Mohammad Yawar; Bhutta, Zulfiqar A.			Vitamin A supplements for preventing mortality, illness, and blindness in children aged under 5: systematic review and meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Review							RESPIRATORY-TRACT INFECTIONS; SCALE RANDOMIZED EVIDENCE; PRESCHOOL-CHILDREN; ZINC SUPPLEMENTATION; CHILDHOOD MORTALITY; 9-MONTH-OLD INFANTS; PUBLICATION BIAS; IMMUNE-RESPONSE; MEASLES-VACCINE; YOUNG-CHILDREN	Objective To determine if vitamin A supplementation is associated with reductions in mortality and morbidity in children aged 6 months to 5 years. Design Systematic review and meta-analysis. Two reviewers independently assessed studies for inclusion. Data were double extracted; discrepancies were resolved by discussion. Meta-analyses were performed for mortality, illness, vision, and side effects. Data sources Cochrane Central Register of Controlled Trials (CENTRAL) in the Cochrane Library, Medline, Embase, Global Health, Latin American and Caribbean Health Sciences, metaRegister of Controlled Trials, and African Index Medicus. Databases were searched to April 2010 without restriction by language or publication status. Eligibility criteria for selecting studies Randomised trials of synthetic oral vitamin A supplements in children aged 6 months to 5 years. Studies of children with current illness (such as diarrhoea, measles, and HIV), studies of children in hospital, and studies of food fortification or beta carotene were excluded. Results 43 trials with about 215 633 children were included. Seventeen trials including 194 483 participants reported a 24% reduction in all cause mortality (rate ratio=0.76, 95% confidence interval 0.69 to 0.83). Seven trials reported a 28% reduction in mortality associated with diarrhoea (0.72, 0.57 to 0.91). Vitamin A supplementation was associated with a reduced incidence of diarrhoea (0.85, 0.82 to 0.87) and measles (0.50, 0.37 to 0.67) and a reduced prevalence of vision problems, including night blindness (0.32, 0.21 to 0.50) and xerophthalmia (0.31, 0.22 to 0.45). Three trials reported an increased risk of vomiting within the first 48 hours of supplementation (2.75, 1.81 to 4.19). Conclusions Vitamin A supplementation is associated with large reductions in mortality, morbidity, and vision problems in a range of settings, and these results cannot be explained by bias. Further placebo controlled trials of vitamin A supplementation in children between 6 and 59 months of age are not required. However, there is a need for further studies comparing different doses and delivery mechanisms (for example, fortification). Until other sources are available, vitamin A supplements should be given to all children at risk of deficiency, particularly in low and middle income countries.	[Imdad, Aamer; Yakoob, Mohammad Yawar; Bhutta, Zulfiqar A.] Aga Khan Univ Hosp, Div Women & Child Hlth, Karachi 74800, Pakistan; [Mayo-Wilson, Evan; Herzer, Kurt] Univ Oxford, Dept Social Policy & Intervent, Ctr Evidence Based Intervent, Oxford OX1 2ER, England	Aga Khan University; University of Oxford	Bhutta, ZA (corresponding author), Aga Khan Univ Hosp, Div Women & Child Hlth, Stadium Rd,POB 3500, Karachi 74800, Pakistan.	zulfiqar.bhutta@aku.edu	Imdad, Aamer/AAJ-3842-2020; Mayo-Wilson, Evan/J-6289-2019; Yaqub, Muhammad Yawar/I-5052-2019	Mayo-Wilson, Evan/0000-0001-6126-2459; 	Department of Nutrition for Health and Development, WHO, Switzerland; University of Oxford's department of social policy and intervention; University of Oxford's centre for evidence-based intervention; Marshall scholarship; Aga Khan University, Karachi, Pakistan	Department of Nutrition for Health and Development, WHO, Switzerland(World Health Organization); University of Oxford's department of social policy and intervention; University of Oxford's centre for evidence-based intervention; Marshall scholarship; Aga Khan University, Karachi, Pakistan	The preparation of this review was funded by the Department of Nutrition for Health and Development, WHO, Switzerland. EMW and KH were supported by the University of Oxford's department of social policy and intervention and the centre for evidence-based intervention. KH received funding from a Marshall scholarship. AI, MYY, and ZAB were supported by Aga Khan University, Karachi, Pakistan.	AGARWAL DK, 1995, NUTR RES, V15, P669, DOI 10.1016/0271-5317(95)00034-G; Aklamati E, 2006, FASEB J, V20, pA1050; [Anonymous], 2009, GLOBAL HEALTH RISKS: MORTALITY AND BURDEN OF DISEASE ATTRIBUTABLE TO SELECTED MAJOR RISKS, P1; [Anonymous], REV MAN REVMAN VERS; [Anonymous], 2007, DEVTA CLUST RAND TRI; Arya S, 2000, Indian Pediatr, V37, P1341; Atkins D, 2004, BMJ-BRIT MED J, V328, P1490; Bahl R, 1999, J NUTR, V129, P1569, DOI 10.1093/jn/129.8.1569; Bahl R, 1997, EUR J CLIN NUTR, V51, P26, DOI 10.1038/sj.ejcn.1600352; Bailar JC, 1997, NEW ENGL J MED, V337, P559, DOI 10.1056/NEJM199708213370810; BARRETO ML, 1994, LANCET, V344, P228, DOI 10.1016/S0140-6736(94)92998-X; BATES CJ, 1995, LANCET, V345, P31, DOI 10.1016/S0140-6736(95)91157-X; Beaton G., 1993, EFFECTIVENESS VITAMI; Benn CS, 1997, LANCET, V350, P101, DOI 10.1016/S0140-6736(96)12019-5; Bhaskaram P., 1997, Indian Journal of Pediatrics, V64, P503, DOI 10.1007/BF02737757; Bhutta ZA, 2008, LANCET, V371, P417, DOI 10.1016/S0140-6736(07)61693-6; Bhutta ZA, 2010, LANCET, V375, P2032, DOI 10.1016/S0140-6736(10)60678-2; Bhutta ZA, 2006, J PEDIATR GASTR NUTR, V43, pS13, DOI 10.1097/01.mpg.0000255846.77034.ed; Biostat, 2005, COMPR MET VERS 2 PRO; BISWAS R, 1994, EUR J EPIDEMIOL, V10, P57, DOI 10.1007/BF01717453; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; BLOEM MW, 1990, AM J CLIN NUTR, V51, P76, DOI 10.1093/ajcn/51.1.76; CHENG L, 1993, EUR J CLIN NUTR, V47, P88; Cherian T, 2003, VACCINE, V21, P2418, DOI 10.1016/S0264-410X(03)00060-4; Cherian T, 2001, Indian Pediatr, V38, P771; Chowdhury S, 2002, Indian J Med Sci, V56, P259; DAULAIRE NMP, 1992, BMJ-BRIT MED J, V304, P207, DOI 10.1136/bmj.304.6821.207; Demissie T, 2009, J HEALTH POPUL NUTR, V27, P666; DEPEE S, 1995, LANCET, V346, P75, DOI 10.1016/S0140-6736(95)92111-7; Dibley MJ, 1996, J NUTR, V126, P434, DOI 10.1093/jn/126.2.434; Distiller SR, 2011, WEB BASED SYSTEMATIC; Donnen P, 1998, J NUTR, V128, P1320, DOI 10.1093/jn/128.8.1320; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Dwan K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003081; Fawzi WW, 2006, J INFECT DIS, V193, P756, DOI 10.1086/500369; FAWZI WW, 1993, JAMA-J AM MED ASSOC, V269, P898, DOI 10.1001/jama.269.7.898; FLORENTINO RF, 1990, AM J CLIN NUTR, V52, P694, DOI 10.1093/ajcn/52.4.694; GLASZIOU PP, 1993, BMJ-BRIT MED J, V306, P366, DOI 10.1136/bmj.306.6874.366; Gogia S, 2008, COCHRANE DB SYST REV, V4; Green HN, 1928, BRIT MED J, V1928, P691, DOI 10.1136/bmj.2.3537.691; HATHCOCK JN, 1990, AM J CLIN NUTR, V52, P183, DOI 10.1093/ajcn/52.2.183; Hedges L. V., 1981, J EDUC STAT, V6, P107, DOI [10.3102/10769986006002107, DOI 10.3102/10769986006002107]; HERRERA MG, 1992, LANCET, V340, P267, DOI 10.1016/0140-6736(92)92357-L; Higgins JPT, 2002, INT J EPIDEMIOL, V31, P96, DOI 10.1093/ije/31.1.96; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Huiming YM, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001479.pub3; Imdad A, 2010, NUTR INTERVENTIONS M, V1; Imdad A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S20; Imdad AHK, 2010, COCHRANE DB SYST REV, V5; Kapil U, 2009, PUBLIC HEALTH NUTR, V12, P285, DOI 10.1017/S1368980008004448; Kartasasmita CB, 1995, TUBERCLE LUNG DIS, V76, P563, DOI 10.1016/0962-8479(95)90535-9; Kirkham JJ, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c365; Klemm RDW, 2010, FOOD NUTR BULL, V31, pS47, DOI 10.1177/15648265100311S105; KOTHARI G, 1991, J TROP PEDIATRICS, V37, P141, DOI 10.1093/tropej/37.3.141; Lassi ZS, 2010, COCHRANE DB SYST REV, V11, DOI DOI 10.1002/14651858.CD007754.PUB2; Latham M., 2010, WORLD NUTR, V1; LeLorier J, 1997, NEW ENGL J MED, V337, P536, DOI 10.1056/NEJM199708213370806; Lima AAM, 2010, J PEDIATR GASTR NUTR, V50, P309, DOI 10.1097/MPG.0b013e3181a96489; Lin J, 2008, EUR J CLIN NUTR, V62, P1412, DOI 10.1038/sj.ejcn.1602881; Lin J, 2009, E SPEN EUROPEAN J CL, V4, pe17, DOI [DOI 10.1016/J.ECLNM.2008.09.001], 10.1016/ j.eclnm.2008.09.001, DOI 10.1016/J.ECLNM.2008.09.001]; Long KZ, 2007, BRIT J NUTR, V97, P337, DOI 10.1017/S0007114507257757; Long KZ, 2006, AM J CLIN NUTR, V83, P693, DOI 10.1093/ajcn.83.3.693; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Mayo-Wilson E, 2010, JOINT C COCHR CAMPB; Mayo-Wilson E, 2007, AM J PUBLIC HEALTH, V97, P630, DOI 10.2105/AJPH.2006.094169; Oliphant NP, 2010, FOOD NUTR BULL, V31, pS248, DOI 10.1177/15648265100313S304; Pant CR, 1996, B WORLD HEALTH ORGAN, V74, P533; Peto R, 1998, BMJ-BRIT MED J, V317, P1170, DOI 10.1136/bmj.317.7167.1170; PETO R, 1995, J CLIN EPIDEMIOL, V48, P23, DOI 10.1016/0895-4356(94)00150-O; PINNOCK CB, 1988, AUST PAEDIATR J, V24, P286; PINNOCK CB, 1986, AUST PAEDIATR J, V22, P95; Rahman MM, 2001, BMJ-BRIT MED J, V323, P314, DOI 10.1136/bmj.323.7308.314; RAHMATHULLAH L, 1990, NEW ENGL J MED, V323, P929, DOI 10.1056/NEJM199010043231401; Ramakrishnan U, 2002, J NUTR, V132, p2947S, DOI 10.1093/jn/132.9.2947S; RAMAKRISHNAN U, 1995, J NUTR, V125, P202; REDDY V, 1986, J TROP PEDIATRICS, V32, P196, DOI 10.1093/tropej/32.4.196; Rice AL., 2004, COMP QUANTIFICATION, V1, P0211; ROSS DA, 1993, LANCET, V342, P7, DOI 10.1016/0140-6736(93)91879-Q; Semba RD, 2005, NUTRITION, V21, P25, DOI 10.1016/j.nut.2004.10.004; SEMBA RD, 1992, J NUTR, V122, P101, DOI 10.1093/jn/122.1.101; SEMBA RD, 1995, LANCET, V345, P1330; SEMBA RD, 1990, AM J OPHTHALMOL, V110, P416, DOI 10.1016/S0002-9394(14)77024-2; Semba RD, 2010, J NUTR, V140, p208S, DOI 10.3945/jn.109.110700; Sempertegui F, 1999, PEDIATRICS, V104, DOI 10.1542/peds.104.1.e1; Shankar AH, 1999, LANCET, V354, P203, DOI 10.1016/S0140-6736(98)08293-2; SINHA DP, 1976, AM J CLIN NUTR, V29, P110, DOI 10.1093/ajcn/29.1.110; SMITH FR, 1976, NEW ENGL J MED, V294, P805, DOI 10.1056/NEJM197604082941503; Smith JC, 1999, J AM COLL NUTR, V18, P213, DOI 10.1080/07315724.1999.10718854; SOMMER A, 1986, LANCET, V1, P1169; Sommer A., 1996, VITAMIN A DEFICIENCY, P19; STABELL C, 1995, EUR J CLIN NUTR, V49, P73; STANSFIELD SK, 1993, LANCET, V342, P578, DOI 10.1016/0140-6736(93)91410-N; Tang GW, 2010, AM J CLIN NUTR, V91, p1468S, DOI 10.3945/ajcn.2010.28674G; VANAGTMAAL EJ, 1988, CURR EYE RES, V7, P43, DOI 10.3109/02713688809047018; Venkatarao T, 1996, Indian Pediatr, V33, P279; VIJAYARAGHAVAN K, 1990, LANCET, V336, P1342, DOI 10.1016/0140-6736(90)92895-O; Villamor E, 2000, J INFECT DIS, V182, pS122, DOI 10.1086/315921; Wallace A, 2009, TROP MED INT HEALTH, V14, P11, DOI 10.1111/j.1365-3156.2008.02196.x; WEST KP, 1991, LANCET, V338, P67, DOI 10.1016/0140-6736(91)90070-6; WHO,UNICEF,InternationalVitaminAConsultativeGroupTaskForce, 1997, VIT A SUPPL GUID THE; World Health Organization (WHO), 2009, GLOB PREV VIT DEF PO; Wu ZhiGang, 2007, China Tropical Medicine, V7, P540; You D, 2010, LANCET, V375, P100, DOI 10.1016/S0140-6736(09)61601-9	105	194	197	2	55	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 25	2011	343								d5094	10.1136/bmj.d5094	http://dx.doi.org/10.1136/bmj.d5094			19	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	813ZQ	21868478	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000294410400004
J	Wengert, O; Siebert, E				Wengert, Oliver; Siebert, Eberhard			Balo's Concentric Sclerosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Wengert, Oliver; Siebert, Eberhard] Charite, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Wengert, O (corresponding author), Charite, D-13353 Berlin, Germany.	oliver.wengert@charite.de		Siebert, Eberhard/0000-0001-7395-6546					0	5	5	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 25	2011	365	8					742	742		10.1056/NEJMicm1008401	http://dx.doi.org/10.1056/NEJMicm1008401			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	811JM	21864168				2022-12-28	WOS:000294205300010
J	Kane, GC; Karon, BL; Mahoney, DW; Redfield, MM; Roger, VL; Burnett, JC; Jacobsen, SJ; Rodeheffer, RJ				Kane, Garvan C.; Karon, Barry L.; Mahoney, Douglas W.; Redfield, Margaret M.; Roger, Veronique L.; Burnett, John C., Jr.; Jacobsen, Steven J.; Rodeheffer, Richard J.			Progression of Left Ventricular Diastolic Dysfunction and Risk of Heart Failure	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PRESERVED EJECTION FRACTION; CARDIOVASCULAR-DISEASE ENTERPRISES; BRAIN NATRIURETIC PEPTIDE; DOPPLER-ECHOCARDIOGRAPHY; MAJOR SHAREHOLDERS; POPULATION; COMMUNITY; PREVALENCE; ARTERIAL; AGE	Context Heart failure incidence increases with advancing age, and approximately half of patients with heart failure have preserved left ventricular ejection fraction. Although diastolic dysfunction plays a role in heart failure with preserved ejection fraction, little is known about age-dependent longitudinal changes in diastolic function in community populations. Objective To measure changes in diastolic function over time and to determine the relationship between diastolic dysfunction and the risk of subsequent heart failure. Design, Setting, and Participants Population-based cohort of participants enrolled in the Olmsted County Heart Function Study. Randomly selected participants 45 years or older (N=2042) underwent clinical evaluation, medical record abstraction, and echocardiography (examination 1 [1997-2000]). Diastolic left ventricular function was graded as normal, mild, moderate, or severe by validated Doppler techniques. After 4 years, participants were invited to return for examination 2 (2001-2004). The cohort of participants returning for examination 2 (n=1402 of 1960 surviving [72%]) then underwent follow-up for ascertainment of new-onset heart failure (2004-2010). Main Outcome Measures Change in diastolic function grade and incident heart failure. Results During the 4 (SD, 0.3) years between examinations 1 and 2, diastolic dysfunction prevalence increased from 23.8% (95% confidence interval [CI], 21.2%-26.4%) to 39.2% (95% CI, 36.3%-42.2%) (P<.001). Diastolic function grade worsened in 23.4% (95% CI, 20.9%-26.0%) of participants, was unchanged in 67.8% (95% CI, 64.8%-70.6%), and improved in 8.8% (95% CI, 7.1%-10.5%). Worsened diastolic dysfunction was associated with age 65 years or older (odds ratio, 2.85 [95% CI, 1.77-4.72]). During 6.3 (SD, 2.3) years of additional follow-up, heart failure occurred in 2.6% (95% CI, 1.4%-3.8%), 7.8% (95% CI, 5.8%-13.0%), and 12.2% (95% CI, 8.5%-18.4%) of persons whose diastolic function normalized or remained normal, remained or progressed to mild dysfunction, or remained or progressed to moderate or severe dysfunction, respectively (P<.001). Diastolic dysfunction was associated with incident heart failure after adjustment for age, hypertension, diabetes, and coronary artery disease (hazard ratio, 1.81 [95% CI, 1.01-3.48]). Conclusions In a population-based cohort undergoing 4 years of follow-up, prevalence of diastolic dysfunction increased. Diastolic dysfunction was associated with development of heart failure during 6 years of subsequent follow-up. JAMA. 2011;306(8):856-863 www.jama.com	[Kane, Garvan C.; Karon, Barry L.; Redfield, Margaret M.; Roger, Veronique L.; Burnett, John C., Jr.; Rodeheffer, Richard J.] Mayo Clin, Div Cardiovasc Dis, Dept Internal Med, Rochester, MN 55905 USA; [Mahoney, Douglas W.; Roger, Veronique L.] Mayo Clin, Dept Hlth Sci Res, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Sch Med, Rochester, MN 55905 USA; [Jacobsen, Steven J.] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA; [Jacobsen, Steven J.] So Calif Permanente Med Grp, Los Angeles, CA 90027 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; University of Southern California; Kaiser Permanente; Southern California Permanente Medical Group (SCPMG); Permanente Medical Groups	Rodeheffer, RJ (corresponding author), Mayo Clin, Div Cardiovasc Dis, Dept Internal Med, 200 1st St SW, Rochester, MN 55905 USA.	rodeheffer.richard@mayo.edu	Roger, Veronique/AAV-5951-2020	Jacobsen, Steven/0000-0002-8174-8533	National Heart, Lung, and Blood Institute [R0155502]; National Institutes of Health (NIH) National Center for Research Resources [1UL 1RR024150, UL RR024150]; Mayo Foundation; NIH [HL-R01-55502, AR-36582, HL63281]; National Institute on Aging [R01-AG034676]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024150] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063281, R01HL055502] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG034676] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health (NIH) National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Mayo Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by National Heart, Lung, and Blood Institute grant R0155502, grant 1UL 1RR024150 from the National Institutes of Health (NIH) National Center for Research Resources, and the Mayo Foundation. The research was supported by NIH HL-R01-55502 (Dr Rodeheffer), NIH AR-36582 (Dr Jacobsen), and NIH HL63281 (Redfield). The project was supported by NIH/National Center for Research Resources (NCRR) Clinical and Translational Science Awards Grant UL RR024150 and by the Rochester Epidemiology Project, grant R01-AG034676 from the National Institute on Aging, and the Mayo Foundation.	Abhayaratna WP, 2006, HEART, V92, P1259, DOI 10.1136/hrt.2005.080150; Abhayaratna WP, 2006, AM J CARDIOL, V98, P1387, DOI 10.1016/j.amjcard.2006.06.035; Ammar KA, 2007, CIRCULATION, V115, P1563, DOI 10.1161/CIRCULATIONAHA.106.666818; [Anonymous], 1997, ARCH INTERN MED, V157, P2413; Bhatia RS, 2006, NEW ENGL J MED, V355, P260, DOI 10.1056/NEJMoa051530; Borlaug Barry A, 2008, Heart Fail Clin, V4, P23, DOI 10.1016/j.hfc.2007.10.001; Borlaug BA, 2009, J AM COLL CARDIOL, V54, P410, DOI 10.1016/j.jacc.2009.05.013; Chantler PD, 2008, J APPL PHYSIOL, V105, P1342, DOI 10.1152/japplphysiol.90600.2008; Cheng S, 2009, CIRC-CARDIOVASC IMAG, V2, P191, DOI 10.1161/CIRCIMAGING.108.819938; Davies MK, 2001, LANCET, V358, P439, DOI 10.1016/S0140-6736(01)05620-3; GERSTENBLITH G, 1977, CIRCULATION, V56, P273, DOI 10.1161/01.CIR.56.2.273; Grewal J, 2009, JAMA-J AM MED ASSOC, V301, P286, DOI 10.1001/jama.2008.1022; Hunt SA, 2005, CIRCULATION, V112, pE154, DOI 10.1161/CIRCULATIONAHA.105.167586; Hurrell DG, 1997, J AM COLL CARDIOL, V30, P459, DOI 10.1016/S0735-1097(97)00184-8; Jacobsen SJ, 2004, ANN EPIDEMIOL, V14, P579, DOI 10.1016/j.annepidem.2003.11.001; Kass DA, 2004, CIRC RES, V94, P1533, DOI 10.1161/01.RES.0000129254.25507.d6; Kass DA, 2005, HYPERTENSION, V46, P185, DOI 10.1161/01.HYP.0000168053.34306.d4; Lakatta EG, 2003, CIRCULATION, V107, P139, DOI 10.1161/01.CIR.0000048892.83521.58; Lakatta EG, 2003, CIRCULATION, V107, P346, DOI 10.1161/01.CIR.0000048893.62841.F7; Levy D, 2002, NEW ENGL J MED, V347, P1397, DOI 10.1056/NEJMoa020265; MCKEE PA, 1971, NEW ENGL J MED, V285, P1441, DOI 10.1056/NEJM197112232852601; McKie PM, 2006, HYPERTENSION, V47, P874, DOI 10.1161/01.HYP.0000216794.24161.8c; Melton LJ, 1996, MAYO CLIN PROC, V71, P266, DOI 10.4065/71.3.266; Mosterd A, 1999, EUR HEART J, V20, P447, DOI 10.1053/euhj.1998.1239; Munagala VK, 2003, J AM SOC ECHOCARDIOG, V16, P1049, DOI 10.1016/S0894-7317(03)00516-9; Nishimura RA, 1997, J AM COLL CARDIOL, V30, P8, DOI 10.1016/S0735-1097(97)00144-7; Okura Y, 2007, CIRC J, V71, P1013, DOI 10.1253/circj.71.1013; Ommen SR, 2000, CIRCULATION, V102, P1788; Owan TE, 2006, NEW ENGL J MED, V355, P251, DOI 10.1056/NEJMoa052256; Pritchett AM, 2005, J AM COLL CARDIOL, V45, P87, DOI 10.1016/j.jacc.2004.09.054; Redfield MM, 2004, NEW ENGL J MED, V350, P1930, DOI 10.1056/NEJMp048064; Redfield MM, 2003, JAMA-J AM MED ASSOC, V289, P194, DOI 10.1001/jama.289.2.194; Redfield MM, 2005, CIRCULATION, V112, P2254, DOI 10.1161/CIRCULATIONAHA.105.541078; Redfield MM, 2002, NEW ENGL J MED, V347, P1442, DOI 10.1056/NEJMe020115; Redfield MM, 2004, CIRCULATION, V109, P3176, DOI 10.1161/01.CIR.0000130845.38133.8F; Redfield MM, 2002, J AM COLL CARDIOL, V40, P976, DOI 10.1016/S0735-1097(02)02059-4; RODEHEFFER RJ, 1993, MAYO CLIN PROC, V68, P1143, DOI 10.1016/S0025-6196(12)60063-9; Roger VL, 2004, JAMA-J AM MED ASSOC, V292, P344, DOI 10.1001/jama.292.3.344; Senni M, 1999, ARCH INTERN MED, V159, P29, DOI 10.1001/archinte.159.1.29; Vasan RS, 1999, J AM COLL CARDIOL, V33, P1948, DOI 10.1016/S0735-1097(99)00118-7; Zile MR, 2004, NEW ENGL J MED, V350, P1953, DOI 10.1056/NEJMoa032566; Zile MR, 2001, CIRCULATION, V104, P779, DOI 10.1161/hc3201.094226; 1998, ARCH INTERN MED, V158, P573	43	462	473	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 24	2011	306	8					856	863		10.1001/jama.2011.1201	http://dx.doi.org/10.1001/jama.2011.1201			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	810VY	21862747	Green Accepted, Bronze			2022-12-28	WOS:000294157300023
J	Barnett, WS				Barnett, W. S.			Effectiveness of Early Educational Intervention	SCIENCE			English	Review							SCHOOL READINESS; HEAD-START; CHILDREN; PROGRAMS; MATTER; YOUNG; MATHEMATICS; BENEFITS; BEHAVIOR; HEALTH	Early educational intervention has been proposed to partially offset the impacts of poverty and inadequate learning environments on child development and school success. A broad range of early educational interventions are found to produce meaningful, lasting effects on cognitive, social, and schooling outcomes. However, all interventions are not equally effective. Two major U.S. programs perform relatively poorly. Research provides some guidance regarding the features of highly effective programs, but much remains to be learned. New experimental studies of key program features would have a high payoff.	Rutgers State Univ, Natl Inst Early Educ Res, New Brunswick, NJ 08901 USA	Rutgers State University New Brunswick	Barnett, WS (corresponding author), Rutgers State Univ, Natl Inst Early Educ Res, New Brunswick, NJ 08901 USA.	sbarnett@nieer.org	Barnett, William/GWU-7996-2022					*ADM CHILDR FAM, 2006, RES PRACT PREL FIND; Aikens N., 2010, ACF OPRE REPORT YEAR; Barnett WS, 2007, ECON EDUC REV, V26, P113, DOI 10.1016/j.econedurev.2005.10.007; Berlinski S, 2009, J PUBLIC ECON, V93, P219, DOI 10.1016/j.jpubeco.2008.09.002; BURCHINAL M, 1989, CHILD DEV, V60, P128; Burger K, 2010, EARLY CHILD RES Q, V25, P140, DOI 10.1016/j.ecresq.2009.11.001; Camilli G, 2010, TEACH COLL REC, V112, P579; CLARKE ADB, 1981, DEV REV, V1, P344, DOI DOI 10.1016/0273-2297(81)90030-7; Diamond A, 2007, SCIENCE, V318, P1387, DOI 10.1126/science.1151148; Engle PL, 2007, LANCET, V369, P229, DOI 10.1016/S0140-6736(07)60112-3; Fantuzzo JW, 2011, AM EDUC RES J, V48, P763, DOI 10.3102/0002831210385446; FREDE EC, 2010, CHILDHOOD PROGRAMS P, P214; Gormley WT, 2008, SCIENCE, V320, P1723, DOI 10.1126/science.1156019; Hair E, 2006, EARLY CHILD RES Q, V21, P431, DOI 10.1016/j.ecresq.2006.09.005; Herbst CM, 2010, ECON EDUC REV, V29, P618, DOI 10.1016/j.econedurev.2010.01.002; Hertzman C, 2010, ANNU REV PUBL HEALTH, V31, P329, DOI 10.1146/annurev.publhealth.012809.103538; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Kiecolt-Glaser JK, 2011, PSYCHOSOM MED, V73, P16, DOI 10.1097/PSY.0b013e31820573b6; Kitzman HJ, 2010, ARCH PEDIAT ADOL MED, V164, P412, DOI 10.1001/archpediatrics.2010.76; Lee VE., 2002, INEQUALITY STARTING; Love J. M., 2002, MAKING DIFFERENCE LI, VI-III; Ludwig J, 2008, ANN NY ACAD SCI, V1136, P257, DOI 10.1196/annals.1425.005; Magnuson KA, 2007, EARLY CHILD RES Q, V22, P18, DOI 10.1016/j.ecresq.2006.10.002; McLaughlin AE, 2007, CHILD DEV, V78, P746, DOI 10.1111/j.1467-8624.2007.01030.x; Melhuish EC, 2008, SCIENCE, V321, P1161, DOI 10.1126/science.1158808; Nores M, 2010, ECON EDUC REV, V29, P271, DOI 10.1016/j.econedurev.2009.09.001; Pianta Robert C, 2009, Psychol Sci Public Interest, V10, P49, DOI 10.1177/1529100610381908; Raine A, 2003, AM J PSYCHIAT, V160, P1627, DOI 10.1176/appi.ajp.160.9.1627; RAMEY CT, 2000, APPL DEV SCI, V0004; Reynolds A., 2000, SUCCESS EARLY INTERV; REYNOLDS AJ, 1995, EARLY CHILD RES Q, V10, P1, DOI 10.1016/0885-2006(95)90024-1; Reynolds AJ, 2011, SCIENCE, V333, P360, DOI 10.1126/science.1203618; Schweinhart LJ, 2005, MONOGRAPHS HIGH SCOP, V14; Spiess CK, 2003, EARLY CHILD RES Q, V18, P255, DOI 10.1016/S0885-2006(03)00023-1; Sweet MA, 2004, CHILD DEV, V75, P1435, DOI 10.1111/j.1467-8624.2004.00750.x; *US ADM CHILDR FAM, 2010, HEAT START IMP STUD; VOGEL CA, 2010, 20118 OPRE HHS ADM C; Walker SP, 2011, PEDIATRICS, V127, P849, DOI 10.1542/peds.2010-2231; Wong VC, 2008, J POLICY ANAL MANAG, V27, P122, DOI 10.1002/pam.20310	39	318	322	7	131	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 19	2011	333	6045					975	978		10.1126/science.1204534	http://dx.doi.org/10.1126/science.1204534			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	808TD	21852490				2022-12-28	WOS:000294000400044
J	Kitajima, TS; Ohsugi, M; Ellenberg, J				Kitajima, Tomoya S.; Ohsugi, Miho; Ellenberg, Jan			Complete Kinetochore Tracking Reveals Error-Prone Homologous Chromosome Biorientation in Mammalian Oocytes	CELL			English	Article							SPINDLE ASSEMBLY CHECKPOINT; MOUSE OOCYTES; MEIOSIS-I; MICROTUBULE ATTACHMENT; METAPHASE PLATE; TISSUE-CELLS; AURORA-B; SEGREGATION; NONDISJUNCTION; CONGRESSION	Chromosomes must establish stable biorientation prior to anaphase to achieve faithful segregation during cell division. The detailed process by which chromosomes are bioriented and how biorientation is coordinated with spindle assembly and chromosome congression remain unclear. Here, we provide complete 3D kinetochore-tracking datasets throughout cell division by high-resolution imaging of meiosis I in live mouse oocytes. We show that in acentrosomal oocytes, chromosome congression forms an intermediate chromosome configuration, the prometaphase belt, which precedes biorientation. Chromosomes then invade the elongating spindle center to form the metaphase plate and start biorienting. Close to 90% of all chromosomes undergo one or more rounds of error correction of their kinetochore-microtubule attachments before achieving correct biorientation. This process depends on Aurora kinase activity. Our analysis reveals the error-prone nature of homologous chromosome biorientation, providing a possible explanation for the high incidence of aneuploid eggs observed in mammals, including humans.	[Kitajima, Tomoya S.; Ellenberg, Jan] European Mol Biol Lab, Cell Biol & Biophys Unit, D-69117 Heidelberg, Germany; [Ohsugi, Miho] Univ Tokyo, Inst Med Sci, Dept Canc Biol, Div Oncol,Minato Ku, Tokyo 1088639, Japan; [Ohsugi, Miho] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan	European Molecular Biology Laboratory (EMBL); University of Tokyo; Japan Science & Technology Agency (JST)	Ellenberg, J (corresponding author), European Mol Biol Lab, Cell Biol & Biophys Unit, Meyerhofstr 1, D-69117 Heidelberg, Germany.	jan.ellenberg@embl.de	Holt, Janet E/B-2415-2013; Kitajima, Tomoya/A-7049-2016; Ellenberg, Jan/I-4688-2014; Ohsugi, Miho/AAY-9339-2020	Kitajima, Tomoya/0000-0002-6486-7143; Ellenberg, Jan/0000-0001-5909-701X; Ohsugi, Miho/0000-0003-0288-3428	HFSP; JSPS; Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science and Technology, Japan; German Research Council; European Commission (DFG) within the MitoSys consortium [EL-246/4-1, SPP1384, FP7/2007-2013-241548]	HFSP(Human Frontier Science Program); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); German Research Council(German Research Foundation (DFG)); European Commission (DFG) within the MitoSys consortium	We thank Alexey Khodjakov for communicating unpublished results; Yoshinori Watanabe for providing mouse CENP-C cDNA and discussion; Andrea Musacchio for providing human Mad2 cDNA; Melina Schuh, Kota Miura, Sebastien Huet, Annelie Wunsche, Thomas Walter, and the members of the Ellenberg lab for advice and discussion; the members of EMBL Laboratory Animal Resources, especially Klaus Schmitt, Silke Brohn, and Angela Burro, for excellent support. This work was supported by HFSP Long-Term Fellowships and JSPS Postdoctoral Fellowships for Research Abroad (to T. S. K.), Grants-in-aid from the Japan Science and Technology Agency and the Ministry of Education, Culture, Sports, Science and Technology, Japan (to M.O.), and the German Research Council as well as the European Commission (DFG EL-246/4-1 within the SPP1384; FP7/2007-2013-241548 within the MitoSys consortium, both to J.E.).	Antonio C, 2000, CELL, V102, P425, DOI 10.1016/S0092-8674(00)00048-9; Brunet S, 1999, J CELL BIOL, V146, P1, DOI 10.1083/jcb.146.1.1; Cai S, 2009, NAT CELL BIOL, V11, P832, DOI 10.1038/ncb1890; Chen RH, 1996, SCIENCE, V274, P242, DOI 10.1126/science.274.5285.242; Chiang T, 2010, CURR BIOL, V20, P1522, DOI 10.1016/j.cub.2010.06.069; Cimini D, 2003, J CELL SCI, V116, P4213, DOI 10.1242/jcs.00716; Dernburg AF, 1996, CELL, V86, P135, DOI 10.1016/S0092-8674(00)80084-7; Foley EA, 2009, NAT CELL BIOL, V11, P787, DOI 10.1038/ncb1902; Funabiki H, 2000, CELL, V102, P411, DOI 10.1016/S0092-8674(00)00047-7; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; HASSOLD T, 1995, AM J HUM GENET, V57, P867; Hauf S, 2003, J CELL BIOL, V161, P281, DOI 10.1083/jcb.200208092; Hodges CA, 2005, NAT GENET, V37, P1351, DOI 10.1038/ng1672; Homer HA, 2005, GENE DEV, V19, P202, DOI 10.1101/gad.328105; Jaffe LA, 2004, METHOD CELL BIOL, V74, P219; Kapitein LC, 2005, NATURE, V435, P114, DOI 10.1038/nature03503; Kapoor TM, 2006, SCIENCE, V311, P388, DOI 10.1126/science.1122142; Karpen GH, 1996, SCIENCE, V273, P118, DOI 10.1126/science.273.5271.118; Kemp B, 2004, GENE DEV, V18, P1946, DOI 10.1101/gad.1227304; Koehler KE, 1996, NAT GENET, V14, P406, DOI 10.1038/ng1296-406; Kops GJPL, 2010, CELL MOL LIFE SCI, V67, P2145, DOI 10.1007/s00018-010-0321-y; Lacefield S, 2007, NAT GENET, V39, P1273, DOI 10.1038/ng2120; Lamb NE, 1997, HUM MOL GENET, V6, P1391, DOI 10.1093/hmg/6.9.1391; Lane SIR, 2010, REPRODUCTION, V140, P521, DOI 10.1530/REP-10-0223; Levesque AA, 2001, J CELL BIOL, V154, P1135, DOI 10.1083/jcb.200106093; Li M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007701; Lipp JJ, 2007, J CELL SCI, V120, P1245, DOI 10.1242/jcs.03425; Lister LM, 2010, CURR BIOL, V20, P1511, DOI 10.1016/j.cub.2010.08.023; Magidson V, 2011, CELL, V146, P555, DOI 10.1016/j.cell.2011.07.012; Maiato H, 2004, J CELL SCI, V117, P5461, DOI 10.1242/jcs.01536; Manandhar G, 2005, BIOL REPROD, V72, P2, DOI 10.1095/biolreprod.104.031245; McGulnness BE, 2009, CURR BIOL, V19, P369, DOI 10.1016/j.cub.2009.01.064; Nezi LG, 2009, CURR OPIN CELL BIOL, V21, P785, DOI 10.1016/j.ceb.2009.09.007; Ohsugi M, 2008, CELL, V132, P771, DOI 10.1016/j.cell.2008.01.029; Rabut G, 2004, J MICROSC-OXFORD, V216, P131, DOI 10.1111/j.0022-2720.2004.01404.x; Ross LO, 1996, P NATL ACAD SCI USA, V93, P4979, DOI 10.1073/pnas.93.10.4979; Salmon ED, 2005, PHILOS T R SOC B, V360, P553, DOI 10.1098/rstb.2004.1610; Schuh M, 2007, CELL, V130, P484, DOI 10.1016/j.cell.2007.06.025; Sharif B, 2010, J CELL SCI, V123, P4292, DOI 10.1242/jcs.067447; Tsurumi C, 2004, J CELL BIOL, V167, P1037, DOI 10.1083/jcb.200405165; Walczak CE, 2008, INT REV CYTOL, V265, P111, DOI 10.1016/S0074-7696(07)65003-7; Wassmann K, 2003, CURR BIOL, V13, P1596, DOI 10.1016/j.cub.2003.08.052; Waters JC, 1998, J CELL BIOL, V141, P1181, DOI 10.1083/jcb.141.5.1181; Wignall SM, 2009, NAT CELL BIOL, V11, P839, DOI 10.1038/ncb1891; Wollman R, 2005, CURR BIOL, V15, P828, DOI 10.1016/j.cub.2005.03.019; Yang KT, 2010, MOL BIOL CELL, V21, P2371, DOI 10.1091/mbc.E10-02-0170; Yokobayashi S, 2005, CELL, V123, P803, DOI 10.1016/j.cell.2005.09.013	47	217	220	1	37	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 19	2011	146	4					568	581		10.1016/j.cell.2011.07.031	http://dx.doi.org/10.1016/j.cell.2011.07.031			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	809HY	21854982	Bronze			2022-12-28	WOS:000294043600012
J	Tabak, LA; Collins, FS				Tabak, Lawrence A.; Collins, Francis S.			Weaving a Richer Tapestry in Biomedical Science	SCIENCE			English	Editorial Material									[Tabak, Lawrence A.; Collins, Francis S.] NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA	Tabak, LA (corresponding author), NIH, Bldg 10, Bethesda, MD 20892 USA.	tabakl@mail.nih.gov; colllinsf@mail.nih.gov			NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000024] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000739] Funding Source: NIH RePORTER; Intramural NIH HHS [Z99 OD999999] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		[Anonymous], GRANTS PROC OV; [Anonymous], **DROPPED REF**; Bertrand M, 2004, AM ECON REV, V94, P991, DOI 10.1257/0002828042002561; Ginther DK, 2011, SCIENCE, V333, P1015, DOI 10.1126/science.1196783; MERTON RK, 1968, SCIENCE, V159, P56, DOI 10.1126/science.159.3810.56; [National Academy of Sciences National Academy of Engineering Institute of Medicine], 2011, EXP UND MIN PART AM; National Institutes of Health, RES CAUS FACT INT PR; National Research Council, 2005, ASS NIH MIN RES TRAI; *NIGMS, RES UND INF PROM RES; *NIH, NIH DIR PATHF AW PRO; *NIH, WORKSH TRAIN; EARLY CAREER REV PRO	12	63	64	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 19	2011	333	6045					940	941		10.1126/science.1211704	http://dx.doi.org/10.1126/science.1211704			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808TD	21852476	Green Accepted			2022-12-28	WOS:000294000400030
J	Jena, AB; Seabury, S; Lakdawalla, D; Chandra, A				Jena, Anupam B.; Seabury, Seth; Lakdawalla, Darius; Chandra, Amitabh			Malpractice Risk According to Physician Specialty	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TORT REFORMS; MEDICINE; CLAIMS; COSTS	BACKGROUND Data are lacking on the proportion of physicians who face malpractice claims in a year, the size of those claims, and the cumulative career malpractice risk according to specialty. METHODS We analyzed malpractice data from 1991 through 2005 for all physicians who were covered by a large professional liability insurer with a nationwide client base (40,916 physicians and 233,738 physician-years of coverage). For 25 specialties, we reported the proportion of physicians who had malpractice claims in a year, the proportion of claims leading to an indemnity payment (compensation paid to a plaintiff), and the size of indemnity payments. We estimated the cumulative risk of ever being sued among physicians in high- and low-risk specialties. RESULTS Each year during the study period, 7.4% of all physicians had a malpractice claim, with 1.6% having a claim leading to a payment (i.e., 78% of all claims did not result in payments to claimants). The proportion of physicians facing a claim each year ranged from 19.1% in neurosurgery, 18.9% in thoracic-cardiovascular surgery, and 15.3% in general surgery to 5.2% in family medicine, 3.1% in pediatrics, and 2.6% in psychiatry. The mean indemnity payment was $274,887, and the median was $111,749. Mean payments ranged from $117,832 for dermatology to $520,923 for pediatrics. It was estimated that by the age of 65 years, 75% of physicians in low-risk specialties had faced a malpractice claim, as compared with 99% of physicians in high-risk specialties. CONCLUSIONS There is substantial variation in the likelihood of malpractice suits and the size of indemnity payments across specialties. The cumulative risk of facing a malpractice claim is high in all specialties, although most claims do not lead to payments to plaintiffs. (Funded by the RAND Institute for Civil Justice and the National Institute on Aging.)	[Chandra, Amitabh] Harvard Univ, Harvard Kennedy Sch, Cambridge, MA 02138 USA; [Jena, Anupam B.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Jena, Anupam B.] Harvard Univ, Sch Med, Boston, MA USA; [Seabury, Seth] RAND Corp, Santa Monica, CA USA; [Lakdawalla, Darius] Univ So Calif, Schaeffer Ctr Hlth Policy & Econ, Los Angeles, CA USA; [Lakdawalla, Darius] Univ So Calif, Sch Policy Planning & Dev, Los Angeles, CA USA	Harvard University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; RAND Corporation; University of Southern California; University of Southern California	Chandra, A (corresponding author), Harvard Univ, Harvard Kennedy Sch, 79 JFK St, Cambridge, MA 02138 USA.	amitabh_chandra@harvard.edu	Lakdawalla, Darius/B-4409-2011	Lakdawalla, Darius/0000-0001-5934-8042	RAND Institute for Civil Justice; National Institute on Aging [7R01AG031544, 1RC4AG039036-01, P01 AG19783-02]; National Institute on Aging Roybal Center at the University of Southern California [5P30AG024968]; NATIONAL INSTITUTE ON AGING [RC4AG039036, P30AG024968, P01AG019783, R01AG031544] Funding Source: NIH RePORTER	RAND Institute for Civil Justice; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute on Aging Roybal Center at the University of Southern California; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Supported by the RAND Institute for Civil Justice; grants (7R01AG031544, to Dr. Seabury; 7R01AG031544 and 1RC4AG039036-01, to Dr. Lakdawalla; and P01 AG19783-02, to Dr. Chandra) from the National Institute on Aging; and a grant (5P30AG024968, to Dr. Lakdawalla) from the National Institute on Aging Roybal Center at the University of Southern California.	[Anonymous], 1987, MED MALPR CHAR CLAIM; [Anonymous], 2006, MED MALPR TORT LIM H; Baicker K, 2004, EFFECT MALPRACTICE L; Baicker K, 2007, HEALTH AFFAIR, V26, P841, DOI 10.1377/hlthaff.26.3.841; Benson JS, 2010, J UROLOGY, V184, P1086, DOI 10.1016/j.juro.2010.05.034; Carrier ER, 2010, HEALTH AFFAIR, V29, P1585, DOI 10.1377/hlthaff.2010.0135; CHANDRA A, 2005, HLTH AFF MILLWOOD S; DANZON P, 1984, J LAW ECON, V27, P115, DOI 10.1086/467060; Health Resources and Service Administration, 2010, NAT PRACT DAT BANK; Kane C., 2010, POLICY RES PERSPECTI, P1; Kessler D, 1996, Q J ECON, V111, P353, DOI 10.2307/2946682; Mello MM, 2010, HEALTH AFFAIR, V29, P1569, DOI 10.1377/hlthaff.2009.0807; Mello MM, 2009, NEW ENGL J MED, V361, P1, DOI 10.1056/NEJMp0903765; Mello MM, 2003, NEW ENGL J MED, V349, P1280, DOI 10.1056/NEJMhpr035095; Mello MM, 2003, NEW ENGL J MED, V348, P2281, DOI 10.1056/NEJMp030064; Mello MM, 2006, 10 ROB WOOD JOHNS FD; SLOAN FA, 1989, JAMA-J AM MED ASSOC, V262, P3291, DOI 10.1001/jama.262.23.3291; SLOAN FA, 1989, J HEALTH POLIT POLIC, V14, P663, DOI 10.1215/03616878-14-4-663; Sowka M., 1980, MALPRACTICE CLAIMS F; Studdert DM, 2006, NEW ENGL J MED, V354, P2024, DOI 10.1056/NEJMsa054479; Studdert DM, 2005, JAMA-J AM MED ASSOC, V293, P2609, DOI 10.1001/jama.293.21.2609; Thorpe KE, 2004, HLTH AFF MILLWOOD S; ZUCKERMAN S, 1990, INQUIRY-J HEALTH CAR, V27, P167	23	650	658	1	52	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 18	2011	365	7					629	636		10.1056/NEJMsa1012370	http://dx.doi.org/10.1056/NEJMsa1012370			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	808ER	21848463	Bronze, Green Accepted			2022-12-28	WOS:000293960500010
J	Yunker, PJ; Still, T; Lohr, MA; Yodh, AG				Yunker, Peter J.; Still, Tim; Lohr, Matthew A.; Yodh, A.G.			Suppression of the coffee-ring effect by shape-dependent capillary interactions	NATURE			English	Article							AIR-WATER-INTERFACE; ELLIPSOIDAL PARTICLES; PATTERN-FORMATION; EVAPORATION; DROPLETS; DROPS	When a drop of liquid dries on a solid surface, its suspended particulate matter is deposited in ring-like fashion. This phenomenon, known as the coffee-ring effect(1-3), is familiar to anyone who has observed a drop of coffee dry. During the drying process, drop edges become pinned to the substrate, and capillary flow outward from the centre of the drop brings suspended particles to the edge as evaporation proceeds. After evaporation, suspended particles are left highly concentrated along the original drop edge. The coffee-ring effect is manifested in systems with diverse constituents, ranging from large colloids(1,4,5) to nanoparticles(6) and individual molecules(7). In fact-despite the many practical applications for uniform coatings in printing(8), biology(9,10) and complex assembly(11)-the ubiquitous nature of the effect has made it difficult to avoid(6,12-16). Here we show experimentally that the shape of the suspended particles is important and can be used to eliminate the coffee-ring effect: ellipsoidal particles are deposited uniformly during evaporation. The anisotropic shape of the particles significantly deforms interfaces, producing strong interparticle apillary interactions(17-23). Thus, after the ellipsoids are carried to the air-water interface by the same outward flow that causes the coffee-ring effect for spheres, strong long-ranged interparticle attractions between ellipsoids lead to the formation of loosely packed or arrested structures on the air-water interface(17,18,21,24). These structures prevent the suspended particles from reaching the drop edge and ensure uniform deposition. Interestingly, under appropriate conditions, suspensions of spheres mixed with a small number of ellipsoids also produce uniform deposition. Thus, particle shape provides a convenient parameter to control the deposition of particles, without modification of particle or solvent chemistry.	Univ Penn, Dept Phys & Astron, Philadelphia, PA 19104 USA; CNRS Rhodia Univ Pennsylvania, Complex Assemblies Soft Matter, UMI 3254, Bristol, PA 19007 USA	University of Pennsylvania; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC)	Yunker, PJ (corresponding author), Univ Penn, Dept Phys & Astron, Philadelphia, PA 19104 USA.	pyunker@sas.upenn.edu		Yunker, Peter/0000-0001-8471-4171				Bigioni TP, 2006, NAT MATER, V5, P265, DOI 10.1038/nmat1611; Bowden N, 2001, LANGMUIR, V17, P1757, DOI 10.1021/la001447o; Brown ABD, 2000, PHYS REV E, V62, P951, DOI 10.1103/PhysRevE.62.951; Champion JA, 2007, P NATL ACAD SCI USA, V104, P11901, DOI 10.1073/pnas.0705326104; DANOV KD, 2010, COLLOID INTERFACE SC, V154, P91; de Gans BJ, 2004, ADV MATER, V16, P203, DOI 10.1002/adma.200300385; Deegan RD, 2000, PHYS REV E, V62, P756, DOI 10.1103/PhysRevE.62.756; Deegan RD, 2000, PHYS REV E, V61, P475, DOI 10.1103/PhysRevE.61.475; Deegan RD, 1997, NATURE, V389, P827, DOI 10.1038/39827; DENKOV ND, 1993, NATURE, V361, P26, DOI 10.1038/361026a0; Dugas V, 2005, LANGMUIR, V21, P9130, DOI 10.1021/la050764y; Dugas V, 2004, SENSOR ACTUAT B-CHEM, V101, P112, DOI 10.1016/j.snb.2004.02.041; Fournier JB, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.031601; HO CC, 1993, COLLOID POLYM SCI, V271, P469, DOI 10.1007/BF00657391; Hu H, 2006, J PHYS CHEM B, V110, P7090, DOI 10.1021/jp0609232; Hu H, 2002, J PHYS CHEM B, V106, P1334, DOI 10.1021/jp0118322; Kajiya T, 2009, J PHYS CHEM B, V113, P15460, DOI 10.1021/jp9077757; Kaya D, 2010, J CHEM PHYS, V133, DOI 10.1063/1.3493687; Lehle H, 2008, EUR PHYS J E, V26, P151, DOI 10.1140/epje/i2007-10314-1; Lewandowski EP, 2009, SOFT MATTER, V5, P886, DOI 10.1039/b812257a; Loudet JC, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.018301; Madivala B, 2009, SOFT MATTER, V5, P1717, DOI 10.1039/b816680c; Madivala B, 2009, LANGMUIR, V25, P2718, DOI 10.1021/la803554u; Nguyen VX, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.164501; PARK BJ, 2011, ATTRACTIVE INTERACTI; Park BJ, 2010, SOFT MATTER, V6, P485, DOI 10.1039/b919629c; Park J, 2006, LANGMUIR, V22, P3506, DOI 10.1021/la053450j; Stamou D, 2000, PHYS REV E, V62, P5263, DOI 10.1103/PhysRevE.62.5263; Weon BM, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.015305	29	1112	1135	41	1174	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 18	2011	476	7360					308	311		10.1038/nature10344	http://dx.doi.org/10.1038/nature10344			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811JV	21850105				2022-12-28	WOS:000294206500047
J	Ban, N; Fetters, MD				Ban, Nobutaro; Fetters, Michael D.			Education for health professionals in Japan-time to change	LANCET			English	Editorial Material							SYSTEMS; CARE		[Ban, Nobutaro] Nagoya Univ, Grad Sch Med, Dept Gen Med Family & Community Med, Showa Ku, Aichi, Japan; [Fetters, Michael D.] Univ Michigan, Dept Family Med, Ann Arbor, MI 48109 USA; [Fetters, Michael D.] Univ Michigan, Japanese Family Hlth Program, Ann Arbor, MI 48109 USA	Nagoya University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Ban, N (corresponding author), Nagoya Univ, Grad Sch Med, Dept Gen Med Family & Community Med, Showa Ku, 65 Tsurumai Cho, Aichi, Japan.	nobuban@med.nagoya-u.ac.jp						Frenk J, 2010, LANCET, V376, P1923, DOI 10.1016/S0140-6736(10)61854-5; Hashimoto H, 2011, LANCET, V378, P1174, DOI 10.1016/S0140-6736(11)60987-2; *JAP SOC MED ED, P 43 ANN M JAP SOC M; Millis JS., 1966, AM MED ASS, DOI [10.1001/jama.1966.03110120095022, DOI 10.1001/JAMA.1966.03110120095022]; Murata C, 2010, INT J ENV RES PUB HE, V7, P1330, DOI 10.3390/ijerph7041330; Starfield B, 2005, MILBANK Q, V83, P457, DOI 10.1111/j.1468-0009.2005.00409.x; WHO, 2008, PHARMAFORUM 0121	7	17	17	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 1	2011	378	9798					1206	1207		10.1016/S0140-6736(11)61189-6	http://dx.doi.org/10.1016/S0140-6736(11)61189-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	831IO	21885111				2022-12-28	WOS:000295723600009
J	Su, H; Cheng, YF; Oswald, R; Behrendt, T; Trebs, I; Meixner, FX; Andreae, MO; Cheng, P; Zhang, Y; Poschl, U				Su, Hang; Cheng, Yafang; Oswald, Robert; Behrendt, Thomas; Trebs, Ivonne; Meixner, Franz X.; Andreae, Meinrat O.; Cheng, Peng; Zhang, Yuanhang; Poeschl, Ulrich			Soil Nitrite as a Source of Atmospheric HONO and OH Radicals	SCIENCE			English	Article							NITROUS-ACID; HUMIC-ACID; OXIDE; DEPOSITION; EXCHANGE; DIOXIDE; FOREST; SOOT	Hydroxyl radicals (OH) are a key species in atmospheric photochemistry. In the lower atmosphere, up to similar to 30% of the primary OH radical production is attributed to the photolysis of nitrous acid (HONO), and field observations suggest a large missing source of HONO. We show that soil nitrite can release HONO and explain the reported strength and diurnal variation of the missing source. Fertilized soils with low pH appear to be particularly strong sources of HONO and OH. Thus, agricultural activities and land-use changes may strongly influence the oxidizing capacity of the atmosphere. Because of the widespread occurrence of nitrite-producing microbes, the release of HONO from soil may also be important in natural environments, including forests and boreal regions.	[Su, Hang; Oswald, Robert; Behrendt, Thomas; Trebs, Ivonne; Meixner, Franz X.; Andreae, Meinrat O.; Poeschl, Ulrich] Max Planck Inst Chem, Biogeochem Dept, D-55020 Mainz, Germany; [Cheng, Yafang; Cheng, Peng; Zhang, Yuanhang] Peking Univ, Coll Environm Sci & Engn, SKJ Lab Environm Simulat & Pollut Control, Beijing 100871, Peoples R China; [Cheng, Yafang] Univ Iowa, Ctr Global & Reg Environm Res, Iowa City, IA 52242 USA; [Meixner, Franz X.] Univ Zimbabwe, Dept Phys, Harare, Zimbabwe	Max Planck Society; Peking University; University of Iowa; University of Zimbabwe	Su, H (corresponding author), Max Planck Inst Chem, Biogeochem Dept, D-55020 Mainz, Germany.	h.su@mpic.de; yafang.cheng@gmail.com; u.poschl@mpic.de	Trebs, Ivonne/L-9125-2013; Pöschl, Ulrich/A-6263-2010; Andreae, Meinrat O./B-1068-2008; cheng, peng/F-1006-2019; Zhang, Yuanhang/F-7038-2011; Cheng, Yafang/F-9362-2010; Su, Hang/A-6226-2010	Pöschl, Ulrich/0000-0003-1412-3557; Andreae, Meinrat O./0000-0003-1968-7925; cheng, peng/0000-0002-0806-9593; Cheng, Yafang/0000-0003-4912-9879; Su, Hang/0000-0003-4889-1669; Trebs, Ivonne/0000-0001-5966-4942	Max Planck Society; European Commission [036833-2, 265148]	Max Planck Society(Max Planck SocietyFoundation CELLEX); European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by the Max Planck Society and the European Commission under the projects EUCAARI (grant no. 036833-2) and PEGASOS (grant no. 265148). We gratefully acknowledge X. G. Chi, S. S. Gunthe, M. Shiraiwa, and N. Knothe for comments and discussions.	Acker K, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL024643; Ammann M, 1998, NATURE, V395, P157, DOI 10.1038/25965; BURNS LC, 1995, SOIL BIOL BIOCHEM, V27, P47, DOI 10.1016/0038-0717(94)00130-S; Canfield DE, 2010, SCIENCE, V330, P192, DOI 10.1126/science.1186120; CHAPMAN HD, 1952, SOIL SCI SOC AM PRO, V16, P276, DOI 10.2136/sssaj1952.03615995001600030014x; Cleemput O., 1995, NUTR CYCL AGROECOSYS, V45, P81; De Jeu R. A. M., 2002, P SOC PHOTO-OPT INS, V2002, P184; Dibb JE, 2002, ATMOS ENVIRON, V36, P2501, DOI 10.1016/S1352-2310(02)00130-9; Finlayson-Pitts BJ, 2003, PHYS CHEM CHEM PHYS, V5, P223, DOI 10.1039/b208564j; Guo JH, 2010, SCIENCE, V327, P1008, DOI 10.1126/science.1182570; Kleffmann J, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022524; Kleffmann J, 2007, CHEMPHYSCHEM, V8, P1137, DOI 10.1002/cphc.200700016; Lammel G, 1996, CHEM SOC REV, V25, P361, DOI 10.1039/cs9962500361; Ludwig J, 2001, BIOGEOCHEMISTRY, V52, P225, DOI 10.1023/A:1006424330555; Monge ME, 2010, P NATL ACAD SCI USA, V107, P6605, DOI 10.1073/pnas.0908341107; O'Connor G.A., 2001, SOIL SCI, DOI [10.1097/00010694-198006000-00010, DOI 10.1097/00010694-198006000-00010]; Pandis S. N., 2006, ATMOSPHERIC CHEM PHY; Reay DS, 2008, NAT GEOSCI, V1, P430, DOI 10.1038/ngeo230; Ren X, 2010, ATMOS CHEM PHYS, V10, P6283, DOI 10.5194/acp-10-6283-2010; Ren XR, 2003, ATMOS ENVIRON, V37, P3639, DOI 10.1016/S1352-2310(03)00459-X; Sorgel M, 2011, ATMOS CHEM PHYS, V11, P841, DOI 10.5194/acp-11-841-2011; Stemmler K, 2007, ATMOS CHEM PHYS, V7, P4237, DOI 10.5194/acp-7-4237-2007; Stemmler K, 2006, NATURE, V440, P195, DOI 10.1038/nature04603; Stutz J, 2010, ATMOS ENVIRON, V44, P4090, DOI 10.1016/j.atmosenv.2009.02.003; Su H, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009060; Trebs I, 2006, ATMOS CHEM PHYS, V6, P447, DOI 10.5194/acp-6-447-2006; Venterea RT, 2000, GLOBAL CHANGE BIOL, V6, P303, DOI 10.1046/j.1365-2486.2000.00309.x; Zhang N, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL038999	28	318	338	25	531	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 16	2011	333	6049					1616	1618		10.1126/science.1207687	http://dx.doi.org/10.1126/science.1207687			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	820JE	21852453				2022-12-28	WOS:000294900900039
J	Granger, CB; Alexander, JH; McMurray, JJV; Lopes, RD; Hylek, EM; Hanna, M; Al-Khalidi, HR; Ansell, J; Atar, D; Avezum, A; Bahit, MC; Diaz, R; Easton, JD; Ezekowitz, JA; Flaker, G; Garcia, D; Geraldes, M; Gersh, BJ; Golitsyn, S; Goto, S; Hermosillo, AG; Hohnloser, SH; Horowitz, J; Mohan, P; Jansky, P; Lewis, BS; Lopez-Sendon, JL; Pais, P; Parkhomenko, A; Verheugt, FWA; Zhu, J; Wallentin, L				Granger, Christopher B.; Alexander, John H.; McMurray, John J. V.; Lopes, Renato D.; Hylek, Elaine M.; Hanna, Michael; Al-Khalidi, Hussein R.; Ansell, Jack; Atar, Dan; Avezum, Alvaro; Cecilia Bahit, M.; Diaz, Rafael; Easton, J. Donald; Ezekowitz, Justin A.; Flaker, Greg; Garcia, David; Geraldes, Margarida; Gersh, Bernard J.; Golitsyn, Sergey; Goto, Shinya; Hermosillo, Antonio G.; Hohnloser, Stefan H.; Horowitz, John; Mohan, Puneet; Jansky, Petr; Lewis, Basil S.; Luis Lopez-Sendon, Jose; Pais, Prem; Parkhomenko, Alexander; Verheugt, Freek W. A.; Zhu, Jun; Wallentin, Lars		ARISTOTLE Comm Investigators	Apixaban versus Warfarin in Patients with Atrial Fibrillation	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							THERAPY; ANTICOAGULATION; DABIGATRAN; EVENTS; STROKE; TRIAL; RISK	Background Vitamin K antagonists are highly effective in preventing stroke in patients with atrial fibrillation but have several limitations. Apixaban is a novel oral direct factor Xa inhibitor that has been shown to reduce the risk of stroke in a similar population in comparison with aspirin. Methods In this randomized, double-blind trial, we compared apixaban (at a dose of 5 mg twice daily) with warfarin (target international normalized ratio, 2.0 to 3.0) in 18,201 patients with atrial fibrillation and at least one additional risk factor for stroke. The primary outcome was ischemic or hemorrhagic stroke or systemic embolism. The trial was designed to test for noninferiority, with key secondary objectives of testing for superiority with respect to the primary outcome and to the rates of major bleeding and death from any cause. Results The median duration of follow-up was 1.8 years. The rate of the primary outcome was 1.27% per year in the apixaban group, as compared with 1.60% per year in the warfarin group (hazard ratio with apixaban, 0.79; 95% confidence interval [CI], 0.66 to 0.95; P<0.001 for noninferiority; P=0.01 for superiority). The rate of major bleeding was 2.13% per year in the apixaban group, as compared with 3.09% per year in the warfarin group (hazard ratio, 0.69; 95% CI, 0.60 to 0.80; P<0.001), and the rates of death from any cause were 3.52% and 3.94%, respectively (hazard ratio, 0.89; 95% CI, 0.80 to 0.99; P=0.047). The rate of hemorrhagic stroke was 0.24% per year in the apixaban group, as compared with 0.47% per year in the warfarin group (hazard ratio, 0.51; 95% CI, 0.35 to 0.75; P<0.001), and the rate of ischemic or uncertain type of stroke was 0.97% per year in the apixaban group and 1.05% per year in the warfarin group (hazard ratio, 0.92; 95% CI, 0.74 to 1.13; P=0.42). Conclusions In patients with atrial fibrillation, apixaban was superior to warfarin in preventing stroke or systemic embolism, caused less bleeding, and resulted in lower mortality. (Funded by Bristol-Myers Squibb and Pfizer; ARISTOTLE ClinicalTrials.govnumber, NCT00412984.)	[Granger, Christopher B.; Alexander, John H.; Lopes, Renato D.; Al-Khalidi, Hussein R.] Duke Univ, Med Ctr, Duke Clin Res Inst, Durham, NC 27715 USA; [McMurray, John J. V.] Univ Glasgow, Glasgow, Lanark, Scotland; [Hylek, Elaine M.] Boston Univ, Med Ctr, Boston, MA USA; [Hanna, Michael; Geraldes, Margarida; Mohan, Puneet] Bristol Myers Squibb Co, Princeton, NJ USA; [Ansell, Jack] Lenox Hill Hosp, New York, NY 10021 USA; [Atar, Dan] Oslo Univ Hosp, Oslo, Norway; [Avezum, Alvaro] Dante Pazzanese Inst Cardiol, Sao Paulo, Brazil; [Cecilia Bahit, M.; Diaz, Rafael] ECLA Estudios Cardiol Latinoamer, Rosario, Santa Fe, Argentina; [Easton, J. Donald] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Ezekowitz, Justin A.] Univ Alberta, Edmonton, AB, Canada; [Flaker, Greg] Univ Missouri Hlth Care, Columbia, MO USA; [Garcia, David] Univ New Mexico, Albuquerque, NM 87131 USA; [Gersh, Bernard J.] Mayo Clin, Rochester, MN USA; [Golitsyn, Sergey] Russian Cardiol Res Ctr, Moscow, Russia; [Goto, Shinya] Tokai Univ, Sch Med, Kanagawa 2591100, Japan; [Hermosillo, Antonio G.] Inst Nacl Cardiol, Tlalpan Cp, Mexico; [Hohnloser, Stefan H.] Goethe Univ Frankfurt, Frankfurt, Germany; [Horowitz, John] Univ Adelaide, Adelaide, SA, Australia; [Jansky, Petr] Motol Univ Hosp, Prague, Czech Republic; [Lewis, Basil S.] Lady Davis Carmel Med Ctr, Haifa, Israel; [Luis Lopez-Sendon, Jose] Hosp Univ La Paz, Madrid, Spain; [Pais, Prem] St Johns Med Coll, Bangalore, Karnataka, India; [Parkhomenko, Alexander] Inst Cardiol, Kiev, Ukraine; [Verheugt, Freek W. A.] Onze Lieve Vrouw Hosp, Amsterdam, Netherlands; [Zhu, Jun] Fuwai Hosp, Beijing, Peoples R China; [Wallentin, Lars] Uppsala Univ, Uppsala Clin Res Ctr, Uppsala, Sweden	Duke University; University of Glasgow; Boston University; Bristol-Myers Squibb; Northwell Health; University of Oslo; Instituto Dante Pazzanese de Cardiologia; University of California System; University of California San Francisco; University of Alberta; University of Missouri System; University of Missouri Columbia; University of New Mexico; Mayo Clinic; National Medical Research Center of Cardiology; Tokai University; Goethe University Frankfurt; University of Adelaide; Motol University Hospital; Clalit Health Services; Carmel Medical Center; Hospital Universitario La Paz; St. John's National Academy of Health Sciences; St. John's Medical College; National Academy of Medical Sciences of Ukraine; National Scientific Center M.D. Strazhesko Institute of Cardiology of the National Academy of Medical Sciences of Ukraine; Onze Lieve Vrouwe Gasthuis Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Uppsala University	Granger, CB (corresponding author), Duke Univ, Med Ctr, Duke Clin Res Inst, DUMC Box 3850, Durham, NC 27715 USA.	christopher.granger@duke.edu	mcmurray, John/B-2467-2013; Reshetko, Olga/I-7011-2013; Hermosillo, Antonio G/E-5752-2014; De Caterina, Raffaele/K-3857-2016; Maggioni, Aldo Pietro/AAL-5334-2020; Golitsyn, Sergey/ABH-2143-2020; Benedek, Imre/E-7052-2017; Bragina, Anna E/E-4581-2017; Leonardi, Sergio/AAK-1490-2020; Yarokhno, Natalya/R-4854-2017; Granger, Christopher B/D-3458-2014; Brat, Radim/G-7925-2019; Urina-Triana, Miguel A/H-2605-2016; Georgescu, Catalina Arsenescu/R-5709-2017; Ezekowitz, Justin A/C-4579-2013; Walters, Darren/A-7069-2011; Avezum, Alvaro/AAP-7687-2020; Avezum, Alvaro AA/K-6137-2016; FENICI, RICCARDO/Q-2859-2019; Alexander, John/GVS-7271-2022; Goto, Shinya/AAU-6045-2020; Verheugt, F.W.A./H-8105-2014; Oh, Byung-Hee/G-9875-2011; Svistov, Aleksandr S/G-8291-2018; Bazylevych, Andriy/G-2834-2019; Villacastín, Julián P/F-8469-2016; Zadionchenko, Vladimir/A-7445-2016; FENICI, RICCARDO/J-4628-2012; Benedek, Theodora/F-6353-2016; Leonardi, Sergio/K-4334-2018; Mareev, Vyacheslav Yurievich/Q-1375-2017	mcmurray, John/0000-0002-6317-3975; Reshetko, Olga/0000-0003-3107-7636; De Caterina, Raffaele/0000-0003-1637-574X; Maggioni, Aldo Pietro/0000-0003-2764-6779; Golitsyn, Sergey/0000-0001-9913-9974; Benedek, Imre/0000-0003-0051-4047; Bragina, Anna E/0000-0002-2699-1610; Leonardi, Sergio/0000-0002-4800-6132; Yarokhno, Natalya/0000-0003-2055-648X; Granger, Christopher B/0000-0002-0045-3291; Brat, Radim/0000-0001-9381-9135; Urina-Triana, Miguel A/0000-0001-6003-4622; Georgescu, Catalina Arsenescu/0000-0001-5142-7598; Ezekowitz, Justin A/0000-0002-2724-4086; Avezum, Alvaro AA/0000-0002-3073-6890; Goto, Shinya/0000-0002-6821-1504; Oh, Byung-Hee/0000-0002-9945-4306; Svistov, Aleksandr S/0000-0003-0246-5680; Bazylevych, Andriy/0000-0001-5053-2548; Villacastín, Julián P/0000-0002-4867-3912; Zadionchenko, Vladimir/0000-0003-2377-5266; FENICI, RICCARDO/0000-0002-4664-2653; Benedek, Theodora/0000-0001-8326-1537; Leonardi, Sergio/0000-0002-4800-6132; Lanas, Fernando/0000-0003-3595-9759; gosse, philippe/0000-0002-5840-7749; Held, Claes/0000-0001-9402-7404; HEDDLE, WILLIAM/0000-0001-8167-2826; Gonzalez-Hermosillo, Jesus Antonio/0000-0002-3563-3081; Alexander, John/0000-0002-1444-2462; Varenhorst, Christoph/0000-0002-8378-3869; Talajic, Mario/0000-0001-8469-4748; Harenberg, Job/0000-0003-4590-4225; Albrecht, Alvaro/0000-0001-9707-2104; Mareev, Vyacheslav Yurievich/0000-0002-7285-2048; Hylek, Elaine/0000-0001-8263-8304; Poppert, Holger/0000-0003-2189-7681	Bristol-Myers Squibb; Pfizer; AstraZeneca; Boehringer Ingelheim; Boehringer Ingelheim, GlaxoSmithKline; Medtronic Foundation; Merck; Sanofi-Aventis; Astellas; Hoffmann-La Roche; Novartis; Otsuka Pharmaceutical; Medicines Company; Merck/Schering-Plough; Regado Biosciences; Ortho-McNeil-Janssen; PolyMedix; Bayer; Daiichi Sankyo; Johnson Johnson; GlaxoSmithKline; Amgen; Abbott; Servier; Amorcyte; Abbott Laboratories; GE Healthcare; St. Jude Medical, Medispec; Boston Scientific; Otuska; Otuska, Eisai; Medtronics-Japan; Tanabe-Mitsubishi; Takeda; Mochida; MSD; Cardiome; St. Jude Medical; Medtronic Vascular; Regado Biotechnologies; Portola; CSL Behring; Athera Biotechnologies; Schering-Plough;  [NCT00412984]; Grants-in-Aid for Scientific Research [21390244] Funding Source: KAKEN	Bristol-Myers Squibb(Bristol-Myers Squibb); Pfizer(Pfizer); AstraZeneca(AstraZeneca); Boehringer Ingelheim(Boehringer Ingelheim); Boehringer Ingelheim, GlaxoSmithKline(Boehringer IngelheimGlaxoSmithKline); Medtronic Foundation; Merck(Merck & Company); Sanofi-Aventis(Sanofi-Aventis); Astellas(Astellas Pharmaceuticals); Hoffmann-La Roche(Hoffmann-La Roche); Novartis(Novartis); Otsuka Pharmaceutical(Otsuka Pharmaceutical); Medicines Company; Merck/Schering-Plough(Merck & CompanySchering Plough Corporation); Regado Biosciences; Ortho-McNeil-Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); PolyMedix; Bayer(Bayer AG); Daiichi Sankyo(Daiichi Sankyo Company Limited); Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); GlaxoSmithKline(GlaxoSmithKline); Amgen(Amgen); Abbott(Abbott Laboratories); Servier(Servier); Amorcyte; Abbott Laboratories(Abbott Laboratories); GE Healthcare(General ElectricGE Healthcare); St. Jude Medical, Medispec(St. Jude Medical); Boston Scientific(Boston Scientific); Otuska; Otuska, Eisai(Eisai Co Ltd); Medtronics-Japan; Tanabe-Mitsubishi; Takeda(Takeda Pharmaceutical Company Ltd); Mochida; MSD; Cardiome; St. Jude Medical(St. Jude Medical); Medtronic Vascular; Regado Biotechnologies; Portola; CSL Behring; Athera Biotechnologies; Schering-Plough(Merck & CompanySchering Plough Corporation); ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Funded by Bristol-Myers Squibb and Pfizer; ARISTOTLE ClinicalTrials.govnumber, NCT00412984.; Dr. Granger reports receiving grants from AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, the Medtronic Foundation, Merck, Sanofi-Aventis, Astellas, and the Medicines Company, consulting fees from AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Hoffmann-La Roche, Novartis, Otsuka Pharmaceutical, Sanofi-Aventis, and the Medicines Company, and support from the Medtronic Foundation and Merck for travel, accommodations, or meeting expenses; Dr. Alexander, receiving grants from Merck/Schering-Plough and Regado Biosciences and consulting fees from Merck/Schering-Plough, AstraZeneca, Boehringer Ingelheim, Ortho-McNeil-Janssen, PolyMedix, Regado Biosciences, and Bayer; Dr. Lopes, receiving grants from Bristol-Myers Squibb, AstraZeneca, Boehringer Ingelheim, and Daiichi Sankyo and consulting fees from Bristol-Myers Squibb; Dr. Hylek, receiving consulting fees from Johnson & Johnson, Boehringer Ingelheim, Bristol-Myers Squibb, Daiichi Sankyo, Merck, Pfizer, and Ortho-McNeil-Janssen and lecture fees from Boehringer Ingelheim; Dr. Hanna, being an employee of Bristol-Myers Squibb and receiving stock as part of his compensation; Dr. Ansell, being a member of Bristol-Myers Squibb's data and safety monitoring boards, receiving consulting fees from Ortho-McNeil-Janssen, Daiichi Sankyo, Boehringer Ingelheim, and Bristol-Myers Squibb, and receiving payments from Daiichi Sankyo for developing educational presentations; Dr. Atar, receiving consulting fees or honoraria from Bristol-Myers Squibb; Dr. Avezum, receiving consulting fees from Boehringer Ingelheim and GlaxoSmithKline; Dr. Bahit, receiving consulting fees or honoraria and other research support from Bristol-Myers Squibb; Dr. Diaz, receiving consulting fees or honoraria and other research support from Bristol-Myers Squibb; Dr. Ezekowitz, receiving research support, honoraria, and payments for continuing medical education events from AstraZeneca, Amgen, Abbott, Servier, Johnson & Johnson, Pfizer, and Bristol-Myers Squibb; Dr. Flaker, receiving consulting fees from Boehringer Ingelheim and Sanofi-Aventis and grants from Boehringer Ingelheim and Sanofi-Aventis; Dr. Garcia, receiving consulting fees from Bristol-Myers Squibb, Pfizer, Boehringer Ingelheim, and Daiichi Sankyo and payments from Boehringer Ingelheim for developing educational presentations; Dr. Geraldes, being an employee of Bristol-Myers Squibb and receiving stock or stock options annually; Dr. Gersh, receiving consulting fees from Ortho-McNeil-Janssen, Amorcyte, Abbott Laboratories, GE Healthcare, St. Jude Medical, Medispec, Merck, and Boston Scientific; Dr. Goto, being a board member of Bristol-Myers Squibb and Sanofi-Aventis, receiving grants from Boehringer Ingelheim, Otuska, Eisai, Sanofi-Aventis, and Daiichi Sankyo, consulting fees from Eisai, lecture fees from Eisai, Otsuka, Daiichi Sankyo, Sanofi-Aventis, Bayer, Novartis, AstraZeneca, Asteras, Pfizer, Medtronics-Japan, Tanabe-Mitsubishi, Takeda, Mochida, and MSD, and payments from Bayer and Sanofi-Aventis for developing educational presentations; Dr. Hermosillo, receiving consulting fees or honoraria from Bristol-Myers Squibb; Dr. Hohnloser, receiving consulting fees from Sanofi-Aventis, St. Jude Medical, Boehringer Ingelheim, Cardiome, and Medtronic Vascular and lecture fees from Sanofi-Aventis, Bristol-Myers Squibb, Pfizer, Boehringer Ingelheim, and St. Jude Medical; Dr. Horowitz, receiving research support from Bristol-Myers Squibb; Dr. Mohan, being an employee of Bristol-Myers Squibb and receiving performance-based stock or stock options annually; Dr.; Lewis, being an dvisory board member for Bayer Healthcare; Dr. Lopez-Sendon, receiving grants from Bristol-Myers Squibb, Boehringer Ingelheim, and Bayer and consulting fees from Boehringer Ingelheim; Dr. Parkhomenko, receiving consulting; fees and grants from Borshchiagovsky Chemical-Pharmaceutical Plant; Dr. Verheugt, receiving lecture fees from Bayer and AstraZeneca and consulting fees from Bayer and Daiichi Sankyo; and Dr. Wallentin, receiving grants from Bristol-Myers Squibb, Pfizer, AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Schering-Plough, and Merck, consulting fees from Regado Biotechnologies, Portola, CSL Behring, Athera Biotechnologies, Boehringer Ingelheim, AstraZeneca, and GlaxoSmithKline, and lecture fees from Bristol-Myers Squibb, Pfizer, AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Schering-Plough, and Merck. No other potential conflict of interest relevant to this article was reported.	Alexander JH, 2011, NEW ENGL J MED, V365, P699, DOI 10.1056/NEJMoa1105819; Connolly S, 2006, LANCET, V367, P1903, DOI 10.1016/s0140-6736(06)68845-4; Connolly SJ, 2011, NEW ENGL J MED, V364, P806, DOI 10.1056/NEJMoa1007432; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Eikelboom JW, 2011, CIRCULATION, V123, P2363, DOI 10.1161/CIRCULATIONAHA.110.004747; Frost C, 2011, 23 C INT SOC THROMB; Go AS, 1999, ANN INTERN MED, V131, P927, DOI 10.7326/0003-4819-131-12-199912210-00004; Hart RG, 1999, ANN INTERN MED, V131, P492, DOI 10.7326/0003-4819-131-7-199910050-00003; Jackson K, 2008, AM HEART J, V155, P829, DOI 10.1016/j.ahj.2008.01.023; Lopes RD, 2010, AM HEART J, V159, P331, DOI 10.1016/j.ahj.2009.07.035; Mackman N, 2009, ANESTH ANALG, V108, P1447, DOI 10.1213/ane.0b013e31819bceb1; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Raghavan N, 2009, DRUG METAB DISPOS, V37, P74, DOI 10.1124/dmd.108.023143; ROSENDAAL FR, 1993, THROMB HAEMOSTASIS, V69, P236; Schulman S, 2005, J THROMB HAEMOST, V3, P692, DOI 10.1111/j.1538-7836.2005.01204.x	15	5808	6087	10	438	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 15	2011	365	11					981	992		10.1056/NEJMoa1107039	http://dx.doi.org/10.1056/NEJMoa1107039			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	819UR	21870978				2022-12-28	WOS:000294857300006
J	Coombes, R				Coombes, Rebecca			NON-COMMUNICABLE DISEASES Trans fats: chasing a global ban	BRITISH MEDICAL JOURNAL			English	Editorial Material							CARDIOVASCULAR-DISEASE; ACIDS; FOODS		BMJ, London WC1H 9JR, England		Coombes, R (corresponding author), BMJ, London WC1H 9JR, England.	rcoombes@bmj.com						Angell SY, 2009, ANN INTERN MED, V151, P129, DOI 10.7326/0003-4819-151-2-200907210-00010; Barton P, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4044; Mozaffarian D, 2006, NEW ENGL J MED, V354, P1601, DOI 10.1056/NEJMra054035; Mozaffarian D, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c1826; National Institute for Health and Clinical Excellence, 2010, PREV CARD DIS POP LE; Stender S, 2006, NEW ENGL J MED, V354, P1650, DOI 10.1056/NEJMc052959; WILLETT WC, 1993, LANCET, V341, P581, DOI 10.1016/0140-6736(93)90350-P; WORLD HEALTH ORGANIZATION (WHO), GLOB STRAT DIET PHYS	8	27	27	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 7	2011	343								d5567	10.1136/bmj.d5567	http://dx.doi.org/10.1136/bmj.d5567			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	819RQ	21900347				2022-12-28	WOS:000294847800004
J	Kerdsin, A; Dejsirilert, S; Sawanpanyalert, P; Boonnark, A; Noithachang, W; Sriyakum, D; Simkum, S; Chokngam, S; Gottschalk, M; Akeda, Y; Oishi, K				Kerdsin, Anusak; Dejsirilert, Surang; Sawanpanyalert, Pathom; Boonnark, Adisorn; Noithachang, Wipa; Sriyakum, Duangdao; Simkum, Somchai; Chokngam, Sukenya; Gottschalk, Marcelo; Akeda, Yukihiro; Oishi, Kazunori			Sepsis and spontaneous bacterial peritonitis in Thailand	LANCET			English	Editorial Material							STREPTOCOCCUS-SUIS		[Akeda, Yukihiro; Oishi, Kazunori] Osaka Univ, Int Res Ctr Infect Dis, Microbial Dis Res Inst, Suita, Osaka 5650871, Japan; [Kerdsin, Anusak; Dejsirilert, Surang; Sawanpanyalert, Pathom] Minist Publ Hlth, Dept Med Sci, Natl Inst Hlth, Nonthaburi, Thailand; [Boonnark, Adisorn; Noithachang, Wipa] Uttaradit Hosp, Dept Clin Pathol, Uttaradit, Thailand; [Sriyakum, Duangdao; Simkum, Somchai; Chokngam, Sukenya] Phetchabul Hosp, Dept Social Med & Clin Pathol, Petchabul, Thailand; [Gottschalk, Marcelo] Univ Montreal, Fac Vet Med, Quebec City, PQ, Canada	Osaka University; Ministry of Public Health - Thailand; Universite de Montreal	Oishi, K (corresponding author), Osaka Univ, Int Res Ctr Infect Dis, Microbial Dis Res Inst, 3-1 Yamadaoka, Suita, Osaka 5650871, Japan.	oishik@biken.osaka-u.ac.jp	Gottschalk, Marcelo/I-8116-2012; Kerdsin, Anusak/H-5360-2019	Kerdsin, Anusak/0000-0003-1055-3656				Gottschalk M, 2010, FUTURE MICROBIOL, V5, P371, DOI [10.2217/fmb.10.2, 10.2217/FMB.10.2]; HO DTN, 2011, PLOS ONE, V0006; Kerdsin A, 2011, EMERG INFECT DIS, V17, P835, DOI 10.3201/eid1705.100754; Koulaouzidis A, 2007, POSTGRAD MED J, V83, P379, DOI 10.1136/pgmj.2006.056168; Nghia HDT, 2008, EMERG INFECT DIS, V14, P155, DOI 10.3201/eid1401.070534	5	47	51	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 3	2011	378	9794					960	960		10.1016/S0140-6736(11)60923-9	http://dx.doi.org/10.1016/S0140-6736(11)60923-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	818XZ	21890062				2022-12-28	WOS:000294791300038
J	Mauer, MP				Mauer, Matthew P.			9/11: the view ahead	LANCET			English	Editorial Material							WORLD-TRADE-CENTER; CENTER DISASTER; RESPIRATORY SYMPTOMS; CENTER RESPONDERS; HEALTH; WORKERS; RESCUE		New York State Dept Hlth, Ctr Environm Hlth, Troy, NY 12180 USA		Mauer, MP (corresponding author), New York State Dept Hlth, Ctr Environm Hlth, Troy, NY 12180 USA.	mpm08@health.state.ny.us						Aldrich TK, 2010, NEW ENGL J MED, V362, P1263, DOI 10.1056/NEJMoa0910087; Brackbill RM, 2009, JAMA-J AM MED ASSOC, V302, P502, DOI 10.1001/jama.2009.1121; Cook A, 2008, J ENVIRON MONITOR, V10, P167, DOI 10.1039/b713256p; Herbert R, 2006, ENVIRON HEALTH PERSP, V114, P1853, DOI 10.1289/ehp.9592; Kleinman EJ, 2011, J OCCUP ENVIRON MED, V53, P618, DOI 10.1097/JOM.0b013e31821f2c83; Landrigan PJ, 2004, ENVIRON HEALTH PERSP, V112, P731, DOI 10.1289/ehp.6702; Mauer MP, 2007, J OCCUP ENVIRON MED, V49, P1197, DOI 10.1097/JOM.0b013e318157d31d; Mauer MP, 2010, LUNG, V188, P107, DOI 10.1007/s00408-009-9206-y; Mauer MP, 2010, OCCUP MED-OXFORD, V60, P145, DOI 10.1093/occmed/kqp176; Mauer MP, 2010, INT ARCH OCC ENV HEA, V83, P21, DOI 10.1007/s00420-009-0474-x; Prezant DJ, 2002, NEW ENGL J MED, V347, P806, DOI 10.1056/NEJMoa021300; Stellman JM, 2008, ENVIRON HEALTH PERSP, V116, P1248, DOI 10.1289/ehp.11164; Tapp LC, 2005, AM J IND MED, V47, P475, DOI 10.1002/ajim.20177; Wisnivesky JP, 2011, LANCET, V378, P888, DOI 10.1016/S0140-6736(11)61180-X; 2011, FED REG, V76, P38914	15	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 3	2011	378	9794					852	854		10.1016/S0140-6736(11)61310-X	http://dx.doi.org/10.1016/S0140-6736(11)61310-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	818XZ	21890031				2022-12-28	WOS:000294791300005
J	Carroll, SB				Carroll, Sean B.			How Great Wings Can Look Alike	SCIENCE			English	Editorial Material							HELICONIUS BUTTERFLIES; MULLERIAN MIMICRY; EVOLUTION		Univ Wisconsin, Howard Hughes Med Inst, Mol Biol Lab, Bock Labs 201, Madison, WI 53706 USA	Howard Hughes Medical Institute; University of Wisconsin System; University of Wisconsin Madison	Carroll, SB (corresponding author), Univ Wisconsin, Howard Hughes Med Inst, Mol Biol Lab, Bock Labs 201, Madison, WI 53706 USA.	sbcarrol@facstaff.wisc.edu			Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Bates H.W., 1862, T LINN SOC LOND, V23, P495; Bates HW, 1988, NATURALIST RIVER AMA; Baxter SW, 2008, GENETICS, V180, P1567, DOI 10.1534/genetics.107.082982; Carroll SB, 2005, PLOS BIOL, V3, P1159, DOI 10.1371/journal.pbio.0030245; Carroll SB, 2008, CELL, V134, P25, DOI 10.1016/j.cell.2008.06.030; Muller F, 1879, P ENTOMOL SOC LOND, V1879, P20; Nijhout H.F., 1991, DEV EVOLUTION BUTTER; Papa R, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-345; Reed RD, 2011, SCIENCE, V333, P1137, DOI 10.1126/science.1208227; Seimiya M, 2000, DEVELOPMENT, V127, P1879; SHEPPARD PM, 1985, PHILOS T R SOC B, V308, P433, DOI 10.1098/rstb.1985.0066; Sherratt TN, 2008, NATURWISSENSCHAFTEN, V95, P681, DOI 10.1007/s00114-008-0403-y; Wray GA, 2007, NAT REV GENET, V8, P206, DOI 10.1038/nrg2063	13	4	5	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 26	2011	333	6046					1100	1101		10.1126/science.1211025	http://dx.doi.org/10.1126/science.1211025			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811VM	21868661				2022-12-28	WOS:000294244300031
J	Nakamura, T; Noguchi, T; Tanaka, M; Zolensky, ME; Kimura, M; Tsuchiyama, A; Nakato, A; Ogami, T; Ishida, H; Uesugi, M; Yada, T; Shirai, K; Fujimura, A; Okazaki, R; Sandford, SA; Ishibashi, Y; Abe, M; Okada, T; Ueno, M; Mukai, T; Yoshikawa, M; Kawaguchi, J				Nakamura, Tomoki; Noguchi, Takaaki; Tanaka, Masahiko; Zolensky, Michael E.; Kimura, Makoto; Tsuchiyama, Akira; Nakato, Aiko; Ogami, Toshihiro; Ishida, Hatsumi; Uesugi, Masayuki; Yada, Toru; Shirai, Kei; Fujimura, Akio; Okazaki, Ryuji; Sandford, Scott A.; Ishibashi, Yukihiro; Abe, Masanao; Okada, Tatsuaki; Ueno, Munetaka; Mukai, Toshifumi; Yoshikawa, Makoto; Kawaguchi, Junichiro			Itokawa Dust Particles: A Direct Link Between S-Type Asteroids and Ordinary Chondrites	SCIENCE			English	Article							HAYABUSA SPACECRAFT; OLIVINE; GEOTHERMOMETRY; METAMORPHISM; THERMOMETRY; PYROXENE; HISTORY	The Hayabusa spacecraft successfully recovered dust particles from the surface of near-Earth asteroid 25143 Itokawa. Synchrotron-radiation x-ray diffraction and transmission and scanning electron microscope analyses indicate that the mineralogy and mineral chemistry of the Itokawa dust particles are identical to those of thermally metamorphosed LL chondrites, consistent with spectroscopic observations made from Earth and by the Hayabusa spacecraft. Our results directly demonstrate that ordinary chondrites, the most abundant meteorites found on Earth, come from S-type asteroids. Mineral chemistry indicates that the majority of regolith surface particles suffered long-term thermal annealing and subsequent impact shock, suggesting that Itokawa is an asteroid made of reassembled pieces of the interior portions of a once larger asteroid.	[Nakamura, Tomoki; Nakato, Aiko; Ogami, Toshihiro; Ishida, Hatsumi] Tohoku Univ, Dept Earth & Planetary Mat Sci, Fac Sci, Aoba Ku, Sendai, Miyagi 9808578, Japan; [Noguchi, Takaaki; Kimura, Makoto] Ibaraki Univ, Coll Sci, Mito, Ibaraki 3108512, Japan; [Tanaka, Masahiko] Natl Inst Mat Sci, Synchrotron Xray Stn SPring 8, Sayo, Hyogo 6795198, Japan; [Zolensky, Michael E.] NASA, Lyndon B Johnson Space Ctr, ARES, Houston, TX 77058 USA; [Tsuchiyama, Akira] Osaka Univ, Grad Sch Sci, Dept Earth & Space Sci, Toyonaka, Osaka 5600043, Japan; [Uesugi, Masayuki; Yada, Toru; Shirai, Kei; Fujimura, Akio; Ishibashi, Yukihiro; Abe, Masanao; Okada, Tatsuaki; Ueno, Munetaka; Mukai, Toshifumi; Yoshikawa, Makoto; Kawaguchi, Junichiro] JAXA ISAS, Sagamihara, Kanagawa 2298510, Japan; [Okazaki, Ryuji] Kyushu Univ, Dept Earth & Planetary Sci, Fac Sci, Fukuoka 8128581, Japan; [Sandford, Scott A.] NASA, Ames Res Ctr, Moffett Field, CA 94035 USA	Tohoku University; Ibaraki University; National Institute for Materials Science; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; Osaka University; Japan Aerospace Exploration Agency (JAXA); Institute of Space & Astronautical Science (ISAS); Kyushu University; National Aeronautics & Space Administration (NASA); NASA Ames Research Center	Nakamura, T (corresponding author), Tohoku Univ, Dept Earth & Planetary Mat Sci, Fac Sci, Aoba Ku, Sendai, Miyagi 9808578, Japan.	tomoki@m.tohoku.ac.jp	Mukai, Toshifumi/ABD-3297-2021	Noguchi, Takaaki/0000-0001-7211-2595; Uesugi, Masayuki/0000-0001-6261-9034; Zolensky, Michael/0000-0002-3181-1303	NASA [769583.07.03]; Grants-in-Aid for Scientific Research [22224010] Funding Source: KAKEN	NASA(National Aeronautics & Space Administration (NASA)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank the Hayabusa project team for sample return; KEK for synchrotron experiments; H. Nakano, Y. Yamazaki, K. Shimada, Y. Kakazu, T. Hashimoto, M. Konno, Y. Katsuya, and Y. Matsushita, for technical support; and J. Grossman, T. Ikeda, T. Hokada, K. Ozawa, Y. Nakamuta, and S. Wakita for helpful discussions. Supported by NASA grant 769583.07.03 (M.E.Z. and S.A.S.).	Abe M, 2006, SCIENCE, V312, P1334, DOI 10.1126/science.1125718; Binzel RP, 2001, METEORIT PLANET SCI, V36, P1167, DOI 10.1111/j.1945-5100.2001.tb01950.x; Brady JB, 2010, REV MINERAL GEOCHEM, V72, P899, DOI 10.2138/rmg.2010.72.20; BREARLEY AJ, 1998, REV MINERAL, V36, P3; BUNCH TE, 1967, GEOCHIM COSMOCHIM AC, V31, P1569; FABRIES J, 1979, CONTRIB MINERAL PETR, V69, P329, DOI 10.1007/BF00372258; Fujiwara A, 2006, SCIENCE, V312, P1330, DOI 10.1126/science.1125841; Huss G. R., 2006, METEORITES EARLY SOL, P567; JOBBINS EA, 1966, MINERAL MAG J M SOC, V35, P881, DOI 10.1180/minmag.1966.035.275.01; Kimura M, 2006, GEOCHIM COSMOCHIM AC, V70, P5634, DOI 10.1016/j.gca.2006.08.023; Korycansky DG, 2004, ICARUS, V171, P110, DOI 10.1016/j.icarus.2004.03.021; LINDSLEY DH, 1983, AM MINERAL, V68, P477; MCCOY TJ, 1991, GEOCHIM COSMOCHIM AC, V55, P601, DOI 10.1016/0016-7037(91)90015-W; McSween H. Y., 2002, ASTEROIDS, P559; Miyamoto H, 2007, SCIENCE, V316, P1011, DOI 10.1126/science.1134390; Miyamoto M., 1981, P LUNAR PLANET SCI, P1145; Nakamuta Y, 1999, METEORIT PLANET SCI, V34, P763, DOI 10.1111/j.1945-5100.1999.tb01389.x; Okada T, 2006, SCIENCE, V312, P1338, DOI 10.1126/science.1125731; OZAWA K, 1984, GEOCHIM COSMOCHIM AC, V48, P2597, DOI 10.1016/0016-7037(84)90308-9; RUBIN AE, 1990, GEOCHIM COSMOCHIM AC, V54, P1217, DOI 10.1016/0016-7037(90)90148-E; Slater-Reynolds V, 2005, METEORIT PLANET SCI, V40, P745, DOI 10.1111/j.1945-5100.2005.tb00977.x; SMITH JV, 1972, J GEOL, V80, P505, DOI 10.1086/627778; STOFFLER D, 1991, GEOCHIM COSMOCHIM AC, V55, P3845, DOI 10.1016/0016-7037(91)90078-J; Trieloff M, 2003, NATURE, V422, P502, DOI 10.1038/nature01499; Tsuchiyama A, 2011, SCIENCE, V333, P1125, DOI 10.1126/science.1207807; VANSCHMUS WR, 1967, GEOCHIM COSMOCHIM AC, V31, P747, DOI 10.1016/S0016-7037(67)80030-9; Yano H, 2006, SCIENCE, V312, P1350, DOI 10.1126/science.1126164	27	391	396	2	114	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 26	2011	333	6046					1113	1116		10.1126/science.1207758	http://dx.doi.org/10.1126/science.1207758			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811VM	21868667				2022-12-28	WOS:000294244300038
J	Gardner, MK; Charlebois, BD; Janosi, IM; Howard, J; Hunt, AJ; Odde, DJ				Gardner, Melissa K.; Charlebois, Blake D.; Janosi, Imre M.; Howard, Jonathon; Hunt, Alan J.; Odde, David J.			Rapid Microtubule Self-Assembly Kinetics	CELL			English	Article							REAL-TIME OBSERVATIONS; DYNAMIC INSTABILITY; LIVING CELLS; PROTEIN; TUBULIN; GROWTH; ENDS; ELONGATION; RESOLUTION; XMAP215	Microtubule assembly is vital for many fundamental cellular processes. Current models for microtubule assembly kinetics assume that the subunit dissociation rate from a microtubule tip is independent of free subunit concentration. Total-Internal-Reflection-Fluorescence (TIRF) microscopy experiments and data from a laser tweezers assay that measures in vitro microtubule assembly with nanometer resolution, provides evidence that the subunit dissociation rate from a microtubule tip increases as the free subunit concentration increases. These data are consistent with a two-dimensional model for microtubule assembly, and are explained by a shift in microtubule tip structure from a relatively blunt shape at low free concentrations to relatively tapered at high free concentrations. We find that because both the association and the dissociation rates increase at higher free subunit concentrations, the kinetics of microtubule assembly are an order-of magnitude higher than currently estimated in the literature.	[Charlebois, Blake D.; Hunt, Alan J.] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA; [Gardner, Melissa K.; Odde, David J.] Univ Minnesota, Dept Biomed Engn, Minneapolis, MN 55455 USA; [Gardner, Melissa K.; Howard, Jonathon] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany; [Gardner, Melissa K.] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA; [Janosi, Imre M.] Eotvos Lorand Univ, Dept Phys Complex Syst, Budapest, Hungary	University of Michigan System; University of Michigan; University of Minnesota System; University of Minnesota Twin Cities; Max Planck Society; University of Minnesota System; University of Minnesota Twin Cities; Eotvos Lorand University	Hunt, AJ (corresponding author), Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA.	ajhunt@umich.edu; oddex002@umn.edu	Howard, Jonathon/D-4229-2011; Jánosi, Imre M./H-4096-2017; Odde, David/AAY-1720-2020; Odde, David/H-4925-2011; Howard, Jonathon/J-7492-2016	Howard, Jonathon/0000-0003-0086-1196; Jánosi, Imre M./0000-0002-3705-5748; Odde, David/0000-0001-7731-2799; Howard, Jonathon/0000-0003-0086-1196	National Institutes of Health (NIH) [GM076177, GM071522]; National Science Foundation (NSF) [615568]; Whitaker International Scholar Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076177, R01GM071522] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF)(National Science Foundation (NSF)); Whitaker International Scholar Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Dominique Seetapun and Dr. Chris Gell for technical assistance. We thank Aleksey Demchouk for providing the microtubule tip tracking code. The LLC-PK1 alpha strain was kindly provided by Dr. Pat Wadsworth. This work was supported by National Institutes of Health (NIH) GM076177 to A.J.H. and D.J.O, NIH GM071522 to D.J.O, and National Science Foundation (NSF) 615568 to D.J.O. M. K. G. was supported in part by a Whitaker International Scholar Fellowship. The collaboration was supported by the Institute for Mathematics and Its Applications (IMA) at the University of Minnesota.	Bakhoum SF, 2009, CURR BIOL, V19, P1937, DOI 10.1016/j.cub.2009.09.055; Bakhoum SF, 2009, NAT CELL BIOL, V11, P27, DOI 10.1038/ncb1809; Brouhard GJ, 2008, CELL, V132, P79, DOI 10.1016/j.cell.2007.11.043; Cannon MJ, 2004, ANAL BIOCHEM, V328, P67, DOI 10.1016/j.ab.2004.01.014; CASSIMERIS L, 1988, J CELL BIOL, V107, P2223, DOI 10.1083/jcb.107.6.2223; Charlebois BD, 2010, METHOD CELL BIOL, V95, P207, DOI 10.1016/S0091-679X(10)95012-7; Charrasse S, 1998, J CELL SCI, V111, P1371; CHRETIEN D, 1995, J CELL BIOL, V129, P1311, DOI 10.1083/jcb.129.5.1311; Collins SR, 2004, PLOS BIOL, V2, P1582, DOI 10.1371/journal.pbio.0020321; Demchouk AO, 2011, CELL MOL BIOENG, V4, P192, DOI 10.1007/s12195-010-0155-6; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Gardner MK, 2008, CELL, V135, P894, DOI 10.1016/j.cell.2008.09.046; HILL TL, 1986, BIOPHYS J, V49, P1017, DOI 10.1016/S0006-3495(86)83730-4; Howard J, 2007, CURR OPIN CELL BIOL, V19, P31, DOI 10.1016/j.ceb.2006.12.009; Hunter AW, 2003, MOL CELL, V11, P445, DOI 10.1016/S1097-2765(03)00049-2; Kerssemakers JWJ, 2006, NATURE, V442, P709, DOI 10.1038/nature04928; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; MITCHISON TJ, 1987, CELL BIOPHYS, V11, P35, DOI 10.1007/BF02797111; MURPHY DB, 1977, J MOL BIOL, V117, P33, DOI 10.1016/0022-2836(77)90021-3; NORTHRUP SH, 1992, P NATL ACAD SCI USA, V89, P3338, DOI 10.1073/pnas.89.8.3338; OOSAWA F, 1970, J THEOR BIOL, V27, P69, DOI 10.1016/0022-5193(70)90129-3; POLLARD TD, 1986, J CELL BIOL, V103, P2747, DOI 10.1083/jcb.103.6.2747; PRYER NK, 1992, J CELL SCI, V103, P965; Rusan NM, 2001, MOL BIOL CELL, V12, P971, DOI 10.1091/mbc.12.4.971; Schek HT, 2007, CURR BIOL, V17, P1445, DOI 10.1016/j.cub.2007.07.011; SHELDEN E, 1993, J CELL BIOL, V120, P935, DOI 10.1083/jcb.120.4.935; SKELLAM JG, 1946, J ROY STAT SOC A STA, V109, P296, DOI 10.2307/2981372; Stiffler LA, 1999, DEVELOPMENT, V126, P5505; Stukalin EB, 2004, J CHEM PHYS, V121, P1097, DOI 10.1063/1.1759316; VanBuren V, 2005, BIOPHYS J, V89, P2911, DOI 10.1529/biophysj.105.060913; VanBuren V, 2002, P NATL ACAD SCI USA, V99, P6035, DOI 10.1073/pnas.092504999; VASQUEZ RJ, 1994, J CELL BIOL, V127, P985, DOI 10.1083/jcb.127.4.985; WINEY M, 1995, J CELL BIOL, V129, P1601, DOI 10.1083/jcb.129.6.1601	33	150	151	1	46	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 19	2011	146	4					582	592		10.1016/j.cell.2011.06.053	http://dx.doi.org/10.1016/j.cell.2011.06.053			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	809HY	21854983	Bronze, Green Accepted			2022-12-28	WOS:000294043600013
J	Spence, D				Spence, Des			FROM THE FRONTLINE A sick society?	BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk							0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 17	2011	343								d5253	10.1136/bmj.d5253	http://dx.doi.org/10.1136/bmj.d5253			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	811LB	21849381				2022-12-28	WOS:000294210500009
J	Pincock, S				Pincock, Stephen			Boyd Swinburn: combating obesity at the community level	LANCET			English	Biographical-Item														Pincock, Stephen/0000-0003-1655-2902					0	5	5	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG-SEP	2011	378	9793					761	761		10.1016/S0140-6736(11)61364-0	http://dx.doi.org/10.1016/S0140-6736(11)61364-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	816FY	21872738				2022-12-28	WOS:000294585300016
J	O'Brien, E				O'Brien, Eoin			Bahrain: continuing imprisonment of doctors	LANCET			English	Editorial Material									Univ Coll Dublin, Conway Inst Biomol & Biomed Res, Dublin 4, Ireland	University College Dublin	O'Brien, E (corresponding author), Univ Coll Dublin, Conway Inst Biomol & Biomed Res, Dublin 4, Ireland.	eobrien@iol.ie						CUNNINGHAM F, 2011, DETAINED BAHRAINI ME; Devi S, 2011, LANCET, V377, P1733, DOI 10.1016/S0140-6736(11)60716-2; HAYES RW, 2011, BAHRAIN DOCTORS PRIS; HILTERMANN J, 2011, BAHRAIN BURNING; *HUM RIGHTS WATCH, 2011, BAHR SYST ATT MED PR; MCCORMACK D, 2011, MED HELD BAHRAIN; OBRIEN E, 2011, TREATMENT MED BAHRAI; OBRIEN E, 1989, J IR COLL PHYS SURG, V18, P6; OBRIEN E, 2011, IRISH EXAMINER  0831; Physicians for Human Rights, 2011, DO NO HARM CALL BAHR	10	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 1	2011	378	9798					1203	1205		10.1016/S0140-6736(11)61353-6	http://dx.doi.org/10.1016/S0140-6736(11)61353-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	831IO	21903252				2022-12-28	WOS:000295723600007
J	Patel, MR; Smalling, RW; Thiele, H; Barnhart, HX; Zhou, Y; Chandra, P; Chew, D; Cohen, M; French, J; Perera, D; Ohman, EM				Patel, Manesh R.; Smalling, Richard W.; Thiele, Holger; Barnhart, Huiman X.; Zhou, Yi; Chandra, Praveen; Chew, Derek; Cohen, Marc; French, John; Perera, Divaka; Ohman, E. Magnus			Intra-aortic Balloon Counterpulsation and Infarct Size in Patients With Acute Anterior Myocardial Infarction Without Shock The CRISP AMI Randomized Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PERCUTANEOUS CORONARY INTERVENTION; CARDIAC MAGNETIC-RESONANCE; HIGH-RISK PATIENTS; PRIMARY ANGIOPLASTY; REPERFUSION; PEXELIZUMAB; MULTICENTER; PREDICTOR; CONTRAST; THERAPY	Context Intra-aortic balloon counterpulsation (IABC) is an adjunct to revascularization in patients with cardiogenic shock and reduces infarct size when placed prior to reperfusion in animal models. Objective To determine if routine IABC placement prior to reperfusion in patients with anterior ST-segment elevation myocardial infarction (STEMI) without shock reduces myocardial infarct size. Design, Setting, and Patients An open, multicenter, randomized controlled trial, the Counterpulsation to Reduce Infarct Size Pre-PCI Acute Myocardial Infarction (CRISP AMI) included 337 patients with acute anterior STEMI but without cardiogenic shock at 30 sites in 9 countries from June 2009 through February 2011. Intervention Initiation of IABC before primary percutaneous coronary intervention (PCI) and continuation for at least 12 hours (IABC plus PCI) vs primary PCI alone. Main Outcome Measures Infarct size expressed as a percentage of left ventricular (LV) mass and measured by cardiac magnetic resonance imaging performed 3 to 5 days after PCI. Secondary end points included all-cause death at 6 months and vascular complications and major bleeding at 30 days. Multiple imputations were performed for missing infarct size data. Results The median time from first contact to first coronary device was 77 minutes (interquartile range, 53 to 114 minutes) for the IABC plus PCI group vs 68 minutes (interquartile range, 40 to 100 minutes) for the PCI alone group (P=.04). The mean infarct size was not significantly different between the patients in the IABC plus PCI group and in the PCI alone group (42.1% [95% CI, 38.7% to 45.6%] vs 37.5% [95% CI, 34.3% to 40.8%], respectively; difference of 4.6% [95% CI, -0.2% to 9.4%], P=.06; imputed difference of 4.5% [95% CI, -0.3% to 9.3%], P=.07) and in patients with proximal left anterior descending Thrombolysis in Myocardial Infarction flow scores of 0 or 1 (46.7% [95% CI, 42.8% to 50.6%] vs 42.3% [95% CI, 38.6% to 45.9%], respectively; difference of 4.4% [95% CI, -1.0% to 9.7%], P=.11; imputed difference of 4.8% [95% CI, -0.6% to 10.1%], P=.08). At 30 days, there were no significant differences between the IABC plus PCI group and the PCI alone group for major vascular complications (n=7 [4.3%; 95% CI, 1.8% to 8.8%] vs n=2 [1.1%; 95% CI, 0.1% to 4.0%], respectively; P=.09) and major bleeding or transfusions (n=5 [3.1%; 95% CI, 1.0% to 7.1%] vs n=3 [1.7%; 95% CI, 0.4% to 4.9%]; P=.49). By 6 months, 3 patients (1.9%; 95% CI, 0.6% to 5.7%) in the IABC plus PCI group and 9 patients (5.2%; 95% CI, 2.7% to 9.7%) in the PCI alone group had died (P=.12). Conclusion Among patients with acute anterior STEMI without shock, IABC plus primary PCI compared with PCI alone did not result in reduced infarct size.	[Patel, Manesh R.; Ohman, E. Magnus] Duke Univ, Med Ctr, Duke Clin Res Inst, Div Cardiol,Dept Med, Durham, NC 27715 USA; [Barnhart, Huiman X.] Duke Univ, Med Ctr, Duke Clin Res Inst, Dept Biostat & Bioinformat, Durham, NC 27715 USA; [Zhou, Yi] Duke Univ, Med Ctr, Duke Clin Res Inst, Clin Trials Stat Grp, Durham, NC 27715 USA; [Smalling, Richard W.] Univ Texas Houston, Div Cardiol, Mem Hermann Heart & Vasc Inst, Houston, TX USA; [Thiele, Holger] Univ Leipzig, Ctr Heart, Dept Internal Med, Leipzig, Germany; [Thiele, Holger] Univ Leipzig, Ctr Heart, Dept Cardiol, Leipzig, Germany; [Chandra, Praveen] Medanta Medicity, Div Cardiol, Gurgaon, Haryana, India; [Chew, Derek] Flinders Med Ctr, Dept Cardiovasc Med, Bedford Pk, SA, Australia; [Cohen, Marc] Newark Beth Israel Med Ctr, Div Cardiol, Newark, NJ USA; [French, John] Liverpool Hosp, Dept Cardiol, Liverpool, Australia; [Perera, Divaka] Kings Coll London, Div Cardiovasc, London WC2R 2LS, England	Duke University; Duke University; Duke University; University of Texas System; University of Texas Health Science Center Houston; Heart Center Leipzig GMBH; Leipzig University; University of Hamburg; University Medical Center Hamburg-Eppendorf; Heart Center Leipzig GMBH; Leipzig University; University of Hamburg; University Medical Center Hamburg-Eppendorf; Flinders Medical Centre; Newark Beth Israel Medical Center; Liverpool Hospital; University of London; King's College London	Patel, MR (corresponding author), Duke Univ, Med Ctr, Duke Clin Res Inst, Div Cardiol,Dept Med, POB 17969, Durham, NC 27715 USA.	manesh.patel@duke.edu	Patel, Manesh/AAC-5385-2019; Thiele, Holger/ABE-6792-2020	Thiele, Holger/0000-0002-0169-998X; Chew, Derek/0000-0003-3593-296X; Perera, Divaka/0000-0001-6362-1291	Maquet; National Heart, Lung, and Blood Institute; AstraZeneca Australia; Eli Lilly; Abbott Vascular; Merck; Johnson Johnson; sanofi-aventis; Daiichi Sankyo; Eli Lilly Company	Maquet; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); AstraZeneca Australia(AstraZeneca); Eli Lilly(Eli Lilly); Abbott Vascular(Abbott Laboratories); Merck(Merck & Company); Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); sanofi-aventis(Sanofi-Aventis); Daiichi Sankyo(Daiichi Sankyo Company Limited); Eli Lilly Company(Eli Lilly)	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Patel reported that his institution has received grant funding and reimbursement for travel expenses from Maquet (formerly Datascope); that he has grants pending with the National Heart, Lung, and Blood Institute; that he is a board member for Genzyme; that he is a consultant for Bayer Healthcare and Ortho McNeil Jansen; and that he has received payment for lectures from the heart.org and the Duke Clinical Medicine Series. Dr Smalling reported that his institution has received grant funding and reimbursement for travel expenses from Maquet; and that he has received honoraria from Maquet. Dr Thiele reported that he has received honoraria and been reimbursed for travel expenses from Maquet. Dr Barnhart reported that her institution has received grant funding from Maquet. Dr Chew reported that his institution has received consulting fees from AstraZeneca Australia, Eli Lilly, and Abbott Vascular; and that he has received payment for lectures from AstraZeneca Australia. Dr Cohen reported that he has received fees for participating in review activities from Merck, Johnson & Johnson, and sanofi-aventis; that he is a board member for Johnson & Johnson, AstraZeneca, and sanofi-aventis; that he has provided expert testimony for Princeton Insurance; and that he has received payment for lectures from Merck, sanofi-aventis, and Bristol-Myers Squibb. Dr Perera reported that he has received payment for lectures and reimbursement for travel expenses from Maquet. Dr Ohman reported that his institution has received grant funding and reimbursement for travel expenses from Maquet; that he has grants pending with Daiichi Sankyo, Maquet, and Eli Lilly & Company; and that he is a consultant for AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Gilead Sciences, Liposcience, Merck, Pozen Inc, Roche, sanofi-aventis, The Medicines Company, and WebMD. No other disclosures were reported.	Achour H, 2005, CATHETER CARDIO INTE, V64, P182, DOI 10.1002/ccd.20271; Adams RJ, 2004, CIRCULATION, V110, P2512, DOI 10.1161/01.CIR.0000134791.68010.FA; Azevedo CF, 2005, EUR HEART J, V26, P1235, DOI 10.1093/eurheartj/ehi137; Bonnefoy E, 2009, EUR HEART J, V30, P1598, DOI 10.1093/eurheartj/ehp156; Brodie BR, 1999, AM J CARDIOL, V84, P18, DOI 10.1016/S0002-9149(99)00185-X; Cohen M, 2003, EUR HEART J, V24, P1763, DOI 10.1016/j.ehj.2003.07.002; Eitel I, 2010, J AM COLL CARDIOL, V55, P2470, DOI 10.1016/j.jacc.2010.01.049; Ezekowitz JA, 2010, AM HEART J, V160, P272, DOI 10.1016/j.ahj.2010.05.035; Flynn A, 2010, ARCH INTERN MED, V170, P1842, DOI 10.1001/archinternmed.2010.381; Francone M, 2009, J AM COLL CARDIOL, V54, P2145, DOI 10.1016/j.jacc.2009.08.024; Hochman JS, 2001, JAMA-J AM MED ASSOC, V285, P190, DOI 10.1001/jama.285.2.190; Ito H, 1996, CIRCULATION, V93, P223, DOI 10.1161/01.CIR.93.2.223; Keeley EC, 2003, LANCET, V361, P13, DOI 10.1016/S0140-6736(03)12113-7; KERN MJ, 1993, CIRCULATION, V87, P500, DOI 10.1161/01.CIR.87.2.500; Kim RJ, 2008, CIRCULATION, V117, P629, DOI 10.1161/CIRCULATIONAHA.107.723262; LeDoux JF, 2008, CATHETER CARDIO INTE, V72, P513, DOI 10.1002/ccd.21698; Lloyd-Jones D, 2009, CIRCULATION, V119, pE21, DOI 10.1161/CIRCULATIONAHA.108.191261; O'Neill WW, 2007, J AM COLL CARDIOL, V50, P397, DOI 10.1016/j.jacc.2007.01.099; Patel MR, 2011, AM HEART J, V162, P47, DOI 10.1016/j.ahj.2011.03.037; Patel MR, 2010, JACC-CARDIOVASC IMAG, V3, P52, DOI 10.1016/j.jcmg.2009.09.014; PATEL MR, 2011, AM HEART J, V162, pE1; Perera D, 2010, JAMA-J AM MED ASSOC, V304, P867, DOI 10.1001/jama.2010.1190; Rezkalla SH, 2002, CIRCULATION, V105, P656, DOI 10.1161/hc0502.102867; Sanborn TA, 2000, J AM COLL CARDIOL, V36, P1123, DOI 10.1016/S0735-1097(00)00875-5; Stone GW, 2007, AM J CARDIOL, V100, P1370, DOI 10.1016/j.amjcard.2007.06.027; Stone GW, 1997, J AM COLL CARDIOL, V29, P1459, DOI 10.1016/S0735-1097(97)00088-0; Thiele H, 2006, J AM COLL CARDIOL, V47, P1641, DOI 10.1016/j.jacc.2005.11.065; Thiele H, 2008, CIRCULATION, V118, P49, DOI 10.1161/CIRCULATIONAHA.107.747642; Wang TY, 2009, ARCH INTERN MED, V169, P1411, DOI 10.1001/archinternmed.2009.223; WILLIAMS DO, 1982, CIRCULATION, V66, P593, DOI 10.1161/01.CIR.66.3.593; Wu E, 2008, HEART, V94, P730, DOI 10.1136/hrt.2007.122622	31	267	293	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 28	2011	306	12					1329	1337		10.1001/jama.2011.1280	http://dx.doi.org/10.1001/jama.2011.1280			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	825FQ	21878431	Bronze			2022-12-28	WOS:000295257000021
J	Kocot, KM; Cannon, JT; Todt, C; Citarella, MR; Kohn, AB; Meyer, A; Santos, SR; Schander, C; Moroz, LL; Lieb, B; Halanych, KM				Kocot, Kevin M.; Cannon, Johanna T.; Todt, Christiane; Citarella, Mathew R.; Kohn, Andrea B.; Meyer, Achim; Santos, Scott R.; Schander, Christoffer; Moroz, Leonid L.; Lieb, Bernhard; Halanych, Kenneth M.			Phylogenomics reveals deep molluscan relationships	NATURE			English	Article							RIBOSOMAL-RNA SEQUENCES; APLACOPHORA; ORIGIN; SOLENOGASTRES; SPICULES; DATABASE; RADULA; MODEL; TREE; TOOL	Evolutionary relationships among the eight major lineages of Mollusca have remained unresolved despite their diversity and importance. Previous investigations of molluscan phylogeny, based primarily on nuclear ribosomal gene sequences(1-3) or morphological data(4), have been unsuccessful at elucidating these relationships. Recently, phylogenomic studies using dozens to hundreds of genes have greatly improved our understanding of deep animal relationships(5). However, limited genomic resources spanning molluscan diversity has prevented use of a phylogenomic approach. Here we use transcriptome and genome data from all major lineages (except Monoplacophora) and recover a well-supported topology for Mollusca. Our results strongly support the Aculifera hypothesis placing Polyplacophora (chitons) in a clade with a monophyletic Aplacophora (worm-like molluscs). Additionally, within Conchifera, a sister-taxon relationship between Gastropoda and Bivalvia is supported. This grouping has received little consideration and contains most (>95%) molluscan species. Thus we propose the node-based name Pleistomollusca. In light of these results, we examined the evolution of morphological characters and found support for advanced cephalization and shells as possibly having multiple origins within Mollusca.	[Kocot, Kevin M.; Cannon, Johanna T.; Santos, Scott R.; Halanych, Kenneth M.] Auburn Univ, Dept Biol Sci, Auburn, AL 36849 USA; [Todt, Christiane; Schander, Christoffer] Univ Bergen, Dept Biol, NO-5020 Bergen, Norway; [Todt, Christiane; Schander, Christoffer] Univ Bergen, Ctr Geobiol, NO-5020 Bergen, Norway; [Citarella, Mathew R.; Kohn, Andrea B.; Moroz, Leonid L.] Univ Florida, Whitney Lab Marine Biosci, St Augustine, FL 32080 USA; [Meyer, Achim; Lieb, Bernhard] Johannes Gutenberg Univ Mainz, Inst Zool, D-55099 Mainz, Germany; [Moroz, Leonid L.] Univ Florida, Dept Neurosci, Gainesville, FL 32611 USA	Auburn University System; Auburn University; University of Bergen; University of Bergen; State University System of Florida; University of Florida; Johannes Gutenberg University of Mainz; State University System of Florida; University of Florida	Kocot, KM (corresponding author), Auburn Univ, Dept Biol Sci, 101 Rouse Life Sci, Auburn, AL 36849 USA.	kmkocot@auburn.edu; ken@auburn.edu	Lieb, Bernhard/AFT-2157-2022; Meyer, Achim/AAE-9061-2021; Halanych, Ken M/A-9480-2009; Cannon, Johanna/V-3842-2019; Santos, Scott R/A-7472-2009	Halanych, Ken M/0000-0002-8658-9674; Cannon, Johanna/0000-0002-3920-7741; Moroz, Leonid/0000-0002-1333-3176; Meyer, Achim/0000-0002-4345-274X	National Science Foundation (NSF) [0744649, 0821622]; National Institute of Health (NIH) [1RO1NS06076, 1R01GM097502, R21 RR025699, R21DA030118]; McKnight Brain Research Foundation; German Science Foundation [Li 998/9-1]; University of Bergen (Norway) [226270]; NATIONAL CENTER FOR RESEARCH RESOURCES [R21RR025699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097502] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039103] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA030118] Funding Source: NIH RePORTER	National Science Foundation (NSF)(National Science Foundation (NSF)); National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McKnight Brain Research Foundation; German Science Foundation(German Research Foundation (DFG)); University of Bergen (Norway); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank W. Jones and K. T. Fielman for help with cDNA library preparation, R. M. Jennings, N. Mikkelsen, and the crews of the RV Hakon Mosby, RV Hans Brattstrom and RV Laurence M. Gould for assistance collecting aplacophorans, and J. C. Havird, P. J. Krug, S. C. Kempf, D. R. Lindberg, M. V. Matz, L. R. Page and T. H. Struck for discussions. D. Speiser kindly shared the photo of Argopecten. F. W. Goetz, A. Gracey and M. L. Blaxter kindly provided sequence quality data for Dreissena rostriformis, Mytilus californianus and Lumbricus rubellus, respectively. We thank A. Di Cosmo, P. Burbach, V. Rehder, W. Wright and R. Gillette for providing samples of Octopus, Loligo, Helisoma, Dolabrifera and Pleurobranchaea as well as sharing some sequencing cost for these species. We also thank D. Young and the Alabama Supercomputer Authority for access to computational resources. The genomes of Capitella teleta, Helobdella robusta, Lottia gigantea and Nematostella vectensis were produced by the US Department of Energy Joint Genome Institute in collaboration with the user community. This work was supported by National Science Foundation (NSF) grants (0744649 and 0821622) to K. M. H., National Institute of Health (NIH) grants (1RO1NS06076, 1R01GM097502, R21 RR025699, R21DA030118) and the McKnight Brain Research Foundation to L. L. M., the Deep Metazoan Phylogeny (DMP) program of the German Science Foundation (Li 998/9-1) to B. L., and The University of Bergen (Norway) free researcher initiated project grant to C. T. (project no. 226270). This work represents contributions 82 and 4 to the Auburn University (AU) Marine Biology Program and Molette Biology Laboratory for Environmental and Climate Change Studies, respectively.	Caron JB, 2006, NATURE, V442, P159, DOI 10.1038/nature04894; Chou HH, 2001, BIOINFORMATICS, V17, P1093, DOI 10.1093/bioinformatics/17.12.1093; Dunn CW, 2008, NATURE, V452, P745, DOI 10.1038/nature06614; Ebersberger I, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-157; Forment J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-5; Giribet G, 2006, P NATL ACAD SCI USA, V103, P7723, DOI 10.1073/pnas.0602578103; Haszprunar G, 2000, AM MALACOL BULL, V15, P115; Haszprunar Gerhard, 2008, P19; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Jorger KM, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-323; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Lartillot N, 2004, MOL BIOL EVOL, V21, P1095, DOI 10.1093/molbev/msh112; Lottaz C, 2003, BIOINFORMATICS, V19, pII103, DOI 10.1093/bioinformatics/btg1067; Lundin K, 2009, J MOLLUS STUD, V75, P69, DOI 10.1093/mollus/eyn042; Meyer A, 2011, METHODS ECOL EVOL, V2, P34, DOI 10.1111/j.2041-210X.2010.00052.x; Meyer A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-70; Misof B., 2009, SYST BIOL; Moroz LL, 2009, BRAIN BEHAV EVOLUT, V74, P177, DOI 10.1159/000258665; Nielsen C, 2007, ACTA ZOOL-STOCKHOLM, V88, P231, DOI 10.1111/j.1463-6395.2007.00270.x; O'Brien KP, 2005, NUCLEIC ACIDS RES, V33, pD476, DOI 10.1093/nar/gki107; Okusu A, 2003, J MOLLUS STUD, V69, P385, DOI 10.1093/mollus/69.4.385; Passamaneck YJ, 2004, MOL PHYLOGENET EVOL, V32, P25, DOI 10.1016/j.ympev.2003.12.016; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Roure B, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-S1-S2; SCHELTEMA AH, 1993, BIOL BULL, V184, P57, DOI 10.2307/1542380; Scheltema AH, 2003, J MORPHOL, V257, P219, DOI 10.1002/jmor.10121; Scheltema AH, 2002, INVERTEBR BIOL, V121, P1; Scheltema Amelie H., 2006, Venus (Tokyo), V65, P19; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Sigwart JD, 2007, P R SOC B, V274, P2413, DOI 10.1098/rspb.2007.0701; Simone L. R. L, 2000, THESIS U SAO PAULO, V164; Smith SA, 2008, BIOINFORMATICS, V24, P715, DOI 10.1093/bioinformatics/btm619; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Struck TH, 2011, NATURE, V471, P95, DOI 10.1038/nature09864; Todt C., 2008, PHYLOGENY EVOLUTION, P105; Todt C, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-6; von Salvini-Plawen Luitfried, 2003, Iberus, V21, P67; Wanninger A, 2002, J MORPHOL, V254, P53, DOI 10.1002/jmor.10004; Wilson NG, 2010, MOL PHYLOGENET EVOL, V54, P187, DOI 10.1016/j.ympev.2009.07.028	39	355	362	6	205	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 22	2011	477	7365					452	U101		10.1038/nature10382	http://dx.doi.org/10.1038/nature10382			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822WH	21892190	Green Accepted			2022-12-28	WOS:000295080500038
J	Mutreja, A; Kim, DW; Thomson, NR; Connor, TR; Lee, JH; Kariuki, S; Croucher, NJ; Choi, SY; Harris, SR; Lebens, M; Niyogi, SK; Kim, EJ; Ramamurthy, T; Chun, J; Wood, JLN; Clemens, JD; Czerkinsky, C; Nair, GB; Holmgren, J; Parkhill, J; Dougan, G				Mutreja, Ankur; Kim, Dong Wook; Thomson, Nicholas R.; Connor, Thomas R.; Lee, Je Hee; Kariuki, Samuel; Croucher, Nicholas J.; Choi, Seon Young; Harris, Simon R.; Lebens, Michael; Niyogi, Swapan Kumar; Kim, Eun Jin; Ramamurthy, T.; Chun, Jongsik; Wood, James L. N.; Clemens, John D.; Czerkinsky, Cecil; Nair, G. Balakrish; Holmgren, Jan; Parkhill, Julian; Dougan, Gordon			Evidence for several waves of global transmission in the seventh cholera pandemic	NATURE			English	Article							VIBRIO-CHOLERAE; EL-TOR; EVOLUTION; POPULATIONS; SEQUENCES; VIETNAM; STRAINS; ELEMENT; O139	Vibrio cholerae is a globally important pathogen that is endemic in many areas of the world and causes 3-5 million reported cases of cholera every year. Historically, there have been seven acknowledged cholera pandemics; recent outbreaks in Zimbabwe and Haiti are included in the seventh and ongoing pandemic(1). Only isolates in serogroup O1 (consisting of two biotypes known as 'classical' and 'El Tor') and the derivative O139 (refs 2, 3) can cause epidemic cholera(2). It is believed that the first six cholera pandemics were caused by the classical biotype, but El Tor has subsequently spread globally and replaced the classical biotype in the current pandemic(1). Detailed molecular epidemiological mapping of cholera has been compromised by a reliance on sub-genomic regions such as mobile elements to infer relationships, making El Tor isolates associated with the seventh pandemic seem superficially diverse. To understand the underlying phylogeny of the lineage responsible for the current pandemic, we identified high-resolution markers (single nucleotide polymorphisms; SNPs) in 154 whole-genome sequences of globally and temporally representative V. cholerae isolates. Using this phylogeny, we show here that the seventh pandemic has spread from the Bay of Bengal in at least three independent but overlapping waves with a common ancestor in the 1950s, and identify several transcontinental transmission events. Additionally, we show how the acquisition of the SXT family of antibiotic resistance elements has shaped pandemic spread, and show that this family was first acquired at least ten years before its discovery in V. cholerae.	[Mutreja, Ankur; Thomson, Nicholas R.; Connor, Thomas R.; Croucher, Nicholas J.; Harris, Simon R.; Parkhill, Julian; Dougan, Gordon] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Kim, Dong Wook; Lee, Je Hee; Choi, Seon Young; Kim, Eun Jin; Clemens, John D.; Czerkinsky, Cecil] SNU Res Pk, Int Vaccine Inst, Seoul 151919, South Korea; [Kim, Dong Wook] Hanyang Univ, Coll Pharm, Dept Pharm, Kyeonggi Do 426791, South Korea; [Lee, Je Hee; Choi, Seon Young; Chun, Jongsik] Seoul Natl Univ, Seoul 151742, South Korea; [Kariuki, Samuel] KEMRI Kenyatta Hosp Compound, Ctr Microbiol Res, Nairobi, Kenya; [Lebens, Michael; Holmgren, Jan] Univ Gothenburg, Sahlgrenska Acad, Dept Microbiol & Immunol, S-40530 Gothenburg, Sweden; [Lebens, Michael; Holmgren, Jan] Univ Gothenburg, Sahlgrenska Acad, Vaccine Res Inst, S-40530 Gothenburg, Sweden; [Niyogi, Swapan Kumar; Ramamurthy, T.; Nair, G. Balakrish] Natl Inst Cholera & Enter Dis, Kolkata 700010, India; [Wood, James L. N.] Univ Cambridge, Dept Vet Med, Cambridge CB3 0ES, England	Wellcome Trust Sanger Institute; International Vaccine Institute; Seoul National University (SNU); Hanyang University; Seoul National University (SNU); University of Gothenburg; University of Gothenburg; Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED); University of Cambridge	Parkhill, J (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge CB10 1SA, England.	parkhill@sanger.ac.uk	Wood, James/A-1626-2008; Chun, Jongsik/R-8458-2017; CZERKINSKY, CECIL/G-6520-2015; Parkhill, Julian/G-4703-2011; Connor, Thomas/ABD-6533-2021; Weinstock, George M/C-6314-2013; Harris, Simon R/K-1318-2013; Connor, Thomas/ABE-5989-2020; Kim, Dong Wook/H-8253-2015; Thomson, Nicholas/P-5988-2014	Wood, James/0000-0002-0258-3188; Chun, Jongsik/0000-0003-3385-5171; Parkhill, Julian/0000-0002-7069-5958; Weinstock, George M/0000-0002-2997-4592; Harris, Simon R/0000-0003-1512-6194; Connor, Thomas/0000-0003-2394-6504; Kim, Dong Wook/0000-0001-5351-7597; Lee, Jehee/0000-0001-9144-3648; Croucher, Nicholas/0000-0001-6303-8768; Holmgren, Jan/0000-0003-1784-5918; Lebens, Michael/0000-0001-9458-9474; Thomson, Nicholas/0000-0002-4432-8505	Wellcome Trust [076964]; Government of Korea; Government of Sweden; Government of Kuwait; Ministry of Knowledge and Economy (MKE), Korea [RTI05-01-01]; Korea Science and Engineering Foundation [R01-2006-000-10255-0]; Alborada Trust; Science & Technology Directorate, Department of Homeland Security	Wellcome Trust(Wellcome Trust); Government of Korea(Korean Government); Government of Sweden; Government of Kuwait; Ministry of Knowledge and Economy (MKE), Korea(Ministry of Trade, Industry & Energy (MOTIE), Republic of Korea); Korea Science and Engineering Foundation(Korea Science and Engineering Foundation); Alborada Trust; Science & Technology Directorate, Department of Homeland Security(United States Department of Homeland Security (DHS))	This work was supported by The Wellcome Trust grant 076964. The IVI is supported by the Governments of Korea, Sweden and Kuwait. D. W. K. was partially supported by grant RTI05-01-01 from the Ministry of Knowledge and Economy (MKE), Korea and by R01-2006-000-10255-0 from the Korea Science and Engineering Foundation; and J.L.N.W. was supported by the Alborada Trust and the RAPIDD program of the Science & Technology Directorate, Department of Homeland Security. Thanks to A. Camilli at Tufts University Medical School for providing the corrected N16961 sequence, to B. M. Nguyen at NIHE, Vietnam and M. Ansaruzzaman at ICDDR, Bangladesh for providing strains, and to M. Fookes at WTSI for training support.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; [Anonymous], 2010, MMWR MORB MORTAL WKL, V59, P1473; Assefa S, 2009, BIOINFORMATICS, V25, P1968, DOI 10.1093/bioinformatics/btp347; Bani S, 2007, FEMS MICROBIOL LETT, V266, P42, DOI 10.1111/j.1574-6968.2006.00518.x; Basu A, 2000, EMERG INFECT DIS, V6, P139, DOI 10.3201/eid0602.000206; Binh MN, 2009, J CLIN MICROBIOL, V47, P1568, DOI 10.1128/JCM.02040-08; Carver T, 2008, BIOINFORMATICS, V24, P2672, DOI 10.1093/bioinformatics/btn529; Chin CS, 2011, NEW ENGL J MED, V364, P33, DOI 10.1056/NEJMoa1012928; Chun J, 2009, P NATL ACAD SCI USA, V106, P15442, DOI 10.1073/pnas.0907787106; Corander J, 2003, GENETICS, V163, P367; Corander J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-539; Croucher NJ, 2011, SCIENCE, V331, P430, DOI 10.1126/science.1198545; CVJETANOVIC B, 1972, NATURE, V239, P137, DOI 10.1038/239137a0; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Faruque SM, 2003, TRENDS MICROBIOL, V11, P505, DOI 10.1016/j.tim.2003.09.003; Faruque SM, 2000, J INFECT DIS, V182, P1161, DOI 10.1086/315807; Garriss G, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000775; Harris SR, 2010, SCIENCE, V327, P469, DOI 10.1126/science.1182395; Heidelberg JF, 2000, NATURE, V406, P477, DOI 10.1038/35020000; Hochhut B, 1999, MOL MICROBIOL, V32, P99, DOI 10.1046/j.1365-2958.1999.01330.x; Lam C, 2010, EMERG INFECT DIS, V16, P1130, DOI 10.3201/eid1607.100131; Lee JH, 2009, J MICROBIOL, V47, P783, DOI 10.1007/s12275-009-0292-6; Nair G B, 1994, Indian J Public Health, V38, P33; O'Shea YA, 2004, MICROBIOL-SGM, V150, P4053, DOI 10.1099/mic.0.27172-0; Safa A, 2010, TRENDS MICROBIOL, V18, P46, DOI 10.1016/j.tim.2009.10.003; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Wozniak RAF, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000786; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	29	446	462	3	128	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 22	2011	477	7365					462	U111		10.1038/nature10392	http://dx.doi.org/10.1038/nature10392			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822WH	21866102	Green Accepted			2022-12-28	WOS:000295080500040
J	Austad, KE; Kesselheim, AS				Austad, Kirsten E.; Kesselheim, Aaron S.			Conflict of Interest Disclosure in Early Education of Medical Students	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Austad, Kirsten E.; Kesselheim, Aaron S.] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02120 USA; [Austad, Kirsten E.] Harvard Univ, Edmond J Safra Ctr Eth, Cambridge, MA 02138 USA; [Austad, Kirsten E.; Kesselheim, Aaron S.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard University; Harvard Medical School	Austad, KE (corresponding author), Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, 1620 Tremont St,Ste 3030, Boston, MA 02120 USA.	kirsten_austad@hms.harvard.edu	Austad, Kirsten/ABC-7684-2021; Kesselheim, Aaron/R-6793-2017	Kesselheim, Aaron/0000-0002-8867-2666; Austad, Kirsten/0000-0001-5237-2955				Accreditation Council for Continuing Medical Education, 2007, ACCME STAND COMM SUP; American Medical Student Association, AMSA PHARMFREE SCOR; Austad KE, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001037; Chimonas S, 2011, ARCH INTERN MED, V171, P81, DOI 10.1001/archinternmed.2010.341; Drazen JM, 2010, JAMA-J AM MED ASSOC, V303, P75, DOI 10.1001/jama.2009.1542; HAFFERTY FW, 1994, ACAD MED, V69, P861, DOI 10.1097/00001888-199411000-00001; Korn D, 2008, SCI BASIS INFLUENCE; Lo B, 2009, CONFLICT INTEREST ME; University of Miami Miller School of Medicine, FAC COMP OUTS PROF A; Zipkin DA, 2005, J GEN INTERN MED, V20, P777, DOI 10.1111/j.1525-1497.2005.0134.x	10	16	17	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 7	2011	306	9					991	992		10.1001/jama.2011.1233	http://dx.doi.org/10.1001/jama.2011.1233			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	815QT	21900140				2022-12-28	WOS:000294542600018
J	Barzansky, B; Etzel, SI				Barzansky, Barbara; Etzel, Sylvia I.			Medical Schools in the United States, 2010-2011	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Barzansky, Barbara] Amer Med Assoc, Div Undergrad Med Educ, Chicago, IL 60654 USA; Amer Med Assoc, Div Grad Med Educ, Chicago, IL 60654 USA	American Medical Association; American Medical Association	Barzansky, B (corresponding author), Amer Med Assoc, Div Undergrad Med Educ, 515 N State St, Chicago, IL 60654 USA.	barbara.barzansky@ama-assn.org							0	18	18	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 7	2011	306	9					1007	1014		10.1001/jama.2011.1220	http://dx.doi.org/10.1001/jama.2011.1220			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	815QT	21900145				2022-12-28	WOS:000294542600023
J	McKee, CF				McKee, Christopher F.			Let There Be Dust	SCIENCE			English	Editorial Material							INTERSTELLAR-MEDIUM; SUPERNOVA REMNANT; DESTRUCTION; CASSIOPEIA; EVOLUTION; UNIVERSE; SHOCKS; GALAXY		[McKee, Christopher F.] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [McKee, Christopher F.] Univ Calif Berkeley, Dept Astron, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	McKee, CF (corresponding author), Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA.	cmckee@berkeley.edu						Barlow MJ, 2010, ASTRON ASTROPHYS, V518, DOI 10.1051/0004-6361/201014585; BARLOW MJ, 1977, ASTROPHYS J, V211, pL83, DOI 10.1086/182346; Diehl R, 2006, NATURE, V439, P45, DOI 10.1038/nature04364; Draine BT, 2009, ASTR SOC P, V414, P453; Draine B.T., 2011, PHYS INTERSTELLAR IN; DRAINE BT, 1979, ASTROPHYS J, V231, P438, DOI 10.1086/157206; DWEK E, 1980, ASTROPHYS J, V239, P193, DOI 10.1086/158100; Dwek E, 2007, ASTROPHYS J, V662, P927, DOI 10.1086/518430; Ercolano B, 2007, MON NOT R ASTRON SOC, V375, P753, DOI 10.1111/j.1365-2966.2006.11336.x; JONES AP, 1994, ASTROPHYS J, V433, P797, DOI 10.1086/174689; Matsuura M, 2011, SCIENCE, V333, P1258, DOI 10.1126/science.1205983; McKee C. F., 1989, ASP C SERIES, V135, P431; Sibthorpe B, 2010, ASTROPHYS J, V719, P1553, DOI 10.1088/0004-637X/719/2/1553; Tacconi LJ, 2010, NATURE, V463, P781, DOI 10.1038/nature08773	14	3	3	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 2	2011	333	6047					1227	1228		10.1126/science.1208381	http://dx.doi.org/10.1126/science.1208381			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	813YM	21885761				2022-12-28	WOS:000294406400029
J	Xie, Z; Wroblewska, L; Prochazka, L; Weiss, R; Benenson, Y				Xie, Zhen; Wroblewska, Liliana; Prochazka, Laura; Weiss, Ron; Benenson, Yaakov			Multi-Input RNAi-Based Logic Circuit for Identification of Specific Cancer Cells	SCIENCE			English	Article							MAMMALIAN-CELLS; GENE-EXPRESSION; MICRORNA EXPRESSION; PROTEINS; NETWORK; TISSUE; SWITCH	Engineered biological systems that integrate multi-input sensing, sophisticated information processing, and precisely regulated actuation in living cells could be useful in a variety of applications. For example, anticancer therapies could be engineered to detect and respond to complex cellular conditions in individual cells with high specificity. Here, we show a scalable transcriptional/posttranscriptional synthetic regulatory circuit-a cell-type "classifier"-that senses expression levels of a customizable set of endogenous microRNAs and triggers a cellular response only if the expression levels match a predetermined profile of interest. We demonstrate that a HeLa cancer cell classifier selectively identifies HeLa cells and triggers apoptosis without affecting non-HeLa cell types. This approach also provides a general platform for programmed responses to other complex cell states.	[Xie, Zhen; Wroblewska, Liliana; Weiss, Ron] MIT, Dept Biol Engn, Cambridge, MA 02142 USA; [Xie, Zhen; Benenson, Yaakov] Harvard Univ, Fac Arts & Sci FAS, Ctr Syst Biol, Cambridge, MA 02138 USA; [Prochazka, Laura; Benenson, Yaakov] ETH, Dept Biosyst Sci & Engn, CH-4058 Basel, Switzerland; [Weiss, Ron] MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Harvard University; Swiss Federal Institutes of Technology Domain; ETH Zurich; Massachusetts Institute of Technology (MIT)	Weiss, R (corresponding author), MIT, Dept Biol Engn, 40 Ames St, Cambridge, MA 02142 USA.	rweiss@mit.edu; kobi.benenson@bsse.ethz.ch	Taylor, Graham/A-4027-2012; Benenson, Yaakov/B-1433-2009; Xie, Zhen/GPW-5925-2022		Bauer Fellows program; National Institute of General Medical Sciences [GM068763]; U.S. Army [W81XWH-09-1-0240 BC085163]; National Cancer Institute [1R01CA155320-01]; ETH Zurich; NATIONAL CANCER INSTITUTE [R01CA155320] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM068763] Funding Source: NIH RePORTER	Bauer Fellows program; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); U.S. Army(United States Department of DefenseUnited States Army); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ETH Zurich(ETH Zurich); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Leisner, J. Lohmueller, L. Bleris, and the members of FAS Center for Systems Biology for discussions; G. Winer for critical reading of the manuscript; and M. Leisner for CAGop-ZsYellow plasmid. We thank B. Tilton, P. Rogers, and G. Paradis for assistance with flow cytometry. The research was funded by the Bauer Fellows program, the National Institute of General Medical Sciences grant GM068763 for National Centers of Systems Biology, U.S. Army Congressionally Directed Medical Research Programs grant W81XWH-09-1-0240 BC085163, National Cancer Institute grant 1R01CA155320-01, and ETH Zurich core funding. Y.B., Z.X., and R. W. conceived of the ideas implemented in this study. Z.X. performed most of the experiments and data analysis. L. W. constructed stable, cell lines and performed experiments with MCF-7 cells and initial testing of the hBax protein and the 2A linker. L. P. performed experiments and data analysis in HEK293, HeLa, and T47D cells. Y.B. and R. W. supervised the project and performed data analysis. Y.B., Z.X., and R. W. wrote the paper. Raw and processed data are stored on our laboratory servers and are available upon request. A U.S. patent concerning the technology described in this paper has been filed by Harvard University and MIT entitled "Multiple Input Biologic Classifier Circuits for Cells."	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Basu S, 2005, NATURE, V434, P1130, DOI 10.1038/nature03461; Benenson Y, 2004, NATURE, V429, P423, DOI 10.1038/nature02551; Brown BD, 2007, NAT BIOTECHNOL, V25, P1457, DOI 10.1038/nbt1372; Culler SJ, 2010, SCIENCE, V330, P1251, DOI 10.1126/science.1192128; Danino T, 2010, NATURE, V463, P326, DOI 10.1038/nature08753; Deans TL, 2007, CELL, V130, P363, DOI 10.1016/j.cell.2007.05.045; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Friedland AE, 2009, SCIENCE, V324, P1199, DOI 10.1126/science.1172005; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Greber D, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn443; Green JJ, 2008, ACCOUNTS CHEM RES, V41, P749, DOI 10.1021/ar7002336; Hooshangi S, 2005, P NATL ACAD SCI USA, V102, P3581, DOI 10.1073/pnas.0408507102; Hornstein E, 2006, NAT GENET, V38, pS20, DOI 10.1038/ng1803; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lee CYF, 2009, CLIN CANCER RES, V15, P5126, DOI 10.1158/1078-0432.CCR-09-0051; Leisner M, 2010, NAT NANOTECHNOL, V5, P666, DOI [10.1038/NNANO.2010.135, 10.1038/nnano.2010.135]; Lowe SL, 2001, GENE THER, V8, P1363, DOI 10.1038/sj.gt.3301531; Mangan S, 2003, P NATL ACAD SCI USA, V100, P11980, DOI 10.1073/pnas.2133841100; Mansfield JH, 2004, NAT GENET, V36, P1079, DOI 10.1038/ng1421; Martin VJJ, 2003, NAT BIOTECHNOL, V21, P796, DOI 10.1038/nbt833; Miyagishi M, 2003, ANTISENSE NUCLEIC A, V13, P1, DOI 10.1089/108729003764097296; Peter ME, 2010, ONCOGENE, V29, P2161, DOI 10.1038/onc.2010.59; Re A, 2009, MOL BIOSYST, V5, P854, DOI 10.1039/b900177h; Rinaudo K, 2007, NAT BIOTECHNOL, V25, P795, DOI 10.1038/nbt1307; Shapiro E, 2006, SCI AM, V294, P44, DOI 10.1038/scientificamerican0506-44; Venkataraman S, 2010, P NATL ACAD SCI USA, V107, P16777, DOI 10.1073/pnas.1006377107; Win MN, 2008, SCIENCE, V322, P456, DOI 10.1126/science.1160311; Wu CX, 2009, MOL THER, V17, P2058, DOI 10.1038/mt.2009.225	29	508	545	3	202	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 2	2011	333	6047					1307	1311		10.1126/science.1205527	http://dx.doi.org/10.1126/science.1205527			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	813YM	21885784				2022-12-28	WOS:000294406400059
J	Sinha, SR; Barry, M				Sinha, Sidhartha R.; Barry, Michele			Health Technologies and Innovation in the Global Health Arena	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Sinha, Sidhartha R.] Stanford Univ, Biodesign Program, Stanford, CA 94305 USA; [Sinha, Sidhartha R.] Stanford Univ, Div Gastroenterol & Hepatol, Stanford, CA 94305 USA; [Sinha, Sidhartha R.; Barry, Michele] Stanford Univ, Dept Med, Stanford, CA 94305 USA; [Barry, Michele] Stanford Univ, Ctr Innovat Global Hlth, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University	Sinha, SR (corresponding author), Stanford Univ, Biodesign Program, Stanford, CA 94305 USA.							Deloitte, 2010, MED TECHN IND IND RI; Institute of Medicine, 2011, MED DEV PUBL HLTH FD; WHO, 2011, COMP NEW EM HLTH TEC; WHO, 2011, 1 WHO GLOB FOR MED D	4	37	38	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 1	2011	365	9					779	782		10.1056/NEJMp1108040	http://dx.doi.org/10.1056/NEJMp1108040			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	813YC	21879894				2022-12-28	WOS:000294405200002
J	Park, HS; Hohn, MJ; Umehara, T; Guo, LT; Osborne, EM; Benner, J; Noren, CJ; Rinehart, J; Soll, D				Park, Hee-Sung; Hohn, Michael J.; Umehara, Takuya; Guo, Li-Tao; Osborne, Edith M.; Benner, Jack; Noren, Christopher J.; Rinehart, Jesse; Soell, Dieter			Expanding the Genetic Code of Escherichia coli with Phosphoserine	SCIENCE			English	Article							ELONGATION-FACTOR TU; DEPENDENT CYSTEINE BIOSYNTHESIS; AMINOACYL-TRANSFER-RNAS; CRYSTAL-STRUCTURE; IN-VIVO; EF-TU; ACID; PHOSPHOPROTEINS; DYNAMICS; AFFINITY	O-Phosphoserine (Sep), the most abundant phosphoamino acid in the eukaryotic phosphoproteome, is not encoded in the genetic code, but synthesized posttranslationally. Here, we present an engineered system for specific cotranslational Sep incorporation (directed by UAG) into any desired position in a protein by an Escherichia coli strain that harbors a Sep-accepting transfer RNA (tRNA(Sep)), its cognate Sep-tRNA synthetase (SepRS), and an engineered EF-Tu (EF-Sep). Expanding the genetic code rested on reengineering EF-Tu to relax its quality-control function and permit Sep-tRNA(Sep) binding. To test our system, we synthesized the activated form of human mitogen-activated ERK activating kinase 1 (MEK1) with either one or two Sep residues cotranslationally inserted in their canonical positions (Sep(218), Sep(222)). This system has general utility in protein engineering, molecular biology, and disease research.	[Osborne, Edith M.; Benner, Jack; Noren, Christopher J.] New England Biolabs Inc, Ipswich, MA 01938 USA; [Park, Hee-Sung; Hohn, Michael J.; Umehara, Takuya; Guo, Li-Tao; Soell, Dieter] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Rinehart, Jesse] Yale Univ, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA; [Rinehart, Jesse] Yale Univ, Syst Biol Inst, West Haven, CT 06516 USA; [Soell, Dieter] Yale Univ, Dept Chem, New Haven, CT 06520 USA	New England Biolabs; Yale University; Yale University; Yale University; Yale University	Noren, CJ (corresponding author), New England Biolabs Inc, Ipswich, MA 01938 USA.	noren@neb.com; jesse.rinehart@yale.edu; dieter.soll@yale.edu	Guo, Li-Tao/C-3126-2014		NSF [MCB-0645283, MCB-0950474]; National Institute of General Medical Sciences [GM 22854]; National Research Foundation of Korea [ABC-20100029737]; National Institute of Diabetes and Digestive and Kidney Diseases [K01DK089006]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK089006] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM022854, R01GM022854] Funding Source: NIH RePORTER; Direct For Biological Sciences [0950474] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Research Foundation of Korea(National Research Foundation of Korea); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank P. Dennis, P. O'Donoghue, and J. Ling for enthusiastic discussions. M.J.H. was a Feodor Lynen Postdoctoral Fellow of the Alexander von Humboldt Foundation (Bonn, Germany). H.-S.P. held a postdoctoral fellowship of the Korean Science Foundation. This work was supported by grants from NSF (MCB-0645283 and MCB-0950474) (to D.S.), National Institute of General Medical Sciences (GM 22854) (to D.S.), National Research Foundation of Korea (ABC-20100029737) (to H.-S.P.), and National Institute of Diabetes and Digestive and Kidney Diseases (K01DK089006) (to J.R.). Yale University holds the U.S. Patent 7,723,069 B2: "Site Specific Incorporation of Phosphoserine into Polypeptides Using Phosphoseryl-tRNA Synthetase" by D. Soll and J. Rinehart. Yale University has applied for a patent that covers the engineered EF-Tu described in this manuscript. Reagents are available under a Yale Material Transfer Agreement.	ALESSI DR, 1994, EMBO J, V13, P1610, DOI 10.1002/j.1460-2075.1994.tb06424.x; Dale T, 2004, BIOCHEMISTRY-US, V43, P6159, DOI 10.1021/bi036290o; Doi Y, 2007, J AM CHEM SOC, V129, P14458, DOI 10.1021/ja075557u; Eargle J, 2008, J MOL BIOL, V377, P1382, DOI 10.1016/j.jmb.2008.01.073; Fukunaga R, 2007, NAT STRUCT MOL BIOL, V14, P272, DOI 10.1038/nsmb1219; Hohn MJ, 2006, P NATL ACAD SCI USA, V103, P18095, DOI 10.1073/pnas.0608762103; Isaacs FJ, 2011, SCIENCE, V333, P348, DOI 10.1126/science.1205822; Kamtekar S, 2007, P NATL ACAD SCI USA, V104, P2620, DOI 10.1073/pnas.0611504104; LaRiviere FJ, 2001, SCIENCE, V294, P165, DOI 10.1126/science.1064242; Ling JQ, 2007, P NATL ACAD SCI USA, V104, P15299, DOI 10.1073/pnas.0704441104; Lipmann F, 1933, BIOCHEM Z, V262, P3; Liu CC, 2010, ANNU REV BIOCHEM, V79, P413, DOI 10.1146/annurev.biochem.052308.105824; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Mukai T, 2010, NUCLEIC ACIDS RES, V38, P8188, DOI 10.1093/nar/gkq707; NISSEN P, 1995, SCIENCE, V270, P1464, DOI 10.1126/science.270.5241.1464; Nozawa K, 2009, NATURE, V457, P1163, DOI 10.1038/nature07611; Ohtsuki T, 2010, J BIOCHEM, V148, P239, DOI 10.1093/jb/mvq053; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Rothman DM, 2005, J AM CHEM SOC, V127, P846, DOI 10.1021/ja043875c; Sauerwald A, 2005, SCIENCE, V307, P1969, DOI 10.1126/science.1108329; Schrader JM, 2011, P NATL ACAD SCI USA, V108, P5215, DOI 10.1073/pnas.1102128108; Scott JD, 2009, SCIENCE, V326, P1220, DOI 10.1126/science.1175668; Sebolt-Leopold JS, 2004, NAT REV CANCER, V4, P937, DOI 10.1038/nrc1503; WANNER BL, 1992, FEMS MICROBIOL LETT, V79, P133; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Yoshizawa S, 2009, BBA-GEN SUBJECTS, V1790, P1404, DOI 10.1016/j.bbagen.2009.03.010	26	250	263	6	116	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 26	2011	333	6046					1151	1154		10.1126/science.1207203	http://dx.doi.org/10.1126/science.1207203			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811VM	21868676	Green Accepted			2022-12-28	WOS:000294244300050
J	Idoyaga, J; Steinman, RM				Idoyaga, Juliana; Steinman, Ralph M.			SnapShot: Dendritic Cells	CELL			English	Editorial Material									[Idoyaga, Juliana; Steinman, Ralph M.] Rockefeller Univ, New York, NY 10065 USA	Rockefeller University	Idoyaga, J (corresponding author), Rockefeller Univ, 1230 York Ave, New York, NY 10065 USA.		Steinman, Ralph/F-7729-2012					Bedoui S, 2009, NAT IMMUNOL, V10, P488, DOI 10.1038/ni.1724; Bogunovic M, 2009, IMMUNITY, V31, P513, DOI 10.1016/j.immuni.2009.08.010; Cheong C, 2010, CELL, V143, P416, DOI 10.1016/j.cell.2010.09.039; Chorro L, 2009, J EXP MED, V206, P3089, DOI 10.1084/jem.20091586; Ginhoux F, 2009, J EXP MED, V206, P3115, DOI 10.1084/jem.20091756; Henri S, 2010, IMMUNOL CELL BIOL, V88, P366, DOI 10.1038/icb.2010.34; Liu K, 2009, SCIENCE, V324, P392, DOI 10.1126/science.1170540; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Sigmundsdottir H, 2007, NAT IMMUNOL, V8, P285, DOI 10.1038/ni1433; Sung SSJ, 2006, J IMMUNOL, V176, P2161, DOI 10.4049/jimmunol.176.4.2161	10	28	28	2	22	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 19	2011	146	4					660	U186	660.e2	10.1016/j.cell.2011.08.010	http://dx.doi.org/10.1016/j.cell.2011.08.010			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	809HY	21854989	Green Published, Bronze			2022-12-28	WOS:000294043600020
J	Lowe, CB; Kellis, M; Siepel, A; Raney, BJ; Clamp, M; Salama, SR; Kingsley, DM; Lindblad-Toh, K; Haussler, D				Lowe, Craig B.; Kellis, Manolis; Siepel, Adam; Raney, Brian J.; Clamp, Michele; Salama, Sofie R.; Kingsley, David M.; Lindblad-Toh, Kerstin; Haussler, David			Three Periods of Regulatory Innovation During Vertebrate Evolution	SCIENCE			English	Article							PARALLEL EVOLUTION; BINDING SITES; GENOME; STICKLEBACKS; CHROMATIN; ELEMENTS	The gain, loss, and modification of gene regulatory elements may underlie a substantial proportion of phenotypic changes on animal lineages. To investigate the gain of regulatory elements throughout vertebrate evolution, we identified genome-wide sets of putative regulatory regions for five vertebrates, including humans. These putative regulatory regions are conserved nonexonic elements (CNEEs), which are evolutionarily conserved yet do not overlap any coding or noncoding mature transcript. We then inferred the branch on which each CNEE came under selective constraint. Our analysis identified three extended periods in the evolution of gene regulatory elements. Early vertebrate evolution was characterized by regulatory gains near transcription factors and developmental genes, but this trend was replaced by innovations near extracellular signaling genes, and then innovations near posttranslational protein modifiers.	[Lowe, Craig B.; Raney, Brian J.; Salama, Sofie R.; Haussler, David] Univ Calif Santa Cruz, Ctr Biomol Sci & Engn, Santa Cruz, CA 95064 USA; [Lowe, Craig B.; Kingsley, David M.] Stanford Univ, Dept Dev Biol, Stanford, CA 94305 USA; [Lowe, Craig B.; Salama, Sofie R.; Kingsley, David M.; Haussler, David] Univ Calif Santa Cruz, Howard Hughes Med Inst, Santa Cruz, CA 95064 USA; [Kellis, Manolis] MIT, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA; [Kellis, Manolis; Clamp, Michele; Lindblad-Toh, Kerstin] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Siepel, Adam] Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY 14853 USA; [Lindblad-Toh, Kerstin] Uppsala Univ, Dept Med Biochem & Microbiol, Sci Life Lab, Uppsala, Sweden	University of California System; University of California Santa Cruz; Stanford University; Howard Hughes Medical Institute; University of California System; University of California Santa Cruz; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Cornell University; Uppsala University	Haussler, D (corresponding author), Univ Calif Santa Cruz, Ctr Biomol Sci & Engn, Santa Cruz, CA 95064 USA.	haussler@soe.ucsc.edu	Kellis, Manolis/ABE-7385-2020; Raney, Brian/ABE-6267-2020; Salama, Sofie/K-6412-2019	Kellis, Manolis/0000-0001-7113-9630; Siepel, Adam/0000-0002-3557-7219; Salama, Sofie/0000-0001-6999-7193	Howard Hughes Medical Institute; NSF [CAREER-0644282, DBI-0644111]; NIH [R01-HG004037, P50- HG02568, U54-HG003067, 1U01-HG004695, 5P41-HG002371]; Sloan Foundation; European Science Foundation (EURYI); NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG002568, U54HG003067, R01HG004037, U01HG004695, P41HG002371] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sloan Foundation(Alfred P. Sloan Foundation); European Science Foundation (EURYI)(European Science Foundation (ESF)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by the Howard Hughes Medical Institute (C. B. L., S. R. S., D. M. K., D. H.), the NSF (CAREER-0644282 to M. K., DBI-0644111 to A. S.), the NIH (R01-HG004037 to M. K., P50- HG02568 to D. M. K., U54-HG003067 to K.L-T., 1U01-HG004695 to C. B. L., 5P41-HG002371to B.J.R.), the Sloan Foundation (M.K.), and the European Science Foundation (EURYI to K.L-T.).	[Anonymous], 2007, NATURE, V449, P851; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Boyle AP, 2008, CELL, V132, P311, DOI 10.1016/j.cell.2007.12.014; Bult CJ, 2008, NUCLEIC ACIDS RES, V36, pD724, DOI 10.1093/nar/gkm961; Chan YF, 2010, SCIENCE, V327, P302, DOI 10.1126/science.1182213; Colosimo PF, 2005, SCIENCE, V307, P1928, DOI 10.1126/science.1107239; Crawford GE, 2006, GENOME RES, V16, P123, DOI 10.1101/gr.4074106; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Holland LZ, 2008, GENOME RES, V18, P1100, DOI 10.1101/gr.073676.107; Karlsson EK, 2007, NAT GENET, V39, P1321, DOI 10.1038/ng.2007.10; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; McGregor AP, 2007, NATURE, V448, P587, DOI 10.1038/nature05988; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Miller CT, 2007, CELL, V131, P1179, DOI 10.1016/j.cell.2007.10.055; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Rebeiz M, 2009, SCIENCE, V326, P1663, DOI 10.1126/science.1178357; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Valouev A, 2008, NAT METHODS, V5, P829, DOI 10.1038/NMETH.1246; Visel A, 2008, NAT GENET, V40, P158, DOI 10.1038/ng.2007.55; Woolfe A, 2005, PLOS BIOL, V3, P116, DOI 10.1371/journal.pbio.0030007; Wray GA, 2007, NAT REV GENET, V8, P206, DOI 10.1038/nrg2063; Wu P, 2004, INT J DEV BIOL, V48, P249, DOI 10.1387/ijdb.15272390; Xie XH, 2007, P NATL ACAD SCI USA, V104, P7145, DOI 10.1073/pnas.0701811104	27	86	88	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 19	2011	333	6045					1019	1024		10.1126/science.1202702	http://dx.doi.org/10.1126/science.1202702			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808TD	21852499	Green Accepted, Green Submitted			2022-12-28	WOS:000294000400056
J	Stratmann, M; Schibler, U				Stratmann, Markus; Schibler, Ueli			Transcription Factor Loading: Please Take My Place!	CELL			English	Editorial Material							GLUCOCORTICOID-RECEPTOR; PROMOTER; GENE		[Stratmann, Markus; Schibler, Ueli] Univ Geneva, Dept Mol Biol, CH-1211 Geneva, Switzerland; [Stratmann, Markus; Schibler, Ueli] Natl Ctr Competence Res Frontiers Genet, CH-1211 Geneva, Switzerland	University of Geneva; University of Geneva	Schibler, U (corresponding author), Univ Geneva, Dept Mol Biol, 30 Quai Ernest Ansermet, CH-1211 Geneva, Switzerland.	ueli.schibler@unige.ch						Bosisio D, 2006, EMBO J, V25, P798, DOI 10.1038/sj.emboj.7600977; Elf J, 2007, SCIENCE, V316, P1191, DOI 10.1126/science.1141967; ERLMANN T, 1990, J BIOL CHEM, V265, P17222; Harper CV, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000607; Karpova TS, 2008, SCIENCE, V319, P466, DOI 10.1126/science.1150559; Larson DR, 2011, SCIENCE, V332, P475, DOI 10.1126/science.1202142; McNally JG, 2000, SCIENCE, V287, P1262, DOI 10.1126/science.287.5456.1262; Nagaich AK, 2004, MOL CELL, V14, P163, DOI 10.1016/S1097-2765(04)00178-9; Suter DM, 2011, SCIENCE, V332, P472, DOI 10.1126/science.1198817; Voss TC, 2011, CELL, V146, P544, DOI 10.1016/j.cell.2011.07.006	10	3	3	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 19	2011	146	4					497	499		10.1016/j.cell.2011.07.037	http://dx.doi.org/10.1016/j.cell.2011.07.037			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	809HY	21854974	Bronze			2022-12-28	WOS:000294043600002
J	Robinson, CV				Robinson, Carol V.			In pursuit of female chemists	NATURE			English	Editorial Material									Univ Oxford, Dept Chem, Oxford OX1 3QZ, England	University of Oxford	Robinson, CV (corresponding author), Univ Oxford, Dept Chem, S Parks Rd, Oxford OX1 3QZ, England.	carol.robinson@chem.ox.ac.uk		robinson, carol/0000-0001-7829-5505				KOLATA G, 2011, NY TIMES        0606; Newsome JessicaLober., 2008, CHEM PHD IMPACT WOME; *ROYAL I, 2011, 7 QUEST SCI; *ROYAL SOC CHEM, 2008, PLANN SUCC GOOD PRAC; *ROYAL SOC CHEM, 2000, FACT AFF CAR CHOIC G; Royal Society of Chemistry, 2008, CHANG HEART CAR INT	6	12	12	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 18	2011	476	7360					273	275		10.1038/476273a	http://dx.doi.org/10.1038/476273a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	811JV	21850083	Bronze			2022-12-28	WOS:000294206500011
J	Srivastava, R				Srivastava, Ranjana			Complicated Lives - Taking the Social History	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Monash Med Ctr, Dept Med Oncol, Melbourne, Vic, Australia	Monash University	Srivastava, R (corresponding author), Monash Med Ctr, Dept Med Oncol, Melbourne, Vic, Australia.								0	10	10	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 18	2011	365	7					587	589		10.1056/NEJMp1106985	http://dx.doi.org/10.1056/NEJMp1106985			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	808ER	21848459				2022-12-28	WOS:000293960500004
J	Heath, I				Heath, Iona			LIFE AND DEATH Opt in not out	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CARDIOPULMONARY-RESUSCITATION		Royal Coll Gen Practitioners, London, England		Heath, I (corresponding author), Royal Coll Gen Practitioners, London, England.	iona.heath22@yahoo.co.uk						Conroy SP, 2006, BRIT MED J, V332, P479, DOI 10.1136/bmj.332.7539.479; Guru V, 1999, CAN MED ASSOC J, V161, P1251; Mallery L, 2011, J PALLIAT CARE, V27, P12, DOI 10.1177/082585971102700104; Ramenofsky DH, FAST FACTS CONCEPTS, V179; Schaper J, 2005, CIRCULATION, V112, P6, DOI 10.1161/CIRCULATIONAHA.105.551846	5	4	4	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 17	2011	343								d5251	10.1136/bmj.d5251	http://dx.doi.org/10.1136/bmj.d5251			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	811LB	21849380				2022-12-28	WOS:000294210500008
J	Stanek, G; Wormser, GP; Gray, J; Strle, F				Stanek, Gerold; Wormser, Gary P.; Gray, Jeremy; Strle, Franc			Lyme borreliosis	LANCET			English	Article							BURGDORFERI SENSU-LATO; POLYMERASE-CHAIN-REACTION; CLINICAL CASE DEFINITIONS; LONG-TERM OUTCOMES; B-CELL LYMPHOMA; ANTIBIOTIC-TREATMENT; ERYTHEMA-MIGRANS; DOUBLE-BLIND; CONTROLLED-TRIAL; IXODES-RICINUS	Lyme borreliosis (Lyme disease) is caused by spirochaetes of the Borrelia burgdorferi sensu lato species complex, which are transmitted by ticks. The most common clinical manifestation is erythema migrans, which eventually resolves, even without antibiotic treatment. However, the infecting pathogen can spread to other tissues and organs, causing more severe manifestations that can involve a patient's skin, nervous system, joints, or heart. The incidence of this disease is increasing in many countries. Laboratory evidence of infection, mainly serology, is essential for diagnosis, except in the case of typical erythema migrans. Diagnosed cases are usually treated with antibiotics for 2-4 weeks and most patients make an uneventful recovery. No convincing evidence exists to support the use of antibiotics for longer than 4 weeks, or for the persistence of spirochaetes in adequately treated patients. Prevention is mainly accomplished by protecting against tick bites. There is no vaccine available for human beings.	[Stanek, Gerold] Med Univ Vienna, Inst Hyg & Appl Immunol, A-1095 Vienna, Austria; [Wormser, Gary P.] New York Med Coll, Valhalla, NY 10595 USA; [Gray, Jeremy] Univ Coll Dublin, Dublin 2, Ireland; [Strle, Franc] Univ Med Ctr Ljubljana, Ljubljana, Slovenia	Medical University of Vienna; New York Medical College; University College Dublin; University Medical Centre Ljubljana	Stanek, G (corresponding author), Med Univ Vienna, Inst Hyg & Appl Immunol, Kinderspitalgasse 15, A-1095 Vienna, Austria.	gerold.stanek@meduniwien.ac.at	DeHaas, Keith/I-4957-2017; Franzeck, Fabian C/B-5055-2011		National Institutes of Health; Immunetics Inc; BioRad; DiaSorin Inc; BioMerieux	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Immunetics Inc; BioRad; DiaSorin Inc; BioMerieux	GS studied specific diagnostic tests and assays as part of his work at the Medical University of Vienna. GPW is a board member of the American Lyme Disease Foundation; has served as an expert witness in malpractice cases involving Lyme disease; has received research grants to study diagnostic tests for Lyme disease from the National Institutes of Health, Immunetics Inc, BioRad, DiaSorin Inc, and BioMerieux; and has equity in Abbott, a company not known to have any approved product for Lyme disease. JG and FS declare that they have no conflicts of interest.	ABERER E, 1987, ACTA DERM-VENEREOL, V67, P225; Aguero-Rosenfeld ME, 2005, CLIN MICROBIOL REV, V18, P484, DOI 10.1128/CMR.18.3.484-509.2005; Anonymous, 2010, REGISTERED COMMUNICA; [Anonymous], 2009, 2008 HLTH STAT YB SU; ASBRINK E, 1988, ANN NY ACAD SCI, V539, P4, DOI 10.1111/j.1749-6632.1988.tb31833.x; Asbrink E., 1993, Aspects of Lyme borreliosis., P193; Aucott J, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-79; Auwaerter PG, 2011, J MED ETHICS, V37, P68, DOI 10.1136/jme.2009.032896; Avery RA, 2005, PEDIATR INFECT DIS J, V24, P705, DOI 10.1097/01.inf.0000172903.14077.4c; Bacon Rendi Murphree, 2008, Morbidity and Mortality Weekly Report, V57, P1; Baranton Guy, 2009, V37, P1, DOI 10.1159/000213066; BARBOUR AG, 1984, YALE J BIOL MED, V57, P521; Berglund J, 2002, SCAND J INFECT DIS, V34, P421, DOI 10.1080/00365540110080421; BERGLUND J, 1995, NEW ENGL J MED, V333, P1319, DOI 10.1056/NEJM199511163332004; Branda JA, 2010, CLIN INFECT DIS, V50, P20, DOI 10.1086/648674; Brouqui P, 2004, CLIN MICROBIOL INFEC, V10, P1108, DOI 10.1111/j.1469-0691.2004.01019.x; Bykowski T, 2008, INT J MED MICROBIOL, V298, P249, DOI 10.1016/j.ijmm.2007.10.002; Cabello FC, 2007, TRENDS MICROBIOL, V15, P350, DOI 10.1016/j.tim.2007.06.003; Cairns V, 2005, INT J EPIDEMIOL, V34, P1340, DOI 10.1093/ije/dyi129; CDC, 2010, LYM DIS; Centers for Disease Control and Prevention (CDC), 1995, MMWR Morb Mortal Wkly Rep, V44, P590; Cerar D, 2010, AM J MED, V123, P79, DOI 10.1016/j.amjmed.2009.05.011; Cerar T, 2010, CLIN VACCINE IMMUNOL, V17, P645, DOI 10.1128/CVI.00341-09; Cerroni L, 1997, J CUTAN PATHOL, V24, P457, DOI 10.1111/j.1600-0560.1997.tb01318.x; Cetin E, 2006, WIEN KLIN WOCHENSCHR, V118, P677, DOI 10.1007/s00508-006-0694-y; Chandra A, 2010, BRAIN BEHAV IMMUN, V24, P1018, DOI 10.1016/j.bbi.2010.03.002; Collares-Pereira M, 2004, J CLIN MICROBIOL, V42, P1316, DOI 10.1128/JCM.42.3.1316-1318.2004; Connally NP, 2009, AM J PREV MED, V37, P201, DOI 10.1016/j.amepre.2009.04.026; Cooper JD, 2004, PEDIATR INFECT DIS J, V23, P1105, DOI 10.1097/01.inf.0000145411.57449.f3; Dattwyler RJ, 2005, WIEN KLIN WOCHENSCHR, V117, P393, DOI 10.1007/s00508-005-0361-8; Dennis David T., 2002, P251, DOI 10.1079/9780851996325.0251; des Vignes F, 2001, J INFECT DIS, V183, P773, DOI 10.1086/318818; Eisen Lars, 2002, P91, DOI 10.1079/9780851996325.0091; Fallon BA, 2008, NEUROLOGY, V70, P992, DOI 10.1212/01.WNL.0000284604.61160.2d; Feder HM, 2007, NEW ENGL J MED, V357, P1422, DOI 10.1056/NEJMra072023; Fingerle V, 2008, INT J MED MICROBIOL, V298, P279, DOI 10.1016/j.ijmm.2007.05.002; Foldvari G, 2005, EMERG INFECT DIS, V11, P1794; Fraser CM, 1997, NATURE, V390, P580, DOI 10.1038/37551; Gern Lise, 2002, P149, DOI 10.1079/9780851996325.0149; Golde WT, 1998, J CLIN MICROBIOL, V36, P1015, DOI 10.1128/JCM.36.4.1015-1019.1998; Gray JS, 1998, EXP APPL ACAROL, V22, P249, DOI 10.1023/A:1006070416135; GRAY JS, 1995, EXP APPL ACAROL, V19, P163, DOI 10.1007/BF00046288; Halperin JJ, 2007, NEUROLOGY, V69, P91, DOI 10.1212/01.wnl.0000265517.66976.28; Halperin JJ, 1996, NEUROLOGY, V46, P619, DOI 10.1212/WNL.46.3.619; Halperin JJ, 2008, INFECT DIS CLIN N AM, V22, P261, DOI 10.1016/j.idc.2007.12.009; HANSEN K, 1992, BRAIN, V115, P399, DOI 10.1093/brain/115.2.399; Hassett AL, 2008, ARTHRIT RHEUM-ARTHR, V59, P1742, DOI 10.1002/art.24314; Hickie I, 2006, BRIT MED J, V333, P575, DOI 10.1136/bmj.38933.585764.AE; Hilton E, 1999, AM J MED, V106, P404, DOI 10.1016/S0002-9343(99)00046-7; Holzbauer SM, 2010, CLIN INFECT DIS, V51, P369, DOI 10.1086/654808; Hunfeld KP, 2005, ANTIMICROB AGENTS CH, V49, P1294, DOI 10.1128/AAC.49.4.1294-1301.2005; Huppertz HI, 1999, EUR J CLIN MICROBIOL, V18, P697, DOI 10.1007/s100960050381; Johnson M, 2010, J PEDIATR-US, V157, P1025, DOI 10.1016/j.jpeds.2010.06.031; Kahl O, 1998, ZBL BAKT-INT J MED M, V287, P41; Kalish RA, 2001, J INFECT DIS, V183, P453, DOI 10.1086/318082; Klempner MS, 2001, NEW ENGL J MED, V345, P85, DOI 10.1056/NEJM200107123450202; Korenberg EI, 1996, INFECTION, V24, P187, DOI 10.1007/BF01713337; Kowalski TJ, 2010, CLIN INFECT DIS, V50, P512, DOI 10.1086/649920; Krause PJ, 2006, AM J TROP MED HYG, V75, P1090, DOI 10.4269/ajtmh.2006.75.1090; KRISTOFERITSCH W, 1991, SCAND J INFECT DIS, P64; Krupp LB, 2003, NEUROLOGY, V60, P1923, DOI 10.1212/01.WNL.0000071227.23769.9E; Kutting B, 1997, J AM ACAD DERMATOL, V36, P311, DOI 10.1016/S0190-9622(97)80405-7; Lakos A, 2010, INT J INFECT DIS, V14, pE494, DOI 10.1016/j.ijid.2009.07.019; Lantos PM, 2010, CLIN INFECT DIS, V51, P1, DOI 10.1086/654809; Li CM, 2003, AM J SURG PATHOL, V27, P1061, DOI 10.1097/00000478-200308000-00003; Ljostad U, 2008, LANCET NEUROL, V7, P690, DOI 10.1016/S1474-4422(08)70119-4; LOGIGIAN EL, 1990, NEW ENGL J MED, V323, P1438, DOI 10.1056/NEJM199011223232102; Lotric-Furlan S, 2001, CLIN INFECT DIS, V33, P503, DOI 10.1086/322586; Maraspin V, 1996, CLIN INFECT DIS, V22, P788, DOI 10.1093/clinids/22.5.788; Maraspin V, 2006, EMERG INFECT DIS, V12, P1177, DOI 10.3201/eid1207.060077; Margos G, 2009, APPL ENVIRON MICROB, V75, P5410, DOI 10.1128/AEM.00116-09; Marques A, 2008, INFECT DIS CLIN N AM, V22, P341, DOI 10.1016/j.idc.2007.12.011; Marques A, 2009, CLIN VACCINE IMMUNOL, V16, P1249, DOI 10.1128/CVI.00167-09; MATUSCHKA FR, 1993, AM J TROP MED HYG, V48, P693, DOI 10.4269/ajtmh.1993.48.693; Morgenstern K, 2009, ANTIMICROB AGENTS CH, V53, P1281, DOI 10.1128/AAC.01247-08; Mygland A, 2010, EUR J NEUROL, V17, P8, DOI 10.1111/j.1468-1331.2009.02862.x; Nadelman RB, 1998, LANCET, V352, P557, DOI 10.1016/S0140-6736(98)01146-5; Nadelman RB, 2007, CLIN INFECT DIS, V45, P1032, DOI 10.1086/521256; NOCTON JJ, 1994, NEW ENGL J MED, V330, P229, DOI 10.1056/NEJM199401273300401; Nowakowski J, 1997, ANN INTERN MED, V127, P130, DOI 10.7326/0003-4819-127-2-199707150-00006; Ogden NH, 1997, PARASITOLOGY, V115, P591, DOI 10.1017/S0031182097001868; Oksi J, 2007, EUR J CLIN MICROBIOL, V26, P571, DOI 10.1007/s10096-007-0340-2; Patel R, 2000, CLIN INFECT DIS, V31, P1107, DOI 10.1086/318138; PEAVEY CA, 1995, J PARASITOL, V81, P175, DOI 10.2307/3283916; Piesman J, 2004, PARASITOLOGY, V129, pS191, DOI 10.1017/S0031182003004694; Piesman Joseph, 2002, P223, DOI 10.1079/9780851996325.0223; PREACMURSIC V, 1986, ZBL BAKT-INT J MED M, V263, P112; Reid MC, 1998, ANN INTERN MED, V128, P354, DOI 10.7326/0003-4819-128-5-199803010-00003; Rosa P, 2005, NAT MED, V11, P831, DOI 10.1038/nm0805-831; Ruzic-Sabljic E, 2002, WIEN KLIN WOCHENSCHR, V114, P544; Schollkopf C, 2008, BLOOD, V111, P5524, DOI 10.1182/blood-2007-08-109611; Scoles GA, 2001, VECTOR-BORNE ZOONOT, V1, P21, DOI 10.1089/153036601750137624; Seltzer EG, 2000, JAMA-J AM MED ASSOC, V283, P609, DOI 10.1001/jama.283.5.609; SHAPIRO ED, 1992, NEW ENGL J MED, V327, P1769, DOI 10.1056/NEJM199212173272501; Sigal LH, 1998, NEW ENGL J MED, V339, P216, DOI 10.1056/NEJM199807233390402; Skogman BH, 2008, PEDIATR INFECT DIS J, V27, P1089, DOI 10.1097/INF.0b013e31817fd423; Solomon SP, 1998, ARTHRIT CARE RES, V11, P419, DOI 10.1002/art.1790110514; Sood SK, 2002, CLIN INFECT DIS, V35, P451, DOI 10.1086/340858; Stafford Kirby C., 2002, P301, DOI 10.1079/9780851996325.0301; Stanek G, 2011, CLIN MICROBIOL INFEC, V17, P69, DOI 10.1111/j.1469-0691.2010.03175.x; Stanek G, 2003, LANCET, V362, P1639, DOI 10.1016/S0140-6736(03)14798-8; Stanek G, 1996, WIEN KLIN WOCHENSCHR, V108, P741; Stanek G, 1996, ZENTRALBL BAKTERIOL, V289, P655; Steere AC, 2006, J EXP MED, V203, P961, DOI 10.1084/jem.20052471; Steere AC, 2004, J CLIN INVEST, V113, P1093, DOI [10.1172/JCI200421681, 10.1172/JCI21681]; Steere AC, 2004, NAT REV IMMUNOL, V4, P143, DOI 10.1038/nri1267; STEERE AC, 1993, JAMA-J AM MED ASSOC, V269, P1812, DOI 10.1001/jama.269.14.1812; Steere AC, 1998, NEW ENGL J MED, V339, P209, DOI 10.1056/NEJM199807233390401; Steere AC, 2008, CLIN INFECT DIS, V47, P188, DOI 10.1086/589242; Steere AC, 2006, ARTHRITIS RHEUM-US, V54, P3079, DOI 10.1002/art.22131; Strle F, 1997, CLIN INFECT DIS, V25, P273, DOI 10.1086/514551; Strle F, 1999, ZBL BAKT-INT J MED M, V289, P643; Strle Franc, 2009, V37, P51, DOI 10.1159/000213070; Strle K, 2009, J INFECT DIS, V200, P1936, DOI 10.1086/648091; Swanson SJ, 2006, CLIN MICROBIOL REV, V19, P708, DOI 10.1128/CMR.00011-06; Telford SR, 2010, EMERG INFECT DIS, V16, P379, DOI 10.3201/eid1603.090443; Vrethem M, 2002, ACTA NEUROL SCAND, V106, P205, DOI 10.1034/j.1600-0404.2002.01358.x; Warshafsky S, 2010, J ANTIMICROB CHEMOTH, V65, P1137, DOI 10.1093/jac/dkq097; WEBER K, 1988, INFECTION, V16, P25, DOI 10.1007/BF01646925; WEBER K, 1990, INFECTION, V18, P91, DOI 10.1007/BF01641422; Weissenbacher S, 2005, DERMATOLOGY, V211, P123, DOI 10.1159/000086441; Wilske B, 2007, FEMS IMMUNOL MED MIC, V49, P13, DOI 10.1111/j.1574-695X.2006.00139.x; Wood GS, 2001, J CUTAN PATHOL, V28, P502, DOI 10.1034/j.1600-0560.2001.281002.x; Wormser GP, 2008, J INFECT DIS, V198, P1358, DOI 10.1086/592279; Wormser GP, 2006, CLIN INFECT DIS, V43, P1089, DOI 10.1086/508667; Wormser GP, 2002, WIEN KLIN WOCHENSCHR, V114, P613; Wormser GP, 2003, ANN INTERN MED, V138, P697, DOI 10.7326/0003-4819-138-9-200305060-00005; Zollinger T, 2010, J CUTAN PATHOL, V37, P571, DOI 10.1111/j.1600-0560.2009.01493.x	128	820	849	8	224	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 4	2012	379	9814					461	473		10.1016/S0140-6736(11)60103-7	http://dx.doi.org/10.1016/S0140-6736(11)60103-7			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	891AF	21903253				2022-12-28	WOS:000300187800036
J	Epstein, JE; Tewari, K; Lyke, KE; Sim, BKL; Billingsley, PF; Laurens, MB; Gunasekera, A; Chakravarty, S; James, ER; Sedegah, M; Richman, A; Velmurugan, S; Reyes, S; Li, M; Tucker, K; Ahumada, A; Ruben, AJ; Li, T; Stafford, R; Eappen, AG; Tamminga, C; Bennett, JW; Ockenhouse, CF; Murphy, JR; Komisar, J; Thomas, N; Loyevsky, M; Birkett, A; Plowe, CV; Loucq, C; Edelman, R; Richie, TL; Seder, RA; Hoffman, SL				Epstein, J. E.; Tewari, K.; Lyke, K. E.; Sim, B. K. L.; Billingsley, P. F.; Laurens, M. B.; Gunasekera, A.; Chakravarty, S.; James, E. R.; Sedegah, M.; Richman, A.; Velmurugan, S.; Reyes, S.; Li, M.; Tucker, K.; Ahumada, A.; Ruben, A. J.; Li, T.; Stafford, R.; Eappen, A. G.; Tamminga, C.; Bennett, J. W.; Ockenhouse, C. F.; Murphy, J. R.; Komisar, J.; Thomas, N.; Loyevsky, M.; Birkett, A.; Plowe, C. V.; Loucq, C.; Edelman, R.; Richie, T. L.; Seder, R. A.; Hoffman, S. L.			Live Attenuated Malaria Vaccine Designed to Protect Through Hepatic CD8(+) T Cell Immunity	SCIENCE			English	Article							SPOROZOITE SURFACE PROTEIN-2; PLASMODIUM-FALCIPARUM SPOROZOITES; CIRCUMSPOROZOITE PROTEIN; INFECTED HEPATOCYTES; PREERYTHROCYTIC STAGES; GAMMA-INTERFERON; IMMUNIZATION; RESPONSES; HUMANS; MICE	Our goal is to develop a vaccine that sustainably prevents Plasmodium falciparum (Pf) malaria in >= 80% of recipients. Pf sporozoites (Pf SPZ) administered by mosquito bites are the only immunogens shown to induce such protection in humans. Such protection is thought to be mediated by CD8(+) T cells in the liver that secrete interferon-gamma (IFN-gamma). We report that purified irradiated Pf SPZ administered to 80 volunteers by needle inoculation in the skin was safe, but suboptimally immunogenic and protective. Animal studies demonstrated that intravenous immunization was critical for inducing a high frequency of Pf SPZ-specific CD8(+), IFN-gamma-producing T cells in the liver (nonhuman primates, mice) and conferring protection (mice). Our results suggest that intravenous administration of this vaccine will lead to the prevention of infection with Pf malaria.	[Tewari, K.; Seder, R. A.] NIAID, Vaccine Res Ctr, Bethesda, MD 20892 USA; [Epstein, J. E.; Sedegah, M.; Reyes, S.; Tamminga, C.; Thomas, N.; Richie, T. L.] USN, Med Res Ctr, US Mil Malaria Vaccine Program, Silver Spring, MD 20910 USA; [Lyke, K. E.; Laurens, M. B.; Plowe, C. V.; Edelman, R.] Univ Maryland, Sch Med, Ctr Vaccine Dev, Baltimore, MD 21201 USA; [Sim, B. K. L.; Billingsley, P. F.; Gunasekera, A.; Chakravarty, S.; James, E. R.; Richman, A.; Velmurugan, S.; Ahumada, A.; Ruben, A. J.; Li, T.; Stafford, R.; Eappen, A. G.; Loyevsky, M.; Hoffman, S. L.] Sanaria Inc, Rockville, MD 20850 USA; [Sim, B. K. L.; Li, M.; Ahumada, A.; Stafford, R.; Hoffman, S. L.] Prot Potential LLC, Rockville, MD 20850 USA; [Laurens, M. B.; Plowe, C. V.] Howard Hughes Med Inst, Baltimore, MD 21201 USA; [Tucker, K.] Stat Collaborat Inc, Washington, DC 20036 USA; [Bennett, J. W.; Ockenhouse, C. F.; Murphy, J. R.; Komisar, J.] Walter Reed Army Inst Res, US Mil Malaria Vaccine Program, Silver Spring, MD 20910 USA; [Birkett, A.; Loucq, C.] PATH Malaria Vaccine Initiat, Bethesda, MD 20814 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); United States Department of Defense; United States Navy; University System of Maryland; University of Maryland Baltimore; Sanaria Inc.; Howard Hughes Medical Institute; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR)	Seder, RA (corresponding author), NIAID, Vaccine Res Ctr, 9000 Rockville Pike, Bethesda, MD 20892 USA.	rseder@mail.nih.gov; slhoffman@sanaria.com	Bennett, Jason W/B-3547-2011; Murugan, Vel/AAX-9679-2020; Murugan, Vel/AAA-3554-2019; Laurens, Matthew/E-7293-2013	Murugan, Vel/0000-0002-7368-7742; Laurens, Matthew/0000-0003-3874-581X; Richie, Thomas/0000-0002-2946-5456	Bill and Melinda Gates Foundation (BMGF); National Institute of Allergy and Infectious Diseases-NIH [5R44AI055229-07, 5R44AI058499-05, 5R44AI058375-05]; Institute for OneWorld Health (BMGF); U.S. Military Infectious Disease; Work Unit [6000.RAD1.F.A0309]; Howard Hughes Medical Institute; Doris Duke Charitable Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R44AI058375, R44AI058499, R44AI055229, ZIAAI005107] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation (BMGF)(Bill & Melinda Gates Foundation); National Institute of Allergy and Infectious Diseases-NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Institute for OneWorld Health (BMGF); U.S. Military Infectious Disease; Work Unit; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the volunteers and the PfSPZ Vaccine Development Teams and NHP team (see SOM) for their participation and efforts. The PATH Malaria Vaccine Initiative (MVI) supported the clinical trial with funds from the Bill and Melinda Gates Foundation (BMGF). Sanaria acknowledges support from National Institute of Allergy and Infectious Diseases-NIH Small Business Innovation Research grants, especially 5R44AI055229-07, 5R44AI058499-05, and 5R44AI058375-05; Institute for OneWorld Health (funds from BMGF); and U.S. Military Infectious Disease Research Program, which enabled development and manufacture of the vaccine. At Naval Medical Research Center, work was funded by Work Unit Number 6000.RAD1.F.A0309. At UMD, PCR work was funded by the Howard Hughes Medical Institute and Doris Duke Charitable Foundation. All of the data reported in the manuscript are tabulated in the main text and in the SOM. A materials transfer agreement will be required for the use of recombinant PfMSP-1 and PfEBA-175 and for HC-04 cells. A number of patents on PfSPZ have been issued, allowed, or filed in the United States and internationally. The U.S. patents include S. L. Hoffman et al., U.S. Patent 7,229,627 (2007) (there is a divisional of this patent with claims directed to aseptic adult Anopheles-species mosquitoes and aseptic Plasmodium-species sporozoites, USSN 11/726,622); S. L. Hoffman et al., U.S. Patent Pub. US2005/0208078 (2005); and B. K. L. Sim, S. L. Hoffman, M. Li, R. E. Stafford, U.S. Patent Pub U. S. 2010/0183680 (2010). There is also a patent on HC-04 cells [J. Prachumsri et al., U.S. Patent 7015036 (2006)].	Amino R, 2006, NAT MED, V12, P220, DOI 10.1038/nm1350; CHULAY JD, 1986, AM J TROP MED HYG, V35, P66, DOI 10.4269/ajtmh.1986.35.66; CLYDE DF, 1973, AM J MED SCI, V266, P169, DOI 10.1097/00000441-197309000-00002; DOLAN SA, 1994, MOL BIOCHEM PARASIT, V64, P55, DOI 10.1016/0166-6851(94)90134-1; Doolan DL, 2000, J IMMUNOL, V165, P1453, DOI 10.4049/jimmunol.165.3.1453; Doolan DL, 2003, P NATL ACAD SCI USA, V100, P9952, DOI 10.1073/pnas.1633254100; Doolan DL, 1997, IMMUNITY, V7, P97, DOI 10.1016/S1074-7613(00)80513-0; EGAN JE, 1993, AM J TROP MED HYG, V49, P166, DOI 10.4269/ajtmh.1993.49.166; Ellis R.W., 2008, VACCINES-BASEL, Vfifth, P1335; FERREIRA A, 1986, SCIENCE, V232, P881, DOI 10.1126/science.3085218; Florens L, 2002, NATURE, V419, P520, DOI 10.1038/nature01107; Guebre-Xabier M, 1999, EUR J IMMUNOL, V29, P3978, DOI 10.1002/(SICI)1521-4141(199912)29:12&lt;3978::AID-IMMU3978&gt;3.0.CO;2-0; Haque A, 2009, FUTURE MICROBIOL, V4, P649, DOI 10.2217/FMB.09.43; HERRINGTON D, 1991, AM J TROP MED HYG, V45, P539, DOI 10.4269/ajtmh.1991.45.539; Hoffman SL, 2000, NAT MED, V6, P1218, DOI 10.1038/81315; Hoffman SL, 2002, J INFECT DIS, V185, P1155, DOI 10.1086/339409; HOFFMAN SL, 1989, SCIENCE, V244, P1078, DOI 10.1126/science.2524877; Hoffman SL, 2010, HUM VACCINES, V6, P97, DOI 10.4161/hv.6.1.10396; Holder AA, 2009, PARASITOLOGY, V136, P1445, DOI 10.1017/S0031182009990515; Jinj Y, 2007, INFECT IMMUN, V75, P5532, DOI 10.1128/IAI.00600-07; Kester KE, 2009, J INFECT DIS, V200, P337, DOI 10.1086/600120; KHUSMITH S, 1991, SCIENCE, V252, P715, DOI 10.1126/science.1827210; Leiriao P, 2005, J INFECT DIS, V191, P1576, DOI 10.1086/429635; Luke TC, 2003, J EXP BIOL, V206, P3803, DOI 10.1242/jeb.00644; malERA Consultative Group on Vaccines, 2011, PLoS Med, V8, pe1000398, DOI 10.1371/journal.pmed.1000398; MALIK A, 1991, P NATL ACAD SCI USA, V88, P3300, DOI 10.1073/pnas.88.8.3300; McConkey SJ, 2003, NAT MED, V9, P729, DOI 10.1038/nm881; MILLET P, 1990, B WORLD HEALTH ORGAN, V68, P60; NARDIN EH, 1993, ANNU REV IMMUNOL, V11, P687, DOI 10.1146/annurev.iy.11.040193.003351; Plowe CV, 2009, J INFECT DIS, V200, P1646, DOI 10.1086/646613; POTOCNJAK P, 1980, J EXP MED, V151, P1504, DOI 10.1084/jem.151.6.1504; RIECKMANN KH, 1974, T ROY SOC TROP MED H, V68, P258, DOI 10.1016/0035-9203(74)90129-1; Roederer M, 2011, CYTOM PART A, V79A, P167, DOI 10.1002/cyto.a.21015; Roestenberg M, 2011, LANCET, V377, P1770, DOI 10.1016/S0140-6736(11)60360-7; Roestenberg M, 2009, NEW ENGL J MED, V361, P468, DOI 10.1056/NEJMoa0805832; ROGERS WO, 1992, P NATL ACAD SCI USA, V89, P9176, DOI 10.1073/pnas.89.19.9176; ROMERO P, 1989, NATURE, V341, P323, DOI 10.1038/341323a0; ROSSIGNOL PA, 1984, AM J TROP MED HYG, V33, P17, DOI 10.4269/ajtmh.1984.33.17; SCHELLER LF, 1995, P NATL ACAD SCI USA, V92, P4066, DOI 10.1073/pnas.92.9.4066; Schmidt NW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000998; SCHOFIELD L, 1987, NATURE, V330, P664, DOI 10.1038/330664a0; SEGUIN MC, 1994, J EXP MED, V180, P353, DOI 10.1084/jem.180.1.353; SIM BKL, 1994, SCIENCE, V264, P1941, DOI 10.1126/science.8009226; Targett GA, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-S1-S10; Trieu A., 2011, MOL CELL PROTEOMICS, V10, pM111; van Schaijk BCL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003549; VanBuskirk KM, 2009, P NATL ACAD SCI USA, V106, P13004, DOI 10.1073/pnas.0906387106; WEISS WR, 1988, P NATL ACAD SCI USA, V85, P573, DOI 10.1073/pnas.85.2.573; WEISS WR, 1990, J EXP MED, V171, P763, DOI 10.1084/jem.171.3.763; WIZEL B, 1995, J IMMUNOL, V155, P766; 2010, LANCET, V375, P1407	51	355	371	1	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 28	2011	334	6055					475	480		10.1126/science.1211548	http://dx.doi.org/10.1126/science.1211548			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837UR	21903775	Green Published			2022-12-28	WOS:000296230500037
J	Barker, S; Knorr, G; Edwards, RL; Parrenin, F; Putnam, AE; Skinner, LC; Wolff, E; Ziegler, M				Barker, Stephen; Knorr, Gregor; Edwards, R. Lawrence; Parrenin, Frederic; Putnam, Aaron E.; Skinner, Luke C.; Wolff, Eric; Ziegler, Martin			800,000 Years of Abrupt Climate Variability	SCIENCE			English	Article							MILLENNIAL-SCALE; PHASE-RELATIONSHIPS; ICE CORES; GREENLAND; RECORD; SEESAW; MODEL; OCEAN; DEEP; CH4	We constructed an 800,000-year synthetic record of Greenland climate variability based on the thermal bipolar seesaw model. Our Greenland analog reproduces much of the variability seen in the Greenland ice cores over the past 100,000 years. The synthetic record shows strong similarity with the absolutely dated speleothem record from China, allowing us to place ice core records within an absolute timeframe for the past 400,000 years. Hence, it provides both a stratigraphic reference and a conceptual basis for assessing the long-term evolution of millennial-scale variability and its potential role in climate change at longer time scales. Indeed, we provide evidence for a ubiquitous association between bipolar seesaw oscillations and glacial terminations throughout the Middle to Late Pleistocene.	[Barker, Stephen; Ziegler, Martin] Cardiff Univ, Sch Earth & Ocean Sci, Cardiff CF10 3AT, S Glam, Wales; [Knorr, Gregor] Alfred Wegener Inst, D-27570 Bremerhaven, Germany; [Edwards, R. Lawrence] Univ Minnesota, Dept Earth Sci, Minneapolis, MN 55455 USA; [Parrenin, Frederic] CNRS, Lab Glaciol, F-38400 Grenoble, France; [Parrenin, Frederic] Univ Grenoble 1, F-38400 Grenoble, France; [Parrenin, Frederic] Lab Chronoenvironm, F-25000 Besancon, France; [Putnam, Aaron E.] Univ Maine, Dept Earth Sci, Orono, ME 04469 USA; [Putnam, Aaron E.] Univ Maine, Climate Change Inst, Orono, ME 04469 USA; [Skinner, Luke C.] Univ Cambridge, Godwin Lab Palaeoclimate Res, Dept Earth Sci, Cambridge CB2 3EQ, England; [Wolff, Eric] British Antarctic Survey, Cambridge CB3 0ET, England	Cardiff University; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; University of Minnesota System; University of Minnesota Twin Cities; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite de Franche-Comte; University of Maine System; University of Maine Orono; University of Maine System; University of Maine Orono; University of Cambridge; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey	Barker, S (corresponding author), Cardiff Univ, Sch Earth & Ocean Sci, Cardiff CF10 3AT, S Glam, Wales.	barkers3@cf.ac.uk	Wolff, Eric/AAB-1097-2021; Parrenin, Frédéric/H-3054-2014; Ziegler, Martin/N-9699-2013; Wolff, Eric W/D-7925-2014; Ziegler, Martin/E-8604-2011; Edwards, R. Lawrence/I-3124-2014; Stephen, Barker/C-2770-2009	Wolff, Eric/0000-0002-5914-8531; Parrenin, Frédéric/0000-0002-9489-3991; Ziegler, Martin/0000-0002-9126-7311; Wolff, Eric W/0000-0002-5914-8531; Edwards, R. Lawrence/0000-0002-7027-5881; Stephen, Barker/0000-0001-7870-6431; Knorr, Gregor/0000-0002-8317-5046; Putnam, Aaron/0000-0002-5358-1473; Ziegler, Martin/0000-0003-3198-6434	Philip Leverhulme Prize; Natural Environment Research Council (UK) [NE/F002734/1, NE/G004021/1]; NSF [0502535, 1103403]; Natural Environment Research Council (UK); NERC [NE/G004021/1, NE/F002734/1, bas0100024] Funding Source: UKRI; Natural Environment Research Council [bas0100024, NE/G004021/1, NE/F002734/1] Funding Source: researchfish; Div Atmospheric & Geospace Sciences [1103403] Funding Source: National Science Foundation	Philip Leverhulme Prize; Natural Environment Research Council (UK)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NSF(National Science Foundation (NSF)); Natural Environment Research Council (UK)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Div Atmospheric & Geospace Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank the authors of all of the studies cited here for making their results available for this work. Supported by a Philip Leverhulme Prize (S.B.), Natural Environment Research Council (UK) awards NE/F002734/1 and NE/G004021/1 (S.B.), and NSF grants 0502535 and 1103403 (R.L.E.). This study is also part of the British Antarctic Survey Polar Science for Planet Earth Programme, funded by the Natural Environment Research Council (UK).	Anderson RF, 2009, SCIENCE, V323, P1443, DOI 10.1126/science.1167441; Barker S, 2009, NATURE, V457, P1097, DOI 10.1038/nature07770; Blunier T, 2001, SCIENCE, V291, P109, DOI 10.1126/science.291.5501.109; BOND G, 1993, NATURE, V365, P143, DOI 10.1038/365143a0; Broecker WS, 1998, PALEOCEANOGRAPHY, V13, P119, DOI 10.1029/97PA03707; Capron E, 2010, CLIM PAST, V6, P345, DOI 10.5194/cp-6-345-2010; Capron E, 2010, QUATERNARY SCI REV, V29, P222, DOI 10.1016/j.quascirev.2009.07.014; Cheng H, 2009, SCIENCE, V326, P248, DOI 10.1126/science.1177840; Chiang JCH, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2003PA000916; DANSGAARD W, 1982, SCIENCE, V218, P1273, DOI 10.1126/science.218.4579.1273; Goni MFS, 1999, EARTH PLANET SC LETT, V171, P123; HAYS JD, 1976, SCIENCE, V194, P1121, DOI 10.1126/science.194.4270.1121; Jouzel J, 2007, SCIENCE, V317, P793, DOI 10.1126/science.1141038; LISIECKI LE, 2005, PALEOCEANOGRAPHY, V0020; Loulergue L, 2008, NATURE, V453, P383, DOI 10.1038/nature06950; Luthi D, 2008, NATURE, V453, P379, DOI 10.1038/nature06949; Margari V, 2010, NAT GEOSCI, V3, P127, DOI 10.1038/NGEO740; Martrat B, 2007, SCIENCE, V317, P502, DOI 10.1126/science.1139994; McManus JF, 1999, SCIENCE, V283, P971, DOI 10.1126/science.283.5404.971; Parrenin F, 2007, CLIM PAST, V3, P485, DOI 10.5194/cp-3-485-2007; Raymo ME, 1997, PALEOCEANOGRAPHY, V12, P577, DOI 10.1029/97PA01169; Schmittner A, 2003, QUATERNARY SCI REV, V22, P659, DOI 10.1016/S0277-3791(02)00184-1; Schulz M, 1999, GEOPHYS RES LETT, V26, P3385, DOI 10.1029/1999GL006069; Shackleton NJ, 2000, PALEOCEANOGRAPHY, V15, P565, DOI 10.1029/2000PA000513; Siddall M, 2006, QUATERNARY SCI REV, V25, P3185, DOI 10.1016/j.quascirev.2005.12.014; Sima A, 2004, EARTH PLANET SC LETT, V222, P741, DOI 10.1016/j.epsl.2004.03.026; Steig EJ, 2002, ANN GLACIOL-SER, V35, P451, DOI 10.3189/172756402781817211; Stocker TF, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2003PA000920; Stuiver M, 2000, QUATERNARY RES, V53, P277, DOI 10.1006/qres.2000.2127; Trenberth KE, 2001, J CLIMATE, V14, P3433, DOI 10.1175/1520-0442(2001)014<3433:EOMAAO>2.0.CO;2; Vellinga M, 2002, CLIMATIC CHANGE, V54, P251, DOI 10.1023/A:1016168827653; Wang YJ, 2008, NATURE, V451, P1090, DOI 10.1038/nature06692; Wolff EW, 2009, NAT GEOSCI, V2, P206, DOI 10.1038/NGEO442	33	250	262	4	161	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 21	2011	334	6054					347	351		10.1126/science.1203580	http://dx.doi.org/10.1126/science.1203580			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	835RC	21903776	Green Submitted			2022-12-28	WOS:000296052500045
J	Wu, GD; Chen, J; Hoffmann, C; Bittinger, K; Chen, YY; Keilbaugh, SA; Bewtra, M; Knights, D; Walters, WA; Knight, R; Sinha, R; Gilroy, E; Gupta, K; Baldassano, R; Nessel, L; Li, HZ; Bushman, FD; Lewis, JD				Wu, Gary D.; Chen, Jun; Hoffmann, Christian; Bittinger, Kyle; Chen, Ying-Yu; Keilbaugh, Sue A.; Bewtra, Meenakshi; Knights, Dan; Walters, William A.; Knight, Rob; Sinha, Rohini; Gilroy, Erin; Gupta, Kernika; Baldassano, Robert; Nessel, Lisa; Li, Hongzhe; Bushman, Frederic D.; Lewis, James D.			Linking Long-Term Dietary Patterns with Gut Microbial Enterotypes	SCIENCE			English	Article							GENOME	Diet strongly affects human health, partly by modulating gut microbiome composition. We used diet inventories and 16S rDNA sequencing to characterize fecal samples from 98 individuals. Fecal communities clustered into enterotypes distinguished primarily by levels of Bacteroides and Prevotella. Enterotypes were strongly associated with long-term diets, particularly protein and animal fat (Bacteroides) versus carbohydrates (Prevotella). A controlled-feeding study of 10 subjects showed that microbiome composition changed detectably within 24 hours of initiating a high-fat/low-fiber or low-fat/high-fiber diet, but that enterotype identity remained stable during the 10-day study. Thus, alternative enterotype states are associated with long-term diet.	[Wu, Gary D.; Chen, Ying-Yu; Keilbaugh, Sue A.; Bewtra, Meenakshi; Lewis, James D.] Univ Penn, Perelman Sch Med, Div Gastroenterol, Philadelphia, PA 19104 USA; [Chen, Jun; Bewtra, Meenakshi; Gilroy, Erin; Nessel, Lisa; Li, Hongzhe; Lewis, James D.] Univ Penn, Perelman Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; [Chen, Jun; Li, Hongzhe; Lewis, James D.] Univ Penn, Perelman Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Hoffmann, Christian; Bittinger, Kyle; Sinha, Rohini; Bushman, Frederic D.] Univ Penn, Perelman Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA; [Hoffmann, Christian] Univ Fed Goias, Inst Ciencias Biol, BR-74001970 Goiania, Go, Brazil; [Knights, Dan] Univ Colorado, Dept Comp Sci, Boulder, CO 80309 USA; [Walters, William A.] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA; [Knight, Rob] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA; [Knight, Rob] Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80309 USA; [Gupta, Kernika; Baldassano, Robert] Childrens Hosp Philadelphia, Div Gastroenterol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Universidade Federal de Goias; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Wu, GD (corresponding author), Univ Penn, Perelman Sch Med, Div Gastroenterol, Philadelphia, PA 19104 USA.	gdwu@mail.med.upenn.edu; bushman@mail.med.upenn.edu; lewisjd@mail.med.upenn.edu	Knight, Rob/D-1299-2010; Hoffmann, Christian/C-1298-2015; Bittinger, Kyle/ABG-2342-2020; chen, ying/HHS-8254-2022	Hoffmann, Christian/0000-0003-1736-8007; Knight, Rob/0000-0002-0975-9019; Bushman, Frederic/0000-0003-4740-4056	NIH [UH2 DK083981, RO1 AI39368]; Penn Genome Frontiers Institute; Penn Digestive Disease Center [P30 DK050306]; Joint Penn-CHOP Center for Digestive, Liver, and Pancreatic Medicine [S10RR024525, UL1RR024134, K24-DK078228]; Howard Hughes Medical Institute; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024525, UL1RR024134] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI039368] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [UH2DK083981, P30DK050306, K24DK078228] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008759] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Penn Genome Frontiers Institute; Penn Digestive Disease Center; Joint Penn-CHOP Center for Digestive, Liver, and Pancreatic Medicine; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by NIH grants UH2 DK083981 (F. D. B., J.D.L., and G. D. W.) and RO1 AI39368 (G. D. W.); Penn Genome Frontiers Institute; Penn Digestive Disease Center grant P30 DK050306; Joint Penn-CHOP Center for Digestive, Liver, and Pancreatic Medicine grants S10RR024525, UL1RR024134, and K24-DK078228; and the Howard Hughes Medical Institute. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Center for Research Resources, National Institutes of Health, or Pennsylvania Department of Health. Accession numbers (Sequence Read Archive): for the CAFE study, SRX021237, SRX021236, SRX020587, SRX020379, and SRX020378 (metagenomic); for the COMBO study, SRX020773, SRX020770, and SRX089367.	Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; EMMINGER A, 1977, CANCER LETT, V2, P273, DOI 10.1016/S0304-3835(77)80032-3; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:fmmtcd]2.0.co;2; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Wu GD, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-206	12	3800	4004	38	1078	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 7	2011	334	6052					105	108		10.1126/science.1208344	http://dx.doi.org/10.1126/science.1208344			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	829KW	21885731	Green Accepted			2022-12-28	WOS:000295580300050
J	Choi, JH; Banks, AS; Kamenecka, TM; Busby, SA; Chalmers, MJ; Kumar, N; Kuruvilla, DS; Shin, YS; He, YJ; Bruning, JB; Marciano, DP; Cameron, MD; Laznik, D; Jurczak, MJ; Schurer, SC; Vidovic, D; Shulman, GI; Spiegelman, BM; Griffin, PR				Choi, Jang Hyun; Banks, Alexander S.; Kamenecka, Theodore M.; Busby, Scott A.; Chalmers, Michael J.; Kumar, Naresh; Kuruvilla, Dana S.; Shin, Youseung; He, Yuanjun; Bruning, John B.; Marciano, David P.; Cameron, Michael D.; Laznik, Dina; Jurczak, Michael J.; Schuerer, Stephan C.; Vidovic, Dusica; Shulman, Gerald I.; Spiegelman, Bruce M.; Griffin, Patrick R.			Antidiabetic actions of a non-agonist PPAR gamma ligand blocking Cdk5-mediated phosphorylation	NATURE			English	Article							ACTIVATED-RECEPTOR-GAMMA; ADIPOCYTE DIFFERENTIATION; SKELETAL-MUSCLE; ROSIGLITAZONE; EXPRESSION; OBESITY; POTENT; THIAZOLIDINEDIONE; PPAR-GAMMA-2; MODULATORS	PPAR gamma is the functioning receptor for the thiazolidinedione (TZD) class of antidiabetes drugs including rosiglitazone and pioglitazone(1). These drugs are full classical agonists for this nuclear receptor, but recent data have shown that many PPAR gamma-based drugs have a separate biochemical activity, blocking the obesity-linked phosphorylation of PPAR gamma by Cdk5 (ref. 2). Here we describe novel synthetic compounds that have a unique mode of binding to PPAR gamma, completely lack classical transcriptional agonism and block the Cdk5-mediated phosphorylation in cultured adipocytes and in insulin-resistant mice. Moreover, one such compound, SR1664, has potent antidiabetic activity while not causing the fluid retention and weight gain that are serious side effects of many of the PPAR gamma drugs. Unlike TZDs, SR1664 also does not interfere with bone formation in culture. These data illustrate that new classes of antidiabetes drugs can be developed by specifically targeting the Cdk5-mediated phosphorylation of PPAR gamma.	[Choi, Jang Hyun; Banks, Alexander S.; Laznik, Dina; Spiegelman, Bruce M.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Choi, Jang Hyun; Banks, Alexander S.; Laznik, Dina; Spiegelman, Bruce M.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Div Metab & Chron Dis, Boston, MA 02115 USA; [Choi, Jang Hyun; Banks, Alexander S.; Laznik, Dina; Spiegelman, Bruce M.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Kamenecka, Theodore M.; Shin, Youseung; He, Yuanjun; Cameron, Michael D.; Griffin, Patrick R.] Scripps Res Inst, Translat Res Inst, Jupiter, FL 33458 USA; [Busby, Scott A.; Chalmers, Michael J.; Kumar, Naresh; Kuruvilla, Dana S.; Marciano, David P.; Cameron, Michael D.; Griffin, Patrick R.] Scripps Res Inst, Dept Mol Therapeut, Jupiter, FL 33458 USA; [Kamenecka, Theodore M.; Cameron, Michael D.; Griffin, Patrick R.] Scripps Res Inst, SRMSC, Jupiter, FL 33458 USA; [Bruning, John B.] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA; [Jurczak, Michael J.; Shulman, Gerald I.] Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Internal Med, New Haven, CT 06510 USA; [Jurczak, Michael J.; Shulman, Gerald I.] Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Cellular & Mol Physiol, New Haven, CT 06510 USA; [Schuerer, Stephan C.; Vidovic, Dusica] Univ Miami, Ctr Computat Sci, Miami, FL 33136 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Texas A&M University System; Texas A&M University College Station; Howard Hughes Medical Institute; Yale University; Howard Hughes Medical Institute; Yale University; University of Miami	Spiegelman, BM (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Biol, 44 Binney St, Boston, MA 02115 USA.	bruce_spiegelman@dfci.harvard.edu; pgriffin@scripps.edu	Choi, Jang Hyun/B-3055-2012; Bruning, John/AAW-8567-2020; Banks, Alexander/B-4832-2012; Shulman, Gerald I./P-7176-2019	Bruning, John/0000-0002-6919-1824; Banks, Alexander/0000-0003-1787-6925; Shulman, Gerald I./0000-0003-1529-5668; Jurczak, Michael/0000-0002-6335-6915; Chalmers, Michael/0000-0002-2139-6089; Marciano, David/0000-0001-8868-2138; Cameron, Michael/0000-0003-3154-4775	National Institutes of Health (NIH), National Institute of Mental Health [U54-MH074404]; National Institute of General Medical Sciences [R01-GM084041]; National Institute of Diabetes and Digestive and Kidney Diseases [1RC4DK090861]; NIH [DK31405]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027270] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK059635, RC4DK090861, R01DK031405, R01DK040936, R37DK031405] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084041] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH074404] Funding Source: NIH RePORTER	National Institutes of Health (NIH), National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We are grateful for support from S. Novick for assistance in the HDX studies and from R. D. Garcia-Ordonez in protein production and mutagenesis. We are grateful for support from B. Pascal and S. Willis for software analysing the HDX data. We are grateful to R. Gupta and P. Cohen for their critical comments on the manuscript. This work was supported in part by the Intramural Research Program of the National Institutes of Health (NIH), National Institute of Mental Health (grant U54-MH074404, H. Rosen principal investigator), the National Institute of General Medical Sciences (grant R01-GM084041, P. R. G.) and the National Institute of Diabetes and Digestive and Kidney Diseases (grant 1RC4DK090861, B. M. S.). This work also supported by NIH DK31405 to B.M.S.	Berger JP, 2003, MOL ENDOCRINOL, V17, P662, DOI 10.1210/me.2002-0217; Bruning JB, 2007, STRUCTURE, V15, P1258, DOI 10.1016/j.str.2007.07.014; Chalmers Michael J, 2007, J Biomol Tech, V18, P194; CHAWLA A, 1994, ENDOCRINOLOGY, V135, P798, DOI 10.1210/en.135.2.798; Choi JH, 2010, NATURE, V466, P451, DOI 10.1038/nature09291; DEFRONZO RA, 1979, AM J PHYSIOL, V237, pE214; FLIER JS, 1987, SCIENCE, V237, P405, DOI 10.1126/science.3299706; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; GRANA X, 1994, P NATL ACAD SCI USA, V91, P3834, DOI 10.1073/pnas.91.9.3834; Grey A, 2007, J CLIN ENDOCR METAB, V92, P1305, DOI 10.1210/jc.2006-2646; Hamuro Y, 2006, PROTEIN SCI, V15, P1883, DOI 10.1110/ps.062103006; Henke BR, 1998, J MED CHEM, V41, P5020, DOI 10.1021/jm9804127; Hu E, 1996, J BIOL CHEM, V271, P10697, DOI 10.1074/jbc.271.18.10697; Kahn BB, 2010, NEW ENGL J MED, V363, P2667, DOI 10.1056/NEJMcibr1012075; Kahn SE, 2008, DIABETES CARE, V31, P845, DOI 10.2337/dc07-2270; Kim HJ, 2004, DIABETES, V53, P1060, DOI 10.2337/diabetes.53.4.1060; KLIEWER SA, 1995, CELL, V83, P813, DOI 10.1016/0092-8674(95)90194-9; Lamotte Y, 2010, BIOORG MED CHEM LETT, V20, P1399, DOI 10.1016/j.bmcl.2009.12.107; Lecka-Czernik B, 1999, J CELL BIOCHEM, V74, P357, DOI 10.1002/(SICI)1097-4644(19990901)74:3<357::AID-JCB5>3.0.CO;2-7; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Mayerson AB, 2002, DIABETES, V51, P797, DOI 10.2337/diabetes.51.3.797; Nesto RW, 2004, DIABETES CARE, V27, P256, DOI 10.2337/diacare.27.1.256; NOLAN JJ, 1994, NEW ENGL J MED, V331, P1188, DOI 10.1056/NEJM199411033311803; Nolte RT, 1998, NATURE, V395, P137, DOI 10.1038/25931; Parulkar AA, 2001, ANN INTERN MED, V134, P61, DOI 10.7326/0003-4819-134-1-200101020-00014; Rocchi S, 2001, MOL CELL, V8, P737, DOI 10.1016/S1097-2765(01)00353-7; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Willson TM, 2001, ANNU REV BIOCHEM, V70, P341, DOI 10.1146/annurev.biochem.70.1.341	28	377	407	0	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 22	2011	477	7365					477	U131		10.1038/nature10383	http://dx.doi.org/10.1038/nature10383			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822WH	21892191	Green Accepted			2022-12-28	WOS:000295080500043
J	Taggart, DP; Banning, AP				Taggart, David P.; Banning, Adrian P.			Stents and failing vein grafts: are we any wiser after ISAR?	LANCET			English	Editorial Material							ARTERIAL REVASCULARIZATION; SURVIVAL		[Taggart, David P.] Univ Oxford, Nuffield Dept Surg, Oxford OX3 9DU, England; [Banning, Adrian P.] John Radcliffe Hosp, Dept Cardiovasc Med, Oxford OX3 9DU, England	University of Oxford; University of Oxford	Taggart, DP (corresponding author), Univ Oxford, Nuffield Dept Surg, Oxford OX3 9DU, England.	david.taggart@orh.nhs.uk	banning, adrian p/AAF-7229-2021	Banning, Adrian/0000-0002-2842-7861				Bridgewater B, 2009, BEHALF SOC CARDIOTHO; Brilakis ES, 2010, JACC-CARDIOVASC INTE, V3, P1068, DOI 10.1016/j.jcin.2010.07.009; FitzGibbon GM, 1996, J AM COLL CARDIOL, V28, P616, DOI 10.1016/0735-1097(96)00206-9; Kappetein AP, 2011, EUR HEART J, V32, P2125, DOI 10.1093/eurheartj/ehr213; Mehilli J, 2011, LANCET, V378, P1071, DOI 10.1016/S0140-6736(11)61255-5; Roukoz H, 2009, AM J MED, V122, DOI 10.1016/j.amjmed.2008.12.019; Schachner T, 2006, J THORAC CARDIOV SUR, V131, P1065, DOI 10.1016/j.jtcvs.2005.11.043; Tabata M, 2009, CIRCULATION, V120, P935, DOI 10.1161/CIRCULATIONAHA.108.832444; Taggart DP, 2010, EUR HEART J, V31, P2470, DOI 10.1093/eurheartj/ehq318; Taggart DP, 2001, LANCET, V358, P870, DOI 10.1016/S0140-6736(01)06069-X; Testa L, 2010, EUROINTERVENTION, V6, P527, DOI 10.4244/EIJ30V6I4A87	11	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 17	2011	378	9796					1054	1055		10.1016/S0140-6736(11)61340-8	http://dx.doi.org/10.1016/S0140-6736(11)61340-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	829BE	21872921				2022-12-28	WOS:000295548900005
J	Black, ME				Black, Mary E.			THE BIGGER PICTURE Different bodies, different futures	BRITISH MEDICAL JOURNAL			English	Editorial Material												drmaryblack@gmail.com							0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 7	2011	343								d5596	10.1136/bmj.d5596	http://dx.doi.org/10.1136/bmj.d5596			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	819RQ	21900350				2022-12-28	WOS:000294847800007
J	Haider, AH; Sexton, J; Sriram, N; Cooper, LA; Efron, DT; Swoboda, S; Villegas, CV; Haut, ER; Bonds, M; Pronovost, PJ; Lipsett, PA; Freischlag, JA; Cornwell, EE				Haider, Adil H.; Sexton, Janel; Sriram, N.; Cooper, Lisa A.; Efron, David T.; Swoboda, Sandra; Villegas, Cassandra V.; Haut, Elliott R.; Bonds, Morgan; Pronovost, Peter J.; Lipsett, Pamela A.; Freischlag, Julie A.; Cornwell, Edward E., III			Association of Unconscious Race and Social Class Bias With Vignette-Based Clinical Assessments by Medical Students	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							IMPLICIT ATTITUDES; ETHNIC DISPARITIES; STEREOTYPES; PHYSICIANS; DECISIONS; RACE/ETHNICITY; MORTALITY; PREJUDICE; EMERGENCY; VALIDITY	Context Studies involving physicians suggest that unconscious bias may be related to clinical decision making and may predict poor patient-physician interaction. The presence of unconscious race and social class bias and its association with clinical assessments or decision making among medical students is unknown. Objective To estimate unconscious race and social class bias among first-year medical students and investigate its relationship with assessments made during clinical vignettes. Design, Setting, and Participants A secure Web-based survey was administered to 211 medical students entering classes at Johns Hopkins School of Medicine, Baltimore, Maryland, in August 2009 and August 2010. The survey included the Implicit Association Test (IAT) to assess unconscious preferences, direct questions regarding students' explicit race and social class preferences, and 8 clinical assessment vignettes focused on pain assessment, informed consent, patient reliability, and patient trust. Adjusting for student demographics, multiple logistic regression was used to determine whether responses to the vignettes were associated with unconscious race or social class preferences. Main Outcome Measures Association of scores on an established IAT for race and a novel IAT for social class with vignette responses. Results Among the 202 students who completed the survey, IAT responses were consistent with an implicit preference toward white persons among 140 students (69%, 95% CI, 61%-75%). Responses were consistent with a preference toward those in the upper class among 174 students (86%, 95% CI, 80%-90%). Assessments generally did not vary by patient race or occupation, and multivariable analyses for all vignettes found no significant relationship between implicit biases and clinical assessments. Regression coefficient for the association between pain assessment and race IAT scores was -0.49 (95% CI, -1.00 to 0.03) and for social class, the coefficient was -0.04 (95% CI, -0.50 to 0.41). Adjusted odds ratios for other vignettes ranged from 0.69 to 3.03 per unit change in IAT score, but none were statistically significant. Analysis stratified by vignette patient race or class status yielded similarly negative results. Tests for interactions between patient race or class status and student IAT D scores in predicting clinical assessments were not statistically significant. Conclusions The majority of first-year medical students at a single school had IAT scores consistent with implicit preference for white persons and possibly for those in the upper class. However, overall vignette-based clinical assessments were not associated with patient race or occupation, and no association existed between implicit preferences and the assessments. JAMA. 2011;306(9):942-951	[Haider, Adil H.; Efron, David T.; Swoboda, Sandra; Villegas, Cassandra V.; Haut, Elliott R.; Bonds, Morgan; Lipsett, Pamela A.; Freischlag, Julie A.] Johns Hopkins Sch Med, Ctr Surg Trials & Outcomes Res, Dept Surg, Div Acute Care Surg, Baltimore, MD 21212 USA; [Sexton, Janel; Pronovost, Peter J.] Johns Hopkins Sch Med, Dept Anesthesia & Crit Care Med, Baltimore, MD 21212 USA; [Cooper, Lisa A.] Johns Hopkins Sch Med, Ctr Eliminat Cardiovasc Dispar, Baltimore, MD 21212 USA; [Sriram, N.] Univ Virginia, Dept Psychol, Charlottesville, VA 22903 USA; [Cornwell, Edward E., III] Howard Univ, Coll Med, Dept Surg, Washington, DC USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; University of Virginia; Howard University	Haider, AH (corresponding author), Johns Hopkins Sch Med, Ctr Surg Trials & Outcomes Res, Dept Surg, Div Acute Care Surg, 600 N Wolfe St,Halsted 610, Baltimore, MD 21212 USA.	ahaider1@jhmi.edu	Mobley, Harry L T/A-6901-2009; Haut, Elliott R./J-3948-2019	Haut, Elliott/0000-0001-7075-771X	National Institute of General Medical Sciences, National Institutes of Health [K23GM093112-01]; American College of Surgeons; National Heart, Lung, and Blood Institute [K24HL083113]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL083113] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K23GM093112] Funding Source: NIH RePORTER	National Institute of General Medical Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); American College of Surgeons; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by grant K23GM093112-01 from the National Institute of General Medical Sciences, National Institutes of Health and by the American College of Surgeons C. James Carrico Fellowship for the study of Trauma and Critical Care (Dr Haider), and grant K24HL083113 from the National Heart, Lung, and Blood Institute (Dr Cooper).	Betancourt JR, 2006, ACAD MED, V81, P788, DOI 10.1097/00001888-200609000-00004; Blair IV, 2002, PERS SOC PSYCHOL REV, V6, P242, DOI 10.1207/S15327957PSPR0603_8; Crompton JG, 2010, AM J SURG, V200, P191, DOI 10.1016/j.amjsurg.2009.07.047; DEVINE PG, 1989, J PERS SOC PSYCHOL, V56, P5, DOI 10.1037/0022-3514.56.5.680; Dovidio JF, 2000, PSYCHOL SCI, V11, P315, DOI 10.1111/1467-9280.00262; Fiske ST, 2010, HDB SOCIAL PSYCHOL, P237; GILBERT DT, 1991, J PERS SOC PSYCHOL, V60, P509, DOI 10.1037/0022-3514.60.4.509; Green AR, 2007, J GEN INTERN MED, V22, P1231, DOI 10.1007/s11606-007-0258-5; Greenwald AG, 2006, AM PSYCHOL, V61, P56, DOI 10.1037/0003-066X.61.1.56; Greenwald AG, 1998, J PERS SOC PSYCHOL, V74, P1464, DOI 10.1037/0022-3514.74.6.1464; Greenwald AG, 2003, J PERS SOC PSYCHOL, V85, P197, DOI 10.1037/0022-3514.85.2.197; Greenwald AG, 2009, J PERS SOC PSYCHOL, V97, P17, DOI 10.1037/a0015575; Haider AH, 2008, ARCH SURG-CHICAGO, V143, P945, DOI 10.1001/archsurg.143.10.945; Haider AH, 2007, J TRAUMA, V62, P1259, DOI 10.1097/TA.0b013e31803c760e; Institute of Medicine Committee on Understanding and Eliminating Racial and Ethnic Disparities in Health Care, 2003, UNEQUAL TREATMENT CO, DOI DOI 10.17226/12875; Johnson RL, 2004, AM J PUBLIC HEALTH, V94, P2084, DOI 10.2105/AJPH.94.12.2084; MACRAE CN, 1994, J PERS SOC PSYCHOL, V66, P37, DOI 10.1037/0022-3514.66.1.37; Nam CB, 2004, POPUL RES POLICY REV, V23, P327, DOI 10.1023/B:POPU.0000040045.51228.34; Nosek B.A., 2007, AUTOMATIC PROCESSES, P265, DOI DOI 10.1037/0022-3514.89.3.277; Nosek BA, 2007, EUR REV SOC PSYCHOL, V18, P36, DOI 10.1080/10463280701489053; Ostafin BD, 2008, J SOC CLIN PSYCHOL, V27, P404, DOI 10.1521/jscp.2008.27.4.404; PAAS FGWC, 1994, EDUC PSYCHOL REV, V6, P351, DOI 10.1007/BF02213420; Sabin JA, 2008, MED CARE, V46, P678, DOI 10.1097/MLR.0b013e3181653d58; Sriram N, 2009, EXP PSYCHOL, V56, P283, DOI 10.1027/1618-3169.56.4.283; StataCorp, 2009, STAT SOFTW REL 11 0; Steiger JH, 1992, BEHAV RES METH INSTR, V4, P581; Tamayo-Sarver JH, 2003, AM J PUBLIC HEALTH, V93, P2067, DOI 10.2105/AJPH.93.12.2067; Tamayo-Sarver JH, 2003, ACAD EMERG MED, V10, P1239, DOI 10.1197/S1069-6563903)00494-9; Teal CR, 2010, J GEN INTERN MED, V25, pS115, DOI 10.1007/s11606-009-1243-y; Thompson BM, 2010, J GEN INTERN MED, V25, pS91, DOI 10.1007/s11606-009-1245-9; TODD KH, 1993, JAMA-J AM MED ASSOC, V269, P1537, DOI 10.1001/jama.269.12.1537; Todd KH, 2000, ANN EMERG MED, V35, P11, DOI 10.1016/S0196-0644(00)70099-0; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124; van Ryn M, 2000, SOC SCI MED, V50, P813, DOI 10.1016/S0277-9536(99)00338-X; van Ryn M, 2003, AM J PUBLIC HEALTH, V93, P248, DOI 10.2105/AJPH.93.2.248; Wiers RW, 2010, ADDICTION, V105, P279, DOI 10.1111/j.1360-0443.2009.02775.x	36	194	195	2	56	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 7	2011	306	9					942	951		10.1001/jama.2011.1248	http://dx.doi.org/10.1001/jama.2011.1248			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	815QT	21900134	Green Accepted, Bronze			2022-12-28	WOS:000294542600012
J	Jeffe, DB; Andriole, DA				Jeffe, Donna B.; Andriole, Dorothy A.			Factors Associated With American Board of Medical Specialties Member Board Certification Among US Medical School Graduates	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PRIMARY-CARE PHYSICIANS; CERTIFYING EXAMINATION; ORTHOPEDIC-SURGERY; PART-I; PERFORMANCE; OUTCOMES; SCORES; DEMOGRAPHICS; RESIDENCY	Context Certification by an American Board of Medical Specialties (ABMS) member board is emerging as a measure of physician quality. Objective To identify demographic and educational factors associated with ABMS member board certification of US medical school graduates. Design, Setting, and Participants Retrospective study of a national cohort of 1997-2000 US medical school graduates, grouped by specialty choice at graduation and followed up through March 2, 2009. In separate multivariable logistic regression models for each specialty category, factors associated with ABMS member board certification were identified. Main Outcome Measure ABMS member board certification. Results Of 42 440 graduates in the study sample, 37 054 (87.3%) were board certified. Graduates in all specialty categories with first-attempt passing scores in the highest tertile (vs first-attempt failing scores) on US Medical Licensing Examination Step 2 Clinical Knowledge were more likely to be board certified; adjusted odds ratios (AORs) varied by specialty category, with the lowest odds for emergency medicine (87.4% vs 73.6%; AOR, 1.82; 95% CI, 1.03-3.20) and highest odds for radiology (98.1% vs 74.9%; AOR, 13.19; 95% CI, 5.55-31.32). In each specialty category except family medicine, graduates self-identified as underrepresented racial/ethnic minorities (vs white) were less likely to be board certified, ranging from 83.5% vs 95.6% in the pediatrics category (AOR, 0.44; 95% CI, 0.33-0.58) to 71.5% vs 83.7% in the other nongeneralist specialties category (AOR, 0.79; 95% CI, 0.64-0.96). With each $50 000 unit increase in debt (vs no debt), graduates choosing obstetrics/gynecology were less likely to be board certified (AOR, 0.89; 95% CI, 0.83-0.96), and graduates choosing family medicine were more likely to be board certified (AOR, 1.13; 95% CI, 1.01-1.26). Conclusion Demographic and educational factors were associated with board certification among US medical school graduates in every specialty category examined; findings varied among specialty categories. JAMA. 2011;306(9):961-970	[Jeffe, Donna B.] Washington Univ, Sch Med, Div Hlth Behav Res, St Louis, MO 63108 USA	Washington University (WUSTL)	Jeffe, DB (corresponding author), Washington Univ, Sch Med, Div Hlth Behav Res, 4444 Forest Pk Ave,Ste 6700, St Louis, MO 63108 USA.	djeffe@dom.wustl.edu	Jeffe, Donna B./AAI-3732-2020	Jeffe, Donna B./0000-0002-7642-3777	National Institutes of Health (NIH); AAMC; AMA; NIH National Institute of General Medical Sciences [R01 GM085350-03]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024992] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085350] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AAMC; AMA; NIH National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Both authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Drs Jeffe and Andriole report receiving travel funds from the National Institutes of Health (NIH) to attend various meetings, at which their research on medical education was presented. Dr Andriole reports receiving an honorarium and travel reimbursement from the University of Cincinnati for a lecture on MD-PhD programs and their graduates. Colleagues at the Association of American Medical Colleges (AAMC) and American Medical Association (AMA) did not receive compensation from the authors for their support, but data files provided by the AAMC and AMA were purchased with grant funds.; Funding for the study was provided by the NIH National Institute of General Medical Sciences (grant R01 GM085350-03).	Accreditation Council for Graduate Medical Education, 2010, POL PROC; Accreditation Council for Graduate Medical Education, COMM PROGR REQ; American Board of Family Medicine, EX PASS RAT 2010 EX; American Board of Obstetrics and Gynecology, ABOG DIPL; American Board of Surgery, AM GEN SURG EX STAT; American Medical Association, DESCR AMA PHYS MAST; [Anonymous], 1998, 1998 MED SCH GRAD QU; [Anonymous], 2010, 2010 ABMS CERT STAT; [Anonymous], 1999, 1999 MED SCH GRAD QU; [Anonymous], 1997, 1997 MED SCH GRAD QU; [Anonymous], 2006, AAMC DAT BOOK; [Anonymous], 2006, 2006 CERT STAT; Association of American Medical Colleges, 2000, MED SCH GRAD QUEST A; Association of American Medical Colleges, GRAD QUEST GQ; Association of American Medical Colleges, GME TRACK; Bach PB, 2004, NEW ENGL J MED, V351, P575, DOI 10.1056/NEJMsa040609; Brennan TA, 2004, JAMA-J AM MED ASSOC, V292, P1038, DOI 10.1001/jama.292.9.1038; Brotherton SE, 2010, JAMA-J AM MED ASSOC, V304, P1255, DOI 10.1001/jama.2010.1273; CASE SM, 1993, ACAD MED, V68, pS51, DOI 10.1097/00001888-199302000-00031; Chen J, 2006, J GEN INTERN MED, V21, P238, DOI 10.1111/j.1525-1497.2006.00326.x; Cohen JJ, 2006, JAMA-J AM MED ASSOC, V296, P1135, DOI 10.1001/jama.296.9.1135; Federation of State Medical Boards, STAT SPEC REQ IN MED; Freed GL, 2006, JAMA-J AM MED ASSOC, V295, P913, DOI 10.1001/jama.295.8.913; Grossman RS, 1996, ACAD MED, V71, pS74, DOI 10.1097/00001888-199610000-00049; *I MED, 2004, NAT COMP INT ENS DIV; Kohatsu ND, 2004, ARCH INTERN MED, V164, P653, DOI 10.1001/archinte.164.6.653; McCaskill QE, 2007, AMBUL PEDIATR, V7, P192, DOI 10.1016/j.ambp.2007.01.002; Mick S S, 1997, J Am Med Womens Assoc (1972), V52, P152; Morrison J, 1998, JAMA-J AM MED ASSOC, V279, P1889, DOI 10.1001/jama.279.23.1889; Norcini J, 2001, ACAD MED, V76, pS21, DOI 10.1097/00001888-200110001-00008; Norcini JJ, 2005, ACAD MED, V80, pS42, DOI 10.1097/00001888-200510001-00014; Norcini JJ, 2010, HEALTH AFFAIR, V29, P1461, DOI 10.1377/hlthaff.2009.0222; Palepu A, 2000, ACAD MED, V75, P157, DOI 10.1097/00001888-200002000-00014; Papadakis MA, 2008, ANN INTERN MED, V148, P869, DOI 10.7326/0003-4819-148-11-200806030-00009; Pham HH, 2005, JAMA-J AM MED ASSOC, V294, P473, DOI 10.1001/jama.294.4.473; Raether J, 2010, RESULTS 2010 NRMP PR; Robert Wood Johnson Foundation, PHYS TRAIN RES MAY A; Rund DA, ACAD PROMOTION TENUR; Sharp LK, 2002, ACAD MED, V77, P534, DOI 10.1097/00001888-200206000-00011; Shellito JL, 2010, AM J SURG, V199, P216, DOI 10.1016/j.amjsurg.2009.03.006; Silber CG, 2005, AM J OBSTET GYNECOL, V192, P318, DOI 10.1016/j.ajog.2004.09.007; Silber JH, 2002, ANESTHESIOLOGY, V96, P1044, DOI 10.1097/00000542-200205000-00004; Smart DR, 2010, PHYS CHARACTERISTICS; Swanson DB, 2009, ACAD MED, V84, pS21, DOI 10.1097/ACM.0b013e3181b37fd2; Wayne State University, 2009, FAC TRACKS GUID APP; Xu G, 1998, ACAD MED, V73, P1283, DOI 10.1097/00001888-199812000-00019	46	24	24	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 7	2011	306	9					961	970		10.1001/jama.2011.1099	http://dx.doi.org/10.1001/jama.2011.1099			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	815QT	21900136	Green Accepted			2022-12-28	WOS:000294542600014
J	Igarashi, K; Uchihashi, T; Koivula, A; Wada, M; Kimura, S; Okamoto, T; Penttila, M; Ando, T; Samejima, M				Igarashi, Kiyohiko; Uchihashi, Takayuki; Koivula, Anu; Wada, Masahisa; Kimura, Satoshi; Okamoto, Tetsuaki; Penttila, Merja; Ando, Toshio; Samejima, Masahiro			Traffic Jams Reduce Hydrolytic Efficiency of Cellulase on Cellulose Surface	SCIENCE			English	Article							NEUTRON FIBER DIFFRACTION; SYNCHROTRON X-RAY; TRICHODERMA-REESEI; CRYSTALLINE CELLULOSE; CELLOBIOHYDROLASE-I; ENZYMATIC-HYDROLYSIS; DEGRADATION; MICROCRYSTALS; MECHANISM; MODEL	A deeper mechanistic understanding of the saccharification of cellulosic biomass could enhance the efficiency of biofuels development. We report here the real-time visualization of crystalline cellulose degradation by individual cellulase enzymes through use of an advanced version of high-speed atomic force microscopy. Trichoderma reesei cellobiohydrolase I (TrCel7A) molecules were observed to slide unidirectionally along the crystalline cellulose surface but at one point exhibited collective halting analogous to a traffic jam. Changing the crystalline polymorphic form of cellulose by means of an ammonia treatment increased the apparent number of accessible lanes on the crystalline surface and consequently the number of moving cellulase molecules. Treatment of this bulky crystalline cellulose simultaneously or separately with T. reesei cellobiohydrolase II (TrCel6A) resulted in a remarkable increase in the proportion of mobile enzyme molecules on the surface. Cellulose was completely degraded by the synergistic action between the two enzymes.	[Igarashi, Kiyohiko; Wada, Masahisa; Kimura, Satoshi; Okamoto, Tetsuaki; Samejima, Masahiro] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biomat Sci, Bunkyo Ku, Tokyo 1138657, Japan; [Uchihashi, Takayuki; Okamoto, Tetsuaki; Ando, Toshio] Kanazawa Univ, Dept Phys, Kanazawa, Ishikawa 9201192, Japan; [Uchihashi, Takayuki; Ando, Toshio] Kanazawa Univ, Coll Sci & Engn, BioAFM Frontier Res Ctr, Kanazawa, Ishikawa 9201192, Japan; [Uchihashi, Takayuki; Ando, Toshio] Japan Sci & Technol Agcy, Chiyoda Ku, Tokyo 1020075, Japan; [Koivula, Anu; Penttila, Merja] VTT Tech Res Ctr Finland, FI-02044 Espoo, Finland; [Wada, Masahisa; Kimura, Satoshi] Kyung Hee Univ, Coll Life Sci, Dept Plant & Environm New Resources, Yongin 446701, Gyeonggi Do, South Korea	University of Tokyo; Kanazawa University; Kanazawa University; Japan Science & Technology Agency (JST); VTT Technical Research Center Finland; Kyung Hee University	Igarashi, K (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biomat Sci, Bunkyo Ku, Tokyo 1138657, Japan.	aquarius@mail.ecc.u-tokyo.ac.jp	Penttilä, Merja E/A-4710-2013; Uchihashi, Takayuki/D-5209-2011; ANDO, Toshio/E-7054-2015; Igarashi, Kiyohiko/E-6799-2016	Uchihashi, Takayuki/0000-0002-0263-5312; ANDO, Toshio/0000-0001-8819-154X; Igarashi, Kiyohiko/0000-0001-5152-7177; Penttila, Merja/0000-0002-6929-1032; Koivula, Anu/0000-0002-7600-5700	Japanese Ministry of Education, Culture, Sports, and Technology [19688016, 21688023, 21023010, 21681017, 20221006]; Knowledge Cluster Initiative; New Energy and Industrial Technology Development Organization [07003004-0]; Japanese Ministry of Agriculture, Forestry and Fisheries	Japanese Ministry of Education, Culture, Sports, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Knowledge Cluster Initiative(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); New Energy and Industrial Technology Development Organization(New Energy and Industrial Technology Development Organization (NEDO)); Japanese Ministry of Agriculture, Forestry and Fisheries(Ministry of Agriculture Forestry & Fisheries - Japan)	The authors are grateful to K. Tokuyasu of the National Food Research Institute, J. Stahlberg of the Swedish University of Agriculture Sciences, and A. Isogai of the University of Tokyo for their critical suggestions during the preparation of this paper. We thank T. Tsukada for his help in checking the activity and purity of TrCel6A. This research was supported by Grants-in-Aid for Scientific Research to K. I. (19688016 and 21688023), T. U. (21023010 and 21681017), and T. A. 20221006) from the Japanese Ministry of Education, Culture, Sports, and Technology; by a grant of the Knowledge Cluster Initiative to T. A.; by a Grant for Development of Technology for High Efficiency Bioenergy Conversion Project to M. S. (07003004-0) from the New Energy and Industrial Technology Development Organization; and by a Grant for Development of Biomass Utilization Technologies for Revitalizing Rural Areas to M. S. from the Japanese Ministry of Agriculture, Forestry and Fisheries.	Ando T, 2001, P NATL ACAD SCI USA, V98, P12468, DOI 10.1073/pnas.211400898; BERGHEM LER, 1975, EUR J BIOCHEM, V53, P55, DOI 10.1111/j.1432-1033.1975.tb04041.x; CHANZY H, 1985, FEBS LETT, V184, P285, DOI 10.1016/0014-5793(85)80623-2; Divne C, 1998, J MOL BIOL, V275, P309, DOI 10.1006/jmbi.1997.1437; DIVNE C, 1994, SCIENCE, V265, P524, DOI 10.1126/science.8036495; HENRISSAT B, 1993, BIOCHEM J, V293, P781, DOI 10.1042/bj2930781; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; HON DNS, 1994, CELLULOSE, V1, P1, DOI 10.1007/BF00818796; Igarashi K, 2007, FEBS J, V274, P1785, DOI 10.1111/j.1742-4658.2007.05727.x; Igarashi K, 2006, FEBS J, V273, P2869, DOI 10.1111/j.1742-4658.2006.05299.x; Igarashi K, 2009, J BIOL CHEM, V284, P36186, DOI 10.1074/jbc.M109.034611; Imai T, 1998, FEBS LETT, V432, P113, DOI 10.1016/S0014-5793(98)00845-X; Jalak J, 2010, BIOTECHNOL BIOENG, V106, P871, DOI 10.1002/bit.22779; Koivula A, 2002, J AM CHEM SOC, V124, P10015, DOI 10.1021/ja012659q; Lehtio J, 2003, P NATL ACAD SCI USA, V100, P484, DOI 10.1073/pnas.212651999; Liu YS, 2011, J BIOL CHEM, V286, P11195, DOI 10.1074/jbc.M110.216556; NIDETZKY B, 1994, BIOCHEM J, V298, P705, DOI 10.1042/bj2980705; Nishiyama Y, 2003, J AM CHEM SOC, V125, P14300, DOI 10.1021/ja037055w; ROUVINEN J, 1990, SCIENCE, V249, P380, DOI 10.1126/science.2377893; STAHLBERG J, 1991, BIO-TECHNOL, V9, P286, DOI 10.1038/nbt0391-286; Teeri TT, 1997, TRENDS BIOTECHNOL, V15, P160, DOI 10.1016/S0167-7799(97)01032-9; Teeri TT, 1998, BIOCHEM SOC T, V26, P173, DOI 10.1042/bst0260173; Wada M, 2004, MACROMOLECULES, V37, P8548, DOI 10.1021/ma0485585; Wolfenden R, 2008, J AM CHEM SOC, V130, P7548, DOI 10.1021/ja802206s; WOOD TM, 1978, BIOCHEM J, V171, P61, DOI 10.1042/bj1710061; Yang B, 2006, BIOTECHNOL BIOENG, V94, P1122, DOI 10.1002/bit.20942	26	403	421	6	314	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 2	2011	333	6047					1279	1282		10.1126/science.1208386	http://dx.doi.org/10.1126/science.1208386			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	813YM	21885779	Green Submitted			2022-12-28	WOS:000294406400051
J	Sykes, SM; Lane, SW; Bullinger, L; Kalaitzidis, D; Yusuf, R; Saez, B; Ferraro, F; Mercier, F; Singh, H; Brumme, KM; Acharya, SS; Scholl, C; Tothova, Z; Attar, EC; Frohling, S; DePinho, RA; Armstrong, SA; Gilliland, DG; Scadden, DT				Sykes, Stephen M.; Lane, Steven W.; Bullinger, Lars; Kalaitzidis, Demetrios; Yusuf, Rushdia; Saez, Borja; Ferraro, Francesca; Mercier, Francois; Singh, Harshabad; Brumme, Kristina M.; Acharya, Sanket S.; Schoell, Claudia; Tothova, Zuzana; Attar, Eyal C.; Froehling, Stefan; DePinho, Ronald A.; Armstrong, Scott A.; Gilliland, D. Gary; Scadden, David T.			AKT/FOXO Signaling Enforces Reversible Differentiation Blockade in Myeloid Leukemias	CELL			English	Article							HEMATOPOIETIC STEM-CELLS; PROTEIN-KINASE-B; FORKHEAD TRANSCRIPTION FACTOR; JUN ACTIVATION DOMAIN; OXIDATIVE STRESS; AKT PHOSPHORYLATION; TUMOR SUPPRESSORS; INITIATING CELLS; INSULIN; FOXO	AKT activation is associated with many malignancies, where AKT acts, in part, by inhibiting FOXO tumor suppressors. We show a converse role for AKT/FOXOs in acute myeloid leukemia (AML). Rather than decreased FOXO activity, we observed that FOXOs are active in similar to 40% of AML patient samples regardless of genetic subtype. We also observe this activity in human MLL-AF9 leukemia allele-induced AML in mice, where either activation of Akt or compound deletion of FoxO1/3/4 reduced leukemic cell growth, with the latter markedly diminishing leukemia-initiating cell (LIC) function in vivo and improving animal survival. FOXO inhibition resulted in myeloid maturation and subsequent AML cell death. FOXO activation inversely correlated with JNK/c-JUN signaling, and leukemic cells resistant to FOXO inhibition responded to JNK inhibition. These data reveal a molecular role for AKT/FOXO and JNK/c-JUN in maintaining a differentiation blockade that can be targeted to inhibit leukemias with a range of genetic lesions.	[Sykes, Stephen M.; Yusuf, Rushdia; Saez, Borja; Ferraro, Francesca; Mercier, Francois; Singh, Harshabad; Acharya, Sanket S.; Attar, Eyal C.; Scadden, David T.] Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA; [Sykes, Stephen M.; Yusuf, Rushdia; Saez, Borja; Ferraro, Francesca; Mercier, Francois; Singh, Harshabad; Acharya, Sanket S.; Attar, Eyal C.; Scadden, David T.] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; [Sykes, Stephen M.; Yusuf, Rushdia; Saez, Borja; Ferraro, Francesca; Mercier, Francois; Acharya, Sanket S.; Scadden, David T.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Lane, Steven W.; Kalaitzidis, Demetrios; Brumme, Kristina M.; Armstrong, Scott A.] Harvard Univ, Sch Med, Div Hematol Oncol, Childrens Hosp Boston, Boston, MA 02115 USA; [Tothova, Zuzana] Harvard Univ, Sch Med, Brigham & Womens Hosp, Boston, MA 02115 USA; [DePinho, Ronald A.] Harvard Univ, Sch Med, Belfer Inst Appl Canc Sci, Dept Med Oncol, Boston, MA 02115 USA; [DePinho, Ronald A.] Harvard Univ, Sch Med, Belfer Inst Appl Canc Sci, Dept Med, Boston, MA 02115 USA; [DePinho, Ronald A.] Harvard Univ, Sch Med, Dept Genet, Dana Farber Canc Inst, Boston, MA 02115 USA; [Bullinger, Lars; Schoell, Claudia; Froehling, Stefan] Univ Hosp Ulm, Dept Internal Med 3, D-89081 Ulm, Germany; [Gilliland, D. Gary] Merck Res Labs, N Wales, PA 19454 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Ulm University; Merck & Company	Scadden, DT (corresponding author), Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA.	dscadden@mgh.harvard.edu	Bullinger, Lars/AAL-7965-2020; Lane, Steven/C-3215-2012; Saez, Borja/L-7411-2015	Lane, Steven/0000-0002-8050-6209; Saez, Borja/0000-0001-7908-7089; Bullinger, Lars/0000-0002-5890-5510; DePinho, Ronald/0000-0002-5625-577X	NHLBI [5T32HL007623-24, U01HL100402]; Deutsche Forschungsgemeinschaft [BU 1339/3-1]; Leukemia and Lymphoma Society; Alex Lemonade Stand Foundation; Chamber of Industry and Commerce of the Government of Spain; NCI [U01CA141508, CA140575]; NIH NHLBI [HL097794, HL097748, HL100402]; NIDDK [DK050234]; Ellison Foundation; Harvard Stem Cell Institute; NATIONAL CANCER INSTITUTE [U01CA141508, R01CA140575] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097794, R01HL097748, T32HL007623, U01HL100402] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK050234] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Alex Lemonade Stand Foundation; Chamber of Industry and Commerce of the Government of Spain; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Ellison Foundation(Lawrence Ellison Foundation); Harvard Stem Cell Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We would like to thank Dr. Christine Ragu, Dr. Andrew Lane, and Dr. David Sykes for critically reading the manuscript and providing valuable suggestions. We would also like to thank Dr. Kira Gritsman and Dr. Michael Kharas for donating the MSCV-IRES-GFP-myr-Akt construct. We would also like to thank M. Milsom for donating the LoxP-STOP-LoxP-hCD34 expression plasmid. S.M.S. was supported by NHLBI 5T32HL007623-24. L.B. was supported by the Deutsche Forschungsgemeinschaft (Heisenberg-Stipendium BU 1339/3-1). R.Y. is supported by the Leukemia and Lymphoma Society and the Alex Lemonade Stand Foundation. B.S. is supported by the Chamber of Industry and Commerce of the Government of Spain. F.F. is supported by NHLBI U01HL100402. R.A.D. was supported by NCI U01CA141508. S.A.A. was supported by the Leukemia and Lymphoma Society and NCI CA140575. D.T.S. is supported by the NIH NHLBI HL097794, HL097748, and HL100402 and NIDDK DK050234, the Ellison Foundation, and the Harvard Stem Cell Institute. D.G.G. is a full-time employee of Merck & Company, Inc.	Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Altomare DA, 2005, ONCOGENE, V24, P7455, DOI 10.1038/sj.onc.1209085; Arden KC, 2006, EXP GERONTOL, V41, P709, DOI 10.1016/j.exger.2006.05.015; Armstrong SA, 2003, SEMIN HEMATOL, V40, P268, DOI 10.1016/S0037-1963(03)00196-3; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Bullinger L, 2004, NEW ENGL J MED, V350, P1605, DOI 10.1056/NEJMoa031046; BURGERING BMT, 1995, NATURE, V376, P599, DOI 10.1038/376599a0; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Dash A, 2001, BEST PRACT RES CL HA, V14, P49, DOI 10.1053/beha.2000.0115; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; delPeso L, 1997, SCIENCE, V278, P687; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; Dohner H, 2010, BLOOD, V115, P453, DOI 10.1182/blood-2009-07-235358; Essers MAG, 2004, EMBO J, V23, P4802, DOI 10.1038/sj.emboj.7600476; Frohling S, 2005, J CLIN ONCOL, V23, P6285, DOI 10.1200/JCO.2005.05.010; Fu Z, 2008, ONCOGENE, V27, P2312, DOI 10.1038/onc.2008.24; Gallay N, 2009, LEUKEMIA, V23, P1029, DOI 10.1038/leu.2008.395; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; HIBI M, 1993, GENE DEV, V7, P2135, DOI 10.1101/gad.7.11.2135; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Kharas MG, 2010, NAT MED, V16, P903, DOI 10.1038/nm.2187; Kharas MG, 2010, BLOOD, V115, P1406, DOI 10.1182/blood-2009-06-229443; Kim AH, 2001, MOL CELL BIOL, V21, P893, DOI 10.1128/MCB.21.3.893-901.2001; Kops GJPL, 1999, NATURE, V398, P630, DOI 10.1038/19328; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; Lee JY, 2010, CELL STEM CELL, V7, P593, DOI 10.1016/j.stem.2010.09.015; Miyamoto K, 2007, CELL STEM CELL, V1, P101, DOI 10.1016/j.stem.2007.02.001; Naka K, 2010, NATURE, V463, P676, DOI 10.1038/nature08734; Nicholson KM, 2002, CELL SIGNAL, V14, P381, DOI 10.1016/S0898-6568(01)00271-6; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Park S, 2010, HAEMATOL-HEMATOL J, V95, P819, DOI 10.3324/haematol.2009.013797; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Santamaria CM, 2009, LEUKEMIA RES, V33, P1706, DOI 10.1016/j.leukres.2009.04.024; Tamburini J, 2007, BLOOD, V110, P1025, DOI 10.1182/blood-2006-12-061283; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Wang MC, 2005, CELL, V121, P115, DOI 10.1016/j.cell.2005.02.030; Wang Z, 2008, NATURE, V455, P1205, DOI 10.1038/nature07284; Yalcin S, 2008, J BIOL CHEM, V283, P25692, DOI 10.1074/jbc.M800517200; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703	39	198	211	1	51	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 2	2011	146	5					697	708		10.1016/j.cell.2011.07.032	http://dx.doi.org/10.1016/j.cell.2011.07.032			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	814SM	21884932	Bronze, Green Accepted			2022-12-28	WOS:000294477500011
J	Caffau, E; Bonifacio, P; Francois, P; Sbordone, L; Monaco, L; Spite, M; Spite, F; Ludwig, HG; Cayrel, R; Zaggia, S; Hammer, F; Randich, S; Molaro, P; Hill, V				Caffau, Elisabetta; Bonifacio, Piercarlo; Francois, Patrick; Sbordone, Luca; Monaco, Lorenzo; Spite, Monique; Spite, Francois; Ludwig, Hans-G.; Cayrel, Roger; Zaggia, Simone; Hammer, Francois; Randich, Sofia; Molaro, Paolo; Hill, Vanessa			An extremely primitive star in the Galactic halo	NATURE			English	Article							3D MODEL ATMOSPHERE; METAL-POOR DWARFS; 1ST STARS; CHEMICAL-COMPOSITION; EARLY GALAXY; ABUNDANCES; LITHIUM; TELESCOPE; CARBON; YIELDS	The early Universe had a chemical composition consisting of hydrogen, helium and traces of lithium(1); almost all other elements were subsequently created in stars and supernovae. The mass fraction of elements more massive than helium, Z, is known as 'metallicity'. A number of very metal-poor stars has been found(2,3), some of which have a low iron abundance but are rich in carbon, nitrogen and oxygen(4-6). For theoretical reasons(7,8) and because of an observed absence of stars with Z<1.5x10(-5), it has been suggested that low-mass stars cannot form from the primitive interstellar medium until it has been enriched above a critical value of Z, estimated to lie in the range 1.5x10(-8) to 1.5x10(-6) (ref. 8), although competing theories claiming the contrary do exist(9). (We use 'low-mass' here to mean a stellar mass of less than 0.8 solar masses, the stars that survive to the present day.) Here we report the chemical composition of a star in the Galactic halo with a very low Z (<= 6.9x10(-7), which is 4.5x10(-5) times that of the Sun(10)) and a chemical pattern typical of classical extremely metal-poor stars(2,3)-that is, without enrichment of carbon, nitrogen and oxygen. This shows that low-mass stars can be formed at very low metallicity, that is, below the critical value of Z. Lithium is not detected, suggesting a low-metallicity extension of the previously observed trend in lithium depletion(11). Such lithium depletion implies that the stellar material must have experienced temperatures above two million kelvin in its history, given that this is necessary to destroy lithium.	[Caffau, Elisabetta; Sbordone, Luca; Ludwig, Hans-G.] Univ Heidelberg, Zentrum Astron, Landessternwarte, D-69117 Heidelberg, Germany; [Caffau, Elisabetta; Bonifacio, Piercarlo; Francois, Patrick; Sbordone, Luca; Spite, Monique; Spite, Francois; Ludwig, Hans-G.; Cayrel, Roger; Hammer, Francois] Univ Paris Diderot, CNRS, Observ Paris, GEPI, F-92190 Meudon, France; [Francois, Patrick] Univ Picardie Jules Verne, UPJV, F-80080 Amiens, France; [Sbordone, Luca] Max Planck Inst Astrophys, D-85741 Garching, Germany; [Monaco, Lorenzo] European So Observ, Santiago 19, Chile; [Zaggia, Simone] Osserv Astron Padova, Ist Nazl Astrofis, I-35122 Padua, Italy; [Randich, Sofia] Osserv Astrofis Arcetri, Ist Nazl Astrofis, I-50125 Florence, Italy; [Molaro, Paolo] Osserv Astron Trieste, Ist Nazl Astrofis, I-34143 Trieste, Italy; [Hill, Vanessa] Univ Nice Sophia Antipolis, Observ Cote Azur, CNRS, Lab Cassiopee, F-06300 Nice, France	Ruprecht Karls University Heidelberg; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Universite Paris Cite; Picardie Universites; Universite de Picardie Jules Verne (UPJV); Max Planck Society; European Southern Observatory; Istituto Nazionale Astrofisica (INAF); University of Padua; Istituto Nazionale Astrofisica (INAF); Istituto Nazionale Astrofisica (INAF); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Observatoire de la Cote d'Azur	Caffau, E (corresponding author), Univ Heidelberg, Zentrum Astron, Landessternwarte, Konigstuhl 12, D-69117 Heidelberg, Germany.	Elisabetta.Caffau@obspm.fr	Monaco, Lorenzo/AAH-4724-2021; Molaro, Paolo/AAE-8956-2021	Monaco, Lorenzo/0000-0002-3148-9836; Molaro, Paolo/0000-0002-0571-4163; Zaggia, Simone/0000-0001-6081-379X; Randich, Sofia/0000-0003-2438-0899; Sbordone, Luca/0000-0002-2285-8708; Ludwig, Hans-Gunter/0000-0001-9333-4410				Abazajian KN, 2009, ASTROPHYS J SUPPL S, V182, P543, DOI 10.1088/0067-0049/182/2/543; Boesgaard AM, 2007, ASTROPHYS J, V667, P1196, DOI 10.1086/521075; Bonifacio P, 2007, ASTRON ASTROPHYS, V462, P851, DOI 10.1051/0004-6361:20064834; Bromm V, 2003, NATURE, V425, P812, DOI 10.1038/nature02071; Caffau E, 2011, SOL PHYS, V268, P255, DOI 10.1007/s11207-010-9541-4; Cayrel R, 2004, ASTRON ASTROPHYS, V416, P1117, DOI 10.1051/0004-6361:20034074; Chieffi A, 2002, ASTROPHYS J, V577, P281, DOI 10.1086/342170; D'Odorico S, 2006, PROC SPIE, V6269, DOI 10.1117/12.672969; Dekker H, 2000, P SOC PHOTO-OPT INS, V4008, P534, DOI 10.1117/12.395512; Francois P, 2007, ASTRON ASTROPHYS, V476, P935, DOI 10.1051/0004-6361:20077706; Frebel A, 2007, MON NOT R ASTRON SOC, V380, pL40, DOI 10.1111/j.1745-3933.2007.00344.x; Gonzalez-Hernandez JI, 2008, ASTRON ASTROPHYS, V480, P233, DOI 10.1051/0004-6361:20078847; Iocco F, 2009, PHYS REP, V472, P1, DOI 10.1016/j.physrep.2009.02.002; Jedamzik K, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/10/105028; Kurucz R.L., 2005, MEM SAIT SUPPL, V8, P14; Ludwig HG, 2010, IAU SYMP P SERIES, V15, P339; Ludwig HG, 2008, PHYS SCRIPTA, VT133, DOI 10.1088/0031-8949/2008/T133/014037; Norris JE, 1997, ASTROPHYS J, V485, P370, DOI 10.1086/304390; Norris JE, 2007, ASTROPHYS J, V670, P774, DOI 10.1086/521919; Richard O, 2005, ASTROPHYS J, V619, P538, DOI 10.1086/426470; Ryan SG, 2002, ASTROPHYS J, V571, P501, DOI 10.1086/339939; Sbordone L, 2010, ASTRON ASTROPHYS, V522, DOI 10.1051/0004-6361/200913282; SPITE M, 1982, NATURE, V297, P483, DOI 10.1038/297483a0	29	256	258	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 1	2011	477	7362					67	69		10.1038/nature10377	http://dx.doi.org/10.1038/nature10377			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	813XT	21886158	Green Submitted			2022-12-28	WOS:000294404300031
J	Rogers, JA; Lagally, MG; Nuzzo, RG				Rogers, J. A.; Lagally, M. G.; Nuzzo, R. G.			Synthesis, assembly and applications of semiconductor nanomembranes	NATURE			English	Review							THIN-FILM TRANSISTORS; SILICON NANOMEMBRANES; BULK WAFERS; COMPOUND SEMICONDUCTORS; STRAINED-SILICON; GRAPHENE FILMS; ALL-CARBON; LARGE-AREA; ELECTRONICS; NANOSHEETS	Research in electronic nanomaterials, historically dominated by studies of nanocrystals/fullerenes and nanowires/nanotubes, now incorporates a growing focus on sheets with nanoscale thicknesses, referred to as nanomembranes. Such materials have practical appeal because their two-dimensional geometries facilitate integration into devices, with realistic pathways to manufacturing. Recent advances in synthesis provide access to nanomembranes with extraordinary properties in a variety of configurations, some of which exploit quantum and other size-dependent effects. This progress, together with emerging methods for deterministic assembly, leads to compelling opportunities for research, from basic studies of two-dimensional physics to the development of applications of heterogeneous electronics.	[Rogers, J. A.] Univ Illinois, Dept Mat Sci & Engn, Urbana, IL 61801 USA; [Lagally, M. G.] Univ Wisconsin Madison, Madison, WI 53706 USA; [Nuzzo, R. G.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Wisconsin System; University of Wisconsin Madison; University of Illinois System; University of Illinois Urbana-Champaign	Rogers, JA (corresponding author), Univ Illinois, Dept Mat Sci & Engn, 1304 W Green St, Urbana, IL 61801 USA.	jrogers@illinois.edu	Rogers, John/L-2798-2016		National Security Science and Engineering Faculty; AFOSR through a Multidisciplinary University Research Initiative [FA9550-08-1-0337]; US DOE [DE-FG02-03ER46028, DE-FG02-07ER46471, DE-FG36-08GO18021, DE-FG02-07ER46453]; US NSF/MRSEC [DMR-0520527]; US AFOSR [FA9550-08-1-0337]; US NSF [DMI-0328162]	National Security Science and Engineering Faculty; AFOSR through a Multidisciplinary University Research Initiative; US DOE(United States Department of Energy (DOE)); US NSF/MRSEC(National Science Foundation (NSF)); US AFOSR(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); US NSF(National Science Foundation (NSF))	We thank F. Du, A.-P. Le and S. Jo for assistance. The preparation of this manuscript was supported by a National Security Science and Engineering Faculty Fellowship and by AFOSR through a Multidisciplinary University Research Initiative grant (FA9550-08-1-0337). Work described in this Review that was performed by the authors was supported by the US DOE (DE-FG02-03ER46028, DE-FG02-07ER46471, DE-FG36-08GO18021 and DE-FG02-07ER46453), the US NSF/MRSEC programme (DMR-0520527), the US AFOSR (FA9550-08-1-0337) and the US NSF (DMI-0328162).	Ahn JH, 2006, SCIENCE, V314, P1754, DOI 10.1126/science.1132394; Baca AJ, 2007, ADV FUNCT MATER, V17, P3051, DOI 10.1002/adfm.200601161; Bae S, 2010, NAT NANOTECHNOL, V5, P574, DOI [10.1038/nnano.2010.132, 10.1038/NNANO.2010.132]; Bernardi A, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2978239; Cai JM, 2010, NATURE, V466, P470, DOI 10.1038/nature09211; Cavallo F, 2010, SOFT MATTER, V6, P439, DOI 10.1039/b916582g; Chen F, 2010, ACS NANO, V4, P2466, DOI 10.1021/nn100275z; Chun IS, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3456098; Coleman JN, 2011, SCIENCE, V331, P568, DOI 10.1126/science.1194975; Colson JW, 2011, SCIENCE, V332, P228, DOI 10.1126/science.1202747; DAVIS GD, 1980, J ELECTRON SPECTROSC, V20, P305, DOI 10.1016/0368-2048(80)85026-2; DIEDERICH F, 1994, NATURE, V369, P199, DOI 10.1038/369199a0; Diederich F, 2010, ADV MATER, V22, P803, DOI 10.1002/adma.200902623; Dikin DA, 2007, NATURE, V448, P457, DOI 10.1038/nature06016; Euaruksakul C, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.147403; Fujita M, 2005, SCIENCE, V308, P1296, DOI 10.1126/science.1110417; Geim AK, 2007, NAT MATER, V6, P183, DOI 10.1038/nmat1849; Geyer W, 1999, APPL PHYS LETT, V75, P2401, DOI 10.1063/1.125027; Green AA, 2009, NANO LETT, V9, P4031, DOI 10.1021/nl902200b; Haley MM, 2008, PURE APPL CHEM, V80, P519, DOI 10.1351/pac200880030519; HEBARD AF, 1993, ANNU REV MATER SCI, V23, P159, DOI 10.1146/annurev.ms.23.080193.001111; Hernandez Y, 2008, NAT NANOTECHNOL, V3, P563, DOI 10.1038/nnano.2008.215; Hirsch A, 2010, NAT MATER, V9, P868, DOI 10.1038/nmat2885; Huang GS, 2009, LAB CHIP, V9, P263, DOI 10.1039/b810419k; Huang MH, 2005, ADV MATER, V17, P2860, DOI 10.1002/adma.200501353; Huang MH, 2011, NANOSCALE, V3, P96, DOI 10.1039/c0nr00648c; Huang MH, 2009, ACS NANO, V3, P721, DOI 10.1021/nn8008883; Ji HX, 2010, ADV MATER, V22, P4591, DOI 10.1002/adma.201001422; Kando H., 2010, MICR C P APMC 2010 A, P920; Kiefer AM, 2011, ACS NANO, V5, P1179, DOI 10.1021/nn103149c; Kim DH, 2008, SCIENCE, V320, P507, DOI 10.1126/science.1154367; Kim DH, 2011, SCIENCE, V333, P838, DOI 10.1126/science.1206157; Kim DH, 2010, ADV MATER, V22, P2108, DOI 10.1002/adma.200902927; Kim RH, 2010, NAT MATER, V9, P929, DOI [10.1038/NMAT2879, 10.1038/nmat2879]; Kim S, 2010, P NATL ACAD SCI USA, V107, P17095, DOI 10.1073/pnas.1005828107; Knuesel RJ, 2010, P NATL ACAD SCI USA, V107, P993, DOI 10.1073/pnas.0909482107; Ko HC, 2008, NATURE, V454, P748, DOI 10.1038/nature07113; Ko HC, 2006, NANO LETT, V6, P2318, DOI 10.1021/nl061846p; Ko HC, 2009, SMALL, V5, P2703, DOI 10.1002/smll.200900934; Ko H, 2010, NATURE, V468, P286, DOI 10.1038/nature09541; KONAGAI M, 1978, J CRYST GROWTH, V45, P277, DOI 10.1016/0022-0248(78)90449-9; Lee KJ, 2006, J APPL PHYS, V100, DOI 10.1063/1.2349837; Lee KJ, 2005, ADV MATER, V17, P2332, DOI 10.1002/adma.200500578; Li F, 2009, OPT EXPRESS, V17, P19933, DOI 10.1364/OE.17.019933; Li XL, 2008, J PHYS D APPL PHYS, V41, DOI 10.1088/0022-3727/41/19/193001; Liu Z, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.016802; Long MQ, 2011, ACS NANO, V5, P2593, DOI 10.1021/nn102472s; Lu W, 2007, NAT MATER, V6, P841, DOI 10.1038/nmat2028; Ma RZ, 2010, ADV MATER, V22, P5082, DOI 10.1002/adma.201001722; Mack S, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2206688; MATTHEWS JW, 1974, J CRYST GROWTH, V27, P118, DOI 10.1016/S0022-0248(74)80055-2; Meitl MA, 2006, NAT MATER, V5, P33, DOI 10.1038/nmat1532; Menard E, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1866637; Menard E, 2004, APPL PHYS LETT, V84, P5398, DOI 10.1063/1.1767591; Moutanabbir O, 2010, ANNU REV MATER RES, V40, P469, DOI 10.1146/annurev-matsci-070909-104448; Novoselov KS, 2005, P NATL ACAD SCI USA, V102, P10451, DOI 10.1073/pnas.0502848102; Osada M, 2009, J MATER CHEM, V19, P2503, DOI 10.1039/b820160a; Park SI, 2009, SCIENCE, V325, P977, DOI 10.1126/science.1175690; Paskiewicz DM, 2011, ACS NANO, V5, P5532, DOI 10.1021/nn2009672; Paskiewicz DM, 2011, ACS NANO, V5, P5814, DOI 10.1021/nn201547k; Prinz VY, 2006, J APPL MECH TECH PH+, V47, P867, DOI 10.1007/s10808-006-0126-9; Radisavljevic B, 2011, NAT NANOTECHNOL, V6, P147, DOI [10.1038/nnano.2010.279, 10.1038/NNANO.2010.279]; Roberts MM, 2006, NAT MATER, V5, P388, DOI 10.1038/nmat1606; Rogers JA, 2010, SCIENCE, V327, P1603, DOI 10.1126/science.1182383; Sakamoto J, 2009, ANGEW CHEM INT EDIT, V48, P1030, DOI 10.1002/anie.200801863; Sanchez-Perez J. R., P NATL ACAD SC UNPUB; Sapienza L, 2010, SCIENCE, V327, P1352, DOI 10.1126/science.1185080; Sasaki DY, 2000, J COLLOID INTERF SCI, V229, P490, DOI 10.1006/jcis.2000.7043; Schmidt OG, 2001, NATURE, V410, P168, DOI 10.1038/35065525; Schultz MJ, 2008, P NATL ACAD SCI USA, V105, P7353, DOI 10.1073/pnas.0710081105; Scott SA, 2007, J PHYS D APPL PHYS, V40, pR75, DOI 10.1088/0022-3727/40/4/R01; Scott SA, 2008, ECS TRANSACTIONS, V16, P215, DOI 10.1149/1.2986772; Siriani DF, 2009, IEEE J SEL TOP QUANT, V15, P909, DOI 10.1109/JSTQE.2008.2012121; Stankovich S, 2007, CARBON, V45, P1558, DOI 10.1016/j.carbon.2007.02.034; STEIGERWALD ML, 1990, ACCOUNTS CHEM RES, V23, P183, DOI 10.1021/ar00174a003; STERN F, 1974, J APPL PHYS, V45, P3904, DOI 10.1063/1.1663884; Sun L, 2010, SMALL, V6, P2553, DOI 10.1002/smll.201000522; Tahara K, 2007, J ORG CHEM, V72, P1437, DOI 10.1021/jo0622781; Tang JY, 2010, NANO LETT, V10, P4279, DOI 10.1021/nl102931z; Timoshenko S, 1925, J OPT SOC AM REV SCI, V11, P233, DOI 10.1364/JOSA.11.000233; Turchanin A, 2009, ADV MATER, V21, P1233, DOI 10.1002/adma.200803078; Unarunotai S, 2010, ACS NANO, V4, P5591, DOI 10.1021/nn101896a; Unarunotai S, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3263942; Viventi J, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000738; Whang D, 2003, NANO LETT, V3, P1255, DOI 10.1021/nl0345062; Wu JS, 2007, CHEM REV, V107, P718, DOI 10.1021/cr068010r; Xu YX, 2008, J AM CHEM SOC, V130, P5856, DOI 10.1021/ja800745y; YABLONOVITCH E, 1987, APPL PHYS LETT, V51, P2222, DOI 10.1063/1.98946; Yoon J, 2010, NATURE, V465, P329, DOI 10.1038/nature09054; Yu JK, 2010, NAT NANOTECHNOL, V5, P718, DOI 10.1038/nnano.2010.149; Yuan HC, 2007, J APPL PHYS, V102, DOI 10.1063/1.2761782; Yuan HC, 2006, J APPL PHYS, V100, DOI 10.1063/1.2214301; Yuan HC, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3176407; Yuan HC, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3062938; Zhang PP, 2006, NATURE, V439, P703, DOI 10.1038/nature04501; Zhang Y, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/4/045603; Zheng Z, 2010, ANGEW CHEM INT EDIT, V49, P8493, DOI 10.1002/anie.201004053; Zwaneveld NAA, 2008, J AM CHEM SOC, V130, P6678, DOI 10.1021/ja800906f	99	530	559	8	707	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 1	2011	477	7362					45	53		10.1038/nature10381	http://dx.doi.org/10.1038/nature10381			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	813XT	21886156	Green Submitted			2022-12-28	WOS:000294404300028
J	Cookson, R				Cookson, Richard			LOBBY WATCH Media Smart	BRITISH MEDICAL JOURNAL			English	Editorial Material												richard@richardcookson.org							0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 31	2011	343								d5415	10.1136/bmj.d5415	http://dx.doi.org/10.1136/bmj.d5415			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	816LE	21880677				2022-12-28	WOS:000294600400004
J	Lamas, DJ; Ingelfinger, JR; Rosenbaum, LS				Lamas, Daniela J.; Ingelfinger, Julie R.; Rosenbaum, Lisa S.			Treatment of a 6-Year-Old Girl with Vesicoureteral Reflux - Polling Results	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							URINARY-TRACT-INFECTION; PROPHYLAXIS											Alon US, 2011, NEW ENGL J MED, V365, P266; Brandstrom P, 2010, J UROLOGY, V184, P286, DOI 10.1016/j.juro.2010.01.061; Craig JC, 2010, NEW ENGL J MED, V362, P1250; Craig JC, 2009, NEW ENGL J MED, V361, P1748, DOI 10.1056/NEJMoa0902295; Hoberman A, 2009, NEW ENGL J MED, V361, P1804, DOI 10.1056/NEJMe0907623; Keren R, 2008, PEDIATRICS, V122, P1409, DOI 10.1542/peds.2008-1285d	6	1	1	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 25	2011	365	8								10.1056/NEJMclde1108637	http://dx.doi.org/10.1056/NEJMclde1108637			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	811JM	21864164				2022-12-28	WOS:000294205300015
J	Allen, JP; Pianta, RC; Gregory, A; Mikami, AY; Lun, J				Allen, Joseph P.; Pianta, Robert C.; Gregory, Anne; Mikami, Amori Yee; Lun, Janetta			An Interaction-Based Approach to Enhancing Secondary School Instruction and Student Achievement	SCIENCE			English	Article							ADOLESCENTS	Improving teaching quality is widely recognized as critical to addressing deficiencies in secondary school education, yet the field has struggled to identify rigorously evaluated teacher-development approaches that can produce reliable gains in student achievement. A randomized controlled trial of My Teaching Partner-Secondary-a Web-mediated approach focused on improving teacher-student interactions in the classroom-examined the efficacy of the approach in improving teacher quality and student achievement with 78 secondary school teachers and 2237 students. The intervention produced substantial gains in measured student achievement in the year following its completion, equivalent to moving the average student from the 50th to the 59th percentile in achievement test scores. Gains appeared to be mediated by changes in teacher-student interaction qualities targeted by the intervention.	[Allen, Joseph P.; Mikami, Amori Yee] Univ Virginia, Dept Psychol, Charlottesville, VA 22904 USA; [Pianta, Robert C.] Univ Virginia, Curry Sch Educ, Charlottesville, VA 22904 USA; [Gregory, Anne] Rutgers State Univ, Dept Psychol, Piscataway, NJ 08854 USA; [Lun, Janetta] Univ Maryland, Dept Psychol, College Pk, MD 20742 USA	University of Virginia; University of Virginia; Rutgers State University New Brunswick; University System of Maryland; University of Maryland College Park	Allen, JP (corresponding author), Univ Virginia, Dept Psychol, Box 400400, Charlottesville, VA 22904 USA.	allen3@virginia.edu		Pianta, Robert/0000-0002-6280-8051; Lun, Janetta/0000-0002-0255-0423; Mikami, Amori/0000-0001-5821-0674	William T. Grant Foundation; Institute for Education Science [R305A100367]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD058305] Funding Source: NIH RePORTER	William T. Grant Foundation; Institute for Education Science(US Department of EducationInstitute of Education Sciences (IES)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study and its write-up were supported by grants from the William T. Grant Foundation and the Institute for Education Science (R305A100367). The authors acknowledge C. Hafen for his contribution to the analyses in this study and J. Wasserman and S. Deal for their contribution to the implementation of the intervention. R. C. P. is part owner of the company that disseminates the pre-K version of the Classroom Assessment Scoring System and co-author of the version used in this investigation. Further information regarding the My Teaching Partner-Secondary program is available at mtpsecondary.net.	Alexander KL, 1997, SOCIOL EDUC, V70, P87, DOI 10.2307/2673158; Allen J. P., 2009, ESCAPING ENDLESS ADO; ALLEN JP, 1994, CHILD DEV, V65, P179, DOI 10.2307/1131374; [Anonymous], 2008, WWC REV PROC; Battistich V, 1999, ELEM SCHOOL J, V99, P415, DOI 10.1086/461933; Beteille T., 2009, HDB ED POLICY RES PP, P596; Center for Data-Driven Reform in Education, BEST EV ENC; Commonwealth of Virginia, 2005, VIRG STAND LEARN TEC; Early D. M., 2005, PREKINDERGARTEN 11 S; Eccles J., 2009, HDB ADOLESCENT PSYCH, DOI DOI 10.1002/9780470479193.ADLPSY001013; Fredricks JA, 2004, REV EDUC RES, V74, P59, DOI 10.3102/00346543074001059; Hambleton R. K., 2000, REV SELECTED TECHNIC; Hamre B. K., 2010, HDB RES SCH SCH HUMA, DOI [10.4324/9780203874844.ch3, DOI 10.4324/9780203874844.CH3]; LAFFEY JM, 1982, J EDUC PSYCHOL, V74, P62, DOI 10.1037/0022-0663.74.1.62; National Research Council, 2002, ACH HIGH ED STAND AL; Newmann F.M., 1992, STUDENT ENGAGEMENT A, P11, DOI DOI 10.4236/OJAPPS.2014.45022; Nye B, 2004, EDUC EVAL POLICY AN, V26, P237, DOI 10.3102/01623737026003237; Odden A., 2002, J ED FINANCE, V28, P51; Pianta R.C., 2008, POSITIVE YOUTH DEV T, DOI [DOI 10.1093/ACPROF:OSO/9780195327892.003.0002, 10.1093/acprof:oso/9780195327892.003.0002]; Pianta R. C., 2012, CLASSROOM ASSESSMENT; Preacher KJ, 2010, PSYCHOL METHODS, V15, P209, DOI 10.1037/a0020141; Resnick MD, 1997, JAMA-J AM MED ASSOC, V278, P823, DOI 10.1001/jama.278.10.823; Roeser RW, 2000, ELEM SCHOOL J, V100, P443, DOI 10.1086/499650; Spivak G., 1987, PREVENTION DELINQUEN, P44; Steinberg L., 1996, CLASSROOM WHY SCH RE; Yoon K. S., 2007, ISSUES ANSWERS REPOR	26	265	269	7	125	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 19	2011	333	6045					1034	1037		10.1126/science.1207998	http://dx.doi.org/10.1126/science.1207998			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	808TD	21852503	Green Accepted			2022-12-28	WOS:000294000400060
J	Ross, JJ; Chamarthi, B; Greene, MF; Dluhy, RG				Ross, John J.; Chamarthi, Bindu; Greene, Michael F.; Dluhy, Robert G.			A Problem in Gestation	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																			0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 18	2011	365	7					E15	E15		10.1056/NEJMimc1102665	http://dx.doi.org/10.1056/NEJMimc1102665			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	808ER	21848456				2022-12-28	WOS:000293960500030
J	Walker, S				Walker, Shaun			PUBLIC HEALTH Russia's alcohol problem	BRITISH MEDICAL JOURNAL			English	Editorial Material												s.walker@independent.co.uk						WHO, 2014, GLOB STAT REP ALC HL; Zaridze D, 2009, LANCET, V373, P2201, DOI 10.1016/S0140-6736(09)61034-5	2	2	2	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 17	2011	343								d5240	10.1136/bmj.d5240	http://dx.doi.org/10.1136/bmj.d5240			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	811LB	21849392				2022-12-28	WOS:000294210500007
J	Moss, WJ; Griffin, DE				Moss, William J.; Griffin, Diane E.			Measles	LANCET			English	Article							SUBACUTE SCLEROSING-PANENCEPHALITIS; VIRUS HEMAGGLUTININ; INFECTED CHILDREN; IMMUNE-RESPONSES; ZAMBIAN CHILDREN; RHESUS MACAQUES; NEUTRALIZING ANTIBODY; AEROSOLIZED MEASLES; INAPPARENT MEASLES; MATERNAL ANTIBODY	Measles is a highly contagious disease caused by measles virus and is one of the most devastating infectious diseases of man-measles was responsible for millions of deaths annually worldwide before the introduction of the measles vaccines. Remarkable progress in reducing the number of people dying from measles has been made through measles vaccination, with an estimated 164 000 deaths attributed to measles in 2008. This achievement attests to the enormous importance of measles vaccination to public health. However, this progress is threatened by failure to maintain high levels of measles vaccine coverage. Recent measles outbreaks in sub-Saharan Africa, Europe, and the USA show the ease with which measles virus can re-enter communities if high levels of population immunity are not sustained. The major challenges for continued measles control and eventual eradication will be logistical, financial, and the garnering of sufficient political will. These challenges need to be met to ensure that future generations of children do not die of measles.	[Moss, William J.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21218 USA; [Moss, William J.; Griffin, Diane E.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Moss, WJ (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, 615 N Wolfe St, Baltimore, MD 21218 USA.	wmoss@jhsph.edu			National Institute of Allergy and Infectious Diseases [AI070018, AI023047]; Bill & Melinda Gates Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI023047] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	WJM was supported by a grant from the National Institute of Allergy and Infectious Diseases (AI070018). DEG was supported by grants from the National Institute of Allergy and Infectious Diseases (AI023047) and the Bill & Melinda Gates Foundation. These funding agencies had no role in the writing of this manuscript.	Akramuzzaman SM, 2000, AM J EPIDEMIOL, V151, P723, DOI 10.1093/oxfordjournals.aje.a010267; Amanna IJ, 2007, NEW ENGL J MED, V357, P1903, DOI 10.1056/NEJMoa066092; [Anonymous], 2009, Wkly Epidemiol Rec, V84, P509; [Anonymous], 2000, Wkly Epidemiol Rec, V75, P411; [Anonymous], 2011, Wkly Epidemiol Rec, V86, P129; [Anonymous], 2010, Wkly Epidemiol Rec, V85, P490; [Anonymous], 2011, Wkly Epidemiol Rec, V86, P173; [Anonymous], 1998, DAHL WORKSH ER INF D; Aurpibul L, 2010, CLIN INFECT DIS, V50, P1415, DOI 10.1086/652150; Avota E, 2010, MED MICROBIOL IMMUN, V199, P227, DOI 10.1007/s00430-010-0152-3; BECKFORD AP, 1985, S AFR MED J, V68, P858; Bellini WJ, 2005, J INFECT DIS, V192, P1686, DOI 10.1086/497169; Bellini WJ, 2003, J INFECT DIS, V187, pS283, DOI 10.1086/368040; Bennett JV, 2002, B WORLD HEALTH ORGAN, V80, P806; BLACK FL, 1966, J THEOR BIOL, V11, P207, DOI 10.1016/0022-5193(66)90161-5; BLACK FL, 1960, JAMA-J AM MED ASSOC, V173, P1183, DOI 10.1001/jama.1960.03020290009002; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Brown AC, 2010, SEX HORMONES AND IMMUNITY TO INFECTION, P281, DOI 10.1007/978-3-642-02155-8_11; Caceres VM, 2000, CLIN INFECT DIS, V31, P110, DOI 10.1086/313926; Campbell H, 2007, INT J EPIDEMIOL, V36, P1334, DOI 10.1093/ije/dym207; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P1036; CHEN RT, 1989, AM J EPIDEMIOL, V129, P173, DOI 10.1093/oxfordjournals.aje.a115106; Condack C, 2007, J INFECT DIS, V196, P541, DOI 10.1086/519689; COOVADIA HM, 1978, INT ARCH ALLER A IMM, V56, P14, DOI 10.1159/000231998; Dallaire F, 2009, J INFECT DIS, V200, P1602, DOI 10.1086/644783; de Quadros CA, 2008, EXPERT REV VACCINES, V7, P355, DOI 10.1586/14760584.7.3.355; de Swart RL, 2007, PLOS PATHOG, V3, P1771, DOI 10.1371/journal.ppat.0030178; deQuadros CA, 1996, JAMA-J AM MED ASSOC, V275, P224, DOI 10.1001/jama.275.3.224; DeStefano F, 2007, CLIN PHARMACOL THER, V82, P756, DOI 10.1038/sj.clpt.6100407; Dietz V, 2004, B WORLD HEALTH ORGAN, V82, P852; Dilraj A, 2000, LANCET, V355, P798, DOI 10.1016/S0140-6736(99)95140-1; Duke T, 2003, LANCET, V361, P763, DOI 10.1016/S0140-6736(03)12661-X; ENDERS JF, 1954, P SOC EXP BIOL MED, V86, P277, DOI 10.3181/00379727-86-21073; Ferrari MJ, 2008, NATURE, V451, P679, DOI 10.1038/nature06509; FINE PEM, 1982, INT J EPIDEMIOL, V11, P5, DOI 10.1093/ije/11.1.5; Frank SA, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-229; Freeman AF, 2004, PEDIATRICS, V114, pE657, DOI 10.1542/peds.2004-0949; FULGINITI VA, 1967, J AMER MED ASSOC, V202, P1075, DOI 10.1001/jama.202.12.1075; Furuse Y, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-52; GARENNE M, 1991, LANCET, V338, P903, DOI 10.1016/0140-6736(91)91771-L; GARENNE M, 1994, INT J EPIDEMIOL, V23, P632, DOI 10.1093/ije/23.3.632; Garg RK, 2008, J NEUROL, V255, P1861, DOI 10.1007/s00415-008-0032-6; Gay NJ, 2004, J INFECT DIS, V189, pS27, DOI 10.1086/381592; Glass K, 2004, EPIDEMIOL INFECT, V132, P675, DOI 10.1017/S0950268804002080; GOOD RA, 1956, PEDIATRICS, V18, P109; GREENBERG BL, 1991, J INFECT DIS, V163, P495, DOI 10.1093/infdis/163.3.495; GRIFFIN DE, 1993, J INFECT DIS, V168, P275, DOI 10.1093/infdis/168.2.275; GRIFFIN DE, 1985, J ALLERGY CLIN IMMUN, V76, P206, DOI 10.1016/0091-6749(85)90703-1; Griffin DE, 2008, FRONT BIOSCI-LANDMRK, V13, P1352, DOI 10.2741/2767; Griffin DE, 2010, IMMUNOL REV, V236, P176, DOI 10.1111/j.1600-065X.2010.00925.x; Griffin Diane E, 2009, Curr Top Microbiol Immunol, V329, P1; Hahm B, 2009, CURR TOP MICROBIOL, V330, P271; HALSEY NA, 1993, PEDIATR INFECT DIS J, V12, P462, DOI 10.1097/00006454-199306000-00002; HALSEY NA, 1983, RECENT ADV IMMUNIZAT, P4; Hashiguchi T, 2007, P NATL ACAD SCI USA, V104, P19535, DOI 10.1073/pnas.0707830104; Helfand RF, 2005, B WORLD HEALTH ORGAN, V83, P329; Helfand RF, 1999, EPIDEMIOL INFECT, V123, P451, DOI 10.1017/S0950268899002988; HIRSCH RL, 1984, CLIN IMMUNOL IMMUNOP, V31, P1, DOI 10.1016/0090-1229(84)90184-3; Huiming Y, 2005, COCHRANE DB SYST REV, V4; Jansen VAA, 2003, SCIENCE, V301, P804, DOI 10.1126/science.1086726; JOHNSON RT, 1984, NEW ENGL J MED, V310, P137, DOI 10.1056/NEJM198401193100301; Kabra SK, 2008, COCHRANE DB SYST REV, V3; Kremer JR, 2006, VACCINE, V24, P2594, DOI 10.1016/j.vaccine.2005.12.015; Kuhne M, 2006, INFECT GENET EVOL, V6, P269, DOI 10.1016/j.meegid.2005.08.003; Leonard VHJ, 2008, J CLIN INVEST, V118, P2448, DOI 10.1172/JCI35454; Lessler J, 2009, LANCET INFECT DIS, V9, P291, DOI 10.1016/S1473-3099(09)70069-6; Leuridan E, 2010, BMJ, V340, pc1626, DOI 10.1136/bmj.c1626; Lievano FA, 2004, J INFECT DIS, V189, pS165, DOI 10.1086/377715; Lin WH, 2011, P NATL ACAD SCI USA, V108, P2987, DOI 10.1073/pnas.1017334108; Low N, 2008, VACCINE, V26, P383, DOI 10.1016/j.vaccine.2007.11.010; Madsen KM, 2002, NEW ENGL J MED, V347, P1477, DOI 10.1056/NEJMoa021134; MALVOISIN E, 1993, J GEN VIROL, V74, P2365, DOI 10.1099/0022-1317-74-11-2365; Mantadakis E, 2010, J PEDIATR-US, V156, P623, DOI 10.1016/j.jpeds.2009.10.015; Marshall TM, 2003, J INFECT DIS, V187, pS97, DOI 10.1086/368041; McLean Huang, 2011, Morbidity and Mortality Weekly Report, V60, P666; McMorrow ML, 2009, SAMJ S AFR MED J, V99, P314; MORLEY D, 1969, BMJ-BRIT MED J, V1, P297, DOI 10.1136/bmj.1.5639.297; Moss WJ, 2007, J INFECT DIS, V196, P347, DOI 10.1086/519169; Moss WJ, 2006, NAT REV MICROBIOL, V4, P900, DOI 10.1038/nrmicro1550; Moss WJ, 1999, CLIN INFECT DIS, V29, P106, DOI 10.1086/520136; Moss WJ, 2002, CLIN INFECT DIS, V35, P189, DOI 10.1086/341248; Moss WJ, 2002, J INFECT DIS, V186, P879, DOI 10.1086/344230; Moss WJ, 2009, WHO IMMUNOLOGICAL BA; Mossong J, 1999, AM J EPIDEMIOL, V150, P1238, DOI 10.1093/oxfordjournals.aje.a009951; Moussallem TM, 2007, HUM PATHOL, V38, P1239, DOI 10.1016/j.humpath.2007.01.015; Muscat M, 2009, LANCET, V373, P383, DOI 10.1016/S0140-6736(08)61849-8; Naniche D, 2009, CURR TOP MICROBIOL, V330, P151; Offit PA, 2003, VACCINE, V22, P1, DOI 10.1016/S0264-410X(03)00532-2; Orenstein WA, 2000, AM J PUBLIC HEALTH, V90, P1521, DOI 10.2105/AJPH.90.10.1521; Ota MO, 2007, J INFECT DIS, V195, P1799, DOI 10.1086/518006; Otten M, 2005, LANCET, V366, P832, DOI 10.1016/S0140-6736(05)67216-9; Pan CH, 2010, J VIROL, V84, P3798, DOI 10.1128/JVI.01566-09; Parker AA, 2006, NEW ENGL J MED, V355, P447, DOI 10.1056/NEJMoa060775; Parks CL, 2001, J VIROL, V75, P910, DOI 10.1128/JVI.75.2.910-920.2001; Pasetti MF, 2003, J VIROL, V77, P5209, DOI 10.1128/JVI.77.9.5209-5217.2003; Permar SR, 2001, J INFECT DIS, V183, P532, DOI 10.1086/318533; Perry Robert T., 2004, Journal of Infectious Diseases, V189, pS4, DOI 10.1086/377712; Polack FP, 2000, NAT MED, V6, P776, DOI 10.1038/77506; Premenko-Lanier M, 2004, J INFECT DIS, V189, P2064, DOI 10.1086/420792; Premenko-Lanier M, 2003, VIROLOGY, V307, P67, DOI 10.1016/S0042-6822(02)00036-3; Reuter D, 2010, MED MICROBIOL IMMUN, V199, P261, DOI 10.1007/s00430-010-0153-2; Riddell MA, 2007, J CLIN VIROL, V39, P312, DOI 10.1016/j.jcv.2007.05.006; Rota PA, 2009, CURR TOP MICROBIOL, V330, P129; Ryon JJ, 2002, CLIN DIAGN LAB IMMUN, V9, P994, DOI 10.1128/CDLI.9.5.994-1003.2002; Scott S, 2008, INT J EPIDEMIOL, V37, P356, DOI 10.1093/ije/dyn007; Scott S, 2007, CLIN INFECT DIS, V45, P1417, DOI 10.1086/522989; Semba RD, 2004, SURV OPHTHALMOL, V49, P243, DOI 10.1016/j.survophthal.2003.12.005; SENCER DJ, 1967, PUBLIC HEALTH REP, V82, P253, DOI 10.2307/4592985; Servet-Delprat C, 2000, J VIROL, V74, P4387, DOI 10.1128/JVI.74.9.4387-4393.2000; Skiadopoulos MH, 2001, J VIROL, V75, P10498, DOI 10.1128/JVI.75.21.10498-10504.2001; Sutcliffe CG, 2010, LANCET INFECT DIS, V10, P630, DOI 10.1016/S1473-3099(10)70116-X; Takeda M, 2008, J CLIN INVEST, V118, P2386, DOI 10.1172/JCI36251; TAMASHIRO VG, 1987, PEDIATR INFECT DIS J, V6, P451, DOI 10.1097/00006454-198705000-00007; TAMIN A, 1994, J INFECT DIS, V170, P795, DOI 10.1093/infdis/170.4.795; Tejiokem MC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001260; Tierney LM, 2006, NEW ENGL J MED, V354, P740, DOI 10.1056/NEJMicm050576; Turnera A, 2006, AM J TRANSPLANT, V6, P1459, DOI 10.1111/j.1600-6143.2006.01330.x; von Pirquet C, 1908, DEUT MED WOCHENSCHR, V34, P1297; Wakefield AJ, 1998, LANCET, V351, P637, DOI 10.1016/S0140-6736(97)11096-0; Warrener L, 2010, J MED VIROL, V82, P485, DOI 10.1002/jmv.21693; Watanabe A, 2010, J VIROL, V84, P4183, DOI 10.1128/JVI.02168-09; Webster DE, 2005, VACCINE, V23, P1859, DOI 10.1016/j.vaccine.2004.11.018; *WHO, 2009, WKLY EPIDEMIOL REC, V84, P349; WHO, 2008, MMWR-MORBID MORTAL W, V57, P657; *WHO DEP VACC BIOL, 2003, WHO REC STAND SURV S; Wolfson LJ, 2007, LANCET, V369, P191, DOI 10.1016/S0140-6736(07)60107-X; Wolfson LJ, 2009, INT J EPIDEMIOL, V38, P192, DOI 10.1093/ije/dyn224; Wong-Chew RM, 2004, J INFECT DIS, V189, P254, DOI 10.1086/380565; Wong-Chew RM, 2006, VACCINE, V24, P683, DOI 10.1016/j.vaccine.2005.08.045; World Health Organization Regional Committee for Africa, 2009, EL MEASL AFR REG 202; World Health Organization & United Nations Children's Fund, 2005, GLOB IMM VIS STRAT 2; Yanagi Y, 2006, J GEN VIROL, V87, P2767, DOI 10.1099/vir.0.82221-0; Yu XL, 2008, J IMMUNOL, V181, P7356, DOI 10.4049/jimmunol.181.10.7356; Zhang Y, 2010, EMERG INFECT DIS, V16, P943, DOI 10.3201/eid1606.100089; [No title captured]	135	233	238	1	100	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 14	2012	379	9811					153	164		10.1016/S0140-6736(10)62352-5	http://dx.doi.org/10.1016/S0140-6736(10)62352-5			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	879GM	21855993				2022-12-28	WOS:000299317700038
J	Chimowitz, MI; Lynn, MJ; Derdeyn, CP; Turan, TN; Fiorella, D; Lane, BF; Janis, LS; Lutsep, HL; Barnwell, SL; Waters, MF; Hoh, BL; Hourihane, JM; Levy, EI; Alexandrov, AV; Harrigan, MR; Chiu, D; Klucznik, RP; Clark, JM; McDougall, CG; Johnson, MD; Pride, GL; Torbey, MT; Zaidat, OO; Rumboldt, Z; Cloft, HJ				Chimowitz, Marc I.; Lynn, Michael J.; Derdeyn, Colin P.; Turan, Tanya N.; Fiorella, David; Lane, Bethany F.; Janis, L. Scott; Lutsep, Helmi L.; Barnwell, Stanley L.; Waters, Michael F.; Hoh, Brian L.; Hourihane, J. Maurice; Levy, Elad I.; Alexandrov, Andrei V.; Harrigan, Mark R.; Chiu, David; Klucznik, Richard P.; Clark, Joni M.; McDougall, Cameron G.; Johnson, Mark D.; Pride, G. Lee, Jr.; Torbey, Michel T.; Zaidat, Osama O.; Rumboldt, Zoran; Cloft, Harry J.		SAMMPRIS Trial Investigators	Stenting versus Aggressive Medical Therapy for Intracranial Arterial Stenosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ISCHEMIC-STROKE; RECURRENT STROKE; WINGSPAN STENT; PATTERNS; DISEASE; RISK; ATHEROSCLEROSIS; ANGIOPLASTY; PREDICTORS; RESTENOSIS	Background Atherosclerotic intracranial arterial stenosis is an important cause of stroke that is increasingly being treated with percutaneous transluminal angioplasty and stenting (PTAS) to prevent recurrent stroke. However, PTAS has not been compared with medical management in a randomized trial. Methods We randomly assigned patients who had a recent transient ischemic attack or stroke attributed to stenosis of 70 to 99% of the diameter of a major intracranial artery to aggressive medical management alone or aggressive medical management plus PTAS with the use of the Wingspan stent system. The primary end point was stroke or death within 30 days after enrollment or after a revascularization procedure for the qualifying lesion during the follow-up period or stroke in the territory of the qualifying artery beyond 30 days. Results Enrollment was stopped after 451 patients underwent randomization, because the 30-day rate of stroke or death was 14.7% in the PTAS group (nonfatal stroke, 12.5%; fatal stroke, 2.2%) and 5.8% in the medical-management group (nonfatal stroke, 5.3%; non-stroke-related death, 0.4%) (P=0.002). Beyond 30 days, stroke in the same territory occurred in 13 patients in each group. Currently, the mean duration of follow-up, which is ongoing, is 11.9 months. The probability of the occurrence of a primary end-point event over time differed significantly between the two treatment groups (P=0.009), with 1-year rates of the primary end point of 20.0% in the PTAS group and 12.2% in the medical-management group. Conclusions In patients with intracranial arterial stenosis, aggressive medical management was superior to PTAS with the use of the Wingspan stent system, both because the risk of early stroke after PTAS was high and because the risk of stroke with aggressive medical therapy alone was lower than expected. (Funded by the National Institute of Neurological Disorders and Stroke and others; SAMMPRIS ClinicalTrials.gov number, NCT00576693.)	[Chimowitz, Marc I.] Med Univ S Carolina, Stroke Program, Dept Neurosci, Charleston, SC 29425 USA; [Rumboldt, Zoran] Med Univ S Carolina, Dept Radiol, Charleston, SC 29425 USA; [Lynn, Michael J.; Lane, Bethany F.] Emory Univ, Rollins Sch Publ Hlth, Dept Biostat & Bioinformat, Atlanta, GA 30322 USA; [Derdeyn, Colin P.] Washington Univ, Sch Med, Mallinckrodt Inst Radiol, St Louis, MO USA; [Derdeyn, Colin P.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Derdeyn, Colin P.] Washington Univ, Sch Med, Dept Neurosurg, St Louis, MO USA; [Fiorella, David] SUNY Stony Brook, Dept Neurosurg, Stony Brook, NY 11794 USA; [Janis, L. Scott] NINDS, NIH, Bethesda, MD 20892 USA; [Lutsep, Helmi L.] Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97201 USA; [Barnwell, Stanley L.] Oregon Hlth & Sci Univ, Dept Neurol Surg, Portland, OR 97201 USA; [Barnwell, Stanley L.] Oregon Hlth & Sci Univ, Dotter Intervent Inst, Portland, OR 97201 USA; [Waters, Michael F.] Univ Florida, Dept Neurol & Neurosci, Gainesville, FL USA; [Hoh, Brian L.] Univ Florida, Dept Neurosurg, Gainesville, FL USA; [Hourihane, J. Maurice] Dent Neurol Inst, Buffalo, NY USA; [Levy, Elad I.] SUNY Buffalo, Dept Neurosurg, Buffalo, NY 14260 USA; [Alexandrov, Andrei V.] Univ Alabama Birmingham, Dept Neurol, Birmingham, AL 35294 USA; [Harrigan, Mark R.] Univ Alabama Birmingham, Dept Neurosurg, Birmingham, AL USA; [Chiu, David] Methodist Hosp, Dept Neurol, Houston, TX 77030 USA; [Klucznik, Richard P.] Methodist Hosp, Dept Radiol, Houston, TX 77030 USA; [Clark, Joni M.] Barrow Neurol Inst, Dept Neurol, Phoenix, AZ 85013 USA; [McDougall, Cameron G.] Barrow Neurol Inst, Dept Neurosurg, Phoenix, AZ 85013 USA; [Johnson, Mark D.] Univ Texas SW Med Ctr Dallas, Dept Neurol, Dallas, TX 75390 USA; [Johnson, Mark D.] Univ Texas SW Med Ctr Dallas, Dept Neurotherapeut, Dallas, TX 75390 USA; [Pride, G. Lee, Jr.] Univ Texas SW Med Ctr Dallas, Dept Radiol, Dallas, TX 75390 USA; [Pride, G. Lee, Jr.] Univ Texas SW Med Ctr Dallas, Dept Neurosurg, Dallas, TX 75390 USA; [Torbey, Michel T.; Zaidat, Osama O.] Med Coll Wisconsin, Dept Neurol, Milwaukee, WI 53226 USA; [Zaidat, Osama O.] Med Coll Wisconsin, Dept Radiol, Milwaukee, WI 53226 USA; [Zaidat, Osama O.] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA; [Cloft, Harry J.] Mayo Clin, Dept Radiol, Rochester, MN USA	Medical University of South Carolina; Medical University of South Carolina; Emory University; Rollins School Public Health; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; The Methodist Hospital System; The Methodist Hospital - Houston; The Methodist Hospital System; The Methodist Hospital - Houston; Barrow Neurological Institute; Barrow Neurological Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Mayo Clinic	Chimowitz, MI (corresponding author), Med Univ S Carolina, Stroke Program, Dept Neurosci, 19 Hagood Ave,Harborview Off Tower,Suite 501, Charleston, SC 29425 USA.	mchimow@musc.edu	Hug, Balthasar L./G-1568-2010; Rumboldt, Zoran/AAA-9893-2019	Rumboldt, Zoran/0000-0001-6833-9762; Gutmann, Laurie/0000-0003-3926-4209; Derdeyn, Colin/0000-0002-5932-2683; Fisher, III, Winfield/0000-0001-5078-8439; Papamitsakis, Nikolaos/0000-0001-9003-3399; Jumaa, Mouhammad/0000-0002-7165-797X; Hsia, Amie/0000-0002-0214-9736; Provencio, Jose Javier/0000-0003-1298-1806; Turan, Tanya/0000-0001-5399-8845; Alexandrov, Andrei V/0000-0001-8871-1023	National Institute of Neurological Disorders and Stroke (NINDS) [U01 NS058728]; National Institutes of Health; Medical University of South Carolina [UL1RR029882]; University of Florida [UL1RR029889]; University of Cincinnati [UL1RR029890]; University of California, San Francisco [UL1RR024131]; AstraZeneca; Stryker Neurovascular (formerly Boston Scientific Neurovascular); SAMMPRIS; National Institute of Neurological Disorders and Stroke [NCT00576693]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024131, TL1RR029889, UL1RR029882, UL1RR029890] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS058728, R01NS067139, K23NS069668] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical University of South Carolina; University of Florida(University of Florida); University of Cincinnati; University of California, San Francisco(University of California System); AstraZeneca(AstraZeneca); Stryker Neurovascular (formerly Boston Scientific Neurovascular); SAMMPRIS; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funded by the National Institute of Neurological Disorders and Stroke and others; SAMMPRIS ClinicalTrials.gov number, NCT00576693.; Supported by a research grant (U01 NS058728) from the National Institute of Neurological Disorders and Stroke (NINDS). In addition, the following institutions received Clinical and Translational Science Awards, funded by the National Institutes of Health, that provided local support for the evaluation of patients in the trial: Medical University of South Carolina (UL1RR029882), University of Florida (UL1RR029889), University of Cincinnati (UL1RR029890), and University of California, San Francisco (UL1RR024131). This research is also supported by the Investigator-Sponsored Study Program of AstraZeneca, which donates rosuvastatin (Crestor) to study patients. Stryker Neurovascular (formerly Boston Scientific Neurovascular) provided study devices and supplemental funding for third-party distribution of devices and continues to provide funding for site monitoring and study auditing, and Nationwide Better Health-INTERVENT provides the lifestyle modification program to the study at a discounted rate. The Regulatory and Clinical Research Institute (Minneapolis) provided assistance in designing the site monitoring processes and performs the site monitoring visits. The Cooperative Studies Program Clinical Research Pharmacy Coordinating Center of the Department of Veterans Affairs (Albuquerque, NM) handles the procurement, labeling, distribution, and inventory management of the study devices and rosuvastatin. Walgreens pharmacies provide study medications, except rosuvastatin, to patients at a discounted price (paid for by the study). The Physician-based Assessment and Counseling for Exercise (PACE) self-assessment forms for physical activity and smoking cessation were provided by the San Diego Center for Health Interventions.; We thank the patients for participating in this study; Drs. Oscar Benavente, Carole White, Robert Hart, Pablo Pergola, and Ana Roldan of the Secondary Prevention of Small Subcortical Strokes trial (SPS3, NCT00059306) for assisting with the development and implementation of the SAMMPRIS blood-pressure management protocol; Drs. George Howard and Thomas Brott for providing advice on study design and other issues on the basis of their experience with the Carotid Revascularization Endarterectomy versus Stenting Trial (CREST, NCT00004732); and Rie Calcaterra for helping with the SAMMPRIS grant application and with launching the trial.	Arenillas JF, 2011, STROKE, V42, pS20, DOI 10.1161/STROKEAHA.110.597278; Bose A, 2007, STROKE, V38, P1531, DOI 10.1161/STROKEAHA.106.477711; Brott TG, 2010, NEW ENGL J MED, V363, P198; Chaturvedi S, 2007, NEUROLOGY, V69, P2063, DOI 10.1212/01.wnl.0000279338.18776.26; Chimowitz MI, 2011, J STROKE CEREBROVASC, V20, P357, DOI 10.1016/j.jstrokecerebrovasdis.2011.05.001; Chimowitz MI, 2005, NEW ENGL J MED, V352, P1305, DOI 10.1056/NEJMoa043033; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Choi JW, 2010, CEREBROVASC DIS, V29, P297, DOI 10.1159/000275508; de Rochemont RD, 2004, RADIOLOGY, V231, P45, DOI 10.1148/radiol.2311030183; Derdeyn CP, 2007, NEUROIMAG CLIN N AM, V17, P303, DOI 10.1016/j.nic.2007.03.001; Famakin BM, 2009, STROKE, V40, P1999, DOI 10.1161/STROKEAHA.108.546150; Fiorella D, 2007, NEUROSURGERY, V61, P236, DOI 10.1227/01.NEU.0000255521.42579.31; Fiorella D, 2007, STROKE, V38, P881, DOI 10.1161/01.STR.0000257963.65728.e8; Gordon NF, 2004, AM J CARDIOL, V94, P1558, DOI 10.1016/j.amjcard.2004.08.039; Gorelick PB, 2008, STROKE, V39, P2396, DOI 10.1161/STROKEAHA.107.505776; Gray WA, 2007, CATHETER CARDIO INTE, V70, P1025, DOI 10.1002/ccd.21359; Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E; Jiang WJ, 2007, NEUROLOGY, V68, P420, DOI 10.1212/01.wnl.0000252939.60764.8e; Kasner SE, 2006, CIRCULATION, V113, P555, DOI 10.1161/CIRCULATIONAHA.105.578229; Kim JK, 2004, J NEUROL NEUROSUR PS, V75, P847, DOI 10.1136/jnnp.2003.019570; Kim Jong S, 2005, J Clin Neurol, V1, P1, DOI 10.3988/jcn.2005.1.1.1; LAN KKG, 1988, BIOMETRICS, V44, P579, DOI 10.2307/2531870; Lee DK, 2005, STROKE, V36, P2583, DOI 10.1161/01.STR.0000189999.19948.14; Levy EI, 2003, J NEUROSURG, V99, P653, DOI 10.3171/jns.2003.99.4.0653; Levy EI, 2007, NEUROSURGERY, V61, P644, DOI 10.1227/01.NEU.0000280023.69511.3A; Lutsep HL, 2004, STROKE, V35, P1388, DOI 10.1161/01.STR.0000128708.86762.d6; Meseguer E, 2010, ANN NEUROL, V68, P9, DOI 10.1002/ana.21921; Rasmussen PA, 2000, J NEUROSURG, V92, P771, DOI 10.3171/jns.2000.92.5.0771; SACCO RL, 1995, STROKE, V26, P14, DOI 10.1161/01.STR.26.1.14; Suh DC, 2008, AM J NEURORADIOL, V29, P781, DOI 10.3174/ajnr.A0922; Topakian R, 2007, EUR J NEUROL, V14, P672, DOI 10.1111/j.1468-1331.2007.01815.x; Turan TN, 2007, CIRCULATION, V115, P2969, DOI 10.1161/CIRCULATIONAHA.106.622464; Turk AS, 2008, AM J NEURORADIOL, V29, P23, DOI 10.3174/ajnr.A0869; Wang X, 2006, J NEUROIMAGING, V16, P266, DOI 10.1111/j.1552-6569.2006.00027.x; Wong KSL, 2010, LANCET NEUROL, V9, P489, DOI 10.1016/S1474-4422(10)70060-0; Wong KS, 2003, STROKE, V34, P2361, DOI 10.1161/01.STR.0000089017.90037.7A; Wong LKS, 2006, INT J STROKE, V1, P158, DOI 10.1111/j.1747-4949.2006.00045.x; Yu SCH, 2011, AM J NEURORADIOL, V32, P753, DOI 10.3174/ajnr.A2363; Zaidat OO, 2008, NEUROLOGY, V70, P1518, DOI 10.1212/01.wnl.0000306308.08229.a3	39	1074	1166	6	96	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 15	2011	365	11					993	1003		10.1056/NEJMoa1105335	http://dx.doi.org/10.1056/NEJMoa1105335			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	819UR	21899409	Green Accepted, Bronze			2022-12-28	WOS:000294857300007
J	Harjutsalo, V; Forsblom, C; Groop, PH				Harjutsalo, Valma; Forsblom, Carol; Groop, Per-Henrik			Time trends in mortality in patients with type 1 diabetes: nationwide population based cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							STAGE RENAL-DISEASE; LONG-TERM MORTALITY; YOUNG-ADULTS; FINNISH CHILDREN; NATURAL-HISTORY; RISK-FACTORS; FOLLOW-UP; CHILDHOOD; ONSET; NEPHROPATHY	Objective To examine short and long term time trends in mortality among patients with early onset (age 0-14 years) and late onset (15-29 years) type 1 diabetes and causes of deaths over time. Design Population based nationwide cohort study. Setting Finland. Participants All Finnish patients diagnosed as having type 1 diabetes below age 30 years between 1970 and 1999 (n=17 306). Main outcome measures Crude mortality, standardised mortality ratios, time trends, and cumulative mortality. Results A total of 1338 deaths occurred during 370 733 person years of follow-up, giving an all cause mortality rate of 361/100 000 person years. The standardised mortality ratio was 3.6 in the early onset cohort and 2.8 in the late onset cohort. Women had higher standardised mortality ratios than did men in both cohorts (5.5 v 3.0 in the early onset cohort; 3.6 v 2.6 in the late onset cohort). The standardised mortality ratio at 20 years' duration of diabetes in the early onset cohort decreased from 3.5 in the patients diagnosed in 1970-4 to 1.9 in those diagnosed in 1985-9. In contrast, the standardised mortality ratio in the late onset cohort increased from 1.4 in those diagnosed in 1970-4 to 2.9 in those diagnosed in 1985-9. Mortality due to chronic complications of diabetes decreased with time in the early onset cohort but not in the late onset cohort. Mortality due to alcohol related and drug related causes increased in the late onset cohort and accounted for 39% of the deaths during the first 20 years of diabetes. Accordingly, mortality due to acute diabetic complications increased significantly in the late onset cohort. Conclusion Survival of people with early onset type 1 diabetes has improved over time, whereas survival of people with late onset type 1 diabetes has deteriorated since the 1980s. Alcohol has become an important cause of death in patients with type 1 diabetes, and the proportion of deaths caused by acute complications of diabetes has increased in patients with late onset type 1 diabetes.	[Harjutsalo, Valma; Forsblom, Carol; Groop, Per-Henrik] Biomedicum Helsinki, Folkhalsan Res Ctr, Folkhalsan Inst Genet, FIN-00014 Helsinki, Finland; [Harjutsalo, Valma; Forsblom, Carol; Groop, Per-Henrik] Univ Helsinki, Cent Hosp, Dept Med, Div Nephrol, Helsinki, Finland; [Harjutsalo, Valma] Natl Inst Hlth & Welf, Diabet Prevent Unit, Helsinki, Finland; [Groop, Per-Henrik] Baker IDI Heart & Diabet Inst, Melbourne, Vic, Australia	Folkhalsan Research Center; University of Helsinki; Helsinki University Central Hospital; Finland National Institute for Health & Welfare; Baker Heart and Diabetes Institute	Harjutsalo, V (corresponding author), Biomedicum Helsinki, Folkhalsan Res Ctr, Folkhalsan Inst Genet, Haartmaninkatu 8,POB 63, FIN-00014 Helsinki, Finland.	valma.harjutsalo@helsinki.fi	Harjutsalo, Valma/AAL-6588-2021	Harjutsalo, Valma/0000-0003-3568-9779	Folkhalsan Research Foundation; Wilhelm and Else Stockmann Foundation; Liv och Halsa Foundation	Folkhalsan Research Foundation; Wilhelm and Else Stockmann Foundation; Liv och Halsa Foundation	This research was supported by grants from the Folkhalsan Research Foundation, Wilhelm and Else Stockmann Foundation, and Liv och Halsa Foundation. The sponsors of the study had no role in the design and conduct of the study or in the collection, management, analysis, and interpretation of the data. The authors are independent from the funders.	Alleman S, 2009, SWISS MED WKLY, V139, P576; ANDERSEN AR, 1983, DIABETOLOGIA, V25, P496; Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069; Asao K, 2003, DIABETES CARE, V26, P2037, DOI 10.2337/diacare.26.7.2037; Astrup AS, 2005, KIDNEY INT, V68, P1250, DOI 10.1111/j.1523-1755.2005.00521.x; Bessaoud K, 2006, DIABETIC MED, V23, P857, DOI 10.1111/j.1464-5491.2006.01925.x; Bruno G, 2009, NUTR METAB CARDIOVAS, V19, P340, DOI 10.1016/j.numecd.2008.03.010; Bryden KS, 2003, DIABETES CARE, V26, P1052, DOI 10.2337/diacare.26.4.1052; Burnet DL, 2007, DIABETES CARE, V30, P2559, DOI 10.2337/dc07-0216; Corrales-Medina VF, 2010, LANCET INFECT DIS, V10, P83, DOI 10.1016/S1473-3099(09)70331-7; Dahlquist G, 2005, DIABETES CARE, V28, P2384, DOI 10.2337/diacare.28.10.2384; Feltbower RG, 2003, DIABETIC MED, V20, P437, DOI 10.1046/j.1464-5491.2003.00960.x; Finne P, 2005, JAMA-J AM MED ASSOC, V294, P1782, DOI 10.1001/jama.294.14.1782; Finnish Diabetes Association DC, 2001, DEV PROGR PREV CAR D; Forssas E, 2003, EUR J PUBLIC HEALTH, V13, P38, DOI 10.1093/eurpub/13.1.38; Fuller-Thomson Esme, 2009, Diabetes Res Clin Pract, V83, pe9, DOI 10.1016/j.diabres.2008.10.004; GOLDSTON DB, 1994, J AM ACAD CHILD PSY, V33, P240, DOI 10.1097/00004583-199402000-00013; Groop PH, 2009, DIABETES, V58, P1651, DOI 10.2337/db08-1543; Harjutsalo V, 2004, DIABETES, V53, P2449, DOI 10.2337/diabetes.53.9.2449; Harjutsalo V, 2011, DIABETOLOGIA, V54, P1992, DOI 10.1007/s00125-011-2144-2; Harjutsalo V, 2008, LANCET, V371, P1777, DOI 10.1016/S0140-6736(08)60765-5; Hovind P, 2003, DIABETES CARE, V26, P1258, DOI 10.2337/diacare.26.4.1258; KROLEWSKI AS, 1985, AM J MED, V78, P785, DOI 10.1016/0002-9343(85)90284-0; Lahti RA., 2005, FINDINGS STAT ASSESS; Laing SP, 2005, DIABETES CARE, V28, P1618, DOI 10.2337/diacare.28.7.1618; Lammi N, 2008, DIABETOLOGIA, V51, P897, DOI 10.1007/s00125-008-0952-9; Lammi N, 2007, DIABETOLOGIA, V50, P1393, DOI 10.1007/s00125-007-0690-4; LAPORTE RE, 1991, DIABETES CARE, V14, P49; Mollsten A, 2010, DIABETES, V59, P1803, DOI 10.2337/db09-1744; Muhlhauser I, 2002, DIABETOLOGIA, V45, P1490, DOI 10.1007/s00125-002-0957-8; Nishimura R, 2001, DIABETES CARE, V24, P823, DOI 10.2337/diacare.24.5.823; Nordwall M, 2004, DIABETOLOGIA, V47, P1266, DOI 10.1007/s00125-004-1431-6; ORCHARD TJ, 1991, DIABETES CARE, V14, P55; Paljarvi T, 2009, ADDICTION, V104, P1168, DOI 10.1111/j.1360-0443.2009.02577.x; Pambianco G, 2006, DIABETES, V55, P1463, DOI 10.2337/db05-1423; Patterson CC, 2007, DIABETOLOGIA, V50, P2439, DOI 10.1007/s00125-007-0824-8; Patterson CC, 2009, LANCET, V373, P2027, DOI 10.1016/S0140-6736(09)60568-7; Radobuljac MD, 2009, PEDIATR DIABETES, V10, P424, DOI 10.1111/j.1399-5448.2009.00501.x; Richardson T, 2005, DIABETES CARE, V28, P1801, DOI 10.2337/diacare.28.7.1801; Roberts SE, 2004, BRIT MED J, V328, P741, DOI 10.1136/bmj.328.7442.741; Skrivarhaug T, 2006, DIABETOLOGIA, V49, P298, DOI 10.1007/s00125-005-0082-6; Tuomilehto J, 1999, DIABETOLOGIA, V42, P655, DOI 10.1007/s001250051212; Waernbaum I, 2006, DIABETOLOGIA, V49, P653, DOI 10.1007/s00125-005-0135-x; Wibell L, 2001, J INTERN MED, V249, P263, DOI 10.1046/j.1365-2796.2001.00802.x	44	103	105	1	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 8	2011	343								d5364	10.1136/bmj.d5364	http://dx.doi.org/10.1136/bmj.d5364			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	819RV	21903695	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000294848300002
J	Kwan, P; Schachter, SC; Brodie, MJ				Kwan, Patrick; Schachter, Steven C.; Brodie, Martin J.			CURRENT CONCEPTS Drug-Resistant Epilepsy	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							MEDICALLY INTRACTABLE EPILEPSY; RANDOMIZED CONTROLLED-TRIAL; TEMPORAL-LOBE EPILEPSY; PARTIAL-ONSET SEIZURES; ANTIEPILEPTIC DRUGS; REFRACTORY EPILEPSY; THERAPEUTIC STRATEGIES; MULTIDRUG-RESISTANCE; ILAE-COMMISSION; GINKGO-BILOBA		[Kwan, Patrick] Prince Wales Hosp, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China; [Kwan, Patrick] Chinese Univ Hong Kong, Dept Med & Therapeut, Div Neurol, Hong Kong, Hong Kong, Peoples R China; [Kwan, Patrick] Royal Melbourne Hosp, Dept Med, Melbourne, Vic, Australia; [Kwan, Patrick] Univ Melbourne, Melbourne, Vic, Australia; [Schachter, Steven C.] Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02215 USA; [Schachter, Steven C.] Harvard Univ, Sch Med, Boston, MA USA; [Schachter, Steven C.] Ctr Integrat Med & Innovat Technol, Boston, MA USA; [Brodie, Martin J.] Univ Glasgow, Western Infirm, Epilepsy Unit, Glasgow G11 6NT, Lanark, Scotland	Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Royal Melbourne Hospital; University of Melbourne; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; University of Glasgow	Kwan, P (corresponding author), Prince Wales Hosp, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China.	patrickkwan@cuhk.edu.hk		Kwan, Patrick/0000-0001-7310-276X	Eisai; GlaxoSmithKline; UCB Pharma; Novartis; Medtronic; Pfizer; Johnson Johnson; Marinus Pharmaceuticals; NeuroTherapeutics Pharma; Sepracor; BrainScope; Cyberonics; Elsevier; Pri-Med	Eisai(Eisai Co Ltd); GlaxoSmithKline(GlaxoSmithKline); UCB Pharma(UCB Pharma SA); Novartis(Novartis); Medtronic(Medtronic); Pfizer(Pfizer); Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); Marinus Pharmaceuticals; NeuroTherapeutics Pharma; Sepracor; BrainScope; Cyberonics; Elsevier; Pri-Med	Dr. Brodie reports receiving consulting fees from Eisai, lecture fees from GlaxoSmithKline, UCB Pharma, Eisai, Novartis, and Medtronic, travel accommodations paid by UCB Pharma, and grant support to his institution from UCB Pharma and Eisai. Dr. Kwan reports receiving consulting fees from Pfizer, lecture fees from Eisai, and travel accommodations paid by UCB Pharma; he also holds a patent related to a rapid HLA typing method (PCT/CN2009/074891), and his institution has received grant support from Eisai, Johnson & Johnson, Pfizer, and UCB Pharma. Dr. Schachter reports receiving consulting fees from Marinus Pharmaceuticals, NeuroTherapeutics Pharma, Sepracor, BrainScope, and Cyberonics, lecture fees from Elsevier and Pri-Med, and payment for serving on a data and safety monitoring board from Quintiles and AXIS Healthcare Communications; he also holds patents related to seizure-detection algorithms and huperzine as a treatment for epilepsy (20100234416, 20060264455, and 20060111644). No other potential conflict of interest relevant to this article was reported.	Anderson WS, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC/2008/25/9/E12; Aronica E, 2003, NEUROSCIENCE, V118, P417, DOI 10.1016/S0306-4522(02)00992-2; Arts WFM, 2004, BRAIN, V127, P1774, DOI 10.1093/brain/awh200; Baltes S, 2007, NEUROPHARMACOLOGY, V52, P333, DOI 10.1016/j.neuropharm.2006.07.038; Banerjee PN, 2009, EPILEPSY RES, V85, P31, DOI 10.1016/j.eplepsyres.2009.03.003; Benifla M, 2006, CHILD NERV SYST, V22, P992, DOI 10.1007/s00381-006-0122-7; Berg AT, 2009, ANN NEUROL, V65, P510, DOI 10.1002/ana.21642; Beyenburg S, 2010, EPILEPSIA, V51, P7, DOI 10.1111/j.1528-1167.2009.02299.x; Bialer M, 2010, NAT REV DRUG DISCOV, V9, P68, DOI 10.1038/nrd2997; Bien CG, 2009, ARCH NEUROL-CHICAGO, V66, P1491, DOI 10.1001/archneurol.2009.283; Birbeck GL, 2002, EPILEPSIA, V43, P535, DOI 10.1046/j.1528-1157.2002.32201.x; Borrelli F, 2009, AAPS J, V11, P710, DOI 10.1208/s12248-009-9146-8; Bournissen FG, 2009, EPILEPSIA, V50, P898, DOI 10.1111/j.1528-1167.2008.01858.x; Brodie MJ, 2010, NEUROLOGY, V75, P1817, DOI 10.1212/WNL.0b013e3181fd6170; Brodie MJ, 1997, EPILEPSY RES, V26, P423, DOI 10.1016/S0920-1211(96)01007-8; CEREGHINO JJ, 1975, CLIN PHARMACOL THER, V18, P733; Chang EF, 2010, NEUROLOGY, V74, P165, DOI 10.1212/WNL.0b013e3181c9185d; Chiron C, 2007, NEUROTHERAPEUTICS, V4, P123, DOI 10.1016/j.nurt.2006.10.001; Choi H, 2008, EPILEPSIA, V49, P1440, DOI 10.1111/j.1528-1167.2008.01601.x; Crespel A, 2005, NEUROLOGY, V65, P762, DOI 10.1212/01.wnl.0000174517.21383.36; Cuadrado A, 2002, EUR J PHARMACOL, V453, P43, DOI 10.1016/S0014-2999(02)02341-5; Dalmau J, 2008, LANCET NEUROL, V7, P1091, DOI 10.1016/S1474-4422(08)70224-2; Deckers CLP, 2000, EPILEPSIA, V41, P1364, DOI 10.1111/j.1528-1157.2000.tb00111.x; Ekstein D, 2010, PHARMACEUTICALS, V3, P1426, DOI 10.3390/ph3051426; Faught E, 2008, NEUROLOGY, V71, P1572, DOI 10.1212/01.wnl.0000319693.10338.b9; Fisher R, 2010, EPILEPSIA, V51, P899, DOI 10.1111/j.1528-1167.2010.02536.x; French J, 2008, NEUROLOGY, V71, P1634, DOI 10.1212/01.wnl.0000336533.19610.1b; Gil-Nagel A, 2009, ACTA NEUROL SCAND, V120, P281, DOI 10.1111/j.1600-0404.2009.01218.x; Glauser T, 2008, NEUROLOGY, V70, P1950, DOI 10.1212/01.wnl.0000303813.95800.0d; Halasz P, 2009, EPILEPSIA, V50, P443, DOI 10.1111/j.1528-1167.2008.01951.x; Kossoff EH, 2008, EPILEPSIA, V49, P37, DOI 10.1111/j.1528-1167.2008.01831.x; Kupiec T, 2005, J ANAL TOXICOL, V29, P755, DOI 10.1093/jat/29.7.755; Kwan P, 2000, NEW ENGL J MED, V342, P314, DOI 10.1056/NEJM200002033420503; Kwan P, 2008, PHARMACOGENET GENOM, V18, P989, DOI 10.1097/FPC.0b013e3283117d67; Kwan P, 2010, EPILEPSIA, V51, P1069, DOI 10.1111/j.1528-1167.2009.02397.x; Lancaster E, 2010, LANCET NEUROL, V9, P67, DOI 10.1016/S1474-4422(09)70324-2; Lawn ND, 2004, NEUROLOGY, V63, P1565, DOI 10.1212/01.WNL.0000142991.14507.B5; Loup F, 2009, BRAIN, V132, P2449, DOI 10.1093/brain/awp178; Luszczki JJ, 2004, EPILEPSIA, V45, P895, DOI 10.1111/j.0013-9580.2004.05104.x; Maehara T, 2001, EPILEPSIA, V42, P67, DOI 10.1046/j.1528-1157.2001.081422.x; McCagh J, 2009, EPILEPSY RES, V86, P1, DOI 10.1016/j.eplepsyres.2009.04.007; McKnight K, 2005, NEUROLOGY, V65, P1730, DOI 10.1212/01.wnl.0000187129.66353.13; Milby AH, 2009, NEUROTHERAPEUTICS, V6, P228, DOI 10.1016/j.nurt.2009.01.010; Mohanraj R, 2006, EUR J NEUROL, V13, P277, DOI 10.1111/j.1468-1331.2006.01215.x; Mohanraj R, 2006, LANCET NEUROL, V5, P481, DOI 10.1016/S1474-4422(06)70448-3; Naegele JR, 2010, NEUROPHARMACOLOGY, V58, P855, DOI 10.1016/j.neuropharm.2010.01.019; Neal EG, 2008, LANCET NEUROL, V7, P500, DOI 10.1016/S1474-4422(08)70092-9; Patsalos PN, 2008, EPILEPSIA, V49, P1239, DOI 10.1111/j.1528-1167.2008.01561.x; Peebles CT, 2000, EPILEPSY BEHAV, V1, P74, DOI 10.1006/ebeh.2000.0031; Picot MC, 2008, EPILEPSIA, V49, P1230, DOI 10.1111/j.1528-1167.2008.01579.x; Pisani F, 1999, EPILEPSIA, V40, P1141, DOI 10.1111/j.1528-1157.1999.tb00832.x; Remy S, 2006, BRAIN, V129, P18, DOI 10.1093/brain/awh682; Remy S, 2003, ANN NEUROL, V53, P469, DOI 10.1002/ana.10473; ROWAN AJ, 1983, ARCH NEUROL-CHICAGO, V40, P797, DOI 10.1001/archneur.1983.04050120047006; Samuels N, 2008, EPILEPSIA, V49, P373, DOI 10.1111/j.1528-1167.2007.01379.x; Sazgar M, 2005, PEDIATR NEUROL, V33, P227, DOI 10.1016/j.pediatrneurol.2005.03.001; Schachter SC, 2009, ENCYCLOPEDIA OF BASIC EPILEPSY RESEARCH, VOLS 1-3, P1450; Schachter SC, 2009, EPILEPSY BEHAV, V16, P3, DOI 10.1016/j.yebeh.2009.06.028; Schiller Y, 2009, ARCH NEUROL-CHICAGO, V66, P1233, DOI 10.1001/archneurol.2009.211; Semah F, 1998, NEUROLOGY, V51, P1256, DOI 10.1212/WNL.51.5.1256; Siddiqui A, 2003, NEW ENGL J MED, V348, P1442, DOI 10.1056/NEJMoa021986; Sillanp M, 2009, BRAIN, V132, P989, DOI 10.1093/brain/awn357; Sisodiya SM, 2002, BRAIN, V125, P22, DOI 10.1093/brain/awf002; Smith D, 1999, QJM-INT J MED, V92, P15, DOI 10.1093/qjmed/92.1.15; Spencer S, 2008, LANCET NEUROL, V7, P525, DOI 10.1016/S1474-4422(08)70109-1; Stephen LJ, 1998, LANCET, V351, P958; Tellez-Zenteno JF, 2005, BRAIN, V128, P1188, DOI 10.1093/brain/awh449; TISHLER DM, 1995, EPILEPSIA, V36, P1, DOI 10.1111/j.1528-1157.1995.tb01657.x; Tomson T, 2008, LANCET NEUROL, V7, P1021, DOI 10.1016/S1474-4422(08)70202-3; Vincent A, 2010, CURR OPIN NEUROL, V23, P144, DOI 10.1097/WCO.0b013e32833735fe; Voss LJ, 2009, EPILEPSIA, V50, P1971, DOI 10.1111/j.1528-1167.2009.02087.x; Wiebe S, 2001, NEW ENGL J MED, V345, P311, DOI 10.1056/NEJM200108023450501; Willmore LJ, 2009, EPILEPSIA, V50, P163, DOI 10.1111/j.1528-1167.2008.01988.x; Yin OQP, 2004, PHARMACOGENETICS, V14, P841, DOI 10.1097/00008571-200412000-00007	75	658	684	9	145	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 8	2011	365	10					919	926		10.1056/NEJMra1004418	http://dx.doi.org/10.1056/NEJMra1004418			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	816JX	21899452				2022-12-28	WOS:000294595600008
J	Wu, T; Mayaffre, H; Kramer, S; Horvatic, M; Berthier, C; Hardy, WN; Liang, RX; Bonn, DA; Julien, MH				Wu, Tao; Mayaffre, Hadrien; Kraemer, Steffen; Horvatic, Mladen; Berthier, Claude; Hardy, W. N.; Liang, Ruixing; Bonn, D. A.; Julien, Marc-Henri			Magnetic-field-induced charge-stripe order in the high-temperature superconductor YBa2Cu3Oy	NATURE			English	Article							QUANTUM OSCILLATIONS; FLUCTUATING STRIPES; FERMI-SURFACE; PSEUDOGAP	Electronic charges introduced in copper-oxide (CuO2) planes generate high-transition-temperature (T-c) superconductivity but, under special circumstances, they can also order into filaments called stripes(1). Whether an underlying tendency towards charge order is present in all copper oxides and whether this has any relationship with superconductivity are, however, two highly controversial issues(2,3). To uncover underlying electronic order, magnetic fields strong enough to destabilize superconductivity can be used. Such experiments, including quantum oscillations(4-6) in YBa2Cu3Oy (an extremely clean copper oxide in which charge order has not until now been observed) have suggested that superconductivity competes with spin, rather than charge, order(7-9). Here we report nuclear magnetic resonance measurements showing that high magnetic fields actually induce charge order, without spin order, in the CuO2 planes of YBa2Cu3Oy. The observed static, unidirectional, modulation of the charge density breaks translational symmetry, thus explaining quantum oscillation results, and we argue that it is most probably the same 4a-periodic modulation as in stripe-ordered copper oxides(1). That it develops only when superconductivity fades away and near the same 1/8 hole doping as in La2-xBaxCuO4 (ref. 1) suggests that charge order, although visibly pinned by CuO chains in YBa2Cu3Oy, is an intrinsic propensity of the superconducting planes of high-T-c copper oxides.	[Wu, Tao; Mayaffre, Hadrien; Kraemer, Steffen; Horvatic, Mladen; Berthier, Claude; Julien, Marc-Henri] CNRS, Lab Natl Champs Magnet Intenses, UPR 3228, UJF,UPS,INSA, F-38042 Grenoble, France; [Hardy, W. N.; Liang, Ruixing; Bonn, D. A.] Univ British Columbia, Dept Phys & Astron, Vancouver, BC V6T 1Z1, Canada; [Hardy, W. N.; Liang, Ruixing; Bonn, D. A.] Canadian Inst Adv Res, Toronto, ON M5G 1Z8, Canada	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of British Columbia; Canadian Institute for Advanced Research (CIFAR)	Julien, MH (corresponding author), CNRS, Lab Natl Champs Magnet Intenses, UPR 3228, UJF,UPS,INSA, F-38042 Grenoble, France.	marc-henri.julien@lncmi.cnrs.fr	Horvatic, Mladen/A-6665-2018; Hardy, Walter Newbold/AAN-7827-2020; Berthier, Claude/D-9686-2011; Julien, Marc-Henri/A-2352-2010	Horvatic, Mladen/0000-0001-7161-0488; Berthier, Claude/0000-0001-6796-0506; Julien, Marc-Henri/0000-0003-2378-3258	Universite Joseph Fourier	Universite Joseph Fourier	We thank C. Proust for discussions and help at several stages of this project, and L. Taillefer and S. Kivelson for discussions. We also thank P. Bourges, P. Carretta, S. Chakraverty, W. Chen, P. Hirschfeld, D. LeBoeuf, A. Millis, M. Norman, B. Ramshaw, S. Sachdev, S. Sanna, M. Takigawa and B. Vignolle for communications. This work was supported by the Universite Joseph Fourier - Grenoble I (pole SMIng) and Euromagnet II.	Ando Y, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.137005; Chang J, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.104525; Coneri F, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.104507; Curro NJ, 2000, PHYS REV LETT, V85, P642, DOI 10.1103/PhysRevLett.85.642; Daou R, 2010, NATURE, V463, P519, DOI 10.1038/nature08716; Doiron-Leyraud N, 2007, NATURE, V447, P565, DOI 10.1038/nature05872; Harrison N, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.206406; Haug D, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.017001; Hinkov V, 2008, SCIENCE, V319, P597, DOI 10.1126/science.1152309; Hunt AW, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.134525; Julien MH, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.144508; Kivelson SA, 1998, NATURE, V393, P550, DOI 10.1038/31177; Laliberte F., 2011, FERMI SURFACE RECONS; Lawler MJ, 2010, NATURE, V466, P347, DOI 10.1038/nature09169; LeBoeuf D, 2007, NATURE, V450, P533, DOI 10.1038/nature06332; LeBoeuf D, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.054506; Lee PA, 2008, REP PROG PHYS, V71, DOI 10.1088/0034-4885/71/1/012501; Millis AJ, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.220503; Ofer R, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.224521; Parker CV, 2010, NATURE, V468, P677, DOI 10.1038/nature09597; Ramshaw BJ, 2011, NAT PHYS, V7, P234, DOI [10.1038/nphys1873, 10.1038/NPHYS1873]; Sachdev S, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.155129; Sebastian SE, 2011, PHILOS T R SOC A, V369, P1687, DOI 10.1098/rsta.2010.0243; Sun K, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.106405; TRANQUADA JM, 1995, NATURE, V375, P561, DOI 10.1038/375561a0; van der Klink JJ, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.094419; Vignolle B., 2011, COHERENT 3 DIMENSION; Vojta M, 2010, EUR PHYS J-SPEC TOP, V188, P49, DOI 10.1140/epjst/e2010-01296-9; Yamani Z, 2004, PHYSICA C, V405, P227, DOI 10.1016/j.physc.2004.02.010	30	588	596	5	236	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 8	2011	477	7363					191	194		10.1038/nature10345	http://dx.doi.org/10.1038/nature10345			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	816MC	21901009	Green Submitted			2022-12-28	WOS:000294603900031
J	Mayrose, I; Zhan, SH; Rothfels, CJ; Magnuson-Ford, K; Barker, MS; Rieseberg, LH; Otto, SP				Mayrose, Itay; Zhan, Shing H.; Rothfels, Carl J.; Magnuson-Ford, Karen; Barker, Michael S.; Rieseberg, Loren H.; Otto, Sarah P.			Recently Formed Polyploid Plants Diversify at Lower Rates	SCIENCE			English	Article							SPECIATION		[Mayrose, Itay; Zhan, Shing H.; Magnuson-Ford, Karen; Rieseberg, Loren H.; Otto, Sarah P.] Univ British Columbia, Biodivers Res Ctr, Vancouver, BC V6T 1Z4, Canada; [Rothfels, Carl J.] Duke Univ, Dept Biol, Durham, NC 27708 USA; [Barker, Michael S.] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA; [Rieseberg, Loren H.] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA	University of British Columbia; Duke University; University of Arizona; Indiana University System; Indiana University Bloomington	Mayrose, I (corresponding author), Tel Aviv Univ, Fac Life Sci, Dept Mol Biol & Ecol Plants, IL-69978 Tel Aviv, Israel.	itaymay@post.tau.ac.il	Otto, Sarah Perin/K-5625-2012; Barker, Mike/AAE-7891-2019; Rieseberg, Loren H/B-3591-2013	Otto, Sarah Perin/0000-0003-3042-0818; Barker, Mike/0000-0001-7173-1319; Rieseberg, Loren H/0000-0002-2712-2417; Rothfels, Carl/0000-0002-6605-1770; Zhan, Shing/0000-0002-6351-8873	Natural Sciences and Engineering Research Council	Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	We thank R. FitzJohn for instrumental help in using diversitree. Funded by Natural Sciences and Engineering Research Council Discovery grants to L. H. R. and S.P.O. Data have been deposited at Dryad (10.5061/dryad.6hf21).	Jiao YN, 2011, NATURE, V473, P97, DOI 10.1038/nature09916; Maddison WP, 2007, SYST BIOL, V56, P701, DOI 10.1080/10635150701607033; Mayrose I, 2010, SYST BIOL, V59, P132, DOI 10.1093/sysbio/syp083; STEBBINS G. L., 1971, Chromosomal evolution in higher plants.; Wood TE, 2009, P NATL ACAD SCI USA, V106, P13875, DOI 10.1073/pnas.0811575106	5	304	316	3	153	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 2	2011	333	6047					1257	1257		10.1126/science.1207205	http://dx.doi.org/10.1126/science.1207205			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	813YM	21852456				2022-12-28	WOS:000294406400044
J	Mariappan, M; Mateja, A; Dobosz, M; Bove, E; Hegde, RS; Keenan, RJ				Mariappan, Malaiyalam; Mateja, Agnieszka; Dobosz, Malgorzata; Bove, Elia; Hegde, Ramanujan S.; Keenan, Robert J.			The mechanism of membrane-associated steps in tail-anchored protein insertion	NATURE			English	Article							ENDOPLASMIC-RETICULUM; TRANSLOCATION; YEAST; COMPLEX; BINDING; MODEL; GET3	Tail-anchored (TA) membrane proteins destined for the endoplasmic reticulum are chaperoned by cytosolic targeting factors that deliver them to a membrane receptor for insertion. Although a basic framework for TA protein recognition is now emerging, the decisive targeting and membrane insertion steps are not understood. Here we reconstitute the TA protein insertion cycle with purified components, present crystal structures of key complexes between these components and perform mutational analyses based on the structures. We show that a committed targeting complex, formed by a TA protein bound to the chaperone ATPase Get3, is initially recruited to the membrane through an interaction with Get2. Once the targeting complex has been recruited, Get1 interacts with Get3 to drive TA protein release in an ATPase-dependent reaction. After releasing its TA protein cargo, the now-vacant Get3 recycles back to the cytosol concomitant with ATP binding. This work provides a detailed structural and mechanistic framework for the minimal TA protein insertion cycle.	[Mateja, Agnieszka; Dobosz, Malgorzata; Bove, Elia; Keenan, Robert J.] Univ Chicago, Dept Biochem & Mol Biol, Gordon Ctr Integrat Sci, Chicago, IL 60637 USA; [Mariappan, Malaiyalam; Hegde, Ramanujan S.] NICHHD, Cell Biol & Metab Program, NIH, Bethesda, MD 20892 USA	University of Chicago; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Keenan, RJ (corresponding author), Univ Chicago, Dept Biochem & Mol Biol, Gordon Ctr Integrat Sci, Room W238,929 E 57th St, Chicago, IL 60637 USA.	hegde.science@gmail.com; bkeenan@uchicago.edu	mariappan, malaiyalam/K-9024-2012	Dobosz-Bartoszek, Malgorzata/0000-0001-7773-596X; Hegde, Ramanujan/0000-0001-8338-852X; Keenan, Robert/0000-0003-1466-0889	US DOE [DE-AC02-06CH11357]; NIH [R01 GM086487]; Camille and Henry Dreyfus Postdoctoral Program in Environmental Chemistry; Edward Mallinckrodt, Jr. Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [ZIAHD008862] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086487] Funding Source: NIH RePORTER	US DOE(United States Department of Energy (DOE)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Camille and Henry Dreyfus Postdoctoral Program in Environmental Chemistry; Edward Mallinckrodt, Jr. Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Data were collected at beamline 21-IDG at the Advanced Photon Source (APS), Argonne National Laboratory, and we thank the beamline staff for support. We thank T. Dever for yeast strains, T. Rapoport for the Sec61 alpha antibody, M. Downing for technical assistance, members of the Hegde, Keenan and E. Perozo labs and D. Freymann for advice, and A. Shiau and S. Shao for discussions and comments on the manuscript. Use of the APS, an Office of Science User Facility operated for the US Department of Energy (DOE) Office of Science by Argonne National Laboratory, was supported by the US DOE under contract no. DE-AC02-06CH11357. This work was supported by the Intramural Research Program of the NIH (to R.S.H.), the Camille and Henry Dreyfus Postdoctoral Program in Environmental Chemistry (to R.J.K. and E.B.), an Edward Mallinckrodt, Jr. Foundation Grant (to R.J.K.) and NIH Grant R01 GM086487 (to R.J.K.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Auld KL, 2006, GENETICS, V174, P215, DOI 10.1534/genetics.106.058362; Beilharz T, 2003, J BIOL CHEM, V278, P8219, DOI 10.1074/jbc.M212725200; Borgese N, 2011, BBA-BIOMEMBRANES, V1808, P937, DOI 10.1016/j.bbamem.2010.07.010; Borgese N, 2010, TRAFFIC, V11, P877, DOI 10.1111/j.1600-0854.2010.01068.x; Bozkurt G, 2009, P NATL ACAD SCI USA, V106, P21131, DOI 10.1073/pnas.0910223106; Brambillasca S, 2005, EMBO J, V24, P2533, DOI 10.1038/sj.emboj.7600730; Brambillasca S, 2006, J CELL BIOL, V175, P767, DOI 10.1083/jcb.200608101; Chang YW, 2010, J BIOL CHEM, V285, P9962, DOI 10.1074/jbc.M109.087098; Chartron JW, 2010, P NATL ACAD SCI USA, V107, P12127, DOI 10.1073/pnas.1006036107; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; DeLano W.L., 2002, PYMOL MOL VIEWER; DESHAIES RJ, 1989, J CELL BIOL, V109, P2653, DOI 10.1083/jcb.109.6.2653; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Favaloro V, 2008, J CELL SCI, V121, P1832, DOI 10.1242/jcs.020321; Favaloro V, 2010, J CELL SCI, V123, P1522, DOI 10.1242/jcs.055970; Fons RD, 2003, J CELL BIOL, V160, P529, DOI 10.1083/jcb.200210095; GORLICH D, 1993, CELL, V75, P615, DOI 10.1016/0092-8674(93)90483-7; HANSEN W, 1986, CELL, V45, P397, DOI 10.1016/0092-8674(86)90325-9; Hu JB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008061; Jonikas MC, 2009, SCIENCE, V323, P1693, DOI 10.1126/science.1167983; Kalbfleisch T, 2007, TRAFFIC, V8, P1687, DOI 10.1111/j.1600-0854.2007.00661.x; Kriechbaumer V, 2009, TRAFFIC, V10, P1753, DOI 10.1111/j.1600-0854.2009.00991.x; Kutay Ulrike, 1993, Trends in Cell Biology, V3, P72, DOI 10.1016/0962-8924(93)90066-A; Leznicki P, 2010, J CELL SCI, V123, P2170, DOI 10.1242/jcs.066738; Mariappan M, 2010, NATURE, V466, P1120, DOI 10.1038/nature09296; Mateja A, 2009, NATURE, V461, P361, DOI 10.1038/nature08319; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; PANZNER S, 1995, CELL, V81, P561, DOI 10.1016/0092-8674(95)90077-2; Renthal R, 2010, CELL MOL LIFE SCI, V67, P1077, DOI 10.1007/s00018-009-0234-9; ROTHBLATT JA, 1986, CELL, V44, P619, DOI 10.1016/0092-8674(86)90271-0; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Schuldiner M, 2008, CELL, V134, P634, DOI 10.1016/j.cell.2008.06.025; Sharma A, 2010, METHODS MOL BIOL, V619, P339, DOI 10.1007/978-1-60327-412-8_20; Sherrill J, 2011, TRAFFIC, V12, P1119, DOI 10.1111/j.1600-0854.2011.01229.x; Stefanovic S, 2007, CELL, V128, P1147, DOI 10.1016/j.cell.2007.01.036; Suloway CJM, 2009, P NATL ACAD SCI USA, V106, P14849, DOI 10.1073/pnas.0907522106; Wang F, 2010, MOL CELL, V40, P159, DOI 10.1016/j.molcel.2010.08.038; Yamagata A, 2010, GENES CELLS, V15, P29, DOI 10.1111/j.1365-2443.2009.01362.x	39	110	111	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 1	2011	477	7362					61	U69		10.1038/nature10362	http://dx.doi.org/10.1038/nature10362			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	813XT	21866104	Green Accepted			2022-12-28	WOS:000294404300030
J	Rosenbaum, L				Rosenbaum, Lisa			The Art of Doing Nothing	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Weill Cornell Med Ctr, New York, NY 10065 USA	Cornell University	Rosenbaum, L (corresponding author), Weill Cornell Med Ctr, New York, NY 10065 USA.							Waber RL, 2008, JAMA-J AM MED ASSOC, V299, P1016, DOI 10.1001/jama.299.9.1016	1	5	5	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 1	2011	365	9					782	785		10.1056/NEJMp1108914	http://dx.doi.org/10.1056/NEJMp1108914			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	813YC	21879895				2022-12-28	WOS:000294405200003
J	Kamerow, D				Kamerow, Douglas			YANKEE DOODLING NIH updates its conflict of interest guidelines	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Kamerow, Douglas] RTI Int, Res Triangle Pk, NC 27709 USA; [Kamerow, Douglas] BMJ, London, England	Research Triangle Institute	Kamerow, D (corresponding author), RTI Int, Res Triangle Pk, NC 27709 USA.	dkamerow@rti.org		Kamerow, Douglas/0000-0001-7000-9957				*DEP HLTH HUM SERV, RESP APPL PROM OBJ R; Kamerow D, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b1835; Lo B, 2009, CONFLICT INTEREST ME; Moses H, 2005, JAMA-J AM MED ASSOC, V294, P1333, DOI 10.1001/jama.294.11.1333; *NIH, 2011, NIH NEWS HHS TIGHT F; Roehr B, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d5447; Tanne JH, 2008, BRIT MED J, V337; THACKER P, 2011, NEW NIH RULES CONFLI	8	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 31	2011	343								d5493	10.1136/bmj.d5493	http://dx.doi.org/10.1136/bmj.d5493			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	816LE	21880680				2022-12-28	WOS:000294600400008
J	Ainsworth, S; Prain, V; Tytler, R				Ainsworth, Shaaron; Prain, Vaughan; Tytler, Russell			Drawing to Learn in Science	SCIENCE			English	Editorial Material							REPRESENTATIONS; STUDENTS; INSTRUCTION; COGNITION; LITERACY; DIAGRAMS; FORMS; TEXT		[Ainsworth, Shaaron] Univ Nottingham, Sch Psychol, Nottingham NG7 2RD, England; [Prain, Vaughan] La Trobe Univ, Fac Educ, Bendigo 3552, Australia; [Tytler, Russell] Deakin Univ, Sch Educ, Waurn Ponds 3217, Australia	University of Nottingham; La Trobe University; Deakin University	Ainsworth, S (corresponding author), Univ Nottingham, Sch Psychol, Univ Pk, Nottingham NG7 2RD, England.	shaaron.ainsworth@nottingham.ac.uk	van Joolingen, Wouter R/A-7148-2011; Ainsworth, Shaaron E/C-1922-2009	van Joolingen, Wouter R/0000-0002-4271-2861; Ainsworth, Shaaron E/0000-0002-9453-7196				Ainsworth S, 2003, COGNITIVE SCI, V27, P669, DOI 10.1016/S0364-0213(03)00033-8; AINSWORTH SE, 2010, P 9 INT C LEARN SCI, V2, P164; Ainsworth S, 2006, LEARN INSTR, V16, P183, DOI 10.1016/j.learninstruc.2006.03.001; Chang HY, 2010, SCI EDUC, V94, P73, DOI 10.1002/sce.20352; CHI MTH, 1989, COGNITIVE SCI, V13, P145, DOI 10.1207/s15516709cog1302_1; Clement JJ, 2008, MODEL MODEL SCI EDUC, V2, P1, DOI 10.1007/978-1-4020-6494-4; Cox R, 1999, LEARN INSTR, V9, P343, DOI 10.1016/S0959-4752(98)00051-6; diSessa AA, 2004, COGNITION INSTRUCT, V22, P293, DOI 10.1207/s1532690xci2203_2; Dove JE, 1999, INT J SCI EDUC, V21, P485, DOI 10.1080/095006999290534; Duschl R. A, 2005, TEACHING SCI INQUIRY; Ehrlen K, 2009, INT J SCI EDUC, V31, P41, DOI 10.1080/09500690701630455; Enyedy N, 2005, COGNITION INSTRUCT, V23, P427, DOI 10.1207/s1532690xci2304_1; Forbus K, 2011, TOP COGN SCI, V3, P648, DOI 10.1111/j.1756-8765.2011.01149.x; Gilbert J.K., 2005, VISUALIZATION SCI ED; Gobert JD, 1999, J RES SCI TEACH, V36, P39, DOI 10.1002/(SICI)1098-2736(199901)36:1<39::AID-TEA4>3.0.CO;2-I; Gooding D. C., 2004, J COGNITION CULTURE, V4, P551, DOI DOI 10.1163/1568537042484896; Greeno JG, 1997, PHI DELTA KAPPAN, V78, P361; Hackling M.W., 2005, PRIMARY CONNECTIONS; Hubber P, 2010, PHYS COMMUNITY COOPE, P45; Hubber P, 2010, RES SCI EDUC, V40, P5, DOI 10.1007/s11165-009-9154-9; Kombartzky U, 2010, LEARN INSTR, V20, P424, DOI 10.1016/j.learninstruc.2009.05.002; Kozma R, 2000, J LEARN SCI, V9, P105, DOI 10.1207/s15327809jls0902_1; Krajcik JS, 2010, SCIENCE, V328, P456, DOI 10.1126/science.1182593; Latour B., 1999, PANDORAS HOPE ESSAYS; Lehrer R, 2006, CAMB HANDB PSYCHOL, P371; Lemke J.L., 2004, CROSSING BORDERS LIT, P33; Linn M.C., 2000, EDUC RESEARCHER, V29, P4, DOI [https://doi.org/10.2307/1176912, DOI 10.2307/1176912]; Lyons T, 2006, INT J SCI EDUC, V28, P591, DOI 10.1080/09500690500339621; Macdonald D, 2009, INT J LEARNING, V16, P319; Nersessian N, 2008, TEACHING SCI INQUIRY, P57; Nkambou R., 2010, ADV INTELLIGENT TUTO, P266; Osborne J., 2008, SCI ED EUROPE CRITIC; Osborne J, 2010, SCIENCE, V328, P463, DOI 10.1126/science.1183944; Pearson PD, 2010, SCIENCE, V328, P459, DOI 10.1126/science.1182595; Scaife M, 1996, INT J HUM-COMPUT ST, V45, P185, DOI 10.1006/ijhc.1996.0048; Schwartz DL, 1995, J LEARN SCI, V4, P321, DOI 10.1207/s15327809jls0403_3; Schwartz DL, 2004, COGNITION INSTRUCT, V22, P129, DOI 10.1207/s1532690xci2202_1; Stern E, 2003, LEARN INSTR, V13, P191, DOI 10.1016/S0959-4752(02)00020-8; Tversky B, 2011, TOP COGN SCI, V3, P499, DOI 10.1111/j.1756-8765.2010.01113.x; Van Meter P, 2005, EDUC PSYCHOL REV, V17, P285, DOI 10.1007/s10648-005-8136-3; ZHANG HZ, 2010, P 9 INT C LEARN SCI, V2, P165	41	346	354	6	110	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 26	2011	333	6046					1096	1097		10.1126/science.1204153	http://dx.doi.org/10.1126/science.1204153			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	811VM	21868658	Green Accepted, Green Submitted			2022-12-28	WOS:000294244300028
J	Krot, AN				Krot, Alexander N.			Bringing Part of an Asteroid Back Home	SCIENCE			English	Editorial Material							ISOTOPIC COMPOSITION; ITOKAWA; WATER; ORIGIN		Univ Hawaii Manoa, Hawaii Inst Geophys & Planetol, Honolulu, HI 96822 USA	University of Hawaii System; University of Hawaii Manoa	Krot, AN (corresponding author), Univ Hawaii Manoa, Hawaii Inst Geophys & Planetol, Honolulu, HI 96822 USA.	sasha@higp.hawaii.edu						Brownlee D, 2006, SCIENCE, V314, P1711, DOI 10.1126/science.1135840; Drake MJ, 2005, METEORIT PLANET SCI, V40, P519, DOI 10.1111/j.1945-5100.2005.tb00960.x; Ebihara M, 2011, SCIENCE, V333, P1119, DOI 10.1126/science.1207865; Krot AN, 2005, TREATISE GEOCHEM, V1, P83; Marty B, 2011, SCIENCE, V332, P1533, DOI 10.1126/science.1204656; McKeegan KD, 2011, SCIENCE, V332, P1528, DOI 10.1126/science.1204636; Mottl MJ, 2007, CHEM ERDE-GEOCHEM, V67, P253, DOI 10.1016/j.chemer.2007.09.002; Nagao K, 2011, SCIENCE, V333, P1128, DOI 10.1126/science.1207785; Nakamura T, 2011, SCIENCE, V333, P1113, DOI 10.1126/science.1207758; Noguchi T, 2011, SCIENCE, V333, P1121, DOI 10.1126/science.1207794; Tsuchiyama A, 2011, SCIENCE, V333, P1125, DOI 10.1126/science.1207807; Yurimoto H, 2011, SCIENCE, V333, P1116, DOI 10.1126/science.1207776; Zolensky ME, 2006, SCIENCE, V314, P1735, DOI 10.1126/science.1135842	14	11	11	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 26	2011	333	6046					1098	1099		10.1126/science.1212145	http://dx.doi.org/10.1126/science.1212145			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811VM	21868659				2022-12-28	WOS:000294244300029
J	Fairchild, AL; Bayer, R				Fairchild, Amy L.; Bayer, Ronald			HIV Surveillance, Public Health, and Clinical Medicine - Will the Walls Come Tumbling Down?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CARE		[Fairchild, Amy L.; Bayer, Ronald] Columbia Univ, Mailman Sch Publ Hlth, Ctr Hist & Eth Publ Hlth, Dept Sociomed Sci, New York, NY 10027 USA	Columbia University	Fairchild, AL (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, Ctr Hist & Eth Publ Hlth, Dept Sociomed Sci, New York, NY 10027 USA.		Fairchild, Amy/F-1811-2018	Fairchild, Amy/0000-0002-1292-7212				COLE J, 2010, 2010 RYAN WHIT GRANT; Gardner EM, 2011, CLIN INFECT DIS, V52, P793, DOI 10.1093/cid/ciq243; Torian LV, 2011, AIDS PATIENT CARE ST, V25, P79, DOI 10.1089/apc.2010.0151; Torian LV, 2011, MEASURING NAS OUTCOM; 2010, HRSA CAREACTION  FEB, P4	5	25	25	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 25	2011	365	8					685	687		10.1056/NEJMp1107294	http://dx.doi.org/10.1056/NEJMp1107294			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	811JM	21864165	Bronze			2022-12-28	WOS:000294205300003
J	Gwilliam, B; Keeley, V; Todd, C; Gittins, M; Roberts, C; Kelly, L; Barclay, S; Stone, PC				Gwilliam, Bridget; Keeley, Vaughan; Todd, Chris; Gittins, Matthew; Roberts, Chris; Kelly, Laura; Barclay, Stephen; Stone, Patrick C.			Development of Prognosis in Palliative care Study (PiPS) predictor models to improve prognostication in advanced cancer: prospective cohort study	BRITISH MEDICAL JOURNAL			English	Article							TERMINALLY-ILL PATIENTS; SURVIVAL PREDICTION; INFORMATION NEEDS; SCORE; VALIDATION; SCALE; PREFERENCES; PHYSICIANS; FAMILIES; WOMEN	Objective To develop a novel prognostic indicator for use in patients with advanced cancer that is significantly better than clinicians' estimates of survival. Design Prospective multicentre observational cohort study. Setting 18 palliative care services in the UK (including hospices, hospital support teams, and community teams). Participants 1018 patients with locally advanced or metastatic cancer, no longer being treated for cancer, and recently referred to palliative care services. Main outcome measures Performance of a composite model to predict whether patients were likely to survive for "days" (0-13 days), "weeks" (14-55 days), or "months+" (>55 days), compared with actual survival and clinicians' predictions. Results On multivariate analysis, 11 core variables (pulse rate, general health status, mental test score, performance status, presence of anorexia, presence of any site of metastatic disease, presence of liver metastases, C reactive protein, white blood count, platelet count, and urea) independently predicted both two week and two month survival. Four variables had prognostic significance only for two week survival (dyspnoea, dysphagia, bone metastases, and alanine transaminase), and eight variables had prognostic significance only for two month survival (primary breast cancer, male genital cancer, tiredness, loss of weight, lymphocyte count, neutrophil count, alkaline phosphatase, and albumin). Separate prognostic models were created for patients without (PiPS-A) or with (PiPS-B) blood results. The area under the curve for all models varied between 0.79 and 0.86. Absolute agreement between actual survival and PiPS predictions was 57.3% (after correction for over-optimism). The median survival across the PiPS-A categories was 5, 33, and 92 days and survival across PiPS-B categories was 7, 32, and 100.5 days. All models performed as well as, or better than, clinicians' estimates of survival. Conclusions In patients with advanced cancer no longer being treated, a combination of clinical and laboratory variables can reliably predict two week and two month survival.	[Gwilliam, Bridget; Stone, Patrick C.] St Georges Univ London, Div Populat Hlth Sci & Educ, London SW17 0RE, England; [Keeley, Vaughan] Royal Derby Hosp, Derby, England; [Todd, Chris] Univ Manchester, Sch Nursing Midwifery & Social Work, Manchester, Lancs, England; [Gittins, Matthew; Roberts, Chris] Univ Manchester, Sch Community Based Med, Manchester, Lancs, England; [Kelly, Laura] Surrey & Sussex Healthcare NHS Trust, E Surrey Hosp, Palliat Care Team, Surrey, England; [Barclay, Stephen] Inst Publ Hlth, Dept Publ Hlth & Primary Care, Gen Practice & Primary Care Res Unit, Cambridge, England	St Georges University London; University of Nottingham; University of Manchester; University of Manchester; East Surrey Hospital; University of Cambridge	Stone, PC (corresponding author), St Georges Univ London, Div Populat Hlth Sci & Educ, London SW17 0RE, England.	pstone@sgul.ac.uk	Todd, Chris/A-7904-2010; Todd, Chris/AAD-8661-2022	Todd, Chris/0000-0001-6645-4505; Todd, Chris/0000-0001-6645-4505; Stone, Patrick/0000-0002-5765-9047; Gittins, Matthew/0000-0002-9888-1197; Barclay, Stephen/0000-0002-4505-7743	Cancer Research UK [C11075/A6126]; Macmillan Cancer Support; NIHR CLAHRC (Collaborations for Leadership in Applied Health Research and Care) for Cambridgeshire and Peterborough	Cancer Research UK(Cancer Research UK); Macmillan Cancer Support; NIHR CLAHRC (Collaborations for Leadership in Applied Health Research and Care) for Cambridgeshire and Peterborough	This study was funded by Cancer Research UK (grant number C11075/A6126). SB is funded by Macmillan Cancer Support and the NIHR CLAHRC (Collaborations for Leadership in Applied Health Research and Care) for Cambridgeshire and Peterborough.	Adams E, 2009, PATIENT EDUC COUNS, V77, P179, DOI 10.1016/j.pec.2009.03.027; Anderson F, 1996, J PALLIAT CARE, V12, P5, DOI 10.1177/082585979601200102; Caraceni A, 2000, CANCER-AM CANCER SOC, V89, P1145, DOI 10.1002/1097-0142(20000901)89:5<1145::AID-CNCR24>3.0.CO;2-X; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; CHEN CH, 1985, STAT MED, V4, P39, DOI 10.1002/sim.4780040107; Christakis NA, 2000, BRIT MED J, V320, P469, DOI 10.1136/bmj.320.7233.469; Chuang RB, 2004, J PAIN SYMPTOM MANAG, V28, P115, DOI 10.1016/j.jpainsymman.2003.11.008; Degner LF, 1997, JAMA-J AM MED ASSOC, V277, P1485, DOI 10.1001/jama.277.18.1485; Ewing G, 2004, PALLIATIVE MED, V18, P452, DOI 10.1191/0269216304pm905oa; Geissbuhler P, 2000, J PAIN SYMPTOM MANAG, V20, P93, DOI 10.1016/S0885-3924(00)00169-X; Glare P, 2003, J PAIN SYMPTOM MANAG, V26, P883, DOI 10.1016/S0885-3924(03)00335-X; Glare P, 2003, BRIT MED J, V327, P195, DOI 10.1136/bmj.327.7408.195; Glare P, 2001, J PAIN SYMPTOM MANAG, V22, P891, DOI 10.1016/S0885-3924(01)00341-4; Glare PA, 2004, J CLIN ONCOL, V22, P4823, DOI 10.1200/JCO.2004.12.056; HARRELL FE, 1982, JAMA-J AM MED ASSOC, V247, P2543, DOI 10.1001/jama.247.18.2543; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; HODKINSON H M, 1972, Age and Ageing, V1, P233, DOI 10.1093/ageing/1.4.233; Kelly L, 2007, ANN ONCOL, V18, P1395, DOI 10.1093/annonc/mdm138; Kirk P, 2004, BMJ-BRIT MED J, V328, P1343, DOI 10.1136/bmj.38103.423576.55; Kutner JS, 1999, SOC SCI MED, V48, P1341, DOI 10.1016/S0277-9536(98)00453-5; Maltoni M, 1999, J PAIN SYMPTOM MANAG, V17, P240, DOI 10.1016/S0885-3924(98)00146-8; Maltoni M, 2005, J CLIN ONCOL, V23, P6240, DOI 10.1200/JCO.2005.06.866; Morita T, 1999, SUPPORT CARE CANCER, V7, P128, DOI 10.1007/s005200050242; Naylor C, 2010, J PAIN SYMPTOM MANAG, V39, P69, DOI 10.1016/j.jpainsymman.2009.05.020; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Pirovano M, 1999, J PAIN SYMPTOM MANAG, V17, P231, DOI 10.1016/S0885-3924(98)00145-6; *PROGN PALL CAR ST, 2011, PIPS PROGN; Roberts C, 2005, STAT METHODS MED RES, V14, P493, DOI 10.1191/0962280205sm413oa; Royston P, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b604; Schumacher M, 1997, STAT MED, V16, P2813, DOI 10.1002/(SICI)1097-0258(19971230)16:24<2813::AID-SIM701>3.0.CO;2-Z; Steinhauser KE, 2001, J PAIN SYMPTOM MANAG, V22, P727, DOI 10.1016/S0885-3924(01)00334-7; STERNE JAC, 2009, BRIT MED J, V338, pD2393; Stevinson C, 2010, PALLIATIVE MED, V24, P462, DOI 10.1177/0269216310368452; Steyerberg E., 2009, CLIN PREDICTION MODE; Stone P, 2008, PALLIATIVE MED, V22, P711, DOI 10.1177/0269216308095200; Stone PC, 2007, ANN ONCOL, V18, P971, DOI 10.1093/annonc/mdl343; Thomas K., 2008, GOLD STANDARDS FRAME; Vigano A, 2000, PALLIATIVE MED, V14, P363, DOI 10.1191/026921600701536192; White C, 2008, SUPPORT CARE CANCER, V16, P1397, DOI 10.1007/s00520-008-0441-1	39	128	128	2	23	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 25	2011	343								d4920	10.1136/bmj.d4920	http://dx.doi.org/10.1136/bmj.d4920			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	813ZQ	21868477	Green Accepted, Green Published, Green Submitted, hybrid			2022-12-28	WOS:000294410400002
J	Ilonidis, S; Zhao, JW; Kosovichev, A				Ilonidis, Stathis; Zhao, Junwei; Kosovichev, Alexander			Detection of Emerging Sunspot Regions in the Solar Interior	SCIENCE			English	Article							TIME-DISTANCE HELIOSEISMOLOGY; MAGNETIC-FLUX; ACTIVE-REGION; FAR-SIDE; SURFACE; DYNAMO; FIELDS; SHEAR	Sunspots are regions where strong magnetic fields emerge from the solar interior and where major eruptive events occur. These energetic events can cause power outages, interrupt telecommunication and navigation services, and pose hazards to astronauts. We detected subsurface signatures of emerging sunspot regions before they appeared on the solar disc. Strong acoustic travel-time anomalies of an order of 12 to 16 seconds were detected as deep as 65,000 kilometers. These anomalies were associated with magnetic structures that emerged with an average speed of 0.3 to 0.6 kilometer per second and caused high peaks in the photospheric magnetic flux rate 1 to 2 days after the detection of the anomalies. Thus, synoptic imaging of subsurface magnetic activity may allow anticipation of large sunspot regions before they become visible, improving space weather forecast.	[Ilonidis, Stathis; Zhao, Junwei; Kosovichev, Alexander] Stanford Univ, WW Hansen Expt Phys Lab, Stanford, CA 94305 USA	Stanford University	Ilonidis, S (corresponding author), Stanford Univ, WW Hansen Expt Phys Lab, Stanford, CA 94305 USA.	ilonidis@sun.stanford.edu	Zhao, Junwei/A-1177-2007	Zhao, Junwei/0000-0002-6308-872X	NASA [NNX09AI90G, NAS5-02139]; Living With A Star-Targeted Research and Technology [NNX07AP61]	NASA(National Aeronautics & Space Administration (NASA)); Living With A Star-Targeted Research and Technology	SOHO is a project of international cooperation between the European Space Agency and NASA. This work was partly supported by NASA contracts NNX09AI90G and NAS5-02139 to Stanford University and by Living With A Star-Targeted Research and Technology grant NNX07AP61. The data used in this work were obtained from http://soi.stanford.edu/data. The authors thank P. Scherrer and T. Duvall for reading the manuscript and providing useful comments. A.K. thanks the International Space Science Institute (Bern) for support.	Birch AC, 2010, ASTROPHYS J LETT, V723, pL190, DOI 10.1088/2041-8205/723/2/L190; Brandenburg A, 2005, ASTROPHYS J, V625, P539, DOI 10.1086/429584; Chang HK, 1999, ASTROPHYS J, V526, pL53, DOI 10.1086/312366; Duvall Jr T.L., 1995, P GONG 94 HEL AST SE, P76; DUVALL TL, 1993, NATURE, V362, P430, DOI 10.1038/362430a0; Fan YH, 2009, LIVING REV SOL PHYS, V6, DOI 10.12942/lrsp-2009-4; Hathaway DH, 2010, LIVING REV SOL PHYS, V7, DOI 10.12942/lrsp-2010-1; Ilonidis S, 2009, SOL PHYS, V258, P181, DOI 10.1007/s11207-009-9428-4; Ilonidis S, 2011, SOL PHYS, V268, P377, DOI 10.1007/s11207-010-9611-7; Jensen JM, 2001, ASTROPHYS J, V553, pL193, DOI 10.1086/320677; Kosovichev AG, 2008, ASTR SOC P, V383, P59; Kosovichev AG, 2009, SPACE SCI REV, V144, P175, DOI 10.1007/s11214-009-9487-8; Kosovichev AG, 2000, SOL PHYS, V192, P159, DOI 10.1023/A:1005251208431; KOSOVICHEV AG, 1996, P SCORE 96 WORKSH SO, P241; Lindsey C, 2005, ASTROPHYS J, V620, P1107, DOI 10.1086/426065; Lindsey C, 2000, SCIENCE, V287, P1799, DOI 10.1126/science.287.5459.1799; Low BC, 2001, J GEOPHYS RES-SPACE, V106, P25141, DOI 10.1029/2000JA004015; Ossendrijver M, 2003, ASTRON ASTROPHYS REV, V11, P287, DOI 10.1007/s00159-003-0019-3; Pipin VV, 2011, ASTROPHYS J LETT, V727, DOI 10.1088/2041-8205/727/2/L45; Scherrer PH, 1995, SOL PHYS, V162, P129, DOI 10.1007/BF00733429; Solanki SK, 2003, ASTRON ASTROPHYS REV, V11, P153, DOI 10.1007/s00159-003-0018-4; Zhao JW, 2007, ASTROPHYS J, V664, pL139, DOI 10.1086/520837; Zhao JW, 2006, ASTROPHYS J, V643, P1317, DOI 10.1086/503248; Zharkov S, 2008, SOL PHYS, V251, P369, DOI 10.1007/s11207-008-9239-z	24	63	66	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 19	2011	333	6045					993	996		10.1126/science.1206253	http://dx.doi.org/10.1126/science.1206253			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808TD	21852494				2022-12-28	WOS:000294000400049
J	Yi, CH; Pan, HL; Seebacher, J; Jang, IH; Hyberts, SG; Heffron, GJ; Vander Heiden, MG; Yang, RL; Li, FP; Locasale, JW; Sharfi, H; Zhai, B; Rodriguez-Mias, R; Luithardt, H; Cantley, LC; Daley, GQ; Asara, JM; Gygi, SP; Wagner, G; Liu, CF; Yuan, JY				Yi, Caroline H.; Pan, Heling; Seebacher, Jan; Jang, Il-Ho; Hyberts, Sven G.; Heffron, Gregory J.; Vander Heiden, Matthew G.; Yang, Renliang; Li, Fupeng; Locasale, Jason W.; Sharfi, Hadar; Zhai, Bo; Rodriguez-Mias, Ricard; Luithardt, Harry; Cantley, Lewis C.; Daley, George Q.; Asara, John M.; Gygi, Steven P.; Wagner, Gerhard; Liu, Chuan-Fa; Yuan, Junying			Metabolic Regulation of Protein N-Alpha-Acetylation by Bcl-xL Promotes Cell Survival	CELL			English	Article							BCL-X(L) PREVENTS; APOPTOSIS; DEATH; CYCLE; (-)-HYDROXYCITRATE; ACCUMULATION; SUBTILISIN; CLONING; SWITCH; YEAST	Previous experiments suggest a connection between the N-alpha-acetylation of proteins and sensitivity of cells to apoptotic signals. Here, we describe a biochemical assay to detect the acetylation status of proteins and demonstrate that protein N-alpha-acetylation is regulated by the availability of acetylCoA. Because the antiapoptotic protein Bcl-xL is known to influence mitochondrial metabolism, we reasoned that Bcl-xL may provide a link between protein N-alpha-acetylation and apoptosis. Indeed, Bcl-xL overexpression leads to a reduction in levels of acetyl-CoA and N-alpha-acetylated proteins in the cell. This effect is independent of Bax and Bak, the known binding partners of Bcl-xL. Increasing cellular levels of acetyl-CoA by addition of acetate or citrate restores protein N-alpha-acetylation in Bcl-xL-expressing cells and confers sensitivity to apoptotic stimuli. We propose that acetyl-CoA serves as a signaling molecule that couples apoptotic sensitivity to metabolism by regulating protein N-alpha-acetylation.	[Yi, Caroline H.; Pan, Heling; Seebacher, Jan; Zhai, Bo; Gygi, Steven P.; Yuan, Junying] Beth Israel Deaconess Med Ctr, Dept Cell Biol, Boston, MA 02115 USA; [Hyberts, Sven G.; Heffron, Gregory J.; Rodriguez-Mias, Ricard; Wagner, Gerhard] Beth Israel Deaconess Med Ctr, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Vander Heiden, Matthew G.; Locasale, Jason W.; Sharfi, Hadar; Cantley, Lewis C.] Beth Israel Deaconess Med Ctr, Dept Syst Biol, Boston, MA 02115 USA; [Jang, Il-Ho; Daley, George Q.] Beth Israel Deaconess Med Ctr, Childrens Hosp Boston, Boston, MA 02115 USA; [Cantley, Lewis C.; Asara, John M.] Beth Israel Deaconess Med Ctr, Div Signal Transduct, Boston, MA 02115 USA; [Cantley, Lewis C.; Asara, John M.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Vander Heiden, Matthew G.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; [Vander Heiden, Matthew G.] MIT, Koch Inst, Cambridge, MA 02142 USA; [Yang, Renliang; Li, Fupeng; Liu, Chuan-Fa] Nanyang Technol Univ, Sch Biol Sci, Div Chem Biol & Biotechnol, Singapore 637551, Singapore; [Luithardt, Harry] Solut Labs, Cambridge, MA 02139 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Boston Children's Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Massachusetts Institute of Technology (MIT); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Yuan, JY (corresponding author), Beth Israel Deaconess Med Ctr, Dept Cell Biol, Boston, MA 02115 USA.	jyuan@hms.harvard.edu	Locasale, Jason W/ABE-6505-2020; Cantley, Lewis C/D-1800-2014; Liu, Chuan Fa/A-2190-2011	Locasale, Jason W/0000-0002-7766-3502; Cantley, Lewis C/0000-0002-1298-7653; Liu, Chuan Fa/0000-0001-7433-2081; Jang, Il Ho/0000-0002-0820-3035	U.S. Army [DAMD17-02-1-0403]; National Institute of Aging [R37-012859]; National Institutes of Health (NIH) [DK070299, GM47467, 5P01CA120964-03]; National Institute of Neurological Disorders and Stroke [1F31NS057872-01]; NATIONAL CANCER INSTITUTE [P01CA120964] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R33DK070299, R21DK070299] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM047467] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS057872] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG012859] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000580] Funding Source: NIH RePORTER	U.S. Army(United States Department of DefenseUnited States Army); National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We are indebted to Alfred Goldberg, Tom Rapoport, Andrew Steele, Marta Lipinski, and Benedicte Py for critical reading of the manuscript, to Pere Puigserver, Harvey Lodish, Kristin White, and Danny Chou for helpful discussions, and to Xuemei Yang for help in acquiring mass spectrometry metabolomics data. We thank Thomas Arnesen and Johan Lillehaug (University of Bergen) for anti-NATH and for help in designing caspase-2 N-alpha-acetylation mutants. We also thank Tullia Lindsten and Craig Thompson (University of Pennsylvania) for providing anti-Bcl-xL as well as Bcl-xL<SUP>+/+</SUP> and Bcl-xL<SUP>-/-</SUP> MEFs. VSV-RAIDD and Bcl-xL mutant constructs were generously provided by Jurg Tschopp (University of Lausanne) and Emily Cheng (Washington University), respectively. This work was supported in part by an Innovator's Award from the U.S. Army Breast Cancer Research Program (grant DAMD17-02-1-0403), a grant from the National Institute of Aging (R37-012859) and a National Institutes of Health (NIH) Director's Pioneer Award to J.Y., NIH grants (DK070299 and GM47467) to G. W., a NIH grant (5P01CA120964-03) to J.M.A., and a Kirchstein National Research Service Award from the National Institute of Neurological Disorders and Stroke (grant 1F31NS057872-01) to C.H.Y.	ABRAHMSEN L, 1991, BIOCHEMISTRY-US, V30, P4151, DOI 10.1021/bi00231a007; Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; Ametzazurra A, 2008, ONCOGENE, V27, P7296, DOI 10.1038/onc.2008.332; Arnesen T, 2009, P NATL ACAD SCI USA, V106, P8157, DOI 10.1073/pnas.0901931106; Arnesen T, 2008, CURR CANCER DRUG TAR, V8, P545, DOI 10.2174/156800908786241113; Bajad SU, 2006, J CHROMATOGR A, V1125, P76, DOI 10.1016/j.chroma.2006.05.019; BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N; Cheng EHY, 1996, NATURE, V379, P554, DOI 10.1038/379554a0; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; Duan H, 1997, NATURE, V385, P86, DOI 10.1038/385086a0; EVAN GI, 1992, CELL, V69, P119, DOI 10.1016/0092-8674(92)90123-T; Gnoni GV, 2009, IUBMB LIFE, V61, P987, DOI 10.1002/iub.249; Goetze S, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000236; Gottlieb E, 2000, MOL CELL BIOL, V20, P5680, DOI 10.1128/MCB.20.15.5680-5689.2000; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Heiden MGV, 2001, J BIOL CHEM, V276, P19414, DOI 10.1074/jbc.M101590200; Hsu JL, 2003, ANAL CHEM, V75, P6843, DOI 10.1021/ac0348625; KAPLAN RS, 1993, J BIOL CHEM, V268, P13682; Khidekel N, 2007, NAT CHEM BIOL, V3, P339, DOI 10.1038/nchembio881; Lu W, 2008, J CHROMATOGR B, V871, P236, DOI 10.1016/j.jchromb.2008.04.031; Mahrus S, 2008, CELL, V134, P866, DOI 10.1016/j.cell.2008.08.012; MARTIN H, 1993, FEBS LETT, V331, P296, DOI 10.1016/0014-5793(93)80356-Y; Martinez A, 2008, PROTEOMICS, V8, P2809, DOI 10.1002/pmic.200701191; Morrish F, 2009, ONCOGENE, V28, P2485, DOI 10.1038/onc.2009.112; Nutt LK, 2009, DEV CELL, V16, P856, DOI 10.1016/j.devcel.2009.04.005; Nutt LK, 2005, CELL, V123, P89, DOI 10.1016/j.cell.2005.07.032; Polevoda B, 2003, BIOCHEM BIOPH RES CO, V308, P1, DOI 10.1016/S0006-291X(03)01316-0; Schafer ZT, 2009, NATURE, V461, P109, DOI 10.1038/nature08268; Shimizu S, 1999, NATURE, V399, P483, DOI 10.1038/20959; Starheim KK, 2008, BIOCHEM J, V415, P325, DOI 10.1042/BJ20080658; Starheim Kristian K, 2009, BMC Proc, V3 Suppl 6, pS3, DOI 10.1186/1753-6561-3-S6-S3; SULLIVAN AC, 1974, LIPIDS, V9, P129, DOI 10.1007/BF02532137; SULLIVAN AC, 1974, LIPIDS, V9, P121, DOI 10.1007/BF02532136; Takahashi H, 2006, MOL CELL, V23, P207, DOI 10.1016/j.molcel.2006.05.040; Tan XH, 2007, CHEMBIOCHEM, V8, P1512, DOI 10.1002/cbic.200700284; Tinel A, 2004, SCIENCE, V304, P843, DOI 10.1126/science.1095432; Vander Heiden MG, 1999, MOL CELL, V3, P159; Vaughn AE, 2008, NAT CELL BIOL, V10, P1477, DOI 10.1038/ncb1807; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097; WELLS JA, 1983, NUCLEIC ACIDS RES, V11, P7911, DOI 10.1093/nar/11.22.7911; WHITEWAY M, 1985, CELL, V43, P483, DOI 10.1016/0092-8674(85)90178-3; Yi CH, 2007, J CELL BIOL, V179, P619, DOI 10.1083/jcb.200708090; Yoshihara HAI, 2008, BIOORG MED CHEM LETT, V18, P6000, DOI 10.1016/j.bmcl.2008.08.044	43	142	145	1	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 19	2011	146	4					607	620		10.1016/j.cell.2011.06.050	http://dx.doi.org/10.1016/j.cell.2011.06.050			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	809HY	21854985	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000294043600015
J	Fuchs, VR				Fuchs, Victor R.			The Doctor's Dilemma - What Is "Appropriate" Care?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Stanford Univ, Stanford, CA 94305 USA	Stanford University	Fuchs, VR (corresponding author), Stanford Univ, Stanford, CA 94305 USA.							Kant I., 1949, CRITIQUE PRACTICAL R; WEISBROD BA, 1991, J ECON LIT, V29, P523	2	29	30	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 18	2011	365	7					585	587		10.1056/NEJMp1107283	http://dx.doi.org/10.1056/NEJMp1107283			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	808ER	21848458				2022-12-28	WOS:000293960500003
J	Lallemant, M; Chang, S; Cohen, R; Pecoul, B				Lallemant, Marc; Chang, Shing; Cohen, Rachel; Pecoul, Bernard			GLOBAL HEALTH Pediatric HIV - A Neglected Disease?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Lallemant, Marc; Chang, Shing; Pecoul, Bernard] Drugs Neglected Dis initiat, Geneva, Switzerland; [Cohen, Rachel] Drugs Neglected Dis initiat, New York, NY USA; [Lallemant, Marc] Inst Rech Dev, Program HIV Prevent, Chiang Mai, Thailand; [Lallemant, Marc] Inst Rech Dev, Program HIV Treatment, Chiang Mai, Thailand	Institut de Recherche pour le Developpement (IRD); Institut de Recherche pour le Developpement (IRD)	Lallemant, M (corresponding author), Drugs Neglected Dis initiat, Geneva, Switzerland.							Coovadia A, 2010, JAMA-J AM MED ASSOC, V304, P1082, DOI 10.1001/jama.2010.1278; *NAT I ALL INF DIS, 2011, TREAT HIV INF PEOPL; Palumbo P, 2011, 18 C RETR OPP INF BO; Violari A, 2008, NEW ENGL J MED, V359, P2233, DOI 10.1056/NEJMoa0800971; World Health Organization, 2010, ANT THER HIV INF INF	5	36	36	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 18	2011	365	7					581	583		10.1056/NEJMp1107275	http://dx.doi.org/10.1056/NEJMp1107275			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	808ER	21848457				2022-12-28	WOS:000293960500001
J	Hoyle, E				Hoyle, Ewan			PERSONAL VIEW It's time for the UK government to fully review drug policy	BRITISH MEDICAL JOURNAL			English	Editorial Material												ewanhoyle@gmail.com							0	1	1	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 17	2011	343								d5235	10.1136/bmj.d5235	http://dx.doi.org/10.1136/bmj.d5235			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	811LB	21849391				2022-12-28	WOS:000294210500006
